PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tittarelli, A; Janji, B; Van Moer, K; Noman, MZ; Chouaib, S				Tittarelli, Andres; Janji, Bassam; Van Moer, Kris; Noman, Muhammad Zaeem; Chouaib, Salem			The Selective Degradation of Synaptic Connexin 43 Protein by Hypoxia-induced Autophagy Impairs Natural Killer Cell-mediated Tumor Cell Killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTIONS; INTERCELLULAR COMMUNICATION; MELANOMA; SUSCEPTIBILITY; APOPTOSIS; CX43	Although natural killer (NK) cells play an important role in the control of melanoma, hypoxic stress in the tumor microenvironment may impair NK-mediated tumor cell killing by mechanisms that are not fully understood. In this study, we investigated the effect of hypoxia on the expression and channel activity of connexin 43 (Cx43) in melanoma cells and its impact on their susceptibility to NK cell-mediated lysis. Our results demonstrated that hypoxic stress increases Cx43 expression in melanoma cells via hypoxia-inducible factor-1 alpha (HIF-1 alpha) transcriptional activity. Hypoxic cells displaying increased Cx43 expression were less susceptible to NK cell-mediated lysis compared with normoxic cells expressing a moderate level of Cx43. Conversely, when overexpressed in normoxic tumor cells, Cx43 improves their susceptibility to N cell-mediated killing. We show that the NK cell immune synapse formed with normoxic melanoma cells is more stable and contains a high level of gap-junctional Cx43 whereas that formed with hypoxic cells is less stable and contains a significant lower level of gap-junctional Cx43. We provide evidence that the activation of autophagy in hypoxic melanoma cells selectively degrades gap-junctional Cx43, leading to the destabilization of the immune synapse and the impairment of NK cell-mediated killing. Inhibition of autophagy by genetic or pharmacological approaches as well as expression of the non-degradable form of Cx43 significantly restore its accumulation at the immune synapse and improves N cell-mediated lysis of hypoxic melanoma cells. This study provides the first evidence that the hypoxic microenvironment negatively affects the immune surveillance of tumors by NK cells through the modulation of Cx43-mediated intercellular communications.	[Tittarelli, Andres; Noman, Muhammad Zaeem; Chouaib, Salem] INSERM U753, F-94805 Villejuif, France; [Janji, Bassam; Van Moer, Kris] Luxembourg Inst Hlth, Lab Expt Canc Res, Dept Oncol, L-1526 Luxembourg, Luxembourg	Institut National de la Sante et de la Recherche Medicale (Inserm); Luxembourg Institute of Health	Chouaib, S (corresponding author), INSERM U753, Gustave Roussy Canc Campus, F-94805 Villejuif, France.	salem.chouaib@gustaveroussy.fr	Chouaib, Salem/F-7939-2016; Tittarelli, Andrés/AAH-6601-2020; NOMAN, Muhammmad Zaeem/AAJ-1466-2021; NOMAN, Muhammmad Zaeem/AAJ-1465-2021; Tittarelli, Andres/AAO-9851-2020; Noman, Muhammad zaeem/AAF-8483-2020	NOMAN, Muhammmad Zaeem/0000-0002-1837-3097; NOMAN, Muhammmad Zaeem/0000-0002-1837-3097; JANJI, Bassam/0000-0002-9763-0943	"Equipe labellisee Ligue Contre le Cancer", European Union Seventh Framework Program (European Project RBUCE-UP) [246556]; INSERM; Universite Paris-Sud; Luxembourg Institute for Health Grant [LHCE-2013-1105]; Fondation Cancer Luxembourg Grant [FC/2012/02]	"Equipe labellisee Ligue Contre le Cancer", European Union Seventh Framework Program (European Project RBUCE-UP); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Sud; Luxembourg Institute for Health Grant; Fondation Cancer Luxembourg Grant	This project was supported by a grant "Equipe labellisee Ligue Contre le Cancer," European Union Seventh Framework Program Grant FP7/2007-2013 under grant agreement 246556 (European Project RBUCE-UP) and by grants from INSERM and the Universite Paris-Sud, by Luxembourg Institute for Health Grant LHCE-2013-1105, and by Fondation Cancer Luxembourg Grant FC/2012/02. The authors declare that they have no conflicts of interest with the contents of this article.	Baginska J, 2013, P NATL ACAD SCI USA, V110, P17450, DOI 10.1073/pnas.1304790110; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Benlalam H, 2013, J MOL MED, V91, P1207, DOI 10.1007/s00109-013-1058-5; Bhaskaracharya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093058; Burke S, 2010, TRENDS IMMUNOL, V31, P339, DOI 10.1016/j.it.2010.06.003; CALLEWAERT DM, 1991, CYTOMETRY, V12, P666, DOI 10.1002/cyto.990120711; Carette D, 2014, BIOCHIMIE, V101, P1, DOI 10.1016/j.biochi.2013.11.015; Catarino S, 2011, BIOCHEM J, V437, P255, DOI 10.1042/BJ20102059; Chen J, 2002, J APPL PHYSIOL, V92, P1480, DOI 10.1152/japplphysiol.00077.2001; Chouaib S, 2014, CRIT REV IMMUNOL, V34, P91, DOI 10.1615/CritRevImmunol.2014010183; Conklin CMJ, 2007, CARCINOGENESIS, V28, P93, DOI 10.1093/carcin/bgl106; Dufour E, 1997, J IMMUNOL, V158, P3787; Elgueta R, 2009, J IMMUNOL, V183, P277, DOI 10.4049/jimmunol.0801854; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; Haass NK, 2004, J MOL HISTOL, V35, P309; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Le HT, 2014, J BIOL CHEM, V289, P1345, DOI 10.1074/jbc.M113.508390; Liu H, 2013, SEMIN CANCER BIOL, V23, P352, DOI 10.1016/j.semcancer.2013.06.008; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Mace EM, 2014, IMMUNOL CELL BIOL, V92, P245, DOI 10.1038/icb.2013.96; Machtaler S, 2011, J CELL SCI, V124, P2611, DOI 10.1242/jcs.089532; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Mendoza-Naranjo A, 2011, J IMMUNOL, V187, P3121, DOI 10.4049/jimmunol.1100378; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Noman MZ, 2011, CANCER RES, V71, P5976, DOI 10.1158/0008-5472.CAN-11-1094; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PUIG S, 1995, AM J HUM GENET, V57, P395; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Saccheri F, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000739; Sceneay J, 2012, CANCER RES, V72, P3906, DOI 10.1158/0008-5472.CAN-11-3873; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Siemens DR, 2008, CANCER RES, V68, P4746, DOI 10.1158/0008-5472.CAN-08-0054; Sirnes S, 2012, INT J CANCER, V131, P570, DOI 10.1002/ijc.26392; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Tittarelli A, 2014, J IMMUNOL, V192, P1313, DOI 10.4049/jimmunol.1301297; Tran K, 2013, J IMMUNOL, V190; Waza AA, 2014, CELL SIGNAL, V26, P1909, DOI 10.1016/j.cellsig.2014.05.002	44	68	69	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23670	23679		10.1074/jbc.M115.651547	http://dx.doi.org/10.1074/jbc.M115.651547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26221040	Green Published, hybrid			2022-12-26	WOS:000361816500017
J	Deng, G; Zheng, XD; Zhou, J; Wei, HM; Tian, ZG; Sun, R				Deng, Gang; Zheng, Xiaodong; Zhou, Jing; Wei, Haiming; Tian, Zhigang; Sun, Rui			Generation and Preclinical Characterization of an NKp80-Fc Fusion Protein for Redirected Cytolysis of Natural Killer (NK) Cells against Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELLS; ACTIVATION; RECEPTORS; CYTOTOXICITY; INDUCTION; ANTIBODY	The capacity of natural killer (NK) cells to mediate Fc receptor-dependent effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), largely contributes to their clinical application. Given that activation-induced C-type lectin (AICL), an identified ligand for the NK-activating receptor NKp80, is frequently highly expressed on leukemia cells, the lack of therapeutic AICL-specific antibodies limits clinical application. Here we explore a strategy to reinforce NK anti-leukemia reactivity by combining targeting AICL-expressing leukemia cells with the induction of NK cell ADCC using NKp80-Fc fusion proteins. The NKp80-Fc fusion protein we generated bound specifically to leukemia cells in an AICL-specific manner. Cell binding assays between NK and leukemia cells showed that NKp80-Fc significantly increased NK target cell conjugation. In functional analyses, treatment with NKp80-Fc clearly induced the ADCC effect of NK cells. NKp80-Fc not only promoted NK-mediated leukemia cell apoptosis in the early stage of cell conjugation but also enhanced NK cell degranulation and cytotoxicity activity in the late stage. The bifunctional NKp80-Fc could redirect NK cells toward leukemia cells and triggered NK cell killing in vitro. Moreover, NKp80-Fc enhanced the lysis of NK cells against tumors in leukemia xenograft non-obese diabetic/severe combined immunodeficiency mice. Taken together, our results demonstrate that NKp80-Fc potently amplifies NK cell anti-leukemia effects in vitro and in vivo through induction of the NK cell ADCC effect. This method could potentially be useful for molecular targeted therapy, and the fusion proteins may be a promising drug for immunotherapy of leukemia.	[Deng, Gang; Zheng, Xiaodong; Zhou, Jing; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Inst Immunol, Hefei 230027, Anhui, Peoples R China; [Deng, Gang; Zheng, Xiaodong; Zhou, Jing; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Key Lab Innate Immun & Chron Dis, Hefei 230027, Anhui, Peoples R China; [Deng, Gang; Zheng, Xiaodong; Zhou, Jing; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China; [Sun, Rui] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Wei, Haiming; Tian, Zhigang; Sun, Rui] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Xiamen University	Zheng, XD (corresponding author), Univ Sci & Technol China, Inst Immunol, Hefei 230027, Anhui, Peoples R China.	zhxdd@ustc.edu.cn; sunr@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Zheng, Xiaodong/N-2830-2013		Ministry of Science and Technology of China [2013CB530506]; Natural Science Foundation of China [91029303]; National Science and Technology Major Project [2012ZX10002014, 2012ZX10002006]; National High Technology Research and Development Program [2012AA020901]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; National High Technology Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by Ministry of Science and Technology of China Grant 2013CB530506, Natural Science Foundation of China Grant 91029303, National Science and Technology Major Project Grants 2012ZX10002014 and 2012ZX10002006, and National High Technology Research and Development Program Grant 2012AA020901. The authors declare that they have no conflicts of interest with the contents of this article.	Akatsuka A, 2010, INT IMMUNOL, V22, P783, DOI 10.1093/intimm/dxq430; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Cremer I, 2012, ONCOIMMUNOLOGY, V1, P244, DOI 10.4161/onci.1.2.18309; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; Feldman EJ, 2005, J CLIN ONCOL, V23, P4110, DOI 10.1200/JCO.2005.09.133; Keating GM, 2010, DRUGS, V70, P1445, DOI 10.2165/11201110-000000000-00000; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Marras F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/152430; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Owen C, 2012, EXPERT OPIN BIOL TH, V12, P343, DOI 10.1517/14712598.2012.657622; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Steinbacher J, 2015, INT J CANCER, V136, P1073, DOI 10.1002/ijc.29083; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	20	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22474	22484		10.1074/jbc.M115.678912	http://dx.doi.org/10.1074/jbc.M115.678912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26198633	hybrid, Green Published			2022-12-26	WOS:000361171500015
J	Futro, A; Maslowska, K; Dwyer, CM				Futro, Agnieszka; Maslowska, Katarzyna; Dwyer, Cathy M.			Ewes Direct Most Maternal Attention towards Lambs that Show the Greatest Pain-Related Behavioural Responses	PLOS ONE			English	Article							REPEATED NEONATAL PAIN; RUBBER RING METHOD; TAIL DOCKING; INFANT RATS; CASTRATION; SENSITIVITY; EXPRESSION; ANALGESIA; DISTRESS; STRESS	Although neonatal farm animals are frequently subjected to painful management procedures, the role of maternal behaviour in pain coping, has not been much studied. We investigated whether ewes were able to distinguish between lambs in pain and those that were not, and whether their behaviour altered depending on the severity of lamb pain. Eighty male lambs were allocated to one of 4 pain treatments within 24 hours of birth. Lambs were either handled only (C), bilaterally castrated with tight rubber rings (RR), as for RR but with the application of a Burdizzo clamp immediately proximal to the ring (Combined) or subjected to short scrotum castration (SSC) where the testicles were retained within the abdomen and only the scrotum removed. The behaviour of the ewe, treated lamb and untreated sibling where present (n = 54) were recorded for 30 minutes after treatment. Castration treatment increased the expression of abnormal standing and lying postures, specific pain-related behaviours (head-turning, stamping/kicking, easing quarters, tail wagging) and composite pain scores (P<0.001 for all). The greatest expression of pain-related behaviours was shown by lambs in the RR group, which were the only group to show rolling responses indicative of severe pain, followed by the SSC group. Ewes expressed more licking/sniffing responses to the RR and SSC lambs than towards the Combined and C lambs (P<0.05), and oriented most to RR lambs and least to C lambs (P<0.001). Ewes with two lambs also directed more attention towards the treated than the untreated lamb (P<0.001). The quantity of maternal care directed towards the lamb was positively correlated with the expression of active pain behaviours. The data demonstrate that ewes are able to discriminate between lambs in pain and those that are not, and that their response is increased with a greater severity of pain.	[Futro, Agnieszka; Maslowska, Katarzyna] Univ Edinburgh, Royal Dick Sch Vet Med, Edinburgh, Midlothian, Scotland; [Futro, Agnieszka; Maslowska, Katarzyna; Dwyer, Cathy M.] SRUC, Edinburgh, Midlothian, Scotland	University of Edinburgh	Dwyer, CM (corresponding author), SRUC, Edinburgh, Midlothian, Scotland.	cathy.dwyer@sruc.ac.uk		Dwyer, Cathy/0000-0001-7511-2056	Scottish Government	Scottish Government	Animals and experimental materials and CD were supported by the Scottish Government as part of a Strategic Programme grant 2011-2016 to SRUC. AF and KM are postgradaute students at University of Edinburgh who worked on the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anseloni V, 2004, PAIN, V109, P507, DOI 10.1016/j.pain.2004.02.031; Archer N, 2004, ANIM WELFARE, V13, P135; BLASS EM, 1995, BEHAV NEUROSCI, V109, P342, DOI 10.1037/0735-7044.109.2.342; Blass EM, 1999, PAIN, V83, P611, DOI 10.1016/S0304-3959(99)00166-9; Chung EKY, 2007, BRAIN RES, V1153, P68, DOI 10.1016/j.brainres.2007.03.047; Clark C, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0273; Colditz IG, 2012, APPL ANIM BEHAV SCI, V136, P136, DOI 10.1016/j.applanim.2011.12.011; de Medeiros CB, 2009, PEDIATR RES, V66, P272, DOI 10.1203/PDR.0b013e3181b1be06; Dwyer CM, 2014, ANIMAL, V8, P102, DOI 10.1017/S1751731113001614; Farm Animal Welfare Council, 2008, FAWC REP IMOL CASTR; Gray L, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e14; Guesgen MJ, 2014, APPL ANIM BEHAV SCI, V159, P41, DOI 10.1016/j.applanim.2014.07.008; Hild S, 2011, APPL ANIM BEHAV SCI, V132, P114, DOI 10.1016/j.applanim.2011.04.003; Hild S, 2010, SMALL RUMINANT RES, V90, P142, DOI 10.1016/j.smallrumres.2009.12.008; Jewell PA, 1997, J ZOOL, V243, P623, DOI 10.1111/j.1469-7998.1997.tb02806.x; Johnston C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008435.pub2; KEMP JD, 1970, J ANIM SCI, V30, P348, DOI 10.2527/jas1970.303348x; Kent JE, 2001, VET J, V162, P250, DOI 10.1053/tvjl.2001.0598; Landa L, 2003, ACTA VET BRNO, V72, P175, DOI 10.2754/avb200372020175; Melches S, 2007, VET J, V173, P554, DOI 10.1016/j.tvjl.2006.01.006; Mellema SC, 2006, VET J, V172, P274, DOI 10.1016/j.tvjl.2005.06.002; MOLONY V, 1993, RES VET SCI, V55, P236, DOI 10.1016/0034-5288(93)90087-V; Molony V, 2002, APPL ANIM BEHAV SCI, V76, P215, DOI 10.1016/S0168-1591(02)00014-X; Molony V, 1997, J ANIM SCI, V75, P266; MOLONY V., 2007, DIS SHEEP, P27; Molony V, 2012, VET J, V193, P81, DOI 10.1016/j.tvjl.2011.09.030; Pickup HE, 2011, APPL ANIM BEHAV SCI, V132, P33, DOI 10.1016/j.applanim.2011.03.010; PORTER RH, 1995, APPL ANIM BEHAV SCI, V45, P239, DOI 10.1016/0168-1591(95)00630-B; Price J, 2001, VET REC, V149, P321, DOI 10.1136/vr.149.11.321; Rand JS, 2002, ANIM WELFARE, V11, P395; Ren K, 1997, P NATL ACAD SCI USA, V94, P1471, DOI 10.1073/pnas.94.4.1471; Walker CD, 2003, DEV BRAIN RES, V140, P253, DOI 10.1016/S0165-3806(02)00611-9; Walker CD, 2008, PAIN, V140, P167, DOI 10.1016/j.pain.2008.08.004; Walker CD, 2010, DEV PSYCHOBIOL, V52, P638, DOI 10.1002/dev.20492; Weaver SA, 2007, J PAIN, V8, P962, DOI 10.1016/j.jpain.2007.07.001	35	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134024	10.1371/journal.pone.0134024	http://dx.doi.org/10.1371/journal.pone.0134024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217942	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900066
J	Aoudjehane, L; Bisch, G; Scatton, O; Granier, C; Gaston, J; Housset, C; Roingeard, P; Cosset, FL; Perdigao, F; Balladur, P; Wakita, T; Calmus, Y; Conti, F				Aoudjehane, Lynda; Bisch, Gregoire; Scatton, Olivier; Granier, Christelle; Gaston, Jesintha; Housset, Chantal; Roingeard, Philippe; Cosset, Francois-Loic; Perdigao, Fabiano; Balladur, Pierre; Wakita, Takaji; Calmus, Yvon; Conti, Filomena			Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C	PLOS ONE			English	Article							STELLATE CELLS; PERIPHERAL-BLOOD; IN-VITRO; REPLICATION; PROTEIN; CD81; HCV; HEPATOCYTES; FIBROBLASTS; CORE	Background Chronic hepatitis C is a major cause of liver fibrosis and cirrhosis. It is generally accepted that inflammation that occurs in response to hepatocyte infection by the hepatitis C virus (HCV) is the main mechanism that triggers myofibroblast differentiation and stimulation in chronic hepatitis C. The aim of this study was to determine if HCV might infect human liver myofibroblasts (HLMF) and directly stimulate their fibrogenic activities. Methods We evaluated the expression of the viral entry receptors, levels of HCV-RNA and HCV-protein and the expression of fibrosis markers in HLMF by using quantitative PCR, western blot and immunofluorescence analyses. Pseudoparticles (HCVpp) and cell culture-derived HCV (HCVcc) were used to study the ability of HLMF to support viral entry, replication and fibrosis induction. Results We showed that HLMF expressed all known molecules of the HCV receptor complex, i.e. CD81, LDL-R, scavenger receptor-BI, claudin-1 and occludin. These cells were also permissive to HCVpp entry. Inoculation with HCVcc caused short-term infection of these cells, as shown by their content in positive-and negative-strand HCV RNA, in core and NS3 viral proteins, and by their release of core protein levels in the culture supernatants. HCV infection stimulated myofibroblastic differentiation, proliferation and collagen production in these cells. In addition, evidence of in vivo infection was provided by the detection of positive- and negative-strand HCV RNA in preparations of HLMF obtained from HCV-infected patients. Conclusion These findings indicate that HCV infection of HLMF can occur and trigger extracellular matrix overproduction, thereby contributing to the development of HCV-related liver fibrosis.	[Aoudjehane, Lynda; Scatton, Olivier; Housset, Chantal; Balladur, Pierre; Calmus, Yvon; Conti, Filomena] Univ Paris 06, Univ Paris 04, CDR St Antoine, UMR S 938, F-75005 Paris, France; [Aoudjehane, Lynda; Scatton, Olivier; Housset, Chantal; Balladur, Pierre; Calmus, Yvon; Conti, Filomena] INSERM, CDR St Antoine, UMR S 938, F-75012 Paris, France; [Aoudjehane, Lynda; Bisch, Gregoire] Hop St Antoine, Human HepCell, F-75012 Paris, France; [Scatton, Olivier; Perdigao, Fabiano; Calmus, Yvon; Conti, Filomena] Hop La Pitie Salpetriere, AP HP, Unite Transplantat Hepat, F-75013 Paris, France; [Granier, Christelle; Cosset, Francois-Loic] Univ Lyon, Team EVIR, CIRI, Int Ctr Infectiol Res, Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] INSERM, U1111, F-69008 Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69364 Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] Univ Lyon 1, Ctr Int Rech Infect, F-69365 Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] CNRS, UMR5308, Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] Univ Lyon, LabEx Ecofect, Lyon, France; [Gaston, Jesintha] Univ Paris 05, Inst Cochin, INSERM U1016, CNRS UMR 8104, Paris, France; [Roingeard, Philippe] Univ Tours, INSERM U966, F-37041 Tours, France; [Roingeard, Philippe] CHRU, Tours, France; [Balladur, Pierre] Hop St Antoine, AP HP, Dept Chirurg Digest, F-75012 Paris, France; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; National Institute of Infectious Diseases (NIID)	Aoudjehane, L (corresponding author), Univ Paris 06, Univ Paris 04, CDR St Antoine, UMR S 938, F-75005 Paris, France.	lynda.aoudjehane@inserm.fr	Cosset, François-Loïc/M-5862-2019	Cosset, François-Loïc/0000-0001-8842-3726; Christelle, GRANIER/0000-0001-8987-0632; Housset, Chantal/0000-0001-6469-0651; Aoudjehane, lynda/0000-0003-4191-0564				Aoudjehane L, 2008, LAB INVEST, V88, P973, DOI 10.1038/labinvest.2008.61; Arrieta JJ, 2001, AM J PATHOL, V158, P259, DOI 10.1016/S0002-9440(10)63964-8; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Boisvert J, 2001, J INFECT DIS, V184, P827, DOI 10.1086/323391; Bosselut N, 2010, PROTEOMICS, V10, P1017, DOI 10.1002/pmic.200900257; BRILLANTI S, 1993, LANCET, V341, P464, DOI 10.1016/0140-6736(93)90210-8; Brown PMJ, 2001, CLIN BIOCHEM, V34, P167, DOI 10.1016/S0009-9120(01)00210-7; Burgel B, 2011, J VIRAL HEPATITIS, V18, P562, DOI 10.1111/j.1365-2893.2010.01339.x; Carriere M, 2007, J MED VIROL, V79, P155, DOI 10.1002/jmv.20773; Caussin-Schwemling C, 2001, J MED VIROL, V65, P14, DOI 10.1002/jmv.1095; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Demetris AJ, 2009, LIVER TRANSPLANT, V15, pS35, DOI 10.1002/lt.21890; Florimond A, 2014, GUT; Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jiang ZT, 2010, MED SCI MONITOR, V16, pBR107; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200; Mederacke I, 2009, J CLIN VIROL, V46, P210, DOI 10.1016/j.jcv.2009.08.014; Molina S, 2008, J VIROL, V82, P569, DOI 10.1128/JVI.01443-07; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Song HS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-40; Tan K, 2003, J VIRAL HEPATITIS, V10, P427, DOI 10.1046/j.1365-2893.2003.00460.x; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watanabe N, 2011, BIOCHEM BIOPH RES CO, V407, P135, DOI 10.1016/j.bbrc.2011.02.125; Wong DKH, 2001, J VIROL, V75, P1229, DOI 10.1128/JVI.75.3.1229-1235.2001; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134141	10.1371/journal.pone.0134141	http://dx.doi.org/10.1371/journal.pone.0134141			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214688	Green Published, Green Submitted, gold			2022-12-26	WOS:000358594300052
J	Gonese, E; Mapako, T; Dzangare, J; Rusakaniko, S; Kilmarx, PH; Postma, MJ; Ngwende, S; Mandisarisa, J; Nyika, P; Mvere, DA; Mugurungi, O; Tshimanga, M; van Hulst, M				Gonese, Elizabeth; Mapako, Tonderai; Dzangare, Janet; Rusakaniko, Simbarashe; Kilmarx, Peter H.; Postma, Maarten J.; Ngwende, Stella; Mandisarisa, John; Nyika, Ponesai; Mvere, David A.; Mugurungi, Owen; Tshimanga, Mufuta; van Hulst, Marinus			Within-Gender Changes in HIV Prevalence among Adults between 2005/6 and 2010/11 in Zimbabwe	PLOS ONE			English	Article							AFRICA; SPREAD; RISK; MEN	Introduction Zimbabwe has reported significant declines in HIV prevalence between 2005/06 and 2010/ 11 Demography and Health Surveys; a within-gender analysis to identify the magnitude and factors associated with this change, which can be masked, is critical for targeting interventions. Methods We analyzed change in HIV prevalence for 6,947 women and 5,848 men in the 2005/06 survey and 7,313 women and 6,250 men in 201011 surveys using 2005/06 as referent. The data was analyzed taking into consideration the survey design and therefore the svy, mean command in Stata was used in both linear and logistic regression. Results There were similar proportional declines in prevalence at national level for males (15% p=0.011) and females (16%, p=0.008). However, there were variations in decline by provincial setting, demographic variables of age, educational level and some sexual risk behaviours. In logistic regression analysis, statistically significant declines were observed among men in Manicaland, Mashonaland East and Harare (p<0.01) and for women in Manicaland, Mashonaland Central and Harare (p<0.01). Although not statistically significant, numerical increases were observed among men in Matebeleland North, Matebeleland South, Midlands and for both men and women in Bulawayo. Young women in the age range 15-34 experienced a decline in prevalence (p<0.01) while older men 30-44 had a statistically significant decline (p<0.01). Having a secondary and above education, regardless of employment status for both men and women recorded a significant decline. For sexual risk behaviours, currently in union for men and women and not in union for women there was a significant decline in prevalence. Conclusion Zimbabwe has reported a significant decline among both men and women but there are important differentials across provinces, demographic characteristics and sexual risk behaviours that suggest that the epidemic in Zimbabwe is heterogeneous and therefore interventions must be targeted in order to achieve epidemic control.	[Gonese, Elizabeth; Kilmarx, Peter H.; Mandisarisa, John] US Ctr Dis Control & Prevent CDC, Harare, Zimbabwe; [Mapako, Tonderai; Mvere, David A.] Natl Blood Serv Zimbabwe, Harare, Zimbabwe; [Mapako, Tonderai; Postma, Maarten J.; van Hulst, Marinus] Univ Groningen, Unit Pharmacoepidemiol & Pharmacoecon PE2, Dept Pharm, Groningen, Netherlands; [Dzangare, Janet; Nyika, Ponesai; Mugurungi, Owen] Minist Hlth & Child Welf, Harare, Zimbabwe; [Rusakaniko, Simbarashe; Tshimanga, Mufuta] Univ Zimbabwe, Dept Community Med, Harare, Zimbabwe; [Kilmarx, Peter H.] CDC, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Ngwende, Stella] Natl Microbiol Reference Lab, Harare, Zimbabwe; [van Hulst, Marinus] Martini Hosp, Dept Clin Pharm & Toxicol, Groningen, Netherlands	University of Groningen; University of Zimbabwe; Centers for Disease Control & Prevention - USA; Martini Hospital	Gonese, E (corresponding author), US Ctr Dis Control & Prevent CDC, Harare, Zimbabwe.	hol9@cdc.gov	Mapako, Tonderai/I-4664-2019	Mapako, Tonderai/0000-0003-2873-4420; Postma, Maarten/0000-0002-6306-3653; Kilmarx, Peter/0000-0001-6464-3345	United States Agency for International Development (USAID) through the MEASURE DHS project [GPO-C-00-08-00008-00]; Centers for Disease Control and Prevention (CDC); T-REC project - European Union [266194]	United States Agency for International Development (USAID) through the MEASURE DHS project(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); T-REC project - European Union	This research is carried out with support provided by the United States Agency for International Development (USAID) through the MEASURE DHS project (#GPO-C-00-08-00008-00) and the Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief. T. Mapako was supported by T-REC project funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 266194.	Adebajo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081981; Akwara P A, 2008, IN DEPTH ANAL HIV PR; [Anonymous], 2004, ANT CLIN SURV PREGN; [Anonymous], NAT CENS REP 2012; [Anonymous], 2009, ANT CLIN SURV PREGN; [Anonymous], 2002, ZIMB DEM HLTH SURV 2; [Anonymous], 2006, ANT CLIN SURV PREGN; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Dlodlo Riitta A, 2011, J Int AIDS Soc, V14 Suppl 1, pS2, DOI 10.1186/1758-2652-14-S1-S2; Fylkesnes K, 2001, AIDS, V15, P907, DOI 10.1097/00002030-200105040-00011; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hong R, 2008, FACTORS ASS PREVALEN; Kayeyi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033652; Mapako T, 2013, TRANSFUSION, V53, P2413, DOI 10.1111/trf.12311; Mishra V, DEMOGR HLTH RES, V207; Mmbanga E, 2013, CALVERTON MD US ICF, V85; Montana L., 2007, SPATIAL MODELLING HI; UNAIDS, 2010, GLOB REP UNAIDS REP; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2, P215; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2007, ZIMB DEM HLTH SURV 2, P219	25	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0129611	10.1371/journal.pone.0129611	http://dx.doi.org/10.1371/journal.pone.0129611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208134	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000005
J	Mizuhashi, K; Chaya, T; Kanamoto, T; Omori, Y; Furukawa, T				Mizuhashi, Koji; Chaya, Taro; Kanamoto, Takashi; Omori, Yoshihiro; Furukawa, Takahisa			Obif, a Transmembrane Protein, Is Required for Bone Mineralization and Spermatogenesis in Mice	PLOS ONE			English	Article							OSTEOBLAST INDUCTION FACTOR; CELL-INTERACTIONS; MALE-INFERTILITY; DIFFERENTIATION; GLYCOSYLATION; EXPRESSION; TESTIS; GLYCANS; LENGTH; WNT	Background Various kinds of transmembrane and secreted proteins play pivotal roles in development through cell-cell communication. We previously reported that Obif (Osteoblast induction factor, Tmem119), encoding a single transmembrane protein, is expressed in differentiating osteoblasts, and that Obif(-/-) mice exhibit significantly reduced bone volume in the femur. In the current study, we characterized the Obif protein and further investigated the biological phenotypes of a variety of tissues in Obif(-/-) mice. Results First, we found that O-glycosylation of the Obif protein occurs at serine residue 36 in the Obif extracellular domain. Next, we observed that Obif(-/-) mice exhibit bone dysplasia in association with significantly increased osteoid volume per osteoid surface (OV/OS) and osteoid maturation time (Omt), and significantly decreased mineral apposition rate (MAR) and bone formation rate per bone surface (BFR/BS). In addition, we observed that Obif(-/-) mice show a significant decrease in testis weight as well as in sperm number. By histological analysis, we found that Obif is expressed in spermatocytes and spermatids in the developing testis and that spermatogenesis is halted at the round spermatid stage in the Obif(-/-) testis that lacks sperm. However, the number of litters fathered by male mice was slightly reduced in Obif(-/-) mice compared with wild-type mice, although this was not statistically significant. Conclusions Our results, taken together with previous observations, indicate that Obif is a type Ia transmembrane protein whose N-terminal region is O-glycosylated. In addition, we found that Obif is required for normal bone mineralization and late testicular differentiation in vivo. These findings suggest that Obif plays essential roles in the development of multiple tissues.	[Mizuhashi, Koji; Chaya, Taro; Omori, Yoshihiro; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 565, Japan; [Mizuhashi, Koji; Chaya, Taro; Kanamoto, Takashi; Omori, Yoshihiro; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Suita, Osaka, Japan; [Kanamoto, Takashi] Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Suita, Osaka, Japan; [Chaya, Taro; Omori, Yoshihiro; Furukawa, Takahisa] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Suita, Osaka, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Furukawa, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka 565, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp			PRESTO from Japan Science and Technology Agency [4118]; Japan Society for the Promotion of Science [25113519, 23113728, 15H04669, 25293070, 15K18955]; Takeda Science Foundation; Uehara Memorial Foundation; Suzuken Memorial Foundation; Naito Foundation [220]; Hyogo Science and Technology Association; Osaka Community Foundation; Grants-in-Aid for Scientific Research [15K18955] Funding Source: KAKEN	PRESTO from Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Suzuken Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Hyogo Science and Technology Association; Osaka Community Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by PRESTO (#4118 for YO) from Japan Science and Technology Agency (http://www.jst.go.jp/), Grants-in-Aid for Scientific Research on Innovative Areas (#25113519, #23113728 for YO), Grant-in-Aid for Scientific Research (B) (#15H04669 for TF, #25293070 for YO), Grant-in-Aid for Young Scientists (B) (#15K18955 for TC) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/), The Takeda Science Foundation (for TF and YO) (http://www.takeda-sci.or.jp/), The Uehara Memorial Foundation (for YO and TC) (http://www.ueharazaidan.or.jp/), Suzuken Memorial Foundation (for YO) (http://www.suzukenzaidan.or.jp/), Naito Foundation (#220 for YO) (https://www.naito-f.or.jp/), Hyogo Science and Technology Association (for TF) (http://www.hyogosta.jp/), The Osaka Community Foundation (for TF) (http://www.osaka-community.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022; Budefeld T, 2009, ANAT HISTOL EMBRYOL, V38, P461, DOI 10.1111/j.1439-0264.2009.00975.x; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ezeh UIO, 2000, HUM REPROD, V15, P2356, DOI 10.1093/humrep/15.11.2356; Fujihara Y, 2012, DEVELOPMENT, V139, P3583, DOI 10.1242/dev.081778; Gabius HJ, 2006, CRIT REV IMMUNOL, V26, P43, DOI 10.1615/CritRevImmunol.v26.i1.30; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hisa I, 2011, J BIOL CHEM, V286, P9787, DOI 10.1074/jbc.M110.179127; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kanamoto T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-70; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Li YM, 2014, CELL REP, V8, P723, DOI 10.1016/j.celrep.2014.06.055; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Mizuhashi K, 2012, DEV GROWTH DIFFER, V54, P474, DOI 10.1111/j.1440-169X.2012.01333.x; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Negishi-Koga Takako, 2012, Bonekey Rep, V1, P183, DOI 10.1038/bonekey.2012.183; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Osato N, 2002, GENOME RES, V12, P1127, DOI 10.1101/gr.75202; Patsos G, 2009, GLYCOBIOLOGY, V19, P382, DOI 10.1093/glycob/cwn149; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Saliba W, 2009, J AM BOARD FAM MED, V22, P574, DOI 10.3122/jabfm.2009.05.090026; Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Ulloa F, 2003, J BIOL CHEM, V278, P12374, DOI 10.1074/jbc.M211909200; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; van der Weyden L, 2006, MOL CELL BIOL, V26, P3595, DOI 10.1128/MCB.26.9.3595-3609.2006; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wong EWP, 2009, INT REV CEL MOL BIO, V278, P309, DOI 10.1016/S1937-6448(09)78007-4; Xiao X, 2013, HUM REPROD UPDATE, V19, P167, DOI 10.1093/humupd/dms049; Zuo C, 2012, OSTEOPOROSIS INT, V23, P1653, DOI 10.1007/s00198-012-1909-x	43	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133704	10.1371/journal.pone.0133704	http://dx.doi.org/10.1371/journal.pone.0133704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207632	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000119
J	Overmars, L; Siezen, RJ; Francke, C				Overmars, Lex; Siezen, Roland J.; Francke, Christof			A Novel Quality Measure and Correction Procedure for the Annotation of Microbial Translation Initiation Sites	PLOS ONE			English	Article							LEADERLESS MESSENGER-RNAS; SEQUENCES; BACTERIAL; GENOMES; GENES; IDENTIFICATION; PREDICTIONS; MECHANISMS; EVOLUTION; FEATURES	The identification of translation initiation sites (TISs) constitutes an important aspect of sequence-based genome analysis. An erroneous TIS annotation can impair the identification of regulatory elements and N-terminal signal peptides, and also may flaw the determination of descent, for any particular gene. We have formulated a reference-free method to score the TIS annotation quality. The method is based on a comparison of the observed and expected distribution of all TISs in a particular genome given prior gene-calling. We have assessed the TIS annotations for all available NCBI RefSeq microbial genomes and found that approximately 87% is of appropriate quality, whereas 13% needs substantial improvement. We have analyzed a number of factors that could affect TIS annotation quality such as GC-content, taxonomy, the fraction of genes with a Shine-Dalgarno sequence and the year of publication. The analysis showed that only the first factor has a clear effect. We have then formulated a straightforward Principle Component Analysis-based TIS identification strategy to self-organize and score potential TISs. The strategy is independent of reference data and a priori calculations. A representative set of 277 genomes was subjected to the analysis and we found a clear increase in TIS annotation quality for the genomes with a low quality score. The PCA-based annotation was also compared with annotation with the current tool of reference, Prodigal. The comparison for the model genome of Escherichia coli K12 showed that both methods supplement each other and that prediction agreement can be used as an indicator of a correct TIS annotation. Importantly, the data suggest that the addition of a PCA-based strategy to a Prodigal prediction can be used to 'flag' TIS annotations for re-evaluation and in addition can be used to evaluate a given annotation in case a Prodigal annotation is lacking.	[Overmars, Lex; Siezen, Roland J.; Francke, Christof] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Overmars, Lex; Siezen, Roland J.; Francke, Christof] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands; [Francke, Christof] Univ Appl Sci Arnhem Nijmegen, HAN BioCtr, Nijmegen, Netherlands	Radboud University Nijmegen	Overmars, L (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Amsterdam, Netherlands.	L.Overmars@gmail.com	Siezen, Roland J/P-5745-2015; Francke, C/AAW-2402-2021		BioRange programme of the Netherlands Bioinformatics Centre (NBIC); Netherlands Genomics Initiative (NGI)	BioRange programme of the Netherlands Bioinformatics Centre (NBIC); Netherlands Genomics Initiative (NGI)	This work was part of the BioRange programme of the Netherlands Bioinformatics Centre (NBIC), which is supported by the Netherlands Genomics Initiative (NGI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dunbar J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-125; Ederveen THA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063523; Hu GQ, 2008, NUCLEIC ACIDS RES, V36, pD114, DOI 10.1093/nar/gkm799; Hu GQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-160; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Klassen JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058387; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Krug K, 2013, MOL CELL PROTEOMICS, V12, P3420, DOI 10.1074/mcp.M113.029165; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Palleja A, 2009, BMC GENOMICS, V10, P1; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; PETTIS GS, 1988, J BIOL CHEM, V263, P18857; Poptsova MS, 2010, MICROBIOL-SGM, V156, P1909, DOI 10.1099/mic.0.033811-0; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; R Core Team, 2018, R LANG ENV STAT COMP; Richardson EJ, 2013, BRIEF BIOINFORM, V14, P1, DOI 10.1093/bib/bbs007; Shah SP, 2003, BIOINFORMATICS, V19, P1296, DOI 10.1093/bioinformatics/btg139; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Skorski P, 2006, J BACTERIOL, V188, P6277, DOI 10.1128/JB.00591-06; Smollett KL, 2009, MICROBIOL-SGM, V155, P186, DOI 10.1099/mic.0.022889-0; Tech M, 2005, BIOINFORMATICS, V21, P3568, DOI 10.1093/bioinformatics/bti563; Udagawa T, 2004, J BIOL CHEM, V279, P8539, DOI 10.1074/jbc.M308784200; Wall ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002284; Wang Chengqi, 2013, Genomics Proteomics & Bioinformatics, V11, P142, DOI 10.1016/j.gpb.2013.04.002; Yada T, 2003, Pac Symp Biocomput, P375; Yok NG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-20; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; Zhu HQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-97; Zur H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003136	42	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133691	10.1371/journal.pone.0133691	http://dx.doi.org/10.1371/journal.pone.0133691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204119	Green Published, gold, Green Submitted			2022-12-26	WOS:000358621000037
J	Steimer, A; Schindler, K				Steimer, Andreas; Schindler, Kaspar			Random Sampling with Interspike-Intervals of the Exponential Integrate and Fire Neuron: A Computational Interpretation of UP-States	PLOS ONE			English	Article							NEOCORTICAL NEURONS; CORTICAL-NEURONS; IN-VIVO; DYNAMICS; NETWORK; VARIABILITY; MECHANISMS; DISCHARGE; MODELS; INPUT	Oscillations between high and low values of the membrane potential (UP and DOWN states respectively) are an ubiquitous feature of cortical neurons during slow wave sleep and anesthesia. Nevertheless, a surprisingly small number of quantitative studies have been conducted only that deal with this phenomenon's implications for computation. Here we present a novel theory that explains on a detailed mathematical level the computational benefits of UP states. The theory is based on random sampling by means of interspike intervals (ISIs) of the exponential integrate and fire (EIF) model neuron, such that each spike is considered a sample, whose analog value corresponds to the spike's preceding ISI. As we show, the EIF's exponential sodium current, that kicks in when balancing a noisy membrane potential around values close to the firing threshold, leads to a particularly simple, approximative relationship between the neuron's ISI distribution and input current. Approximation quality depends on the frequency spectrum of the current and is improved upon increasing the voltage baseline towards threshold. Thus, the conceptually simpler leaky integrate and fire neuron that is missing such an additional current boost performs consistently worse than the EIF and does not improve when voltage baseline is increased. For the EIF in contrast, the presented mechanism is particularly effective in the high-conductance regime, which is a hallmark feature of UP-states. Our theoretical results are confirmed by accompanying simulations, which were conducted for input currents of varying spectral composition. Moreover, we provide analytical estimations of the range of ISI distributions the EIF neuron can sample from at a given approximation level. Such samples may be considered by any algorithmic procedure that is based on random sampling, such as Markov Chain Monte Carlo or message-passing methods. Finally, we explain how spike-based random sampling relates to existing computational theories about UP states during slow wave sleep and present possible extensions of the model in the context of spike-frequency adaptation.	[Steimer, Andreas; Schindler, Kaspar] Univ Bern, Dept Neurol, Univ Hosp Bern, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern	Steimer, A (corresponding author), Univ Bern, Dept Neurol, Univ Hosp Bern, Inselspital, Bern, Switzerland.	Andreas.Steimer@insel.ch	Schindler, Kaspar/L-7115-2013	Schindler, Kaspar/0000-0002-2387-7767	Swiss National Science Foundation (SNF) [SNF 32003B_155950]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was funded by the Swiss National Science Foundation (SNF) (Project No: SNF 32003B_155950).	Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Badel L, 2006, NEUROCOMPUTING, V69, P1062, DOI 10.1016/j.neucom.2005.12.046; Barranca VJ, 2014, J COMPUT NEUROSCI, V37, P161, DOI 10.1007/s10827-013-0494-0; Bishop C. M, 2006, PATTERN RECOGNITION; Bottou L., 1998, ONLINE LEARNING AND; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cox DR, 1966, THE STATISTICAL ANAL; Dauwels J, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, VOLS 1-6, PROCEEDINGS, P2052, DOI 10.1109/ISIT.2006.261910; Dayan P., 2002, HDB BRAIN THEORY NEU, P522; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A., 2001, THALAMOCORTICAL ASSE, DOI [10.7554/elife.47314, DOI 10.7554/eLife.47314]; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; El Boustani S, 2012, J NEUROSCI, V32, P194, DOI 10.1523/JNEUROSCI.2496-11.2012; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fanselow EE, 2010, J NEUROPHYSIOL, V104, P596, DOI 10.1152/jn.00206.2010; Fourcaud-Trocme N, 2005, J COMPUT NEUROSCI, V18, P311, DOI 10.1007/s10827-005-0337-8; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; Gerstner W, 2002, SPIKING NEURON MODEL; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Lundstrom BN, 2006, J NEUROSCI, V26, P9030, DOI 10.1523/JNEUROSCI.0225-06.2006; MacKay D. J. C., 2019, INFORM THEORY INFERE; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Mensi S., 2011, ADV NEURAL INF PROCE, P1377; Milojkovic BA, 2005, J NEUROSCI, V25, P3940, DOI 10.1523/JNEUROSCI.5314-04.2005; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Nawrot MP, 2007, NEUROCOMPUTING, V70, P1717, DOI 10.1016/j.neucom.2006.10.101; Pfister JP, 2010, NAT NEUROSCI, V13, P1271, DOI 10.1038/nn.2640; Plesser HE, 2000, NEURAL COMPUT, V12, P367, DOI 10.1162/089976600300015835; Reich DS, 2000, J NEUROSCI, V20, P1964; Rudolph M, 2005, J NEUROPHYSIOL, V94, P2805, DOI 10.1152/jn.01313.2004; Rudolph M, 2003, NEUROSCIENCE, V119, P855, DOI 10.1016/S0306-4522(03)00164-7; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shih JY, 2011, J NEUROPHYSIOL, V105, P1908, DOI 10.1152/jn.01055.2010; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Steimer A., 2012, NEURALLY INSPIRED MO; Steimer A, 2013, NEURAL COMPUT, V25, P2303, DOI 10.1162/NECO_a_00477; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Watson BO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003971; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; Wilson CJ, 1996, J NEUROSCI, V16, P2397	55	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132906	10.1371/journal.pone.0132906	http://dx.doi.org/10.1371/journal.pone.0132906			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203657	Green Published, gold			2022-12-26	WOS:000358621000014
J	Kurth, F; Franco-Obregon, A; Casarosa, M; Kuster, SK; Wuertz-Kozak, K; Dittrich, PS				Kurth, Felix; Franco-Obregon, Alfredo; Casarosa, Marco; Kuester, Simon K.; Wuertz-Kozak, Karin; Dittrich, Petra S.			Transient receptor potential vanilloid 2-mediated shear-stress responses in C2C12 myoblasts are regulated by serum and extracellular matrix	FASEB JOURNAL			English	Article						mechanotransduction; calcium; laminin; myogenesis; microfluidics	MECHANOSENSITIVE ION CHANNELS; VASCULAR ENDOTHELIAL-CELLS; OPERATED CALCIUM-CHANNELS; PATCH-CLAMPED MEMBRANES; SKELETAL-MUSCLE FIBERS; TRP CHANNELS; MECHANICAL STIMULATION; MUSCULAR-DYSTROPHY; CATION CHANNELS; 2-AMINOETHOXYDIPHENYL BORATE	The developmental sensitivity of skeletal muscle to mechanical forces is unparalleled in other tissues. Calcium entry via reputedly mechanosensitive transient receptor potential (TRP) channel classes has been shown to play an essential role in both the early proliferative stage and subsequent differentiation of skeletal muscle myoblasts, particularly TRP canonical (TRPC) 1 and TRP vanilloid (TRPV) 2. Here we show that C2C12 murine myoblasts respond to fluid flow-induced shear stress with increments in cytosolic calcium that are largely initiated by the mechanosensitive opening of TRPV2 channels. Response to fluid flow was augmented by growth in low extracellular serum concentration (5 vs. 20% fetal bovine serum) by greater than 9-fold and at 18 h in culture, coincident with the greatest TRPV2 channel expression under identical conditions (P < 0.02). Fluid flow responses were also enhanced by substrate functionalization with laminin, rather than with fibronectin, agreeing with previous findings that the gating of TRPV2 is facilitated by laminin. Fluid flow-induced calcium increments were blocked by ruthenium red (27%) and SKF-96365 (38%), whereas they were unaltered by 2-aminoethoxydiphenyl borate, further corroborating that TRPV2 channels play a predominant role in fluid flow mechanosensitivity over that ofTRPC1 andTRPmelastatin (TRPM) 7.	[Kurth, Felix; Kuester, Simon K.; Dittrich, Petra S.] ETH, Dept Biosyst & Sci Engn, CH-8093 Zurich, Switzerland; [Casarosa, Marco; Wuertz-Kozak, Karin] ETH, Inst Biomech, CH-8093 Zurich, Switzerland; [Franco-Obregon, Alfredo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Franco-Obregon, Alfredo] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Franco-Obregon, Alfredo] Natl Univ Singapore Hosp, Sports Ctr, Singapore 119228, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore; National University of Singapore; National University of Singapore	Franco-Obregon, A (corresponding author), Natl Univ Singapore Hosp, Dept Surg, NUHS Tower Block,Level 8,1E Kent Ridge Rd, Singapore 119228, Singapore.	suraf@nus.edu.sg; petra.dittrich@bsse.ethz.ch	Franco-Obregon, Alfredo/F-3056-2019; Obregón, Alfredo/G-1756-2014; Wuertz-Kozak, Karin/G-3144-2012; Kurth, Felix/L-5799-2019	Wuertz-Kozak, Karin/0000-0002-3281-4629; Kurth, Felix/0000-0002-3211-6820; Franco-Obregon, Alfredo/0000-0002-2514-1083	European Research Council [203428]	European Research Council(European Research Council (ERC)European Commission)	The authors kindly appreciate fabrication of the master molds by P. Kuhn and thank B. Sebastian for providing the mean squared displacement analysis-Matlab code. Funding from the European Research Council (Starting Grant n mu LIPIDS, no. 203428) is gratefully acknowledged.	Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; ANDO J, 1988, IN VITRO CELL DEV B, V24, P871; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Boels K, 2001, J CELL SCI, V114, P3599; Cachaco AS, 2005, DEV DYNAM, V232, P1069, DOI 10.1002/dvdy.20280; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Chin LK, 2011, LAB CHIP, V11, P1856, DOI 10.1039/c0lc00651c; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crocetti S, 2014, CYTOM PART A, V85A, P525, DOI 10.1002/cyto.a.22461; Damm TB, 2013, CELL CYCLE, V12, P3001, DOI 10.4161/cc.26029; Damm TB, 2013, FASEB J, V27, P2045, DOI 10.1096/fj.12-218693; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Ferrer-Montiel A, 2012, EXPERT OPIN THER PAT, V22, P999, DOI 10.1517/13543776.2012.711320; Flemming R, 2003, BRIT J PHARMACOL, V139, P955, DOI 10.1038/sj.bjp.0705327; Formigli L, 2007, J CELL PHYSIOL, V211, P296, DOI 10.1002/jcp.20936; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; FRANCO A, 1990, J PHYSIOL-LONDON, V427, P361, DOI 10.1113/jphysiol.1990.sp018176; Franco-Obregon A, 2002, J PHYSIOL-LONDON, V539, P391, DOI 10.1113/jphysiol.2001.013043; FRANCOOBREGON A, 1994, J PHYSIOL-LONDON, V481, P299, DOI 10.1113/jphysiol.1994.sp020440; Gailly P, 2012, CURR OPIN PHARMACOL, V12, P326, DOI 10.1016/j.coph.2012.01.018; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Grossi A, 2008, CELL BIOL INT, V32, P615, DOI 10.1016/j.cellbi.2008.01.005; Grossi A, 2007, J BIOMECH, V40, P3354, DOI 10.1016/j.jbiomech.2007.05.007; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; HAMILL OP, 1992, P NATL ACAD SCI USA, V89, P7462, DOI 10.1073/pnas.89.16.7462; Harisseh R, 2013, AM J PHYSIOL-CELL PH, V304, pC881, DOI 10.1152/ajpcell.00182.2012; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Ho TC, 2012, CHANNELS, V6, P246, DOI 10.4161/chan.20719; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Juvin V, 2007, MOL PHARMACOL, V72, P1258, DOI 10.1124/mol.107.037044; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kim BJ, 2005, GASTROENTEROLOGY, V129, P1504, DOI 10.1053/j.gastro.2005.08.016; Kirber MT, 2000, J PHYSIOL-LONDON, V524, P3, DOI 10.1111/j.1469-7793.2000.t01-4-00003.x; Kobayashi Y, 2006, EXP CELL RES, V312, P3152, DOI 10.1016/j.yexcr.2006.06.026; Kuras Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043859; Kurth F, 2015, ANALYST, V140, P127, DOI 10.1039/c4an01758g; Kurth F, 2012, CURR OPIN CHEM BIOL, V16, P400, DOI 10.1016/j.cbpa.2012.03.014; LANSMAN JB, 1988, NATURE, V331, P481, DOI 10.1038/331481a0; Lansman JB, 2006, CLIN EXP PHARMACOL P, V33, P649, DOI 10.1111/j.1440-1681.2006.04393.x; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Matsumura CY, 2011, AM J PHYSIOL-CELL PH, V301, pC1344, DOI 10.1152/ajpcell.00056.2011; MCBRIDE DW, 1992, PFLUG ARCH EUR J PHY, V421, P606, DOI 10.1007/BF00375058; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nagasawa M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12296; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park SW, 2007, BIOCHEM BIOPH RES CO, V358, P1021, DOI 10.1016/j.bbrc.2007.05.024; Peng SQ, 2005, BRAIN RES, V1045, P116, DOI 10.1016/j.brainres.2005.03.039; Pla AF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00311; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rahimzadeh J, 2011, AM J PHYSIOL-CELL PH, V301, pC646, DOI 10.1152/ajpcell.00099.2011; Rouillard AD, 2014, BIOPHYS J, V106, P932, DOI 10.1016/j.bpj.2013.12.002; RUKNUDIN A, 1991, J CELL BIOL, V112, P125, DOI 10.1083/jcb.112.1.125; Rychkov G., 2007, V179, P23; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; SHEN J, 1992, AM J PHYSIOL, V262, pC384, DOI 10.1152/ajpcell.1992.262.2.C384; Silberberg SD, 1997, J PHYSIOL-LONDON, V505, P551, DOI 10.1111/j.1469-7793.1997.551ba.x; Slavchov RI, 2014, J PHYS CHEM B, V118, P12660, DOI 10.1021/jp506965v; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; SPITZER A, 1970, AM J PHYSIOL, V218, P1188, DOI 10.1152/ajplegacy.1970.218.4.1188; Stiber JA, 2005, DEV BIOL, V287, P213, DOI 10.1016/j.ydbio.2005.06.030; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Tidball JG, 2005, J APPL PHYSIOL, V98, P1900, DOI 10.1152/japplphysiol.01178.2004; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Vandebrouck A, 2007, FASEB J, V21, P608, DOI 10.1096/fj.06-6683com; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033; Zhou Y, 2007, BIOCHEMISTRY-US, V46, P14907, DOI 10.1021/bi701384k; Zou H, 2002, P NATL ACAD SCI USA, V99, P6404, DOI 10.1073/pnas.092654999	88	22	22	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4726	4737		10.1096/fj.15-275396	http://dx.doi.org/10.1096/fj.15-275396			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26207028				2022-12-26	WOS:000364514700028
J	Chantepie, S; Robert, A; Sorci, G; Hingrat, Y; Charmantier, A; Leveque, G; Lacroix, F; Teplitsky, C				Chantepie, Stephane; Robert, Alexandre; Sorci, Gabriele; Hingrat, Yves; Charmantier, Anne; Leveque, Gwenaelle; Lacroix, Frederic; Teplitsky, Celine			Quantitative Genetics of the Aging of Reproductive Traits in the Houbara Bustard	PLOS ONE			English	Article							AGE-SPECIFIC MORTALITY; NATURAL-POPULATIONS; DROSOPHILA-MELANOGASTER; INBREEDING DEPRESSION; EVOLUTIONARY-THEORIES; SEXUAL SELECTION; TRADE-OFFS; SENESCENCE; WILD; PATTERNS	Do all traits within an organism age for the same reason? Evolutionary theories of aging share a common assumption: the strength of natural selection declines with age. A corollary is that additive genetic variance should increase with age. However, not all senescent traits display such increases suggesting that other mechanisms may be at play. Using longitudinal data collected from more than 5400 houbara bustards (Chlamydotis undulata) with an exhaustive recorded pedigree, we investigated the genetics of aging in one female reproductive trait (egg production) and three male reproductive traits (courtship display rate, ejaculate size and sperm viability), that display senescence at the phenotypic level. Animal models revealed an increase in additive genetic variance with age for courtship display rate and egg production but an unexpected absence of increased additive genetic variance for ejaculate size and no additive genetic variance for sperm viability. Our results suggest that the mechanisms behind the senescence of some traits are linked with a change in genetic expression, whereas for some other traits, aging may result from the constraints associated with physiological wear and tear on the organism throughout the life of the individual.	[Chantepie, Stephane; Robert, Alexandre; Teplitsky, Celine] UPMC, Museum Natl Hist Nat, CNRS, Ctr Ecol & Sci Conservat,UMR 7204, Paris, France; [Sorci, Gabriele] Univ Bourgogne, UMR CNRS, UB Biogeosci 6282, Dijon, France; [Hingrat, Yves; Lacroix, Frederic] Reneco Wildlife Preservat, Abu Dhabi, U Arab Emirates; [Charmantier, Anne] CNRS, CEFE, UMR 5175, Montpellier, France; [Leveque, Gwenaelle] Emirates Ctr Wildlife Propagat, Missour, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Chantepie, S (corresponding author), UPMC, Museum Natl Hist Nat, CNRS, Ctr Ecol & Sci Conservat,UMR 7204, Paris, France.	stephane.chantepie@gmail.com	Hingrat, Yves/AAR-3275-2021; Teplitsky, Celine/H-3621-2019	Teplitsky, Celine/0000-0001-9458-709X; Sorci, Gabriele/0000-0002-0799-3995; Hingrat, Yves/0000-0003-2388-8826	Centre National de la Recherche Scientifique (National Center for Scientific Research); French ANR [ANR-12-ADAP-0006]	Centre National de la Recherche Scientifique (National Center for Scientific Research); French ANR(French National Research Agency (ANR))	Stephane Chantepie's work is funded by a Phd grant from the Centre National de la Recherche Scientifique (National Center for Scientific Research). SC, CT, AC and AR were funded by the French ANR (grant ANR-12-ADAP-0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Reneco Wildlife Preservation provided support in the form of a salary for author YH and data collection used in the manuscript but did not have any additional role in the analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Arnaud CM, 2013, BEHAV ECOL, V24, P683, DOI 10.1093/beheco/ars214; Bonduriansky R, 2005, J EVOLUTION BIOL, V18, P1332, DOI 10.1111/j.1420-9101.2005.00957.x; Brody S, 1923, J GEN PHYSIOL, V6, P41, DOI 10.1085/jgp.6.1.41; Brommer JE, 2010, HEREDITY, V104, P363, DOI 10.1038/hdy.2009.125; Brommer JE, 2007, AM NAT, V170, P643, DOI 10.1086/521241; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Burger JMS, 2006, EXP GERONTOL, V41, P1108, DOI 10.1016/j.exger.2006.08.008; Chantepie S, 2016, OIKOS, V125, P167, DOI 10.1111/oik.02216; Charge R, 2013, J ANIM ECOL, V82, P399, DOI 10.1111/1365-2656.12023; Charlesworth B, 1996, P NATL ACAD SCI USA, V93, P6140, DOI 10.1073/pnas.93.12.6140; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Charmantier A, 2006, P ROY SOC B-BIOL SCI, V273, P225, DOI 10.1098/rspb.2005.3294; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Combreau O, 2001, ANIM CONSERV, V4, P133, DOI 10.1017/S1367943001001160; Dean R, 2010, CURR BIOL, V20, P1192, DOI 10.1016/j.cub.2010.04.059; Flatt Thomas, 2012, Frontiers in Genetics, V3, P148, DOI 10.3389/fgene.2012.00148; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Gaucher P, 1996, IBIS, V138, P273, DOI 10.1111/j.1474-919X.1996.tb04339.x; Gavrilov L a, 2006, HDB BIOL AGING, P6; Gilmour A.R., 2009, ASREML USER GUIDE RE; Goriup Paul D., 1997, Bird Conservation International, V7, P373; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hayward AD, 2013, FUNCT ECOL, V27, P184, DOI 10.1111/1365-2435.12029; HOULE D, 1992, GENETICS, V130, P195; Hughes KA, 2002, P NATL ACAD SCI USA, V99, P14286, DOI 10.1073/pnas.222326199; Jing HC, 2007, J EXP BOT, V58, P3885, DOI 10.1093/jxb/erm237; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Laird RA, 2009, J EVOLUTION BIOL, V22, P974, DOI 10.1111/j.1420-9101.2009.01709.x; LAKE PE, 1984, BRIT POULTRY SCI, V25, P145, DOI 10.1080/13632758408454852; Lesobre L, 2010, J AVIAN BIOL, V41, P117, DOI 10.1111/j.1600-048X.2009.04794.x; Lindsay C, 1999, J REPROD FERTIL, V117, P307; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.1890/0012-9658(1999)080[2539:ASSIFP]2.0.CO;2; Lynch M, 1998, GENETICS AND ANALYSI; MARTIN K, 1995, AM ZOOL, V35, P340; Massot M, 2011, FUNCT ECOL, V25, P848, DOI 10.1111/j.1365-2435.2011.01837.x; Medawar P B., 1952, UNSOLVED PROBLEM BIO; Moller AP, 1999, J ANIM ECOL, V68, P163, DOI 10.1046/j.1365-2656.1999.00274.x; Moorad JA, 2009, P ROY SOC B-BIOL SCI, V276, P2271, DOI 10.1098/rspb.2009.0183; Moore PJ, 2004, EVOLUTION, V58, P1773, DOI 10.1111/j.0014-3820.2004.tb00460.x; Morrissey MB, 2014, QUANTITATIVE GENETICS IN THE WILD, P228; Morrissey MB, 2010, MOL ECOL RESOUR, V10, P711, DOI 10.1111/j.1755-0998.2009.02817.x; Mysterud A, 2001, P ROY SOC B-BIOL SCI, V268, P911, DOI 10.1098/rspb.2001.1585; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2008, P ROY SOC B-BIOL SCI, V275, P745, DOI 10.1098/rspb.2007.0986; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Nussey DH, 2009, AM NAT, V174, P342, DOI 10.1086/603615; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Pletcher SD, 1999, GENETICS, V153, P813; Pletcher SD, 1998, GENETICS, V148, P287; Preston BT, 2011, ECOL LETT, V14, P1017, DOI 10.1111/j.1461-0248.2011.01668.x; Promislow DEL, 1996, GENETICS, V143, P839; Pujol B, 2014, CURR BIOL, V24, P744, DOI 10.1016/j.cub.2014.02.012; R Core Team, 2021, R LANGUAGE ENV STAT; Reale D, 1999, HEREDITY, V83, P526, DOI 10.1038/sj.hdy.6885430; Reid JM, 2011, AM NAT, V177, P177, DOI 10.1086/657977; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; Rose Michael R., 2012, Frontiers in Genetics, V3, P134, DOI 10.3389/fgene.2012.00134; Saint Jalme M, 2003, THERIOGENOLOGY, V59, P875, DOI 10.1016/S0093-691X(02)01153-6; Shaw FH, 1999, GENETICS, V152, P553; Simmons L, 2008, SPERM EVOLUTION EVOL; Sloter E, 2006, HUM REPROD, V21, P2868, DOI 10.1093/humrep/del250; Snoke MS, 2003, HEREDITY, V91, P546, DOI 10.1038/sj.hdy.6800353; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2006, TRENDS ECOL EVOL, V21, P458, DOI 10.1016/j.tree.2006.05.008; Wilson AJ, 2008, FUNCT ECOL, V22, P431, DOI 10.1111/j.1365-2435.2008.01412.x; Wilson AJ, 2007, CURR BIOL, V17, P2136, DOI 10.1016/j.cub.2007.11.043	73	12	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133140	10.1371/journal.pone.0133140	http://dx.doi.org/10.1371/journal.pone.0133140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218735	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900019
J	De Paris, R; Quevedo, CV; Ruiz, DDA; de Souza, ON				De Paris, Renata; Quevedo, Christian V.; Ruiz, Duncan D. A.; de Souza, Osmar Norberto			An Effective Approach for Clustering InhA Molecular Dynamics Trajectory Using Substrate-Binding Cavity Features	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SIMULATIONS; ALGORITHMS; DOCKING; ZINC	Protein receptor conformations, obtained from molecular dynamics (MD) simulations, have become a promising treatment of its explicit flexibility in molecular docking experiments applied to drug discovery and development. However, incorporating the entire ensemble of MD conformations in docking experiments to screen large candidate compound libraries is currently an unfeasible task. Clustering algorithms have been widely used as a means to reduce such ensembles to a manageable size. Most studies investigate different algorithms using pairwise Root-Mean Square Deviation (RMSD) values for all, or part of the MD conformations. Nevertheless, the RMSD only may not be the most appropriate gauge to cluster conformations when the target receptor has a plastic active site, since they are influenced by changes that occur on other parts of the structure. Hence, we have applied two partitioning methods (k-means and k-medoids) and four agglomerative hierarchical methods (Complete linkage, Ward's, Unweighted Pair Group Method and Weighted Pair Group Method) to analyze and compare the quality of partitions between a data set composed of properties from an enzyme receptor substrate-binding cavity and two data sets created using different RMSD approaches. Ensembles of representative MD conformations were generated by selecting a medoid of each group from all partitions analyzed. We investigated the performance of our new method for evaluating binding conformation of drug candidates to the InhA enzyme, which were performed by cross-docking experiments between a 20 ns MD trajectory and 20 different ligands. Statistical analyses showed that the novel ensemble, which is represented by only 0.48% of the MD conformations, was able to reproduce 75% of all dynamic behaviors within the binding cavity for the docking experiments performed. Moreover, this new approach not only outperforms the other two RMSD-clustering solutions, but it also shows to be a promising strategy to distill biologically relevant information from MD trajectories, especially for docking purposes.	[De Paris, Renata; Quevedo, Christian V.; Ruiz, Duncan D. A.] Pontificia Univ Catolica Rio Grande do Sul, Fac Informat, GPIN, Porto Alegre, RS, Brazil; [de Souza, Osmar Norberto] Pontificia Univ Catolica Rio Grande do Sul, Fac Informat, Lab Bioinformat Modelagem & Simulacao Biossistema, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Ruiz, DDA (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Informat, GPIN, Av Ipiranga 6681-Predio 32,Sala 628, Porto Alegre, RS, Brazil.	duncan.ruiz@pucrs.br; osmar.norberto@pucrs.br	Ruiz, Duncan/J-7498-2012; de Souza, Osmar Norberto/B-7328-2013	Ruiz, Duncan/0000-0002-4071-3246; de Souza, Osmar Norberto/0000-0002-4602-1208	Hewlett Packard - PROFACC; Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS); National Council for Scientific and Technological Development (CNPq)	Hewlett Packard - PROFACC; Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Hewlett Packard - PROFACC, PhD Scholarship: RDP; the Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS) (http://www.fapergs.rs.gov.br/), PhD Scholarship: CVQ, Project Grant: DDAR, Project Grant: ONS; and the National Council for Scientific and Technological Development (CNPq) (http://www.cnpq.br/), Project Grant: ONS, CNPq Research Fellow: ONS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; Amaro RE, 2010, CURR TOP MED CHEM, V10, P3, DOI 10.2174/156802610790232279; [Anonymous], 2009, CLUSTER ANAL; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binkowski TA, 2006, NUCLEIC ACIDS RES, V31, P3352; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Case AC, 2009, AMBER 9; Case DA, 2014, AMBER 14; Chen JH, 2007, BIOINFORMATICS, V23, P2348, DOI 10.1093/bioinformatics/btm341; Chen JY, 1992, BIOL DATA MINING; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; De Paris R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/469363; Deng JX, 2005, J MED CHEM, V48, P1496, DOI 10.1021/jm049410e; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; DOANE D., 2012, APPL STAT BUSINESS E; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Gargano F., 2007, ANN 3 INT C BRAZ ASS; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hruschka ER, 2009, IEEE T SYST MAN CY C, V39, P133, DOI 10.1109/TSMCC.2008.2007252; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jain AK., 1988, TECHNOMETRICS; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Landon MR, 2008, CHEM BIOL DRUG DES, V71, P106, DOI 10.1111/j.1747-0285.2007.00614.x; Li Y, 2006, J CHEM INF MODEL, V46, P1742, DOI 10.1021/ci050463u; Liu Zhi-Ping, 2008, Int J Bioinform Res Appl, V4, P445, DOI 10.1504/IJBRA.2008.021179; Lyman E, 2006, BIOPHYS J, V91, P164, DOI 10.1529/biophysj.106.082941; Machado KS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S6; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pauli I, 2013, J CHEM INF MODEL, V53, P2390, DOI 10.1021/ci400202t; Phillips JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-445; Quevedo CV, 2014, EXPERT SYST APPL, V41, P7608, DOI 10.1016/j.eswa.2014.05.038; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; RYDE U, 1995, PROTEINS, V21, P40, DOI 10.1002/prot.340210106; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Tan P., 2006, INTRO DATA MINING; Team RC R, 2012, TECHNICAL REPORT; TORDA AE, 1994, J COMPUT CHEM, V15, P1331, DOI 10.1002/jcc.540151203; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; TROYER JM, 1995, PROTEINS, V23, P97, DOI 10.1002/prot.340230111; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhong S, 2008, J MED CHEM, V51, P4553, DOI 10.1021/jm8001668	55	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133172	10.1371/journal.pone.0133172	http://dx.doi.org/10.1371/journal.pone.0133172			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218832	Green Submitted, gold, Green Published			2022-12-26	WOS:000358595900020
J	Farrell, D; Shaughnessy, RG; Britton, L; MacHugh, DE; Markey, B; Gordon, SV				Farrell, Damien; Shaughnessy, Ronan G.; Britton, Louise; MacHugh, David E.; Markey, Bryan; Gordon, Stephen V.			The Identification of Circulating MiRNA in Bovine Serum and Their Potential as Novel Biomarkers of Early Mycobacterium avium subsp paratuberculosis Infection	PLOS ONE			English	Article							JOHNES-DISEASE; MICRORNA; CATTLE; RNAS; REVEALS; TARGETS; GENES; SEQUENCE; DATABASE; PROFILE	Mycobacterium avium subspecies paratuberculosis (MAP) is the aetiological agent of Johne's disease (JD), a chronic enteritis in ruminants that causes substantial economic loses to agriculture worldwide. Current diagnostic assays are hampered by low sensitivity and specificity that seriously complicate disease control; a new generation of diagnostic and prognostic assays are therefore urgently needed. Circulating microRNAs (miRNAs) have been shown to have significant potential as novel biomarkers for a range of human diseases, but their potential application in the veterinary sphere has been less well characterised. The aim of this study was therefore to apply RNA-sequencing approaches to serum from an experimental JD infection model as a route to identify novel diagnostic and prognostic miRNA biomarkers. Sera from experimental MAP-challenged calves (n = 6) and age-matched controls (n = 6) were used. We identified a subset of known miRNAs from bovine serum across all samples, with approximately 90 being at potentially functional abundance levels. The majority of known bovine miRNAs displayed multiple isomiRs that differed from the canonical sequences. Thirty novel miRNAs were identified after filtering and were found within sera from all animals tested. No significant differential miRNA expression was detected when comparing sera from MAP-challenged animals to their age-matched controls at six-month's post-infection. However, comparing sera from pre-infection bleeds to six-month's post-infection across all 12 animals did identify increased miR-205 (2-fold) and decreased miR-432 (2-fold) within both challenged and control groups, which suggests changes in circulating miRNA profiles due to ageing or development (P<0.00001). In conclusion our study has identified a range of novel miRNA in bovine serum, and shown the utility of small RNA sequencing approaches to explore the potential of miRNA as novel biomarkers for infectious disease in cattle.	[Farrell, Damien; Shaughnessy, Ronan G.; Britton, Louise; Markey, Bryan; Gordon, Stephen V.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [MacHugh, David E.] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Med, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [MacHugh, David E.; Gordon, Stephen V.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin; University College Dublin	Gordon, SV (corresponding author), Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland.	stephen.gordon@ucd.ie		Farrell, Damien/0000-0003-3020-7945; Gordon, Stephen/0000-0002-4833-5542; Shaughnessy, Ronan/0000-0002-9164-3583; MacHugh, David/0000-0002-8112-4704	Department of Agriculture Food and the Marine [RSF11/S/141, EMIDA ERA_NET 11/RD/EMIDA/1]	Department of Agriculture Food and the Marine	This work was supported by the Department of Agriculture Food and the Marine grants RSF11/S/141 (ICONMAP) and EMIDA ERA_NET 11/RD/EMIDA/1 (MycobactDiagnosis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bu D, 2011, NONCODE V3 0 INTEGRA; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Cho J, 2012, J DAIRY SCI, V95, P1855, DOI 10.3168/jds.2011-4787; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; Clark DL, 2008, J DAIRY SCI, V91, P2620, DOI 10.3168/jds.2007-0902; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; de Candia P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00043; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Geraghty T, 2014, PREV VET MED, V116, P1, DOI 10.1016/j.prevetmed.2014.06.003; Gilardoni LR, 2012, REV ARGENT MICROBIOL, V44, P201; Golby P, 2014, VACCINE, V32, P5839, DOI 10.1016/j.vaccine.2014.07.034; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guo DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091354; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Juan L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06277; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Krauskopf J, 2015, TOXICOL SCI, V143, P268, DOI 10.1093/toxsci/kfu232; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Mehta MD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00231; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Miotto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080149; Olsen I, 2002, VET QUART, V24, P12, DOI 10.1080/01652176.2002.9695120; Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qi YH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-384; Qian NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068004; Rihani A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09027; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roussey JA, 2014, FRONTIERS IN VETERIN, V1; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Schaefer JS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0069-0; Scott MC, 2010, FOODBORNE PATHOG DIS, V7, P1291, DOI 10.1089/fpd.2010.0541; Shin SJ, 2007, J CLIN MICROBIOL, V45, P1941, DOI 10.1128/JCM.02616-06; Sita-Lumsden A, 2013, BRIT J CANCER, V108, P1925, DOI 10.1038/bjc.2013.192; Timms VJ, 2011, J MICROBIOL METH, V85, P1, DOI 10.1016/j.mimet.2011.01.026; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vosgha H, 2014, CURR CANCER DRUG TAR, V14, P621, DOI 10.2174/156800961407140926105634; Wang WJ, 2015, FEBS LETT, V589, P555, DOI 10.1016/j.febslet.2015.01.012; Wells SJ, 2006, CLIN VACCINE IMMUNOL, V13, P1125, DOI 10.1128/CVI.00236-06; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Zhang HY, 2015, J GERONTOL A-BIOL, V70, P102, DOI 10.1093/gerona/glu145; Zhang HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088909; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076; Zhao C, 2015, HUM CELL	68	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134310	10.1371/journal.pone.0134310	http://dx.doi.org/10.1371/journal.pone.0134310			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218736	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900108
J	Hancke, K; Dalsgaard, T; Sejr, MK; Markager, S; Glud, RN				Hancke, Kasper; Dalsgaard, Tage; Sejr, Mikael Kristian; Markager, Stiig; Glud, Ronnie Nohr			Phytoplankton Productivity in an Arctic Fjord (West Greenland): Estimating Electron Requirements for Carbon Fixation and Oxygen Production	PLOS ONE			English	Article							FLUORESCENCE EXCITATION-SPECTRA; AMPLITUDE-MODULATED FLUORESCENCE; IN-VIVO FLUORESCENCE; CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-II; MARINE-PHYTOPLANKTON; O-2 PRODUCTION; PHOTOSYNTHETIC PRODUCTION; CHARGE SEPARATION; LIGHT-ABSORPTION	Accurate quantification of pelagic primary production is essential for quantifying the marine carbon turnover and the energy supply to the food web. Knowing the electron requirement (K) for carbon (C) fixation (K-C) and oxygen (O-2) production (K-O2), variable fluorescence has the potential to quantify primary production in microalgae, and hereby increasing spatial and temporal resolution of measurements compared to traditional methods. Here we quantify K-C and K-O2 through measures of Pulse Amplitude Modulated (PAM) fluorometry, C fixation and O-2 production in an Arctic fjord (Godthabsfjorden, W Greenland). Through short- (2h) and long-term (24h) experiments, rates of electron transfer (ETRPSII), C fixation and/or O-2 production were quantified and compared. Absolute rates of ETR were derived by accounting for Photosystem II light absorption and spectral light composition. Two-hour incubations revealed a linear relationship between ETRPSII and gross C-14 fixation (R-2 = 0.81) during light-limited photosynthesis, giving a K-C of 7.6 +/- 0.6 (mean +/- S.E.) mole (mol C)(-1). Diel net rates also demonstrated a linear relationship between ETRPSII and C fixation giving a K-C of 11.2 +/- 1.3 mole (mol C)(-1) (R-2 = 0.86). For net O-2 production the electron requirement was lower than for net C fixation giving 6.5 +/- 0.9 mole (mol O-2)(-1) (R-2 = 0.94). This, however, still is an electron requirement 1.6 times higher than the theoretical minimum for O-2 production [i.e. 4 mole (mol O-2)(-1)]. The discrepancy is explained by respiratory activity and non-photochemical electron requirements and the variability is discussed. In conclusion, the bio-optical method and derived electron requirement support conversion of ETR to units of C or O-2, paving the road for improved spatial and temporal resolution of primary production estimates.	[Hancke, Kasper; Glud, Ronnie Nohr] Univ Southern Denmark, Dept Biol, Nord Ctr Earth Evolut NordCEE, Odense, Denmark; [Hancke, Kasper; Sejr, Mikael Kristian; Glud, Ronnie Nohr] Greenland Inst Nat Resources, Greenland Climate Res Ctr, Nuuk, Greenland; [Dalsgaard, Tage; Sejr, Mikael Kristian; Glud, Ronnie Nohr] Aarhus Univ, Arctic Res Ctr, Aarhus, Denmark; [Markager, Stiig] Aarhus Univ, Inst Biosci, Aarhus, Denmark; [Glud, Ronnie Nohr] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland	University of Southern Denmark; Greenland Institute of Natural Resources; Aarhus University; Aarhus University; UHI Millennium Institute	Hancke, K (corresponding author), Univ Southern Denmark, Dept Biol, Nord Ctr Earth Evolut NordCEE, Odense, Denmark.	khancke@biology.sdu.dk	Dalsgaard, Tage/J-6258-2014; Sejr, Mikael K./P-4235-2019; Markager, Stiig/I-7587-2013	Dalsgaard, Tage/0000-0003-2604-6499; Sejr, Mikael K./0000-0001-8370-5791; Glud, Ronnie N./0000-0002-7069-893X; Markager, Stiig/0000-0001-5427-2026	Nordic Center for Earth Evolution/Danish National Research Foundation (NordCEE, DNRF) [53]; Commission for Scientific Research in Greenland [GCRC6507]; Arctic Research Centre (ARC, Aarhus University); Canada Excellence Research Chair (CERC)	Nordic Center for Earth Evolution/Danish National Research Foundation (NordCEE, DNRF); Commission for Scientific Research in Greenland; Arctic Research Centre (ARC, Aarhus University); Canada Excellence Research Chair (CERC)	Funding is acknowledged to KH and RNG from the Nordic Center for Earth Evolution/Danish National Research Foundation (NordCEE, DNRF#53) and The Commission for Scientific Research in Greenland (GCRC6507). TD and MKS were supported by the Arctic Research Centre (ARC, Aarhus University) and the Canada Excellence Research Chair (CERC). This work is a part of the Greenland Institute of Natural Resources activities and a contribution to the Arctic Science Partnership (ASP) (asp-net.org).	Babin M, 1996, INT J REMOTE SENS, V17, P2417, DOI 10.1080/01431169608948781; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; BRICAUD A, 1990, LIMNOL OCEANOGR, V35, P562, DOI 10.4319/lo.1990.35.3.0562; CLEVELAND JS, 1993, LIMNOL OCEANOGR, V38, P1321, DOI 10.4319/lo.1993.38.6.1321; Cosgrove J, 2010, DEVEL APPL PHYCOL, V4, P1, DOI 10.1007/978-90-481-9268-7_1; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FALKOWSKI PG, 1986, BIOCHIM BIOPHYS ACTA, V849, P183, DOI 10.1016/0005-2728(86)90024-1; Flameling IA, 1998, LIMNOL OCEANOGR, V43, P284, DOI 10.4319/lo.1998.43.2.0284; Gaarder T., 1927, RAPP P VERB CONS INT, V42, P3; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilbert M, 2000, PHOTOSYNTHETICA, V38, P111, DOI 10.1023/A:1026708327185; Gilbert M, 2000, J PLANT PHYSIOL, V157, P307, DOI 10.1016/S0176-1617(00)80052-8; Grasshoff K, 1999, METHODS SEAWATER ANA; Halsey KH, 2010, PHOTOSYNTH RES, V103, P125, DOI 10.1007/s11120-009-9526-z; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; Hancke TB, 2008, J PHYCOL, V44, P803, DOI 10.1111/j.1529-8817.2008.00509.x; Hansen JW, 2000, MAR ECOL PROG SER, V208, P273, DOI 10.3354/meps208273; Johnsen G, 1997, LIMNOL OCEANOGR, V42, P1166, DOI 10.4319/lo.1997.42.5_part_2.1166; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Johnson KS, 2008, LIMNOL OCEANOGR, V53, P2237, DOI 10.4319/lo.2008.53.5_part_2.2237; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kromkamp JC, 2008, EUR J PHYCOL, V43, P327, DOI 10.1080/09670260802080895; KROON B, 1993, J PHYCOL, V29, P453, DOI 10.1111/j.1529-8817.1993.tb00146.x; Kruskopf M, 2006, NEW PHYTOL, V169, P525, DOI 10.1111/j.1469-8137.2005.01601.x; Lagaria A, 2011, BIOGEOSCIENCES, V8, P2595, DOI 10.5194/bg-8-2595-2011; LANGDON C, 1995, J GEOPHYS RES-OCEANS, V100, P6645, DOI 10.1029/94JC02286; Lawrenz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058137; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lippemeier S, 1999, J PLANKTON RES, V21, P269, DOI 10.1093/plankt/21.2.269; Longstaff BJ, 2002, PHOTOSYNTH RES, V74, P281, DOI 10.1023/A:1021279627409; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; Maranon E, 2004, LIMNOL OCEANOGR, V49, P1652, DOI 10.4319/lo.2004.49.5.1652; Markager S, 2001, J PLANKTON RES, V23, P1373, DOI 10.1093/plankt/23.12.1373; MARRA J, 1988, J EXP MAR BIOL ECOL, V115, P263, DOI 10.1016/0022-0981(88)90159-1; Marra J, 2007, PHYTOPLANKTON PRODUC, P78; Marra J, 2009, AQUAT MICROB ECOL, V56, P123, DOI 10.3354/ame01306; Masojidek J, 2001, J PLANKTON RES, V23, P57, DOI 10.1093/plankt/23.1.57; MITCHELL BG, 1988, DEEP-SEA RES, V35, P639, DOI 10.1016/0198-0149(88)90024-6; Morris EP, 2003, EUR J PHYCOL, V38, P133, DOI 10.1080/0967026031000085832; Napoleon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066423; Napoleon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040284; NEORI A, 1988, MAR ECOL PROG SER, V44, P297, DOI 10.3354/meps044297; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pei S, 2013, DEEP-SEA RES PT I, V82, P1, DOI 10.1016/j.dsr.2013.07.011; PETERSON BJ, 1980, ANNU REV ECOL SYST, V11, P359, DOI 10.1146/annurev.es.11.110180.002043; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rysgaard S, 2012, MAR CHEM, V128, P26, DOI 10.1016/j.marchem.2011.11.002; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Staehr PA, 2004, INT J REMOTE SENS, V25, P5117, DOI 10.1080/01431160410001716932; Steeman-Nielsen E., 1952, J CONSEIL INT EXPLOR, V18, P177; Suggett D, 2001, LIMNOL OCEANOGR, V46, P802, DOI 10.4319/lo.2001.46.4.0802; Suggett D, 2011, DEV APPL PHYCOLOGY, V4, DOI [10.1007/978-90-481-9268-7_6, DOI 10.1007/978-90-481-9268-7_]; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Williams PJL, 1996, J PLANKTON RES, V18, P1961, DOI 10.1093/plankt/18.10.1961; Yun MS, 2014, CONT SHELF RES, V76, P1, DOI 10.1016/j.csr.2014.01.001	66	17	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133275	10.1371/journal.pone.0133275	http://dx.doi.org/10.1371/journal.pone.0133275			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218096	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900024
J	Sawada, H; Oeda, T; Umemura, A; Tomita, S; Kohsaka, M; Park, K; Yamamoto, K; Sugiyama, H				Sawada, Hideyuki; Oeda, Tomoko; Umemura, Atsushi; Tomita, Satoshi; Kohsaka, Masayuki; Park, Kwiyoung; Yamamoto, Kenji; Sugiyama, Hiroshi			Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALPHA-SYNUCLEIN; SYSTEMIC INFLAMMATION; CHRONIC NEURODEGENERATION; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; MICROGLIA; BRAIN; RISK	Background C-reactive protein (CRP) is a biomarker of inflammation, and high levels of CRP correlate with vascular death. Chronic inflammation is considered to be involved in neurodegeneration, although there is no evidence linking it with the process of neurodegenerative diseases. Objective To determine the role of baseline CRP levels in the prognosis of patients with Parkinson disease (PD). Methods A cohort of 313 patients with a mean age of 69.1 and mean PD duration of 7.9 years was retrospectively followed for a mean observation time of 1,753 days. CRP was measured when patients were not diagnosed with any infections, and levels were repetitively measured to investigate a tendency of "regression to mean." The primary outcome measure was a survival time from study enrollment to death. Results During the observation period 56 patients died. Baseline CRP was log-linearly associated with a risk of death in PD. Mean survival time was 3,149 (95% confidence interval; 3,0093,289) days in patients with CRP <= 0.8mg/L (lower two thirds) and 2,620 (2,343-2,897) days in those with CRP >0.8 mg/L (top third, p<0.001, log-rank test). The adjusted hazard ratio (HR) per two-fold higher CRP concentration for all deaths was 1.29 (1.10-1.52), and after excluding PD-unrelated deaths, such as cancer or stroke, HR was 1.23 (1.01-1.49) (adjusted for age, sex, PD duration, modified Hohen-Yahr stages, MMSE scores, and serum albumin). Conclusions Baseline CRP concentrations were associated with the risk of death and predicted life prognosis of patients with PD. The associations were independent from PD duration, PD severity, cognitive function, ages, and nutritional conditions, suggesting the possibility that subclinical chronic inflammation is associated with a neurodegenerative process in PD.	[Sawada, Hideyuki] Natl Hosp Org, Natl Utano Hosp, Dept Neurol, Kyoto, Japan; Natl Hosp Org, Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan		Sawada, H (corresponding author), Natl Hosp Org, Natl Utano Hosp, Dept Neurol, Kyoto, Japan.	sawada@unh.hosp.go.jp	Yamamoto, Kenji/AAD-8766-2019; Umemura, Atsushi/ABC-4716-2021	Yamamoto, Kenji/0000-0003-1240-6369; Umemura, Atsushi/0000-0001-8557-6014; Sawada, Hideyuki/0000-0002-5909-3366; Tomita, Satoshi/0000-0003-4410-6539	National Hospital Organization in Japan; Grants-in-Aid for Scientific Research [26461287] Funding Source: KAKEN	National Hospital Organization in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by Grants-in-Aid from the National Hospital Organization in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima H, 2008, ARTERIOSCL THROM VAS, V28, P1385, DOI 10.1161/ATVBAHA.107.157164; BENSHLOMO Y, 1995, J NEUROL NEUROSUR PS, V58, P293, DOI 10.1136/jnnp.58.3.293; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Cao SW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-259; Cerejeira J, 2010, ACTA NEUROPATHOL, V119, P737, DOI 10.1007/s00401-010-0674-1; Closhen D, 2010, CYTOKINE, V50, P117, DOI 10.1016/j.cyto.2010.02.011; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Driver JA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d198; Ebadi M, 2003, ANTIOXID REDOX SIGN, V5, P319, DOI 10.1089/152308603322110896; Emberson JR, 2004, EUR J CARDIOV PREV R, V11, P125, DOI 10.1097/01.hjr.0000114967.39211.e5; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Gao XA, 2011, NEUROLOGY, V76, P863, DOI 10.1212/WNL.0b013e31820f2d79; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hristova K, 2014, NUTRITION, V30, P1085, DOI [10.1016/j.nut.2013.12.013, 10.1016/j.nut.2014.01.007]; Ibi M, 1999, J NEUROCHEM, V73, P1696, DOI 10.1046/j.1471-4159.1999.731696.x; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kuhlmann CRW, 2009, STROKE, V40, P1458, DOI 10.1161/STROKEAHA.108.535930; Levy G, 2002, NEUROLOGY, V59, P1708, DOI 10.1212/01.WNL.0000036610.36834.E0; Li YN, 2008, J NEUROSCI RES, V86, P3556, DOI 10.1002/jnr.21810; Lunnon K, 2011, J IMMUNOL, V186, P7215, DOI 10.4049/jimmunol.0903833; Matsumoto H, 2014, J NEUROL SCI, V343, P149, DOI 10.1016/j.jns.2014.05.060; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Morgante L, 2000, ARCH NEUROL-CHICAGO, V57, P507, DOI 10.1001/archneur.57.4.507; Mortensen RF, 2000, J LEUKOCYTE BIOL, V67, P495, DOI 10.1002/jlb.67.4.495; Nakanishi S, 2003, DIABETES CARE, V26, P2754, DOI 10.2337/diacare.26.10.2754; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Reynolds AD, 2008, J NEUROCHEM, V104, P1504, DOI 10.1111/j.1471-4159.2007.05087.x; Sawada H, 1996, J NEUROSCI RES, V43, P503, DOI 10.1002/(SICI)1097-4547(19960215)43:4<503::AID-JNR12>3.0.CO;2-2; Sawada H, 1996, J NEUROSCI RES, V43, P55, DOI 10.1002/jnr.490430107; Sawada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085886; Sharma SK, 2003, ANTIOXID REDOX SIGN, V5, P251, DOI 10.1089/152308603322110832; Umemura A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094944; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X	45	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134118	10.1371/journal.pone.0134118	http://dx.doi.org/10.1371/journal.pone.0134118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218286	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900081
J	Vashishta, M; Khan, N; Mehto, S; Sehgal, D; Natarajan, K				Vashishta, Mohit; Khan, Naeem; Mehto, Subhash; Sehgal, Devinder; Natarajan, Krishnamurthy			Pneumococal Surface Protein A (PspA) Regulates Programmed Death Ligand 1 Expression on Dendritic Cells in a Toll-Like Receptor 2 and Calcium Dependent Manner	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; IMMUNE-RESPONSE; PROTECTIVE IMMUNITY; ANTIBODIES; IMMUNIZATION; ACTIVATION; COMPLEMENT; INFECTION; RELEASE; ADULTS	Pneumonia leads to high mortality in children under the age of five years worldwide, resulting in close to 20 percent of all deaths in this age group. Therefore, investigations into host-pathogen interactions during Streptococcus pneumoniae infection are key in devising strategies towards the development of better vaccines and drugs. To that end, in this study we investigated the role of S. pneumoniae and its surface antigen Pneumococcal surface protein A (PspA) in modulating the expression of co-stimulatory molecule Programmed Death Ligand 1 (PD-L1) expression on dendritic cells (DCs) and the subsequent effects of increased PD-L1 on key defence responses. Our data indicate that stimulation of DCs with PspA increases the surface expression of PD-L1 in a time and dose dependent manner. Characterization of mechanisms involved in PspA induced expression of PD-L1 indicate the involvement of Toll-Like Receptor 2 (TLR2) and calcium homeostasis. While calcium release from intracellular stores positively regulated PD-L1 expression, calcium influx from external milieu negatively regulated PD-L1 expression. Increase in PD-L1 expression, when costimulated with PspA and through TLR2 was higher than when stimulated with PspA or through TLR2. Further, knockdown of TLR2 and the intermediates in the TLR signaling machinery pointed towards the involvement of a MyD88 dependent pathway in PspA induced PD-L1 expression. Incubation of DCs with S. pneumoniae resulted in the up-regulation of PD-L1 expression, while infection with a strain lacking surface PspA failed to do so. Our data also suggests the role of PspA in ROS generation. These results suggest a novel and specific role for PspA in modulating immune responses against S. pneumoniae by regulating PD-L1 expression.	[Vashishta, Mohit; Mehto, Subhash; Natarajan, Krishnamurthy] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India; [Khan, Naeem; Sehgal, Devinder] Natl Inst Immunol, Mol Immunol Lab, New Delhi 110067, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Vashishta, M (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India.	mohitp.biotech@gmail.com; devinder@nii.ac.in; knatarajan@acbr.du.ac.in	Khan, Naeem/ABB-4214-2021	Mehto, Subhash/0000-0002-5351-7850	University of Delhi; National Institute of Immunology	University of Delhi(University of Delhi); National Institute of Immunology	This work was funded by grants from the University of Delhi to KN and the intramural research programme of the National Institute of Immunology to DS. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Asmat TM, 2011, J BIOL CHEM, V286, P17861, DOI 10.1074/jbc.M110.212225; Bowers NL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003993; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Brown KE, 2010, CURR OPIN IMMUNOL, V22, P397, DOI 10.1016/j.coi.2010.03.007; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Buddhisa S, 2015, J IMMUNOL, V194, P4413, DOI 10.4049/jimmunol.1402417; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Cao J, 2013, J LEUKOCYTE BIOL, V93, P737, DOI 10.1189/jlb.0812428; Choi YW, 2005, VIROLOGY, V332, P454, DOI 10.1016/j.virol.2004.11.019; Colino J, 2003, J IMMUNOL, V171, P2354, DOI 10.4049/jimmunol.171.5.2354; CRAIN MJ, 1990, INFECT IMMUN, V58, P3293, DOI 10.1128/IAI.58.10.3293-3299.1990; Daniels CC, 2010, INFECT IMMUN, V78, P2163, DOI 10.1128/IAI.01199-09; Ginsburg AS, 2012, EXPERT REV VACCINES, V11, P279, DOI [10.1586/ERV.12.5, 10.1586/erv.12.5]; Goulart C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059605; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hollingshead SK, 2006, J MED MICROBIOL, V55, P215, DOI 10.1099/jmm.0.46268-0; Hotomi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058124; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Khan N, 2015, CLINICAL VAC IMM, V1, P99; Koedel U, 2003, J IMMUNOL, V170, P438, DOI 10.4049/jimmunol.170.1.438; Krishnappa LG, 2014, ACTA MICROBIOL IMM H, V61, P173, DOI 10.1556/AMicr.61.2014.2.7; Littmann M, 2009, EMBO MOL MED, V1, P211, DOI 10.1002/emmm.200900025; Mckay JT, 2015, J IMMUNOL, V194, P2289, DOI 10.4049/jimmunol.1401673; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Noske N, 2009, J IMMUNOL, V183, P1952, DOI 10.4049/jimmunol.0804383; Oma K, 2009, VACCINE, V27, P3181, DOI 10.1016/j.vaccine.2009.03.055; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Piao ZY, 2014, VACCINE, V32, P5607, DOI 10.1016/j.vaccine.2014.07.108; Rabe H, 2014, IMMUNOLOGY, V141, P467, DOI 10.1111/imm.12209; Rada B, 2014, INFLAMM RES, V63, P821, DOI 10.1007/s00011-014-0756-y; Ren B, 2004, INFECT IMMUN, V72, P114, DOI 10.1128/IAI.72.1.114-122.2004; Richard AL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004339; Rohatgi S, 2009, J IMMUNOL, V182, P5570, DOI 10.4049/jimmunol.0803254; Rosendahl A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00021; Selvakumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096427; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Singhal J, 2012, J BIOL CHEM, V287, P11108, DOI 10.1074/jbc.M111.300319; Tan TQ, 2012, CLIN MICROBIOL REV, V25, P409, DOI 10.1128/CMR.00018-12; Tart RC, 1996, J INFECT DIS, V173, P380, DOI 10.1093/infdis/173.2.380; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van Haasteren G, 1999, J RECEPT SIGNAL TR R, V19, P481, DOI 10.3109/10799899909036666; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wang JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00606; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; YOTHER J, 1992, J BACTERIOL, V174, P601, DOI 10.1128/jb.174.2.601-609.1992; Zdrenghea MT, 2012, MICROBES INFECT, V14, P495, DOI 10.1016/j.micinf.2012.01.002; Zhang JY, 2008, J IMMUNOL, V181, P3741, DOI 10.4049/jimmunol.181.6.3741	56	3	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133601	10.1371/journal.pone.0133601	http://dx.doi.org/10.1371/journal.pone.0133601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214513	Green Submitted, Green Published, gold			2022-12-26	WOS:000358594300023
J	Mortimer, M; Visser, K; de Beer, D; Joubert, E; Louw, A				Mortimer, M.; Visser, K.; de Beer, D.; Joubert, E.; Louw, A.			Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met	PLOS ONE			English	Article							ROOIBOS ASPALATHUS-LINEARIS; CAMELLIA-SINENSIS TEAS; HUMAN BREAST-CANCER; RANDOMIZED CONTROLLED-TRIAL; AFRICAN HERBAL TEAS; RECEPTOR-BETA; POSTMENOPAUSAL WOMEN; DRUG DISCOVERY; ALTERNATIVE MEDICINE; PHENOLIC COMPOSITION	The genus Cyclopia, an indigenous South African fynbos plant used to prepare honeybush tea, contains phytoestrogenic compounds. An extract from C. subternata, SM6Met, displays three desirable estrogenic attributes for future development of a phytoestrogenic nutraceutical, namely, ER alpha antagonism, ER beta agonism, and also antagonism of E-2-induced breast cancer cell proliferation. Activity-guided fractionation of SM6Met was used in an attempt to isolate and identify compounds conferring the desirable estrogenic profile to SM6Met. Initial liquid-liquid fractionation of SM6Met yielded a polar fraction (PF) and a non-polar fraction (NPF), with the desirable estrogenic attributes retained in the NPF. Subsequent high performance counter-current chromatography (HPCCC) fractionation of the NPF yielded three fractions (F1-F3). Interestingly, the fractions revealed separation of the previously demonstrated positive estrogenic attributes of the NPF into separate fractions, with F1 and F2 acting as ERa antagonists, only F2 inducing antagonism of E-2-induced breast cancer cell proliferation and only F3 retaining robust ER beta agonist activity. In terms of major polyphenols, quantitative HPLC and liquid chromatography tandem mass spectrometry (LC-MS/MS) indicated that HPCCC fractionation resulted in a divergence of polyphenolic classes, with F1 emerging as the dihydrochalcone-rich fraction and F2 as the flavanone- and benzophenone-rich fraction, while the xanthones, flavones and phenolic acids were retained in F3. F3 was re-engineered into F3R by reassembling the major polyphenols identified in the fraction. F3R could, however, not replicate the effect of F3. In conclusion, although activity-guided fractionation results suggest that retention of all the desirable estrogenic attributes of the original SM6Met in one fraction is not an attainable goal, fractionation is a useful tool to enhance specific desirable estrogenic attributes.	[Mortimer, M.; Visser, K.; Louw, A.] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, Western Cape, South Africa; [de Beer, D.; Joubert, E.] Agr Res Council South Africa Infruitec Nietvoorbi, Postharvest & Wine Technol Div, Stellenbosch, Western Cape, South Africa; [Joubert, E.] Univ Stellenbosch, Dept Food Sci, ZA-7600 Stellenbosch, Western Cape, South Africa	Stellenbosch University; Agricultural Research Council of South Africa; Stellenbosch University	Louw, A (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, Western Cape, South Africa.	al@sun.ac.za	De Beer, Dalene/E-8831-2010; Louw, Ann/A-7620-2012	De Beer, Dalene/0000-0002-3680-142X; Louw, Ann/0000-0002-1021-6732; Joubert, Elizabeth/0000-0002-9717-9769	Medical Research Council; Cancer Association of South Africa; National Research Foundation; Harry Crossley Foundation; National Research Foundation IFRR grant [85277]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Association of South Africa; National Research Foundation; Harry Crossley Foundation; National Research Foundation IFRR grant	The authors would like to thank the Medical Research Council (http://www.mrc.ac.za/) and the Cancer Association of South Africa (http://www.cansa.org.za/) for financial support to AL (grant for projects entitled "Cyclopia Phytoestrogens" and "Cyclopia and breast cancer") and for financial support to KV and MM the National Research Foundation (http://www.nrf.ac.za/) and the Harry Crossley Foundation (http://www.educationinnovations.org/funder/harry-crossley-foundation) is acknowledged. The National Research Foundation IFRR grant 85277 to EJ is also acknowledged. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors and therefore the funders do not accept any liability in regard thereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bader S, 2009, NAT BIOTECHNOL, V27, P427, DOI 10.1038/nbt0509-427; Al-Janabi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082576; Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Anderson LN, 2013, INT J CANCER, V132, P1683, DOI 10.1002/ijc.27788; Andlauer W, 2004, CLIN NUTR, V23, P989, DOI 10.1016/j.clnu.2003.11.009; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bartoszewski R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092128; Basu S. K., 2007, Australian Journal of Basic and Applied Sciences, V1, P637; Bedell S, 2014, J STEROID BIOCHEM, V139, P225, DOI 10.1016/j.jsbmb.2012.12.004; Beelders T, 2014, J NAT PROD, V77, P2694, DOI 10.1021/np5007247; Bhutani K., 2003, INDIAN J NATURAL PRO, V19, P3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carusi, 2000, Prim Care Update Ob Gyns, V7, P253, DOI 10.1016/S1068-607X(00)00055-X; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chawla R, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-35; Chen MF, 2011, APPETITE, V57, P253, DOI 10.1016/j.appet.2011.05.305; Collins-Burow BM, 2000, NUTR CANCER, V38, P229, DOI 10.1207/S15327914NC382_13; Das L, 2012, J FOOD SCI TECH MYS, V49, P173, DOI 10.1007/s13197-011-0269-4; de Beer D, 2012, MOLECULES, V17, P14602, DOI 10.3390/molecules171214602; de Kleijn MJJ, 2002, J NUTR, V132, P276, DOI 10.1093/jn/132.2.276; Dillard CJ, 2000, J SCI FOOD AGR, V80, P1744, DOI [10.1002/1097-0010(20000915)80:12<1744::AID-JSFA725>3.0.CO;2-W, 10.1002/1097-0010(20000915)80:12&lt;1744::AID-JSFA725&gt;3.0.CO;2-W]; Efferth T, 2011, CURR DRUG TARGETS, V12, P122, DOI 10.2174/138945011793591626; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904; Ghorbani A, 2012, EUR J NUTR, V51, P39, DOI 10.1007/s00394-011-0187-2; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hardy G, 2002, CURR OPIN CLIN NUTR, V5, P671, DOI 10.1097/00075197-200211000-00010; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hostettmann K, 1999, IUPAC, V70, P1; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Joubert E, 2008, J ETHNOPHARMACOL, V119, P376, DOI 10.1016/j.jep.2008.06.014; Joubert E, 2011, S AFR J BOT, V77, P887, DOI 10.1016/j.sajb.2011.05.014; Joubert E, 2008, J AGR FOOD CHEM, V56, P954, DOI 10.1021/jf072904a; Katiyar Chandrakant, 2012, Ayu, V33, P10, DOI 10.4103/0974-8520.100295; Kitalong C, 2012, REC NAT PROD, V6, P296; Kokate C, 1990, PHARMACOGNOSY, P105; Kokotkiewicz A, 2012, FOOD CHEM, V133, P1373, DOI 10.1016/j.foodchem.2012.01.114; Kong DX, 2009, DRUG DISCOV TODAY, V14, P115, DOI 10.1016/j.drudis.2008.07.002; Kronenberg F, 2002, ANN INTERN MED, V137, P805, DOI 10.7326/0003-4819-137-10-200211190-00009; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lee CJ, 2010, PHYTOTHER RES, V24, pS15, DOI 10.1002/ptr.2856; Li AP, 2001, DRUG DISCOV TODAY, V6, P357, DOI 10.1016/S1359-6446(01)01712-3; Louw A, 2013, PLANTA MED, V79, P580, DOI 10.1055/s-0032-1328463; Marnewick J, 2005, CANCER LETT, V224, P193, DOI 10.1016/j.canlet.2004.11.014; Marnewick JL, 2009, FOOD CHEM TOXICOL, V47, P220, DOI 10.1016/j.fct.2008.11.004; Marnewick JL, 2003, J AGR FOOD CHEM, V51, P8113, DOI 10.1021/jf0344643; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 1999, J MED CHEM, V42, P2456, DOI 10.1021/jm990101b; Mfenyana C, 2008, J STEROID BIOCHEM, V112, P74, DOI 10.1016/j.jsbmb.2008.08.005; Natarajan N., 2011, BIOMEDICINE PREVENTI, V1, P207, DOI DOI 10.1016/j.bionut.2011.07.001; Nikander E, 2004, J CLIN ENDOCR METAB, V89, P1207, DOI 10.1210/jc.2003-031166; Palmieri C, 2002, ENDOCR-RELAT CANCER, V9, P1, DOI 10.1677/erc.0.0090001; Park HJ, 2008, PHYTOMEDICINE, V15, P147, DOI 10.1016/j.phymed.2007.07.061; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Paruthiyil S, 2011, BREAST CANCER RES TR, V129, P777, DOI 10.1007/s10549-010-1273-5; Pasquet V, 2011, MAR DRUGS, V9, P819, DOI 10.3390/md9050819; Patwardhan B, 2009, DRUG DISCOV TODAY, V14, P804, DOI 10.1016/j.drudis.2009.05.009; Piersen Colleen E, 2003, Integr Cancer Ther, V2, P120, DOI 10.1177/1534735403002002004; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Rezaie R, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-18; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Shaaban AM, 2003, AM J SURG PATHOL, V27, P1502, DOI 10.1097/00000478-200312000-00002; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Sissing L, 2011, NUTR CANCER, V63, P600, DOI 10.1080/01635581.2011.539313; Soto AM, 2006, BEST PRACT RES CL EN, V20, P15, DOI 10.1016/j.beem.2005.09.001; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Sun J, 1999, ENDOCRINOLOGY, V140, P800, DOI 10.1210/en.140.2.800; Tsuboy MS, 2014, J MED FOOD, V17, P218, DOI 10.1089/jmf.2013.0067; van de Weijer PHM, 2002, MATURITAS, V42, P187, DOI 10.1016/S0378-5122(02)00080-4; van der Merwe JD, 2006, MUTAT RES-GEN TOX EN, V611, P42, DOI 10.1016/j.mrgentox.2006.06.030; Verhoog NJD, 2007, S AFR J SCI, V103, P13; Verhoog NJD, 2007, J AGR FOOD CHEM, V55, P4371, DOI 10.1021/jf063588n; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Wagner H, 2011, FITOTERAPIA, V82, P34, DOI 10.1016/j.fitote.2010.11.016; Zhu JTT, 2007, J AGR FOOD CHEM, V55, P2438, DOI 10.1021/jf063299z; Zych M, 2009, ACTA BIOCHIM POL, V56, P503	79	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132950	10.1371/journal.pone.0132950	http://dx.doi.org/10.1371/journal.pone.0132950			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208351	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000047
J	Scheelings, TF; Frith, SE				Scheelings, Titus Franciscus; Frith, Sarah Elizabeth			Anthropogenic Factors Are the Major Cause of Hospital Admission of a Threatened Species, the Grey-Headed Flying Fox (Pteropus poliocephalus), in Victoria, Australia	PLOS ONE			English	Article							PTEROPODIDAE; CHIROPTERA	To determine the reasons for presentation and outcomes of hospitalised grey-headed flying foxes (Pteropus poliocephalus) in Victoria, Australia, a retrospective analysis was performed on 532 records from two wildlife hospitals. Cases were categorised based on presenting signs and outcomes determined. Anthropogenic factors (63.7%) were a major cause of flying fox admissions with entanglement in fruit netting the most significant risk for bats (36.8%). Overall the mortality rate for flying fox admissions was 59.3%. This study highlights the effects of urbanisation on wild animal populations and a need for continued public education in order to reduce morbidity and mortality of wildlife, especially threatened species.	[Scheelings, Titus Franciscus] Healesville Sanctuary, Australian Wildlife Hlth Ctr, Healesville, Vic, Australia; [Frith, Sarah Elizabeth] Royal Melbourne Zool Gardens, Parkville, Vic, Australia		Scheelings, TF (corresponding author), Healesville Sanctuary, Australian Wildlife Hlth Ctr, Healesville, Vic, Australia.	fscheelings@zoo.org.au	Scheelings, Franciscus/GQH-4874-2022					Acevedo-Whitehouse K, 2009, PHILOS T R SOC B, V364, P3429, DOI 10.1098/rstb.2009.0128; Bradshaw CJA, 2012, J PLANT ECOL, V5, P109, DOI 10.1093/jpe/rtr038; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Duncan A, 1999, ACTION PLAN AUSTR BA, P85; EBY P, 1991, WILDLIFE RES, V18, P547, DOI 10.1071/WR9910547; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; Hall L.S., 2000, FLYING FOXES FRUIT B; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Ng JHJ, 2013, AUST J ZOOL, V61, P48, DOI 10.1071/ZO12126; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Saunders L, 2004, AUSTRALASIAN BAT SOC, V23, P18; Schenk AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093517; Schrader GM, 2010, J WILDLIFE DIS, V46, P1079, DOI 10.7589/0090-3558-46.4.1079; van der Ree R, 2006, J ZOOL, V268, P177, DOI 10.1111/j.1469-7998.2005.00005.x	15	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133638	10.1371/journal.pone.0133638	http://dx.doi.org/10.1371/journal.pone.0133638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207984	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000113
J	Simoes, RV; Munoz-Moreno, E; Carbajo, RJ; Gonzalez-Tendero, A; Illa, M; Sanz-Cortes, M; Pineda-Lucena, A; Gratacos, E				Simoes, Rui V.; Munoz-Moreno, Emma; Carbajo, Rodrigo J.; Gonzalez-Tendero, Anna; Illa, Miriam; Sanz-Cortes, Magdalena; Pineda-Lucena, Antonio; Gratacos, Eduard			In Vivo Detection of Perinatal Brain Metabolite Changes in a Rabbit Model of Intrauterine Growth Restriction (IUGR)	PLOS ONE			English	Article							H-1-NMR SPECTROSCOPY; GESTATIONAL-AGE; FETAL; TEMPERATURE; INFANTS; GLYCINE; INJURY; QUANTIFICATION; PERTURBATION; ASSOCIATION	Background Intrauterine growth restriction (IUGR) is a risk factor for abnormal neurodevelopment. We studied a rabbit model of IUGR by magnetic resonance imaging (MRI) and spectroscopy (MRS), to assess in vivo brain structural and metabolic consequences, and identify potential metabolic biomarkers for clinical translation. Methods IUGR was induced in 3 pregnant rabbits at gestational day 25, by 40-50% uteroplacental vessel ligation in one horn; the contralateral horn was used as control. Fetuses were delivered at day 30 and weighted. A total of 6 controls and 5 IUGR pups underwent T2-w MRI and localized proton MRS within the first 8 hours of life, at 7T. Changes in brain tissue volumes and respective contributions to each MRS voxel were estimated by semi-automated registration of MRI images with a digital atlas of the rabbit brain. MRS data were used for: (i) absolute metabolite quantifications, using linear fitting; (ii) local temperature estimations, based on the water chemical shift; and (iii) classification, using spectral pattern analysis. Results Lower birth weight was associated with (i) smaller brain sizes, (ii) slightly lower brain temperatures, and (iii) differential metabolite profile changes in specific regions of the brain parenchyma. Specifically, we found estimated lower levels of aspartate and N-acetylaspartate (NAA) in the cerebral cortex and hippocampus (suggesting neuronal impairment), and higher glycine levels in the striatum (possible marker of brain injury). Our results also suggest that the metabolic changes in cortical regions are more prevalent than those detected in hippocampus and striatum. Conclusions IUGR was associated with brain metabolic changes in vivo, which correlate well with the neurostructural changes and neurodevelopment problems described in IUGR. Metabolic parameters could constitute non invasive biomarkers for the diagnosis and abnormal neurodevelopment of perinatal origin.	[Simoes, Rui V.; Munoz-Moreno, Emma; Gonzalez-Tendero, Anna; Illa, Miriam; Sanz-Cortes, Magdalena; Gratacos, Eduard] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Simoes, Rui V.; Munoz-Moreno, Emma; Gonzalez-Tendero, Anna; Illa, Miriam; Sanz-Cortes, Magdalena; Gratacos, Eduard] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, Hosp St Joan de Deu, Fetal i D Fetal Med Res Ctr,IDIBAPS, Barcelona, Spain; [Carbajo, Rodrigo J.; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Struct Biochem Lab, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Prince Felipe Research Center	Gratacos, E (corresponding author), Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain.	gratacos@clinic.ub.es	Simoes, Rui Vasco/AAB-3303-2020; Muñoz-Moreno, Emma/ABD-6424-2021; Muñoz-Moreno, Emma/A-2363-2016; Gratacos, Eduard/AAR-4939-2020; Pineda-Lucena, Antonio/B-1320-2014	Simoes, Rui Vasco/0000-0001-7574-4723; Muñoz-Moreno, Emma/0000-0003-2104-7265; Muñoz-Moreno, Emma/0000-0003-2104-7265; Gratacos, Eduard/0000-0002-7405-7224; Pineda-Lucena, Antonio/0000-0002-3532-8781; Illa, Miriam/0000-0002-8366-830X; Sanz-Cortes, Magda/0000-0002-0265-9859	Obra Social "La Caixa" (Barcelona, Spain); Fundacion Dexeus (Barcelona, Spain); AGAUR SGR [928]; Ministerio de Ciencia e Innovacion [SAF2011-28350]	Obra Social "La Caixa" (Barcelona, Spain)(La Caixa Foundation); Fundacion Dexeus (Barcelona, Spain); AGAUR SGR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work funded by grants from Obra Social "La Caixa" (Barcelona, Spain), Fundacion Dexeus (Barcelona, Spain), AGAUR 2014 SGR (grant no 928), and Ministerio de Ciencia e Innovacion (SAF2011-28350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als H, 2011, J PERINATOL, V31, P130, DOI 10.1038/jp.2010.81; Baschat AA, 2004, OBSTET GYNECOL SURV, V59, P617, DOI 10.1097/01.OGX.0000133943.54530.76; Bassan H, 2000, PEDIATR NEPHROL, V15, P192, DOI 10.1007/s004670000457; Batalle D, 2014, NEUROIMAGE, V100, P24, DOI 10.1016/j.neuroimage.2014.05.065; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Bishop C. M, 2006, PATTERN RECOGNITION; BOTTOMLEY PA, 1984, Patent No. 4480228; Cerdan S, 2006, NEUROCHEM INT, V48, P523, DOI 10.1016/j.neuint.2005.12.036; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Corbett RJT, 1999, AM J NEURORADIOL, V20, P1851; Cruz-Lemini M, 2012, FETAL DIAGN THER, V32, P116, DOI 10.1159/000333001; Derrick M, 2004, J NEUROSCI, V24, P24, DOI 10.1523/JNEUROSCI.2816-03.2004; Dezortova M, 2008, EUR J RADIOL, V67, P240, DOI 10.1016/j.ejrad.2008.02.035; Duda R.O., 2006, PATTERN CLASSIFICATI; Egana-Ugrinovic G, 2014, PRENATAL DIAG, V34, P843, DOI 10.1002/pd.4381; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Erickson KM, 2003, ANESTH ANALG, V96, P1460, DOI 10.1213/01.ANE.0000061221.23197.CE; Figueras F, 2009, PEDIATRICS, V124, pE934, DOI 10.1542/peds.2008-3346; Haber S, 2001, BRAIN RES, V896, P102, DOI 10.1016/S0006-8993(01)02065-0; Hall M.A, 1999, CORRELATION BASED FE; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hernandez-Andrade E, 2014, NEUROSCI LETT; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Illa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076453; Kiyatkin EA, 2005, PHYSIOL BEHAV, V84, P563, DOI 10.1016/j.physbeh.2005.02.002; Knobel R, 2007, JOGNN-J OBST GYN NEO, V36, P280, DOI 10.1111/j.1552-6909.2007.00149.x; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Lu Y, 2012, NEUROCHEM INT, V61, P649, DOI 10.1016/j.neuint.2012.07.005; Masoller N, 2014, ULTRASOUND OBST GYN, V44, P2; Munoz-Moreno E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067418; Narendran V, 1999, J PEDIATR-US, V134, P529, DOI 10.1016/S0022-3476(99)70232-5; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; NEWELL DW, 1995, BRAIN RES, V675, P38, DOI 10.1016/0006-8993(95)00039-S; Ortega-Martorell S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-106; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Pardo B, 2011, J CEREBR BLOOD F MET, V31, P90, DOI 10.1038/jcbfm.2010.146; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Sanz-Cortes M, 2014, FETAL DIAGN THER; Simoes RV, 2010, NMR BIOMED, V23, P23, DOI 10.1002/nbm.1421; Story L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.032; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tristan-Vega A, 2007, FAST B SPLINE PSEUDO, P768; van Vliet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064545; Simoes RV, 2012, INTEGR BIOL-UK, V4, P183, DOI 10.1039/c2ib00079b; Warfield SK, 2002, ADV NONRIGID REGISTR, P661; WEINBERG JM, 1987, J CLIN INVEST, V80, P1446, DOI 10.1172/JCI113224; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	51	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131310	10.1371/journal.pone.0131310	http://dx.doi.org/10.1371/journal.pone.0131310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208165	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000015
J	Yang, L; Yu, SJ; Hong, Q; Yang, Y; Shao, ZM				Yang, Liu; Yu, San-Jian; Hong, Qi; Yang, Yu; Shao, Zhi-Ming			Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer	PLOS ONE			English	Article							DNA METHYLATION; MAMMALIAN DNA; HUMAN-DISEASE; 5-HYDROXYMETHYLCYTOSINE; MALIGNANCIES; DYNAMICS; MELANOMA; CHINA	Purpose The purpose of this study was to determine the prognostic role of ten eleven translocation (TET) family proteins and DNA glycosylase (TDG) in patients with early breast cancer (EBC). Methods Expression of mRNAs encoding TET1-3 and TDG in 162 breast cancer tissues was quantified using real-time polymerase chain reaction analysis. The general characteristics of patients and clinicopathologic factors were collected. Estimation of patient survival was calculated using the Kaplan-Meier method, and independent prognostic indicators were analyzed using Cox regression analysis. Results The level of TET1 mRNA was significantly related to overall survival (OS) (P = 0.022). Multivariate analysis shows that the TNM stage was an independent predictor of disease-free survival (DFS) (HR = 1.761, 95% CI: 1.124-2.761, P = 0.014) and OS (HR = 2.135, 95% CI: 1.070-4.263, P = 0.032). Further, in patients with EBC who were treated with anthracy-clines, Kaplan-Meier analysis indicates that the levels of TET3 and TDG mRNAs were related to DFS (P = 0.026 and 0.030, respectively), and multivariate analysis reveals that high levels of TET3 (HR = 1.944, 95% CI: 1.029-3.672, P = 0.040) and TDG (HR = 2.178, 95% CI: 1.140-4.163, P = 0.018) mRNAs were independent indicators of favorable DFS. Conclusions Our study indicates that EBC patients with decreased expression of TET1 mRNA had worse OS and that the levels of TET3 and TDG mRNAs were independent prognostic factors for patients who received anthracycline chemotherapy.	[Yang, Liu; Yu, San-Jian; Hong, Qi; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China; [Yang, Liu; Yu, San-Jian; Hong, Qi; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Hong, Qi; Shao, Zhi-Ming] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yang, Yu] Chengdu Univ Tradit Chinese Med, Sch Basic Med Sci, Chengdu, Peoples R China	Fudan University; Fudan University; Fudan University; Chengdu University of Traditional Chinese Medicine	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [30971143, 30972936, 81302303]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; Key Clinical Program of the Ministry of Health; Shanghai Key laboratory of Breast Cancer [12DZ2260100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai United Developing Technology Project of Municipal Hospitals; Key Clinical Program of the Ministry of Health; Shanghai Key laboratory of Breast Cancer	This research is supported by grants from the National Natural Science Foundation of China (30971143, 30972936, and 81302303), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the Key Clinical Program of the Ministry of Health (2010-2012), and the Shanghai Key laboratory of Breast Cancer (12DZ2260100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet A, 2014, J GERONTOL A-BIOL, V69, pS17, DOI 10.1093/gerona/glu042; Chen L, 2012, BREAST CANCER RES TR, V136, P565, DOI 10.1007/s10549-012-2265-4; Chung YR, 2012, INT J HEMATOL, V96, P413, DOI 10.1007/s12185-012-1181-z; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Gambichler T, 2013, MELANOMA RES, V23, P218, DOI 10.1097/CMR.0b013e32835f9bd4; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hassan MSU, 2010, ONCOL REP, V24, P1121, DOI 10.3892/or_00000963; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hong W, 2014, CANCER LETT, V351, P1, DOI 10.1016/j.canlet.2014.04.007; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Justo N, 2013, ONCOLOGIST, V18, P248, DOI 10.1634/theoncologist.2012-0373; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Milstein M, 2007, CANCER RES, V67, P11510, DOI 10.1158/0008-5472.CAN-07-1147; Nickerson ML, 2013, HUM MUTAT, V34, P1231, DOI 10.1002/humu.22346; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi S, 2013, INT J MOL MED, V32, P532, DOI 10.3892/ijmm.2013.1417; Takeshima H, 2015, CARCINOGENESIS, V36, P192, DOI 10.1093/carcin/bgu238; Thiagarajan RD, 2014, EPIGENOMICS-UK, V6, P121, DOI 10.2217/epi.13.80; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu Q, 2014, ONCOTARGET, V5, P11552, DOI 10.18632/oncotarget.2594; Wu YC, 2014, HISTOL HISTOPATHOL, V29, P991, DOI 10.14670/HH-29.991; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	29	47	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133896	10.1371/journal.pone.0133896	http://dx.doi.org/10.1371/journal.pone.0133896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207381	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000168
J	Zhu, ZB; Yuan, DJ; Luo, DH; Lu, XT; Huang, S				Zhu, Zuobin; Yuan, Dejian; Luo, Denghui; Lu, Xitong; Huang, Shi			Enrichment of Minor Alleles of Common SNPs and Improved Risk Prediction for Parkinson's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LRRK2 MUTATION; EFFECT SIZES; GENE; COMPLEX; FREQUENT; ATP13A2; VPS35	Parkinson disease (PD) is the second most common neurodegenerative disorder in the aged population and thought to involve many genetic loci. While a number of individual single nucleotide polymorphisms (SNPs) have been linked with PD, many remain to be found and no known markers or combinations of them have a useful predictive value for sporadic PD cases. The collective effects of genome wide minor alleles of common SNPs, or the minor allele content (MAC) in an individual, have recently been shown to be linked with quantitative variations of numerous complex traits in model organisms with higher MAC more likely linked with lower fitness. Here we found that PD cases had higher MAC than matched controls. A set of 37564 SNPs with MA (MAF < 0.4) more common in cases (P < 0.05) was found to have the best predictive accuracy. A weighted risk score calculated by using this set can predict 2% of PD cases (100% specificity), which is comparable to using familial PD genes to identify familial PD cases. These results suggest a novel genetic component in PD and provide a useful genetic method to identify a small fraction of PD cases.	[Zhu, Zuobin; Yuan, Dejian; Luo, Denghui; Lu, Xitong; Huang, Shi] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China	Central South University	Huang, S (corresponding author), Cent S Univ, State Key Lab Med Genet, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	huangshi@sklmg.edu.cn		zhu, zuobin/0000-0003-1022-5943	National Natural Science Foundation of China grant [81171880]; National Basic Research Program of China grant [2011CB51001]	National Natural Science Foundation of China grant(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China grant(National Basic Research Program of China)	This work was supported by The National Natural Science Foundation of China grant, grant number: 81171880, (URL: http://www.nsfc.gov.cn/) and The National Basic Research Program of China grant, grant number: 2011CB51001 (SH) (URL: http://www.nsfc.gov.cn/).	Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Chen Bowang, 2009, BMC Res Notes, V2, P214, DOI 10.1186/1756-0500-2-214; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Di Fonzo A, 2005, LANCET, V365, P412; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Fung KL, 2014, CANCER RES, V74, P598, DOI 10.1158/0008-5472.CAN-13-2064; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Hall TO, 2013, GENET MED, V15, P361, DOI 10.1038/gim.2012.109; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hand DJ, 2010, STAT MED, V29, P1502, DOI 10.1002/sim.3859; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Hu TB, 2013, SCI CHINA LIFE SCI, V56, P254, DOI 10.1007/s11427-013-4452-x; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kang J, 2011, HUM MOL GENET, V20, P2435, DOI 10.1093/hmg/ddr116; Kay DM, 2006, MOVEMENT DISORD, V21, P519, DOI 10.1002/mds.20751; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Pepe MS, 2008, JNCI-J NATL CANCER I, V100, P978, DOI 10.1093/jnci/djn215; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yuan D., 2012, ARXIV12092911; Yuan DJ, 2014, SCI CHINA LIFE SCI, V57, P876, DOI 10.1007/s11427-014-4704-4; Zhu Z, 2015, GENOMICS; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	46	15	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133421	10.1371/journal.pone.0133421	http://dx.doi.org/10.1371/journal.pone.0133421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207627	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000089
J	Hernandez-Pando, R; Barrios-Payan, J; Mata-Espinosa, D; Marquina-Castillo, B; Hernandez-Ramirez, D; Botasso, OA; Bini, EI				Hernandez-Pando, Rogelio; Barrios-Payan, Jorge; Mata-Espinosa, Dulce; Marquina-Castillo, Brenda; Hernandez-Ramirez, Diego; Adelmo Botasso, Oscar; Isabel Bini, Estela			The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis	PLOS ONE			English	Article							CHROMOSOMAL-PROTEINS; CELL RECRUITMENT; RELEASE; INFLAMMATION; CYTOKINE; LOCALIZATION; ACTIVATION; APOPTOSIS; KINETICS	Background The high mobility group box 1 (HMGB1) is the prototype of alarmin protein released by stressed or dying cells. The redox state of this protein confers different functions in the regulation of inflammation and immune response. Aim Determine the kinetics, cellular sources and function of HMGB1 in experimental tuberculosis. Methods BALB/c mice were infected with Mycobacterium tuberculosis strain H37Rv. At different time points, HMGB1 was quantified in bronchial lavage fluid (BALF) and in lungs was determined its cellular sources by immunohistochemistry. HMGB1 was blocked with specific antibodies or recombinant HMGB1 was administered during early or late infection. Bacilli burdens, inflammation and cytokines expression were determined. Results The maximal concentration of HMGB1 in BALF was at day one of infection. Bronchial epithelium and macrophages were the most important sources. At day 7 to 21 the oxidized HMGB1 was predominant, while during late infection only the reduced form was seen. Blocking HMGB1 during early infection produced significant decrease of bacilli burdens and high production of pro-inflammatory cytokines, while the opposite was seen when HMGB1 was administered. Blocking HMGB1 activity or administrated it in high amounts during late infection worsening the disease. Conclusions HMGB1 is liberated during experimental tuberculosis and promotes or suppress the immune response and inflammation depending on the redox state.	[Hernandez-Pando, Rogelio; Barrios-Payan, Jorge; Mata-Espinosa, Dulce; Marquina-Castillo, Brenda; Isabel Bini, Estela] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City 14000, DF, Mexico; [Hernandez-Ramirez, Diego] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Immunol, Mexico City 14000, DF, Mexico; [Adelmo Botasso, Oscar; Isabel Bini, Estela] Inst Expt & Clin Immunol, Rosario, Santa Fe, Argentina; [Adelmo Botasso, Oscar; Isabel Bini, Estela] Consejo Nacl Invest Cient & Tecn, IDICER, Sch Med Sci, RA-3100 Santa Fe, Argentina; [Adelmo Botasso, Oscar; Isabel Bini, Estela] Consejo Nacl Invest Cient & Tecn, IDICER, Sch Med Sci, RA-2000 Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bini, EI (corresponding author), Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City 14000, DF, Mexico.	estelabini@yahoo.com.ar	Bini, Estela/F-8924-2018	Bini, Estela/0000-0001-9256-429X; Hernandez-Ramirez, Diego/0000-0001-7293-2278; Hernandez-Pando, Rogelio/0000-0003-1292-3833	DMM Company of Biologists, England; Bilateral International Project Argentina/Mexico, CONICET/CONACYT [190527]	DMM Company of Biologists, England; Bilateral International Project Argentina/Mexico, CONICET/CONACYT	Estela Isabel Bini was awarded with a travelling fellowship from DMM Company of Biologists, England. This work was supported by the Bilateral International Project Argentina/Mexico, CONICET/CONACYT, number 190527.	Adolfo RBV, 2006, EUR J IMMUNOL, V36, P345, DOI 10.1002/eji.200535202; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Hernandez-Pando R, 2001, EXP TOXICOL PATHOL, V53, P257, DOI 10.1078/0940-2993-00182; HernandezPando R, 1997, IMMUNOLOGY, V90, P607, DOI 10.1046/j.1365-2567.1997.00193.x; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Jiang WW, 2007, J IMMUNOL, V178, P6495, DOI 10.4049/jimmunol.178.10.6495; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Li GQ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00068; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pisetsky DS, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13256; Rook GAW, 1996, ANNU REV MICROBIOL, V50, P259, DOI 10.1146/annurev.micro.50.1.259; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wild CA, 2012, INT IMMUNOL, V24, P485, DOI 10.1093/intimm/dxs051; Wu AH, 2015, EVID BASE COMPL ALTE, V2015, P1; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang LT, 2008, SHOCK, V30, P449, DOI 10.1097/SHK.0b013e3181672495	37	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133200	10.1371/journal.pone.0133200	http://dx.doi.org/10.1371/journal.pone.0133200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201072	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100056
J	Johnston, DW; Frungillo, J; Smith, A; Moore, K; Sharp, B; Schuh, J; Read, AJ				Johnston, David W.; Frungillo, Jaime; Smith, Ainsley; Moore, Katie; Sharp, Brian; Schuh, Janelle; Read, Andrew J.			Trends in Stranding and By-Catch Rates of Gray and Harbor Seals along the Northeastern Coast of the United States: Evidence of Divergence in the Abundance of Two Sympatric Phocid Species?	PLOS ONE			English	Article							HALICHOERUS-GRYPUS; GREY SEALS; POPULATION TRENDS; DISTEMPER VIRUS; SABLE-ISLAND; VITULINA; MORTALITY; MASSACHUSETTS; INFLUENZA	Harbor seals and gray seals are sympatric phocid pinnipeds found in coastal waters of the temperate and sub-Arctic North Atlantic. In the Northwest Atlantic, both species were depleted through a combination of subsistence hunts and government supported bounties, and are now re-occupying substantial portions of their original ranges. While both species appear to have recovered during the past 2 decades, our understanding of their population dynamics in US waters is incomplete. Here we describe trends in stranding and bycatch rates of harbor and gray seals in the North East United States (NEUS) over the past 16 years through an exploratory curve-fitting exercise and structural break-point analysis. Variability in gray seal strandings in Southern New England and bycatch in the Northeast Sink Gillnet Fishery were best described by fitting positive exponential and linear models, and exhibited rates of increase as high as 22%. In contrast, neither linear nor exponential models fit the oscillation of harbor seal strandings and bycatch over the study period. However, a breakpoint Chow test revealed that harbor seal strandings in the Cape Cod, Massachusetts region and harbor seal bycatch in the Northeast Sink Gillnet Fishery increased in the 1990s and then started declining in the early to mid-2000s. Our analysis indicates that ongoing variation in natural and anthropogenic mortality rates of harbor and gray seals in the NEUS is not synchronous, and likely represents diverging trends in abundance of these species as they assume new roles in the marine ecosystems of the region.	[Johnston, David W.; Frungillo, Jaime; Smith, Ainsley; Read, Andrew J.] Duke Univ, Nicholas Sch Environm, Marine Lab, Div Marine Sci & Conservat, Beaufort, NC 28516 USA; [Smith, Ainsley] Integrated Stat, Woods Hole, MA 02543 USA; [Moore, Katie; Sharp, Brian] Int Fund Anim Welf, Marine Mammal Rescue & Res Program, Yarmouth Port, MA 02675 USA; [Schuh, Janelle] Sea Res Fdn, Anim Rescue Program, Mystic, CT 06355 USA	Duke University	Johnston, DW (corresponding author), Duke Univ, Nicholas Sch Environm, Marine Lab, Div Marine Sci & Conservat, 135 Duke Marine Lab Rd, Beaufort, NC 28516 USA.	david.johnston@duke.edu	Read, Andrew/AAE-8386-2019; Johnston, David/AAJ-5013-2020	Frungillo, Jaime/0000-0001-5636-0927; Johnston, David/0000-0003-2424-036X	Duke University Marine Laboratory	Duke University Marine Laboratory	This project would not have been possible without the help of the many volunteers who contributed to stranding response in the NEUS. We would like to thank Jerry Moxley, Susan Heaslip, Kristina Cammen, Ari Friedlaender, Nichola Hill and Wendy Puryear for providing feedback on drafts of this manuscript. This paper constitutes Sea Research Foundation publication #254. This project was supported in part by the Duke University Marine Laboratory.	Baird RW, 2001, CAN FIELD NAT, V115, P663; Barlas ME, 1999, DISTRIBUTION ABUNDAN; Bodewes R, 2015, EMERGING INFECT DIS, V21; Bodewes R, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.2; Boehme L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053000; Bogomolni AL, 2010, DIS AQUAT ORGAN, V88, P143, DOI 10.3354/dao02146; Bowen WD, 2003, ICES J MAR SCI, V60, P1265, DOI 10.1016/S1054-3139(03)00147-4; Bowen WD, 2003, J ZOOL, V261, P155, DOI 10.1017/S0952836903004047; Brasseur SMJM, 2015, MAR MAMMAL SCI, V31, P405, DOI 10.1111/mms.12160; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; CORNWELL HJC, 1992, SCI TOTAL ENVIRON, V115, P99, DOI 10.1016/0048-9697(92)90036-R; Curtis TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099240; DiGiovanni R, 2011, 19 BIENN C BIOL MAR; Geraci JR., 1993, MARINE MAMMALS ASHOR, P371; GILMARTIN WG, 1995, CAN J ZOOL, V73, P1185, DOI 10.1139/z95-141; HANSEN S, 1995, PHYSIOL ZOOL, V68, P290, DOI 10.1086/physzool.68.2.30166505; Hanson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080727; Harris DE, 2003, NORTHEAST NAT, V10, P141, DOI 10.2307/3858283; Hayes S.A., 2012, DRAFT US ATLANTIC GU, P96; Johnston DW, 2012, PLOS ONE, V7; Lelli B, 2009, NORTHEAST NAT, V16, P239, DOI 10.1656/045.016.0206; Lonergan M, 2007, J ZOOL, V271, P261, DOI 10.1111/j.1469-7998.2007.00311.x; Lonergan M, 2011, ICES J MAR SCI, V68, P2201, DOI 10.1093/icesjms/fsr161; Lucas Z, 2000, J ZOOL, V252, P405, DOI 10.1017/S0952836900000157; McPherson JM, 2009, DIVERS DISTRIB, V15, P880, DOI 10.1111/j.1472-4642.2009.00596.x; Mowat F., 2004, SEA OF SLAUGHTER; Murray MJ, 2008, BEHAV INTERACTIONS H; Osinga N, 2012, J COMP PATHOL, V147, P550, DOI 10.1016/j.jcpa.2012.04.001; Pannozzo L., 2013, DEVIL DEEP BLUE SEA; Peltier H, 2014, ECOL INDIC, V39, P203, DOI 10.1016/j.ecolind.2013.12.019; Pyenson ND, 2011, P ROY SOC B-BIOL SCI, V278, P3608, DOI 10.1098/rspb.2011.0441; R Core Team, 2021, R LANGUAGE ENV STAT; Runstadler J, 2013, INFECT GENET EVOL, V17, P162, DOI 10.1016/j.meegid.2013.02.020; Skomal Gregory B., 2012, P405; Soulen BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068779; Svensson CJ, 2011, AMBIO, V40, P52, DOI 10.1007/s13280-010-0091-7; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thompson Dave, 2010, NAMMCO Scientific Publications, V8, P117; van Neer A, 2014, J SEA RES ELSEVIER B, V97, P1; Waring GT, 2013, US ATLANTIC IN PRESS, P236; WEBSTER RG, 1981, VIROLOGY, V113, P712, DOI 10.1016/0042-6822(81)90200-2; Wood SA, 2011, CAN J ZOOL, V89, P490, DOI 10.1139/Z11-012	43	8	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131660	10.1371/journal.pone.0131660	http://dx.doi.org/10.1371/journal.pone.0131660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200461	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100019
J	Malik, A; Lee, EJ; Jan, AT; Ahmad, S; Cho, KH; Kim, J; Choi, I				Malik, Adeel; Lee, Eun Ju; Jan, Arif Tasleem; Ahmad, Sarafraz; Cho, Kyung-Hyun; Kim, Jihoe; Choi, Inho			Network Analysis for the Identification of Differentially Expressed Hub Genes Using Myogenin Knock-down Muscle Satellite Cells	PLOS ONE			English	Article							COMMUNITY STRUCTURE; CYCLE WITHDRAWAL; SKELETAL; MYOD; MYF-5; ROLES; IG	Muscle, a multinucleate syncytium formed by the fusion of mononuclear myoblasts, arises from quiescent progenitors (satellite cells) via activation of muscle-specific transcription factors (MyoD, Myf5, myogenin: MYOG, and MRF4). Subsequent to a decline in Pax7, induction in the expression of MYOG is a hallmark of myoblasts that have entered the differentiation phase following cell cycle withdrawal. It is evident that MYOG function cannot be compensated by any other myogenic regulatory factors (MRFs). Despite a plethora of information available regarding MYOG, the mechanism by which MYOG regulates muscle cell differentiation has not yet been identified. Using an RNA-Seq approach, analysis of MYOG knock-down muscle satellite cells (MSCs) have shown that genes associated with cell cycle and division, DNA replication, and phosphate metabolism are differentially expressed. By constructing an interaction network of differentially expressed genes (DEGs) using Gene-MANIA, cadherin-associated protein (CTNNA2) was identified as the main hub gene in the network with highest node degree. Four functional clusters (modules or communities) were identified in the network and the functional enrichment analysis revealed that genes included in these clusters significantly contribute to skeletal muscle development. To confirm this finding, in vitro studies revealed increased expression of CTNNA2 in MSCs on day 12 compared to day 10. Expression of CTNNA2 was decreased in MYOG knock-down cells. However, knocking down CTNNA2, which leads to increased expression of extracellular matrix (ECM) genes (type I collagen alpha 1 and type I collagen alpha 2) along with myostatin (MSTN), was not found significantly affecting the expression of MYOG in C2C12 cells. We therefore propose that MYOG exerts its regulatory effects by acting upstream of CTNNA2, which in turn regulates the differentiation of C2C12 cells via interaction with ECM genes. Taken together, these findings highlight a new mechanism by which MYOG interacts with CTNNA2 in order to promote myoblast differentiation.	[Malik, Adeel; Lee, Eun Ju; Jan, Arif Tasleem; Ahmad, Sarafraz; Cho, Kyung-Hyun; Kim, Jihoe; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Malik, Adeel] Perdana Univ, Ctr Bioinformat, Serdang 43400, Selangor, Malaysia; [Lee, Eun Ju; Choi, Inho] Yeungnam Univ, Bovine Genome Resources Bank, Gyongsan, South Korea	Yeungnam University; Perdana University; Yeungnam University	Choi, I (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	inhochoi@ynu.ac.kr	Jan, Arif Tasleem/AAX-6531-2020; Malik, Adeel/ABD-4831-2020	Jan, Arif Tasleem/0000-0002-3607-543X; Malik, Adeel/0000-0002-3453-6001	National Research Foundation of Korea (NRF) - Republic of Korea government (MSIP) [2014R1A2A2A01006324]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2059308]	National Research Foundation of Korea (NRF) - Republic of Korea government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Republic of Korea government (MSIP; no. 2014R1A2A2A01006324) along with the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2059308).	Abe T, 2004, BRAIN RES, V1009, P159, DOI 10.1016/j.brainres.2004.03.003; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; [Anonymous], INT J INFORM TECHNOL; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bischoff R, 1994, MYOLOGY, P97; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; COSSU G, 1987, CURR TOP DEV BIOL, V23, P185; Desaphy JF, 1998, AM J PHYSIOL-CELL PH, V275, pC1465, DOI 10.1152/ajpcell.1998.275.6.C1465; Dinh P, 2007, BREAST, V16, pS10, DOI 10.1016/j.breast.2007.07.032; Firoz A, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/837365; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Janot M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-483; Kablar B, 1998, BIOCHEM CELL BIOL, V76, P1079, DOI 10.1139/bcb-76-6-1079; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079780; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063627; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060372; Lee Seung-Hwan, 2014, J Anim Sci Technol, V56, P2, DOI 10.1186/2055-0391-56-2; Li Y, 2010, INT J BIOL SCI, V6, P350; Liu QC, 2012, J MOL CELL BIOL, V4, P386, DOI 10.1093/jmcb/mjs045; Malik A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095480; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Mohun T, CURR OPIN CELL BIOL, V4, P923; Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; OLSON EN, 1991, MOL CELL BIOCHEM, V104, P7; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Rajan S, 2012, PHYSIOL GENOMICS, V44, P183, DOI 10.1152/physiolgenomics.00093.2011; RAWLS A, 1995, DEV BIOL, V172, P37, DOI 10.1006/dbio.1995.0004; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; van Dongen S, MCL ALGORITHM CLUSTE; Van Dongen SM, 2000, THESIS U UTRECHT NET; Wang YK, 1997, DEVELOPMENT, V124, P2507; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wicik Z, 2011, POL J VET SCI, V14, P643, DOI 10.2478/v10181-011-0095-7	52	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133597	10.1371/journal.pone.0133597	http://dx.doi.org/10.1371/journal.pone.0133597			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200109	gold, Green Published, Green Submitted			2022-12-26	WOS:000358597100073
J	Kassem, A; Henning, P; Kindlund, B; Lindholm, C; Lerner, UH				Kassem, Ali; Henning, Petra; Kindlund, Bert; Lindholm, Catharina; Lerner, Ulf H.			TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss	FASEB JOURNAL			English	Article						inflammation; Toll-like receptors; osteoclasts; bone resorption; flagellin	NF-KAPPA-B; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; TOLL; RESORPTION; RANKL; RECEPTORS; DIFFERENTIATION; STIMULATION; FLAGELLIN	Accumulating evidence points to the importance of the innate immune system in inflammation-induced bone loss in infectious and autoimmune diseases. TLRs are well known for being activated by ligands expressed by bacteria, viruses, and fungi. Recent findings indicate that also endogenous ligands in inflammatory processes are important, one being a TLR5 agonist present in synovial fluid from patients with rheumatoid arthritis (RA). We found that activation of TLR5 by its specific ligand, flagellin, caused robust osteoclast formation and bone loss in cultured mouse neonatal parietal bones dependent on increased receptor activator of NF-kappa B ligand (RANKL): osteoprotegerin ratio, with half-maximal stimulation at 0.01 mu g/ml. Flagellin enhanced Rankl mRNA in isolated osteoblasts by a myeloid differentiation primary response gene 88 and NF-kappa B-dependent mechanism. Injection of flagellin locally over skull bones in 5-wk-oldmice resulted in increased mRNA expression of Rankl and osteoclastic genes, robust osteoclast formation, and bone loss. The effects in vitro and in vivo were absent in Tlr5(-/-) mice. These data show that TLR5 is a novel activator of RANKL and osteoclast formation and, therefore, a potential key factor in inflammation-induced bone erosions in diseases like RA, reactive arthritis, and periodontitis. TLR5 might be a promising novel treatment target for prevention of inflammatory bone loss.	[Kassem, Ali; Lerner, Ulf H.] Umea Univ, Dept Mol Periodontol, S-90187 Umea, Sweden; [Henning, Petra; Kindlund, Bert; Lindholm, Catharina; Lerner, Ulf H.] Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Lindholm, Catharina] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Umea University; University of Gothenburg; University of Gothenburg	Lerner, UH (corresponding author), Umea Univ, Dept Mol Periodontol, S-90187 Umea, Sweden.	ulf.lerner@umu.se		Kassem, Ali/0000-0002-1820-8518; Henning, Petra/0000-0002-9330-6265; Lerner, Ulf/0000-0002-3579-1960	Swedish Research Council; Swedish National Graduate School in Odontological Sciences; Swedish COMBINE (Vinnova) program; County Council of Vastra Gotaland (ALF/LUA; Gothenburg, Sweden); Lundberg Foundation; Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V, County Council of Vasterbotten; Swedish Dental Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Graduate School in Odontological Sciences; Swedish COMBINE (Vinnova) program; County Council of Vastra Gotaland (ALF/LUA; Gothenburg, Sweden); Lundberg Foundation(European Commission); Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V, County Council of Vasterbotten; Swedish Dental Society	The authors are grateful for the skillful technical assistance by Mrs. Anita Lie, Mrs. Ingrid Bostrom, and Mrs. Inger Lundgren (Molecular Periodontology, Umea University, Umea, Sweden); and Ms. Anette Hansevi (Centre for Bone and Arthritis Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden). This study was supported by the Swedish Research Council, Swedish National Graduate School in Odontological Sciences, the Swedish COMBINE (Vinnova) program, the County Council of Vastra Gotaland (ALF/LUA; Gothenburg, Sweden), Lundberg Foundation, Swedish Rheumatism Association, Royal 80 Year Fund of King Gustav V, County Council of Vasterbotten, and Swedish Dental Society. The authors declare no conflicts of interest.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bar-Shavit Z, 2008, AUTOIMMUNITY, V41, P195, DOI 10.1080/08916930701694469; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Beklen A, 2009, ORAL MICROBIOL IMMUN, V24, P38, DOI 10.1111/j.1399-302X.2008.00473.x; Chakravarti A, 2009, BLOOD, V114, P1633, DOI 10.1182/blood-2008-09-178301; Chamberlain ND, 2012, J IMMUNOL, V189, P475, DOI 10.4049/jimmunol.1102977; Conaway HH, 2011, J BIOL CHEM, V286, P31425, DOI 10.1074/jbc.M111.247734; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Granholm S, 2013, BONE, V52, P83, DOI 10.1016/j.bone.2012.09.019; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; Ha H, 2008, J IMMUNOL, V180, P1382, DOI 10.4049/jimmunol.180.3.1382; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim SJ, 2014, J IMMUNOL, V193, P3902, DOI 10.4049/jimmunol.1302998; Kim SJ, 2013, ARTHRITIS RHEUM-US, V65, P2024, DOI 10.1002/art.37992; Klingelhofer J, 2007, ARTHRITIS RHEUM-US, V56, P779, DOI 10.1002/art.22398; Koh JM, 2009, BONE, V45, P650, DOI 10.1016/j.bone.2009.06.007; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; LeirisaloRepo M, 1997, ANN RHEUM DIS, V56, P516, DOI 10.1136/ard.56.9.516; LERNER UH, 1987, J BONE MINER RES, V2, P375; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Mizel SB, 2002, J BIOL CHEM, V277, P22414, DOI 10.1074/jbc.M201762200; Nakamura H, 2008, ORAL MICROBIOL IMMUN, V23, P190, DOI 10.1111/j.1399-302X.2007.00410.x; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Palmqvist P, 2006, J BIOL CHEM, V281, P2414, DOI 10.1074/jbc.M510160200; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schwab AM, 2005, ENDOCRINOLOGY, V146, P4349, DOI 10.1210/en.2005-0601; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zhang X, 2004, INFECT IMMUN, V72, P7183, DOI 10.1128/IAI.72.12.7183-7189.2004; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	48	27	31	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4449	4460		10.1096/fj.15-272559	http://dx.doi.org/10.1096/fj.15-272559			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26207027				2022-12-26	WOS:000364514700006
J	Aizawa, M; Fukuda, M				Aizawa, Megumi; Fukuda, Mitsunori			Small GTPase Rab2B and Its Specific Binding Protein Golgi-associated Rab2B Interactor-like 4 (GARI-L4) Regulate Golgi Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTEROGRADE MELANOSOME TRANSPORT; COILED-COIL PROTEINS; ACTIVATING PROTEINS; MEMBRANE IDENTITY; DISTINCT; CELLS; COMPLEX; DOMAIN; SECRETION; FAMILY	Rab small GTPases are crucial regulators of the membrane traffic that maintains organelle identity and morphology. Several Rab isoforms are present in the Golgi, and it has been suggested that they regulate the compacted morphology of the Golgi in mammalian cells. However, the functional relationships among the Golgi-resident Rabs, e.g. whether they are functionally redundant or different, are poorly understood. In this study, we used specific siRNAs to perform genome-wide screening for human Rabs that are involved in Golgi morphology in HeLa-S3 cells. The results showed that knockdown of any one of the six Rab isoforms (Rab1A/1B/2A/2B/6B/8A) induced fragmentation of the Golgi in HeLa-S3 cells and that its phenotype was rescued by re-expression of their respective siRNA-resistant construct. We then performed systematic knockdown-rescue experiments in relation to each of the six Rabs. Interestingly, with the exception of the Rab8A knockdown, the Golgi fragmentation phenotype induced by knockdown of a single Rab isoform, e.g. Rab2B, was efficiently rescued by re-expression of its siRNA-resistant Rab alone, not by any of the other five Rabs, e.g. Rab2A, which is highly homologous to Rab2B, indicating that these Rab isoforms non-redundantly regulate Golgi morphology possibly through interaction with isoform-specific effector molecules. In addition, we identified Golgi-associated Rab2B interactor-like 4 (GARI-L4) as a novel Golgi-resident Rab2B-specific binding protein whose knockdown also induced fragmentation of the Golgi. Our findings suggest that the compacted Golgi morphology of mammalian cells is finely tuned by multiple sets of Rab (or Rab-effector complexes) that for the most part function independently.	[Aizawa, Megumi; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology of Japan [26111501, 15H04367, 15H01198]; Grants-in-Aid for Scientific Research [26111501] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 26111501, 15H04367, and 15H01198 from the Ministry of Education, Culture, Sports, and Technology of Japan (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Chen S, 2001, J BIOL CHEM, V276, P13209, DOI 10.1074/jbc.M010798200; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Galea G, 2015, J CELL SCI, V128, P2339, DOI 10.1242/jcs.167973; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Ishibashi K, 2012, MOL BIOL CELL, V23, P3193, DOI 10.1091/mbc.E12-01-0010; Ishida M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08238; Ishida M, 2012, J CELL SCI, V125, P5177, DOI 10.1242/jcs.109314; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; James P, 1996, GENETICS, V144, P1425; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kelly EE, 2012, BIOL CELL, V104, P84, DOI 10.1111/boc.201100080; Kuroda TS, 2005, METHOD ENZYMOL, V403, P419, DOI 10.1016/S0076-6879(05)03037-5; Lapierre LA, 2003, EXP CELL RES, V290, P322, DOI 10.1016/S0014-4827(03)00340-9; Liu SJ, 2015, INT REV CEL MOL BIO, V315, P1, DOI 10.1016/bs.ircmb.2014.12.002; Majeed W, 2014, TRAFFIC, V15, P630, DOI 10.1111/tra.12167; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Papanikou E, 2014, CURR OPIN CELL BIOL, V29, P74, DOI 10.1016/j.ceb.2014.04.010; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Pfeffer SR, 2012, BIOCHEM SOC T, V40, P1373, DOI 10.1042/BST20120168; Pfeffer SR, 2010, P NATL ACAD SCI USA, V107, P19614, DOI 10.1073/pnas.1011016107; Rendon WO, 2013, HISTOCHEM CELL BIOL, V139, P671, DOI 10.1007/s00418-012-1059-4; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Singh RK, 2013, FEBS J, V280, P892, DOI 10.1111/febs.12081; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Wang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096242; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Zenner HL, 2011, J VIROL, V85, P8012, DOI 10.1128/JVI.00500-11; Zheng JY, 1998, J CELL SCI, V111, P1061	51	35	36	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22250	22261		10.1074/jbc.M115.669242	http://dx.doi.org/10.1074/jbc.M115.669242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26209634	Green Published, hybrid			2022-12-26	WOS:000360968500041
J	Chao, J; Lee, T; Ward, ES; Ober, RJ				Chao, Jerry; Lee, Taiyoon; Ward, E. Sally; Ober, Raimund J.			Fluorescent Microspheres as Point Sources: A Localization Study	PLOS ONE			English	Article							MICROSCOPY; COLOCALIZATION; RESOLUTION; ACCURACY	The localization of fluorescent microspheres is often employed for drift correction and image registration in single molecule microscopy, and is commonly carried out by fitting a point spread function to the image of the given microsphere. The mismatch between the point spread function and the image of the microsphere, however, calls into question the suitability of this localization approach. To investigate this issue, we subject both simulated and experimental microsphere image data to a maximum likelihood estimator that localizes a microsphere by fitting an Airy pattern to its image, and assess the suitability of the approach by evaluating the ability of the estimator to recover the true location of the microsphere with the best possible accuracy as determined based on the Cramer - Rao lower bound. Assessing against criteria based on the standard errors of the mean and the variance for an ideal estimator of the microsphere's location, we find that microspheres up to 100 nm in diameter can in general be localized using a fixed width Airy pattern, and that microspheres as large as 1 mu m in diameter can in general be localized using a floated width Airy pattern.	[Chao, Jerry; Ober, Raimund J.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA; [Chao, Jerry; Ward, E. Sally; Ober, Raimund J.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA; [Lee, Taiyoon] Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75083 USA; [Ward, E. Sally] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Dallas; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Ober, RJ (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	raimund.ober@tamu.edu		Ober, Raimund/0000-0002-1290-7430; Ward, E. Sally/0000-0003-3232-7238	National Institutes of Health [R01 GM085575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM085575 to RJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AV, 2009, OPT EXPRESS, V17, P23352, DOI 10.1364/OE.17.023352; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Casella G., 2002, STAT INFERENCE, V2nd; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Erdelyi M, 2013, OPT EXPRESS, V21, P10978, DOI 10.1364/OE.21.010978; GIBSON SF, 1991, J OPT SOC AM A, V8, P1601, DOI 10.1364/JOSAA.8.001601; Goodman J. W., 1996, INTRO FOURIER OPTICS; Janesick J.R., 2001, SCI CHARGE COUPLED D; Malkusch S, 2012, HISTOCHEM CELL BIOL, V137, P1, DOI 10.1007/s00418-011-0880-5; Metcalf DJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50579; Newberry M., 1998, PIXEL RESPONSE EFFEC; Ober RJ, 2004, BIOPHYS J, V86, P1185, DOI 10.1016/S0006-3495(04)74193-4; PREZA C, 1992, MICRON MICROSC ACTA, V23, P501, DOI 10.1016/0739-6260(92)90024-8; Ram S, 2006, MULTIDIM SYST SIGN P, V17, P27, DOI 10.1007/s11045-005-6237-2; Ram S, 2009, OPT EXPRESS, V17, P6881, DOI 10.1364/OE.17.006881; Rao C.R., 1965, LINEAR STAT INFERENC, V2nd; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SNYDER DL, 1995, J OPT SOC AM A, V12, P272, DOI 10.1364/JOSAA.12.000272; Zessin PJM, 2013, OPT NANOSCOPY, V2, P4, DOI [10.1186/2192-2853-2-4, DOI 10.1186/2192-2853-2-4]	20	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134112	10.1371/journal.pone.0134112	http://dx.doi.org/10.1371/journal.pone.0134112			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218251	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000358595900080
J	Liu, XR; Ren, JQ; Li, SG; Zhang, QW				Liu, Xing-ren; Ren, Jian-qiang; Li, Sheng-gong; Zhang, Qing-wen			Effects of Simulated Nitrogen Deposition on Soil Net Nitrogen Mineralization in the Meadow Steppe of Inner Mongolia, China	PLOS ONE			English	Article							N MINERALIZATION; IMMOBILIZATION TURNOVER; MICROBIAL BIOMASS; CONIFER FOREST; NITRIFICATION; GRASSLAND; CARBON; FERTILIZATION; TEMPERATURE; MOISTURE	Effects of simulated nitrogen (N) deposition on soil net nitrogen mineralization (NNM) were examined in situ during two growing seasons, using the resin-core technique in the semiarid meadow steppe in Inner Mongolia, China. The aim of this study is to clarify the effect of N levels (0, 10, and 20 kg N ha(-1)yr(-1)) and forms (NH4+ and NO3-) on soil mineral N and NNM. Our results showed that N levels had no significant differences on soil mineral N and NNM. In the first year, three N treatments ((NH4)(2)SO4, NH4Cl and KNO3) increased soil NH4+ concentrations but had no significant effects on soil NO3- concentrations. In the second year, (NH4)(2)SO4 treatment increased soil NO3- concentrations, NH4Cl and KNO3 treatments decreased them. Three N treatments significantly decreased soil NH4+ concentrations in the later stages of the second year. As for the soil NNM, three N treatments had no significant effects on the rates of soil NNM (R-m) and net nitrification (R-n) in the first year, but significantly decreased them in the second year. The contribution of N addition to Rm was higher from (NH4)(2)SO4 than from NH4Cl and KNO3. However, Soil Rm was mainly affected by soil water content (SWC), accumulated temperature (T-a), and soil total N (TN). These results suggest that the short-term atmospheric N deposition may inhibit soil NNM in the meadow steppe of Inner Mongolia.	[Liu, Xing-ren; Zhang, Qing-wen] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Agr Clear Watershed Grp, Beijing 100081, Peoples R China; [Liu, Xing-ren; Zhang, Qing-wen] Minist Agr, Key Lab Agr Environm, Beijing, Peoples R China; [Ren, Jian-qiang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100081, Peoples R China; [Li, Sheng-gong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhang, QW (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Agr Clear Watershed Grp, Beijing 100081, Peoples R China.	ellenzhqw@163.com	Li, Sheng-Gong/H-5101-2012	Li, Sheng-Gong/0000-0003-4889-9927	National Natural Science Foundation of China [31130009, 31300375]; National Key Project of Scientific and Technical Supporting Program [2013BAC03B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Scientific and Technical Supporting Program	This work was supported by the National Natural Science Foundation of China (Grant No. 31130009, 31300375) and the National Key Project of Scientific and Technical Supporting Program (Grant No. 2013BAC03B03).	Aber JD, 2004, FOREST ECOL MANAG, V196, P1, DOI 10.1016/j.foreco.2004.03.009; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Bhogal A, 1999, PLANT SOIL, V207, P15, DOI 10.1023/A:1004420602776; Booth MS, 2005, ECOL MONOGR, V75, P139, DOI 10.1890/04-0988; Chen YT, 2011, SOIL BIOL BIOCHEM, V43, P333, DOI 10.1016/j.soilbio.2010.10.020; Currey PM, 2010, GLOBAL CHANGE BIOL, V16, P2307, DOI 10.1111/j.1365-2486.2009.02082.x; Dalias P, 2002, SOIL BIOL BIOCHEM, V34, P691, DOI 10.1016/S0038-0717(01)00234-6; Emmett BA, 1998, ECOSYSTEMS, V1, P352, DOI 10.1007/s100219900029; Fang HJ, 2014, GEODERMA, V213, P444, DOI 10.1016/j.geoderma.2013.08.006; Fang HJ, 2012, PLANT SOIL, V351, P177, DOI 10.1007/s11104-011-0942-4; Fenn ME, 2005, CAN J FOREST RES, V35, P1464, DOI 10.1139/X05-068; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Ghani A, 2003, SOIL BIOL BIOCHEM, V35, P1231, DOI 10.1016/S0038-0717(03)00186-X; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; Gundersen P, 1998, FOREST ECOL MANAG, V101, P251, DOI 10.1016/S0378-1127(97)00141-2; Guntias ME, 2011, EUROPEAN J SOIL BIOL, V48, P1; Hatch DJ, 2000, BIOL FERT SOILS, V30, P492, DOI 10.1007/s003740050028; Jiao Y, 2012, J ARID LAND, V4, P420, DOI 10.3724/SP.J.1227.2012.00420; Jussy JH, 2004, BIOGEOCHEMISTRY, V69, P241, DOI 10.1023/B:BIOG.0000031050.13663.82; Killham K., 1994, SOIL ECOLOGY, V4th ed.; Li HL, 2003, GEODERMA, V115, P161, DOI 10.1016/S0016-7061(02)00358-0; Li Y, 2014, J ARID LAND, V6, P571, DOI 10.1007/s40333-014-0025-5; Liu WX, 2007, BIOL FERT SOILS, V44, P259, DOI 10.1007/s00374-007-0198-6; Liu XR, 2010, NUTR CYCL AGROECOSYS, V87, P59, DOI 10.1007/s10705-009-9312-5; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; Luxhoi J, 2006, SOIL SCI SOC AM J, V70, P1121, DOI 10.2136/sssaj2005.0133; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; McNulty SG, 2005, FOREST ECOL MANAG, V219, P279, DOI 10.1016/j.foreco.2005.09.004; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; [秦子娴 Qin Zixian], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P3392; Sparrius LB, 2013, PLANT SOIL, V364, P219, DOI 10.1007/s11104-012-1351-z; Sun SH, 2013, PLANT SOIL, V372, P597, DOI 10.1007/s11104-013-1758-1; Throop HL, 2004, GLOBAL CHANGE BIOL, V10, P1092, DOI 10.1111/j.1529-8817.2003.00791.x; Tietema A, 1998, FOREST ECOL MANAG, V101, P19, DOI 10.1016/S0378-1127(97)00123-0; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Turner MM, 2010, OECOLOGIA, V162, P227, DOI 10.1007/s00442-009-1435-5; Vernimmen RRE, 2007, SOIL BIOL BIOCHEM, V39, P2992, DOI 10.1016/j.soilbio.2007.06.005; Vestgarden LS, 2003, FOREST ECOL MANAG, V176, P205, DOI 10.1016/S0378-1127(02)00275-X; Vor T, 2002, SOIL BIOL BIOCHEM, V34, P541, DOI 10.1016/S0038-0717(01)00190-0; Vourlitis GL, 2007, BIOL FERT SOILS, V43, P611, DOI 10.1007/s00374-006-0137-y; Wang CH, 2006, SOIL BIOL BIOCHEM, V38, P1101, DOI 10.1016/j.soilbio.2005.09.009; Xu XK, 2009, GEODERMA, V151, P370, DOI 10.1016/j.geoderma.2009.05.008; Yan ER, 2008, BIOGEOCHEMISTRY, V89, P239, DOI 10.1007/s10533-008-9216-5; Zaman M, 2004, BIOL FERT SOILS, V39, P269, DOI 10.1007/s00374-003-0716-0; Zhang Lu, 2009, Chinese Journal of Plant Ecology, V33, P563, DOI 10.3773/j.issn.1005-264x.2009.03.015; Zhang NL, 2008, PLANT SOIL, V311, P19, DOI 10.1007/s11104-008-9650-0; Zhang XL, 2008, ACTA OECOL, V34, P322, DOI 10.1016/j.actao.2008.06.004; Zhou PD, 2002, PLANT NUTR FERTIL SC, V7, P397; Zhu TB, 2013, BIOL FERT SOILS, V49, P323, DOI 10.1007/s00374-012-0725-y	52	11	17	6	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134039	10.1371/journal.pone.0134039	http://dx.doi.org/10.1371/journal.pone.0134039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218275	Green Submitted, gold, Green Published			2022-12-26	WOS:000358595900070
J	Massey, AJ				Massey, Andrew J.			Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGIC	PLOS ONE			English	Article							KI-67 PROTEIN; INHIBITOR; REPAIR	High-content imaging is a powerful tool for determining cell phenotypes at the single cell level. Characterising the effect of small molecules on cell cycle distribution is important for understanding their mechanism of action especially in oncology drug discovery but also for understanding potential toxicology liabilities. Here, a high-throughput phenotypic assay utilising the PerkinElmer Operetta high-content imager and Harmony software to determine cell cycle distribution is described. PhenoLOGIC, a machine learning algorithm within Harmony software was employed to robustly separate single cells from cell clumps. DNA content, EdU incorporation and pHH3 (S10) expression levels were subsequently utilised to separate cells into the various phases of the cell cycle. The assay is amenable to multiplexing with an additional pharmacodynamic marker to assess cell cycle changes within a specific cellular sub-population. Using this approach, the cell cycle distribution of gamma H2AX positive nuclei was determined following treatment with DNA damaging agents. Likewise, the assay can be multiplexed with Ki67 to determine the fraction of quiescent cells and with BrdU dual labelling to determine S-phase duration. This methodology therefore provides a relatively cheap, quick and high-throughput phenotypic method for determining accurate cell cycle distribution for small molecule mechanism of action and drug toxicity studies.	Vernalis Res, Cambridge CB21 6GB, England	Vernalis	Massey, AJ (corresponding author), Vernalis Res, Granta Pk, Cambridge CB21 6GB, England.	a.massey@vernalis.com	Massey, Andrew J./H-6954-2019	Massey, Andrew J./0000-0002-0276-2573	Vernalis Research	Vernalis Research	This work was funded by Vernalis Research who agreed to the publication of this manuscript. The funder provided support in the form of salaries for author AJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author are articulated in the 'author contributions' section.	Andreassen Paul R, 2004, Methods Mol Biol, V281, P213; Bradford JA., 2011, CURR PROTOC CYTOM, DOI 10.1002/0471142956.cy0738s55; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Chan GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063583; Gasparri F, 2007, ADV EXP MED BIOL, V604, P137, DOI 10.1007/978-0-387-69116-9_13; Gasparri F, 2006, J BIOMOL SCREEN, V11, P586, DOI 10.1177/1087057106289406; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; HANG HY, 2003, METH MOL B, V241, P23; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; KUWANO M, 1973, CANCER RES, V33, P2965; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Martin HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088338; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Mouchet EH, 2008, IDRUGS, V11, P422; O'Brien PJ, 2014, BASIC CLIN PHARMACOL, V115, P4, DOI 10.1111/bcpt.12227; ORMEROD MG, 2000, FLOW CYTOMETRY; Persson M, 2014, BASIC CLIN PHARMACOL, V115, P18, DOI 10.1111/bcpt.12200; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; SHIBUI S, 1989, J HISTOCHEM CYTOCHEM, V37, P1007, DOI 10.1177/37.7.2659659; VANDIERENDONCK JH, 1989, CANCER RES, V49, P2999; Vignon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068425	27	28	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134306	10.1371/journal.pone.0134306	http://dx.doi.org/10.1371/journal.pone.0134306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218638	Green Submitted, gold, Green Published			2022-12-26	WOS:000358595900107
J	Skaar, K; Korza, HJ; Tarry, M; Sekyrova, P; Hogbom, M				Skaar, Karin; Korza, Henryk J.; Tarry, Michael; Sekyrova, Petra; Hogbom, Martin			Expression and Subcellular Distribution of GFP-Tagged Human Tetraspanin Proteins in Saccharomyces cerevisiae	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MEMBRANE-PROTEINS; EXTRACELLULAR DOMAIN; FREE PURIFICATION; QUALITY-CONTROL; FUSION PROTEIN; BINDING; RECONSTITUTION; COMPLEXES; ANTIGEN	Tetraspanins are integral membrane proteins that function as organizers of multimolecular complexes and modulate function of associated proteins. Mammalian genomes encode approximately 30 different members of this family and remotely related eukaryotic species also contain conserved tetraspanin homologs. Tetraspanins are involved in a number of fundamental processes such as regulation of cell migration, fusion, immunity and signaling. Moreover, they are implied in numerous pathological states including mental disorders, infectious diseases or cancer. Despite the great interest in tetraspanins, the structural and biochemical basis of their activity is still largely unknown. A major bottleneck lies in the difficulty of obtaining stable and homogeneous protein samples in large quantities. Here we report expression screening of 15 members of the human tetraspanin superfamily and successful protocols for the production in S. cerevisiae of a subset of tetraspanins involved in human cancer development. We have demonstrated the subcellular localization of overexpressed tetraspanin-green fluorescent protein fusion proteins in S. cerevisiae and found that despite being mislocalized, the fusion proteins are not degraded. The recombinantly produced tetraspanins are dispersed within the endoplasmic reticulum membranes or localized in granule-like structures in yeast cells. The recombinantly produced tetraspanins can be extracted from the membrane fraction and purified with detergents or the poly (styreneco-maleic acid) polymer technique for use in further biochemical or biophysical studies.	[Skaar, Karin; Korza, Henryk J.; Tarry, Michael; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Sekyrova, Petra] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Sekyrova, Petra] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	Stockholm University; Karolinska Institutet; Masaryk University Brno	Hogbom, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	hogbom@dbb.su.se	Korza, Henryk/H-9331-2012	Korza, Henryk/0000-0003-4434-3972; Hogbom, Martin/0000-0001-5574-9383	Swedish Cancer Society [CAN 2012/571]; Swedish Foundation for Strategic Research [SSF FFL4]; Knut and Alice Wallenberg foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Cancer Society (CAN 2012/571), www.cancerfonden.se and the Swedish Foundation for Strategic Research (SSF FFL4), http://www.stratresearch.se. The confocal microscopy facility was supported by the Knut and Alice Wallenberg foundation, www.wallenberg.com/kaw/.	Ailane N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00364; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; Bailey RL, 2011, BIOCHEM SOC T, V39, P1667, DOI 10.1042/BST20110745; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berthier-Vergnes O, 2011, BRIT J CANCER, V104, P155, DOI 10.1038/sj.bjc.6605994; Boavida LC, 2013, PLANT PHYSIOL, V163, P696, DOI 10.1104/pp.113.216598; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Damek-Poprawa M, 2005, J BIOL CHEM, V280, P9217, DOI 10.1074/jbc.M407166200; Detchokul S, 2014, BRIT J PHARMACOL, V171, P5462, DOI 10.1111/bph.12260; Dorr JM, 2014, P NATL ACAD SCI USA, V111, P18607, DOI 10.1073/pnas.1416205112; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; DUNCAN R, 1992, ANTI-CANCER DRUG, V3, P175, DOI 10.1097/00001813-199206000-00001; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fairchild CL, 2013, J CELL SCI, V126, P1464, DOI 10.1242/jcs.120915; Gesierich S, 2006, CANCER RES, V66, P7083, DOI 10.1158/0008-5472.CAN-06-0391; Goddard AD, 2015, METHOD ENZYMOL, V556, P405, DOI 10.1016/bs.mie.2015.01.004; Gulati S, 2014, BIOCHEM J, V461, P269, DOI 10.1042/BJ20131477; Guo QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038464; He Y, 2014, PROTEIN CELL, V5, P658, DOI 10.1007/s13238-014-0086-4; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Henry SM, 2006, BIOMACROMOLECULES, V7, P2407, DOI 10.1021/bm060143z; HIGASHIHARA M, 1990, FEBS LETT, V264, P270, DOI 10.1016/0014-5793(90)80265-K; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Ito E, 2003, AM J PATHOL, V163, P2165, DOI 10.1016/S0002-9440(10)63573-0; Jamshad M, 2008, PROTEIN EXPRES PURIF, V57, P206, DOI 10.1016/j.pep.2007.10.013; Jamshad M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140171; Jamshad M, 2011, BIOCHEM SOC T, V39, P813, DOI 10.1042/BST0390813; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kevany BM, 2013, J BIOL CHEM, V288, P36272, DOI 10.1074/jbc.M113.520700; Kitadokoro K, 2002, BIOL CHEM, V383, P1447, DOI 10.1515/BC.2002.164; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Knoblich K, 2014, CELL MOL LIFE SCI, V71, P1305, DOI 10.1007/s00018-013-1444-8; Knowles TJ, 2009, J AM CHEM SOC, V131, P7484, DOI 10.1021/ja810046q; Kwon MS, 2007, LUNG CANCER, V57, P46, DOI 10.1016/j.lungcan.2007.01.032; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Li D, 2015, PROTEIN CELL, V6, P229, DOI 10.1007/s13238-014-0129-x; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Long AR, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-41; MAEDA H, 1979, INT J PEPT PROT RES, V14, P81; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Mus-Veteau I, 2014, MEMBRANE PROTEINS PR, DOI [10.1007/978-1-4939-0662-8, DOI 10.1007/978-1-4939-0662-8]; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; Orwick MC, 2012, ANGEW CHEM INT EDIT, V51, P4653, DOI 10.1002/anie.201201355; Parker JL, 2014, PROTEIN SCI, V23, P1309, DOI 10.1002/pro.2507; Postis V, 2015, BBA-BIOMEMBRANES, V1848, P496, DOI 10.1016/j.bbamem.2014.10.018; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; RADFORD KJ, 1995, INT J CANCER, V62, P631, DOI 10.1002/ijc.2910620523; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Rath A, 2013, P NATL ACAD SCI USA, V110, P15668, DOI 10.1073/pnas.1311305110; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Sala-Valdes M, 2012, EXPERT OPIN THER TAR, V16, P985, DOI 10.1517/14728222.2012.712688; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Swainsbury DJK, 2014, ANGEW CHEM INT EDIT, V53, P11803, DOI 10.1002/anie.201406412; SZALA S, 1990, P NATL ACAD SCI USA, V87, P6833, DOI 10.1073/pnas.87.17.6833; TAKAGI S, 1995, INT J CANCER, V61, P706, DOI 10.1002/ijc.2910610519; Takayama H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002314; Tarry M, 2012, PROTEIN EXPRES PURIF, V82, P373, DOI 10.1016/j.pep.2012.02.003; Thomas JA, 2014, J MOL BIOL, V426, P4139, DOI 10.1016/j.jmb.2014.10.012; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang HX, 2011, BIOCHEM SOC T, V39, P547, DOI 10.1042/BST0390547; Xia YF, 2012, NAT CELL BIOL, V14, P257, DOI 10.1038/ncb2428; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	80	19	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134041	10.1371/journal.pone.0134041	http://dx.doi.org/10.1371/journal.pone.0134041			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218426	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900071
J	Verbeke, LPC; Van den Eynden, J; Fierro, AC; Demeester, P; Fostier, J; Marchal, K				Verbeke, Lieven P. C.; Van den Eynden, Jimmy; Fierro, Ana Carolina; Demeester, Piet; Fostier, Jan; Marchal, Kathleen			Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration	PLOS ONE			English	Article							OVARIAN-CANCER; BREAST; NOTCH; PRIORITIZATION; ARCHITECTURE; KERNELS	The study of cancer, a highly heterogeneous disease with different causes and clinical outcomes, requires a multi-angle approach and the collection of large multi-omics datasets that, ideally, should be analyzed simultaneously. We present a new pathway relevance ranking method that is able to prioritize pathways according to the information contained in any combination of tumor related omics datasets. Key to the method is the conversion of all available data into a single comprehensive network representation containing not only genes but also individual patient samples. Additionally, all data are linked through a network of previously identified molecular interactions. We demonstrate the performance of the new method by applying it to breast and ovarian cancer datasets from The Cancer Genome Atlas. By integrating gene expression, copy number, mutation and methylation data, the method's potential to identify key pathways involved in breast cancer development shared by different molecular subtypes is illustrated. Interestingly, certain pathways were ranked equally important for different subtypes, even when the underlying (epi)-genetic disturbances were diverse. Next to prioritizing universally high-scoring pathways, the pathway ranking method was able to identify subtype-specific pathways. Often the score of a pathway could not be motivated by a single mutation, copy number or methylation alteration, but rather by a combination of genetic and epi-genetic disturbances, stressing the need for a network-based data integration approach. The analysis of ovarian tumors, as a function of survival-based subtypes, demonstrated the method's ability to correctly identify key pathways, irrespective of tumor subtype. A differential analysis of survival-based subtypes revealed several pathways with higher importance for the bad-outcome patient group than for the good-outcome patient group. Many of the pathways exhibiting higher importance for the bad-outcome patient group could be related to ovarian tumor proliferation and survival.	[Verbeke, Lieven P. C.; Van den Eynden, Jimmy; Fierro, Ana Carolina; Demeester, Piet; Fostier, Jan; Marchal, Kathleen] Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium; [Van den Eynden, Jimmy; Fierro, Ana Carolina; Marchal, Kathleen] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	Ghent University; IMEC; Ghent University	Verbeke, LPC (corresponding author), Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium.	lieven.verbeke@intec.ugent.be; jan.fostier@intec.ugent.be; kathleen.marchal@intec.ugent.be	Marchal, Kathleen/O-7936-2017; Van den Eynden, Jimmy/AAB-7221-2020; Marchal, Kathleen/B-5001-2013; Fostier, Jan/A-8275-2012	Marchal, Kathleen/0000-0002-2169-4588; Van den Eynden, Jimmy/0000-0003-0002-5614; Marchal, Kathleen/0000-0002-2169-4588; Fostier, Jan/0000-0002-9994-8269	Ghent University Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks'; Fonds Wetenschappelijk Onderzoek-Vlaanderen [G.0329.09]; Agentschap voor Innovatie door Wetenschap en Technologie: NEMOA; KULeuven [NATAR PF/10/010]	Ghent University Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks'(Ghent University); Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO); Agentschap voor Innovatie door Wetenschap en Technologie: NEMOA; KULeuven(KU Leuven)	This work was supported by the Ghent University Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks' (http://www.nucleotides2networks.be/), Fonds Wetenschappelijk Onderzoek-Vlaanderen G.0329.09 (http://www.fwo.be/), Agentschap voor Innovatie door Wetenschap en Technologie: NEMOA (http://www.nemoa.net/), and KULeuven NATAR PF/10/010 (http://www.kuleuven.be/kuleuven/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend RC, 2013, GYNECOL ONCOL, V131, P772, DOI 10.1016/j.ygyno.2013.09.034; Attisano Liliana, 2013, F1000Prime Rep, V5, P17, DOI 10.12703/P5-17; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhattacharya D, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/716564; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Dutta B, 2012, BRIT J CANCER, V106, P1107, DOI 10.1038/bjc.2011.584; Fouss F, 2012, NEURAL NETWORKS, V31, P53, DOI 10.1016/j.neunet.2012.03.001; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Groeneweg JW, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0095-1; Gubbay O, 2006, J ENDOCRINOL, V191, P275, DOI 10.1677/joe.1.06928; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hu W, 2014, CANCER RES, V74, P3282, DOI 10.1158/0008-5472.CAN-13-2066; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lavi O, 2012, J COMPUT BIOL, V19, P694, DOI 10.1089/cmb.2012.0065; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Ng S, 2012, BIOINFORMATICS, V28, pI640, DOI 10.1093/bioinformatics/bts402; Nitsch D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-460; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Pham Trang T, 2013, Genes Cancer, V4, P419, DOI 10.1177/1947601913513950; Qi Y, 2008, GENOME RES, V18, P1991, DOI 10.1101/gr.077693.108; Ribeiro JR, 2014, J STEROID BIOCHEM, V143, P160, DOI 10.1016/j.jsbmb.2014.02.010; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rose SL, 2010, GYNECOL ONCOL, V117, P130, DOI 10.1016/j.ygyno.2009.12.003; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Verbeke LPC, 2013, BIOINFORMATICS, V29, P1308, DOI 10.1093/bioinformatics/btt142; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]	43	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133503	10.1371/journal.pone.0133503	http://dx.doi.org/10.1371/journal.pone.0133503			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217958	Green Published, gold			2022-12-26	WOS:000358595900033
J	Chu, PY; Walder, K; Horlock, D; Williams, D; Nelson, E; Byrne, M; Jandeleit-Dahm, K; Zimmet, P; Kaye, DM				Chu, Po-Yin; Walder, Ken; Horlock, Duncan; Williams, David; Nelson, Erin; Byrne, Melissa; Jandeleit-Dahm, Karin; Zimmet, Paul; Kaye, David M.			CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; REGULATORY T-CELLS; MYOCARDIAL-INFARCTION; DIASTOLIC FUNCTION; MELLITUS; DYSFUNCTION; CARDIOMYOPATHY; IMPACT; SPIRONOLACTONE; EPIDEMIOLOGY	Heart failure (HF) is an increasingly recognized complication of diabetes. Cardiac fibrosis is an important causative mechanism of HF associated with diabetes. Recent data indicate that inflammation may be particularly important in the pathogenesis of cardiovascular fibrosis. We sought to determine the mechanism by which cardiac fibrosis develops and to specifically investigate the role of the CXCR4 axis in this process. Animals with type I diabetes (streptozotocin treated mice) or type II diabetes (Israeli Sand-rats) and controls were randomized to treatment with a CXCR4 antagonist, candesartan or vehicle control. Additional groups of mice also underwent bone marrow transplantation (GFP+ donor marrow) to investigate the potential role of bone marrow derived cell mobilization in the pathogenesis of cardiac fibrosis. Both type I and II models of diabetes were accompanied by the development of significant cardiac fibrosis. CXCR4 antagonism markedly reduced cardiac fibrosis in both models of diabetes, similar in magnitude to that seen with candesartan. In contrast to candesartan, the anti-fibrotic actions of CXCR4 antagonism occurred in a blood pressure independent manner. Whilst the induction of diabetes did not increase the overall myocardial burden of GFP+ cells, it was accompanied by an increase in GFP+ cells expressing the fibroblast marker alpha-smooth muscle actin and this was attenuated by CXCR4 antagonism. CXCR4 antagonism was also accompanied by increased levels of circulating regulatory T cells. Taken together the current data indicate that pharmacological inhibition of CXCR4 significantly reduces diabetes induced cardiac fibrosis, providing a potentially important therapeutic approach.	[Chu, Po-Yin; Horlock, Duncan; Williams, David; Nelson, Erin; Byrne, Melissa; Kaye, David M.] Baker IDI Heart & Diabet Res Inst, Heart Failure Res Grp, Melbourne, Vic, Australia; [Walder, Ken] Deakin Univ, Sch Med, Metab Res Unit, Waurn Ponds, Vic, Australia; [Jandeleit-Dahm, Karin] Baker IDI Heart & Diabet Res Inst, Diabet Complicat Div, Melbourne, Vic, Australia; [Zimmet, Paul] Baker IDI Heart & Diabet Res Inst, Clin Diabet & Epidemiol Dept, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Deakin University	Kaye, DM (corresponding author), Baker IDI Heart & Diabet Res Inst, Heart Failure Res Grp, Melbourne, Vic, Australia.	david.kaye@bakeridi.edu.au	Zimmet, Paul/O-8486-2019; Kaye, David/AAF-1202-2021	Zimmet, Paul/0000-0003-0627-0776; Kaye, David/0000-0003-4058-0372	National Health and Medical Research Council of Australia; National Heart Foundation; Victorian Government Operational Infrastructure Scheme (OIS)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia); Victorian Government Operational Infrastructure Scheme (OIS)	This study was performed with support from the National Health and Medical Research Council of Australia, National Heart Foundation, and the Victorian Government Operational Infrastructure Scheme (OIS).	Abe T, 2002, AM J PHYSIOL-HEART C, V282, pH138, DOI 10.1152/ajpheart.2002.282.1.H138; Alberti KGMM, 2013, NAT REV ENDOCRINOL, V9, P258, DOI 10.1038/nrendo.2013.54; Amador CA, 2014, HYPERTENSION, V63, P797, DOI 10.1161/HYPERTENSIONAHA.113.02883; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Aronow WS, 2001, AM J CARDIOL, V87, P224, DOI 10.1016/S0002-9149(00)01324-2; Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; Bertoni AG, 2004, DIABETES CARE, V27, P699, DOI 10.2337/diacare.27.3.699; Bodart V, 2009, BIOCHEM PHARMACOL, V78, P993, DOI 10.1016/j.bcp.2009.06.010; Chu PY, 2011, CIRC-HEART FAIL, V4, P651, DOI 10.1161/CIRCHEARTFAILURE.110.960831; Chu PY, 2010, AM J PATHOL, V176, P1735, DOI 10.2353/ajpath.2010.090574; de Simone G, 2010, J HYPERTENS, V28, P353, DOI 10.1097/HJH.0b013e3283331169; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Dhingra R, 2012, HEART FAIL CLIN, V8, P125, DOI 10.1016/j.hfc.2011.08.008; From AM, 2006, AM J MED, V119, P591, DOI 10.1016/j.amjmed.2006.05.024; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Iribarren C, 2001, CIRCULATION, V103, P2668; Jie W, 2010, INT J EXP PATHOL, V91, P436, DOI 10.1111/j.1365-2613.2010.00720.x; Kaiser Nurit, 2012, Methods Mol Biol, V933, P89, DOI 10.1007/978-1-62703-068-7_7; Kanellakis P, 2011, J HYPERTENS, V29, P1820, DOI 10.1097/HJH.0b013e328349c62d; Konig A, 2012, HEART FAIL CLIN, V8, P551, DOI 10.1016/j.hfc.2012.06.001; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lewis EF, 2003, J AM COLL CARDIOL, V42, P1446, DOI 10.1016/S0735-1097(03)01057-X; Lindman BR, 2011, CIRC-HEART FAIL, V4, P286, DOI 10.1161/CIRCHEARTFAILURE.110.960039; Matsushita K, 2010, DIABETES, V59, P2020, DOI 10.2337/db10-0165; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Miric G, 2001, BRIT J PHARMACOL, V133, P687, DOI 10.1038/sj.bjp.0704131; Murcia AM, 2004, ARCH INTERN MED, V164, P2273, DOI 10.1001/archinte.164.20.2273; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Rijzewijk LJ, 2009, J AM COLL CARDIOL, V54, P1524, DOI 10.1016/j.jacc.2009.04.074; SAVAGE MP, 1988, AM J CARDIOL, V62, P665, DOI 10.1016/0002-9149(88)91199-X; Schilling JD, 2012, HEART FAIL CLIN, V8, P619, DOI 10.1016/j.hfc.2012.06.007; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Shivalkar B, 2006, AM J CARDIOL, V97, P77, DOI 10.1016/j.amjcard.2005.07.111; Walder K R, 2000, Int J Exp Diabetes Res, V1, P177, DOI 10.1155/EDR.2000.177; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	39	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133616	10.1371/journal.pone.0133616	http://dx.doi.org/10.1371/journal.pone.0133616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214690	Green Published, Green Submitted, gold			2022-12-26	WOS:000358594300024
J	Ganu, RS; Ishida, Y; Koutmos, M; Kolokotronis, SO; Roca, AL; Garrow, TA; Schook, LB				Ganu, Radhika S.; Ishida, Yasuko; Koutmos, Markos; Kolokotronis, Sergios-Orestis; Roca, Alfred L.; Garrow, Timothy A.; Schook, Lawrence B.			Evolutionary Analyses and Natural Selection of Betaine-Homocysteine S-Methyltransferase (BHMT) and BHMT2 Genes	PLOS ONE			English	Article							RAT-LIVER; DNA-SEQUENCES; PHYLOGENETIC ANALYSIS; DIETARY METHIONINE; DUPLICATED GENES; ANALYSIS TOOLS; CDNA CLONING; EXPRESSION; CHOLINE; METABOLISM	Betaine-homocysteine S-methyltransferase (BHMT) and BHMT2 convert homocysteine to methionine using betaine and S-methylmethionine, respectively, as methyl donor substrates. Increased levels of homocysteine in blood are associated with cardiovascular disease. Given their role in human health and nutrition, we identified BHMT and BHMT2 genes and proteins from 38 species of deuterostomes including human and non-human primates. We aligned the genes to look for signatures of selection, to infer evolutionary rates and events across lineages, and to identify the evolutionary timing of a gene duplication event that gave rise to two genes, BHMT and BHMT2. We found that BHMT was present in the genomes of the sea urchin, amphibians, reptiles, birds and mammals; BHMT2 was present only across mammals. BHMT and BHMT2 were present in tandem in the genomes of all monotreme, marsupial and placental species examined. Evolutionary rates were accelerated for BHMT2 relative to BHMT. Selective pressure varied across lineages, with the highest dN/dS ratios for BHMT and BHMT2 occurring immediately following the gene duplication event, as determined using GA Branch analysis. Nine codons were found to display signatures suggestive of positive selection; these contribute to the enzymatic or oligomerization domains, suggesting involvement in enzyme function. Gene duplication likely occurred after the divergence of mammals from other vertebrates but prior to the divergence of extant mammalian subclasses, followed by two deletions in BHMT2 that affect oligomerization and methyl donor specificity. The faster evolutionary rate of BHMT2 overall suggests that selective constraints were reduced relative to BHMT. The dN/dS ratios in both BHMT and BHMT2 was highest following the gene duplication, suggesting that purifying selection played a lesser role as the two paralogs diverged in function.	[Ganu, Radhika S.; Schook, Lawrence B.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Ishida, Yasuko; Roca, Alfred L.; Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Kolokotronis, Sergios-Orestis] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; [Garrow, Timothy A.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Uniformed Services University of the Health Sciences - USA; Fordham University; University of Illinois System; University of Illinois Urbana-Champaign	Schook, LB (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.	schook@illinois.edu	Kolokotronis, Sergios-Orestis/GWM-5773-2022; Kolokotronis, Sergios-Orestis/A-1910-2009	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Roca, Alfred/0000-0001-9217-5593; Schook, Lawrence/0000-0002-6580-8364; Koutmos, Markos/0000-0003-0933-6312	USDA/Agricultural Research Service (ARS) [AG 58-5438-7-3171]; USDA/Cooperative State Research, Education and Extension Service (CSREES) [AG 2009-34480-19875]; USDA National Institute of Food and Agriculture [ILLU-538-395, 0232734]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK 52501]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK052501, R01DK052501] Funding Source: NIH RePORTER	USDA/Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA/Cooperative State Research, Education and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support of RG and LS was provided by the USDA/Agricultural Research Service (ARS) (AG 58-5438-7-3171) and USDA/Cooperative State Research, Education and Extension Service (CSREES) (AG 2009-34480-19875). Support for AR and YI was provided by the USDA National Institute of Food and Agriculture through Hatch project ILLU-538-395 (Accession Number 0232734). Support for TG was provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK 52501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ananth CV, 2007, MOL GENET METAB, V91, P104, DOI 10.1016/j.ymgme.2007.02.004; BERGLUND L, 1990, J PERINAT MED, V18, P89, DOI 10.1515/jpme.1990.18.2.89; Breksa AP, 1999, BIOCHEMISTRY-US, V38, P13991, DOI 10.1021/bi991003v; Chadwick LH, 2000, GENOMICS, V70, P66, DOI 10.1006/geno.2000.6319; Delgado-Reyes CV, 2005, AM J PHYSIOL-REG I, V288, pR182, DOI 10.1152/ajpregu.00406.2004; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DYKHUIZEN D, 1980, GENETICS, V96, P801; Evans JC, 2002, STRUCTURE, V10, P1159, DOI 10.1016/S0969-2126(02)00796-7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Furness D, 2013, MATERN CHILD NUTR, V9, P155, DOI 10.1111/j.1740-8709.2011.00364.x; Ganu RS, 2011, GENE, V473, P133, DOI 10.1016/j.gene.2010.11.015; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Gonzalez B, 2004, J MOL BIOL, V338, P771, DOI 10.1016/j.jmb.2004.03.005; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hague WM, 2003, BEST PRACT RES CL OB, V17, P459, DOI 10.1016/S1521-6934(03)00009-9; Hughes AL, 1999, ADAPTIVE EVOLUTION O; Jordan IK, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-22; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan AA, 2011, EVOL BIOINFORM, V7, P7, DOI 10.4137/EBO.S6179; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; KOVATSCHEVA EG, 1977, NAHRUNG, V21, P465, DOI 10.1002/food.19770210602; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YN, 1996, HUM MOL GENET, V5, P1851, DOI 10.1093/hmg/5.12.1851; Liu HH, 2010, GENOME RES, V20, P28, DOI 10.1101/gr.097212.109; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Miller CM, 2005, BIOCHEM J, V392, P443, DOI 10.1042/BJ20050356; Mizrahi EH, 2002, ISR MED ASSOC J, V4, P187; Neece DJ, 2000, GENE, V250, P31, DOI 10.1016/S0378-1119(00)00191-8; Ohno S, 1970, EVOLUTION BY GENE DU; OHTA T, 1994, GENETICS, V138, P1331; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Park EI, 1999, J BIOL CHEM, V274, P7816, DOI 10.1074/jbc.274.12.7816; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Poon AFY, 2009, METHODS MOL BIOL, V537, P163, DOI 10.1007/978-1-59745-251-9_8; Rao PV, 1998, J BIOL CHEM, V273, P30669, DOI 10.1074/jbc.273.46.30669; Refsum H, 2001, BRIT J NUTR, V85, pS109, DOI 10.1079/BJN2000302; Roca AL, 2010, ENCYCLOPEDIA OF BIOT, V1, P320; Sakamoto A, 2002, PEDIATR INT, V44, P409, DOI 10.1046/j.1442-200X.2002.01591.x; Schafer C, 2007, AM J PHYSIOL-GASTR L, V292, pG1089, DOI 10.1152/ajpgi.00088.2006; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Schrodinger LLC, 2010, THE PYMOL MOLECULAR; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Sunden SLF, 1997, ARCH BIOCHEM BIOPHYS, V345, P171, DOI 10.1006/abbi.1997.0246; SWEIRY JH, 1986, J DEV PHYSIOL, V8, P435; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; Szegedi SS, 2004, ARCH BIOCHEM BIOPHYS, V426, P32, DOI 10.1016/j.abb.2004.03.040; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Ueland P M, 1989, Nord Med, V104, P293; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Woodside JV, 2004, FOLATE HOMOCYSTEINE; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; XUE GP, 1986, COMP BIOCHEM PHYS B, V83, P115, DOI 10.1016/0305-0491(86)90340-8; XUE GP, 1985, COMP BIOCHEM PHYS B, V80, P489, DOI 10.1016/0305-0491(85)90278-0; Zanton GI, 2014, J DAIRY SCI, V97, P7085, DOI 10.3168/jds.2014-8220; Zeisel SH, 2003, J NUTR, V133, P1302; ZEISEL SH, 1995, J NUTR, V125, P3049; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	70	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134084	10.1371/journal.pone.0134084	http://dx.doi.org/10.1371/journal.pone.0134084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213999	Green Published, Green Submitted, gold			2022-12-26	WOS:000358594300048
J	Geselbracht, LL; Freeman, K; Birch, AP; Brenner, J; Gordon, DR				Geselbracht, Laura L.; Freeman, Kathleen; Birch, Anne P.; Brenner, Jorge; Gordon, Doria R.			Modeled Sea Level Rise Impacts on Coastal Ecosystems at Six Major Estuaries on Florida's Gulf Coast: Implications for Adaptation Planning	PLOS ONE			English	Article								The Sea Level Affecting Marshes Model (SLAMM) was applied at six major estuaries along Florida's Gulf Coast (Pensacola Bay, St. Andrews/Choctawhatchee Bays, Apalachicola Bay, Southern Big Bend, Tampa Bay and Charlotte Harbor) to provide quantitative and spatial information on how coastal ecosystems may change with sea level rise (SLR) and to identify how this information can be used to inform adaption planning. High resolution LiDAR-derived elevation data was utilized under three SLR scenarios: 0.7 m, 1 m and 2 m through the year 2100 and uncertainty analyses were conducted on selected input parameters at three sites. Results indicate that the extent, spatial orientation and relative composition of coastal ecosystems at the study areas may substantially change with SLR. Under the 1 m SLR scenario, total predicted impacts for all study areas indicate that coastal forest (-69,308 ha; -18%), undeveloped dry land (-28,444 ha; -2%) and tidal flat (-25,556 ha; -47%) will likely face the greatest loss in cover by the year 2100. The largest potential gains in cover were predicted for saltmarsh (+32,922 ha; +88%), transitional saltmarsh (+23,645 ha; na) and mangrove forest (+12,583 ha; +40%). The Charlotte Harbor and Tampa Bay study areas were predicted to experience the greatest net loss in coastal wetlands The uncertainty analyses revealed low to moderate changes in results when some numerical SLAMM input parameters were varied highlighting the value of collecting long-term sedimentation, accretion and erosion data to improve SLAMM precision. The changes predicted by SLAMM will affect exposure of adjacent human communities to coastal hazards and ecosystem functions potentially resulting in impacts to property values, infrastructure investment and insurance rates. The results and process presented here can be used as a guide for communities vulnerable to SLR to identify and prioritize adaptation strategies that slow and/or accommodate the changes underway.	[Geselbracht, Laura L.; Freeman, Kathleen; Birch, Anne P.; Gordon, Doria R.] Nature Conservancy, Florida Chapter, Altamonte Springs, FL 32714 USA; [Brenner, Jorge] Nature Conservancy, Texas Chapter, Corpus Christi, TX USA; [Gordon, Doria R.] Univ Florida, Dept Biol, Gainesville, FL USA	Nature Conservancy; State University System of Florida; University of Florida	Geselbracht, LL (corresponding author), Nature Conservancy, Florida Chapter, Altamonte Springs, FL 32714 USA.	lgeselbracht@tnc.org		Brenner, Jorge/0000-0002-4962-4784	US Environmental Protection Agency, Gulf of Mexico Program [MX-95463410]; Florida Department of Environmental Protection, Coastal Management Program [CM112]; National Oceanic and Atmospheric Administration [NOAA-GOMA-1001]	US Environmental Protection Agency, Gulf of Mexico Program; Florida Department of Environmental Protection, Coastal Management Program; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding was provided by the US Environmental Protection Agency, Gulf of Mexico Program, Agreement No. MX-95463410, http://www.epa.gov/gmpo/, to LG; Florida Department of Environmental Protection, Coastal Management Program, Agreement #CM112, http://www.dep.state.fl.us/cmp/default.htm, to DG; and National Oceanic and Atmospheric Administration, Grant #NOAA-GOMA-1001, http://www.noaa.gov/, to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony A, 2009, ECOL SOC, V14; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Brooks SM, 2014, J COAST CONSERV, V18, P581, DOI 10.1007/s11852-013-0279-7; Camoin GF, 2012, GEOLOGY, V40, P643, DOI 10.1130/G32057.1; Castaneda H., 2007, Florida Scientist, V70, P166; Chatterjee N., 2013, BLOOMBERG       1120; Chu-Agor ML, 2011, ENVIRON MODELL SOFTW, V26, P593, DOI 10.1016/j.envsoft.2010.12.003; Church J.A., 2013, CLIMATE CHANGE 2013, P1137, DOI [10.1017/CBO9781107415324.026, DOI 10.1017/CBO9781107415324.026, DOI 10.1017/CB09781107415324.026]; Clough J, 2010, SLAMM 6 0 1 BETA USE; Clough J.S., 2012, SLAMM 6 2 TECHNICAL; Corbett Catherine A., 2006, Florida Scientist, V69, P7; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Costanza R, 2007, ECOL ECON, V63, P249, DOI 10.1016/j.ecolecon.2007.03.002; Creel L., 2003, RIPPLE EFFECTS POPUL; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Davis R.A., 1997, GEOLOGY FLORIDA, P155; Desantis LRG, 2007, GLOBAL CHANGE BIOL, V13, P2349, DOI 10.1111/j.1365-2486.2007.01440.x; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Florida Natural Areas Inventory, 2010, DEV COOP LAND COV MA; Florida Ocean Alliance, 2013, FLOR OC COASTS EC CL; Frazer TK, 2002, WATER QUALITY CHARAC; Fussel HM, 2007, SUSTAIN SCI, V2, P265, DOI 10.1007/s11625-007-0032-y; Geselbracht L, 2011, CLIMATIC CHANGE, DOI [10.1007/s10584-011-0084-y, DOI 10.1007/S10584-011-0084-YAVAILABLE]; Geselbracht L, 2009, AQUAT CONSERV, V19, P408, DOI 10.1002/aqc.992; GLICK P., 2006, UNFAVORABLE TIDE GLO; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Jackson AC, 2011, J EXP MAR BIOL ECOL, V400, P314, DOI 10.1016/j.jembe.2011.02.012; Jevrejeva S, 2012, GLOBAL PLANET CHANGE, V80-81, P14, DOI 10.1016/j.gloplacha.2011.09.006; Keppner E, 2001, 004 BAY ENG STUD TEA; LEONARD LA, 1995, J COASTAL RES, V11, P322; Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022; McIvor A., 2012, NATURAL COASTAL PROT; McKay MD, 1999, COMPUT PHYS COMMUN, V117, P44, DOI 10.1016/S0010-4655(98)00155-6; Moretzsohn F, 2013, GULFBASE RESOURCE DA; National Ocean Service NOAA, 2011, GULF MEX GLANC 2 GLA; National Oceanic and Atmospheric Administration, TID CURR WEBS SEA LE; New York State Homes and Community Renewal, 2013, STAT NEW YORK ACT PL; Osterman LE, 2009, GEO-MAR LETT, V29, P395, DOI 10.1007/s00367-009-0159-1; Park RA, 1986, SUPPL P 1986 E SIM C, P149; Parry ML, 2007, CLIMATE CHANGE 2007; Pendleton L., 2008, EC MARKET VALUE COAS; Pfeffer WT, 2008, KINEMATIC CONSTRAINT, DOI [10.1126/science.1159099, DOI 10.1126/SCIENCE.1159099]; Pilkey Orrin H., 2009, THE RISING SEA; Rahmstorf S, 2012, ENVIRON RES LETT, V7, DOI [10.1088/1748-9326/7/4/044035, 10.1088/1748-9326/7/2/021001]; Reece JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080658; Shepard CC, 2011, NAT HAZARDS, DOI [10.1007/s11069-011-0046-8, DOI 10.1007/S11069-011-0046-8]; Stewart MG, 2011, RISK ASSESSMENT CLIM; Stutz ML, 2011, J COASTAL RES, V27, P207, DOI 10.2112/09-1190.1; Swedeen P, 2008, EARTH EC; Tanaka N, 2006, LANDSC ECOL ENG, V7, P127; The Nature Conservancy, 2013, RED CLIM RISKS NAT I; Titus J. G., 2009, COASTAL SENSITIVITY, P141; United Nations Environmental Program-World Conservation Monitoring Centre, 2006, FRONT LIN SHOR PROT; United Nations University Institute for Environment and Human Security and The Nature Conservancy, 2012, FOC ENV DEGR DIS; US Geological Survey US Environmental Protection Agency (USEPA), 2004, 855R04001 USEPA US G; USEPA, 1999, 620R98004 USEPA NAT; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Whitney E. N., 2004, PRICELESS FLORIDA NA; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361	59	30	30	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132079	10.1371/journal.pone.0132079	http://dx.doi.org/10.1371/journal.pone.0132079			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207914	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000022
J	Wang, PL; Wang, Z; Wang, DN; Tian, Y; Li, F; Zhang, SY; Zhang, L; Guo, YY; Liu, WB; Wang, CH; Chen, SG; Guo, JH				Wang, Peiliang; Wang, Zheng; Wang, Dongni; Tian, Yu; Li, Fan; Zhang, Shaoyao; Zhang, Lin; Guo, Yaoyu; Liu, Weibo; Wang, Chunhui; Chen, Shanguang; Guo, Jinhu			Altered Gravity Simulated by Parabolic Flight and Water Immersion Leads to Decreased Trunk Motion	PLOS ONE			English	Article							HEART-RATE; US ASTRONAUTS; BED REST; MICROGRAVITY; WEIGHTLESSNESS; CENTRIFUGATION; ACTIHEART; RESPONSES	Gravity is one of the important environmental factors that influence the physiologies and behaviors of animals and humans, and changes in gravity elicit a variety of physiological and behavioral alterations that include impaired movement coordination, vertigo, spatial disorientation, and perceptual illusions. To elucidate the effects of gravity on human physiology and behavior, we examined changes in wrist and trunk activities and heart rate during parabolic flight and the activity of wrist and trunk in water immersion experiments. Data from 195 person-time parabolas performed by eight subjects revealed that the trunk motion counts decreased by approximately half during ascending legs (hypergravity), relative to the data acquired before the parabolic flights. In contrast, the wrist activity remained unchanged. The results from the water immersion experiments demonstrated that in the underwater condition, both the wrist and trunk activities were significantly decreased but the latter decreased to a much lower level. Together, these data suggest that gravitational alterations can result in differential influences on the motions of the wrist and the trunk. These findings might be important for understanding the degeneration of skeleton and muscular system and performance of astronauts in microgravity.	[Wang, Peiliang; Wang, Zheng; Wang, Dongni; Zhang, Lin; Guo, Jinhu] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Minist Educ,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Tian, Yu; Li, Fan; Zhang, Shaoyao; Guo, Yaoyu; Liu, Weibo; Wang, Chunhui; Chen, Shanguang] China Astronaut Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences	Guo, JH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Minist Educ,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.	guojinhu@mail.sysu.edu.cn	ZHANG, LIN/GYD-9123-2022; zhan, lin/AAP-5149-2020		National Basic Program of China [2011CB711000, 2012CB947600]; National Natural Science Foundation of China [31171119, 71201148]; New Century Training Program Foundation for the Talents by the State Education Commission [NCET-12-0566]	National Basic Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Training Program Foundation for the Talents by the State Education Commission	This work was supported by the National Basic Program of China (2011CB711000, 2012CB947600, http://most.gov.cn/), the National Natural Science Foundation of China (31171119, 71201148, http://www.nsfc.gov.cn/), the New Century Training Program Foundation for the Talents by the State Education Commission (NCET-12-0566, http://www.moe.edu.cn/).	Beckers F, 2003, EUR J APPL PHYSIOL, V90, P83, DOI 10.1007/s00421-003-0854-y; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; CLEMENT G, 1988, EXP BRAIN RES, V72, P381; Dalecki M, 2012, EXP BRAIN RES, V218, P41, DOI 10.1007/s00221-012-2999-6; De Witt JK, 2010, AVIAT SPACE ENVIR MD, V81, P1092, DOI 10.3357/ASEM.2413.2010; DIETZ V, 1992, EXP BRAIN RES, V89, P229; DUDDY JH, 1969, HUM FACTORS, V11, P507, DOI 10.1177/001872086901100509; Grabherr L, 2010, J VESTIBUL RES-EQUIL, V20, P53, DOI 10.3233/VES-2010-0364; GREENLEAF JE, 1989, J APPL PHYSIOL, V67, P2191, DOI 10.1152/jappl.1989.67.6.2191; Guo JH, 2014, MILITARY MED RES, V1, DOI 10.1186/2054-9369-1-23; Hecht H, 2001, J VESTIBUL RES-EQUIL, V11, P115; Hides JA, 2011, EUR SPINE J, V20, P808, DOI 10.1007/s00586-010-1491-x; Holley DC, 2003, J APPL PHYSIOL, V95, P1266, DOI 10.1152/japplphysiol.00707.2002; Johnston SL, 2010, AVIAT SPACE ENVIR MD, V81, P566, DOI 10.3357/ASEM.2427.2010; LATHERS CM, 1990, J CLIN PHARMACOL, V30, P494, DOI 10.1002/j.1552-4604.1990.tb03614.x; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; Liang XD, 2014, BIOL RHYTHM RES, V45, P591, DOI 10.1080/09291016.2014.882093; Liang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047984; Liu ZZ, 2015, LIFE SCI SPACE RES, V4, P62, DOI 10.1016/j.lssr.2015.01.001; Masumoto K, 2005, EUR J APPL PHYSIOL, V94, P54, DOI 10.1007/s00421-004-1288-x; McPhee J. C., 2009, HUMAN HLTH PERFORMAN; Melzer K., 2012, E SPEN J, V7, pe5, DOI [10.1016/j.eclnm.2011.12.008, DOI 10.1016/J.ECLNM.2011.12.008]; Mori S, 1995, Nagoya J Med Sci, V58, P71; Osborne JR, 2014, MICROGRAVITY SCI TEC, V26, P11, DOI 10.1007/s12217-014-9365-1; Pletser V, 2004, ACTA ASTRONAUT, V55, P829, DOI 10.1016/j.actaastro.2004.04.006; Putcha L, 1999, AVIAT SPACE ENVIR MD, V70, P705; Ruttkay-Nedecky I, 1977, Act Nerv Super (Praha), V19 Suppl 2, P391; Sayson JV, 2008, AVIAT SPACE ENVIR MD, V79, P365, DOI 10.3357/ASEM.1994.2008; Somody L, 1998, LIFE SCI, V63, P851, DOI 10.1016/S0024-3205(98)00342-7; Takken T, 2010, EUR J CLIN NUTR, V64, P1494, DOI 10.1038/ejcn.2010.196; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; TROUT OF, 1969, HUM FACTORS, V11, P473, DOI 10.1177/001872086901100507; Verheyden B, 2005, EUR J APPL PHYSIOL, V95, P557, DOI 10.1007/s00421-005-0016-5; Verheyden B, 2009, RESP PHYSIOL NEUROBI, V169, pS13, DOI 10.1016/j.resp.2009.03.008; Wang D, 2014, SCI HUMAN PERFORMA S, P15; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415	36	1	1	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133398	10.1371/journal.pone.0133398	http://dx.doi.org/10.1371/journal.pone.0133398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208253	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000086
J	Wu, Y; Sun, Y; Shen, K; Sun, S; Wang, J; Jiang, TT; Cao, S; Josiah, SM; Pang, JS; Lin, XY; Liu, B				Wu, Ying; Sun, Yue; Shen, Kun; Sun, Shuai; Wang, Jie; Jiang, Tingting; Cao, Shuai; Josiah, Samuel Manthi; Pang, Jinsong; Lin, Xiuyun; Liu, Bao			Immediate Genetic and Epigenetic Changes in F1 Hybrids Parented by Species with Divergent Genomes in the Rice Genus (Oryza)	PLOS ONE			English	Article							TERMINAL REPEAT ELEMENT; CYTOSINE METHYLATION; DNA METHYLATION; WIDE HYBRIDIZATION; RETROTRANSPOSON; WHEAT; ELIMINATION; ALLOPOLYPLOIDY; SATIVA; INTROGRESSION	Background Inter-specific hybridization occurs frequently in higher plants, and represents a driving force of evolution and speciation. Inter-specific hybridization often induces genetic and epigenetic instabilities in the resultant homoploid hybrids or allopolyploids, a phenomenon known as genome shock. Although genetic and epigenetic consequences of hybridizations between rice subspecies (e.g., japonica and indica) and closely related species sharing the same AA genome have been extensively investigated, those of inter-specific hybridizations between more remote species with different genomes in the rice genus, Oryza, remain largely unknown. Methodology/Principal Findings We investigated the immediate chromosomal and molecular genetic/epigenetic instability of three triploid F1 hybrids produced by inter-specific crossing between species with divergent genomes of Oryza by genomic in situ hybridization (GISH) and molecular marker analysis. Transcriptional and transpositional activity of several transposable elements (TEs) and methylation stability of their flanking regions were also assessed. We made the following principle findings: (i) all three triploid hybrids are stable in both chromosome number and gross structure; (ii) stochastic changes in both DNA sequence and methylation occurred in individual plants of all three triploid hybrids, but in general methylation changes occurred at lower frequencies than genetic changes; (iii) alteration in DNA methylation occurred to a greater extent in genomic loci flanking potentially active TEs than in randomly sampled loci; (iv) transcriptional activation of several TEs commonly occurred in all three hybrids but transpositional events were detected in a genetic context-dependent manner. Conclusions/Significance Artificially constructed inter-specific hybrids of remotely related species with divergent genomes in genus Oryza are chromosomally stable but show immediate and highly stochastic genetic and epigenetic instabilities at the molecular level. These novel hybrids might provide a rich resource of genetic and epigenetic diversities for potential utilization in rice genetic improvements.	[Wu, Ying; Sun, Yue; Shen, Kun; Sun, Shuai; Wang, Jie; Jiang, Tingting; Cao, Shuai; Josiah, Samuel Manthi; Pang, Jinsong; Lin, Xiuyun; Liu, Bao] NE Normal Univ, MOE, Key Lab Mol Epigenet, Changchun, Peoples R China; [Wu, Ying; Sun, Yue; Shen, Kun; Sun, Shuai; Wang, Jie; Jiang, Tingting; Cao, Shuai; Josiah, Samuel Manthi; Pang, Jinsong; Lin, Xiuyun; Liu, Bao] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Lin, Xiuyun] Jilin Acad Agr Sci, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Jilin Academy of Agricultural Sciences	Lin, XY (corresponding author), NE Normal Univ, MOE, Key Lab Mol Epigenet, Changchun, Peoples R China.	linxiuyun1965@163.com; baoliu@nenu.edu.cn		Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279	National Natural Science Foundation of China [31290210, 11301064]; S & T Agency of Jilin Province [20140101014JC]; Program for Introducing Talents to Universities [B07017]; Graduate Student Innovation Fund of Northeast Normal University [12SSXT130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); S & T Agency of Jilin Province; Program for Introducing Talents to Universities; Graduate Student Innovation Fund of Northeast Normal University	This work was supported by the National Natural Science Foundation of China (31290210, 11301064), a project from the S & T Agency of Jilin Province (20140101014JC), the Program for Introducing Talents to Universities (B07017), and the Graduate Student Innovation Fund of Northeast Normal University (12SSXT130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Bimpong I. K., 2011, International Journal of Genetics and Molecular Biology, V3, P7; Chen LZ, 2008, GENOME, V51, P789, DOI 10.1139/G08-063; Chodavarapu RK, 2012, P NATL ACAD SCI USA, V109, P12040, DOI 10.1073/pnas.1209297109; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Feldman M, 1997, GENETICS, V147, P1381; Feldman M, 2009, J GENET GENOMICS, V36, P511, DOI 10.1016/S1673-8527(08)60142-3; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gao LH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-18; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Han FP, 2004, THEOR APPL GENET, V109, P1070, DOI 10.1007/s00122-004-1720-y; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hegarty MJ, 2011, MOL ECOL, V20, P105, DOI 10.1111/j.1365-294X.2010.04926.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Jiang BA, 2011, PLANT MOL BIOL, V77, P225, DOI 10.1007/s11103-011-9804-y; Jiang N, 2002, PLANT PHYSIOL, V130, P1697, DOI 10.1104/pp.015412; Jiang N, 2002, GENETICS, V161, P1293; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Jin HJ, 2008, THEOR APPL GENET, V117, P1271, DOI 10.1007/s00122-008-0861-9; Kawakami T, 2011, GENOME BIOL EVOL, V3, P156, DOI 10.1093/gbe/evr005; Khasdan V, 2010, GENETICS, V185, P387, DOI 10.1534/genetics.110.116178; Kraitshtein Z, 2010, GENETICS, V186, P801, DOI 10.1534/genetics.110.120790; Li H, 2010, J GENET GENOMICS, V37, P703, DOI 10.1016/S1673-8527(09)60088-6; Lin XY, 2006, J EXP BOT, V57, P2313, DOI 10.1093/jxb/erj203; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Liu ZL, 2004, PLANT MOL BIOL, V54, P571, DOI 10.1023/B:PLAN.0000038270.48326.7a; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Parisod C, 2009, NEW PHYTOL, V184, P1003, DOI 10.1111/j.1469-8137.2009.03029.x; Picault N, 2009, PLANT J, V58, P754, DOI 10.1111/j.1365-313X.2009.03813.x; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Saze H, 2011, CURR OPIN PLANT BIOL, V14, P81, DOI 10.1016/j.pbi.2010.08.017; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Senerchia N, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2874; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Tan GX, 2005, THEOR APPL GENET, V111, P1585, DOI 10.1007/s00122-005-0090-4; Ungerer MC, 2006, CURR BIOL, V16, pR872, DOI 10.1016/j.cub.2006.09.020; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074479; Wu Y, 2016, J INTEGR PLANT BIOL, V58, P150, DOI 10.1111/jipb.12357; Xu Chunming, 2014, Mol Biol Evol, V31, P1066, DOI 10.1093/molbev/msu085; Yaakov B, 2012, PLANT MOL BIOL, V80, P419, DOI 10.1007/s11103-012-9957-3; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P3447, DOI 10.1073/pnas.1300153110; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao N, 2011, GENETICS, V188, P499, DOI 10.1534/genetics.111.127688	61	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132911	10.1371/journal.pone.0132911	http://dx.doi.org/10.1371/journal.pone.0132911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208215	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000045
J	Zhu, JX; Zhan, X; Shi, GG; Yi, KH; Tan, XR				Zhu, Jinxiu; Zhan, Xin; Shi, Ganggang; Yi, Kaihong; Tan, Xuerui			Atrial Fibrillation Is an Independent Risk Factor for Hospital-Acquired Pneumonia	PLOS ONE			English	Article							ACUTE STROKE; HEART; COMPLICATIONS; EPIDEMIOLOGY; ETIOLOGY	Background Patients who were hospitalized for community-based pneumonia frequently had pre-existing atrial fibrillation (AF) and had subsequent cardiovascular complications. Whether patients who had AF would be susceptible to the development of hospital-acquired pneumonia (HAP) is a serious concern but this has not been investigated. In our clinics, we have made empirical observation of such susceptibility. Objectives To investigate the association between newly developed HAP and pre-existing AF, and to identify whether AF is an independent risk factor for HAP. Methods Hospital data from 8657 sequentially admitted inpatients [1059 patients with AF and 7598 without AF (NAF)] were collected from the Department of Cardiology, First Affiliated Hospital of Shantou University Medical College, Shantou, China, from January 1, 2009 to December 31, 2011. Exclusion criteria were: having previous or current pneumonia, pacemakers, sick sinus syndrome and repeated hospitalization. The incidence of HAP (within 48 hours after hospitalization) was identified among all the patients. Results Among the AF patients, 274 had HAP (adjusted rate 25.64%) which was significantly higher than the 276 NAF patients who had HAP (adjusted rate 3.66%; P<0.001). The increased risk was also associated with high blood pressure, heart failure and age, but not with gender, smoking, coronary heart disease, diabetes, congenital heart disease. In addition, our multiple regression analysis indicates that AF is an independent risk factor for HAP. Conclusion We have identified, for the first time, that AF is an important risk factor for HAP. Although additional clinical confirmation is needed, our data provide valuable evidence for use in prevention of HAP which is the most common cause of death from nosocomial infection.	[Zhu, Jinxiu; Yi, Kaihong; Tan, Xuerui] Shantou Univ, Coll Med, Dept Cardiol, Affiliated Hosp 1, Shantou 515041, Guangdong, Peoples R China; [Zhan, Xin] Shantou Univ, Coll Med, Mol Cardiol Lab, Affiliated Hosp 1, Shantou 515041, Guangdong, Peoples R China; [Shi, Ganggang] Shantou Univ, Coll Med, Dept Pharmacol, Shantou 515032, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University	Tan, XR (corresponding author), Shantou Univ, Coll Med, Dept Cardiol, Affiliated Hosp 1, Shantou 515041, Guangdong, Peoples R China.	tanxuerui@vip.sina.com			Provincial Project of Science and Technology of Guangdong, China [2011b031600011]; National Natural Science Foundation of China [81172776]	Provincial Project of Science and Technology of Guangdong, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Provincial Project of Science and Technology of Guangdong, China (No. 2011b031600011, UCRs:http://www.gdstc.gov.cn/) which was obtained by Dr. Jinxiu Zhu, and partially supported by the National Natural Science Foundation of China (No. 81172776, UCLs:http://www.nsfc.gov.cn/) which was gotten by Dr. Xuerui Tan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arai Tadashi, 2006, Nihon Rinsho, V64 Suppl 7, P463; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chawla R, 2008, AM J INFECT CONTROL, V36, pS93, DOI 10.1016/j.ajic.2007.05.011; Connelly SM, 2009, AM J INFECT CONTROL, V37, P143, DOI 10.1016/j.ajic.2008.03.011; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Gamst J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006486; Ji RJ, 2013, STROKE, V44, P3436, DOI 10.1161/STROKEAHA.113.001931; Leder SB, 2002, DYSPHAGIA, V17, P214, DOI 10.1007/s00455-002-0054-7; de Oliveira TFL, 2011, REV ASSOC MED BRAS, V57, P630, DOI 10.1590/S0104-42302011000600008; Masrur S, 2013, J STROKE CEREBROVASC, V22, pE301, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.013; McEachern R, 1998, INFECT DIS CLIN N AM, V12, P761, DOI 10.1016/S0891-5520(05)70209-9; Mor A, 2013, EUR J INTERN MED, V24, P349, DOI 10.1016/j.ejim.2013.02.013; Ruff CT, 2014, INT J CARDIOL, V170, P413, DOI 10.1016/j.ijcard.2013.11.030; Soto-Gomez N, 2013, AM J MED, V126, P43, DOI 10.1016/j.amjmed.2012.08.005; Topal AE, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2012-005; Tu HTH, 2011, CEREBROVASC DIS, V32, P454, DOI 10.1159/000332028; Ucgun I, 2013, EUR REV MED PHARMACO, V17, P2; Zhou Zi-qiang, 2004, Zhonghua Nei Ke Za Zhi, V43, P491	21	99	102	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0131782	10.1371/journal.pone.0131782	http://dx.doi.org/10.1371/journal.pone.0131782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204447	Green Submitted, Green Published, gold			2022-12-26	WOS:000358621000004
J	Lupattelli, A; Spigset, O; Torgersen, L; Zerwas, S; Hatle, M; Reichborn-Kjennerud, T; Bulik, CM; Nordeng, H				Lupattelli, Angela; Spigset, Olav; Torgersen, Leila; Zerwas, Stephanie; Hatle, Marianne; Reichborn-Kjennerud, Ted; Bulik, Cynthia M.; Nordeng, Hedvig			Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; LOW-BIRTH-WEIGHT; ANOREXIA-NERVOSA; GENERAL-POPULATION; PERINATAL OUTCOMES; BULIMIA-NERVOSA; DEPRESSION; RISK; MOBA; FERTILITY	Introduction Little is known about medication use among women with eating disorders in relation to pregnancy. Aims To explore patterns of and associations between use of psychotropic, gastrointestinal and analgesic medications and eating disorders in the period before, during and after pregnancy. Method This study is based on the Norwegian Mother and Child Cohort Study (MoBa). A total of 62,019 women, enrolled at approximately 17 weeks' gestation, had valid data from the Norwegian Medical Birth Registry and completed three MoBa questionnaires. The questionnaires provided diagnostic information on broadly defined anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED) and recurrent self-induced purging in the absence of binge eating (EDNOS-P), along with self-reported use of medication six months before, during, and 0-6 months after pregnancy. Results The prevalence of eating disorder subtypes before and/or during pregnancy was: 0.09% AN (n = 54), 0.94% BN (n = 585), 0.10% EDNOS-P (n = 61) and 5.00% BED (n = 3104). The highest over-time prevalence of psychotropic use was within the AN (3.7-22.2%) and EDNOS-P (3.3-9.8%) groups. Compared to controls, BN was directly associated with incident use of psychotropics in pregnancy (adjusted RR: 2.25, 99% CI: 1.17-4.32). Having AN (adjusted RR: 5.11, 99% CI: 1.53-17.01) or EDNOS-P (adjusted RR: 6.77, 99% CI: 1.41-32.53) was directly associated with use of anxiolytics/sedatives postpartum. The estimates of use of analgesics (BED) and laxatives (all eating disorders subtypes) were high at all time periods investigated. Conclusions Use of psychotropic, gastrointestinal, and analgesic medications is extensive among women with eating disorders in the period around pregnancy. Female patients with eating disorders should receive evidence-based counseling about the risk of medication exposure versus the risk of untreated psychiatric illness during pregnancy and postpartum.	[Lupattelli, Angela; Nordeng, Hedvig] Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, PharmaTox Strateg Initiat,Fac Math & Nat Sci, Oslo, Norway; [Spigset, Olav] St Olavs Univ Hosp, Dept Clin Pharmacol, Trondheim, Norway; [Spigset, Olav] Norwegian Univ Sci & Technol, Childrens & Womens Hlth, Dept Lab Med, N-7034 Trondheim, Norway; [Torgersen, Leila; Reichborn-Kjennerud, Ted; Nordeng, Hedvig] Norwegian Inst Publ Hlth, Div Mental Hlth, Oslo, Norway; [Zerwas, Stephanie; Bulik, Cynthia M.] Univ N Carolina, Dept Psychiat, UNC Ctr Excellence Eating Disorders, Chapel Hill, NC USA; [Hatle, Marianne] Clin Eating Disorders, Oslo, Norway; [Reichborn-Kjennerud, Ted] Univ Oslo, Dept Psychiat, Oslo, Norway; [Bulik, Cynthia M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Bulik, Cynthia M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH); University of North Carolina; University of North Carolina Chapel Hill; University of Oslo; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	Lupattelli, A (corresponding author), Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, PharmaTox Strateg Initiat,Fac Math & Nat Sci, Oslo, Norway.	angela.lupattelli@farmasi.uio.no	Zerwas, Stephanie/AAG-1595-2020	Zerwas, Stephanie/0000-0002-8927-3755; Bulik, Cynthia/0000-0001-7772-3264; Lupattelli, Angela/0000-0002-8787-3183	Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; National Institutes of Health [HD047186]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH100435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, NIH/NIEHS (contract no. N01-ES-75558), NIH/NINDS (grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1), and the Norwegian Research Council/FUGE (grant no. 151918/S10). This work is also supported by the grant HD047186 From the National Institutes of Health (PI: CMB).	Aigner M, 2011, WORLD J BIOL PSYCHIA, V12, P400, DOI 10.3109/15622975.2011.602720; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], SUMM PROD CHAR SPC; ATC/DDD Index, 2012, ATC DDD IND 2012; Bacaltchuk J, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003391; Berg CK, 2008, AUST NZ J PSYCHIAT, V42, P396, DOI 10.1080/00048670801961149; Berg CK, 2011, INT J EAT DISORDER, V44, P124, DOI 10.1002/eat.20797; Boyd C, 2005, SCAND J GASTROENTERO, V40, P929, DOI 10.1080/00365520510015836; Briggs GG., 2017, DRUGS PREGNANCY LACT; Bulik CM, 1999, J CLIN PSYCHIAT, V60, P130, DOI 10.4088/JCP.v60n0212; Bulik CM, 2007, PSYCHOL MED, V37, P1109, DOI 10.1017/S0033291707000724; Bulik CM, 2010, OBSTET GYNECOL, V116, P1136, DOI 10.1097/AOG.0b013e3181f7efdc; Bulik CM, 2009, INT J EAT DISORDER, V42, P9, DOI 10.1002/eat.20578; BUSHNELL JA, 1994, PSYCHOL MED, V24, P605, DOI 10.1017/S0033291700027756; Claudino AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004365.pub2; Coughlin JW, 2008, CLIN J PAIN, V24, P406, DOI 10.1097/AJP.0b013e3181633fc5; Coughlin JW, 2010, INT J EAT DISORDER, V43, P737, DOI 10.1002/eat.20766; Dellava JE, 2011, INT J EAT DISORDER, V44, P325, DOI 10.1002/eat.20831; Easter A, 2011, BJOG-INT J OBSTET GY, V118, P1491, DOI 10.1111/j.1471-0528.2011.03077.x; Easter A, 2015, EUR EAT DISORD REV, V23, P19, DOI 10.1002/erv.2328; Easter A, 2013, EUR EAT DISORD REV, V21, P340, DOI 10.1002/erv.2229; Eberhard-Gran M, 2004, J PSYCHOSOM OBST GYN, V25, P15, DOI 10.1080/01674820410001737405; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; Fazeli PK, 2012, INT J EAT DISORDER, V45, P970, DOI 10.1002/eat.22037; Fink P, 2004, J PSYCHOSOM RES, V56, P371, DOI 10.1016/S0022-3999(03)00071-0; Flament MF, 2012, INT J NEUROPSYCHOPH, V15, P189, DOI 10.1017/S1461145711000381; Franko DL, 2001, AM J PSYCHIAT, V158, P1461, DOI 10.1176/appi.ajp.158.9.1461; Gable KN, 2005, CURR THER RES CLIN E, V66, P572, DOI 10.1016/j.curtheres.2005.12.011; GOTESTAM KG, 1995, INT J EAT DISORDER, V18, P119, DOI 10.1002/1098-108X(199509)18:2&lt;119::AID-EAT2260180203&gt;3.0.CO;2-U; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Harris JR, 2002, TWIN RES, V5, P415, DOI 10.1375/136905202320906192; Hendrick V., 2006, PSYCHIAT DISORDERS P; Hoffman Elizabeth R, 2011, Expert Rev Obstet Gynecol, V6, P403; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jasper JD, 2001, LANCET, V358, P1237, DOI 10.1016/S0140-6736(01)06353-X; Kaye WH, 2001, BIOL PSYCHIAT, V49, P644, DOI 10.1016/S0006-3223(00)01013-1; Kelly NR, 2013, INT J EAT DISORDER, V46, P127, DOI 10.1002/eat.22096; Knoph C, 2013, INT J EAT DISORDER, V46, P355, DOI 10.1002/eat.22088; Linna MS, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.067; Linna MS, 2013, INT J EAT DISORDER, V46, P826, DOI 10.1002/eat.22179; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Micali N, 2014, BJOG-INT J OBSTET GY, V121, P408, DOI 10.1111/1471-0528.12503; Micali N, 2012, BJOG-INT J OBSTET GY, V119, P1493, DOI 10.1111/j.1471-0528.2012.03467.x; Micali N, 2012, BRIT J NUTR, V108, P2093, DOI 10.1017/S0007114512000256; Micali N, 2011, J AFFECT DISORDERS, V131, P150, DOI 10.1016/j.jad.2010.09.034; Mitchell JE, 2013, INT J EAT DISORDER, V46, P470, DOI 10.1002/eat.22104; Mond JM, 2007, EUR EAT DISORD REV, V15, P403, DOI 10.1002/erv.792; Mulder E, 2012, J OBSTET GYNAECOL CA, V34, P66, DOI 10.1016/S1701-2163(16)35136-2; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Norwegian Institute of Public Health, NOW MOTH CHILD COH S; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Reichborn-Kjennerud T, 2003, ACTA PSYCHIAT SCAND, V108, P196, DOI 10.1034/j.1600-0447.2003.00106.x; Sandanger I, 1998, SOC PSYCH PSYCH EPID, V33, P345, DOI 10.1007/s001270050064; Shakeel N, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-014-0420-0; Skurtveit S, 2013, J CLIN EPIDEMIOL, V66, P964, DOI 10.1016/j.jclinepi.2013.02.011; Solmi F, 2014, EPIDEMIOL REV, V36, P49, DOI 10.1093/epirev/mxt004; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; Swann RA, 2009, INT J EAT DISORDER, V42, P394, DOI 10.1002/eat.20632; TAMBS K, 1993, ACTA PSYCHIAT SCAND, V87, P364, DOI 10.1111/j.1600-0447.1993.tb03388.x; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Torgersen L, 2008, INT J EAT DISORDER, V41, P722, DOI 10.1002/eat.20564; Zerwas SC, 2014, EUR EAT DISORD REV	65	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133045	10.1371/journal.pone.0133045	http://dx.doi.org/10.1371/journal.pone.0133045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200658	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100052
J	Kitazawa, M; Kubo, Y; Nakajo, K				Kitazawa, Masahiro; Kubo, Yoshihiro; Nakajo, Koichi			Kv4.2 and Accessory Dipeptidyl Peptidase-like Protein 10 (DPP10) Subunit Preferentially Form a 4:2 (Kv4.2:DPP10) Channel Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT OUTWARD CURRENT; ALPHA-SUBUNITS; K+ CHANNEL; MOLECULAR PHYSIOLOGY; VENTRICULAR-MUSCLE; BETA-SUBUNIT; EXPRESSION; STOICHIOMETRY; INACTIVATION; MODULATION	Kv4 is a member of the voltage-gated K+ channel family and forms a complex with various accessory subunits. Dipeptidyl aminopeptidase-like protein (DPP) is one of the auxiliary subunits for the Kv4 channel. Although DPP has been well characterized and is known to increase the current amplitude and accelerate the inactivation and recovery from inactivation of Kv4 current, it remains to be determined how many DPPs bind to one Kv4 channel. To examine whether the expression level of DPP changes the biophysical properties of Kv4, we expressed Kv4.2 and DPP10 in different ratios in Xenopus oocytes and analyzed the currents under two-electrode voltage clamp. The current amplitude and the speed of recovery from inactivation of Kv4.2 changed depending on the co-expression level of DPP10. This raised the possibility that the stoichiometry of the Kv4.2-DPP10 complex is variable and affects the biophysical properties of Kv4.2. We next determined the stoichiometry of DPP10 alone by subunit counting using single-molecule imaging. Approximately 70% of the DPP10 formed dimers in the plasma membrane, and the rest existed as monomers in the absence of Kv4.2. We next determined the stoichiometry of the Kv4.2-DPP10 complex; Kv4.2-mCherry and mEGFP-DPP10 were co-expressed in different ratios and the stoichiometries of Kv4.2-DPP10 complexes were evaluated by the subunit counting method. The stoichiometry of the Kv4.2-DPP10 complex was variable depending on the relative expression level of each subunit, with a preference for 4: 2 stoichiometry. This preference may come from the bulky dimeric structure of the extracellular domain of DPP10.	[Kubo, Yoshihiro] Natl Inst Physiol Sci, Dept Mol Physiol, Div Biophys & Neurobiol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Hayama, Kanagawa 2400155, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Kubo, Y (corresponding author), Natl Inst Physiol Sci, Dept Mol Physiol, Div Biophys & Neurobiol, Okazaki, Aichi 4448585, Japan.	ykubo@nips.ac.jp	Nakajo, Koichi/J-2601-2019	Nakajo, Koichi/0000-0003-0766-7281; Kubo, Yoshihiro/0000-0001-6707-0837	(KAKENHI) from the Japan Society for the Promotion of Science	(KAKENHI) from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid for scientific research (KAKENHI) from the Japan Society for the Promotion of Science (to K.N. and Y.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; Arant RJ, 2014, CHEMPHYSCHEM, V15, P600, DOI 10.1002/cphc.201301092; Bezerra GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08769; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Brahmajothi MV, 1999, J GEN PHYSIOL, V113, P581, DOI 10.1085/jgp.113.4.581; Chen T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/209398; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Chien CH, 2004, J BIOL CHEM, V279, P52338, DOI 10.1074/jbc.M406185200; Clark BD, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.008.2008; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; DIXON JE, 1994, CIRC RES, V75, P252, DOI 10.1161/01.RES.75.2.252; Dougherty K, 2009, CHANNELS, V3, P122, DOI 10.4161/chan.3.2.8333; Foeger NC, 2012, J BIOL CHEM, V287, P9640, DOI 10.1074/jbc.M111.324574; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Hastie P, 2013, P NATL ACAD SCI USA, V110, P5163, DOI 10.1073/pnas.1218765110; Jerng HH, 2007, MOL CELL NEUROSCI, V35, P604, DOI 10.1016/j.mcn.2007.03.008; Jerng HH, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00082; Jerng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038205; Jerng HH, 2009, CHANNELS, V3, P448, DOI 10.4161/chan.3.6.10216; Jerng HH, 2008, J BIOL CHEM, V283, P36046, DOI 10.1074/jbc.M806852200; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kaulin YA, 2009, J NEUROSCI, V29, P3242, DOI 10.1523/JNEUROSCI.4767-08.2009; Kim J, 2008, J NEUROPHYSIOL, V100, P1835, DOI 10.1152/jn.90261.2008; Kitazawa M, 2014, J BIOL CHEM, V289, P17597, DOI 10.1074/jbc.M114.563452; Liao C, 2013, EUR J MED GENET, V56, P484, DOI 10.1016/j.ejmg.2013.06.008; Lin L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3270; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Marionneau C, 2011, SEMIN CELL DEV BIOL, V22, P145, DOI 10.1016/j.semcdb.2010.10.004; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matsuyoshi H, 2012, LIFE SCI, V91, P258, DOI 10.1016/j.lfs.2012.07.007; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Sanguinetti MC, 2002, CIRC RES, V90, P497, DOI 10.1161/01.RES.0000014284.39141.8C; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; Soh H, 2008, J BIOL CHEM, V283, P15072, DOI 10.1074/jbc.M706964200; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; Takimoto K, 2006, BIOCHEM BIOPH RES CO, V348, P1094, DOI 10.1016/j.bbrc.2006.07.157; Ulbrich MH, 2008, P NATL ACAD SCI USA, V105, P14163, DOI 10.1073/pnas.0802075105; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Wang WC, 2015, J COMP NEUROL, V523, P608, DOI 10.1002/cne.23698; Xu HD, 1999, J PHYSIOL-LONDON, V519, P11, DOI 10.1111/j.1469-7793.1999.0011o.x; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zhou JH, 2015, BIOPHYS J, V108, P2658, DOI 10.1016/j.bpj.2015.04.024	61	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22724	22733		10.1074/jbc.M115.646794	http://dx.doi.org/10.1074/jbc.M115.646794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26209633	hybrid, Green Published			2022-12-26	WOS:000361171500036
J	Aspatwar, A; Tolvanen, MEE; Ojanen, MJT; Barker, HR; Saralahti, AK; Bauerlein, CA; Ortutay, C; Pan, P; Kuuslahti, M; Parikka, M; Ramet, M; Parkkila, S				Aspatwar, Ashok; Tolvanen, Martti E. E.; Ojanen, Markus J. T.; Barker, Harlan R.; Saralahti, Anni K.; Bauerlein, Carina A.; Ortutay, Csaba; Pan, Peiwen; Kuuslahti, Marianne; Parikka, Mataleena; Ramet, Mika; Parkkila, Seppo			Inactivation of ca10a and ca10b Genes Leads to Abnormal Embryonic Development and Alters Movement Pattern in Zebrafish	PLOS ONE			English	Article							ANHYDRASE-RELATED PROTEIN; CARBONIC-ANHYDRASES; HUMAN BRAIN; SEQUENCE ALIGNMENTS; CDNA SEQUENCE; I-TASSER; EXPRESSION; VIII; XI; GENERATION	Carbonic anhydrase related proteins (CARPs) X and XI are highly conserved across species and are predominantly expressed in neural tissues. The biological role of these proteins is still an enigma. Ray-finned fish have lost the CA11 gene, but instead possess two co-orthologs of CA10. We analyzed the expression pattern of zebrafish ca10a and ca10b genes during embryonic development and in different adult tissues, and studied 61 CARP X/XI-like sequences to evaluate their phylogenetic relationship. Sequence analysis of zebrafish ca10a and ca10b reveals strongly predicted signal peptides, N-glycosylation sites, and a potential disulfide, all of which are conserved, suggesting that all of CARP X and XI are secretory proteins and potentially dimeric. RT-qPCR showed that zebrafish ca10a and ca10b genes are expressed in the brain and several other tissues throughout the development of zebrafish. Antisense morpholino mediated knockdown of ca10a and ca10b showed developmental delay with a high rate of mortality in larvae. Zebrafish morphants showed curved body, pericardial edema, and abnormalities in the head and eye, and there was increased apoptotic cell death in the brain region. Swim pattern showed abnormal movement in morphant zebrafish larvae compared to the wild type larvae. The developmental phenotypes of the ca10a and ca10b morphants were confirmed by inactivating these genes with the CRISPR/Cas9 system. In conclusion, we introduce a novel zebrafish model to investigate the mechanisms of CARP Xa and CARP Xb functions. Our data indicate that CARP Xa and CARP Xb have important roles in zebrafish development and suppression of ca10a and ca10b expression in zebrafish larvae leads to a movement disorder.	[Aspatwar, Ashok; Tolvanen, Martti E. E.; Ojanen, Markus J. T.; Saralahti, Anni K.; Bauerlein, Carina A.; Ortutay, Csaba; Parikka, Mataleena; Ramet, Mika] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland; [Aspatwar, Ashok; Barker, Harlan R.; Pan, Peiwen; Kuuslahti, Marianne; Parkkila, Seppo] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Tolvanen, Martti E. E.] Univ Turku, Dept Informat Technol, Turku, Finland; [Ramet, Mika] Univ Oulu, PEDEGO Res Ctr, Oulu, Finland; [Ramet, Mika] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Ramet, Mika] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Parkkila, Seppo] Fimlab Ltd, Tampere, Finland; [Parkkila, Seppo] Tampere Univ, FIN-33101 Tampere, Finland	Tampere University; Tampere University; University of Turku; University of Oulu; University of Oulu; University of Oulu; Tampere University	Aspatwar, A (corresponding author), Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland.	ashok.aspatwar@staff.uta.fi	Ortutay, Csaba/H-2827-2012; Ojanen, Markus/AAI-8316-2021; Aspatwar, Ashok/I-4358-2019	Ortutay, Csaba/0000-0001-6306-6101; Ojanen, Markus/0000-0001-6623-844X; Aspatwar, Ashok/0000-0002-6938-7835; Barker, Harlan/0000-0003-4125-2522; Saralahti, Anni/0000-0002-6145-6875; Tolvanen, Martti/0000-0003-3434-7646; Parikka, Mataleena/0000-0001-5555-3815; Parkkila, Seppo/0000-0001-7323-8536	Tampere University Hospital; Jane and Aatos Erkko Foundation; Academy of Finland; Finnish Cultural Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Biocenter Finland	Tampere University Hospital; Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Biocenter Finland	This work was supported by the competitive Research Funding of the Tampere University Hospital and grants from the Jane and Aatos Erkko Foundation (SP, MR), Academy of Finland (SP, MR, MP), Finnish Cultural Foundation (HB), Sigrid Juselius Foundation (SP, MR), and Tampere Tuberculosis Foundation (SP, MR and MP). The zebrafish work was carried out at the Tampere Zebrafish Core Facility funded by the Biocenter Finland and Tampere Tuberculosis Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aspatwar A, 2014, SUBCELL BIOCHEM, V75, P135, DOI 10.1007/978-94-007-7359-2_8; Aspatwar A, 2013, HUM MOL GENET, V22, P417, DOI 10.1093/hmg/dds438; Aspatwar A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-25; Bellingham J, 1998, BIOCHEM BIOPH RES CO, V253, P364, DOI 10.1006/bbrc.1998.9449; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Chen X, 2008, J NEUROSCI, V28, P12713, DOI 10.1523/JNEUROSCI.3909-08.2008; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fujikawa-Adachi K, 1999, BBA-PROTEIN STRUCT M, V1431, P518, DOI 10.1016/S0167-4838(99)00067-9; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hruscha A, 2015, METHODS MOL BIOL, V1254, P341, DOI 10.1007/978-1-4939-2152-2_24; Hsieh M, 2013, CEREBELLUM; Huang M, 2014, BIOCHIMICA ET BIOPHY; Huang MS, 2014, BBA-GEN SUBJECTS, V1840, P2829, DOI 10.1016/j.bbagen.2014.04.017; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; Kaya N, 2011, AM J MED GENET B, V156B, P826, DOI 10.1002/ajmg.b.31227; Kleiderlein JJ, 1998, HUM GENET, V103, P666, DOI 10.1007/s004390050889; Krebs J, 2014, CRISPR DESIGN TOOL A; Linser PJ, 2009, J EXP BIOL, V212, P1662, DOI 10.1242/jeb.028084; Lohi O, 2013, ACTA PAEDIATR, V102, P104, DOI 10.1111/j.1651-2227.2012.02835.x; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Morimoto K, 2005, VIRCHOWS ARCH, V447, P66, DOI 10.1007/s00428-005-1225-3; Nishimori Isao, 2003, Biomedical Research (Aligarh), V14, P70; Okamoto N, 2001, BBA-GENE STRUCT EXPR, V1518, P311, DOI 10.1016/S0167-4781(01)00193-2; Ortutay C, 2010, HAUPPAUGE, P145; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pastorekova S, 2004, J ENZYM INHIB MED CH, V19, P199, DOI 10.1080/14756360410001689540; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Taniuchi K, 2002, MOL BRAIN RES, V109, P207, DOI 10.1016/S0169-328X(02)00563-6; Taniuchi K, 2002, NEUROSCIENCE, V112, P93, DOI 10.1016/S0306-4522(02)00066-0; Tolvanen MEE, 2013, BIOORGAN MED CHEM, V21, P1503, DOI 10.1016/j.bmc.2012.08.060; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; Westerfield M., 2000, THE ZEBRAFISH BOOK A; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	52	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134263	10.1371/journal.pone.0134263	http://dx.doi.org/10.1371/journal.pone.0134263			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218428	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900104
J	Kansiime, C; Atuyambe, LM; Asiimwe, BB; Mugisha, A; Mugisha, S; Guma, V; Rwego, IB; Rutebemberwa, E				Kansiime, Catherine; Atuyambe, Lynn M.; Asiimwe, Benon B.; Mugisha, Anthony; Mugisha, Samuel; Guma, Victor; Rwego, Innocent B.; Rutebemberwa, Elizeus			Community Perceptions on Integrating Animal Vaccination and Health Education by Veterinary and Public Health Workers in the Prevention of Brucellosis among Pastoral Communities of South Western Uganda	PLOS ONE			English	Article							DISEASES	Background Brucellosis is a zoonotic disease of veterinary, public health, and economic significance in most developing countries, yet there are few studies that show integrated human and veterinary health care intervention focusing on integration at both activity and actors levels. The aim of our study, therefore, was to explore community perceptions on integration of animal vaccination and health education by veterinary and public health workers in the management of brucellosis in Uganda. Methods This study used a qualitative design where six Focus Group Discussions (FGDs) that were homogenous in nature were conducted, two from each sub-county, one with the local leaders, and another with pastoralists and farmers. Five Key Informant Interviews (KIIs) with two public health workers and three veterinary extension workers from three sub-counties in Kiruhura district, Uganda were conducted. All FGDs were conducted in the local language and tape recorded with consent from the participants. KIIs were in English and later transcribed and analyzed using latent content data analysis method. Results All the groups mentioned that they lacked awareness on brucellosis commonly known as Brucella and its vaccination in animals. Respondents perceived improvement in human resources in terms of training and recruiting more health personnel, facilitation of the necessary activities such as sensitization of the communities about brucellosis, and provision of vaccines and diagnostic tests as very important in the integration process in the communities. The FGD participants also believed that community participation was crucial for sustainability and ownership of the integration process. Conclusions The respondents reported limited knowledge of brucellosis and its vaccination in animals. The community members believed that mass animal vaccination in combination with health education about the disease is important and possible if it involves government and all other stakeholders such as wildlife authorities, community members, local to national political leaders, as well as the technical personnel from veterinary, medical and public health sectors since it affects both humans and animals.	[Kansiime, Catherine; Rutebemberwa, Elizeus] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Atuyambe, Lynn M.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Asiimwe, Benon B.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Mugisha, Anthony] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Dept Vet Med, Kampala, Uganda; [Mugisha, Samuel; Rwego, Innocent B.] Makerere Univ, Coll Nat Sci, Dept Biol Sci, Kampala, Uganda; [Guma, Victor] Makerere Univ, Coll Humanities & Social Sci, Dept Mental Hlth & Community Psychol, Kampala, Uganda; [Rwego, Innocent B.] Univ Minnesota, Coll Vet Med, Ecosyst Hlth Initiat, St Paul, MN 55108 USA	Makerere University; Makerere University; Makerere University; Makerere University; Makerere University; Makerere University; University of Minnesota System; University of Minnesota Twin Cities	Kansiime, C (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda.	cathie.kansiime@gmail.com	Rwego, Innocent Bidason/I-5049-2013	Rwego, Innocent Bidason/0000-0003-1274-7788; Rutebemberwa, Elizeus/0000-0001-8363-7928	International Development Research Centre (IDRC), Canada	International Development Research Centre (IDRC), Canada	CK, SM, BBA, and IBR received funding from the International Development Research Centre (IDRC), Canada (http://www.idrc.ca/EN/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard F, 2005, PREV VET MED, V67, P267, DOI 10.1016/j.prevetmed.2004.11.002; BROWN M, 1992, HLTH CARE MANAGEMENT; Choudhary V, 2011, UGANDA DAIRY SUPPLY; Dawson S, 1992, MANUAL USE FOCUS GRO; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Garcia-Barbero M, 2001, INT J INTEGRATED CAR; Godfroid J, 2002, VET MICROBIOL, V90, P135, DOI 10.1016/S0378-1135(02)00217-1; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Goering PN, 1996, CAN J PSYCHIAT, V41, P491, DOI 10.1177/070674379604100804; Gul S. T., 2007, Pakistan Veterinary Journal, V27, P145; Holstein J. A., 1995, ACTIVE INTERVIEW; Ibironke Ademola A, 2008, Vet Ital, V44, P549; Jelastopulu E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-241; Kalema-Zikusoka G, 2005, ONDERSTEPOORT J VET, V72, P145; Kangethe EK, 2007, E AFR MED J, V84, P96; Kansiime C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-242; KHAN M E, 1991, World Health Statistics Quarterly, V44, P145; KHAN ME, 1992, HEALTH POLICY PLANN, V7, P56, DOI 10.1093/heapol/7.1.56; Kodner D, 2002, EQUITABLE EFFICIENT; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; Lakshman M., 2000, Indian Journal of Pediatrics, V67, P358, DOI 10.1007/BF02820688; Lawrence P.R., 1967, ORG ENV MANAGING DIF; Magona JW, 2009, TROP ANIM HEALTH PRO, V41, P1765, DOI 10.1007/s11250-009-9375-y; Makita K, 2008, ANN NY ACAD SCI, V1149, P309, DOI 10.1196/annals.1428.015; Makita K, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-52; Makita K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014188; Marshall Catherine, 2006, DESIGNING QUALITATIV; Meslin F. X., 1996, Livestock production and diseases in the tropics: livestock production and human welfare. Proceedings of the 8th International Conference of Institutions of Tropical Medicine held from the 25 to 29 September, 1995 in Berlin, Germany Volume 1., P101; Mugabi R, 2012, THESIS MAKERERE U KA; Newman W.L., 2003, SOCIAL RES METHODS Q; NICHTER M, 1995, SOC SCI MED, V41, P617, DOI 10.1016/0277-9536(95)00034-5; Pfeffer J., 1982, ORG ORG THEORY; Program for Appropriate Technology in Health (PATH), 2011, INT HLTH SERV THEOR; Reviriego FJ, 2000, PREV VET MED, V44, P167, DOI 10.1016/S0167-5877(00)00108-2; Rhyan JC, 2000, EMERGING DISEASES OF ANIMALS, P161; Rice P., 1999, QUALITATIVE RES METH; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Schelling E, 2002, NOMADIC PASTORALISTS; Scott R, 1992, ORG RATIONAL NATURAL, V3, P199; Smits HL, 2004, AFRICAN J BIOTECHNOL, V12, P631; Thakur S. D., 2002, Journal of Communicable Diseases, V34, P287; Ward D. E., 1993, Nomadic Peoples, P55; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8	43	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132206	10.1371/journal.pone.0132206	http://dx.doi.org/10.1371/journal.pone.0132206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218368	Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900004
J	Mayordomo-Cava, J; Yajeya, J; Navarro-Lopez, JD; Jimenez-Diaz, L				Mayordomo-Cava, Jennifer; Yajeya, Javier; Navarro-Lopez, Juan D.; Jimenez-Diaz, Lydia			Amyloid-beta((25-35)) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; ADULT-RAT BRAIN; REAL-TIME PCR; ALZHEIMERS-DISEASE; POTASSIUM CHANNEL; RNA INTEGRITY; PRION PROTEIN; DOWN-SYNDROME; FYN-KINASE; MECHANISMS	During early stages of Alzheimer's disease (AD), synaptic dysfunction induced by toxic amyloid-beta (A beta) is present before the accumulation of histopathological hallmarks of the disease. This scenario produces impaired functioning of neuronal networks, altered patterns of synchronous activity and severe functional deficits mainly due to hyperexcitability of hippocampal networks. The molecular mechanisms underlying these alterations remain unclear but functional evidence, shown by our laboratory and others, points to the involvement of receptors/channels which modulate neuronal excitability, playing a pivotal role in early A beta-induced AD pathogenesis. In particular, two potassium channels that control neuronal excitability, G protein-coupled activated inwardly-rectifying potassium channel (GirK), and voltage-gated K channel (KCNQ), have been recently linked to A beta pathophysiology in the hippocampus. Specifically, by using A beta 25-35, we previously found that GirK conductance is greatly decreased in the hippocampus, and similar effects have also been reported on KCNQ conductance. Thus, in the present study, our goal was to determine the effect of A beta on the transcriptional expression pattern of 17 genes encoding neurotransmitter receptors and associated channels which maintain excitatory-inhibitory neurotransmission balance in hippocampal circuits, with special focus in potassium channels. For this purpose, we designed a systematic and reliable procedure to analyze mRNA expression by reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) in hippocampal rat slices incubated with A beta(25-35). We found that: 1) A beta down-regulated mRNA expression of ionotropic GluN1 and metabotropic mGlu1 glutamate receptor subunits as previously reported in other AD models; 2) A beta also reduced gene expression levels of GirK2, 3, and 4 subunits, and KCNQ2 and 3 subunits, but did not change expression levels of its associated GABA(B) and M1 receptors, respectively. Our results provide evidence that A beta can modulate the expression of these channels which could affect the hippocampal activity balance underlying learning and memory processes impaired in AD.	[Mayordomo-Cava, Jennifer; Navarro-Lopez, Juan D.; Jimenez-Diaz, Lydia] Univ Castilla La Mancha, CRIB, Sch Med Ciudad Real, Neurophysiol & Behav Lab, E-13071 Ciudad Real, Spain; [Yajeya, Javier] Univ Salamanca, Dept Physiol & Pharmacol, E-37008 Salamanca, Spain	Universidad de Castilla-La Mancha; University of Salamanca	Navarro-Lopez, JD (corresponding author), Univ Castilla La Mancha, CRIB, Sch Med Ciudad Real, Neurophysiol & Behav Lab, E-13071 Ciudad Real, Spain.	Juan.Navarro@uclm.es; Lydia.Jimenez@uclm.es	Jiménez-Diaz, Lydia/R-8383-2019; Yajeya, Javier/B-4325-2017; de Dios Navarro López, Juan/Q-9318-2019; MC, Jennifer/U-1506-2017	Jiménez-Diaz, Lydia/0000-0001-9121-0334; de Dios Navarro López, Juan/0000-0002-1877-7833; MC, Jennifer/0000-0001-6476-1173; Yajeya, Javier/0000-0003-1617-4227	Spanish Ministry of Economy and Competitivity [BFU2009-07341, SAF2010-14878, BFU2011-22740, BFU2014-56164-P]; Fundacion Eugenio Rodriguez Pascual; Fundacion Tatiana Perez de Guzman el Bueno	Spanish Ministry of Economy and Competitivity(Spanish Government); Fundacion Eugenio Rodriguez Pascual; Fundacion Tatiana Perez de Guzman el Bueno	This work was supported by Spanish Ministry of Economy and Competitivity Grants (BFU2009-07341 to JY; SAF2010-14878 and BFU2011-22740 to JDNL; BFU2014-56164-P to LJD and JDNL); Fundacion Eugenio Rodriguez Pascual to JDNL; Fundacion Tatiana Perez de Guzman el Bueno to LJD. JDNL held a Ramon y Cajal Research Fellow (RYC-2009-03827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasanz JL, 2005, NEUROBIOL DIS, V20, P685, DOI 10.1016/j.nbd.2005.05.001; Amaral D., 2007, HIPPOCAMPAL NEUROANA; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersen P., 2007, HIPPOCAMPUS BOOK; Ashenafi S, 2005, NEUROBIOL AGING, V26, P419, DOI 10.1016/j.neurobiolaging.2004.05.008; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Caccamo A, 2009, CURR ALZHEIMER RES, V6, P112, DOI 10.2174/156720509787602915; Chang ZW, 2011, J PHYS CHEM B, V115, P1165, DOI 10.1021/jp107558e; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Colom LV, 2006, J NEUROCHEM, V96, P609, DOI 10.1111/j.1471-4159.2005.03630.x; Cooper A, 2012, P NATL ACAD SCI USA, V109, P2642, DOI 10.1073/pnas.1109099109; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Duran-Gonzalez J, 2013, NEUROBIOL AGING, V34, P2071, DOI 10.1016/j.neurobiolaging.2013.02.005; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Fidzinski P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7254; Fisher A, 2012, J NEUROCHEM, V120, P22, DOI 10.1111/j.1471-4159.2011.07507.x; Fitzjohn SM, 2008, EUR J PHARMACOL, V585, P50, DOI 10.1016/j.ejphar.2008.02.077; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gaisler-Salomon I, 2014, NEUROBIOL AGING, V35, P1785, DOI 10.1016/j.neurobiolaging.2014.02.018; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Hynd MR, 2001, J NEUROCHEM, V78, P175, DOI 10.1046/j.1471-4159.2001.00409.x; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Janickova H, 2013, NEUROPHARMACOLOGY, V67, P272, DOI 10.1016/j.neuropharm.2012.11.014; Jimenez-Diaz Lydia, 2011, Front Neurol, V2, P59, DOI 10.3389/fneur.2011.00059; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaufmann K, 2013, ACS CHEM NEUROSCI, V4, P1278, DOI 10.1021/cn400062a; Kerrigan TL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00009; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kumar A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00215; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Leao RN, 2012, NEUROBIOL AGING, V33, P2046, DOI 10.1016/j.neurobiolaging.2011.07.013; Linley JE, 2012, J PHYSIOL-LONDON, V590, P793, DOI 10.1113/jphysiol.2011.223404; Lott IT, 2005, NEUROBIOL AGING, V26, P383, DOI 10.1016/j.neurobiolaging.2004.08.005; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lujan R, 2014, TRENDS NEUROSCI, V37, P20, DOI 10.1016/j.tins.2013.10.006; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Millucci L, 2010, CURR PROTEIN PEPT SC, V11, P54, DOI 10.2174/138920310790274626; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; Mota SI, 2014, NEUROPHARMACOLOGY, V76, P16, DOI 10.1016/j.neuropharm.2013.08.013; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Murer G, 1997, NEUROSCIENCE, V80, P345, DOI 10.1016/S0306-4522(97)00001-8; Nava-Mesa MO, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00167; Nava-Mesa MO, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00117; Navarro-Lopez JD, 2004, J NEUROSCI, V24, P5109, DOI 10.1523/JNEUROSCI.0235-04.2004; Navarro-Lopez J, 2009, J MOL NEUROSCI, V37, P263, DOI 10.1007/s12031-008-9130-2; Nistico R, 2012, MOL NEUROBIOL, V46, P572, DOI 10.1007/s12035-012-8324-3; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NEUROMOL MED, V12, P48, DOI 10.1007/s12017-009-8097-7; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Parra-Damas A, 2014, J NEUROSCI, V34, P5776, DOI 10.1523/JNEUROSCI.5288-13.2014; Pena F, 2010, HIPPOCAMPUS, V20, P78, DOI 10.1002/hipo.20592; Perry CA, 2008, P NATL ACAD SCI USA, V105, P8148, DOI 10.1073/pnas.0803261105; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Rockwood K, 1997, CAN J NEUROL SCI, V24, P140, DOI 10.1017/S031716710002148X; Santos-Torres J, 2007, J NEUROSCI RES, V85, P634, DOI 10.1002/jnr.21150; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P1, DOI 10.1016/S0028-3908(98)00170-1; Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471; Seifert S., 2022, DANNY BOY THE STEVE; Spauschus A, 1996, J NEUROSCI, V16, P930; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Swanberg MM, 2004, ARCH NEUROL-CHICAGO, V61, P556, DOI 10.1001/archneur.61.4.556; Tsang SWY, 2006, NEUROBIOL AGING, V27, P1216, DOI 10.1016/j.neurobiolaging.2005.07.010; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Xi YD, 2015, CELL MOL NEUROBIOL, V35, P555, DOI 10.1007/s10571-014-0151-9	88	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134385	10.1371/journal.pone.0134385	http://dx.doi.org/10.1371/journal.pone.0134385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218288	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900114
J	Montezano, D; Meek, L; Gupta, R; Bermudez, LE; Bermudez, JCM				Montezano, Daniel; Meek, Laura; Gupta, Rashmi; Bermudez, Luiz E.; Bermudez, Jose C. M.			Flux Balance Analysis with Objective Function Defined by Proteomics Data-Metabolism of Mycobacterium tuberculosis Exposed to Mefloquine	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; MODELS; GROWTH; RESISTANCE; NETWORKS; DRUGS	We present a study of the metabolism of the Mycobacterium tuberculosis after exposure to antibiotics using proteomics data and flux balance analysis (FBA). The use of FBA to study prokaryotic organisms is well-established and allows insights into the metabolic pathways chosen by the organisms under different environmental conditions. To apply FBA a specific objective function must be selected that represents the metabolic goal of the organism. FBA estimates the metabolism of the cell by linear programming constrained by the stoichiometry of the reactions in an in silico metabolic model of the organism. It is assumed that the metabolism of the organism works towards the specified objective function. A common objective is the maximization of biomass. However, this goal is not suitable for situations when the bacterium is exposed to antibiotics, as the goal of organisms in these cases is survival and not necessarily optimal growth. In this paper we propose a new approach for defining the FBA objective function in studies when the bacterium is under stress. The function is defined based on protein expression data. The proposed methodology is applied to the case when the bacterium is exposed to the drug mefloquine, but can be easily extended to other organisms, conditions or drugs. We compare our method with an alternative method that uses experimental data for adjusting flux constraints. We perform comparisons in terms of essential enzymes and agreement using enzyme abundances. Results indicate that using proteomics data to define FBA objective functions yields less essential reactions with zero flux and lower error rates in prediction accuracy. With flux variability analysis we observe that overall variability due to alternate optima is reduced with the incorporation of proteomics data. We believe that incorporating proteomics data in the objective function used in FBA may help obtain metabolic flux representations that better support experimentally observed features.	[Montezano, Daniel; Bermudez, Jose C. M.] Univ Fed Santa Catarina, Lab Pesquisa Proc Digital Sinais LPDS, Florianopolis, SC, Brazil; [Meek, Laura; Bermudez, Luiz E.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Gupta, Rashmi] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA	Universidade Federal de Santa Catarina (UFSC); Oregon State University; State University System of Florida; University of Central Florida	Montezano, D (corresponding author), Univ Fed Santa Catarina, Lab Pesquisa Proc Digital Sinais LPDS, Florianopolis, SC, Brazil.	daniel@lpds.ufsc.br	Bermudez, Jose C M/A-3670-2008	Bermudez, Jose C M/0000-0002-6712-939X	Bill and Melinda Gates Foundation [OPP50277]; Foundation for Microbiology [10923SR]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for Microbiology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Bill and Melinda Gates Foundation, grant number OPP50277 (www.gatesfoundation.org, LEB), and by Foundation for Microbiology, grant number 10923SR (www.waksman-foundation.org, LEB).	Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Danelishvili L, 2005, ANTIMICROB AGENTS CH, V49, P3707, DOI 10.1128/AAC.49.9.3707-3714.2005; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; Gevorgyan A, 2011, BIOINFORMATICS, V27, P433, DOI 10.1093/bioinformatics/btq679; Lakshmanan M, 2014, BRIEF BIOINFORM, V15, P108, DOI 10.1093/bib/bbs069; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; McNamara M, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-45; McNamara M, 2012, INFECT IMMUN, V80, P1868, DOI 10.1128/IAI.06151-11; Movahedzadeh F, 2004, MOL MICROBIOL, V51, P1003, DOI 10.1046/j.1365-2958.2003.03900.x; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Proteome Software, 2014, PROTEOME SOFTWARE WI; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Reed JL, 2004, GENOME RES, V14, P1797, DOI 10.1101/gr.2546004; Sanz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022178; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Segre Daniel, 2003, OMICS A Journal of Integrative Biology, V7, P301, DOI 10.1089/153623103322452413; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; van Berlo RJP, 2011, IEEE ACM T COMPUT BI, V8, P206, DOI 10.1109/TCBB.2009.55; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994	27	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134014	10.1371/journal.pone.0134014	http://dx.doi.org/10.1371/journal.pone.0134014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218987	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900065
J	Srutkova, D; Schwarzer, M; Hudcovic, T; Zakostelska, Z; Drab, V; Spanova, A; Rittich, B; Kozakova, H; Schabussova, I				Srutkova, Dagmar; Schwarzer, Martin; Hudcovic, Tomas; Zakostelska, Zuzana; Drab, Vladimir; Spanova, Alena; Rittich, Bohuslav; Kozakova, Hana; Schabussova, Irma			Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; TIGHT JUNCTION; IMMUNOMODULATORY PROPERTIES; DENDRITIC CELLS; DEXTRAN SULFATE; IN-VIVO; ANTIINFLAMMATORY CAPACITY; PROBIOTIC PREPARATION	Background Reduced microbial diversity has been associated with inflammatory bowel disease (IBD) and probiotic bacteria have been proposed for its prevention and/or treatment. Nevertheless, comparative studies of strains of the same subspecies for specific health benefits are scarce. Here we compared two Bifidobacterium longum ssp. longum strains for their capacity to prevent experimental colitis. Methods Immunomodulatory properties of nine probiotic bifidobacteria were assessed by stimulation of murine splenocytes. The immune responses to B. longum ssp. longum CCM 7952 (Bl 7952) and CCDM 372 (Bl 372) were further characterized by stimulation of bone marrow-derived dendritic cell, HEK293/TLR2 or HEK293/NOD2 cells. A mouse model of dextran sulphate sodium (DSS)-induced colitis was used to compare their beneficial effects in vivo. Results The nine bifidobacteria exhibited strain-specific abilities to induce cytokine production. Bl 372 induced higher levels of both pro-and anti-inflammatory cytokines in spleen and dendritic cell cultures compared to Bl 7952. Both strains engaged TLR2 and contain ligands for NOD2. In a mouse model of DSS-induced colitis, Bl 7952, but not Bl 372, reduced clinical symptoms and preserved expression of tight junction proteins. Importantly, Bl 7952 improved intestinal barrier function as demonstrated by reduced FITC-dextran levels in serum. Conclusions We have shown that Bl 7952, but not Bl 372, protected mice from the development of experimental colitis. Our data suggest that although some immunomodulatory properties might be widespread among the genus Bifidobacterium, others may be rare and characteristic only for a specific strain. Therefore, careful selection might be crucial in providing beneficial outcome in clinical trials with probiotics in IBD.	[Srutkova, Dagmar; Schwarzer, Martin; Hudcovic, Tomas; Kozakova, Hana] Acad Sci Czech Republ, Inst Microbiol, Vvi, Lab Gnotobiol, Novy Hradek, Czech Republic; [Zakostelska, Zuzana] Acad Sci Czech Republ, Inst Microbiol, Vvi, Lab Cellular & Mol Immunol, Prague, Czech Republic; [Drab, Vladimir] Dairy Res Inst Ltd, Prague, Czech Republic; [Spanova, Alena; Rittich, Bohuslav] Brno Univ Technol, Fac Chem, CS-61090 Brno, Czech Republic; [Schabussova, Irma] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Dairy Research Institute; Brno University of Technology; Medical University of Vienna	Kozakova, H (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Vvi, Lab Gnotobiol, Novy Hradek, Czech Republic.	kozakova@biomed.cas.cz	Zákostelská, Zuzana/ABB-9807-2021; Zakostelska, Zuzana/D-6518-2012; Hudcovic, Tomas/H-7917-2014; Kozakova, Hana/I-1153-2014; Schwarzer, Martin/P-9871-2017; Drab, Vladimir/E-3133-2010; Šrůtková, Dagmar/H-8511-2014	Hudcovic, Tomas/0000-0002-4761-5040; Kozakova, Hana/0000-0001-7352-5922; Schwarzer, Martin/0000-0002-1401-6578; Šrůtková, Dagmar/0000-0003-0054-5396; Rittich, Bohuslav/0000-0002-1167-4604; Schabussova, Irma/0000-0002-2109-2640; Zakostelska, Zuzana/0000-0002-6695-8188	Czech Science Foundation [303/09/0449, P303/12/0535]; OeAD-GmbH grant [CZ 15/2015]; Austrian Science Fund [SFB F46];  [CZ.3.22/2.1.00/09.01574];  [CZ.3.22/2.1.00/13.03892];  [FCH-S- 14-2325]	Czech Science Foundation(Grant Agency of the Czech Republic); OeAD-GmbH grant; Austrian Science Fund(Austrian Science Fund (FWF)); ; ; 	Supported by grants 303/09/0449 and P303/12/0535 of the Czech Science Foundation, grants CZ.3.22/2.1.00/09.01574 and CZ.3.22/2.1.00/13.03892, OeAD-GmbH grant CZ 15/2015 and grant SFB F46 from Austrian Science Fund. The financial support of internal grant FCH-S- 14-2325 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Biswas A, 2013, INT IMMUNOL, V25, P207, DOI 10.1093/intimm/dxs116; Boirivant M, 2012, ORAL DIS, V18, P1, DOI 10.1111/j.1601-0825.2011.01811.x; Buning C, 2012, INFLAMM BOWEL DIS, V18, P1932, DOI 10.1002/ibd.22909; Cinova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016169; COOPER HS, 1993, LAB INVEST, V69, P238; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Dong HL, 2012, BRIT J NUTR, V108, P459, DOI 10.1017/S0007114511005824; Favier C, 1997, DIGEST DIS SCI, V42, P817, DOI 10.1023/A:1018876400528; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Fujiwara M, 2003, DIGESTION, V67, P90, DOI 10.1159/000069704; Furrie E, 2005, GUT, V54, P242, DOI 10.1136/gut.2004.044834; Geier MS, 2007, INT J FOOD MICROBIOL, V115, P1, DOI 10.1016/j.ijfoodmicro.2006.10.006; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gyires K, 2014, CURR PHARM DESIGN, V20, P1063, DOI 10.2174/13816128113199990417; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kole A, 2014, CURR TOP MICROBIOL, V380, P19, DOI 10.1007/978-3-662-43492-5_2; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Krizova J, 2006, SYST APPL MICROBIOL, V29, P36, DOI 10.1016/j.syapm.2005.07.003; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Latvala S, 2008, WORLD J GASTROENTERO, V14, P5570, DOI 10.3748/wjg.14.5570; Lopez P, 2010, INT J FOOD MICROBIOL, V138, P157, DOI 10.1016/j.ijfoodmicro.2009.12.023; Makino H, 2011, APPL ENVIRON MICROB, V77, P6788, DOI 10.1128/AEM.05346-11; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Mann ER, 2013, IMMUNOL LETT, V150, P30, DOI 10.1016/j.imlet.2013.01.007; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Miele E, 2009, AM J GASTROENTEROL, V104, P437, DOI 10.1038/ajg.2008.118; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Neurath MF, 2012, DIGEST DIS, V30, P91, DOI 10.1159/000341131; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Prantera C, 2002, GUT, V51, P405, DOI 10.1136/gut.51.3.405; Preising J, 2010, APPL ENVIRON MICROB, V76, P3048, DOI 10.1128/AEM.03127-09; Rahimi R, 2008, DIGEST DIS SCI, V53, P2524, DOI 10.1007/s10620-007-0171-0; Repa A, 2003, VACCINE, V22, P87, DOI 10.1016/S0264-410X(03)00528-0; Rolfe VE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004826; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schabussova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040271; Schabussova I, 2011, VACCINE, V29, P1981, DOI 10.1016/j.vaccine.2010.12.101; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Schwarzer M, 2013, VACCINE, V31, P5405, DOI 10.1016/j.vaccine.2013.09.014; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Srutkova D, 2011, J MICROBIOL METH, V87, P10, DOI 10.1016/j.mimet.2011.06.014; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Steinbach EC, 2014, INFLAMM BOWEL DIS, V20, P166, DOI 10.1097/MIB.0b013e3182a69dca; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Turroni F, 2009, ISME J, V3, P745, DOI 10.1038/ismej.2009.19; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Ventura M, 2014, J SCI FOOD AGR, V94, P163, DOI 10.1002/jsfa.6356; Venturi A, 1999, ALIMENT PHARM THER, V13, P1103; Verbeke KA, 2014, P NUTR SOC, V73, P490, DOI 10.1017/S0029665114000639; Weinstock JV, 2013, INT J PARASITOL, V43, P245, DOI 10.1016/j.ijpara.2012.10.016; Wildt S, 2011, J CROHNS COLITIS, V5, P115, DOI 10.1016/j.crohns.2010.11.004; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961; Zenlea T, 2014, WORLD J GASTROENTERO, V20, P3146, DOI 10.3748/wjg.v20.i12.3146; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	80	106	112	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134050	10.1371/journal.pone.0134050	http://dx.doi.org/10.1371/journal.pone.0134050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218526	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900072
J	Pratt, DR; Lohrer, AM; Thrush, SF; Hewitt, JE; Townsend, M; Cartner, K; Pilditch, CA; Harris, RJ; van Colen, C; Rodil, IF				Pratt, Daniel R.; Lohrer, Andrew M.; Thrush, Simon F.; Hewitt, Judi E.; Townsend, Michael; Cartner, Katie; Pilditch, Conrad A.; Harris, Rachel J.; van Colen, Carl; Rodil, Ivan F.			Detecting Subtle Shifts in Ecosystem Functioning in a Dynamic Estuarine Environment	PLOS ONE			English	Article							INTERTIDAL SANDFLATS; INTERACTION NETWORKS; MARINE; COASTAL; BIODIVERSITY; MACROFAUNA; SEDIMENTS; BIOTURBATION; DISTURBANCE; DENSITY	Identifying the effects of stressors before they impact ecosystem functioning can be challenging in dynamic, heterogeneous 'real-world' ecosystems. In aquatic systems, for example, reductions in water clarity can limit the light available for photosynthesis, with knock-on consequences for secondary consumers, though in naturally turbid wave-swept estuaries, detecting the effects of elevated turbidity can be difficult. The objective of this study was to investigate the effects of shading on ecosystem functions mediated by sandflat primary producers (microphytobenthos) and deep-dwelling surface-feeding macrofauna (Macomona liliana; Bivalvia, Veneroida, Tellinidae). Shade cloths (which reduced incident light intensity by similar to 80%) were deployed on an exposed, intertidal sandflat to experimentally stress the microphytobenthic community associated with the sediment surface. After 13 weeks, sediment properties, macrofauna and fluxes of oxygen and inorganic nutrients across the sediment-water interface were measured. A multivariate metric of ecosystem function (MF) was generated by combining flux-based response variables, and distance-based linear models were used to determine shifts in the drivers of ecosystem function between non-shaded and shaded plots. No significant differences in MF or in the constituent ecosystem function variables were detected between the shaded and non-shaded plots. However, shading reduced the total explained variation in MF (from 64% in non-shaded plots to 15% in shaded plots) and affected the relative influence of M. liliana and other explanatory variables on MF. This suggests that although shade stress may shift the drivers of ecosystem functioning (consistent with earlier investigations of shading effects on sandflat interaction networks), ecosystem functions appear to have a degree of resilience to those changes.	[Pratt, Daniel R.; Lohrer, Andrew M.; Thrush, Simon F.; Hewitt, Judi E.; Townsend, Michael; Cartner, Katie] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [Thrush, Simon F.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand; [Pilditch, Conrad A.; Harris, Rachel J.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [van Colen, Carl] Univ Ghent, Dept Biol, Marine Biol Grp, B-9000 Ghent, Belgium; [Rodil, Ivan F.] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4100 Oporto, Portugal	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Auckland; University of Waikato; Ghent University; Universidade do Porto	Pratt, DR (corresponding author), Natl Inst Water & Atmospher Res, POB 11-115, Hamilton, New Zealand.	dan.prtt@gmail.com	Harris, Rachel Joy/R-5903-2019; Pratt, Dan/H-3919-2019; Rodil, Iván F./I-5305-2013	Harris, Rachel Joy/0000-0001-5117-7592; Pratt, Dan/0000-0003-1781-4468; Rodil, Iván F./0000-0001-6375-1598; Thrush, Simon/0000-0002-4005-3882	Ministry of Business, Innovation and Employment [CO 1X1005]; National Institute of Water and Atmospheric Research under the Coasts and Oceans Research Programme 3 [2012/13 SCI]; Flemish Fund for Scientific Research [FWO-1.2.380.11.N.00]; Xunta de Galicia, Spain	Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); National Institute of Water and Atmospheric Research under the Coasts and Oceans Research Programme 3; Flemish Fund for Scientific Research(FWO); Xunta de Galicia, Spain(Xunta de Galicia)	This work was funded by Ministry of Business, Innovation and Employment (CO 1X1005) and National Institute of Water and Atmospheric Research under the Coasts and Oceans Research Programme 3 (2012/13 SCI). C. Van Colen acknowledges a postdoctoral fellowship provided by the Flemish Fund for Scientific Research (FWO-1.2.380.11.N.00). Funding to I. F. Rodil was provided by a post-doctoral fellowship (Angeles Alvarino, Xunta de Galicia, Spain).	Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Anderson MJ, 1998, PERMANOVA PRIMER GUI; Asmus R., 1998, PRIMARY PRODUCTION M, P367; Bengtsson J, 1998, APPL SOIL ECOL, V10, P191, DOI 10.1016/S0929-1393(98)00120-6; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; CLAVERO V, 1992, HYDROBIOLOGIA, V235, P387, DOI 10.1007/BF00026228; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Friberg N, 2014, WIRES WATER, V1, P513, DOI 10.1002/wat2.1040; Harris RJ, 2015, MAR ECOL PROG SER, V523, P15, DOI 10.3354/meps11164; Hedman JE, 2011, J EXP MAR BIOL ECOL, V407, P294, DOI 10.1016/j.jembe.2011.06.026; Hewitt JE, 1997, J EXP MAR BIOL ECOL, V216, P77, DOI 10.1016/S0022-0981(97)00091-9; Kang CK, 2003, MAR ECOL PROG SER, V259, P79, DOI 10.3354/meps259079; Kristensen E, 2013, ESTUAR COAST SHELF S, V134, P80, DOI 10.1016/j.ecss.2013.09.020; Lelieveld SD, 2004, NEW ZEAL J MAR FRESH, V38, P115, DOI 10.1080/00288330.2004.9517223; Lohrer AM, 2010, J EXP MAR BIOL ECOL, V390, P6, DOI 10.1016/j.jembe.2010.04.035; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Lohrer AM, 2012, MAR POLLUT BULL, V64, P2761, DOI 10.1016/j.marpolbul.2012.09.012; Mccauley DJ, 2014, CONSERV BIOL, V28, P1312, DOI 10.1111/cobi.12314; Mermillod-Blondin F, 2006, AQUAT SCI, V68, P434, DOI 10.1007/s00027-006-0858-x; Michener WK, 2001, BIOSCIENCE, V51, P1018, DOI 10.1641/0006-3568(2001)051[1018:DAUB]2.0.CO;2; Needham HR, 2011, ECOSYSTEMS, V14, P1096, DOI 10.1007/s10021-011-9468-0; Norkko A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02646; Painting SJ, 2013, BIOGEOCHEMISTRY, V113, P237, DOI 10.1007/s10533-012-9774-4; Pillay D, 2007, MAR BIOL, V152, P611, DOI 10.1007/s00227-007-0715-z; Pratt DR, 2015, ESTUAR COAST, V38, P722, DOI 10.1007/s12237-014-9857-7; Pratt DR, 2014, J SEA RES, V92, P170, DOI 10.1016/j.seares.2013.07.009; PRIDMORE RD, 1990, NEW ZEAL J MAR FRESH, V24, P81, DOI 10.1080/00288330.1990.9516404; Rodil IF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081646; Rossi F, 2007, MAR BIOL, V151, P2077, DOI 10.1007/s00227-007-0641-0; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Thornton DCO, 1999, MAR ECOL PROG SER, V184, P11, DOI 10.3354/meps184011; Thrush SF, 2012, ECOL APPL, V22, P1213, DOI 10.1890/11-1403.1; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thrush SF, 2014, ECOLOGY, V95, P1451, DOI 10.1890/13-1879.1; Townsend M, 2011, MAR ECOL PROG SER, V434, P291, DOI 10.3354/meps09118; Van Colen C, 2015, J SEA RES, V98, P42, DOI 10.1016/j.seares.2014.10.016; Van De Koppel J, 2001, ECOLOGY, V82, P3449, DOI 10.1890/0012-9658(2001)082[3449:DASSOI]2.0.CO;2; Villnas A, 2013, ECOLOGY, V94, P2275, DOI 10.1890/12-1716.1; Volkenborn N, 2012, J MAR RES, V70, P794, DOI 10.1357/002224012806770955; Welsh DT, 2003, CHEM ECOL, V19, P321, DOI 10.1080/0275754031000155474; Woodin SA, 2012, J EXP MAR BIOL ECOL, V413, P184, DOI 10.1016/j.jembe.2011.12.010; Woodin SA, 2010, INTEGR COMP BIOL, V50, P176, DOI 10.1093/icb/icq031; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005	51	23	23	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133914	10.1371/journal.pone.0133914	http://dx.doi.org/10.1371/journal.pone.0133914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214854	Green Published, gold			2022-12-26	WOS:000358594300040
J	Kazmi, SA; Yang, ZK; Hong, N; Wang, GP; Wang, YF				Kazmi, Syeda Amber; Yang, Zuokun; Hong, Ni; Wang, Guoping; Wang, Yanfen			Characterization by Small RNA Sequencing of Taro Bacilliform CH Virus (TaBCHV), a Novel Badnavirus	PLOS ONE			English	Article							COMPLETE GENOMIC SEQUENCE; MOTTLE VIRUS; COLOCASIA-ESCULENTA; MOSAIC-VIRUS; BANANA; DIVERSITY; DISCOVERY; CLONING	RNA silencing is an antiviral immunity that regulates gene expression through the production of small RNAs (sRNAs). In this study, deep sequencing of small RNAs was used to identify viruses infecting two taro plants. Blast searching identified five and nine contigs assembled from small RNAs of samples T1 and T2 matched onto the genome sequences of badnaviruses in the family Caulimoviridae. Complete genome sequences of two isolates of the badnavirus determined by sequence specific amplification comprised of 7,641 nucleotides and shared overall nucleotide similarities of 44.1%-55.8% with other badnaviruses. Six open reading frames (ORFs) were identified on the plus strand, showed amino acid similarities ranging from 59.8%(ORF3) to 10.2% (ORF6) to the corresponding proteins encoded by other badnaviruses. Phylogenetic analysis also supports that the virus is a new member in the genus Badnavirus. The virus is tentatively named as Taro bacilliform CH virus (TaBCHV), and it is the second badnavirus infecting taro plants, following Taro bacilliform virus (TaBV). In addition, analyzes of viral derived small RNAs (vsRNAs) from TaBCHV showed that almost equivalent number of vsRNAs were generated from both strands and the most abundant vsRNAs were 21 nt, with uracil bias at 5' terminal. Furthermore, TaBCHV vsRNAs were asymmetrically distributed on its entire circular genome at both orientations with the hotspots mainly generated in the ORF5 region.	[Kazmi, Syeda Amber; Hong, Ni; Wang, Guoping] Huazhong Agr Univ, State Key Lab Agromicrobiol, Wuhan, Hubei, Peoples R China; [Kazmi, Syeda Amber; Yang, Zuokun; Hong, Ni; Wang, Guoping; Wang, Yanfen] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Hong, N (corresponding author), Huazhong Agr Univ, State Key Lab Agromicrobiol, Wuhan, Hubei, Peoples R China.	whni@mail.hzau.edu.cn			 [nyhzx-200903017-08]		This work was financially supported by the agricultural project (nyhzx-200903017-08) administered by the Chinese Ministry of Agriculture. HN has received the funding. The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOEKE JD, 1989, ANNU REV MICROBIOL, V43, P403, DOI 10.1146/annurev.micro.43.1.403; BOUHIDA M, 1993, J GEN VIROL, V74, P15, DOI 10.1099/0022-1317-74-1-15; Brunt A, 1990, VIRUSES TROPICAL PLA; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Lara A, 2015, VIRUS GENES, V50, P104, DOI 10.1007/s11262-014-1149-6; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; HAGEN LS, 1993, VIROLOGY, V196, P619, DOI 10.1006/viro.1993.1518; Hany U, 2014, ARCH VIROL, V159, P385, DOI 10.1007/s00705-013-1824-2; Harper G, 1998, VIRUS GENES, V17, P271, DOI 10.1023/A:1008021921849; Harper G, 2005, ARCH VIROL, V150, P2407, DOI 10.1007/s00705-005-0610-1; Huang Q, 2001, J GEN VIROL, V82, P2549, DOI 10.1099/0022-1317-82-10-2549; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Kalischuka ML, 2013, VIRUS RES, V178, P306, DOI 10.1016/j.virusres.2013.09.026; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; King AMQ, 2012, VIRUS TAXONOMY 9 REP; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; LACO GS, 1995, VIROLOGY, V208, P207, DOI 10.1006/viro.1995.1144; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LOCKHART BEL, 1990, PHYTOPATHOLOGY, V80, P127, DOI 10.1094/Phyto-80-127; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marmey P, 1999, VIROLOGY, V253, P319, DOI 10.1006/viro.1998.9519; MEDBERRY SL, 1990, NUCLEIC ACIDS RES, V18, P5505, DOI 10.1093/nar/18.18.5505; MEDBERRY SL, 1993, PLANT J, V3, P619, DOI 10.1046/j.1365-313X.1993.03040619.x; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Pearson MN, 1999, AUSTRALAS PLANT PATH, V28, P248, DOI 10.1071/AP99040; Rajeswaran R, 2014, J VIROL, V88, P11516, DOI 10.1128/JVI.01496-14; Revill P, 2005, J GEN VIROL, V86, P491, DOI 10.1099/vir.0.80591-0; Revill PA, 2005, AUSTRALAS PLANT PATH, V34, P327, DOI 10.1071/AP05032; Rychlik Wojciech, 2007, V402, P35; Seguin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088513; Sether DM, 2012, PLANT DIS, V96, P1798, DOI 10.1094/PDIS-08-11-0718-RE; [施世明 Shi Shiming], 2013, [植物病理学报, Acta Phytopathologica Sinica], V43, P590; Su L, 2007, VIRUS GENES, V35, P423, DOI 10.1007/s11262-007-0102-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tzafrir I, 1997, VIROLOGY, V232, P359, DOI 10.1006/viro.1997.8569; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Wang YF, 2014, PLANT DIS, V98, P574, DOI 10.1094/PDIS-09-13-0916-PDN; Wang YL, 2014, VIRUS RES, V188, P103, DOI 10.1016/j.virusres.2014.04.006; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xu DL, 2011, VIRUS GENES, V43, P130, DOI 10.1007/s11262-011-0614-8; Yang IC, 2003, ARCH VIROL, V148, P1957, DOI 10.1007/s00705-003-0163-0; Yang IC, 2003, ARCH VIROL, V148, P937, DOI 10.1007/s00705-002-0969-1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	47	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134147	10.1371/journal.pone.0134147	http://dx.doi.org/10.1371/journal.pone.0134147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207896	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000212
J	Liang, ZF; He, XH; Ceritoglu, C; Tang, XY; Li, Y; Kutten, KS; Oishi, K; Miller, MI; Mori, S; Faria, AV				Liang, Zifei; He, Xiaohai; Ceritoglu, Can; Tang, Xiaoying; Li, Yue; Kutten, Kwame S.; Oishi, Kenichi; Miller, Michael I.; Mori, Susumu; Faria, Andreia V.			Evaluation of Cross-Protocol Stability of a Fully Automated Brain Multi-Atlas Parcellation Tool	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; IMAGE SEGMENTATION; MRI; PREDICTION; ATROPHY; CLASSIFICATION; HIPPOCAMPAL; MORPHOMETRY; STRATEGIES	Brain parcellation tools based on multiple-atlas algorithms have recently emerged as a promising method with which to accurately define brain structures. When dealing with data from various sources, it is crucial that these tools are robust for many different imaging protocols. In this study, we tested the robustness of a multiple-atlas, likelihood fusion algorithm using Alzheimer's Disease Neuroimaging Initiative (ADNI) data with six different protocols, comprising three manufacturers and two magnetic field strengths. The entire brain was parceled into five different levels of granularity. In each level, which defines a set of brain structures, ranging from eight to 286 regions, we evaluated the variability of brain volumes related to the protocol, age, and diagnosis (healthy or Alzheimer's disease). Our results indicated that, with proper pre-processing steps, the impact of different protocols is minor compared to biological effects, such as age and pathology. A precise knowledge of the sources of data variation enables sufficient statistical power and ensures the reliability of an anatomical analysis when using this automated brain parcellation tool on datasets from various imaging protocols, such as clinical databases.	[Liang, Zifei; He, Xiaohai] Sichuan Univ, Coll Elect & Informat Engn, Chengdu 610064, Peoples R China; [Kutten, Kwame S.; Miller, Michael I.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Liang, Zifei; Li, Yue; Oishi, Kenichi; Mori, Susumu; Faria, Andreia V.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Ceritoglu, Can; Tang, Xiaoying; Miller, Michael I.] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD USA	Sichuan University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Faria, AV (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	afaria1@jhmi.edu	Oishi, Kenichi/H-1371-2013	Oishi, Kenichi/0000-0002-1200-8611	American Heart Association [12SDG12080169]; National Institutes of Health [R03EB014367, R21AG033774, NS084957, EB017638, EB015909, NS058299]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017638, P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084957, R01NS058299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, R21AG033774] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by American Heart Association 12SDG12080169 (AVF) and National Institutes of Health: R03EB014367 (AVF), R21AG033774 (KO), NS084957 (SM), EB017638 (SM, MIM), EB015909 (SM, MIM), NS058299 (SM).	Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Beg MF, 2005, INT J COMPUT VISION, V61, P139, DOI 10.1023/B:VISI.0000043755.93987.aa; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Djamanakova A, 2014, NEUROIMAGE; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Eskildsen SF, 2013, NEUROIMAGE, V65, P511, DOI 10.1016/j.neuroimage.2012.09.058; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Hua X, 2009, NEUROIMAGE, V48, P668, DOI 10.1016/j.neuroimage.2009.07.011; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kovacevic S, 2009, ALZ DIS ASSOC DIS, V23, P139, DOI 10.1097/WAD.0b013e318192e745; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Mori S, 2013, ANNU REV BIOMED ENG, V15, P71, DOI 10.1146/annurev-bioeng-071812-152335; Morra JH, 2009, HUM BRAIN MAPP, V30, P2766, DOI 10.1002/hbm.20708; Pich EM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt276; Pitiot A, 2004, NEUROIMAGE, V23, pS85, DOI 10.1016/j.neuroimage.2004.07.040; Ridha BH, 2008, J NEUROL, V255, P567, DOI 10.1007/s00415-008-0750-9; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Schott JM, 2008, NEUROPSYCHOLOGIA, V46, P1732, DOI 10.1016/j.neuropsychologia.2008.02.015; Tang XY, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00061; Tang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065591; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wang Hongzhi, 2013, Inf Process Med Imaging, V23, P548, DOI 10.1007/978-3-642-38868-2_46; Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056	37	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133533	10.1371/journal.pone.0133533	http://dx.doi.org/10.1371/journal.pone.0133533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208327	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000097
J	Quaranta, N; Squeo, V; Sangineto, M; Graziano, G; Sabba, C				Quaranta, Nicola; Squeo, Valentina; Sangineto, Moris; Graziano, Giusi; Sabba, Carlo			High Total Cholesterol in Peripheral Blood Correlates with Poorer Hearing Recovery in Idiopathic Sudden Sensorineural Hearing Loss	PLOS ONE			English	Article							RISK-FACTORS; CARDIOVASCULAR RISK; CHINESE PATIENTS; DEAFNESS; DISTURBANCE; GUIDELINE; CORONARY; ADULTS	Idiopathic sudden sensorineural hearing loss (ISSHL) is a common otologic emergency whose cause is still unclear. The importance of blood lipids in the pathogenesis of ISSHL is widely reported in literature. In fact elevated levels of low density lipoprotein cholesterol (LDL), total cholesterol (TC) and apolipoprotein B (Apo-B) have been proposed as risk factors for this pathology. No correlation has been described between serum lipid parameters and the prognosis of ISSHL. Aim of the present study was to identify prognostic factors associated with hearing recovery in a group of patients affected by ISSHL. Ninety-four patients with the diagnosis of ISSHL hospitalized between March 2013 and October 2014 were included in this study. Patients' blood sampling and hearing assessments were carried out. Patients were divided into two groups as "recovered" and "unrecovered", according to their response to the treatment. We found a statistically significant higher level of total cholesterol in the unrecovered group compared to the recovered one (p=0.03). None of the other routine laboratory parameters have shown a statistically significant difference between the patients successfully treated and patients with poor outcomes. Total cholesterol concentrations may be a prognostic factor for recovery in ISSHL and should be assessed together with routine tests in patients with this condition. The other routine laboratory parameters seem to have no effect on the development and prognosis of this pathology.	[Quaranta, Nicola; Squeo, Valentina] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sensory Organs, Otolaryngol, I-70124 Bari, Italy; [Sangineto, Moris; Sabba, Carlo] Univ Bari Aldo Moro, Dept Interdisciplinary Med, Clin Med Cesare Frugoni, I-70124 Bari, Italy; [Graziano, Giusi] IRCCS Ist Tumori Giovanni Paolo II, I-70124 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II	Quaranta, N (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sensory Organs, Otolaryngol, I-70124 Bari, Italy.	nicolaantonioadolfo.quaranta@uniba.it	Graziano, Giusi/J-9083-2016; Sangineto, Moris/AAJ-8889-2021; Quaranta, Nicola/AAC-7494-2022	Graziano, Giusi/0000-0002-3347-8049; Sangineto, Moris/0000-0002-0936-8843; Quaranta, Nicola/0000-0001-6214-2336				Arruda-Olson AM, 2009, CIRC-CARDIOVASC QUAL, V2, P656, DOI 10.1161/CIRCOUTCOMES.108.831024; BYL FM, 1984, LARYNGOSCOPE, V94, P647; Cadoni G, 2010, ANN OTO RHINOL LARYN, V119, P82, DOI 10.1177/000348941011900203; Canis Martin, 2012, Clin Res Cardiol Suppl, V7, P36; Chang IJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121025; Ciccone MM, 2012, ATHEROSCLEROSIS, V225, P511, DOI 10.1016/j.atherosclerosis.2012.10.024; CIUFFETTI G, 1991, LARYNGOSCOPE, V101, P65; Eisenman DJ, 2000, ARCH OTOLARYNGOL, V126, P1161, DOI 10.1001/archotol.126.9.1161; Guo YK, 2005, HEARING RES, V208, P54, DOI 10.1016/j.heares.2005.05.010; Kanzaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104680; Li J, 2014, J CLIN LAB ANAL; Lin RJ, 2012, LARYNGOSCOPE, V122, P624, DOI 10.1002/lary.22480; Lu YY, 2008, ACTA OTO-LARYNGOL, V128, P1168, DOI 10.1080/00016480801901626; Menotti A, 1997, EUR HEART J, V18, P566; Merchant SN, 2008, ORL-J OTO-RHIN-LARYN, V70, P52, DOI 10.1159/000111048; Mosnier I, 2011, AUDIOL NEURO-OTOL, V16, P55, DOI 10.1159/000312640; OHINATA Y, 1994, ACTA OTO-LARYNGOL, V114, P601, DOI 10.3109/00016489409126112; Owens AP, 2014, TRENDS CARDIOVAS MED, V24, P95, DOI 10.1016/j.tcm.2013.07.003; Quaranta N, 2008, OTOL NEUROTOL, V29, P470, DOI 10.1097/MAO.0b013e318170b650; Quaranta N, 2011, ACTA OTO-LARYNGOL, V131, P347, DOI 10.3109/00016489.2010.536990; Rudack C, 2006, THROMB HAEMOSTASIS, V95, P454, DOI 10.1160/TH05-08-0554; SHIRAISHI T, 1993, ACTA OTO-LARYNGOL, P46; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126; Suzuki H, 2011, EUR ARCH OTO-RHINO-L, V268, P497, DOI 10.1007/s00405-010-1400-2; Ulu S, 2013, OTOL NEUROTOL, V34, P1400, DOI 10.1097/MAO.0b013e31829b57df; Weng TW, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-95	28	21	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133300	10.1371/journal.pone.0133300	http://dx.doi.org/10.1371/journal.pone.0133300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208311	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000076
J	Suominen, T; Piepponen, TP; Kostiainen, R				Suominen, Tina; Piepponen, T. Petteri; Kostiainen, Risto			Permeation of Dopamine Sulfate through the Blood-Brain Barrier	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; IN-VIVO MICRODIALYSIS; RAT-BRAIN; ISOFLURANE ANESTHESIA; MONOAMINE METABOLITES; PREGNENOLONE SULFATE; MOUSE-BRAIN; 5-HYDROXYTRYPTAMINE; SEROTONIN	Dopamine sulfate (DA-3- and DA-4-S) have been determined in the human brain, but it is unclear whether they are locally formed in the central nervous system (CNS), or transported into the CNS from peripheral sources. In the current study, permeation of the blood-brain barrier (BBB) by DA-S was studied by injecting C-13(6)-labelled regioisomers of DA-S ((13)DA-3-S and (13)DA-4-S) and dopamine (DA) subcutaneously (s.c.) in anesthetized rats, then analyzing brain microdialysis and plasma samples by UPLC-MS/MS. The results in the microdialysis samples demonstrated that brain concentrations of (13)DA-S regioisomers clearly increased after the s.c. injections. The concentration of DA did not change, indicating the permeation of DA-S through an intact BBB. The analysis of plasma samples, however, showed that DA-S only permeates the BBB to a small extent, as the concentrations in plasma were substantially higher than in the microdialysis samples. The results also showed that the concentrations of DA-3-S were around three times higher than the concentrations of DA-4-S in rat brain, as well as in the plasma samples after the s.c. injections, indicating that DA-3-S and DA-4-S permeate the BBB with similar efficiency. The fate of (13)DA-S in brain was followed by monitoring C-13(6)-labelled DA-S hydrolysis products, i.e. (13)DA and its common metabolites; however, no C-13(6)-labelled products were detected. This suggests that DA-S either permeates through the BBB back to the peripheral circulation or is dissociated or metabolized by unexpected mechanisms.	[Suominen, Tina; Kostiainen, Risto] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Helsinki, Finland; [Piepponen, T. Petteri] Univ Helsinki, Fac Pharm, Div Pharmacol & Pharmacotherapy, Helsinki, Finland	University of Helsinki; University of Helsinki	Kostiainen, R (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Helsinki, Finland.	risto.kostiainen@helsinki.fi	Kostiainen, Risto K/B-5491-2008	Piepponen, Petteri/0000-0002-2318-1612; Kostiainen, Risto/0000-0003-2454-4574	Academy of Finland [251575]	Academy of Finland(Academy of Finland)	Funding was provided to RK: Academy of Finland, project 251575; http://www.aka.fi/en-GB/A/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Adachi Y, 2000, J Anesth, V14, P82, DOI 10.1007/s005400050072; Adachi YU, 2005, BRAIN RES BULL, V67, P176, DOI 10.1016/j.brainresbull.2005.06.020; Adachi YU, 2008, NEUROCHEM INT, V52, P384, DOI 10.1016/j.neuint.2007.07.012; Asaba H, 2000, J NEUROCHEM, V75, P1907, DOI 10.1046/j.1471-4159.2000.0751907.x; BARBEAU A, 1969, Canadian Medical Association Journal, V101, P59; BUU NT, 1981, LIFE SCI, V29, P2311, DOI 10.1016/0024-3205(81)90564-6; BUU NT, 1984, LIFE SCI, V35, P1083, DOI 10.1016/0024-3205(84)90073-0; Davies MI, 2000, ADV DRUG DELIVER REV, V45, P169, DOI 10.1016/S0169-409X(00)00114-9; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Hagenbuch B, 2002, NEWS PHYSIOL SCI, V17, P231, DOI 10.1152/nips.01402.2002; Itaaho K, 2007, BIOCHEM PHARMACOL, V74, P504, DOI 10.1016/j.bcp.2007.05.003; Jantti SE, 2010, ANAL CHEM, V82, P3168, DOI 10.1021/ac902321z; Kauffman FC, 2004, DRUG METAB REV, V36, P823, DOI 10.1081/DMR-200033496; Kimura-Kuroiwa K, 2012, BRAIN RES BULL, V89, P223, DOI 10.1016/j.brainresbull.2012.08.006; King CD, 1999, ARCH BIOCHEM BIOPHYS, V365, P156, DOI 10.1006/abbi.1999.1155; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Miyajima M, 2011, DRUG METAB DISPOS, V39, P814, DOI 10.1124/dmd.110.036863; Mukaida K, 2007, ANESTH ANALG, V104, P836, DOI 10.1213/01.ane.0000255200.42574.22; Nowak P, 2007, NEUROTOX RES, V11, P131, DOI 10.1007/BF03033391; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Panin F, 2012, J PHARMACOL TOX MET, V65, P83, DOI 10.1016/j.vascn.2012.01.003; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; RACZ K, 1984, AM J PHYSIOL, V247, pE431, DOI 10.1152/ajpendo.1984.247.4.E431; Gonzalez RR, 2011, J NEUROSCI METH, V198, P187, DOI 10.1016/j.jneumeth.2011.03.023; Ronaldson PT, 2013, PHARMACOL REV, V65, P291, DOI 10.1124/pr.112.005991; Schumacher M, 2008, NEUROCHEM INT, V52, P522, DOI 10.1016/j.neuint.2007.08.022; SHIMOMURA K, 1971, TOHOKU J EXP MED, V105, P45, DOI 10.1620/tjem.105.45; Su FL, 2009, CHROMATOGRAPHIA, V69, P207, DOI 10.1365/s10337-008-0879-9; Suleman FG, 1998, ARCH BIOCHEM BIOPHYS, V358, P63, DOI 10.1006/abbi.1998.0842; Suominen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068007; SWAHN CG, 1976, PSYCHOPHARMACOLOGY, V48, P147, DOI 10.1007/BF00423253; SWAHN CG, 1976, J NEURAL TRANSM, V39, P281, DOI 10.1007/BF01266304; Uutela P, 2009, ANAL CHEM, V81, P8417, DOI 10.1021/ac901320z; Uutela P, 2009, ANAL CHEM, V81, P427, DOI 10.1021/ac801846w; Wang MD, 1997, J STEROID BIOCHEM, V62, P299, DOI 10.1016/S0960-0760(97)00041-1; WARNHOFF M, 1984, J CHROMATOGR, V307, P271, DOI 10.1016/S0378-4347(00)84099-2; Watson C, 2006, RAT BRAIN STEREOTAXI; Webster R. A., 2001, NEUROTRANSMITTERS DR; WERLE E, 1988, N-S ARCH PHARMACOL, V338, P28; Westerink BHC, 2000, J CHROMATOGR B, V747, P21, DOI 10.1016/S0378-4347(00)00338-8; Whittington RA, 2006, ANESTH ANALG, V103, P92, DOI 10.1213/01.ane.0000221488.48352.61; Yoshitake T, 2004, J CHROMATOGR B, V807, P177, DOI 10.1016/j.jchromb.2004.03.069	44	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133904	10.1371/journal.pone.0133904	http://dx.doi.org/10.1371/journal.pone.0133904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207745	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000170
J	de Taffin, M; Carrier, Y; Dubois, L; Bataille, L; Painset, A; Le Gras, S; Jost, B; Crozatier, M; Vincent, A				de Taffin, Mathilde; Carrier, Yannick; Dubois, Laurence; Bataille, Laetitia; Painset, Anais; Le Gras, Stephanie; Jost, Bernard; Crozatier, Michele; Vincent, Alain			Genome-Wide Mapping of Collier In Vivo Binding Sites Highlights Its Hierarchical Position in Different Transcription Regulatory Networks	PLOS ONE			English	Article							B-CELL FACTOR; CHIP-SEQ DATA; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; DROSOPHILA-MELANOGASTER; MUSCLE DEVELOPMENT; ENRICHMENT ANALYSIS; TARGET GENES; DNA; SPECIFICATION	Collier, the single Drosophila COE (Collier/EBF/Olf-1) transcription factor, is required in several developmental processes, including head patterning and specification of muscle and neuron identity during embryogenesis. To identify direct Collier (Col) targets in different cell types, we used ChIP-seq to map Col binding sites throughout the genome, at mid-embryogenesis. In vivo Col binding peaks were associated to 415 potential direct target genes. Gene Ontology analysis revealed a strong enrichment in proteins with DNA binding and/or transcription-regulatory properties. Characterization of a selection of candidates, using transgenic CRM-reporter assays, identified direct Col targets in dorso-lateral somatic muscles and specific neuron types in the central nervous system. These data brought new evidence that Col direct control of the expression of the transcription regulators apterous and eyes-absent (eya) is critical to specifying neuronal identities. They also showed that cross-regulation between coland eya in muscle progenitor cells is required for specification of muscle identity, revealing a new parallel between the myogenic regulatory networks operating in Drosophila and vertebrates. Col regulation of eya, both in specific muscle and neuronal lineages, may illustrate one mechanism behind the evolutionary diversification of Col biological roles.	[de Taffin, Mathilde; Carrier, Yannick; Dubois, Laurence; Bataille, Laetitia; Painset, Anais; Crozatier, Michele; Vincent, Alain] Univ Toulouse 3, Ctr Dev Biol, UMR CNRS 5547, F-31062 Toulouse 09, France; [Painset, Anais] INRA, Plate Forme Bioinformat Genotoul MIA T, F-31326 Castanet Tolosan, France; [Le Gras, Stephanie; Jost, Bernard] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vincent, A (corresponding author), Univ Toulouse 3, Ctr Dev Biol, UMR CNRS 5547, 118 Route Narbonne, F-31062 Toulouse 09, France.	alain.vincent@univ-tlse3.fr	Vincent, Alain/AAE-4712-2019	bataille, laetitia/0000-0002-3897-9520; Le Gras, Stephanie/0000-0001-6293-6507	Fondation de la Recherche Medicale (FRM) [DEQ20090515429]; Agence Nationale de la Recherche [13-BSVE2-0010-0]; Association Francaise contre lesMyopathies	Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre lesMyopathies(Association Francaise contre les Myopathies)	This work was supported by Fondation de la Recherche Medicale (FRM) grant DEQ20090515429, http://www.frm.org/; Agence Nationale de la Recherche grant 13-BSVE2-0010-0, http://www.agence-nationale-recherche.fr/; and Association Francaise contre lesMyopathies, http://www.afm-telethon.fr/association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Blanchette M, 2002, J COMPUT BIOL, V9, P211, DOI 10.1089/10665270252935421; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Boukhatmi H, 2012, DEVELOPMENT, V139, P3572, DOI 10.1242/dev.083410; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Crozatier M, 1999, DEVELOPMENT, V126, P4385; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 1996, CURR BIOL, V6, P707, DOI 10.1016/S0960-9822(09)00452-7; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Crozatier M, 2008, DEV BIOL, V315, P232, DOI 10.1016/j.ydbio.2007.12.030; Daburon V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-131; Demilly A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021213; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Dubois L, 2007, DEVELOPMENT, V134, P4347, DOI 10.1242/dev.008409; Eade KT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002501; Enriquez J, 2012, DEV BIOL, V363, P27, DOI 10.1016/j.ydbio.2011.12.018; Enriquez J, 2010, DEVELOPMENT, V137, P457, DOI 10.1242/dev.045286; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Fujioka M, 2002, DEVELOPMENT, V129, P4411; Garel S, 1999, DEVELOPMENT, V126, P5285; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Green YS, 2011, DEV BIOL, V358, P240, DOI 10.1016/j.ydbio.2011.07.034; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Hattori Y, 2007, GENES CELLS, V12, P1011, DOI 10.1111/j.1365-2443.2007.01107.x; Hattori Y, 2013, DEV CELL, V27, P530, DOI 10.1016/j.devcel.2013.10.024; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Jackson DJ, 2010, DEV GENES EVOL, V220, P221, DOI 10.1007/s00427-010-0343-3; Jin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4793; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kieslinger M, 2010, CELL STEM CELL, V7, P496, DOI 10.1016/j.stem.2010.07.015; KITAMOTO T, 1992, J NEUROSCI, V12, P1628; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Kuzin A, 2005, DEV BIOL, V277, P347, DOI 10.1016/j.ydbio.2004.09.027; Kuzin II, 2008, J IMMUNOL, V180, P7443, DOI 10.4049/jimmunol.180.11.7443; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; Narlikar L, 2012, METHODS MOL BIOL, V802, P305, DOI 10.1007/978-1-61779-400-1_20; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Ntini E, 2011, DEV BIOL, V360, P403, DOI 10.1016/j.ydbio.2011.09.035; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Razy-Krajka F, 2014, DEV CELL, V29, P263, DOI 10.1016/j.devcel.2014.04.001; Relaix F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003425; Richard JP, 2011, DEVELOPMENT, V138, P1483, DOI 10.1242/dev.063115; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Seecoomar M, 2000, MECH DEVELOP, V91, P209, DOI 10.1016/S0925-4773(99)00305-6; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; TRAVIS A, 1993, MOL CELL BIOL, V13, P3392, DOI 10.1128/MCB.13.6.3392; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Tsai RYL, 1997, J NEUROSCI, V17, P4159; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 2004, DEVELOPMENT, V131, P1377, DOI 10.1242/dev.01009; Wang SS, 2002, MOL CELL NEUROSCI, V20, P404, DOI 10.1006/mcne.2002.1138; Wilczynski B, 2010, DEV BIOL, V340, P161, DOI 10.1016/j.ydbio.2009.10.032; Zeitlinger J, 2010, DEV BIOL, V339, P230, DOI 10.1016/j.ydbio.2009.12.039	77	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133387	10.1371/journal.pone.0133387	http://dx.doi.org/10.1371/journal.pone.0133387			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204530	Green Published, Green Submitted, gold			2022-12-26	WOS:000358621000027
J	Alvarez-Sandoval, BA; Manzanilla, LR; Gonzalez-Ruiz, M; Malgosa, A; Montiel, R				Alvarez-Sandoval, Brenda A.; Manzanilla, Linda R.; Gonzalez-Ruiz, Mercedes; Malgosa, Assumpcio; Montiel, Rafael			Genetic Evidence Supports the Multiethnic Character of Teopancazco, a Neighborhood Center of Teotihuacan, Mexico (AD 200-600)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MTDNA HAPLOGROUPS; POPULATIONS; ORGANIZATION; AFFINITIES; SEQUENCE	Multiethnicity in Teopancazco, Teotihuacan, is supported by foreign individuals found in the neighborhood center as well as by the diversity observed in funerary rituals at the site. Studies of both stable and strontium isotopes as well as paleodietary analysis, suggest that the population of Teopancazco was composed by three population groups: people from Teotihuacan, people from nearby sites (Tlaxcala-Hidalgo-Puebla), and people from afar, including the coastal plains. In an attempt to understand the genetic dynamics in Teopancazco we conducted an ancient DNA (aDNA) analysis based on mtDNA. Our results show that the level of genetic diversity is consistent with the multiethnicity phenomenon at the neighborhood center. Levels of genetic diversity at different time periods of Teopancazco's history show that multiethnicity was evident since the beginning and lasted until the collapse of the neighborhood center. However, a PCA and a Neighbor-Joining tree suggested the presence of a genetically differentiated group (buried at the Transitional phase) compared to the population from the initial phase (Tlamimilolpa) as well as the population from the final phase (Xolalpan) of the history of Teopancazco. Genetic studies showed no differences in genetic diversity between males and females in the adult population of Teopancazco, this data along with ample archaeological evidence, suggest a neolocal post-marital pattern of residence in Teopancazco. Nevertheless, genetic analyses on the infant population showed that the males are significantly more heterogeneous than the females suggesting a possible differential role in cultural practices by sex in the infant sector. Regarding interpopulation analysis, we found similar indices of genetic diversity between Teopancazco and heterogeneous native groups, which support the multiethnic character of Teopancazco. Finally, our data showed a close genetic relationship between Teopancazco and populations from the "Teotihuacan corridor" and from Oaxaca and the Maya region, in agreement with previous archaeological evidence.	[Alvarez-Sandoval, Brenda A.; Montiel, Rafael] Ctr Invest & Estudios Avanzados, Inst Politecn Nacl, Unidad Genom Avanzada, Lab Nacl Genom Biodivers, Guanajuato, Mexico; [Manzanilla, Linda R.] Univ Nacl Autonoma Mexico, Inst Invest Antropol, Mexico City 04510, DF, Mexico; [Gonzalez-Ruiz, Mercedes; Malgosa, Assumpcio] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol, E-08193 Barcelona, Spain	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Autonomous University of Barcelona	Montiel, R (corresponding author), Ctr Invest & Estudios Avanzados, Inst Politecn Nacl, Unidad Genom Avanzada, Lab Nacl Genom Biodivers, Guanajuato, Mexico.	montiel@langebio.cinvestav.mx	Malgosa, Assumpció/K-2406-2014; Montiel, Rafael/A-6774-2008	Malgosa, Assumpció/0000-0003-1723-3671; Montiel, Rafael/0000-0001-8052-0679	Consejo Nacional de Ciencia y Tecnologia [CB-2008-01-105481]; Consejo Nacional de Ciencia y Tecnologia fellowship [300750]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia fellowship	This work was supported by Consejo Nacional de Ciencia y Tecnologia (www.conacyt.gob.mx) grant No. CB-2008-01-105481 to RM and Consejo Nacional de Ciencia y Tecnologia (www.conacyt.gob.mx) fellowship (Reg. No. 300750) to BAA-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LM, 2007, THESIS NATL AUTONOMO; Alvarado-Vinas LA, 2013, THESIS NATL AUTONOMO; Alvarez-Sandoval BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104629; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Beramendi-Orosco LE, 2012, ESTUDIOS ARQUEOMETRI, P111; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Cowgill GL, 2008, ANTIQUITY, V82, P962, DOI 10.1017/S0003598X00097714; Cowgill George L., 2003, MAYA TEOTIHUACAN REI, P315; Diehl RA., 1989, MESOAMERICA DECLINE, P9; EBIHARA M, 1977, ANN NY ACAD SCI, V293, P51; EMBER M, 1967, T NEW YORK ACAD SCI, V30, P291, DOI 10.1111/j.2164-0947.1967.tb02466.x; Ensor B., 2013, ADV INTERPRETATION C; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 2013, PHYLIP VERSION 3 695; Forster P, 1996, AM J HUM GENET, V59, P935; Gallego JR, 2013, THESIS NATL AUTONOMO; Garcia Cook Angel, 1981, SUPPLEMENT HDB MIDDL, V1, P244; Gonzalez-Jose R, 2007, P ROY SOC B-BIOL SCI, V274, P681, DOI 10.1098/rspb.2006.0151; Gonzalez-Oliver A, 2001, AM J PHYS ANTHROPOL, V116, P230, DOI 10.1002/ajpa.1118; Gonzalez-Ruiz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048904; Gorostiza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044666; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Kemp BM, 2005, BIOMOLECULAR ARCHAEO, P22; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kohl J, 2006, NUCLEIC ACIDS RES, V34, pD700, DOI 10.1093/nar/gkj030; Lailson B., 2009, THESIS NATL AUTONOMO; Lorenz JG, 1996, AM J PHYS ANTHROPOL, V101, P307, DOI 10.1002/(SICI)1096-8644(199611)101:3<307::AID-AJPA1>3.0.CO;2-W; Malgosa A., 2010, NINOS ACTORES SOCIAL, P21; Malhi RS, 2003, AM J PHYS ANTHROPOL, V120, P108, DOI 10.1002/ajpa.10138; Manzanilla L., 2006, CUICUILCO, V13, P13; Manzanilla L.R., 2009, DOMESTIC LIFE PREHIS, V46, P21; Manzanilla Linda, 2006, ARQUEOLOGIA MEXICANA, V80, P28; Manzanilla Linda R., 2011, ANALES ANTROPOLOGIA, V45, P9; Manzanilla LR, 2007, MEMORIA 2007 COLEGIO, P453; Manzanilla LR, 2012, ESTUDIOS ARQUEOMETRI, P17; Manzanilla LR, 2011, PRODUCCION ARTESANAL, P59; Manzanilla LR, 2012, ESTUDIOS ARQUEOMETRI, P449; Mata-Miguez J, 2012, AM J PHYS ANTHROPOL, V149, P504, DOI 10.1002/ajpa.22152; Mejia-Appel GI, 2012, ESTUDIOS ARQUEOMETRI, P347; Mejia-Appel GI, 2011, ESTUDIOS ANTROPOLOGI, V15, P13; MILLON R, 1973, URBANIZATION TEOTI 1, V1; Molero I, 2013, FUTURO PASADO, V4, P87; Montiel R., 2001, THESIS AUTONOMOUS U; Morales-Puente P., 2012, ESTUDIOS ARQUEOM TRI, P347; Murdock GP, 1965, SOCIAL STRUCTURE; Nei M., 1987, MOL EVOLUTIONARY GEN; Ortiz Ceballos P, 1998, RITMOS CAMBIO TEOTIH, P377; Pasternak B., 1976, INTRO KINSHIP SOCIAL; Penaloza-Espinosa RI, 2007, HUM BIOL, V79, P313, DOI 10.1353/hub.2007.0042; Peregrine PN, 2001, AM ANTIQUITY, V66, P36, DOI 10.2307/2694316; PERRY M., 2005, ARCHEOLOGICAL PAPERS, V15, P89, DOI DOI 10.1525/AP3A.2005.15.89; Rattray EC., 1998, RUTAS INTERCAMBIO ME, P77; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; REYNOLDS J, 1983, GENETICS, V105, P767; Rodriguez-Galicia B., 2006, THESIS NATL AUTONOMO; Rodriguez-Galicia B., 2010, THESIS NATL AUTONOMO; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandoval K, 2009, HUM GENET, V126, P521, DOI 10.1007/s00439-009-0693-y; Schroeder S., 2010, OXFORD HIST MEXICO, P45; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Solis-Pichardo G., 2012, ESTUDIOS ARQUEOMETRI, P425; Solorzano-Navarro E., 2006, THESIS AUTONOMOUS U; SPENCE MW, 1974, MAN, V9, P262, DOI 10.2307/2800077; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson J.E. S., 1970, MAYA HIST RELIG; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Valenzuela Juan H., 1945, MUSEO NACL ARQUEOLOG, V5, P83; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Velazquez A, 2012, ESTUDIOS ARQUEOMETRI, P285; Vergara-Perez M., 2006, THESIS AUTONOMOUS U	77	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132371	10.1371/journal.pone.0132371	http://dx.doi.org/10.1371/journal.pone.0132371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200455	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100035
J	Cortes-Vieyra, R; Silva-Garcia, O; Oviedo-Boyso, J; Huante-Mendoza, A; Bravo-Patino, A; Valdez-Alarcon, JJ; Finlay, BB; Baizabal-Aguirre, VM				Cortes-Vieyra, Ricarda; Silva-Garcia, Octavio; Oviedo-Boyso, Javier; Huante-Mendoza, Alejandro; Bravo-Patino, Alejandro; Valdez-Alarcon, Juan J.; Finlay, B. Brett; Baizabal-Aguirre, Vctor M.			The Glycogen Synthase Kinase 3 alpha and beta Isoforms Differentially Regulates Interleukin-12p40 Expression in Endothelial Cells Stimulated with Peptidoglycan from Staphylococcus aureus	PLOS ONE			English	Article							KAPPA-B ACTIVATION; PROINFLAMMATORY CYTOKINE; SIGNALING PATHWAY; INNATE IMMUNITY; TLR2 RECEPTOR; IL-12; PHOSPHORYLATION; PURIFICATION; INFLAMMATION; MACROPHAGES	Glycogen synthase kinase 3 (GSK3) is a constitutively active regulatory enzyme that is important in cancer, diabetes, and cardiovascular, neurodegenerative, and psychiatric diseases. While GSK3 alpha is usually important in neurodegenerative and psychiatric diseases GSK3 beta is fundamental in the inflammatory response caused by bacterial components. Peptidoglycan (PGN), one of the most abundant cell-wall structures of Gram-positive bacteria, is an important inducer of inflammation. To evaluate whether inhibition of GSK3 alpha and GSK3 beta activity in bovine endothelial cells (BEC) regulates the expression of the pro-inflammatory cytokine IL-12p40, we treated BEC with SDS-purified PGN from Staphylococcus aureus. We found that PGN triggered a TLR2/PI3K/Akt-dependent phosphorylation of GSK3 alpha at Ser21, GSK3 beta at Ser9, and NF-kappa B p65 subunit (p65) at Ser536, and the phosphorylation of GSK3 alpha was consistently higher than that of GSK3 beta. The expression of IL-12p40 was inhibited in BEC stimulated with PGN and pre-treated with a specific neutralizing anti-TLR2 antibody that targets the extracellular domain of TLR2 or by the addition of Akt-i IV (an Akt inhibitor). Inhibition of GSK3 alpha and GSK3 beta with LiCl or SB216763 induced an increase in IL-12p40 mRNA and protein. The effect of each isoform on IL-12p40 expression was evaluated by siRNA-gene expression silencing of GSK3 alpha and GSK3 beta. GSK3 alpha gene silencing resulted in a marked increase in IL-12p40 mRNA and protein while GSK3 beta gene silencing had the opposite effect on IL-12p40 expression. These results indicate that the TLR2/PI3K/Akt-dependent inhibition of GSK3 alpha activity also plays an important role in the inflammatory response caused by stimulation of BEC with PGN from S. aureus.	[Cortes-Vieyra, Ricarda; Silva-Garcia, Octavio; Oviedo-Boyso, Javier; Huante-Mendoza, Alejandro; Bravo-Patino, Alejandro; Valdez-Alarcon, Juan J.; Baizabal-Aguirre, Vctor M.] Univ Michoacana, Fac Med Vet & Zootecnia, Ctr Multidisciplinario Estudios Biotecnol, Mol Immunol & Signal Transduct Lab, Morelia, Michoacan, Mexico; [Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	Universidad Michoacana de San Nicolas de Hidalgo; University of British Columbia	Baizabal-Aguirre, VM (corresponding author), Univ Michoacana, Fac Med Vet & Zootecnia, Ctr Multidisciplinario Estudios Biotecnol, Mol Immunol & Signal Transduct Lab, Carretera Morelia Zinapecuaro, Morelia, Michoacan, Mexico.	baizabal@umich.mx	Cortés-Vieyra, Ricarda/L-8405-2019	Cortés-Vieyra, Ricarda/0000-0001-9314-6591	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (CONACyT)-MEXICO [152518]; Coordinacion de Investigacion Cientifica, Universidad Michoacana de San Nicolas de Hidalgo	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (CONACyT)-MEXICO(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Coordinacion de Investigacion Cientifica, Universidad Michoacana de San Nicolas de Hidalgo	This work was supported by CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (CONACyT)-MEXICO grant number 152518 VMB), Coordinacion de Investigacion Cientifica, Universidad Michoacana de San Nicolas de Hidalgo, grant-2014-2015 to VMBA.	Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Barrell WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050422; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cajero-Juarez M, 2002, EUR J CELL BIOL, V81, P1, DOI 10.1078/0171-9335-00213; Chen BC, 2004, J BIOL CHEM, V279, P20889, DOI 10.1074/jbc.M311279200; Chen BC, 2009, MOL IMMUNOL, V46, P1179, DOI 10.1016/j.molimm.2008.11.006; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Cortes-Vieyra R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-23; Dziarski R, 2000, CHEM IMMUNOL, V74, P83; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Fitzner N, 2008, CLIN VACCINE IMMUNOL, V15, P138, DOI 10.1128/CVI.00257-07; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Giambelluca MS, 2014, FASEB J, V28, P3679, DOI 10.1096/fj.14-251900; Gulen MF, 2012, IMMUNITY, V37, P800, DOI 10.1016/j.immuni.2012.08.019; Ha SJ, 1999, J IMMUNOL, V163, P2902; Heidemann J, 2007, AM J PHYSIOL-GASTR L, V293, pG1315, DOI 10.1152/ajpgi.00142.2007; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaidanovich-Beilin O, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-35; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Konnai S, 2003, VET MICROBIOL, V94, P283, DOI 10.1016/S0378-1135(03)00119-6; Lienenluke B, 2000, EUR J IMMUNOL, V30, P2864, DOI 10.1002/1521-4141(200010)30:10<2864::AID-IMMU2864>3.0.CO;2-W; Lin HY, 2010, INT IMMUNOPHARMACOL, V10, P883, DOI 10.1016/j.intimp.2010.04.026; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mitola S, 2003, J IMMUNOL, V171, P3725, DOI 10.4049/jimmunol.171.7.3725; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Oviedo-Boyso J, 2011, INFECT IMMUN, V79, P4569, DOI 10.1128/IAI.05303-11; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Satta N, 2008, MOL IMMUNOL, V46, P145, DOI 10.1016/j.molimm.2008.07.017; STERN AS, 1990, P NATL ACAD SCI USA, V87, P6808, DOI 10.1073/pnas.87.17.6808; Strasly M, 2001, J IMMUNOL, V166, P3890, DOI 10.4049/jimmunol.166.6.3890; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Zhang CY, 2012, CELL MOL IMMUNOL, V9, P324, DOI 10.1038/cmi.2012.11	49	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132867	10.1371/journal.pone.0132867	http://dx.doi.org/10.1371/journal.pone.0132867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200352	gold, Green Submitted, Green Published			2022-12-26	WOS:000358597100050
J	Lee, S; Axelsen, TV; Andersen, AP; Vahl, P; Pedersen, SF; Boedtkjer, E				Lee, S.; Axelsen, T. V.; Andersen, A. P.; Vahl, P.; Pedersen, S. F.; Boedtkjer, E.			Disrupting Na+, HCO3--cotransporter NBCn1 (Slc4a7) delays murine breast cancer development	ONCOGENE			English	Article							INTRACELLULAR PH; SUSCEPTIBILITY LOCI; COTRANSPORTER NBCN1; NHE1; METABOLISM; EXCHANGER; SKELETAL; CELLS; PROLIFERATION; GLYCOLYSIS	Increased metabolism and insufficient blood supply cause acidic waste product accumulation in solid cancers. During carcinogenesis, cellular acid extrusion is upregulated but the underlying molecular mechanisms and their consequences for cancer growth and progression have not been established. Genome-wide association studies have indicated a possible link between the Na+, HCO3--cotransporter NBCn1 (SLC4A7) and breast cancer. We tested the functional consequences of NBCn1 knockout (KO) for breast cancer development. NBCn1 protein expression increased 2.5-fold during breast carcinogenesis and was responsible for the increased net acid extrusion and alkaline intracellular pH of breast cancer compared with normal breast tissue. Genetic disruption of NBCn1 delayed breast cancer development: tumor latency was similar to 50% increased while tumor growth rate was similar to 65% reduced in NBCn1 KO compared with wild-type (WT) mice. Breast cancer histopathology in NBCn1 KO mice differed from that in WT mice and included less aggressive tumor types. The extracellular tumor microenvironment in NBCn1 KO mice contained higher concentrations of glucose and lower concentrations of lactate than that in WT mice. Independently of NBCn1 genotype, the cleaved fraction of poly(ADP-ribose) polymerase (PARP)-1 and expression of monocarboxylate transporter (MCT) 1 increased while phosphorylation of Akt and ERK1 decreased as functions of tumor volume. Cell proliferation, evaluated from Ki-67 and phosphohistone H-3 staining, was similar to 60% lower in breast cancer of NBCn1 KO than that of WT mice when corrected for variations in tumor size. We conclude that NBCn1 facilitates acid extrusion from breast cancer tissue, maintains the alkaline intracellular environment and promotes aggressive cancer development and growth.	[Lee, S.; Axelsen, T. V.; Boedtkjer, E.] Aarhus Univ, Dept Biomed, Ole Worms Alle 3,Bldg 1170, DK-8000 Aarhus C, Denmark; [Andersen, A. P.; Pedersen, S. F.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Vahl, P.] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus, Denmark	Aarhus University; University of Copenhagen; Aarhus University	Boedtkjer, E (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3,Bldg 1170, DK-8000 Aarhus C, Denmark.	eb@biomed.au.dk	Pedersen, Stine Falsig/O-1133-2019; Boedtkjer, Ebbe/O-8449-2019; Boedtkjer, Ebbe/B-7315-2008	Pedersen, Stine Falsig/0000-0002-3044-7714; Boedtkjer, Ebbe/0000-0002-5078-9279; Boedtkjer, Ebbe/0000-0002-5078-9279; Andersen, Anne Poder/0000-0002-6693-1524	Danish Council for Independent Research [10-094816, 12-127290]; Novo Nordisk Foundation [2131, 7393]; Danish Cancer Society [R72-A4273-13-S2]; MEMBRANES at Aarhus University; Novo Nordisk Fonden [NNF13OC0007393] Funding Source: researchfish; The Danish Cancer Society [R72-A4273] Funding Source: researchfish	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); MEMBRANES at Aarhus University; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	Financial support was provided from the Danish Council for Independent Research (10-094816 to EB and 12-127290 to SFP), Novo Nordisk Foundation (2131 and 7393 to EB), Danish Cancer Society (R72-A4273-13-S2 to EB) and MEMBRANES at Aarhus University. We thank Dr. Christian Aalkjaer (Aarhus University) for valuable discussions, Drs Frauke Alves and Roser Ufartes (Max Planck Institute for Experimental Medicine) for advice on chemical breast cancer induction and Dr Vibeke Dam, Jane Ronn and Ida Tvilling for expert technical assistance.	Aalkjaer C, 2014, COMPR PHYSIOL, V4, P1605, DOI 10.1002/cphy.c130005; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Andersen AP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0098; Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; Boedtkjer E, 2006, CIRC RES, V98, P515, DOI 10.1161/01.RES.0000204750.04971.76; Boedtkjer E, 2012, CURR PHARM DESIGN, V18, P1345, DOI 10.2174/138161212799504830; Boedtkjer E, 2013, INT J CANCER, V132, P1288, DOI 10.1002/ijc.27782; Boedtkjer E, 2011, CIRCULATION, V124, P1819, DOI 10.1161/CIRCULATIONAHA.110.015974; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Brunner A, 2012, BRIT J CANCER, V107, P84, DOI 10.1038/bjc.2012.198; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Chiche J, 2012, INT J CANCER, V130, P1511, DOI 10.1002/ijc.26125; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; Damkier HH, 2006, AM J PHYSIOL-HEART C, V290, pH172, DOI 10.1152/ajpheart.00713.2005; De Milito A, 2012, CURR PHARM DESIGN, V18, P1395, DOI 10.2174/138161212799504911; Eigenbrodt E, 1998, ANTICANCER RES, V18, P3267; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FIDELMAN ML, 1982, AM J PHYSIOL, V242, pC87, DOI 10.1152/ajpcell.1982.242.1.C87; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Gorbatenko A, 2014, FASEB J, V28, P350, DOI 10.1096/fj.13-233288; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Han W, 2011, CANCER EPIDEM BIOMAR, V20, P793, DOI 10.1158/1055-9965.EPI-10-1282; Hulikova A, 2013, J CELL PHYSIOL, V228, P743, DOI 10.1002/jcp.24221; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Jenkins CM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203661; Landis MD, 2006, ONCOGENE, V25, P3325, DOI 10.1038/sj.onc.1209365; Lauritzen G, 2010, EXP CELL RES, V316, P2538, DOI 10.1016/j.yexcr.2010.06.005; Lauritzen G, 2012, CANCER LETT, V317, P172, DOI 10.1016/j.canlet.2011.11.023; Lee S, 2015, PFLUG ARCH EUR J PHY, V467, P367, DOI 10.1007/s00424-014-1524-0; Long JR, 2010, CANCER EPIDEM BIOMAR, V19, P2357, DOI 10.1158/1055-9965.EPI-10-0054; Loo SY, 2012, CURR PHARM DESIGN, V18, P1372; Mortensen B, 2013, AM J PHYSIOL-ENDOC M, V304, pE1379, DOI 10.1152/ajpendo.00295.2012; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Pedersen SF, 2007, CELL PHYSIOL BIOCHEM, V20, P735, DOI 10.1159/000110434; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Silva AS, 2009, CANCER RES, V69, P2677, DOI 10.1158/0008-5472.CAN-08-2394; Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2; Sueta A, 2012, BREAST CANCER RES TR, V132, P711, DOI 10.1007/s10549-011-1904-5; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; VAUPEL P, 1989, CANCER RES, V49, P6449; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003	50	52	53	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2112	2122		10.1038/onc.2015.273	http://dx.doi.org/10.1038/onc.2015.273			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26212013				2022-12-26	WOS:000374505600010
J	Wilderman, A; Guo, YR; Divakaruni, AS; Perkins, G; Zhang, LZ; Murphy, AN; Taylor, SS; Insel, PA				Wilderman, Andrea; Guo, Yurong; Divakaruni, Ajit S.; Perkins, Guy; Zhang, Lingzhi; Murphy, Anne N.; Taylor, Susan S.; Insel, Paul A.			Proteomic and Metabolic Analyses of S49 Lymphoma Cells Reveal Novel Regulation of Mitochondria by cAMP and Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; CAMP/PROTEIN-KINASE; GENE-EXPRESSION; WILD-TYPE; SPECIFICITY; APOPTOSIS; SUBUNIT; DEATH	Cyclic AMP (cAMP), acting via protein kinase A (PKA), regulates many cellular responses, but the role of mitochondria in such responses is poorly understood. To define such roles, we used quantitative proteomic analysis of mitochondria-enriched fractions and performed functional and morphologic studies of wildtype (WT) and kin(-) (PKA-null) murine S49 lymphoma cells. Basally, 75 proteins significantly differed in abundance between WTand kin(-) S49 cells. WT, but not kin(-) S49 cells incubated with the cAMP analog 8-(4-chlorophenylthio)adenosine cAMP (CPT-cAMP) for 16 h have (a) increased expression of mitochondria-related genes and proteins, including ones in pathways of branched-chain amino acid and fatty acid metabolism and (b) increased maximal capacity of respiration on branched-chain keto acids and fatty acids. CPT-cAMP also regulates the cellular rate of ATP-utilization, as the rates of both ATP-linked respiration and proton efflux are decreased in WT but not kin(-) cells. CPT-cAMP protected WT S49 cells from glucose or glutamine deprivation, In contrast, CPT-cAMP did not protect kin(-) cells or WT cells treated with the PKA inhibitor H89 from glutamine deprivation. Under basal conditions, the mitochondrial structure of WT and kin(-) S49 cells is similar. Treatment with CPT-cAMP produced apoptotic changes (i.e. decreased mitochondrial density and size and loss of cristae) in WT, but not kin(-) cells. Together, these findings show that cAMP acts via PKA to regulate multiple aspects of mitochondrial function and structure. Mitochondrial perturbation thus likely contributes to cAMP/PKA-mediated cellular responses.	[Wilderman, Andrea; Divakaruni, Ajit S.; Zhang, Lingzhi; Murphy, Anne N.; Taylor, Susan S.; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guo, Yurong; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Perkins, Guy] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr,BSB 3073,0636, La Jolla, CA 92093 USA.	pinsel@ucsd.edu	Regan, Clinton/E-6250-2012; Murphy, Anne N/H-3217-2016	Murphy, Anne N/0000-0002-5222-9902; Perkins, Guy/0000-0002-1834-6646; Wilderman, Andrea/0000-0002-4832-9476	National Institutes of Health [DK54441, GM066232, HL107200, CA189477]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R21CA189477] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412, R01GM066232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54441 (to S. S. T.) and GM066232, HL107200, and CA189477 (to P. A. I.). This work was also supported by the Howard Hughes Medical Institute (to S. S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Conti M, 2014, J GEN PHYSIOL, V143, P29, DOI 10.1085/jgp.201311083; Dekkers BGJ, 2013, PHARMACOL THERAPEUT, V137, P248, DOI 10.1016/j.pharmthera.2012.10.006; Dent P, 1997, CELL SIGNAL, V9, P539, DOI 10.1016/S0898-6568(97)00048-X; Divakaruni Ajit S, 2014, Curr Protoc Toxicol, V60, DOI 10.1002/0471140856.tx2502s60; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Field MS, 2015, P NATL ACAD SCI USA, V112, P400, DOI 10.1073/pnas.1414555112; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Giansanti P, 2013, MOL CELL PROTEOMICS, V12, P3350, DOI 10.1074/mcp.O113.028456; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Guo YR, 2012, BIOCHEMISTRY-US, V51, P9323, DOI 10.1021/bi301282k; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006; Herrmann PC, 2012, METHODS MOL BIOL, V823, P265, DOI 10.1007/978-1-60327-216-2_17; HOCHMAN J, 1975, P NATL ACAD SCI USA, V72, P5051, DOI 10.1073/pnas.72.12.5051; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Insel PA, 2014, HORM METAB RES, V46, P854, DOI 10.1055/s-0034-1384519; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; INSEL PA, 1975, SCIENCE, V190, P896, DOI 10.1126/science.171770; Keshwani MM, 2012, P NATL ACAD SCI USA, V109, pE1221, DOI 10.1073/pnas.1202741109; Kitamura T, 2013, BBA-MOL CELL BIOL L, V1831, P1395, DOI 10.1016/j.bbalip.2013.05.007; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Laden BP, 2000, ARCH BIOCHEM BIOPHYS, V374, P381, DOI 10.1006/abbi.1999.1629; Lamb D, 2002, J CELL PHYSIOL, V192, P216, DOI 10.1002/jcp.10131; Lemire BD, 2015, BBA-BIOENERGETICS, V1847, P451, DOI 10.1016/j.bbabio.2015.01.014; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; Marchitti SA, 2010, FREE RADICAL BIO MED, V49, P1432, DOI 10.1016/j.freeradbiomed.2010.08.004; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; O'Brien RN, 2010, MOL CELL PROTEOMICS, V9, P2238, DOI 10.1074/mcp.M110.000281; Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113; Palorini R, 2013, ONCOGENE, V32, P352, DOI 10.1038/onc.2012.50; Pichler P, 2010, ANAL CHEM, V82, P6549, DOI 10.1021/ac100890k; RICHARDSON MD, 1994, LIFE SCI, V54, P863, DOI 10.1016/0024-3205(94)00623-7; Robertson LS, 2000, P NATL ACAD SCI USA, V97, P5984, DOI 10.1073/pnas.100113397; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Stangherlin A, 2012, AM J PHYSIOL-HEART C, V302, pH379, DOI 10.1152/ajpheart.00766.2011; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Valsecchi F, 2013, PHYSIOLOGY, V28, P199, DOI 10.1152/physiol.00004.2013; van Daalen Wetters T, 1987, Methods Enzymol, V151, P9; Wang B, 2014, BIOCHEM BIOPH RES CO, V447, P441, DOI 10.1016/j.bbrc.2014.04.028; Warda M, 2013, EXPERT REV PROTEOMIC, V10, P97, DOI [10.1586/EPR.12.69, 10.1586/epr.12.69]; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhang LZ, 2008, J BIOL CHEM, V283, P4304, DOI 10.1074/jbc.M708673200; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	51	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22274	22286		10.1074/jbc.M115.658153	http://dx.doi.org/10.1074/jbc.M115.658153			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26203188	hybrid, Green Published			2022-12-26	WOS:000360968500043
J	Awad, W; Adamczyk, B; Ornros, J; Karlsson, NG; Mani, K; Logan, DT				Awad, Wael; Adamczyk, Barbara; Ornros, Jessica; Karlsson, Niclas G.; Mani, Katrin; Logan, Derek T.			Structural Aspects of N-Glycosylations and the C-terminal Region in Human Glypican-1.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; SECONDARY STRUCTURE PREDICTION; HEPARAN-SULFATE; BIOLOGICAL MACROMOLECULES; CRYSTAL-STRUCTURE; CORE PROTEIN; WEB SERVER; DALLY-LIKE; GLYCANS; CELLS	Glypicans are multifunctional cell surface proteoglycans involved in several important cellular signaling pathways. Glypican-1 (Gpc1) is the predominant heparan sulfate proteoglycan in the developing and adult human brain. The two N-linked glycans and the C-terminal domain that attach the core protein to the cell membrane are not resolved in the Gpc1 crystal structure. Therefore, we have studied Gpc1 using crystallography, small angle x-ray scattering, and chromatographic approaches to elucidate the composition, structure, and function of the N-glycans and the Cterminus and also the topology of Gpc1 with respect to the membrane. The Cterminus is shown to be highly flexible in solution, but it orients the core protein transverse to the membrane, directing a surface evolutionarily conserved in Gpc1 orthologs toward the membrane, where it may interact with signaling molecules and/or membrane receptors on the cell surface, or even the enzymes involved in heparan sulfate substitution in the Golgi apparatus. Furthermore, the N-glycans are shown to extend the protein stability and lifetime by protection against proteolysis and aggregation.	[Awad, Wael; Logan, Derek T.] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Adamczyk, Barbara; Ornros, Jessica; Karlsson, Niclas G.] Univ Gothenburg, Dept Biochem & Cell Biol, SE-40530 Gothenburg, Sweden; [Mani, Katrin] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden	Lund University; University of Gothenburg; Lund University	Logan, DT (corresponding author), Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Box 124, SE-22100 Lund, Sweden.	derek.logan@biochemistry.lu.se	Adamczyk, Barbara/G-9660-2013; Logan, Derek/O-2497-2019; Logan, Derek T/A-1114-2011; Karlsson, Niclas/G-5235-2013	Adamczyk, Barbara/0000-0001-9111-1301; Logan, Derek/0000-0002-0098-8560; Logan, Derek T/0000-0002-0098-8560; Karlsson, Niclas/0000-0002-3045-2628; Awad, Wael/0000-0002-7597-2133; Mani, Katrin/0000-0002-1821-0634	Swedish Research Council; European Union FP7 GastricGlycoExplorer ITN [316929]; Swedish Cancer Society; Ahlen and Olle Engkvist Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union FP7 GastricGlycoExplorer ITN; Swedish Cancer Society(Swedish Cancer Society); Ahlen and Olle Engkvist Foundation	This work was supported by the Swedish Research Council, European Union FP7 GastricGlycoExplorer ITN Grant 316929, the Swedish Cancer Society, Alfred Osterlund, and the Ahlen and Olle Engkvist Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Awad W., 2014, ATLAS GENET CYTOGENE, V18, P461; Awad W, 2013, ACTA CRYSTALLOGR D, V69, P2524, DOI 10.1107/S0907444913025250; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bowler MW, 2015, CRYST GROWTH DES, V15, P1043, DOI 10.1021/cg500890r; Brewer AK, 2011, ANALYST, V136, P515, DOI 10.1039/c0an00738b; BROWN D, 1992, J AM SOC NEPHROL, V3, P895; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Campbell MP, 2008, BIOINFORMATICS, V24, P1214, DOI 10.1093/bioinformatics/btn090; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng W, 2008, CARCINOGENESIS, V29, P1319, DOI 10.1093/carcin/bgn091; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fico A, 2011, CELL MOL LIFE SCI, V68, P923, DOI 10.1007/s00018-007-7471-6; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Guttman M, 2013, STRUCTURE, V21, P321, DOI 10.1016/j.str.2013.02.004; Hamouda H, 2014, J PROTEOME RES, V13, P6144, DOI 10.1021/pr5003005; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Hooper NM, 2011, J NEUROCHEM, V116, P721, DOI 10.1111/j.1471-4159.2010.06936.x; Incardona MF, 2009, J SYNCHROTRON RADIAT, V16, P872, DOI 10.1107/S0909049509036681; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Khan S, 2013, J BIOL CHEM, V288, P27737, DOI 10.1074/jbc.M113.492223; Kim HI, 2013, J PROTEOME RES, V12, P3547, DOI 10.1021/pr400276r; Kim MS, 2011, P NATL ACAD SCI USA, V108, P13112, DOI 10.1073/pnas.1109877108; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Matsuda K, 2001, CANCER RES, V61, P5562; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Pei JM, 2012, PROTEIN SCI, V21, P1172, DOI 10.1002/pro.2105; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Royle Louise, 2006, V347, P125; Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Su G, 2006, AM J PATHOL, V168, P2014, DOI 10.2353/ajpath.2006.050800; Svensson G, 2012, J BIOL CHEM, V287, P14040, DOI 10.1074/jbc.M111.322487; Svensson G, 2011, BIOCHEMISTRY-US, V50, P9377, DOI 10.1021/bi200218s; Svensson G, 2009, BIOCHEMISTRY-US, V48, P9994, DOI 10.1021/bi901402x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watanabe N, 2004, FASEB J, V18, P1013, DOI 10.1096/fj.03-1040fje; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zuegg J, 2000, GLYCOBIOLOGY, V10, P959, DOI 10.1093/glycob/10.10.959	63	16	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22991	23008		10.1074/jbc.M115.660878	http://dx.doi.org/10.1074/jbc.M115.660878			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26203194	hybrid, Green Published			2022-12-26	WOS:000361685500012
J	Hii, HP; Liao, MH; Chen, SJ; Wu, CC; Shih, CC				Hii, Hiong-Ping; Liao, Mei-Hui; Chen, Shiu-Jen; Wu, Chin-Chen; Shih, Chih-Chin			Distinct Patterns of Wnt3a and Wnt5a Signaling Pathway in the Lung from Rats with Endotoxic Shock	PLOS ONE			English	Article							BETA-CATENIN; PROTEIN-KINASE; MECHANISMS; EXPRESSION; SEPSIS; MACROPHAGES; ACTIVATION; RECEPTORS; WINGLESS; OUTCOMES	Septic shock is a syndrome with severe hypotension and multiple organ dysfunction caused by an imbalance between pro-inflammatory and anti-inflammatory response. The most common risk factor of acute lung injury is severe sepsis. Patients with sepsis-related acute respiratory distress syndrome have higher mortality. Recent studies reveal regulatory roles of Wnt3a and Wnt5a signaling in inflammatory processes. Wnt3a signaling has been implicated in anti-inflammatory effects, whereas Wnt5a signaling has been postulated to have pro-inflammatory properties. However, the balance between Wnt3a and Wnt5a signaling pathway in the lung of rats with endotoxic shock has not been determined. Thus, we investigated the major components of Wnt3a and Wnt5a signaling pathway in the lung of endotoxemic rats. Male Wistar rats were intravenously infused with saline or lipopolysaccharide (LPS, 10 mg/kg). The changes of hemodynamics, biochemical variables, and arterial blood gas were examined during the experimental period. At 6 h after saline or LPS, animals were sacrificed, and lungs were obtained for analyzing superoxide production, water accumulation, histologic assessment, and protein expressions of Wnt3a and Wnt5a signaling pathway. Animals that received LPS showed circulatory failure, multiple organ dysfunction, metabolic acidosis, hyperventilation, lung edema, and high mortality. The lung from rats with endotoxic shock exhibited significant decreases in the levels of Wnt3a, Fzd1, Dsh1, phosphorylated GSK-3 beta at Ser9, and beta-catenin. In contrast, the expressions of Wnt5a, Fzd5, and CaMKII were up-regulated in the lung of endotoxemic rats. These findings indicate the major components of Wnt3a and Wnt5a signaling in the lung are disturbed under endotoxic insult.	[Hii, Hiong-Ping] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Liao, Mei-Hui; Wu, Chin-Chen; Shih, Chih-Chin] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Chen, Shiu-Jen] Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan; [Chen, Shiu-Jen] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Shih, Chih-Chin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Chi Mei Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Shih, CC (corresponding author), Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan.	898010201@mail.ndmctsgh.edu.tw			National Defense Medical Center, R.O.C., Taiwan [MAB-102-52, 103-M025]	National Defense Medical Center, R.O.C., Taiwan	This research was supported by grants MAB-102-52 and 103-M025 from National Defense Medical Center, R.O.C., Taiwan.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bhatt PM, 2014, ATHEROSCLEROSIS, V237, P155, DOI 10.1016/j.atherosclerosis.2014.08.027; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guo Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.254; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malhotra S, 2009, EXP HEMATOL, V37, P19, DOI 10.1016/j.exphem.2008.08.008; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sheu CC, 2010, CHEST, V138, P559, DOI 10.1378/chest.09-2933; Tanjore H, 2013, AM J RESP CRIT CARE, V187, P630, DOI 10.1164/rccm.201205-0972OC; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Villar J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0568-z	33	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134492	10.1371/journal.pone.0134492	http://dx.doi.org/10.1371/journal.pone.0134492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218875	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900120
J	Hoffmann, K; Peersman, W; George, A; Dorner, TE				Hoffmann, Kathryn; Peersman, Wim; George, Aaron; Dorner, Thomas Ernst			Associations and Synergistic Effects for Psychological Distress and Chronic Back Pain on the Utilization of Different Levels of Ambulatory Health Care. A Cross-Sectional Study from Austria	PLOS ONE			English	Article							DISABILITY PENSION; SICK LEAVE; DEPRESSION; SERVICES; INTERVENTION; COMORBIDITY; EUROPE; ACCESS; ADULTS; TIME	The aim of this analysis was to assess the impact of chronic back pain and psychological distress on the utilization of primary and secondary levels of care in the ambulatory health care sector in Austria - a country without a gatekeeping system. Additionally, we aimed to determine if the joint effect of chronic back pain and psychological distress was higher than the impact of the sum of the two single conditions. The database used for this analysis was the Austrian Health Interview Survey, with data from 15,474 individuals. Statistical methods used were descriptive tests, regression models and the calculation of synergistic effects. Both chronic back pain and psychological distress had a positive association with the utilization of the primary (OR for chronic back pain 1.53 and psychological distress 1.33) and secondary (OR for chronic back pain 1.32 and psychological distress 1.24) levels of the health care sector. In the fully adjusted model, the synergistic effect of chronic back pain and psychological distress was significant for the secondary level of care (S 1.99, PAF 0.20), but not for the primary level of care (S 1.16, PAF 0.07). Synergistic effects and associations for chronic back pain and psychological distress on the utilization of both the primary and secondary levels of the ambulatory health care sector were observed, particularly for the secondary level of care. Our results demonstrate the utilization of health care services settings by individuals with these conditions, and offer opportunities to consider reorganization and structuring of the Austrian health care system.	[Hoffmann, Kathryn] Med Univ Vienna, Ctr Publ Hlth, Dept Gen Practice, Vienna, Austria; [Peersman, Wim] Univ Ghent, Dept Family Med & Primary Care, B-9000 Ghent, Belgium; [George, Aaron] Duke Med Ctr, Dept Community & Family Med, Durham, NC USA; [Dorner, Thomas Ernst] Med Univ Vienna, Ctr Publ Hlth, Inst Social Med, Vienna, Austria	Medical University of Vienna; Ghent University; Duke University; Medical University of Vienna	Hoffmann, K (corresponding author), Med Univ Vienna, Ctr Publ Hlth, Dept Gen Practice, Vienna, Austria.	kathryn.hoffmann@meduniwien.ac.at	Hoffmann, Kathryn/AAK-9099-2021; Peersman, Wim/K-3576-2019	Peersman, Wim/0000-0002-4276-7408; Dorner, Thomas Ernst/0000-0002-5218-1160; Hoffmann, Kathryn/0000-0001-8760-4250				Alexanderson K, 2012, J EPIDEMIOL COMMUN H, V66, P155, DOI 10.1136/jech.2010.126789; Anderson Daren, 2012, Qual Prim Care, V20, P421; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], MED OUTC STUD 36 IT; [Anonymous], 2009, STROBE STAT CHECKL C; [Anonymous], 2012, PRIM CAR 21 CENT; Aromaa A, 2003, EUR J PUBLIC HEALTH, V13, P67, DOI 10.1093/eurpub/13.suppl_1.67; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bakker Ingrid M, 2007, PLoS Clin Trials, V2, pe26, DOI 10.1371/journal.pctr.0020026; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Chouinard MC, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-49; De Maeseneer J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652553; Dorner TE, 2015, EUR J PAIN; Dorner TE, 2010, WIEN KLIN WOCHENSCHR, V122, P103, DOI 10.1007/s00508-010-1312-6; Eriksen J, 2004, EUR J PAIN, V8, P517, DOI 10.1016/j.ejpain.2003.12.001; Expert Panel on Effective Ways of Investing in Health, 2014, EXP PAN EFF WAYS INV; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Gleicher Y, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-147; Hoffmann K, 2013, EUR J PUBLIC HEALTH, V23, P933, DOI 10.1093/eurpub/ckt008; Hofmarcher M, 2013, AUSTRIA HLTH SYSTEM; Klimont J, 2007, AUSTRIAN HLTH SURVEY; Kringos D, 2013, BRIT J GEN PRACT, V63, pE742, DOI 10.3399/bjgp13X674422; Lazarus R. S., 1984, STRESS APPRAISAL COP; Overland S, 2012, EUR J PAIN, V16, P611, DOI 10.1016/j.ejpain.2011.08.005; Pearson WS, 2009, INT J PUBLIC HEALTH, V54, P23, DOI 10.1007/s00038-009-0003-4; Peersman W, 2014, EUR J PUBLIC HEALTH, V24, P91, DOI 10.1093/eurpub/ckt079; Pichlhofer O, 2015, EUR J PUBLIC HEALTH, V25, P401, DOI 10.1093/eurpub/cku189; Pieber K, 2012, J REHABIL MED, V44, P658, DOI 10.2340/16501977-1010; Rumball-Smith J, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-149; Saastamoinen P, 2012, PAIN, V153, P526, DOI 10.1016/j.pain.2011.11.005; Starfleld B, 2005, ANN FAM MED, V3, P215, DOI 10.1370/afm.307; Stein KV, 2010, SCHMERZ, V24, P468, DOI 10.1007/s00482-010-0962-7; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Stigler FL, 2013, FAM PRACT, V30, P185, DOI 10.1093/fampra/cms067; Stinson J, 2013, CLIN J PAIN, V29, P600, DOI 10.1097/AJP.0b013e31826dce65; Taloyan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044721; Terluin B, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-58; The European definition of General Practice / Family Medicine, 2011, EUR DEF GEN PRACT FA; Tripp D. A., 2006, PAIN RES MANAG, V11, P225, DOI DOI 10.1155/2006/720895; Ullrich PM, 2013, REHABIL PSYCHOL, V58, P158, DOI 10.1037/a0032047; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weimer MB, 2013, PAIN MED, V14, P1839, DOI 10.1111/pme.12177; WELLS JE, 1994, SOC PSYCH PSYCH EPID, V29, P155; WHO, 2008, WORLD HLTH REPORT 20	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134136	10.1371/journal.pone.0134136	http://dx.doi.org/10.1371/journal.pone.0134136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218661	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900085
J	Lin, GG; Yi, L; Zhang, K; Wang, LN; Zhang, R; Xie, JH; Li, JM				Lin, Guigao; Yi, Lang; Zhang, Kuo; Wang, Lunan; Zhang, Rui; Xie, Jiehong; Li, Jinming			Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach	PLOS ONE			English	Article							GENETIC-POLYMORPHISM; ASSOCIATION; POPULATIONS; GUIDELINES; VARIANT; EVENTS; UPDATE; CYP2D6	Laboratories are increasingly requested to perform CYP2C19 genetic testing when managing clopidogrel therapy, especially in patients with acute coronary syndrome undergoing percutaneous coronary intervention. To ensure high quality molecular testing and ascertain that the referring clinician has the correct information for CYP2C19 genotype-directed antiplatelet therapy, a proficiency testing scheme was set up to evaluate the laboratory performance for the entire testing process. Proficiency panels of 10 cell samples encompassing the common CYP2C19 genetic polymorphisms were distributed to 62 participating laboratories for routine molecular testing and the responses were analyzed for accuracy of genotyping and the reporting of results. Data including the number of samples tested, the accreditation/certification status, and test methodology of each individual laboratory were also reviewed. Fifty-seven of the 62 participants correctly identified the CYP2C19 variants in all samples. There were six genotyping errors, with a corresponding analytical sensitivity of 98.5%(333/338 challenges; 95% confidence interval: 96.5-99.5%) and an analytic specificity of 99.6% (281/282; 95% confidence interval: 98.0-99.9%). Reports of the CYP2C19 genotyping results often lacked essential information. In conclusion, clinical laboratories demonstrated good analytical sensitivity and specificity; however, the pharmacogenetic testing community requires additional education regarding the correct reporting of CYP2C19 genetic test results.	[Lin, Guigao; Yi, Lang; Zhang, Kuo; Wang, Lunan; Zhang, Rui; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing 100730, Peoples R China; [Yi, Lang] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing 100730, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, JM (corresponding author), Beijing Hosp, Natl Ctr Clin Labs, Beijing 100730, Peoples R China.	jmli@nccl.org.cn	Wang, Lunan/AAS-9785-2021	Wang, Lunan/0000-0003-3163-7891	Beijing Municipal Public Health Bureau [2011-4011-02]; Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China [201402018]	Beijing Municipal Public Health Bureau; Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China	This work was supported by the capital development fund from the Beijing Municipal Public Health Bureau (No. 2011-4011-02) (JL) and the Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China (No. 201402018) (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz N, 2014, ARCH PATHOL IN PRESS; Chen LL, 2008, PHARMACOGENOMICS, V9, P691, DOI 10.2217/14622416.9.6.691; Geisler T, 2008, PHARMACOGENOMICS, V9, P1251, DOI 10.2217/14622416.9.9.1251; International Organization for Standardization, 2007, 151892007 ISO; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Lewis JP, 2013, J THROMB HAEMOST, V11, P1640, DOI 10.1111/jth.12342; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Myrand SP, 2008, CLIN PHARMACOL THER, V84, P347, DOI 10.1038/sj.clpt.6100482; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Tiroch KA, 2010, AM HEART J, V160, P506, DOI 10.1016/j.ahj.2010.06.039; Wu AHB, 2013, ARCH PATHOL LAB MED, V137, P1232, DOI 10.5858/arpa.2012-0261-CP; Yamamoto K, 2011, J CARDIOL, V57, P194, DOI 10.1016/j.jjcc.2010.10.007; Zhou Q, 2009, PHARMACOGENOMICS J, V9, P380, DOI 10.1038/tpj.2009.31	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134174	10.1371/journal.pone.0134174	http://dx.doi.org/10.1371/journal.pone.0134174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218263	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900091
J	Zhang, Y; Berhane, K; Eckel, SP; Salam, MT; Linn, WS; Rappaport, EB; Bastain, TM; Gilliland, FD				Zhang, Yue; Berhane, Kiros; Eckel, Sandrah P.; Salam, Muhammad T.; Linn, William S.; Rappaport, Edward B.; Bastain, Theresa M.; Gilliland, Frank D.			Determinants of Children's Exhaled Nitric Oxide: New Insights from Quantile Regression	PLOS ONE			English	Article							ALLERGIC RHINITIS; ASTHMA; HEALTHY; ADOLESCENTS; MANAGEMENT	While the fractional concentration of exhaled nitric oxide (FeNO) has proven useful in asthma research, its exact role in clinical care remains unclear, in part due to unexplained inter-subject heterogeneity. In this study, we assessed the hypothesis that the effects of determinants of the fractional concentration of exhaled nitric oxide (FeNO) vary with differing levels of FeNO. In a population-based cohort of 1542 school children aged 12-15 from the Southern California Children's Health Study, we used quantile regression to investigate if the relationships of asthma, socio-demographic and clinical covariates with FeNO vary across its distribution. Differences in FeNO between children with and without asthma increased steeply as FeNO increased (Estimated asthma effects (in ppb) at selected 20th, 50th and 80th percentiles of FeNO are 2.4, 6.3 and 22.2, respectively) but the difference was steeper with increasing FeNO in boys and in children with active rhinitis (p-values<0.01). Active rhinitis also showed significantly larger effects on FeNO at higher concentrations of FeNO (Estimated active rhinitis effects (in ppb) at selected 20th, 50th and 80th percentiles of FeNO are 2.1, 5.7 and 14.3, respectively). Boys and children of Asian descent had higher FeNO than girls and non-Hispanic whites; these differences were significantly larger in those with higher FeNO (p-values<0.01). In summary, application of quantile regression techniques provides new insights into the determinants of FeNO showing substantially varying effects in those with high versus low concentrations.	[Zhang, Yue] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Zhang, Yue] Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT USA; [Zhang, Yue] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Berhane, Kiros; Eckel, Sandrah P.; Salam, Muhammad T.; Linn, William S.; Rappaport, Edward B.; Bastain, Theresa M.; Gilliland, Frank D.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Salam, Muhammad T.] Kern Med Ctr, Dept Psychiat, Bakersfield, CA USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Southern California	Zhang, Y (corresponding author), Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.	zhang.yue@hsc.utah.edu		Bastain, Theresa/0000-0002-0029-5641	National Heart, Lung and Blood Institute [5R01HL61768, 5R01HL76647]; Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences [5P30ES007048]; Children's Environmental Health Center - National Institute of Environmental Health Sciences [5P01ES009581, R826708-01, RD831861-01]; Environmental Protection Agency; National Institute of Environmental Health Sciences [5P01ES011627, 1K22ES022987, R01ES023262]; James H. Zumberge Research and Innovation Fund; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076647, R01HL061768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, R01ES023262, K22ES022987, P01ES011627, P01ES009581] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences; Children's Environmental Health Center - National Institute of Environmental Health Sciences; Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); James H. Zumberge Research and Innovation Fund; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Heart, Lung and Blood Institute (grants 5R01HL61768 and 5R01HL76647); the Southern California Environmental Health Sciences Center (grant 5P30ES007048) funded by the National Institute of Environmental Health Sciences; the Children's Environmental Health Center (grants 5P01ES009581, R826708-01 and RD831861-01) funded by the National Institute of Environmental Health Sciences and the Environmental Protection Agency; the National Institute of Environmental Health Sciences (grants 5P01ES011627, 1K22ES022987 and R01ES023262); the James H. Zumberge Research and Innovation Fund, and the Hastings Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, ALLERGY, V64, P123, DOI 10.1111/j.1398-9995.2008.01884.x; ALVING K, 1993, EUR RESPIR J, V6, P1368; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090; Berhane K, 2014, OCCUP ENV MED; Bjermer L, 2014, RESP MED; de Groot EP, 2012, THORAX, V67, P582, DOI 10.1136/thoraxjnl-2011-201168; Kalpaklioglu AF, 2012, AM J RHINOL ALLERGY, V26, pE50, DOI 10.2500/ajra.2012.26.3717; Koch B, 2011, RESP MED, V105, P352, DOI 10.1016/j.rmed.2010.10.014; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Kovesi T, 2008, CHEST, V133, P169, DOI 10.1378/chest.07-1177; Levesque MC, 2008, J ALLERGY CLIN IMMUN, V121, P396, DOI 10.1016/j.jaci.2007.09.031; Linn WS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-28; Malinovschi A, 2012, CLIN EXP ALLERGY, V42, P433, DOI 10.1111/j.1365-2222.2011.03947.x; Malinovschi A, 2013, J ALLERGY CLIN IMMUN, V132, P821, DOI 10.1016/j.jaci.2013.06.007; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; Olivieri M, 2007, CHEST, V132, P1410, DOI 10.1378/chest.07-0741; Pavord ID, 2008, J ASTHMA, V45, P523, DOI 10.1080/02770900801978557; Pedersen S, 2008, LANCET, V372, P1015, DOI 10.1016/S0140-6736(08)61420-8; Ricciardolo FLM, 2014, CURR OPIN PULM MED, V20, P53, DOI 10.1097/MCP.0000000000000006; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Taylor DR, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-82; Van der Valk RJ, 2013, J ALLERGY CLIN IMMUN; Van Sickle D, 2011, AM J RESP CRIT CARE, V184, P521, DOI 10.1164/rccm.201012-2095OC; Xu F, 2011, J ASTHMA, V48, P1001, DOI 10.3109/02770903.2011.627487; Yao TC, 2012, EUR RESPIR J, V39, P378, DOI 10.1183/09031936.00013911	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0130505	10.1371/journal.pone.0130505	http://dx.doi.org/10.1371/journal.pone.0130505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214692	Green Published, gold, Green Submitted			2022-12-26	WOS:000358594300003
J	Cao, BY; Wang, SW; Tian, ZY; Hu, PL; Feng, L; Wang, L				Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Hu, Pinliang; Feng, Lu; Wang, Lei			DNA Microarray Characterization of Pathogens Associated with Sexually Transmitted Diseases	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CHLAMYDIA-TRACHOMATIS; NEISSERIA-GONORRHOEAE; UREAPLASMA-UREALYTICUM; ANTIGEN-DETECTION; CLINICAL-SAMPLES; PCR; DIAGNOSIS; HERPES; INFECTIONS	This study established a multiplex PCR-based microarray to detect simultaneously a diverse panel of 17 sexually transmitted diseases (STDs)-associated pathogens including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma, Herpes simplex virus (HSV) types 1 and 2, and Human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 35, 39, 54 and 58. The target genes are 16S rRNA gene for N. gonorrhoeae, M. genitalium, M. hominism, and Ureaplasma, the major outer membrane protein gene (ompA) for C. trachomatis, the glycoprotein B gene (gB) for HSV; and the L1 gene for HPV. A total of 34 probes were selected for the microarray including 31 specific probes, one as positive control, one as negative control, and one as positional control probe for printing reference. The microarray is specific as the commensal and pathogenic microbes (and closely related organisms) in the genitourinary tract did not cross-react with the microarray probes. The microarray is 10 times more sensitive than that of the multiplex PCR. Among the 158 suspected HPV specimens examined, the microarray showed that 49 samples contained HPV, 21 samples contained Ureaplasma, 15 contained M. hominis, four contained C. trachomatis, and one contained N. gonorrhoeae. This work reports the development of the first high through-put detection system that identifies common pathogens associated with STDs from clinical samples, and paves the way for establishing a time-saving, accurate and high-throughput diagnostic tool for STDs.	[Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Inst Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Hu, Pinliang; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Res Ctr Funct Genom & Biochips, Tianjin 300071, Peoples R China; [Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Hu, Pinliang; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University	Wang, L (corresponding author), Nankai Univ, TEDA Coll, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China.	leiwang@nankai.edu.cn	Wang, Lei/C-5176-2009; feng, lu/M-5113-2015	Wang, Lei/0000-0003-4427-0881; 	National program of China [2012AA020103]; National Natural Science Foundation of China (NSFC) Program [31170094]	National program of China; National Natural Science Foundation of China (NSFC) Program(National Natural Science Foundation of China (NSFC))	This work was supported by the National program of China (2012AA020103) and the National Natural Science Foundation of China (NSFC) Program (31170094). The authors thank the General Hospital of Tianjin Medical University, the Renmin Hospital of Tianjin, and the Changzheng Hospital of Tianjin for supplying the clinical specimens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boel CHE, 2005, J CLIN MICROBIOL, V43, P2231, DOI 10.1128/JCM.43.5.2231-2235.2005; Cao X, 2006, BIOSENS BIOELECTRON, V22, P393, DOI 10.1016/j.bios.2006.05.011; CLES LD, 1988, J CLIN MICROBIOL, V26, P1735, DOI 10.1128/JCM.26.9.1735-1737.1988; CONE RW, 1991, J INFECT DIS, V164, P757, DOI 10.1093/infdis/164.4.757; Corey L, 2005, J MED VIROL, V76, P350, DOI 10.1002/jmv.20365; Farrell DJ, 1999, J CLIN MICROBIOL, V37, P386, DOI 10.1128/JCM.37.2.386-390.1999; Geisler WM, 2003, INFECT MED, V20, P340; Gevelber MA, 1999, PEDIATR CLIN N AM, V46, P747, DOI 10.1016/S0031-3955(05)70150-4; HALLSWORTH PG, 1995, PATHOLOGY, V27, P168, DOI 10.1080/00313029500169812; JENKINS A, 1991, APMIS, V99, P667, DOI 10.1111/j.1699-0463.1991.tb01244.x; Jephcott AE, 1997, GENITOURIN MED, V73, P245; LAN J, 1995, J CLIN PATHOL, V48, P815, DOI 10.1136/jcp.48.9.815; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Li YY, 2006, J CLIN MICROBIOL, V44, P4376, DOI 10.1128/JCM.01389-06; MCELHINNEY LM, 1995, J VIROL METHODS, V53, P223, DOI 10.1016/0166-0934(95)00019-Q; Morshed MG, 2007, FEMS IMMUNOL MED MIC, V49, P184, DOI 10.1111/j.1574-695X.2006.00191.x; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Shi G, 2005, J MICROBIOL METH, V62, P245, DOI 10.1016/j.mimet.2005.02.017; Slomka MJ, 1998, J MED VIROL, V55, P177, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;177::AID-JMV15&gt;3.0.CO;2-F; Stothard DR, 2001, J CLIN MICROBIOL, V39, P2655, DOI 10.1128/JCM.39.7.2655-2659.2001; Tuuminen T, 2000, J MICROBIOL METH, V42, P265, DOI 10.1016/S0167-7012(00)00209-8; Van Dyck E, 2001, J CLIN MICROBIOL, V39, P1751, DOI 10.1128/JCM.39.5.1751-1756.2001; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Wallace J, 2005, J MOL DIAGN, V7, P72, DOI 10.1016/S1525-1578(10)60011-6; Wang Ying, 2008, Disease Surveillance, V23, P481; Yoshida T, 2002, J CLIN MICROBIOL, V40, P105, DOI 10.1128/JCM.40.1.105-110.2002; Zhou N, 2015, CHIN J AIDS STD, V21, P213	28	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133927	10.1371/journal.pone.0133927	http://dx.doi.org/10.1371/journal.pone.0133927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208181	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000175
J	Ferreira, A; Sagkriotis, A; Olson, M; Lu, JS; Makin, C; Milnes, F				Ferreira, Alberto; Sagkriotis, Alexandros; Olson, Melvin; Lu, Jingsong; Makin, Charles; Milnes, Fran			Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA	PLOS ONE			English	Article							VISUAL-ACUITY; DISEASE; EYE; VERTEPORFIN; PREVALENCE; MECHANISMS; SAFETY	Purpose To compare treatment patterns of intravitreal ranibizumab and aflibercept for the management of neovascular age-related macular degeneration (nAMD) in a real-world setting over the first 12 months of treatment. Methods A proprietary clinical database was used to identify treatment-naive patients with nAMD in the USA with claims for ranibizumab or aflibercept between November 1, 2011 and November 30, 2013 and with follow-up of at least 12 months. Patients were considered treatment-naive if they had no anti-VEGF treatment code for 6 months before the index date. Mean numbers of injections and of non-injection visits to a treating physician were compared between the two treatment cohorts (ranibizumab or aflibercept). In addition, the mean interval between doses was also investigated. Results Patient characteristics were similar for those receiving either ranibizumab (n = 5421) or aflibercept (n = 3506) at the index date. The mean (+/- standard deviation) numbers of injections received by patients treated with ranibizumab (4.9 +/- 3.3) or aflibercept (5.2 +/- 2.9) were not clinically different. The mean number of non-injection visits was 2.8 +/- 2.8 and 2.1 +/- 2.5 for ranibizumab and aflibercept, respectively. Mean dosing interval was 51.0 days (+/- 41.8 days) in patients receiving ranibizumab and 54.1 days (+/- 36.0 days) in those receiving aflibercept. Results were robust to sensitivity analyses for definition of treatment-naive, length of follow-up and treatment in the index eye only. Conclusions Limited data exist regarding real-world treatment patterns of aflibercept for the management of nAMD. Our results suggest that, in routine clinical practice, patients receive a comparable number of injections in the first year of treatment with ranibizumab or aflibercept.	[Ferreira, Alberto; Sagkriotis, Alexandros; Olson, Melvin; Milnes, Fran] Novartis Pharma AG, Basel, Switzerland; [Lu, Jingsong; Makin, Charles] IMS Hlth, Plymouth Meeting, PA USA	Novartis	Ferreira, A (corresponding author), Novartis Pharma AG, Basel, Switzerland.	alberto.ferreira@novartis.com			Novartis Pharma AG, Basel, Switzerland	Novartis Pharma AG, Basel, Switzerland	Novartis Pharma AG, Basel, Switzerland funded this study. AF, AS, MO and FM are employees of Novartis Pharma AG. JL and CM are employees of IMS Health, USA, which received funding from Novartis Pharma AG, Basel, Switzerland.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; American Society of Retina Specialists, 2013, PREF TRENDS PAT SURV; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Bandello F, 2008, DRUG AGING, V25, P255, DOI 10.2165/00002512-200825030-00007; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Busbee BG, 2013, OPHTHALMOLOGY, V120, P1046, DOI 10.1016/j.ophtha.2012.10.014; Cruess AF, 2008, PHARMACOECONOMICS, V26, P57, DOI 10.2165/00019053-200826010-00006; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; EMA, 2012, EYL SUMM PROD CHAR; EMA, 2013, LUC SUMM PROD CHAR; FDA, 2013, LUC PRESCR INF; FDA, 2013, EYL PRESCR INF; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Heier JS, 2012, INTRAVITREAL AFLIBER; Holekamp NM, 2014, AM J OPHTHALMOL, V157, P825, DOI 10.1016/j.ajo.2013.12.018; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P1161, DOI 10.1136/bjophthalmol-2013-303232; Hyman L, 1992, EPIDEMIOLOGY OF AMD; Johnston SS, 2013, ADV THER, V30, P1111, DOI 10.1007/s12325-013-0078-4; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Rakic JM, 2013, CLIN OPHTHALMOL, V7, P1849, DOI 10.2147/OPTH.S49385; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ross AH, 2013, EYE, V27, P56, DOI 10.1038/eye.2012.225; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Stewart MW, 2012, CLIN OPHTHALMOL, V6, P1175, DOI 10.2147/OPTH.S33372; Sunness J S, 1998, Geriatrics, V53, P70; Sunness JS., 1998, GERIATRICS, V53, P77	28	42	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133968	10.1371/journal.pone.0133968	http://dx.doi.org/10.1371/journal.pone.0133968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208030	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000183
J	Jeong, HS; Lee, HK				Jeong, Hii-Sun; Lee, Hye-Kyung			Correction of Inverted Nipple Using Subcutaneous Turn-Over Flaps to Create a Tent Suspension-Like Effect	PLOS ONE			English	Article							DERMAL FLAPS; SURGICAL-CORRECTION	Background Many techniques have been reported for the correction of inverted nipples. However, the conventional methods may be insufficient, especially for moderate to severe inversions. We propose a modification of Elsahy's method and report satisfactory results. Methods A single-institutional retrospective review was performed for all patients who received the modified operation. Patient charts were reviewed for demographic data, pertinent preoperative factors such as Han and Hong classification, and clinical outcomes including postoperative nipple height and sensation. Surgical details are described within the main text. Results The review identified 26 female patients amongst whom 47 inverted nipples were corrected using the modified method. The mean nipple height was 9 mm with an average follow-up period of 14 months. Brush stimulation elicited nipple contraction in all patients. There was no recurrence of nipple inversion, nor were there any surgical complications to report. Conclusion The suspension technique is a simple, reliable method for correcting grade II and III nipple inversions.	[Jeong, Hii-Sun] Hallym Univ, Coll Med, Dept Plast & Reconstruct Surg, Kangnam Sacred Heart Hosp,Hallym Univ Med Ctr, Seoul, South Korea; [Lee, Hye-Kyung] Eulji Univ, Sch Med, Dept Plast & Reconstruct Surg, Eulji Gen Hosp, Seoul, South Korea	Hallym University; Eulji University	Lee, HK (corresponding author), Eulji Univ, Sch Med, Dept Plast & Reconstruct Surg, Eulji Gen Hosp, Seoul, South Korea.	hklee240@gmail.com		JEONG, HII-SUN/0000-0001-9408-8207				BROADBENT TR, 1976, PLAST RECONSTR SURG, V58, P673, DOI 10.1097/00006534-197612000-00003; Burm JS, 2007, PLAST RECONSTR SURG, V120, P1483, DOI 10.1097/01.prs.0000282028.29647.ad; CRESTINU JM, 1987, PLAST RECONSTR SURG, V79, P127, DOI 10.1097/00006534-198701000-00024; Elsahy N, 2009, PLAST RECONSTR SURG, V123, P1131, DOI 10.1097/PRS.0b013e31819a3456; ELSAHY NI, 1976, PLAST RECONSTR SURG, V57, P438, DOI 10.1097/00006534-197604000-00004; HAESEKER B, 1984, BRIT J PLAST SURG, V37, P253, DOI 10.1016/0007-1226(84)90019-5; Han SH, 1999, PLAST RECONSTR SURG, V104, P389, DOI 10.1097/00006534-199908000-00010; HUGO NE, 1993, ANN PLAS SURG, V30, P510, DOI 10.1097/00000637-199306000-00006; Kim DY, 2003, ANN PLAS SURG, V51, P636, DOI 10.1097/01.sap.0000095722.82954.82; Kim JT, 2006, PLAST RECONSTR SURG, V118, P1526, DOI 10.1097/01.prs.0000233028.14581.3f; Kolker AR, 2009, ANN PLAS SURG, V62, P549, DOI 10.1097/SAP.0b013e31819fb190; Lee HB, 1998, PLAST RECONSTR SURG, V102, P1253, DOI 10.1097/00006534-199809040-00055; Lee KY, 2004, PLAST RECONSTR SURG, V113, P328, DOI 10.1097/01.PRS.0000097166.83987.C6; Longo B, 2013, PLAST RECONSTR SURG, V132, p735E, DOI 10.1097/PRS.0b013e3182a3bf05; Park HS, 1999, AESTHET PLAST SURG, V23, P144, DOI 10.1007/s002669900258; Schlenz I, 2000, PLAST RECONSTR SURG, V105, P905, DOI 10.1097/00006534-200003000-00012; SCHWAGER RG, 1974, PLAST RECONSTR SURG, V54, P564, DOI 10.1097/00006534-197411000-00007; Shiau JP, 2011, AESTHET PLAST SURG, V35, P1137, DOI 10.1007/s00266-011-9739-3; Taylor DM, 2011, J PLAST RECONSTR AES, V64, pE297, DOI 10.1016/j.bjps.2011.05.002; TEIMOURIAN B, 1980, PLAST RECONSTR SURG, V65, P504, DOI 10.1097/00006534-198004000-00020; Tezer M, 2012, J ANDROL, V33, P805, DOI 10.2164/jandrol.111.014951; TOWNSEND PL, 1974, BRIT J PLAST SURG, V27, P308, DOI 10.1016/0007-1226(74)90027-7	22	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133588	10.1371/journal.pone.0133588	http://dx.doi.org/10.1371/journal.pone.0133588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208118	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000104
J	Jonson, M; Pokrzywa, M; Starkenberg, A; Hammarstrom, P; Thor, S				Jonson, Maria; Pokrzywa, Malgorzata; Starkenberg, Annika; Hammarstrom, Per; Thor, Stefan			Systematic A beta Analysis in Drosophila Reveals High Toxicity for the 1-42, 3-42 and 11-42 Peptides, and Emphasizes N- and C-Terminal Residues	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID FIBRILS; IN-VITRO; COGNITIVE DECLINE; MODEL; PROTEIN; AGGREGATION; A-BETA-42; OLIGOMERIZATION; MELANOGASTER	Brain amyloid plaques are a hallmark of Alzheimer's disease (AD), and primarily consist of aggregated A beta peptides. While A beta 1-40 and A beta 1-42 are the most abundant, a number of other A beta peptides have also been identified. Studies have indicated differential toxicity for these various A beta peptides, but in vivo toxicity has not been systematically tested. To address this issue, we generated improved transgenic Drosophila UAS strains expressing 11 pertinent A beta peptides. UAS transgenic flies were generated by identical chromosomal insertion, hence removing any transgenic position effects, and crossed to a novel and robust Gal4 driver line. Using this improved Gal4/UAS set-up, survival and activity assays revealed that A beta 1-42 severely shortens lifespan and reduces activity. N-terminal truncated peptides were quite toxic, with 3-42 similar to 1-42, while 11-42 showed a pronounced but less severe phenotype. N-terminal mutations in 3-42 (E3A) or 11-42 (E11A) resulted in reduced toxicity for 11-42, and reduced aggregation for both variants. Strikingly, C-terminal truncation of A beta (1-41, -40, -39, -38, -37) were non-toxic. In contrast, C-terminal extension to 1-43 resulted in reduced lifespan and activity, but not to the same extent as 1-42. Mutating residue 42 in 1-42 (A42D, A42R and A42W) greatly reduced A beta accumulation and toxicity. Histological and biochemical analysis revealed strong correlation between in vivo toxicity and brain A beta aggregate load, as well as amount of insoluble A beta. This systematic Drosophila in vivo and in vitro analysis reveals crucial N- and C-terminal specificity for A beta neurotoxicity and aggregation, and underscores the importance of residues 1-10 and E11, as well as a pivotal role of A42.	[Pokrzywa, Malgorzata; Starkenberg, Annika; Thor, Stefan] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Jonson, Maria; Hammarstrom, Per] Linkoping Univ, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden	Linkoping University; Linkoping University	Thor, S (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	stefan.thor@liu.se	Thor, Stefan/Y-5804-2019; Pokrzywa, Małgorzata/GQA-6257-2022	Thor, Stefan/0000-0001-5095-541X; 	Swedish VINNOVA; King Gustaf V's and Queen Victoria's Freemasons' Foundation; AstraZeneca, Sodertalje; Swedish Research Council; VINNOVA grant, "Innovations for future health"	Swedish VINNOVA(Vinnova); King Gustaf V's and Queen Victoria's Freemasons' Foundation; AstraZeneca, Sodertalje(AstraZeneca); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA grant, "Innovations for future health"(Vinnova)	This work was supported by Swedish VINNOVA, by King Gustaf V's and Queen Victoria's Freemasons' Foundation, and by AstraZeneca, Sodertalje, to ST, and by the Swedish Research Council to PH. MJ was supported by a VINNOVA grant, "Innovations for future health". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1958, J AM STAT ASS; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Berg I, 2009, NEURODEGENER DIS, V6, P127, DOI 10.1159/000213761; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BURDICK D, 1992, J BIOL CHEM, V267, P546; Burnouf S, 2015, ACTA NEUROPATHOL, V130, P35, DOI 10.1007/s00401-015-1419-y; Caesar I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031424; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Crowther DC, 2004, CURR OPIN PHARMACOL, V4, P513, DOI 10.1016/j.coph.2004.07.001; D'Arrigo C, 2009, BIOPOLYMERS, V91, P861, DOI 10.1002/bip.21271; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Davis S, 2003, MOL NEUROBIOL, V27, P249, DOI 10.1385/MN:27:3:249; Elder GA, 2010, MT SINAI J MED, V77, P69, DOI 10.1002/msj.20159; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jahn TR, 2011, J NEUROSCI METH, V197, P186, DOI 10.1016/j.jneumeth.2011.01.026; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Liu KN, 2006, ACTA NEUROPATHOL, V112, P163, DOI 10.1007/s00401-006-0077-5; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Parvathy S, 2001, ARCH NEUROL-CHICAGO, V58, P2025, DOI 10.1001/archneur.58.12.2025; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Philipson O, 2010, FEBS J, V277, P1389, DOI 10.1111/j.1742-4658.2010.07564.x; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2007, BIOCHEMISTRY-US, V46, P10921, DOI 10.1021/bi701043x; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2012, J NEUROCHEM, V121, P774, DOI 10.1111/j.1471-4159.2012.07707.x; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Schoonenboom NS, 2005, ANN NEUROL, V58, P139, DOI 10.1002/ana.20508; Tekirian TL, 2001, J ALZHEIMERS DIS, V3, P241; Vandersteen A, 2012, J BIOL CHEM, V287, P36732, DOI 10.1074/jbc.M112.394635; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Wittnam JL, 2012, J BIOL CHEM, V287, P8154, DOI 10.1074/jbc.M111.308601	58	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133272	10.1371/journal.pone.0133272	http://dx.doi.org/10.1371/journal.pone.0133272			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208119	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000074
J	Takahashi, K; Takahashi, K; Washitani, I				Takahashi, Kazuaki; Takahashi, Kaori; Washitani, Izumi			Do Small Canopy Gaps Created by Japanese Black Bears Facilitate Fruiting of Fleshy-Fruited Plants?	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; ECOSYSTEM ENGINEERS; ECOLOGICAL COMMUNITIES; TREE DIVERSITY; LIGHT-GAP; GROWTH; SIZE; ARCHITECTURE; POPULATION; DYNAMICS	Japanese black bears often break branches when climbing trees and feeding on fruit in canopies, thereby creating small canopy gaps. However, the role of black bear-created canopy gaps has not been evaluated in the context of multiple forest dynamics. Our hypothesis was that small canopy gaps created by black bears improve light conditions, which facilitates fruiting of adult fleshy-fruited plants located beneath the gaps, and also that this chain interaction depends on interactions among the size of gaps, improved light conditions, forest layers, and life form of plants. The rPPFD, size of black bear-created canopy gaps, and fruiting/non-fruiting of fleshy-fruited plants were investigated in five forest layers beneath black-bear-created canopy gaps and closed canopies of Mongolian oak (Quercus crispula). We found that light conditions improved beneath black bear-disturbed trees with canopy gaps of large size, and the effect of improvement of light conditions was reduced with descending forest layers. Fruiting of fleshy-fruited plants, especially woody lianas and trees, was facilitated by the improvement of light conditions accompanied by an increase in the size of black-bear-created gaps. Data from this study revealed that canopy disturbance by black bears was key for improving light conditions and accelerating fruiting of fleshy-fruited trees and woody lianas in the canopy layers in particular. Therefore, our hypothesis was mostly supported. Our results provide evidence that Japanese black bears have high potential as ecosystem engineers that increase the availability of resources (light and fruit in this study) to other species by causing physical state changes in biotic materials (branches of Q. crispula in this study).	[Takahashi, Kazuaki] Nagano Univ, Fac Tourism & Environm Studies, Ueda, Nagano, Japan; [Takahashi, Kaori] Shinshu Univ, Res Ctr Human & Environm Sci, Dept Life Sci, Div Gene Res, Ueda, Nagano, Japan; [Washitani, Izumi] Univ Tokyo, Inst Agr & Life Sci, Biodivers & Ecosyst Restorat, Bunkyo Ku, Tokyo, Japan	Shinshu University; University of Tokyo	Takahashi, K (corresponding author), Nagano Univ, Fac Tourism & Environm Studies, Ueda, Nagano, Japan.	k-takahashi@nagano.ac.jp		Washitani, Izumi/0000-0002-5761-7947	Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [21780154, 26450203]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI (21780154, 26450203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGSPURGER CK, 1981, ECOLOGY, V62, P775, DOI 10.2307/1937745; Berkenbusch K, 2003, NEW ZEAL J ECOL, V27, P67; Binkley D, 2013, FOREST ECOL MANAG, V288, P5, DOI 10.1016/j.foreco.2011.11.002; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; DAHLEM TS, 1987, CAN J BOT, V65, P242, DOI 10.1139/b87-034; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Faegri K., 1979, PRINCIPLES POLLINATI; FEINSINGER P, 1991, ECOLOGY, V72, P1953, DOI 10.2307/1941550; FEINSINGER P, 1987, ECOLOGY, V68, P1294, DOI 10.2307/1939214; Fleming T.H., 1991, P119; Frazer GW, 1999, GAP LIGHT ANAL V2 0; Gribben PE, 2009, ECOL LETT, V12, P1127, DOI 10.1111/j.1461-0248.2009.01366.x; Grindeland JM, 2005, FUNCT ECOL, V19, P383, DOI 10.1111/j.1365-2435.2005.00988.x; Hale SE, 2003, FOREST ECOL MANAG, V179, P341, DOI 10.1016/S0378-1127(02)00540-6; Harper J. L, 1977, POPULATION BIOL PLAN; Hashimoto Y, 2003, ECOL RES, V18, P485, DOI 10.1046/j.1440-1703.2003.00572.x; Hashimoto Y., 1997, MAMMALIAN SCI, V37, P1; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kikuzawa K, 1995, REPROD ECOLOGY PLANT, P146; Kishimoto Ryosuke, 2008, Honyurui Kagaku, V48, P73; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Koike S., 2008, Journal of the Japanese Forest Society, V90, P26, DOI 10.4005/jjfs.90.26; Koike S, 2008, ECOL RES, V23, P385, DOI 10.1007/s11284-007-0399-3; LEVEY DJ, 1988, ECOL MONOGR, V58, P251, DOI 10.2307/1942539; LEVEY DJ, 1988, ECOLOGY, V69, P1076, DOI 10.2307/1941263; NAKASHIZUKA T, 1989, ECOLOGY, V70, P1273, DOI 10.2307/1938186; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; R Development Core Team, 2014, R LANG ENV STAT COMP; Rathcke B., 1983, P305; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Schnitzer SA, 2005, FOREST CLIMBING PLANTS OF WEST AFRICA: DIVERSITY, ECOLOGY AND MANAGEMENT, P59, DOI 10.1079/9780851999142.0059; Takahashi K, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-23; Takanose Yoichiro, 2003, Ornithological Science, V2, P25, DOI 10.2326/osj.2.25; VanderMeer PJ, 1996, J ECOL, V84, P19, DOI 10.2307/2261696; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Yamamoto S, 1999, PLANT ECOL, V140, P167, DOI 10.1023/A:1009713002039; Yamamoto S.I., 2000, J FORESTRY RES, V5, P223, DOI DOI 10.1007/BF02767114	44	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130956	10.1371/journal.pone.0130956	http://dx.doi.org/10.1371/journal.pone.0130956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207908	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000012
J	Verma, SK; Das Murmu, T				Verma, Sushant Kumar; Das Murmu, Thakur			Impact of Environmental and Disturbance Variables on Avian Community Structure along a Gradient of Urbanization in Jamshedpur, India	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; SPECIES-DIVERSITY; URBAN GRADIENT; BREEDING BIRDS; LAND-USE; BIODIVERSITY; CONSERVATION; POPULATION; LANDSCAPE; HABITAT	Gradient pattern analysis was used to investigate the impact of environmental and disturbance variables on species richness, species diversity, abundance and seasonal variation of birds in and around Jamshedpur, which is one of the fastest growing cities of India. It was observed that avian community structure is highly influenced by the vegetation habitat variables, food availability and human-related disturbance variables. A total of 61 species belonging to 33 families were recorded from the suburban area. 55 species belonging to 32 families were observed in nearby wildland habitat consisting of natural vegetation whereas only 26 species belonging to 18 families were observed in urban area. Results indicated that the suburban habitat had more complex bird community structure in terms of higher species richness, higher species diversity and higher evenness in comparison to urban and wildland habitat. Bird species richness and diversity varied across seasons. Maximum species richness and diversity was observed during spring season in all type of habitat. Most of the birds observed in urban areas were found to belong to either rare or irregular category on the basis of their abundance. The observed pattern of avian community structure is due to combined effect of both environmental and human related disturbance variables.	[Verma, Sushant Kumar] Guru Ghasidas Vishwavidyalaya, Dept Zool, Bilaspur, Chhattisgarh, India	Guru Ghasidas Vishwavidyalaya	Verma, SK (corresponding author), Guru Ghasidas Vishwavidyalaya, Dept Zool, Bilaspur, Chhattisgarh, India.	vermasushant2010@gmail.com	Verma, Sushant/AAU-1890-2020					Ali S, 2001, BOOK INDIAN BIRDS; [Anonymous], 2007, UN WORLD URBANIZATIO; [Anonymous], 2010, UN WORLD POP PROSP 2; Bhullar Simrath, 2000, Pacific Conservation Biology, V6, P171; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Blair RB, 1999, ECOL APPL, V9, P164, DOI 10.1890/1051-0761(1999)009[0164:BABAAU]2.0.CO;2; Burke DM, 2000, ECOL APPL, V10, P1749, DOI 10.1890/1051-0761(2000)010[1749:LAFSEO]2.0.CO;2; Carr D, 2009, PROG HUM GEOG, V33, P355, DOI 10.1177/0309132508096031; Caula S, 2008, LANDSCAPE URBAN PLAN, V87, P1, DOI 10.1016/j.landurbplan.2008.03.006; Chapman KA, 2007, BIOL CONSERV, V135, P527, DOI 10.1016/j.biocon.2006.10.050; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; City Mayors, 2014, WORLDS FAST GROW URB; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2013, ESTIMATES STAT ESTIM; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; Fernandez-Juricic E, 2005, MICROHABITAT SELECTI; Fernandez-Juricic E, 2000, CONSERV BIOL, V106, P129; Germaine SS, 1998, ECOL APPL, V8, P680, DOI 10.1890/1051-0761(1998)008[0680:RABBHA]2.0.CO;2; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gotelli N. J., 2001, NULL MODELS ECOLOGY; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grimmett R., 1998, BIRDS INDIAN SUBCONT, DOI DOI 10.3732/ajb.1000230; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Heileman MR, 2007, HABITAT EFFECTS BIRD; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; HUTTO R. L., 1995, MONITORING BIRD POPU, P103; Inskipp T, 1996, ANNOTATED CHECKLIST; JOKIMAKI J, 1993, ORNIS FENNICA, V70, P71; Kazmierczak K, 2001, BIRD WATCHERS GUIDE; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marzluff J. M., 2001, AVIAN ECOLOGY URBANI; Marzluff JM, 1998, AVIAN CONSERVATION R; Mattu V. K., 2006, Indian Forester, V132, P1271; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Nolan PM, 2004, ANIM BEHAV, V67, P403, DOI 10.1016/j.anbehav.2003.03.018; Norris DR, 2007, CONDOR, V109, P535; Ramirez-Albores Jorge E., 2002, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V73, P91; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Sandstrom UG, 2006, LANDSCAPE URBAN PLAN, V77, P39, DOI 10.1016/j.landurbplan.2005.01.004; Sauter A, 2006, BEHAV ECOL SOCIOBIOL, V60, P465, DOI 10.1007/s00265-006-0187-z; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Soderstrom B, 2000, CONSERV BIOL, V14, P522, DOI 10.1046/j.1523-1739.2000.98564.x; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Styring AR, 2011, FOREST ECOL MANAG, V261, P531, DOI 10.1016/j.foreco.2010.11.003; Thakur ML., 2010, INDIAN BIRDS, V5, P162; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; United Nations, 2007, STAT WORLD POP 2007; Verma Sushant Kumar, 2011, Journal of Threatened Taxa, V3, P1764; Villegas Mariana, 2010, Urban Ecosystems, V13, P375, DOI 10.1007/s11252-010-0126-7; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014	57	12	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133383	10.1371/journal.pone.0133383	http://dx.doi.org/10.1371/journal.pone.0133383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218583	Green Submitted, gold, Green Published			2022-12-26	WOS:000358595900029
J	Wang, XY; Guo, YM; FitzGerald, G; Aitken, P; Tippett, V; Chen, D; Wang, XM; Tong, SL				Wang, Xiao Yu; Guo, Yuming; FitzGerald, Gerry; Aitken, Peter; Tippett, Vivienne; Chen, Dong; Wang, Xiaoming; Tong, Shilu			The Impacts of Heatwaves on Mortality Differ with Different Study Periods: A Multi-City Time Series Investigation	PLOS ONE			English	Article							HEAT-RELATED MORTALITY; WAVES; TEMPERATURE; COLD	Background Different locations and study periods were used in the assessment of the relationships between heatwaves and mortality. However, little is known about the comparability and consistency of the previous effect estimates in the literature. This study assessed the heatwave-mortality relationship using different study periods in the three largest Australian cities (Brisbane, Melbourne and Sydney). Methods Daily data on climatic variables and mortality for the three cities were obtained from relevant government agencies between 1988 and 2011. A consistent definition of heatwaves was used for these cities. Poisson generalised additive model was fitted to assess the impact of heatwaves on mortality. Results Non-accidental and circulatory mortality significantly increased during heatwaves across the three cities even with different heatwave definitions and study periods. Using the summer data resulted in the largest increase in effect estimates compared to those using the warm season or the whole year data. Conclusion The findings may have implications for developing standard approaches to evaluating the heatwave-mortality relationship and advancing heat health warning systems. It also provides an impetus to methodological advance for assessing climate change-related health consequences.	[Wang, Xiao Yu; FitzGerald, Gerry; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Guo, Yuming] Univ Queensland, Sch Populat Hlth, Fac Med & Biomed Sci, Brisbane, Qld, Australia; [Aitken, Peter] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Tippett, Vivienne] Queensland Univ Technol, Sch Clin Sci, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Chen, Dong] CSIRO, Ecosyst Sci, Melbourne, Vic, Australia; [Wang, Xiaoming] CSIRO, Climate Adaptat & Sustainable Dev, Melbourne, Vic, Australia	Queensland University of Technology (QUT); University of Queensland; James Cook University; Queensland University of Technology (QUT); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Tong, SL (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia.	s.tong@qut.edu.au	Chen, Dong/A-6385-2011; Wang, Xiaoming/A-3804-2008; Guo, Yuming/I-8353-2018; Tippett, Vivienne/J-1224-2012	Chen, Dong/0000-0001-6495-678X; Wang, Xiaoming/0000-0002-6648-0057; Guo, Yuming/0000-0002-1766-6592; Fitzgerald, Gerard/0000-0002-5586-0097; Tippett, Vivienne/0000-0003-1660-0089	Australian Research Council [LP882699]; Horticulture Australia Limited using the Nursery Industry Levy [NY 11013]; CSIRO Climate Adaptation Flagship; Queensland Department of Environment and Resources Management, Department of Community Safety, Queensland Health and the Environmental Protection Agency; NHMRC research fellowship [553043]	Australian Research Council(Australian Research Council); Horticulture Australia Limited using the Nursery Industry Levy(Horticulture Australia Limited); CSIRO Climate Adaptation Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Queensland Department of Environment and Resources Management, Department of Community Safety, Queensland Health and the Environmental Protection Agency; NHMRC research fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was partly funded by the Australian Research Council (LP882699), Horticulture Australia Limited using the Nursery Industry Levy (Project # NY 11013) and CSIRO Climate Adaptation Flagship, the Queensland Department of Environment and Resources Management, Department of Community Safety, Queensland Health and the Environmental Protection Agency. ST was supported by a NHMRC research fellowship (#553043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS (Australian Burean of Statistics), 2012, AUSTR BUR STAT REG P; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; [Anonymous], AGBM CLIM STAT AUSTR; Australian Bureau of Statistics (ABS), 2007, CLIM SYDN 2000 OL GA; Baccini M, 2011, J EPIDEMIOL COMMUN H, V65, P64, DOI 10.1136/jech.2008.085639; Barnett AG, 2012, ENVIRON RES, V112, P218, DOI 10.1016/j.envres.2011.12.010; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Buckley JP, 2014, EPIDEMIOLOGY, V25, P242, DOI 10.1097/EDE.0000000000000051; D'Ippoliti D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-37; Fouillet A, 2008, INT J EPIDEMIOL, V37, P309, DOI 10.1093/ije/dym253; Hajat S, 2010, J EPIDEMIOL COMMUN H, V64, P753, DOI 10.1136/jech.2009.087999; IPCC, CLIM CHANG 2013 PHYS; Linacre E., 2002, CLIMATES WEATHER EXP, DOI DOI 10.4324/9780203291030; Metzger KB, 2010, ENVIRON HEALTH PERSP, V118, P80, DOI 10.1289/ehp.0900906; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Pascal M, 2013, INT J BIOMETEOROL, V57, P21, DOI 10.1007/s00484-012-0530-1; Peng RD, 2011, ENVIRON HEALTH PERSP, V119, P701, DOI 10.1289/ehp.1002430; Schifano P, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-50; Son JY, 2012, ENVIRON HEALTH PERSP, V120, P566, DOI 10.1289/ehp.1103759; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Sturman A. P., 2006, WEATHER CLIMATE AUST; Tong SL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003579; Tong SL, 2010, INT J BIOMETEOROL, V54, P393, DOI 10.1007/s00484-009-0290-8; Vaneckova P, 2011, J APPL METEOROL CLIM, V50, P1165, DOI 10.1175/2011JAMC2632.1; Yu WW, 2011, SCI TOTAL ENVIRON, V409, P3431, DOI 10.1016/j.scitotenv.2011.05.027	26	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134233	10.1371/journal.pone.0134233	http://dx.doi.org/10.1371/journal.pone.0134233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217945	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900099
J	Hsiao, CY; Yang, HY; Hsiao, MC; Hung, PH; Wang, MC				Hsiao, Chih-Yen; Yang, Huang-Yu; Hsiao, Meng-Chang; Hung, Peir-Haur; Wang, Ming-Cheng			Risk Factors for Development of Acute Kidney Injury in Patients with Urinary Tract Infection	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE PYELONEPHRITIS; SEPTIC SHOCK; DIALYSIS; DEATH; INSUFFICIENCY; BACTEREMIA; MORTALITY; THERAPY; DISEASE	Acute kidney injury (AKI) is associated with high morbidity and mortality. Urinary tract infection (UTI) may be associated with sepsis or septic shock, and cause sudden deterioration of renal function. This study investigated the clinical characteristics and change of renal function to identify the risk factors for development of AKI in UTI patients. This retrospective study was conducted in a tertiary referral center. From January 2006 to January 2013, a total of 790 UTI patients necessitating hospital admission were included for final analysis. Their demographic and clinical characteristics and comorbidities were collected and compared. Multivariate logistic regression analysis was performed to evaluate the risk factors for AKI in UTI patients. There were 97 (12.3%) patients developing AKI during hospitalization. Multivariate logistic regression analysis showed that patients with older age (OR 1.02, 95% CI 1.00-1.04, P = 0.04), diabetes mellitus (DM) (OR 2.23, 95% CI 1.35-3.68, P = 0002), upper UTI (OR 2.63, 95% CI 1.53-4.56, P = 0001), afebrile during hospitalization (OR 1.71, 95% CI 1.04-2.83, P = 0036) and lower baseline eGFR [baseline eGFR 45-59 mL/min/1.73 m(2) (OR 2.12, 95% CI 1.12-4.04, P = 0.022), baseline eGFR 30-44 mL/min/1.73 m(2) (OR 4.44, 95% CI 2.30-8.60 P < 0.001) baseline eGFR < 30 mL/min/1.73 m(2) (OR 4.72, 95% CI 2.13-10.45, P < 0.001), respectively] were associated with increased risk for development of AKI. were associated with increased risk for development of AKI. Physicians should pay attention to UTI patients at risk of AKI (advancing age, DM, upper UTI, afebrile, and impaired baseline renal function).	[Hsiao, Chih-Yen; Hung, Peir-Haur] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan; [Hsiao, Chih-Yen] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Yang, Huang-Yu] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Nephrol, Taoyuan, Taiwan; [Hsiao, Meng-Chang] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Hung, Peir-Haur] Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth, Tainan, Taiwan; [Wang, Ming-Cheng] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Nephrol, Tainan, Taiwan; [Yang, Huang-Yu] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Chia Nan University of Pharmacy & Science; Chang Gung Memorial Hospital; Chang Gung University; University of Alabama System; University of Alabama Birmingham; Chia Nan University of Pharmacy & Science; National Cheng Kung University; National Cheng Kung University Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wang, MC (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Nephrol, Tainan, Taiwan.	tsutsugamushi8901@gmail.com		YANG, HUANG-YU/0000-0001-6826-9717				BAKER LRI, 1979, Q J MED, V48, P603; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boscia J A, 1987, Infect Dis Clin North Am, V1, P893; Boyko EJ, 2002, DIABETES CARE, V25, P1778, DOI 10.2337/diacare.25.10.1778; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cotran RS, 1981, URINARY TRACT INFECT, P1571; Dalal Shalini, 2006, J Support Oncol, V4, P9; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Funfstuck R, 2006, INT J ANTIMICROB AG, V28, pS72, DOI 10.1016/j.ijantimicag.2006.05.004; Gilbert DN, 2006, CLIN J AM SOC NEPHRO, V1, P327, DOI 10.2215/CJN.01931105; GLECKMAN R, 1982, JAMA-J AM MED ASSOC, V248, P1478, DOI 10.1001/jama.248.12.1478; HOLLOWAY WA, 1984, GERIATRICS, V39, P48; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; JONES SR, 1992, CLIN INFECT DIS, V14, P243, DOI 10.1093/clinids/14.1.243; Kalra OP, 2009, J GLOB INFECT DIS, V1, P57, DOI 10.4103/0974-777X.52984; Kooman JP, 2000, NETH J MED, V57, P185, DOI 10.1016/S0300-2977(00)00063-2; Kushimoto S, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-14; Laupland KB, 2007, INFECTION, V35, P150, DOI 10.1007/s15010-007-6180-2; Lee CC, 2007, MEDICINE, V86, P138, DOI 10.1097/SHK.0b013e318067da56; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liangos O, 2012, MINERVA UROL NEFROL, V64, P51; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; LORENTZ WB, 1990, NEPHRON, V54, P256, DOI 10.1159/000185865; Ma RCW, 2007, DIABETES CARE, V30, P182, DOI 10.2337/dc06-2040; Medeiros P, 2014, CLIN EXP NEPHROL; Mori T, 2010, CONTRIB NEPHROL, V166, P40, DOI 10.1159/000314849; Nahar A, 2004, AM J MED SCI, V328, P121, DOI 10.1097/00000441-200408000-00009; Nduka OO, 2009, CRIT CARE CLIN, V25, P677, DOI 10.1016/j.ccc.2009.08.002; Nicolle LE, 2001, INFECT MED, V18, P153; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Patterson JE, 1997, INFECT DIS CLIN N AM, V11, P735, DOI 10.1016/S0891-5520(05)70383-4; Plataki M, 2011, CLIN J AM SOC NEPHRO, V6, P1744, DOI 10.2215/CJN.05480610; Qari FA, 2003, SAUDI MED J, V24, P1064; Robbins SL, 1944, NEW ENGL J MED, V231, P865, DOI 10.1056/NEJM194412282312601; ROBERTS NJ, 1991, REV INFECT DIS, V13, P462; Rosser CJ, 1999, AM J SURG, V177, P287, DOI 10.1016/S0002-9610(99)00048-3; Sant G R, 1987, Semin Urol, V5, P126; SCHAEFFER AJ, 1991, EUR UROL, V19, P2; Schappert S.M., 2011, VITAL HLTH STAT, V13, P1; Scholes D, 2005, ANN INTERN MED, V142, P20, DOI 10.7326/0003-4819-142-1-200501040-00008; Singh P, 2010, CLIN J AM SOC NEPHRO, V5, P1690, DOI 10.2215/CJN.00830110; SMITH JW, 1989, AM J MED SCI, V297, P53, DOI 10.1097/00000441-198901000-00013; Soylemezoglu O., 1995, International Urology and Nephrology, V27, P137, DOI 10.1007/BF02551309; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thatte L, 1996, POSTGRAD MED, V100, P83, DOI 10.3810/pgm.1996.12.128; Tiruvoipati R, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-70; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wijeysundera DN, 2007, JAMA-J AM MED ASSOC, V297, P1801, DOI 10.1001/jama.297.16.1801; WOLK PJ, 1978, ARCH INTERN MED, V138, P1084, DOI 10.1001/archinte.138.7.1084	55	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133835	10.1371/journal.pone.0133835	http://dx.doi.org/10.1371/journal.pone.0133835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213991	Green Published, gold, Green Submitted			2022-12-26	WOS:000358594300034
J	Baltensperger, AP; Huettmann, F				Baltensperger, A. P.; Huettmann, F.			Predicted Shifts in Small Mammal Distributions and Biodiversity in the Altered Future Environment of Alaska: An Open Access Data and Machine Learning Perspective	PLOS ONE			English	Article							NO-ANALOG COMMUNITIES; CLIMATE-CHANGE; ELEVATIONAL GRADIENTS; DIVERSITY; DYNAMICS; CONSERVATISM; IMPACTS; ADAPTATION; EVOLUTION; PATTERNS	Climate change is acting to reallocate biomes, shift the distribution of species, and alter community assemblages in Alaska. Predictions regarding how these changes will affect the biodiversity and interspecific relationships of small mammals are necessary to pro-actively inform conservation planning. We used a set of online occurrence records and machine learning methods to create bioclimatic envelope models for 17 species of small mammals (rodents and shrews) across Alaska. Models formed the basis for sets of species-specific distribution maps for 2010 and were projected forward using the IPCC (Intergovernmental Panel on Climate Change) A2 scenario to predict distributions of the same species for 2100. We found that distributions of cold-climate, northern, and interior small mammal species experienced large decreases in area while shifting northward, upward in elevation, and inland across the state. In contrast, many southern and continental species expanded throughout Alaska, and also moved down-slope and toward the coast. Statewide community assemblages remained constant for 15 of the 17 species, but distributional shifts resulted in novel species assemblages in several regions. Overall biodiversity patterns were similar for both time frames, but followed general species distribution movement trends. Biodiversity losses occurred in the Yukon-Kuskokwim Delta and Seward Peninsula while the Beaufort Coastal Plain and western Brooks Range experienced modest gains in species richness as distributions shifted to form novel assemblages. Quantitative species distribution and biodiversity change projections should help land managers to develop adaptive strategies for conserving dispersal corridors, small mammal biodiversity, and ecosystem functionality into the future.	[Baltensperger, A. P.; Huettmann, F.] Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, EWHALE Lab, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Baltensperger, AP (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, EWHALE Lab, Fairbanks, AK 99775 USA.	abaltens@alaska.edu			University of Alaska Fairbanks	University of Alaska Fairbanks	APB received a 2014-15 Doctoral Dissertation Completion Fellowship from the University of Alaska Fairbanks that funded this research.	ACIA, 2005, ARCTIC CLIMATE IMPAC, P1042; Alo CA, 2008, J GEOPHYS RES BIOGEO, V113; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; Baltensperger A. P., 2015, CANADIAN J IN PRESS; Baltensperger AP, 2015, LANDSCAPE ECOL, V30, P681, DOI 10.1007/s10980-014-0150-8; Baltensperger AP, 2015, DETECTING EFFECTS EN; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Boden T. A., 2011, GLOBAL REGIONAL NATL; Booms TL, 2010, POLAR BIOL, V33, P347, DOI 10.1007/s00300-009-0711-5; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; BUCKNER CH, 1964, CAN J ZOOLOG, V42, P259, DOI 10.1139/z64-026; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; CAREY AB, 1992, ECOL MONOGR, V62, P223, DOI 10.2307/2937094; Carleton MD, 2014, J MAMMAL, V95, P943, DOI 10.1644/14-MAMM-A-004; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dial RJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000453; Dobrowski SZ, 2013, GLOBAL CHANGE BIOL, V19, P241, DOI 10.1111/gcb.12026; Drew CA, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-7390-0; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elsen PR, 2015, NAT CLIM CHANGE, V5, P772, DOI [10.1038/nclimate2656, 10.1038/NCLIMATE2656]; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Forero-Medina G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013210; Fox JW, 2007, OIKOS, V116, P189, DOI 10.1111/j.2006.0030-1299.15280.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Glick P, 2011, MOVING CONSERVATION, P1; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Gotthans T, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON MICROWAVES, COMMUNICATIONS, ANTENNAS AND ELECTRONICS SYSTEMS (IEEE COMCAS 2013); Gough L, 2007, OIKOS, V116, P407, DOI 10.1111/j.0030-1299.2007.15449.x; Guisan A, 2007, ECOL LETT, V10, P435, DOI 10.1111/j.1461-0248.2007.01044.x; Hallett J, 2003, MAMMAL COMMUNITY DYN, P22; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Hegel TM, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P273, DOI 10.1007/978-4-431-87771-4_16; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holland MM, 2003, CLIM DYNAM, V21, P221, DOI 10.1007/s00382-003-0332-6; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; Hope AG, 2013, NAT CLIM CHANGE, V3, P931, DOI 10.1038/NCLIMATE1926; Hope AG, 2010, J MAMMAL, V91, P1041, DOI 10.1644/09-MAMM-A-402.1; Huettmann F, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P189, DOI 10.1007/978-1-4419-7390-0_10; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Kerr J, 1998, ENVIRON MONIT ASSESS, V49, P263, DOI 10.1023/A:1005846910199; Kozak KH, 2010, AM NAT, V176, P40, DOI 10.1086/653031; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; Li J, 2011, ENVIRON MODELL SOFTW, V26, P1647, DOI 10.1016/j.envsoft.2011.07.004; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Luoma Daniel L., 2003, P343, DOI 10.1017/CBO9780511615757.011; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; MASER C, 1978, ECOLOGY, V59, P799, DOI 10.2307/1938784; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Monzon J, 2011, BIOSCIENCE, V61, P752, DOI 10.1525/bio.2011.61.10.5; Murphy K, 2010, CONNECTING ALASKA LA, P100; Novillo A, 2012, AUSTRAL ECOL, V37, P758, DOI 10.1111/j.1442-9993.2011.02336.x; Olofsson J, 2012, NAT CLIM CHANGE, V2, P880, DOI 10.1038/NCLIMATE1537; Pank LF, 1974, BIBLIO SEED EATING M; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; PROST S, 2013, GLOBAL CHANGE BIOL, V19, P1; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Staudinger MD, 2013, FRONT ECOL ENVIRON, V11, P465, DOI 10.1890/120272; Stein BA, 2013, FRONT ECOL ENVIRON, V11, P502, DOI 10.1890/120277; Tape KD, 2012, ECOSYSTEMS, V15, P711, DOI 10.1007/s10021-012-9540-4; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vihma T, 2014, SURV GEOPHYS, V35, P1175, DOI 10.1007/s10712-014-9284-0; Wackernagel M, 1999, ECOL ECON, V29, P375, DOI 10.1016/S0921-8009(98)90063-5; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiersma YF, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-7390-0_1; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; ZWEIG MH, 1993, CLIN CHEM, V39, P561	87	25	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132054	10.1371/journal.pone.0132054	http://dx.doi.org/10.1371/journal.pone.0132054			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207828	Green Published, gold			2022-12-26	WOS:000358622000021
J	Gao, JM; Huang, Y; Li, M; Zhao, HC; Zhao, Y; Li, R; Yan, J; Yu, Y; Qiao, J				Gao, Jiangman; Huang, Ying; Li, Min; Zhao, Hongcui; Zhao, Yue; Li, Rong; Yan, Jie; Yu, Yang; Qiao, Jie			Effect of Local Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Subcutaneously Allotransplanted Ovarian Tissue in Ovariectomized Mice	PLOS ONE			English	Article							FACTOR-INDUCED ANGIOGENESIS; IN-VITRO; FOLLICULAR DEVELOPMENT; FACTOR EXPRESSION; VEGF; TRANSPLANTATION; APOPTOSIS; PROMOTES; SURVIVAL; CELLS	Objective One of the major obstacles to ovarian tissue preservation is delayed angiogenesis that leads follicles lost after transplantation. The aim of the present study was to investigate the effects of bFGF and VEGF on heterotopic transplanted ovarian tissue using a mouse model. Methods Female mice underwent bilateral ovariectomy. Ovarian tissues encapsulated by fibrin hydrogels were transplanted subcutaneously into recipient mice, in which ovarian hormonal cyclicity was absent. The fibrinogen solution was mixed with bFGF, VEGF, or a mixture of bFGF and VEGF. The grafts were recovered 21 days after transplantation. Follicle morphology and follicle numbers were observed by H&E staining. Blood vessels were observed in transplanted intra-ovarian tissue by CD31 antibody IHC staining. Daily vaginal cytology was performed to determine estrous cycle and functional restoration of transplanted ovarian tissue. Blood was collected weekly and serum FSH levels were measured with a radioimmunoassay kit. Apoptosis analysis was performed by anti-AC-3 staining and survivin mRNA expression. Results The number of primordial follicles and secondary follicles in the bFGF+VEGF group was significantly higher than in the control group. The vascular density in the bFGF+VEGF groups were significantly higher than in the bFGF and the VEGF groups; there was no significant difference between the bFGF and VEGF groups. Estrous cycle was earlier in the bFGF+VEGF group compared with the control group; all mice in this group restored ovarian function. Serum FSH levels in the bFGF+VEGF group were significantly lower than in the control group by day 14 post-transplantation. The AC-3-positive in control group was significantly higher compared with bFGF group and VEGF group, and in bFGF+VEGF group was significantly lower than bFGF group and VEGF group. Survivin mRNA expression in bFGF+VEGF group was significantly higher than control group. Conclusion The combination of bFGF and VEGF has beneficial effects on follicle survival, angiogenesis, and resumption of estrous cycles.	[Gao, Jiangman; Huang, Ying; Li, Min; Zhao, Hongcui; Zhao, Yue; Li, Rong; Yan, Jie; Yu, Yang; Qiao, Jie] Peking Univ, Dept Obstet & Gynecol, Ctr Reprod Med, Hosp 3, Beijing 100191, Peoples R China; [Gao, Jiangman; Huang, Ying; Zhao, Yue; Li, Rong; Yu, Yang; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Zhao, Hongcui; Li, Rong; Yan, Jie; Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100191, Peoples R China	Peking University	Yan, J (corresponding author), Peking Univ, Dept Obstet & Gynecol, Ctr Reprod Med, Hosp 3, Beijing 100191, Peoples R China.	yanjiebjmu@bjmu.edu.cn; yuyang5012@hotmail.com		Yu, Yang/0000-0002-4310-1966; Qiao, Jie/0000-0003-2126-1376	Ministry of Science and Technology of China Grants (973 program) [2011CB944504, 2014CB943203]; National Natural Science Funds for general program [31371521, 31230047]	Ministry of Science and Technology of China Grants (973 program); National Natural Science Funds for general program	This work was supported in part by the Ministry of Science and Technology of China Grants (973 program; 2011CB944504 and 2014CB943203), and the National Natural Science Funds for general program (31371521 and 31230047).	Abir R, 2011, FERTIL STERIL, V95, P1205, DOI 10.1016/j.fertnstert.2010.07.1082; Abramovich D, 2006, BIOL REPROD, V75, P434, DOI 10.1095/biolreprod.106.051052; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Beamer B., 2010, HSS J, V6, P85, DOI [10. 1007/s11420-009- 9129-4, DOI 10.1007/S11420-009-9129-4, 10.1007/s11420-009-9129-4]; Danforth DR, 2003, BIOL REPROD, V68, P1736, DOI 10.1095/biolreprod.101.000679; De Laporte L, 2011, J BIOMED MATER RES A, V98A, P372, DOI 10.1002/jbm.a.33112; Donnez J, 2013, NAT REV ENDOCRINOL, V9, P735, DOI 10.1038/nrendo.2013.205; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gao JM, 2013, HUM REPROD, V28, P2784, DOI 10.1093/humrep/det296; Grasselli F, 2002, REPROD DOMEST ANIM, V37, P362, DOI 10.1046/j.1439-0531.2002.00386.x; Hata Y, 1999, DIABETES, V48, P1145, DOI 10.2337/diabetes.48.5.1145; Hazzard TM, 2000, BEST PRACT RES CL OB, V14, P883, DOI 10.1053/beog.2000.0133; Hunter MG, 2004, ANIM REPROD SCI, V82-3, P461, DOI 10.1016/j.anireprosci.2004.05.013; Imbert R, 2014, HUM REPROD, V29, P1931, DOI 10.1093/humrep/deu158; Kolibianakis S, 2015, REPROD BIOMED ONLINE, V30, P4, DOI 10.1016/j.rbmo.2014.11.003; Labied S, 2013, TRANSPLANTATION, V95, P426, DOI 10.1097/TP.0b013e318279965c; Li PP, 2014, J BONE MINER METAB, V32, P627, DOI 10.1007/s00774-013-0538-6; Majima M, 2000, BRIT J PHARMACOL, V130, P641, DOI 10.1038/sj.bjp.0703327; Mandriota SJ, 1997, J CELL SCI, V110, P2293; Quintana R, 2004, FERTIL STERIL, V82, P1101, DOI 10.1016/j.fertnstert.2004.03.036; Saadeh PB, 2000, ENDOCRINOLOGY, V141, P2075, DOI 10.1210/en.141.6.2075; Santos JMS, 2014, REPROD DOMEST ANIM, V49, P522, DOI 10.1111/rda.12322; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.TEA.2011.0204, 10.1089/ten.tea.2011.0204]; Silber S, 2015, REPROD BIOMED ONLINE, V30, P643, DOI 10.1016/j.rbmo.2015.02.010; Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475; Sun XT, 2004, WORLD J GASTROENTERO, V10, P2524, DOI 10.3748/wjg.v10.i17.2524; Tille JC, 2001, J PHARMACOL EXP THER, V299, P1073; Wang L, 2013, J ASSIST REPROD GEN, V30, P1301, DOI 10.1007/s10815-013-0043-9; Wang TR, 2014, HUM REPROD, V29, P568, DOI 10.1093/humrep/det465; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086; Yoshiji H, 2002, HEPATOLOGY, V35, P834, DOI 10.1053/jhep.2002.32541	32	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134035	10.1371/journal.pone.0134035	http://dx.doi.org/10.1371/journal.pone.0134035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208097	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000194
J	Gong, SJ; Hao, ZJ; Meng, JS; Liu, D; Wei, MR; Tao, J				Gong, Saijie; Hao, Zhaojun; Meng, Jiasong; Liu, Ding; Wei, Mengran; Tao, Jun			Digital Gene Expression Analysis to Screen Disease Resistance-Relevant Genes from Leaves of Herbaceous Peony (Paeonia lactiflora Pall.) Infected by Botrytis cinerea	PLOS ONE			English	Article							PROTEIN-KINASE; TRANSCRIPTOME; PLANTS; LIGNIFICATION; PATHOGENS; NETWORKS; TOBACCO; POPLARS; COMPLEX; BAK1	Herbaceous peony (Paeonia lactiflora Pall.) is a well-known traditional flower in China and is widely used for landscaping and garden greening due to its high ornamental value. However, disease spots usually appear after the flowering of the plant and may result in the withering of the plant in severe cases. This study examined the disease incidence in an herbaceous peony field in the Yangzhou region, Jiangsu Province. Based on morphological characteristics and molecular data, the disease in this area was identified as a gray mold caused by Botrytis cinerea. Based on previously obtained transcriptome data, eight libraries generated from two herbaceous peony cultivars 'Zifengyu' and 'Dafugui' with different susceptibilities to the disease were then analyzed using digital gene expression profiling (DGE). Thousands of differentially expressed genes (DEGs) were screened by comparing the eight samples, and these genes were annotated using the Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) database. The pathways related to plant-pathogen interaction, secondary metabolism synthesis and antioxidant system were concentrated, and 51, 76, and 13 disease resistance-relevant candidate genes were identified, respectively. The expression patterns of these candidate genes differed between the two cultivars: their expression of the disease-resistant cultivar 'Zifengyu' sharply increased during the early stages of infection, while it was relatively subdued in the disease-sensitive cultivar 'Dafugui'. A selection of ten candidate genes was evaluated by quantitative real-time PCR (qRT-PCR) to validate the DGE data. These results revealed the transcriptional changes that took place during the interaction of herbaceous peony with B. cinerea, providing insight into the molecular mechanisms of host resistance to gray mold.	[Gong, Saijie; Hao, Zhaojun; Meng, Jiasong; Liu, Ding; Wei, Mengran; Tao, Jun] Yangzhou Univ, Coll Hort & Plant Protect, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Tao, J (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.	taojunyzu@163.com			Agricultural Science & Technology Independent Innovation Fund of Jiangsu Province [CX[13]2014]; Agricultural Science & Technology Support Project of Jiangsu Province [BE2013389]; College Natural Science Research of Jiangsu Province [14KJB210011]; Postgraduate Science Research Innovation Project of Jiangsu province [CXLX_1426]; Priority Academic Program Development from Jiangsu Government	Agricultural Science & Technology Independent Innovation Fund of Jiangsu Province; Agricultural Science & Technology Support Project of Jiangsu Province; College Natural Science Research of Jiangsu Province; Postgraduate Science Research Innovation Project of Jiangsu province; Priority Academic Program Development from Jiangsu Government	This work was supported by the Agricultural Science & Technology Independent Innovation Fund of Jiangsu Province (CX[13]2014), Agricultural Science & Technology Support Project of Jiangsu Province (BE2013389), College Natural Science Research of Jiangsu Province (14KJB210011), Postgraduate Science Research Innovation Project of Jiangsu province (CXLX_1426) and the Priority Academic Program Development from Jiangsu Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; Alam AKMM, 2014, PLANT PATHOLOGY J, V30, P261, DOI 10.5423/PPJ.OA.03.2014.0023; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Baniecki JF, 2000, BOTRYTIS BLIGHT PEON; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Blanco-Ulate B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00142; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Chen QZ., 2013, THESIS FUJIAN AGR FO; Chen SN., 2011, THESIS BEIJING FORES; Chen XiaoHong, 2006, Southwest China Journal of Agricultural Sciences, V19, P58; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dutartre L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-64; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fang Z. D., 1998, RES METHODS PLANT DI, V3ed Edn; Fox R. T. V., 2001, Mycologist, V15, P88; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Frias M, 2013, MOL PLANT PATHOL, V14, P191, DOI 10.1111/j.1364-3703.2012.00842.x; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hansen M.A, 2009, BOTRYTIS BLIGHT PEON; HE ZH, 2001, ACTA PHYTOPHYSIOL SI, V27, P281; Ho GD, 1999, PHYTOPATHOLOGY, V89, P673, DOI 10.1094/PHYTO.1999.89.8.673; Huntley SK, 2003, J AGR FOOD CHEM, V51, P6178, DOI 10.1021/jf034320o; Ibrahim T, 2014, PHILIPP J CROP SCI, V39, P27; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jouanin L, 2000, PLANT PHYSIOL, V123, P1363, DOI 10.1104/pp.123.4.1363; Kajita S, 2002, J SCI FOOD AGR, V82, P1216, DOI 10.1002/jsfa.1168; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keller M, 2003, PHYTOPATHOLOGY, V93, P316, DOI 10.1094/PHYTO.2003.93.3.316; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Lakshmanan V, 2012, PLANT PHYSIOL, V160, P1642, DOI 10.1104/pp.112.200386; Lan Y, 1987, J NANJING FORESTRY U, V1, P8; Lanot A, 2006, PLANT J, V48, P286, DOI 10.1111/j.1365-313X.2006.02872.x; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang Ye, 2011, Yichuan, V33, P1317, DOI 10.3724/SP.J.1005.2011.01317; Liu B, 2014, PLANT SCI, V227, P145, DOI 10.1016/j.plantsci.2014.08.001; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qiao ZC, 2009, THESIS XINJIANG AGR; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Rivera MC, 2006, PLANT DIS, V90, P970, DOI 10.1094/PD-90-0970B; Romeis T, 2000, PLANT CELL, V12, P803, DOI 10.1105/tpc.12.5.803; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Sun Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-852; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wagner A, 2007, P NATL ACAD SCI USA, V104, P11856, DOI 10.1073/pnas.0701428104; Wang GuangJin, 1997, Acta Phytopathologica Sinica, V27, P215; Wei JC, 1979, FUNDAL IDENTIFICATIO; White FF, 2000, CURR OPIN PLANT BIOL, V3, P291, DOI 10.1016/S1369-5266(00)00082-0; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; White-McDougall W. J., 1998, DIS PEONY; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Wu Y, 2013, J INTEGR PLANT BIOL, V55, P1271, DOI 10.1111/jipb.12123; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xing T, 2001, MOL PLANT MICROBE IN, V14, P1261, DOI 10.1094/MPMI.2001.14.10.1261; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu Z., 1987, J HENAN AGR U, V21, P435; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045953; Zhang Z., 2006, FLORA FUNGORUM SINIC, V26; Zhao DQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-689; Zhao DaQiu, 2012, African Journal of Agricultural Research, V7, P2153; Zhao DQ, 2011, MOL BIOL REP, V38, P3935, DOI 10.1007/s11033-010-0510-7; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhao S, 2012, WORLD J MICROB BIOT, V28, P2919, DOI 10.1007/s11274-012-1102-6; Zou Q, 2000, PLANT PHYSL EXPT INS; 赵大球, 2011, [江苏农业科学, Jiangsu Agricultural Sciences], V39, P286; 朱丽梅, 2011, [江苏农业科学, Jiangsu Agricultural Sciences], V39, P134	88	6	7	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133305	10.1371/journal.pone.0133305	http://dx.doi.org/10.1371/journal.pone.0133305			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208357	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000077
J	Yuan, S; Lei, F; Liu, ZF; Tong, QP; Si, T; Xu, RX				Yuan, Shuai; Lei, Fan; Liu, Zhongfa; Tong, Qingping; Si, Ting; Xu, Ronald X.			Coaxial Electrospray of Curcumin-Loaded Microparticles for Sustained Drug Release	PLOS ONE			English	Article							PLGA NANOPARTICLES; ENCAPSULATION; MICROSPHERES; ANGIOGENESIS; PARTICLES; PROTEINS; DELIVERY; JETS	Curcumin exhibits superior anti-inflammatory, antiseptic and analgesic activities without significant side effects. However, clinical dissemination of this natural medicine is limited by its low solubility and poor bio-availability. To overcome this limitation, we propose to encapsulate curcumin in poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) by an improved coaxial electrospray (CES) process. This process is able to generate a stable cone-jet mode in a wide range of operation parameters in order to produce curcumin-loaded PLGA MPs with a clear core-shell structure and a designated size of several micrometers. In order to optimize the process outcome, the effects of primary operation parameters such as the applied electric voltages and the liquid flow rates are studied systemically. In vitro drug release experiments are also carried out for the CES-produced MPs in comparison with those by a single axial electrospray process. Our experimental results show that the CES process can be effectively controlled to encapsulate drugs of low aqueous solubility for high encapsulation efficiency and optimal drug release profiles.	[Yuan, Shuai; Xu, Ronald X.] Univ Sci & Technol China, Dept Precis Machinery & Precis Instrumentat, Hefei 230027, Anhui, Peoples R China; [Lei, Fan; Si, Ting] Univ Sci & Technol China, Dept Modern Mech, Hefei 230027, Anhui, Peoples R China; [Liu, Zhongfa] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Tong, Qingping] 105th Hosp PLA, Dept Ultrasound, Hefei 230031, Anhui, Peoples R China; [Si, Ting; Xu, Ronald X.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Si, T (corresponding author), Univ Sci & Technol China, Dept Modern Mech, Hefei 230027, Anhui, Peoples R China.	tsi@ustc.edu.cn; xu.202@osu.edu	Si, Ting/D-9203-2018	Si, Ting/0000-0001-9071-8646	National Natural Science Foundation of China [11472270, 81327803]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is partially supported by the National Natural Science Foundation of China (11472270, 81327803) and the Fundamental Research Funds for the Central Universities.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Almeria B, 2010, J COLLOID INTERF SCI, V343, P125, DOI 10.1016/j.jcis.2009.10.002; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Chan JM, 2009, BIOMATERIALS, V30, P1627, DOI 10.1016/j.biomaterials.2008.12.013; Cohen-Sela E, 2009, J CONTROL RELEASE, V133, P90, DOI 10.1016/j.jconrel.2008.09.073; Ho ML, 2008, J CONTROL RELEASE, V128, P142, DOI 10.1016/j.jconrel.2008.02.012; Ji JL, 2012, ANTI-CANCER AGENT ME, V12, P210, DOI 10.2174/187152012800228733; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lee YH, 2010, J CONTROL RELEASE, V145, P58, DOI 10.1016/j.jconrel.2010.03.014; Li F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036304; Li L, 2007, MOL CANCER THER, V6, P1276, DOI 10.1158/1535-7163.MCT-06-0556; Lopez-Herrera JM, 2003, J AEROSOL SCI, V34, P535, DOI 10.1016/S0021-8502(03)00021-1; Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595; Nath SD, 2013, INT J PHARMACEUT, V443, P87, DOI 10.1016/j.ijpharm.2012.12.037; Nie HM, 2010, J BIOMED MATER RES A, V95A, P709, DOI 10.1002/jbm.a.32867; Sato M, 2009, IEEE T DIELECT EL IN, V16, P320, DOI 10.1109/TDEI.2009.4815159; Si T, 2015, MICROFLUID NANOFLUID, V18, P967, DOI 10.1007/s10404-014-1486-8; Si T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.075003; Sou K, 2008, INT J PHARM, V352, P287, DOI 10.1016/j.ijpharm.2007.10.033; Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769; Wichitnithad W, 2009, PHYTOCHEM ANALYSIS, V20, P314, DOI 10.1002/pca.1129; Xie JW, 2008, J COLLOID INTERF SCI, V317, P469, DOI 10.1016/j.jcis.2007.09.082; Xie JW, 2007, BIOTECHNOL BIOENG, V97, P1278, DOI 10.1002/bit.21334; Xu RX, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548878; Yao J, 2008, J AEROSOL SCI, V39, P987, DOI 10.1016/j.jaerosci.2008.07.003; Zhang LL, 2012, EXPERT REV MED DEVIC, V9, P595, DOI [10.1586/erd.12.58, 10.1586/ERD.12.58]; Zhu ZQ, 2015, LAB CHIP, V15, P646, DOI 10.1039/c4lc01032a	27	43	47	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132609	10.1371/journal.pone.0132609	http://dx.doi.org/10.1371/journal.pone.0132609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208167	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000035
J	Al-Marzooq, F; Yusof, MYM; Tay, ST				Al-Marzooq, Farah; Yusof, Mohd Yasim Mohd; Tay, Sun Tee			Molecular Analysis of Antibiotic Resistance Determinants and Plasmids in Malaysian Isolates of Multidrug Resistant Klebsiella pneumoniae	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI; INCF PLASMIDS; GENETIC ENVIRONMENTS; DIVERSE CLONES; ENTEROBACTERIACEAE; BLA(CTX-M-15); HYPERPRODUCTION; IDENTIFICATION; DISSEMINATION	Infections caused by multidrug resistant Klebsiella pneumoniae have been increasingly reported in many parts of the world. A total of 93 Malaysian multidrug resistant K. pneumoniae isolated from patients attending to University of Malaya Medical Center, Kuala Lumpur, Malaysia from 2010-2012 were investigated for antibiotic resistance determinants including extended-spectrum beta-lactamases (ESBLs), aminoglycoside and trimethoprim/sulfamethoxazole resistance genes and plasmid replicons. CTX-M-15 (91.3%) was the predominant ESBL gene detected in this study. aacC2 gene (67.7%) was the most common gene detected in aminoglycoside-resistant isolates. Trimethoprim/sulfamethoxazole resistance (90.3%) was attributed to the presence of sul1 (53.8%) and dfrA (59.1%) genes in the isolates. Multiple plasmid replicons (1-4) were detected in 95.7% of the isolates. FIIK was the dominant replicon detected together with 13 other types of plasmid replicons. Conjugative plasmids (1-3 plasmids of similar to 3-100 kb) were obtained from 27 of 43 K. pneumoniae isolates. An ESBL gene (either CTX-M-15, CTX-M-3 or SHV-12) was detected from each transconjugant. Co-detection with at least one of other antibiotic resistance determinants [sul1, dfrA, aacC2, aac(60)-Ib, aac(60)-Ib-cr and qnrB] was noted in most conjugative plasmids. The transconjugants were resistant to multiple antibiotics including beta-lactams, gentamicin and cotrimoxazole, but not ciprofloxacin. This is the first study describing the characterization of plasmids circulating in Malaysian multidrug resistant K. pneumoniae isolates. The results of this study suggest the diffusion of highly diverse plasmids with multiple antibiotic resistance determinants among the Malaysian isolates. Effective infection control measures and antibiotic stewardship programs should be adopted to limit the spread of the multidrug resistant bacteria in healthcare settings.	[Al-Marzooq, Farah; Yusof, Mohd Yasim Mohd; Tay, Sun Tee] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya	Tay, ST (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	tayst@um.edu.my	Ha, Dat Thinh/D-4995-2015; Tay, Sun Tee/N-2295-2019	Ha, Dat Thinh/0000-0003-4260-4876; Tay, Sun Tee/0000-0002-3120-6998; Al-Marzooq, Farah/0000-0001-5711-6264	University of Malaya [PV037-2012A]; HIR-MOHE [E000013-20001]	University of Malaya(Universiti Malaya); HIR-MOHE	This study was supported by University of Malaya postgraduate grant (PV037-2012A) (STT, FA), and HIR-MOHE E000013-20001 (subprogramme 4) grant (STT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marzooq F, 2015, INT J ANTIMICROBIAL; Al-Marzooq F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/601630; Al-Marzooq F, 2013, JPN J INFECT DIS, V66, P555, DOI 10.7883/yoken.66.555; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P53, DOI 10.1111/j.1469-0691.2007.01849.x; Canton R, 2003, CURR OPIN INFECT DIS, V16, P315, DOI 10.1097/00001432-200308000-00003; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2006, EMERG INFECT DIS, V12, P1145, DOI 10.3201/eid1207.051555; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Carattoli A, 2010, J ANTIMICROB CHEMOTH, V65, P2070, DOI 10.1093/jac/dkq269; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chen IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065621; Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI S; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; Coelho A, 2009, J ANTIMICROB CHEMOTH, V64, P862, DOI 10.1093/jac/dkp264; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Daxboeck F, 2006, J HOSP INFECT, V62, P214, DOI 10.1016/j.jhin.2005.07.009; Diestra K, 2009, J ANTIMICROB CHEMOTH, V63, P60, DOI 10.1093/jac/dkn453; Dolejska M, 2013, ANTIMICROB AGENTS CH, V57, P1073, DOI 10.1128/AAC.01886-12; Dolejska M, 2012, INT J ANTIMICROB AG, V40, P510, DOI 10.1016/j.ijantimicag.2012.07.016; Du JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095181; Fevre C, 2005, ANTIMICROB AGENTS CH, V49, P5149, DOI 10.1128/AAC.49.12.5149-5152.2005; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Harajly M, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-19; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Heritage J, 1999, J ANTIMICROB CHEMOTH, V44, P309, DOI 10.1093/jac/44.3.309; Ho PL, 2010, J MED MICROBIOL, V59, P702, DOI 10.1099/jmm.0.015032-0; Huang XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040360; Huovinen P, 2001, CLIN INFECT DIS, V32, P1608, DOI 10.1086/320532; Jacoby GA, 1996, J CLIN MICROBIOL, V34, P908, DOI 10.1128/JCM.34.4.908-911.1996; Jones LA, 2005, ANTIMICROB AGENTS CH, V49, P794, DOI 10.1128/AAC.49.2.794-797.2005; Kim YT, 2006, J MICROBIOL BIOTECHN, V16, P889; Kor SB, 2013, J MED MICROBIOL, V62, P412, DOI 10.1099/jmm.0.053645-0; Lai CC, 2014, J GLOB ANTIMICROB RE, V2, P141, DOI 10.1016/j.jgar.2014.02.007; Lee MY, 2011, INT J ANTIMICROB AG, V38, P160, DOI 10.1016/j.ijantimicag.2011.03.020; Li B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042280; Lim KT, 2009, J MED MICROBIOL, V58, P1463, DOI 10.1099/jmm.0.011114-0; Lister PD, 2000, PHARMACOTHERAPY, V20, p213S, DOI 10.1592/phco.20.14.213S.35045; Lu PL, 2012, INT J ANTIMICROB AG, V40, pS37, DOI 10.1016/S0924-8579(12)70008-0; Ma L, 2009, ANTIMICROB AGENTS CH, V53, P104, DOI 10.1128/AAC.00852-08; Markovska R, 2008, MICROB DRUG RESIST, V14, P119, DOI 10.1089/mdr.2008.0814; Mataseje LF, 2011, J ANTIMICROB CHEMOTH, V66, P1273, DOI 10.1093/jac/dkr092; Mendonca N, 2009, INT J ANTIMICROB AG, V34, P29, DOI 10.1016/j.ijantimicag.2008.11.014; Palasubramaniam S, 2005, INT J INFECT DIS, V9, P170, DOI 10.1016/j.ijid.2004.07.005; Palasubramaniam S, 2007, MICROB DRUG RESIST, V13, P186, DOI 10.1089/mdr.2007.726; Palasubramaniam S, 2009, J MICROBIOL IMMUNOL, V42, P129; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6029, DOI 10.1128/AAC.01189-12; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Pornruangwong S, 2011, FOODBORNE PATHOG DIS, V8, P203, DOI 10.1089/fpd.2010.0626; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Roy S, 2013, INDIAN J MED RES, V137, P791; Ruiz E, 2012, J ANTIMICROB CHEMOTH, V67, P886, DOI 10.1093/jac/dkr548; Ryoo NH, 2005, J ANTIMICROB CHEMOTH, V56, P698, DOI 10.1093/jac/dki324; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Shin J, 2012, J ANTIMICROB CHEMOTH, V67, P1853, DOI 10.1093/jac/dks143; Tarnberg M, 2009, MOL CELL PROBE, V23, P195, DOI 10.1016/j.mcp.2009.01.005; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; Villa L, 2009, HIGH THROUGHPUT DNA; Villa L, 2012, J ANTIMICROB CHEMOTH, V67, P1645, DOI 10.1093/jac/dks114; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Voets GM, 2011, INT J ANTIMICROB AG, V37, P356, DOI 10.1016/j.ijantimicag.2011.01.005; Wu PJ, 1995, J ANTIMICROB CHEMOTH, V36, P927, DOI 10.1093/jac/36.6.927; Xiang XQ, 1997, J ANTIMICROB CHEMOTH, V40, P525, DOI 10.1093/jac/40.4.525; Younes A, 2011, J ANTIMICROB CHEMOTH, V66, P313, DOI 10.1093/jac/dkq453; Yu FY, 2009, DIAGN MICR INFEC DIS, V64, P57, DOI 10.1016/j.diagmicrobio.2009.01.020; Zhuo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052222	73	40	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133654	10.1371/journal.pone.0133654	http://dx.doi.org/10.1371/journal.pone.0133654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203651	Green Submitted, gold, Green Published			2022-12-26	WOS:000358621000035
J	Leikfoss, IS; Keshari, PK; Gustavsen, MW; Bjolgerud, A; Brorson, IS; Celius, EG; Spurkland, A; Bos, SD; Harbo, HF; Berge, T				Leikfoss, Ingvild S.; Keshari, Pankaj K.; Gustavsen, Marte W.; Bjolgerud, Anja; Brorson, Ina S.; Celius, Elisabeth G.; Spurkland, Anne; Bos, Steffan D.; Harbo, Hanne F.; Berge, Tone			Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+T Cells	PLOS ONE			English	Article							GENE-EXPRESSION; RHEUMATOID-ARTHRITIS; CIITA; SUSCEPTIBILITY; ASSOCIATION; IDENTIFICATION; POLYMORPHISMS; INFLAMMATION; EPIGENETICS; MECHANISMS	For multiple sclerosis, genome wide association studies and follow up studies have identified susceptibility single nucleotide polymorphisms located in or near CLEC16A at chromosome 16p13.13, encompassing among others CIITA, DEXI and SOCS1 in addition to CLEC16A. These genetic variants are located in intronic or intergenic regions and display strong linkage disequilibrium with each other, complicating the understanding of their functional contribution and the identification of the direct causal variant(s). Previous studies have shown that multiple sclerosis-associated risk variants in CLEC16A act as expression quantitative trait loci for CLEC16A itself in human pancreatic beta-cells, for DEXI and SOCS1 in thymic tissue samples, and for DEXI in monocytes and lymphoblastoid cell lines. Since T cells are major players in multiple sclerosis pathogenesis, we have performed expression analyses of the CIITA-DEXI-CLEC16A-SOCS1 gene cluster in CD4+ and CD8+ T cells isolated from multiple sclerosis patients and healthy controls. We observed a higher expression of SOCS1 and CLEC16A in CD4+ T cells in samples homozygous for the risk allele of CLEC16A rs12927355. Pair-wise linear regression analysis revealed high correlation in gene expression in peripheral T cells of CIITA, DEXI, CLEC16A and SOCS1. Our data imply a possible regulatory role for the multiple sclerosis-associated rs12927355 in CLEC16A.	[Leikfoss, Ingvild S.; Keshari, Pankaj K.; Gustavsen, Marte W.; Bjolgerud, Anja; Brorson, Ina S.; Celius, Elisabeth G.; Bos, Steffan D.; Harbo, Hanne F.; Berge, Tone] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Leikfoss, Ingvild S.; Keshari, Pankaj K.; Gustavsen, Marte W.; Bjolgerud, Anja; Brorson, Ina S.; Celius, Elisabeth G.; Bos, Steffan D.; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Spurkland, Anne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Leikfoss, IS (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	i.s.leikfoss@medisin.uio.no	Spurkland, Anne/L-3369-2019; Celius, Elisabeth Gulowsen/S-1387-2019; Bos, Steffan D/L-7896-2016	Spurkland, Anne/0000-0003-4421-0766; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Bos, Steffan D/0000-0002-2975-7520	South-Eastern Norway Regional Health Authority; Norwegian Research Council; Odd Fellow Society; Novartis; Henrik Homans Minde (UNIFOR)	South-Eastern Norway Regional Health Authority; Norwegian Research Council(Research Council of NorwayEuropean Commission); Odd Fellow Society; Novartis(Novartis); Henrik Homans Minde (UNIFOR)	This study has been supported by The South-Eastern Norway Regional Health Authority, the Norwegian Research Council, the Odd Fellow Society, Novartis and Henrik Homans Minde (UNIFOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayarsaihan D, 2011, J DENT RES, V90, P9, DOI 10.1177/0022034510378683; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Berge T, 2013, INT J MOL SCI, V14, P4476, DOI 10.3390/ijms14034476; Bos SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117403; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Davison LJ, 2012, HUM MOL GENET, V21, P322, DOI 10.1093/hmg/ddr468; De Santis M, 2012, CLIN REV ALLERG IMMU, V42, P92, DOI 10.1007/s12016-011-8293-8; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Disanto G, 2014, HUM MOL GENET, V23, P942, DOI 10.1093/hmg/ddt489; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Edgar AJ, 2001, AM J RESP CELL MOL, V25, P119, DOI 10.1165/ajrcmb.25.1.4417; Eike MC, 2012, GENES IMMUN, V13, P431, DOI 10.1038/gene.2012.11; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Fowden AL, 2009, EXP PHYSIOL, V94, P607, DOI 10.1113/expphysiol.2008.046359; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Genome UCSC, UCSC GEN BROWS 2002; Gyllenberg A, 2014, GENES IMMUN, V15, P162, DOI 10.1038/gene.2013.71; Gyllenberg A, 2012, GENES IMMUN, V13, P632, DOI 10.1038/gene.2012.44; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Kim S, 2012, P NATL ACAD SCI USA, V109, pE1072, DOI 10.1073/pnas.1120320109; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; KOLMEL HW, 1988, J NEUROIMMUNOL, V20, P229, DOI 10.1016/0165-5728(88)90164-6; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Leikfoss IS, 2013, GENES IMMUN, V14, P62, DOI 10.1038/gene.2012.52; Li J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7804; de Lapuente AL, 2015, MULT SCLER J, V21, P1498, DOI 10.1177/1352458514566418; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mero IL, 2011, GENES IMMUN, V12, P191, DOI 10.1038/gene.2010.59; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; O'Gorman C, 2012, INT J MOL SCI, V13, P11718, DOI 10.3390/ijms130911718; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schuster C, 2015, IMMUNITY, V42, P942, DOI 10.1016/j.immuni.2015.04.011; Skinningsrud B, 2008, J CLIN ENDOCR METAB, V93, P3310, DOI 10.1210/jc.2008-0821; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tomlinson MJ, 2014, DIABETES, V63, P4360, DOI 10.2337/db13-1785; van Luijn MM, 2015, BRAIN, V138, P1531, DOI 10.1093/brain/awv080; Vandenbroeck K, 2012, GENES IMMUN, V13, P21, DOI 10.1038/gene.2011.44; Zuvich RL, 2011, HUM MOL GENET, V20, P3517, DOI 10.1093/hmg/ddr250	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132957	10.1371/journal.pone.0132957	http://dx.doi.org/10.1371/journal.pone.0132957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203907	Green Published, gold, Green Submitted			2022-12-26	WOS:000358621000015
J	Murphy, S; Barber, JL; Learmonth, JA; Read, FL; Deaville, R; Perkins, MW; Brownlow, A; Davison, N; Penrose, R; Pierce, GJ; Law, RJ; Jepson, PD				Murphy, Sinead; Barber, Jonathan L.; Learmonth, Jennifer A.; Read, Fiona L.; Deaville, Robert; Perkins, Matthew W.; Brownlow, Andrew; Davison, Nick; Penrose, Rod; Pierce, Graham J.; Law, Robin J.; Jepson, Paul D.			Reproductive Failure in UK Harbour Porpoises Phocoena phocoena: Legacy of Pollutant Exposure?	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; CALIFORNIA SEA LIONS; ENDOCRINE-DISRUPTING CHEMICALS; PERSISTENT ORGANIC POLLUTANTS; ST-LAWRENCE ESTUARY; MINK MUSTELA-VISON; POLYCHLORINATED-BIPHENYLS; ZALOPHUS-CALIFORNIANUS; TURSIOPS-TRUNCATUS; DELPHINUS-DELPHIS	Reproductive failure in mammals due to exposure to polychlorinated biphenyls (PCBs) can occur either through endocrine disrupting effects or via immunosuppression and increased disease risk. To investigate further, full necropsies and determination of summed 25 polychlorinated biphenyls congeners (Sigma PCBs lipid weight) in blubber were undertaken on 329 UK-stranded female harbour porpoises (1990-2012). In sexually mature females, 25/127 (19.7%) showed direct evidence of reproductive failure (foetal death, aborting, dystocia or stillbirth). A further 21/127 (16.5%) had infections of the reproductive tract or tumours of reproductive tract tissues that could contribute to reproductive failure. Resting mature females (non-lactating or non-pregnant) had significantly higher mean Sigma PCBs (18.5 mg/kg) than both lactating (7.5 mg/kg) and pregnant females (6 mg/kg), though not significantly different to sexually immature females (14.0 mg/kg). Using multinomial logistic regression models Sigma PCBs was found to be a significant predictor of mature female reproductive status, adjusting for the effects of confounding variables. Resting females were more likely to have a higher PCB burden. Health status (proxied by "trauma" or "infectious disease" causes of death) was also a significant predictor, with lactating females (i.e. who successfully reproduced) more likely to be in good health status compared to other individuals. Based on contaminant profiles (>11 mg/kg lipid), at least 29/60 (48%) of resting females had not off-loaded their pollutant burden via gestation and primarily lactation. Where data were available, these non-offloading females were previously gravid, which suggests foetal or newborn mortality. Furthermore, a lower pregnancy rate of 50% was estimated for "healthy" females that died of traumatic causes of death, compared to other populations. Whether or not PCBs are part of an underlying mechanism, we used individual PCB burdens to show further evidence of reproductive failure in the North-east Atlantic harbour porpoise population, results that should inform conservation management.	[Murphy, Sinead; Deaville, Robert; Perkins, Matthew W.; Law, Robin J.; Jepson, Paul D.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Barber, Jonathan L.; Law, Robin J.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Learmonth, Jennifer A.; Read, Fiona L.; Pierce, Graham J.] Univ Aberdeen, Oceanlab, Newburgh, Aberdeen, Scotland; [Brownlow, Andrew; Davison, Nick] SRUC Vet Serv Drummondhill, Scottish Marine Anim Stranding Scheme, Inverness, Scotland; [Penrose, Rod] Marine Environm Monitoring, Cardigan, Ceredigion, Wales	Zoological Society of London; Centre for Environment Fisheries & Aquaculture Science; University of Aberdeen	Murphy, S (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	sinead.noirin.murphy@gmail.com	Brownlow, Andrew/ABA-4653-2020; Pierce, Graham/A-5404-2018; Brownlow, Andrew C/P-6593-2018	Brownlow, Andrew/0000-0001-9885-7480; Pierce, Graham/0000-0002-4744-4501; Davison, Nicholas/0000-0001-7286-1836; Murphy, Sinead/0000-0002-3810-6439	Marie Curie International Outgoing Fellowship within the Seventh European Community Framework Programme (Project Cetacean-stressors) [PIOF-GA-2010-276145]; Agreement on the Conservation of Small Cetaceans of the Baltic, North East Atlantic, Irish and North Seas (ASCOBANS) [SSFA/2008, SSFA/ASCOBANS/2010/5]; EC [EVK3-2000-00027]; Marine Scotland; Department for Environment, Food and Rural Affairs (Defra); UK Devolved Administration in Scotland; UK Defra; UK Devolved Administration Wales; Centre for Environment, Fisheries and Aquaculture Science	Marie Curie International Outgoing Fellowship within the Seventh European Community Framework Programme (Project Cetacean-stressors); Agreement on the Conservation of Small Cetaceans of the Baltic, North East Atlantic, Irish and North Seas (ASCOBANS); EC(European CommissionEuropean Commission Joint Research Centre); Marine Scotland; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); UK Devolved Administration in Scotland; UK Defra(Department for Environment, Food & Rural Affairs (DEFRA)); UK Devolved Administration Wales; Centre for Environment, Fisheries and Aquaculture Science	This research was supported by a Marie Curie International Outgoing Fellowship within the Seventh European Community Framework Programme (Project Cetacean-stressors, PIOF-GA-2010-276145 to PDJ and SM). Additional funding was provided through the Agreement on the Conservation of Small Cetaceans of the Baltic, North East Atlantic, Irish and North Seas (ASCOBANS) (Grants SSFA/2008 and SSFA/ASCOBANS/2010/5 to SM). Analysis of Scottish reproductive and teeth samples was funded by the EC-funded BIOCET project (BIOaccumulation of persistent organic pollutants in small CETaceans in European waters: transport pathways and impact on reproduction, grant EVK3-2000-00027 to GJP), and Marine Scotland (GJP). Samples examined in this research were collected under the collaborative Cetacean Strandings Investigation Programme (http://ukstrandings.org/), which is funded by the Department for Environment, Food and Rural Affairs (Defra) and the UK's Devolved Administrations in Scotland and Wales (http://sciencesearch.defra.gov.uk/Default.aspx? Menu=Menu&Module=More&Location= None&Completed=0&ProjectID=15331) (grants to PDJ, RD). UK Defra also funded the chemical analysis under a service-level agreement with the Centre for Environment, Fisheries and Aquaculture Science (grants to RJL, JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISON RF, 1989, CAN J FISH AQUAT SCI, V46, P360, DOI 10.1139/f89-047; Aguilar A., 1999, Journal of Cetacean Research and Management Special Issue, V1, P83; AMAP, 2004, AMAP ASS 2002 PERS O; Backlin BM, 1997, J APPL TOXICOL, V17, P297, DOI 10.1002/(SICI)1099-1263(199709)17:5<297::AID-JAT445>3.0.CO;2-N; Backlin BM, 1998, APMIS, V106, P785, DOI 10.1111/j.1699-0463.1998.tb00225.x; BELAND P, 1993, J GREAT LAKES RES, V19, P766, DOI 10.1016/S0380-1330(93)71264-2; Bergman, 2007, THESIS SWEDISH U AGR; Bergman A, 1999, APMIS, V107, P270, DOI 10.1111/j.1699-0463.1999.tb01554.x; Bergman A., 1985, FINNISH GAME RES, V44, P47; Bignert A, 2012, ECOLOGY ANIMAL HLTH, P73; Bjorge A, 1996, SC47SM7 INT WHAL COM; Borrell A, 2005, B ENVIRON CONTAM TOX, V75, P149, DOI 10.1007/s00128-005-0731-y; BORRELL A, 1995, ENVIRON POLLUT, V88, P283, DOI 10.1016/0269-7491(95)93441-2; BOYD IL, 1991, CAN J ZOOL, V69, P1135, DOI 10.1139/z91-162; Bredhult C, 2008, REPROD TOXICOL, V25, P247, DOI 10.1016/j.reprotox.2007.11.008; Brodie EC, 2006, MAR MAMMAL SCI, V22, P700, DOI 10.1111/j.1748-7692.2006.00045.x; Brodie Paul F., 1995, Reports of the International Whaling Commission Special Issue, V16, P181; Caserta D, 2008, HUM REPROD UPDATE, V14, P59, DOI 10.1093/humupd/dmm025; CLEEN, 2005, EUROPCB INV PCB EN 1; COCKCROFT VG, 1989, S AFR J MARINE SCI, V8, P207, DOI 10.2989/02577618909504562; Deaville R, 2011, CSIP FINAL REPORT PE; DEGUISE S, 1994, J WILDLIFE DIS, V30, P287, DOI 10.7589/0090-3558-30.2.287; DELONG RL, 1973, SCIENCE, V181, P1168, DOI 10.1126/science.181.4105.1168; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Duras-Gomercic M, 2010, 24 C EUR CET SOC 22, P269; EEA, 2012, URBAN ADAPTATION CLI; EEA. European Environment Agency, 2013, HAZ SUBST MAR ORG MA; Field A, 2000, INTRO STAT METHODS S; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Frasier TR, 2013, ECOL EVOL, V3, P3483, DOI 10.1002/ece3.738; Fukushima M, 1981, STUDIES LEVELS ORGAN, P97; GASKIN DE, 1984, REP INT WHAL COMMN, V6, P135; Geraci Joseph R., 1999, P367; Geraci JR, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P546; Gibbens J, 2010, J MAMMAL, V91, P510, DOI 10.1644/08-MAMM-A-377.1; Gulland FMD, 1996, J WILDLIFE DIS, V32, P250, DOI 10.7589/0090-3558-32.2.250; Hall, 2011, THESIS U BRIT COLUMB; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P60, DOI 10.1289/ehp.8053; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; HELLE E, 1976, Ambio, V5, P261; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hickie BE, 2013, ENVIRON SCI TECHNOL, V47, P12314, DOI 10.1021/es403166b; Hohn AA, 1989, THESIS U CALIFORNIA; Hohn AA, 2007, REPROD BIOL PHYLOGEN, V7, P371; Houde M, 2005, REV ENVIRON CONTAM T, V184, P1, DOI 10.1007/0-387-27565-7_1; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; Jauniaux TP, 2010, EMERG INFECT DIS, V16, P1966, DOI 10.3201/eid1612.101008; Jepson PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060953; Jepson PD, 2005, ENVIRON TOXICOL CHEM, V24, P238, DOI 10.1897/03-663.1; Jepson PD, TOXIC LEGACY S UNPUB; JEPSON PD, 2003, THESIS U LONDON; Kannan K, 2000, HUM ECOL RISK ASSESS, V6, P181, DOI 10.1080/10807030091124491; KANNAN K, 1993, ARCH ENVIRON CON TOX, V25, P227, DOI 10.1007/BF00212134; King DP, 2002, VET MICROBIOL, V86, P131, DOI 10.1016/S0378-1135(01)00497-7; Kuiken T., 1991, ECS NEWSLETT, V17, P1; LACAVE G, 1991, Aquatic Mammals, V17, P37; Law RJ, 2012, MAR POLLUT BULL, V64, P1485, DOI 10.1016/j.marpolbul.2012.05.024; Le Boeuf Burney J, 2002, BMC Ecol, V2, P11, DOI 10.1186/1472-6785-2-11; Learmonth JA, 2014, MAR MAMMAL SCI, V30, P1427, DOI 10.1111/mms.12130; Letcher RJ, 2010, SCI TOTAL ENVIRON, V408, P2995, DOI 10.1016/j.scitotenv.2009.10.038; Lipscomb TP, 2000, VET PATHOL, V37, P609, DOI 10.1354/vp.37-6-609; Lockyer C., 2003, HARBOUR PORPOISES N, V5, P71; Lockyer CH., 1995, REV FACTORS INVOLVED; Lockyer Christina, 1995, V16, P189; MARTINEAU D, 1987, ARCH ENVIRON CON TOX, V16, P137, DOI 10.1007/BF01055795; MARTINEAU D, 1994, SCI TOTAL ENVIRON, V154, P201, DOI 10.1016/0048-9697(94)90088-4; MARTINEAU D, 2002, ENV HLTH PERSPECT, V110, P1; McKenzie J, 2005, J MAMMAL, V86, P1237, DOI 10.1644/05-MAMM-A-085R.1; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1010, DOI 10.1289/ehp.1002922; Mendes JJA, 2002, FOOD CHEM TOXICOL, V40, P781, DOI 10.1016/S0278-6915(02)00018-2; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; Munson L, 1998, J WILDLIFE DIS, V34, P656, DOI 10.7589/0090-3558-34.3.656; Murphy S., 2008, MF0736 UK DEP ENV FO; Murphy S., 2010, J NORTHWEST ATL FISH, V42, P153, DOI [10.2960/J.v42.m658, DOI 10.2960/J.V42.M658]; Murphy S, 2012, IWC64SCMRED1 ICES WG; Murphy S, 2013, OCEANOGR MAR BIOL, V51, P193; Murphy S, 2009, MAR ECOL PROG SER, V388, P273, DOI 10.3354/meps08129; Nakamura K, 2008, J ASSIST REPROD GEN, V25, P47, DOI 10.1007/s10815-008-9206-5; Neimanis AS, 2000, J ZOOL, V250, P221, DOI 10.1111/j.1469-7998.2000.tb01072.x; Newman SJ, 2006, VET PATHOL, V43, P865, DOI 10.1354/vp.43-6-865; O'Shea TJ, 1998, MAR POLLUT BULL, V36, P159, DOI 10.1016/S0025-326X(97)00102-1; Olafsdottir D., 2003, NAMMCO Scientific Publications, V5, P195; OLSSON M, 1994, SCI TOTAL ENVIRON, V154, P217, DOI 10.1016/0048-9697(94)90089-2; Padmanabhan V, 2010, INT J ANDROL, V33, P394, DOI 10.1111/j.1365-2605.2009.01024.x; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P1; Pierce GJ, 2008, ENVIRON POLLUT, V153, P401, DOI 10.1016/j.envpol.2007.08.019; Polacheck T, 1995, BIOL PHOCOENIDS, P169; READ AJ, 1995, MAR MAMMAL SCI, V11, P423, DOI 10.1111/j.1748-7692.1995.tb00667.x; READ AJ, 1990, CAN J FISH AQUAT SCI, V47, P561, DOI 10.1139/f90-064; READ AJ, 1990, CAN J FISH AQUAT SCI, V47, P2158, DOI 10.1139/f90-240; Read AJ, 1997, CAN J ZOOL, V75, P122, DOI 10.1139/z97-016; Reijnders PJH, 2003, N P TOX ENV, P55; REIJNDERS PJH, 1986, NATURE, V324, P456, DOI 10.1038/324456a0; Richardson SF, 1992, THESIS MEMORIAL U NE; Rolland, 2001, 0116 NE FISH SCI CTR; Saltzman W, 2010, ENCY APPL ANIMAL BEH, P522; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schwacke LH, 2002, ENVIRON TOXICOL CHEM, V21, P2752, DOI 10.1897/1551-5028(2002)021<2752:PRAORE>2.0.CO;2; Seibel H, 2012, DIS AQUAT ORGAN, V99, P79, DOI 10.3354/dao02449; Sharp SM, 2014, MAR MAMMAL SCI, V30, P864, DOI 10.1111/mms.12093; Siebert U, 2009, J APPL MICROBIOL, V106, P329, DOI 10.1111/j.1365-2672.2008.04006.x; Siebert U, 2006, J COMP PATHOL, V134, P134, DOI 10.1016/j.jcpa.2005.09.002; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; SORENSEN TB, 1994, OPHELIA, V39, P159, DOI 10.1080/00785326.1994.10429541; Steinberg RM, 2008, BIOL REPROD, V78, P1091, DOI 10.1095/biolreprod.107.067249; Stockley P., 2003, P ROYAL SOC LONDON B, V270; Toft G, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-22; Tregenza NJC, 1997, ICES J MAR SCI, V54, P896, DOI 10.1006/jmsc.1996.0212; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; Vafeiadi M, 2014, ENVIRON INT, V64, P116, DOI 10.1016/j.envint.2013.12.015; Van Bressem MF, 1999, VET REC, V144, P592, DOI 10.1136/vr.144.21.592; Vinther Morten, 2004, Journal of Cetacean Research and Management, V6, P19; Viquerat S, 2014, MAR BIOL, V161, P745, DOI 10.1007/s00227-013-2374-6; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176; Ward EJ, 2009, J APPL ECOL, V46, P632, DOI 10.1111/j.1365-2664.2009.01647.x; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; Wells RS, 2005, SCI TOTAL ENVIRON, V349, P106, DOI 10.1016/j.scitotenv.2005.01.010; Wells RS, 2014, FLORIDA AQUATIC MAMM, V40, P252, DOI DOI 10.1578/; Williams R, 2013, ICES J MAR SCI, V70, P1273, DOI 10.1093/icesjms/fst059; Ylitalo GM, 2005, MAR POLLUT BULL, V50, P30, DOI 10.1016/j.marpolbul.2004.08.005; Yordy JE, 2010, SCI TOTAL ENVIRON, V408, P2163, DOI 10.1016/j.scitotenv.2010.01.032	121	72	75	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131085	10.1371/journal.pone.0131085	http://dx.doi.org/10.1371/journal.pone.0131085			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200456	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100011
J	Orban, LL; Chartier, S				Orban, Levente L.; Chartier, Sylvain			Unsupervised Neural Network Quantifies the Cost of Visual Information Processing	PLOS ONE			English	Article							1ST FIND FLOWERS; INNATE PREFERENCE; METABOLIC COST; BUMBLEBEES; SYMMETRY; ACUITY; COLOR; SELECTION; VISION; TIME	Untrained, "flower-naive" bumblebees display behavioural preferences when presented with visual properties such as colour, symmetry, spatial frequency and others. Two unsupervised neural networks were implemented to understand the extent to which these models capture elements of bumblebees' unlearned visual preferences towards flower-like visual properties. The computational models, which are variants of Independent Component Analysis and Feature-Extracting Bidirectional Associative Memory, use images of test-patterns that are identical to ones used in behavioural studies. Each model works by decomposing images of floral patterns into meaningful underlying factors. We reconstruct the original floral image using the components and compare the quality of the reconstructed image to the original image. Independent Component Analysis matches behavioural results substantially better across several visual properties. These results are interpreted to support a hypothesis that the temporal and energetic costs of information processing by pollinators served as a selective pressure on floral displays: flowers adapted to pollinators' cognitive constraints.	[Orban, Levente L.; Chartier, Sylvain] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Orban, LL (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada.	llo@kpu.ca		Chartier, Sylvain/0000-0003-1952-2303	Natural Sciences and Engineering Research Council of the Government of Canada	Natural Sciences and Engineering Research Council of the Government of Canada	A grant from the Natural Sciences and Engineering Research Council of the Government of Canada funded SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2002, PROCEEDINGS OF THE 6TH JOINT CONFERENCE ON INFORMATION SCIENCES, P824; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bingham E, 2000, Int J Neural Syst, V10, P1, DOI 10.1142/S0129065700000028; BRODBECK DR, 1995, J EXP PSYCHOL ANIM B, V21, P64, DOI 10.1037/0097-7403.21.1.64; Buss D.M., 2005, HDB EVOLUTIONARY PSY; Chartier S, 2007, IEEE IJCNN, P1679, DOI 10.1109/IJCNN.2007.4371210; Chartier S, 2009, NEURAL NETWORKS, V22, P568, DOI 10.1016/j.neunet.2009.06.011; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Eldar YC, 2003, IEEE T INFORM THEORY, V49, P1846, DOI 10.1109/TIT.2003.813507; ENQUIST M, 1993, NATURE, V361, P446, DOI 10.1038/361446a0; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; Enquist M, 1997, P ROY SOC B-BIOL SCI, V264, P1345, DOI 10.1098/rspb.1997.0186; Fitzpatrick DC, 2000, J NEUROSCI, V20, P1605; Forrest J, 2009, NATURWISSENSCHAFTEN, V96, P921, DOI 10.1007/s00114-009-0549-2; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; Huynh-Thu Q, 2008, ELECTRON LETT, V44, P800, DOI 10.1049/el:20080522; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; JOHNSTONE RA, 1994, NATURE, V372, P172, DOI 10.1038/372172a0; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; KOSKO B, 1988, IEEE T SYST MAN CYB, V18, P49, DOI 10.1109/21.87054; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Langlois D, 2010, TUTOR QUANT METHODS, V6, P31, DOI 10.20982/tqmp.06.1.p031; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LEHRER M, 1995, PHILOS T R SOC B, V347, P123, DOI DOI 10.1098/rstb.1995.0017; Leonard AS, 2011, FUNCT ECOL, V25, P1293, DOI 10.1111/j.1365-2435.2011.01885.x; Levin R, 2011, WORK MEETS LIFE; Liu XW, 2003, J OPT SOC AM A, V20, P1271, DOI 10.1364/JOSAA.20.001271; Luo JB, 2005, PATTERN RECOGN, V38, P1507, DOI 10.1016/j.patcog.2005.02.015; Macuda T, 2001, J EXP BIOL, V204, P559; MANNING AUBREY, 1956, BEHAVIOUR, V9, P114, DOI 10.1163/156853956X00273; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Orban L.L., 2013, 21 P EUR S NEUR NETW, P149; Orban LL, 2014, JOVE-J VIS EXP, DOI 10.3791/52033; Orban LL, 2013, NATURWISSENSCHAFTEN, V100, P621, DOI 10.1007/s00114-013-1059-9; Orban LL, 2015, J COMP PSY; Orban LL, 2014, BEHAV STUDIES COMPUT; Plowright CMS, 2011, LEARN MOTIV, V42, P76, DOI 10.1016/j.lmot.2010.08.009; Plowright CMS, 2006, LEARN MOTIV, V37, P66, DOI 10.1016/j.lmot.2005.03.002; Rodriguez I, 2004, NATURWISSENSCHAFTEN, V91, P374, DOI 10.1007/s00114-004-0537-5; Simonds V, 2004, ANIM BEHAV, V67, P379, DOI 10.1016/j.anbehav.2003.03.020; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081	46	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132218	10.1371/journal.pone.0132218	http://dx.doi.org/10.1371/journal.pone.0132218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200767	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100029
J	Sorensen, MV; Dal Zotto, M; Rho, HS; Herranz, M; Sanchez, N; Pardos, F; Yamasaki, H				Sorensen, Martin V.; Dal Zotto, Matteo; Rho, Hyun Soo; Herranz, Maria; Sanchez, Nuria; Pardos, Fernando; Yamasaki, Hiroshi			Phylogeny of Kinorhyncha Based on Morphology and Two Molecular Loci	PLOS ONE			English	Article							RIBOSOMAL DNA-SEQUENCES; SP NOV.-A; ECHINODERES KINORHYNCHA; POSTEMBRYONIC DEVELOPMENT; RNA GENE; DEEP-SEA; CYCLORHAGIDA; REDESCRIPTION; ANTYGOMONAS; PHYLUM	The phylogeny of Kinorhyncha was analyzed using morphology and the molecular loci 18S rRNA and 28S rRNA. The different datasets were analyzed separately and in combination, using maximum likelihood and Bayesian Inference. Bayesian inference of molecular sequence data in combination with morphology supported the division of Kinorhyncha into two major clades: Cyclorhagida comb. nov. and Allomalorhagida nom. nov. The latter clade represents a new kinorhynch class, and accommodates Dracoderes, Franciscideres, a yet undescribed genus which is closely related with Franciscideres, and the traditional homalorhagid genera. Homalorhagid monophyly was not supported by any analyses with molecular sequence data included. Analysis of the combined molecular and morphological data furthermore supported a cyclorhagid clade which included all traditional cyclorhagid taxa, except Dracoderes that no longer should be considered a cyclorhagid genus. Accordingly, Cyclorhagida is divided into three main lineages: Echinoderidae, Campyloderidae, and a large clade, 'Kentrorhagata', which except for species of Campyloderes, includes all species with a midterminal spine present in adult individuals. Maximum likelihood analysis of the combined datasets produced a rather unresolved tree that was not regarded in the following discussion. Results of the analyses with only molecular sequence data included were incongruent at different points. However, common for all analyses was the support of several major clades, i.e., Campyloderidae, Kentrorhagata, Echinoderidae, Dracoderidae, Pycnophyidae, and a clade with Paracentrophyes+ New Genus and Franciscideres(in those analyses where the latter was included). All molecular analyses including 18S rRNA sequence data furthermore supported monophyly of Allomalorhagida. Cyclorhagid monophyly was only supported in analyses of combined 18S rRNA and 28S rRNA (both ML and BI), and only in a restricted dataset where taxa with incomplete information from 28S rRNA had been omitted. Analysis of the morphological data produced results that were similar with those from the combined molecular and morphological analysis. E.g., the morphological data also supported exclusion of Dracoderes from Cyclorhagida. The main differences between the morphological analysis and analyses based on the combined datasets include: 1) Homalorhagida appears as monophyletic in the morphological tree only, 2) the morphological analyses position Franciscideres and the new genus within Cyclorhagida near Zelinkaderidae and Cateriidae, whereas analyses including molecular data place the two genera inside Allomalorhagida, and 3) species of Campyloderes appear in a basal trichotomy within Kentrorhagata in the morphological tree, whereas analysis of the combined datasets places species of Campyloderes as a sister clade to Echinoderidae and Kentrorhagata.	[Sorensen, Martin V.] Univ Copenhagen, Nat Hist Museum Denmark, Sect GeoGenet, Copenhagen, Denmark; [Dal Zotto, Matteo] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Rho, Hyun Soo] Korean Inst Ocean Sci & Technol, Dokdo Res Ctr, Uljin, South Korea; [Herranz, Maria; Sanchez, Nuria; Pardos, Fernando] Univ Complutense Madrid, Dept Zool & Anthropol, Madrid, Spain; [Yamasaki, Hiroshi] Univ Ryukyus, Dept Chem Biol & Marine Sci, Okinawa, Japan	University of Copenhagen; Universita di Modena e Reggio Emilia; Complutense University of Madrid; University of the Ryukyus	Sorensen, MV (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Sect GeoGenet, Copenhagen, Denmark.	mvsorensen@snm.ku.dk	Herranz, Maria/J-8042-2014; MARTINEZ, FERNANDO PARDOS/I-5218-2017; Yamasaki, Hiroshi/I-8585-2018; Pardos, Fernando/GNP-2750-2022; Sørensen, Martin V/A-8852-2013; Herranz, Maria/AAT-6007-2020	Herranz, Maria/0000-0002-3020-6072; MARTINEZ, FERNANDO PARDOS/0000-0002-6292-9793; Yamasaki, Hiroshi/0000-0002-0282-982X; Sørensen, Martin V/0000-0002-0377-0276; Herranz, Maria/0000-0002-3020-6072; SANCHEZ, NURIA/0000-0003-4908-8755; Dal Zotto, Matteo/0000-0003-1386-7626	Danish Council for Independent Research \ Natural Sciences [21-04-0331]; Carlsberg Foundation [2011_01_0048, 2013-01-0035]; Korean Institute of Ocean Science and Technology [PE99318, PO01135]; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics from the University of the Ryukyus; grant for cultivation of young scientists from the Research Institute of Marine Invertebrate; Spanish Ministry of Science and Technology [CGL 2009-08928]; Association of European Marine Biological Laboratories	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); Korean Institute of Ocean Science and Technology; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics from the University of the Ryukyus; grant for cultivation of young scientists from the Research Institute of Marine Invertebrate; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Association of European Marine Biological Laboratories(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Danish Council for Independent Research vertical bar Natural Sciences (http://ufm.dk/en Grant no: 21-04-0331 to MVS-collecting and sequencing of specimens), The Carlsberg Foundation (http://www.carlsbergfondet.dk/ Grants no: 2011_01_0048 and 2013-01-0035 to MVS-collecting and sequencing of specimens), Korean Institute of Ocean Science and Technology (http://eng.kiost.ac/kordi_eng/main/ Grant no. PE99318 and PO01135 to HSR-collecting and sequencing of specimens), "International Research Hub Project for Climate Change and Coral Reef/Island Dynamics from the University of the Ryukyus" and "grant for cultivation of young scientists from the Research Institute of Marine Invertebrate" (to HY-collecting and sequencing of specimens), Spanish Ministry of Science and Technology (http://www.csic.es/ Grant no CGL 2009-08928 to FP-collecting of specimens), and Association of European Marine Biological Laboratories (http://www.assemblemarine.org/access-rules/ to FP, MH, and NS-collecting of specimens).	Adrianov AV, 2002, ZOOL SCI, V19, P463, DOI 10.2108/zsj.19.463; Adrianov AV, 2002, P BIOL SOC WASH, V115, P205; Adrianov AV, 1996, ZOOSYST ROSS, V4, P23; Adrianov AV, 1999, CEPHALORHYNCHA WORLD; Altenburger A, 2015, ZOOL STUD IN PRESS; Bauer-Nebelsick Monika, 1995, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V97, P57; Borner J, 2014, MOL PHYLOGENET EVOL, V80, P79, DOI 10.1016/j.ympev.2014.08.001; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Claparede ARE, 1863, KENNTNIS GATTUNG ECH; Dal Zotto M, 2015, MAR BIOL RES, V11, P689, DOI 10.1080/17451000.2015.1007872; Dal Zotto M, 2013, SYST BIODIVERS, V11, P303, DOI 10.1080/14772000.2013.819045; Dujardin F., 1851, ANN SCI NAT ZOOL SE, V3, P158; Gerlach S. A., 1956, Kieler Meeresforschungen, V12, P120; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Goloboff P.A., 2003, TREE ANAL USING NEW; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Herranz M, 2013, ZOOL ANZ, V253, P93, DOI 10.1016/j.jcz.2013.09.005; Herranz M, 2012, ZOOL ANZ, V251, P161, DOI 10.1016/j.jcz.2011.08.004; HIGGINS R P, 1969, Proceedings of the Biological Society of Washington, V82, P113; Higgins R. P., 1969, Smithsonian Contributions to Zoology, VNo. 14, P1; Higgins R.P., 1977, Smithsonian Contributions to Zoology, VNo. 248, P1; Higgins R.P., 1990, SMITHSON CONTR ZOOL, V500, P1, DOI DOI 10.5479/SI.00810282.500; HIGGINS ROBERT P., 1964, BULL MAR SCI GULF CARIBBEAN, V14, P479; HIGGINS RP, 1978, T AM MICROSC SOC, V97, P171, DOI 10.2307/3225589; HIGGINS RP, 1977, T AM MICROSC SOC, V96, P340, DOI 10.2307/3225864; HIGGINS RP, 1968, T AM MICROSC SOC, V87, P21, DOI 10.2307/3224334; HIGGINS RP, 1990, ZOOL SCI, V7, P939; Higgins RP, 1983, SMITHSON CONTRIB MAR, V18, P1, DOI DOI 10.5479/SI.01960768.18.1; Higgins RP, 1988, SMITHSON CONTRIB ZOO, V458, P1, DOI DOI 10.5479/SI.00810282.458; Hyman LH, 1951, INVERTEBRATES ACANTH, V3; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kim CG, 2000, MOL BIOL EVOL, V17, P137, DOI 10.1093/oxfordjournals.molbev.a026226; Luan YX, 2005, MOL BIOL EVOL, V22, P1579, DOI 10.1093/molbev/msi148; Maddison W. P, 2014, MESQUITE MODULAR SYS; NEBELSICK M, 1993, ZOOMORPHOLOGY, V113, P211, DOI 10.1007/BF00403313; NEBELSICK M, 1992, ACTA ZOOL-STOCKHOLM, V73, P185, DOI 10.1111/j.1463-6395.1992.tb01186.x; NELLES L, 1984, NUCLEIC ACIDS RES, V12, P8749, DOI 10.1093/nar/12.23.8749; NEUHAUS B, 1995, ZOOL SCR, V24, P179, DOI 10.1111/j.1463-6409.1995.tb00398.x; Neuhaus B, 2002, INTEGR COMP BIOL, V42, P619, DOI 10.1093/icb/42.3.619; Neuhaus B., 2004, MEIOFAUNA MAR, V13, P3; Neuhaus Birger, 1993, Microfauna Marina, V8, P163; Neuhaus B, 2006, ZOOL ANZ, V245, P19, DOI 10.1016/j.jcz.2006.03.003; Neuhaus B, 2014, ZOOTAXA, V3901, P1, DOI 10.11646/zootaxa.3901.1.1; Neuhaus B, 2013, HBK ZOOL, P181; Neuhaus B, 2013, ZOOL ANZ, V252, P48, DOI 10.1016/j.jcz.2012.03.002; Neuhaus B, 2013, CAH BIOL MAR, V54, P109; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Noren M, 2002, ZOOL SCR, V31, P403, DOI 10.1046/j.1463-6409.2002.00082.x; Noren M, 1999, CLADISTICS, V15, P103, DOI 10.1111/j.1096-0031.1999.tb00252.x; Page R.D.M., 2001, NDE NEXUS DATA EDITO; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Paps J, 2009, MOL BIOL EVOL, V26, P2397, DOI 10.1093/molbev/msp150; Park JK, 2000, MOL PHYLOGENET EVOL, V14, P75, DOI 10.1006/mpev.1999.0691; Park JK, 2006, ZOOL SCI, V23, P943, DOI 10.2108/zsj.23.943; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez N, 2014, HELGOLAND MAR RES, V68, P221, DOI 10.1007/s10152-014-0383-6; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sorensen MV, 2008, J ZOOL SYST EVOL RES, V46, P231, DOI 10.1111/j.1439-0469.2008.00478.x; Sorensen M. V., 2010, OPEN ZOOLOGY J, V3, P42, DOI [DOI 10.2174/187, 10.2174/1874336601003010042, DOI 10.2174/1874336601003010042]; Sorensen MV, 2007, HELGOLAND MAR RES, V61, P247, DOI 10.1007/s10152-007-0073-8; Sorensen Martin V., 2006, Meiofauna Marina, V15, P51; Sorensen MV, 2007, CAH BIOL MAR, V48, P155; Sorensen MV, 2012, ZOOTAXA, P161; Sorensen MV, 2014, MAR BIODIVERS, V44, P251, DOI 10.1007/s12526-013-0181-4; Sorensen MV, 2013, ZOOTAXA, V3703, P63; Sorensen MV, 2013, HELGOLAND MAR RES, V67, P291, DOI 10.1007/s10152-012-0323-2; Sorensen MV, 2012, MAR BIOL RES, V8, P210, DOI 10.1080/17451000.2011.615328; Sorensen Martin V., 2010, Marine Biodiversity, V40, P261, DOI 10.1007/s12526-010-0048-x; Sorensen MV, 2010, MAR BIOL RES, V6, P472, DOI 10.1080/17451000903334702; Sorensen MV, 2010, ZOOL SCI, V27, P234, DOI 10.2108/zsj.27.234; Sorensen MV, 2009, J MAR BIOL ASSOC UK, V89, P1269, DOI 10.1017/S0025315409000526; Sorensen MV, 2009, HELGOLAND MAR RES, V63, P129, DOI 10.1007/s10152-008-0132-9; Sorensen MV, 2008, ORG DIVERS EVOL, V8, P233, DOI 10.1016/j.ode.2007.11.002; Sorensen MV, 2008, ORG DIVERS EVOL, V8, DOI 10.1016/j.ode.2007.11.003; Sorensen MV, 2000, CAH BIOL MAR, V41, P167; Sorensen MV, 2005, P BIOL SOC WASH, V118, P499, DOI 10.2988/0006-324X(2005)118[499:ANSOEF]2.0.CO;2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thomsen VG, 2013, ZOOTAXA, V3682, P133, DOI 10.11646/zootaxa.3682.1.6; Thormar Jonas, 2010, Meiofauna Marina, V18, P67; Todaro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017892; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Yamaguchi S, 2003, MAR BIOL, V143, P23, DOI 10.1007/s00227-003-1062-3; Yamasaki H, 2012, ZOOTAXA, P23; Yamasaki H, 2013, MOL PHYLOGENET EVOL, V67, P303, DOI 10.1016/j.ympev.2013.02.016; Zelinka C., 1907, Zoologischer Anzeiger Leipzig, V32; Zelinka K., 1896, VERH DEUTSCH ZOOL GE, V6, P197	88	63	65	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133440	10.1371/journal.pone.0133440	http://dx.doi.org/10.1371/journal.pone.0133440			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200115	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358597100065
J	Santha, S; Viswakarma, N; Das, S; Rana, A; Rana, B				Santha, Sreevidya; Viswakarma, Navin; Das, Subhasis; Rana, Ajay; Rana, Basabi			Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; CYCLIN D1 TRANSCRIPTION; BETA-CATENIN; PPAR-GAMMA; GENE-EXPRESSION; DOWN-REGULATION; IN-VIVO; GROWTH; PATHWAYS; CLEAVAGE	Prostate cancer (PCa) is one of the most frequently diagnosed cancers in men with limited treatment options for the hormone-resistant forms. Development of novel therapeutic options is critically needed to target advanced forms. Here we demonstrate that combinatorial treatment with the thiazolidinedione troglitazone (TZD) and TNF-related apoptosis-inducing ligand (TRAIL) can induce significant apoptosis in various PCa cells independent of androgen receptor status. Because TZD is known to activate AMP-activated protein kinase (AMPK), we determined whether AMPK is a molecular target mediating this apoptotic cascade by utilizing PCa cell lines stably overexpressing AMPK alpha 1 dominant negative (C4-2-DN) or empty vector (C4-2-EV). Our results indicated a significantly higher degree of apoptosis with TRAIL-TZD combination in C4-2-EV cells compared with C4-2-DN cells. Similarly, results from a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed a larger reduction of viability of C4-2-EV cells compared with C4-2-DN cells when treated with TRAIL-TZD, thus suggesting that C4-2-DN cells were more apoptosisresistant. Additionally, siRNA-mediated knockdown of endogenousAMPK alpha 1 expression showed a reduction of TRAIL-TZD-induced apoptosis, further confirming the participation of AMPK in mediating this apoptosis. Apoptosis induction by this combinatorial treatment was also associated with a cleavage of beta-catenin that was inhibited in both C4-2-DN cells and those cells in which AMPK alpha 1 was knocked down. In addition, time course studies showed an increase in pACC(S79) (AMPK target) levels coinciding with the time of apoptosis. These studies indicate the involvement of AMPK in TRAIL-TZD-mediated apoptosis and beta-catenin cleavage and suggest the possibility of utilizing AMPK as a therapeutic target in apoptosis-resistant prostate cancer.	[Santha, Sreevidya; Rana, Basabi] Loyola Univ Chicago, Dept Med, Div Gastroenterol & Nutr, Maywood, IL 60153 USA; [Viswakarma, Navin; Das, Subhasis; Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Rana, Ajay; Rana, Basabi] Edward Hines Vet Adm Med Ctr, Hines, IL 60141 USA	Loyola University Chicago; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Rana, B (corresponding author), Loyola Univ Chicago, Bldg 101,Rm 2729,2160 S First Ave, Maywood, IL 60153 USA.	arnavr_299@hotmail.com	DAS, SUBHASIS/O-8421-2017; Regan, Clinton/E-6250-2012; Rana, Ajay/ABE-3739-2020	DAS, SUBHASIS/0000-0003-1032-4407; Rana, Ajay/0000-0003-0951-2566	Department of Defense [W81XWH-10-1-0195]; VA Merit Awards [BX000571, BX002703]; National Institutes of Health [CA178063, CA176846]; NATIONAL CANCER INSTITUTE [R01CA178063, R01CA176846] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000571, I01BX002703] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); VA Merit Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Department of Defense Award W81XWH-10-1-0195 (to B. R.), VA Merit Awards BX000571 (to B. R.) and BX002703 (to A. R.) and National Institutes of Health Grants CA178063 (to B. R.) and CA176846 (to A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Akinyeke TO, 2011, CANCER BIOL THER, V11, P1046, DOI 10.4161/cbt.11.12.15709; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bracarda S, 2011, BJU INT, V107, P13, DOI 10.1111/j.1464-410X.2010.10036.x; Christian PA, 2009, CANCER BIOL THER, V8, P73, DOI 10.4161/cbt.8.1.7132; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; Goke R, 2000, CELL IMMUNOL, V201, P77, DOI 10.1006/cimm.2000.1650; Guseva NV, 2004, J CELL BIOCHEM, V91, P70, DOI 10.1002/jcb.10707; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Johnson TR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-148; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Nimmanapalli R, 2001, CANCER RES, V61, P759; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Rencurel F, 2005, J BIOL CHEM, V280, P4367, DOI 10.1074/jbc.M412711200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3; Senthivinayagam S, 2009, J BIOL CHEM, V284, P13577, DOI 10.1074/jbc.M900248200; Sharma C, 2004, J BIOL CHEM, V279, P16927, DOI 10.1074/jbc.M309045200; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Steffan JJ, 2012, J BIOL CHEM, V287, P29968, DOI 10.1074/jbc.M112.379396; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tencer L, 2008, ANTICANCER RES, V28, P895; THALMANN GN, 1994, CANCER RES, V54, P2577; van Ophoven A, 1999, PROSTATE CANCER P D, V2, P227, DOI 10.1038/sj.pcan.4500373; Voelkel-Johnson C, 2002, CANCER GENE THER, V9, P164, DOI 10.1038/sj.cgt.7700420; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Wu XX, 2002, INT J ONCOL, V20, P949; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Zadra G, 2014, EMBO MOL MED, V6, P519, DOI 10.1002/emmm.201302734; Zadra G, 2013, BBA-MOL CELL BIOL L, V1831, P1518, DOI 10.1016/j.bbalip.2013.03.010; Zadra G, 2010, CLIN CANCER RES, V16, P3322, DOI 10.1158/1078-0432.CCR-09-1955; Zhang XY, 2009, TRANSL ONCOL, V2, P21, DOI 10.1593/tlo.08190; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou J, 2009, ONCOGENE, V28, P1993, DOI 10.1038/onc.2009.63; Zisman A, 2001, J IMMUNOTHER, V24, P459, DOI 10.1097/00002371-200111000-00003; Zou W, 2007, CANCER BIOL THER, V6, P99, DOI 10.4161/cbt.6.1.3555	55	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21865	21875		10.1074/jbc.M115.663526	http://dx.doi.org/10.1074/jbc.M115.663526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198640	Green Published, hybrid			2022-12-26	WOS:000360968500009
J	Edmonds, GW; Cote, HCF; Hampson, SE				Edmonds, Grant W.; Cote, Helene C. F.; Hampson, Sarah E.			Childhood Conscientiousness and Leukocyte Telomere Length 40 Years Later in Adult Women-Preliminary Findings of a Prospective Association	PLOS ONE			English	Article							PERSONALITY-TRAITS; ELEMENTARY-SCHOOL; EDUCATIONAL-ATTAINMENT; HEALTH; MORTALITY; LIFE; MIDLIFE; COHORT; MEN; ENVIRONMENTS	Leukocyte telomere length (LTL) shortens with age, and is a prospective marker of mortality related to cardiovascular disease. Many health behaviors and social environmental factors have been found to be associated with LTL. Several of these are also associated with conscientiousness, a dispositional personality trait. Conscientiousness is a propensity to be planful, adhere to social norms, and inhibit pre-potent responses. Like LTL, conscientiousness is prospectively related to mortality, possibly through cumulative effects on health over the life course via multiple pathways. As a result, we hypothesized that childhood levels of conscientiousness would predict LTL prospectively in adulthood. We selected a sample of 60 women in the Hawaii Personality and Health Cohort; 30 described by their teachers as high on conscientiousness in childhood and 30 described as low on the trait. Dried blood spot samples collected in adulthood 40 years later were used as sources of DNA for the LTL assay. Conscientiousness was associated with longer LTL (p=.02). Controlling for age did not account for this association. Controlling for education and physiological dysregulation partially attenuated the association, and the effect remained significant when accounting for differences in LTL across cultural groups. These results represent the first evidence that childhood personality prospectively predicts LTL 40 years later in adulthood. Our findings would be consistent with a mediation hypothesis whereby conscientiousness predicts life paths and trajectories of health that are reflected in rates of LTL erosion across the lifespan.	[Edmonds, Grant W.; Hampson, Sarah E.] Oregon Res Inst, Eugene, OR 97403 USA; [Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	Oregon Research Institute; University of British Columbia	Edmonds, GW (corresponding author), Oregon Res Inst, Eugene, OR 97403 USA.	gedmonds@ori.org			National Institute on Aging, National Institutes of Health [AG020048, R21AG045015]; Oregon Research Institute; NATIONAL INSTITUTE ON AGING [R21AG045015, R01AG020048] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Oregon Research Institute; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants AG020048 and R21AG045015 from the National Institute on Aging, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Aging or the National Institutes of Health. Additional support included pilot funds provided by the Oregon Research Institute. These funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler N, 2013, BRAIN BEHAV IMMUN, V27, P15, DOI 10.1016/j.bbi.2012.08.014; Bekaert S, 2005, ANTICANCER RES, V25, P3011; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305; Buchanan T, 2005, EUR J PSYCHOL ASSESS, V21, P115, DOI 10.1027/1015-5759.21.2.115; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chapman Benjamin P, 2011, J Aging Res, V2011, P759170, DOI 10.4061/2011/759170; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Cote HCF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039266; Der G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045166; Eaton NR, 2012, J GERONTOL A-BIOL, V67, P480, DOI 10.1093/gerona/gls090; Edmonds GW, 2013, J RES PERS, V47, P505, DOI 10.1016/j.jrp.2013.05.003; Epel ES, 2009, CURR DIR PSYCHOL SCI, V18, P6, DOI 10.1111/j.1467-8721.2009.01596.x; Epel ES, 2009, AGING-US, V1, P81; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Fjell AM, 2012, P NATL ACAD SCI USA, V109, P19620, DOI 10.1073/pnas.1208243109; Friedman HS, 2000, J PERS, V68, P1089, DOI 10.1111/1467-6494.00127; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Goldberg LR, 2001, J PERS, V69, P709, DOI 10.1111/1467-6494.695161; Hagger-Johnson GE, 2001, PERS INDIV DIFFER, V43, P1235; Hampson SE, 2007, HEALTH PSYCHOL, V26, P121, DOI 10.1037/0278-6133.26.1.121; Hampson SE, 2006, J PERS SOC PSYCHOL, V91, P763, DOI 10.1037/0022-3514.91.4.763; Hampson SE, 2013, HEALTH PSYCHOL, V32, P925, DOI 10.1037/a0031655; Hampson SE, 2012, ANNU REV PSYCHOL, V63, P315, DOI 10.1146/annurev-psych-120710-100419; Hampson SE, 2001, J RES PERS, V35, P375, DOI 10.1006/jrpe.2001.2317; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Jackson JJ, 2010, J RES PERS, V44, P501, DOI 10.1016/j.jrp.2010.06.005; Jonassaint CR, 2011, INT J BEHAV MED, V18, P13, DOI 10.1007/s12529-009-9069-x; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kern ML, 2008, HEALTH PSYCHOL, V27, P505, DOI 10.1037/0278-6133.27.5.505; Lodi-Smith J, 2010, PSYCHOL HEALTH, V25, P305, DOI 10.1080/08870440902736964; Lonnqvist JE, 2011, EUR J PERSONALITY, V25, P306, DOI 10.1002/per.791; Mather J, 2011, J GERONTOL BIOL SCI, V61, P871; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Mottus R, 2013, PSYCHOSOM MED, V75, P11, DOI 10.1097/PSY.0b013e31827576cc; O'Donovan A, 2012, BRAIN BEHAV IMMUN, V26, P573, DOI 10.1016/j.bbi.2012.01.007; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; Sadahiro R, 2014, EUR PSYCHIAT, V30, P187; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Strandberg TE, 2011, J GERONTOL A-BIOL, V66, P815, DOI 10.1093/gerona/glr064; Taylor MD, 2009, PSYCHOSOM MED, V71, P631, DOI 10.1097/PSY.0b013e3181a65298; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Woods SA, 2010, J APPL PSYCHOL, V95, P1045, DOI 10.1037/a0020600; Zanet DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057787	51	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134077	10.1371/journal.pone.0134077	http://dx.doi.org/10.1371/journal.pone.0134077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218760	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900075
J	Falcon-Urrutia, P; Carrasco, CM; Lois, P; Palma, V; Roth, AD				Falcon-Urrutia, Paulina; Carrasco, Carlos M.; Lois, Pablo; Palma, Veronica; Roth, Alejandro D.			Shh Signaling through the Primary Cilium Modulates Rat Oligodendrocyte Differentiation	PLOS ONE			English	Article							SONIC HEDGEHOG; GROWTH-FACTOR; NERVOUS-SYSTEM; CELLS; PRECURSORS; INHIBITORS; REGULATOR; MIGRATION; MYELIN	Primary Cilia (PC) are a very likely place for signal integration where multiple signaling pathways converge. Two major signaling pathways clearly shown to signal through the PC, Sonic Hedgehog (Shh) and PDGF-Ra, are particularly important for the proliferation and differentiation of oligodendrocytes, suggesting that their interaction occurs in or around this organelle. We identified PC in rat oligodendrocyte precursor cells (OPCs) and found that, while easily detectable in early OPCs, PC are lost as these cells progress to terminal differentiation. We confirmed the interaction between these pathways, as cyclopamine inhibition of Hedgehog function impairs both PDGF-mediated OPC proliferation and Shh-dependent cell branching. However, we failed to detect PDGF-Ra localization into the PC. Remarkably, ciliobrevin-mediated disruption of PC and reduction of OPC process extension was counteracted by recombinant Shh treatment, while PDGF had no effect. Therefore, while PDGFR alpha-dependent OPC proliferation and survival most probably does not initiate at the PC, still the integrity of this organelle and cilium-centered pathway is necessary for OPC survival and differentiation.	[Falcon-Urrutia, Paulina; Carrasco, Carlos M.; Lois, Pablo; Palma, Veronica; Roth, Alejandro D.] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Falcon-Urrutia, Paulina; Lois, Pablo; Palma, Veronica] FONDAP Ctr Genome Regulat, Santiago, Chile	Universidad de Chile	Palma, V (corresponding author), Univ Chile, Fac Sci, Dept Biol, Santiago, Chile.	vpalma@uchile.cl; alejroth@u.uchile.cl	Roth, Alejandro D/A-5086-2009	Roth, Alejandro D/0000-0001-5679-8136; Palma, Veronica/0000-0002-4320-7525; Falcon Urrutia, Paulina/0000-0003-4759-8540	Programa de Apoyo a la Investigacion de la Facultad de Ciencias; Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [1140697]; FONDAP CENTER FOR GENOME REGULATION (Fondo Nacional de Desarrollo de Areas Prioritarias)	Programa de Apoyo a la Investigacion de la Facultad de Ciencias; Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP CENTER FOR GENOME REGULATION (Fondo Nacional de Desarrollo de Areas Prioritarias)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work was supported by the Programa de Apoyo a la Investigacion de la Facultad de Ciencias (www.ciencias.uchile.cl) to ADR, the Fondo Nacional de Ciencia y Tecnologia (FONDECYT No 1140697; http://www.conicyt.cl/fondecyt/) to VP, and the FONDAP CENTER FOR GENOME REGULATION (Fondo Nacional de Desarrollo de Areas Prioritarias; http://www.conicyt.cl/fondap/) to VP.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cenacchi G, 1996, ULTRASTRUCT PATHOL, V20, P537, DOI 10.3109/01913129609016358; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Espinosa-Jeffrey A, 2009, CURRENT PROTOCOLS ST, V2, P41; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Ichimura K, 2010, CELL TISSUE RES, V341, P197, DOI 10.1007/s00441-010-0983-7; Jain R, 2010, AM J RESP CELL MOL, V43, P731, DOI 10.1165/rcmb.2009-0328OC; Jarjour AA, 2004, NEUROSCIENTIST, V10, P99, DOI 10.1177/1073858403260751; Kim J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104070; Lelievre V, 2006, REGUL PEPTIDES, V137, P58, DOI 10.1016/j.regpep.2006.04.024; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Lunn KF, 1997, J NEUROSCI, V17, P4921; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Martinez C, 2011, J DENT RES, V90, P483, DOI 10.1177/0022034510391797; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Moser JJ, 2010, SEMIN CELL DEV BIOL, V21, P148, DOI 10.1016/j.semcdb.2009.06.006; Murray K, 2002, MOL CELL NEUROSCI, V19, P320, DOI 10.1006/mcne.2001.1079; Nery S, 2001, DEVELOPMENT, V128, P527; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Ortega JA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00254; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sasai N, 2012, WIRES DEV BIOL, V1, P753, DOI 10.1002/wdev.43; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Yoshimura K, 2012, DIFFERENTIATION, V83, pS78, DOI 10.1016/j.diff.2011.10.006	44	22	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133567	10.1371/journal.pone.0133567	http://dx.doi.org/10.1371/journal.pone.0133567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218245	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900036
J	Zhang, MZ; Zhang, Y; Ma, J; Guo, FM; Cao, Q; Zhang, Y; Zhou, B; Chai, JJ; Zhao, WQ; Zhao, RB				Zhang, Meizi; Zhang, Ying; Ma, Jun; Guo, Feima; Cao, Qian; Zhang, Yu; Zhou, Bin; Chai, Jijie; Zhao, Wenqing; Zhao, Renbin			The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CELL MESSENGER-RNA; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; ADULT OBESITY; FOOD-INTAKE; 5' TERMINUS; ADIPOGENESIS; N6-METHYLADENOSINE; METHYLATION	FTO (fat mass and obesity associated gene) was genetically identified to be associated with body mass index (BMI), presumably through functional regulation of energy homeostasis. However, the cellular and molecular mechanisms by which FTO functions remain largely unknown. Using 3T3-L1 preadipocyte as a model to study the role of FTO in adipogenesis, we demonstrated that FTO is functionally required for 3T3-L1 differentiation. FTO knock-down with siRNA inhibited preadipocyte differentiation, whereas ectopic overexpression of FTO enhanced the process. The demethylase activity of FTO is required for differentiation. Level of N-6-methyladenosine (m(6)A) is decreased in cells over-expressing FTO. In contrast, overexpression of R96Q, a FTO missense mutant lack of demethylase activity, had no effect on cellular m(6)A level and impeded differentiation. Treatment with Rosiglitazone, a PPAR. agonist, could overcome the differentiation inhibition imposed by R96Q mutant, suggesting the effect of FTO is mediated through PPAR gamma.	[Zhang, Meizi; Zhang, Ying; Ma, Jun; Guo, Feima; Cao, Qian; Zhang, Yu; Zhao, Wenqing; Zhao, Renbin] China Acad Space Technol, Beijing Engn Res Ctr Space Biol, Space Biol Res & Technol Ctr, Beijing 100190, Peoples R China; [Zhou, Bin; Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Zhao, RB (corresponding author), China Acad Space Technol, Beijing Engn Res Ctr Space Biol, Space Biol Res & Technol Ctr, Beijing 100190, Peoples R China.	zhaorenbin@tsinghua.org.cn		Chai, Jijie/0000-0001-7591-3873				BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Bravard A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-4; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gan XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074235; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerhold DL, 2002, ENDOCRINOLOGY, V143, P2106, DOI 10.1210/en.143.6.2106; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li JJ, 2007, BIOCHEM BIOPH RES CO, V357, P648, DOI 10.1016/j.bbrc.2007.03.184; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Luo WJ, 2008, EXP CELL RES, V314, P3382, DOI 10.1016/j.yexcr.2008.07.003; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Merkestein M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097162; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Muller TD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003223; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Rosen ED, 2000, GENE DEV, V14, P1293; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; SANEYOSHI M, 1969, BIOCHIM BIOPHYS ACTA, V190, P264, DOI 10.1016/0005-2787(69)90078-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Simon R, 2007, CANCER INFORM, V3, P11; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tews D, 2013, ENDOCRINOLOGY, V154, P3141, DOI 10.1210/en.2012-1873; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151	57	66	73	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133788	10.1371/journal.pone.0133788	http://dx.doi.org/10.1371/journal.pone.0133788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218273	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900047
J	Guo, P; Zeng, FF; Hu, XM; Zhang, DM; Zhu, SM; Deng, Y; Hao, YT				Guo, Pi; Zeng, Fangfang; Hu, Xiaomin; Zhang, Dingmei; Zhu, Shuming; Deng, Yu; Hao, Yuantao			Improved Variable Selection Algorithm Using a LASSO-Type Penalty, with an Application to Assessing Hepatitis B Infection Relevant Factors in Community Residents	PLOS ONE			English	Article							VIRUS-INFECTIONS; RISK-FACTORS; CHINA; POPULATION; SHRINKAGE; MODELS; REGRESSION; IMPACT	Objectives In epidemiological studies, it is important to identify independent associations between collective exposures and a health outcome. The current stepwise selection technique ignores stochastic errors and suffers from a lack of stability. The alternative LASSO-penalized regression model can be applied to detect significant predictors from a pool of candidate variables. However, this technique is prone to false positives and tends to create excessive biases. It remains challenging to develop robust variable selection methods and enhance predictability. Material and methods Two improved algorithms denoted the two-stage hybrid and bootstrap ranking procedures, both using a LASSO-type penalty, were developed for epidemiological association analysis. The performance of the proposed procedures and other methods including conventional LASSO, Bolasso, stepwise and stability selection models were evaluated using intensive simulation. In addition, methods were compared by using an empirical analysis based on large-scale survey data of hepatitis B infection-relevant factors among Guangdong residents. Results The proposed procedures produced comparable or less biased selection results when compared to conventional variable selection models. In total, the two newly proposed procedures were stable with respect to various scenarios of simulation, demonstrating a higher power and a lower false positive rate during variable selection than the compared methods. In empirical analysis, the proposed procedures yielding a sparse set of hepatitis B infection-relevant factors gave the best predictive performance and showed that the procedures were able to select a more stringent set of factors. The individual history of hepatitis B vaccination, family and individual history of hepatitis B infection were associated with hepatitis B infection in the studied residents according to the proposed procedures. Conclusions The newly proposed procedures improve the identification of significant variables and enable us to derive a new insight into epidemiological association analysis.	[Guo, Pi; Zeng, Fangfang; Hu, Xiaomin; Zhang, Dingmei; Zhu, Shuming; Deng, Yu; Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China; [Guo, Pi; Zeng, Fangfang; Hu, Xiaomin; Zhang, Dingmei; Zhu, Shuming; Deng, Yu; Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Hlth Informat Res Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Guo, Pi; Zeng, Fangfang; Hu, Xiaomin; Zhang, Dingmei; Zhu, Shuming; Deng, Yu; Hao, Yuantao] Sun Yat Sen Univ, Guangdong Key Lab Med, Lab Hlth Informat, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Hao, YT (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China.	haoyt@mail.sysu.edu.cn	Zhang, Dingmei/ABC-7476-2020; Hu, Xiaomin/GRY-1539-2022		National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX10004902, 2013ZX10004901]	National Science and Technology Major Project of the Ministry of Science and Technology of China	This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (2012ZX10004902, 2013ZX10004901). HYT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Avalos M, 2012, EPIDEMIOLOGY, V23, P706, DOI 10.1097/EDE.0b013e31825fa528; Bach FR., 2008, P 25 INT C MACHINE L, V33, P40, DOI [10.1145/1390156.1390161, DOI 10.1145/1390156.1390161]; Bach FR, 2008, J MACH LEARN RES, V9, P1179; Breiman L, 1996, ANN STAT, V24, P2350; Chen QX, 2013, STAT MED, V32, P3646, DOI 10.1002/sim.5783; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Galar M, 2012, IEEE T SYST MAN CY C, V42, P463, DOI 10.1109/TSMCC.2011.2161285; GREENLAND S, 1989, AM J EPIDEMIOL, V130, P1066, DOI 10.1093/oxfordjournals.aje.a115409; Greenland S, 2008, AM J EPIDEMIOL, V167, P523, DOI 10.1093/aje/kwm355; Guo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105470; Guo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100052; Guo P, 2014, GENOMICS, V103, P48, DOI 10.1016/j.ygeno.2013.11.001; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hesterberg T, 2008, STAT SURV, V2, P61, DOI 10.1214/08-SS035; Huang J, 2008, 392 U IOW; Kredler C, 1982, COMPSTAT 1982 5 S HE, P294; Leng CL, 2006, STAT SINICA, V16, P1273; Li XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-272; Luo ZB, 2012, INT J INFECT DIS, V16, pE82, DOI 10.1016/j.ijid.2011.10.009; Mansiaux Y, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-99; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Muggeo VMR, 2011, BIOINFORMATICS, V27, P161, DOI 10.1093/bioinformatics/btq647; Qian J, 2014, BIOMETRICS, V70, P153, DOI 10.1111/biom.12113; R Core Team, 2021, R LANGUAGE ENV STAT; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sabbe N, 2013, STAT MED, V32, P3143, DOI 10.1002/sim.5760; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Toh S, 2013, EPIDEMIOLOGY, V24, P349, DOI [10.1097/EDE.0b013e3182a71390, 10.1097/EDE.0b013e31828ac65e]; Walter S, 2009, EUR J EPIDEMIOL, V24, P733, DOI 10.1007/s10654-009-9411-2; Wang D, 2011, J AGR BIOL ENVIR ST, V16, P170, DOI 10.1007/s13253-010-0046-2; Wang SJ, 2011, ANN APPL STAT, V5, P468, DOI 10.1214/10-AOAS377; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Xia X, 2008, EPIDEMIOLOGY, V19, pS237; Zhang CY, 2013, BIOSCI TRENDS, V7, P7, DOI 10.5582/bst.2013.v7.1.7; Zhang H, 2011, INT J MED SCI, V8, P321, DOI 10.7150/ijms.8.321; Zhou XH, 2012, STAT MED, V31, P628, DOI 10.1002/sim.3980; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	43	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134151	10.1371/journal.pone.0134151	http://dx.doi.org/10.1371/journal.pone.0134151			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214802	Green Published, Green Submitted, gold			2022-12-26	WOS:000358594300053
J	Cymerman, IA; Gozdz, A; Urbanska, M; Milek, J; Dziembowska, M; Jaworski, J				Cymerman, Iwona A.; Gozdz, Agata; Urbanska, Malgorzata; Milek, Jacek; Dziembowska, Magdalena; Jaworski, Jacek			Structural Plasticity of Dendritic Spines Requires GSK3 alpha and GSK3 beta	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; LONG-TERM DEPRESSION; CELL-PROLIFERATION; KINASE 3; TRAFFICKING; HIPPOCAMPUS; GSK-3-BETA; RECEPTORS; MIGRATION; MICE	Although memories appear to be elusive phenomena, they are stored in the network of physical connections between neurons. Dendritic spines, which are actin-rich dendritic protrusions, serve as the contact points between networked neurons. The spines' shape contributes to the strength of signal transmission. To acquire and store information, dendritic spines must remain plastic, i.e., able to respond to signals, by changing their shape. We asked whether glycogen synthase kinase (GSK) 3 alpha and GSK3 beta, which are implicated in diseases with neuropsychiatric symptoms, such as Alzheimer's disease, bipolar disease and schizophrenia, play a role in a spine structural plasticity. We used Latrunculin B, an actin polymerization inhibitor, and chemically induced Long-Term Depression to trigger fast spine shape remodeling in cultured hippocampal neurons. Spine shrinkage induced by either stimulus required GSK3 alpha activity. GSK3 beta activity was only important for spine structural changes after treatment with Latrunculin B. Our results indicate that GSK3 alpha is an essential component for short-term spine structural plasticity. This specific function should be considered in future studies of neurodegenerative diseases and neuropsychiatric conditions that originate from suboptimal levels of GSK3 alpha/beta activity.	[Cymerman, Iwona A.; Gozdz, Agata; Urbanska, Malgorzata; Jaworski, Jacek] Int Inst Mol & Cell Biol, Warsaw, Poland; [Milek, Jacek; Dziembowska, Magdalena] Nencki Inst, Neurobiol Lab, Warsaw, Poland; [Milek, Jacek; Dziembowska, Magdalena] Univ Warsaw, Ctr New Technol, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; University of Warsaw	Cymerman, IA (corresponding author), Int Inst Mol & Cell Biol, Warsaw, Poland.	icymerman@iimcb.gov.pl; jaworski@iimcb.gov.pl	Gozdz, Agata/AAD-2974-2022	Gozdz, Agata/0000-0001-8421-0598; Jaworski, Jacek/0000-0001-8760-7865; Urbanska, Malgorzata/0000-0001-9521-0366; Dziembowska, Magdalena/0000-0002-0650-6438	Polish National Science Centre [2011/01/M/NZ3/05413, 2011/01/B/NZ3/05397, 2011/01/N/NZ3/05409]; NCRD [ERA-NET NEURON/06/2011]; FP7 European Union grant [223276]; Foundation for Polish Science	Polish National Science Centre; NCRD; FP7 European Union grant; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This research was supported by the Polish National Science Centre-(http://www.ncn.gov.pl/) (2011/01/M/NZ3/05413, 2011/01/B/NZ3/05397 and 2011/01/N/NZ3/05409), ERA-NET NEURON/06/2011- (http://www.neuron-eranet.eu) (co-financed by NCRD) and FP7 European Union grant (#223276, "NeuroGSK3"). JJ is a recipient of "Mistrz" Professorial subsidy from the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Calabrese B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094787; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Gillespie JR, 2011, ENDOCRINOLOGY, V152, P1755, DOI 10.1210/en.2010-1412; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang W, 2008, J BIOL CHEM, V283, P20978, DOI 10.1074/jbc.M802588200; Kaidanovich-Beilin O, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00048; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lo Monte F, 2012, J MED CHEM, V55, P4407, DOI 10.1021/jm300309a; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Maurin H, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-27; Nelson CD, 2013, J NEUROSCI, V33, P12122, DOI 10.1523/JNEUROSCI.0131-13.2013; Ochs SM, 2015, MOL PSYCHIATR, V20, P482, DOI 10.1038/mp.2014.55; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Shahab L, 2014, HIPPOCAMPUS, V24, P1413, DOI 10.1002/hipo.22362; Shin S, 2014, ONCOGENE, V33, P1690, DOI 10.1038/onc.2013.113; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Steuber-Buchberger P, 2008, GENESIS, V46, P144, DOI 10.1002/dvg.20376; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Wei J, 2010, J BIOL CHEM, V285, P26369, DOI 10.1074/jbc.M110.121376; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	34	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134018	10.1371/journal.pone.0134018	http://dx.doi.org/10.1371/journal.pone.0134018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207897	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000192
J	Grieb, M; Burkovski, A; Strang, JE; Kraus, JM; Gross, A; Palm, G; Kuhl, M; Kestler, HA				Grieb, Melanie; Burkovski, Andre; Straeng, J. Eric; Kraus, Johann M.; Gross, Alexander; Palm, Guenther; Kuehl, Michael; Kestler, Hans A.			Predicting Variabilities in Cardiac Gene Expression with a Boolean Network Incorporating Uncertainty	PLOS ONE			English	Article							MODELS	Gene interactions in cells can be represented by gene regulatory networks. A Boolean network models gene interactions according to rules where gene expression is represented by binary values (on / off or {1, 0}). In reality, however, the gene's state can have multiple values due to biological properties. Furthermore, the noisy nature of the experimental design results in uncertainty about a state of the gene. Here we present a new Boolean network paradigm to allow intermediate values on the interval [0, 1]. As in the Boolean network, fixed points or attractors of such a model correspond to biological phenotypes or states. We use our new extension of the Boolean network paradigm to model gene expression in first and second heart field lineages which are cardiac progenitor cell populations involved in early vertebrate heart development. By this we are able to predict additional biological phenotypes that the Boolean model alone is not able to identify without utilizing additional biological knowledge. The additional phenotypes predicted by the model were confirmed by published biological experiments. Furthermore, the new method predicts gene expression propensities for modelled but yet to be analyzed genes.	[Gross, Alexander; Kestler, Hans A.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Grieb, Melanie; Burkovski, Andre; Straeng, J. Eric; Kraus, Johann M.; Kestler, Hans A.] Univ Ulm, Core Unit Med Syst Biol, D-89069 Ulm, Germany; [Burkovski, Andre; Palm, Guenther; Kestler, Hans A.] Univ Ulm, Neural Informat Proc, D-89069 Ulm, Germany; [Kuehl, Michael] Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany; [Grieb, Melanie; Burkovski, Andre] Univ Ulm, Int Grad Sch Mol Med, D-89069 Ulm, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Ulm University; Ulm University; Ulm University; Ulm University	Kuhl, M (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany.	michael.kuehl@uni-ulm.de; hkestler@fli-leibniz.de	Kestler, Hans A./D-5799-2012	Kestler, Hans A./0000-0002-4759-5254; Burkovski, Andreas/0000-0003-1896-4521; Strang, Jan Eric/0000-0001-6681-8735	German federal ministry of education and research (BMBF) within the framework GERONTOSYS II (Forschungskern SyStaR) [0315894A]; European Community [602783]; International Graduate School in Molecular Medicine at Ulm University [GSC270]	German federal ministry of education and research (BMBF) within the framework GERONTOSYS II (Forschungskern SyStaR)(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); International Graduate School in Molecular Medicine at Ulm University	This work was funded in part by the German federal ministry of education and research (BMBF) within the framework GERONTOSYS II (Forschungskern SyStaR, Project ID 0315894A to MK and HAK), European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602783 (to HAK), and the International Graduate School in Molecular Medicine at Ulm University (GSC270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; ALSINA C, 1983, J MATH ANAL APPL, V93, P15, DOI 10.1016/0022-247X(83)90216-0; [Anonymous], 2014, R LANG ENV STAT COMP; Berestovsky N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066031; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; BROYDEN CG, 1965, MATH COMPUT, V19, P557; Cornelius SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2939; Davidson EH, 2006, REG GEN GEN REG; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dubois D., 1980, FUZZY SETS SYSTEMS T; Dumcke S, 2014, BIOINFORMATICS, V30, P414, DOI 10.1093/bioinformatics/btt696; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Franke R, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-151; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Gessert S, 2009, DEV BIOL, V334, P395, DOI 10.1016/j.ydbio.2009.07.037; Han ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115806; Hasselman B., 2014, NLEQSLV SOLVE SYSTEM; Herrmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046798; Hopfensitz M, 2013, COMPUTATION STAT, V28, P19, DOI 10.1007/s00180-012-0324-2; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kestler HA, 2008, BIOESSAYS, V30, P1110, DOI 10.1002/bies.20834; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; KLEMENT EP, 1982, J MATH ANAL APPL, V85, P543, DOI 10.1016/0022-247X(82)90015-4; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MacNamara A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045003; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Naldi A, 2015, BIOINFORMATICS, V31, P1154, DOI 10.1093/bioinformatics/btv013; Powell M.J.D., 1970, NUMERICAL METHODS NO, P87; Shmulevich I., 2007, GENOMIC SIGNAL PROCE; Sridharan S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S4; Wittmann DM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000569; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Yao JT, 2008, IEEE INT CONF FUZZY, P983, DOI 10.1109/FUZZY.2008.4630489; Zadeh L. A., 1978, Fuzzy Sets and Systems, V1, P3, DOI 10.1016/0165-0114(78)90029-5; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131832	10.1371/journal.pone.0131832	http://dx.doi.org/10.1371/journal.pone.0131832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207376	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000018
J	Karremans, AP; Pupulin, F; Gravendeel, B				Karremans, Adam P.; Pupulin, Franco; Gravendeel, Barbara			Specklinia dunstervillei, a New Species Long Confused with Specklinia endotrachys (Orchidaceae: Pleurothallidinae)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; COSTA-RICA; DNA; NUCLEAR; SEQUENCES; GENUS	Specklinia dunstervillei is described as a new species in recognition of the distinctness of a Venezuelan species related to and confused with Specklinia endotrachys. It was illustrated for the first time by G. C. K. Dunsterville in 1963 from a plant collected in Trujillo on the Cordillera de Merida. The newly named species can be easily recognized by its small habit, short leaves and small reddish-orange flowers, the non-ascending dorsal sepal and the obtuse petals that are shortly apiculate. Specklinia dunstervillei is formally described and illustrated once again and compared morphologically and genetically with its closest relatives.	[Karremans, Adam P.; Pupulin, Franco] Univ Costa Rica, Lankester Bot Garden, Cartago, Costa Rica; [Karremans, Adam P.; Gravendeel, Barbara] Leiden Univ, Naturalis Biodivers Ctr, Leiden, Netherlands; [Pupulin, Franco] Harvard Univ Hebaria, Cambridge, MA 02138 USA; [Pupulin, Franco] Marie Selby Bot Gardens, Sarasota, FL USA	Universidad Costa Rica; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; Harvard University	Karremans, AP (corresponding author), Univ Costa Rica, Lankester Bot Garden, POB 302-7050, Cartago, Costa Rica.	adam.karremans@ucr.ac.cr	Karremans, Adam P./H-6996-2019	Karremans, Adam P./0000-0001-5987-7710	University of Costa Rica [814-B1-239, 814-B3-075]	University of Costa Rica	We are very thankful to Gerson Villalobos and Koos Wubben who were happy to allow us access to their cultivated plants used for description and illustrations in this manuscript. Karen Gil was kind enough to share the herbarium and photographical material prepared by Misas Urreta of this species in Colombia. Sylvia Stigari made a beautiful painting of the species and allowed us to reproduce it here. Esmee Winkel prepared an excellent line drawing of the novel taxon for us. Rogier van Vugt photographed the novelty at the Hortus botanicus in Leiden. We are especially thankful to Gustavo Romero, curator of the Orchid Herbarium of Oakes Ames, who kindly provided Dunsterville's material at the Harvard University Herbaria. We are also in debt to the Vice-Presidency of Research of the University of Costa Rica for providing support through the projects "Filogenia molecular de las especies de Orchidaceae endemicas de Costa Rica" (814-B1-239) and "Taxonomia, filogenia molecular, aislamiento reproductivo y diferenciacion de nichos de Specklinia endotrachys" (814-B3-075).	Bogarin D., 2007, LANKESTERIANA, V7, P543; Bogarin D, 2013, PHYTOTAXA, V115, P31, DOI 10.11646/phytotaxa.115.2.1; Chase MW, 2009, ANN BOT-LONDON, V104, P387, DOI 10.1093/aob/mcp067; Chiron GR, 2012, PHYTOTAXA, V46, P34, DOI 10.11646/phytotaxa.46.1.5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunsterville GCK, 1965, VENEZUELAN ORCHIDS I, V3; Karremans A. P., 2013, PLANT SYST EVOL, V29, P69; Karremans AP, 2010, THESIS WAGENINGEN U; KARREMANS AP, 2013, LANKESTERIANA, V13, P132, DOI DOI 10.15517/LANK.V0I0.11556; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Leopardi C, 2012, PHYTOTAXA, V65, P23, DOI 10.11646/phytotaxa.65.1.3; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; MEYER GE, 2012, ORCHIDEENJOURNAL, V19, P107; Ortiz P, 2007, GALERIA ORQUIDEAS CO; Pridgeon A. M., 2005, GENERA ORCHIDACEAR 1, V4, P319; Pridgeon AM, 2001, AM J BOT, V88, P2286, DOI 10.2307/3558390; Pupulin F, 2013, ORCHIDEE HAMBURG 2, V64, P475; Pupulin F, 2013, ORCHIDEE HAMBURG 1, V64, P392; Pupulin F, 2012, PHYTOTAXA, V63, P1; Rambaut A, 2009, FIGTREE V1 3 1; Ramos-Castro SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048822; Staden R, 2003, INTRO BIOINFORMATICS; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978	25	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131971	10.1371/journal.pone.0131971	http://dx.doi.org/10.1371/journal.pone.0131971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207634	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000019
J	Orly, G; Manor, U; Gov, NS				Orly, Gilad; Manor, Uri; Gov, Nir S.			A Biophysical Model for the Staircase Geometry of Stereocilia	PLOS ONE			English	Article							HAIR-CELLS; ACTIN-FILAMENTS; BIRD COCHLEA; MECHANOELECTRICAL TRANSDUCTION; LOCALIZATION; ELONGATION; DYNAMICS; ESPIN; CHANNELS; ROOTLETS	Cochlear hair cell bundles, made up of 10s to 100s of individual stereocilia, are essential for hearing, and even relatively minor structural changes, due to mutations or injuries, can result in total deafness. Consistent with its specialized role, the staircase geometry (SCG) of hair cell bundles presents one of the most striking, intricate, and precise organizations of actin-based cellular shapes. Composed of rows of actin-filled stereocilia with increasing lengths, the hair cell's staircase-shaped bundle is formed from a progenitor field of smaller, thinner, and uniformly spaced microvilli with relatively invariant lengths. While recent genetic studies have provided a significant increase in information on the multitude of stereocilia protein components, there is currently no model that integrates the basic physical forces and biochemical processes necessary to explain the emergence of the SCG. We propose such a model derived from the biophysical and biochemical characteristics of actin-based protrusions. We demonstrate that polarization of the cell's apical surface, due to the lateral polarization of the entire epithelial layer, plays a key role in promoting SCG formation. Furthermore, our model explains many distinct features of the manifestations of SCG in different species and in the presence of various deafness-associated mutations.	[Orly, Gilad; Gov, Nir S.] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Manor, Uri] NIH, Sect Organelle Biol, Bethesda, MD 20892 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA	Gov, NS (corresponding author), Weizmann Inst Sci, Dept Chem Phys, POB 26, IL-76100 Rehovot, Israel.	nir.gov@weizmann.ac.il	GOV, NIR/K-1415-2012	GOV, NIR/0000-0001-7774-1139; Manor, Uri/0000-0002-9802-1955				Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Bashtanov ME, 2004, J PHYSIOL-LONDON, V559, P287, DOI 10.1113/jphysiol.2004.065565; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Ben Isaac E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022718; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chou SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014807; Fettiplace R, 2014, PHYSIOL REV, V94, P951, DOI 10.1152/physrev.00038.2013; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Gov NS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.018101; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; Hudspeth AJ, 2014, NAT REV NEUROSCI, V15, P600, DOI 10.1038/nrn3786; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Jacobo A, 2014, P NATL ACAD SCI USA; Kachar B, 1997, HEARING RES, V107, P102, DOI 10.1016/S0378-5955(97)00027-0; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Mburu P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011627; Mogensen MM, 2007, CELL MOTIL CYTOSKEL, V64, P496, DOI 10.1002/cm.20199; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Naoz M, 2008, BIOPHYS J, V95, P5706, DOI 10.1529/biophysj.108.143453; Nin F, 2012, P NATL ACAD SCI USA, V109, P21076, DOI 10.1073/pnas.1219379110; Orly G, 2014, BIOPHYS J, V107, P576, DOI 10.1016/j.bpj.2014.05.040; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; TILNEY LG, 1988, J CELL BIOL, V107, P2563, DOI 10.1083/jcb.107.6.2563; TILNEY LG, 1988, J CELL BIOL, V106, P355, DOI 10.1083/jcb.106.2.355; TILNEY LG, 1986, DEV BIOL, V116, P100, DOI 10.1016/0012-1606(86)90047-3; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Zampini V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001048; Zhuravlev PI, 2012, P NATL ACAD SCI USA, V109, P10849, DOI 10.1073/pnas.1200160109	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0127926	10.1371/journal.pone.0127926	http://dx.doi.org/10.1371/journal.pone.0127926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207893	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000002
J	Peron, G; Altwegg, R				Peron, Guillaume; Altwegg, Res			Departures from the Energy-Biodiversity Relationship in South African Passerines: Are the Legacies of Past Climates Mediated by Behavioral Constraints on Dispersal?	PLOS ONE			English	Article							GEOGRAPHICAL PATTERNS; SPECIES DISTRIBUTION; DIVERSITY PATTERNS; POTENTIAL IMPACTS; OCCUPANCY MODELS; TECTONIC UPLIFT; EVOLUTION; COMMUNITY; DISTRIBUTIONS; ORIGINS	Legacies of paleoclimates in contemporary biodiversity patterns have mostly been investigated with global datasets, or with weakly dispersive organisms, and as a consequence been interpreted in terms of geographical or physical constraints. If paleoclimatic legacies also occurred at the regional scale in the distributions of vagile organisms within biomes, they would rather suggest behavioral constraints on dispersal, i.e., philopatric syndromes. We examined 1) the residuals of the regression between contemporary energy and passerine species richness in South African biomes and 2) phylogenetic dispersion of passerine assemblages, using occupancy models and quarter-degree resolution citizen science data. We found a northeast to southwest gradient within mesic biomes congruent with the location of Quaternary mesic refugia, overall suggesting that as distance from refugia increased, more clades were lacking from local assemblages. A similar but weaker pattern was detected in the arid Karoo Biomes. In mobile organisms such as birds, behavioral constraints on dispersal appear strong enough to influence species distributions thousands of years after historical range contractions.	[Peron, Guillaume; Altwegg, Res] Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7701 Cape Town, South Africa; [Altwegg, Res] Univ Cape Town, African Climate & Dev Initiat, ZA-7701 Rondebosch, South Africa	University of Cape Town; University of Cape Town	Altwegg, R (corresponding author), Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7701 Cape Town, South Africa.	res.altwegg@gmail.com	PERON, Guillaume/C-5379-2013	PERON, Guillaume/0000-0002-6311-4377	National Research Foundation of South Africa [85802]; South African National Biodiversity Institute; U.S. Fish and Wildlife Service; Commonwealth of the Northern Mariana Islands Division of Fish Wildlife; French National Parks (PNF)	National Research Foundation of South Africa(National Research Foundation - South Africa); South African National Biodiversity Institute; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Commonwealth of the Northern Mariana Islands Division of Fish Wildlife; French National Parks (PNF)	This study was supported by a grant from the National Research Foundation of South Africa (Grant 85802) and by the South African National Biodiversity Institute. GP also received support from the U.S. Fish and Wildlife Service, the Commonwealth of the Northern Mariana Islands Division of Fish & Wildlife, and French National Parks (PNF). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; [Anonymous], 1878, TROPICAL NATURE OTHE; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Bentley J, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-27; Blach-Overgaard A, 2013, ECOLOGY, V94, P2426, DOI 10.1890/12-1577.1; Bled F, 2013, ECOL EVOL, V3, P4896, DOI 10.1002/ece3.858; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Boyd JH, 2014, TAXONOMY FLUX CHECKL; Broms KM, 2014, ECOL APPL, V24, P363, DOI 10.1890/12-2151.1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; Chase BM, 2009, QUATERNARY SCI REV, V28, P301, DOI 10.1016/j.quascirev.2008.10.008; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chazdon RL, 2003, ECOL MONOGR, V73, P331, DOI 10.1890/02-4037; Clements JF, 2013, EBIRD CLEMENTS CHECK; Couvreur TLP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-54; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; De Klerk HM, 2002, DIVERS DISTRIB, V8, P147, DOI 10.1046/j.1472-4642.2002.00142.x; Delgado MD, 2011, BIOL REV, V86, P717, DOI 10.1111/j.1469-185X.2010.00167.x; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Demos TC, 2014, MOL PHYLOGENET EVOL, V71, P41, DOI 10.1016/j.ympev.2013.10.014; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P372, DOI 10.1111/j.1466-822x.2006.00228.x; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Finlayson C., 2011, AVIAN SURVIVORS HIST; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; FJELDSA J, 1994, BIODIVERS CONSERV, V3, P207, DOI 10.1007/BF00055939; Gill F, 2013, IOC WORLD BIRD LIST; Goldberg EE, 2007, AM NAT, V170, P297, DOI 10.1086/518946; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harrison JA, 1997, ATLAS SO AFRICAN BIR; Helm B, 2006, PLOS BIOL, V4, P611, DOI 10.1371/journal.pbio.0040110; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Huntley B, 2014, J BIOGEOGR, V41, P1338, DOI 10.1111/jbi.12288; Huntley B, 2012, DIVERS DISTRIB, V18, P769, DOI 10.1111/j.1472-4642.2012.00890.x; Hurlbert AH, 2014, ECOL LETT, V17, P401, DOI 10.1111/ele.12240; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Meller L, 2014, DIVERS DISTRIB, V20, P309, DOI 10.1111/ddi.12162; Mucina L., 2011, VEGETATION S AFRICA; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Nichol JE, 1999, GEOGR J, V165, P79, DOI 10.2307/3060512; ORD K, 1975, J AM STAT ASSOC, V70, P120, DOI 10.2307/2285387; Partridge TC, 1999, QUATERN INT, V57-8, P207, DOI 10.1016/S1040-6182(98)00061-5; Pearse WD, 2013, ECOLOGY, V94, P2861, DOI 10.1890/12-1676.1; Peron G, 2015, ECOGRAPHY, P1; Peron G, 2015, GLOBAL CHANGE BIOL, V21, P3347, DOI 10.1111/gcb.12909; Peron G, 2010, J ANIM ECOL, V79, P317, DOI 10.1111/j.1365-2656.2009.01635.x; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; R Core Team, 2021, R LANGUAGE ENV STAT; Ribeiro AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085903; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; SCHULZE RE, 2007, S AFRICAN ATLAS CLIM; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Singarayer JS, 2010, QUATERNARY SCI REV, V29, P43, DOI 10.1016/j.quascirev.2009.10.011; Smitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056235; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stokes S, 1997, NATURE, V388, P154, DOI 10.1038/40596; Tolley KA, 2014, ECOLOGY EVOLUTION FY, P143; Verboom GA, 2009, MOL PHYLOGENET EVOL, V51, P44, DOI 10.1016/j.ympev.2008.01.037; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Voelker G, 2013, MOL ECOL, V22, P3333, DOI 10.1111/mec.12305; Walther BA, 2007, IBIS, V149, P701, DOI 10.1111/j.1474-919X.2007.00690.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2011, ECOL LETT, V14, P643, DOI 10.1111/j.1461-0248.2011.01625.x; Winger BM, 2014, P NATL ACAD SCI USA, V111, P12115, DOI 10.1073/pnas.1405000111	80	3	3	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133992	10.1371/journal.pone.0133992	http://dx.doi.org/10.1371/journal.pone.0133992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208300	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000186
J	Sandelin, LL; Tolf, C; Larsson, S; Wilhelmsson, P; Salaneck, E; Jaenson, TGT; Lindgren, PE; Olsen, B; Waldenstrom, J				Sandelin, Lisa Labbe; Tolf, Conny; Larsson, Sara; Wilhelmsson, Peter; Salaneck, Erik; Jaenson, Thomas G. T.; Lindgren, Per-Eric; Olsen, Bjorn; Waldenstrom, Jonas			Candidatus Neoehrlichia mikurensis in Ticks from Migrating Birds in Sweden	PLOS ONE			English	Article							IXODES-RICINUS TICKS; BORNE PATHOGENS; ANAPLASMA-PHAGOCYTOPHILUM; SPECIES IDENTIFICATION; INFECTIONS; RODENTS; SPP.	Candidatus Neoehrlichia mikurensis (CNM; family Anaplasmataceae) was recently recognized as a potential tick-borne human pathogen. The presence of CNM in mammals, in host-seeking Ixodes ticks and in ticks attached to mammals and birds has been reported recently. We investigated the presence of CNM in ornithophagous ticks from migrating birds. A total of 1,150 ticks (582 nymphs, 548 larvae, 18 undetermined ticks and two adult females) collected from 5,365 birds captured in south-eastern Sweden was screened for CNM by molecular methods. The birds represented 65 different species, of which 35 species were infested with one or more ticks. Based on a combination of morphological and molecular species identification, the majority of the ticks were identified as Ixodes ricinus. Samples were initially screened by real-time PCR targeting the CNM 16S rRNA gene, and confirmed by a second real-time PCR targeting the groEL gene. For positive samples, a 1260 base pair fragment of the 16S rRNA gene was sequenced. Based upon bacterial gene sequence identification, 2.1% (24/1150) of the analysed samples were CNM-positive. Twenty-two out of 24 CNM-positive ticks were molecularly identified as I. ricinus nymphs, and the remaining two were identified as I. ricinus based on morphology. The overall CNM prevalence in I. ricinus nymphs was 4.2%. None of the 548 tested larvae was positive. CNM-positive ticks were collected from 10 different bird species. The highest CNM-prevalences were recorded in nymphs collected from common redpoll (Carduelis flammea, 3/7), thrush nightingale (Luscinia luscinia, 2/29) and dunnock (Prunella modularis, 1/17). The 16S rRNA sequences obtained in this study were all identical to each other and to three previously reported European strains, two of which were obtained from humans. It is concluded that ornithophagous ticks may be infected with CNM and that birds most likely can disperse CNM-infected ticks over large geographical areas.	[Sandelin, Lisa Labbe; Salaneck, Erik; Jaenson, Thomas G. T.; Olsen, Bjorn] Uppsala Univ, Uppsala, Sweden; [Sandelin, Lisa Labbe] Kalmar Cty Hosp, Dept Infect Dis, Kalmar, Sweden; [Tolf, Conny; Larsson, Sara; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden; [Wilhelmsson, Peter; Lindgren, Per-Eric] Linkoping Univ, Linkoping, Sweden	Uppsala University; Linnaeus University; Linkoping University	Waldenstrom, J (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden.	jonas.waldenstrom@lnu.se	Waldenström, Jonas/E-4460-2013; Sandelin, Lisa Labbé/S-3387-2019; Labbé Sandelin, Lisa/A-5568-2013	Waldenström, Jonas/0000-0002-1152-4235; Sandelin, Lisa Labbé/0000-0002-5621-5655; Labbé Sandelin, Lisa/0000-0002-5621-5655; Olsen, Bjorn/0000-0002-4646-691X; Salaneck, Erik/0000-0002-0000-8948; Wilhelmsson, Peter/0000-0002-9200-2964	Medical Research Council of Southeast Sweden [FORSS-307591, FORSS-387231]; Carl Trygger's Foundation for Scientific Research; Langmanska kulturfonden; Magnus Bergvall's Foundation for Scientific Research; Helge Ax:son Johnson's Foundation; EU Interreg IVA project ScandTick	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Carl Trygger's Foundation for Scientific Research; Langmanska kulturfonden; Magnus Bergvall's Foundation for Scientific Research; Helge Ax:son Johnson's Foundation; EU Interreg IVA project ScandTick	Funding for this study came from the Medical Research Council of Southeast Sweden (grant numbers FORSS-307591 and FORSS-387231), Carl Trygger's Foundation for Scientific Research, Langmanska kulturfonden, Magnus Bergvall's Foundation for Scientific Research, Helge Ax:son Johnson's Foundation and the EU Interreg IVA project ScandTick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2013, VECTOR-BORNE ZOONOT, V13, P438, DOI 10.1089/vbz.2012.1118; Andersson M, 2011, EMERG INFECT DIS, V17, P1716, DOI 10.3201/eid1709.101058; Andreasson K, 2014, RHEUMATOLOGY OXFORD; Arthur DR, 1963, BRITISH TICKS; Derdakova M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-160; Filippova NA, 1977, IXODID TICKS OF THE; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grankvist A, 2014, CLIN INFECT DIS, V58, P1716, DOI 10.1093/cid/ciu189; Hasle G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00048; Heylen D, 2014, TICKS TICK-BORNE DIS, V5, P693, DOI 10.1016/j.ttbdis.2014.05.006; Hillyard PD, 1996, SYNOPSES OF THE BRIT, V52; Hornok S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-128; Jahfari S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-74; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Li H, 2012, EMERG INFECT DIS, V18, P1636, DOI 10.3201/eid1810.120594; Lommano E, 2014, TICKS TICK-BORNE DIS, V5, P871, DOI 10.1016/j.ttbdis.2014.07.001; Lv JZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-93; Lv JZ, 2014, MITOCHONDR DNA, V25, P142, DOI 10.3109/19401736.2013.792052; Maurer FP, 2013, J CLIN MICROBIOL, V51, P169, DOI 10.1128/JCM.01955-12; Movila A, 2012, MED VET ENTOMOL; Richter D, 2013, PARASITOL RES, V112, P107, DOI 10.1007/s00436-012-3110-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schouls LM, 1999, J CLIN MICROBIOL, V37, P2215, DOI 10.1128/JCM.37.7.2215-2222.1999; Spitalska E, 2006, WIEN KLIN WOCHENSCHR, V118, P759, DOI 10.1007/s00508-006-0729-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vayssier-Taussat M, 2012, EMERG INFECT DIS, V18, P2063, DOI 10.3201/eid1812.120846; Welc-Faleciak R, 2014, J CLIN MICROBIOL, V52, P3072, DOI 10.1128/JCM.00741-14; Welinder-Olsson C, 2010, J CLIN MICROBIOL, V48, P1956, DOI 10.1128/JCM.02423-09; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433; Zhang RL, 2014, TICKS TICK-BORNE DIS, V5, P352, DOI 10.1016/j.ttbdis.2014.01.001	30	20	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133250	10.1371/journal.pone.0133250	http://dx.doi.org/10.1371/journal.pone.0133250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207834	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000071
J	Shao, YB; Sun, XF; He, YN; Liu, CJ; Liu, H				Shao, Yingbo; Sun, Xianfu; He, Yaning; Liu, Chaojun; Liu, Hui			Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer	PLOS ONE			English	Article							ONCOLOGY 2007 UPDATE; CA 15-3; AMERICAN SOCIETY; RECOMMENDATIONS; CA-15-3; EXPRESSION; DIAGNOSIS; THERAPY	Background & Aims The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in patients with breast cancer remains controversial. The present study aims to investigate the prognostic value of preoperative serum CEA and CA15-3 levels in breast cancer patients. Methods Serum preoperative CEA and CA 15-3 concentration levels were measured in a total of 432 breast cancer patients. The association of tumor markers levels with clinicopathological parameters and outcomes were analyzed. Results Elevated serum levels of CEA and CA15-3 were identified in 47 (10.9%) and 60(13.9%) patients, respectively. Larger tumor size, advanced axillary lymph nodal and TNM stage exhibited higher proportion of elevated CEA and CA15-3 levels. The elevation of CEA levels was significantly greater in patients with HER2 positive tumors, and the elevation of CA15-3 levels was significantly greater in ER negative breast patients. Univariate and multivariate Cox's regression analysis revealed that elevated preoperative CEA and CA 15-3 levels were independent prognostic factors for DFS and OS. When considering the combination of both markers levels, patients with both elevated markers presented the worst survival. Independent prognostic significance of elevated preoperative serum CEA and CA15-3 levels were reconfirmed in Luminal B breast cancer. Conclusions Preoperative serum levels of CEA and CA15-3 are independent prognostic parameters for breast cancer.	[Shao, Yingbo; Sun, Xianfu; He, Yaning; Liu, Chaojun; Liu, Hui] Zhengzhou Univ, Dept Breast Oncol, Affiliated Canc Hosp, Zhengzhou 450052, Peoples R China; [Shao, Yingbo; Sun, Xianfu; He, Yaning; Liu, Chaojun; Liu, Hui] Henan Prov Tumor Hosp, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Liu, H (corresponding author), Zhengzhou Univ, Dept Breast Oncol, Affiliated Canc Hosp, Zhengzhou 450052, Peoples R China.	liuhuimed@126.com	Liu, Chaojun/P-7848-2016	liu, chaojun/0000-0002-4676-3981	key scientific and technological projects of Science and Technology Department of Henan Province [122102310535]	key scientific and technological projects of Science and Technology Department of Henan Province	This work was supported by the key scientific and technological projects of Science and Technology Department of Henan Province (No. 122102310535).	Ades F, 2014, J CLIN ONCOL, V32, P2794, DOI 10.1200/JCO.2013.54.1870; Ali HQ, 2013, J PAK MED ASSOC, V63, P1138; Cardoso F, 2008, J CLIN ONCOL, V26, P2058, DOI 10.1200/JCO.2007.15.6638; Dai N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058001; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Di Gioia D, 2011, TUMOR BIOL, V32, P777, DOI 10.1007/s13277-011-0180-7; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hashim ZM, 2014, INT J IMMUNOPATH PH, V27, P45, DOI 10.1177/039463201402700107; Incoronato M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-356; Laessig D, 2007, ANTICANCER RES, V27, P1963; Lee JS, 2013, ANN ONCOL, V24, P1225, DOI 10.1093/annonc/mds604; Lee JS, 2013, BREAST CANCER RES TR, V141, P477, DOI 10.1007/s10549-013-2695-7; Lonning PE, 2007, ANN ONCOL, V18, P3, DOI 10.1093/annonc/mdm260; Maric P, 2011, COLLEGIUM ANTROPOL, V35, P241; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Molina R, 2005, TUMOR BIOL, V26, P281, DOI 10.1159/000089260; Ogba N, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0489-4; Park BW, 2008, ANN ONCOL, V19, P675, DOI 10.1093/annonc/mdm538; Pedersen AC, 2013, CLIN CHEM LAB MED, V51, P1511, DOI 10.1515/cclm-2012-0488; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Samy N, 2010, CANCER BIOMARK, V6, P63, DOI 10.3233/CBM-2009-0119; Selz J, 2012, INT J RADIAT ONCOL, V84, P1123, DOI 10.1016/j.ijrobp.2012.02.047; Skrbo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113278; Soletormos G, 2004, EUR J CANCER, V40, P481, DOI 10.1016/j.ejca.2003.10.015; Uehara M, 2008, INT J CLIN ONCOL, V13, P447, DOI 10.1007/s10147-008-0773-3; Wu SL, 2014, APPL MATH LETT, V38, P57, DOI 10.1016/j.aml.2014.07.002; Zhou C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100159	28	114	116	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133830	10.1371/journal.pone.0133830	http://dx.doi.org/10.1371/journal.pone.0133830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207909	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000152
J	Kleint, NI; Wittchen, HU; Lueken, U				Kleint, Nina I.; Wittchen, Hans-Ulrich; Lueken, Ulrike			Probing the Interoceptive Network by Listening to Heartbeats: An fMRI Study	PLOS ONE			English	Article							INFERIOR PARIETAL LOBULE; ANTERIOR INSULA; BRAIN ACTIVATION; CARDIOVASCULAR AROUSAL; CORTEX; ATTENTION; EMOTION	Exposure to cues of homeostatic relevance (i.e. heartbeats) is supposed to increase the allocation of attentional resources towards the cue, due to its importance for self-regulatory, interoceptive processes. This functional magnetic resonance imaging (fMRI) study aimed at determining whether listening to heartbeats is accompanied by activation in brain areas associated with interoception, particularly the insular cortex. Brain activity was measured with fMRI during cue-exposure in 36 subjects while listening to heartbeats vs. sinus tones. Autonomic markers (skin conductance) and subjective measures of state and trait anxiety were assessed. Stimulation with heartbeat sounds triggered activation in brain areas commonly associated with the processing of interoceptive information, including bilateral insular cortices, the inferior frontal operculum, and the middle frontal gyrus. A psychophysiological interaction analysis indicated a functional connectivity between the middle frontal gyrus (seed region) and bilateral insular cortices, the left amygdala and the supplementary motor area. The magnitude of neural activation in the right anterior insular cortex was positively associated with autonomic arousal. The present findings indicate that listening to heartbeats induced activity in areas of the interoception network as well as changes in psychophysiological arousal and subjective emotional experience. As this approach constitutes a promising method for studying interoception in the fMRI environment, a clinical application in anxiety prone populations should be addressed by future studies.	[Kleint, Nina I.; Wittchen, Hans-Ulrich; Lueken, Ulrike] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Germany; [Kleint, Nina I.; Wittchen, Hans-Ulrich; Lueken, Ulrike] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, D-01062 Dresden, Germany; [Lueken, Ulrike] Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychoatherapy, Wurzburg, Germany	Technische Universitat Dresden; Technische Universitat Dresden; University of Wurzburg	Lueken, U (corresponding author), Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-01062 Dresden, Germany.	Lueken_U@ukw.de	Lueken, Ulrike/A-8109-2014; Wittchen, Hans-Ulrich/A-8507-2014; Wittchen, Hans-Ulrich/ABA-8901-2020	Lueken, Ulrike/0000-0003-1564-4012; Wittchen, Hans-Ulrich/0000-0002-6311-7711	Open Access Publication Funds of the TU Dresden	Open Access Publication Funds of the TU Dresden	The authors acknowledge support by the Open Access Publication Funds of the TU Dresden.	Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Benedek M, 2010, PSYCHOPHYSIOLOGY, V47, P647, DOI 10.1111/j.1469-8986.2009.00972.x; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Cameron OG, 2000, PSYCHOSOM MED, V62, P549, DOI 10.1097/00006842-200007000-00014; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Cauda F, 2012, NEUROIMAGE, V62, P343, DOI 10.1016/j.neuroimage.2012.04.012; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008; Dziobek I, 2011, NEUROIMAGE, V57, P539, DOI 10.1016/j.neuroimage.2011.05.005; EHLERS A, 1993, ADV BEHAV RES THER, V15, P3, DOI 10.1016/0146-6402(93)90001-I; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Holtz K, 2012, NEUROIMAGE, V61, P857, DOI 10.1016/j.neuroimage.2012.03.019; Holzl R, 1996, BIOL PSYCHOL, V42, P199, DOI 10.1016/0301-0511(95)05155-4; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Lovero KL, 2009, NEUROIMAGE, V45, P976, DOI 10.1016/j.neuroimage.2008.12.070; Lueken U, 2014, SOC COGN AFFECT NEUR, V9, P1668, DOI 10.1093/scan/nst159; LYKKEN DT, 1972, PSYCHOPHYSIOLOGY, V9, P373, DOI 10.1111/j.1469-8986.1972.tb03222.x; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Peterson RA., 1992, ANXIETY SENSITIVITY; Pfleiderer B, 2014, J NEURAL TRANSM, V121, P1417, DOI 10.1007/s00702-014-1248-5; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Sandrini M, 2004, NEUROPSYCHOLOGIA, V42, P1902, DOI 10.1016/j.neuropsychologia.2004.05.005; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Stephani C, 2011, BRAIN STRUCT FUNCT, V216, P137, DOI 10.1007/s00429-010-0296-3; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Terasawa Y, 2013, SOC COGN AFFECT NEUR, V8, P259, DOI 10.1093/scan/nss108; Terasawa Y, 2013, HUM BRAIN MAPP, V34, P598, DOI 10.1002/hbm.21458; Tracy J, 2007, PSYCHOSOM MED, V69, P952, DOI 10.1097/PSY.0b013e31815b60cf; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; Wendt J, 2008, PSYCHOPHYSIOLOGY, V45, P205, DOI 10.1111/j.1469-8986.2007.00620.x; Weston CSE, 2012, NEUROSCI BIOBEHAV R, V36, P90, DOI 10.1016/j.neubiorev.2011.04.014; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012	52	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133164	10.1371/journal.pone.0133164	http://dx.doi.org/10.1371/journal.pone.0133164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204524	gold, Green Published, Green Submitted			2022-12-26	WOS:000358621000020
J	Zhou, SM; Chen, LM; Liu, SQ; Wang, XF; Sun, XD				Zhou, Shu-Mei; Chen, Li-Mei; Liu, Shi-Qi; Wang, Xiu-Feng; Sun, Xiu-Dong			De Novo Assembly and Annotation of the Chinese Chive (Allium tuberosum Rottler ex Spr.) Transcriptome Using the Illumina Platform	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; GENERATION; MARKERS; GENOMES; LILIUM; PLANTS; LIFE; TOOL	Chinese chive (A. tuberosum Rottler ex Spr.) is one of the most widely cultivated Allium species in China. However, minimal transcriptomic and genomic data are available to reveal its evolution and genetic diversity. In this study, de novo transcriptome sequencing was performed to produce large transcript sequences using an Illumina HiSeq 2000 instrument. We produced 51,968,882 high-quality clean reads and assembled them into 150,154 contigs. A total of 60,031 unigenes with an average length of 631 bp were identified. Of these, 36,523 unigenes were homologous to existing database sequences, 35,648 unigenes were annotated in the NCBI non-redundant (Nr) sequence database, and 23,509 unigenes were annotated in the Swiss-Prot database. A total of 26,798 unigenes were assigned to 57 Gene Ontology (GO) terms, and 13,378 unigenes were assigned to Cluster of Orthologous Group categories. Using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database, we mapped 21,361 unigenes onto 128 pathways. Furthermore, 2,125 sequences containing simple sequence repeats (SSRs) were identified. This new dataset provides the most comprehensive resource currently available for gene expression, gene discovery, and future genomic research on Chinese chive. The sequence resources developed in this study can be used to develop molecular markers that will facilitate further genetic research on Chinese chive and related species.	[Zhou, Shu-Mei] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Chen, Li-Mei; Liu, Shi-Qi; Wang, Xiu-Feng; Sun, Xiu-Dong] Shandong Agr Univ, State Key Lab Crop Biol, Key Lab Biol & Genet Improvement Hort Crops Huanh, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Sun, XD (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Key Lab Biol & Genet Improvement Hort Crops Huanh, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China.	xdsun@sdau.edu.cn			National Natural Science Foundation of China [31372084]; Chinese National Department Public Benefit Research Foundation [201303108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Department Public Benefit Research Foundation	This work was supported by the National Natural Science Foundation of China (31372084), ShiqiLiu, (http://www.nsfc.gov.cn/) and the Chinese National Department Public Benefit Research Foundation (201303108); ShiqiLiu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Du F, 2015, PLANT MOL BIOL REP, V33, P281, DOI 10.1007/s11105-014-0746-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths G, 2002, PHYTOTHER RES, V16, P603, DOI 10.1002/ptr.1222; Gross SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-563; Guo H, 2013, FISH SHELLFISH IMMUN, V35, P2008, DOI 10.1016/j.fsi.2013.09.019; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Jung WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111982; Kamenetsky R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1212-2; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092087; Kim S, 2014, DNA RES; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106438; Liu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113290; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Peng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090636; Randle W. M., 2002, ALLIUM CROP SCI RECE; Shahin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-640; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Tsukazaki H, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0265-x; Wang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060449; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091740; Zhu LC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/750961	27	25	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133312	10.1371/journal.pone.0133312	http://dx.doi.org/10.1371/journal.pone.0133312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204518	Green Published, gold, Green Submitted			2022-12-26	WOS:000358621000026
J	Piacenza, SE; Thurman, LL; Barner, AK; Benkwitt, CE; Boersma, KS; Cerny-Chipman, EB; Ingeman, KE; Kindinger, TL; Lindsley, AJ; Nelson, J; Reimer, JN; Rowe, JC; Shen, CC; Thompson, KA; Heppell, SS				Piacenza, Susan E.; Thurman, Lindsey L.; Barner, Allison K.; Benkwitt, Cassandra E.; Boersma, Kate S.; Cerny-Chipman, Elizabeth B.; Ingeman, Kurt E.; Kindinger, Tye L.; Lindsley, Amy J.; Nelson, Jake; Reimer, Jessica N.; Rowe, Jennifer C.; Shen, Chenchen; Thompson, Kevin A.; Heppell, Selina S.			Evaluating Temporal Consistency in Marine Biodiversity Hotspots	PLOS ONE			English	Article							PROPAGULE DISPERSAL; BIOLOGICAL HOTSPOTS; NORTH PACIFIC; HOT-SPOTS; CONSERVATION; PREDATORS; RECOVERY; RATES	With the ongoing crisis of biodiversity loss and limited resources for conservation, the concept of biodiversity hotspots has been useful in determining conservation priority areas. However, there has been limited research into how temporal variability in biodiversity may influence conservation area prioritization. To address this information gap, we present an approach to evaluate the temporal consistency of biodiversity hotspots in large marine ecosystems. Using a large scale, public monitoring dataset collected over an eight year period off the US Pacific Coast, we developed a methodological approach for avoiding biases associated with hotspot delineation. We aggregated benthic fish species data from research trawls and calculated mean hotspot thresholds for fish species richness and Shannon's diversity indices over the eight year dataset. We used a spatial frequency distribution method to assign hotspot designations to the grid cells annually. We found no areas containing consistently high biodiversity through the entire study period based on the mean thresholds, and no grid cell was designated as a hotspot for greater than 50% of the time-series. To test if our approach was sensitive to sampling effort and the geographic extent of the survey, we followed a similar routine for the northern region of the survey area. Our finding of low consistency in benthic fish biodiversity hotspots over time was upheld, regardless of biodiversity metric used, whether thresholds were calculated per year or across all years, or the spatial extent for which we calculated thresholds and identified hotspots. Our results suggest that static measures of benthic fish biodiversity off the US West Coast are insufficient for identification of hotspots and that long-term data are required to appropriately identify patterns of high temporal variability in biodiversity for these highly mobile taxa. Given that ecological communities are responding to a changing climate and other environmental perturbations, our work highlights the need for scientists and conservation managers to consider both spatial and temporal dynamics when designating biodiversity hotspots.	[Piacenza, Susan E.; Thurman, Lindsey L.; Lindsley, Amy J.; Rowe, Jennifer C.; Thompson, Kevin A.; Heppell, Selina S.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Barner, Allison K.; Benkwitt, Cassandra E.; Boersma, Kate S.; Cerny-Chipman, Elizabeth B.; Ingeman, Kurt E.; Kindinger, Tye L.; Reimer, Jessica N.; Shen, Chenchen] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Nelson, Jake] Oregon State Univ, Dept Geog Environm Sci & Marine Resource Manageme, Corvallis, OR 97331 USA; [Boersma, Kate S.] Univ San Diego, Dept Biol, San Diego, CA 92110 USA; [Nelson, Jake] Drexel Univ, Dept Informat Syst, Philadelphia, PA 19104 USA	Oregon State University; Oregon State University; Oregon State University; University of San Diego; Drexel University	Piacenza, SE (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	susan.hilber@oregonstate.edu	Thurman, Lindsey/AAF-7056-2020; Reimer, Jessica/GQZ-4144-2022	Benkwitt, Cassandra/0000-0001-6756-7958; Nelson, Jake/0000-0001-9300-4892; Thurman, Lindsey/0000-0003-3142-4909; Barner, Allison/0000-0001-9909-5713; Rowe, Jennifer/0000-0002-5253-2223	National Science Foundation Grant [1050680]; University of Washington; Thomas G. Scott Publication Fund	National Science Foundation Grant(National Science Foundation (NSF)); University of Washington(University of Washington); Thomas G. Scott Publication Fund	Funding was provided by a National Science Foundation Grant to Sandy Andelman and Julia Parrish: The Dimensions of Biodiversity Distributed Graduate Seminar (1050680). A sub-grant, via the University of Washington, was provided to Selina Heppell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.nsf.gov/awardsearch/showAward?AWD_ID=1050680&HistoricalAwards=false. Publication of this paper was supported, in part, by the Thomas G. Scott Publication Fund	Allen AP, 2006, ECOL LETT, V9, P947, DOI 10.1111/j.1461-0248.2006.00946.x; Aquarone M, 2009, UNEP LARGE MARINE EC, P851; Baird AH, 2002, SCIENCE, V296, P1026, DOI 10.1126/science.296.5570.1026; Bartolino V, 2011, POPUL ECOL, V53, P603, DOI 10.1007/s10144-011-0273-6; Bartolino V, 2011, POPUL ECOL, V53, P351, DOI 10.1007/s10144-010-0229-2; Bonar Scott A., 2011, P11; Bradburn MJ, 2011, 2003 2008 US BOTTOM, P323; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Cayuela L, 2011, POPUL ECOL, V53, P597, DOI 10.1007/s10144-011-0272-7; Davoren G, 2013, MAR BIOL, V160, P3043, DOI 10.1007/s00227-013-2294-5; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Hutchings JA, 2005, PHILOS T R SOC B, V360, P315, DOI 10.1098/rstb.2004.1586; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Keller AA, 2014, MAR ECOL PROG SER, V501, P169, DOI 10.3354/meps10674; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Lin BB, 2013, ECOL SOC, V18, DOI 10.5751/ES-05128-180128; Link H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074077; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Maurer Brian A., 2011, P55; Maxwell SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3688; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Munasinghe M., 2005, PRIMER CLIMATE CHANG; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; National Oceanic and Atmospheric Administration, 2013, MULTIVARIATE ENSO IN; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Piacenza SE, PLOS ONE IN PRESS; Pico FX, 2003, OIKOS, V103, P69, DOI 10.1034/j.1600-0706.2003.12553.x; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Reese DC, 2006, DEEP-SEA RES PT II, V53, P291, DOI 10.1016/j.dsr2.2006.01.014; Reese DC, 2015, J MARINE SYST, V146, P3, DOI 10.1016/j.jmarsys.2014.10.009; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Sigler MF, 2012, DEEP-SEA RES PT II, V65-70, P292, DOI 10.1016/j.dsr2.2012.02.017; Stefansdottir L, 2010, FISH OCEANOGR, V19, P42, DOI 10.1111/j.1365-2419.2009.00527.x; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Toole CL, 2011, MAR ECOL PROG SER, V428, P201, DOI 10.3354/meps09028; US Department of Commerce NO and AA, 2013, NAT MAR PROT AR CTR; Wallington TJ, 2005, ECOL SOC, V10; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; WILHM JL, 1968, ECOLOGY, V49, P153, DOI 10.2307/1933573; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Willis KJ, 2007, PHILOS T R SOC B, V362, P169, DOI 10.1098/rstb.2006.1976	52	10	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133301	10.1371/journal.pone.0133301	http://dx.doi.org/10.1371/journal.pone.0133301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200354	Green Submitted, Green Published, gold			2022-12-26	WOS:000358597100058
J	Yamauchi, Y; Iwamoto, N; Rogers, MA; Abe-Dohmae, S; Fujimoto, T; Chang, CCY; Ishigami, M; Kishimoto, T; Kobayashi, T; Ueda, K; Furukawa, K; Chang, TY; Yokoyama, S				Yamauchi, Yoshio; Iwamoto, Noriyuki; Rogers, Maximillian A.; Abe-Dohmae, Sumiko; Fujimoto, Toyoshi; Chang, Catherine C. Y.; Ishigami, Masato; Kishimoto, Takuma; Kobayashi, Toshihide; Ueda, Kazumitsu; Furukawa, Koichi; Chang, Ta-Yuan; Yokoyama, Shinji			Deficiency in the Lipid Exporter ABCA1 Impairs Retrograde Sterol Movement and Disrupts Sterol Sensing at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CASSETTE TRANSPORTER A1; HMG COA REDUCTASE; CELLULAR CHOLESTEROL; PLASMA-MEMBRANE; HELICAL APOLIPOPROTEINS; MEDIATED ENDOCYTOSIS; HDL CHOLESTEROL; TANGIER DISEASE; CELLS	Cellular cholesterol homeostasis involves sterol sensing at the endoplasmic reticulum (ER) and sterol export from the plasma membrane (PM). Sterol sensing at the ER requires efficient sterol delivery from the PM; however, the macromolecules that facilitate retrograde sterol transport at the PM have not been identified. ATP-binding cassette transporter A1 (ABCA1) mediates cholesterol and phospholipid export to apolipoprotein A-I for the assembly of high density lipoprotein (HDL). Mutations in ABCA1 cause Tangier disease, a familial HDL deficiency. Several lines of clinical and experimental evidence suggest a second function of ABCA1 in cellular cholesterol homeostasis in addition to mediating cholesterol efflux. Here, we report the unexpected finding that ABCA1 also plays a key role in facilitating retrograde sterol transport from the PM to the ER for sterol sensing. Deficiency in ABCA1 delays sterol esterification at the ER and activates the SREBP-2 cleavage pathway. The intrinsic ATPase activity in ABCA1 is required to facilitate retrograde sterol transport. ABCA1 deficiency causes alternation of PM composition and hampers a clathrin-independent endocytic activity that is required for ER sterol sensing. Our finding identifies ABCA1 as a key macromolecule facilitating bidirectional sterol movement at the PM and shows that ABCA1 controls retrograde sterol transport by modulating a certain clathrin-independent endocytic process.	[Yamauchi, Yoshio; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4668550, Japan; [Rogers, Maximillian A.; Chang, Catherine C. Y.; Chang, Ta-Yuan] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Iwamoto, Noriyuki; Abe-Dohmae, Sumiko] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem, Nagoya, Aichi 4678601, Japan; [Fujimoto, Toyoshi] Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4668550, Japan; [Ishigami, Masato; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Inst Integrated Cell Mat Sci, Kyoto 6068502, Japan; [Ishigami, Masato; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; [Kishimoto, Takuma; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Yokoyama, Shinji] Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 4878501, Japan; [Yokoyama, Shinji] Chubu Univ, Dept Food & Nutr Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; Dartmouth College; Nagoya City University; Nagoya University; Kyoto University; Kyoto University; RIKEN; Chubu University; Chubu University	Yamauchi, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	yyoshio@med.nagoya-u.ac.jp; Ta.Yuan.Chang@Dartmouth.edu	KOBAYASHI, TOSHIHIDE/S-8313-2019; Yamauchi, Yoshio/I-7539-2014; Kishimoto, Takuma/AAP-1813-2021; Regan, Clinton/E-6250-2012; Fujimoto, Toyoshi/ABH-9058-2020	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Yamauchi, Yoshio/0000-0001-5559-4596; Fujimoto, Toyoshi/0000-0002-3601-7977; Ueda, Kazumitsu/0000-0003-2980-6078; Rogers, Maximillian/0000-0001-9277-3200	National Institutes of Health [AG037609, HL060306]; Japan Society for Promotion of Sciences; Ministry of Education, Sciences, Technology, Culture, and Sports of Japan; MEXT-supported program for Strategic Research Foundation at Private Universities; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037609] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05897, 25460385] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Sciences, Technology, Culture, and Sports of Japan; MEXT-supported program for Strategic Research Foundation at Private Universities; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants AG037609 and HL060306 (to T. Y. C. and C. C. Y. C.). This work was also supported by a grant-in-aid for young scientists from the Japan Society for the Promotion of Sciences (to Y. Y.), grants-in-aid for scientific research from the Ministry of Education, Sciences, Technology, Culture, and Sports of Japan (to Y. Y., to S. A.- D., to T. F., to K. U, and to S. Y.), and a MEXT-supported program for the Strategic Research Foundation at Private Universities (to S. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Assmann G, 2001, METABOLIC MOL BASES, P2937; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Brandis KA, 2013, J BIOL CHEM, V288, P35703, DOI 10.1074/jbc.M113.488577; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Chang CCY, 2010, BIOCHEMISTRY-US, V49, P9957, DOI 10.1021/bi1013936; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Chaudhary N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001832; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Du XM, 2015, CIRC RES, V116, P1133, DOI 10.1161/CIRCRESAHA.116.305485; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Frechin M, 2015, NATURE, V523, P88, DOI 10.1038/nature14429; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Hu W, 2008, J LIPID RES, V49, P386, DOI 10.1194/jlr.M700402-JLR200; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ito J, 2000, J LIPID RES, V41, P894; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Metherall JE, 1996, J BIOL CHEM, V271, P2634, DOI 10.1074/jbc.271.5.2634; MOLLER ML, 1961, J LIPID RES, V2, P342; NISHIKAWA O, 1986, J BIOCHEM, V99, P295, DOI 10.1093/oxfordjournals.jbchem.a135473; Olsen BN, 2013, BIOPHYS J, V105, P1838, DOI 10.1016/j.bpj.2013.08.042; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; Parathath S, 2011, CIRC RES, V109, P1141, DOI 10.1161/CIRCRESAHA.111.246363; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Quazi F, 2013, J BIOL CHEM, V288, P34414, DOI 10.1074/jbc.M113.508812; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; Shvets E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7867; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Sugii S, 2003, J BIOL CHEM, V278, P27180, DOI 10.1074/jbc.M300542200; Suzuki S, 2004, ARTERIOSCL THROM VAS, V24, P519, DOI 10.1161/01.ATV.0000117178.94087.ba; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tanaka N, 2010, J LIPID RES, V51, P2591, DOI 10.1194/jlr.M006049; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Yamauchi Y, 2004, J LIPID RES, V45, P1943, DOI 10.1194/jlr.M400264-JLR200; Yamauchi Y, 2007, J BIOL CHEM, V282, P34994, DOI 10.1074/jbc.M703653200; Yamauchi Y, 2011, CANCER RES, V71, P4989, DOI 10.1158/0008-5472.CAN-10-4108; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8; Zarubica A, 2009, FASEB J, V23, P1775, DOI 10.1096/fj.08-122192; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	70	42	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23464	23477		10.1074/jbc.M115.662668	http://dx.doi.org/10.1074/jbc.M115.662668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26198636	Green Published, hybrid			2022-12-26	WOS:000361816500001
J	Kleven, MD; Dlakic, M; Lawrence, CM				Kleven, Mark D.; Dlakic, Mensur; Lawrence, C. Martin			Characterization of a Single b-type Heme, FAD, and Metal Binding Sites in the Transmembrane Domain of Six-transmembrane Epithelial Antigen of the Prostate (STEAP) Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IDENTIFICATION; FERRIREDUCTASE; OXIDOREDUCTASE	Six-transmembrane epithelial antigen of the prostate 3 (Steap3) is the major ferric reductase in developing erythrocytes. Steap family proteins are defined by a shared transmembrane domain that in Steap3 has been shown to function as a transmembrane electron shuttle, moving cytoplasmic electrons derived from NADPH across the lipid bilayer to the extracellular face where they are used to reduce Fe3+ to Fe2+ and potentially Cu2+ to Cu1+. Although the cytoplasmic N-terminal oxidoreductase domain of Steap3 and Steap4 are relatively well characterized, little work has been done to characterize the transmembrane domain of any member of the Steap family. Here we identify high affinity FAD and iron biding sites and characterize a single b-type heme binding site in the Steap3 transmembrane domain. Furthermore, we show that Steap3 is functional as a homodimer and that it utilizes an intrasubunit electron transfer pathway through the single heme moiety rather than an intersubunit electron pathway through a potential domain-swapped dimer. Importantly, the sequence motifs in the transmembrane domain that are associated with the FAD and metal binding sites are not only present in Steap2 and Steap4 but also in Steap1, which lacks the N-terminal oxidoreductase domain. This strongly suggests that Steap1 harbors latent oxidoreductase activity.	[Kleven, Mark D.; Lawrence, C. Martin] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Dlakic, Mensur] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Lawrence, CM (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	lawrence@chemistry.montana.edu	Lawrence, C. Martin/AAH-3420-2020; Dlakic, Mensur/S-2702-2019	Lawrence, C. Martin/0000-0002-5398-466X; Dlakic, Mensur/0000-0003-4315-1514; Kleven, Mark/0000-0003-1204-6658	National Science Foundation Major Research Instrumentation Program; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084326] Funding Source: NIH RePORTER	National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are deeply grateful to Mark D. Fleming for valuable insight and careful reading of the manuscript. We thank Chang-Deng Hu (Purdue University) for providing Venus plasmids that were used for making Gateway vectors. The Montana State University confocal microscope was purchased with funding from the National Science Foundation Major Research Instrumentation Program and the M. J. Murdock Charitable Trust. We also thank Jan Phillipp Kreysing for gracious help in producing Fig. 6.	Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Gauss GH, 2013, J BIOL CHEM, V288, P20668, DOI 10.1074/jbc.M113.479154; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Lambe T, 2009, BLOOD, V113, P1805, DOI 10.1182/blood-2007-11-120402; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lu PL, 2014, P NATL ACAD SCI USA, V111, P1813, DOI 10.1073/pnas.1323931111; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Moreaux J, 2012, BIOCHEM BIOPH RES CO, V429, P148, DOI 10.1016/j.bbrc.2012.10.123; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Ohgami RS, 2005, BLOOD, V106, P3625, DOI 10.1182/blood-2005-01-0379; Porkka KP, 2003, INT J CANCER, V106, P729, DOI 10.1002/ijc.11278; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Spratt DE, 2014, INT J RADIAT ONCOL, V90, pS791, DOI 10.1016/j.ijrobp.2014.05.2286; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Warkentin E, 2001, EMBO J, V20, P6561, DOI 10.1093/emboj/20.23.6561; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058126	30	24	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22558	22569		10.1074/jbc.M115.664565	http://dx.doi.org/10.1074/jbc.M115.664565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26205815	Green Published, hybrid			2022-12-26	WOS:000361171500022
J	Wang, GZ; Goff, SP				Wang, Gary Z.; Goff, Stephen P.			Regulation of Yin Yang 1 by Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YY1; GROWTH-FACTOR RECEPTOR; MURINE LEUKEMIA-VIRUS; GENE-EXPRESSION; C-SRC; PROTEIN; KINASES; LYN; ASSOCIATION; REPRESSION	Yin Yang 1 (YY1) is a member of the GLI-Kruppel class of DNA and RNA binding transcription factors that can either activate or repress gene expression during cell growth, differentiation, and embryogenesis. Although much is known about YY1 interacting proteins and the target promoters regulated by YY1, much less is known about YY1 regulation through post-translational modifications. In this study we show that YY1 is tyrosine-phosphorylated in multiple cell types. Using a combination of pharmacological inhibition, kinase overexpression, and kinase knock-out studies, we demonstrate that YY1 is a target of multiple Src family kinases in vitro and in vivo. Moreover, we have identified multiple sites of YY1 phosphorylation and analyzed the effect of phosphorylation on the activity of YY1-responsive retroviral and cellular promoters. Phosphorylation of tyrosine 383 interferes with DNA and RNA binding, leading to the down-regulation of YY1 activity. Finally, we provide the first evidence that YY1 is a downstream target of epidermal growth factor receptor signaling in vivo. Taken together, the identification of YY1 as a target of Src family kinases provide key insights into the inhibitory role of tyrosine kinases in modulating YY1 activity.	Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; [Goff, Stephen P.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Goff, Stephen P.] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Goff, Stephen P.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Wang, Gary Z.] Columbia Univ Coll Phys & Surg, Med Scientist Training Program, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Goff, SP (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	spg1@columbia.edu	Goff, Stephen P/K-6337-2014; Regan, Clinton/E-6250-2012	Goff, Stephen P/0000-0003-0693-5547; 	National Institutes of Health [R01 CA30488]; NATIONAL CANCER INSTITUTE [R01CA030488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA30488 (NCI). The authors declare that they have no conflicts of interest with the contents of this article.	Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Belak ZR, 2008, BIOCHEM CELL BIOL, V86, P31, DOI [10.1139/O07-155, 10.1139/o07-155]; Bernhard W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077052; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; FLANAGAN JR, 1992, MOL CELL BIOL, V12, P38, DOI 10.1128/MCB.12.1.38; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; GUALBERTO A, 1992, MOL CELL BIOL, V12, P4209, DOI 10.1128/MCB.12.9.4209; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Hongo F, 2005, BIOCHEM BIOPH RES CO, V336, P692, DOI 10.1016/j.bbrc.2005.08.150; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kassardjian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050645; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LEE TC, 1994, ONCOGENE, V9, P1047; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARGOLIS DM, 1994, J VIROL, V68, P905, DOI 10.1128/JVI.68.2.905-910.1994; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; Radha V, 1996, EUR J BIOCHEM, V236, P352, DOI 10.1111/j.1432-1033.1996.00352.x; Rizkallah R, 2011, CELL CYCLE, V10, P3327, DOI 10.4161/cc.10.19.17619; Rizkallah R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015928; Rizkallah R, 2009, MOL BIOL CELL, V20, P4766, DOI 10.1091/mbc.E09-04-0264; Schlesinger S, 2013, CELL REP, V4, P50, DOI 10.1016/j.celrep.2013.06.003; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wang GZ, 2014, J VIROL, V88, P1825, DOI 10.1128/JVI.02578-13; WEERNINK PAO, 1995, J BIOL CHEM, V270, P2264, DOI 10.1074/jbc.270.5.2264; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632	46	15	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21890	21900		10.1074/jbc.M115.660621	http://dx.doi.org/10.1074/jbc.M115.660621			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198631	Green Published, hybrid			2022-12-26	WOS:000360968500011
J	Sloniecka, M; Le Roux, S; Boman, P; Bystrom, B; Zhou, QJ; Danielson, P				Sloniecka, Marta; Le Roux, Sandrine; Boman, Peter; Bystrom, Berit; Zhou, Qingjun; Danielson, Patrik			Expression Profiles of Neuropeptides, Neurotransmitters, and Their Receptors in Human Keratocytes In Vitro and In Situ	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; KERATAN SULFATE PROTEOGLYCAN; 3-D COLLAGEN MATRICES; WOUND-HEALING MODEL; SUBSTANCE-P; NEUROKININ-1 RECEPTOR; CORNEAL KERATOCYTES; STROMAL CELLS; CHOLINE-ACETYLTRANSFERASE; ACETYLCHOLINE-RECEPTOR	Keratocytes, the quiescent cells of the corneal stroma, play a crucial role in corneal wound healing. Neuropeptides and neurotransmitters are usually associated with neuronal signaling, but have recently been shown to be produced also by non-neuronal cells and to be involved in many cellular processes. The aim of this study was to assess the endogenous intracellular and secreted levels of the neuropeptides substance P (SP) and neurokinin A (NKA), and of the neurotransmitters acetylcholine (ACh), catecholamines (adrenaline, noradrenaline and dopamine), and glutamate, as well as the expression profiles of their receptors, in human primary keratocytes in vitro and in keratocytes of human corneal tissue sections in situ. Cultured keratocytes expressed genes encoding for SP and NKA, and for catecholamine and glutamate synthesizing enzymes, as well as genes for neuropeptide, adrenergic and ACh (muscarinic) receptors. Keratocytes in culture produced SP, NKA, catecholamines, ACh, and glutamate, and expressed neurokinin-1 and -2 receptors (NK-1R and NK-2R), dopamine receptor D-2, muscarinic ACh receptors, and NDMAR1 glutamate receptor. Human corneal sections expressed SP, NKA, NK-1R, NK-2R, receptor D2, choline acetyl transferase (ChAT), M-3, M4 and M-5 muscarinic ACh receptors, glutamate, and NMDAR1, but not catecholamine synthesizing enzyme or the alpha(1) and beta(2) adrenoreceptors, nor M1 receptor. In addition, expression profiles assumed significant differences between keratocytes from the peripheral cornea as compared to those from the central cornea, as well as differences between keratocytes cultured under various serum concentrations. In conclusion, human keratocytes express an array of neuropeptides and neurotransmitters. The cells furthermore express receptors for neuropeptides/neurotransmitters, which suggests that they are susceptible to stimulation by these substances in the cornea, whether of neuronal or non-neuronal origin. As it has been shown that neuropeptides/neurotransmitters are involved in cell proliferation, migration, and angiogenesis, it is possible that they play a role in corneal wound healing.	[Sloniecka, Marta; Le Roux, Sandrine; Boman, Peter; Zhou, Qingjun; Danielson, Patrik] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Bystrom, Berit; Danielson, Patrik] Umea Univ, Dept Clin Sci Ophthalmol, Umea, Sweden; [Zhou, Qingjun] Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China	Umea University; Umea University; Shandong First Medical University & Shandong Academy of Medical Sciences	Sloniecka, M (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	marta.sloniecka@umu.se			national Swedish Research Council [521-2013-2612]; Swedish Society of Medicine [SLS-176511/-248321/-329341]; Cronqvist foundation [SLS-120651/-249071/-329561]; foundation Kronprinsessan Margaretas Arbetsnamnd for synskadade [2010/30 2012/26, 2013/10]; foundation Ogonfonden; National Natural Science Foundation of China [81170816]; J.C. Kempe and Seth M. Kempe Memorial Foundations [JCK-1222]	national Swedish Research Council(Swedish Research Council); Swedish Society of Medicine; Cronqvist foundation; foundation Kronprinsessan Margaretas Arbetsnamnd for synskadade; foundation Ogonfonden; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); J.C. Kempe and Seth M. Kempe Memorial Foundations	Financial support was obtained by P.D. from the national Swedish Research Council (grant no. 521-2013-2612), the J.C. Kempe and Seth M. Kempe Memorial Foundations (JCK-1222), the Swedish Society of Medicine (SLS-176511/-248321/-329341), the Cronqvist foundation (SLS-120651/-249071/-329561), the foundation Kronprinsessan Margaretas Arbetsnamnd for synskadade (2010/30 2012/26, 2013/10), the foundation Ogonfonden, and also through a regional agreement between Umea University and Vasterbotten County Council (ALF). Q.Z. was partially supported by the National Natural Science Foundation of China (81170816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearne M, 2010, EXP EYE RES, V91, P584, DOI 10.1016/j.exer.2010.07.013; Ainscough SL, 2011, EXP EYE RES, V92, P10, DOI 10.1016/j.exer.2010.10.004; Andersson G, 2008, REGUL PEPTIDES, V150, P81, DOI 10.1016/j.regpep.2008.02.005; Backman LJ, 2013, SCAND J MED SCI SPOR, V23, P687, DOI 10.1111/j.1600-0838.2011.01442.x; Backman LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027209; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Blais M, 2014, TISSUE ENG PT A, V20, P2180, DOI 10.1089/ten.tea.2013.0535; Brain SD, 1997, IMMUNOPHARMACOLOGY, V37, P133, DOI 10.1016/S0162-3109(97)00055-6; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Cheret J, 2014, J DERMATOL SCI, V74, P193, DOI 10.1016/j.jdermsci.2014.02.001; Cheret J, 2013, WOUND REPAIR REGEN, V21, P772, DOI 10.1111/wrr.12101; Cooke JP, 2007, LIFE SCI, V80, P2347, DOI 10.1016/j.lfs.2007.01.061; DAHL IM, 1981, EXP EYE RES, V32, P419, DOI 10.1016/S0014-4835(81)80021-8; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Eisenhofer G, 1996, J NEUROCHEM, V66, P1565; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Fong G, 2013, CELL TISSUE RES, V351, P465, DOI 10.1007/s00441-012-1530-5; Funderburgh JL, 1996, J BIOL CHEM, V271, P31431, DOI 10.1074/jbc.271.49.31431; Gill SS, 2001, TOXICOL PATHOL, V29, P208, DOI 10.1080/019262301317052486; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; GNADINGER MC, 1973, EXP EYE RES, V15, P395, DOI 10.1016/0014-4835(73)90155-3; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Gonzalez S, 2013, EXP EYE RES, V116, P169, DOI 10.1016/j.exer.2013.08.020; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Grueb M, 2006, GRAEF ARCH CLIN EXP, V244, P1191, DOI 10.1007/s00417-006-0263-0; Haas HS, 2013, ANTICANCER RES, V33, P1267; Haas HS, 2010, HEAD NECK-J SCI SPEC, V32, P1554, DOI 10.1002/hed.21438; HASSELL JR, 1992, INVEST OPHTH VIS SCI, V33, P547; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P3705, DOI 10.1073/pnas.77.6.3705; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; Ho WZ, 1997, J IMMUNOL, V159, P5654; Jester JV, 1996, CORNEA, V15, P505; JESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P730; JESTER JV, 1995, INVEST OPHTH VIS SCI, V36, P809; Julio-Pieper M, 2011, PHARMACOL REV, V63, P35, DOI 10.1124/pr.110.004036; Kim A, 2012, EXP CELL RES, V318, P741, DOI 10.1016/j.yexcr.2011.12.018; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; Lakshman N, 2012, INVEST OPHTH VIS SCI, V53, P1077, DOI 10.1167/iovs.11-8609; LAWRENSON JG, 1991, J ANAT, V177, P75; Levite M, 1998, J IMMUNOL, V160, P993; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; MASUR SK, 1993, INVEST OPHTH VIS SCI, V34, P2690; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; MIDURA RJ, 1989, J BIOL CHEM, V264, P1423; MINDEL JS, 1976, INVEST OPHTH VISUAL, V15, P808; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; MULLER LJ, 1995, INVEST OPHTH VIS SCI, V36, P2557; Munoz M, 2010, DISCOV MED, V10, P305; Musselmann K, 2005, J BIOL CHEM, V280, P32634, DOI 10.1074/jbc.m504724200; Nelson DA, 2004, FRONT BIOSCI-LANDMRK, V9, P2166, DOI 10.2741/1372; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Nicoletti F, 2007, PSYCHONEUROENDOCRINO, V32, pS40, DOI 10.1016/j.psyneuen.2007.04.015; Notara M, 2010, STEM CELL RES, V5, P188, DOI 10.1016/j.scr.2010.07.002; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Robert L, 2001, PATHOL BIOL, V49, P353, DOI 10.1016/S0369-8114(01)00144-4; Sarkar C, 2013, J NEUROIMMUNE PHARM, V8, P7, DOI 10.1007/s11481-012-9395-7; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Sloniecka M, 2015, INT IMMUNOPHARMACOL, V29, P57, DOI 10.1016/j.intimp.2015.05.039; VANALPHEN GWHM, 1957, ARCH OPHTHALMOL-CHIC, V58, P449; Watanabe M, 2002, JPN J OPHTHALMOL, V46, P616, DOI 10.1016/S0021-5155(02)00617-2; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; YUE BYJT, 1976, BIOCHEM J, V158, P567, DOI 10.1042/bj1580567; Zhao DZ, 2002, BIOCHEM J, V368, P665, DOI 10.1042/BJ20020950	66	37	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134157	10.1371/journal.pone.0134157	http://dx.doi.org/10.1371/journal.pone.0134157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214847	gold, Green Published, Green Submitted			2022-12-26	WOS:000358594300054
J	Dias, LFO; Dias, DV; Magnusson, WE				Dias, Lilian Fernandes Oliveira; Dias, David Valentim; Magnusson, William Ernest			Influence of Environmental Governance on Deforestation in Municipalities of the Brazilian Amazon	PLOS ONE			English	Article							DYNAMICS; IMPACTS	It has been argued that measuring governance at scales smaller than global could be an important management tool. However, current studies are conducted on a global scale and use expensive methods. In the present study, we assess whether the reported governance of Amazonian municipalities is related to reductions in deforestation. Economic activity (EA) affected general governance (G) positively (G = 0.81 + 1.19 * EA, F1, 98 = 77.36, p < 0.001). Environmental governance (EG) was not affected significantly (p = 0.43) by deforestation before 2000 (PD), but increased significantly (p < 0.001) with general governance (G) (EG = -0.29 + 0.04 PD+0.98*OG, F2,97 = 42.6, p < 0.001). Deforestation was not significantly related to environmental governance (p = 0.82). The only indirect effect of significant magnitude was the effect of the density of forest reserves on recent deforestation through deforestation before 2000, which was strongly negative (-0.49). It is possible to assess reported actions to promote municipal governance through official data. However, it is not enough to assume that general governance or environmental governance at the municipal level, as reflected in the official statistics, benefits environmental conservation. In fact, even at the level of nation states, at which most quantification of governance has been undertaken, it seems that the relationship between governance and environmental preservation is only an assumption, because we are aware of no study that supports that hypothesis quantitatively.	[Dias, Lilian Fernandes Oliveira; Dias, David Valentim; Magnusson, William Ernest] Inst Nacl de Pesquisas da Amazonia, CBIO, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia	Dias, LFO (corresponding author), Inst Nacl de Pesquisas da Amazonia, CBIO, Manaus, Amazonas, Brazil.	lilianfernandes@gmail.com			Amazonas Research Foundation (FAPEAM); National Council for Scientific Research (CNPq); National Institute for Science and Technology for Amazonian Biodiversity (INCT-CENBAM)	Amazonas Research Foundation (FAPEAM); National Council for Scientific Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute for Science and Technology for Amazonian Biodiversity (INCT-CENBAM)	LFOD thanks the Amazonas Research Foundation (FAPEAM) for a Masters scholarship and the National Institute for Amazonian Research (INPA) for the infrastructure support that enabled the development of the research. WEM holds a productivity scholarship from the National Council for Scientific Research (CNPq), and DVD holds a scholarship from the National Institute for Science and Technology for Amazonian Biodiversity (INCT-CENBAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A., 1989, EST AV, V3, P4, DOI [10.1590/S0103-40141989000100002, DOI 10.1590/S0103-40141989000100002]; Alencar A., 2004, DESMATAMENTO AMAZONI; Amaral EF do, 2000, ZONEAMENTO ECOLOGICO, V2, P79; [Anonymous], 2010, REV IBEROAMERICANA E; [Anonymous], 2005, MEGADIVERSIDADE; Araujo IV., 2011, P 3 ENABRI 2011; Azevedo AA, 2013, CERNE, V19, P111, DOI 10.1590/S0104-77602013000100014; Bank World, 1992, GOV DEV; BROWN IM, 2002, ECOLOGY LAND USE CON, P8; Buss PM, 2012, CIENC SAUDE COLETIVA, V17, P1479, DOI 10.1590/S1413-81232012000600012; Cardoso GD, 2013, AN ENC NAC ANPUR, P15; Cavalcante MMDA, 2011, REV FRANCOBRESILIENN, P11; Cavalcanti C., 2004, REV RED IBERO AM EC, V1, P1; Cruz NF, 2011, 8 C NAC ADM PUBL; de Almeida AN, 2013, FLORESTA AMBIENTE, P20143; Diniz V, 2010, C CONS GEST PUBL 3 B, VIII; Fearnside Philip M., 2006, Acta Amaz., V36, P395, DOI 10.1590/S0044-59672006000300018; FEARNSIDE PM, 1993, AMBIO, V22, P537; Fearnside PM, NCN NOVOS CADERNOS N, P12; Fearnside PM., 2010, SCI AM BRASIL ESPECI, P54; Fearnside PM, 2012, NCN NOVOS CADERNOS N; Fonseca Igor Ferraz da, 2009, Soc. estado., V24, P17; Franzese C, 2005, MUNICIPIO ESTADO UNI; Fukuyama F, 2013, GOVERNANCE, V26, P347, DOI 10.1111/gove.12035; Gomides JE, 2010, REV CIENCIAS GERENCI, V13, P177; Goncalves A., 2005, 14 ENC CONP; Instituto Brasileiro de Geografia e Estatistica (IBGE), PERF MUN BRAS; Kampel SA, 2005, ANALISE EXPLORATORIA; Kampel SA, 2000, ANALISE EXPLORATORIA; Kern AP, 2012, EVIDENCIAS RELACAO G; Kjaer AM., 2011, PUBLIC ADM IN PRESS; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lima JADS, 2014, BANCO MUNDIAL ESTRAT; Machado JS, 2013, SCI PLENA; Medina G, 2012, REV BRASILEIRA CIENC, V27; (MMA) Ministerio do Meio Ambiente (Brazil), DAD GEORR; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Rothberg D, 2013, OPINIAO PUBLICA CIDA; Santos RI, 2013, AMAZONIA ORG SUSTENT, V2, P23; Sayer J. A., 2012, Round Table (London), V101, P137, DOI 10.1080/00358533.2012.661531; Serrano ALM, 2013, AVALIACAO IMPACTO PO; Silva LDJDS, 2013, SOMANLU REV ESTUDOS, V12, P128; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Soares BS, 2001, BIOSCIENCE, V51, P1059, DOI 10.1641/0006-3568(2001)051[1059:MTSTPO]2.0.CO;2; Soares-Filho BS, 2005, CENARIOS DESMATAMENT, V19, P137; TORRES H. G., 2003, SAO PAULO PERSPECT, V17, P80, DOI DOI 10.1590/S0102-88392003000300009; Umemiya C, 2010, ENVIRON SCI POLICY, V13, P695, DOI 10.1016/j.envsci.2010.07.002; Valente E, 2012, ESTATISTICA SOC, V2; Viola E, 2013, 373 CEPS	49	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131425	10.1371/journal.pone.0131425	http://dx.doi.org/10.1371/journal.pone.0131425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208282	Green Published, gold			2022-12-26	WOS:000358622000016
J	Goovaerts, O; Jennes, W; Massinga-Loembe, M; Ondoa, P; Ceulemans, A; Vereecken, C; Worodria, W; Mayanja-Kizza, H; Colebunders, R; Kestens, L				Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ondoa, Pascale; Ceulemans, Ann; Vereecken, Chris; Worodria, William; Mayanja-Kizza, Harriet; Colebunders, Robert; Kestens, Luc		TB-IRIS Study Grp	Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome	PLOS ONE			English	Article							STARTING ANTIRETROVIRAL THERAPY; CO-INFECTED PATIENTS; HIV-1 INFECTION; RISK-FACTORS; HLA-DR; LYMPHOCYTES; EFFECTOR; IMMUNOPATHOGENESIS; DIFFERENTIATION; PREVENTION	Background Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an inflammatory complication in HIV-TB co-infected patients receiving antiretroviral therapy (ART). The role of disturbed T cell reconstitution in TB-IRIS is not well understood. We investigated T cell activation and maturation profiles in patients who developed TB-IRIS at different intervals during ART. Methods Twenty-two HIV-TB patients who developed early-onset TB-IRIS and 10 who developed late-onset TB-IRIS were matched for age, sex and CD4 count to equal numbers of HIV-TB patients who did not develop TB-IRIS. Flow cytometry analysis was performed on fresh blood, drawn before and after ART initiation and during TB-IRIS events. T cell activation and maturation was measured on CD4+ and CD8+ T cells using CD45RO, CD38, HLA-DR, CCR7 and CD27 antibodies. Results CD8+ T cell activation before ART was decreased in both early-onset (77% vs. 82%, p = 0.014) and late-onset (71% vs. 83%, p = 0.012) TB-IRIS patients compared to non-IRIS controls. After ART initiation, the observed differences in T cell activation disappeared. During late-onset, but not early-onset TB-IRIS, we observed a skewing from memory to terminal effector CD4+ and CD8+ T cell populations (p<0.028). Conclusion Our data provide evidence of reduced CD8+ T cell activation before ART as a common predisposing factor of early- and late-onset TB-IRIS. The occurrence of TB-IRIS itself was not marked by an over-activated CD8+ T cell compartment. Late-but not early- onset TB-IRIS was characterized by a more terminally differentiated T cell phenotype.	[Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ceulemans, Ann; Vereecken, Chris; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Goovaerts, Odin; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Massinga-Loembe, Marguerite] Albert Schweitzer Hosp, Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Massinga-Loembe, Marguerite] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Worodria, William; Mayanja-Kizza, Harriet] Mulago Hosp, Dept Med, Kampala, Uganda; [Worodria, William; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Worodria, William] Infect Dis Network Treatment & Res Africa INTERAC, Kampala, Uganda; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, Epidemiol & Social Med, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp; Eberhard Karls University of Tubingen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Mulago National Referral Hospital; Makerere University; Institute of Tropical Medicine (ITM); University of Antwerp	Goovaerts, O (corresponding author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	Odin.Goovaerts@gmail.com	Mayanja-Kizza, Harriet/AAM-5372-2020; Locht, Camille/L-3516-2018; Jennes, Wim/M-2523-2013	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Jennes, Wim/0000-0002-3125-6389; Colebunders, Robert/0000-0002-1919-1340; Locht, Camille/0000-0001-7295-7336; Massinga Loembe, Marguerite/0000-0002-7822-566X	EC [LSHP-CT-2007-037659-TBIRIS]; Belgian Institute for Science and Technology (IWT)	EC(European CommissionEuropean Commission Joint Research Centre); Belgian Institute for Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was supported by EC FP6 Specific Targeted Research Project (STREP) grant LSHP-CT-2007-037659-TBIRIS. PhD student scholarship from the Belgian Institute for Science and Technology (IWT).	Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Barber DL, 2012, NAT REV MICROBIOL, V10, P150, DOI 10.1038/nrmicro2712; Beishuizen SJE, 2009, NETH J MED, V67, P327; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Burman W, 2007, INT J TUBERC LUNG D, V11, P1282; Conesa-Botella A, 2011, JAIDS-J ACQ IMM DEF, V58, P463, DOI 10.1097/QAI.0b013e31823801de; da Silva TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066095; Elliott JH, 2009, J INFECT DIS, V200, P1736, DOI 10.1086/644784; Espinosa E, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-21; Gagnon J, 2008, J IMMUNOL, V180, P7958, DOI 10.4049/jimmunol.180.12.7958; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS131, DOI 10.1002/cyto.b.20391; Goovaerts O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113101; Goovaerts O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081856; Grant PM, 2012, J INFECT DIS, V206, P1715, DOI 10.1093/infdis/jis604; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hazenberg MD, 2003, AIDS, V17, P1419, DOI 10.1097/00002030-200307040-00001; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Huyst V, 2007, ACTA CLIN BELG, V62, P126, DOI 10.1179/acb.2007.022; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; KESTENS L, 1992, AIDS, V6, P793, DOI 10.1097/00002030-199208000-00004; KESTENS L, 1994, CLIN EXP IMMUNOL, V95, P436, DOI 10.1111/j.1365-2249.1994.tb07015.x; Kestens L, 2008, CURR OPIN HIV AIDS, V3, P419, DOI 10.1097/COH.0b013e328302ebbb; Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/eri.11.21, 10.1586/ERI.11.21]; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Manosuthi W, 2006, J INFECTION, V53, P357, DOI 10.1016/j.jinf.2006.01.002; Martin M, 2001, EUR J CLIN MICROBIOL, V20, P871, DOI 10.1007/s100960100631; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2008, AM J RESP CRIT CARE, V178, P1083, DOI 10.1164/rccm.200806-858OC; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murdoch David M, 2007, AIDS Res Ther, V4, P9, DOI 10.1186/1742-6405-4-9; Murdoch David M, 2009, AIDS Res Ther, V6, P16, DOI 10.1186/1742-6405-6-16; Ondoa P, 2006, JAIDS-J ACQ IMM DEF, V41, P416, DOI 10.1097/01.qai.0000209901.12750.d0; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Plowden J, 2004, CELL IMMUNOL, V229, P86, DOI 10.1016/j.cellimm.2004.07.001; Radziewicz H, 2007, WORLD J GASTROENTERO, V13, P4848, DOI 10.3748/wjg.v13.i36.4848; Ruhwald M, 2007, AIDS, V21, P882, DOI 10.1097/QAD.0b013e3280b079c8; Sepulveda H, 1999, J IMMUNOL, V163, P1133; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Wellons MF, 2001, J INFECT DIS, V183, P1522, DOI 10.1086/320193; (WHO) WHO, 2012, IMPR DIAGN TREATM SM; Worodria W, 2012, ANTIVIR THER, V17, P841, DOI 10.3851/IMP2108; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2; Worodria W, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/758350; Worodria William, 2009, Expert Rev Respir Med, V3, P147, DOI 10.1586/ers.09.8	48	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133924	10.1371/journal.pone.0133924	http://dx.doi.org/10.1371/journal.pone.0133924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208109	gold, Green Published			2022-12-26	WOS:000358622000174
J	Graebner, RC; Wise, M; Cuesta-Marcos, A; Geniza, M; Blake, T; Blake, VC; Butler, J; Chao, SM; Hole, DJ; Horsley, R; Jaiswal, P; Obert, D; Smith, KP; Ullrich, S; Hayes, PM				Graebner, Ryan C.; Wise, Mitchell; Cuesta-Marcos, Alfonso; Geniza, Matthew; Blake, Tom; Blake, Victoria C.; Butler, Joshua; Chao, Shiaomen; Hole, David J.; Horsley, Rich; Jaiswal, Pankaj; Obert, Don; Smith, Kevin P.; Ullrich, Steven; Hayes, Patrick M.			Quantitative Trait Loci Associated with the Tocochromanol (Vitamin E) Pathway in Barley	PLOS ONE			English	Article							ALPHA-TOCOPHEROL; GAMMA-TOCOPHEROL; SERUM-CHOLESTEROL; BETA-GLUCAN; LINKAGE MAP; BIOSYNTHESIS; TOCOTRIENOLS; PREVENTION; GENOTYPE; DIOXIDE	The Genome-Wide Association Studies approach was used to detect Quantitative Trait Loci associated with tocochromanol concentrations using a panel of 1,466 barley accessions. All major tocochromanol types- alpha-, beta-, delta-,gamma-tocopherol and tocotrienol-were assayed. We found 13 single nucleotide polymorphisms associated with the concentration of one or more of these tocochromanol forms in barley, seven of which were within 2 cM of sequences homologous to cloned genes associated with tocochromanol production in barley and/or other plants. These associations confirmed a prior report based on bi-parental QTL mapping. This knowledge will aid future efforts to better understand the role of toco-chromanols in barley, with specific reference to abiotic stress resistance. It will also be useful in developing barley varieties with higher tocochromanol concentrations, although at current recommended daily consumption amounts, barley would not be an effective sole source of vitamin E. However, it could be an important contributor in the context of whole grains in a balanced diet.	[Graebner, Ryan C.; Cuesta-Marcos, Alfonso; Hayes, Patrick M.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Wise, Mitchell] USDA ARS, Cereal Crops Res, Madison, WI USA; [Geniza, Matthew; Jaiswal, Pankaj] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Blake, Tom] Montana State Univ, Plant Sci & Plant Pathol Dept, Bozeman, MT 59717 USA; [Blake, Victoria C.] USDA ARS, Crop Improvement & Genet Res, Albany, CA USA; [Butler, Joshua] Busch Agr Resources Inc, Ft Collins, CO USA; [Chao, Shiaomen] USDA ARS, Cereal Crops Res Unit, Fargo, ND USA; [Hole, David J.] Utah State Univ, Plants Soils & Climate Dept, Logan, UT 84322 USA; [Horsley, Rich] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Obert, Don] Limagrain Cereal Seeds, Lafayette, IN USA; [Smith, Kevin P.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Ullrich, Steven] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Oregon State University; United States Department of Agriculture (USDA); Oregon State University; Montana State University System; Montana State University Bozeman; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; North Dakota State University Fargo; University of Minnesota System; University of Minnesota Twin Cities; Washington State University	Hayes, PM (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.	patrick.m.hayes@oregonstate.edu	Jaiswal, Pankaj/H-7599-2016; Hole, David J/A-7173-2008; Jaiswal, Pankaj/R-4214-2019	Jaiswal, Pankaj/0000-0002-1005-8383; Hole, David J/0000-0003-1325-3181; Jaiswal, Pankaj/0000-0002-1005-8383; Geniza, Matthew/0000-0003-4828-7891; Smith, Kevin/0000-0001-8253-3326	USDA-NIFA TCAP Project [2011-68002-30029]; USDA-NIFA Collaborative Project [2013-31100-06041]; Busch Agricultural Resources, Inc; Limagrain Cereal Seeds; ARS [ARS-0424878] Funding Source: Federal RePORTER	USDA-NIFA TCAP Project; USDA-NIFA Collaborative Project; Busch Agricultural Resources, Inc; Limagrain Cereal Seeds; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by USDA-NIFA TCAP Project No. 2011-68002-30029, and USDA-NIFA Collaborative Project No. 2013-31100-06041. Busch Agricultural Resources, Inc and Limagrain Cereal Seeds provided support in the form of salaries for authors JB & DO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger GL, 2013, THEOR APPL GENET, V126, P693, DOI 10.1007/s00122-012-2011-7; Blake VC, 2012, PLANT GENOME-US, V5, P81, DOI 10.3835/plantgenome2012.03.0002; Bruno RS, 2005, FREE RADIC BIOL MED, V40, P555; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chutimanitsakun Y, 2013, PLANT BREEDING, V132, P563, DOI 10.1111/pbr.12086; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; COONEY RV, 1993, P NATL ACAD SCI USA, V90, P1771, DOI 10.1073/pnas.90.5.1771; Cordero Z, 2010, CRIT REV FOOD SCI, V50, P420, DOI 10.1080/10408390802304230; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Desel C, 2005, J PLANT PHYSIOL, V162, P771, DOI 10.1016/j.jplph.2005.04.008; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Frank J, 2005, J PLANT PHYSIOL, V162, P834, DOI 10.1016/j.jplph.2005.04.017; Fratianni A, 2002, EUR FOOD RES TECHNOL, V215, P353, DOI 10.1007/s00217-002-0566-2; GEY KF, 1991, AM J CLIN NUTR, V53, pS326, DOI 10.1093/ajcn/53.1.326S; HANDELMAN GJ, 1985, J NUTR, V115, P807, DOI 10.1093/jn/115.6.807; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Hunter S., 2011, NUCLEIC ACIDS RES; Jaiswal P, 2011, METHODS MOL BIOL, V678, P247, DOI 10.1007/978-1-60761-682-5_18; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Maeda H, 2006, PLANT CELL, V18, P2710, DOI 10.1105/tpc.105.039404; Massman J, 2011, MOL BREEDING, V27, P439, DOI 10.1007/s11032-010-9442-0; Matsushita Y, 1996, GENE, V172, P207, DOI 10.1016/0378-1119(96)00054-6; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mohammadi M, 2014, MOL BREEDING, V34, P1229, DOI 10.1007/s11032-014-0112-5; Munne-Bosch S, 2005, J PLANT PHYSIOL, V162, P743, DOI 10.1016/j.jplph.2005.04.022; Munoz-Amatriain M, 2014, BRIEF FUNCT GENOMICS, V13, P341, DOI 10.1093/bfgp/elu006; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Navara S, 2014, THEOR APPL GENET, V127, P633, DOI 10.1007/s00122-013-2247-x; Oliver RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096276; Pauli D, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0037; PETERSON DM, 1993, CEREAL CHEM, V70, P157, DOI 10.1006/jcrs.1993.1016; QURESHI AA, 1991, AM J CLIN NUTR, V53, pS1021, DOI 10.1093/ajcn/53.4.1021S; QURESHI AA, 1986, J BIOL CHEM, V261, P544; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Sadre R, 2006, FEBS LETT, V580, P5357, DOI 10.1016/j.febslet.2006.09.002; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; THOMPSON JN, 1979, J LIQ CHROMATOGR, V2, P327, DOI 10.1080/01483917908060067; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; TRABER MG, 1992, J LIPID RES, V33, P1171; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Watts EJ, 2014, J MED FOOD; Yang JL, 2003, J NUTR SCI VITAMINOL, V49, P381, DOI 10.3177/jnsv.49.381	55	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133767	10.1371/journal.pone.0133767	http://dx.doi.org/10.1371/journal.pone.0133767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208213	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000135
J	Himes, BE; Koziol-White, C; Johnson, M; Nikolos, C; Jester, W; Klanderman, B; Litonjua, AA; Tantisira, KG; Truskowski, K; MacDonald, K; Panettieri, RA; Weiss, ST				Himes, Blanca E.; Koziol-White, Cynthia; Johnson, Martin; Nikolos, Christina; Jester, William; Klanderman, Barbara; Litonjua, Augusto A.; Tantisira, Kelan G.; Truskowski, Kevin; MacDonald, Kevin; Panettieri, Reynold A., Jr.; Weiss, Scott T.			Vitamin D Modulates Expression of the Airway Smooth Muscle Transcriptome in Fatal Asthma	PLOS ONE			English	Article							RNA-SEQ; DIFFERENTIAL GENE; DRUG-THERAPY; RECEPTOR; CELLS; INFLAMMATION; PROTEIN; MIGRATION; AMERICANS; LUNG	Globally, asthma is a chronic inflammatory respiratory disease affecting over 300 million people. Some asthma patients remain poorly controlled by conventional therapies and experience more life-threatening exacerbations. Vitamin D, as an adjunct therapy, may improve disease control in severe asthma patients since vitamin D enhances glucocorticoid responsiveness and mitigates airway smooth muscle (ASM) hyperplasia. We sought to characterize differences in transcriptome responsiveness to vitamin D between fatal asthma-and non-asthma-derived ASM by using RNA-Seq to measure ASM transcript expression in five donors with fatal asthma and ten non-asthma-derived donors at baseline and with vitamin D treatment. Based on a Benjamini-Hochberg corrected p-value < 0.05, 838 genes were differentially expressed in fatal asthma vs. non-asthma-derived ASM at baseline, and vitamin D treatment compared to baseline conditions induced differential expression of 711 and 867 genes in fatal asthma-and non-asthma-derived ASM, respectively. Functional gene categories that were highly represented in all groups included extracellular matrix, and responses to steroid hormone stimuli and wounding. Genes differentially expressed by vitamin D also included cytokine and chemokine activity categories. Follow-up qPCR and individual analyte ELISA experiments were conducted for four cytokines (i.e. CCL2, CCL13, CXCL12, IL8) to measure TNF alpha-induced changes by asthma status and vitamin D treatment. Vitamin D inhibited TNF alpha-induced IL8 protein secretion levels to a comparable degree in fatal asthma-and non-asthma-derived ASM even though IL8 had significantly higher baseline levels in fatal asthma-derived ASM. Our findings identify vitamin D-specific gene targets and provide transcriptomic data to explore differences in the ASM of fatal asthma-and non-asthma-derived donors.	[Himes, Blanca E.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Koziol-White, Cynthia; Johnson, Martin; Nikolos, Christina; Jester, William; Truskowski, Kevin; MacDonald, Kevin; Panettieri, Reynold A., Jr.] Univ Penn, Airways Biol Initiat, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Klanderman, Barbara; Weiss, Scott T.] Partners Personalized Med, Boston, MA USA; [Litonjua, Augusto A.; Tantisira, Kelan G.; Weiss, Scott T.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Litonjua, Augusto A.; Tantisira, Kelan G.; Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Himes, BE (corresponding author), Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	bhimes@upenn.edu	panettieri, reynold/AAG-9485-2019	Jester Jr., William/0000-0002-2872-6095	National Institutes of Health (NIH) [U01 HL65899]; NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance [R01 HL097796, R01 HL114769, P30 ES013508, P01-HL114471, P30-ES013508]; NIH [R00 HL105663]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL105663, R01HL097796, P01HL114471, R01HL114769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by National Institutes of Health (NIH) U01 HL65899, an NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance, R01 HL097796, R01 HL114769, P30 ES013508, P01-HL114471 and P30-ES013508. BEH was funded by NIH R00 HL105663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2012, J CLIN IMMUNOL, V32, P1093, DOI 10.1007/s10875-012-9696-x; Amrani Y, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-104; Andrews S, FASTQC QUALITY CONTR; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Banerjee A, 2008, BRIT J PHARMACOL, V155, P84, DOI 10.1038/bjp.2008.232; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bolger AM, 2014, BIOINFORMATICS; Bosse Y, 2007, PHYSIOL GENOMICS, V29, P161, DOI 10.1152/physiolgenomics.00134.2006; Chambers ES, 2011, CURR ALLERGY ASTHM R, V11, P29, DOI 10.1007/s11882-010-0161-8; Chan IHS, 2009, PEDIAT ALLERG IMM-UK, V20, P142, DOI 10.1111/j.1399-3038.2008.00757.x; Collington SJ, 2010, J IMMUNOL, V184, P6114, DOI 10.4049/jimmunol.0904177; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Damera G, 2009, BRIT J PHARMACOL, V158, P1429, DOI 10.1111/j.1476-5381.2009.00428.x; Daubeuf F, 2013, J BIOL CHEM, V288, P11865, DOI 10.1074/jbc.M112.449348; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Global Initiative for Asthma (GINA), 2012, GLOB STRAT ASTHM MAN; Godot V, 2007, J ALLERGY CLIN IMMUN, V120, P827, DOI 10.1016/j.jaci.2007.05.046; Gupta A, 2012, PAEDIATR RESPIR REV, V13, P236, DOI 10.1016/j.prrv.2011.07.003; Gupta A, 2011, AM J RESP CRIT CARE, V184, P1342, DOI 10.1164/rccm.201107-1239OC; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Hawrylowicz C, 2002, J ALLERGY CLIN IMMUN, V109, P369, DOI 10.1067/mai.2002.121455; Hoshino M, 2003, EUR RESPIR J, V21, P804, DOI 10.1183/09031936.03.00082002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joubert P, 2005, J IMMUNOL, V175, P2702, DOI 10.4049/jimmunol.175.4.2702; Kalayci O, 2004, J ASTHMA, V41, P27, DOI 10.1081/JAS-120024590; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lane SJ, 1998, J CLIN INVEST, V102, P2156, DOI 10.1172/JCI2680; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Moorman JE, 2012, NATL SURVEILLANCE AS, P3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; National Asthma Education Program, 2007, 3 US DEP HLTH HUM SE; NELSON HS, 1995, NEW ENGL J MED, V333, P499, DOI 10.1056/NEJM199508243330807; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Ng K, 2014, AM J CLIN NUTR, V99, P587, DOI 10.3945/ajcn.113.067777; Nocker RET, 1996, INT ARCH ALLERGY IMM, V109, P183, DOI 10.1159/000237218; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri RA, 2008, AM J RESP CRIT CARE, V177, P248, DOI 10.1164/rccm.200708-1217PP; Patel KK, 2010, PEDIATR INFECT DIS J, V29, P1093, DOI 10.1097/INF.0b013e3181eaebdc; Zafra MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091996; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Singh SR, 2014, ALLERGY, V69, P1189, DOI 10.1111/all.12444; Song YF, 2007, RESPIROLOGY, V12, P486, DOI 10.1111/j.1440-1843.2007.01099.x; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang AL, 2015, INT ARCH ALLERGY IMM, V166, P52, DOI 10.1159/000371764; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC	58	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134057	10.1371/journal.pone.0134057	http://dx.doi.org/10.1371/journal.pone.0134057			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207385	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000198
J	Sanchez-Velazquez, EJ; Santillan-Galicia, MT; Novelli, VM; Nunes, MA; Mora-Aguilera, G; Valdez-Carrasco, JM; Otero-Colina, G; Freitas-Astua, J				Sanchez-Velazquez, E. J.; Santillan-Galicia, M. T.; Novelli, V. M.; Nunes, M. A.; Mora-Aguilera, G.; Valdez-Carrasco, J. M.; Otero-Colina, G.; Freitas-Astua, J.			Diversity and Genetic Variation among Brevipalpus Populations from Brazil and Mexico	PLOS ONE			English	Article							CITRI ACARI TETRANYCHIDAE; PHOENICIS ACARI; MITES; LEPROSIS; VECTOR; TENUIPALPIDAE; HISTORY; MARKERS	Brevipalpus phoenicis s.l. is an economically important vector of the Citrus leprosis virus-C (CiLV-C), one of the most severe diseases attacking citrus orchards worldwide. Effective control strategies for this mite should be designed based on basic information including its population structure, and particularly the factors that influence its dynamics. We sampled sweet orange orchards extensively in eight locations in Brazil and 12 in Mexico. Population genetic structure and genetic variation between both countries, among locations and among sampling sites within locations were evaluated by analysing nucleotide sequence data from fragments of the mitochondrial cytochrome oxidase subunit I (COI). In both countries, B. yothersi was the most common species and was found in almost all locations. Individuals from B. papayensis were found in two locations in Brazil. Brevipalpus yothersi populations collected in Brazil were more genetically diverse (14 haplotypes) than Mexican populations (four haplotypes). Although geographical origin had a low but significant effect (ca. 25%) on the population structure, the greatest effect was from the within location comparison (37.02 %). Potential factors driving our results were discussed.	[Sanchez-Velazquez, E. J.; Santillan-Galicia, M. T.; Valdez-Carrasco, J. M.; Otero-Colina, G.] Colegio Postgrad, Postgrado Fitosanidad Entomol & Acarol, Montecillo, Edo De Mexico, Mexico; [Novelli, V. M.; Nunes, M. A.; Freitas-Astua, J.] Ctr APTA Citros Sylvio Moreira IAC, Cordeiropolis, SP, Brazil; [Mora-Aguilera, G.] Colegio Postgrad, Postgrado Fitosanidad Fitopatol, Montecillo, Edo De Mexico, Mexico	Colegio de Postgraduados - Mexico; Instituto Agronomico de Campinas (IAC); Colegio de Postgraduados - Mexico	Santillan-Galicia, MT (corresponding author), Colegio Postgrad, Postgrado Fitosanidad Entomol & Acarol, Montecillo, Edo De Mexico, Mexico.	tgalicia@colpos.mx	Novelli, Valdenice Moreira/C-4341-2012; Freitas-Astua, Juliana/C-5833-2013	Novelli, Valdenice Moreira/0000-0001-7717-4488; Freitas-Astua, Juliana/0000-0002-0506-6880; SANTILLAN-GALICIA, MA TERESA/0000-0002-0408-3638	Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico; Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria (SENASICA), Mexico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil	Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria (SENASICA), Mexico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	ESV received a scholarship from Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico. This research was done under the project 'Implicaciones epidemiologicas del CTV en el sistema vector - planta: bases epidemiologicas y cuantitativas para la aplicacion de la campana en Mexico' funded by the Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria (SENASICA), Mexico and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil.	BAKER E W, 1975, Smithsonian Contributions to Zoology, V194, P1; Baker EW, 1987, USDA ARS TECH B; Bassanezi RB, 2007, PLANT PATHOL, V56, P97, DOI 10.1111/j.1365-3059.2006.01457.x; Bastianel Marinês, 2006, Summa phytopathol., V32, P211, DOI 10.1590/S0100-54052006000300001; Bastianel M, 2010, PLANT DIS, V94, P284, DOI 10.1094/PDIS-94-3-0284; Beard JJ, 2015, ZOOTAXA, V3944, P1, DOI 10.11646/zootaxa.3944.1.1; Beard JJ, 2012, FLAT MITES WORLD 1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brlansky RH, 2006, CITRUS DIS EXOTIC FL; Carbonnelle S, 2007, EXP APPL ACAROL, V41, P225, DOI 10.1007/s10493-007-9068-z; Carew ME, 2004, ENTOMOL EXP APPL, V111, P87, DOI 10.1111/j.0013-8703.2004.00149.x; CHIAVEGATO LG, 1986, PESQUI AGROPECU BRAS, V21, P813; Childers CC, 2003, EXP APPL ACAROL, V30, P1, DOI 10.1023/B:APPA.0000006542.96404.63; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; DE LEON D., 1961, FLORIDA ENT, V44, P41; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Groot TVM, 2006, EXP APPL ACAROL, V39, P257, DOI 10.1007/s10493-006-9019-0; Groot TVM, 2005, EXP APPL ACAROL, V36, P165, DOI 10.1007/s10493-005-3360-6; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HELLE W, 1980, GENETICA, V54, P45, DOI 10.1007/BF00122407; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Krantz G., 2009, MANUAL ACAROLOGY; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x; Mata J, 2010, ANN ENTOMOL SOC AM, V103, P898, DOI 10.1603/AN09099; Mendez Mendez Prisciliano, 2012, Fitosanidad, V16, P73; Mesa NC, 2009, ZOOTAXA, P1; Miller AD, 2013, MOL PHYLOGENET EVOL, V66, P928, DOI 10.1016/j.ympev.2012.11.021; Miranda LC, 2007, NEOTROP ENTOMOL, V36, P587, DOI 10.1590/S1519-566X2007000400018; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; Navajas M, 2000, EXP APPL ACAROL, V24, P751, DOI 10.1023/A:1006497906793; Navia D, 2013, ZOOL SCR, V42, P406, DOI 10.1111/zsc.12013; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; Nunes MA, 2012, PLANT DIS, V96, P968, DOI 10.1094/PDIS-06-11-0538; Ochoa R, 2011, 3 SIBAC S BRAS AC CA; PIJNACKER LP, 1980, GENETICA, V51, P211, DOI 10.1007/BF00121613; PIJNACKER LP, 1981, ACAROLOGIA, V22, P157; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; Rodrigues JCV, 2004, EXP APPL ACAROL, V34, P275, DOI 10.1007/s10493-004-0571-1; Rodrigues VJC, 2003, EXP APPL ACAROL, V34, P275; Rossi-Zalaf LS, 2006, EXP APPL ACAROL, V40, P37, DOI 10.1007/s10493-006-9024-3; Roy A., 2015, PHYTOPATHOL IN PRESS; Salinas-Vargas D, 2013, NEOTROP ENTOMOL, V42, P419, DOI 10.1007/s13744-013-0140-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weeks AR, 2001, SCIENCE, V292, P2479, DOI 10.1126/science.1060411; Welbourn WC, 2003, EXP APPL ACAROL, V30, P107, DOI 10.1023/B:APPA.0000006545.40017.a0; Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026; Yuan ML, 2011, ANN ENTOMOL SOC AM, V104, P800, DOI 10.1603/AN10159; Yuan ML, 2010, J ECON ENTOMOL, V103, P2204, DOI 10.1603/EC09392; [No title captured]	55	31	31	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133861	10.1371/journal.pone.0133861	http://dx.doi.org/10.1371/journal.pone.0133861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207373	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000158
J	Taipale, SJ; Peltomaa, E; Hiltunen, M; Jones, RI; Hahn, MW; Biasi, C; Brett, MT				Taipale, Sami J.; Peltomaa, Elina; Hiltunen, Minna; Jones, Roger I.; Hahn, Martin W.; Biasi, Christina; Brett, Michael T.			Inferring Phytoplankton, Terrestrial Plant and Bacteria Bulk delta C-13 Values from Compound Specific Analyses of Lipids and Fatty Acids	PLOS ONE			English	Article							CARBON-ISOTOPE FRACTIONATION; MAJOR PHOTOSYNTHETIC PIGMENTS; FRESH-WATER ALGAE; HERBIVOROUS ZOOPLANKTON; METHANOTROPHIC BACTERIA; ALLOCHTHONOUS CARBON; INORGANIC CARBON; STABLE-ISOTOPES; CO2 FIXATION; LOCH-NESS	Stable isotope mixing models in aquatic ecology require delta C-13 values for food web end members such as phytoplankton and bacteria, however it is rarely possible to measure these directly. Hence there is a critical need for improved methods for estimating the delta C-13 ratios of phytoplankton, bacteria and terrestrial detritus from within mixed seston. We determined the delta C-13 values of lipids, phospholipids and biomarker fatty acids and used these to calculate isotopic differences compared to the whole-cell delta C-13 values for eight phytoplankton classes, five bacterial taxa, and three types of terrestrial organic matter (two trees and one grass). The lipid content was higher amongst the phytoplankton (9.5 +/- 4.0%) than bacteria (7.3 +/- 0.8%) or terrestrial matter (3.9 +/- 1.7%). Our measurements revealed that the delta C-13 values of lipids followed phylogenetic classification among phytoplankton (78.2% of variance was explained by class), bacteria and terrestrial matter, and there was a strong correlation between the delta C-13 values of total lipids, phospholipids and individual fatty acids. Amongst the phytoplankton, the isotopic difference between biomarker fatty acids and bulk biomass averaged -10.7 +/- 1.1 parts per thousand for Chlorophyceae and Cyanophyceae, and -6.1 +/- 1.7 parts per thousand for Cryptophyceae, Chrysophyceae and Diatomophyceae. For heterotrophic bacteria and for type I and type II methane-oxidizing bacteria our results showed a -1.3 +/- 1.3 parts per thousand, -8.0 +/- 4.4 parts per thousand, and -3.4 +/- 1.4 parts per thousand delta C-13 difference, respectively, between biomarker fatty acids and bulk biomass. For terrestrial matter the isotopic difference averaged -6.6 +/- 1.2 parts per thousand. Based on these results, the delta C-13 values of total lipids and biomarker fatty acids can be used to determine the delta C-13 values of bulk phytoplankton, bacteria or terrestrial matter with +/- 1.4 parts per thousand uncertainty (i.e., the pooled SD of the isotopic difference for all samples). We conclude that when compound-specific stable isotope analyses become more widely available, the determination of delta C-13 values for selected biomarker fatty acids coupled with established isotopic differences, offers a promising way to determine taxa-specific bulk delta C-13 values for the phytoplankton, bacteria, and terrestrial detritus embedded within mixed seston.	[Taipale, Sami J.; Peltomaa, Elina] Univ Helsinki, Lammi Biol Stn, Lammi, Finland; [Hiltunen, Minna] Univ Eastern Finland, Dept Biol, Joensuu, Finland; [Jones, Roger I.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Hahn, Martin W.] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria; [Biasi, Christina] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland; [Brett, Michael T.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of Helsinki; University of Eastern Finland; University of Jyvaskyla; University of Innsbruck; University of Eastern Finland; University of Washington; University of Washington Seattle	Taipale, SJ (corresponding author), Univ Helsinki, Lammi Biol Stn, Lammi, Finland.	samit@u.washington.edu	Hahn, Martin W./B-9998-2008; Jones, Roger I/C-7703-2011; Taipale, Sami/AAO-3492-2020; Biasi, Christina/E-1130-2013	Hahn, Martin W./0000-0003-0501-2556; Jones, Roger I/0000-0002-0835-8264; Biasi, Christina/0000-0002-7413-3354; Hiltunen, Minna/0000-0002-0003-3000; Peltomaa, Elina/0000-0002-2858-8358	Academy of Finland grant [251665]; Foundation for Research of Natural Resources in Finland grant; Foundation of Nessling grant	Academy of Finland grant(Academy of Finland); Foundation for Research of Natural Resources in Finland grant; Foundation of Nessling grant	This project was supported by the Academy of Finland grant (251665) to Sami Taipale, the Foundation for Research of Natural Resources in Finland grant to Elina Peltomaa and Foundation of Nessling grant to Christina Biasi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bade DL, 2006, AQUAT SCI, V68, P142, DOI 10.1007/s00027-006-0818-5; Bec A, 2011, METHODS ECOL EVOL, V2, P651, DOI 10.1111/j.2041-210X.2011.00111.x; BIDIGARE RR, 1991, ANAL CHEM, V63, P130, DOI 10.1021/ac00002a008; BLAIR N, 1985, APPL ENVIRON MICROB, V50, P996, DOI 10.1128/AEM.50.4.996-1001.1985; Boschker HTS, 2002, FEMS MICROBIOL ECOL, V40, P85, DOI 10.1111/j.1574-6941.2002.tb00940.x; Brett MT, 2014, LIMNOL OCEANOGR, V59, P1795, DOI 10.4319/lo.2014.59.5.1795; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Chikaraishi Y., 2014, TREATISE GEOCHEMISTR, P95; Cole JJ, 2006, ECOL LETT, V9, P558, DOI 10.1111/j.1461-0248.2006.00898.x; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Cowie BR, 2009, ORG GEOCHEM, V40, P956, DOI 10.1016/j.orggeochem.2009.06.004; DEMOTT WR, 1986, OECOLOGIA, V69, P334, DOI 10.1007/BF00377053; Dijkman NA, 2006, MAR ECOL PROG SER, V324, P113, DOI 10.3354/meps324113; FLATT JP, 1970, J LIPID RES, V11, P131; Francis TB, 2011, ECOL LETT, V14, P364, DOI 10.1111/j.1461-0248.2011.01597.x; Galloway AWE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130053; Galloway AWE, 2014, FRESHWATER BIOL, V59, P1902, DOI 10.1111/fwb.12394; Galloway AWE, 2012, J PHYCOL, V48, P956, DOI 10.1111/j.1529-8817.2012.01173.x; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P112, DOI 10.1099/ijs.0.001743-0; Hahn MW, 2004, J MICROBIOL METH, V57, P379, DOI 10.1016/j.mimet.2004.02.004; Hayes DG, 2006, J AM OIL CHEM SOC, V73, P253; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; HOLO H, 1986, ARCH MICROBIOL, V145, P173, DOI 10.1007/BF00446776; ISOnumbers (The Database of Stable Isotope Numbers), 2015, RES; Jahnke LL, 1999, GEOCHIM COSMOCHIM AC, V63, P79, DOI 10.1016/S0016-7037(98)00270-1; Jones RI, 2001, GLOBAL BIOGEOCHEM CY, V15, P863, DOI 10.1029/2001GB001423; Jones RI, 2000, FRESHWATER BIOL, V45, P219, DOI 10.1046/j.1365-2427.2000.00672.x; Kankaala P, 2010, AQUAT ECOL, V44, P781, DOI 10.1007/s10452-010-9316-x; Kritzberg ES, 2006, ECOSYSTEMS, V9, P489, DOI 10.1007/s10021-005-0115-5; Marty J, 2008, LIMNOL OCEANOGR-METH, V6, P51, DOI 10.4319/lom.2008.6.51; NICHOLS PD, 1986, J MICROBIOL METH, V5, P49, DOI 10.1016/0167-7012(86)90023-0; Pace ML, 2007, LIMNOL OCEANOGR, V52, P2177, DOI 10.4319/lo.2007.52.5.2177; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Ruess L, 2005, ECOLOGY, V86, P2075, DOI 10.1890/04-1399; Sachs JP, 1999, GEOCHIM COSMOCHIM AC, V63, P1431, DOI 10.1016/S0016-7037(99)00097-6; Schagerl M, 2003, ANN LIMNOL-INT J LIM, V39, P35, DOI 10.1051/limn/2003003; Schagerl M, 2003, ANN LIMNOL-INT J LIM, V39, P49, DOI 10.1051/limn/2003005; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; Strandberg U, 2014, LIPIDS, V49, P591, DOI 10.1007/s11745-014-3902-y; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; Taipale S, 2008, ECOLOGY, V89, P463, DOI 10.1890/07-0702.1; Taipale S, 2013, AQUAT MICROB ECOL, V71, P165, DOI 10.3354/ame01671; Taipale SJ, 2014, ECOLOGY, V95, P563, DOI 10.1890/13-0650.1; Templeton AS, 2006, GEOCHIM COSMOCHIM AC, V70, P1739, DOI 10.1016/j.gca.2005.12.002; Vadeboncoeur Y, 2014, FRESHW SCI, V33, P524, DOI 10.1086/676315; Van den Meersche K, 2009, LIMNOL OCEANOGR, V54, P62, DOI 10.4319/lo.2009.54.1.0062; van Dongen BE, 2002, MAR ECOL PROG SER, V232, P83, DOI 10.3354/meps232083; Vuorio K, 2006, FRESHWATER BIOL, V51, P807, DOI 10.1111/j.1365-2427.2006.01529.x; Vuorio K, 2007, FUND APPL LIMNOL, V169, P237, DOI 10.1127/1863-9135/2007/0169-0237; Wartiainen I, 2006, INT J SYST EVOL MICR, V56, P109, DOI 10.1099/ijs.0.63728-0; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Yang C, 2014, INLAND WATERS, V4, P233, DOI 10.5268/IW-4.2.700; Zhang CLL, 2002, CURR OPIN BIOTECH, V13, P25, DOI 10.1016/S0958-1669(02)00280-X	59	36	37	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133974	10.1371/journal.pone.0133974	http://dx.doi.org/10.1371/journal.pone.0133974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208114	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000184
J	Zhang, WH; Zhou, T				Zhang, Wanhong; Zhou, Tong			A Sparse Reconstruction Approach for Identifying Gene Regulatory Networks Using Steady-State Experiment Data	PLOS ONE			English	Article							DIFFERENTIAL-EQUATION MODELS; SIGNAL RECOVERY; INFERENCE; SYSTEMS; ALGORITHMS; BIOLOGY	Motivation Identifying gene regulatory networks (GRNs) which consist of a large number of interacting units has become a problem of paramount importance in systems biology. Situations exist extensively in which causal interacting relationships among these units are required to be reconstructed from measured expression data and other a priori information. Though numerous classical methods have been developed to unravel the interactions of GRNs, these methods either have higher computing complexities or have lower estimation accuracies. Note that great similarities exist between identification of genes that directly regulate a specific gene and a sparse vector reconstruction, which often relates to the determination of the number, location and magnitude of nonzero entries of an unknown vector by solving an underdetermined system of linear equations y = Phi x. Based on these similarities, we propose a novel framework of sparse reconstruction to identify the structure of a GRN, so as to increase accuracy of causal regulation estimations, as well as to reduce their computational complexity. Results In this paper, a sparse reconstruction framework is proposed on basis of steady-state experiment data to identify GRN structure. Different from traditional methods, this approach is adopted which is well suitable for a large-scale underdetermined problem in inferring a sparse vector. We investigate how to combine the noisy steady-state experiment data and a sparse reconstruction algorithm to identify causal relationships. Efficiency of this method is tested by an artificial linear network, a mitogen-activated protein kinase (MAPK) pathway network and the in silico networks of the DREAM challenges. The performance of the suggested approach is compared with two state-of-the-art algorithms, the widely adopted total least-squares (TLS) method and those available results on the DREAM project. Actual results show that, with a lower computational cost, the proposed method can significantly enhance estimation accuracy and greatly reduce false positive and negative errors. Furthermore, numerical calculations demonstrate that the proposed algorithm may have faster convergence speed and smaller fluctuation than other methods when either estimate error or estimate bias is considered.	[Zhang, Wanhong; Zhou, Tong] Qinghai Univ, Sch Chem Machinery, Xining, Qinghai, Peoples R China; [Zhang, Wanhong] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China	Qinghai University; Tsinghua University; Tsinghua University	Zhang, WH (corresponding author), Qinghai Univ, Sch Chem Machinery, Xining, Qinghai, Peoples R China.	zhangwh11@mails.tsinghua.edu.cn	Zhou, Tong/AAD-1593-2019		973 Program of China [2012CB316504]; National Natural Science Foundation of China [61174122, 61021063]; Specialized Research Fund for the Doctoral Program of Higher Education, P.R.C. [20110002110045]	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education, P.R.C.(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported in part by 973 Program of China (grant no. 2012CB316504), National Natural Science Foundation of China (grant nos. 61174122 and 61021063), and Specialized Research Fund for the Doctoral Program of Higher Education, P.R.C. (grant no. 20110002110045).	Akutsu T, 2003, THEOR COMPUT SCI, V298, P235, DOI 10.1016/S0304-3975(02)00425-5; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Andrec M, 2005, J THEOR BIOL, V232, P427, DOI 10.1016/j.jtbi.2004.08.022; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Candes EJ, 2008, CR MATH, V346, P589, DOI 10.1016/j.crma.2008.03.014; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Chang R, 2008, IEEE T KNOWL DATA EN, V20, P1587, DOI 10.1109/TKDE.2008.89; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Donoho DL, 2012, IEEE T INFORM THEORY, V58, P1094, DOI 10.1109/TIT.2011.2173241; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; Ferrazzi F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S2; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Iba H, 2008, INFORM SCIENCES, V178, P4453, DOI 10.1016/j.ins.2008.07.029; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Li Z, 2011, BIOINFORMATICS, V27, P2686, DOI 10.1093/bioinformatics/btr454; Liu B, 2008, GENETICS, V178, P1763, DOI 10.1534/genetics.107.080069; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Needell D, 2009, FOUND COMPUT MATH, V9, P317, DOI 10.1007/s10208-008-9031-3; Penfold CA, 2012, BIOINFORMATICS, V28, pI233, DOI 10.1093/bioinformatics/bts222; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Sarvotham S, 2006, PREPRINT; Shmulevich I., 2010, PROB BOOL NETW; Sontag ED, 2008, ESSAYS BIOCHEM, V45, P161, DOI 10.1042/BSE0450161; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang J, 2012, IEEE T SIGNAL PROCES, V60, P6202, DOI 10.1109/TSP.2012.2218810; Wang YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031194; Xiong J, 2013, CHIN CONTR CONF, P8235; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043819; Yun Z, 2004, I C CONT AUTOMAT ROB, P1049; Zhang WH, 2013, CHIN CONTR CONF, P1951; Zhou T, 2012, CHIN CONTR CONF, P7408; Zhou T, 2010, BIOINFORMATICS, V26, P2020, DOI 10.1093/bioinformatics/btq325	40	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130979	10.1371/journal.pone.0130979	http://dx.doi.org/10.1371/journal.pone.0130979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207991	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000013
J	Timsah, Z; Ahmed, Z; Ivan, C; Berrout, J; Gagea, M; Zhou, Y; Pena, GNA; Hu, X; Vallien, C; Kingsley, CV; Lu, Y; Hancock, JF; Liu, J; Gladden, AB; Mills, GB; Lopez-Berestein, G; Hung, MC; Sood, AK; Bogdanov, M; Ladbury, JE				Timsah, Z.; Ahmed, Z.; Ivan, C.; Berrout, J.; Gagea, M.; Zhou, Y.; Pena, G. N. A.; Hu, X.; Vallien, C.; Kingsley, C. V.; Lu, Y.; Hancock, J. F.; Liu, J.; Gladden, A. B.; Mills, G. B.; Lopez-Berestein, G.; Hung, M-C; Sood, A. K.; Bogdanov, M.; Ladbury, J. E.			Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer	ONCOGENE			English	Article							PI3K/AKT/MTOR INHIBITORS; SIGNALING PATHWAY; PHOSPHORYLATION; FGFR2; PHOSPHATASE; ACTIVATION; QUANTIFICATION; MUTATIONS; KINASE; RAS	In the absence of extracellular stimulation the adaptor protein growth factor receptor-bound protein (Grb2) and the phospholipase Plc gamma 1 compete for the same binding site on fibroblast growth factor receptor 2 (FGFR2). Reducing cellular Grb2 results in upregulation of Plc gamma 1 and depletion of the phospholipid PI(4,5)P-2. The functional consequences of this event on signaling pathways are unknown. We show that the decrease in PI(4,5)P-2 level under non-stimulated conditions inhibits PTEN activity leading to the aberrant activation of the oncoprotein Akt. This results in excessive cell proliferation and tumor progression in a xenograft mouse model. As well as defining a novel mechanism of Akt phosphorylation with important therapeutic consequences, we also demonstrate that differential expression levels of FGFR2, Plc gamma 1 and Grb2 correlate with patient survival. Oncogenesis through fluctuation in the expression levels of these proteins negates extracellular stimulation or mutation and defines them as novel prognostic markers in ovarian cancer.	[Timsah, Z.; Ahmed, Z.; Ladbury, J. E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, Houston, TX 77030 USA; [Timsah, Z.; Berrout, J.; Ladbury, J. E.] Univ Leeds, Sch Mol & Cellular Biol, Miall Bldg, Leeds LS2 9JT, W Yorkshire, England; [Ahmed, Z.; Ladbury, J. E.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Unit 1000, Houston, TX 77030 USA; [Ivan, C.; Pena, G. N. A.; Lopez-Berestein, G.; Sood, A. K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Ivan, C.; Lopez-Berestein, G.; Sood, A. K.] Univ Texas MD Anderson Canc Ctr, Ctr RNAi & Noncoding RNA, Houston, TX 77030 USA; [Berrout, J.] Baylor Coll Med, Ctr Cell & Gene Therapy, Stem Cells & Regenerat Med Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gagea, M.; Vallien, C.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Unit 63, Houston, TX 77030 USA; [Zhou, Y.; Hancock, J. F.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Hu, X.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Kingsley, C. V.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Unit 1472, Houston, TX 77030 USA; [Lu, Y.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Liu, J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol Lab Med, Div Pathol Lab Med, Houston, TX 77030 USA; [Gladden, A. B.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Unit 1010, Houston, TX 77030 USA; [Lopez-Berestein, G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Sood, A. K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Bogdanov, M.] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Sch Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Leeds; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Ladbury, JE (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Miall Bldg, Leeds LS2 9JT, W Yorkshire, England.	J.E.Ladbury@leeds.ac.uk	Hung, Mien-Chie/ABD-5911-2021; Bogdanov, Mikhail/J-3695-2017; Sood, Anoop Kumar/A-7344-2013	Hung, Mien-Chie/0000-0003-4317-4740; Sood, Anoop Kumar/0000-0001-5702-4108; Ladbury, John/0000-0002-6328-7200; Hancock, John/0000-0003-0542-4710; Zhou, Yong/0000-0002-0214-8151; Ivan, Cristina/0000-0002-4848-0168; Armaiz-Pena, Guillermo N/0000-0002-9081-5339	G. Harold and Leila Y. Mathers Charitable Foundation; NIH [U54CA151668, P50 CA083639, P50 CA098258]; RGK Foundation; Gilder Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, U54CA151668, P50CA083639] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RGK Foundation; Gilder Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the G. Harold and Leila Y. Mathers Charitable Foundation. This work was supported by NIH grants U54CA151668, P50 CA083639, P50 CA098258 and by the RGK Foundation and the Gilder Foundation.	Ahmed Z, 2013, J CELL BIOL, V200, P493, DOI 10.1083/jcb.201204106; Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Ahmed Z, 2008, BIOCHEM J, V413, P37, DOI 10.1042/BJ20071594; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Byron SA, 2009, FUTURE ONCOL, V5, P27, DOI 10.2217/14796694.5.1.27; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Ching JK, 2010, AM J PHYSIOL-CELL PH, V299, pC1171, DOI 10.1152/ajpcell.00514.2009; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Cole C, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12585; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fry Michael J., 2009, V462, P345, DOI 10.1007/978-1-60327-115-8_22; Gauglhofer C, 2011, HEPATOLOGY, V53, P854, DOI 10.1002/hep.24099; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Katoh Y, 2009, INT J MOL MED, V23, P307, DOI 10.3892/ijmm_00000132; Khan KH, 2013, CHIN J CANCER, V32, P253, DOI 10.5732/cjc.013.10057; Konig S, 2008, ANAL BIOCHEM, V378, P197, DOI 10.1016/j.ab.2008.03.052; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; Matsuda Yoko, 2012, Patholog Res Int, V2012, P574768, DOI 10.1155/2012/574768; Mazzoletti M, 2010, CURR MED CHEM, V17, P4433, DOI 10.2174/092986710794182999; Ooms Lisa M., 2009, V462, P223, DOI 10.1007/978-1-60327-115-8_15; Pan JJ, 2010, CHEM RES TOXICOL, V23, P568, DOI 10.1021/tx9003193; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Rodriguez EF, 2011, ACTA NEUROPATHOL, V121, P407, DOI 10.1007/s00401-010-0784-9; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Sato K., 2012, J SIGNAL TRANSDUCT, V2012; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Timsah Z, 2014, NAT STRUCT MOL BIOL, V21, P180, DOI 10.1038/nsmb.2752; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Troncoso R, 2012, CARDIOVASC RES, V93, P320, DOI 10.1093/cvr/cvr321; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yamamoto N, 2006, J CELL SCI, V119, P4623, DOI 10.1242/jcs.03236; Yang K, 2011, METABOLITES, V1, P21, DOI 10.3390/metabo1010021; Zhou Y, 2014, MOL CELL BIOL, V34, P862, DOI 10.1128/MCB.01227-13	45	23	23	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2186	2196		10.1038/onc.2015.279	http://dx.doi.org/10.1038/onc.2015.279			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26212011	Green Accepted, Green Published			2022-12-26	WOS:000374986000005
J	Benlhabib, H; Guo, W; Pierce, BM; Mendelson, CR				Benlhabib, Houda; Guo, Wei; Pierce, Brianne M.; Mendelson, Carole R.			The miR-200 Family and Its Targets Regulate Type II Cell Differentiation in Human Fetal Lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-A GENE; TRANSCRIPTION FACTOR-I; SURFACTANT PROTEINS; TUMOR PROGRESSION; REPRESSORS ZEB1; CANCER-CELLS; CYCLIC-AMP; MOUSE LUNG; TGF-BETA	Type II cell differentiation and expression of the major surfactant protein, SP-A, in mid-gestation human fetal lung (HFL) are induced by cAMP and inhibited by TGF-beta. cAMP induction of SP-A promoter activity is mediated by increased phosphorylation and DNA binding of thyroid transcription factor-1 (TTF1/Nkx2.1), a master regulator of lung development. To further define mechanisms for developmental induction of surfactant synthesis in HFL, herein, we investigated the potential roles of microRNAs (miRNAs, miRs). To identify and characterize differentially regulated miRNAs in mid-gestation HFL explants during type II pneumocyte differentiation in culture, we performed miRNA microarray of RNA from epithelial cells isolated from mid-gestation HFL explants before and after culture with or without Bt2cAMP. Interestingly, the miR-200 family was significantly up-regulated during type II cell differentiation; miR-200 induction was inversely correlated with expression of known targets, transcription factors ZEB1/2 and TGF-beta 2. miR-200 antagonists inhibited TTF-1 and surfactant proteins and up-regulated TGF-beta 2 and ZEB1 expression in type II cells. Overexpression of ZEB1 in type II cells decreased DNA binding of endogenous TTF-1, blocked cAMP stimulation of surfactant proteins, and inhibited miR-200 expression, whereas cAMP markedly inhibited ZEB1/2 and TGF-beta. Importantly, overexpression of ZEB1 or miR-200 antagonists in HFL type II cells also inhibited LPCAT1 and ABCA3, enzymes involved in surfactant phospholipid synthesis and trafficking, and blocked lamellar body biogenesis. Our findings suggest that the miR-200 family and ZEB1, which exist in a double-negative feedback loop regulated by TGF-beta, serve important roles in the developmental regulation of type II cell differentiation and function in HFL.	Univ Texas SW Med Ctr Dallas, North Texas March Dimes Birth Defects Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, North Texas March Dimes Birth Defects Ctr, Dept Obstet & Gynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelson, CR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	carole.mendelson@utsouthwestern.edu	Regan, Clinton/E-6250-2012	Dentel, Brianne/0000-0003-4384-3529; Benlhabib, Houda/0000-0002-7776-1508; Mendelson, Carole Ruth/0000-0003-1696-9791	National Institutes of Health [R01 HL050022]; March of Dimes Foundation Prematurity Research Initiative Grant [21-FY14-146]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation Prematurity Research Initiative Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL050022 (to C. R. M.). This work was also supported by March of Dimes Foundation Prematurity Research Initiative Grant 21-FY14-146 (to C. R. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ACARREGUI MJ, 1993, AM J PHYSIOL, V264, pL465, DOI 10.1152/ajplung.1993.264.5.L465; ALCORN JL, 1993, MOL ENDOCRINOL, V7, P1072, DOI 10.1210/me.7.8.1072; Alcorn JL, 2004, AM J PHYSIOL-LUNG C, V286, pL767, DOI 10.1152/ajplung.00280.2003; Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; Ambalavanan N, 2008, AM J PHYSIOL-LUNG C, V295, pL86, DOI 10.1152/ajplung.00534.2007; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beers MF, 1998, AM J PHYSIOL-LUNG C, V275, pL950, DOI 10.1152/ajplung.1998.275.5.L950; Benlhabib H, 2011, MOL CELL BIOL, V31, P1949, DOI 10.1128/MCB.01063-10; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Cheong N, 2007, J BIOL CHEM, V282, P23811, DOI 10.1074/jbc.M703927200; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Furusawa T, 1999, MOL CELL BIOL, V19, P8581; Gao L, 2015, J CLIN INVEST, V125, P2808, DOI 10.1172/JCI78544; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Insel PA, 2012, BRIT J PHARMACOL, V166, P447, DOI 10.1111/j.1476-5381.2012.01847.x; Islam KN, 2008, MOL ENDOCRINOL, V22, P585, DOI 10.1210/me.2007-0412; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Islam KN, 2002, MOL ENDOCRINOL, V16, P1428, DOI 10.1210/me.16.6.1428; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li CG, 2002, J BIOL CHEM, V277, P38399, DOI 10.1074/jbc.M203188200; Li JX, 1998, J BIOL CHEM, V273, P4592, DOI 10.1074/jbc.273.8.4592; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; McDevitt TM, 2007, AM J PHYSIOL-LUNG C, V292, pL249, DOI 10.1152/ajplung.00088.2006; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Minoo P, 2008, NUCLEIC ACIDS RES, V36, P179, DOI 10.1093/nar/gkm871; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; ODOM MJ, 1988, ENDOCRINOLOGY, V123, P1712; ODOM MJ, 1987, ENDOCRINOLOGY, V121, P1155, DOI 10.1210/endo-121-3-1155; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng SB, 2005, BIOCHEMISTRY-US, V44, P2293, DOI 10.1021/bi048851x; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Scavo LM, 1998, AM J PHYSIOL-LUNG C, V275, pL653, DOI 10.1152/ajplung.1998.275.4.L653; Schiller M, 2003, ONCOGENE, V22, P8881, DOI 10.1038/sj.onc.1206871; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; SMITH BT, 1977, AM REV RESPIR DIS, V115, P285; SNYDER JM, 1981, CELL TISSUE RES, V220, P17; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wakabayashi Y, 2011, J BIOL CHEM, V286, P35456, DOI 10.1074/jbc.M111.236794; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang J, 2009, INT IMMUNOL, V21, P227, DOI 10.1093/intimm/dxn143; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; WHITSETT JA, 1992, BIOCHIM BIOPHYS ACTA, V1123, P257, DOI 10.1016/0005-2760(92)90004-F; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yang HB, 2008, AM J PHYSIOL-GASTR L, V295, pG170, DOI 10.1152/ajpgi.00492.2007; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang Y, 2012, INT J MOL MED, V29, P393, DOI 10.3892/ijmm.2011.855; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103	72	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22409	22422		10.1074/jbc.M114.636068	http://dx.doi.org/10.1074/jbc.M114.636068			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26203191	Green Published, hybrid			2022-12-26	WOS:000361171500008
J	Torres-Salazar, D; Jiang, J; Divito, CB; Garcia-Olivares, J; Amara, SG				Torres-Salazar, Delany; Jiang, Jie; Divito, Christopher B.; Garcia-Olivares, Jennie; Amara, Susan G.			A Mutation in Transmembrane Domain 7 (TM7) of Excitatory Amino Acid Transporters Disrupts the Substrate-dependent Gating of the Intrinsic Anion Conductance and Drives the Channel into a Constitutively Open State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUTAMATE TRANSPORTER; CHLORIDE CHANNEL; FUNCTIONAL-PROPERTIES; VOLTAGE-DEPENDENCE; EXTRACELLULAR GATE; NOISE-ANALYSIS; ION-CHANNEL; BINDING; HOMOLOG; TRANSLOCATION	In the mammalian central nervous system, excitatory amino acid transporters (EAATs) are responsible for the clearance of glutamate after synaptic release. This energetically demanding activity is crucial for precise neuronal communication and for maintaining extracellular glutamate concentrations below neurotoxic levels. In addition to their ability to recapture glutamate from the extracellular space, EAATs exhibit a sodium-and glutamate-gated anion conductance. Here we show that substitution of a conserved positively charged residue (Arg-388, hEAAT1) in transmembrane domain 7 with a negatively charged amino acid eliminates the ability of glutamate to further activate the anion conductance. When expressed in oocytes, R388D or R388E mutants show large anion currents that display no further increase in amplitude after application of saturating concentrations of Na+ and glutamate. They also show a substantially reduced transport activity. The mutant transporters appear to exist preferentially in a sodium-and glutamate-independent constitutive open channel state that rarely transitions to complete the transport cycle. In addition, the accessibility of cytoplasmic residues to membrane-permeant modifying reagents supports the idea that this substrate-independent open state correlates with an intermediate outward facing conformation of the transporter. Our data provide additional insights into the mechanism by which substrates gate the anion conductance in EAATs and suggest that in EAAT1, Arg-388 is a critical element for the structural coupling between the substrate translocation and the gating mechanisms of the EAAT-associated anion channel.	[Torres-Salazar, Delany; Garcia-Olivares, Jennie; Amara, Susan G.] NIMH, Bethesda, MD 20892 USA; [Jiang, Jie; Divito, Christopher B.; Amara, Susan G.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15213 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Torres-Salazar, D (corresponding author), NIMH, Lab Mol & Cellular Neurobiol, NIH, 35 Convent Dr,Rm 3A-207, Bethesda, MD 20892 USA.	delany.torressalazar@nih.gov; susan.amara@nih.gov	Regan, Clinton/E-6250-2012	Torres-Salazar, Delany/0000-0002-6789-9810; Amara, Susan/0000-0001-8914-1106	National Institutes of Health [MH080726]; National Institute of Mental Health [MH002946]; American Heart Association [09POST2010115]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946, R01MH080726, T32MH016804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH080726 (to S. G. A.) and National Institute of Mental Health intramural research program Grant MH002946. This work was also supported by American Heart Association postdoctoral fellowship 09POST2010115 (to D. T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Focke PJ, 2011, J NEUROSCI, V31, P6255, DOI 10.1523/JNEUROSCI.6096-10.2011; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hotzy J, 2012, J BIOL CHEM, V287, P20016, DOI 10.1074/jbc.M112.344077; Huang SW, 2007, BIOCHEMISTRY-US, V46, P9685, DOI 10.1021/bi700647f; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Jiang J, 2011, NEUROPHARMACOLOGY, V60, P172, DOI 10.1016/j.neuropharm.2010.07.019; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; Machtens JP, 2011, CHANNELS, V5, P468, DOI 10.4161/chan.5.6.17453; Machtens JP, 2011, J BIOL CHEM, V286, P23780, DOI 10.1074/jbc.M110.207514; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2005, CLIN EXP PHARMACOL P, V32, P1, DOI 10.1111/j.1440-1681.2005.04164.x; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Schneider N, 2014, J BIOL CHEM, V289, P1815, DOI 10.1074/jbc.M113.517177; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; Seal RP, 1998, METHOD ENZYMOL, V296, P318; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Shlaifer I, 2007, MOL PHARMACOL, V71, P1341, DOI 10.1124/mol.106.032607; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	57	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22977	22990		10.1074/jbc.M115.660860	http://dx.doi.org/10.1074/jbc.M115.660860			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26203187	Green Published, hybrid			2022-12-26	WOS:000361685500011
J	Kovari, H; Russmann, S; Ledergerber, B; Muller, D; Rotger, M; Velli, P; Cavassini, M; Ambrosioni, J; Bregenzer, A; Stockle, M; Bernasconi, E; Rauch, A; Speck, RF				Kovari, Helen; Russmann, Stefan; Ledergerber, Bruno; Mueller, Daniel; Rotger, Margalida; Velli, Pablo; Cavassini, Matthias; Ambrosioni, Juan; Bregenzer, Andrea; Stoeckle, Marcel; Bernasconi, Enos; Rauch, Andri; Speck, Roberto F.		Swiss HIV Cohort Study	Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ALPHA-2A PLUS RIBAVIRIN; INFECTED PATIENTS; GENETIC-VARIATION; VIRUS; PEGINTERFERON; IL28B	Background Ribavirin (RBV) is an essential component of most current hepatitis C (HCV) treatment regimens and still standard of care in the combination with pegylated interferon (pegIFN) to treat chronic HCV in resource limited settings. Study results in HIV/HCV-coinfected patients are contradicting as to whether RBV concentration correlates with sustained virological response (SVR). Methods We included 262 HCV treatment naive HIV/HCV-coinfected Swiss HIV Cohort Study (SHCS) participants treated with RBV and pegIFN between 01.01.2001-01.01.2010, 134 with HCV genotype (GT) 1/4, and 128 with GT 2/3 infections. RBV levels were measured retrospectively in stored plasma samples obtained between HCV treatment week 4 and end of therapy. Uni- and multivariable logistic regression analyses were used to evaluate the association between RBV concentration and SVR in GT 1/4 and GT 2/3 infections. The analyses were repeated stratified by treatment phase (week 4-12, 13-24, >24) and IL28B genotype (CC versus CT/TT). Results SVR rates were 35.1% in GT 1/4 and 70.3% in GT 2/3 infections. Overall, median RBV concentration was 2.0 mg/L in GT 1/4, and 1.9 mg/L in GT 2/3, and did not change significantly across treatment phases. Patients with SVR had similar RBV concentrations compared to patients without SVR in both HCV genotype groups. SVR was not associated with RBV levels >= 2.0 mg/L (GT 1/4, OR 1.19 [0.5-2.86]; GT 2/3, 1.94 [0.78-4.80]) and >= 2.5 mg/L (GT 1/4, 1.56 [0.64-3.84]; GT 2/3 2.72 [0.85-8.73]), regardless of treatment phase, and IL28B genotype. Conclusion In HIV/HCV-coinfected patients treated with pegIFN/RBV, therapeutic drug monitoring of RBV concentrations does not enhance the chance of HCV cure, regardless of HCV genotype, treatment phase and IL28B genotype.	[Kovari, Helen; Ledergerber, Bruno; Speck, Roberto F.] Univ Zurich, Univ Hosp, Div Infect Dis, Zurich, Switzerland; [Kovari, Helen; Ledergerber, Bruno; Speck, Roberto F.] Univ Zurich, Univ Hosp, Hosp Epidemiol, Zurich, Switzerland; [Russmann, Stefan] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Mueller, Daniel] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Rotger, Margalida; Velli, Pablo] Univ Hosp, Inst Microbiol, Lausanne, Switzerland; [Cavassini, Matthias] Univ Hosp, Div Infect Dis, Lausanne, Switzerland; [Ambrosioni, Juan] Univ Hosp, Div Infect Dis, Geneva, Switzerland; [Bregenzer, Andrea] Cantonal Hosp, Div Infect Dis, St Gallen, Switzerland; [Stoeckle, Marcel] Univ Hosp, Div Infect Dis, Basel, Switzerland; [Stoeckle, Marcel] Univ Hosp, Hosp Epidemiol, Basel, Switzerland; [Bernasconi, Enos] Osped Reg, Lugano, Switzerland; [Rauch, Andri] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Kantonsspital St. Gallen; University of Bern; University Hospital of Bern; University of Bern	Kovari, H (corresponding author), Univ Zurich, Univ Hosp, Div Infect Dis, Zurich, Switzerland.	helen.kovari@usz.ch	Rauch, Andri/E-9948-2017; Ledergerber, Bruno/B-5656-2009; Speck, Roberto F/O-2433-2016; cavassini, matthias/F-8987-2017	Rauch, Andri/0000-0001-5297-6062; Ledergerber, Bruno/0000-0002-6881-4401; cavassini, matthias/0000-0003-0933-7833; Speck, Roberto/0000-0002-8453-1137; Mueller, Daniel/0000-0002-4674-4019	Roche Pharma AG; Swiss HIV Cohort Study - Swiss National Science Foundation [148522]; SHCS project [650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070114, R01AI099026] Funding Source: NIH RePORTER	Roche Pharma AG(Roche Holding); Swiss HIV Cohort Study - Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); SHCS project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded within the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant #148522), by SHCS project #650, and by an unrestricted grant from Roche Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GUIDELINES SCREENING; Arase Y, 2004, J GASTROENTEROL, V39, P1090, DOI 10.1007/s00535-004-1483-x; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bodeau S, 2013, THER DRUG MONIT, V35, P791, DOI 10.1097/FTD.0b013e3182966dee; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chan AHW, 2009, ANN PHARMACOTHER, V43, P2044, DOI 10.1345/aph.1M225; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Crespo M, 2007, ANTIVIR THER, V12, P1217; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Glue P, 1999, SEMIN LIVER DIS, V19, P17; Hatu G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-150; Ioannou GN, 2013, ALIMENT PHARM THER, V38, P1373, DOI 10.1111/apt.12524; Jen JF, 2000, THER DRUG MONIT, V22, P555, DOI 10.1097/00007691-200010000-00010; Jin RY, 2012, AM J GASTROENTEROL, V107, P1675, DOI 10.1038/ajg.2012.306; Larrat S, 2003, ANTIMICROB AGENTS CH, V47, P124, DOI 10.1128/AAC.47.1.124-129.2003; Lopez-Cortes LF, 2008, CLIN PHARMACOL THER, V84, P573, DOI 10.1038/clpt.2008.110; Marucco DA, 2008, J ANTIMICROB CHEMOTH, V61, P919, DOI 10.1093/jac/dkn013; Morello J, 2008, J ANTIMICROB CHEMOTH, V62, P1174, DOI 10.1093/jac/dkn421; Morello J, 2010, ANTIMICROB AGENTS CH, V54, P1647, DOI 10.1128/AAC.01399-09; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Nicot F, 2008, J MED VIROL, V80, P1523, DOI 10.1002/jmv.21227; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Slavenburg S, 2011, THER DRUG MONIT, V33, P40, DOI 10.1097/FTD.0b013e318205f892; Torres-Cornejo A, 2014, J VIRAL HEPATITIS, V21, P178, DOI 10.1111/jvh.12128; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133879	10.1371/journal.pone.0133879	http://dx.doi.org/10.1371/journal.pone.0133879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218843	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000358595900053
J	Salgotra, RK; Gupta, BB; Bhat, JA; Sharma, S				Salgotra, R. K.; Gupta, B. B.; Bhat, Javaid Akhter; Sharma, Sandeep			Genetic Diversity and Population Structure of Basmati Rice (Oryza sativa L.) Germplasm Collected from North Western Himalayas Using Trait Linked SSR Markers	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; VARIETIES; CULTIVARS; IDENTIFICATION; ACCESSIONS; DISTANCE; PANELS	One hundred forty one basmati rice genotypes collected from different geographic regions of North Western Himalayas were characterized using 40 traits linked microsatellite markers. Number of alleles detected by the abovementioned primers were 112 with a maximum and minimum frequency of 5 and 2 alleles, respectively. The maximum and minimum polymorphic information content values were found to be 0.63 and 0.17 for the primers RM206 and RM213, respectively. The genetic similarity coefficient for the most number of pairs ranged between of 0.2-0.9 with the average value of 0.60 for all possible combinations, indicating moderate genetic diversity among the chosen genotypes. Phylogenetic cluster analysis of the SSR data based on distance divided all genotypes into four groups (I, II, III and IV), whereas model based clustering method divided these genotypes into five groups (A, B, C, D and E). However, the result from both the analysis are in well agreement with each other for clustering on the basis of place of collection and geographic region, except the local basmati genotypes which clustered into three subpopulations in structure analysis comparison to two clusters in distance based clustering. The diverse genotypes and polymorphic trait linked microsatellites markers in the present study will be used for the identification of quantitative trait loci/genes for different economically important traits to be utilized in molecular breeding programme of rice in the future.	[Salgotra, R. K.; Sharma, Sandeep] Sher e Kashmir Univ Agr Sci & Technol Jammu, Sch Biotechnol, Jammu, J&K, India; [Gupta, B. B.; Bhat, Javaid Akhter] Sher e Kashmir Univ Agr Sci & Technol Jammu, Div Plant Breeding & Genet, Jammu, J&K, India	Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu); Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu)	Salgotra, RK (corresponding author), Sher e Kashmir Univ Agr Sci & Technol Jammu, Sch Biotechnol, Jammu, J&K, India.	rks_2959@rediffmail.com	Gupta, Brij B/E-9813-2011	Gupta, Brij B/0000-0003-4929-4698; Salgotra, Romesh Kumar/0000-0001-7605-0926	Department of Biotechnology, Ministry of Science and Technology, Govt. of India, New Delhi [102/IFD/SAN/1727/2011-12]	Department of Biotechnology, Ministry of Science and Technology, Govt. of India, New Delhi(Department of Biotechnology (DBT) India)	102/IFD/SAN/1727/2011-12, dated 23-08-2011 Department of Biotechnology, Ministry of Science and Technology, Govt. of India, New Delhi for sanctioning the project entitled, "Assessment of genetic diversity of Basmati rice using molecular markers and in situ conservation through participatory approach" under which the present work was undertaken aT Sher-e-Kashmir University of Agricultural Sciences &Tecnology of Jammu, (J&K) India.	Allhgholipour M, 2014, GENETIKA-BELGRADE, V46, P187, DOI 10.2298/GENSR1401187A; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Archak S, 2007, ELECTROPHORESIS, V28, P2396, DOI 10.1002/elps.200600646; Babu BK, 2014, MOL BIOL REP, V41, P4329, DOI 10.1007/s11033-014-3304-5; Chakhonkaen S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-19; Chaudhary RC, 2001, SPECIALITY RICES OF THE WORLD: BREEDING, PRODUCTION AND MARKETING, P3; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Chuang HY, 2011, BOT STUD, V52, P393; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Deshmukh R, 2010, FUNCT INTEGR GENOMIC, V10, P339, DOI 10.1007/s10142-010-0167-2; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Herrera TG, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue5-fulltext-6; Islam M.M., 2012, J BIOSCI BIOTECHNOL, V1, P107; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jairin J, 2009, FIELD CROP RES, V110, P263, DOI 10.1016/j.fcr.2008.09.009; Jayamani P, 2007, CROP SCI, V47, P879, DOI 10.2135/cropsci2006.04.0236; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Nagaraju J, 2002, P NATL ACAD SCI USA, V99, P5836, DOI 10.1073/pnas.042099099; NEI M, 1978, GENETICS, V89, P583; Ni J, 2002, CROP SCI, V42, P601, DOI 10.2135/cropsci2002.0601; Pessoa-Filho M, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-23; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Prevost A, 1999, THEOR APPL GENET, V98, P107, DOI 10.1007/s001220051046; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Rabbani MA, 2010, PAK J BOT, V42, P2551; Ram SG, 2007, J APPL GENET, V48, P337, DOI 10.1007/BF03195230; Rashid M, 2009, AFR J BIOTECHNOL, V8, P6777; Sakthivel K, 2009, BIOTECHNOL ADV, V27, P468, DOI 10.1016/j.biotechadv.2009.04.001; Sarker M.M., 2013, J BANGLADESH AGRIC U, V11, P233, DOI 10.3329/jbau.v11i2.19900; Shah SM, 2013, PAK J BOT, V45, P423; Singh D, 2011, AFR J BIOTECHNOL, V10, P499; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; Sivaranjani AKP, 2010, CURR SCI INDIA, V99, P221; Tessier C, 1999, THEOR APPL GENET, V98, P171, DOI 10.1007/s001220051054; Thompson JA, 1998, CROP SCI, V38, P1348, DOI [10.2135/cropsci1998.0011183X003800050034x, 10.2135/cropsci1998.0011183X003800050035x]; Thomson MJ, 2007, THEOR APPL GENET, V114, P559, DOI 10.1007/s00122-006-0457-1; Thomson MJ, 2009, RICE, V2, P80, DOI 10.1007/s12284-009-9023-1; Vinita Pachauri, 2013, Australian Journal of Crop Science, V7, P923; Wang CH, 2014, HEREDITY, V112, P489, DOI 10.1038/hdy.2013.130; Yadav S, 2013, J GENET, V92, P3; Yu SB, 2003, THEOR APPL GENET, V108, P131, DOI 10.1007/s00122-003-1400-3; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhang T, 2010, RICE SCI, V17, P288, DOI 10.1016/S1672-6308(09)60029-9	47	40	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0131858	10.1371/journal.pone.0131858	http://dx.doi.org/10.1371/journal.pone.0131858			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218261	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900003
J	Zhang, XQ; Li, JM; Wei, DP; Li, B; Ma, YB				Zhang, Xiaoqing; Li, Jumei; Wei, Dongpu; Li, Bo; Ma, Yibing			Predicting Soluble Nickel in Soils Using Soil Properties and Total Nickel	PLOS ONE			English	Article							CONTAMINATED SOILS; ORGANIC-MATTER; HUMIC SUBSTANCES; HEAVY-METALS; SPECIATION; NI; CU; CD; BINDING; ZN	Soil soluble nickel (Ni) concentration is very important for determining soil Ni toxicity. In the present study, the relationships between soil properties, total and soluble Ni concentrations in soils were developed in a wide range of soils with different properties and climate characteristics. The multiple regressions showed that soil pH and total soil Ni concentrations were the most significant parameters in predicting soluble Ni concentrations with the adjusted determination coefficients (R-adj(2)) values of 0.75 and 0.68 for soils spiked with soluble Ni salt and the spiked soils leached with artificial rainwater to mimic field conditions, respectively. However, when the soils were divided into three categories (pH < 7, 7-8 and > 8), they obtained better predictions with R-adj(2) values of 0.78-0.90 and 0.79-0.94 for leached and unleached soils, respectively. Meanwhile, the other soil properties, such as amorphous Fe and Al oxides and clay, were also found to be important for determining soluble Ni concentrations, indicating that they were also presented as active adsorbent surfaces. Additionally, the whole soil speciation including bulk soil properties and total soils Ni concentrations were analyzed by mechanistic speciation models WHAM VI and Visual MINTEQ3.0. It was found that WHAM VI provided the best predictions for the soils with pH < 7, was relatively reasonable for pH 7 to 8, and gave an overestimation for pH > 8. The Visual MINTEQ3.0 could provide better estimation for pH < 8 and meanwhile quite reasonable results for pH > 8. These results indicated the possibility and applicability of these models to predict soil soluble Ni concentration by soil properties.	[Zhang, Xiaoqing] Hubei Univ Nationalities, Sch Forestry & Hort, Enshi 445000, Hubei Province, Peoples R China; [Li, Jumei; Wei, Dongpu; Li, Bo] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100081, Peoples R China; [Ma, Yibing] Univ Jinan, Sch Resources & Environm, Jinan 250022, Shandong, Peoples R China	Hubei Minzu University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; University of Jinan	Ma, YB (corresponding author), Univ Jinan, Sch Resources & Environm, Jinan 250022, Shandong, Peoples R China.	ybma@caas.ac.cn		Ma, Yibing/0000-0002-9340-8181	Special Fund for Environmental Protection Scientific Research in the Public Interest [201509032]; Nickel Producers Environmental Research Association; International Copper Association; Rio Tinto Pty Ltd.	Special Fund for Environmental Protection Scientific Research in the Public Interest; Nickel Producers Environmental Research Association; International Copper Association; Rio Tinto Pty Ltd.	The manuscript was financially supported by Special Fund for Environmental Protection Scientific Research in the Public Interest (Project no. 201509032), the International Copper Association, Rio Tinto Pty Ltd., and the Nickel Producers Environmental Research Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axe L, 2002, J COLLOID INTERF SCI, V247, P259, DOI 10.1006/jcis.2001.8125; Bonten LTC, 2008, GEODERMA, V146, P303, DOI 10.1016/j.geoderma.2008.06.005; Buekers J, 2007, EUR J SOIL SCI, V58, P1514, DOI 10.1111/j.1365-2389.2007.00958.x; Contin M, 2007, GEODERMA, V140, P164, DOI 10.1016/j.geoderma.2007.03.017; Dijkstra JJ, 2004, ENVIRON SCI TECHNOL, V38, P4390, DOI 10.1021/es049885v; Fairbrother A, 2007, ECOTOX ENVIRON SAFE, V68, P145, DOI 10.1016/j.ecoenv.2007.03.015; Gandois L, 2010, EUR J SOIL SCI, V61, P271, DOI 10.1111/j.1365-2389.2009.01215.x; Gustafsson JP, 2003, EUR J SOIL SCI, V54, P295, DOI 10.1046/j.1365-2389.2003.00526.x; Gustafsson JP, 2003, ENVIRON SCI TECHNOL, V37, P2767, DOI 10.1021/es026249t; Li B, 2011, ECOTOX ENVIRON SAFE, V74, P459, DOI 10.1016/j.ecoenv.2010.10.021; Li B, 2009, ECOTOX ENVIRON SAFE, V72, P1760, DOI 10.1016/j.ecoenv.2009.05.003; Nolan AL, 2009, J ENVIRON QUAL, V38, P485, DOI 10.2134/jeq2006.0275; Oorts K, 2007, ENVIRON TOXICOL CHEM, V26, P1130, DOI 10.1897/06-533R.1; Parat C, 2009, ANAL CHIM ACTA, V648, P157, DOI 10.1016/j.aca.2009.06.052; Ponizovsky AA, 2006, ENVIRON TOXICOL CHEM, V25, P671, DOI 10.1897/04-621R.1; Sauve S, 2000, ENVIRON SCI TECHNOL, V34, P1125, DOI 10.1021/es9907764; Sauve S, 2003, ENVIRON SCI TECHNOL, V37, P5191, DOI 10.1021/es030059g; Shi ZQ, 2012, ENVIRON SCI TECHNOL, V46, P2212, DOI 10.1021/es202376c; Sjostedt CS, 2010, ENVIRON SCI TECHNOL, V44, P8587, DOI 10.1021/es102415r; Thakali S, 2006, ENVIRON SCI TECHNOL, V40, P7085, DOI 10.1021/es061171s; Tipping E, 2003, ENVIRON POLLUT, V125, P213, DOI 10.1016/S0269-7491(03)00058-7; Tipping E, 2002, GEOCHIM COSMOCHIM AC, V66, P3211, DOI 10.1016/S0016-7037(02)00930-4; TIPPING E, 1995, EUR J SOIL SCI, V46, P77, DOI 10.1111/j.1365-2389.1995.tb01814.x; Tye AM, 2004, EUR J SOIL SCI, V55, P579, DOI 10.1111/j.1365-2389.2004.00627.x; Weng LP, 2001, ENVIRON SCI TECHNOL, V35, P4436, DOI 10.1021/es010085j; Weng LP, 2004, ENVIRON SCI TECHNOL, V38, P156, DOI 10.1021/es030053r; Ytreberg E, 2011, ENVIRON SCI TECHNOL, V45, P3145, DOI 10.1021/es1039166; Zarcinas BA, 1996, COMMUN SOIL SCI PLAN, V27, P1331, DOI 10.1080/00103629609369636	28	10	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133920	10.1371/journal.pone.0133920	http://dx.doi.org/10.1371/journal.pone.0133920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217951	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900055
J	Zhou, HW; Deng, HJ; Huang, DG; Zhu, ML				Zhou, Huiwei; Deng, Huijie; Huang, Degen; Zhu, Minling			Hedge Scope Detection in Biomedical Texts: An Effective Dependency-Based Method	PLOS ONE			English	Article								Hedge detection is used to distinguish uncertain information from facts, which is of essential importance in biomedical information extraction. The task of hedge detection is often divided into two subtasks: detecting uncertain cues and their linguistic scope. Hedge scope is a sequence of tokens including the hedge cue in a sentence. Previous hedge scope detection methods usually take all tokens in a sentence as candidate boundaries, which inevitably generate a large number of negatives for classifiers. The imbalanced instances seriously mislead classifiers and result in lower performance. This paper proposes a dependency-based candidate boundary selection method (DCBS), which selects the most likely tokens as candidate boundaries and removes the exceptional tokens which have less potential to improve the performance based on dependency tree. In addition, we employ the composite kernel to integrate lexical and syntactic information and demonstrate the effectiveness of structured syntactic features for hedge scope detection. Experiments on the CoNLL-2010 Shared Task corpus show that our method achieves 71.92% F1-score on the golden standard cues, which is 4.11% higher than the system without using DCBS. Although the candidate boundary selection method is only evaluated on hedge scope detection here, it can be popularized to other kinds of scope learning tasks.	[Zhou, Huiwei; Deng, Huijie; Huang, Degen] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China; [Zhu, Minling] Beijing Informat Sci & Technol Univ, Sch Comp, Beijing, Peoples R China	Dalian University of Technology; Beijing Information Science & Technology University	Zhou, HW (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	zhouhuiwei@dlut.edu.cn			National Natural Science Foundation of China [61272375, 61173100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 61272375 and 61173100, http://www.nsfc.gov.cn/Portal0/default152.htm).	[Anonymous], 2006, P C N AM CHAPT ASS C, DOI DOI 10.3115/1220835.1220872; APOSTOLOVA E, 2011, P 49 ANN M ASS COMP, V2, P283; Bokharaeian B., 2013, P 2 JOINT C LEX COMP, P644; Collins M, 2002, ADV NEUR IN, V14, P625; Farkas Richard, 2010, P 14 C COMP NAT LANG, P1; He LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065814; Liu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060954; Morante R., 2010, P 14 C COMP NAT LANG, P40; Morante R., 2009, P WORKSH BIONLP, P28; Moschitti A., 2006, P 10 C COMP NAT LANG, P61; Ovrelid L., 2010, P 23 INT C COMP LING, P1379; Ozgur Arzucan, 2009, P 2009 C EMPIRICAL M, P1398; Plank B, 2013, P 51 ANN M ASS COMP, V1, P1498; Qi Su, 2013, Chinese Lexical Semantics. 14th Workshop, CLSW 2013. Revised Selected Papers: LNCS 8229, P436, DOI 10.1007/978-3-642-45185-0_46; Szarvas G., 2008, P WORKSHOP CURRENT T, P38; Szarvas G, 2012, COMPUT LINGUIST, V38, P335, DOI 10.1162/COLI_a_00098; Velldal E, 2012, COMPUT LINGUIST, V38, P369, DOI 10.1162/COLI_a_00126; Wei Z. Y., 2013, P 51 ANN M ASS COMP, P58; [周惠巍 Zhou Huiwei], 2013, [中文信息学报, Journal of Chinese Information Processing], V27, P137; Zhou HW, 2011, CHINESE J ELECTRON, V20, P476; Zhu Q., 2010, P 2010 C EMP METH NA, P714; Zou Bowei, 2013, P 2013 C EMP METH NA, P968	22	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133715	10.1371/journal.pone.0133715	http://dx.doi.org/10.1371/journal.pone.0133715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218847	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900043
J	Pereira, MR; Mercaldi, GF; Maester, TC; Balan, A; Lemos, EGD				Pereira, Mariana Rangel; Mercaldi, Gustavo Fernando; Maester, Thais Carvalho; Balan, Andrea; de Macedo Lemos, Eliana Gertrudes			Est16, a New Esterase Isolated from a Metagenomic Library of a Microbial Consortium Specializing in Diesel Oil Degradation	PLOS ONE			English	Article							CLASSIFICATION; IDENTIFICATION; ENZYMES	Lipolytic enzymes have attracted attention from a global market because they show enormous biotechnological potential for applications such as detergent production, leather processing, cosmetics production, and use in perfumes and biodiesel. Due to the intense demand for biocatalysts, a metagenomic approach provides methods of identifying new enzymes. In this study, an esterase designated as Est16 was selected from 4224 clones of a fosmid metagenomic library, revealing an 87% amino acid identity with an esterase/lipase (accession number ADM63076.1) from an uncultured bacterium. Phylogenetic studies showed that the enzyme belongs to family V of bacterial lipolytic enzymes and has sequence and structural similarities with an aryl-esterase from Pseudomonas fluorescens and a patented Anti-Kazlauskas lipase (patent number US20050153404). The protein was expressed and purified as a highly soluble, thermally stable enzyme that showed a preference for basic pH. Est16 exhibited activity toward a wide range of substrates and the highest catalytic efficiency against p-nitrophenyl butyrate and p-nitrophenyl valerate. Est16 also showed tolerance to the presence of organic solvents, detergents and metals. Based on molecular modeling, we showed that the large alpha-beta domain is conserved in the patented enzymes but not the substrate pocket. Here, it was demonstrated that a metagenomic approach is suitable for discovering the lipolytic enzyme diversity and that Est16 has the biotechnological potential for use in industrial processes.	[Pereira, Mariana Rangel; Mercaldi, Gustavo Fernando; Balan, Andrea] Brazilian Ctr Res Energy & Mat CNPEM, Natl Lab Biosci LNBio, Campinas, SP, Brazil; [Pereira, Mariana Rangel; Maester, Thais Carvalho] Univ Sao Paulo, Sao Paulo, SP, Brazil; [Pereira, Mariana Rangel; Maester, Thais Carvalho; de Macedo Lemos, Eliana Gertrudes] Sao Paulo State Univ, Dept Technol, Jaboticabal, SP, Brazil; [Mercaldi, Gustavo Fernando] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Balan, Andrea] Univ Sao Paulo, Inst Biomed Sci 2, Dept Microbiol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Lemos, EGD (corresponding author), Sao Paulo State Univ, Dept Technol, Jaboticabal, SP, Brazil.	egerle@fcav.unesp.br	Pereira, Mariana/GSE-3546-2022; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; Mercaldi, Gustavo Fernando/AGB-3253-2022; Balan, Andrea/D-1891-2014; LEMOS, ELIANA GM/A-3604-2008	de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; Mercaldi, Gustavo Fernando/0000-0003-1445-6060; Balan, Andrea/0000-0001-6199-3198; LEMOS, ELIANA GM/0000-0002-1119-7748	Sao Paulo Research Foundation [2011/09136-7]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo Research Foundation (grant number: 2011/09136-7, http://www.fapesp.br/) to MRP.	Accorsini FR, 2012, BRAZ J MICROBIOL, V43, P116, DOI [10.1590/S1517-83822012000100013, 10.1590/S1517-838220120001000013]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Paixao DAA, 2010, REV BRAS CIENC SOLO, V34, P773, DOI 10.1590/S0100-06832010000300019; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bornscheuer UT, 2006, HYDROLASES IN ORGANIC SYNTHESIS: REGIO- AND STEREOSELECTIVE BIOTRANSFORMATIONS, 2ND EDITION, P1; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Brault G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091872; Casas-Godoy L, 2012, METHODS MOL BIOL, V861, P3, DOI 10.1007/978-1-61779-600-5_1; CBMT, 2008, MARK BUS INT CO REV; Cheeseman JD, 2004, ACTA CRYSTALLOGR D, V60, P1237, DOI 10.1107/S0907444904010522; DeLano WL., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fang ZM, 2014, J MICROBIOL BIOTECHN, V24, P771, DOI 10.4014/jmb.1311.11071; Global Industry Analysts, 2004, IND ENZY GLOB MULT M; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Jeon JH, 2012, APPL MICROBIOL BIOT, V93, P623, DOI 10.1007/s00253-011-3433-x; Jiang Y, 2011, CHEMBIOCHEM, V12, P768, DOI 10.1002/cbic.201000693; Jin P, 2012, BIORESOURCE TECHNOL, V116, P234, DOI 10.1016/j.biortech.2011.10.087; JunGang Li, 2010, Microb Cell Fact, V9, P83, DOI 10.1186/1475-2859-9-83; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Panda T, 2005, APPL MICROBIOL BIOT, V67, P160, DOI 10.1007/s00253-004-1840-y; Peng Q, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-1; Rees HC, 2003, EXTREMOPHILES, V7, P415, DOI 10.1007/s00792-003-0339-2; Roh C, 2013, APPL BIOCHEM BIOTECH, V171, P1750, DOI 10.1007/s12010-013-0464-z; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 2001, MOL CLONING LAB MANU; Seo S, 2014, WORLD J MICROB BIOT, V30, P879, DOI 10.1007/s11274-013-1496-9; Steele HL, 2009, J MOL MICROB BIOTECH, V16, P25, DOI 10.1159/000142892; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao W, 2011, J MICROBIOL, V49, P178, DOI 10.1007/s12275-011-1102-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Yu EY, 2011, APPL MICROBIOL BIOT, V90, P573, DOI 10.1007/s00253-011-3132-7	36	25	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133723	10.1371/journal.pone.0133723	http://dx.doi.org/10.1371/journal.pone.0133723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214846	gold, Green Submitted, Green Published			2022-12-26	WOS:000358594300026
J	Yan, LB; Kanada, M; Zhang, JY; Okazaki, S; Terakawa, S				Yan, Libo; Kanada, Masamitsu; Zhang, Jinyan; Okazaki, Shigetoshi; Terakawa, Susumu			Photodynamic Treatment of Tumor with Bacteria Expressing KillerRed	PLOS ONE			English	Article							CANCER GENE-THERAPY; DELIVERY; VECTORS; OXYGEN; CELLS	Photodynamic therapy (PDT) is a cancer treatment modality in which a photosensitizing dye is administered and exposed to light to kill tumor cells via the production of reactive oxygen species (ROS). A fundamental obstacle for PDT is the low specificity for staining solid tumors with dyes. Recently, a tumor targeting system guided by anaerobic bacteria was proposed for tumor imaging and treatment. Here, we explore the feasibility of the genetically encoded photosensitizer KillerRed, which is expressed in Escherichia coli, to treat tumors. Using nitroblue tetrazolium (NBT), we detected a lengthy ROS diffusion from the bodies of KillerRed-expressing bacteria in vitro, which demonstrated the feasibility of using bacteria to eradicate cells in their surroundings. In nude mice, Escherichia coli (E. coli) expressing KillerRed (KR-E. coli) were subcutaneously injected into xenografts comprising CNE2 cells, a human nasopharyngeal carcinoma cell line, and HeLa cells, a human cervical carcinoma cell line. KR-E. coli seemed to proliferate rapidly in the tumors as observed under an imaging system. When the intensity of fluorescence increased and the fluorescent area became as large as the tumor one day after KR-E. coli injection, the KR-E. coli-bearing tumor was irradiated with an orange light (lambda = 540 - 580 nm). In all cases, the tumors became necrotic the next day and were completely eliminated in a few days. No necrosis was observed after the irradiation of tumors injected with a vehicle solution or a vehicle carrying the E. coli without KillerRed. In successfully treated mice, no tumor recurrence was observed for more than two months. E. coli genetically engineered for KillerRed expression are highly promising for the diagnosis and treatment of tumors when the use of bacteria in patients is cleared for infection safety.	[Yan, Libo; Kanada, Masamitsu; Zhang, Jinyan; Okazaki, Shigetoshi; Terakawa, Susumu] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine	Terakawa, S (corresponding author), Tokoha Univ, Dept Hlth Sci, Aoi Ku, Shizuoka, Japan.	terakawa@sz.tokoha-u.ac.jp	Kanada, Masamitsu/AAP-1664-2020	Zhang, Jinyan/0000-0002-9874-2744	Hamamatsu University School of Medicine	Hamamatsu University School of Medicine	This work was supported partly by an intramural grant for "Cancer Research by Photonics" from Hamamatsu University School of Medicine to S. T. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baban Chwanrow K, 2010, Bioeng Bugs, V1, P385, DOI 10.4161/bbug.1.6.13146; Baumler W, 1999, BRIT J CANCER, V80, P360, DOI 10.1038/sj.bjc.6690363; Brown SB, 2004, LANCET ONCOL, V5, P497, DOI 10.1016/S1470-2045(04)01529-3; Bulina ME, 2006, NAT PROTOC, V1, P947, DOI 10.1038/nprot.2006.89; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Chen J, 2002, CANCER J, V8, P154, DOI 10.1097/00130404-200203000-00009; Cronin M, 2012, CANCER GENE THER, V19, P731, DOI 10.1038/cgt.2012.59; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Ell C, 1998, GUT, V43, P345, DOI 10.1136/gut.43.3.345; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; KHAN AU, 1979, P NATL ACAD SCI USA, V76, P6047, DOI 10.1073/pnas.76.12.6047; Lemmon MJ, 1997, GENE THER, V4, P791, DOI 10.1038/sj.gt.3300468; Liu SC, 2002, GENE THER, V9, P291, DOI 10.1038/sj.gt.3301659; [刘世东 Liu Shidong], 2011, [中国全科医学, Chinese General Practice], V14, P987; Min JJ, 2008, MOL IMAGING BIOL, V10, P54, DOI 10.1007/s11307-007-0120-5; Mose J R, 1967, Med Klin, V62, P189; Mueller G, 2010, J PHOTOCH PHOTOBIO B, V98, P95, DOI 10.1016/j.jphotobiol.2009.11.009; Nishiyama N, 2007, NEW J CHEM, V31, P1074, DOI 10.1039/b616050f; Nishiyama N, 2009, ADV DRUG DELIVER REV, V61, P327, DOI 10.1016/j.addr.2009.01.004; Odo J, 2010, CHEM PHARM BULL, V58, P1576, DOI 10.1248/cpb.58.1576; Okazaki S, 2010, CHEM PHYS LETT, V485, P202, DOI 10.1016/j.cplett.2009.12.055; ROSENTHAL I, 1995, INT J RADIAT BIOL, V67, P85, DOI 10.1080/09553009514550111; Ryan RM, 2009, GENE THER, V16, P329, DOI 10.1038/gt.2008.188; Serebrovskaya EO, 2011, BIOCHEM J, V435, P65, DOI 10.1042/BJ20101217; Serebrovskaya EO, 2009, P NATL ACAD SCI USA, V106, P9221, DOI 10.1073/pnas.0904140106; Shirmanova MV, 2012, J BIOPHOTONICS, V10, P1; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sternberg ED, 1998, TETRAHEDRON, V54, P4151, DOI 10.1016/S0040-4020(98)00015-5; Sznol M, 2000, J CLIN INVEST, V105, P1027, DOI 10.1172/JCI9818; Teh C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-110; THIELE EH, 1964, CANCER RES, V24, P222; van Dongen GAMS, 2004, ADV DRUG DELIVER REV, V56, P31, DOI 10.1016/j.addr.2003.09.003; Vegh RB, 2011, CHEM COMMUN, V47, P4887, DOI 10.1039/c0cc05713d; Yazawa K, 2000, CANCER GENE THER, V7, P269, DOI 10.1038/sj.cgt.7700122; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937	37	16	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0131518	10.1371/journal.pone.0131518	http://dx.doi.org/10.1371/journal.pone.0131518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213989	Green Published, gold, Green Submitted			2022-12-26	WOS:000358594300006
J	Juarez-Montiel, M; Romero-Maldonado, A; Monreal-Escalante, E; Becerra-Flora, A; Korban, SS; Rosales-Mendoza, S; Jimenez-Bremont, JF				Juarez-Montiel, Margarita; Romero-Maldonado, Andrea; Monreal-Escalante, Elizabeth; Becerra-Flora, Alicia; Korban, Schuyler S.; Rosales-Mendoza, Sergio; Francisco Jimenez-Bremont, Juan			The Corn Smut ('Huitlacoche') as a New Platform for Oral Vaccines	PLOS ONE			English	Article							TOXIN B-SUBUNIT; FUNGUS USTILAGO-MAYDIS; RECOMBINANT PROTEINS; FILAMENTOUS FUNGI; PROTECTS MICE; CHOLERA; ANTIGEN; EXPRESSION; PLANTS; CELLS	The development of new alternative platforms for subunit vaccine production is a priority in the biomedical field. In this study, Ustilago maydis, the causal agent of common corn smut or 'huitlacoche' has been genetically engineered to assess expression and immunogenicity of the B subunit of the cholera toxin (CTB), a relevant immunomodulatory agent in vaccinology. An oligomeric CTB recombinant protein was expressed in corn smut galls at levels of up to 1.3 mg g(-1) dry weight (0.8% of the total soluble protein). Mice orally immunized with 'huitlacoche'-derived CTB showed significant humoral responses that were well-correlated with protection against challenge with the cholera toxin (CT). These findings demonstrate the feasibility of using edible corn smut as a safe, effective, and low-cost platform for production and delivery of a subunit oral vaccine. The implications of this platform in the area of molecular pharming are discussed.	[Juarez-Montiel, Margarita; Becerra-Flora, Alicia; Francisco Jimenez-Bremont, Juan] Inst Potosino Invest Cient & Tecnol AC, Div Biol Mol, Lab Estudios Mol Respuesta Estres Plantas, San Luis Potosi, San Luis Potosi, Mexico; [Romero-Maldonado, Andrea; Monreal-Escalante, Elizabeth; Rosales-Mendoza, Sergio] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Lab Biofarmaceut Recombinantes, San Luis Potosi, San Luis Potosi, Mexico; [Korban, Schuyler S.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Autonoma de San Luis Potosi; University of Massachusetts System; University of Massachusetts Boston	Rosales-Mendoza, S (corresponding author), Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Lab Biofarmaceut Recombinantes, San Luis Potosi, San Luis Potosi, Mexico.	rosales.s@fcq.uaslp.mx; jbremont@ipicyt.edu.mx	Jiménez Bremont, Juan Francisco/CAI-1278-2022; Rosales-Mendoza, Sergio/ABA-2752-2021; Jiménez Bremont, Juan Francisco/C-9256-2011; Monreal-Escalante, Elizabeth/AAY-2441-2020; Jiménez Bremont, Juan Francisco/CAF-4866-2022	Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Jiménez Bremont, Juan Francisco/0000-0001-6230-0250; Monreal-Escalante, Elizabeth/0000-0002-2798-6151	CONACYT Investigacion Ciencia Basica [2008-103106]; UASLP-FAI	CONACYT Investigacion Ciencia Basica; UASLP-FAI	This work was financially supported by CONACYT Investigacion Ciencia Basica 2008-103106 (JFJB) and UASLP-FAI-2014 (SRM) funding.	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Banuett F, 1996, DEVELOPMENT, V122, P2965; Banuett F, 1995, ANNU REV GENET, V29, P179, DOI 10.1146/annurev.ge.29.120195.001143; Basset C, 2010, TOXINS, V2, P1774, DOI 10.3390/toxins2071774; Bolker M, 2008, FUNGAL GENET BIOL, V45, pS88, DOI 10.1016/j.fgb.2008.05.007; Bosch D, 2010, EXPERT REV VACCINES, V9, P835, DOI 10.1586/erv.10.83; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Chikwamba R, 2002, TRANSGENIC RES, V11, P479, DOI 10.1023/A:1020393426750; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Feldbrugge M, 2013, APPL MICROBIOL BIOT, V97, P3253, DOI 10.1007/s00253-013-4777-1; Fernandez-Alvarez A, 2010, FUNGAL GENET BIOL, V47, P727, DOI 10.1016/j.fgb.2010.06.004; Franklin S, 2002, PLANT J, V30, P733, DOI 10.1046/j.1365-313X.2002.01319.x; George-Chandy A, 2001, INFECT IMMUN, V69, P5716, DOI 10.1128/IAI.69.9.5716-5725.2001; Giddings G, 2000, NAT BIOTECHNOL, V18, P1151, DOI 10.1038/81132; GILLISSEN B, 1992, CELL, V68, P647, DOI 10.1016/0092-8674(92)90141-X; Hamorsky KT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002046; Harakuni T, 2005, INFECT IMMUN, V73, P5654, DOI 10.1128/IAI.73.9.5654-5665.2005; Hernandez-Rodriguez AA, 2014, PLANT MOL BIOL REP, V32, P1187, DOI [10.1007/s11105-014-0714-4, DOI 10.1007/S11105-014-0714-4]; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Juarez-Montiel M, 2011, REV IBEROAM MICOL, V28, P69, DOI 10.1016/j.riam.2011.01.001; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Karaman S, 2012, PLANT CELL REP, V31, P527, DOI 10.1007/s00299-011-1146-3; Langridge W, 2010, CURR OPIN INVEST DR, V11, P919; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maskery B, 2013, J INFECT DIS, V208, pS15, DOI 10.1093/infdis/jit233; Matsumoto Y, 2009, TRANSGENIC RES, V18, P185, DOI 10.1007/s11248-008-9205-4; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Miyata T, 2012, VACCINE, V30, P948, DOI 10.1016/j.vaccine.2011.11.059; Nevalainen H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00075; Nozoye T, 2009, J VET MED SCI, V71, P995, DOI 10.1292/jvms.71.995; Payero JO, 2006, AGR WATER MANAGE, V84, P101, DOI 10.1016/j.agwat.2006.01.009; RICHARDSON SH, 1984, INFECT IMMUN, V43, P482, DOI 10.1128/IAI.43.2.482-486.1984; Rodriguez-Kessler M, 2012, MICROBIOL RES, V167, P270, DOI 10.1016/j.micres.2011.10.007; Rosales-Mendoza S, 2008, PLANT CELL REP, V27, P79, DOI 10.1007/s00299-007-0439-z; Rosales-Mendoza S, 2014, EXPERT REV VACCINES, V13, P737, DOI 10.1586/14760584.2014.913483; Rosales-Mendoza S, 2012, PLANT CELL REP, V31, P479, DOI 10.1007/s00299-011-1186-8; Ruiz-Herrera J, 1998, Int Microbiol, V1, P149; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shin MK, 2013, VACCINE, V31, P4287, DOI 10.1016/j.vaccine.2013.07.029; Soria-Guerra RE, 2011, PLANT CELL REP, V30, P1367, DOI 10.1007/s00299-011-1065-3; SPELLIG T, 1994, EMBO J, V13, P1620, DOI 10.1002/j.1460-2075.1994.tb06425.x; Spellig T, 1996, MOL GEN GENET, V252, P503, DOI 10.1007/BF02172396; Stock J, 2012, J BIOTECHNOL, V161, P80, DOI 10.1016/j.jbiotec.2012.03.004; Sun JB, 2010, SCAND J IMMUNOL, V71, P1, DOI 10.1111/j.1365-3083.2009.02321.x; Terfruchte M, 2014, FUNGAL GENET BIOL, V62, P1, DOI 10.1016/j.fgb.2013.10.012; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; Valdez-Morales M, 2010, FOOD CHEM, V119, P689, DOI 10.1016/j.foodchem.2009.07.015; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Ward OP, 2012, BIOTECHNOL ADV, V30, P1119, DOI 10.1016/j.biotechadv.2011.09.012; Wilkhu J, 2011, THER DELIV, V2, P1141, DOI 10.4155/TDE.11.82	50	8	8	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133535	10.1371/journal.pone.0133535	http://dx.doi.org/10.1371/journal.pone.0133535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207365	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000098
J	Livingstone, M; Sikstrom, K; Robert, PA; Uze, G; Larsson, O; Pellegrini, S				Livingstone, Mark; Sikstrom, Kristina; Robert, Philippe A.; Uze, Gilles; Larsson, Ola; Pellegrini, Sandra			Assessment of mTOR-Dependent Translational Regulation of Interferon Stimulated Genes	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; KINASE-C-DELTA; P70 S6 KINASE; I INTERFERONS; GENOME-WIDE; DIFFERENTIAL TRANSLATION; MAMMALIAN TARGET; HUMAN CANCER; CELL-SIZE; PKC-DELTA	Type-I interferon (IFN)-induced activation of the mammalian target of rapamycin (mTOR) signaling pathway has been implicated in translational control of mRNAs encoding interferon-stimulated genes (ISGs). However, mTOR-sensitive translatomes commonly include mRNAs with a 5' terminal oligopyrimidine tract (TOP), such as those encoding ribosomal proteins, but not ISGs. Because these translatomes were obtained under conditions when ISG expression is not induced, we examined the mTOR-sensitive translatome in human WISH cells stimulated with IFN beta. The mTOR inhibitor Torin1 resulted in a repression of global protein synthesis, including that of ISG products, and translation of all but 3 ISG mRNAs (TLR3, NT5C3A, and RNF19B) was not selectively more sensitive to mTOR inhibition. Detailed studies of NT5C3A revealed an IFN-induced change in transcription start site resulting in a switch from a non-TOP to a TOP-like transcript variant and mTOR sensitive translation. Thus, we show that, in the cell model used, translation of the vast majority of ISG mRNAs is not selectively sensitive to mTOR activity and describe an uncharacterized mechanism wherein the 5'-UTR of an mRNA is altered in response to a cytokine, resulting in a shift from mTOR-insensitive to mTOR-sensitive translation.	[Livingstone, Mark; Robert, Philippe A.; Pellegrini, Sandra] Inst Pasteur, CNRS URA1961, Cytokine Signaling Unit, Paris, France; [Sikstrom, Kristina; Larsson, Ola] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Uze, Gilles] Univ Montpellier 2, CNRS UMR5235, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Pellegrini, S (corresponding author), Inst Pasteur, CNRS URA1961, Cytokine Signaling Unit, Paris, France.	Ola.Larsson@ki.se; sandra.pellegrini@pasteur.fr	Pellegrini, Sandra/Y-6351-2019; Robert, Philippe A./Z-2816-2019; Uzé, Gilles/O-6383-2019	Pellegrini, Sandra/0000-0001-5837-7589; Robert, Philippe A./0000-0003-1345-5015; Larsson, Ola/0000-0003-1412-1308; Uze, Gilles/0000-0002-4150-5772; Livingstone, Mark/0000-0002-2757-7008	Pasteur Foundation; Swedish Research Council; Wallenberg Academy Fellows program	Pasteur Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Academy Fellows program	This research was supported by funding (to ML) from the Pasteur Foundation, institutional support from Institut Pasteur and CNRS, and grants from the Swedish Research Council and the Wallenberg Academy Fellows program (to OL).	Aksoy P, 2009, PHARMACOGENET GENOM, V19, P567, DOI 10.1097/FPC.0b013e32832c14b8; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Colman H, 2013, J VIROL, V87, P6668, DOI 10.1128/JVI.00538-13; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Eliseeva IA, 2013, TRANSLATION, V1, P18; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Furic L, 2009, CURR ONCOL, V16, P59; Genolet R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-33; Gingras AC, 2001, GENE DEV, V15, P2852; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kaur S, 2005, EXP HEMATOL, V33, P550, DOI 10.1016/j.exphem.2005.01.014; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2014, J BIOL CHEM, V289, P6581, DOI 10.1074/jbc.M113.537852; Kroczynska B, 2011, J BIOL CHEM, V286, P1147, DOI 10.1074/jbc.M110.183566; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Larsson O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012302; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Larsson O, 2011, BIOINFORMATICS, V27, P1440, DOI 10.1093/bioinformatics/btr146; Larsson O, 2010, P NATL ACAD SCI USA, V107, P21487, DOI 10.1073/pnas.1006821107; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Li YZ, 2005, J BIOL CHEM, V280, P10001, DOI 10.1074/jbc.M410972200; Livingstone Mark, 2012, F1000Res, V1, P4, DOI 10.12688/f1000research.1-4.v1; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; MARUYAMA K, 1994, GENE, V138, P171; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Rastogi R, 2013, J BIOL CHEM, V288, P33966, DOI 10.1074/jbc.M113.492702; Rees DC, 2003, BRIT J HAEMATOL, V120, P375, DOI 10.1046/j.1365-2141.2003.03980.x; Rich SA, 1996, J BIOL CHEM, V271, P1118, DOI 10.1074/jbc.271.2.1118; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Schmeisser H, 2013, AUTOPHAGY, V9, P683, DOI 10.4161/auto.23921; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tait S, 2010, P NATL ACAD SCI USA, V107, P17627, DOI 10.1073/pnas.1008242107; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Tomoo K, 2006, J BIOCHEM, V140, P237, DOI 10.1093/jb/mvj143; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Wang XR, 2008, CANCER BIOL THER, V7, P1952, DOI 10.4161/cbt.7.12.6944; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zhao JW, 2010, MOL IMMUNOL, V48, P294, DOI 10.1016/j.molimm.2010.07.014	65	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133482	10.1371/journal.pone.0133482	http://dx.doi.org/10.1371/journal.pone.0133482			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207988	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000093
J	Si, XY; Li, JJ; Bi, XH; Wu, L; Wu, XY				Si, Xiaoyun; Li, Jingjing; Bi, Xiaohong; Wu, Lan; Wu, Xiaoyan			Clinical Evaluation of High-Volume Hemofiltration with Hemoperfusion Followed by Intermittent Hemodialysis in the Treatment of Acute Wasp Stings Complicated by Multiple Organ Dysfunction Syndrome	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; RENAL REPLACEMENT THERAPY; SEVERE ACUTE-PANCREATITIS; LUNG INJURY; METAANALYSIS; RECOVERY; FAILURE; ALLERGY; SEPSIS; VENOM	Multiple organ dysfunction syndrome (MODS) is a rare complication of wasp stings. Currently, there is no standardized treatment for MODS secondary to multiple wasp stings, although blood purification techniques are often used. This study aimed to analyze our experiences of using intermittent hemodialysis (IHD) with or without high-volume hemofiltration (HVHF) for treating acute wasp stings complicated by MODS. In this retrospective study, 36 patients with wasp stings complicated by MODS received either IHD combined with hemoperfusion, or HVHF (ultrafiltration flow rate, 70 mL/kg/h) combined with hemoperfusion for 5 days followed by IHD. Clinical symptoms, blood biochemical parameters, duration of mechanical ventilation, use of vasoactive agents, duration of hospital stay and survival rate were recorded, and Acute Physiology and Chronic Health Evaluation II (APACHE II) and multiple organ dysfunction (MOD) scores estimated. Patients treated with HVHF followed by IHD appeared to exhibit a faster recovery than those receiving IHD alone, as evidenced by superior improvements in MOD (4.29 +/- 1.08 vs. 2.27 +/- 1.07) and APACHE II (7.09 +/- 2.62 vs. 4.20 +/- 1.69) scores (P < 0.05). Patients treated with HVHF had significantly lower myoglobin, creatine kinase-MB, lactate dehydrogenase, bilirubin and creatinine levels than patients treated with IHD alone. In addition, the durations of hospital stay (13.15 +/- 2.77 vs. 27.92 +/- 3.18 days), vasopressor use (1.76 +/- 0.24 vs. 3.43 +/- 1.01 days), mechanical ventilation (3.02 +/- 1.63 vs. 5.94 +/- 2.11 days) and oliguria (6.57 +/- 2.45 vs. 15.29 +/- 3.51 days) were reduced, and renal function more often recovered (85.1% vs. 53.1%), in the HVHF group compared with the IHD group (P < 0.05). These results raise the possibility that HVHF plus IHD may be superior to IHD alone for the treatment of acute wasp stings complicated by MODS; additional prospective studies are merited to explore this further.	[Si, Xiaoyun; Li, Jingjing; Bi, Xiaohong; Wu, Lan; Wu, Xiaoyan] Wuhan Univ, Dept Nephrol, Zhongnan Hosp, Wuhan 430071, Hubei Province, Peoples R China	Wuhan University	Si, XY (corresponding author), Wuhan Univ, Dept Nephrol, Zhongnan Hosp, Wuhan 430071, Hubei Province, Peoples R China.	lzgklxm2013@163.com						Bich HNX, 2010, NEPHROL DIAL TRANSPL, V25, P1146, DOI 10.1093/ndt/gfp583; Clark E, 2014, CRIT CARE, V18, DOI 10.1186/cc13184; Du XG, 2011, INT J ARTIF ORGANS, V34, P348, DOI 10.5301/IJAO.2011.7742; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Gong DH, 2010, INT J ARTIF ORGANS, V33, P22; GREENGRAIF Y, 1987, CLIN ALLERGY, V17, P431, DOI 10.1111/j.1365-2222.1987.tb02037.x; Jacka MJ, 2005, CAN J ANAESTH, V52, P327, DOI 10.1007/BF03016071; Lehner GF, 2014, MINERVA ANESTESIOL, V80, P595; Lima Rafael Siqueira Athayde, 2008, Saudi J Kidney Dis Transpl, V19, P721; Lin CJ, 2011, SOUTH MED J, V104, P378, DOI 10.1097/SMJ.0b013e318213ebee; Liu Chang-wen, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P657; Malyszko JS, 2006, J NEPHROL, V19, P150; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Monti G, 2007, CONTRIB NEPHROL, V156, P434; Ozdemir C, 2011, CLIN EXP ALLERGY, V41, P1226, DOI 10.1111/j.1365-2222.2011.03812.x; Paudel B, 2009, Nepal Med Coll J, V11, P52; Rekik Sofiene, 2012, J Emerg Med, V42, pe73, DOI 10.1016/j.jemermed.2009.02.019; Rimmele T, 2012, ANESTHESIOLOGY, V116, P1377, DOI 10.1097/ALN.0b013e318256f0c0; Sharmila RR, 2007, INDIAN J PEDIATR, V74, P1111, DOI 10.1007/s12098-007-0208-6; Yavuz ST, 2013, INT ARCH ALLERGY IMM, V160, P313, DOI 10.1159/000341666; Zhang L, 2009, BLOOD PURIFICAT, V27, P296; Zhang L, 2013, CLIN J AM SOC NEPHRO, V8, P1850, DOI 10.2215/CJN.12081112; Zhang L, 2010, BLOOD PURIFICAT, V30, P106, DOI 10.1159/000319600; Zhang P, 2010, INT J ARTIF ORGANS, V33, P505, DOI 10.1177/039139881003300801; Zhang P, 2012, NEPHROL DIAL TRANSPL, V27, P967, DOI 10.1093/ndt/gfr486; Zhang YuHua, 2009, Zhongguo Shiyong Neike Zazhi / Chinese Journal of Practical Internal Medicine, V29, P1027; Zhu YL, 2011, PANCREAS, V40, P109, DOI 10.1097/MPA.0b013e3181f83019	27	12	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132708	10.1371/journal.pone.0132708	http://dx.doi.org/10.1371/journal.pone.0132708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207371	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000038
J	Sumida, K; Chong, Y; Miyake, N; Akahoshi, T; Yasuda, M; Shimono, N; Shimoda, S; Maehara, Y; Akashi, K				Sumida, Kosuke; Chong, Yong; Miyake, Noriko; Akahoshi, Tomohiko; Yasuda, Mitsuhiro; Shimono, Nobuyuki; Shimoda, Shinji; Maehara, Yoshihiko; Akashi, Koichi			Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study	PLOS ONE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; XANTHOMONAS-MALTOPHILIA; MORTALITY; THERAPY	Stenotrophomonas maltophilia is an important nosocomial bacterial pathogen, as is Pseudomonas aeruginosa. Differentiation of these bacteria as bacteremic agents is critical in the clinical setting and to define a therapeutic strategy; however, the associated factors and prognosis for S. maltophilia bacteremia have not been fully evaluated to adequately characterize these factors. We first conducted a matched case-control study to clarify these questions. A total of 30 case patients with S. maltophilia bacteremia were compared with 30 control patients with P. aeruginosa bacteremia between January 2005 and August 2014, according to matching criteria based on underlying disease, age, and gender. The 30-day mortality rate for the case patients (53.3%) was significantly higher than that of the control group (30.0%) (P = 0.047, using the log-rank test). Conditional logistic regression analysis showed that the predisposing factors specific for the detection of S. maltophilia bacteremia were indwelling artificial products other than a central venous catheter, ICU stay, and previous use of anti-MRSA drugs. The high severity of illness was associated with mortality in both case and control patients. Interestingly, inappropriate antimicrobial treatment was an additional independent risk factor for mortality in only the case patients with S. maltophilia bacteremia (odds ratio = 13.64, P = 0.048). Monotherapy with fluoroquinolones inactive against the S. maltophiliaisolates was mainly responsible for the inappropriate treatment. These results suggest that more precise prediction and more appropriate treatment might improve the prognosis of patients with S. maltophilia bacteremia.	[Sumida, Kosuke; Akahoshi, Tomohiko; Yasuda, Mitsuhiro; Maehara, Yoshihiko] Kyushu Univ Hosp, Emergency & Crit Care Ctr, Fukuoka 812, Japan; [Chong, Yong; Miyake, Noriko; Shimoda, Shinji; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Med & Biosyst Sci, Fukuoka 812, Japan; [Shimono, Nobuyuki] Kyushu Univ Hosp, Ctr Study Global Infect, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University	Chong, Y (corresponding author), Kyushu Univ, Grad Sch Med Sci, Med & Biosyst Sci, Fukuoka 812, Japan.	ychong@gj9.so-net.ne.jp	Akahoshi, Tomohiko/AAU-4886-2021					Apisarnthanarak A, 2003, INFECT CONT HOSP EP, V24, P269, DOI 10.1086/502197; Araoka H, 2010, EUR J CLIN MICROBIOL, V29, P605, DOI 10.1007/s10096-010-0882-6; Ba BB, 2004, ANTIMICROB AGENTS CH, V48, P946, DOI 10.1128/AAC.48.3.946-953.2004; Cho SY, 2014, ANTIMICROB AGENTS CH, V58, P581, DOI 10.1128/AAC.01682-13; CLSI, 2012, M02A11 CLSI; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fihman V, 2012, J INFECTION, V64, P391, DOI 10.1016/j.jinf.2012.01.001; Friedman ND, 2002, J INFECTION, V45, P47, DOI 10.1053/jinf.2002.0978; Garazi M, 2012, J HOSP INFECT, V81, P114, DOI 10.1016/j.jhin.2012.02.008; Paez JIG, 2008, EUR J CLIN MICROBIOL, V27, P901, DOI 10.1007/s10096-008-0518-2; Hotta G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112208; Labarca JA, 2000, CLIN INFECT DIS, V30, P195, DOI 10.1086/313591; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Metan G, 2005, ANTIMICROB AGENTS CH, V49, P3980, DOI 10.1128/AAC.49.9.3980-3981.2005; Metan G, 2006, SCAND J INFECT DIS, V38, P527, DOI 10.1080/00365540500452481; Micozzi A, 2000, CLIN INFECT DIS, V31, P705, DOI 10.1086/314043; Muder RR, 1996, CLIN INFECT DIS, V22, P508, DOI 10.1093/clinids/22.3.508; Safdar A, 2007, CLIN INFECT DIS, V45, P1602, DOI 10.1086/522998; Senol E, 2002, CLIN INFECT DIS, V34, P1653, DOI 10.1086/340707; VICTOR MA, 1994, SCAND J INFECT DIS, V26, P163, DOI 10.3109/00365549409011780; Wang YL, 2014, ANTIMICROB AGENTS CH, V58, P176, DOI 10.1128/AAC.01324-13	22	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133731	10.1371/journal.pone.0133731	http://dx.doi.org/10.1371/journal.pone.0133731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208218	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000125
J	Walldorf, JA; Cohee, LM; Coalson, JE; Bauleni, A; Nkanaunena, K; Kapito-Tembo, A; Seydel, KB; Ali, D; Mathanga, D; Taylor, TE; Valim, C; Laufer, MK				Walldorf, Jenny A.; Cohee, Lauren M.; Coalson, Jenna E.; Bauleni, Andy; Nkanaunena, Kondwani; Kapito-Tembo, Atupele; Seydel, Karl B.; Ali, Doreen; Mathanga, Don; Taylor, Terrie E.; Valim, Clarissa; Laufer, Miriam K.			School-Age Children Are a Reservoir of Malaria Infection in Malawi	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; RISK-FACTORS; PARASITEMIA; AFRICA; FEVER; AREA	Malaria surveillance and interventions in endemic countries often target young children at highest risk of malaria morbidity and mortality. We aimed to determine whether school-age children and adults not captured in surveillance serve as a reservoir for malaria infection and may contribute to malaria transmission. Cross-sectional surveys were conducted in one rainy and one dry season in southern Malawi. Demographic and health information was collected for all household members. Blood samples were obtained for microscopic and PCR identification of Plasmodium falciparum. Among 5796 individuals aged greater than six months, PCR prevalence of malaria infection was 5%, 10%, and 20% in dry, and 9%, 15%, and 32% in rainy seasons in Blantyre, Thyolo, and Chikhwawa, respectively. Over 88% of those infected were asymptomatic. Participants aged 6-15 years were at higher risk of infection (OR=4.8; 95% CI, 4.0-5.8) and asymptomatic infection (OR=4.2; 95% CI, 2.76.6) than younger children in all settings. School-age children used bednets less frequently than other age groups. Compared to young children, school-age children were brought less often for treatment and more often to unreliable treatment sources. Conclusion: School-age children represent an underappreciated reservoir of malaria infection and have less exposure to antimalarial interventions. Malaria control and elimination strategies may need to expand to include this age group.	[Walldorf, Jenny A.; Cohee, Lauren M.; Laufer, Miriam K.] Univ Maryland, Sch Med, Ctr Malaria Res, Inst Global Hlth, Baltimore, MD 21201 USA; [Coalson, Jenna E.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bauleni, Andy; Nkanaunena, Kondwani; Kapito-Tembo, Atupele; Mathanga, Don] Univ Malawi, Blantyre Malaria Project, Coll Med, Blantyre, Malawi; [Seydel, Karl B.; Taylor, Terrie E.] Michigan State Univ, E Lansing, MI 48824 USA; [Ali, Doreen] Minist Hlth, Natl Malaria Control Program, Lilongwe, Malawi; [Valim, Clarissa] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan; University of Malawi; Michigan State University; Harvard University; Harvard T.H. Chan School of Public Health	Laufer, MK (corresponding author), Univ Maryland, Sch Med, Ctr Malaria Res, Inst Global Hlth, Baltimore, MD 21201 USA.	mlaufer@medicine.umaryland.edu	Coalson, Jenna/AAD-6653-2020	Laufer, Miriam/0000-0001-8300-9593; Kapito-Tembo, Atupele/0000-0001-8619-515X; Coalson, Jenna/0000-0002-8591-5642	U.S. National Institutes of Health, Bethesda, Maryland [U19AI089683]; National Institutes of Health National Research Service Award training grants [T32AI05724]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089683, T32AI007524] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service Award training grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. National Institutes of Health, Bethesda, Maryland (grant number U19AI089683) for the Malawi International Center for Excellence in Malaria. JAW and LMC were supported by National Institutes of Health National Research Service Award training grants (grant number T32AI05724).	Afrane YA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-405; [Anonymous], 2012, MALAWI MALARIA INDIC; [Anonymous], PLOS ONE; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Gil JP, 2003, MOL CELL PROBE, V17, P85, DOI 10.1016/S0890-8508(03)00006-9; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kachur SP, 2006, TROP MED INT HEALTH, V11, P441, DOI 10.1111/j.1365-3156.2006.01588.x; Kazembe LN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-40; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Mharakurwa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-223; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Molyneux CS, 1999, TROP MED INT HEALTH, V4, P836, DOI 10.1046/j.1365-3156.1999.00489.x; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Pullan RL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-2; Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269; Sumba PO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-245; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Woyessa A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-273	23	118	118	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134061	10.1371/journal.pone.0134061	http://dx.doi.org/10.1371/journal.pone.0134061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207758	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000200
J	Akter, S; Okazaki, H; Kuwahara, K; Miyamoto, T; Murakami, T; Shimizu, C; Shimizu, M; Tomita, K; Nagahama, S; Eguchi, M; Kochi, T; Imai, T; Nishihara, A; Sasaki, N; Nakagawa, T; Yamamoto, S; Honda, T; Uehara, A; Yamamoto, M; Hori, A; Sakamoto, N; Nishiura, C; Totsuzaki, T; Kato, N; Fukasawa, K; Pham, NM; Kurotani, K; Nanri, A; Kabe, I; Mizoue, T; Sone, T; Dohi, S				Akter, Shamima; Okazaki, Hiroko; Kuwahara, Keisuke; Miyamoto, Toshiaki; Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko; Tomita, Kentaro; Nagahama, Satsue; Eguchi, Masafumi; Kochi, Takeshi; Imai, Teppei; Nishihara, Akiko; Sasaki, Naoko; Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru; Uehara, Akihiko; Yamamoto, Makoto; Hori, Ai; Sakamoto, Nobuaki; Nishiura, Chiro; Totsuzaki, Takafumi; Kato, Noritada; Fukasawa, Kenji; Ngoc M. Pham; Kurotani, Kayo; Nanri, Akiko; Kabe, Isamu; Mizoue, Tetsuya; Sone, Tomofumi; Dohi, Seitaro		Japan Epidemiol Collaboration Occu	Smoking, Smoking Cessation, and the Risk of Type 2 Diabetes among Japanese Adults: Japan Epidemiology Collaboration on Occupational Health Study	PLOS ONE			English	Article							CIGARETTE-SMOKING; INSULIN-RESISTANCE; OXIDATIVE STRESS; MELLITUS; INFLAMMATION; OBESITY	Aims To examine the association of smoking status, smoking intensity, and smoking cessation with the risk of type 2 diabetes (T2D) using a large database. Methods The present study included 53,930 Japanese employees, aged 15 to 83 years, who received health check-up and did not have diabetes at baseline. Diabetes was defined as fasting plasma glucose >= 126 mg/dl, random plasma glucose >= 200 mg/dl, HbA1c >= 6.5% (>= 48 mmol/mol), or receiving medication for diabetes. Cox proportional-hazards regression models were used to investigate the association between smoking and the risk of diabetes. Results During 3.9 years of median follow-up, 2,441 (4.5%) individuals developed T2D. The multi-variable-adjusted hazard ratios (95% CI) for diabetes were 1 (reference), 1.16 (1.04 to 1.30) and 1.34 (1.22 to 1.48) for never smokers, former smokers, and current smokers, respectively. Diabetes risk increased with increasing numbers of cigarette consumption among current smokers (P for trend <0.001). Although the relative risk of diabetes was greater among subjects with lower BMIs (<23 kg/m(2)), attributable risk was greater in subjects with higher BMIs (>= 23 kg/m(2)). Compared with individuals who had never smoked, former smokers who quit less than 5 years, 5 to 9 years, and 10 years or more exhibited hazards ratios for diabetes of 1.36 (1.14 to 1.62), 1.23 (1.01 to 1.51), and 1.02 (0.85 to 1.23), respectively. Conclusions Results suggest that cigarette smoking is associated with an increased risk of T2D, which may decrease to the level of a never smoker after 10 years of smoking cessation.	[Akter, Shamima; Kuwahara, Keisuke; Kurotani, Kayo; Nanri, Akiko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Okazaki, Hiroko; Dohi, Seitaro] Mitsui Chem Inc, Tokyo, Japan; [Kuwahara, Keisuke] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 173, Japan; [Miyamoto, Toshiaki] Nippon Steel & Sumitomo Met Corp Kimitsu Works, Chiba, Japan; [Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko] JFE Steel Corp, Kanagawa, Japan; [Tomita, Kentaro] Mitsubishi Plast Inc, Tokyo, Japan; [Nagahama, Satsue] All Japan Labour Welf Fdn, Tokyo, Japan; [Eguchi, Masafumi; Kochi, Takeshi; Kabe, Isamu] Furukawa Elect Corp Ltd, Tokyo, Japan; [Imai, Teppei; Nishihara, Akiko] Azbil Corp, Tokyo, Japan; [Sasaki, Naoko] Mitsubishi Fuso Truck & Bus Corp, Kanagawa, Japan; [Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru] Hitachi Ltd, Ibaraki, Japan; [Uehara, Akihiko; Yamamoto, Makoto] YAMAHA Corp, Shizuoka, Japan; [Hori, Ai; Nishiura, Chiro] Tokyo Gas Co Ltd, Dept Safety & Hlth, Tokyo, Japan; [Sakamoto, Nobuaki] Genkiplaza Med Ctr Hlth Care, Tokyo, Japan; [Totsuzaki, Takafumi] Mizuho Bank Ltd, Tokyo, Japan; [Kato, Noritada] Fuji Elect Co Ltd, Kanagawa, Japan; [Fukasawa, Kenji] Ricoh Co Ltd, Kanagawa, Japan; [Ngoc M. Pham] Thai Nguyen Univ Med & Pharm, Fac Publ Hlth, Dept Epidemiol, Thai Nguyen, Thai Nguyen Pro, Vietnam; [Sone, Tomofumi] Natl Inst Publ Hlth, Saitama, Japan	National Center for Global Health & Medicine - Japan; Mitsui Chemicals; Teikyo University; Nippon Steel & Sumitomo Metal Corporation; JFE Holdings, Inc.; JFE Steel; Furukawa Electric; Daimler AG; Hitachi Limited; Yamaha; Fuji Electric Co., LTD.; Ricoh Company, Ltd.; Thai Nguyen University; National Institute of Public Health - Japan	Akter, S (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.	samimarub@yahoo.com	Nishiura, Chihiro/Q-7938-2019; Nishiura, Chihiro/C-4132-2017; Hori, Ai/G-5277-2019	Nishiura, Chihiro/0000-0002-8850-5446; Nishiura, Chihiro/0000-0002-8850-5446; Hori, Ai/0000-0002-0191-5996; Kuwahara, Keisuke/0000-0002-7503-1333; Kochi, Takeshi/0000-0002-3411-1070	Industrial Health Foundation; National Cancer Center Research and Development Fund; Mitsui Chemicals, Inc.; Nippon Steel AMP; Sumitomo Metal Corporation Kimitsu Works; JFE Steel Corporation; Mitsubishi Plastics, Inc.; Furukawa Electric Co., Ltd.; Azbil Corporation; Mitsubishi Fuso Truck and Bus Corporation; Hitachi, Ltd.; YAMAHA CORPORATION; Tokyo Gas Co., Ltd; Mizuho Bank, Ltd; Fuji Electric Co., Ltd; Ricoh Co., Ltd;  [25293146]	Industrial Health Foundation; National Cancer Center Research and Development Fund(National Cancer Center - Japan); Mitsui Chemicals, Inc.; Nippon Steel AMP; Sumitomo Metal Corporation Kimitsu Works; JFE Steel Corporation; Mitsubishi Plastics, Inc.; Furukawa Electric Co., Ltd.; Azbil Corporation; Mitsubishi Fuso Truck and Bus Corporation; Hitachi, Ltd.; YAMAHA CORPORATION; Tokyo Gas Co., Ltd; Mizuho Bank, Ltd(Fukuda Foundation for Medical TechnologyMukai Science and Technology FoundationSENSHIN Medical Research FoundationKayamori FoundationKayamori Foundation of Informational Science AdvancementMizuho Foundation for the Promotion of Sciences); Fuji Electric Co., Ltd; Ricoh Co., Ltd; 	This study was supported by a grant from the Industrial Health Foundation (to Dr Mizoue), the National Cancer Center Research and Development Fund (to Dr Mizoue), and Grant-in-Aid for Scientific Research (B) (25293146) (to Dr Mizoue). "Mitsui Chemicals, Inc.", "Nippon Steel & Sumitomo Metal Corporation Kimitsu Works", "JFE Steel Corporation", "Mitsubishi Plastics, Inc.", "Furukawa Electric Co., Ltd.", "Azbil Corporation", "Mitsubishi Fuso Truck and Bus Corporation", "Hitachi, Ltd.", "YAMAHA CORPORATION", "Tokyo Gas Co., Ltd", "Mizuho Bank, Ltd", "Fuji Electric Co., Ltd" and "Ricoh Co., Ltd" provided support in the form of salaries for authors [H. Okazaki, S. Dohi, T. Miyamoto, T. Murakami, C. Shimizu, M. Shimizu, K. Tomita, M. Eguchi, T. Kochi, I. Kabe, T. Imai, A. Nishihara, N. Sasaki, T. Nakagawa, S. Yamamoto, and T. Honda, A. Uehara, M. Yamamoto, A. Hori, C. Nishiura, T. Totsuzaki, N. Kato, and K. Fukasawa], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Berlin I, 2008, DIABETES METAB, V34, P307, DOI 10.1016/j.diabet.2008.01.008; Cho NH, 2009, CLIN ENDOCRINOL, V71, P679, DOI 10.1111/j.1365-2265.2009.03586.x; Chowdhury P, 2002, EXP BIOL MED, V227, P445, DOI 10.1177/153537020222700708; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Foy CG, 2005, DIABETES CARE, V28, P2501, DOI 10.2337/diacare.28.10.2501; Hur NW, 2007, EUR J CARDIOV PREV R, V14, P244, DOI 10.1097/01.hjr.0000239474.41379.79; IDF, 2019, IDF DIABETES ATLAS; Jee SH, 2010, DIABETES CARE, V33, P2567, DOI 10.2337/dc10-0261; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kuwahara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095732; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Luo JH, 2013, AM J EPIDEMIOL, V178, P937, DOI 10.1093/aje/kwt071; Ministry of Education Culture Sports Science and Technology. Ministry of Health Labour and Welfare, 2000, ETH GUID EP RES; Morimoto A, 2012, DIABETES RES CLIN PR, V96, P407, DOI 10.1016/j.diabres.2012.03.007; Morimoto A, 2012, PREV MED, V54, P341, DOI 10.1016/j.ypmed.2012.02.016; Nakanishi N, 2000, ANN INTERN MED, V133, P183, DOI 10.7326/0003-4819-133-3-200008010-00009; Oba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0017061; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Teratani T, 2012, DRUG ALCOHOL DEPEN, V125, P276, DOI 10.1016/j.drugalcdep.2012.03.002; TROISI RJ, 1991, AM J CLIN NUTR, V53, P1104, DOI 10.1093/ajcn/53.5.1104; Uehara A, 2014, DIABETES RES CLIN PR, V106, P118, DOI 10.1016/j.diabres.2014.07.013; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Weyer C, 2002, ATHEROSCLEROSIS, V161, P233, DOI 10.1016/S0021-9150(01)00626-8; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Zhang LX, 2011, DIABETES CARE, V34, P892, DOI 10.2337/dc10-2087	33	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132166	10.1371/journal.pone.0132166	http://dx.doi.org/10.1371/journal.pone.0132166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200457	gold, Green Published, Green Submitted			2022-12-26	WOS:000358597100027
J	Liu, J; Liu, JX; Gao, YL; Kong, XZ; Wang, XS; Wang, D				Liu, Jian; Liu, Jin-Xing; Gao, Ying-Lian; Kong, Xiang-Zhen; Wang, Xue-Song; Wang, Dong			A P-Norm Robust Feature Extraction Method for Identifying Differentially Expressed Genes	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; PENALIZED MATRIX DECOMPOSITION; CLASSIFICATION; APPROXIMATION; FACTORIZATION; DISCOVERY; ONTOLOGY; CANCER; ARRAYS; RANK	In current molecular biology, it becomes more and more important to identify differentially expressed genes closely correlated with a key biological process from gene expression data. In this paper, based on the Schatten p-norm and L-p-norm, a novel p-norm robust feature extraction method is proposed to identify the differentially expressed genes. In our method, the Schatten p-norm is used as the regularization function to obtain a low-rank matrix and the L-p-norm is taken as the error function to improve the robustness to outliers in the gene expression data. The results on simulation data show that our method can obtain higher identification accuracies than the competitive methods. Numerous experiments on real gene expression data sets demonstrate that our method can identify more differentially expressed genes than the others. Moreover, we confirmed that the identified genes are closely correlated with the corresponding gene expression data.	[Liu, Jian; Liu, Jin-Xing; Kong, Xiang-Zhen; Wang, Dong] Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao 276826, Shandong, Peoples R China; [Gao, Ying-Lian] Qufu Normal Univ, Lib Qufu Normal Univ, Rizhao 276826, Shandong, Peoples R China; [Liu, Jian; Wang, Xue-Song] China Univ Min & Technol, Sch Informat & Elect Engn, Xuzhou 221000, Jiangsu, Peoples R China; [Liu, Jin-Xing] Harbin Inst Technol, Biocomp Res Ctr, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China; [Wang, Xue-Song] Chinese Acad Sci, Inst Automat, Key Lab Complex Syst & Intelligence Sci, Beijing 100000, Peoples R China	Qufu Normal University; Qufu Normal University; China University of Mining & Technology; Harbin Institute of Technology; University Town of Shenzhen; Chinese Academy of Sciences; Institute of Automation, CAS	Liu, JX (corresponding author), Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao 276826, Shandong, Peoples R China.	sdcavell@126.com	Liu, Jin-Xing/AAU-7257-2020	wang, xuesong/0000-0002-5327-1088	NSFC [61373027, 61308116]; China Postdoctoral Science Foundation [2014M560264]; Shandong Provincial Natural Science Foundation [ZR2013FL016, ZR2012FM023]; Shenzhen Municipal Science and Technology Innovation Council [JCYJ20130329151843309, JCYJ20140417172417174]	NSFC(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Shenzhen Municipal Science and Technology Innovation Council	This work was supported in part by the NSFC under grant Nos. 61373027 and 61308116; the China Postdoctoral Science Foundation funded project, No. 2014M560264; the Shandong Provincial Natural Science Foundation, under grant Nos. ZR2013FL016 and ZR2012FM023; Shenzhen Municipal Science and Technology Innovation Council (Nos. JCYJ20130329151843309 and JCYJ20140417172417174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bertsekas D. P., 1982, COMPUTER SCI APPL MA, V1982, P1; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Eckart C, 1936, PSYCHOMETRIKA, V1, P211, DOI 10.1007/BF02288367; Gabay D., 1976, Computers & Mathematics with Applications, V2, P17, DOI 10.1016/0898-1221(76)90003-1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hestenes M. R., 1969, Journal of Optimization Theory and Applications, V4, P303, DOI 10.1007/BF00927673; Huang Jin, 2013, P 23 INT JOINT C ART; Journee M, 2010, J MACH LEARN RES, V11, P517; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Liang F, 2007, COMPUT STAT DATA AN, V51, P6355, DOI 10.1016/j.csda.2007.01.022; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106097; Liu JX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S3; Liu JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038873; Liu JX, 2012, COMPUT BIOL MED, V42, P582, DOI 10.1016/j.compbiomed.2012.02.002; Ma S, 2009, BIOINFORMATICS, V25, P882, DOI 10.1093/bioinformatics/btp085; Mazumder R, 2010, J MACH LEARN RES, V11, P2287; Nie F., 2012, P AAAI C ART INT; Nie F., 2013, KNOWL INF SYST, P1; Powell M.J., 1967, METHOD NONLINEAR CON; Sarmah CK, 2011, COMPUT BIOL MED, V41, P980, DOI 10.1016/j.compbiomed.2011.08.007; Toh KC, 2010, PAC J OPTIM, V6, P615; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Wu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066256; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zheng CH, 2011, IEEE T NANOBIOSCI, V10, P86, DOI 10.1109/TNB.2011.2144998	32	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133124	10.1371/journal.pone.0133124	http://dx.doi.org/10.1371/journal.pone.0133124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201006	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100055
J	Ranasinghe, A; Dasgupta, P; Althoefer, K; Nanayakkara, T				Ranasinghe, Anuradha; Dasgupta, Prokar; Althoefer, Kaspar; Nanayakkara, Thrishantha			Identification of Haptic Based Guiding Using Hard Reins	PLOS ONE			English	Article							MOVEMENTS	This paper presents identifications of human-human interaction in which one person with limited auditory and visual perception of the environment (a follower) is guided by an agent with full perceptual capabilities (a guider) via a hard rein along a given path. We investigate several identifications of the interaction between the guider and the follower such as computational models that map states of the follower to actions of the guider and the computational basis of the guider to modulate the force on the rein in response to the trust level of the follower. Based on experimental identification systems on human demonstrations show that the guider and the follower experience learning for an optimal stable state-dependent novel 3rd and 2nd order auto-regressive predictive and reactive control policies respectively. By modeling the follower's dynamics using a time varying virtual damped inertial system, we found that the coefficient of virtual damping is most appropriate to explain the trust level of the follower at any given time. Moreover, we present the stability of the extracted guiding policy when it was implemented on a planar 1-DoF robotic arm. Our findings provide a theoretical basis to design advanced human-robot interaction algorithms applicable to a variety of situations where a human requires the assistance of a robot to perceive the environment.	[Ranasinghe, Anuradha; Althoefer, Kaspar; Nanayakkara, Thrishantha] Kings Coll London, Ctr Robot Res, Dept Informat, London, England; [Dasgupta, Prokar] Kings Coll London, DTIMB, MRC Ctr Transplantat, London, England; [Dasgupta, Prokar] Kings Coll London, NIHR BRC, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Ranasinghe, A (corresponding author), Kings Coll London, Ctr Robot Res, Dept Informat, London, England.	anuradha.ranasinghe@kcl.ac.uk	Nanayakkara, Thrishantha/AAM-5964-2020; Althoefer, Kaspar/AAA-5984-2022	Nanayakkara, Thrishantha/0000-0002-1882-1232; Dasgupta, Prokar/0000-0001-8690-0445	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/I028765/1]; Guy's and St Thomas' Charity grant on developing clinician-scientific interfaces in robotic assisted surgery: translating technical innovation into improved clinical care [R090705]; Vattikuti foundation; EPSRC [EP/I028765/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I028765/1] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Guy's and St Thomas' Charity grant on developing clinician-scientific interfaces in robotic assisted surgery: translating technical innovation into improved clinical care; Vattikuti foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is supported by the UK Engineering and Physical Sciences Research Council (EPSRC) grant no. EP/I028765/1, the Guy's and St Thomas' Charity grant on developing clinician-scientific interfaces in robotic assisted surgery: translating technical innovation into improved clinical care (grant no. R090705), and Vattikuti foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan MA, 2009, PROC OF THE INTERNAT; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; Casper J, 2003, IEEE T SYST MAN CY B, V33, P367, DOI 10.1109/TSMCB.2003.811794; Duchaine V., 2009, ROBOTICS AUTOMATION, P3383, DOI DOI 10.1109/ROBOT.2009.5152664; Finzi A, 2005, AMERICAN ASSOCIATION; Flanders M, 2002, J NEUROSCI METH, V116, P165, DOI 10.1016/S0165-0270(02)00038-9; Freedy E, 2007, IEEE INTERNATIONAL C; Goodrich Michael A., 2007, Foundations and Trends in Human-Computer Interaction, V1, P203, DOI 10.1561/1100000005; Hancock PA, 2011, HUM FACTORS, V53, P517, DOI 10.1177/0018720811417254; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; JOHANNSEN G, 1979, HUM FACTORS, V21, P733, DOI 10.1177/001872087912210610; Kalia H, 2014, ADV COMPU INTELL ROB, P147, DOI 10.4018/978-1-4666-4936-1.ch007; Loomis JM, 2001, OPTOMETRY VISION SCI, V78, P282, DOI 10.1097/00006324-200105000-00011; Loomis JM, 1998, IEEE T BIOMEDICAL EN, V7, P163; Marston JR, 2007, J VISUAL IMPAIR BLIN, V101, P203, DOI 10.1177/0145482X0710100403; Mitsunaga N., 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P218, DOI 10.1109/IROS.2005.1545206; Mortl A, 2012, INT J ROBOT RES, V31, P1656, DOI 10.1177/0278364912455366; Murphy RR, 2004, IEEE T SYST MAN CY C, V34, P138, DOI 10.1109/TSMCC.2004.826267; Park E, 2008, PROCEEDINGS OF THE J, V7; Penders J, 2011, ADV ROBOTICS, V25, P93, DOI 10.1163/016918610X538507; Ranasinghe A, 2013, IEEE SYS MAN CYBERN, P2322, DOI 10.1109/SMC.2013.397; Ranasinghe A, 2013, IEEE INT C INT ROBOT, P116, DOI 10.1109/IROS.2013.6696341; Richardson MJE, 2002, J NEUROSCI, V22, P8201; Saeb S, 2011, PLOS COMPUTATIONAL B, P7; Scheggi S, 2014, IEEE INT CONF ROBOT, P2693, DOI 10.1109/ICRA.2014.6907245; Sterman JD, 1988, SYST DYNAM REV, V4, P148, DOI 10.1002/sdr.4260040109; Stokes IAF, 2001, J BIOMECH, V34, P733, DOI 10.1016/S0021-9290(01)00034-3; Stormont DP, 2008, P HUM IMPL HUM ROB I, P27; TACHI S, 1985, IEEE T BIO-MED ENG, V32, P461, DOI 10.1109/TBME.1985.325561; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Ulrich I, 2001, IEEE T SYST MAN CY A, V31, P131, DOI 10.1109/3468.911370; van Mourik AM, 2006, BIOL CYBERN, V94, P233, DOI 10.1007/s00422-005-0041-9	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132020	10.1371/journal.pone.0132020	http://dx.doi.org/10.1371/journal.pone.0132020			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201076	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100024
J	Bojakowski, K; Janusz, G; Grabowska, I; Zegrocka-Stendel, O; Surowiecka-Pastewka, A; Kowalewska, M; Maciejko, D; Koziak, K				Bojakowski, Krzysztof; Janusz, Gabriela; Grabowska, Iwona; Zegrocka-Stendel, Oliwia; Surowiecka-Pastewka, Agnieszka; Kowalewska, Magdalena; Maciejko, Dorota; Koziak, Katarzyna			Rat Model of Parkes Weber Syndrome	PLOS ONE			English	Article							BLOOD-FLOW RESTRICTION; INTENSITY RESISTANCE EXERCISE; MUSCLE PROTEIN-SYNTHESIS; VASCULAR ANOMALIES; SATELLITE CELLS; GROWTH; MALFORMATIONS; REGENERATION; OSTEOBLASTS; MUTATIONS	The Parkes Weber syndrome is a congenital vascular malformation, characterized by varicose veins, arterio-venous fistulas and overgrown limbs. No broadly accepted animal model of Parkes Weber syndrome has been described. We created side-to-side arteriovenous fistula between common femoral vessels with proximal non-absorbable ligature on common femoral vein limiting the enlargement of the vein diameter in Wistar rats. Contralateral limb was sham operated. Invasive blood pressure measurements in both iliac and inferior cava veins were performed in rats 30 days after fistula creation. Tight circumference and femoral bone length were measured. Histopathology and morphology of soleus muscle, extensor digitorum longus muscle, and the common femoral vessel were analyzed. 30 days following arterio-venous fistula creation, a statistically significant elevation of blood pressure in common iliac vein and limb overgrowth was observed. Limb enlargement was caused by muscle overgrowth, varicose veins formation and bone elongation. Arteriovenous fistula with proximal outflow limitation led to significant increase of femoral vein circumference and venous wall thickness. Our study indicates that the described rat model mimics major clinical features characteristic for the human Parkes Weber syndrome: presence of arterio-venous fistula, venous hypertension and dilatation, varicose veins formation, and the limb hypertrophy. We reveal that limb overgrowth is caused by bone elongation, muscle hypertrophy, and venous dilatation. The newly established model will permit detailed studies on the mechanisms underlying the disease and on the efficacy of novel therapeutic strategies for the Parkes Weber syndrome treatment.	[Bojakowski, Krzysztof; Janusz, Gabriela; Zegrocka-Stendel, Oliwia; Surowiecka-Pastewka, Agnieszka; Kowalewska, Magdalena; Maciejko, Dorota; Koziak, Katarzyna] Med Univ Warsaw, Dept Immunol Biochem & Nutr, Warsaw, Poland; [Bojakowski, Krzysztof] Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland; [Grabowska, Iwona] Univ Warsaw, Fac Biol, Dept Cytol, Warsaw, Poland; [Kowalewska, Magdalena] Maria Sklodowska Curie Mem Canc Ctr, Dept Mol & Translat Oncol, Warsaw, Poland; [Kowalewska, Magdalena] Inst Oncol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Koziak, K (corresponding author), Med Univ Warsaw, Dept Immunol Biochem & Nutr, Warsaw, Poland.	katarzyna.koziak@wum.edu.pl	Grabowska, Iwona/AAY-8564-2021; Zegrocka-Stendel, Oliwia/T-8148-2018	Grabowska, Iwona/0000-0001-6455-9434; Zegrocka-Stendel, Oliwia/0000-0001-6481-372X; Bojakowski, Krzysztof/0000-0001-6899-8741; Kowalewska, Magdalena/0000-0002-3413-9612	European Union Operational Program "Innovative Economy" grant [POIG.01.01.02-14-072/09]	European Union Operational Program "Innovative Economy" grant	This work was supported by the European Union Operational Program "Innovative Economy" grant No. POIG.01.01.02-14-072/09. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J TRAIN SCI EXERC SP, V16, P199; Araldi E, 2010, BONE, V47, P190, DOI 10.1016/j.bone.2010.04.606; BASSAGLIA Y, 1995, J MUSCLE RES CELL M, V16, P420, DOI 10.1007/BF00114507; Breugem CC, 2004, BRIT J PLAST SURG, V57, P754, DOI 10.1016/j.bjps.2004.05.006; Burrows PE, 2013, P NATL ACAD SCI USA, V110, P8621, DOI 10.1073/pnas.1222722110; Enjolras O, 2004, J PEDIATR ORTHOP B, V13, P349, DOI 10.1097/01202412-200411000-00001; Fernandez-Pineda I, 2009, ANN VASC SURG, V23, DOI 10.1016/j.avsg.2008.08.021; Fry CS, 2010, J APPL PHYSIOL, V108, P1199, DOI 10.1152/japplphysiol.01266.2009; Fujita S, 2007, J APPL PHYSIOL, V103, P903, DOI 10.1152/japplphysiol.00195.2007; Giron-Vallejo O, 2013, ANN VASC SURG, V27, P820, DOI 10.1016/j.avsg.2013.01.001; Kalhovde JM, 2005, J PHYSIOL-LONDON, V562, P847, DOI 10.1113/jphysiol.2004.073684; Kawasaki J, 2014, J CLIN INVEST, V124, P2774, DOI 10.1172/JCI67084; Konner K, 2003, J AM SOC NEPHROL, V14, P1669, DOI 10.1097/01.ASN.0000069219.88168.39; Kubo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037934; Lapinski PE, 2007, GENESIS, V45, P762, DOI 10.1002/dvg.20354; Lee BB, 2004, J VASC SURG, V39, P590, DOI 10.1016/j.jvs.2003.10.048; Loenneke JP, 2012, MED HYPOTHESES, V78, P523, DOI 10.1016/j.mehy.2012.01.024; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Moraczewski J, 1996, ACTA BIOCHIM POL, V43, P693; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; NONAKA I, 1983, ACTA NEUROPATHOL, V60, P167, DOI 10.1007/BF00691863; Parsa Cameron F, 2013, Trans Am Ophthalmol Soc, V111, P180; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Takarada Y, 2000, J APPL PHYSIOL, V88, P61, DOI 10.1152/jappl.2000.88.1.61; Tombran-Tink J, 2004, BIOCHEM BIOPH RES CO, V316, P573, DOI 10.1016/j.bbrc.2004.02.076; Weber FP, 1907, BRIT J DERMATOL, V19, P231; Zimowska M, 2001, J CELL PHYSIOL, V188, P178, DOI 10.1002/jcp.1106; Ziyeh S, 2004, EUR RADIOL, V14, P2025, DOI 10.1007/s00330-004-2274-8	28	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133752	10.1371/journal.pone.0133752	http://dx.doi.org/10.1371/journal.pone.0133752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217941	Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900044
J	Hrkac, M; Wurm, MF; Kuhn, AB; Schubotz, RI				Hrkac, Mari; Wurm, Moritz F.; Kuehn, Anne B.; Schubotz, Ricarda I.			Objects Mediate Goal Integration in Ventrolateral Prefrontal Cortex during Action Observation	PLOS ONE			English	Article							HUMAN BRAIN; RECOGNITION; MEMORY; FMRI	Actions performed by others are mostly not observed in isolation, but embedded in sequences of actions tied together by an overarching goal. Therefore, preceding actions can modulate the observer's expectations in relation to the currently perceived action. Ventrolateral prefrontal cortex (vlPFC), and inferior frontal gyrus (IFG) in particular, is suggested to subserve the integration of episodic as well as semantic information and memory, including action scripts. The present fMRI study investigated if activation in IFG varies with the effort to integrate expected and observed action, even when not required by the task. During an fMRI session, participants were instructed to attend to short videos of single actions and to deliver a judgment about the actor's current goal. We manipulated the strength of goal expectation induced by the preceding action, implementing the parameter "goal-relatedness" between the preceding and the currently observed action. Moreover, since objects point to the probability of certain actions, we also manipulated whether the current and the preceding action shared at least one object or not. We found an interaction between the two factors goal-relatedness and shared object: IFG activation increased the weaker the goal-relatedness between the preceding and the current action was, but only when they shared at least one object. Here, integration of successive action steps was triggered by the reappearing (shared) object but hampered by a weak goal-relatedness between the actually observed manipulation. These findings foster the recently emerging view that IFG is enhanced by goal-related conflicts during action observation.	[Hrkac, Mari; Schubotz, Ricarda I.] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Hrkac, Mari; Wurm, Moritz F.; Kuehn, Anne B.; Schubotz, Ricarda I.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Wurm, Moritz F.] Univ Trento, Ctr Mind Brain Sci, I-38100 Mattarello, TN, Italy	University of Munster; Max Planck Society; University of Trento	Wurm, MF (corresponding author), Univ Trento, Ctr Mind Brain Sci, Via Regole 101, I-38100 Mattarello, TN, Italy.	moritz.wurm@unitn.it	Schubotz, Ricarda/B-2871-2013; Wurm, Moritz/AAB-2603-2019	Wurm, Moritz/0000-0003-4358-9815; Schubotz, Ricarda/0000-0001-5802-6869	Max Planck Institute	Max Planck Institute(Max Planck Society)	The Max Planck Institute financed the fMRI study (http://www.nf.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Grafman J., 2002, PRINCIPLES FRONTAL L, P292, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0019; Green AE, 2010, CEREB CORTEX, V20, P70, DOI 10.1093/cercor/bhp081; Hrkac M, 2014, HUM BRAIN MAPP, V35, P2178, DOI 10.1002/hbm.22319; Johnson JS, 2003, J VISION, V3, P499, DOI 10.1167/3.7.4; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kroger S, 2012, BRAIN RES, V1430, P52, DOI 10.1016/j.brainres.2011.10.031; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lohmann G, 2008, 11 INT C MED IM COMP, P1; Newman SD, 2013, BRAIN TOPOGR, V26, P458, DOI 10.1007/s10548-012-0264-8; Norris DG, 2000, JMRI-J MAGN RESON IM, V11, P445, DOI 10.1002/(SICI)1522-2586(200004)11:4<445::AID-JMRI13>3.0.CO;2-T; Phillips WA, 2013, BEHAV BRAIN SCI, V36, P222, DOI 10.1017/S0140525X12002257; Schank RC., 1977, SCRIPTS PLANS GOALS; Talairach J, 1988, CO PLANAR STEREOTAXI; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Woodward AL, 2000, PSYCHOL SCI, V11, P73, DOI 10.1111/1467-9280.00218; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Wurm MF, 2014, BEHAV BRAIN RES, V274, P108, DOI 10.1016/j.bbr.2014.07.053; Wurm MF, 2012, NEUROIMAGE, V59, P1551, DOI 10.1016/j.neuroimage.2011.08.038	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134316	10.1371/journal.pone.0134316	http://dx.doi.org/10.1371/journal.pone.0134316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218102	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900112
J	Jee, HB; Park, MJ; Lee, HS; Park, MS; Kim, MJ; Chung, YE				Jee, Han Bum; Park, Min Jung; Lee, Hye Sun; Park, Mi-Suk; Kim, Myeong-Jin; Chung, Yong Eun			Is Non-Contrast CT Adequate for the Evaluation of Hepatic Metastasis in Patients Who Cannot Receive Iodinated Contrast Media?	PLOS ONE			English	Article							COLORECTAL LIVER METASTASES; HELICAL CT; SPIRAL CT; PET; MANAGEMENT; ULTRASOUND; TIME	Objective To evaluate the appropriateness of follow-up with only non-enhanced CT (NECT) in patients with gastrointestinal cancer. Subjects and Methods This retrospective study included 323 patients with colorectal and gastric cancer who underwent two consecutive CT examinations (CT1 and CT2), including non-contrast and portal venous phase CT images, with an interval of 1 year. Patients were divided into 2 groups: Group A included patients with no hepatic metastasis on CT1 and with or without newly developed metastasis on CT2 to evaluate the diagnostic performance of NECT for detecting newly developed hepatic metastasis; Group B included patients with known hepatic metastasis both on CT1 and CT2 to evaluate the accuracy of NECT for the assessment of hepatic metastasis based on RECIST criteria (version 1.1). Contrast-enhanced CT (CECT) images were considered as reference standards. Results Group A included 172 patients (M:F = 107: 65; mean age, 62.6 years). Among them, 57 patients had 95 metastases (mean size, 2.2 +/- 1.3 cm). Per patient and per lesion sensitivity for diagnosing newly developed hepatic metastasis was 56.1-66.7% and 52.6-56.8%, respectively. In terms of small metastases (<1.5 cm), per lesion sensitivity was significantly decreased to 28.1-34.4% (P<0.05). Metastasis size measurements were significantly smaller on NECT (P<0.001) compared with reference standards. In Group B, the accuracy of response evaluation based on RECIST criteria was 65.6-72.2%. Conclusions NECT showed inadequate diagnostic performances in both detecting newly developed hepatic metastasis and evaluating the response of hepatic metastasis based on RECIST criteria.	[Jee, Han Bum; Park, Mi-Suk; Kim, Myeong-Jin; Chung, Yong Eun] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul 120749, South Korea; [Park, Min Jung] Ajou Univ, Sch Med, Dept Radiol, Suwon 441749, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Ajou University; Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul 120749, South Korea.	yelv@yuhs.ac	Lee, Hye Sun/J-2154-2015; Kim, Myeong-Jin/E-1623-2011	Lee, Hye Sun/0000-0001-6328-6948; Chung, Yong Eun/0000-0003-0811-9578; Park, Mi-Suk/0000-0001-5817-2444; Kim, Myeong-Jin/0000-0001-7949-5402	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014-31-0623]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014-31-0623). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albrecht T, 2003, EUR RADIOL, V13, pN79, DOI 10.1007/s00330-003-0012-2; BERLAND LL, 1982, AM J ROENTGENOL, V138, P853, DOI 10.2214/ajr.138.5.853; BRINK JA, 1995, RADIOLOGY, V197, P83, DOI 10.1148/radiology.197.1.7568859; Broome DR, 2007, AM J ROENTGENOL, V188, P586, DOI 10.2214/AJR.06.1094; Chung YE, 2006, J COMPUT ASSIST TOMO, V30, P182, DOI 10.1097/00004728-200603000-00003; Chung YE, 2015, ULTRASONOGRAPHY, V34, P3, DOI 10.14366/usg.14034; COX IH, 1991, RADIOLOGY, V181, P18, DOI 10.1148/radiology.181.1.1887031; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Frederick MG, 1997, J COMPUT ASSIST TOMO, V21, P229, DOI 10.1097/00004728-199703000-00012; Kinkel K, 2002, RADIOLOGY, V224, P748, DOI 10.1148/radiol.2243011362; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Mainenti PP, 2010, ABDOM IMAGING, V35, P511, DOI 10.1007/s00261-009-9555-2; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Moulton CA, 2014, JAMA-J AM MED ASSOC, V311, P1863, DOI 10.1001/jama.2014.3740; Nazarian LN, 1999, RADIOLOGY, V213, P825, DOI 10.1148/radiology.213.3.r99dc29825; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Park JH, 2001, ACAD RADIOL, V8, P698, DOI 10.1016/S1076-6332(03)80576-7; Quaia E, 2006, EUR RADIOL, V16, P1599, DOI 10.1007/s00330-006-0192-7; Robinson PJA, 2000, BRIT J RADIOL, V73, P234, DOI 10.1259/bjr.73.867.10817037; Ruers TJM, 2009, J NUCL MED, V50, P1036, DOI 10.2967/jnumed.109.063040; Schima Wolfgang, 2005, Cancer Imaging, V5 Spec No A, pS149, DOI 10.1102/1470-7330.2005.0035; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; SILVERMAN PM, 1995, AM J ROENTGENOL, V165, P73, DOI 10.2214/ajr.165.1.7785637; Soussan M, 2010, EUR RADIOL, V20, P1715, DOI 10.1007/s00330-009-1700-3; van Kessel CS, 2012, ANN SURG ONCOL, V19, P2805, DOI 10.1245/s10434-012-2300-z	25	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134133	10.1371/journal.pone.0134133	http://dx.doi.org/10.1371/journal.pone.0134133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218533	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900083
J	Kwak, J; Jo, HH; Luttinen, T; Kosonen, I				Kwak, Jaeyoung; Jo, Hang-Hyun; Luttinen, Tapio; Kosonen, Iisakki			Effects of Switching Behavior for the Attraction on Pedestrian Dynamics	PLOS ONE			English	Article							SOCIAL FORCE MODEL; CROWD; ENVIRONMENTS; CONVERSION; ATTENTION; SALES	Walking is a fundamental activity of our daily life not only for moving to other places but also for interacting with surrounding environment. While walking on the streets, pedestrians can be aware of attractions like shopping windows. They can be influenced by the attractions and some of them might shift their attention towards the attractions, namely switching behavior. As a first step to incorporate the switching behavior, this study investigates collective effects of switching behavior for an attraction by developing a behavioral model. Numerical simulations exhibit different patterns of pedestrian behavior depending on the strength of the social influence and the average length of stay. When the social influence is strong along with a long length of stay, a saturated phase can be defined at which all the pedestrians have visited the attraction. If the social influence is not strong enough, an unsaturated phase appears where one can observe that some pedestrians head for the attraction while others walk in their desired direction. These collective patterns of pedestrian behavior are summarized in a phase diagram by comparing the number of pedestrians who visited the attraction to the number of passersby near the attraction. Measuring the marginal benefits with respect to the strength of the social influence and the average length of stay enables us to identify under what conditions enhancing these variables would be more effective. The findings from this study can be understood in the context of the pedestrian facility management, for instance, for retail stores.	[Kwak, Jaeyoung; Luttinen, Tapio; Kosonen, Iisakki] Aalto Univ, Dept Civil & Environm Engn, Espoo, Finland; [Jo, Hang-Hyun] Pohang Univ Sci & Technol, BK21plus Phys Devis, Pohang, South Korea; [Jo, Hang-Hyun] Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea; [Jo, Hang-Hyun] Aalto Univ, Dept Comp Sci, Espoo, Finland	Aalto University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Aalto University	Kwak, J (corresponding author), Aalto Univ, Dept Civil & Environm Engn, Espoo, Finland.	jaeyoung.kwak@aalto.fi	Jo, Hang-Hyun/F-4666-2012; Luttinen, Tapio/G-2343-2013	Jo, Hang-Hyun/0000-0002-4214-9204; Luttinen, Tapio/0000-0002-8830-9787; Kwak, Jaeyoung/0000-0002-9627-3569	Aalto University School of Engineering Doctoral Program; Aalto University postdoctoral program; Mid-career Researcher Program through the National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning [2014030018]; Basic Science Research Program through the National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning [2014046922]	Aalto University School of Engineering Doctoral Program; Aalto University postdoctoral program; Mid-career Researcher Program through the National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning	JK was supported by Aalto University School of Engineering Doctoral Program. HJ was supported by Aalto University postdoctoral program and by Mid-career Researcher Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning (2014030018), and Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning (2014046922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEARDEN WO, 1989, J CONSUM RES, V15, P473, DOI 10.1086/209186; Blue VJ, 2001, TRANSPORT RES B-METH, V35, P293, DOI 10.1016/S0191-2615(99)00052-1; Bruce Goldstein E., 2007, SENSATION PERCEPTION; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; CHILDERS TL, 1992, J CONSUM RES, V19, P198, DOI 10.1086/209296; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; Gallup AC, 2012, P NATL ACAD SCI USA, V109, P7245, DOI 10.1073/pnas.1116141109; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2000, PHYS REV LETT, V84, P1240, DOI 10.1103/PhysRevLett.84.1240; Johansson A, 2012, LANCET INFECT DIS, V12, P150, DOI 10.1016/S1473-3099(11)70287-0; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; Kaltcheva VD, 2006, J MARKETING, V70, P107, DOI 10.1509/jmkg.2006.70.1.107; Kwak J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062810; Lam SY, 2001, MARKET SCI, V20, P194, DOI 10.1287/mksc.20.2.194.10192; Lamarche F, 2004, COMPUT GRAPH FORUM, V23, P509, DOI 10.1111/j.1467-8659.2004.00782.x; MILGRAM S, 1969, J PERS SOC PSYCHOL, V13, P79, DOI 10.1037/h0028070; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Nicolis SC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.268104; Perdikaki O, 2012, M&SOM-MANUF SERV OP, V14, P145, DOI 10.1287/msom.1110.0356; Seyfried A, 2006, PHYSICA A, V368, P232, DOI 10.1016/j.physa.2005.11.052; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Wickens C.D., 1999, ENG PSYCHOL HUMAN PE, V3; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Xu S, 2010, IEEE T INTELL TRANSP, V11, P153, DOI 10.1109/TITS.2009.2036152; Yu W, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046105; Yu WJ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026112; Zanlungo F, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68005; Zanlungo F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012811	30	4	5	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133668	10.1371/journal.pone.0133668	http://dx.doi.org/10.1371/journal.pone.0133668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218430	Green Published, gold			2022-12-26	WOS:000358595900038
J	Schippers, P; Hemerik, L; Baveco, JM; Verboom, J				Schippers, Peter; Hemerik, Lia; Baveco, Johannes M.; Verboom, Jana			Rapid Diversity Loss of Competing Animal Species in Well-Connected Landscapes	PLOS ONE			English	Article							WOODPECKER DENDROCOPOS-MEDIUS; SQUIRREL SCIURUS-CAROLINENSIS; GREAT SPOTTED WOODPECKERS; NEUTRAL-THEORY; HABITAT FRAGMENTATION; RIVERINE FOREST; CLIMATE-CHANGE; COEXISTENCE; ABUNDANCE; METAPOPULATIONS	Population viability of a single species, when evaluated with metapopulation based landscape evaluation tools, always increases when the connectivity of the landscape increases. However, when interactions between species are taken into account, results can differ. We explore this issue using a stochastic spatially explicit meta-community model with 21 competing species in five different competitive settings: (1) weak, coexisting competition, (2) neutral competition, (3) strong, excluding competition, (4) hierarchical competition and (5) random species competition. The species compete in randomly generated landscapes with various fragmentation levels. With this model we study species loss over time. Simulation results show that overall diversity, the species richness in the entire landscape, decreases slowly in fragmented landscapes whereas in well-connected landscapes rapid species losses occur. These results are robust with respect to changing competitive settings, species parameters and spatial configurations. They indicate that optimal landscape configuration for species conservation differs between metapopulation approaches, modelling species separately and meta-community approaches allowing species interactions. The mechanism behind this is that species in well-connected landscapes rapidly outcompete each other. Species that become abundant, by chance or by their completive strength, send out large amounts of dispersers that colonize and take over other patches that are occupied by species that are less abundant. This mechanism causes rapid species loss. In fragmented landscapes the colonization rate is lower, and it is difficult for a new species to establish in an already occupied patch. So, here dominant species cannot easily take over patches occupied by other species and higher diversity is maintained for a longer time. These results suggest that fragmented landscapes have benefits for species conservation previously unrecognized by the landscape ecology and policy community. When species interactions are important, landscapes with a low fragmentation level can be better for species conservation than well-connected landscapes. Moreover, our results indicate that metapopulation based landscape evaluation tools may overestimate the value of connectivity and should be replaced by more realistic meta-community based tools.	[Schippers, Peter; Verboom, Jana] Wageningen Univ & Res Ctr, Dept Alterra Biodivers & Policy, NL-6700 AA Wageningen, Netherlands; [Hemerik, Lia] Wageningen Univ, Dept Math & Stat Methods, Biometris, NL-6700 AA Wageningen, Netherlands; [Baveco, Johannes M.] Wageningen Univ & Res Ctr, Dept Alterra Environm Risk Assessment, NL-6700 AA Wageningen, Netherlands; [Schippers, Peter] Wageningen Univ, Dept Forest Ecol & Forest Management, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Schippers, P (corresponding author), Wageningen Univ & Res Ctr, Dept Alterra Biodivers & Policy, POB 47, NL-6700 AA Wageningen, Netherlands.	peter.schippers@wur.nl	Schippers, Peter/H-2920-2012	Hemerik, Lia/0000-0002-6892-2840	W.O.T. of the Dutch ministry of economic affairs	W.O.T. of the Dutch ministry of economic affairs	The research was supported by the W.O.T. of the Dutch ministry of economic affairs.	Abbott I, 2000, J BIOGEOGR, V27, P333, DOI 10.1046/j.1365-2699.2000.00409.x; Abrams PA, 2004, ECOL LETT, V7, P929, DOI 10.1111/j.1461-0248.2004.00644.x; Allee W., 1938, SOCIAL LIFE ANIMALS; Allee W.C, 1931, ANIMAL AGGREGATION S; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; Baz A, 1996, BIODIVERS CONSERV, V5, P493, DOI 10.1007/BF00056393; BAZ A, 1995, J BIOGEOGR, V22, P129, DOI 10.2307/2846077; Bertolino S, 2003, BIOL CONSERV, V109, P351, DOI 10.1016/S0006-3207(02)00161-1; Bertolino S, 2008, CURR SCI INDIA, V95, P903; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; Cooper SE, 2012, WILDLIFE BIOL, V18, P366, DOI 10.2981/11-093; Etienne RS, 2005, CURRENT THEMES IN THEORETICAL BIOLOGY: A DUTCH PERSPECTIVE, P203, DOI 10.1007/1-4020-2904-7_8; Gu WD, 2002, LANDSCAPE ECOL, V17, P699, DOI 10.1023/A:1022993317717; Hale ML, 2004, CONSERV GENET, V5, P167, DOI 10.1023/B:COGE.0000030001.86288.12; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Karsai I, 2011, ECOL MODEL, V222, P447, DOI 10.1016/j.ecolmodel.2010.11.002; Kosenko SM, 2001, ZOOL ZH, V80, P71; Kosinski Z, 2006, ANN ZOOL FENN, V43, P198; Kosinski Z, 2004, ORNIS FENNICA, V81, P145; Kosinski Z, 2004, ACTA ORNITHOL, V39, P29, DOI 10.3161/068.039.0108; Kosinski Z, 2006, BIRD STUDY, V53, P237, DOI 10.1080/00063650609461438; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; MAC ARTHUR ROBERT H., 1967; May F, 2012, OIKOS, V121, P942, DOI 10.1111/j.1600-0706.2011.20078.x; Nagelkerke CJ, 2002, CONCEPTS APPL LANDSC, P330; Neuhauser C, 1999, ANN APPL PROBAB, V9, P1226; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; Opdam P, 2003, LANDSCAPE ECOL, V18, P113, DOI 10.1023/A:1024429715253; Parmesan C, 1999, NATURE, V399, P747; PETTERSSON B, 1985, HOLARCTIC ECOL, V8, P53; PETTERSSON B, 1983, HOLARCTIC ECOL, V6, P263; PETTERSSON B, 1985, BIOL CONSERV, V32, P335, DOI 10.1016/0006-3207(85)90022-9; Prakash S, 2002, THEOR POPUL BIOL, V62, P231, DOI 10.1006/tpbi.2002.1611; Ripa J, 2000, OIKOS, V90, P89, DOI 10.1034/j.1600-0706.2000.900109.x; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schippers P, 2014, ECOL COMPLEX, V17, P20, DOI 10.1016/j.ecocom.2013.07.002; Schippers P, 2011, ECOGRAPHY, V34, P909, DOI 10.1111/j.1600-0587.2011.06712.x; Schippers P, 2011, ECOL MODEL, V222, P3061, DOI 10.1016/j.ecolmodel.2011.05.022; Schippers P, 2009, POPUL ECOL, V51, P459, DOI 10.1007/s10144-009-0159-z; Schmickl T, 2010, ECOL MODEL, V221, P1089, DOI 10.1016/j.ecolmodel.2009.12.028; Shoemaker KT, 2014, J APPL ECOL, V51, P735, DOI 10.1111/1365-2664.12223; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Verboom J, 2001, BIOL CONSERV, V100, P89, DOI 10.1016/S0006-3207(00)00210-X; VERBOOM J, 1991, OIKOS, V61, P149, DOI 10.2307/3545332; Verboom J, 2010, LANDSCAPE ECOL, V25, P1289, DOI 10.1007/s10980-010-9497-7; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Vos CC, 2001, AM NAT, V157, P24, DOI 10.1086/317004	57	6	6	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132383	10.1371/journal.pone.0132383	http://dx.doi.org/10.1371/journal.pone.0132383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218682	Green Published, gold			2022-12-26	WOS:000358595900008
J	Yuan, J; Li, MZ; Lin, SJ				Yuan, Jian; Li, Meizhen; Lin, Senjie			An Improved DNA Extraction Method for Efficient and Quantitative Recovery of Phytoplankton Diversity in Natural Assemblages	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; RIBOSOMAL-RNA GENE; CYTOCHROME-B GENE; PCR; QUANTIFICATION; COMMUNITIES; REGIONS; ENVIRONMENT; SEQUENCES; ABUNDANCE	Marine phytoplankton are highly diverse with different species possessing different cell coverings, posing challenges for thoroughly breaking the cells in DNA extraction yet preserving DNA integrity. While quantitative molecular techniques have been increasingly used in phytoplankton research, an effective and simple method broadly applicable to different lineages and natural assemblages is still lacking. In this study, we developed a bead-beating protocol based on our previous experience and tested it against 9 species of phytoplankton representing different lineages and different cell covering rigidities. We found the bead-beating method enhanced the final yield of DNA (highest as 2 folds) in comparison with the non-bead-beating method, while also preserving the DNA integrity. When our method was applied to a field sample collected at a subtropical bay located in Xiamen, China, the resultant ITS clone library revealed a highly diverse assemblage of phytoplankton and other micro-eukaryotes, including Archaea, Amoebozoa, Chlorophyta, Ciliphora, Bacillariophyta, Dinophyta, Fungi, Metazoa, etc. The appearance of thecate dinoflagellates, thin-walled phytoplankton and "naked" unicellular organisms indicates that our method could obtain the intact DNA of organisms with different cell coverings. All the results demonstrate that our method is useful for DNA extraction of phytoplankton and environmental surveys of their diversity and abundance.	[Yuan, Jian; Li, Meizhen; Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Yuan, Jian; Li, Meizhen; Lin, Senjie] Xiamen Univ, Marine Biodivers & Global Change Res Ctr, Xiamen, Fujian, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Xiamen University; Xiamen University; University of Connecticut	Lin, SJ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016		National Natural Science Foundation of China [41176091, 41330959]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China grant 41176091 and 41330959 (http://www.nsfc.gov.cn/publish/portal1/) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, J PHYCOL, V32, P424, DOI 10.1111/j.0022-3646.1996.00424.x; Aguilera A, 2006, SYST APPL MICROBIOL, V29, P593, DOI 10.1016/j.syapm.2006.01.006; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; ANDERSON DM, 1994, SCI AM, V271, P62, DOI 10.1038/scientificamerican0894-62; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bessetti J., 2007, J MICROBIOL METH, V28, P159; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bradford TM, 2013, FRESHWATER BIOL, V58, P2401, DOI 10.1111/fwb.12219; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Charvet S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00422; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Connell L, 2002, PHYCOLOGIA, V41, P15, DOI 10.2216/i0031-8884-41-1-15.1; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; Erdner DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022965; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; FUHRMAN JA, 1988, APPL ENVIRON MICROB, V54, P1426, DOI 10.1128/AEM.54.6.1426-1429.1988; Ghiglione JF, 2012, P NATL ACAD SCI USA, V109, P17633, DOI 10.1073/pnas.1208160109; Gomez F, 2014, ACTA PROTOZOOL, V53, P63, DOI 10.4467/16890027AP.13.0021.1118; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Kohli GS, 2014, HARMFUL ALGAE, V39, P134, DOI 10.1016/j.hal.2014.07.007; Krsek M, 1999, J MICROBIOL METH, V39, P1, DOI 10.1016/S0167-7012(99)00093-7; Lin S, 2008, INT J ENVIRON POLLUT, V33, P381, DOI 10.1504/IJEP.2008.020569; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Liu JQ, 2008, HARMFUL ALGAE, V7, P1, DOI 10.1016/j.hal.2007.04.009; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Pinhassi J, 2005, APPL ENVIRON MICROB, V71, P7650, DOI 10.1128/AEM.71.12.7650-7660.2005; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Simon D, 1998, WATER RES, V32, P2220, DOI 10.1016/S0043-1354(97)00452-1; Stern RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042780; Thi NMN, 2011, J MICROBIOL METH, V84, P33, DOI 10.1016/j.mimet.2010.10.008; Wang L, 2014, HARMFUL ALGAE, V31, P100, DOI 10.1016/j.hal.2013.10.013; Wang Qu-yuan, 2013, Yingyong Shengtai Xuebao, V24, P541; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102; Yuan J, 2012, HARMFUL ALGAE, V17, P83, DOI 10.1016/j.hal.2012.03.004; Zhang H, 2005, APPL ENVIRON MICROB, V71, P7053, DOI 10.1128/AEM.71.11.7053-7063.2005; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zhuang YY, 2013, HARMFUL ALGAE, V26, P71, DOI 10.1016/j.hal.2013.04.002	43	31	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133060	10.1371/journal.pone.0133060	http://dx.doi.org/10.1371/journal.pone.0133060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218575	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900017
J	Madeddu, S; Woods, TA; Mukherjee, P; Sturdevant, D; Butchi, NB; Peterson, KE				Madeddu, Silvia; Woods, Tyson A.; Mukherjee, Piyali; Sturdevant, Dan; Butchi, Niranjan B.; Peterson, Karin E.			Identification of Glial Activation Markers by Comparison of Transcriptome Changes between Astrocytes and Microglia following Innate Immune Stimulation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ALZHEIMER-DISEASE; DENDRITIC CELLS; NERVOUS-SYSTEM; UP-REGULATION; EXPRESSION; VIRUS; CYTOKINES; TLR7; INTERFERON	The activation of astrocytes and microglia is often associated with diseases of the central nervous system (CNS). Understanding how activation alters the transcriptome of these cells may offer valuable insight regarding how activation of these cells mediate neurological damage. Furthermore, identifying common and unique pathways of gene expression during activation may provide new insight into the distinct roles these cells have in the CNS during infection and inflammation. Since recent studies indicate that TLR7 recognizes not only viral RNA but also microRNAs that are released by damaged neurons and elevated during neurological diseases, we first examined the response of glial cells to TLR7 stimulation using microarray analysis. Microglia were found to generate a much stronger response to TLR7 activation than astrocytes, both in the number of genes induced as well as fold induction. Although the primary pathways induced by both cell types were directly linked to immune responses, microglia also induced pathways associated with cellular proliferation, while astrocytes did not. Targeted analysis of a subset of the upregulated genes identified unique mRNA, including Ifi202b which was only upregulated by microglia and was found to be induced during both retroviral and bunyavirus infections in the CNS. In addition, other genes including Birc3 and Gpr84 as well as two expressed sequences AW112010 and BC023105 were found to be induced in both microglia and astrocytes and were upregulated in the CNS following virus infection. Thus, expression of these genes may a useful measurement of glial activation during insult or injury to the CNS.	[Madeddu, Silvia; Woods, Tyson A.; Mukherjee, Piyali; Butchi, Niranjan B.; Peterson, Karin E.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Sturdevant, Dan] NIAID, Res Technol Branch, RML, NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Peterson, KE (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	petersonka@niaid.nih.gov	Peterson, Karin/D-1492-2016	Peterson, Karin/0000-0003-4177-7249	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health; Sardinia Regional Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001102, ZIAAI001101] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health; Sardinia Regional Government(Regione Sardegna); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health. The authors gratefully acknowledge the Sardinia Regional Government for the financial support of Silvia Maddeddu through her Ph.D. scholarship (P.O.R. Sardegna F.S.E Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013).	Aguirre A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/893521; Bennett RS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-25; Bennett RS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-41; Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952; Du M, 2010, J VIROL, V84, P11076, DOI 10.1128/JVI.01022-10; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201; Gorina R, 2009, GLIA, V57, P93, DOI 10.1002/glia.20738; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Guedes J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/186872; Gurley C, 2008, PPAR RES, V2008, DOI 10.1155/2008/453120; He WA, 2014, P NATL ACAD SCI USA, V111, P4525, DOI 10.1073/pnas.1402714111; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kallfass C, 2012, J VIROL, V86, P11223, DOI 10.1128/JVI.01093-12; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Lawrence DMP, 2006, GLIA, V53, P81, DOI 10.1002/glia.20261; Lee H, 2013, CURR PROTEIN PEPT SC, V14, P33, DOI 10.2174/1389203711314010006; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Olivieri F, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-11; Perez CJ, 2013, J HERED, V104, P565, DOI 10.1093/jhered/est023; Possel H, 2000, GLIA, V32, P51, DOI 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; Robertson SJ, 1997, J VIROL, V71, P5287, DOI 10.1128/JVI.71.7.5287-5294.1997; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Savage CD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00288; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Sioud M, 2006, TRENDS MOL MED, V12, P167, DOI 10.1016/j.molmed.2006.02.004; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tang SQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5657; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Villalba M, 2012, MED MICROBIOL IMMUN, V201, P371, DOI 10.1007/s00430-012-0247-0; Vogel H, 2012, HUM MOL GENET, V21, P3845, DOI 10.1093/hmg/dds213; Vontell R, 2013, DEV NEUROSCI-BASEL, V35, P130, DOI 10.1159/000346158; Winkler CW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005407; Yang Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-80; Yin Q, 2013, CELL REP, V4, P327, DOI 10.1016/j.celrep.2013.06.024; Yu DD, 2006, ADV EXP MED BIOL, V581, P407; Zhang ZR, 2005, J NEUROIMMUNOL, V164, P154, DOI 10.1016/j.jneuroim.2005.03.014; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	52	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0127336	10.1371/journal.pone.0127336	http://dx.doi.org/10.1371/journal.pone.0127336			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214311	Green Published, Green Submitted, gold			2022-12-26	WOS:000358594300001
J	Zhang, XQ; Pan, Y; Yu, CH; Xu, CF; Xu, L; Li, YM; Chen, WX				Zhang, Xue-qun; Pan, Yue; Yu, Chao-hui; Xu, Cheng-fu; Xu, Lei; Li, You-ming; Chen, Wei-xing			PDIA3 Knockdown Exacerbates Free Fatty Acid-Induced Hepatocyte Steatosis and Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN LIVER-CELLS; NONALCOHOLIC STEATOHEPATITIS; DISEASE; ACTIVATION; LIPOAPOPTOSIS; PROGRESSION; LIPOGENESIS; CIRRHOSIS	Nonalcoholic fatty liver disease (NAFLD) has emerged as one of the most common chronic liver disease over the past decades. Endoplasmic reticulum stress (ERS) plays a pivotal role during the development of NAFLD. This study aims to analyze the potential role of protein disulfide isomerase A3 precursor (PDIA3), one of the ER chaperones, in free fatty acid-induced cell model of NAFLD. Human liver L02 cell line was treated with sodium palmitate for 24 hours, which developed severe intracellular lipid accumulation. The increased protein level of PDIA3 was detected via immunoblotting analysis in the fat loaded cell models of NAFLD. siRNA-mediated knockdown of PDIA3 in L02 cells not only increased the cellular lipid accumulation, but also exacerbated hepatocytes apoptosis induced by sodium palmitate. Further investigation revealed that knockdown of PDIA3 up-regulated protein expression of fatty acid synthase (FAS), a key enzyme involved in fatty acid synthesis. PDIA3 knockdown also up-regulated key molecules of ERS pathway, including glucose-regulated protein 78 (GRP78), phospho-PKR-like ER kinase (p-PERK), and C/EBP homologous protein (CHOP). Our results suggested that ER chaperone PDIA3 plays a pivotal role in FFA-induced hepatocyte steatosis and apoptosis.	[Zhang, Xue-qun; Pan, Yue; Yu, Chao-hui; Xu, Cheng-fu; Li, You-ming; Chen, Wei-xing] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Lei] Ningbo 1 Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China	Zhejiang University	Chen, WX (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	zhangxuequn720@163.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, Han/0000-0001-9985-3035	National Key Basic Research Development Program [2012CB524905]; National Science and Technology Support Plan Project [2012BAI06B04]; National Natural Science Foundation of China [30900677, 81070315, 81100278, 81470838, 81300703, 81170378, 81230012, 81270487]; Zhejiang Provincial Natural Science Foundation of China [Y2090463]; International Science and Technology Cooperation Projects of Zhejiang Province [2013C24010]; Science Foundation of Health Bureau of Zhejiang Province [2012RCA026]	National Key Basic Research Development Program(National Basic Research Program of China); National Science and Technology Support Plan Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); International Science and Technology Cooperation Projects of Zhejiang Province; Science Foundation of Health Bureau of Zhejiang Province	The study was supported by National Key Basic Research Development Program (No. 2012CB524905); National Science and Technology Support Plan Project (No. 2012BAI06B04); National Natural Science Foundation of China, (No. 30900677, No. 81070315, No. 81100278, No. 81470838, No. 81300703, No. 81170378, No. 81230012 and No. 81270487); Zhejiang Provincial Natural Science Foundation of China (No. Y2090463); International Science and Technology Cooperation Projects of Zhejiang Province (No. 2013C24010), and Science Foundation of Health Bureau of Zhejiang Province (No. 2012RCA026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Boden G, 2011, METHOD ENZYMOL, V489, P67, DOI 10.1016/B978-0-12-385116-1.00004-2; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Cao J, 2014, DIGEST DIS SCI, V59, P346, DOI 10.1007/s10620-013-2896-2; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Diehl JA, 2011, GASTROENTEROLOGY, V141, P38, DOI 10.1053/j.gastro.2011.05.018; Dihazi H, 2013, J CELL SCI, V126, P3649, DOI 10.1242/jcs.125088; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gentile CL, 2011, ANTIOXID REDOX SIGN, V15, P505, DOI 10.1089/ars.2010.3790; Glimcher LH, 2009, ANN NY ACAD SCI, V1173, pE2, DOI 10.1111/j.1749-6632.2009.04956.x; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pagliassotti MJ, 2007, ENDOCRINOLOGY, V148, P3338, DOI 10.1210/en.2006-1710; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Rinella Mary E, 2011, Hepatology, V54, P1600, DOI 10.1002/hep.24553; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Zhang XQ, 2010, HEPATOLOGY, V51, P1190, DOI 10.1002/hep.23486	35	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133882	10.1371/journal.pone.0133882	http://dx.doi.org/10.1371/journal.pone.0133882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214517	gold, Green Published, Green Submitted			2022-12-26	WOS:000358594300037
J	Borges, V; Pinheiro, M; Antelo, M; Sampaio, DA; Vieira, L; Ferreira, R; Nunes, A; Almeida, F; Mota, LJ; Borrego, MJ; Gomes, JP				Borges, Vitor; Pinheiro, Miguel; Antelo, Minia; Sampaio, Daniel A.; Vieira, Luis; Ferreira, Rita; Nunes, Alexandra; Almeida, Filipe; Mota, Luis J.; Borrego, Maria J.; Gomes, Joao P.			Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; GUANYLATE BINDING-PROTEINS; III SECRETION MECHANISM; EARLY-CYCLE DEVELOPMENT; OUTER-MEMBRANE COMPLEX; HISTONE-LIKE PROTEIN; MESSENGER-RNA DECAY; KAPPA-B PATHWAY; LYMPHOGRANULOMA-VENEREUM; ESCHERICHIA-COLI	Research on the obligate intracellular bacterium Chlamydia trachomatis demands culture in cell-lines, but the adaptive process behind the in vivo to in vitro transition is not understood. We assessed the genomic and transcriptomic dynamics underlying C. trachomatis in vitro adaptation of strains representing the three disease groups (ocular, epithelial-genital and lymphogranuloma venereum) propagated in epithelial cells over multiple passages. We found genetic features potentially underlying phase variation mechanisms mediating the regulation of a lipid A biosynthesis enzyme (CT533/LpxC), and the functionality of the cytotoxin (CT166) through an ON/OFF mechanism. We detected inactivating mutations in CT713/porB, a scenario suggesting metabolic adaptation to the available carbon source. CT135 was inactivated in a tropism-specific manner, with CT135-negative clones emerging for all epithelial-genital populations (but not for LGV and ocular populations) and rapidly increasing in frequency (similar to 23% mutants per10 passages). RNA-sequencing analyses revealed that a deletion event involving CT135 impacted the expression of multiple virulence factors, namely effectors known to play a role in the C. trachomatis host-cell invasion or subversion (e.g., CT456/Tarp, CT694, CT875/TepP and CT868/ChlaDub1). This reflects a scenario of attenuation of C. trachomatis virulence in vitro, which may take place independently or in a cumulative fashion with the also observed down-regulation of plasmid-related virulence factors. This issue may be relevant on behalf of the recent advances in Chlamydia mutagenesis and transformation where culture propagation for selecting mutants/transformants is mandatory. Finally, there was an increase in the growth rate for all strains, reflecting gradual fitness enhancement over time. In general, these data shed light on the adaptive process underlying the C. trachomatis in vivo to in vitro transition, and indicates that it would be prudent to restrict culture propagation to minimal passages and check the status of the CT135 genotype in order to avoid the selection of CT135-negative mutants, likely originating less virulent strains.	[Borges, Vitor; Antelo, Minia; Ferreira, Rita; Nunes, Alexandra; Borrego, Maria J.; Gomes, Joao P.] Natl Inst Hlth, Dept Infect Dis, Reference Lab Bacterial Sexually Transmitted Infe, Lisbon, Portugal; [Borges, Vitor; Nunes, Alexandra; Gomes, Joao P.] Natl Inst Hlth, Dept Infect Dis, Bioinformat Unit, Lisbon, Portugal; [Pinheiro, Miguel] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Sampaio, Daniel A.; Vieira, Luis] Natl Inst Hlth, Dept Human Genet, Innovat & Technol Unit, Lisbon, Portugal; [Almeida, Filipe; Mota, Luis J.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, UCIBIO,REQUIMTE, Caparica, Portugal	University of St Andrews; Universidade Nova de Lisboa	Gomes, JP (corresponding author), Natl Inst Hlth, Dept Infect Dis, Reference Lab Bacterial Sexually Transmitted Infe, Lisbon, Portugal.	j.paulo.gomes@insa.min-saude.pt	Vieira, Luis/I-6378-2019; Almeida, Filipe/O-2871-2015; Mota, Luis/B-9497-2008; da Silva Almeida, Filipe Manuel Baeta/AAP-5315-2021; Nunes, Alexandra/ABE-3699-2020; Pinheiro, Miguel/K-6572-2017	Vieira, Luis/0000-0002-7703-1409; Almeida, Filipe/0000-0001-5114-7721; Mota, Luis/0000-0002-5592-8397; da Silva Almeida, Filipe Manuel Baeta/0000-0001-5114-7721; Pinheiro, Miguel/0000-0002-6601-7513; Nunes, Alexandra/0000-0001-6449-8053; Borrego, Maria Jose/0000-0002-8604-8800; Gomes, Joao Paulo/0000-0002-2697-2399; Antelo, Minia/0000-0001-7864-1906; Borges, Vitor/0000-0003-3767-2209; Ferreira, Rita/0000-0002-0016-7543	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/68527/2010]; Wellcome Trust ISSF grant [097831/Z/11/Z]; FCT [SFRH/BD/68532/2010, SFRH/BPD/75295/2010]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust ISSF grant(Wellcome Trust); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	VB was a recipient of Ph.D. fellowship (SFRH/BD/68527/2010) from Fundacao para a Ciencia e a Tecnologia (FCT). MP is funded by a Wellcome Trust ISSF grant (097831/Z/11/Z). RF and AN are recipients of a Ph.D. (SFRH/BD/68532/2010) and post-doctoral fellowships (SFRH/BPD/75295/2010) from FCT, respectively.	Al-Zeer MA, 2013, AUTOPHAGY, V9, P50, DOI 10.4161/auto.22482; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; ALIFANO P, 1994, GENETICA, V94, P157, DOI 10.1007/BF01443430; Almeida F, 2012, J BACTERIOL, V194, P6574, DOI 10.1128/JB.01428-12; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson P, 2013, CLIN MICROBIOL INFEC, V19, pE405, DOI 10.1111/1469-0691.12237; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Bao XF, 2014, J BACTERIOL, V196, P2989, DOI 10.1128/JB.01677-14; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Birkelund S, 2009, FEMS IMMUNOL MED MIC, V55, P187, DOI 10.1111/j.1574-695X.2009.00522.x; Bonner CA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00017; Borges V, 2010, J MICROBIOL METH, V82, P256, DOI 10.1016/j.mimet.2010.06.013; Borges V, 2014, GENOME ANNOUNC, P2; Borges V, 2015, INFECT GENET EVOL, V32, P74, DOI 10.1016/j.meegid.2015.02.026; Borges V, 2013, INFECT GENET EVOL, V17, P23, DOI 10.1016/j.meegid.2013.03.035; Borges V, 2012, J BACTERIOL, V194, P6143, DOI 10.1128/JB.01291-12; Bothe M, 2015, TOXINS, V7, P621, DOI 10.3390/toxins7020621; BRICKMAN TJ, 1993, J BACTERIOL, V175, P4274, DOI 10.1128/JB.175.14.4274-4281.1993; Brinkworth AJ, 2011, MOL MICROBIOL, V82, P131, DOI 10.1111/j.1365-2958.2011.07802.x; Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI [10.1172/JCI200317993, 10.1172/JCI17993]; Carabeo R, 2011, CELL MICROBIOL, V13, P1460, DOI 10.1111/j.1462-5822.2011.01651.x; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Carlson JH, 2004, INFECT IMMUN, V72, P7063, DOI 10.1128/IAI.72.12.7063-7072.2004; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; Carmichael JR, 2013, MICROBES INFECT, V15, P219, DOI 10.1016/j.micinf.2012.12.001; Chellas-Gery B, 2007, CELL MICROBIOL, V9, P2417, DOI 10.1111/j.1462-5822.2007.00970.x; Chen CQ, 2015, INFECT IMMUN, V83, P1881, DOI 10.1128/IAI.03158-14; Chen YS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003954; Christiansen MT, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0591-3; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Cooper KK, 2013, RES MICROBIOL, V164, P6, DOI 10.1016/j.resmic.2012.10.002; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Cowley SC, 1996, MOL MICROBIOL, V20, P867, DOI 10.1111/j.1365-2958.1996.tb02524.x; da Cunha M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-40; Dal Conte I, 2014, PANMINERVA MED, V56, P73; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; Ding HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080534; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Engstrom P, 2015, MBIO, V6, DOI 10.1128/mBio.02304-14; Engstrom P, 2013, J BACTERIOL, V195, P4221, DOI 10.1128/JB.00506-13; Engstrom P, 2010, FEMS IMMUNOL MED MIC, V58, P244, DOI 10.1111/j.1574-695X.2009.00631.x; Fadel S, 2007, J MED MICROBIOL, V56, P15, DOI 10.1099/jmm.0.46801-0; FAHR MJ, 1995, J BACTERIOL, V177, P4252, DOI 10.1128/jb.177.15.4252-4260.1995; Fechtner T, 2013, J BACTERIOL, V195, P5323, DOI 10.1128/JB.00780-13; Ferreira R, 2015, G3-GENES GENOM GENET, V5, P9, DOI 10.1534/g3.114.015354; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Gerard HC, 2013, NANOMED-NANOTECHNOL, V9, P996, DOI 10.1016/j.nano.2013.04.004; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gomes JP, 2005, MICROBES INFECT, V7, P410, DOI 10.1016/j.micinf.2004.11.014; Gong SQ, 2011, MICROBIOL-SGM, V157, P1134, DOI 10.1099/mic.0.047746-0; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Griffiths E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-14; Grimwood J, 2001, INFECT IMMUN, V69, P2383, DOI 10.1128/IAI.69.4.2383-2389.2001; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Hobolt-Pedersen AS, 2009, FEMS IMMUNOL MED MIC, V57, P46, DOI 10.1111/j.1574-695X.2009.00581.x; Hong WL, 2013, CELL SIGNAL, V25, P660, DOI 10.1016/j.cellsig.2012.11.019; Hou SP, 2013, J BACTERIOL, V195, P951, DOI 10.1128/JB.02087-12; Hovis KM, 2013, PATHOG DIS, V69, P213, DOI 10.1111/2049-632X.12070; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Humphrys MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080597; Iliopoulos I, 2003, BIOINFORMATICS, V19, P717, DOI 10.1093/bioinformatics/btg077; Jansen G, 2013, DRUG RESIST UPDATE, V16, P96, DOI 10.1016/j.drup.2014.02.002; Jasper DK, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv003; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Johnson CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083989; Jones HM, 2000, GENE, V258, P173, DOI 10.1016/S0378-1119(00)00367-X; Jorgensen I, 2008, INFECT IMMUN, V76, P3940, DOI 10.1128/IAI.00632-08; Jorgensen I, 2011, CELL HOST MICROBE, V10, P21, DOI 10.1016/j.chom.2011.06.008; Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198; Joubert BC, 2011, J MED MICROBIOL, V60, P1565, DOI 10.1099/jmm.0.032169-0; Kabeya Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-57; Kari L, 2008, J INFECT DIS, V197, P449, DOI 10.1086/525285; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; Kersh GJ, 2011, VECTOR-BORNE ZOONOT, V11, P1433, DOI 10.1089/vbz.2011.0670; Kubo A, 2001, MICROBIOL-SGM, V147, P3135, DOI 10.1099/00221287-147-11-3135; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Labiran C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00068; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Negrate G, 2008, CELL MICROBIOL, V10, P1879, DOI 10.1111/j.1462-5822.2008.01178.x; Lee CJ, 2011, CHEM BIOL, V18, P38, DOI 10.1016/j.chembiol.2010.11.011; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Lo CC, 2012, MICROBIOL MOL BIOL R, V76, P405, DOI 10.1128/MMBR.05013-11; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Lu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068764; LUKACOVA M, 1994, INFECT IMMUN, V62, P2270; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Misaghi S, 2006, MOL MICROBIOL, V61, P142, DOI 10.1111/j.1365-2958.2006.05199.x; Mishra MK, 2012, MOL PHARMACEUT, V9, P413, DOI 10.1021/mp200512f; Miyairi I, 2006, J INFECT DIS, V194, P350, DOI 10.1086/505432; Moore ER, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00157; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Muschiol S, 2011, INFECT IMMUN, V79, P571, DOI 10.1128/IAI.00825-10; Nelson DE, 2007, CELL MICROBIOL, V9, P2289, DOI 10.1111/j.1462-5822.2007.00959.x; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Nguyen BD, 2011, P NATL ACAD SCI USA, V108, P10284, DOI 10.1073/pnas.1107478108; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Nunes A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r153; Nunes A, 2013, INFECT GENET EVOL, V16, P392, DOI 10.1016/j.meegid.2013.03.018; Nunes A, 2009, J BACTERIOL, V191, P7182, DOI 10.1128/JB.00895-09; O'Connell CM, 2011, INFECT IMMUN, V79, P1044, DOI 10.1128/IAI.01118-10; O'Neill CE, 2013, MICROBIOL-SGM, V159, P748, DOI 10.1099/mic.0.065391-0; Orsi RH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-102; Ortega AD, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00162; Pais SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056292; Pedersen AS, 2001, FEMS MICROBIOL LETT, V203, P153, DOI 10.1016/S0378-1097(01)00341-X; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Putman TE, 2013, MICROBIOL-SGM, V159, P2109, DOI 10.1099/mic.0.070029-0; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ramsey KH, 2009, INFECT IMMUN, V77, P3284, DOI 10.1128/IAI.00147-09; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Rosario CJ, 2014, MOL MICROBIOL, V94, P888, DOI 10.1111/mmi.12804; Rosario CJ, 2012, MOL MICROBIOL, V84, P1097, DOI 10.1111/j.1365-2958.2012.08077.x; Russell M, 2011, INFECT IMMUN, V79, P98, DOI 10.1128/IAI.01105-10; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Scidmore MA, 2011, MICROBES INFECT, V13, P527, DOI 10.1016/j.micinf.2011.02.001; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Seth-Smith HMB, 2013, GENOME RES, V23, P855, DOI 10.1101/gr.150037.112; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Skinner MC, 2009, ANTIMICROB AGENTS CH, V53, P1482, DOI 10.1128/AAC.01179-08; Snavely EA, 2014, PATHOG DIS, V71, P336, DOI 10.1111/2049-632X.12179; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Stothard DR, 1998, J CLIN MICROBIOL, V36, P3686, DOI 10.1128/JCM.36.12.3686-3688.1998; Sturdevant GL, 2014, PATHOG DIS, V71, P90, DOI 10.1111/2049-632X.12121; Sturdevant GL, 2010, INFECT IMMUN, V78, P3660, DOI 10.1128/IAI.00386-10; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Subtil A, 2014, TRENDS PLANT SCI, V19, P36, DOI 10.1016/j.tplants.2013.10.005; Suchland RJ, 2008, INFECT IMMUN, V76, P5438, DOI 10.1128/IAI.00984-08; Tattersall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047439; Thalmann J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009887; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vannucci FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046708; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Viratyosin W, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-38; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; WEISBERG RA, 1977, ANNU REV GENET, V11, P451, DOI 10.1146/annurev.ge.11.120177.002315; White JA, 2009, CURR OPIN INFECT DIS, V22, P57, DOI 10.1097/QCO.0b013e328320a8ae; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Yeruva L, 2014, MBIO, V5, DOI 10.1128/mBio.01241-14; Zhong GM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00014; Zinser ER, 2003, GENETICS, V164, P1271	177	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133420	10.1371/journal.pone.0133420	http://dx.doi.org/10.1371/journal.pone.0133420			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207372	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000088
J	Green, DE; Murphy, TC; Kang, BY; Searles, CD; Hart, M				Green, David E.; Murphy, Tamara C.; Kang, Bum-Yong; Searles, Charles D.; Hart, Michael			PPAR gamma Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21	PLOS ONE			English	Article							HYPERTENSION; EXPRESSION; ROSIGLITAZONE; MIR-21; LUNG; ACTIVATION; RESISTANCE; INHIBITION; MOUSE; PTEN	Pulmonary hypertension (PH) is a progressive and often fatal disorder whose pathogenesis involves pulmonary artery smooth muscle cell (PASMC) proliferation. Although modern PH therapies have significantly improved survival, continued progress rests on the discovery of novel therapies and molecular targets. MicroRNA (miR)-21 has emerged as an important non-coding RNA that contributes to PH pathogenesis by enhancing vascular cell proliferation, however little is known about available therapies that modulate its expression. We previously demonstrated that peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists attenuated hypoxia-induced HPASMC proliferation, vascular remodeling and PH through pleiotropic actions on multiple targets, including transforming growth factor (TGF)-beta 1 and phosphatase and tensin homolog deleted on chromosome 10 (PTEN). PTEN is a validated target of miR-21. We therefore hypothesized that antiproliferative effects conferred by PPAR. activation are mediated through inhibition of hypoxia-induced miR-21 expression. Human PASMC monolayers were exposed to hypoxia then treated with the PPAR. agonist, rosiglitazone (RSG, 10 mu M), or in parallel, C57Bl/6J mice were exposed to hypoxia then treated with RSG. RSG attenuated hypoxic increases in miR-21 expression in vitro and in vivo and abrogated reductions in PTEN and PASMC proliferation. Antiproliferative effects of RSG were lost following siRNA-mediated PTEN depletion. Furthermore, miR-21mimic decreased PTEN and stimulated PASMC proliferation, whereas miR-21 inhibition increased PTEN and attenuated hypoxia-induced HPASMC proliferation. Collectively, these results demonstrate that PPAR gamma ligands regulate proliferative responses to hypoxia by preventing hypoxic increases in miR-21 and reductions in PTEN. These findings further clarify molecular mechanisms that support targeting PPAR gamma to attenuate pathogenic derangements in PH.	[Green, David E.; Murphy, Tamara C.; Kang, Bum-Yong; Hart, Michael] Emory Univ, Dept Med, Atlanta Vet Affairs Med Ctr, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Searles, Charles D.] Emory Univ, Dept Med, Atlanta Vet Affairs Med Ctr, Div Cardiol, Atlanta, GA 30322 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Green, DE (corresponding author), Emory Univ, Dept Med, Atlanta Vet Affairs Med Ctr, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA.	degree4@emory.edu			Veterans Affairs Career Development -02 [1 IK2 BX001707-01A1]; National Institutes of Health R01 [HL102167]; Veterans Affairs Merit Review Award [101BX001910-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102167] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001707] Funding Source: NIH RePORTER	Veterans Affairs Career Development -02; National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Veterans Affairs Career Development -02 (1 IK2 BX001707-01A1)- http://www.research.va.gov/funding/-to DG, the National Institutes of Health R01 (HL102167) http://www.grants.nih.gov/grants/funding/r01.htm- to CH, and the Veterans Affairs Merit Review Award (101BX001910-01) http://www.research.va.gov/funding/to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382; Ameshima S, 2003, CIRC RES, V92, P1162, DOI 10.1161/01.RES.0000073585.50092.14; [Anonymous], 2010, BASIC SCIENCE OF PUL; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Bertero T, 2015, J BIOL CHEM, V290, P2069, DOI 10.1074/jbc.M114.617845; Bijli KM, 2015, FREE RADICAL BIO MED, V80, P111, DOI 10.1016/j.freeradbiomed.2014.12.019; Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Crossno JT, 2007, AM J PHYSIOL-LUNG C, V292, pL885, DOI 10.1152/ajplung.00258.2006; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Gao M, 2011, SHOCK, V36, P228, DOI 10.1097/SHK.0b013e318225b29a; Gong KZ, 2011, AM J PHYSIOL-LUNG C, V301, pL899, DOI 10.1152/ajplung.00062.2011; Green David E, 2011, Pulm Circ, V1, P33; Green DE, 2012, AM J RESP CELL MOL, V47, P718, DOI 10.1165/rcmb.2011-0418OC; GREEN DE, 2012, PULM CIRC, V2, P483, DOI DOI 10.4103/2045-8932.105037; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Horita H, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000188; Jamaluddin MS, 2011, EXPERT REV MOL DIAGN, V11, P79, DOI [10.1586/erm.10.103, 10.1586/ERM.10.103]; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Joshi Sachindra R, 2011, Pulm Circ, V1, P357, DOI 10.4103/2045-8932.87301; Kang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079503; Kang BY, 2011, AM J PHYSIOL-LUNG C, V301, pL881, DOI 10.1152/ajplung.00195.2011; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kim EK, 2010, RESPIROLOGY, V15, P659, DOI 10.1111/j.1440-1843.2010.01756.x; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Lee J, 2013, DIABETIC PATIENTS TH, V19, P99; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu YH, 2012, HYPERTENSION, V60, P1471, DOI 10.1161/HYPERTENSIONAHA.112.198887; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XH, 2013, FREE RADICAL BIO MED, V63, P151, DOI 10.1016/j.freeradbiomed.2013.05.013; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Matsuda Yasushi, 2005, Nihon Kokyuki Gakkai Zasshi, V43, P283; Meloche J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005157; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Pi WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035283; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rabinovitch M, 2010, ADV EXP MED BIOL, V661, P447, DOI 10.1007/978-1-60761-500-2_29; Ravi Y, 2013, CELL BIOCHEM BIOPHYS, V67, P363, DOI 10.1007/s12013-011-9332-z; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Stenmark KR, 2010, PEDIATR CRIT CARE ME, V11, pS85, DOI 10.1097/PCC.0b013e3181c76db3; Sutliff Roy L, 2010, Ther Adv Respir Dis, V4, P143, DOI 10.1177/1753465809369619; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tan XH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-21; Tian J, 2009, PHYSIOL GENOMICS, V40, P48, DOI 10.1152/physiolgenomics.00094.2009; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; White Kevin, 2012, Pulm Circ, V2, P278, DOI 10.4103/2045-8932.101395; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; Zhang DX, 2014, LIFE SCI, V98, P39, DOI 10.1016/j.lfs.2013.12.208; Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR	62	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133391	10.1371/journal.pone.0133391	http://dx.doi.org/10.1371/journal.pone.0133391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208095	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000084
J	Hoffmann, J; Altenbuchner, J				Hoffmann, Jana; Altenbuchner, Josef			Functional Characterization of the Mannitol Promoter of Pseudomonas fluorescens DSM 50106 and Its Application for a Mannitol-Inducible Expression System for Pseudomonas putida KT2440	PLOS ONE			English	Article							BROAD-HOST-RANGE; MELR TRANSCRIPTION ACTIVATOR; META-CLEAVAGE PATHWAY; DNA-BINDING DOMAIN; ESCHERICHIA-COLI; ARAC/XYLS FAMILY; REGULATED EXPRESSION; NUCLEOTIDE-SEQUENCE; PROTEIN EXPRESSION; STRUCTURAL BASIS	A new pBBR1MCS-2-derived vector containing the Pseudomonas fluorescens DSM10506 mannitol promoter P-mtlE and mtlR encoding its AraC/XylS type transcriptional activator was constructed and optimized for low basal expression. Mannitol, arabitol, and glucitol-inducible gene expression was demonstrated with Pseudomonas putida and eGFP as reporter gene. The new vector was applied for functional characterization of P-mtlE. Identification of the DNA binding site of MtlR was achieved by in vivo eGFP measurement with P-mtlE wild type and mutants thereof. Moreover, purified MtlR was applied for detailed in vitro investigations using electrophoretic mobility shift assays and DNaseI footprinting experiments. The obtained data suggest that MtlR binds to P-mtlE as a dimer. The proposed DNA binding site of MtlR is AGTGC-N-5-AGTAT-N-7-AGTGC-N-5-AGGAT. The transcription activation mechanism includes two binding sites with different binding affinities, a strong upstream binding site and a weaker downstream binding site. The presence of the weak downstream binding site was shown to be necessary to sustain mannitol-inducibility of P-mtlE. Two possible functions of mannitol are discussed; the effector might stabilize binding of the second monomer to the downstream half site or promote transcription activation by inducing a conformational change of the regulator that influences the contact to the RNA polymerase.	[Hoffmann, Jana; Altenbuchner, Josef] Univ Stuttgart, Inst Ind Genet, Allmandring 31, D-70569 Stuttgart, Germany	University of Stuttgart	Hoffmann, J (corresponding author), Univ Stuttgart, Inst Ind Genet, Allmandring 31, D-70569 Stuttgart, Germany.	jana.hoffmann@iig.uni-stuttgart.de						AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Bourgerie SJ, 1997, NUCLEIC ACIDS RES, V25, P1685, DOI 10.1093/nar/25.9.1685; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Brenner D.J., 2005, BERGEYS MANUAL SYSTE, V2, P323, DOI DOI 10.1007/0-387-28022-7_9; Brunker P, 1998, GENE, V206, P117, DOI 10.1016/S0378-1119(97)00574-X; Brunker P, 1998, GENE, V215, P19, DOI 10.1016/S0378-1119(98)00274-1; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; CASWELL R, 1992, BIOCHEM J, V287, P501, DOI 10.1042/bj2870501; Chen A, 2014, J IND MICROBIOL BIOT, P1; Dammeyer T, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-49; Dennis J J, 1995, Methods Mol Biol, V47, P125; Dominguez-Cuevas P, 2010, J BACTERIOL, V192, P2682, DOI 10.1128/JB.00165-10; Durante-Rodriguez G, 2014, METHODS MOL BIOL, V1149, P469, DOI 10.1007/978-1-4939-0473-0_36; Duval Valerie, 2013, Int J Biotechnol Wellness Ind, V2, P101; EGAN SM, 1994, J MOL BIOL, V243, P821, DOI 10.1006/jmbi.1994.1684; FANG FC, 1991, J BACTERIOL, V173, P5861, DOI 10.1128/jb.173.18.5861-5868.1991; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Giacalone MJ, 2006, BIOTECHNIQUES, V40, P355, DOI 10.2144/000112112; Gonzalez-Perez MM, 1999, J BIOL CHEM, V274, P2286, DOI 10.1074/jbc.274.4.2286; Graf N, 2013, APPL MICROBIOL BIOT, V97, P8239, DOI 10.1007/s00253-013-5030-7; Graf N, 2011, APPL ENVIRON MICROB, V77, P5549, DOI 10.1128/AEM.05055-11; Griffith KL, 2001, MOL MICROBIOL, V40, P1141, DOI 10.1046/j.1365-2958.2001.02456.x; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; Hoffmann J, 2012, FEBS J, V279, P3911, DOI 10.1111/j.1742-4658.2012.08751.x; Ibarra JA, 2008, GENETICA, V133, P65, DOI 10.1007/s10709-007-9185-y; Itoh N, 2003, APPL MICROBIOL BIOT, V61, P240, DOI 10.1007/s00253-002-1195-1; Jeske M, 2010, APPL MICROBIOL BIOT, V85, P1923, DOI 10.1007/s00253-009-2245-8; Kaldalu N, 1996, MOL MICROBIOL, V20, P569, DOI 10.1046/j.1365-2958.1996.5381060.x; KESSLER B, 1994, MOL GEN GENET, V244, P596, DOI 10.1007/BF00282749; Kolin A, 2008, MOL MICROBIOL, V68, P448, DOI 10.1111/j.1365-2958.2008.06164.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MERMOD N, 1986, J BACTERIOL, V167, P447, DOI 10.1128/jb.167.2.447-454.1986; MICHAN CM, 1995, NUCLEIC ACIDS RES, V23, P1518, DOI 10.1093/nar/23.9.1518; Ni L, 2013, NUCLEIC ACIDS RES, V41, P1998, DOI 10.1093/nar/gks1207; Niland P, 1996, J MOL BIOL, V264, P667, DOI 10.1006/jmbi.1996.0668; Papaneophytou CP, 2014, PROTEIN EXPRES PURIF, V94, P22, DOI 10.1016/j.pep.2013.10.016; Perez-Pantoja D, 2015, ENVIRON MICROBIOL, V17, P64, DOI 10.1111/1462-2920.12443; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Rother D, 1999, MOL GEN GENET, V262, P154, DOI 10.1007/s004380051070; Ruiz R, 2003, J BACTERIOL, V185, P3036, DOI 10.1128/JB.185.10.3036-3041.2003; Samarasinghe S, 2008, NUCLEIC ACIDS RES, V36, P2667, DOI 10.1093/nar/gkn119; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuller A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/103132; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; Sidorova NY, 2010, ELECTROPHORESIS, V31, P648, DOI 10.1002/elps.200900573; Soisson SM, 1997, SCIENCE, V276, P421, DOI 10.1126/science.276.5311.421; Troeschel SC, 2012, J BIOTECHNOL, V161, P71, DOI 10.1016/j.jbiotec.2012.02.020; van den Berg B, 2012, J BIOL CHEM, V287, P41044, DOI 10.1074/jbc.M112.408518; Wang C, 2012, BIOTECHNIQUES, P1; WATERS SH, 1983, NUCLEIC ACIDS RES, V11, P6089, DOI 10.1093/nar/11.17.6089; Wickstrum JR, 2007, J BACTERIOL, V189, P4984, DOI 10.1128/JB.00530-07; WYLIE JL, 1995, J BACTERIOL, V177, P3021, DOI 10.1128/jb.177.11.3021-3026.1995; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	58	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133248	10.1371/journal.pone.0133248	http://dx.doi.org/10.1371/journal.pone.0133248			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207762	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000070
J	Mwatelah, RS; Lwembe, RM; Osman, S; Ogutu, BR; Aman, R; Kitawi, RC; Wangai, LN; Oloo, FA; Kokwaro, GO; Ochieng, W				Mwatelah, Ruth S.; Lwembe, Raphael M.; Osman, Saida; Ogutu, Bernhards R.; Aman, Rashid; Kitawi, Rose C.; Wangai, Laura N.; Oloo, Florence A.; Kokwaro, Gilbert O.; Ochieng, Washingtone			Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast	PLOS ONE			English	Article							DRUG USE; HIV PREVENTION; RISK; POPULATIONS; BEHAVIORS; INFECTION; SERVICES; MOMBASA; PEOPLE	Background Injection drug use is steadily rising in Kenya. We assessed the prevalence of both human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) infections among injecting heroin users (IHUs) at the Kenyan Coast. Methods A total of 186 IHUs (mean age, 33 years) from the Omari rehabilitation center program in Malindi were consented and screened for HIV-1 and HCV by serology and PCR and their CD4 T-cells enumerated by FACS. Results Prevalence of HIV-1 was 87.5%, that of HCV was 16.4%, co-infection was 17.9% and 18/152 (11.8%) were uninfected. Only 5.26% of the HIV-1 negative injectors were HCV positive. Co-infection was higher among injectors aged 30 to 40 years (20.7%) and among males (22.1%) than comparable groups. About 35% of the injectors were receiving antiretroviral treatment (ART). Co-infection was highest among injectors receiving D4T (75%) compared to those receiving AZT (21.6%) or TDF (10.5%) or those not on ART (10.5%). Mean CD4 T-cells were 404 (95% CI, 365 - 443) cells/mm(3) overall, significantly lower for co-infected (mean, 146; 95% CI 114 - 179 cells/mm(3)) than HIV mono infected (mean, 437, 95% CI 386 - 487 cells/mm(3), p<0.001) or uninfected (mean, 618, 95% CI 549 - 687 cells/mm(3), p<0.001) injectors and lower for HIV mono-infected than uninfected injectors (p=0.002). By treatment arm, CD4 T-cells were lower for injectors receiving D4T (mean, 78; 95% CI, 0.4 - 156 cells/mm(3)) than TDF (mean 607, 95% CI, 196 - 1018 cells/mm(3), p=0.005) or AZT (mean 474, 95% CI - 377 - 571 cells/mm(3), p=0.004). Conclusion Mono and dual infections with HIV-1 and HCV is high among IHUs in Malindi, but ART coverage is low. The co-infected IHUs have elevated risk of immunodeficiency due to significantly depressed CD4 T-cell numbers. Coinfection screening, treatment-as-prevention for both HIV and HCV and harm reduction should be scaled up to alleviate infection burden.	[Mwatelah, Ruth S.; Ogutu, Bernhards R.; Aman, Rashid; Kitawi, Rose C.; Oloo, Florence A.; Ochieng, Washingtone] Strathmore Univ, Ctr Res Therapeut Sci, Nairobi, Kenya; [Mwatelah, Ruth S.; Kitawi, Rose C.] Inst Trop Med & Infect Dis, Nairobi, Kenya; [Mwatelah, Ruth S.; Kitawi, Rose C.; Wangai, Laura N.] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Lwembe, Raphael M.; Osman, Saida; Ochieng, Washingtone] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya; [Ogutu, Bernhards R.] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya; [Ogutu, Bernhards R.; Aman, Rashid; Kokwaro, Gilbert O.; Ochieng, Washingtone] Strathmore Univ, Inst Healthcare Management, Nairobi, Kenya; [Aman, Rashid] African Ctr Clin Trials, Nairobi, Kenya; [Oloo, Florence A.] Tech Univ Kenya, Nairobi, Kenya	Strathmore University; Jomo Kenyatta University of Agriculture & Technology; Kenya Medical Research Institute; Kenya Medical Research Institute; Strathmore University; Technical University of Kenya	Ochieng, W (corresponding author), Strathmore Univ, Ctr Res Therapeut Sci, Nairobi, Kenya.	ochiengwashingtone@gmail.com		Mwatelah, Ruth/0000-0001-5761-1169; Ochieng, Washingtone/0000-0002-9035-4405	Consortium for National Health Research (CNHR) [RCDG-2012-005]; Kenya medical Research Institute (KEMRI) [IRG51/2]	Consortium for National Health Research (CNHR); Kenya medical Research Institute (KEMRI)	This study was funded partly by the Consortium for National Health Research (CNHR; www.cnhrkenya.org), Grant# RCDG-2012-005 awarded to WO and partly by Internal Research Grant from the Kenya medical Research Institute (KEMRI; www.kemri.org), Grant# IRG51/2 awarded to RML.	Ahamad K, 2014, AM J DRUG ALCOHOL AB, V40, P151, DOI 10.3109/00952990.2013.860983; [Anonymous], 2011, GUID ANT THER KEN; Bailey JR, 2015, J INFECT DIS, V212, P914, DOI 10.1093/infdis/jiv139; Barreiro P, 2014, ANTIVIR RES, V105, P1, DOI 10.1016/j.antiviral.2014.02.004; Barrett L, 2011, J VIRAL HEPATITIS, V18, P170, DOI 10.1111/j.1365-2893.2010.01293.x; Beckerleg S, 2006, SUBST USE MISUSE, V41, P1029, DOI 10.1080/10826080600667193; Beckerleg S, 2004, DRUG-EDUC PREV POLIC, V11, P67, DOI 10.1080/0968763031000140192; Beckerleg Susan, 2005, Harm Reduct J, V2, P12, DOI 10.1186/1477-7517-2-12; Brodish P, 2011, DRUG ALCOHOL DEPEN, V119, P138, DOI 10.1016/j.drugalcdep.2011.05.030; Chami G, 2013, DRUG ALCOHOL DEPEN, V132, P486, DOI 10.1016/j.drugalcdep.2013.03.011; Cho KT, 2014, FORENSIC SCI INT, V235, P78, DOI 10.1016/j.forsciint.2013.12.006; Datta D, 2009, SAHARA J-J SOC ASP H, V6, P170, DOI 10.1080/17290376.2009.9724945; de Vos AS, 2012, EPIDEMICS-NETH, V4, P57, DOI 10.1016/j.epidem.2012.01.001; Deveau C, 2006, AFRICAN J DRUG ALCOH, V5, P95; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Githuka G, 2014, JAIDS-J ACQ IMM DEF, V66, pS46, DOI 10.1097/QAI.0000000000000137; Gyarmathy VA, 2014, AIDS BEHAV, V18, P505, DOI 10.1007/s10461-014-0702-6; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Kitawi RC, 2015, AIDS RES HUM RETROV, V31, P452, DOI [10.1089/aid.2014.0306, 10.1089/AID.2014.0306]; Liao MZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-172; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Meijerink H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18844; Mishra RK, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-5; Muasya T, 2008, East Afr Med J, V85, P318; National AIDS and STI Control Programme (NASCOP), MOST AT RISK POP UNV; National AIDS Control Council, 2009, KEN HIV PREV RESP MO; National AIDS Control Council of Kenya, 2014, KEN AIDS RESP PROGR; Needle RH, 2005, INT J DRUG POLICY, V16, pS45, DOI 10.1016/j.drugpo.2005.02.009; Ng'ang'a A, 2014, JAIDS-J ACQ IMM DEF, V66, pS27, DOI 10.1097/QAI.0000000000000102; Njuki R, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-77; Nzomo TJ, 2015, AIDS RES HUM RETROV, V31, P550, DOI [10.1089/aid.2015.0031, 10.1089/AID.2015.0031]; Ochieng W, 2015, JAIDS-J ACQ IMM DEF, V69, pE49, DOI 10.1097/QAI.0000000000000580; Ochieng Washingtone, 2006, Afr Health Sci, V6, P3; Petersen Z, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-13; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Reid SR, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-24; Republic of Kenya, 2013, NATL FOOD SAFETY POL; Rogalska-Plonska M, 2015, VIRAL IMMUNOL, V28, P145, DOI 10.1089/vim.2014.0114; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Simon D, 2014, EPIDEMIOL INFECT, V142, P2616, DOI 10.1017/S0950268814000041; Smith DB, 2014, J NEUROVIROL, V20, P28, DOI 10.1007/s13365-013-0225-3; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sypsa V, 2015, AM J PUBLIC HEALTH, V105, P196, DOI 10.2105/AJPH.2013.301656; Syvertsen JL, 2015, DRUG ALCOHOL DEPEN, V151, P262, DOI 10.1016/j.drugalcdep.2015.02.037; UNAIDS, GLOB REP UNAIDS REP; United Nations Office on Drugs and Crim (UNDOC), WORLD DRUG REP 2011; Waruiru W, 2014, JAIDS-J ACQ IMM DEF, V66, pS3, DOI 10.1097/QAI.0000000000000114	48	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132287	10.1371/journal.pone.0132287	http://dx.doi.org/10.1371/journal.pone.0132287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208212	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000025
J	Sankavaram, SR; Svensson, MA; Olsson, T; Brundin, L; Johansson, CB				Sankavaram, Sreenivasa R.; Svensson, Mikael A.; Olsson, Tomas; Brundin, Lou; Johansson, Clas B.			Cell Fusion along the Anterior-Posterior Neuroaxis in Mice with Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; MARROW-DERIVED CELLS; BONE-MARROW; PURKINJE NEURONS; HETEROKARYON FORMATION; MUSCLE REGENERATION; SKELETAL-MUSCLE; NEURODEGENERATION; HEPATOCYTES	Background It is well documented that bone marrow-derived cells can fuse with a diverse range of cells, including brain cells, under normal or pathological conditions. Inflammation leads to robust fusion of bone marrow-derived cells with Purkinje cells and the formation of binucleate heterokaryons in the cerebellum. Heterokaryons form through the fusion of two developmentally differential cells and as a result contain two distinct nuclei without subsequent nuclear or chromosome loss. Aim In the brain, fusion of bone marrow-derived cells appears to be restricted to the complex and large Purkinje cells, raising the question whether the size of the recipient cell is important for cell fusion in the central nervous system. Purkinje cells are among the largest neurons in the central nervous system and accordingly can harbor two nuclei. Results Using a well-characterized model for heterokaryon formation in the cerebellum (experimental autoimmune encephalomyelitis - a mouse model of multiple sclerosis), we report for the first time that green fluorescent protein-labeled bone marrow-derived cells can fuse and form heterokaryons with spinal cord motor neurons. These spinal cord heterokaryons are predominantly located in or adjacent to an active or previously active inflammation site, demonstrating that inflammation and infiltration of immune cells are key for cell fusion in the central nervous system. While some motor neurons were found to contain two nuclei, co-expressing green fluorescent protein and the neuronal marker, neuron-specific nuclear protein, a number of small interneurons also co-expressed green fluorescent protein and the neuronal marker, neuron-specific nuclear protein. These small heterokaryons were scattered in the gray matter of the spinal cord. Conclusion This novel finding expands the repertoire of neurons that can form heterokaryons with bone marrow-derived cells in the central nervous system, albeit in low numbers, possibly leading to a novel therapy for spinal cord motor neurons or other neurons that are compromised in the central nervous system.	[Sankavaram, Sreenivasa R.; Olsson, Tomas; Brundin, Lou; Johansson, Clas B.] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Sankavaram, Sreenivasa R.; Svensson, Mikael A.; Olsson, Tomas; Brundin, Lou; Johansson, Clas B.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Johansson, Clas B.] Jamtland Harjedalen Cty Council, Publ Dent Serv Gallo, Gallo, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Johansson, CB (corresponding author), Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden.	clas.johansson@ki.se	Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003; Brundin, Lou/0000-0003-4408-7817; Olsson, Tomas/0000-0002-2938-1877	Alltid Litt Sterkere; Hallsten Research Foundation; Stichting af Jochnick; Magnus Bergvalls Stiftelse; Stroke forbundet; Hjarnfonden; NHR; Tore Nilssons stiftelse; Wenner-Gren Foundations; Stiftelsen Clas Groschinskys Minnesfond; Ake Wibergs Stiftelse; Karolinska Institutes fonder; Familjen Iversens minnesgaveri	Alltid Litt Sterkere; Hallsten Research Foundation; Stichting af Jochnick; Magnus Bergvalls Stiftelse; Stroke forbundet; Hjarnfonden; NHR; Tore Nilssons stiftelse; Wenner-Gren Foundations; Stiftelsen Clas Groschinskys Minnesfond; Ake Wibergs Stiftelse; Karolinska Institutes fonder; Familjen Iversens minnesgaveri	This work was supported by Alltid Litt Sterkere, the Hallsten Research Foundation, Stichting af Jochnick, Magnus Bergvalls Stiftelse, Stroke forbundet, Hjarnfonden, NHR, Tore Nilssons stiftelse, the Wenner-Gren Foundations, Stiftelsen Clas Groschinskys Minnesfond, Ake Wibergs Stiftelse, Karolinska Institutes fonder, and Familjen Iversens minnesgaveri.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Bae JS, 2005, HUM GENE THER, V16, P1006, DOI 10.1089/hum.2005.16.1006; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; GIBSON AJ, 1995, J CELL SCI, V108, P207; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kaji K, 2004, REPRODUCTION, V127, P423, DOI 10.1530/rep.1.00163; Kang H, 2014, CELL REP, V8, P1210, DOI 10.1016/j.celrep.2014.07.032; Kemp K, 2012, BRAIN, V135, P2962, DOI 10.1093/brain/aws226; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Magrassi L, 2007, J NEUROSCI, V27, P9885, DOI 10.1523/JNEUROSCI.2539-07.2007; Nern C, 2009, J NEUROSCI, V29, P3799, DOI 10.1523/JNEUROSCI.5848-08.2009; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Ridder K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001874; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Sanges D, 2013, CELL REP, V4, P271, DOI 10.1016/j.celrep.2013.06.015; Sullivan S, 2006, STEM CELL REV, V2, P341, DOI 10.1007/BF02698061; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Willenbring H, 2005, BRIT J SURG, V92, P923, DOI 10.1002/bjs.5110; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	30	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133903	10.1371/journal.pone.0133903	http://dx.doi.org/10.1371/journal.pone.0133903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207625	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000169
J	Shen, P; Zhang, H; Su, ZL; Wang, SJ; Xu, HX				Shen, Pei; Zhang, Hong; Su, Zhaoliang; Wang, Shengjun; Xu, Huaxi			In Silico Analysis of Tumor Necrosis Factor alpha-Induced Protein 8-Like-1 (TIPE1) Protein	PLOS ONE			English	Article							TNFAIP8 OVEREXPRESSION; IMMUNE HOMEOSTASIS; CELL-LINES; METASTASIS; EXPRESSION; CANCER; IDENTIFICATION; ACTIVATION; PROLIFERATION; REGULATOR	Tumor necrosis factor alpha-induced protein 8 (TNFAIP8)-like protein 1 (TIPE1) was a member of TNFAIP8 family. Previous studies have shown that TIPE1 could induce apoptosis in hepatocellular carcinoma. In this study, we attempted to predict its potential structure. Bioinformatic analysis of TIPE1 was performed to predict its potential structure using the bioinfomatic web services or softwares. The results showed that the amino acid sequences of TIPE1 were well conserved in mammals. No signal peptide and no transmembrane domain existed in human TIPE1. The aliphatic index of TIPE1 was 100.75 and the theoretical pI was 9.57. TIPE1 was a kind of stable protein and its grand average of hydropathicity was -0.108. Various post-translational modifications were also speculated to exist in TIPE1. In addition, the results of Swiss-Model Server and Swiss-Pdb Viewer program revealed that the predicted three-dimensional structure of TIPE1 protein was stable and it may accord with the rule of stereochemistry. TIPE1 was predicted to interact with FBXW5, caspase8 and so on. In conclusion, TIPE1 may be a stable protein with no signal peptide and no transmembrane domain. The bioinformatic analysis of TIPE1 will provide the basis for the further study on the function of TIPE1.	[Shen, Pei; Su, Zhaoliang; Wang, Shengjun; Xu, Huaxi] Jiangsu Univ, Inst Lab Med, Dept Immunol, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Hong] Yangzhou Univ, Clin Coll 4, Dept Clin Lab, Nantong Rich Hosp, Nantong, Jiangsu, Peoples R China; [Shen, Pei] Nantong Univ, Affiliated Hosp, Lab Med Ctr, Nantong, Jiangsu, Peoples R China	Jiangsu University; Yangzhou University; Nantong University	Xu, HX (corresponding author), Jiangsu Univ, Inst Lab Med, Dept Immunol, Zhenjiang, Jiangsu, Peoples R China.	xuhx@ujs.edu.cn			Graduate Student Research and Innovation Program of Jiangsu Province [CXLX12_0677]	Graduate Student Research and Innovation Program of Jiangsu Province	This work was supported by Graduate Student Research and Innovation Program of Jiangsu Province (CXLX12_0677).	Cao XL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-149; Cui J, 2011, MOL IMMUNOL, V48, P1548, DOI 10.1016/j.molimm.2011.04.023; Fayngerts SA, 2014, CANCER CELL, V26, P465, DOI 10.1016/j.ccr.2014.07.025; Freundt EC, 2008, CELL, V133, P401, DOI 10.1016/j.cell.2008.04.017; Ha JY, 2014, J NEUROCHEM, V129, P527, DOI [10.1111/jnc.12643, 10.1111/j.1471-4159.2013.12643.x]; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Li XM, 2014, CANCER BIOMARK, V14, P233, DOI 10.3233/CBM-140402; Liu QQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126176; Liu TB, 2014, TUMOR BIOL, V35, P5805, DOI 10.1007/s13277-014-1770-y; Liu TB, 2014, HUM PATHOL, V45, P1251, DOI 10.1016/j.humpath.2014.02.005; Lou YW, 2014, J IMMUNOL, V193, P1064, DOI 10.4049/jimmunol.1400415; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Randhawa R, 2015, GENE, V562, P40, DOI 10.1016/j.gene.2015.02.056; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Wang LC, 2014, TUMOR BIOL, V35, P2319, DOI 10.1007/s13277-013-1307-9; Yang M, 2014, HISTOPATHOLOGY, V65, P517, DOI 10.1111/his.12413; Zhang SY, 2010, BBA-MOL BASIS DIS, V1802, P1078, DOI 10.1016/j.bbadis.2010.08.003; Zhang X, 2009, NAT STRUCT MOL BIOL, V16, P89, DOI 10.1038/nsmb.1522; Zhang YH, 2015, INT J ONCOL, V46, P254, DOI 10.3892/ijo.2014.2725; Zhang Z, 2015, ONCOGENE, V34, P2566, DOI 10.1038/onc.2014.208	23	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134114	10.1371/journal.pone.0134114	http://dx.doi.org/10.1371/journal.pone.0134114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207809	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000211
J	Torres-Espinola, FJ; Berglund, SK; Garcia-Valdes, LM; Segura, MT; Jerez, A; Campos, D; Moreno-Torres, R; Rueda, R; Catena, A; Perez-Garcia, M; Campoy, C				Torres-Espinola, Francisco J.; Berglund, Staffan K.; Garcia-Valdes, Luz Ma; Teresa Segura, Ma; Jerez, Antonio; Campos, Daniel; Moreno-Torres, Rosario; Rueda, Ricardo; Catena, Andres; Perez-Garcia, Miguel; Campoy, Cristina		PREOBE Team	Maternal Obesity, Overweight and Gestational Diabetes Affect the Offspring Neurodevelopment at 6 and 18 Months of Age - A Follow Up from the PREOBE Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; PREPREGNANCY OVERWEIGHT; CHILD NEURODEVELOPMENT; INFANTS; RISK; SUPPLEMENTATION; INTRAUTERINE; PERFORMANCE; EXPERIENCES; PREGNANCY	Background Brain development in fetal life and early infancy is critical to determine lifelong performance in various neuropsychological domains. Metabolic pathologies such as overweight, obesity, and gestational diabetes in pregnant women are prevalent and increasing risk factors that may adversely affect long-term brain development in their offspring. Objective The objective of this research was to investigate the influence of maternal metabolic pathologies on the neurodevelopment of the offspring at 6 and 18 months of life. Design This was a prospective case-control study of 331 mother- and child pairs from Granada, Spain. The mothers were included during pregnancy into four groups according to their pre-gestational body mass index and their gestational diabetes status; overweight (n:56), obese (n:64), gestational diabetic (n:79), and healthy normal weight controls (n:132). At 6 months and 18 months we assessed the children with the Bayley III scales of neurodevelopment. Results At 6 months (n=215), we found significant group differences in cognition composite language, and expressive language. Post hoc test revealed unexpectedly higher scores in the obese group compared to the normal weight group and a similar trend in overweight and diabetic group. The effects on language remained significant after adjusting for confounders with an adjusted odds ratio for a value above median in composite language score of 3.3 (95% CI: 1.1, 10.0; p=0.035) for children of obese mothers. At 18 month (n=197), the off-spring born to obese mothers had lost five points in language composite scores and the previous differences in language and cognition was replaced by a suggestive trend of lower gross motor scores in the overweight, obese, and diabetic groups. Conclusions Infants of obese mothers had a temporary accelerated development of cognition and language, followed by a rapid deceleration until 18 months of age, particularly of language scores. This novel observation prompts further confirmative studies to explore possible placental and neurodevelopmental mechanisms involved.	[Torres-Espinola, Francisco J.; Berglund, Staffan K.; Garcia-Valdes, Luz Ma; Teresa Segura, Ma; Jerez, Antonio; Campos, Daniel; Moreno-Torres, Rosario; Campoy, Cristina] Univ Granada, Ctr Excellence Paediat Res EURISTIKOS, Granada, Spain; [Berglund, Staffan K.] Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden; [Jerez, Antonio; Campoy, Cristina] Univ Granada, Dept Paediat, Granada, Spain; [Rueda, Ricardo] Abbott Labs, R&D Dept, Granada, Spain; [Catena, Andres; Perez-Garcia, Miguel] Univ Granada, Mind Brain & Behav Int Res Ctr CIMCYC, Granada, Spain	University of Granada; Umea University; University of Granada; University of Granada	Campoy, C (corresponding author), Univ Granada, Ctr Excellence Paediat Res EURISTIKOS, Granada, Spain.	ccampoy@ugr.es	Campoy, Cristina/F-4946-2017; Catena, Andres/I-2159-2015; perez, miguel/GXF-5077-2022; Rusanova, Iryna/B-9068-2019; García, Miguel Pérez/F-9630-2010; Alvarez, J. Carlos/R-9722-2019; Altmae, Signe/J-2441-2015; LORENTE, JOSE A./B-8372-2008; Anjos, Tania/E-6917-2011	Campoy, Cristina/0000-0002-9860-6785; Catena, Andres/0000-0002-0775-5751; Rusanova, Iryna/0000-0002-9034-7600; García, Miguel Pérez/0000-0003-4775-7556; Alvarez, J. Carlos/0000-0002-5884-9918; Martinez-Zaldivar Moreno, Cristina/0000-0003-4643-0236; Altmae, Signe/0000-0002-0708-1865; Desoye, Gernot/0000-0002-5715-3230; Campos Consuegra, Daniel/0000-0003-0755-3823; Segura, Maria Teresa/0000-0003-4269-7662; LORENTE, JOSE A./0000-0002-9892-7386; Agil, Ahmad/0000-0003-0164-9648; Anjos, Tania/0000-0002-9596-1626; Miranda Leon, Maria Teresa/0000-0002-6254-7402	Spanish Ministry of Innovation and Science; Junta de Andalucia: Excellence Projects [P06-CTS-02341]; Spanish Ministry of Education [SB2010-0025]; Spanish Ministry of Economy and Competitiveness [BFU2012-40254-C03-01]; Abbott Laboratories, Granada, Spain	Spanish Ministry of Innovation and Science(Spanish Government); Junta de Andalucia: Excellence Projects(Junta de Andalucia); Spanish Ministry of Education(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Abbott Laboratories, Granada, Spain	This study was funded by Spanish Ministry of Innovation and Science. Junta de Andalucia: Excellence Projects (P06-CTS-02341); Spanish Ministry of Education (Grant no. SB2010-0025); Spanish Ministry of Economy and Competitiveness (BFU2012-40254-C03-01); Further support was received by Abbott Laboratories, Granada, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was registered at www.ClinicalTrials.gov, identifier: NCT01634464).	Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Aylward GP, 2014, J DEV BEHAV PEDIATR, V35, P394, DOI 10.1097/01.DBP.0000452240.39511.d4; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bayley N., 2019, BAYLEY SCALES INFANT; Braun K, 1996, Z KLIN PSYCH PSYCHIA, V44, P253; Brion MJ, 2011, PEDIATRICS, V127, pE202, DOI 10.1542/peds.2010-0651; Casas M, 2013, INT J EPIDEMIOL, V42, P506, DOI 10.1093/ije/dyt002; Clausen TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067107; Cusick SE, 2012, ARCH PEDIAT ADOL MED, V166, P481, DOI 10.1001/archpediatrics.2012.199; DeBoer T, 2005, DEV MED CHILD NEUROL, V47, P525, DOI 10.1017/S0012162205001039; deReginer RA, 2000, J PEDIATR-US, V137, P777, DOI 10.1067/mpd.2000.109149; Dionne G, 2008, PEDIATRICS, V122, pE1073, DOI 10.1542/peds.2007-3028; Favaro A, 2006, ARCH GEN PSYCHIAT, V63, P82, DOI 10.1001/archpsyc.63.1.82; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; Georgieff MK, 2007, AM J CLIN NUTR, V85, p614S; Hadders-Algra M, 2011, AM J CLIN NUTR, V94, p1874S, DOI 10.3945/ajcn.110.001065; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Heikura U, 2008, AM J EPIDEMIOL, V167, P169, DOI 10.1093/aje/kwm291; Herring SJ, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.01.039; Hinkle SN, 2012, INT J OBESITY, V36, P1312, DOI 10.1038/ijo.2012.143; Huang LS, 2014, INT J EPIDEMIOL, V43, P783, DOI 10.1093/ije/dyu030; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Langie SAS, 2012, BEST PRACT RES CL EN, V26, P613, DOI 10.1016/j.beem.2012.03.004; LAUCHT M, 1992, PRAX KINDERPSYCHOL K, V41, P274; Neggers YH, 2003, ACTA OBSTET GYN SCAN, V82, P235, DOI 10.1034/j.1600-0412.2003.00090.x; Nielsen GL, 2010, DIABETIC MED, V27, P786, DOI 10.1111/j.1464-5491.2010.03024.x; Ornoy A, 2001, J PEDIATR ENDOCR MET, V14, P681; Robinson M, 2013, J DEV ORIG HLTH DIS, V4, P42, DOI 10.1017/S2040174412000578; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Sesma HW, 2003, DEV PSYCHOPATHOL, V15, P991, DOI 10.1017/S0954579403000488; Tanda R, 2013, MATERN CHILD HLTH J, V17, P222, DOI 10.1007/s10995-012-0964-4; Tomalski P, 2010, CURR OPIN PSYCHIATR, V23, P233, DOI 10.1097/YCO.0b013e3283387a8c; Van Lieshout RJ, 2011, OBES REV, V12, pe548, DOI 10.1111/j.1467-789X.2010.00850.x; Van Lieshout RJ, 2013, NUTR REV, V71, pS95, DOI 10.1111/nure.12059; Van Lieshout RJ, 2013, CHILD PSYCHIAT HUM D, V44, P382, DOI 10.1007/s10578-012-0332-z	36	54	56	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133010	10.1371/journal.pone.0133010	http://dx.doi.org/10.1371/journal.pone.0133010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208217	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000055
J	Chen, Y; Liang, ZY; Fei, EK; Chen, YW; Zhou, XP; Fang, WQ; Fu, WY; Fu, AKY; Ip, NY				Chen, Yu; Liang, Zhuoyi; Fei, Erkang; Chen, Yuewen; Zhou, Xiaopu; Fang, Weiqun; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.			Axin Regulates Dendritic Spine Morphogenesis through Cdc42-Dependent Signaling	PLOS ONE			English	Article							STRUCTURAL PLASTICITY; CEREBRAL-CORTEX; RHO-GTPASES; RECEPTOR; PROTEINS; MECHANISM; INTERACTS; SYNAPSES; SCAFFOLD; ACTIN	During development, scaffold proteins serve as important platforms for orchestrating signaling complexes to transduce extracellular stimuli into intracellular responses that regulate dendritic spine morphology and function. Axin ("axis inhibitor") is a key scaffold protein in canonical Wnt signaling that interacts with specific synaptic proteins. However, the cellular functions of these protein-protein interactions in dendritic spine morphology and synaptic regulation are unclear. Here, we report that Axin protein is enriched in synaptic fractions, colocalizes with the postsynaptic marker PSD-95 in cultured hippocampal neurons, and interacts with a signaling protein Ca2+/calmodulin-dependent protein kinase II (CaMKII) in synaptosomal fractions. Axin depletion by shRNA in cultured neurons or intact hippocampal CA1 regions significantly reduced dendritic spine density. Intriguingly, the defective dendritic spine morphogenesis in Axin-knockdown neurons could be restored by overexpression of the small Rho-GTPase Cdc42, whose activity is regulated by CaMKII. Moreover, pharmacological stabilization of Axin resulted in increased dendritic spine number and spontaneous neurotransmission, while Axin stabilization in hippocampal neurons reduced the elimination of dendritic spines. Taken together, our findings suggest that Axin promotes dendritic spine stabilization through Cdc42-dependent cytoskeletal reorganization.	[Chen, Yu; Liang, Zhuoyi; Fei, Erkang; Chen, Yuewen; Zhou, Xiaopu; Fang, Weiqun; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Chen, Yu; Liang, Zhuoyi; Fei, Erkang; Chen, Yuewen; Zhou, Xiaopu; Fang, Weiqun; Fu, Wing-Yu; Fu, Amy K. Y.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China; [Chen, Yu; Chen, Yuewen; Fu, Amy K. Y.; Ip, Nancy Y.] HKUST Shenzhen Res Inst, Guangdong Key Lab Brain Sci Dis & Drug Dev, Shenzhen, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Chen, Y (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	bcyuchen@ust.hk; boip@ust.hk	Fang, Wei-Qun/AAW-5945-2020; FEI, Erkang/AAI-9825-2021; ZHOU, Xiaopu/ABB-2263-2021	ZHOU, Xiaopu/0000-0001-5307-5805; Fu, Kit Yu/0000-0003-4085-6201; Fang, Weiqun/0000-0002-6741-860X; FEI, Erkang/0000-0002-3581-9521; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Liang, Zhuoyi/0000-0003-1622-524X	Research Grants Council of Hong Kong (HKUST) [660110, 661111, 661013]; National Basic Research Program of China (973 Program) [2013CB530900]; Theme-based Research Scheme of the University Grants Committee [T13607/12-R]; Shenzhen Peacock Plan, funding for establishing the Guangdong Key Laboratory; Asia Fund for Cancer Research [AFCR14SC02]	Research Grants Council of Hong Kong (HKUST)(Hong Kong Research Grants Council); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Theme-based Research Scheme of the University Grants Committee; Shenzhen Peacock Plan, funding for establishing the Guangdong Key Laboratory; Asia Fund for Cancer Research	This study was supported in part by the Research Grants Council of Hong Kong (HKUST 660110, 661111 and 661013), the National Basic Research Program of China (973 Program; 2013CB530900), the Theme-based Research Scheme of the University Grants Committee (T13607/12-R), the Shenzhen Peacock Plan, funding for establishing the Guangdong Key Laboratory and the Asia Fund for Cancer Research (AFCR14SC02).	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bellot A, 2014, BRAIN RES, V1573, P1, DOI 10.1016/j.brainres.2014.05.024; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chen Y, 2013, IUBMB LIFE, V65, P685, DOI 10.1002/iub.1184; Chen Y, 2012, CELL SIGNAL, V24, P606, DOI 10.1016/j.cellsig.2011.11.016; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Fang WQ, 2014, CELL REP, V9, P1635, DOI 10.1016/j.celrep.2014.11.003; Fang WQ, 2013, NEURON, V79, P665, DOI 10.1016/j.neuron.2013.06.017; Fang WQ, 2011, J NEUROSCI, V31, P13613, DOI 10.1523/JNEUROSCI.3120-11.2011; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hirabayashi S, 2004, J NEUROCHEM, V90, P332, DOI 10.1111/j.1471-4159.2004.02497.x; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kim Y, 2013, J BIOL CHEM, V288, P29453, DOI 10.1074/jbc.M113.468801; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Lai KO, 2013, BBA-MOL BASIS DIS, V1832, P2257, DOI 10.1016/j.bbadis.2013.08.012; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Nieland TJF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091744; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Oliva CA, 2013, AGEING RES REV, V12, P786, DOI 10.1016/j.arr.2013.03.006; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shen Y, 2013, J NEUROSCI, V33, P464, DOI 10.1523/JNEUROSCI.3282-12.2013; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931; Yudowski GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053965	34	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133115	10.1371/journal.pone.0133115	http://dx.doi.org/10.1371/journal.pone.0133115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204446	gold, Green Published, Green Submitted			2022-12-26	WOS:000358621000018
J	Foureaux, G; Franca, JR; Nogueira, JC; Fulgencio, GD; Ribeiro, TG; Castilho, RO; Yoshida, MI; Fuscaldi, LL; Fernandes, SOA; Cardoso, VN; Cronemberger, S; Faraco, AAG; Ferreira, AJ				Foureaux, Giselle; Franca, Jucara Ribeiro; Nogueira, Jose Carlos; Fulgencio, Gustavo de Oliveira; Ribeiro, Tatiana Gomes; Castilho, Rachel Oliveira; Yoshida, Maria Irene; Fuscaldi, Leonardo Lima; Antunes Fernandes, Simone Odlia; Cardoso, Valbert Nascimento; Cronemberger, Sebastiao; Faraco, Andre Augusto Gomes; Ferreira, Anderson Jose			Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DRUG-DELIVERY; INTRAOCULAR-PRESSURE; VIVO EVALUATION; NITRIC-OXIDE; HUMAN EYE; IN-VITRO; SYSTEM; RECEPTOR; CHITOSAN	The aim of this study was to develop and evaluate the effects of chitosan inserts for sustained release of the angiotensin-converting enzyme 2 (ACE2) activator, diminazene aceturate (DIZE), in experimental glaucoma. Monolayer DIZE loaded inserts (D+I) were prepared and characterized through swelling, attenuated total reflectance Fourier transformed infrared spectroscopy (ATR-FTIR), differential scanning calorimetry (DSC) and in vitro drug release. Functionally, the effects of D+I were tested in glaucomatous rats. Glaucoma was induced by weekly injections of hyaluronic acid (HA) into the anterior chamber and intraocular pressure (IOP) measurements were performed. Retinal ganglion cells (RGC) and optic nerve head cupping were evaluated in histological sections. Biodistribution of the drug was accessed by scintigraphic images and ex vivo radiation counting. We found that DIZE increased the swelling index of the inserts. Also, it was molecularly dispersed and interspersed in the polymeric matrix as a freebase. DIZE did not lose its chemical integrity and activity when loaded in the inserts. The functional evaluation demonstrated that D+I decreased the IOP and maintained the IOP lowered for up to one month (last week: 11.0 +/- 0.7 mmHg). This effect of D+I prevented the loss of RGC and degeneration of the optic nerve. No toxic effects in the eyes related to application of the inserts were observed. Moreover, biodistribution studies showed that D+I prolonged the retention of DIZE in the corneal site. We concluded that D+I provided sustained DIZE delivery in vivo, thereby evidencing the potential application of polymeric-based DIZE inserts for glaucoma management.	[Foureaux, Giselle; Nogueira, Jose Carlos; Ferreira, Anderson Jose] Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil; [Franca, Jucara Ribeiro; Fulgencio, Gustavo de Oliveira; Ribeiro, Tatiana Gomes; Castilho, Rachel Oliveira; Faraco, Andre Augusto Gomes] Univ Fed Minas Gerais, Dept Pharmaceut Prod, Belo Horizonte, MG, Brazil; [Yoshida, Maria Irene] Univ Fed Minas Gerais, Inst Exact Sci, Belo Horizonte, MG, Brazil; [Fuscaldi, Leonardo Lima; Antunes Fernandes, Simone Odlia; Cardoso, Valbert Nascimento] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil; [Cronemberger, Sebastiao] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Ferreira, AJ (corresponding author), Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil.	anderson@icb.ufmg.br	Cronemberger, Sebastião/F-7225-2012; Yoshida, Maria Irene/ABC-8143-2020; Faraco, Andre AG/A-8965-2009; Cardoso, Valbert Nascimento/AAA-7240-2019; Fuscaldi, Leonardo Lima/V-1812-2017; fernandes, simone/AAU-8611-2020	Cronemberger, Sebastião/0000-0003-1466-9963; Yoshida, Maria Irene/0000-0002-6795-9457; Faraco, Andre AG/0000-0002-2344-6158; Fuscaldi, Leonardo Lima/0000-0001-7864-1324; Antunes Fernandes, Simone Odilia/0000-0002-6139-5187	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburahma MH, 2011, AAPS PHARMSCITECH, V12, P1335, DOI 10.1208/s12249-011-9701-3; Aggarwal D, 2005, INT J PHARMACEUT, V290, P155, DOI 10.1016/j.ijpharm.2004.10.026; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Baranowski P, 2014, SCI WORLD J, DOI 10.1155/2014/861904; CHEN RH, 1994, CARBOHYD POLYM, V24, P41, DOI 10.1016/0144-8617(94)90115-5; CONSTAD WH, 1988, AM J OPHTHALMOL, V105, P674, DOI 10.1016/0002-9394(88)90063-3; Costa VP, 2003, PROG RETIN EYE RES, V22, P769, DOI 10.1016/S1350-9462(03)00064-8; Costagliola C, 1995, Eur J Ophthalmol, V5, P19; Costagliola C, 2000, EXP EYE RES, V71, P167, DOI 10.1006/exer.2000.0866; DANSER AHJ, 1994, INVEST OPHTH VIS SCI, V35, P1008; Dobaria NB, 2009, AAPS PHARMSCITECH, V10, P951, DOI 10.1208/s12249-009-9288-0; Eroglu H, 2007, DRUG DEV IND PHARM, V33, P265, DOI 10.1080/03639040600713134; Ferrario CM, 2006, HYPERTENSION, V47, P515, DOI 10.1161/01.HYP.0000196268.08909.fb; FERRARIO CM, 1990, J CARDIOVASC PHARM, V15, pS1, DOI 10.1097/00005344-199000153-00001; Ferreira AJ, 2012, EXPERT OPIN THER PAT, V22, P567, DOI 10.1517/13543776.2012.682572; Ferreira AJ, 2011, EXP PHYSIOL, V96, P287, DOI 10.1113/expphysiol.2010.055277; Ferreira AJ, 2010, HYPERTENSION, V55, P207, DOI 10.1161/HYPERTENSIONAHA.109.140145; Foureaux G, 2013, INVEST OPHTH VIS SCI, V54, P4296, DOI 10.1167/iovs.12-11427; Ghate D, 2008, J GLAUCOMA, V17, P147, DOI 10.1097/IJG.0b013e31814b990d; Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033; Hashizume K, 2005, INVEST OPHTH VIS SCI, V46, P1993, DOI 10.1167/iovs.04-1100; Inoue T, 2001, CURR EYE RES, V23, P139, DOI 10.1076/ceyr.23.2.139.5470; KAUFMAN PL, 1981, CURR EYE RES, V1, P307, DOI 10.3109/02713688108999452; Kearns VR, 2009, EXPERT REV MED DEVIC, V6, P277, DOI [10.1586/erd.09.4, 10.1586/ERD.09.4]; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Kulemina LV, 2011, J BIOMOL SCREEN, V16, P878, DOI 10.1177/1087057111413919; Kuntner C, 2011, MOL IMAGING BIOL, V13, P222, DOI 10.1007/s11307-010-0352-7; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Lee SS, 2010, PHARM RES-DORDR, V27, P2043, DOI 10.1007/s11095-010-0159-x; Loftsson T, 2010, ACTA OPHTHALMOL, V88, P337, DOI 10.1111/j.1755-3768.2008.01495.x; LOTTI VJ, 1990, J OCUL PHARMACOL, V6, P1, DOI 10.1089/jop.1990.6.1; Ludwig A, 2005, ADV DRUG DELIVER REV, V57, P1595, DOI 10.1016/j.addr.2005.07.005; Luhtala S, 2009, J OCUL PHARMACOL TH, V25, P23, DOI 10.1089/jop.2008.0081; Moradi M, 2012, ANALYST, V137, P3549, DOI 10.1039/c2an35304k; Moreno MC, 2005, EXP EYE RES, V81, P71, DOI 10.1016/j.exer.2005.01.008; Murca TM, 2012, REGUL PEPTIDES, V177, P107, DOI 10.1016/j.regpep.2012.05.093; NATHANSON JA, 1995, INVEST OPHTH VIS SCI, V36, P1765; Natu MV, 2011, INT J PHARMACEUT, V415, P73, DOI 10.1016/j.ijpharm.2011.05.047; Neufeld AH, 1999, SURV OPHTHALMOL, V43, pS129, DOI 10.1016/S0039-6257(99)00010-7; Olbrich C, 2002, J DRUG TARGET, V10, P387, DOI 10.1080/1061186021000001832; Peng CC, 2012, J CONTROL RELEASE, V162, P152, DOI 10.1016/j.jconrel.2012.06.017; Perumal VA, 2008, INT J PHARM, V358, P184, DOI 10.1016/j.ijpharm.2008.03.005; Qiu YG, 2014, INVEST OPHTH VIS SCI, V55, P3809, DOI 10.1167/iovs.14-13883; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramirez M, 1996, J OCUL PHARMACOL TH, V12, P299, DOI 10.1089/jop.1996.12.299; Rodrigues LB, 2009, INT J PHARMACEUT, V368, P1, DOI 10.1016/j.ijpharm.2008.09.047; Santos RAS, 2000, REGUL PEPTIDES, V91, P45, DOI 10.1016/S0167-0115(00)00138-5; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Schindler C, 2007, VASC HEALTH RISK MAN, V3, P125; Senanayake PD, 2007, INVEST OPHTH VIS SCI, V48, P3301, DOI 10.1167/iovs.06-1024; Shah GB, 2000, J CARDIOVASC PHARM, V36, P169, DOI 10.1097/00005344-200008000-00005; Soliman GM, 2008, INT J PHARM, V356, P248, DOI 10.1016/j.ijpharm.2007.12.029; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Tikellis C, 2004, CURR EYE RES, V29, P419, DOI 10.1080/02713680490517944; Vaajanen A, 2011, BASIC CLIN PHARMACOL, V109, P217, DOI 10.1111/j.1742-7843.2011.00729.x; Vaajanen A, 2010, ACTA OPHTHALMOL, V88, P431, DOI 10.1111/j.1755-3768.2009.01563.x; Wagner J, 1996, BRIT J OPHTHALMOL, V80, P159, DOI 10.1136/bjo.80.2.159; Wang RF, 2005, EXP EYE RES, V80, P629, DOI 10.1016/j.exer.2004.11.012; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Zambito Y, 2010, J DRUG DELIV SCI TEC, V20, P45, DOI 10.1016/S1773-2247(10)50005-4	60	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133149	10.1371/journal.pone.0133149	http://dx.doi.org/10.1371/journal.pone.0133149			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204514	Green Submitted, Green Published, gold			2022-12-26	WOS:000358621000019
J	Herrador, Z; Perez-Formigo, J; Sordo, L; Gadisa, E; Moreno, J; Benito, A; Aseffa, A; Custodio, E				Herrador, Zaida; Perez-Formigo, Jesus; Sordo, Luis; Gadisa, Endalamaw; Moreno, Javier; Benito, Agustin; Aseffa, Abraham; Custodio, Estefania			Low Dietary Diversity and Intake of Animal Source Foods among School Aged Children in Libo Kemkem and Fogera Districts, Ethiopia	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SOCIOECONOMIC-STATUS; HOUSEHOLDS; INFECTION; VARIETY; SCORES; WOMEN	Background A low dietary diversity score (DDS) and low consumption of food from animal sources (ASF) are among the factors related to malnutrition in school-aged children living in Libo Kemkem and Fogera (Ethiopia). Objectives This study aimed to identify associated determinants for low dietary diversity and lack of consumption of ASF. Methods In 2009, a cross-sectional survey was carried out in May, at the end of the lean season. Socio-demographic characteristics and diet habits were collected from 886 school-aged children. Additionally, 516 children from rural sites were followed up in the post-harvest season, in December of the same year. Bivariate and multivariable statistical methods were employed to assess low DDS and ASF intake and their association with different factors. Results Up to 80% and 60% of school-aged children living in rural and urban sites, respectively, ate <= 3 food groups the day before the survey. The percentage of children consuming ASF was significantly higher in urban settings (64% vs 18%). In the rural areas, if the head of the household was male (OR: 1.91; 95%CI: 1.00-3.65) and older than 40 years (OR: 1.56; 95%CI: 1.02-2.38) the child had a lower DDS in the lean season, while differences by socioeconomic indexes were observed in the post-harvest season. Males took more ASF than females in rural settings (OR: 1.73; 95%CI: 1.14-2.62) and differences by socioeconomic indexes were observed in both settings in the lean season, though not in post-harvest survey. Conclusions The findings of this study revealed that the diet among school-aged children in Libo Kemkem and Fogera districts lacked diversity, and that the intake of foods from animal sources was low, especially among rural girls. To effectively tackle malnutrition, dietary diversification strategies oriented to the local needs are recommended.	[Herrador, Zaida; Benito, Agustin; Custodio, Estefania] Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain; [Herrador, Zaida; Moreno, Javier; Benito, Agustin; Custodio, Estefania] Trop Dis Res Network RICET Spanish, Madrid, Spain; [Perez-Formigo, Jesus; Sordo, Luis] ISCIII, Natl Ctr Epidemiol, Madrid, Spain; [Perez-Formigo, Jesus] Spanish Field Epidemiol Training Program PEAC, Madrid, Spain; [Sordo, Luis] Univ Complutense, Dept Prevent Med & Publ Hlth, Fac Med, E-28040 Madrid, Spain; [Sordo, Luis] Epidemiol & Publ Hlth CIBERESP, Network Biomed Res Ctr, Madrid, Spain; [Gadisa, Endalamaw; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Moreno, Javier] ISCIII, Natl Ctr Microbiol, Madrid, Spain; [Custodio, Estefania] European Commiss Joint Res Ctr, Monitoring Agr Resources Unit H04, Inst Environm & Sustainabil, Ispra, Italy	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Instituto de Salud Carlos III; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); European Commission Joint Research Centre; EC JRC ISPRA Site	Custodio, E (corresponding author), Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain.	ecustodio2014@gmail.com	Aseffa, Abraham/J-3248-2016; Moreno, Javier/AAB-5386-2021	Aseffa, Abraham/0000-0002-8028-1150; sordo, Luis/0000-0003-1760-9472; Moreno, Javier/0000-0003-0087-4659; Herrador, Zaida/0000-0002-6508-3818; Benito, Agustin/0000-0001-8229-5540	UBS-Optimus Foundation (Switzerland); Instituto de Salud Carlos III [RD06/0021/0009, RD06/0021/0000]	UBS-Optimus Foundation (Switzerland); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was funded by the UBS-Optimus Foundation (Switzerland) through the Visceral Leishmaniasis and Malnutrition in Amhara State, Ethiopia Project. Support was also provided by the Instituto de Salud Carlos III through Tropical Diseases Research Network Grants RICET RD06/0021/0009 and RD06/0021/0000. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES FOOD FORT; Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; Amare Y., 2000, FOOD SECURITY RESOUR; Andersen O., 2002, FIELD CROPS RES, V11, P347; [Anonymous], 2013, FOOD AGR ETHIOPIA PR; [Anonymous], 2011, ETHIOPIA DEMOGRAPHIC, P452; Arimond M, 2002, PROGR DEV INFANT CHI; Ayele Z, 2003, J NUTR, V133, p3981S, DOI 10.1093/jn/133.11.3981S; Belachew T, 2007, ETHIOP J HLTH SCI, P17; Belew TA, 2008, NUTR COUNTR PROF; Berhane G, 2011, 23 IFPRI EDRI ESSP 2; BOKU-University of Natural Resources and Life Sciences Vienna., 2014, SUST DEV FISH VAL CH; Chaillot C, 2012, ETHIOPIAN ORTHODOX C, P234; Custodio E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001813; de Rezende María José, 2010, Investig. desarro., V18, P218; Degye Goshu, 2013, Journal of Development and Agricultural Economics, V5, P174; Dorosh P, 2010, 13 IFPRI ESSP2; Egata G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-864; FAO [Food and Agriculture Organization of the United Nations] IFAD [International Fund for Agricultural Development] and WFP [World Food Programme], 2013, STAT FOOD INS WORLD; FAO & WFP, 2014, STAT FOOD INS WORLD; Ferro-Luzzi A, 2001, 118 IFPRI; Food and Agriculture Organization of the United Nations, 2009, DECL WORLD SUMM FOOD; Food and Agriculture Organization of the United Nations (FAO), 2010, FAO WFP CROP FOOD SE; Food and Agriculture Organization of the United Nations (FAO), 2001, TARG NUTR IMPR RES A; Fotso JC, 2005, SOC INDIC RES, V72, P189, DOI 10.1007/s11205-004-5579-8; Frehiwot F., 2007, FOOD INSECURITY ITS; Gebre GG, 2012, INTERDISCIP DESCR CO, V10, P159; Gibson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048708; Girma W., 2002, DETERMINANTS NUTR ST; Gordon A., 2007, MARKETING SYSTEMS FI; Headey D D E., 2012, IMPROVING MEASUREMEN; Helen Keller International, 2001, NUTR SURV PROJ B; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112858; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880; Keding GB, 2012, FOOD SECUR, V4, P129, DOI 10.1007/s12571-011-0163-y; Kennedy G., 2011, GUID MEAS HOUS IND D; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Paulos Z., 2009, INT FOOD POLICY RES; Popkin BM, 2011, P NUTR SOC, V70, P82, DOI 10.1017/S0029665110003903; Ross J, 1995, DIMENSIONS NEED ATLA; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Sordo L, 2012, AM J TROP MED HYG, V86, P955, DOI 10.4269/ajtmh.2012.11-0436; Steyn NP, 2006, PUBLIC HEALTH NUTR, V9, P644, DOI 10.1079/PHN2005912; Thompson B., 2010, NARROWING NUTR GAP I; Tolossa D, 2002, HOUSEHOLD SEASONAL F; United Nations Children's Fund (UNICEF), 2003, STRAT RED MAT CHILD; United Nations Children's Fund (UNICEF), 2009, SUMM FOOD SEC VULN S; United States Agency for International Development (USAID), 2014, 2014 SCH MILK DAY CA; Viswanath N., 2012, AFR POLICY J, V8, P30; Von Braun J, 2009, FOOD POLICY DEV CTR, V2, P175; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; World Food Program, 2014, TECHN SPEC BARL GRAI; World Health Organization (WHO), 2014, 2012 2013 BIENN REP	54	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133435	10.1371/journal.pone.0133435	http://dx.doi.org/10.1371/journal.pone.0133435			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203904	Green Published, gold, Green Submitted			2022-12-26	WOS:000358621000029
J	Verma, P; Sengupta, S				Verma, Prateek; Sengupta, Supratim			Bribe and Punishment: An Evolutionary Game-Theoretic Analysis of Bribery	PLOS ONE			English	Article							CORRUPTION; CULTURE	Harassment bribes, paid by citizens to corrupt officers for services the former are legally entitled to, constitute one of the most widespread forms of corruption in many countries. Nation states have adopted different policies to address this form of corruption. While some countries make both the bribe giver and the bribe taker equally liable for the crime, others impose a larger penalty on corrupt officers. We examine the consequences of asymmetric and symmetric penalties by developing deterministic and stochastic evolutionary game-theoretic models of bribery. We find that the asymmetric penalty scheme can lead to a reduction in incidents of bribery. However, the extent of reduction depends on how the players update their strategies over time. If the interacting members change their strategies with a probability proportional to the payoff of the alternative strategy option, the reduction in incidents of bribery is less pronounced. Our results indicate that changing from a symmetric to an asymmetric penalty scheme may not suffice in achieving significant reductions in incidents of harassment bribery.	[Verma, Prateek; Sengupta, Supratim] Indian Inst Sci Educ & Res Kolkata, Dept Phys Sci, Kolkata, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Sengupta, S (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Phys Sci, Kolkata, India.	supratim.sen@iiserkol.ac.in		Verma, Prateek/0000-0003-3431-246X				Abbink K, 2002, J LAW ECON ORGAN, V18, P428, DOI 10.1093/jleo/18.2.428; Abbink K., 2004, EUR J POLIT ECON, V20, P887, DOI [10.1016/j.ejpoleco.2003.10.008, DOI 10.1016/J.EJPOLECO.2003.10.008]; Abbink K, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, P418; Abbink K, 2006, EXP ECON, V9, P103, DOI 10.1007/s10683-006-5385-z; Abbink K, 2014, J PUBLIC ECON, V111, P17, DOI 10.1016/j.jpubeco.2013.12.012; Alatas V, 2009, SOUTH ECON J, V75, P663; [Anonymous], 2014, 2014 CORRUPTION PERC; Banuri S, 2010, 0901 CTR BEH EXPT EC; Banuri S, 2012, RES EXP ECON, V15, P51, DOI 10.1108/S0193-2306(2012)0000015005; Barr A, 2009, EXP ECON, V12, P488, DOI 10.1007/s10683-009-9225-9; Cameron L, 2009, J PUBLIC ECON, V93, P843, DOI 10.1016/j.jpubeco.2009.03.004; Dreze J, 2011, INDIAN EXPRESS, P17; Dufwenberg M, 2011, LEGALIZING BRIBES; Dugatkin L. A., 2000, GAME THEORY ANIMAL B; Engel C, 2012, SSRN ELECT J, DOI [10.2139/ssrn.1983969, DOI 10.2139/SSRN.1983969]; European Comission, 2014, EU ANT REP; HELBING D, 1992, PHYSICA A, V181, P29, DOI 10.1016/0378-4371(92)90195-V; Lee JH, 2015, J THEOR BIOL, V367, P1, DOI 10.1016/j.jtbi.2014.10.037; Maynard Smith J., 1982, pi; McBride M, 2012, CRIME PUNISHMENT EVO, P1; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ryvkin D., 2013, DOES COMPETITION PUB; Schickora JT, 2011, BRINGING 4 EYES PRIN; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Serra D., 2012, NEW ADV EXPT RES COR; Serra D, 2012, J LAW ECON ORGAN, V28, P569, DOI 10.1093/jleo/ewr010; Sigmund K, 1998, EVOLUTIONARY GAMES P; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011901	31	16	16	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133441	10.1371/journal.pone.0133441	http://dx.doi.org/10.1371/journal.pone.0133441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NJ	26204110	Green Published, Green Submitted, gold			2022-12-26	WOS:000358621000030
J	Lazzarin, M; Cozzi, R; Malito, E; Martinelli, M; D'Onofrio, M; Maione, D; Margarit, I; Rinaudo, CD				Lazzarin, Maddalena; Cozzi, Roberta; Malito, Enrico; Martinelli, Manuele; D'Onofrio, Mariapina; Maione, Domenico; Margarit, Immaculada; Rinaudo, C. Daniela			Noncanonical sortase-mediated assembly of pilus type 2b in group B Streptococcus	FASEB JOURNAL			English	Article						crystal structure; backbone protein; ancillary protein; FRET assay	PROTEIN; SURFACE; IDENTIFICATION; FEATURES; VACCINE	Group B Streptococcus (GBS) expresses 3 structurally distinct pilus types (1, 2a, and 2b) identified as important virulence factors and vaccine targets. These pili are heterotrimeric polymers, covalently assembled on the cell wall by sortase (Srt) enzymes. We investigated the pilus-2b biogenesis mechanism by using a multidisciplinary approach integrating genetic, biochemical, and structural studies to dissect the role of the 2 pilus-2b-associated Srts. We show that only 1 sortase (SrtC1-2b) is responsible for pilus protein polymerization, whereas the second one (Srt2-2b) does not act as a pilin polymerase, but similarly to the housekeeping class A Srt (SrtA), it is involved in cell-wall pilus anchoring by targeting the minor ancillary subunit. Based on its function and sequence features, Srt2-2b does not belong to class C Srts (SrtCs), nor is it a canonical member of any other known family of Srts. We also report the crystal structure of SrtC1-2b at 1.9 angstrom resolution. The overall fold resembles the typical structure of SrtCs except for the N-terminal lid region that appears in an open conformation displaced from the active site. Our findings reveal that GBS pilus type 2b biogenesis differs significantly from the current model of pilus assembly in gram-positive pathogens.	[Lazzarin, Maddalena; Cozzi, Roberta; Malito, Enrico; Martinelli, Manuele; Maione, Domenico; Margarit, Immaculada; Rinaudo, C. Daniela] GlaxoSmithKline, Novartis Vaccines & Diagnost, Siena, Italy; [D'Onofrio, Mariapina] Univ Verona, Nucl Magnet Resonance Lab, Dept Biotechnol, I-37100 Verona, Italy	GlaxoSmithKline; Novartis; University of Verona	Rinaudo, CD (corresponding author), Novartis Vaccines & Diagnost, Via Fiorentina 1, I-53100 Siena, Italy.	daniela.rinaudo@novartis.com		D'ONOFRIO, Mariapina/0000-0002-8699-0847; martinelli, manuele/0000-0002-9371-076X	University of Verona; Novartis Vaccines and Diagnostics	University of Verona; Novartis Vaccines and Diagnostics	The authors thank R. Rosini and E. Campisi (Novartis Vaccines and Diagnostics, GlaxoSmithKline) for critical and useful discussion. This work was supported by the Joint Research Project 2010 between the University of Verona and Novartis Vaccines and Diagnostics.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Barnett TC, 2004, J BACTERIOL, V186, P5865, DOI 10.1128/JB.186.17.5865-5875.2004; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Chaiswing L, 2010, ANTIOXID REDOX SIGN, V13, P449, DOI 10.1089/ars.2009.3020; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cozzi R, 2013, FASEB J, V27, P3144, DOI 10.1096/fj.13-227793; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; Cozzi R, 2011, FASEB J, V25, P1874, DOI 10.1096/fj.10-174797; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Khare B, 2011, J MOL BIOL, V414, P563, DOI 10.1016/j.jmb.2011.10.017; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Levin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059175; Lu GW, 2011, PROTEINS, V79, P2764, DOI 10.1002/prot.23093; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Necchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025300; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Nuccitelli A, 2011, P NATL ACAD SCI USA, V108, P10278, DOI 10.1073/pnas.1106590108; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Schneewind O, 2014, BBA-MOL CELL RES, V1843, P1687, DOI 10.1016/j.bbamcr.2013.11.009; Shaik MM, 2014, J BIOL CHEM, V289, P16988, DOI 10.1074/jbc.M114.555854; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07	45	9	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4629	4640		10.1096/fj.15-272500	http://dx.doi.org/10.1096/fj.15-272500			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26202865				2022-12-26	WOS:000364514700021
J	Zhu, GY; Fei, T; Li, ZW; Yan, XH; Chen, YG				Zhu, Gaoyang; Fei, Teng; Li, Zhongwei; Yan, Xiaohua; Chen, Ye-Guang			Activin Regulates Self-renewal and Differentiation of Trophoblast Stem Cells by Down-regulating the X Chromosome Gene Bcor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; TRANSCRIPTION FACTORS; POLYCOMB GROUP; MOUSE EMBRYO; EXPRESSION; FAMILY; SMADS; PROLIFERATION; COMPLICATIONS	The development of a functional placenta is largely dependent upon proper proliferation and differentiation of trophoblast stem cells (TSCs). Activin signaling has long been regarded to play important roles during this process, but the exact mechanism is largely unknown. Here, we demonstrate that the X chromosome gene BCL-6 corepressor (Bcor) is a critical downstream effector of activin to fine-tune mouse TSC fate decision. Bcor was specifically down-regulated by activinAin TSCs in a dose-dependent manner, and immediately up-regulated upon TSC differentiation. Knockdown of Bcor partially compensated for the absence of activin A in maintaining the self-renewal of TSCs together with FGF4, while promoting syncytiotrophoblast differentiation in the absence of FGF4. Moreover, the impaired trophoblast giant cell and spongiotrophoblast differentiation upon Bcor knockdown also resembled the function of activin. Reporter analysis showed that BCOR inhibited the expression of the key trophoblast regulator genes Eomes and Cebpa by binding to their promoter regions. Our findings provide us with a better understanding of placental development and placenta-related diseases.	[Zhu, Gaoyang; Fei, Teng; Li, Zhongwei; Yan, Xiaohua; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China	Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Yan, Xiaohua/J-4922-2015	Yan, Xiaohua/0000-0002-7528-5771	973 Program [2011CB943803, 2013CB933700]; National Natural Science Foundation of China [31221064, 31330049]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the 973 Program (2011CB943803 and 2013CB933700) and the National Natural Science Foundation of China (31221064 and 31330049) (to Y. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi K, 2013, MOL CELL, V52, P380, DOI 10.1016/j.molcel.2013.09.002; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; Bergsmedh A, 2011, GENES-BASEL, V2, P420, DOI 10.3390/genes2030420; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Bouillot S, 2006, PLACENTA, V27, P882, DOI 10.1016/j.placenta.2005.09.009; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Datto M, 2000, CYTOKINE GROWTH F R, V11, P37, DOI 10.1016/S1359-6101(99)00027-1; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Fei T, 2010, SCI CHINA LIFE SCI, V53, P497, DOI 10.1007/s11427-010-0096-2; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Guzman-Ayala M, 2004, P NATL ACAD SCI USA, V101, P15656, DOI 10.1073/pnas.0405429101; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horn D, 2005, EUR J HUM GENET, V13, P563, DOI 10.1038/sj.ejhg.5201391; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Huynh KD, 2000, GENE DEV, V14, P1810; Jackman SM, 2012, MOL REPROD DEV, V79, P564, DOI 10.1002/mrd.22062; Jauniaux E, 2010, CURR OPIN OBSTET GYN, V22, P452, DOI 10.1097/GCO.0b013e3283404e44; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kondo Y, 2012, J HUM GENET, V57, P197, DOI 10.1038/jhg.2012.4; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Natale D. R., 2009, ACTIVIN PROMOTES DIF; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Norwitz ER, 2006, REPROD BIOMED ONLINE, V13, P591, DOI 10.1016/S1472-6483(10)60649-9; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wamstad JA, 2007, GENE EXPR PATTERNS, V7, P550, DOI 10.1016/j.modgep.2007.01.006; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; Wang DG, 2008, CANCER RES, V68, P783, DOI 10.1158/0008-5472.CAN-07-0008; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wu T, 2011, STEM CELLS, V29, P755, DOI 10.1002/stem.617; Zhang JP, 2013, J BIOL CHEM, V288, P8053, DOI 10.1074/jbc.M112.433995	47	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22019	22029		10.1074/jbc.M115.674127	http://dx.doi.org/10.1074/jbc.M115.674127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26221038	hybrid, Green Published			2022-12-26	WOS:000360968500022
J	Dupre, E; Lesne, E; Guerin, J; Lensink, MF; Verger, A; de Ruyck, J; Brysbaert, G; Vezin, H; Locht, C; Antoine, R; Jacob-Dubuisson, F				Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Lensink, Marc F.; Verger, Alexis; de Ruyck, Jerome; Brysbaert, Guillaume; Vezin, Herve; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise			Signal Transduction by BvgS Sensor Kinase BINDING OF MODULATOR NICOTINATE AFFECTS THE CONFORMATION AND DYNAMICS OF THE ENTIRE PERIPLASMIC MOIETY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDETELLA-PERTUSSIS; MICROSCALE THERMOPHORESIS; GLUTAMATE-RECEPTOR; HISTIDINE KINASE; PAS DOMAIN; PROTEIN; VIRULENCE; MECHANISM; SYSTEM; TRANSPORT	The two-component sensory transduction system BvgAS controls the virulence regulon of the whooping-cough agent Bordetella pertussis. The periplasmic moiety of the homodimeric sensor kinase BvgS is composed of four bilobed Venus flytrap (VFT) perception domains followed by alpha helices that extend into the cytoplasmic membrane. In the virulent phase, the default state of B. pertussis, the cytoplasmic enzymatic moiety of BvgS acts as kinase by autophosphorylating and transferring the phosphoryl group to the response regulator BvgA. Under laboratory conditions, BvgS shifts to phosphatase activity in response to modulators, notably nicotinate ions. Here we characterized the effects of nicotinate and related modulators on the BvgS periplasmic moiety by using site-directed mutagenesis and in silico and biophysical approaches. Modulators bind with low affinity to BvgS in the VFT2 cavity. Electron paramagnetic resonance shows that their binding globally affects the conformation and dynamics of the periplasmic moiety. Specific amino acid substitutions designed to slacken interactions within and between the VFT lobes prevent BvgS from responding to nicotinate, showing that BvgS shifts from kinase to phosphatase activity in response to this modulator via a tense transition state that involves a large periplasmic structural block. We propose that this transition enables the transmembrane helices to adopt a distinct conformation that sets the cytoplasmic enzymatic moiety in the phosphatase mode. The bona fide, in vivo VFT ligands that remain to be identified are likely to trigger similar effects on the transmembrane and cytoplasmic moieties. This mechanism may be relevant to the other VFT-containing sensor kinases homologous to BvgS.	[Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Lensink, Marc F.; Verger, Alexis; de Ruyck, Jerome; Brysbaert, Guillaume; Vezin, Herve; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] Univ Lille Nord France, F-59000 Lille, France; [Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] CNRS, UMR 8204, F-59046 Lille, France; [Dupre, Elian; Lesne, Elodie; Guerin, Jeremy; Locht, Camille; Antoine, Rudy; Jacob-Dubuisson, Francoise] INSERM, U1019, F-59045 Lille, France; [Lensink, Marc F.; Verger, Alexis; de Ruyck, Jerome; Brysbaert, Guillaume] CNRS, Unite Glycobiol Struct & Fonct, UMR 8576, F-59658 Villeneuve Dascq, France; [Vezin, Herve] CNRS, Lab Spectrochim Infrarouge & Raman LASIR, UMR 8516, F-59658 Villeneuve Dascq, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lille - ISITE; Universite de Lille	Antoine, R (corresponding author), Inst Pasteur, Ctr Infect & Immun Lille, 1 Rue Calmette, F-59019 Lille, France.	rudy.antoine@pasteur-lille.fr; francoise.jacob@ibl.cnrs.fr	Lensink, Marc F/A-1678-2008; Vezin, Hervé/I-8004-2015; Jacob-Dubuisson, Françoise/F-1610-2018; Antoine, Rudy/L-1630-2018; Locht, Camille/L-3516-2018; Antoine, Rudy/CAH-6653-2022	Lensink, Marc F/0000-0003-3957-9470; Vezin, Hervé/0000-0002-7282-2703; Jacob-Dubuisson, Françoise/0000-0002-5102-1704; Antoine, Rudy/0000-0002-7369-0626; Antoine, Rudy/0000-0002-7369-0626; Brysbaert, Guillaume/0000-0002-6807-6621; Locht, Camille/0000-0001-7295-7336; Dupre, Elian/0000-0001-5281-0337; verger, alexis/0000-0002-0299-2344; de Ruyck, Jerome/0000-0003-4397-1870	Agence Nationale de la Recherche [ANR-13-BSV8-0002-01]; Fonds de la Recherche Scientifique (F. R. S.)-FNRS [2.4520.11]; French Research Ministry; Fonds de la Recherche Medicale	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fonds de la Recherche Scientifique (F. R. S.)-FNRS(Fonds de la Recherche Scientifique - FNRS); French Research Ministry(Ministry of Research, France); Fonds de la Recherche Medicale(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Grant ANR-13-BSV8-0002-01 from the Agence Nationale de la Recherche (to F. J. D.). This research used resources from the Plateforme Technologique de Calcul Intensif at the University of Namur, Belgium, which is supported by the Fonds de la Recherche Scientifique (F. R. S.)-FNRS under convention 2.4520.11. The authors declare that they have no conflict of interest with the contents of this manuscript.; Recipient of predoctoral fellowships from the French Research Ministry and the Fonds de la Recherche Medicale.	Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; Antoine R, 2000, J BACTERIOL, V182, P5902, DOI 10.1128/JB.182.20.5902-5905.2000; Ayers RA, 2008, BIOCHEMISTRY-US, V47, P12078, DOI 10.1021/bi801254c; Boulanger A, 2013, MOL MICROBIOL, V88, P156, DOI 10.1111/mmi.12177; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Dupre E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004700; Dupre E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-172; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Huth JR, 1997, PROTEIN SCI, V6, P2359; Jacobdubuisson F, 2012, 2 COMPONENT SYSTEM B, P57; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; King HA, 2011, J MOL BIOL, V413, P561, DOI 10.1016/j.jmb.2011.08.048; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kristensen AS, 2006, TRENDS PHARMACOL SCI, V27, P65, DOI 10.1016/j.tips.2005.12.005; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Little R, 2011, MOL MICROBIOL, V82, P222, DOI 10.1111/j.1365-2958.2011.07812.x; Martinez de Tejada G. M., 1996, MOL MICROBIOL, V22, P895; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mechaly AE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001776; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Molnar KS, 2014, STRUCTURE, V22, P1239, DOI 10.1016/j.str.2014.04.019; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; SCHNEIDER DR, 1982, INFECT IMMUN, V38, P548, DOI 10.1128/IAI.38.2.548-553.1982; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Slavny P, 2010, MOL MICROBIOL, V75, P61, DOI 10.1111/j.1365-2958.2009.06956.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stockbauer KE, 2001, MOL MICROBIOL, V39, P65, DOI 10.1046/j.1365-2958.2001.02191.x; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Yelshanskaya MV, 2014, SCIENCE, V345, P1070, DOI 10.1126/science.1256508	48	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23307	23319		10.1074/jbc.M115.655720	http://dx.doi.org/10.1074/jbc.M115.655720			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26203186	Green Published, hybrid			2022-12-26	WOS:000361685500038
J	Bergmann, C; Ten Bosch, L; Fikkert, P; Boves, L				Bergmann, Christina; Ten Bosch, Louis; Fikkert, Paula; Boves, Lou			Modelling the Noise-Robustness of Infants' Word Representations: The Impact of Previous Experience	PLOS ONE			English	Article							SPEECH RECOGNITION; VARIABILITY; DATABASE; SOUNDS; NAME	During language acquisition, infants frequently encounter ambient noise. We present a computational model to address whether specific acoustic processing abilities are necessary to detect known words in moderate noise-an ability attested experimentally in infants. The model implements a general purpose speech encoding and word detection procedure. Importantly, the model contains no dedicated processes for removing or cancelling out ambient noise, and it can replicate the patterns of results obtained in several infant experiments. In addition to noise, we also addressed the role of previous experience with particular target words: does the frequency of a word matter, and does it play a role whether that word has been spoken by one or multiple speakers? The simulation results show that both factors affect noise robustness. We also investigated how robust word detection is to changes in speaker identity by comparing words spoken by known versus unknown speakers during the simulated test. This factor interacted with both noise level and past experience, showing that an increase in exposure is only helpful when a familiar speaker provides the test material. Added variability proved helpful only when encountering an unknown speaker. Finally, we addressed whether infants need to recognise specific words, or whether a more parsimonious explanation of infant behaviour, which we refer to as matching, is sufficient. Recognition involves a focus of attention on a specific target word, while matching only requires finding the best correspondence of acoustic input to a known pattern in the memory. Attending to a specific target word proves to be more noise robust, but a general word matching procedure can be sufficient to simulate experimental data stemming from young infants. A change from acoustic matching to targeted recognition provides an explanation of the improvements observed in infants around their first birthday. In summary, we present a computational model incorporating only the processes infants might employ when hearing words in noise. Our findings show that a parsimonious interpretation of behaviour is sufficient and we offer a formal account of emerging abilities.	[Bergmann, Christina; Ten Bosch, Louis; Fikkert, Paula; Boves, Lou] Radboud Univ Nijmegen, Ctr Language Studies, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bergmann, C (corresponding author), PSL Res Univ, Ecole Normale Super, Dept Etudes Cognit, Lab Sci Cognit & Psycholinguist ENS EHESS CNRS, Paris, France.	chbergma@gmail.com	Bergmann, Christina/J-2765-2014	Bergmann, Christina/0000-0003-2656-9070; Fikkert, Paula/0000-0001-7317-2100; ten bosch, louis/0000-0002-0152-9024	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [360-70-350]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	The present work was supported by grant no. 360-70-350 from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (http://www.nwo.nl/) to LB, PF to support the work of CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbaum KS, 2011, COGNITIVE SCI, V35, P1105, DOI 10.1111/j.1551-6709.2011.01181.x; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; Barker BA, 2004, COGNITION, V94, pB45, DOI 10.1016/j.cognition.2004.06.001; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Bergmann C, 2015, INWORDDB DATABASE IN; Bergmann C, 2013, FRONT PSYCHOL, V4, P1; Bergmann C, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2910; Bregman A.S., 1994, AUDITORY SCENE ANAL; Coleman J, 2005, SPEECH LANGUAGE PROC; Dale PS, 1996, BEHAV RES METH INS C, V28, P125, DOI 10.3758/BF03203646; Driesen J, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P1711; Eichenbaum H., 2011, COGNITIVE NEUROSCIEN, V2, DOI [10.1093/acprof:oso/9780199778614.001.0001, DOI 10.1093/ACPROF:OSO/9780199778614.001.0001]; Gaskell MG, 1997, LANG COGNITIVE PROC, V12, P613, DOI 10.1080/016909697386646; GLEITMAN LR, 1994, PHILOS T ROY SOC B, V346, P71, DOI 10.1098/rstb.1994.0130; Gogate LJ, 2010, PSYCHOL REV, V117, P496, DOI 10.1037/a0019049; Gout A, 2004, J MEM LANG, V51, P548, DOI 10.1016/j.jml.2004.07.002; Hermansky H, 2011, SADHANA-ACAD P ENG S, V36, P729, DOI 10.1007/s12046-011-0044-2; Hollich G, 2005, CHILD DEV, V76, P598, DOI 10.1111/j.1467-8624.2005.00866.x; Johnson EK, 2008, INFANCY, V13, P440, DOI 10.1080/15250000802329321; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; MANDEL DR, 1995, PSYCHOL SCI, V6, P314, DOI 10.1111/j.1467-9280.1995.tb00517.x; Moerel M, 2012, J NEUROSCI, V32, P14205, DOI 10.1523/JNEUROSCI.1388-12.2012; Ness SR, 2012, AUDITORY SPARSE CODI; Newman RS, 2008, CURR DIR PSYCHOL SCI, V17, P229, DOI 10.1111/j.1467-8721.2008.00580.x; Newman RS, 2013, J ACOUST SOC AM, V133, pEL377, DOI 10.1121/1.4798269; Newman RS, 2009, ATTEN PERCEPT PSYCHO, V71, P822, DOI 10.3758/APP.71.4.822; Newman RS, 2005, DEV PSYCHOL, V41, P352, DOI 10.1037/0012-1649.41.2.352; Newman RS, 1996, PERCEPT PSYCHOPHYS, V58, P1145, DOI 10.3758/BF03207548; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Parise E, 2012, PSYCHOL SCI, V23, P728, DOI 10.1177/0956797612438734; Polka L, 2008, INFANCY, V13, P421, DOI 10.1080/15250000802329297; POLLACK I, 1975, J ACOUST SOC AM, V57, pS5, DOI 10.1121/1.1995329; Pols LCW, 1996, SPEECH COMMUN, V19, P161, DOI 10.1016/0167-6393(96)00033-7; Rost GC, 2009, DEVELOPMENTAL SCI, V12, P339, DOI 10.1111/j.1467-7687.2008.00786.x; Roy D, 2006, LECT NOTES ARTIF INT, V4211, P192; Roy DK, 2002, COGNITIVE SCI, V26, P113, DOI 10.1207/s15516709cog2601_4; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2007, HDB CHILD PSYCHOL CO, P59; Schatz T., 2013, INTERSPEECH 2013, P1781; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Smith LB, 2011, DEVELOPMENTAL SCI, V14, P9, DOI 10.1111/j.1467-7687.2009.00947.x; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; Synnaeve G, 2014, SPEECH FEATURES PIPE; Thiessen ED, 2013, COGNITIVE SCI, V37, P310, DOI 10.1111/cogs.12011; van de Weijer J., 1998, LANGUAGE INPUT WORD; Van hamme H, 2011, SIGN PROC AD SPARS S, P119; Van Hamme H, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P2554; VARGA A, 1993, SPEECH COMMUN, V12, P247, DOI 10.1016/0167-6393(93)90095-3; Verberne S, 2010, COMPUT LINGUIST, V36, P229, DOI 10.1162/coli.2010.09-032-R1-08-034; Versteegh M, 2013, P INT; Versteegh M, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2930; Wachs T.D., 1986, CHILDRENS ENV Q, V3, P23; Wade NJ, 2012, VISUAL PERCEPTION IN; Werker JF, 2005, LANG LEARN DEV, V1, P197, DOI 10.1080/15475441.2005.9684216; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Yu C., 2013, PSYCHONOMIC B REV, V1, P1	56	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132245	10.1371/journal.pone.0132245	http://dx.doi.org/10.1371/journal.pone.0132245			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218504	Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900005
J	Zito, S; Vankan, D; Bennett, P; Paterson, M; Phillips, CJC				Zito, Sarah; Vankan, Dianne; Bennett, Pauleen; Paterson, Mandy; Phillips, Clive J. C.			Cat Ownership Perception and Caretaking Explored in an Internet Survey of People Associated with Cats	PLOS ONE			English	Article							FREE-ROAMING CATS; FERAL DOMESTIC CATS; SHELTER PRACTICES; ATTITUDES; BEHAVIORS; MANAGEMENT; WELFARE; ADMISSIONS; ONLINE; URBAN	People who feed cats that they do not perceive they own (sometimes called semi-owners) are thought to make a considerable contribution to unwanted cat numbers because the cats they support are generally not sterilized. Understanding people's perception of cat ownership and the psychology underlying cat semi-ownership could inform approaches to mitigate the negative effects of cat semi-ownership. The primary aims of this study were to investigate cat ownership perception and to examine its association with human-cat interactions and caretaking behaviours. A secondary aim was to evaluate a definition of cat semi-ownership (including an association time of >= 1 month and frequent feeding), revised from a previous definition proposed in the literature to distinguish cat semi-ownership from casual interactions with unowned cats. Cat owners and semi-owners displayed similar types of interactions and caretaking behaviours. Nevertheless, caretaking behaviours were more commonly displayed towards owned cats than semi-owned cats, and semi-owned cats were more likely to have produced kittens (p<0.01). All interactions and caretaking behaviours were more likely to be displayed towards cats in semi-ownership relationships compared to casual interaction relationships. Determinants of cat ownership perception were identified (p<0.05) and included association time, attachment, perceived cat friendliness and health, and feelings about unowned cats, including the acceptability of feeding unowned cats. Encouraging semi-owners to have the cats they care for sterilized may assist in reducing the number of unwanted kittens and could be a valuable alternative to trying to prevent semi-ownership entirely. Highly accessible semi-owner "gatekeepers" could help to deliver education messages and facilitate the provision of cat sterilization services to semi-owners. This research enabled semi-ownership to be distinguished from casual interaction relationships and can assist welfare and government agencies to identify cat semi-owners in order to develop strategies to address this source of unwanted cats.	[Zito, Sarah; Phillips, Clive J. C.] Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton, Qld, Australia; [Vankan, Dianne] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Bennett, Pauleen] La Trobe Univ, Sch Psychol & Publ Hlth, Bendigo, Vic, Australia; [Paterson, Mandy] RSPCA Queensland, Wacol, Qld, Australia	University of Queensland; University of Queensland; La Trobe University	Zito, S (corresponding author), Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton Campus, Gatton, Qld, Australia.	s.zito@uq.edu.au	; Bennett, Pauleen/C-2138-2016	Paterson, Mandy/0000-0003-4564-9877; Bennett, Pauleen/0000-0001-5864-4464	Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia; Royal Society for the Prevention of Cruelty to Animals (RSPCA) Queensland	Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia; Royal Society for the Prevention of Cruelty to Animals (RSPCA) Queensland	The Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia and Queensland both contributed financially to this project (www.rspca.org.au and www.rspcaqld.org.au). Dr. Mandy Paterson, who works as the Principal Scientist for RSPCA Queensland, had a role in study design, data analysis, decision to publish, and preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Alberthsen C, 2013, AUST VET J, V91, P35, DOI 10.1111/avj.12013; Alberthsen C, 2014, THESIS U QUEENSLAND; Aronson E., 1969, ADV EXP SOC PSYCHOL, P1, DOI [10.1016/s0065-2601(08)60075-1, DOI 10.1016/S0065-2601(08)60075-1]; Aronson E., 2013, SOCIAL PSYCHOL; Aronson Elliot, 1998, COGNITIVE DISSONANCE, P21; Australian Bureau of Statistics, 2011, CENS HOM; Australian Companion Animal Council, 2010, CONTR PET CAR IND AU; Baltar F, 2012, INTERNET RES, V22, P57, DOI 10.1108/10662241211199960; Bhutta CB, 2012, SOCIOL METHOD RES, V41, P57, DOI 10.1177/0049124112440795; Cassese EC, 2013, PS-POLIT SCI POLIT, V46, P775, DOI 10.1017/S1049096513001029; Centonze LA, 2002, J AM VET MED ASSOC, V220, P1627, DOI 10.2460/javma.2002.220.1627; Denny E., 2010, REV CAT ECOLOGY MANA; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Emmel N, 2007, SOCIOL RES ONLINE, V12; Farnworth MJ, 2010, J APPL ANIM WELF SCI, V13, P180, DOI 10.1080/10888700903584846; Finkler H, 2012, PREV VET MED, V104, P125, DOI 10.1016/j.prevetmed.2011.11.006; Finkler H, 2011, ANTHROZOOS, V24, P31, DOI 10.2752/175303711X12923300467320; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gunaseelan S, 2013, ANTHROZOOS, V26, P199, DOI 10.2752/175303713X13636846944123; Haspel C., 1992, Anthrozoos, V3, P155, DOI 10.2752/089279390787057630; Hood J., 1998, PET OWNERSHIP ASIAN; Katcher AH, 1983, SAFETY INTIMACY PHYS, P112; Levy JK, 2003, J AM VET MED ASSOC, V223, P202, DOI 10.2460/javma.2003.223.202; Lord LK, 2008, JAVMA-J AM VET MED A, V232, P1159, DOI 10.2460/javma.232.8.1159; Lord LK, 2007, JAVMA-J AM VET MED A, V230, P1835, DOI 10.2460/javma.230.12.1835; Loyd KAT, 2012, ANTHROZOOS, V25, P337, DOI 10.2752/175303712X13403555186299; MacArthur SL, 2012, MADD SHELT MED C; Marston LC, 2009, J APPL ANIM WELF SCI, V12, P189, DOI 10.1080/10888700902955948; Mornement K, 2012, ANTHROZOOS, V25, P457, DOI 10.2752/175303712X13479798785850; Natoli E, 1999, ANTHROZOOS, V12, P16, DOI 10.2752/089279399787000408; Natoli E, 2006, PREV VET MED, V77, P180, DOI 10.1016/j.prevetmed.2006.06.005; Neidhart Laura, 2002, Journal of Applied Animal Welfare Science, V5, P175, DOI 10.1207/S15327604JAWS0503_02; Paterson M, 2014, ANIM PUB, P169; Phillips C, 2011, ANIMALS-BASEL, V1, P7, DOI 10.3390/ani1010007; Riva G, 2003, CYBERPSYCHOL BEHAV, V6, P73, DOI 10.1089/109493103321167983; Rochberg-Halton E, 1979, THESIS U CHIGACO CHI; Rohlf VI, 2012, ANTHROZOOS, V25, P171, DOI 10.2752/175303712X13316289505341; Rohlf VI, 2010, ANTHROZOOS, V23, P143, DOI 10.2752/175303710X12682332909972; Slater MR, 2008, PREV VET MED, V85, P267, DOI 10.1016/j.prevetmed.2008.02.001; Spindel ME, 2013, J FELINE MED SURG, V15, P323, DOI 10.1177/1098612X13477801; Toribio JALM, 2009, J FELINE MED SURG, V11, P449, DOI 10.1016/j.jfms.2008.06.010; Toukhsati SR, 2007, ANTHROZOOS, V20, P131, DOI 10.2752/175303707X207927; Toukhsati Samia R, 2012, Animals (Basel), V2, P611, DOI 10.3390/ani2040611; Toukhsati SR, 2012, ANTHROZOOS, V25, P61, DOI 10.2752/175303712X13240472427195; Victorian Government, 2013, DOM AN MAN PLAN 1 JU; Webb C, 2008, AAWS INT AN WELF C G; Webb C., 1995, MANAGEMENT UNOWNED C; Zito S, 2015, J APPL ANIM IN PRESS	51	33	33	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133293	10.1371/journal.pone.0133293	http://dx.doi.org/10.1371/journal.pone.0133293			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218243	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900025
J	Blumental, S; Granger-Farbos, A; Moisi, JC; Soullie, B; Leroy, P; Njanpop-Lafourcade, BM; Yaro, S; Nacro, B; Hallin, M; Koeck, JL				Blumental, Sophie; Granger-Farbos, Alexandra; Moisi, Jennifer C.; Soullie, Bruno; Leroy, Philippe; Njanpop-Lafourcade, Berthe-Marie; Yaro, Seydou; Nacro, Boubacar; Hallin, Marie; Koeck, Jean-Louis			Virulence Factors of Streptococcus pneumoniae. Comparison between African and French Invasive Isolates and Implication for Future Vaccines	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; SURFACE PROTEIN-A; CAPSULAR SEROTYPES; DISEASE; PNEUMOLYSIN; MENINGITIS; IMMUNOGENICITY; IDENTIFICATION; IMMUNIZATION; DIVERSITY	Background Many surface proteins thought to promote Streptocococcus pneumoniae virulence have recently been discovered and are currently being considered as future vaccine targets. We assessed the prevalence of 16 virulence genes among 435 S. pneumoniae invasive isolates from France and the "African meningitis belt" region, with particular focus on serotype 1 (Sp1), to compare their geographical distribution, assess their association with site of infection and evaluate their potential interest as new vaccine candidates. Methods Detection by PCR of pspA (+families), pspC (+pspC.4), pavA, lytA, phtA, B,D,E, nanA,B,C, rrgA (Pilus-1), sipA (Pilus-2), pcpA and psrp was performed on all isolates, as well as antibiotic resistance testing and MLVA typing (+MLST on 54 representative strains). Determination of ply alleles was performed by sequencing (Sp1 isolates). Results MLVA and virulence genes profiles segregated Sp1 isolates into 2 groups that followed continent distribution. The ply allele 5 and most of the genes that were variable (nanC, Pilus-2, psrp, pcpA, phtD) were present in the French Sp1 isolates (PMEN clone Sweden(1)-28, ST306) but absent from the African ones. Whereas all African Sp1 isolates clustered into a single MLST CC (CC217), MLVA distinguished two CCs that followed temporal evolution. Pilus-2 and psrp were more prevalent in bacteraemic pneumonia yielded isolates and phtB in meningitis-related isolates. Considering vaccine candidates, phtD was less prevalent than anticipated (50%) and pcpA varied importantly between France and Africa (98% versus 34%). Pilus-1 was carried by 7-11% of isolates and associated with beta-lactams resistance. Conclusions Most virulence genes were carried by the European ST306 clone but were lacking on Sp1 isolates circulating in the African meningitis belt, where a more serious pattern of infection is observed. While virulence proteins are now considered as vaccine targets, the geographical differences in their prevalence could affect the efficacy expected from future vaccines.	[Blumental, Sophie] Hop Univ Enfants Reine Fabiola, Paediat Infect Dis Unit, Brussels, Belgium; [Granger-Farbos, Alexandra; Soullie, Bruno; Leroy, Philippe; Koeck, Jean-Louis] Hop Instruct Armees Robert Picque, Dept Biol, Mol Biol Lab, Bordeaux, France; [Moisi, Jennifer C.; Njanpop-Lafourcade, Berthe-Marie] Agence Med Prevent, Paris, France; [Yaro, Seydou] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Nacro, Boubacar] Ctr Hosp Univ Souro Sanou, Paediat Unit, Bobo Dioulasso, Burkina Faso; [Hallin, Marie] IRIS Lab, Ctr Mol Diag, Brussels, Belgium	Agence de Medecine Preventive; Centre Muraz	Blumental, S (corresponding author), Hop Univ Enfants Reine Fabiola, Paediat Infect Dis Unit, Brussels, Belgium.	sophie.blumental@ulb.ac.be			Belgian Kids' Funds; Iris Research Network	Belgian Kids' Funds; Iris Research Network	This study was supported by two scientific research grants received from the Belgian Kids' Funds and the Iris Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Angoulvant F, 2014, CLIN INFECT DIS, V58, P918, DOI 10.1093/cid/ciu006; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Bercion R, 2008, J TROP PEDIATRICS, V54, P125, DOI 10.1093/tropej/fmm075; Berglund J, 2014, CLIN VACCINE IMMUNOL, V21, P56, DOI 10.1128/CVI.00430-13; Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019668; Everett DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044250; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Garnacho-Montero J, 2012, DIAGN MICR INFEC DIS, V73, P39, DOI 10.1016/j.diagmicrobio.2012.02.002; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hamidou AA, 2007, 13 C ACT PHAR MARS F; Hanquet G, 2010, EMERG INFECT DIS, V16, P1428, DOI 10.3201/eid1609.100102; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hyams C, 2013, INFECT IMMUN, V81, P354, DOI 10.1128/IAI.00862-12; Imai S, 2011, CLIN MICROBIOL INFEC, V17, P1409, DOI 10.1111/j.1469-0691.2010.03446.x; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Kerr AR, 2006, INFECT IMMUN, V74, P5319, DOI 10.1128/IAI.00543-06; Koeck JL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-66; Kothari N, 2015, VACCINE, V33, P783, DOI 10.1016/j.vaccine.2014.12.032; Mann B, 2014, J INFECT DIS, V209, P1116, DOI 10.1093/infdis/jit502; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pettigrew MM, 2006, INFECT IMMUN, V74, P3360, DOI 10.1128/IAI.01442-05; Prymula R, 2014, VACCINE, V32, P3025, DOI 10.1016/j.vaccine.2014.03.066; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Selva L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041587; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Syk A, 2014, J INFECT DIS, V210, P4, DOI 10.1093/infdis/jiu038; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Verhoeven D, 2014, VACCINE, V32, P3205, DOI 10.1016/j.vaccine.2014.04.004; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	50	23	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133885	10.1371/journal.pone.0133885	http://dx.doi.org/10.1371/journal.pone.0133885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214695	Green Submitted, gold, Green Published			2022-12-26	WOS:000358594300038
J	Severijns, D; Octavia, JR; Kerkhofs, L; Coninx, K; Lamers, I; Feys, P				Severijns, Deborah; Octavia, Johanna Renny; Kerkhofs, Lore; Coninx, Karin; Lamers, Ilse; Feys, Peter			Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis	PLOS ONE			English	Article							MEAN POWER FREQUENCY; MOTOR FATIGUE; UPPER-LIMB; MUSCLE; STRENGTH; PROTOCOLS; DOMINANCE; RESPONSES; SIGNAL; GRIP	Background People with multiple sclerosis (MS) are encouraged to engage in exercise programs but an increased experience of fatigue may impede sustained participation in training sessions. A high number of movements is, however, needed for obtaining optimal improvements after rehabilitation. Methods This cross-sectional study investigated whether people with MS show abnormal fatigability during a robot-mediated upper limb movement trial. Sixteen people with MS and sixteen healthy controls performed five times three minutes of repetitive shoulder anteflexion movements. Movement performance, maximal strength, subjective upper limb fatigue and surface electromyography (median frequency and root mean square of the amplitude of the electromyography (EMG) signal of the anterior deltoid) were recorded during or in-between these exercises. After fifteen minutes of rest, one extra movement bout was performed to investigate how rest influences performance. Results A fifteen minutes upper limb movement protocol increased the perceived upper limb fatigue and induced muscle fatigue, given a decline in maximal anteflexion strength and changes of both the amplitude and the median frequency of EMG the anterior deltoid. In contrast, performance during the 3 minutes of anteflexion movements did not decline. There was no relation between changes in subjective fatigue and the changes in the amplitude and the median frequency of the anterior deltoid muscle, however, there was a correlation between the changes in subjective fatigue and changes in strength in people with MS. People with MS with upper limb weakness report more fatigue due to the repetitive movements, than people with MS with normal upper limb strength, who are comparable to healthy controls. The weak group could, however, keep up performance during the 15 minutes of repetitive movements. Discussion and Conclusion Albeit a protocol of repetitive shoulder anteflexion movements did not elicit a performance decline, fatigue feelings clearly increased in both healthy controls and people with MS, with the largest increase in people with MS with upper limb weakness. Objective fatigability was present in both groups with a decline in the muscle strength and increase of muscle fatigue, shown by changes in the EMG parameters. However, although weak people with multiple sclerosis experienced more fatigue, the objective signs of fatigability were less obvious in weak people with MS, perhaps because this subgroup has central limiting factors, which influence performance from the start of the movements.	[Severijns, Deborah; Lamers, Ilse; Feys, Peter] Hasselt Univ, BIOMED, Fac Med & Life Sci, REVAL Rehabil Res Ctr, Diepenbeek, Belgium; [Octavia, Johanna Renny] Parahyangan Catholic Univ, Dept Ind Engn, Bandung 40141, Indonesia; [Octavia, Johanna Renny; Coninx, Karin] Hasselt Univ, tUL, iMinds, Expertise Ctr Digital Media, Diepenbeek, Belgium; [Kerkhofs, Lore] Rehabil & MS Ctr Overpelt, Overpelt, Belgium	Hasselt University; Universitas Katolik Parahyangan; Hasselt University; IMEC	Severijns, D (corresponding author), Hasselt Univ, BIOMED, Fac Med & Life Sci, REVAL Rehabil Res Ctr, Diepenbeek, Belgium.	deborah.severijns@uhasselt.be	Octavia, Johanna Renny/ABE-2566-2020	Octavia, Johanna Renny/0000-0002-5581-2634; Feys, Peter/0000-0002-5680-5495; Lamers, Ilse/0000-0001-6147-4769				Bastiaens H, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975507, DOI 10.1109/ICORR.2011.5975507; Bertoni R, 2015, MULT SCLER; Bohannon R W, 1998, J Hand Ther, V11, P258; Burd NA, 2012, APPL PHYSIOL NUTR ME, V37, P551, DOI [10.1139/h2012-022, 10.1139/H2012-022]; Carpinella I, 2012, IEEE T NEUR SYS REH, V20, P351, DOI 10.1109/TNSRE.2012.2187462; Chopp JN, 2011, CLIN BIOMECH, V26, P40, DOI 10.1016/j.clinbiomech.2010.09.001; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Crenshaw AG, 2000, ACTA PHYSIOL SCAND, V170, P119, DOI 10.1046/j.1365-201x.2000.00765.x; Dalgas U, 2010, MULT SCLER J, V16, P480, DOI 10.1177/1352458509360040; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; Djaldetti R, 1996, NEUROLOGY, V46, P632, DOI 10.1212/WNL.46.3.632; Dobkin BH, 2008, NEUROREHAB NEURAL RE, V22, P105, DOI 10.1177/1545968308315046; Feys P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0043-3; Flachenecker P, 2002, MULT SCLER J, V8, P523, DOI 10.1191/1352458502ms839oa; Fuller JR, 2009, J ELECTROMYOGR KINES, V19, P1043, DOI 10.1016/j.jelekin.2008.10.009; Gijbels D, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-5; Gordon NM, 2012, J NEUROPHYSIOL, V108, P1501, DOI 10.1152/jn.01144.2011; Hayward K, 2010, DISABIL REHABIL, V32, P1973, DOI 10.3109/09638288.2010.481027; Hermens H.J., 1999, ROESSINGH RES DEV, V8, P11; Hummel A, 2005, EUR J APPL PHYSIOL, V95, P321, DOI 10.1007/s00421-005-0014-7; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Kister Ilya, 2013, Int J MS Care, V15, P146, DOI 10.7224/1537-2073.2012-053; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Konz S, 1998, INT J IND ERGONOM, V22, P67, DOI 10.1016/S0169-8141(97)00068-1; Kos D, 2003, ACTA NEUROL BELG, V103, P185; Krebs Herman Igo, 2012, Am J Phys Med Rehabil, V91, pS290, DOI 10.1097/PHM.0b013e31826bcd80; Lamers I, 2014, ARCH PHYS MED REHAB, V95, P1184, DOI 10.1016/j.apmr.2014.02.023; Lamers I, 2013, MULT SCLER J, V19, P1341, DOI 10.1177/1352458513475832; MERLETTI R, 1984, EUR J APPL PHYSIOL, V52, P258, DOI 10.1007/BF01015206; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; OBERG T, 1990, EUR J APPL PHYSIOL, V61, P362, DOI 10.1007/BF00236054; Octavia JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/345728; Octavia JR, 2015, MULTIPLE SCLEROSIS I, V2015, P11; Phan-Ba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034744; Schwid SR, 1999, NEUROLOGY, V53, P743, DOI 10.1212/WNL.53.4.743; Sehle A, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-59; Severijns D, 2015, J REHABIL MED, V47, P154, DOI 10.2340/16501977-1897; Steens A, 2011, NEUROIMAGE; Steens A, 2012, NEUROREHAB NEURAL RE, V26, P48, DOI 10.1177/1545968311416991; Surakka J, 2004, CLIN REHABIL, V18, P652, DOI 10.1191/0269215504cr781oa; Szucs K, 2009, MED BIOL ENG COMPUT, V47, P487, DOI 10.1007/s11517-009-0485-5; Thickbroom GW, 2006, J NEUROL, V253, P1048, DOI 10.1007/s00415-006-0159-2; Turner DL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00184; Wens I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108158; Werle S, 2009, J HAND SURG-EUR VOL, V34E, P76, DOI 10.1177/1753193408096763; Wittstein J, 2010, J SHOULDER ELB SURG, V19, P874, DOI 10.1016/j.jse.2010.01.018; Zwarts MJ, 2008, CLIN NEUROPHYSIOL, V119, P2, DOI 10.1016/j.clinph.2007.09.126	47	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133729	10.1371/journal.pone.0133729	http://dx.doi.org/10.1371/journal.pone.0133729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213990	gold, Green Published			2022-12-26	WOS:000358594300027
J	Bibault, JE; Mirabel, X; Lacornerie, T; Tresch, E; Reynaert, N; Lartigau, E				Bibault, Jean-Emmanuel; Mirabel, Xavier; Lacornerie, Thomas; Tresch, Emmanuelle; Reynaert, Nick; Lartigau, Eric			Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; CANCER; THERAPY; ELECTRON; SABR	Purpose SBRT is the standard of care for inoperable patients with early-stage lung cancer without lymph node involvement. Excellent local control rates have been reported in a large number of series. However, prescription doses and calculation algorithms vary to a great extent between studies, even if most teams prescribe to the D95 of the PTV. Type A algorithms are known to produce dosimetric discrepancies in heterogeneous tissues such as lungs. This study was performed to present a Monte Carlo (MC) prescription dose for NSCLC adapted to lesion size and location and compare the clinical outcomes of two cohorts of patients treated with a standard prescription dose calculated by a type A algorithm or the proposed MC protocol. Patients and Methods Patients were treated from January 2011 to April 2013 with a type B algorithm (MC) prescription with 54 Gy in three fractions for peripheral lesions with a diameter under 30 mm, 60 Gy in 3 fractions for lesions with a diameter over 30 mm, and 55 Gy in five fractions for central lesions. Clinical outcome was compared to a series of 121 patients treated with a type A algorithm (TA) with three fractions of 20 Gy for peripheral lesions and 60 Gy in five fractions for central lesions prescribed to the PTV D95 until January 2011. All treatment plans were recalculated with both algorithms for this study. Spearman's rank correlation coefficient was calculated for GTV and PTV. Local control, overall survival and toxicity were compared between the two groups. Results 205 patients with 214 lesions were included in the study. Among these, 93 lesions were treated with MC and 121 were treated with TA. Overall survival rates were 86% and 94% at one and two years, respectively. Local control rates were 79% and 93% at one and two years respectively. There was no significant difference between the two groups for overall survival (p = 0.785) or local control (p = 0.934). Fifty-six patients (27%) developed grade I lung fibrosis without clinical consequences. GTV size was a prognostic factor for overall survival (HR = 1.026, IC95% [1.01-1.041], p<0.001) and total dose was a prognostic factor for local control (HR = 0.924, IC95% [0.870-0.982], p = 0.011). D50 of the GTV calculated with MC correlated poorly with the D95 of the PTV calculated with TA (r = 0.116) for lesions with a diameter of 20 mm or less. For lesions larger than 20 mm, spearman correlation was higher (r = 0.618), but still insufficient. Conclusion No difference in local control or overall survival was found between patients treated with a type A or a type B algorithm in our cohort. A size and location adapted GTV-based prescription method could be used with a type B algorithm. External validation of these results is warranted.	[Bibault, Jean-Emmanuel; Mirabel, Xavier; Lacornerie, Thomas; Reynaert, Nick; Lartigau, Eric] Oscar Lambret Comprehens Canc Ctr, Acad Radiat Oncol Dept, Lille, France; [Tresch, Emmanuelle] Oscar Lambret Comprehens Canc Ctr, Dept Biostat, Lille, France; [Bibault, Jean-Emmanuel; Mirabel, Xavier; Lacornerie, Thomas; Reynaert, Nick; Lartigau, Eric] Univ Lille 2, Fac Med, Lille, France; [Bibault, Jean-Emmanuel; Mirabel, Xavier; Lacornerie, Thomas; Tresch, Emmanuelle; Reynaert, Nick; Lartigau, Eric] Maison Reg Rech Clin, ONCOLille, Lille, France	UNICANCER; Centre Oscar Lambret; UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille	Lartigau, E (corresponding author), Oscar Lambret Comprehens Canc Ctr, Acad Radiat Oncol Dept, 3 Rue Frederic Combemale, Lille, France.	e-lartigau@o-lambret.fr	lartigau, eric/GSI-5327-2022	Bibault, Jean-Emmanuel/0000-0002-1728-6776; Lacornerie, Thomas/0000-0001-8994-5999; Mirabel, Xavier/0000-0002-6546-7627; Reynaert, Nick/0000-0001-9221-9103	Accuray	Accuray	The radiation therapy department at the Oscar Lambret Comprehensive Cancer Center has a clinical research program partially funded by Accuray. Dr. Lartigau has been acting Chief Medical Officer at Accuray from April 2014 until September 2014 and has participated in coordination of the study, provided mentorship and edited the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPM, 2004, TISS INH CORR MEG PH; Aarup LR, 2009, RADIOTHER ONCOL, V91, P405, DOI 10.1016/j.radonc.2009.01.008; Das IJ, 2008, MED PHYS, V35, P206, DOI 10.1118/1.2815356; Deng J, 2001, PHYS MED BIOL, V46, P1429, DOI 10.1088/0031-9155/46/5/308; Deng J, 2000, PHYS MED BIOL, V45, P411, DOI 10.1088/0031-9155/45/2/311; Ding GX, 2007, MED PHYS, V34, P2985, DOI 10.1118/1.2745923; Guckenberger M, 2010, RADIOTHER ONCOL, V97, P65, DOI 10.1016/j.radonc.2010.04.027; Huang K, 2012, RADIOTHER ONCOL, V102, P335, DOI 10.1016/j.radonc.2011.12.018; Hurkmans CW, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-1; Jiang SB, 2000, MED PHYS, V27, P180, DOI 10.1118/1.598883; Jones AO, 2005, MED PHYS, V32, P766, DOI 10.1118/1.1861154; Knoos T, 2006, PHYS MED BIOL, V51, P5785, DOI 10.1088/0031-9155/51/22/005; Kry SF, 2013, INT J RADIAT ONCOL, V85, pE95, DOI 10.1016/j.ijrobp.2012.08.039; Lacornerie T, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0223-5; Latifi K, 2014, INT J RADIAT ONCOL, V88, P1108, DOI 10.1016/j.ijrobp.2013.12.047; Li J, 2012, INT J RADIAT ONCOL, V84, P508, DOI 10.1016/j.ijrobp.2011.12.005; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Olsen JR, 2011, INT J RADIAT ONCOL, V81, pE299, DOI 10.1016/j.ijrobp.2011.01.038; Rassiah-Szegedi P, 2006, ACTA ONCOL, V45, P989, DOI 10.1080/02841860600919225; Sharma SC, 2010, J APPL CLIN MED PHYS, V11, P170, DOI 10.1120/jacmp.v11i1.3142; Solda F, 2013, RADIOTHER ONCOL, V109, P1, DOI 10.1016/j.radonc.2013.09.006; van Zyp NCV, 2010, RADIOTHER ONCOL, V96, P55, DOI 10.1016/j.radonc.2010.04.009; Vanderstraeten B, 2006, MED PHYS, V33, P3149, DOI 10.1118/1.2241992; Xiao Y, 2009, INT J RADIAT ONCOL, V73, P1235, DOI 10.1016/j.ijrobp.2008.11.019	24	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133617	10.1371/journal.pone.0133617	http://dx.doi.org/10.1371/journal.pone.0133617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207808	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000111
J	Jiang, T; Liu, GX; Wang, L; Liu, HC				Jiang, Tao; Liu, Guoxia; Wang, Lin; Liu, Hongchen			Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ARREST-SPECIFIC GENE-6; NF-KAPPA-B; GROWTH-ARREST; AXL; CANCER; ACTIVATION; EXPRESSION; INVASION; DIAGNOSIS	Objective This study explored the level and clinical significance of serum Gas6 in patients with oral squamous cell carcinoma (OSCC). Methods A total of 128 OSCC patients and 145 normal controls were selected. Enzyme-linked immunosorbent assay was used to detect Gas6 concentration in sera from the OSCC patients and controls. The correlations of serum Gas6 concentration and clinicopathological characteristics of OSCC patients were assessed, and the prognostic significance of serum Gas6 was evaluated with a Kaplan-Meier curve and log-rank test. Results The results showed that serum Gas6 concentration was significantly higher in OSCC patients than in controls (P < 0.05). OSCC patients with late TNM stage (III, IV) had a relatively high serum Gas6 concentration compared with those with early stage (I, II) (P < 0.01) and patients with poorly differentiated tumors had a higher level of serum Gas6 than those with well-differentiated tumors (P < 0.01). Multivariate logistic regression analysis demonstrated that high serum Gas6 was an independent risk factor for lymph nodal metastases in OSCC patients (OR = 2.79, 95% CI: 1.72-4.48). For predicting OSCC development, ROC curve analysis showed a sensitivity of 0.63 with a specificity of 0.92 (AUC = 0.79, 95% CI: 0.74-0.85). Cox analysis revealed that high serum Gas6 was an independent biomarker for predicting poor overall survival in OSCC patients (HR = 2.07, 95% CI: 1.79-3.62). In addition, we found that Gas6 expression was increased in OSCC tissues and it may significantly decrease E-cadherin expression, and increase P-cadherin and N-cadherin expression, in OSCC cells. Further, Gas6 could promote the migratory and invasive ability of OSCC cells in vitro. Conclusion Taken together, these results suggest that Gas6 increases the metastatic capacity of OSCC cells and serum Gas6 could be a candidate biomarker for diagnostic and prognostic use in OSCC patients.	[Jiang, Tao; Wang, Lin; Liu, Hongchen] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing, Peoples R China; [Jiang, Tao] Jinan Stomatol Hosp, Dept Gen Dent, Jinan, Shandong, Peoples R China; [Liu, Guoxia] Jinan Stomatol Hosp, Dept Clin Lab, Jinan, Shandong, Peoples R China	Chinese People's Liberation Army General Hospital	Liu, HC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing, Peoples R China.	liuhcoral@163.com						Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Angelillo-Scherrer A, 2008, J CLIN INVEST, V118, P583, DOI 10.1172/JCI30375; Buehler M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/238284; Chippagiri P, 2014, J CLIN DIAGN RES, V8, pZC1, DOI 10.7860/JCDR/2014/7534.4211; Cummings CT, 2013, CLIN CANCER RES, V19, P5275, DOI 10.1158/1078-0432.CCR-12-1451; Ding L, 2014, TUMOR BIOL, V35, P10539, DOI 10.1007/s13277-014-2306-1; Ekyalongo RC, 2014, ANTICANCER RES, V34, P3337; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lee CH, 2014, ANN SURG ONCOL, V21, P1031, DOI 10.1245/s10434-013-3400-0; Lee CH, 2012, ANN SURG ONCOL, V19, pS500, DOI 10.1245/s10434-011-1985-8; Lee HJ, 2014, CARCINOGENESIS, V35, P769, DOI 10.1093/carcin/bgt372; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lin CW, 2014, INT J ONCOL, V45, P710, DOI 10.3892/ijo.2014.2427; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Mirjalili N, 2014, ORAL ONCOL, V50, pE52, DOI 10.1016/j.oraloncology.2014.07.005; Paccez JD, 2015, MOL BIOL CELL, V26, P821, DOI 10.1091/mbc.E14-04-0868; Petrick JL, 2014, BRIT J CANCER, V110, P2369, DOI 10.1038/bjc.2014.96; Prabhu A, 2013, ALIMENT PHARM THER, V38, P1145, DOI 10.1111/apt.12514; RESCIGNO J, 1991, ONCOGENE, V6, P1909; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Sawabu T, 2007, MOL CARCINOGEN, V46, P155, DOI 10.1002/mc.20211; Schmidt T, 2012, CELL MOL LIFE SCI, V69, P1391, DOI 10.1007/s00018-011-0863-7; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Sun WS, 2003, ANN ONCOL, V14, P898, DOI 10.1093/annonc/mdg257; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Tsantoulis PK, 2007, ORAL ONCOL, V43, P523, DOI 10.1016/j.oraloncology.2006.11.010; van Ginkel PR, 2004, CANCER RES, V64, P128, DOI 10.1158/0008-5472.CAN-03-0245; Whitman SP, 2014, LEUKEMIA, V28, P1252, DOI 10.1038/leu.2013.371; Yang CZ, 2014, J ORAL PATHOL MED, V43, P28, DOI 10.1111/jop.12091; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	35	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133940	10.1371/journal.pone.0133940	http://dx.doi.org/10.1371/journal.pone.0133940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207647	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000179
J	LaDisa, JF; Bozdag, S; Olson, J; Ramchandran, R; Kersten, JR; Eddinger, TJ				LaDisa, John F., Jr.; Bozdag, Serdar; Olson, Jessica; Ramchandran, Ramani; Kersten, Judy R.; Eddinger, Thomas J.			Gene Expression in Experimental Aortic Coarctation and Repair: Candidate Genes for Therapeutic Intervention?	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SARCOPLASMIC-RETICULUM CA2+-ATPASE; PLASMA-RENIN ACTIVITY; BLOOD-PRESSURE; CARDIAC-HYPERTROPHY; ARTERIAL-HYPERTENSION; HEART-DISEASE; FOLLOW-UP; HEMODYNAMICS; ASSOCIATION	Coarctation of the aorta (CoA) is a constriction of the proximal descending thoracic aorta and is one of the most common congenital cardiovascular defects. Treatments for CoA improve life expectancy, but morbidity persists, particularly due to the development of chronic hypertension (HTN). Identifying the mechanisms of morbidity is difficult in humans due to confounding variables such as age at repair, follow-up duration, coarctation severity and concurrent anomalies. We previously developed an experimental model that replicates aortic pathology in humans with CoA without these confounding variables, and mimics correction at various times using dissolvable suture. Here we present the most comprehensive description of differentially expressed genes (DEGs) to date from the pathology of CoA, which were obtained using this model. Aortic samples (n=4/group) from the ascending aorta that experiences elevated blood pressure (BP) from induction of CoA, and restoration of normal BP after its correction, were analyzed by gene expression microarray, and enriched genes were converted to human orthologues. 51 DEGs with > 6 fold-change (FC) were used to determine enriched Gene Ontology terms, altered pathways, and association with National Library of Medicine Medical Subject Headers (MeSH) IDs for HTN, cardiovascular disease (CVD) and CoA. The results generated 18 pathways, 4 of which (cell cycle, immune system, hemostasis and metabolism) were shared with MeSH ID's for HTN and CVD, and individual genes were associated with the CoA MeSH ID. A thorough literature search further uncovered association with contractile, cytoskeletal and regulatory proteins related to excitation-contraction coupling and metabolism that may explain the structural and functional changes observed in our experimental model, and ultimately help to unravel the mechanisms responsible for persistent morbidity after treatment for CoA.	[LaDisa, John F., Jr.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [LaDisa, John F., Jr.] Med Coll Wisconsin, Dept Med, Div Cardiovasc Med, Milwaukee, WI 53226 USA; [LaDisa, John F., Jr.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [LaDisa, John F., Jr.] Childrens Hosp Wisconsin, Herma Heart Ctr, Milwaukee, WI 53201 USA; [Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Olson, Jessica] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Childrens Hosp Wisconsin, Dev Vasc Biol Program, Milwaukee, WI 53201 USA; [Kersten, Judy R.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Kersten, Judy R.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Eddinger, Thomas J.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Marquette University; Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Marquette University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Marquette University	LaDisa, JF (corresponding author), Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA.	john.ladisa@marquette.edu		Olson, Jessica/0000-0002-8941-794X	Academic Research Enhancement Award from the National Institutes of Health [R15HL096096-01]; Departments of Biological Sciences and Biomedical Engineering at Marquette University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL096096] Funding Source: NIH RePORTER	Academic Research Enhancement Award from the National Institutes of Health; Departments of Biological Sciences and Biomedical Engineering at Marquette University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an Academic Research Enhancement Award from the National Institutes of Health (R15HL096096-01 to JFL), assistance from the Alvin and Marion Birnschein Foundation (to JFL), and support from the Departments of Biological Sciences and Biomedical Engineering at Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM EA, 1969, AM J CARDIOL, V23, P396, DOI 10.1016/0002-9149(69)90520-7; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; Bonaventura D, 2011, LIFE SCI, V89, P595, DOI 10.1016/j.lfs.2011.07.022; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; CASTA A, 1982, CLIN CARDIOL, V5, P551; Chang KC, 1997, J CLIN INVEST, V100, P1742, DOI 10.1172/JCI119699; Cheng GM, 1996, ARCH BIOCHEM BIOPHYS, V329, P65, DOI 10.1006/abbi.1996.0192; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840; Craig DB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-84; Dai HJ, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas061; Deng J, 2009, EUR J PHARMACOL, V608, P42, DOI 10.1016/j.ejphar.2009.01.048; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehret GB, 2009, EUR J HUM GENET, V17, P1650, DOI 10.1038/ejhg.2009.94; FALLO F, 1983, CLIN EXP HYPERTENS A, V5, P321, DOI 10.3109/10641968309069491; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Figueroa CA, 2010, J VASC SURG, V51, P1488, DOI 10.1016/j.jvs.2010.01.058; Gallego-Delgado J, 2006, J AM SOC NEPHROL, V17, pS159, DOI 10.1681/ASN.2006080937; GARDINER HM, 1994, CIRCULATION, V89, P1745, DOI 10.1161/01.CIR.89.4.1745; GIDDING SS, 1985, CIRCULATION, V71, P495, DOI 10.1161/01.CIR.71.3.495; Gorman CL, 2010, METHODS MOL BIOL, V616, P253, DOI 10.1007/978-1-60761-461-6_16; Hager A, 2007, J THORAC CARDIOV SUR, V134, P738, DOI 10.1016/j.jtcvs.2007.04.027; Hager A, 2011, INT J CARDIOL, V151, P63, DOI 10.1016/j.ijcard.2010.04.090; Hand BD, 2006, LIFE SCI, V79, P1413, DOI 10.1016/j.lfs.2006.04.003; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ibarra-Lara L, 2010, EUR J PHARMACOL, V627, P185, DOI 10.1016/j.ejphar.2009.10.039; Kaushal S, 2009, ANN THORAC SURG, V88, P1932, DOI 10.1016/j.athoracsur.2009.08.035; Krishnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028979; Kuehl K, 2010, BIRTH DEFECTS RES A, V88, P101, DOI 10.1002/bdra.20630; Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14; Kvitting JPE, 2009, ANN THORAC SURG, V87, P342, DOI 10.1016/j.athoracsur.2008.08.072; Liu W, 2013, CIRC-HEART FAIL, V6, P833, DOI 10.1161/CIRCHEARTFAILURE.112.000123; Lompre AM, 1999, CLIN EXP PHARMACOL P, V26, P553, DOI 10.1046/j.1440-1681.1999.03079.x; Marques FZ, 2010, HYPERTENSION, V56, P319, DOI 10.1161/HYPERTENSIONAHA.110.155366; Menon A, 2012, AM J PHYSIOL-HEART C, V303, pH1304, DOI 10.1152/ajpheart.00420.2012; Menon A, 2012, J PHARMACOL TOX MET, V65, P18, DOI 10.1016/j.vascn.2011.10.003; Morgan NV, 2011, J CLIN INVEST, V121, P695, DOI 10.1172/JCI41931; Morrison TM, 2009, J VASC SURG, V49, P1029, DOI 10.1016/j.jvs.2008.11.056; Nielsen JC, 2005, CIRCULATION, V111, P622, DOI 10.1161/01.CIR.0000154549.53684.64; O'Sullivan JJ, 2002, HEART, V88, P163, DOI 10.1136/heart.88.2.163; Oliveros J.C., VENNY INTERACTIVE TO; Ong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068335; OROURKE MF, 1971, CIRCULATION, V44, P281, DOI 10.1161/01.CIR.44.2.281; Pacileo G, 2001, AM J CARDIOL, V87, P748, DOI 10.1016/S0002-9149(00)01495-8; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Perloff JK, 2003, CLIN RECOGNITION CON; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; PETTERSSON G, 1985, ACTA PHARMACOL TOX, V57, P184, DOI 10.1111/bcpt.1985.57.3.184; Pfaltzgraff ER, 2014, J MOL CELL CARDIOL, V69, P88, DOI 10.1016/j.yjmcc.2014.01.016; Qin ZX, 2014, J MOL CELL CARDIOL, V72, P56, DOI 10.1016/j.yjmcc.2014.02.019; Qu JX, 2007, J MOL CELL CARDIOL, V43, P319, DOI 10.1016/j.yjmcc.2007.06.006; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosenthal E, 2001, J AM COLL CARDIOL, V38, P1524, DOI 10.1016/S0735-1097(01)01573-X; Rouine-Rapp Kathryn, 2003, Pediatr Crit Care Med, V4, P327, DOI 10.1097/01.PCC.0000075557.41987.A3; Rudemiller N, 2014, HYPERTENSION, V63, P559, DOI 10.1161/HYPERTENSIONAHA.113.02191; Ruggiero A, 2013, CARDIOVASC RES, V97, P44, DOI 10.1093/cvr/cvs294; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; Sealy W C, 1967, Ann Thorac Surg, V3, P15; SEHESTED J, 1984, SCAND J THORAC CARD, P1; Tagariello A, 2012, CURR MOL MED, V12, P199, DOI 10.2174/156652412798889027; Taguchi K, 2007, EUR J PHARMACOL, V556, P121, DOI 10.1016/j.ejphar.2006.11.026; Van Hove CE, 2009, BRIT J PHARMACOL, V158, P920, DOI 10.1111/j.1476-5381.2009.00396.x; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; WERNING C, 1969, CIRCULATION, V40, P731, DOI 10.1161/01.CIR.40.5.731; WOLINSKY H, 1967, CIRC RES, V20, P99, DOI 10.1161/01.RES.20.1.99; Wu CH, 2005, LIFE SCI, V78, P347, DOI 10.1016/j.lfs.2005.04.077; Zhang F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S7; Zwadlo C, 2006, TOXICOL APPL PHARM, V213, P224, DOI 10.1016/j.taap.2005.10.012	69	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133356	10.1371/journal.pone.0133356	http://dx.doi.org/10.1371/journal.pone.0133356			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207811	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000081
J	Li, XB; Shen, LZ; Shang, XQ; Liu, WB				Li, Xianbin; Shen, Liangzhong; Shang, Xuequn; Liu, Wenbin			Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway	PLOS ONE			English	Article							CELL LUNG-CANCER; FOCAL ADHESION KINASE; SET ENRICHMENT ANALYSIS; NF-KAPPA-B; COLORECTAL-CANCER; COLON-CANCER; GENE SET; PROGNOSTIC-SIGNIFICANCE; CIGARETTE-SMOKING; INDUCED-APOPTOSIS	Pathway analysis is a common approach to gain insight from biological experiments. Signaling-pathway impact analysis (SPIA) is one such method and combines both the classical enrichment analysis and the actual perturbation on a given pathway. Because this method focuses on a single pathway, its resolution generally is not very high because the differentially expressed genes may be enriched in a local region of the pathway. In the present work, to identify cancer-related pathways, we incorporated a recent subpathway analysis method into the SPIA method to form the "sub-SPIA method." The original subpathway analysis uses the k-clique structure to define a subpathway. However, it is not sufficiently flexible to capture subpathways with complex structure and usually results in many overlapping subpathways. We therefore propose using the minimal-spanning-tree structure to find a subpathway. We apply this approach to colorectal cancer and lung cancer datasets, and our results show that sub-SPIA can identify many significant pathways associated with each specific cancer that other methods miss. Based on the entire pathway network in the Kyoto Encyclopedia of Genes and Genomes, we find that the pathways identified by sub-SPIA not only have the largest average degree, but also are more closely connected than those identified by other methods. This result suggests that the abnormality signal propagating through them might be responsible for the specific cancer or disease.	[Li, Xianbin; Shen, Liangzhong; Liu, Wenbin] Wenzhou Univ, Dept Phys & Elect Informat Engn, Wenzhou, Zhejiang, Peoples R China; [Shang, Xuequn] Northwestern Polytech Univ, Sch Comp Sci & Technol, Xian 710072, Peoples R China	Wenzhou University; Northwestern Polytechnical University	Liu, WB (corresponding author), Wenzhou Univ, Dept Phys & Elect Informat Engn, Wenzhou, Zhejiang, Peoples R China.	wbliu6910@126.com	liu, wenbin/ABD-9826-2020	li, xianbin/0000-0001-8212-9761	National Science Foundation of China [61272018, 60970065, 61332014, 61272121]; Zhejiang Provincial Natural Science Foundation of China [R1110261, LY13F010007]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	Funding was provided by National Science Foundation of China (Grants No. 61272018(WL), No. 60970065(WL), No. 61332014(SQ), and No. 61272121(SQ)), the Zhejiang Provincial Natural Science Foundation of China (Grant No. R1110261 (WL), LY13F010007(SL)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkader I, 2005, ONCOL REP, V14, P1527; Albasri A, 2014, ANTICANCER RES, V34, P3969; Amado NG, 2014, INT J MOL SCI, V15, P12094, DOI 10.3390/ijms150712094; [Anonymous], 2013, EURO SURVEILL, V18; Argaw A, 2011, J NEUROSCI, V31, P1489, DOI 10.1523/JNEUROSCI.4134-09.2011; Astin Margaret, 2011, Br J Gen Pract, V61, pe231, DOI 10.3399/bjgp11X572427; Au NHC, 2004, J PATHOL, V204, P101, DOI 10.1002/path.1612; Baby J, 2007, CANCER LETT, V255, P85, DOI 10.1016/j.canlet.2007.03.024; Benjamini Y, 2001, ANN STAT, V29, P1165; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Cao LL, 2014, INT J ONCOL, V44, P1207, DOI 10.3892/ijo.2014.2266; Chen QY, 2011, INT J MOL MED, V28, P769, DOI 10.3892/ijmm.2011.775; Chen WS, 2011, FRONT BIOSCI-LANDMRK, V16, P1172, DOI 10.2741/3782; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Dobashi Y, 2005, PATHOL INT, V55, P95, DOI 10.1111/j.1440-1827.2005.01799.x; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Dy GK, 2014, J THORAC ONCOL, V9, P1278, DOI 10.1097/JTO.0000000000000248; Fang XC, 2013, CANCER TREAT REV, V39, P77, DOI 10.1016/j.ctrv.2012.06.001; Grossi V, 2014, WORLD J GASTROENTERO, V20, P9744, DOI 10.3748/wjg.v20.i29.9744; Gupta J, 2014, CANCER CELL, V25, P484, DOI 10.1016/j.ccr.2014.02.019; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Han JW, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0937; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Havel LS, 2015, ONCOGENE, V34, P1979, DOI 10.1038/onc.2014.123; Heffler M, 2013, CANCER BIOL THER, V14, P761, DOI 10.4161/cbt.25185; Hirashima T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-770; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Hu TH, 2014, CANCER LETT, V354, P417, DOI 10.1016/j.canlet.2014.08.012; Huang MY, 2011, ONCOL REP, V25, P1297, DOI 10.3892/or.2011.1193; Ishibashi K, 2009, SURG TODAY, V39, P1032, DOI 10.1007/s00595-009-3994-9; Jacob L, 2012, ANN APPL STAT, V6, P561, DOI 10.1214/11-AOAS528; Je EM, 2013, PATHOLOGY, V45, P645, DOI 10.1097/PAT.0000000000000007; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanaan Z, 2010, GENET TEST MOL BIOMA, V14, P347, DOI 10.1089/gtmb.2009.0197; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Khelwatty SA, 2013, FRONT BIOSCI-LANDMRK, V18, P394, DOI 10.2741/4110; Kono K, 1998, INT J CANCER, V78, P301, DOI 10.1002/(SICI)1097-0215(19981029)78:3<301::AID-IJC7>3.0.CO;2-Z; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; Koshiol J, 2011, BRIT J CANCER, V105, P320, DOI 10.1038/bjc.2011.221; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Li CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047326; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021131; Liu XX, 2013, INT J ONCOL, V43, P1925, DOI 10.3892/ijo.2013.2124; Liu ZH, 2014, INT J CLIN EXP PATHO, V7, P870; Lourenco FC, 2014, GUT, V63, P480, DOI 10.1136/gutjnl-2012-303883; Lu Xue, 2014, Oncol Lett, V7, P1992; Malusecka E, 1999, FOLIA HISTOCHEM CYTO, V37, P19; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; Martini P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks866; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neradugomma NK, 2014, CARCINOGENESIS, V35, P795, DOI 10.1093/carcin/bgt379; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Pan T, 2013, ONCOL LETT, V5, P521, DOI 10.3892/ol.2012.1064; Pasto A, 2014, CANCER RES, V74, P2106, DOI 10.1158/0008-5472.CAN-13-2022; Pesson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087761; Pooja T, 2014, EUR J PHARMACOL, V742, P55, DOI 10.1016/j.ejphar.2014.08.028; Qiu X, 2012, MINERVA MED, V103, P151; Rahnenfuhrer J, 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1055, DOI 10.2202/1544-6115.1055]; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Rubinson DA, 2014, INVEST NEW DRUG, V32, P113, DOI 10.1007/s10637-013-9956-5; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Samonis G, 2003, J CLIN MICROBIOL, V41, P5820, DOI 10.1128/JCM.41.12.5820-5822.2003; Sauer K, 2010, NAT REV IMMUNOL, V10, P257, DOI 10.1038/nri2745; Sebastian-Leon P, BMC SYST BIOL, V82014, P121; Serafin V, 2011, J PATHOL, V224, P448, DOI 10.1002/path.2895; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan X, 2014, TUMOR BIOL, V35, P12189, DOI 10.1007/s13277-014-2527-3; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Varol Y, 2014, INT J TUBERC LUNG D, V18, P1121, DOI 10.5588/ijtld.14.0152; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vincenzi B, 2006, HISTOL HISTOPATHOL, V21, P423, DOI 10.14670/HH-21.423; Wang LH, 2014, BRIT J CANCER, V110, P341, DOI 10.1038/bjc.2013.752; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Warin RF, 2014, J AGR FOOD CHEM, V62, P1352, DOI 10.1021/jf405573e; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xu B, 2010, NEUROSCIENCE, V169, P932, DOI 10.1016/j.neuroscience.2010.05.025; Yao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078086; You DJ, 2014, J BIOL CHEM, V289, P17709, DOI 10.1074/jbc.M114.553552; Zheng F, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-36; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zuo L, 2013, FOOD CHEM TOXICOL, V62, P892, DOI 10.1016/j.fct.2013.10.028	88	30	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132813	10.1371/journal.pone.0132813	http://dx.doi.org/10.1371/journal.pone.0132813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207919	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000042
J	Mueller-Tribbensee, SM; Karna, M; Khalil, M; Neurath, MF; Reeh, PW; Engel, MA				Mueller-Tribbensee, Sonja M.; Karna, Manoj; Khalil, Mohammad; Neurath, Markus F.; Reeh, Peter W.; Engel, Matthias A.			Differential Contribution of TRPA1, TRPV4 and TRPM8 to Colonic Nociception in Mice	PLOS ONE			English	Article							RECEPTOR POTENTIAL VANILLOID-4; INFLAMMATORY RESPONSES; CATION CHANNEL; ION CHANNELS; SUBSTANCE-P; MOUSE COLON; VR-OAC; MENTHOL; PAIN; HYPERSENSITIVITY	Background Various transient receptor potential (TRP) channels in sensory neurons contribute to the transduction of mechanical stimuli in the colon. Recently, even the cold-sensing menthol receptor TRPM(melastatin) 8 was suggested to be involved in murine colonic mechanonociception. Methods To analyze the roles of TRPM8, TRPA1 and TRPV4 in distension-induced colonic nociception and pain, TRP-deficient mice and selective pharmacological blockers in wild-type mice (WT) were used. Visceromotor responses (VMR) to colorectal distension (CRD) in vivo were recorded and distension/pressure-induced CGRP release from the isolated murine colon ex vivo was measured by EIA. Results Distension-induced colonic CGRP release was markedly reduced in TRPA1(-/-) and TRPV4(-/-) mice at 90/150 mmHg compared to WT. In TRPM8-deficient mice the reduction was only distinct at 150 mmHg. Exposure to selective pharmacological antagonists (HC030031, 100 mu M; RN1734, 10 mu M; AMTB, 10 mu M) showed corresponding effects. The unselective TRP blocker ruthenium red (RR, 10 mu M) was as efficient in inhibiting distension-induced CGRP release as the unselective antagonists of mechanogated DEG/ENaC (amiloride, 100 mu M) and stretch-activated channels (gadolinium, 50 mu M). VMR to CRD revealed prominent deficits over the whole pressure range (up to 90 mmHg) in TRPA1(-/-) and TRPV4(-/-) but not TRPM8(-/-) mice; the drug effects of the TRP antagonists were again highly consistent with the results from mice lacking the respective TRP receptor gene. Conclusions TRPA1 and TRPV4 mediate colonic distension pain and CGRP release and appear to govern a wide and congruent dynamic range of distensions. The role of TRPM8 seems to be confined to signaling extreme noxious distension, at least in the healthy colon.	[Mueller-Tribbensee, Sonja M.; Karna, Manoj; Reeh, Peter W.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Khalil, Mohammad; Neurath, Markus F.; Engel, Matthias A.] Univ Klinikum Erlangen, Dept Med 1, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Engel, MA (corresponding author), Univ Klinikum Erlangen, Dept Med 1, Erlangen, Germany.	matthias.engel@uk-erlangen.de	Engel, Matthias/W-5831-2018; Reeh, Peter W./J-8981-2012	Reeh, Peter W./0000-0002-4367-094X	Federal Ministry of Edu. Res. [BMBF0315449C]; Marohn-Stiftung; ELAN; IZKF; Universitatsbund of the Friedrich-Alexander-Universitat Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft (DFG) [EN 1060/2-1]	Federal Ministry of Edu. Res.; Marohn-Stiftung; ELAN; IZKF; Universitatsbund of the Friedrich-Alexander-Universitat Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	P. W. R. was supported by the Federal Ministry of Edu. & Res. (BMBF0315449C); M. A. E. received support from the Marohn-Stiftung, ELAN, IZKF and Universitatsbund of the Friedrich-Alexander-Universitat Erlangen-Nurnberg and the Deutsche Forschungsgemeinschaft (DFG EN 1060/2-1).	Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Banke TG, 2011, BRAIN RES, V1381, P21, DOI 10.1016/j.brainres.2011.01.021; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Blackshaw LA, 2010, GUT, V59, P126, DOI 10.1136/gut.2009.179523; BRETAG AH, 1969, LIFE SCI PT 1 PHYSI, V8, P319, DOI 10.1016/0024-3205(69)90283-5; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Brierley SM, 2010, AUTON NEUROSCI-BASIC, V153, P58, DOI 10.1016/j.autneu.2009.07.017; Brierley SM, 2009, GASTROENTEROLOGY, V137, P2084, DOI 10.1053/j.gastro.2009.07.048; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Carter R, 2007, GASTROENTEROLOGY, V133, P184, DOI 10.1053/j.gastro.2007.04.042; Cattaruzza F, 2010, AM J PHYSIOL-GASTR L, V298, pG81, DOI 10.1152/ajpgi.00221.2009; Cenac N, 2008, GASTROENTEROLOGY, V135, P937, DOI 10.1053/j.gastro.2008.05.024; Chan CLH, 2003, LANCET, V361, P385, DOI 10.1016/S0140-6736(03)12392-6; Choung RS, 2011, GASTROENTEROL CLIN N, V40, P1, DOI 10.1016/j.gtc.2010.12.006; Christianson JA, 2007, NAT PROTOC, V2, P2624, DOI 10.1038/nprot.2007.392; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Davidson JB, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01651.x; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gonlachanvit S, 2009, NEUROGASTROENT MOTIL, V21, P23, DOI 10.1111/j.1365-2982.2008.01167.x; Hamill OP, 1996, PHARMACOL REV, V48, P231; Harrington AM, 2011, PAIN, V152, P1459, DOI 10.1016/j.pain.2011.01.027; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Hosoya T, 2014, NEUROGASTROENT MOTIL, V26, P1112, DOI 10.1111/nmo.12368; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Karashima Y, 2008, PFLUG ARCH EUR J PHY, V457, P77, DOI 10.1007/s00424-008-0493-6; Kim D, 2008, AM J PHYSIOL-CELL PH, V295, pC92, DOI 10.1152/ajpcell.00023.2008; Kuhn FJP, 2009, J BIOL CHEM, V284, P4102, DOI 10.1074/jbc.M806651200; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Munaron Luca, 2011, World J Biol Chem, V2, P59, DOI 10.4331/wjbc.v2.i4.59; Pedersen SF, 2006, AM J PHYSIOL-CELL PH, V291, pC1286, DOI 10.1152/ajpcell.00325.2005; Poole DP, 2011, GASTROENTEROLOGY, V141, P565, DOI 10.1053/j.gastro.2011.04.049; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Ramachandran R, 2013, P NATL ACAD SCI USA, V110, P7476, DOI 10.1073/pnas.1217431110; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Roza C, 2001, PAIN, V93, P213, DOI 10.1016/S0304-3959(01)00318-9; Sipe WEB, 2008, AM J PHYSIOL-GASTR L, V294, pG1288, DOI 10.1152/ajpgi.00002.2008; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002; Wrigley PJ, 2009, BRIT J PHARMACOL, V157, P371, DOI 10.1111/j.1476-5381.2009.00167.x; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008	56	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0128242	10.1371/journal.pone.0128242	http://dx.doi.org/10.1371/journal.pone.0128242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207981	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000003
J	Placencio, VR; Ichimura, A; Miyata, T; DeClerck, YA				Placencio, Veronica R.; Ichimura, Atsuhiko; Miyata, Toshio; DeClerck, Yves A.			Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity	PLOS ONE			English	Article							TUMOR PROGRESSION; PAI-1 DEFICIENCY; MECHANISM; APOPTOSIS; TYPE-1; CELLS	Numerous studies have shown a paradoxical positive correlation between elevated levels of plasminogen activator inhibitior-1 (PAI-1) in tumors and blood of cancer patients with poor clinical outcome, suggesting that PAI-1 could be a therapeutic target. Here we tested two orally bioavailable small molecule inhibitors of PAI-1 (TM5275 and TM5441) for their efficacy in pre-clinical models of cancer. We demonstrated that these inhibitors decreased cell viability in several human cancer cell lines with an IC50 in the 9.7 to 60.3 mu M range and induced intrinsic apoptosis at concentrations of 50 mu M. In vivo, oral administration of TM5441 (20 mg/kg daily) to HT1080 and HCT116 xenotransplanted mice increased tumor cell apoptosis and had a significant disruptive effect on the tumor vasculature that was associated with a decrease in tumor growth and an increase in survival that, however, were not statistically significant. Pharmacokinetics studies indicated an average peak plasma concentration of 11.4 mu M one hour after oral administration and undetectable levels 23 hours after administration. The effect on tumor vasculature in vivo was further examined in endothelial cells (EC) in vitro and this analysis indicated that both TM5275 and TM5441 inhibited EC branching in a 3D Matrigel assay at concentrations where they had little effect on EC apoptosis. These studies bring novel insight on the activity of PAI-1 inhibitors and provide important information for the future design of inhibitors targeting PAI-1 as therapeutic agents in cancer.	[Placencio, Veronica R.; DeClerck, Yves A.] Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Bone Marrow Transplan, Los Angeles, CA 90089 USA; [Placencio, Veronica R.; DeClerck, Yves A.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Ichimura, Atsuhiko; Miyata, Toshio] Tohoku Univ, Grad Sch Med, Miyagi, Japan; [DeClerck, Yves A.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California; Children's Hospital Los Angeles; Tohoku University; University of Southern California	DeClerck, YA (corresponding author), Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Bone Marrow Transplan, Los Angeles, CA 90089 USA.	declerck@usc.edu	Miyata, Toshio/A-4872-2010	Ichimura, Atsuhiko/0000-0003-0366-5211; DeClerck, Yves/0000-0002-3688-0113	NIH [5 R01 CA 129377]; NATIONAL CANCER INSTITUTE [R01CA129377] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH 5 R01 CA 129377 to YAD and VRP.	Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Balsara RD, 2006, J BIOL CHEM, V281, P22527, DOI 10.1074/jbc.M512819200; Balsara RD, 2008, THROMB HAEMOSTASIS, V100, P1029, DOI 10.1160/TH08-07-0427; Binder BR, 2008, IMMUNOL LETT, V118, P116, DOI 10.1016/j.imlet.2008.03.017; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Chen YB, 2004, J CELL BIOCHEM, V92, P178, DOI 10.1002/jcb.20058; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; Fang H, 2012, JNCI-J NATL CANCER I, V104, P1470, DOI 10.1093/jnci/djs377; Fay WP, 1997, BLOOD, V90, P204; Foekens JA, 2000, CANCER RES, V60, P636; Fortenberry YM, 2013, EXPERT OPIN THER PAT, V23, P801, DOI 10.1517/13543776.2013.782393; Gomes-Giacoia E, 2013, MOL CANCER THER, V12, P2697, DOI 10.1158/1535-7163.MCT-13-0500; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Huang WT, 2012, AM J RESP CELL MOL, V46, P87, DOI 10.1165/rcmb.2011-0139OC; Isogai C, 2001, CANCER RES, V61, P5587; Iwaki T, 2012, THROMB RES, V129, pE161, DOI 10.1016/j.thromres.2011.10.008; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Lademann UA, 2008, THROMB HAEMOSTASIS, V100, P1041, DOI 10.1160/TH08-04-0266; Mashiko S, 2015, CANC BIOL THER; Masuda T, 2013, MOL CANCER THER, V12, P2378, DOI 10.1158/1535-7163.MCT-13-0041; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mouchess ML, 2006, J COMPUT ASSIST TOMO, V30, P525, DOI 10.1097/00004728-200605000-00030; Pelisch N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124510; Placencio VR, 2015, CANC RES; R Core Team, 2014, LANG ENV STAT COMP; Rossignol P, 2006, J THROMB HAEMOST, V4, P664, DOI 10.1111/j.1538-7836.2005.01765.x; Schneider DJ, 2008, THROMB HAEMOSTASIS, V100, P1037, DOI 10.1160/TH08-04-0234; StataCorp, 2021, STATA STAT SOFTWARE; Van de Craen B, 2012, THROMB RES, V130, P576, DOI 10.1016/j.thromres.2012.06.023; Vercauteren E, 2012, J THROMB HAEMOST, V10, P2555, DOI 10.1111/jth.12036; Yamaoka N, 2011, CHEM PHARM BULL, V59, P215, DOI 10.1248/cpb.59.215; Zoellner H, 1998, THROMB RES, V91, P209, DOI 10.1016/S0049-3848(98)00087-5	37	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133786	10.1371/journal.pone.0133786	http://dx.doi.org/10.1371/journal.pone.0133786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207899	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000142
J	Rejc, E; Angeli, C; Harkema, S				Rejc, Enrico; Angeli, Claudia; Harkema, Susan			Effects of Lumbosacral Spinal Cord Epidural Stimulation for Standing after Chronic Complete Paralysis in Humans	PLOS ONE			English	Article							LUMBAR CORD; NEUROPHYSIOLOGICAL ASSESSMENT; INTRASPINAL MICROSTIMULATION; SENSORIMOTOR INTERACTIONS; ELECTRICAL-STIMULATION; POSTERIOR STRUCTURES; EVOKED-POTENTIALS; INJURY; LOCOMOTION; REFLEXES	Sensory and motor complete spinal cord injury (SCI) has been considered functionally complete resulting in permanent paralysis with no recovery of voluntary movement, standing or walking. Previous findings demonstrated that lumbosacral spinal cord epidural stimulation can activate the spinal neural networks in one individual with motor complete, but sensory incomplete SCI, who achieved full body weight-bearing standing with independent knee extension, minimal self-assistance for balance and minimal external assistance for facilitating hip extension. In this study, we showed that two clinically sensory and motor complete participants were able to stand over-ground bearing full body-weight without any external assistance, using their hands to assist balance. The two clinically motor complete, but sensory incomplete participants also used minimal external assistance for hip extension. Standing with the least amount of assistance was achieved with individual-specific stimulation parameters, which promoted overall continuous EMG patterns in the lower limbs' muscles. Stimulation parameters optimized for one individual resulted in poor standing and additional need of external assistance for hip and knee extension in the other participants. During sitting, little or negligible EMG activity of lower limb muscles was induced by epidural stimulation, showing that the weight-bearing related sensory information was needed to generate sufficient EMG patterns to effectively support full weight-bearing standing. In general, electrode configurations with cathodes selected in the caudal region of the array at relatively higher frequencies (25-60 Hz) resulted in the more effective EMG patterns for standing. These results show that human spinal circuitry can generate motor patterns effective for standing in the absence of functional supraspinal connections; however the appropriate selection of stimulation parameters is critical.	[Rejc, Enrico; Angeli, Claudia; Harkema, Susan] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Angeli, Claudia; Harkema, Susan] Kentucky One Hlth, Frazier Rehab Inst, Louisville, KY USA	University of Louisville	Harkema, S (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.	SusanHarkema@KentuckyOneHealth.org		Angeli, Claudia/0000-0003-4127-7121	US National Institutes of Health, NIBIB [R01EB007615]; NIGMS [P30 GM103507]; Christopher and Dana Reeve Foundation; Kessler Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Kentucky Spinal Cord Injury Research Center; Jewish Hospital; St. Mary's Foundation; University of Louisville Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER	US National Institutes of Health, NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Christopher and Dana Reeve Foundation; Kessler Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Kentucky Spinal Cord Injury Research Center; Jewish Hospital; St. Mary's Foundation; University of Louisville Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: US National Institutes of Health, NIBIB, under the award number R01EB007615 and NIGMS P30 GM103507, Christopher and Dana Reeve Foundation, Kessler Foundation, the Leona M. and Harry B. Helmsley Charitable Trust, Kentucky Spinal Cord Injury Research Center, University of Louisville Foundation, Jewish Hospital and St. Mary's Foundation.	Angeli CA, 2014, BRAIN; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Barthelemy D, 2007, J NEUROPHYSIOL, V97, P1986, DOI 10.1152/jn.00818.2006; Beauparlant J, 2013, BRAIN, V136, P3347, DOI 10.1093/brain/awt204; Budh CN, 2007, CLIN REHABIL, V21, P89, DOI 10.1177/0269215506070313; BURNS S, 2012, TOP SPINAL CORD INJ, V18, P85, DOI DOI 10.1310/SCI1801-85; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; de Leon RD, 1999, J NEUROPHYSIOL, V81, P85, DOI 10.1152/jn.1999.81.1.85; Dimitrijevic M R, 1988, Adv Neurol, V47, P138; DIMITRIJEVIC MR, 1992, ELECTROEN CLIN NEURO, V85, P365, DOI 10.1016/0168-5597(92)90049-H; DIMITRIJEVIC MR, 1983, J NEUROL SCI, V60, P253, DOI 10.1016/0022-510X(83)90067-9; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; DIMITRIJEVIC MR, 1992, J NEUROTRAUM, V9, pS293; Etlin A, 2010, J NEUROSCI, V30, P10324, DOI 10.1523/JNEUROSCI.1208-10.2010; Gad P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-2; Gaunt RA, 2006, J NEUROPHYSIOL, V96, P2995, DOI 10.1152/jn.00061.2006; Gerasimenko Yu P, 2002, Neurosci Behav Physiol, V32, P417, DOI 10.1023/A:1015836428932; Gerasimenko Y, 2008, EXP NEUROL, V209, P417, DOI 10.1016/j.expneurol.2007.07.015; Gerasimenko YP, 2007, J NEUROPHYSIOL, V98, P2525, DOI 10.1152/jn.00836.2007; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1588, DOI 10.1016/j.apmr.2012.04.032; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; Ivanenko YP, 2006, J NEUROPHYSIOL, V95, P602, DOI 10.1152/jn.00767.2005; IWAHARA T, 1992, BRAIN RES BULL, V28, P99, DOI 10.1016/0361-9230(92)90235-P; Jilge B, 2004, BIOL CYBERN, V91, P359, DOI 10.1007/s00422-004-0511-5; Jilge B, 2004, EXP BRAIN RES, V154, P308, DOI 10.1007/s00221-003-1666-3; Lavrov I, 2006, J NEUROPHYSIOL, V96, P1699, DOI 10.1152/jn.00325.2006; Li K, 2012, J NEUROSURG-SPINE, V17, P77, DOI 10.3171/2012.6.AOSPINE12117; Marino RJ., 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Mckay WB, 2011, SPINAL CORD, V49, P421, DOI 10.1038/sc.2010.145; McKay WB, 1997, J NEUROTRAUM, V14, P539, DOI 10.1089/neu.1997.14.539; McKay WB, 2004, NEUROREHAB NEURAL RE, V18, P144, DOI 10.1177/0888439004267674; Minassian K, 2007, HUM MOVEMENT SCI, V26, P275, DOI 10.1016/j.humov.2007.01.005; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Murg M, 2000, SPINAL CORD, V38, P394, DOI 10.1038/sj.sc.3101038; Musienko P E, 2013, Ross Fiziol Zh Im I M Sechenova, V99, P392; Musienko PE, 2010, J NEUROPHYSIOL, V103, P1080, DOI 10.1152/jn.00575.2009; Musienko P, 2012, EXP NEUROL, V235, P100, DOI 10.1016/j.expneurol.2011.08.025; Musienko P, 2012, J NEUROPHYSIOL, V107, P2072, DOI 10.1152/jn.00730.2011; NELSON SG, 1978, J NEUROPHYSIOL, V41, P778, DOI 10.1152/jn.1978.41.3.778; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rossignol S, 2008, BRAIN RES REV, V57, P228, DOI 10.1016/j.brainresrev.2007.06.019; Sayenko DG, 2014, J NEUROPHYSIOL, V111, P1088, DOI 10.1152/jn.00489.2013; Schindler-Ivens S, 2000, EXP BRAIN RES, V133, P233, DOI 10.1007/s002210000377; Tseng SC, 2013, CLIN NEUROPHYSIOL, V124, P982, DOI 10.1016/j.clinph.2012.10.020; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Waring WP, 2010, J SPINAL CORD MED, V33, P346, DOI 10.1080/10790268.2010.11689712; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784	54	92	97	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133998	10.1371/journal.pone.0133998	http://dx.doi.org/10.1371/journal.pone.0133998			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207623	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000189
J	Sudhoff, H; Klenke, C; Greiner, JFW; Muller, J; Brotzmann, V; Ebmeyer, J; Kaltschmidt, B; Kaltschmidt, C				Sudhoff, Holger; Klenke, Christin; Greiner, Johannes F. W.; Mueller, Janine; Brotzmann, Viktoria; Ebmeyer, Joerg; Kaltschmidt, Barbara; Kaltschmidt, Christian			1,8-Cineol Reduces Mucus-Production in a Novel Human Ex Vivo Model of Late Rhinosinusitis	PLOS ONE			English	Article							NF-KAPPA-B; PLACEBO-CONTROLLED TRIAL; EPITHELIAL-CELLS; DOUBLE-BLIND; RESPIRATORY-TRACT; GENE-EXPRESSION; ESSENTIAL OILS; UP-REGULATION; MUCIN GENES; AIRWAYS	Inflammatory diseases of the respiratory system such as rhinosinusitis, chronic obstructive pulmonary disease, or bronchial asthma are strongly associated with overproduction and hypersecretion of mucus lining the epithelial airway surface. 1,8-cineol, the active ingredient of the pharmaceutical drug Soledum, is commonly applied for treating such inflammatory airway diseases. However, its potential effects on mucus overproduction still remain unclear. In the present study, we successfully established ex vivo cultures of human nasal turbinate slices to investigate the effects of 1,8-cineol on mucus hypersecretion in experimentally induced rhinosinusitis. The presence of acetyl-alpha-tubulin-positive cilia confirmed the integrity of the ex vivo cultured epithelium. Mucin-filled goblet cells were also detectable in nasal slice cultures, as revealed by Alcian Blue and Periodic acid-Schiff stainings. Treatment of nasal slice cultures with lipopolysaccharides mimicking bacterial infection as observed during late rhinosinusitis led to a significantly increased number of mucin-filled goblet cells. Notably, the number of mucin-filled goblet cells was found to be significantly decreased after co-treatment with 1,8-cineol. On a molecular level, real time PCR-analysis further showed 1,8-cineol to significantly reduce the expression levels of the mucin genes MUC2 and MUC19 in close association with significantly attenuated NF-kappa B-activity. In conclusion, we demonstrate for the first time a 1,8-cineol-dependent reduction of mucin-filled goblet cells and MUC2-gene expression associated with an attenuated NF-kappa B-activity in human nasal slice cultures. Our findings suggest that these effects partially account for the clinical benefits of 1,8-cineol-based therapy during rhinosinusitis. Therefore, topical application of 1,8-cineol may offer a novel therapeutic approach to reduce bacteria-induced mucus hypersecretion.	[Sudhoff, Holger; Klenke, Christin; Greiner, Johannes F. W.; Mueller, Janine; Brotzmann, Viktoria; Ebmeyer, Joerg] Klinikum Bielefeld, Dept Otolaryngol Head & Neck Surg, D-33604 Bielefeld, Germany; [Greiner, Johannes F. W.; Brotzmann, Viktoria; Kaltschmidt, Barbara; Kaltschmidt, Christian] Univ Bielefeld, Dept Cell Biol, D-33501 Bielefeld, Germany; [Mueller, Janine; Kaltschmidt, Barbara] Univ Bielefeld, AG Mol Neurobiol, D-33501 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Kaltschmidt, C (corresponding author), Univ Bielefeld, Dept Cell Biol, D-33501 Bielefeld, Germany.	c.kaltschmidt@uni-bielefeld.de	Sudhoff, Holger/AAV-9741-2020; Greiner, Johannes/Y-6372-2019	Sudhoff, Holger/0000-0002-9274-5645; Greiner, Johannes/0000-0002-0524-662X	Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany	Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany	This study was sponsored by Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos VPD, 2011, BASIC CLIN PHARMACOL, V108, P34, DOI 10.1111/j.1742-7843.2010.00622.x; Bomer K, 1998, ARCH OTOLARYNGOL, V124, P1227, DOI 10.1001/archotol.124.11.1227; Caramori G, 2004, HISTOPATHOLOGY, V45, P477, DOI 10.1111/j.1365-2559.2004.01952.x; Cloez M.S., 1870, COMPTES RENDUS, V70, P687; Davies JR, 1996, BIOCHEM J, V313, P431, DOI 10.1042/bj3130431; Djenane D, 2011, FOOD SCI TECHNOL INT, V17, P505, DOI 10.1177/1082013211398803; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; Greiner JFW, 2013, BBA-MOL CELL RES, V1833, P2866, DOI 10.1016/j.bbamcr.2013.07.001; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Inoue KI, 2005, INT J MOL MED, V16, P315; Jono H, 2002, J BIOL CHEM, V277, P45547, DOI 10.1074/jbc.M206883200; Juergens U R, 2014, Drug Res (Stuttg), V64, P638, DOI 10.1055/s-0034-1372609; Juergens U R, 1998, Eur J Med Res, V3, P508; Juergens UR, 2003, RESP MED, V97, P250, DOI 10.1053/rmed.2003.1432; Kehrl W, 2004, LARYNGOSCOPE, V114, P738, DOI 10.1097/00005537-200404000-00027; Kerschner JE, 2009, GLYCOCONJUGATE J, V26, P1275, DOI 10.1007/s10719-009-9245-x; Kim DH, 2004, ARCH OTOLARYNGOL, V130, P747, DOI 10.1001/archotol.130.6.747; Kim DH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/360457; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lane AP, 2010, J NEUROSCI, V30, P2324, DOI 10.1523/JNEUROSCI.4507-09.2010; LEVINE SJ, 1995, AM J RESP CELL MOL, V12, P196, DOI 10.1165/ajrcmb.12.2.7865217; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Morcillo EJ, 2006, CURR OPIN PULM MED, V12, P1, DOI 10.1097/01.mcp.0000198064.27586.37; Mygind N, 1998, ADV DRUG DELIVER REV, V29, P3, DOI 10.1016/S0169-409X(97)00058-6; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Santos FA, 2000, PHYTOTHER RES, V14, P240, DOI 10.1002/1099-1573(200006)14:4&lt;240::AID-PTR573&gt;3.0.CO;2-X; STEEDMAN HF, 1950, Q J MICROSC SCI, V91, P477; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; THORNTON DJ, 1991, BIOCHEM J, V276, P667, DOI 10.1042/bj2760667; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Worth H, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-69; Zhao CZ, 2014, INFLAMMATION, V37, P566, DOI 10.1007/s10753-013-9770-4	36	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133040	10.1371/journal.pone.0133040	http://dx.doi.org/10.1371/journal.pone.0133040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207629	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000059
J	Xie, Y; Liu, SF; Zhao, YF; Zhang, L; Zhao, Y; Liu, BH; Guo, ZJ				Xie, Ying; Liu, Shufeng; Zhao, Yufei; Zhang, Lan; Zhao, Yue; Liu, Binghui; Guo, Zhanjun			Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma	PLOS ONE			English	Article							PROMOTER MUTATIONS; VIRAL LOAD; RISK; GENOTYPE; CORE; EPIDEMIOLOGY; CARRIERS; LEVEL	Hepatitis B virus (HBV) DNA is prone to mutations because of the proofreading deficiencies of HBV polymerase. We have identified hepatocellular carcinoma (HCC) survival-associated HBV mutations in the X protein region of HBV DNA. In the present study, we extend our research to assess HCC survival-associated HBV mutations in the HBV precore/core (PreC/C) region. The PreC/C region was amplified and sequenced and the HBV mutations were identified according to the NCBI database (http://www.ncbi.nlm.nih.gov/genome/5536). The relationships between the mutations in the PreC/C region and HCC survival were analyzed. Survival curves were generated using the Kaplan-Meier method, and comparisons between the curves were made using the log-rank test. Multivariate survival analysis was performed using a Cox proportional hazards model. After adjusting for clinical characteristics, the 1915, 2134, 2221, 2245 and 2288 mutational sites were identified as statistically significant independent predictors of HCC survival by multivariate survival analysis using a Cox proportional hazards model. In addition, the mutational site of 1896 was identified for its association with survival at a borderline significance level. A total of five mutations in the precore/core region were identified as independent predictors of postoperative survival in HCC patients. The analysis of HBV DNA mutations may help identify patient subgroups with poor prognosis and may help refine therapeutic decisions regarding HCC patients.	[Xie, Ying; Liu, Shufeng; Liu, Binghui] Hebei Med Univ, Hebei Key Lab Lab Anim Sci, Shijiazhuang, Hebei Province, Peoples R China; [Zhao, Yufei; Zhang, Lan; Zhao, Yue; Guo, Zhanjun] Hebei Med Univ, Hosp 4, Dept Gastroenterol & Hepatol, Shijiazhuang, Peoples R China; [Xie, Ying] Peking Union Med Coll, Inst Lab Anim Sci, Beijing, Peoples R China	Hebei Medical University; Hebei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Peking Union Medical College	Guo, ZJ (corresponding author), Hebei Med Univ, Hosp 4, Dept Gastroenterol & Hepatol, Shijiazhuang, Peoples R China.	zjguo5886@aliyun.com			Key basic research program of Hebei [14967713D]; Construction Program of Hebei Scientific Conditions [13967607D]	Key basic research program of Hebei; Construction Program of Hebei Scientific Conditions	ZG was supported by Key basic research program of Hebei (14967713D), and SL was supported by the Construction Program of Hebei Scientific Conditions (13967607D). But these funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chen JS, 2007, J CLIN VIROL, V38, P238, DOI 10.1016/j.jcv.2006.12.007; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Jang JW, 2012, CANCER SCI, V103, P296, DOI 10.1111/j.1349-7006.2011.02170.x; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047372; Lin CL, 2007, J GASTROEN HEPATOL, V22, P1098, DOI 10.1111/j.1440-1746.2006.04515.x; Liu CJ, 2006, J INFECT DIS, V194, P594, DOI 10.1086/505883; Liu CJ, 2006, J INFECT DIS, V193, P1258, DOI 10.1086/502978; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Maki A, 2007, ANN SURG ONCOL, V14, P1182, DOI 10.1245/s10434-006-9049-1; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Wang CJ, 2011, BIOCHEM BIOPH RES CO, V406, P493, DOI 10.1016/j.bbrc.2011.02.088; Xie Y, 2014, TUMOR BIOL, V35, P10325, DOI 10.1007/s13277-014-2331-0; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; Yousif M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095377; Yu MC, 2000, CAN J GASTROENTEROL, V14, P703, DOI 10.1155/2000/371801; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Zheng JX, 2011, J VIRAL HEPATITIS, V18, pE423, DOI 10.1111/j.1365-2893.2011.01458.x	22	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133393	10.1371/journal.pone.0133393	http://dx.doi.org/10.1371/journal.pone.0133393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208136	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000085
J	Song, YN; Hakoda, Y; Sanefuji, W; Cheng, C				Song, Yongning; Hakoda, Yuji; Sanefuji, Wakako; Cheng, Chen			Can They See It? The Functional Field of View Is Narrower in Individuals with Autism Spectrum Disorder	PLOS ONE			English	Article							SUPERIOR VISUAL-SEARCH; ASPERGER-SYNDROME; LOCAL PRECEDENCE; CHILDREN; PERCEPTION; AGE; ADOLESCENTS; PERFORMANCE; ATTENTION; DETAIL	Although social cognitive deficits have long been thought to underlie the characteristic and pervasive difficulties with social interaction observed in individuals with autism spectrum disorder (ASD), several recent behavioral and neuroimaging studies have indicated that visual perceptual impairments might also play a role. People with ASD show a robust bias towards detailed information at the expense of global information, although the mechanisms that underlie this phenomenon remain elusive. To address this issue, we investigated the functional field of view in a group of high-functioning children with autism (n = 13) and a paired non-ASD group (n = 13). Our results indicate that the ability to correctly detect and identify stimuli sharply decreases with greater eccentricity from the fovea in people with ASD. Accordingly, a probe analysis revealed that the functional field of view in the ASD group was only about 6.62 degrees of retinal eccentricity, compared with 8.57 degrees in typically developing children. Thus, children with ASD appear to have a narrower functional field of view. These results challenge the conventional hypothesis that the deficit in global processing in individuals with ASD is solely due to weak central coherence. Alternatively, our data suggest that a narrower functional field of view may also contribute to this bias.	[Song, Yongning] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Shanghai Key Lab Brain Funct Genom,Sch Psychol &, Shanghai 200062, Peoples R China; [Hakoda, Yuji] Kyoto Womens Univ, Fac Human Dev & Educ, Kyoto, Japan; [Sanefuji, Wakako] Kyushu Univ, Fac Human Environm Studies, Fukuoka 812, Japan; [Cheng, Chen] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA	East China Normal University; Kyoto Womens University; Kyushu University; University of Massachusetts System; University of Massachusetts Boston	Song, YN (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Shanghai Key Lab Brain Funct Genom,Sch Psychol &, Shanghai 200062, Peoples R China.	Ynsong@psy.ecnu.edu.cn			National Natural Foundation of China [31300839]; JSPS Postdoctoral Fellowship for Foreign Researchers [P13311]; Shanghai Pujiang Program [12PJC034]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [13YJC190020]; SRF for ROCS, SEM	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); JSPS Postdoctoral Fellowship for Foreign Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Shanghai Pujiang Program(Shanghai Pujiang Program); MOE (Ministry of Education in China) Project of Humanities and Social Sciences; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Natural Foundation of China (31300839), Grant-in-Aid for JSPS Postdoctoral Fellowship for Foreign Researchers (P13311), Shanghai Pujiang Program (12PJC034), MOE (Ministry of Education in China) Project of Humanities and Social Sciences (13YJC190020) and SRF for ROCS, SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C, 2007, AUTISM, V11, P173, DOI 10.1177/1362361307075710; ANGOLD A, 1995, PSYCHOL MED, V25, P739, DOI 10.1017/S003329170003498X; APA, 2000, DIAGN STAT MAN MENT; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Ball KK, 2002, GERONTECHNOLOGY, V1, P251, DOI DOI 10.4017/GT.2002.01.04.004.00; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brian JA, 1996, J CHILD PSYCHOL PSYC, V37, P865, DOI 10.1111/j.1469-7610.1996.tb01482.x; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Deruelle C, 2004, J AUTISM DEV DISORD, V34, P199, DOI 10.1023/B:JADD.0000022610.09668.4c; Ehlers S, 1999, J AUTISM DEV DISORD, V29, P129, DOI 10.1023/A:1023040610384; Finney DJ, 1947, PROBIT ANAL STAT TRE; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gagnon L, 2004, J AUTISM DEV DISORD, V34, P679, DOI 10.1007/s10803-004-5288-9; Gernsbacher MA, 2008, CHILD DEV PERSPECT, V2, P38, DOI 10.1111/j.1750-8606.2008.00039.x; Gillberg C, 2001, AUTISM, V5, P57, DOI 10.1177/1362361301005001006; Greenaway R, 2013, NEUROPSYCHOLOGIA, V51, P592, DOI 10.1016/j.neuropsychologia.2013.01.005; Gross TF, 2005, J AUTISM DEV DISORD, V35, P773, DOI 10.1007/s10803-005-0023-8; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Happe F., 1994, AUTISM INTRO PSYCHOL; Happe FGE., 1991, THESIS U LONDON; Jarrold C, 1997, J AUTISM DEV DISORD, V27, P25, DOI 10.1023/A:1025817121137; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kemner C, 2008, J AUTISM DEV DISORD, V38, P553, DOI 10.1007/s10803-007-0406-0; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Lahaie A, 2006, NEUROPSYCHOLOGY, V20, P30, DOI 10.1037/0894-4105.20.1.30; LAMB MR, 1988, PERCEPT PSYCHOPHYS, V44, P172, DOI 10.3758/BF03208710; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Loukusa S, 2007, J AUTISM DEV DISORD, V37, P1049, DOI 10.1007/s10803-006-0247-2; Mackworth N. H., 1965, PSYCHON SCI, V3, P67, DOI DOI 10.3758/BF03343023; Mann TA, 2003, J CHILD PSYCHOL PSYC, V44, P274, DOI 10.1111/1469-7610.00120; McCleery JP, 2007, BIOL PSYCHIAT, V62, P1007, DOI 10.1016/j.biopsych.2007.02.009; Mitsudo H, 2007, PERCEPTION, V36, P125, DOI 10.1068/p5562; Mottron L, 2003, J CHILD PSYCHOL PSYC, V44, P904, DOI 10.1111/1469-7610.00174; MOTTRON L, 1993, BRAIN COGNITION, V23, P279, DOI 10.1006/brcg.1993.1060; O'Riordan M, 2001, Q J EXP PSYCHOL-A, V54, P961, DOI 10.1080/02724980042000543; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; O'Riordan MA, 2004, AUTISM, V8, P229, DOI 10.1177/1362361304045219; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Plaisted K, 2003, PHILOS T ROY SOC B, V358, P375, DOI 10.1098/rstb.2002.1211; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; Raven J, 2003, STANDARD PROGR MATRI; Rinehart NJ, 2000, J CHILD PSYCHOL PSYC, V41, P769, DOI 10.1017/S002196309900596X; Ropar D, 2001, J CHILD PSYCHOL PSYC, V42, P539, DOI 10.1017/S002196300100717X; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Teunisse JP, 2003, BRAIN COGNITION, V52, P285, DOI 10.1016/S0278-2626(03)00042-3; TOWNSEND J, 1994, J COGNITIVE NEUROSCI, V6, P220, DOI 10.1162/jocn.1994.6.3.220; van der Geest JN, 2002, J CHILD PSYCHOL PSYC, V43, P669, DOI 10.1111/1469-7610.00055; VANESSEN DC, 1983, TRENDS NEUROSCI, V6, P370, DOI 10.1016/0166-2236(83)90167-4; Witkin HA, MANUAL EMBEDDED FIGU	54	13	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133237	10.1371/journal.pone.0133237	http://dx.doi.org/10.1371/journal.pone.0133237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204121	gold, Green Published, Green Submitted			2022-12-26	WOS:000358621000023
J	Davy, CM; Kidd, AG; Wilson, CC				Davy, Christina M.; Kidd, Anne G.; Wilson, Chris C.			Development and Validation of Environmental DNA (eDNA) Markers for Detection of Freshwater Turtles	PLOS ONE			English	Article							CONSERVATION; GENETICS; SAMPLES; PCR	Environmental DNA (eDNA) is a potentially powerful tool for detection and monitoring of rare species, including threatened native species and recently arrived invasive species. Here, we develop DNA primers for a suite of nine sympatric freshwater turtles, and use it to test whether turtle eDNA can be successfully detected in samples from aquaria and an outdoor pond. We also conduct a cost comparison between eDNA detection and detection through traditional survey methods, using data from field surveys at two sites in our target area. We find that eDNA from turtles can be detected using both conventional polymerase chain reaction (PCR) and quantitative PCR (qPCR), and that the cost of detection through traditional survey methods is 2-10X higher than eDNA detection for the species in our study range. We summarize necessary future steps for application of eDNA surveys to turtle monitoring and conservation and propose specific cases in which the application of eDNA could further the conservation of threatened turtle species.	[Davy, Christina M.] Wildlife Preservat Canada, Guelph, ON, Canada; [Davy, Christina M.] Trent Univ, Peterborough, ON K9J 7B8, Canada; [Kidd, Anne G.; Wilson, Chris C.] Ontario Minist Nat Resources & Forestry, Peterborough, ON, Canada	Trent University; Ministry of Natural Resources & Forestry	Davy, CM (corresponding author), Wildlife Preservat Canada, Guelph, ON, Canada.	christinadavy@trentu.ca	Wilson, Chris C/J-4851-2012	Wilson, Chris C/0000-0002-9528-0652	Government of Ontario [31-14]; Wildlife Preservation Canada; Rogers Foundation; Liber Ero Fellowship	Government of Ontario; Wildlife Preservation Canada; Rogers Foundation; Liber Ero Fellowship	This study was funded by the Government of Ontario (Species at Risk Research Fund for Ontario grant #31-14 to CMD) and by Wildlife Preservation Canada and the Rogers Foundation (www.wildlifepreservation.ca; Canada Collections grant to CMD). CMD is supported by a Liber Ero Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Amato ML, 2008, MOL ECOL, V17, P570, DOI 10.1111/j.1365-294X.2007.03580.x; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bronnenhuber JE, 2013, CONSERV GENET RESOUR, V5, P971, DOI 10.1007/s12686-013-9946-0; Browne CL, 2007, BIOL CONSERV, V138, P421, DOI 10.1016/j.biocon.2007.05.008; Chambers EA, 2014, THESIS U GUELPH; COSEWIC, 2007, COSEWIC ASS UPD STAT; COSEWIC, 2006, COSEWIC ASS STAT REP; COSEWIC, 2005, COSEWIC ASS UPD STAT; COSEWIC, 2008, COSEWIC ASS STAT REP; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COSEWIC ASS STAT REP; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2002, COSEWIC ASS STAT REP; Davy CM, 2014, ANIM BEHAV, V93, P15, DOI 10.1016/j.anbehav.2014.04.013; Davy CM, 2014, CONSERV GENET, V15, P319, DOI 10.1007/s10592-013-0540-5; Davy CM, 2014, CAN J ZOOL, V92, P149, DOI 10.1139/cjz-2013-0188; Davy CM, 2013, EUR J WILDLIFE RES, V59, P123, DOI 10.1007/s10344-012-0680-9; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Ficetola G F, 2015, MOL ECOL RES, V15, P1755; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Innis MA, 1990, PCR PROTOCOLS GUIDE; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lepitzki D.A.W., 2008, COSEWIC ASSESSMENT U; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Polo-Cavia N, 2008, ETHOLOGY, V114, P115, DOI 10.1111/j.1439-0310.2007.01441.x; Polo-Cavia N, 2010, ANIM BEHAV, V80, P461, DOI 10.1016/j.anbehav.2010.06.004; Rainwater TR, 2012, CHELONIAN CONSERV BI, V11, P97, DOI 10.2744/CCB-0932.1; Rhodin A. G. J, 2011, IUCN SSC TORTOISE FR; Rozen S, 2000, Methods Mol Biol, V132, P365; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Sterrett SC, 2010, HERPETOL CONSERV BIO, V5, P490; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; United Stated Fish and Wildlife Service, 2013, QUAL ASS PROJ PLAN E; van Dijk P. P., 2012, CHELYDRA SERPENTINA; van Dijk PP, 2013, CLEMMYS GUTTATA IUCN; van Dijk PP, 2013, APALONE SPINIFERA IU; van Dijk PP, 2013, EMYDOIDEA BLANDINGII; van Dijk PP, 2013, TRACHEMYS SCRIPTA IU; van Dijk PP, 2013, GLYPTEMYS INSCULPTA; van Dijk PP, 2013, CHRYSEMYS PICTA IUCN; van Dijk PP, 2013, GRAPTEMYS GEOGRAPHIC; van Dijk PP, 2013, STERNOTHERUS ODORATU; Walker D, 1998, ANIM CONSERV, V1, P55, DOI 10.1111/j.1469-1795.1998.tb00226.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wilson C, 2014, MANAGE BIOL IN PRESS, V5	55	76	81	8	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0130965	10.1371/journal.pone.0130965	http://dx.doi.org/10.1371/journal.pone.0130965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200348	Green Submitted, Green Published, gold			2022-12-26	WOS:000358597100010
J	Deol, P; Evans, JR; Dhahbi, J; Chellappa, K; Han, DS; Spindler, S; Sladek, FM				Deol, Poonamjot; Evans, Jane R.; Dhahbi, Joseph; Chellappa, Karthikeyani; Han, Diana S.; Spindler, Stephen; Sladek, Frances M.			Soybean Oil Is More Obesogenic and Diabetogenic than Coconut Oil and Fructose in Mouse: Potential Role for the Liver	PLOS ONE			English	Article							DIETARY LINOLEIC-ACID; WESTERN-TYPE DIETS; HIGH-FAT DIETS; SWEETENED BEVERAGES; INSULIN-RESISTANCE; GAMMA-TOCOPHEROL; GENE-EXPRESSION; LIPID DROPLETS; BODY-WEIGHT; EPOXYEICOSATRIENOIC ACIDS	The obesity epidemic in the U.S. has led to extensive research into potential contributing dietary factors, especially fat and fructose. Recently, increased consumption of soybean oil, which is rich in polyunsaturated fatty acids (PUFAs), has been proposed to play a causal role in the epidemic. Here, we designed a series of four isocaloric diets (HFD, SO-HFD, F-HFD, F-SO-HFD) to investigate the effects of saturated versus unsaturated fat, as well as fructose, on obesity and diabetes. C57/BL6 male mice fed a diet moderately high in fat from coconut oil and soybean oil (SO-HFD, 40% kcal total fat) showed statistically significant increases in weight gain, adiposity, diabetes, glucose intolerance and insulin resistance compared to mice on a diet consisting primarily of coconut oil (HFD). They also had fatty livers with hepatocyte ballooning and very large lipid droplets as well as shorter colonic crypt length. While the high fructose diet (F-HFD) did not cause as much obesity or diabetes as SO-HFD, it did cause rectal prolapse and a very fatty liver, but no balloon injury. The coconut oil diet (with or without fructose) increased spleen weight while fructose in the presence of soybean oil increased kidney weight. Metabolomics analysis of the liver showed an increased accumulation of PUFAs and their metabolites as well as.-tocopherol, but a decrease in cholesterol in SO-HFD. Liver transcriptomics analysis revealed a global dysregulation of cytochrome P450 (Cyp) genes in SO-HFD versus HFD livers, most notably in the Cyp3a and Cyp2c families. Other genes involved in obesity (e.g., Cidec, Cd36), diabetes (Igfbp1), inflammation (Cd63), mitochondrial function (Pdk4) and cancer (H19) were also upregulated by the soybean oil diet. Taken together, our results indicate that in mice a diet high in soybean oil is more detrimental to metabolic health than a diet high in fructose or coconut oil.	[Deol, Poonamjot; Evans, Jane R.; Chellappa, Karthikeyani; Han, Diana S.; Sladek, Frances M.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Dhahbi, Joseph; Spindler, Stephen] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Sladek, FM (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	frances.sladek@ucr.edu		Deol, Sonia/0000-0002-7109-0619	National Institute of Environmental Health Sciences [T32 5T32-ES018827]; National Institutes of Health [R01DK053892]; University of California Riverside Collaborative Seed grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES018827] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1429826] Funding Source: National Science Foundation	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Riverside Collaborative Seed grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Institute of Environmental Health Sciences T32 5T32-ES018827 to PD (http://www.niehs.nih.gov/), the National Institutes of Health R01DK053892 to FMS (http://nih.gov/), and University of California Riverside Collaborative Seed grant to FMS (http://www.research.ucr.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abel S, 2009, PROSTAG LEUKOTR ESS, V81, P391, DOI 10.1016/j.plefa.2009.08.003; Ackerman Z, 2005, HYPERTENSION, V45, P1012, DOI 10.1161/01.HYP.0000164570.20420.67; Alvheim AR, 2013, BRIT J NUTR, V109, P1508, DOI 10.1017/S0007114512003364; Alvheim AR, 2012, OBESITY, V20, P1984, DOI 10.1038/oby.2012.38; ANDERSSON DEH, 1978, ACTA MED SCAND, V203, P87; ARAVANIS C, 1970, Circulation Research Supplement, V41, P88; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bacigalupo ML, 2013, WORLD J GASTROENTERO, V19, P8831, DOI 10.3748/wjg.v19.i47.8831; Bantle JP, 2009, J NUTR, V139, pS1263, DOI 10.3945/jn.108.098020; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; BIERI JG, 1974, AM J CLIN NUTR, V27, P980, DOI 10.1093/ajcn/27.8.980; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bocarsly ME, 2010, PHARMACOL BIOCHEM BE, V97, P101, DOI 10.1016/j.pbb.2010.02.012; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bray GA, 2007, AM J CLIN NUTR, V86, P895, DOI 10.1093/ajcn/86.4.895; Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085; Burr GOB, 1929, J BIOL CHEM, VLXXXII; Burr GOB, 1930, J BIOL CHEM, VLXXXVI; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; CERECEDO LR, 1952, J NUTR, V48, P41, DOI 10.1093/jn/48.1.41; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Cohen E, 2015, NUTRITION, V31, P727, DOI 10.1016/j.nut.2015.02.007; da Costa CAS, 2013, HORM METAB RES, V45, P652, DOI 10.1055/s-0033-1345150; DAYTON S, 1966, J LIPID RES, V7, P103; de Roos NM, 2001, J NUTR, V131, P242, DOI 10.1093/jn/131.2.242; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190; Fang X, 1999, J LIPID RES, V40, P699; Farah V, 2006, AUTON NEUROSCI-BASIC, V130, P41, DOI 10.1016/j.autneu.2006.05.006; GARFINKEL M, 1992, J SURG RES, V52, P328, DOI 10.1016/0022-4804(92)90111-C; Ghosh S, 2013, BRIT J NUTR, V110, P515, DOI 10.1017/S0007114512005326; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Haguenauer A, 2005, J BIOL CHEM, V280, P22036, DOI 10.1074/jbc.M412136200; Hashimoto Y, 2013, LIPIDS, V48, P803, DOI 10.1007/s11745-013-3805-3; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hoekstra M, 2006, J LIPID RES, V47, P2198, DOI 10.1194/jlr.M600095-JLR200; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Howlader N, 2014, SEER CANC STAT REV 1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010; Ichi I, 2014, BBA-MOL CELL BIOL L, V1841, P204, DOI 10.1016/j.bbalip.2013.10.013; Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Queipo-Ortuno MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048605; Jeoung Nam Ho, 2010, Korean Diabetes J, V34, P274, DOI 10.4093/kdj.2010.34.5.274; Jiang Q, 2004, P NATL ACAD SCI USA, V101, P17825, DOI 10.1073/pnas.0408340102; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; Jiang Q, 2003, FASEB J, V17, P816, DOI 10.1096/fj.02-0877com; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Jurgonski A, 2014, NUTRIENTS, V6, P616, DOI 10.3390/nu6020616; Kahn R, 2014, DIABETES CARE, V37, P957, DOI 10.2337/dc13-2506; KEYS A, 1957, JAMA-J AM MED ASSOC, V164, P1912, DOI 10.1001/jama.1957.62980170024007e; Kimura N, 1970, CIRCULATION, V41, pI101; Klurfeld DM, 2012, INT J OBES LOND; Konig R, 2008, CHEM RES TOXICOL, V21, P572, DOI 10.1021/tx7002728; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Kritchevsky D, 1998, J NUTR, V128, p449S, DOI 10.1093/jn/128.2.449S; Lamarche B, 2014, APPL PHYSIOL NUTR ME, P1, DOI [10.1139/apnm-2013-0026, DOI 10.1139/APNM-2013-0026]; LANDS WEM, 1990, LIPIDS, V25, P505, DOI 10.1007/BF02537156; Larsson SC, 2007, BRIT J CANCER, V97, P1005, DOI 10.1038/sj.bjc.6603932; Lazic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107658; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lee KT, 2000, J AGR FOOD CHEM, V48, P5696, DOI 10.1021/jf000072+; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; LOCKERETZ W, 1988, FOOD POLICY, V13, P154, DOI 10.1016/0306-9192(88)90028-0; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Marriott BP, 2010, CRIT REV FOOD SCI, V50, P228, DOI 10.1080/10408391003626223; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; Massiera F, 2010, J LIPID RES, V51, P2352, DOI 10.1194/jlr.M006866; McCullough JS, 1998, GUT, V42, P799, DOI 10.1136/gut.42.6.799; MCGARRITY TJ, 1988, GASTROENTEROLOGY, V95, P343, DOI 10.1016/0016-5085(88)90489-1; Merat S, 1999, ARTERIOSCL THROM VAS, V19, P1223, DOI 10.1161/01.ATV.19.5.1223; MESJJ J, 2015, NANOTECHONOLOGY FUNC; Midtbo LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053094; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; Mumme K, 2015, J ACAD NUTR DIET, V115, P249, DOI 10.1016/j.jand.2014.10.022; Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nieto G., 2012, MODIFICATION FATTY A; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Ogbolu DO, 2007, J MED FOOD, V10, P384, DOI 10.1089/jmf.2006.1209; Oliveros J.C., 2007, VENNY INTERACTIVE TO; OOI GT, 1992, MOL ENDOCRINOL, V6, P2219, DOI 10.1210/me.6.12.2219; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; PAGE IH, 1961, CIRCULATION, V23, P133, DOI 10.1161/01.CIR.23.1.133; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PARK YMK, 1993, AM J CLIN NUTR, V58, P737; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Reebye V, 2014, HEPATOLOGY, V59, P216, DOI 10.1002/hep.26669; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rett BS, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-36; Roat R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086815; Roccisano D, 2011, AM J PHYS ANTHROPOL, V144, P255; Rogue A, 2010, PPAR RES, V2010, DOI 10.1155/2010/325183; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosillo-Calle F., 2009, GLOBAL OVERVIEW VEGE, V40; Sanders TAB, 2014, P NUTR SOC, V73, P73, DOI 10.1017/S0029665113003789; Schaefer EJ, 2009, J NUTR, V139, pS1257, DOI 10.3945/jn.108.098186; Sena CM, 2008, MED CHEM, V4, P293, DOI 10.2174/157340608784325115; Shimonishi T, 2001, HUM PATHOL, V32, P302, DOI 10.1053/hupa.2001.22767; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; da Costa CAS, 2011, CLINICS, V66, P1811, DOI 10.1590/S1807-59322011001000022; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Spector AA, 2014, BIOCH BIOPHYS ACTA; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stanhope KL, 2013, CURR OPIN LIPIDOL, V24, P198, DOI 10.1097/MOL.0b013e3283613bca; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; SUNTER JP, 1979, VIRCHOWS ARCH B, V32, P75; Swarbrick MM, 2008, BRIT J NUTR, V100, P947, DOI 10.1017/S0007114508968252; Tao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071997; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; TAYLOR H L, 1970, Circulation Research Supplement, V41, P20; Thompson F., 2014, OVERCOMING OBESITY I; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9; Tsuchiya H, 2013, METABOLISM, V62, P62, DOI 10.1016/j.metabol.2012.06.008; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; van Buul VJ, 2014, NUTR RES REV, V27, P119, DOI 10.1017/S0954422414000067; van Waterschoot RAB, 2008, MOL PHARMACOL, V73, P1029, DOI 10.1124/mol.107.043869; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Vos Miriam B, 2008, Medscape J Med, V10, P160; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Wu H, 2012, J GASTROEN HEPATOL, V27, P1312, DOI 10.1111/j.1440-1746.2012.07130.x; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Xue C, 2009, EUR J CLIN NUTR, V63, P879, DOI 10.1038/ejcn.2008.76; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Yarmishyn AA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00145; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zha WB, 2014, J LIPID RES, V55, P2124, DOI 10.1194/jlr.M053199; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhang XH, 2007, ASIA PAC J CLIN NUTR, V16, P368; Zhang ZF, 2015, J ADOLESCENT HEALTH, V56, P352, DOI 10.1016/j.jadohealth.2014.12.001; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	167	62	64	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132672	10.1371/journal.pone.0132672	http://dx.doi.org/10.1371/journal.pone.0132672			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200659	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100044
J	Fedrizzi, N; Stiassny, MLJ; Boehm, JT; Dougherty, ER; Amato, G; Mendez, M				Fedrizzi, Nathan; Stiassny, Melanie L. J.; Boehm, J. T.; Dougherty, Eric R.; Amato, George; Mendez, Martin			Population Genetic Structure of the Dwarf Seahorse (Hippocampus zosterae) in Florida	PLOS ONE			English	Article							DNA POLYMORPHISM; LOOP CURRENT; TAMPA BAY; CONSERVATION; MANAGEMENT; CONNECTIVITY; SYNGNATHIDAE; PHYLOGEOGRAPHY; SOFTWARE; DISTANCE	The dwarf seahorse (Hippocampus zosterae) is widely distributed throughout near-shore habitats of the Gulf of Mexico and is of commercial significance in Florida, where it is harvested for the aquarium and curio trades. Despite its regional importance, the genetic structure of dwarf seahorse populations remains largely unknown. As an aid to ongoing conservation efforts, we employed three commonly applied mtDNA markers (ND4, DLoop and CO1) to investigate the genetic structuring of H. zosterae in Florida using samples collected throughout its range in the state. A total of 1450 bp provided sufficient resolution to delineate four populations of dwarf seahorses, as indicated by significant fixation indices. Despite an overall significant population structure, we observed evidence of interbreeding between individuals from geographically distant sites, supporting the hypothesis that rafting serves to maintain a degree of population connectivity. All individuals collected from Pensacola belong to a single distinct subpopulation, which is highly differentiated from the rest of Floridian dwarf seahorses sampled. Our findings highlight the utility of mtDNA markers in evaluating barriers to gene flow and identifying genetically distinct populations, which are vital to the development of comprehensive conservation strategies for exploited taxa.	[Fedrizzi, Nathan] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Fedrizzi, Nathan; Stiassny, Melanie L. J.; Boehm, J. T.; Dougherty, Eric R.; Amato, George; Mendez, Martin] Amer Museum Nat Hist, Sackler Inst Comparat Gen, New York, NY 10024 USA; [Stiassny, Melanie L. J.] Amer Museum Nat Hist, Div Vertebrate Zool, Dept Ichthyol, New York, NY 10024 USA; [Boehm, J. T.] CUNY, Grad Ctr, Dept Ecol Evolut & Behav, New York, NY 10021 USA; [Dougherty, Eric R.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Mendez, Martin] Wildlife Conservat Soc, Latin Amer & Caribbean Program, Bronx, NY USA	Columbia University; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); City University of New York (CUNY) System; University of California System; University of California Berkeley; Wildlife Conservation Society	Fedrizzi, N (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	nathanfedrizzi@gmail.com			Columbia University Earth Institute Travel Grant; Lerner Gray Memorial Fund of the American Museum of Natural History	Columbia University Earth Institute Travel Grant; Lerner Gray Memorial Fund of the American Museum of Natural History	This work was supported by The Columbia University Earth Institute Travel Grant for field work, and The Lerner Gray Memorial Fund of the American Museum of Natural History funded laboratory work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 2001, AQUARIUM SCI CONSERV, V3, P25, DOI DOI 10.1023/A:1011389603693; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boehm JT, 2013, J BIOGEOGR, V40, P1839, DOI 10.1111/jbi.12127; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Carney RS, 2012, GULF MEXICO LOOP CUR; Chang CH, 2013, MITOCHONDR DNA, V24, P199, DOI 10.3109/19401736.2012.744983; Choo CK, 2006, J FISH BIOL, V69, P426, DOI 10.1111/j.1095-8649.2006.01105.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dias TL, 2002, ENVIRON BIOL FISH, V65, P326, DOI 10.1023/A:1020539222587; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Fu YX, 1997, GENETICS, V147, P915; Goswami M, 2009, HYDROBIOLOGIA, V621, P213, DOI 10.1007/s10750-008-9642-3; Hartl :D. L, 2000, PRIMER POPULATION GE; HUH OK, 1981, J GEOPHYS RES-OCEANS, V86, P4186, DOI 10.1029/JC086iC05p04186; IVERSON RL, 1986, ESTUAR COAST SHELF S, V22, P577, DOI 10.1016/0272-7714(86)90015-6; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; KIMURA M, 1964, GENETICS, V49, P561; LEE TN, 1992, CONT SHELF RES, V12, P971, DOI 10.1016/0278-4343(92)90055-O; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOURIE S, 2003, PROJECT SEAHORSE TEC, V3, P1; Lourie S.A., 2004, GUIDE IDENTIFICATION; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Masonjones HD, 2000, ANIM BEHAV, V59, P11, DOI 10.1006/anbe.1999.1269; Masonjones HD, 2010, CURR ZOOL, V56, P118, DOI 10.1093/czoolo/56.1.118; Mendez M, 2008, CONSERV GENET, V9, P419, DOI 10.1007/s10592-007-9354-7; Meyer DL, 1999, FISH B-NOAA, V97, P193; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Murugan A, 2009, AQUACULTURE, V290, P87, DOI 10.1016/j.aquaculture.2009.01.033; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi SR, 2003, ECOL APPL, V13, pS146; Platt AR, 2007, BIOTECHNIQUES, V43, P58, DOI 10.2144/000112499; Powell AB, 2002, NMFSSEFSC488 NOAA; Project Seahorse, 2003, HIPP ZOST IUCN RED L; Rose E, 2014, J HERED, V105, P828, DOI 10.1093/jhered/esu050; Sefc KM, 2007, EVOL ECOL RES, V9, P21; STRAWN K, 1954, COPEIA, P195; STRAWN KIRK, 1958, COPEIA, V1958, P16, DOI 10.2307/1439534; STURGES W, 1983, J MAR RES, V41, P639, DOI 10.1357/002224083788520487; TAJIMA F, 1989, GENETICS, V123, P585; Teske PR, 2005, MAR ECOL PROG SER, V286, P249, DOI 10.3354/meps286249; Tollis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038474; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Vincent ACJ, 2011, J FISH BIOL, V78, P1681, DOI 10.1111/j.1095-8649.2011.03003.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woodall L., 2009, THESIS U LONDON; Woodall LC, 2011, J FISH BIOL, V78, P1738, DOI 10.1111/j.1095-8649.2011.02974.x; Woodall LC, 2009, J FISH BIOL, V75, P1505, DOI 10.1111/j.1095-8649.2009.02371.x	51	14	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132308	10.1371/journal.pone.0132308	http://dx.doi.org/10.1371/journal.pone.0132308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200110	Green Published, gold			2022-12-26	WOS:000358597100033
J	Legendre, F; Nel, A; Svenson, GJ; Robillard, T; Pellens, R; Grandcolas, P				Legendre, Frederic; Nel, Andre; Svenson, Gavin J.; Robillard, Tony; Pellens, Roseli; Grandcolas, Philippe			Phylogeny of Dictyoptera: Dating the Origin of Cockroaches, Praying Mantises and Termites with Molecular Data and Controlled Fossil Evidence	PLOS ONE			English	Article							ORTHOPTEROID INSECTS POLYNEOPTERA; DIVERGENCE TIMES; CLARENS FORMATION; ABSOLUTE RATES; ISOPTERA NESTS; TULI BASIN; CLADE AGES; EVOLUTION; MITOCHONDRIAL; MANTODEA	Understanding the origin and diversification of organisms requires a good phylogenetic estimate of their age and diversification rates. This estimate can be difficult to obtain when samples are limited and fossil records are disputed, as in Dictyoptera. To choose among competing hypotheses of origin for dictyopteran suborders, we root a phylogenetic analysis (similar to 800 taxa, 10 kbp) within a large selection of outgroups and calibrate datings with fossils attributed to lineages with clear synapomorphies. We find the following topology: (mantises, (other cockroaches, (Cryptocercidae, termites)). Our datings suggest that crown-Dictyoptera-and stem-mantises-would date back to the Late Carboniferous (similar to 300 Mya), a result compatible with the oldest putative fossil of stem-dictyoptera. Crown-mantises, however, would be much more recent (similar to 200 Mya; Triassic/Jurassic boundary). This pattern (i.e., old origin and more recent diversification) suggests a scenario of replacement in carnivory among polyneopterous insects. The most recent common ancestor of (cockroaches + termites) would date back to the Permian (similar to 275 Mya), which contradicts the hypothesis of a Devonian origin of cockroaches. Stem-termites would date back to the Triassic/Jurassic boundary, which refutes a Triassic origin. We suggest directions in extant and extinct species sampling to sharpen this chronological framework and dictyopteran evolutionary studies.	[Legendre, Frederic; Nel, Andre; Robillard, Tony; Pellens, Roseli; Grandcolas, Philippe] Univ Paris 06, Sorbonne Univ, ISYEB UMR MNHN 7205,CNRS, Dept Systemat & Evolut,Inst Systemat,Evolut,Biodi, Paris, France; [Svenson, Gavin J.] Cleveland Museum Nat Hist, Dept Invertebrate Zool, Cleveland, OH USA	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Cleveland Museum of Natural History	Legendre, F (corresponding author), Univ Paris 06, Sorbonne Univ, ISYEB UMR MNHN 7205,CNRS, Dept Systemat & Evolut,Inst Systemat,Evolut,Biodi, Paris, France.	legendre@mnhn.fr	Legendre, Frederic/B-5101-2013; Robillard, Tony/H-3523-2011	Legendre, Frederic/0000-0001-5900-8048; Robillard, Tony/0000-0002-2177-9549; Grandcolas, Philippe/0000-0003-1374-1222	Agence Nationale de la Recherche; US National Science Foundation [DEB-1216309]; Museum national d'Histoire naturelle; Direct For Biological Sciences [1216309] Funding Source: National Science Foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); US National Science Foundation(National Science Foundation (NSF)); Museum national d'Histoire naturelle; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by Agence Nationale de la Recherche under the grant BIONEOCAL to PG (www.agence-nationale-recherche.fr) and by the US National Science Foundation under the grant DEB-1216309 to GJS (www.nsf.gov/funding). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Molecular analyses were partially funded by Museum national d'Histoire naturelle (www.mnhn.fr) under the grant "ATM - Taxonomie moleculaire: DNA barcode et gestion durable des collections" to FL. Some specimens were collected through fieldworks supported by Museum national d'Histoire naturelle under the grant "ATM - Biodiversite actuelle et fossile. Crises, stress, restaurations et panchronisme: le message systematique" to FL.	Agudelo AA, 2014, ZOOTAXA, V3797, P194, DOI 10.11646/zootaxa.3797.1.14; Akaike H, 1973, 2 INT S INF THEOR, P276; Aristov DS, 2013, PALEONTOL J+, V47, P641, DOI 10.1134/S0031030113070010; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bethoux O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-248; Bethoux O, 2010, J PALEONTOL, V84, P746, DOI 10.1666/09-121.1; Bethoux O, 2009, ZOOL J LINN SOC-LOND, V156, P79, DOI 10.1111/j.1096-3642.2008.00485.x; Bordy EM, 2009, S AFR J SCI, V105, P356; Bordy EM, 2004, PALAIOS, V19, P68, DOI 10.1669/0883-1351(2004)019<0068:AEJTII>2.0.CO;2; Bourguignon T, 2015, MOL BIOL EVOL, V32, P406, DOI 10.1093/molbev/msu308; Bumby A.J., 2006, P5; Cameron SL, 2012, MOL PHYLOGENET EVOL, V65, P163, DOI 10.1016/j.ympev.2012.05.034; Cornwell PB, 1968, THE COCKROACH, V1; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Davis RB, 2009, J EVOLUTION BIOL, V22, P1750, DOI 10.1111/j.1420-9101.2009.01789.x; De Man E, 2010, EPISODES, V33, P3; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Djernaes M, 2015, MOL PHYLOGENET EVOL; Djernaes M, 2012, SYST ENTOMOL, V37, P65, DOI 10.1111/j.1365-3113.2011.00598.x; Donoghue MJ, 2003, INTEGR COMP BIOL, V43, P261, DOI 10.1093/icb/43.2.261; Dornburg A, 2011, SYST BIOL, V60, P519, DOI 10.1093/sysbio/syr019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel MS, 2008, J KANSAS ENTOMOL SOC, V81, P194, DOI 10.2317/JKES-0802.01.1; Engel MS, 2011, ZOOKEYS, P105, DOI 10.3897/zookeys.148.1797; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3592[1:NDFEAI]2.0.CO;2; Engel MS, 2009, AM MUS NOVIT, P1, DOI 10.1206/651.1; Escudero M, 2013, AM J BOT, V100, P2403, DOI 10.3732/ajb.1300162; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Gade G, 1997, P ROY SOC B-BIOL SCI, V264, P763, DOI 10.1098/rspb.1997.0108; Garwood R, 2010, BIOL LETTERS, V6, P699, DOI 10.1098/rsbl.2010.0199; Genise JF, 2005, PALAIOS, V20, P303, DOI 10.2110/palo.2004.p05-C01; Gorochov AV, 2006, PALEONTOL J+, V40, P646, DOI 10.1134/S0031030106060074; Gorochov A. V., 2012, ZOOSYSTEMATICA ROSSICA, V22, P6; Gorokhov AV, 2007, PALEONTOL J+, V41, P156, DOI 10.1134/S0031030107020062; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999; Grandcolas P, 1996, CAN J ZOOL, V74, P508, DOI 10.1139/z96-059; GRANDCOLAS P, 1994, SYST ENTOMOL, V19, P145; Grandcolas P, 2004, CLADISTICS, V20, P579, DOI 10.1111/j.1096-0031.2004.00037.x; Grandcolas P, 1996, CLADISTICS, V12, P93, DOI 10.1111/j.1096-0031.1996.tb00195.x; Grandcolas Philippe, 1997, Memoires du Museum National d'Histoire Naturelle, V171, P91; Grimaldi D, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)412<0001:AROCMA>2.0.CO;2; Grimaldi David, 2005, pi; Grimaldi DA, 2008, AM MUS NOVIT, P1, DOI 10.1206/616.1; Guan Z, 2015, ACTA PALAEONTOL POL; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hasiotis Stephen T., 1995, Ichnos, V4, P119; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Hedman MM, 2010, PALEOBIOLOGY, V36, P16, DOI 10.1666/0094-8373-36.1.16; Hennig W., 1981, INSECT PHYLOGENY; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Howard KJ, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P97, DOI 10.1007/978-90-481-3977-4_5; Huang CJ, 2010, GEOLOGY, V38, P899, DOI 10.1130/G31177.1; Huang DY, 2008, NATURWISSENSCHAFTEN, V95, P947, DOI 10.1007/s00114-008-0412-x; Imms AD, 1937, RECENT ADVANCES IN E; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; IturraldeVinent MA, 1996, SCIENCE, V273, P1850, DOI 10.1126/science.273.5283.1850; Jovane L, 2010, EARTH PLANET SC LETT, V298, P77, DOI 10.1016/j.epsl.2010.07.027; Kambhampati S, 1996, SYST ENTOMOL, V21, P89; KAMBHAMPATI S, 1995, P NATL ACAD SCI USA, V92, P2017, DOI 10.1073/pnas.92.6.2017; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Klass K-D, 1995, THESIS; Klass Klaus-Dieter, 1997, Bonner Zoologische Monographien, V42, P1; Klass Klaus-Dieter, 2006, Entomologische Abhandlungen (Dresden), V63, P3; Knittel U, 2013, NEUES JAHRB GEOL P-A, V270, P1, DOI 10.1127/0077-7749/2013/0353; Krishna Kumar, 2013, Bulletin of the American Museum of Natural History, V377, P1; Krishna Kumar, 1996, American Museum Novitates, V3176, P1; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; Kukalova-Peck J, 2012, EUR J ENTOMOL, V109, P633, DOI 10.14411/eje.2012.075; Kupczok A, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-37; LAURENTIAUX D, 1960, CR HEBD ACAD SCI, V250, P1700; Laurentiaux D, 1951, ANN PALEONTOL, V37, P186; Laurentiaux D, 1966, ANN SOC GEOL NORD, V86, P231; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Legendre F, 2014, BIOL J LINN SOC, V111, P58, DOI 10.1111/bij.12199; Legendre F, 2013, EVOL DEV, V15, P146, DOI 10.1111/ede.12023; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; LEWIS SE, 1973, ANN ENTOMOL SOC AM, V66, P1359, DOI 10.1093/aesa/66.6.1359; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032152; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Liu YX, 2006, ACTA GEOL SIN-ENGL, V80, P733; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; Lo N, 2007, BIOL LETTERS, V3, P327, DOI 10.1098/rsbl.2006.0614; Loader C., 1999, LOCAL REGRESSION LIK; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; [卢立伍 Lu Liwu], 2002, [地球学报, Acta Geoscientia Sinica], V23, P165; Maekawa K, 2000, SYST ENTOMOL, V25, P511, DOI 10.1046/j.1365-3113.2000.00128.x; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Magallon S, 2010, SYST BIOL, V59, P384, DOI 10.1093/sysbio/syq027; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; Martinez-Delclos X., 1993, Boletin Geologico y Minero (Madrid), V104, P516; MARTINEZDELCLOS X, 1995, J PALEONTOL, V69, P594, DOI 10.1017/S0022336000034983; McKittrick F. A., 1964, Memoirs Cornell Agric Expt Sta Ithaca, Vno. 389, P1; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Murienne J, 2008, CLADISTICS, V24, P802, DOI 10.1111/j.1096-0031.2008.00204.x; Murienne J, 2009, ORG DIVERS EVOL, V9, P44, DOI 10.1016/j.ode.2008.10.005; Nel A, 1996, EUR J ENTOMOL, V93, P223; Nel A., 1993, CAHIERS PALEONTOLOGI, P102; Nylander JAA, 2004, PROGRAM DISTRIBUTED; Palfy J, 2000, CAN J EARTH SCI, V37, P923, DOI 10.1139/cjes-37-6-923; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2013, MOL PHYLOGENET EVOL, V67, P436, DOI 10.1016/j.ympev.2013.02.008; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pellens R, 2007, MOL PHYLOGENET EVOL, V43, P616, DOI 10.1016/j.ympev.2006.12.017; Pointon MA, 2012, J GEOL SOC LONDON, V169, P713, DOI 10.1144/jgs2011-092; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prokop J, 2014, J SYST PALAEONTOL, V12, P601, DOI 10.1080/14772019.2013.823468; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Pyron RA, 2014, ECOL LETT, V17, P13, DOI 10.1111/ele.12168; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; RAU PHIL, 1941, ENT NEWS, V52, P256; Raymond A, 2001, EVOLUTIONARY PALEOECOLOGY, P235; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; ROTH LM, 1970, ANNU REV ENTOMOL, V15, P75, DOI 10.1146/annurev.en.15.010170.000451; ROTH LM, 1989, P ENTOMOL SOC WASH, V91, P441; Roth LM, 2003, ORIENT INSECTS, V37, P1, DOI 10.1080/00305316.2003.10417344; Roth S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-50; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sanderson MJ, 2002, R8S VERSION 1 50 USE; Sharaf E, 2005, STRATIGRAPHY, V2, P239; Siddall ME, 1999, CLADISTICS, V15, P9, DOI 10.1111/j.1096-0031.1999.tb00391.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan J, 1999, MOL BIOL EVOL, V16, P1347, DOI 10.1093/oxfordjournals.molbev.a026045; Svenson GJ, 2009, CLADISTICS, V25, P468, DOI 10.1111/j.1096-0031.2009.00263.x; Svenson GJ, 2004, SYST ENTOMOL, V29, P359, DOI 10.1111/j.0307-6970.2004.00240.x; Symmank L, 2011, J BIOGEOGR, V38, P2337, DOI 10.1111/j.1365-2699.2011.02586.x; Tanner Lawrence H., 2006, Ichnos, V13, P21, DOI 10.1080/10420940500511520; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Tillyard R. J., 1936, Nature London, V137, P655, DOI 10.1038/137655a0; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; von Haeseler A, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-13; Von Rosen K, 1913, T 2 INT C ENTOMOLOGY, V2, P318; Vrsansky P, 2002, HIST INSECTS, P263; Vrsansky Peter, 2002, AMBA Projekty, V6, P1; Vrsansky P, 2014, EUR J ENTOMOL, V111, P137, DOI 10.14411/eje.2014.014; Vrsansky P, 2013, ZOOTAXA, V3635, P117, DOI 10.11646/zootaxa.3635.2.2; Vrsansky Peter, 1997, Entomological Problems, V28, P67; Vrsansky P, 2010, ACTA GEOL SIN-ENGL, V84, P793, DOI 10.1111/j.1755-6724.2010.00261.x; WANG Y, 2013, PLOS ONE, V2013; Wappler T, 2009, P ROY SOC B-BIOL SCI, V276, P4271, DOI 10.1098/rspb.2009.1255; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; Ware JL, 2010, ARTHROPOD STRUCT DEV, V39, P204, DOI 10.1016/j.asd.2009.11.003; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Wieland F., 2013, SPECIES PHYLOGENY EV, V3, P3, DOI [10.17875/gup2013-711, DOI 10.17875/GUP2013-711]; Yager DD, 2008, BIOL J LINN SOC, V94, P541, DOI 10.1111/j.1095-8312.2008.00996.x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhang ZJ, 2013, J SYST PALAEONTOL, V11, P27, DOI 10.1080/14772019.2011.634443	156	133	136	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0130127	10.1371/journal.pone.0130127	http://dx.doi.org/10.1371/journal.pone.0130127			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200914	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100006
J	Zech, J; Godfrey, EL; Masai, H; Hartsuiker, E; Dalgaard, JZ				Zech, Juergen; Godfrey, Emma Louise; Masai, Hisao; Hartsuiker, Edgar; Dalgaard, Jacob Zeuthen			The DNA-Binding Domain of S-pombe Mrc1 (Claspin) Acts to Enhance Stalling at Replication Barriers	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; FISSION YEAST HOMOLOGS; CHECKPOINT KINASE CDS1; RIBOSOMAL-RNA GENES; SCHIZOSACCHAROMYCES-POMBE; FORK ARREST; SACCHAROMYCES-CEREVISIAE; IN-VIVO; EUKARYOTIC DNA; CGG REPEATS	During S-phase replication forks can stall at specific genetic loci. At some loci, the stalling events depend on the replisome components Schizosaccharomyces pombe Swi1 (Saccharomyces cerevisiae Tof1) and Swi3 (S. cerevisiae Csm3) as well as factors that bind DNA in a site-specific manner. Using a new genetic screen we identified Mrc1 (S. cerevisiae Mrc1/metazoan Claspin) as a replisome component involved in replication stalling. Mrc1 is known to form a sub-complex with Swi1 and Swi3 within the replisome and is required for the intra-S phase checkpoint activation. This discovery is surprising as several studies show that S. cerevisiae Mrc1 is not required for replication barrier activity. In contrast, we show that deletion of S. pombe mrc1 leads to an approximately three-fold reduction in barrier activity at several barriers and that Mrc1's role in replication fork stalling is independent of its role in checkpoint activation. Instead, S. pombe Mrc1 mediated fork stalling requires the presence of a functional copy of its phylogenetically conserved DNA binding domain. Interestingly, this domain is on the sequence level absent from S. cerevisiae Mrc1. Our study indicates that direct interactions between the eukaryotic replisome and the DNA are important for site-specific replication stalling.	[Zech, Juergen; Godfrey, Emma Louise; Dalgaard, Jacob Zeuthen] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo 1568613, Japan; [Hartsuiker, Edgar] Bangor Univ, Sch Biol Sci, Bangor LI57 2UW, Gwynedd, Wales	University of Warwick; Tokyo Metropolitan Institute of Medical Science; Bangor University	Zech, J (corresponding author), Univ St Andrews, Sch Biol, St Andrews KY16 9TF, Fife, Scotland.	jz42@st-andrews.ac.uk; j.z.dalgaard@warwick.ac.uk		Dalgaard, Jacob/0000-0001-9545-7254; Hartsuiker, Edgar/0000-0002-7257-6389	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council; Cancer Research UK; Cancer Research UK [11809] Funding Source: researchfish	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	Marie Curie Cancer Care (J.Z. and J.Z.D.), Biotechnology and Biological Sciences Research Council (J.Z.D.) and Cancer Research UK (E.H.) supported this work.	Ahn JS, 2005, EMBO J, V24, P2011, DOI 10.1038/sj.emboj.7600670; Akamatsu Y, 2015, MOL CELL BIOL; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Codlin S, 2003, EMBO J, V22, P3431, DOI 10.1093/emboj/cdg330; Dalgaard JZ, 2011, DNA REPLICATION - CURRENT ADVANCES, P269; Dalgaard JZ, 2012, TRENDS GENET, V28, P592, DOI 10.1016/j.tig.2012.07.008; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Dalgaard JZ, 2001, GENE DEV, V15, P2060, DOI 10.1101/gad.200801; Dalgaard LZ, 1999, NATURE, V400, P181, DOI 10.1038/22139; EGEL R, 1984, P NATL ACAD SCI-BIOL, V81, P3481, DOI 10.1073/pnas.81.11.3481; Eydmann T, 2008, GENETICS, V180, P27, DOI 10.1534/genetics.108.089243; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Gordon M, 2007, MOL CELL BIOL, V27, P4058, DOI 10.1128/MCB.02044-06; Gruber M, 2000, MOL CELL BIOL, V20, P5777, DOI 10.1128/MCB.20.15.5777-5787.2000; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Holmes A, 2012, CELL REP, V2, P1513, DOI 10.1016/j.celrep.2012.10.011; Inagawa T, 2009, P NATL ACAD SCI USA, V106, P7927, DOI 10.1073/pnas.0812323106; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KIGER JA, 1969, J MOL BIOL, V40, P467, DOI 10.1016/0022-2836(69)90166-1; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339; Krasilnikova Maria M., 2004, V277, P19; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Krings G, 2005, J BIOL CHEM, V280, P39135, DOI 10.1074/jbc.M508996200; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Kumar S, 2004, J BIOL CHEM, V279, P43574, DOI 10.1074/jbc.M407819200; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Liu GQ, 2012, J BIOL CHEM, V287, P33412, DOI 10.1074/jbc.M112.402503; MacLeod RAF, 2000, LEUKEMIA, V14, P1803, DOI 10.1038/sj.leu.2401894; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Matsumoto S, 2010, CELL CYCLE, V9, P4627, DOI 10.4161/cc.9.23.13937; Mejia-Ramirez E, 2005, MOL CELL BIOL, V25, P8755, DOI 10.1128/MCB.25.19.8755-8761.2005; Mohanty BK, 2009, EUKARYOT CELL, V8, P487, DOI 10.1128/EC.00382-08; Mohanty BK, 2006, P NATL ACAD SCI USA, V103, P897, DOI 10.1073/pnas.0506540103; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Naylor ML, 2009, P NATL ACAD SCI USA, V106, P12765, DOI 10.1073/pnas.0904623106; Nicolas E, 2006, J BIOL CHEM, V281, P35983, DOI 10.1074/jbc.M606349200; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Opel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000386; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Pryce DW, 2009, P NATL ACAD SCI USA, V106, P4770, DOI 10.1073/pnas.0807739106; Rao BS, 1996, MOL CELL BIOCHEM, V156, P163; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Sanchez JA, 1998, EXP CELL RES, V238, P220, DOI 10.1006/excr.1997.3835; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; Sayrac S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001328; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; STYRKARSDOTTIR U, 1993, CURR GENET, V23, P184, DOI 10.1007/BF00352020; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2010, BIOSCI BIOTECH BIOCH, V74, P2367, DOI 10.1271/bbb.100583; Tanaka T, 2010, J BIOL CHEM, V285, P39609, DOI 10.1074/jbc.M110.173344; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; Vengrova S, 2006, EMBO REP, V7, P59, DOI 10.1038/sj.embor.7400576; Vengrova S, 2004, GENE DEV, V18, P794, DOI 10.1101/gad.289404; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; WEAVER DT, 1984, J MOL BIOL, V180, P961, DOI 10.1016/0022-2836(84)90266-3; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876; Yasuhira S, 2009, MOL GENET GENOMICS, V281, P497, DOI 10.1007/s00438-009-0426-x; Yue M, 2011, J BIOL CHEM, V286, P22864, DOI 10.1074/jbc.M111.236687; Zaratiegui M, 2011, NATURE, V469, P112, DOI 10.1038/nature09608; Zhao H, 2004, J BIOL CHEM, V279, P53023, DOI 10.1074/jbc.M410449200; Zhu M, 2014, NUCLEIC ACIDS RES, V42, P13074, DOI 10.1093/nar/gku978	85	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132595	10.1371/journal.pone.0132595	http://dx.doi.org/10.1371/journal.pone.0132595			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201080	Green Published, gold			2022-12-26	WOS:000358597100040
J	Cannon, B; Kachroo, AH; Jarmoskaite, I; Jayaram, M; Russell, R				Cannon, Brian; Kachroo, Aashiq H.; Jarmoskaite, Inga; Jayaram, Makkuni; Russell, Rick			Hexapeptides That Inhibit Processing of Branched DNA Structures Induce a Dynamic Ensemble of Holliday Junction Conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; SINGLE-MOLECULE FRET; ENERGY-TRANSFER ANALYSIS; STRAND EXCHANGE; CRYSTAL-STRUCTURE; PEPTIDE INHIBITORS; ESCHERICHIA-COLI; GENOME STABILITY; FLUORESCENCE; RESOLUTION	Holliday junctions are critical intermediates in DNA recombination, repair, and restart of blocked replication. Hexapeptides have been identified that bind to junctions and inhibit various junction-processing enzymes, and these peptides confer anti-microbial and anti-tumor properties. Earlier studies suggested that inhibition results from stabilization of peptide-bound Holliday junctions in the square planar conformation. Here, we use single molecule fluorescence resonance energy transfer (smFRET) and two model junctions, which are AT-or GC-rich at the branch points, to show that binding of the peptide KWWCRW induces a dynamic ensemble of junction conformations that differs from both the square planar and stacked X conformations. The specific features of the conformational distributions differ for the two peptide-bound junctions, but both junctions display greatly decreased Mg2+ dependence and increased conformational fluctuations. The smFRET results, complemented by gel mobility shift and small angle x-ray scattering analyses, reveal structural effects of peptides and highlight the sensitivity of smFRET for analyzing complex mixtures of DNA structures. The peptide-induced conformational dynamics suggest multiple stacking arrangements of aromatic amino acids with the nucleobases at the junction core. This conformational heterogeneity may inhibit DNA processing by increasing the population of inactive junction conformations, thereby preventing the binding of processing enzymes and/or resulting in their premature dissociation.	[Jayaram, Makkuni] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Jayaram, M (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	jayaram@austin.utexas.edu; rick_russell@cm.utexas.edu	Regan, Clinton/E-6250-2012; Kachroo, Aashiq/Z-2505-2019	Kachroo, Aashiq/0000-0001-9770-778X; Jarmoskaite, Inga/0000-0001-5847-5867	National Institutes of Health [GM070456]; Robert F. Welch Foundation [F-1563, F-1274]; National Science Foundation [MCB1049925]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert F. Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070456 (to R.R.), Robert F. Welch Foundation Grants F-1563 (to R.R.) and F-1274 (to M.J.), and National Science Foundation Grant MCB1049925 (to M.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Boldt JL, 2004, J BIOL CHEM, V279, P3472, DOI 10.1074/jbc.M309361200; Cannon B, 2013, P NATL ACAD SCI USA, V110, P18868, DOI 10.1073/pnas.1309816110; Cannon B, 2013, MOL BIOTECHNOL, V53, P19, DOI 10.1007/s12033-012-9505-z; Cannon B, 2012, ANAL BIOCHEM, V431, P40, DOI 10.1016/j.ab.2012.08.017; Cassell G, 2000, J MOL BIOL, V299, P1193, DOI 10.1006/jmbi.2000.3828; Cassell GD, 2003, J MOL BIOL, V327, P413, DOI 10.1016/S0022-2836(03)00058-5; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; CHURCHILL MEA, 1988, P NATL ACAD SCI USA, V85, P4653, DOI 10.1073/pnas.85.13.4653; CLEGG RM, 1994, BIOPHYS J, V66, P99, DOI 10.1016/S0006-3495(94)80765-9; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; Craig NL, 2015, MOBILE DNA 3, P43; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Duyne G.D.V., 2015, MICROBIOL SPECTR, V3, P119; Fogg JM, 2001, J MOL BIOL, V313, P751, DOI 10.1006/jmbi.2001.5081; Ghosh K, 2005, J BIOL CHEM, V280, P8290, DOI 10.1074/jbc.M411668200; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Grainger RJ, 1998, BIOCHEMISTRY-US, V37, P23, DOI 10.1021/bi9721492; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Gunderson CW, 2009, J BACTERIOL, V191, P2169, DOI 10.1128/JB.01559-08; Gunderson CW, 2006, MOL MICROBIOL, V59, P1129, DOI 10.1111/j.1365-2958.2005.05009.x; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Hyeon C, 2012, NAT CHEM, V4, P907, DOI [10.1038/nchem.1463, 10.1038/NCHEM.1463]; Joo C, 2004, J MOL BIOL, V341, P739, DOI 10.1016/j.jmb.2004.06.024; Karymov MA, 2008, BIOPHYS J, V95, P4372, DOI 10.1529/biophysj.108.135103; Kepple KV, 2008, NUCLEIC ACIDS RES, V36, P5319, DOI 10.1093/nar/gkn512; Kepple KV, 2005, P NATL ACAD SCI USA, V102, P6867, DOI 10.1073/pnas.0409496102; Klemm M, 2000, J MOL BIOL, V299, P1203, DOI 10.1006/jmbi.2000.3829; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lee J, 1998, MOL CELL, V1, P483, DOI 10.1016/S1097-2765(00)80049-0; Lilley DMJ, 2008, Q REV BIOPHYS, V41, P1, DOI 10.1017/S0033583508004678; Liu J, 2005, CHEM BIOL, V12, P217, DOI 10.1016/j.chembiol.2004.12.006; Ma CH, 2014, J MOL BIOL, V426, P793, DOI 10.1016/j.jmb.2013.11.017; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Miick SM, 1997, P NATL ACAD SCI USA, V94, P9080, DOI 10.1073/pnas.94.17.9080; MURCHIE AIH, 1991, EMBO J, V10, P713, DOI 10.1002/j.1460-2075.1991.tb08001.x; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Nollmann M, 2004, BIOPHYS J, V86, P3060, DOI 10.1016/S0006-3495(04)74355-6; Rajeev L, 2007, J BIOL CHEM, V282, P31228, DOI 10.1074/jbc.M705370200; Rideout MC, 2013, PEPTIDES, V40, P112, DOI 10.1016/j.peptides.2012.12.025; Sarbajna S, 2014, TRENDS BIOCHEM SCI, V39, P409, DOI 10.1016/j.tibs.2014.07.003; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; Su LY, 2010, ANTIMICROB AGENTS CH, V54, P1888, DOI 10.1128/AAC.01610-09; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; Yu J, 2004, NUCLEIC ACIDS RES, V32, P6683, DOI 10.1093/nar/gkh1006	51	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22734	22746		10.1074/jbc.M115.663930	http://dx.doi.org/10.1074/jbc.M115.663930			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26209636	Green Published, hybrid			2022-12-26	WOS:000361171500037
J	Herrmann, D; Straubinger, M; Hashemolhosseini, S				Herrmann, Dustin; Straubinger, Marion; Hashemolhosseini, Said			Protein Kinase CK2 Interacts at the Neuromuscular Synapse with Rapsyn, Rac1, 14-3-3 gamma, and Dok-7 Proteins and Phosphorylates the Latter Two	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; HEPATOCELLULAR-CARCINOMA; JUNCTION; SYNAPTOGENESIS; IDENTIFICATION; SITES; AGRIN; MUSK	Previously, we demonstrated that the protein kinase CK2 associates with and phosphorylates the receptor tyrosine kinase MuSK (muscle specific receptor tyrosine kinase) at the neuromuscular junction (NMJ), thereby preventing fragmentation of the NMJs (Cheusova, T., Khan, M. A., Schubert, S. W., Gavin, A. C., Buchou, T., Jacob, G., Sticht, H., Allende, J., Boldyreff, B., Brenner, H. R., and Hashemolhosseini, S. (2006) Genes Dev. 20, 1800-1816). Here, we asked whether CK2 interacts with other proteins involved in processes at the NMJ, which would be consistent with the previous observation that CK2 appears enriched at the NMJ. We identified the following proteins to interact with protein kinase CK2: (a) the alpha and beta subunits of the nicotinic acetylcholine receptors with weak interaction, (b) dishevelled (Dsh), and (c) another four proteins, Rapsyn, Rac1, 14-3-3 gamma, and Dok-7, with strong interaction. CK2 phosphorylated 14-3-3 gamma at serine residue 235 and Dok-7 at several serine residues but does not phosphorylate Rapsyn or Rac1. Furthermore, phosphomimetic Dok-7 mutants aggregated nicotinic acetylcholine receptors in C2C12 myotubes with significantly higher frequency than wild type Dok-7. Additionally, we mapped the interacting epitopes of all four binding partners to CK2 and thereby gained insights into the potential role of the CK2/Rapsyn interaction.	[Herrmann, Dustin; Straubinger, Marion; Hashemolhosseini, Said] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Hashemolhosseini, S (corresponding author), Univ Erlangen Nurnberg, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	said.hashemolhosseini@fau.de	Hashemolhosseini, Said/N-2464-2013	Hashemolhosseini, Said/0000-0002-6564-5649; Herrmann, Dustin/0000-0002-1555-540X	Deutsche Forschungsgemeinschaft [HA 3309/1-1, HA 3309/1-2, HA 3309/1-3]; Interdisciplinary Centre for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg [E2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg	This work was supported by Deutsche Forschungsgemeinschaft Grants HA 3309/1-1 to 1-3) and by the Interdisciplinary Centre for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg (Grant E2) (both to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Boekhorst J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r144; Chakraborty S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7184; Cheusova T, 2006, GENE DEV, V20, P1800, DOI 10.1101/gad.375206; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; Cozza G, 2013, CURR MED CHEM, V20, P671, DOI 10.2174/092986713804999312; Feng GP, 1998, J NEUROSCI, V18, P4166; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Hamuro J, 2008, J BIOL CHEM, V283, P5518, DOI 10.1074/jbc.M708607200; Leshinsky-Silver E, 2012, J NEUROL SCI, V316, P112, DOI 10.1016/j.jns.2012.01.012; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MOSCOSO LM, 1995, MOL CELL NEUROSCI, V6, P80, DOI 10.1006/mcne.1995.1008; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nghiem HO, 2000, FASEB J, V14, P543, DOI 10.1096/fasebj.14.3.543; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Sass G, 2008, J HEPATOL, V48, pS135, DOI 10.1016/S0168-8278(08)60347-5; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044358; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Strochlic L, 2004, P NATL ACAD SCI USA, V101, P18189, DOI 10.1073/pnas.0406905102; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Willmann R, 2002, CELL MOL LIFE SCI, V59, P1296, DOI 10.1007/s00018-002-8509-4; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711	30	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22370	22384		10.1074/jbc.M115.647610	http://dx.doi.org/10.1074/jbc.M115.647610			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26198629	hybrid, Green Published			2022-12-26	WOS:000361171500005
J	Reynolds, V; Lloyd, AW; English, CJ; Lyons, P; Dodd, H; Hobaiter, C; Newton-Fisher, N; Mullins, C; Lamon, N; Schel, AM; Fallon, B				Reynolds, Vernon; Lloyd, Andrew W.; English, Christopher J.; Lyons, Peter; Dodd, Howard; Hobaiter, Catherine; Newton-Fisher, Nicholas; Mullins, Caroline; Lamon, Noemie; Schel, Anne Marijke; Fallon, Brittany			Mineral Acquisition from Clay by Budongo Forest Chimpanzees	PLOS ONE			English	Article							WILD CHIMPANZEES; SOIL CONSUMPTION; KIBALE FOREST; UGANDA; GEOPHAGY; COLOBUS; SODIUM; DIET	Chimpanzees of the Sonso community, Budongo Forest, Uganda were observed eating clay and drinking clay-water from waterholes. We show that clay, clay-rich water, and clay obtained with leaf sponges, provide a range of minerals in different concentrations. The presence of aluminium in the clay consumed indicates that it takes the form of kaolinite. We discuss the contribution of clay geophagy to the mineral intake of the Sonso chimpanzees and show that clay eaten using leaf sponges is particularly rich in minerals. We show that termite mound soil, also regularly consumed, is rich in minerals. We discuss the frequency of clay and termite soil geophagy in the context of the disappearance from Budongo Forest of a formerly rich source of minerals, the decaying pith of Raphia farinifera palms.	[Reynolds, Vernon] Univ Oxford, Sch Anthropol, Oxford, England; [Lloyd, Andrew W.; English, Christopher J.; Lyons, Peter; Dodd, Howard] Univ Brighton, Sch Environm & Technol, Brighton, E Sussex, England; [Reynolds, Vernon; Hobaiter, Catherine; Lamon, Noemie; Schel, Anne Marijke; Fallon, Brittany] Budongo Conservat Field Stn, Masindi, Uganda; [Hobaiter, Catherine; Mullins, Caroline; Fallon, Brittany] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Newton-Fisher, Nicholas] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England; [Lamon, Noemie] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Schel, Anne Marijke] Univ Utrecht, Anim Ecol, Utrecht, Netherlands	University of Oxford; University of Brighton; University of St Andrews; University of Kent; University of Neuchatel; Utrecht University	Reynolds, V (corresponding author), Univ Oxford, Sch Anthropol, Oxford, England.	vreynolds@btopenworld.com	Lloyd, Andrew/D-1369-2011	Lloyd, Andrew/0000-0003-2778-8195; Newton-Fisher, Nicholas/0000-0002-7657-2641; Hobaiter, Cat/0000-0002-3893-0524	Mohamed bin Zayed Species Conservation Fund; Primate Action Fund of Conservation International; Royal Zoological Society of Scotland	Mohamed bin Zayed Species Conservation Fund; Primate Action Fund of Conservation International; Royal Zoological Society of Scotland	Financial supprot was provided by the Mohamed bin Zayed Species Conservation Fund (http://www.speciesconservation.org/). Additional support came from the Primate Action Fund of Conservation International, and the Royal Zoological Society of Scotland via its support to BCFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, NATL RES COUNCIL NUT; Hladik C. M., 1977, PRIMATE ECOLOGY, P324; Hladik Claude, 2007, CONSUMING INEDIBLE, P121; Hladik Claude Marcel, 1996, Evolutionary Anthropology, V5, P58, DOI 10.1002/(SICI)1520-6505(1996)5:2<58::AID-EVAN5>3.0.CO;2-S; Hladik CM, 2003, ANTHROPOLOGIE, V41, P9; JOHNS T, 1991, AM J CLIN NUTR, V53, P448, DOI 10.1093/ajcn/53.2.448; Klein N, 2008, NATURWISSENSCHAFTEN, V95, P325, DOI 10.1007/s00114-007-0333-0; Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004; Krief S, 2015, ANTIQUITY, V89, P464, DOI 10.15184/aqy.2014.7; Lambe TW, 1969, SOIL MECH, P52; Mahaney WC, 1997, PRIMATES, V38, P159, DOI 10.1007/BF02382006; Mahaney WC, 2005, INT J PRIMATOL, V26, P1375, DOI 10.1007/s10764-005-8857-7; Mahaney WC, 1996, PRIMATES, V37, P121, DOI 10.1007/BF02381400; Matsubayashi H, 2007, ECOL RES, V22, P742, DOI 10.1007/s11284-006-0313-4; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Petimar J, AF J ECOL UNPUB; Quiatt D, 2006, PRIMATES W UGANDA; Reynolds V, 1998, OECOLOGIA, V115, P331, DOI 10.1007/s004420050524; Reynolds V., 2012, AFR PRIMATES, V7, P156; Reynolds V., 2005, CHIMPANZEES BUDONGO; Reynolds V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006194; Rode KD, 2003, INT J PRIMATOL, V24, P541, DOI 10.1023/A:1023788330155; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480; Rozin P., 1976, ADV STUD BEHAV, V6, P21, DOI [10. 1016/S0065-3454(08)60081-9, DOI 10.1016/S0065-3454(08)60081-9]; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257	27	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134075	10.1371/journal.pone.0134075	http://dx.doi.org/10.1371/journal.pone.0134075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218593	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000358595900073
J	Dou, J; Bui, DT; Yunus, AP; Jia, K; Song, X; Revhaug, I; Xia, H; Zhu, ZF				Dou, Jie; Bui, Dieu Tien; Yunus, Ali P.; Jia, Kun; Song, Xuan; Revhaug, Inge; Xia, Huan; Zhu, Zhongfan			Optimization of Causative Factors for Landslide Susceptibility Evaluation Using Remote Sensing and GIS Data in Parts of Niigata, Japan	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CERTAINTY-FACTOR; ROAD SECTION; BIVARIATE; ZONATION; AREA; INTEGRATION; STATISTICS; RESOLUTION; CATCHMENT	This paper assesses the potentiality of certainty factor models (CF) for the best suitable causative factors extraction for landslide susceptibility mapping in the Sado Island, Niigata Prefecture, Japan. To test the applicability of CF, a landslide inventory map provided by National Research Institute for Earth Science and Disaster Prevention (NIED) was split into two subsets: (i) 70% of the landslides in the inventory to be used for building the CF based model; (ii) 30% of the landslides to be used for the validation purpose. A spatial database with fifteen landslide causative factors was then constructed by processing ALOS satellite images, aerial photos, topographical and geological maps. CF model was then applied to select the best subset from the fifteen factors. Using all fifteen factors and the best subset factors, landslide susceptibility maps were produced using statistical index (SI) and logistic regression (LR) models. The susceptibility maps were validated and compared using landslide locations in the validation data. The prediction performance of two susceptibility maps was estimated using the Receiver Operating Characteristics (ROC). The result shows that the area under the ROC curve (AUC) for the LR model (AUC = 0.817) is slightly higher than those obtained from the SI model (AUC = 0.801). Further, it is noted that the SI and LR models using the best subset outperform the models using the fifteen original factors. Therefore, we conclude that the optimized factor model using CF is more accurate in predicting landslide susceptibility and obtaining a more homogeneous classification map. Our findings acknowledge that in the mountainous regions suffering from data scarcity, it is possible to select key factors related to landslide occurrence based on the CF models in a GIS platform. Hence, the development of a scenario for future planning of risk mitigation is achieved in an efficient manner.	[Dou, Jie; Yunus, Ali P.] Univ Tokyo, Dept Nat Environm Studies, Kashiwa, Chiba, Japan; [Bui, Dieu Tien] Telemark Univ Coll, Dept Business Adm & Comp Sci, Geog Informat Syst Grp, Telemark, Norway; [Jia, Kun] Beijing Normal Univ, Sch Geog, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Song, Xuan] Univ Tokyo, Ctr Spatial Informat Sci, Kashiwa, Chiba, Japan; [Revhaug, Inge] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway; [Xia, Huan] Guizhou Univ Finance & Econ, Guiyang, Peoples R China; [Zhu, Zhongfan] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China	University of Tokyo; University College of Southeast Norway; Beijing Normal University; University of Tokyo; Norwegian University of Life Sciences; Guizhou University of Finance & Economics; Beijing Normal University	Dou, J (corresponding author), Univ Tokyo, Dept Nat Environm Studies, Kashiwa, Chiba, Japan.	doujie@csis.u-tokyo.ac.jp; songxuan@csis.u-tokyo.ac.jp	Jia, Kun/Q-6539-2016; Dou, Jie/K-2809-2013; ALI, YUNUS/O-7015-2019; Yunus, Ali P./K-9965-2013; Song, Xuan/L-8086-2018; Tien Bui, Dieu/K-2125-2012	Jia, Kun/0000-0001-8586-4243; Dou, Jie/0000-0001-5930-199X; ALI, YUNUS/0000-0001-6852-145X; Song, Xuan/0000-0003-4042-7888; Tien Bui, Dieu/0000-0001-5161-6479; Zhu, Zhongfan/0000-0003-0579-608X	JST, Strategic International Collaborative Research Program (SICORP); Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [26730113]	JST, Strategic International Collaborative Research Program (SICORP); Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by, JST, Strategic International Collaborative Research Program (SICORP); Grant-in-Aid for Young Scientists (26730113(tel:26730113)) of Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Ahmed B, 2015, LANDSLIDES, V12, P1077, DOI 10.1007/s10346-014-0521-x; Aleotti P., 1999, B ENG GEOL ENVIRON, V58, P21, DOI [10.1007/s100640050066, DOI 10.1007/S100640050066]; Anbazhagan S, 2014, J MT SCI-ENGL, V11, P1308, DOI 10.1007/s11629-012-2618-9; Ayalew L, 2005, ENG GEOL, V81, P432, DOI 10.1016/j.enggeo.2005.08.004; Bahsan E, 2014, ENG GEOL, V172, P85, DOI 10.1016/j.enggeo.2014.01.005; Bai SB, 2011, ENVIRON EARTH SCI, V62, P139, DOI 10.1007/s12665-010-0509-3; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Binaghi E, 1998, NAT HAZARDS, V17, P77, DOI 10.1023/A:1008001724538; Brabb EE, 1984, P 4 INT S LANDSL TOR, P307; Catani F, 2013, NAT HAZARD EARTH SYS, V13, P2815, DOI 10.5194/nhess-13-2815-2013; Chung CF, 1993, NONRENEWABLE RESOURC, V2, P122, DOI DOI 10.1007/BF02272809; Conoscenti C, 2015, GEOMORPHOLOGY, V242, P49, DOI 10.1016/j.geomorph.2014.09.020; Costanzo D, 2012, NAT HAZARD EARTH SYS, V12, P327, DOI 10.5194/nhess-12-327-2012; Cross M, 1998, GEOL SOC ENG GEOL SP, P247; Dai FC, 2003, EARTH SURF PROC LAND, V28, P527, DOI 10.1002/esp.456; Devkota KC, 2013, NAT HAZARDS, V65, P135, DOI 10.1007/s11069-012-0347-6; Bui DT, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/974638; Bui DT, 2011, NAT HAZARDS, V59, P1413, DOI 10.1007/s11069-011-9844-2; Dou J., 2014, LANDSLIDE SCI SAFER, P419; Dou J, 2015, NAT HAZARDS, V78, P1749, DOI 10.1007/s11069-015-1799-2; Dou J, 2015, NAT HAZARDS, V78, P1021, DOI 10.1007/s11069-015-1756-0; Dou J, 2015, TERR ATMOS OCEAN SCI, V26, P227, DOI 10.3319/TAO.2014.12.02.07(EOSI); Dou J, 2015, REMOTE SENS-BASEL, V7, P4318, DOI 10.3390/rs70404318; Felicisimo A, 2013, LANDSLIDES, V10, P175, DOI 10.1007/s10346-012-0320-1; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Guzzetti F, 1999, GEOMORPHOLOGY, V31, P181, DOI 10.1016/S0169-555X(99)00078-1; Irigaray C, 2007, NAT HAZARDS, V41, P61, DOI 10.1007/s11069-006-9027-8; Jamsawang P, 2015, ENG GEOL, V188, P159, DOI 10.1016/j.enggeo.2015.01.017; Jebur MN, 2014, REMOTE SENS ENVIRON, V152, P150, DOI 10.1016/j.rse.2014.05.013; Jie Dou, 2009, Proceedings of the SPIE - The International Society for Optical Engineering, V7471, DOI 10.1117/12.836328; Komac M, 2012, GEOL Q, V56, P41; Lee CT, 2008, ENG GEOL, V100, P43, DOI 10.1016/j.enggeo.2008.03.004; Lee S, 2005, ENVIRON GEOL, V47, P982, DOI 10.1007/s00254-005-1228-z; Lee S, 2004, GEOSCI J, V8, P51, DOI 10.1007/BF02910278; Lee S, 2007, LANDSLIDES, V4, P33, DOI 10.1007/s10346-006-0047-y; Lucas PJF, 2001, KNOWL-BASED SYST, V14, P327, DOI 10.1016/S0950-7051(00)00073-3; Magliulo P, 2008, NAT HAZARDS, V47, P411, DOI 10.1007/s11069-008-9230-x; Martinez-Alvarez F, 2013, KNOWL-BASED SYST, V50, P198, DOI 10.1016/j.knosys.2013.06.011; Matanle P., 2008, PROJECT OFFICE PHILI, P42; Meinhardt M, 2015, GEOMORPHOLOGY, V234, P80, DOI 10.1016/j.geomorph.2014.12.042; Neuhauser B, 2012, LANDSLIDES, V9, P511, DOI 10.1007/s10346-011-0305-5; Nolasco-Javier D, 2015, NAT HAZARDS, V78, P1587, DOI 10.1007/s11069-015-1790-y; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ohlmacher GC, 2007, ENG GEOL, V91, P117, DOI 10.1016/j.enggeo.2007.01.005; Peng L, 2014, GEOMORPHOLOGY, V204, P287, DOI 10.1016/j.geomorph.2013.08.013; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pourghasemi H, 2013, GEOMAT NAT HAZ RISK, V4, P93, DOI 10.1080/19475705.2012.662915; Pradhan B, 2013, COMPUT GEOSCI-UK, V51, P350, DOI 10.1016/j.cageo.2012.08.023; Pradhan B, 2010, ENVIRON MODELL SOFTW, V25, P747, DOI 10.1016/j.envsoft.2009.10.016; Shahabi H, 2013, ARAB J GEOSCI, V6, P3885, DOI 10.1007/s12517-012-0650-2; Shortliffe EH., 1975, MATH BIOSCI, V23, P351, DOI [10.1016/0025-5564(75)90047-4, DOI 10.1016/0025-5564(75)90047-4]; Suzen ML, 2004, ENG GEOL, V71, P303, DOI 10.1016/S0013-7952(03)00143-1; Tofani V, 2014, REMOTE SENS-BASEL, V6, P907, DOI 10.3390/rs6020907; vanWesten CJ, 1997, GEOL RUNDSCH, V86, P404, DOI 10.1007/s005310050149; Wang HB, 2008, LANDSLIDES, V5, P387, DOI 10.1007/s10346-008-0131-6; Wang LJ, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073561; Wu Q, 2008, GEOINFORMATICS 2008, V7144, DOI [10.1117/12.812837, DOI 10.1117/12.812837]; Yalcin A, 2011, CATENA, V85, P274, DOI 10.1016/j.catena.2011.01.014; Yilmaz C, 2012, ENVIRON EARTH SCI, V65, P2161, DOI 10.1007/s12665-011-1196-4; Zhu J, 2010, J ANHUI AGR SCI, V38, P10828	60	133	136	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133262	10.1371/journal.pone.0133262	http://dx.doi.org/10.1371/journal.pone.0133262			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214691	Green Accepted, gold, Green Published			2022-12-26	WOS:000358594300017
J	Filip, S; Vougas, K; Zoidakis, J; Latosinska, A; Mullen, W; Spasovski, G; Mischak, H; Vlahou, A; Jankowski, J				Filip, Szymon; Vougas, Konstantinos; Zoidakis, Jerome; Latosinska, Agnieszka; Mullen, William; Spasovski, Goce; Mischak, Harald; Vlahou, Antonia; Jankowski, Joachim			Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine	PLOS ONE			English	Article							PEPTIDE LIGAND LIBRARIES; CHRONIC KIDNEY-DISEASE; PROTEOME ANALYSIS; MASS-SPECTROMETRY; BIOMARKER DISCOVERY; PLASMA-PROTEINS; AFFINITY-CHROMATOGRAPHY; HUMAN SERUM; IDENTIFICATION; ALBUMIN	Proteome analysis of complex biological samples for biomarker identification remains challenging, among others due to the extended range of protein concentrations. High-abundance proteins like albumin or IgG of plasma and urine, may interfere with the detection of potential disease biomarkers. Currently, several options are available for the depletion of abundant proteins in plasma. However, the applicability of these methods in urine has not been thoroughly investigated. In this study, we compared different, commercially available immunodepletion and ion-exchange based approaches on urine samples from both healthy subjects and CKD patients, for their reproducibility and efficiency in protein depletion. A starting urine volume of 500 mu L was used to simulate conditions of a multi-institutional biomarker discovery study. All depletion approaches showed satisfactory reproducibility (n=5) in protein identification as well as protein abundance. Comparison of the depletion efficiency between the unfractionated and fractionated samples and the different depletion strategies, showed efficient depletion in all cases, with the exception of the ion-exchange kit. The depletion efficiency was found slightly higher in normal than in CKD samples and normal samples yielded more protein identifications than CKD samples when using both initial as well as corresponding depleted fractions. Along these lines, decrease in the amount of albumin and other targets as applicable, following depletion, was observed. Nevertheless, these depletion strategies did not yield a higher number of identifications in neither the urine from normal nor CKD patients. Collectively, when analyzing urine in the context of CKD biomarker identification, no added value of depletion strategies can be observed and analysis of unfractionated starting urine appears to be preferable.	[Filip, Szymon; Vougas, Konstantinos; Zoidakis, Jerome; Latosinska, Agnieszka; Vlahou, Antonia] Biomed Res Fdn Acad Athens, Div Biotechnol, Athens, Greece; [Filip, Szymon; Latosinska, Agnieszka] Charite, D-13353 Berlin, Germany; [Mullen, William; Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Spasovski, Goce] Ss Cyril & Methodius Univ Skopje, Dept Nephrol, Skopje, Macedonia; [Mischak, Harald] Mosa Diagnost GmbH, Hannover, Germany; [Jankowski, Joachim] Univ Hosp RWTH Aachen, Inst Mol Cardiovasc Res, Aachen, Germany	Academy of Athens; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Glasgow; Saints Cyril & Methodius University of Skopje; Modular Open Systems Approach (MOSA) Solutions; RWTH Aachen University; RWTH Aachen University Hospital	Jankowski, J (corresponding author), Univ Hosp RWTH Aachen, Inst Mol Cardiovasc Res, Aachen, Germany.	jjankowski@ukaachen.de	Filip, Szymon/J-8866-2019; Zoidakis, Jerome/P-9599-2018; Zoidakis, Jerome/AAO-8236-2021; Mullen, William/GWC-8078-2022	Filip, Szymon/0000-0003-2175-6176; Zoidakis, Jerome/0000-0002-4557-3430; Zoidakis, Jerome/0000-0002-4557-3430; Vlahou, Antonia/0000-0003-3284-5713; Latosinska, Agnieszka/0000-0001-8917-2412; Mullen, William/0000-0002-5685-1563; Vougas, Konstantinos/0000-0002-8873-4740; Mischak, Harald/0000-0003-0323-0306	Clinical and system -omics for the identification of the Molecular Determinants of established Chronic Kidney Disease (iMODE-CKD) [PEOPLE-ITN-GA-2013-608332]	Clinical and system -omics for the identification of the Molecular Determinants of established Chronic Kidney Disease (iMODE-CKD)	The research presented in this manuscript was supported by "Clinical and system -omics for the identification of the Molecular Determinants of established Chronic Kidney Disease (iMODE-CKD, PEOPLE-ITN-GA-2013-608332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Afkarian M, 2010, MOL CELL PROTEOMICS, V9, P2195, DOI 10.1074/mcp.M110.000992; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Boschetti E, 2008, BIOTECHNIQUES, V44, P663, DOI 10.2144/000112762; Brott DA, 2014, DRUG DES DEV THER, V8, P227, DOI 10.2147/DDDT.S54956; Chen CL, 2013, J PROTEOMICS, V85, P28, DOI 10.1016/j.jprot.2013.04.024; Cheung RCF, 2012, APPL MICROBIOL BIOT, V96, P1411, DOI 10.1007/s00253-012-4507-0; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Decramer S, 2008, MOL CELL PROTEOMICS, V7, P1850, DOI 10.1074/mcp.R800001-MCP200; Doucette AA, 2011, EXPERT REV PROTEOMIC, V8, P787, DOI [10.1586/EPR.11.67, 10.1586/epr.11.67]; Duong-Ly KC, 2014, METHOD ENZYMOL, V541, P105, DOI 10.1016/B978-0-12-420119-4.00009-4; Echan LA, 2005, PROTEOMICS, V5, P3292, DOI 10.1002/pmic.200401228; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Filip S, 2014, BIOANALYSIS, V6, P2549, DOI 10.4155/bio.14.210; Filippone S., 2014, ENCY POLYM NANOMATER, P1, DOI [10.1586/14789450.2014.926224, DOI 10.1586/14789450.2014.926224]; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; Fountoulakis M, 2004, AMINO ACIDS, V27, P249, DOI 10.1007/s00726-004-0141-1; Goo YA, 2010, INT BRAZ J UROL, V36, P79; Goo YA, 2010, INT BRAZ J UROL, V36, P78; Goo YA, 2012, J PROTEOME RES, V11, P5650, DOI 10.1021/pr3004437; Goo YA, 2010, INT BRAZ J UROL, V36, P464, DOI 10.1590/S1677-55382010000400010; Granger J, 2005, PROTEOMICS, V5, P4713, DOI 10.1002/pmic.200401331; Hortin GL, 2007, PHARMACOGENOMICS, V8, P237, DOI 10.2217/14622416.8.3.237; Jungbauer A, 2009, METHOD ENZYMOL, V463, P349, DOI 10.1016/S0076-6879(09)63022-6; Kullolli M, 2013, J CHROMATOGR B, V939, P10, DOI 10.1016/j.jchromb.2013.09.008; Kushnir Mark M, 2009, J Biomol Tech, V20, P101; Law KP, 2013, EXPERT REV PROTEOMIC, V10, P551, DOI 10.1586/14789450.2013.858022; Magagnotti C, 2010, CLIN CHEM LAB MED, V48, P531, DOI 10.1515/CCLM.2010.109; Magistroni R, 2009, NEPHROL DIAL TRANSPL, V24, P1672, DOI 10.1093/ndt/gfp020; Martin-Lorenzo M, 2014, ELECTROPHORESIS, V35, P2634, DOI 10.1002/elps.201300601; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; Mischak H, 2015, NAT REV NEPHROL, V11, P221, DOI 10.1038/nrneph.2014.247; Mischak H, 2010, PROTEOM CLIN APPL, V4, P464, DOI 10.1002/prca.200900189; Moser AC, 2010, BIOANALYSIS, V2, P769, DOI [10.4155/bio.10.31, 10.4155/BIO.10.31]; Perkins BA, 2010, KIDNEY INT, V77, P57, DOI 10.1038/ki.2009.399; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Righetti PG, 2008, MASS SPECTROM REV, V27, P596, DOI 10.1002/mas.20178; Righetti PG, 2015, ANAL CHEM, V87, P293, DOI 10.1021/ac502171b; Righetti PG, 2015, METHODS MOL BIOL, V1243, P55, DOI 10.1007/978-1-4939-1872-0_4; Serang O, 2012, STAT INTERFACE, V5, P3; Stempfer R, 2008, ELECTROPHORESIS, V29, P4316, DOI 10.1002/elps.200800211; Thomas R, 2008, PRIMARY CARE, V35, P329, DOI 10.1016/j.pop.2008.01.008; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Urh M, 2009, METHOD ENZYMOL, V463, P417, DOI 10.1016/S0076-6879(09)63026-3; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Zerefos PG, 2012, PROTEOMICS, V12, P391, DOI 10.1002/pmic.201100212	47	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133773	10.1371/journal.pone.0133773	http://dx.doi.org/10.1371/journal.pone.0133773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208298	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000358622000136
J	Harris, RB; Wang, WY; Badinqiuying; Smith, AT; Bedunah, DJ				Harris, Richard B.; Wang Wenying; Badinqiuying; Smith, Andrew T.; Bedunah, Donald J.			Herbivory and Competition of Tibetan Steppe Vegetation in Winter Pasture: Effects of Livestock Exclosure and Plateau Pika Reduction	PLOS ONE			English	Article							DELAYED SPRING PHENOLOGY; ALPINE GRASSLANDS; GRAZING-EXCLUSION; OCHOTONA-CURZONIAE; RANGELAND DEGRADATION; ABOVEGROUND BIOMASS; LAND-USE; RESPONSES; BIODIVERSITY; ECOSYSTEMS	Rangeland degradation has been identified as a serious concern in alpine regions of western China on the Qinghai-Tibetan plateau (QTP). Numerous government-sponsored programs have been initiated, including many that feature long-term grazing prohibitions and some that call for eliminating pastoralism altogether. As well, government programs have long favored eliminating plateau pikas (Ochotona curzoniae), assumed to contribute to degraded conditions. However, vegetation on the QTP evolved in the presence of herbivory, suggesting that deleterious effects from grazing are, to some extent, compensated for by reduced plant-plant competition. We examined the dynamics of common steppe ecosystem species as well as physical indicators of rangeland stress by excluding livestock and reducing pika abundance on experimental plots, and following responses for 4 years. We established 12 fenced livestock exclosures within pastures grazed during winter by local pastoralists, and removed pikas on half of these. We established paired, permanent vegetation plots within and outside exclosures and measured indices of erosion and biomass of common plant species. We observed modest restoration of physical site conditions (reduced bare soil, erosion, greater vegetation cover) with both livestock exclusion and pika reduction. As expected in areas protected from grazing, we observed a reduction in annual productivity of plant species avoided by livestock and assumed to compete poorly when protected from grazing. Contrary to expectation, we observed similar reductions in annual productivity among palatable, perennial graminoids under livestock exclusion. The dominant grass, Stipa purpurea, displayed evidence of density-dependent growth, suggesting that intra-specific competition exerted a regulatory effect on annual production in the absence of grazing. Complete grazing bans on winter pastures in steppe habitats on the QTP may assist in the recovery of highly eroded pastures, but may not increase annual vegetative production.	[Harris, Richard B.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Wang Wenying] Qinghai Normal Univ, Xining, Qinghai, Peoples R China; [Badinqiuying; Smith, Andrew T.] Arizona State Univ, Dept Life Sci, Tempe, AZ USA; [Bedunah, Donald J.] Univ Montana, Dept Forest Management, Missoula, MT 59812 USA	University of Montana System; University of Montana; Qinghai Normal University; Arizona State University; Arizona State University-Tempe; University of Montana System; University of Montana	Harris, RB (corresponding author), Washington Dept Fish & Wildlife, Olympia, WA 98501 USA.	rharris@montana.com			US National Science Foundation [0815441]	US National Science Foundation(National Science Foundation (NSF))	Support was provided by US National Science Foundation grant 0815441 [http://www.nsf.gov/awardsearch/showAward?AWD_ID=0815441]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur AD, 2008, BIOL CONSERV, V141, P1972, DOI 10.1016/j.biocon.2008.05.010; Augustine DJ, 2013, ECOL APPL, V23, P850, DOI 10.1890/12-0890.1; Cao JJ, 2013, J ARID ENVIRON, V97, P3, DOI 10.1016/j.jaridenv.2013.05.002; Chen H, 2011, P NATL ACAD SCI USA, V108, pE93, DOI 10.1073/pnas.1100091108; Chen SB, 2006, CLIMATIC CHANGE, V76, P291, DOI 10.1007/s10584-006-9080-z; Cingolani AM, 2005, J APPL ECOL, V42, P50, DOI 10.1111/j.1365-2664.2004.00978.x; Del-Val EK, 2005, J ECOL, V93, P1005, DOI 10.1111/j.1365-2745.2005.01011.x; Delibes-Mateos M, 2011, BIOL CONSERV, V144, P1335, DOI 10.1016/j.biocon.2011.02.012; Detling James K., 2006, P65; Dong SK, 2010, AFR J AGR RES, V5, P3542; Fan Naichang, 1999, ACIAR Monograph Series, V59, P285; Frauenfeld OW, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005230; Gao YH, 2014, J CLIMATE, V27, P1876, DOI 10.1175/JCLI-D-13-00321.1; Gao YH, 2011, ARID LAND RES MANAG, V25, P164, DOI 10.1080/15324982.2011.554954; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Harris R.B., 2008, WILDLIFE CONSERVATIO; Harris RB, 2010, PASTORALISM, V1, P325; Harris RB, 2014, J MAMMAL, V95, P1207, DOI 10.1644/14-MAMM-A-021; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Hogan BW, 2010, THESIS AZ ARIZONA ST; Holzner W, 2001, BODENKULTUR, V52, P37; Hutchinson M., 2001, ANUSPLIN VERSION 4 2; Hutchinson MF, 2001, INT J GEOGR INF SCI, V9, P385; Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1; Lai CH, 2003, BIODIVERS CONSERV, V12, P1901, DOI 10.1023/A:1024161409110; Li XL, 2013, LAND DEGRAD DEV, V24, P72, DOI 10.1002/ldr.1108; Li YY, 2013, J ENVIRON MANAGE, V128, P393, DOI 10.1016/j.jenvman.2013.05.058; Liu YS, 1995, INTEGRATING PEOPLE W, P63; Luan JW, 2014, ECOL ENG, V64, P262, DOI 10.1016/j.ecoleng.2013.12.057; Luedeling E, 2011, P NATL ACAD SCI USA, V108, pE95, DOI 10.1073/pnas.1103336108; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Miehe G, 2011, J ARID ENVIRON, V75, P711, DOI 10.1016/j.jaridenv.2011.03.001; Miehe G, 2008, AMBIO, V37, P272, DOI 10.1579/0044-7447(2008)37[272:SADOTK]2.0.CO;2; Miehe G, 2014, QUATERNARY SCI REV, V86, P190, DOI 10.1016/j.quascirev.2013.12.004; National Research Council (NRC) Committee on Rangeland Classification, 1994, RANG HLTH NEW METH C; Oesterheld M, 2004, OIKOS, V107, P576, DOI 10.1111/j.0030-1299.2004.13442.x; Pech RP, 2007, J APPL ECOL, V44, P615, DOI 10.1111/j.1365-2664.2007.01287.x; Piao SL, 2011, AGR FOREST METEOROL, V151, P1599, DOI 10.1016/j.agrformet.2011.06.016; Qu JP, 2013, MAMM BIOL, V78, P68, DOI 10.1016/j.mambio.2012.09.005; Retzer V, 2007, BASIC APPL ECOL, V8, P147, DOI 10.1016/j.baae.2006.05.002; Ryavec K. E., 1998, GeoJournal, V44, P61, DOI 10.1023/A:1006815130932; Schaller GB., 1998, WILDLIFE TIBETAN STE; Shang ZH, 2014, RANGELAND J, V36, P267, DOI 10.1071/RJ14008; Shang ZH, 2013, PLANT SOIL, V364, P229, DOI 10.1007/s11104-012-1362-9; Shen MG, 2011, AGR FOREST METEOROL, V151, P1711, DOI 10.1016/j.agrformet.2011.07.003; Shen MG, 2011, P NATL ACAD SCI USA, V108, pE91, DOI 10.1073/pnas.1018390108; Shi XM, 2013, ECOL ENG, V57, P183, DOI 10.1016/j.ecoleng.2013.04.032; SHI Y, 1983, Acta Theriologica Sinica, V3, P181; SMITH A E, 1990, P14; Smith Andrew T., 2006, P285; Smith AT, 1999, ANIM CONSERV, V2, P235, DOI 10.1111/j.1469-1795.1999.tb00069.x; Smith AT, IUCN RED LIST THREAT; Sun JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099299; Wang LW, 2008, J GEOGR SCI, V18, P73, DOI 10.1007/s11442-008-0073-x; Wang XD, 2008, J ARID ENVIRON, V72, P1929, DOI 10.1016/j.jaridenv.2008.06.005; Wangdwei M, 2013, J MAMMAL, V94, P1077, DOI 10.1644/12-MAMM-A-253.1; Wei D, 2012, PLANT SOIL, V359, P45, DOI 10.1007/s11104-011-1105-3; Wilson MC, 2015, AMBIO, V44, P16, DOI 10.1007/s13280-014-0568-x; Wu GL, 2009, PLANT SOIL, V319, P115, DOI 10.1007/s11104-008-9854-3; Wu JS, 2014, ARCT ANTARCT ALP RES, V46, P419, DOI 10.1657/1938-4246-46.2.419; Wu JS, 2013, RANGELAND ECOL MANAG, V66, P454, DOI 10.2111/REM-D-12-00051.1; Wu JianShuang, 2012, Journal of Resources and Ecology, V3, P236; Wu N, 2002, ERDKUNDE, V56, P2, DOI DOI 10.3112/ERDKUNDE.2002.01.01; Xu AC, 2006, URSUS, V17, P132; Yan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081466; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Yang ZL, 2013, OECOLOGIA, V171, P495, DOI 10.1007/s00442-012-2433-6; Yeh ET, 2011, AREA, V43, P165, DOI 10.1111/j.1475-4762.2010.00976.x; Yi SH, 2011, P NATL ACAD SCI USA, V108, pE94, DOI 10.1073/pnas.1100394108; Yu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049230; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhang YM, 2003, MAMMAL REV, V33, P284, DOI 10.1046/j.1365-2907.2003.00020.x; Zhang YQ, 1996, ARCTIC ALPINE RES, V28, P203, DOI 10.2307/1551761; Zhao L, 2004, GLOBAL PLANET CHANGE, V43, P19, DOI 10.1016/j.gloplacha.2004.02.003; Zhou Huakun, 2005, Grassland Science, V51, P191, DOI 10.1111/j.1744-697X.2005.00028.x	78	39	43	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132897	10.1371/journal.pone.0132897	http://dx.doi.org/10.1371/journal.pone.0132897			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208005	gold, Green Published			2022-12-26	WOS:000358622000043
J	Koer, ZA; Carter, R; Wu, G; Zhang, JH; Webster, RG				Koer, Zeynep A.; Carter, Robert; Wu, Gang; Zhang, Jinghui; Webster, Robert G.			The Genomic Contributions of Avian H1N1 Influenza A Viruses to the Evolution of Mammalian Strains	PLOS ONE			English	Article							PROTEIN; ORIGIN; SWINE; GENE	Among the influenza A viruses (IAVs) in wild aquatic birds, only H1, H2, and H3 subtypes have caused epidemics in humans. H1N1 viruses of avian origin have also caused 3 of 5 pandemics. To understand the reappearance of H1N1 in the context of pandemic emergence, we investigated whether avian H1N1 IAVs have contributed to the evolution of human, swine, and 2009 pandemic H1N1 IAVs. On the basis of phylogenetic analysis, we concluded that the polymerase gene segments (especially PB2 and PA) circulating in North American avian H1N1 IAVs have been reintroduced to swine multiple times, resulting in different lineages that led to the emergence of the 2009 pandemic H1N1 IAVs. Moreover, the similar topologies of hemagglutinin and nucleoprotein and neuraminidase and matrix gene segments suggest that each surface glycoprotein coevolved with an internal gene segment within the H1N1 subtype. The genotype of avian H1N1 IAVs of Charadriiformes origin isolated in 2009 differs from that of avian H1N1 IAVs of Anseriformes origin. When the antigenic sites in the hemagglutinin of all 31 North American avian H1N1 IAVs were considered, 60%-80% of the amino acids at the antigenic sites were identical to those in 1918 and/or 2009 pandemic H1N1 viruses. Thus, although the pathogenicity of avian H1N1 IAVs could not be inferred from the phylogeny due to the small dataset, the evolutionary process within the H1N1 IAV subtype suggests that the circulation of H1N1 IAVs in wild birds poses a continuous threat for future influenza pandemics in humans.	[Koer, Zeynep A.; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Carter, Robert; Wu, Gang; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Webster, Robert G.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia	St Jude Children's Research Hospital; St Jude Children's Research Hospital; King Abdulaziz University	Webster, RG (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.	robert.webster@stjude.org	Zhang, Jing/GWZ-7332-2022; Wu, Gang/M-8012-2014; Kocer, Zeynep A./P-8983-2019	Wu, Gang/0000-0002-1678-5864; Kocer, Zeynep A./0000-0001-9178-0142	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services [HHSN266200700005C]; ALSAC (American Lebanese Syrian Associated Charities); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ALSAC (American Lebanese Syrian Associated Charities)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Contract No. HHSN266200700005C from the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, and by ALSAC (American Lebanese Syrian Associated Charities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; KANEGAE Y, 1994, ARCH VIROL, V134, P17, DOI 10.1007/BF01379103; Kocer ZA, 2013, J VIROL; Kocer ZA, 2014, SCI REP-UK, V4, DOI 10.1038/srep07455; Kocer ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041609; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SCHOLTISSEK C, 1983, VIROLOGY, V129, P521, DOI 10.1016/0042-6822(83)90194-0; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tong S, 2013, NEW WORLD BATS ARE R; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; TREANOR JJ, 1989, VIROLOGY, V171, P1, DOI 10.1016/0042-6822(89)90504-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Zhu XY, 2012, P NATL ACAD SCI USA, V109, P18903, DOI 10.1073/pnas.1212579109	28	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133795	10.1371/journal.pone.0133795	http://dx.doi.org/10.1371/journal.pone.0133795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208281	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000146
J	van der Plas, AGM; Vissers, KC; Francke, AL; Donker, GA; Jansen, WJJ; Deliens, L; Onwuteaka-Philipsen, BD				van der Plas, Annicka G. M.; Vissers, Kris C.; Francke, Anneke L.; Donker, Ge A.; Jansen, Wim J. J.; Deliens, Luc; Onwuteaka-Philipsen, Bregje D.			Involvement of a Case Manager in Palliative Care Reduces Hospitalisations at the End of Life in Cancer Patients; A Mortality Follow-Back Study in Primary Care	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; PREFERENCES	Background Case managers have been introduced in primary palliative care in the Netherlands; these are nurses with expertise in palliative care who offer support to patients and informal carers in addition to the care provided by the general practitioner (GP) and home-care nurse. Objectives To compare cancer patients with and without additional support from a case manager on: 1) the patients' general characteristics, 2) characteristics of care and support given by the GP, 3) palliative care outcomes. Methods This article is based on questionnaire data provided by GPs participating in two different studies: the Sentimelc study (280 cancer patients) and the Capalca study (167 cancer patients). The Sentimelc study is a mortality follow-back study amongst a representative sample of GPs that monitors the care provided via GPs to a general population of end-of-life patients. Data from 2011 and 2012 were analysed. The Capalca study is a prospective study investigating the implementation and outcome of the support provided by case managers in primary palliative care. Data were gathered between March 2011 and December 2013. Results The GP is more likely to know the preferred place of death (OR 7.06; CI 3.47-14.36), the place of death is more likely to be at the home (OR 2.16; CI 1.33-3.51) and less likely to be the hospital (OR 0.26; CI 0.13-0.52), and there are fewer hospitalisations in the last 30 days of life (none: OR 1.99; CI 1.12-3.56 and one: OR 0.54; CI 0.30-0.96), when cancer patients receive additional support from a case manager compared with patients receiving the standard GP care. Conclusions Involvement of a case manager has added value in addition to palliative care provided by the GP, even though the role of the case manager is 'only' advisory and he or she does not provide hands-on care or prescribe medication.	[van der Plas, Annicka G. M.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [van der Plas, Annicka G. M.; Francke, Anneke L.; Jansen, Wim J. J.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, Ctr Expertise Palliat Care, Amsterdam, Netherlands; [van der Plas, Annicka G. M.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Vissers, Kris C.] Radboud Univ Nijmegen, Dept Anaesthesiol Pain & Palliat Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Francke, Anneke L.] NIVEL Netherlands Inst Hlth Serv Res, Nursing Care, Utrecht, Netherlands; [Donker, Ge A.] NIVEL Primary Care Database, Sentinel Practices, Utrecht, Netherlands; [Jansen, Wim J. J.] Vrije Univ Amsterdam, Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands; [Deliens, Luc] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Deliens, Luc] Univ Ghent, Brussels, Belgium; [Deliens, Luc] Vrije Univ Brussel, End Of Life Care Res Grp, Ghent, Belgium; [Deliens, Luc] Univ Ghent, B-9000 Ghent, Belgium	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Netherlands Institute for Health Services Research; Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Brussel; Ghent University	van der Plas, AGM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	eol@vumc.nl	Vissers, Kris C.P./D-3569-2009; Vissers, Kris/H-8110-2014; Donker, Gé/AAX-8564-2021	Vissers, Kris C.P./0000-0002-2919-6356; Vissers, Kris/0000-0002-2919-6356; Deliens, Luc/0000-0002-8158-2422; van der Plas, Annicka/0000-0003-4599-1795; Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248	Netherlands Organisation for Health Research and Development (ZonMw) [80-82100-98-066]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The authors wish to thank the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 80-82100-98-066] for their financial support. The funders had no role in study design, data collection and analysis, selection of respondents, decision to publish, or preparation of the manuscript.	Abarshi E, 2011, J PALLIAT MED, V14, P323, DOI 10.1089/jpm.2010.0312; Abarshi E, 2009, J PAIN SYMPTOM MANAG, V38, P568, DOI 10.1016/j.jpainsymman.2008.12.007; Becker G, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-43; Central Bureau for Statistics, POP COUNT; College Bescherming Persoonsgegevens [Dutch Data Protection Authority], INF DUTCH DAT PROT A; de Korte-Verhoef MC, 2014, THESIS VU U; De Roo ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093762; Dutch Government, WET BESCH PERS; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Groot MM, 2005, PALLIATIVE MED, V19, P111, DOI 10.1191/0269216305pm937oa; Ko W, 2013, EUR J CANCER, V49, P1967, DOI 10.1016/j.ejca.2013.01.006; Middelburg-Hebly M, 2014, PALLIATIEVE ZORG BEE; Minkman MMN, 2009, HEALTH SOC CARE COMM, V17, P485, DOI 10.1111/j.1365-2524.2009.00850.x; Nursing Staff Panel, 2012, SURV END LIF CAR; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Rolden HJA, 2014, SOC SCI MED, V120, P110, DOI 10.1016/j.socscimed.2014.09.020; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; Van den Block L, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-73; van der Plas AGM, BMC PALLIAT IN PRESS; van der Plas AGM, 2014, J PALLIATIV IN PRESS; van der Plas AGM, 2013, INT J NURS STUD, V50, P1504, DOI 10.1016/j.ijnurstu.2013.03.002; van der Velden Lud F J, 2009, BMC Palliat Care, V8, P4, DOI 10.1186/1472-684X-8-4; Vroomen JM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-132	26	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133197	10.1371/journal.pone.0133197	http://dx.doi.org/10.1371/journal.pone.0133197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208099	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000064
J	Yuan, AD; Hassinger, L; Rao, MV; Julien, JP; Miller, CCJ; Nixon, RA				Yuan, Aidong; Hassinger, Linda; Rao, Mala V.; Julien, Jean-Pierre; Miller, Christopher C. J.; Nixon, Ralph A.			Dissociation of Axonal Neurofilament Content from Its Transport Rate	PLOS ONE			English	Article							MOLECULAR-MASS SUBUNIT; IN-VIVO; RADIAL GROWTH; HEAVY SUBUNIT; PHOSPHORYLATED TAIL; ALPHA-INTERNEXIN; TRIPLET PROTEINS; CELL NEURONS; MICE LACKING; MOUSE MODEL	The axonal cytoskeleton of neurofilament (NF) is a long-lived network of fibrous elements believed to be a stationary structure maintained by a small pool of transported cytoskeletal precursors. Accordingly, it may be predicted that NF content in axons can vary independently from the transport rate of NF. In the present report, we confirm this prediction by showing that human NFH transgenic mice and transgenic mice expressing human NFL Ser55 (Asp) develop nearly identical abnormal patterns of NF accumulation and distribution in association with opposite changes in NF slow transport rates. We also show that the rate of NF transport in wild-type mice remains constant along a length of the optic axon where NF content varies 3-fold. Moreover, knockout mice lacking NFH develop even more extreme (6-fold) proximal to distal variation in NF number, which is associated with a normal wild-type rate of NF transport. The independence of regional NF content and NF transport is consistent with previous evidence suggesting that the rate of incorporation of transported NF precursors into a metabolically stable stationary cytoskeletal network is the major determinant of axonal NF content, enabling the generation of the striking local variations in NF number seen along axons.	[Yuan, Aidong; Rao, Mala V.; Nixon, Ralph A.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Yuan, Aidong; Rao, Mala V.; Nixon, Ralph A.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Nixon, Ralph A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Hassinger, Linda] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA; [Julien, Jean-Pierre] Univ Laval, Dept Anat & Physiol, Ctr Rech, CHU Laval, Quebec City, PQ, Canada; [Miller, Christopher C. J.] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Miller, Christopher C. J.] Kings Coll London, Inst Psychiat, Clin Neurosci, London WC2R 2LS, England	Nathan Kline Institute for Psychiatric Research; New York University; New York University; Harvard University; McLean Hospital; Laval University; University of London; King's College London; University of London; King's College London	Yuan, AD (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA.	yuan@nki.rfmh.org; nixon@nki.rfmh.org		Nixon, Ralph A/0000-0001-5124-1021; Miller, Christopher/0000-0002-5130-1845; Rao, Mala/0000-0001-7985-2414	National Institutes on Aging Grant [AG05604]; United Kingdom Medical Research Council; Wellcome Trust; Medical Research Council [G0501573] Funding Source: researchfish; MRC [G0501573] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R01AG005604, R37AG005604] Funding Source: NIH RePORTER	National Institutes on Aging Grant; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes on Aging Grant AG05604 (AY RAN MVR). The United Kingdom Medical Research Council and the Wellcome Trust (CCJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami NH, 2009, J NEUROSCI, V29, P6625, DOI 10.1523/JNEUROSCI.3829-08.2009; BENNETT GS, 1985, J CELL BIOL, V100, P1799, DOI 10.1083/jcb.100.5.1799; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Brown A, 1998, J CELL SCI, V111, P455; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Francis F, 2005, J NEUROSCI RES, V79, P442, DOI 10.1002/jnr.20399; Gibb BJM, 1998, J NEUROCHEM, V70, P492; Gibb BJM, 1996, J NEUROCHEM, V66, P1306; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; GRIFFIN JW, 1978, SCIENCE, V202, P633, DOI 10.1126/science.81524; Grubb MS, 2011, J NEUROSCI, V31, P16049, DOI 10.1523/JNEUROSCI.4064-11.2011; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; Hirokawa N., 1991, NEURONAL CYTOSKELETO, P5; Hirokawa Nobutaka, 1993, Current Opinion in Neurobiology, V3, P724, DOI 10.1016/0959-4388(93)90144-N; HOFFMAN PN, 1983, J NEUROSCI, V3, P1694; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; Jacomy H, 1999, J NEUROCHEM, V73, P972, DOI 10.1046/j.1471-4159.1999.0730972.x; Jung CH, 2004, J NEUROSCI, V24, P9486, DOI 10.1523/JNEUROSCI.1665-04.2004; Jung CW, 1999, CELL MOTIL CYTOSKEL, V42, P230, DOI 10.1002/(SICI)1097-0169(1999)42:3<230::AID-CM6>3.3.CO;2-1; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; LEWIS SE, 1988, J CELL BIOL, V107, P2689, DOI 10.1083/jcb.107.6.2689; Li YY, 2012, J NEUROSCI, V32, P746, DOI 10.1523/JNEUROSCI.4926-11.2012; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; MONACO S, 1985, P NATL ACAD SCI USA, V82, P920, DOI 10.1073/pnas.82.3.920; NAKAGAWA T, 1995, J CELL BIOL, V129, P411, DOI 10.1083/jcb.129.2.411; NIXON RA, 1986, J CELL BIOL, V102, P647, DOI 10.1083/jcb.102.2.647; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Rao MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044320; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Rao MV, 2002, J CELL BIOL, V158, P681, DOI 10.1083/jcb.200202037; Rao MV, 1998, J CELL BIOL, V143, P171, DOI 10.1083/jcb.143.1.171; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; Sanchez I, 2000, J CELL BIOL, V151, P1013, DOI 10.1083/jcb.151.5.1013; SCHLAEPFER WW, 1990, J NEUROCHEM, V55, P453, DOI 10.1111/j.1471-4159.1990.tb04157.x; Shen H, 2010, NEUROSCIENCE, V170, P16, DOI 10.1016/j.neuroscience.2010.07.014; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Yabe JT, 1999, J CELL SCI, V112, P3799; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5; Yuan A, 2015, MOL PSYCHIATR, V20, P986, DOI [10.1038/mp.2015.45, 10.1038/mp.2015.99]; Yuan AD, 1999, CELL MOL NEUROBIOL, V19, P733, DOI 10.1023/A:1006953022763; Yuan AD, 2000, CELL MOL NEUROBIOL, V20, P623, DOI 10.1023/A:1007090422866; Yuan AD, 2006, NEUROSCI LETT, V393, P264, DOI 10.1016/j.neulet.2005.10.029; Yuan AD, 1997, BRAIN RES, V771, P203, DOI 10.1016/S0006-8993(97)00766-X; Yuan AD, 2003, J NEUROSCI, V23, P9452; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Yuan AD, 2012, J NEUROSCI, V32, P8501, DOI 10.1523/JNEUROSCI.1081-12.2012; Yuan AD, 2011, ADV NEUROBIOL, V3, P189, DOI 10.1007/978-1-4419-6787-9_8; Yuan AD, 2011, ADV NEUROBIOL, V3, P503, DOI 10.1007/978-1-4419-6787-9_21; Yuan AD, 2009, J NEUROSCI, V29, P11316, DOI 10.1523/JNEUROSCI.1942-09.2009; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	61	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133848	10.1371/journal.pone.0133848	http://dx.doi.org/10.1371/journal.pone.0133848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208164	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000155
J	Wu, YC; Tang, SJ; Sun, GH; Sun, KH				Wu, Y-C; Tang, S-J; Sun, G-H; Sun, K-H			CXCR7 mediates TGF beta 1-promoted EMT and tumor-initiating features in lung cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; CHEMOKINE RECEPTOR; STEM-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; BREAST; EXPRESSION; MIGRATION; SURVIVAL; ADHESION	In the tumor microenvironment, chemokine system has a critical role in tumorigenesis and metastasis. The acquisition of stem-like properties by cancer cells is involved in metastasis and drug resistance, which are pivotal problems that result in poor outcomes in patients with lung cancer. Patients with advanced lung cancer present high plasma levels of transforming growth factor-beta 1 (TGF beta 1), which correlate with poor prognostic features. Therefore, TGF beta 1 may be important in the tumor microenvironment, where chemokines are widely expressed. However, the role of chemokines in TGF beta 1-induced tumor progression still remains unclear. In our study, TGF beta 1 upregulated CXC chemokine receptor expression, migration, invasion, epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) formation in lung adenocarcinoma. We found that CXCR7 was the most upregulated chemokine receptor induced by TGF beta 1. CXCR7 knockdown resulted in reduction of migration, invasion and EMT induced by TGF beta 1, whereas CXCR4 knockdown did not reverse TGF beta 1-promoted EMT. CXCR7 silencing significantly decreased cancer sphere-forming capacity, stem-like properties, chemoresistance and TGF beta 1-induced CSC tumor initiation in vivo. In clinical samples, high TGF beta 1 and CXCR7 expression was significantly associated with the late stages of lung adenocarcinoma. Moreover, TGF beta 1 and CXCR7 coexpression was positively correlated with the CSC marker, CD44, which is associated with lymph node metastasis. Besides, patients with high expression of both CXCR7 and TGF beta 1 presented a significantly worse survival rate. These results suggest that the TGF beta 1-CXCR7 axis may be a prognostic marker and may provide novel targets for combinational therapies to be used in the treatment of advanced lung cancer in the future.	[Wu, Y-C; Sun, K-H] Natl Yang Ming Univ, Taipei City Hosp, Dept Educ & Res, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Tang, S-J] Natl Taiwan Ocean Univ, Inst Marine Biotechnol, Keelung, Taiwan; [Sun, G-H] Triserv Gen Hosp, Dept Surg, Div Surg, 325,Sect 2,Chenggong Rd, Taipei 114, Taiwan; [Sun, G-H] Natl Def Med Ctr, 325,Sect 2,Chenggong Rd, Taipei 114, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; National Taiwan Ocean University; Tri-Service General Hospital; National Defense Medical Center	Sun, GH (corresponding author), Triserv Gen Hosp, Dept Surg, Div Surg, 325,Sect 2,Chenggong Rd, Taipei 114, Taiwan.; Sun, GH (corresponding author), Natl Def Med Ctr, 325,Sect 2,Chenggong Rd, Taipei 114, Taiwan.; Sun, KH (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, 155,Sect 2,Linong St, Taipei 11221, Taiwan.; Sun, KH (corresponding author), Taipei City Hosp, Dept Educ & Res, 155,Sect 2,Linong St, Taipei 11221, Taiwan.	ghsun@ndmctsgh.edu.tw; khsun@ym.edu.tw			Ministry of Science and Technology (MOST) [103-2320-B-010-039-MY3, 103-2321-B-010-029]; Ministry of Education (Aim for the Top University Plan); Tri-Service General Hospital; National Defense Medical Center [TSGHC-C103-062, TSGH-104-507]; Taipei City Hospital, Taiwan	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Ministry of Education (Aim for the Top University Plan)(Ministry of Education, Taiwan); Tri-Service General Hospital; National Defense Medical Center; Taipei City Hospital, Taiwan	This study was supported by the Ministry of Science and Technology (MOST 103-2320-B-010-039-MY3, 103-2321-B-010-029), the Ministry of Education (Aim for the Top University Plan), the Tri-Service General Hospital and the National Defense Medical Center (TSGHC-C103-062, TSGH-104-507) and the Taipei City Hospital, Taiwan.	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Bareschino Maria Anna, 2011, J Thorac Dis, V3, P122, DOI 10.3978/j.issn.2072-1439.2010.12.08; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Bertran E, 2009, CELL SIGNAL, V21, P1595, DOI 10.1016/j.cellsig.2009.06.006; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Hasegawa Y, 2001, CANCER-AM CANCER SOC, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; Hou YL, 2013, CANCER EPIDEMIOL, V37, P750, DOI 10.1016/j.canep.2013.04.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang Xiefang, 2010, Zhongguo Fei Ai Za Zhi, V13, P451, DOI 10.3779/j.issn.1009-3419.2010.05.14; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Schaeffer D, 2014, MOL CELL BIOL, V34, P3486, DOI 10.1128/MCB.00694-14; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Su LP, 2005, CLIN CANCER RES, V11, P8273, DOI 10.1158/1078-0432.CCR-05-0537; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Suzuki M, 2008, INT J ONCOL, V33, P113; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Xu CC, 2011, MOL MED REP, V4, P1007, DOI 10.3892/mmr.2011.530; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455; Zhao XP, 2010, ACTA PHARMACOL SIN, V31, P347, DOI 10.1038/aps.2009.204; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	41	77	79	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2123	2132		10.1038/onc.2015.274	http://dx.doi.org/10.1038/onc.2015.274			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26212008				2022-12-26	WOS:000374505600011
J	Ben-Eliezer, I; Pomerantz, Y; Galiani, D; Nevo, N; Dekel, N				Ben-Eliezer, Inbal; Pomerantz, Yael; Galiani, Dalia; Nevo, Nava; Dekel, Nava			Appropriate expression of Ube2C and Ube2S controls the progression of the first meiotic division	FASEB JOURNAL			English	Article						oocyte; spindle; proteasome; spindle assembly checkpoint	ANAPHASE-PROMOTING COMPLEX; SPINDLE ASSEMBLY CHECKPOINT; FEMALE MOUSE MEIOSIS; METAPHASE-I ARREST; CYCLIN-B; PROTEASOMAL DEGRADATION; UBIQUITIN CHAINS; MITOTIC EXIT; OOCYTES; PROTEIN	Timely degradation of protein regulators of the cell cycle is essential for the completion of cell division. This degradation is promoted by the E3 anaphase-promoting complex/cyclosome(APC/C) and mediated by the E2 ubiquitin-conjugating enzymes (Ube2s). Unlike the ample information gathered regarding the meiotic E3 APC/C, the E2s participating in this cell division have never been studied. We identified Ube2C, -S, and -D3 as the E2 enzymes that regulate APC/C activity during meiosis of mouse oocytes. Their depletion reduces the levels of the first meiotic cytokinesis by 50%, and their overexpression doubles and accelerates its completion (50% as compared with 4% at 11 h). We also demonstrated that these E2s take part in ensuring appropriate spindle formation. It is noteworthy that high levels of Ube2C bring about the resumption of the first meiotic division, regardless of the formation of the spindle, overriding the spindle assembly checkpoint. Thus, alongside their canonical function in protein degradation, Ube2C and -S also control the extrusion of the first polar body. Overall, our study characterizes new regulators and unveils the novel roles they play during the meiotic division. These findings shed light on faithful chromosome segregation in oocytes and may contribute to better understanding of aneuploidy and its consequent genetic malformations.	[Ben-Eliezer, Inbal; Pomerantz, Yael; Galiani, Dalia; Nevo, Nava; Dekel, Nava] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dekel, N (corresponding author), Weizmann Inst Sci, 234 Herzl St, IL-76100 Rehovot, Israel.	nava.dekel@weizmann.ac.il	DEKEL, NAVA/R-8817-2019					Berlingieri MT, 2007, ONCOGENE, V26, P2136, DOI 10.1038/sj.onc.1210010; CHOI T, 1991, DEVELOPMENT, V113, P789; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Davydenko O, 2013, J CELL BIOL, V202, P221, DOI 10.1083/jcb.201303019; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; HAMPL A, 1995, DEVELOPMENT, V121, P925; Hao ZL, 2012, TUMOR BIOL, V33, P723, DOI 10.1007/s13277-011-0291-1; HASHIMOTO N, 1988, DEV BIOL, V126, P242, DOI 10.1016/0012-1606(88)90135-2; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; HERSHKO A, 1994, J BIOL CHEM, V269, P4940; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoermanseder E, 2011, EMBO REP, V12, P436, DOI 10.1038/embor.2011.32; Homer HA, 2005, REPRODUCTION, V130, P829, DOI 10.1530/rep.1.00856; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Homer H, 2013, REPRODUCTION, V146, pR61, DOI 10.1530/REP-13-0163; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Horikoshi Y, 2013, CELL CYCLE, V12, P961, DOI 10.4161/cc.23946; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jones KT, 2013, DEVELOPMENT, V140, P3719, DOI 10.1242/dev.090589; Jones KT, 2011, RESULTS PROBL CELL D, V53, P343, DOI 10.1007/978-3-642-19065-0_15; Karabinova P, 2011, CELL TISSUE RES, V346, P1, DOI 10.1007/s00441-011-1235-1; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kitagawa R, 2002, CURR BIOL, V12, P2118, DOI 10.1016/S0960-9822(02)01392-1; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Li S, 2012, CELL CYCLE, V11, P3211, DOI 10.4161/cc.21553; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Niault T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001165; Pomerantz Y, 2012, FASEB J, V26, P4495, DOI 10.1096/fj.12-209866; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sako K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4667; Sharif B, 2010, J CELL SCI, V123, P4292, DOI 10.1242/jcs.067447; Song L, 2014, MOL CELL, V53, P179, DOI 10.1016/j.molcel.2013.12.022; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Sun SC, 2012, HUM REPROD UPDATE, V18, P60, DOI 10.1093/humupd/dmr044; Sun SC, 2011, CELL CYCLE, V10, P2419, DOI 10.4161/cc.10.15.15932; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Walker A, 2008, J CELL SCI, V121, P2319, DOI 10.1242/jcs.031591; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4; Zhang QH, 2010, CELL CYCLE, V9, P2230, DOI 10.4161/cc.9.11.11895	55	19	23	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4670	4681		10.1096/fj.15-274522	http://dx.doi.org/10.1096/fj.15-274522			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26207029				2022-12-26	WOS:000364514700024
J	Xiao, JX; Sun, XX; Madhan, B; Brodsky, B; Baum, J				Xiao, Jianxi; Sun, Xiuxia; Madhan, Balaraman; Brodsky, Barbara; Baum, Jean			NMR Studies Demonstrate a Unique AAB Composition and Chain Register for a Heterotrimeric Type IV Collagen Model Peptide Containing a Natural Interruption Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL PEPTIDE; BASEMENT-MEMBRANE; MATRIX METALLOPROTEINASES; MOLECULAR-STRUCTURE; BACKBONE DYNAMICS; NEGATIVE DESIGN; RATIONAL DESIGN; CLEAVAGE SITE; SPECTROSCOPY; STABILITY	All non-fibrillar collagens contain interruptions in the (Gly-X-Y)(n) repeating sequence, such as the more than 20 interruptions found in chains of basement membrane type IV collagen. Two selectively doubly labeled peptides are designed to model a site in type IV collagen with a GVG interruption in the alpha 1(IV) and a corresponding GISLK sequence within the alpha 2(IV) chain. CD and NMR studies on a 2:1 mixture of these two peptides support the formation of a single-component heterotrimer that maintains the one-residue staggering in the triple-helix, has a unique chain register, and contains hydrogen bonds at the interruption site. Formation of hydrogen bonds at interruption sites may provide a driving force for self-assembly and chain register in type IV and other non-fibrillar collagens. This study illustrates the potential role of interruptions in the structure, dynamics, and folding of natural collagen heterotrimers and forms a basis for understanding their biological role.	[Xiao, Jianxi; Baum, Jean] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Xiao, Jianxi; Sun, Xiuxia] Lanzhou Univ, Coll Chem & Chem Engn, State Key Lab Appl Organ Chem, Key Lab Nonferrous Met Chem & Resources Utilizat, Lanzhou 730000, Peoples R China; [Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02446 USA; [Madhan, Balaraman] Cent Leather Res Inst, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India	Rutgers State University New Brunswick; Lanzhou University; Tufts University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI)	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02446 USA.	barbara.brodsky@tufts.edu; jean.baum@rutgers.edu	Balaraman, Madhan/B-3136-2009; Regan, Clinton/E-6250-2012; Xiao, Jianxi/Q-8692-2017	Balaraman, Madhan/0000-0002-4198-8452; Xiao, Jianxi/0000-0002-9863-572X	National Institutes of Health [GM45302, GM60048]; National Science Foundation [DBI-0403062, DBI-0320746]; National Natural Science Foundation of China [21305056]; Fundamental Research Funds for the Central Universities [lzujbky-2014-73]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM045302, R01GM060048, R01GM045302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM45302 (to J. B.) and GM60048 (to B. B.); National Science Foundation Grants DBI-0403062 and DBI-0320746 (to J. B.); and National Natural Science Foundation of China Grant 21305056 and Fundamental Research Funds for the Central Universities Grant lzujbky-2014-73) (to J. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014; Bella J, 2014, J STRUCT BIOL, V186, P438, DOI 10.1016/j.jsb.2014.03.022; Boudko SP, 2012, J BIOL CHEM, V287, P44536, DOI 10.1074/jbc.M112.417543; BRAZEL D, 1987, EUR J BIOCHEM, V168, P529, DOI 10.1111/j.1432-1033.1987.tb13450.x; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Buevich AV, 2000, BIOCHEMISTRY-US, V39, P4299, DOI 10.1021/bi992584r; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Fallas JA, 2012, J AM CHEM SOC, V134, P1430, DOI 10.1021/ja209669u; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; FURCHT LT, 1994, LAB INVEST, V70, P781; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jalan AA, 2014, J AM CHEM SOC, V136, P7535, DOI 10.1021/ja5001246; Jalan AA, 2013, CURR OPIN CHEM BIOL, V17, P960, DOI 10.1016/j.cbpa.2013.10.019; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; MILES AJ, 1994, J BIOL CHEM, V269, P30939; MILES AJ, 1995, J BIOL CHEM, V270, P29047, DOI 10.1074/jbc.270.49.29047; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; O'Leary LER, 2011, J AM CHEM SOC, V133, P5432, DOI 10.1021/ja111239r; Palmer Arthur G. Iii, 1993, Current Opinion in Biotechnology, V4, P385, DOI 10.1016/0958-1669(93)90002-E; Persikov AV, 2004, HUM MUTAT, V24, P330, DOI 10.1002/humu.20091; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075; Xiao JX, 2011, BIOCHEMISTRY-US, V50, P10771, DOI 10.1021/bi201476a; Xiao JX, 2010, J BIOL CHEM, V285, P34181, DOI 10.1074/jbc.M110.128355; Xu F, 2012, J AM CHEM SOC, V134, P47, DOI 10.1021/ja2077894; Xu F, 2011, J AM CHEM SOC, V133, P15260, DOI 10.1021/ja205597g; Xu F, 2010, BIOCHEMISTRY-US, V49, P2307, DOI 10.1021/bi902077d; Xu YJ, 2003, BIOCHEMISTRY-US, V42, P8696, DOI 10.1021/bi034006n	49	15	15	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24201	24209		10.1074/jbc.M115.654871	http://dx.doi.org/10.1074/jbc.M115.654871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26209635	Green Published, hybrid			2022-12-26	WOS:000362218900013
J	Maitra, D; Elenbaas, JS; Whitesall, SE; Basrur, V; D'Alecy, LG; Omary, MB				Maitra, Dhiman; Elenbaas, Jared S.; Whitesall, Steven E.; Basrur, Venkatesha; D'Alecy, Louis G.; Omary, M. Bishr			Ambient Light Promotes Selective Subcellular Proteotoxicity after Endogenous and Exogenous Porphyrinogenic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-ELECTRON REDUCTION; PHOTODYNAMIC THERAPY; PROTOPORPHYRIN-IX; LIVER; HEME; PORPHYRIAS; AGGREGATION; METABOLISM; DISEASE; PROTEIN	Hepatic accumulation of protoporphyrin-IX (PP-IX) in erythropoietic protoporphyria (EPP) or X-linked-dominant protoporphyria (XLP) cause liver damage. Hepatocyte nuclear lamin aggregation is a sensitive marker for PP-IX-mediated liver injury. We tested the hypothesis that extracellular or intracellular protoporphyria cause damage to different subcellular compartments, in a light-triggered manner. Three hepatoma cell lines (HepG2, Hepa-1, and Huh-7) were treated with exogenous PP-IX (mimicking XLP extrahepatic protoporphyria) or with the iron chelator deferoxamine and the porphyrin precursor 5-aminolevulinic acid (ALA) (mimicking intracellular protoporphyrin accumulation in EPP). Exogenous PP-IX accumulated predominantly in the nuclear fraction and caused nuclear shape deformation and cytoplasmic vacuoles containing electron-dense particles, whereas ALA + deferoxamine treatment resulted in higher PP-IX in the cytoplasmic fraction. Protein aggregation in the nuclear and cytoplasmic fractions paralleled PP-IX levels and, in cell culture, the effects were exclusively ambient light-mediated. PP-IX and ALA caused proteasomal inhibition, whereas endoplasmic reticulum protein aggregation was more prominent in ALA-treated cells. The enhanced ALA-related toxicity is likely due to generation of additional porphyrin intermediates including uroporphyrin and coproporphyrin, based on HPLC analysis of cell lysates and the culture medium, as well as cell-free experiments with uroporphyrin/coproporphyrin. Mouse livers from drug-induced porphyria phenocopied the in vitro findings, and mass spectrometry of liver proteins isolated in light/dark conditions showed diminished (as compared with light-harvested) but detectable aggregation under dark-harvested conditions. Therefore, PP-IX leads to endoplasmic reticulum stress and proteasome inhibition in a manner that depends on the source of porphyrin buildup and light exposure. Porphyrin-mediated selective protein aggregation provides a potential mechanism for porphyria-associated tissue injury.	[Maitra, Dhiman; Elenbaas, Jared S.; Whitesall, Steven E.; D'Alecy, Louis G.; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Basrur, Venkatesha] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Maitra, D (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7744 Med Sci Bldg 2,1137 Catherine St, Ann Arbor, MI 48109 USA.	dhimanm@med.umich.edu	Regan, Clinton/E-6250-2012	, dhiman/0000-0002-8775-2963; Elenbaas, Jared/0000-0002-9612-7764; Omary, Bishr/0000-0002-8624-2347	NIH [DK034933]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951, P30DK034933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by an institutional grant to the University of Michigan (NIH Grant DK034933).	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Andrzejak M, 2011, AUTOPHAGY, V7, P979, DOI 10.4161/auto.7.9.15865; Balwani Manisha, 2013, Mol Med, V19, P26, DOI 10.2119/molmed.2012.00340; Balwani M, 2012, BLOOD, V120, P4496, DOI 10.1182/blood-2012-05-423186; Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Barr H, 1996, LANCET, V348, P584, DOI 10.1016/S0140-6736(96)03054-1; Bloomer JR, 1998, J GASTROEN HEPATOL, V13, P324, DOI 10.1111/j.1440-1746.1998.01548.x; Bonkovsky HL, 2013, COMPR PHYSIOL, V3, P365, DOI 10.1002/cphy.c120006; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Donohue E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114964; GRANT WE, 1993, LANCET, V342, P147, DOI 10.1016/0140-6736(93)91347-O; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Casanova-Gonzalez MJ, 2010, WORLD J GASTROENTERO, V16, P4526, DOI 10.3748/wjg.v16.i36.4526; KNOBLER E, 1989, HEPATOLOGY, V10, P995, DOI 10.1002/hep.1840100617; KONINGSBERGER JC, 1995, J HEPATOL, V22, P57, DOI 10.1016/0168-8278(95)80260-6; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MOREHOUSE KM, 1990, ARCH BIOCHEM BIOPHYS, V283, P306, DOI 10.1016/0003-9861(90)90647-H; MOREHOUSE KM, 1987, ARCH BIOCHEM BIOPHYS, V257, P276, DOI 10.1016/0003-9861(87)90567-4; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Schaffer M, 2003, CURR PHARM DESIGN, V9, P2024, DOI 10.2174/1381612033454153; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Scolaro LM, 2002, J PHYS CHEM B, V106, P2453, DOI 10.1021/jp013155h; Singla A, 2013, J CELL SCI, V126, P3105, DOI 10.1242/jcs.123026; Snider NT, 2011, J CELL BIOL, V195, P217, DOI 10.1083/jcb.201102142; Stumptner C, 2001, J HEPATOL, V34, P665, DOI 10.1016/S0168-8278(00)00099-4; To-Figueras J, 2011, BLOOD, V118, P1443, DOI 10.1182/blood-2011-03-342873; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Woods J S, 2001, Curr Protoc Toxicol, VChapter 8, DOI 10.1002/0471140856.tx0809s07	32	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23711	23724		10.1074/jbc.M114.636001	http://dx.doi.org/10.1074/jbc.M114.636001			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26205816	Green Published, hybrid			2022-12-26	WOS:000361816500020
J	Strobel, KL; Pfeiffer, KA; Blanch, HW; Clark, DS				Strobel, Kathryn L.; Pfeiffer, Katherine A.; Blanch, Harvey W.; Clark, Douglas S.			Structural Insights into the Affinity of Cel7A Carbohydrate-binding Module for Lignin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAM PRETREATED SOFTWOOD; ENZYMATIC-HYDROLYSIS; TRICHODERMA-REESEI; CELLULASE CEL7A; AMINO-ACIDS; SURFACE; INHIBITION; ADSORPTION; CELLOBIOHYDROLASES; LIGNOCELLULOSE	The high cost of hydrolytic enzymes impedes the commercial production of lignocellulosic biofuels. High enzyme loadings are required in part due to their non-productive adsorption to lignin, a major component of biomass. Despite numerous studies documenting cellulase adsorption to lignin, few attempts have been made to engineer enzymes to reduce lignin binding. In this work, we used alanine-scanning mutagenesis to elucidate the structural basis for the lignin affinity of Trichoderma reesei Cel7A carbohydrate binding module (CBM). T. reesei Cel7A CBM mutants were produced with a Talaromyces emersonii Cel7A catalytic domain and screened for their binding to cellulose and lignin. Mutation of aromatic and polar residues on the planar face of the CBM greatly decreased binding to both cellulose and lignin, supporting the hypothesis that the cellulose-binding face is also responsible for lignin affinity. Cellulose and lignin affinity of the 31 mutants were highly correlated, although several mutants displayed selective reductions in lignin or cellulose affinity. Four mutants with increased cellulose selectivity (Q2A, H4A, V18A, and P30A) did not exhibit improved hydrolysis of cellulose in the presence of lignin. Further reduction in lignin affinity while maintaining a high level of cellulose affinity is thus necessary to generate an enzyme with improved hydrolysis capability. This work provides insights into the structural underpinnings of lignin affinity, identifies residues amenable to mutation without compromising cellulose affinity, and informs engineering strategies for family one CBMs.	[Strobel, Kathryn L.; Pfeiffer, Katherine A.; Blanch, Harvey W.; Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Clark, DS (corresponding author), Univ Calif Berkeley, 201 Gilman Hall, Berkeley, CA 94720 USA.	clark@berkeley.edu			Energy Biosciences Institute	Energy Biosciences Institute	This work was supported by the Energy Biosciences Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Alekozai EM, 2014, CELLULOSE, V21, P951, DOI 10.1007/s10570-013-0026-0; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Berlin A, 2005, 26 S BIOT FUELS CHEM, P163, DOI DOI 10.1007/978-1-59259-991-2_14; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Borjesson J, 2007, ENZYME MICROB TECH, V41, P186, DOI 10.1016/j.enzmictec.2007.01.003; Dana CM, 2012, BIOTECHNOL BIOENG, V109, P2710, DOI 10.1002/bit.24708; Ishizawa CI, 2009, CELLULOSE, V16, P677, DOI 10.1007/s10570-009-9313-1; Ju XH, 2013, BIORESOURCE TECHNOL, V132, P137, DOI 10.1016/j.biortech.2013.01.049; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kumar L, 2012, BIORESOURCE TECHNOL, V103, P201, DOI 10.1016/j.biortech.2011.09.091; Kumar R, 2009, BIOTECHNOL PROGR, V25, P807, DOI 10.1002/btpr.153; Labbe S, 1999, METHOD ENZYMOL, V306, P145; Lai CH, 2014, BIORESOURCE TECHNOL, V163, P320, DOI 10.1016/j.biortech.2014.04.065; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Machado DL, 2015, BIOTECHNOL APPL BIOC, V62, P681, DOI 10.1002/bab.1307; Mooney CA, 1998, BIORESOURCE TECHNOL, V64, P113, DOI 10.1016/S0960-8524(97)00181-8; Nakagame S, 2011, BIORESOURCE TECHNOL, V102, P4507, DOI 10.1016/j.biortech.2010.12.082; Nakagame S, 2011, BIOTECHNOL BIOENG, V108, P538, DOI 10.1002/bit.22981; Nakagame S, 2010, BIOTECHNOL BIOENG, V105, P871, DOI 10.1002/bit.22626; NIDETZKY B, 1994, BIOCHEM J, V303, P817, DOI 10.1042/bj3030817; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Nordwald EM, 2014, BIOTECHNOL BIOENG, V111, P1541, DOI 10.1002/bit.25216; Palonen H, 2004, J BIOTECHNOL, V107, P65, DOI 10.1016/j.jbiotec.2003.09.011; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Pfeiffer K. A., 2015, BIOTECHNOL BIOENG, DOI 10.1002./bit.25657; Rahikainen J, 2011, BIOTECHNOL BIOENG, V108, P2823, DOI 10.1002/bit.23242; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V133, P270, DOI 10.1016/j.biortech.2013.01.075; Rahikainen JL, 2013, ENZYME MICROB TECH, V53, P315, DOI 10.1016/j.enzmictec.2013.07.003; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V146, P118, DOI 10.1016/j.biortech.2013.07.069; Sammond DW, 2014, J BIOL CHEM, V289, P20960, DOI 10.1074/jbc.M114.573642; Scott BR, 2010, Novel lignin-resistant cellulase enzymes., Patent No. [US-2010/0221778-A1, 20100221778]; Shill K, 2011, BIOTECHNOL BIOENG, V108, P511, DOI 10.1002/bit.23014; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	38	45	47	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22818	22826		10.1074/jbc.M115.673467	http://dx.doi.org/10.1074/jbc.M115.673467			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26209638	hybrid, Green Published			2022-12-26	WOS:000361171500044
J	Vogt, AD; Chakraborty, P; Di Cera, E				Vogt, Austin D.; Chakraborty, Pradipta; Di Cera, Enrico			Kinetic Dissection of the Pre-existing Conformational Equilibrium in the Trypsin Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-THROMBOMODULIN COMPLEX; CRYSTAL-STRUCTURE ANALYSIS; COLI ALKALINE-PHOSPHATASE; PROTEIN-C ACTIVATION; LIGAND-BINDING; ACTIVE-SITE; NA+ BINDING; BOVINE TRYPSINOGEN; SERINE PROTEASES; ENZYME SPECIFICITY	Structural biology has recently documented the conformational plasticity of the trypsin fold for both the protease and zymogen in terms of a pre-existing equilibrium between closed (E*) and open (E) forms of the active site region. How such plasticity is manifested in solution and affects ligand recognition by the protease and zymogen is poorly understood in quantitative terms. Here we dissect the E*-E equilibrium with stopped-flow kinetics in the presence of excess ligand or macromolecule. Using the clotting protease thrombin and its zymogen precursor prethrombin-2 as relevant models we resolve the relative distribution of the E* and E forms and the underlying kinetic rates for their interconversion. In the case of thrombin, the E* and E forms are distributed in a 1:4 ratio and interconvert on a time scale of 45 ms. In the case of prethrombin-2, the equilibrium is shifted strongly (10:1 ratio) in favor of the closed E* form and unfolds over a faster time scale of 4.5 ms. The distribution of E* and E forms observed for thrombin and prethrombin-2 indicates that zymogen activation is linked to a significant shift in the pre-existing equilibrium between closed and open conformations that facilitates ligand binding to the active site. These findings broaden our mechanistic understanding of how conformational transitions control ligand recognition by thrombin and its zymogen precursor prethrombin-2 and have direct relevance to other members of the trypsin fold.	[Vogt, Austin D.; Chakraborty, Pradipta; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [HL49413, HL73813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073813, R29HL049413, U54HL112303, R01HL049413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL73813, and HL112303. The authors declare that they have no conflicts of interest with the contents of this article.	Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; AYALA YH, 1994, J MOL BIOL, V235, P733, DOI 10.1006/jmbi.1994.1024; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Barranco-Medina S, 2013, J BIOL CHEM, V288, P35749, DOI 10.1074/jbc.M113.509786; BODE W, 1978, FEBS LETT, V90, P265, DOI 10.1016/0014-5793(78)80382-2; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BODE W, 1992, PROTEIN SCI, V1, P426; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2008, NAT CHEM BIOL, V4, P270, DOI 10.1038/nchembio0508-270; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; Eigen M, 1968, Q Rev Biophys, V1, P3; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FEHLHAMMER H, 1975, J MOL BIOL, V98, P683, DOI 10.1016/S0022-2836(75)80004-0; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Feixas F, 2014, BIOPHYS CHEM, V186, P31, DOI 10.1016/j.bpc.2013.10.007; Fersht A.R., 1999, ENZYME STRUCTURE MEC; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Fuglestad B, 2013, J PHYS CHEM B, V117, P12857, DOI 10.1021/jp402107u; Fuglestad B, 2012, BIOPHYS J, V103, P79, DOI 10.1016/j.bpj.2012.05.047; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Galletto R, 2005, CELL BIOCHEM BIOPHYS, V42, P121, DOI 10.1385/CBB:42:2:121; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; HALFORD SE, 1971, BIOCHEM J, V125, P319, DOI 10.1042/bj1250319; HALFORD SE, 1972, BIOCHEM J, V126, P727, DOI 10.1042/bj1260727; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henry BL, 2014, THROMB RES, V134, P1123, DOI 10.1016/j.thromres.2014.08.024; Hill T.L., 1977, FREE ENERGY TRANSDUC; HORTIN GL, 1991, J BIOL CHEM, V266, P6866; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; Lai MT, 1997, J BIOL CHEM, V272, P30275, DOI 10.1074/jbc.272.48.30275; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; LIU LW, 1991, J BIOL CHEM, V266, P16977; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mengwasser KE, 2005, J BIOL CHEM, V280, P26997, DOI 10.1074/jbc.M502678200; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; NEURATH H, 1957, FED PROC, V16, P791; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; OLSON ST, 1981, J BIOL CHEM, V256, P1073; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; PARRY MAA, 1993, BIOCHEM J, V290, P665, DOI 10.1042/bj2900665; Pelc LA, 2015, BIOCHEMISTRY-US, V54, P1457, DOI 10.1021/acs.biochem.5b00014; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6275, DOI 10.1021/bi0100992; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Plattner N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8653; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; Pozzi N, 2011, BIOPHYS CHEM, V159, P6, DOI 10.1016/j.bpc.2011.04.003; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Rezaie AR, 2003, P NATL ACAD SCI USA, V100, P12051, DOI 10.1073/pnas.2135346100; ROSING J, 1980, J BIOL CHEM, V255, P274; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; vandeLocht A, 1997, EMBO J, V16, P2977, DOI 10.1093/emboj/16.11.2977; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; Vogt AD, 2014, BIOPHYS CHEM, V186, P13, DOI 10.1016/j.bpc.2013.09.003; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wyman J., 1990, BINDING AND LINKAGE; Yamamoto E, 2011, BIOSCI BIOTECH BIOCH, V75, P2070, DOI 10.1271/bbb.110515; Yang LK, 2006, P NATL ACAD SCI USA, V103, P879, DOI 10.1073/pnas.0507700103; Yang LK, 2004, J BIOL CHEM, V279, P38519, DOI 10.1074/jbc.M407304200; YE J, 1991, J BIOL CHEM, V266, P23016	88	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22435	22445		10.1074/jbc.M115.675538	http://dx.doi.org/10.1074/jbc.M115.675538			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216877	Green Published, hybrid			2022-12-26	WOS:000361171500010
J	Martinez, J; Truffault, V; Hothorn, M				Martinez, Jacobo; Truffault, Vincent; Hothorn, Michael			Structural Determinants for Substrate Binding and Catalysis in Triphosphate Tunnel Metalloenzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA CAPPING ENZYME; 25-KDA THIAMINE TRIPHOSPHATASE; IV ADENYLYL-CYCLASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; POLYPHOSPHATE KINASE; 2-METAL MECHANISM; ESCHERICHIA-COLI; SUPERFAMILY; PROTEINS	Triphosphate tunnel metalloenzymes (TTMs) are present in all kingdoms of life and catalyze diverse enzymatic reactions such as mRNA capping, the cyclization of adenosine triphosphate, the hydrolysis of thiamine triphosphate, and the synthesis and breakdown of inorganic polyphosphates. TTMs have an unusual tunnel domain fold that harbors substrate-and metal co-factor binding sites. It is presently poorly understood how TTMs specifically sense different triphosphate-containing substrates and how catalysis occurs in the tunnel center. Here we describe substrate-bound structures of inorganic polyphosphatases from Arabidopsis and Escherichia coli, which reveal an unorthodox yet conserved mode of triphosphate and metal cofactor binding. We identify two metal binding sites in these enzymes, with one co-factor involved in substrate coordination and the other in catalysis. Structural comparisons with a substrate- and product-bound mammalian thiamine triphosphatase and with previously reported structures of mRNA capping enzymes, adenylate cyclases, and polyphosphate polymerases suggest that directionality of substrate binding defines TTM catalytic activity. Our work provides insight into the evolution and functional diversification of an ancient enzyme family.	[Martinez, Jacobo; Hothorn, Michael] Univ Geneva, Dept Bot & Plant Biol, Struct Plant Biol Lab, CH-1211 Geneva, Switzerland; [Truffault, Vincent] Max Planck Inst Dev Biol, Dept Biochem, D-72076 Tubingen, Germany	University of Geneva; Max Planck Society	Hothorn, M (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Struct Plant Biol Lab, Sci 3, 30 Quai E Ansermet, CH-1211 Geneva, Switzerland.	michael.hothorn@unige.ch		Hothorn, Michael/0000-0002-3597-5698	European Research Council under the European Union's Seventh Framework Programme/ERC [310856]; Max Planck Society; European Molecular Biology Organisation (EMBO) Young Investigator Programme	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Max Planck Society(Max Planck Society); European Molecular Biology Organisation (EMBO) Young Investigator Programme	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement 310856, the Max Planck Society, and the European Molecular Biology Organisation (EMBO) Young Investigator Programme (to MH). The authors declare that they have no conflicts of interest with the contents of this article.	AHN KH, 1990, J BIOL CHEM, V265, P11734; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Benarroch D, 2008, STRUCTURE, V16, P501, DOI 10.1016/j.str.2008.01.009; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; Bettendorff L, 2013, FEBS J, V280, P6443, DOI 10.1111/febs.12498; Bisaillon M, 2001, J BIOL CHEM, V276, P17261, DOI 10.1074/jbc.M100980200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delvaux D, 2013, BBA-GEN SUBJECTS, V1830, P4513, DOI 10.1016/j.bbagen.2013.05.014; Delvaux D, 2011, J BIOL CHEM, V286, P34023, DOI 10.1074/jbc.M111.233585; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gallagher DT, 2006, J MOL BIOL, V362, P114, DOI 10.1016/j.jmb.2006.07.008; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Gerasimaite R, 2014, J CELL SCI, V127, P5093, DOI 10.1242/jcs.159772; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Gong CL, 2003, J BIOL CHEM, V278, P50843, DOI 10.1074/jbc.M309188200; Gong CL, 2003, VIROLOGY, V309, P125, DOI 10.1016/S0042-6822(03)00002-3; Gong CL, 2002, J BIOL CHEM, V277, P15317, DOI 10.1074/jbc.M200532200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jain Ruchi, 2008, J Biol Chem, V283, P31047, DOI 10.1074/jbc.M805392200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; Kohn G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043879; KORNBERG SR, 1957, BIOCHIM BIOPHYS ACTA, V26, P294, DOI 10.1016/0006-3002(57)90008-2; Kyrieleis OJP, 2014, STRUCTURE, V22, P452, DOI 10.1016/j.str.2013.12.014; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P1348, DOI 10.1016/j.biocel.2003.11.013; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Martins A, 2003, NUCLEIC ACIDS RES, V31, P1455, DOI 10.1093/nar/gkg244; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moeder W, 2013, PLANT J, V76, P615, DOI 10.1111/tpj.12325; Pei Y, 2001, NUCLEIC ACIDS RES, V29, P387, DOI 10.1093/nar/29.2.387; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Song JK, 2008, J BIOL CHEM, V283, P10939, DOI 10.1074/jbc.M709675200; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhu Y, 2005, EMBO REP, V6, P681, DOI 10.1038/sj.embor.7400448	46	18	19	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23348	23360		10.1074/jbc.M115.674473	http://dx.doi.org/10.1074/jbc.M115.674473			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26221030	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000361685500041
J	Curto-Reyes, V; Kirschmann, G; Pertin, M; Drexler, SK; Decosterd, I; Suter, MR				Curto-Reyes, Verdad; Kirschmann, Guylene; Pertin, Marie; Drexler, Stephan K.; Decosterd, Isabelle; Suter, Marc R.			Neuropathic Pain Phenotype Does Not Involve the NLRP3 Inflammasome and Its End Product Interleukin-1 beta in the Mice Spared Nerve Injury Model	PLOS ONE			English	Article							SPINAL GLIAL ACTIVATION; NECROSIS-FACTOR-ALPHA; RAT SCIATIC-NERVE; THERMAL HYPERALGESIA; IL-1-BETA SECRETION; BRAIN-INJURY; EXPRESSION; CORD; INJECTION; RECEPTORS	The NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome is one of the main sources of interleukin-1 beta (IL-1 beta) and is involved in several inflammatory-related pathologies. To date, its relationship with pain has not been studied in depth. The aim of our study was to elucidate the role of NLRP3 inflammasome and IL-1 beta production on neuropathic pain. Results showed that basal pain sensitivity is unaltered in NLRP3(-/-) mice as well as responses to formalin test. Spared nerve injury (SNI) surgery induced the development of mechanical allodynia and thermal hyperalgesia in a similar way in both genotypes and did not modify mRNA levels of the NLRP3 inflammasome components in the spinal cord. Intrathecal lipopolysaccharide (LPS) injection increases apoptosis-associated speck like protein (ASC), caspase-1 and IL-1 beta expression in both wildtype and NLRP3(-/-) mice. Those data suggest that NLRP3 is not involved in neuropathic pain and also that other sources of IL-1 beta are implicated in neuroinflammatory responses induced by LPS.	[Curto-Reyes, Verdad; Kirschmann, Guylene; Pertin, Marie; Decosterd, Isabelle; Suter, Marc R.] Lausanne Univ Hosp CHUV, Pain Ctr, Dept Anesthesiol, Lausanne, Switzerland; [Curto-Reyes, Verdad; Kirschmann, Guylene; Pertin, Marie; Decosterd, Isabelle; Suter, Marc R.] Univ Lausanne, Lausanne, Switzerland; [Curto-Reyes, Verdad; Kirschmann, Guylene; Pertin, Marie; Decosterd, Isabelle] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Drexler, Stephan K.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; University of Lausanne	Suter, MR (corresponding author), Lausanne Univ Hosp CHUV, Pain Ctr, Dept Anesthesiol, Lausanne, Switzerland.	marc.suter@chuv.ch	Menendez, Luis/AAH-1542-2019	Menendez, Luis/0000-0003-1617-4171	Swiss National Science Foundation grants [310030A_124996, 33CM30-124117]; IASP Early Career Grant - ScanDesign Foundation BY INGER JENS BRUUN; Swiss Society of Anesthesiology	Swiss National Science Foundation grants(Swiss National Science Foundation (SNSF)); IASP Early Career Grant - ScanDesign Foundation BY INGER JENS BRUUN; Swiss Society of Anesthesiology	Swiss National Science Foundation grants 310030A_124996 (ID) and 33CM30-124117 (MRS and ID), the 2011 IASP Early Career Grant funded by the ScanDesign Foundation BY INGER & JENS BRUUN (MRS) and the Swiss Society of Anesthesiology (MRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baamonde A, 2007, LIFE SCI, V81, P673, DOI 10.1016/j.lfs.2007.07.003; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Cahill CM, 2003, BRAIN RES, V960, P209, DOI 10.1016/S0006-8993(02)03885-4; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Clark AK, 2010, J NEUROSCI, V30, P573, DOI 10.1523/JNEUROSCI.3295-09.2010; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Cordero MD, 2014, ANTIOXID REDOX SIGN, V20, P1169, DOI 10.1089/ars.2013.5198; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Ellis A, 2013, BRIT J ANAESTH, V111, P26, DOI 10.1093/bja/aet128; Falchi M, 2001, DRUG EXP CLIN RES, V27, P97; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0; Fu D, 2006, NEUROCHEM RES, V31, P333, DOI 10.1007/s11064-005-9032-4; FUKUOKA H, 1994, BRAIN RES, V657, P133, DOI 10.1016/0006-8993(94)90960-1; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Gruber-Schoffnegger D, 2013, J NEUROSCI, V33, P6540, DOI 10.1523/JNEUROSCI.5087-12.2013; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Gustafson-Vickers SL, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-63; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Jia HB, 2013, NEUROSCI LETT, V543, P130, DOI 10.1016/j.neulet.2013.03.046; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Klusakova I, 2009, ANN ANAT, V191, P248, DOI 10.1016/j.aanat.2009.02.007; Kuipers MT, 2012, ANESTHESIOLOGY, V116, P1104, DOI 10.1097/ALN.0b013e3182518bc0; Lee HL, 2004, NEUROREPORT, V15, P2807; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lopes AH, 2015, PAIN, V156, P451, DOI 10.1097/01.j.pain.0000460322.72396.53; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; OKA T, 1993, BRAIN RES, V624, P61, DOI 10.1016/0006-8993(93)90060-Z; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Piller Nicolas, 2013, BMC Res Notes, V6, P266, DOI 10.1186/1756-0500-6-266; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; da Silva KABS, 2011, PAIN, V152, P1872, DOI 10.1016/j.pain.2011.04.005; Sung CS, 2004, BRAIN RES, V1015, P145, DOI 10.1016/j.brainres.2004.04.068; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Tadano T, 1999, LIFE SCI, V65, P255, DOI 10.1016/S0024-3205(99)00244-1; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Winkelstein BA, 2001, J COMP NEUROL, V439, P127; Zelenka M, 2005, PAIN, V116, P257, DOI 10.1016/j.pain.2005.04.018; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	62	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133707	10.1371/journal.pone.0133707	http://dx.doi.org/10.1371/journal.pone.0133707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218747	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900042
J	Nishihara, E; Hirokawa, M; Ito, M; Fukata, S; Nakamura, H; Amino, N; Miyauchi, A				Nishihara, Eijun; Hirokawa, Mitsuyoshi; Ito, Mitsuru; Fukata, Shuji; Nakamura, Hirotoshi; Amino, Nobuyuki; Miyauchi, Akira			Graves' Disease Patients with Persistent Hyperthyroidism and Diffuse Lymphoplasmacytic Infiltration in the Thyroid Show No Histopathological Compatibility with IgG4-Related Disease	PLOS ONE			English	Article							HASHIMOTOS-THYROIDITIS; IGG4	Background IgG4-related disease is a novel disease entity characterized by diffuse lymphoplasmacytic infiltration rich in IgG4-positive plasma cells and fibrosis into multiple organs. There is still controversy over whether some thyroid diseases are actually IgG4-related disease. The objective of this study was to elucidate the clinicopathological features of Graves' disease with diffuse lymphoplasmacytic infiltration in the thyroid. Patients and Methods Among 1,484 Graves' disease patients who underwent thyroidectomy, we examined their histopathological findings including the degree of lymphoplasmacytic and fibrotic infiltration and levels of IgG4-positive plasma cells in the thyroid. Their clinical pictures were defined by laboratory and ultrasonographic evaluation. Results A total of 11 patients (0.74%) showed diffuse lymphoplasmacytic infiltration in the stroma of the thyroid gland. Meanwhile, other patients showed variable lymphoid infiltration ranging from absent to focally dense but no aggregation of plasma cells in the thyroid gland. Based on the diagnostic criteria of IgG4-related disease, 5 of the 11 subjects had specifically increased levels of IgG4-positive plasma cells in the thyroid. Fibrotic infiltration was present in only 1 patient developing hypothyroidism after anti-thyroid drug treatment for 4 years, but not in the other 10 patients with persistent hyperthyroidism. Obliterative phlebitis was not identified in any of the 11 subjects. Thyroid ultrasound examination showed 1 patient developing hypothyroidism who had diffuse hypoechogenicity, but the other hyperthyroid patients had a coarse echo texture. Conclusions In our study, Graves' disease patients with persistent hyperthyroidism who had diffuse lymphoplasmacytic infiltration rich in IgG4-positive plasma cells in the thyroid showed no concomitant fibrosis or obliterative phlebitis.	[Nishihara, Eijun; Hirokawa, Mitsuyoshi; Ito, Mitsuru; Fukata, Shuji; Nakamura, Hirotoshi; Amino, Nobuyuki; Miyauchi, Akira] Kuma Hosp, Ctr Excellence Thyroid Care, Kobe, Hyogo, Japan	Kuma Hospital	Nishihara, E (corresponding author), Kuma Hosp, Ctr Excellence Thyroid Care, Kobe, Hyogo, Japan.	nishihara@kuma-h.or.jp	Nishihara, Eijun/AAU-9152-2021	Nishihara, Eijun/0000-0003-1786-0077; Hirokawa, Mitsuyoshi/0000-0001-5558-7142; Miyauchi, Akira/0000-0003-0041-197X				Biddinger PW, 2009, DIAGNOSTIC PATHOLOGY, P60; Biddinger PW, 2009, DIAGNOSTIC PATHOLOGY, P39; Bozkirli E, 2014, CLIN ENDOCR IN PRESS; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; FATOURECHI V, 1971, MAYO CLIN PROC, V46, P682; Hammerstad SS, 2014, THYROID, V24, P537, DOI 10.1089/thy.2013.0287; HAYASHI N, 1986, J CLIN ULTRASOUND, V14, P123, DOI 10.1002/jcu.1870140208; Kawashima ST, 2014, ENDOCRINE, V45, P236, DOI 10.1007/s12020-013-9988-9; KNECHT H, 1981, VIRCHOWS ARCH A, V393, P215, DOI 10.1007/BF00431078; Kojima M, 2010, PATHOBIOLOGY, V77, P267, DOI 10.1159/000319873; Li YQ, 2012, MODERN PATHOL, V25, P1086, DOI 10.1038/modpathol.2012.68; Li YQ, 2010, J CLIN ENDOCR METAB, V95, P1309, DOI 10.1210/jc.2009-1794; Li YQ, 2009, PATHOL INT, V59, P636, DOI 10.1111/j.1440-1827.2009.02419.x; Nishihara E, 2008, THYROID, V18, P1221, DOI 10.1089/thy.2008.0096; Nishihara E, 2013, THYROID, V23, P1496, DOI 10.1089/thy.2013.0181; Rapoport B, 2014, J CLIN ENDOCR METAB, V99, P4060, DOI 10.1210/jc.2014-3011; SOSTRE S, 1991, J ENDOCRINOL INVEST, V14, P115, DOI 10.1007/BF03350281; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Takeshima K, 2014, THYROID, V24, P736, DOI 10.1089/thy.2013.0448; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z	20	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134143	10.1371/journal.pone.0134143	http://dx.doi.org/10.1371/journal.pone.0134143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218874	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900087
J	Thiam, AR; Pincet, F				Thiam, Abdou Rachid; Pincet, Frederic			The Energy of COPI for Budding Membranes	PLOS ONE			English	Article							LIPID DROPLETS; CURVATURE; TENSION; DEFORMATIONS; MECHANISMS; STABILITY; TRANSPORT; PROTEINS; VESICLES; FISSION	As a major actor of cellular trafficking, COPI coat proteins assemble on membranes and locally bend them to bud 60 nm-size coated particles. Budding requires the energy of the coat assembly to overcome the one necessary to deform the membrane which primarily depends on the bending modulus and surface tension, gamma. Using a COPI-induced oil nano-droplet formation approach, we modulated the budding of nanodroplets using various amounts and types of surfactant. We found a Heaviside-like dependence between the budding efficiency and.: budding was only dependent on. and occurred beneath 1.3 mN/m. With the sole contribution of. to the membrane deformation energy, we assessed that COPI supplies similar to 1500 k(B)T for budding particles from membranes, which is consistent with common membrane deformation energies. Our results highlight how a simple remodeling of the composition of membranes could mechanically modulate budding in cells.	[Thiam, Abdou Rachid; Pincet, Frederic] Univ Paris Diderot, Univ Paris 06, Ecole Normale Super Paris, CNRS,Lab Phys Stat, F-75005 Paris, France; [Thiam, Abdou Rachid; Pincet, Frederic] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Yale University	Thiam, AR (corresponding author), Univ Paris Diderot, Univ Paris 06, Ecole Normale Super Paris, CNRS,Lab Phys Stat, 24 Rue Lhomond, F-75005 Paris, France.	thiam@lps.ens.fr; pincet@lps.ens.fr		PINCET, FREDERIC/0000-0002-4243-2157	 [PIOF-GA-2011-299292]		This work was supported by International Outgoing Fellowship no PIOF-GA-2011-299292 to ART.	Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Faini M, 2012, SCIENCE, V336, P1451, DOI 10.1126/science.1221443; Foret L, 2008, P NATL ACAD SCI USA, V105, P14763, DOI 10.1073/pnas.0801173105; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Kabalnov A, 1996, LANGMUIR, V12, P276, DOI 10.1021/la950359e; Kabalnov A, 1996, J COLLOID INTERF SCI, V184, P227, DOI 10.1006/jcis.1996.0615; Kozlov MM, 2002, TRAFFIC, V3, P256, DOI 10.1034/j.1600-0854.2002.030403.x; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Manneville JB, 2008, P NATL ACAD SCI USA, V105, P16946, DOI 10.1073/pnas.0807102105; Marsh D, 2006, CHEM PHYS LIPIDS, V144, P146, DOI 10.1016/j.chemphyslip.2006.08.004; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; Pinot M, 2010, MOL MEMBR BIOL, V27, P428, DOI 10.3109/09687688.2010.510485; Saleem M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7249; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Sens P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238101; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Thiam AR, 2013, P NATL ACAD SCI USA, V110, P13244, DOI 10.1073/pnas.1307685110; Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yeung A, 2000, COLLOID SURFACE A, V174, P169, DOI 10.1016/S0927-7757(00)00509-4; Yildirim OE, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1938227; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	29	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133757	10.1371/journal.pone.0133757	http://dx.doi.org/10.1371/journal.pone.0133757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218078	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900045
J	Wang, JY; Li, L; Zhang, Z; Qiu, HP; Li, DM; Fang, Y; Jiang, H; Chai, RY; Mao, XQ; Wang, YL; Sun, GC				Wang, Jiaoyu; Li, Ling; Zhang, Zhen; Qiu, Haiping; Li, Dongmei; Fang, Yuan; Jiang, Hua; Chai, Rong Yao; Mao, Xueqin; Wang, Yanli; Sun, Guochang			One of Three Pex11 Family Members Is Required for Peroxisomal Proliferation and Full Virulence of the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							MEDIATED PLANT INFECTION; WORONIN BODY FORMATION; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; BETA-OXIDATION; BIOGENESIS; GRISEA; DIVISION; GENE	Peroxisomes play important roles in metabolisms of eukaryotes and infection of plant fungal pathogens. These organelles proliferate by de novo formation or division in response to environmental stimulation. Although the assembly of peroxisomes was documented in fungal pathogens, their division and its relationship to pathogenicity remain obscure. In present work, we analyzed the roles of three Pex11 family members in peroxisomal division and pathogenicity of the rice blast fungus Magnaporthe oryzae. Deletion of MoPEX11A led to fewer but enlarged peroxisomes, and impaired the separation of Woronin bodies from peroxisomes, while deletion of MoPEX11B or MoPEX11C put no evident impacts to peroxisomal profiles. MoPEX11A mutant exhibited typical peroxisome related defects, delayed conidial germination and appressoria formation, and decreased appressorial turgor and host penetration. As a result, the virulence of MoPEX11A mutant was greatly reduced. Deletion of MoPEX11B and MoPEX11C did not alter the virulence of the fungus. Further, double or triple deletions of the three genes were unable to enhance the virulence decrease in MoPEX11A mutant. Our data indicated that MoPEX11A is the main factor modulating peroxisomal division and is required for full virulence of the fungus.	[Wang, Jiaoyu; Li, Ling; Zhang, Zhen; Qiu, Haiping; Li, Dongmei; Fang, Yuan; Jiang, Hua; Chai, Rong Yao; Mao, Xueqin; Wang, Yanli; Sun, Guochang] Zhejiang Acad Agr Sci, Inst Plant Protect Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Li, Ling] Zhejiang Agr & Forest Univ, Sch Agr & Food Sci, Hangzhou, Zhejiang, Peoples R China; [Fang, Yuan] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang A&F University; Zhejiang Normal University	Sun, GC (corresponding author), Zhejiang Acad Agr Sci, Inst Plant Protect Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	sungc01@sina.com			National Natural Science Foundation of China [30900933, 31170136, 31470249, 30970082]; National Basic Research Program (973) from the Ministry of Science and Technology of China [2012CB722504]; Zhejiang Provincial Natural Science Foundation [Q13C140004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973) from the Ministry of Science and Technology of China(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by the grants (No. 30900933, 31170136 and 31470249 to JW and 30970082 to GS) from National Natural Science Foundation of China and the National Basic Research Program (973) (No. 2012CB722504) from the Ministry of Science and Technology of China and the grants (Q13C140004 to YF) from Zhejiang Provincial Natural Science Foundation (http://www.nsfc.gov.cn/Portal0/default152.htm; http://www.973.gov.cn/AreaAppl.aspx; http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 1998, FEBS LETT, V431, P468, DOI 10.1016/S0014-5793(98)00815-1; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Bonnet C, 2006, MOL MICROBIOL, V62, P157, DOI 10.1111/j.1365-2958.2006.05353.x; Camoes F, 2009, J INHERIT METAB DIS, V32, P163, DOI 10.1007/s10545-008-1018-3; Cepinska MN, 2011, TRAFFIC, V12, P925, DOI 10.1111/j.1600-0854.2011.01198.x; CRAWFORD MS, 1986, GENETICS, V114, P1111; Delille HK, 2010, J CELL SCI, V123, P2750, DOI 10.1242/jcs.062109; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Elgersma Y, 1996, BBA-REV BIOMEMBRANES, V1286, P269, DOI 10.1016/S0304-4157(96)00012-3; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Escano CS, 2009, EUKARYOT CELL, V8, P296, DOI 10.1128/EC.00197-08; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fagarasanu A, 2010, NAT REV MOL CELL BIO, V11, P644, DOI 10.1038/nrm2960; Fujihara N, 2010, MOL PLANT MICROBE IN, V23, P436, DOI 10.1094/MPMI-23-4-0436; Geuze HJ, 2003, MOL BIOL CELL, V14, P2900, DOI 10.1091/mbc.E02-11-0734; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Huber A, 2012, TRAFFIC, V13, P157, DOI 10.1111/j.1600-0854.2011.01290.x; Hynes MJ, 2010, FEMS MICROBIOL LETT, V306, P67, DOI 10.1111/j.1574-6968.2010.01934.x; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch J, 2012, J CELL SCI, V125, P3813, DOI 10.1242/jcs.102178; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; Krensel P, 2006, EUR J CELL BIOL, V85, P55; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085252; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; Lingard MJ, 2006, J CELL SCI, V119, P1961, DOI 10.1242/jcs.02904; Lingard MJ, 2009, P NATL ACAD SCI USA, V106, P4561, DOI 10.1073/pnas.0811329106; Liu FF, 2008, J CELL BIOL, V180, P325, DOI 10.1083/jcb.200705049; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Magliano P, 2011, J BIOL CHEM, V286, P42133, DOI 10.1074/jbc.M111.279687; Managadze D, 2007, TRAFFIC, V8, P687, DOI 10.1111/j.1600-0854.2007.00560.x; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Nagotu S, 2010, TRAFFIC, V11, P175, DOI 10.1111/j.1600-0854.2009.01019.x; NOTTEGHEM JL, 1992, PHYTOPATHOLOGY, V82, P421, DOI 10.1094/Phyto-82-421; Opalinski L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035490; Orth T, 2007, PLANT CELL, V19, P333, DOI 10.1105/tpc.106.045831; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Rho HS, 2001, MOL CELLS, V12, P407; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Schluter A, 2010, NUCLEIC ACIDS RES, V38, pD800, DOI 10.1093/nar/gkp935; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Tanaka A, 2003, BIOCHEM BIOPH RES CO, V300, P819, DOI 10.1016/S0006-291X(02)02936-4; Tey WK, 2005, MOL BIOL CELL, V16, P2651, DOI 10.1091/mbc.e04-10-0937; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; van der Klei Ida J, 2013, Subcell Biochem, V69, P135, DOI 10.1007/978-94-007-6889-5_8; Vanacova S, 2003, INT J PARASITOL, V33, P235, DOI 10.1016/S0020-7519(02)00267-9; VANDENBOSCH H, 1993, BIOCHIMIE, V75, P183, DOI 10.1016/0300-9084(93)90076-5; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P802, DOI 10.1631/jzus.B0860001; Wang JR, 2013, NONLINEAR ANAL-HYBRI, V8, P1, DOI 10.1016/j.nahs.2012.08.003; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475	64	9	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134249	10.1371/journal.pone.0134249	http://dx.doi.org/10.1371/journal.pone.0134249			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218097	Green Submitted, gold, Green Published			2022-12-26	WOS:000358595900101
J	Ranaivomanana, P; Raharimanga, V; Dubois, PM; Richard, V; Razanamparany, VR				Ranaivomanana, Paulo; Raharimanga, Vaomalala; Dubois, Patrice M.; Richard, Vincent; Razanamparany, Voahangy Rasolofo			Study of the BCG Vaccine-Induced Cellular Immune Response in Schoolchildren in Antananarivo, Madagascar	PLOS ONE			English	Article							TUBERCULIN SKIN-TEST; CALMETTE-GUERIN VACCINATION; GAMMA RELEASE ASSAYS; ROUTINE CLINICAL-PRACTICE; INTERFERON-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; IFN-GAMMA; INFECTION; CHILDREN	Objective Although the Bacillus Calmette-Guerin vaccine (BCG) protects young children against serious forms of TB, protection against pulmonary TB is variable. We assessed BCG vaccine-induced cellular immune responses and determined for how long they could be detected during childhood in Antananarivo, Madagascar. Methods We assessed BCG vaccine-induced cellular immune responses by TST and IGRA (in-house ELISPOT assay) using BCG and PPD as stimulation antigen, and compared results between vaccinated and non-vaccinated schoolchildren of two age groups, 6-7 and 13-14 years old. Results Three hundred and sixty-three healthy schoolchildren were enrolled. TST was performed on 351 children and IGRA on 142. A high proportion (66%; 229/343) of the children had no TST reactivity (induration size 0 mm). TST-positive responses (>= 15 mm) were more prevalent among 13-14 year-old (31.7%) than 6-7 year old (16.5%) children, both in the non-vaccinated (43% vs. 9%, p<0.001) and vaccinated (29% vs. 13%, p=0.002) subgroups. There were no significant differences in TST responses between vaccinated and non-vaccinated children in either of the age groups. The IGRA response to BCG and to PPD stimulation was not significantly different according to BCG vaccination record or to age group. A high rate (15.5%; 22/142) of indeterminate IGRA responses was observed. There was very poor agreement between TST and IGRA-PPD findings (k=0.08) and between TST and IGRA-BCG findings (k=0.02) Conclusion Analysis of TST and IGRA response to stimulation with BCG and PPD revealed no difference in immune response between BCG-vaccinated and non-vaccinated children; also no decrease of the BCG vaccine-induced cellular immune response over time was observed. We conclude that TST and IGRA have limitations in assessing a role of BCG or tuberculosis- related immunity.	[Ranaivomanana, Paulo; Razanamparany, Voahangy Rasolofo] Inst Pasteur Madagascar, Mycobacteria Unit, Antananarivo, Madagascar; [Raharimanga, Vaomalala; Richard, Vincent] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Dubois, Patrice M.] Immunovacc Consulting, Hevillers, Belgium; [Richard, Vincent] Inst Pasteur, Epidemiol Unit, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Razanamparany, VR (corresponding author), Inst Pasteur Madagascar, Mycobacteria Unit, Antananarivo, Madagascar.	vrasolof@pasteur.mg		Vincent, RICHARD/0000-0002-6961-1753	Institut Pasteur de Madagascar (IPM); EDCTP [EDCTP GC_ct_05_32080]; ImmunoVacc Consulting	Institut Pasteur de Madagascar (IPM); EDCTP; ImmunoVacc Consulting	This work was funded by a grant from the Institut Pasteur de Madagascar (IPM) and EDCTP (EDCTP GC_ct_05_32080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ImmunoVacc Consulting provided support in the form of salaries for author PMD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Beffa P, 2008, EUR RESPIR J, V31, P842, DOI 10.1183/09031936.00117207; Bergeri I, 2002, Med Trop (Mars), V62, P634; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Escobar AL, 2004, INT J TUBERC LUNG D, V8, P45; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; HARBOE M, 1981, AM REV RESPIR DIS, V124, P80; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jenum S, 2014, PEDIAT INFECT DIS J; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kagina BMN, 2009, VACCINE, V27, P5488, DOI 10.1016/j.vaccine.2009.06.103; Kaufmann SHE, 2010, J INTERN MED, V267, P337, DOI 10.1111/j.1365-2796.2010.02216.x; Kleinert S, 2012, ANN RHEUM DIS, V71, P1791, DOI 10.1136/annrheumdis-2011-200941; Kobashi Y, 2009, EUR RESPIR J, V33, P812, DOI 10.1183/09031936.00075008; Lagrange P H, 1977, Dev Biol Stand, V38, P223; Lee YM, 2013, INFECT CHEMOTHER, V45, P44, DOI 10.3947/ic.2013.45.1.44; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Lutwama F, 2014, J INFECT DIS, V209, P887, DOI 10.1093/infdis/jit570; Machado A, 2009, INT J TUBERC LUNG D, V13, P446; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; Marchant A, 1999, J IMMUNOL, V163, P2249; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; Moodie Z, 2006, J IMMUNOL METHODS, V315, P121, DOI 10.1016/j.jim.2006.07.015; Moodie Z, 2012, METHODS MOL BIOL, V792, P185, DOI 10.1007/978-1-61779-325-7_15; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; Pang Y, 2015, VACCINE, V33, P209, DOI 10.1016/j.vaccine.2014.10.030; Raharimanga V, 2012, TROP MED INT HEALTH, V17, P871, DOI 10.1111/j.1365-3156.2012.03013.x; Rakotosamimanana N, 2012, CLIN VACCINE IMMUNOL, V17, P1094; Ratovoson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095494; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Salehzadeh F., 2009, International Journal of Tropical Medicine, V4, P37; Sayyahfar S, 2014, J EPIDEMIOL GLOB HEA, V4, P45, DOI 10.1016/j.jegh.2013.09.002; Shaik J, 2013, PAEDIAT RESP REV; Sleiman R, 2007, PEDIATR INFECT DIS J, V26, P134, DOI 10.1097/01.inf.0000253058.48277.86; Smith SG, 2012, EUR J IMMUNOL, V42, P2511, DOI 10.1002/eji.201142297; Smith SG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-35; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Suciliene E, 1999, INT J TUBERC LUNG D, V3, P956; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; WHO, 2014, WHO REPORT 2014	56	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0127590	10.1371/journal.pone.0127590	http://dx.doi.org/10.1371/journal.pone.0127590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214514	Green Published, gold, Green Submitted			2022-12-26	WOS:000358594300002
J	Reddin, CJ; Docmac, F; O'Connor, NE; Bothwell, JH; Harrod, C				Reddin, Carl J.; Docmac, Felipe; O'Connor, Nessa E.; Bothwell, John H.; Harrod, Chris			Coastal Upwelling Drives Intertidal Assemblage Structure and Trophic Ecology	PLOS ONE			English	Article							HUMBOLDT CURRENT SYSTEM; BOTTOM-UP; SOUTH-AFRICA; TOP-DOWN; COMMUNITY REGULATION; SPECIES RICHNESS; STABLE-ISOTOPES; FOOD WEBS; NORTHERN; DELTA-N-15	Similar environmental driving forces can produce similarity among geographically distant ecosystems. Coastal oceanic upwelling, for example, has been associated with elevated biomass and abundance patterns of certain functional groups, e.g., corticated macroalgae. In the upwelling system of Northern Chile, we examined measures of intertidal macrobenthic composition, structure and trophic ecology across eighteen shores varying in their proximity to two coastal upwelling centres, in a hierarchical sampling design (spatial scales of >1 and >10 km). The influence of coastal upwelling on intertidal communities was confirmed by the stable isotope values (delta C-13 and delta N-15) of consumers, including a dominant suspension feeder, grazers, and their putative resources of POM, epilithic biofilm, and macroalgae. We highlight the utility of muscle delta N-15 from the suspension feeding mussel, Perumytilus purpuratus, as a proxy for upwelling, supported by satellite data and previous studies. Where possible, we used corrections for broader-scale trends, spatial autocorrelation, ontogenetic dietary shifts and spatial baseline isotopic variation prior to analysis. Our results showed macroalgal assemblage composition, and benthic consumer assemblage structure, varied significantly with the intertidal influence of coastal upwelling, especially contrasting bays and coastal headlands. Coastal topography also separated differences in consumer resource use. This suggested that coastal upwelling, itself driven by coastline topography, influences intertidal communities by advecting nearshore phytoplankton populations offshore and cooling coastal water temperatures. We recommend the isotopic values of benthic organisms, specifically long-lived suspension feeders, as in situ alternatives to offshore measurements of upwelling influence.	[Reddin, Carl J.; O'Connor, Nessa E.; Harrod, Chris] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Docmac, Felipe; Harrod, Chris] Univ Antofagasta, Inst Ciencias Nat Alexander Von Humboldt, Antofagasta, Chile; [O'Connor, Nessa E.] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Bothwell, John H.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Queens University Belfast; Universidad de Antofagasta; Queens University Belfast; Durham University	Reddin, CJ (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	creddin01@qub.ac.uk	Reddin, Carl J/D-2154-2016; Harrod, Chris/A-8830-2008	Reddin, Carl J/0000-0001-5930-1164; Harrod, Chris/0000-0002-5353-1556; O'Connor, Nessa/0000-0002-3133-0913; Bothwell, John/0000-0003-2964-5980	Department of Employment and Learning Northern Ireland; Comision Nacional de Investigacion Cientifica y Tecnologica project [MEL 81105006]	Department of Employment and Learning Northern Ireland; Comision Nacional de Investigacion Cientifica y Tecnologica project	CJR was funded by the Department of Employment and Learning Northern Ireland as part of his PhD thesis. CH & FD were funded through the Comision Nacional de Investigacion Cientifica y Tecnologica project MEL 81105006.	Allan EL, 2010, ESTUAR COAST SHELF S, V87, P463, DOI 10.1016/j.ecss.2010.02.004; Barnes C, 2007, FUNCT ECOL, V21, P356, DOI 10.1111/j.1365-2435.2006.01224.x; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Bode A, 2006, MAR ECOL PROG SER, V318, P89, DOI 10.3354/meps318089; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BOSMAN AL, 1987, OECOLOGIA, V72, P226, DOI 10.1007/BF00379273; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Bustamante RH, 1996, J EXP MAR BIOL ECOL, V196, P1, DOI 10.1016/0022-0981(95)00093-3; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Castilla JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110301; Castilla JC, 2008, REV BIOL MAR OCEANOG, V43, P457; Carr ME, 2003, DEEP-SEA RES PT II, V50, P3199, DOI 10.1016/j.dsr2.2003.07.015; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Daneri G, 2000, MAR ECOL PROG SER, V197, P41, DOI 10.3354/meps197041; Dubois S, 2007, MAR ECOL PROG SER, V336, P151, DOI 10.3354/meps336151; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; ENCEP, 2012, NIN SO OSC ENSO DIAG; Escribano R, 2004, CONT SHELF RES, V24, P37, DOI 10.1016/j.csr.2003.09.005; Escribano R, 2002, OCEANOGRAPHY ECOLOGY, P145; Feldman GC, 2014, OCEAN COLOR WEB AQUA; Fernandez M, 2000, REV CHIL HIST NAT, V73, P797; Fonseca T., 1987, INVESTIGACIONES PESQ, V34, P33; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; GOUGH L, 1994, OIKOS, V70, P271, DOI 10.2307/3545638; Hill JM, 2006, MAR ECOL PROG SER, V318, P63, DOI 10.3354/meps318063; Hill JM, 2008, ESTUAR COAST SHELF S, V80, P261, DOI 10.1016/j.ecss.2008.08.005; Kelaher BP, 2005, ESTUAR COAST SHELF S, V63, P155, DOI 10.1016/j.ecss.2004.10.017; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Lagos NA, 2008, ECOL MONOGR, V78, P245, DOI 10.1890/07-0041.1; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Lefebvre S, 2009, MAR ECOL PROG SER, V390, P27, DOI 10.3354/meps08187; LESSER MP, 1992, J EXP MAR BIOL ECOL, V165, P91, DOI 10.1016/0022-0981(92)90291-H; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lorrain A, 2002, J EXP MAR BIOL ECOL, V275, P47, DOI 10.1016/S0022-0981(02)00220-4; Mallela J, 2008, MAR ECOL PROG SER, V368, P41, DOI 10.3354/meps07589; Maloy AP, 2013, MAR BIOL, V160, P479, DOI 10.1007/s00227-012-2105-4; Marin V., 2003, INVEST MAR, V31, P47, DOI DOI 10.4067/S0717-71782003000200005; Marincovich L. Jr., 1973, Natural Hist Mus Los Angeles Co Sci Bull, VNo. 16, P1; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mendez LT, 2002, GUIA BIODIVERSIDAD N; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; MENGE BA, 1992, ECOLOGY, V73, P755, DOI 10.2307/1940155; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; MULLIN MM, 1984, LIMNOL OCEANOGR, V29, P1267, DOI 10.4319/lo.1984.29.6.1267; Ng JSS, 2007, MAR CHEM, V103, P97, DOI 10.1016/j.marchem.2006.09.001; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; O'Connor NE, 2013, GLOBAL CHANGE BIOL, V19, P431, DOI 10.1111/gcb.12061; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; Oksanen J., 2007, COMMUN ECOL PACK, P631; Osorio F., 2012, R PACKAGE VERSION 02, V3, P4; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pinones A, 2007, CIENC MAR, V33, P37, DOI 10.7773/cm.v33i1.1226; R Core Team, 2021, R LANGUAGE ENV STAT; Richoux NB, 2014, MARINE ECOLOGY; Rivadeneira MM, 2010, AQUAT CONSERV, V20, P74, DOI 10.1002/aqc.1051; Romero OZ, 2002, GUIA BIODIVERSIDAD N; Rossi F, 2004, LIMNOL OCEANOGR, V49, P408, DOI 10.4319/lo.2004.49.2.0408; ROUGHGARDEN J, 1994, PHILOS T ROY SOC B, V343, P79, DOI 10.1098/rstb.1994.0010; Sanford E, 2001, MAR ECOL PROG SER, V209, P143, DOI 10.3354/meps209143; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Santelices B., 1989, ALGAS MARINAS CHILE; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Schmidt K, 2003, LIMNOL OCEANOGR, V48, P277, DOI 10.4319/lo.2003.48.1.0277; SIGMAN DM, 2009, ENCY OCEAN SCI, P40, DOI DOI 10.1016/B978-012374473-9.00632-9; Smale DA, 2013, ECOL EVOL, V3, P4016, DOI 10.1002/ece3.774; Smit AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081944; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tapia FJ, 2009, PROG OCEANOGR, V83, P278, DOI 10.1016/j.pocean.2009.07.035; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Ulloa O, 2001, GEOPHYS RES LETT, V28, P1591, DOI 10.1029/2000GL011548; Vokhshoori NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098087; WARTENBERG D, 1985, SYST ZOOL, V34, P259, DOI 10.2307/2413147; WHITTAKER R H, 1975, P385; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Wieters EA, 2009, LIMNOL OCEANOGR, V54, P1060, DOI 10.4319/lo.2009.54.4.1060	80	27	27	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0130789	10.1371/journal.pone.0130789	http://dx.doi.org/10.1371/journal.pone.0130789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214806	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000358594300004
J	Osthoff, M; Dean, MM; Baird, PN; Richardson, AJ; Daniell, M; Guymer, RH; Eisen, DP				Osthoff, Michael; Dean, Melinda M.; Baird, Paul N.; Richardson, Andrea J.; Daniell, Mark; Guymer, Robyn H.; Eisen, Damon P.			Association Study of Mannose-Binding Lectin Levels and Genetic Variants in Lectin Pathway Proteins with Susceptibility to Age-Related Macular Degeneration: A Case-Control Study	PLOS ONE			English	Article							ENVIRONMENT INTERACTION; H-FICOLIN; COMPLEMENT; RISK; INFECTION; CELLS; AMD; HAPLOTYPE; GENOTYPES; CANCER	Background In age-related macular degeneration (AMD) the complement system is thought to be activated by chronic oxidative damage with genetic variants identified in the alternative pathway as susceptibility factors. However, the involvement of the lectin pathway of complement, a key mediator of oxidative damage, is controversial. This study investigated whether mannose-binding lectin (MBL) levels and genetic variants in lectin pathway proteins, are associated with the predisposition to and severity of AMD. Methods MBL levels and single nucleotide polymorphisms (SNPs) in the MBL2 and the ficolin-2 (FCN2) gene were determined in 109 patients with AMD and 109 age-and sex-matched controls. Results MBL expression levels were equally distributed in both cases (early and late AMD) and controls (p>0.05). However, there was a trend towards higher median MBL levels in cases with late AMD compared to cases with early AMD (1.0 vs. 0.4 mu g/ml, p = 0.09) and MBL deficiency (<0.5 mu g/ml) was encountered less frequently in the late AMD group (35% vs 56%, p = 0.03). FCN2 and MBL2 allele frequencies were similarly distributed in early and late AMD cases compared with controls (p>0.05 for all analyses) as were MBL2 genotypes. Similarly, there was no significant difference in allele frequencies in any SNPs in either the MBL2 or FCN2 gene in cases with early vs. late AMD. Conclusions SNPs of lectin pathway proteins investigated in this study were not associated with AMD or AMD severity. However, MBL levels deserve further study in a larger cohort of early vs. late AMD patients to elucidate any real effect on AMD severity.	[Osthoff, Michael; Eisen, Damon P.] Melbourne Hlth, Victorian Infect Dis Serv, Doherty Inst, Melbourne, Vic, Australia; [Osthoff, Michael; Eisen, Damon P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Osthoff, Michael] Univ Basel Hosp, Dept Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; [Dean, Melinda M.] Australian Red Cross Blood Serv, Res & Dev, Kelvin Grove, Qld, Australia; [Baird, Paul N.; Richardson, Andrea J.; Daniell, Mark; Guymer, Robyn H.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; University of Basel; Australian Red Cross Blood Service; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Osthoff, M (corresponding author), Melbourne Hlth, Victorian Infect Dis Serv, Doherty Inst, Melbourne, Vic, Australia.	michael.osthoff@usb.ch	eisen, damon/AAC-7433-2019; Daniell, Mark/AAS-1363-2020	Daniell, Mark/0000-0001-9528-7005; Osthoff, Michael/0000-0001-5439-957X; Guymer, Robyn/0000-0002-9441-4356; Baird, Paul/0000-0002-1305-3502				Abou Ouf E, 2012, J INFECT DIS, V206, P562, DOI 10.1093/infdis/jis396; Adams MKM, 2011, AM J EPIDEMIOL, V173, P1246, DOI 10.1093/aje/kwr005; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Baird PN, 2008, HUM MOL GENET, V17, P1299, DOI 10.1093/hmg/ddn018; Bernig T, 2007, CARCINOGENESIS, V28, P828, DOI 10.1093/carcin/bgl198; Cipriani V, 2012, HUM MOL GENET, V21, P4138, DOI 10.1093/hmg/dds225; Dinu V, 2007, GENET EPIDEMIOL, V31, P224, DOI 10.1002/gepi.20204; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu BJ, 2013, FASEB J, V27, P1479, DOI 10.1096/fj.12-215368; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Herpers BL, 2009, CLIN EXP IMMUNOL, V156, P488, DOI 10.1111/j.1365-2249.2009.03929.x; Joseph K, 2013, J BIOL CHEM, V288, P12753, DOI 10.1074/jbc.M112.421891; Kilpatrick DC, 2013, HUM IMMUNOL, V74, P867, DOI 10.1016/j.humimm.2013.04.011; Kilpatrick DC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/138797; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Miller DM, 2004, AM J OPHTHALMOL, V138, P323, DOI 10.1016/j.ajo.2004.03.018; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Naj AC, 2013, ANN HUM GENET, V77, P215, DOI 10.1111/ahg.12011; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Rohrer Barbel, 2011, Mol Immunol, V48, pe1, DOI 10.1016/j.molimm.2010.12.016; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Shen D, 2009, BRIT J OPHTHALMOL, V93, P405, DOI 10.1136/bjo.2008.145383; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zanetti KA, 2012, CANCER RES, V72, P1467, DOI 10.1158/0008-5472.CAN-11-3073; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134107	10.1371/journal.pone.0134107	http://dx.doi.org/10.1371/journal.pone.0134107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207622	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000358622000209
J	Wei, W; Yu, Y; Chen, LD				Wei, Wei; Yu, Yun; Chen, Liding			Response of Surface Soil Hydrology to the Micro-Pattern of Bio-Crust in a Dry-Land Loess Environment, China	PLOS ONE			English	Article							BIOLOGICAL CRUSTS; EROSION PROCESSES; TENGGER DESERT; RUNOFF; RAINFALL; DYNAMICS; INFILTRATION; ECOSYSTEMS; IMPACT; COVER	The specific bio-species and their spatial patterns play crucial roles in regulating eco-hydrologic process, which is significant for large-scale habitat promotion and vegetation restoration in many dry-land ecosystems. Such effects, however, are not yet fully studied. In this study, 12 micro-plots, each with size of 0.5 m in depth and 1 m in length, were constructed on a gentle grassy hill-slope with a mean gradient of 8 degrees in a semiarid loess hilly area of China. Two major bio-crusts, including mosses and lichens, had been cultivated for two years prior to the field simulation experiments, while physical crusts and non-crusted bare soils were used for comparison. By using rainfall simulation method, four designed micropatterns (i.e., upper bio-crust and lower bare soil, scattered bio-crust, upper bare soil and lower bio-crust, fully-covered bio-crust) to the soil hydrological response were analyzed. We found that soil surface bio-crusts were more efficient in improving soil structure, water holding capacity and runoff retention particularly at surface 10 cm layers, compared with physical soil crusts and non-crusted bare soils. We re-confirmed that mosses functioned better than lichens, partly due to their higher successional stage and deeper biomass accumulation. Physical crusts were least efficient in water conservation and erosion control, followed by non-crusted bare soils. More importantly, there were marked differences in the efficiency of the different spatial arrangements of bio-crusts in controlling runoff and sediment generation. Fully-covered bio-crust pattern provides the best option for soil loss reduction and runoff retention, while a combination of upper bio-crust and lower bare soil pattern is the least one. These findings are suggested to be significant for surface-cover protection, rainwater infiltration, runoff retention, and erosion control in water-restricted and degraded natural slopes.	[Wei, Wei; Yu, Yun; Chen, Liding] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Chen, LD (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	liding@rcees.ac.cn			National Natural Science Foundation of China [41390462, 41371123]; Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China [SKLURE2013-1-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China	This research was supported by the National Natural Science Foundation of China (No. 41390462; No. 41371123) and the Innovation Project of the State Key Laboratory of Urban and Regional Ecology of China (SKLURE2013-1-02).	Arnau-Rosalen E, 2008, GEOMORPHOLOGY, V101, P595, DOI 10.1016/j.geomorph.2008.03.001; Badorreck A, 2013, SOIL TILL RES, V129, P1, DOI 10.1016/j.still.2013.01.001; Belnap J, 2006, APPL SOIL ECOL, V32, P63, DOI 10.1016/j.apsoil.2004.12.010; Belnap J, 2005, ECOLOGY, V86, P298, DOI 10.1890/03-0567; Belnap J, 1998, J ARID ENVIRON, V39, P133, DOI 10.1006/jare.1998.0388; Bowker MA, 2008, SOIL BIOL BIOCHEM, V40, P2309, DOI 10.1016/j.soilbio.2008.05.008; Chamizo S, 2013, J HYDROL, V489, P74, DOI 10.1016/j.jhydrol.2013.02.051; Chamizo S, 2012, SOIL BIOL BIOCHEM, V49, P96, DOI 10.1016/j.soilbio.2012.02.017; Chen L, 2006, J ARID ENVIRON, V67, P521, DOI 10.1016/j.jaridenv.2006.02.018; Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290; Concostrina-Zubiri L, 2013, SOIL BIOL BIOCHEM, V64, P28, DOI 10.1016/j.soilbio.2013.03.029; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P389, DOI 10.1071/SR9940389; Eldridge DJ, 2003, J ARID ENVIRON, V53, P457, DOI 10.1006/jare.2002.1068; Eldridge DJ, 2002, LANDSCAPE ECOL, V17, P587, DOI 10.1023/A:1021575503284; Eldridge DJ, 2000, CATENA, V40, P323, DOI 10.1016/S0341-8162(00)00082-5; Fiener P, 2011, EARTH-SCI REV, V106, P92, DOI 10.1016/j.earscirev.2011.01.004; Fox DM, 2004, GEODERMA, V120, P109, DOI 10.1016/j.geoderma.2003.08.010; Greene RSB, 2004, EARTH SURF PROC LAND, V29, P1077, DOI 10.1002/esp.1103; HOOGMOED WB, 1984, SOIL TILL RES, V4, P5, DOI 10.1016/0167-1987(84)90013-8; Jiang DS, 1997, CONTROLLING PATTERNS, P446; Aguilar AJ, 2009, J ARID ENVIRON, V73, P1158, DOI 10.1016/j.jaridenv.2009.05.009; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Kidron GJ, 2014, J HYDROL, V509, P398, DOI 10.1016/j.jhydrol.2013.11.041; Kidron GJ, 2012, GEOMORPHOLOGY, V139, P484, DOI 10.1016/j.geomorph.2011.11.013; Kirkby M, 2002, CATENA, V46, P89, DOI 10.1016/S0341-8162(01)00160-6; Li XR, 2007, GEOMORPHOLOGY, V88, P254, DOI 10.1016/j.geomorph.2006.11.009; Li XR, 2011, APPL SOIL ECOL, V47, P59, DOI 10.1016/j.apsoil.2010.10.010; Li X. R., 2012, ECOHYDROLOGY BIOL SO; MALAMISSA O, 2011, GEODERMA, V167, P22; MORIN J, 1981, J HYDROL, V52, P321, DOI 10.1016/0022-1694(81)90178-5; Neave M, 2007, GEOMORPHOLOGY, V87, P378, DOI 10.1016/j.geomorph.2006.10.007; POESEN J, 1992, CATENA, V19, P451, DOI 10.1016/0341-8162(92)90044-C; Powell JT, 2015, J ARID ENVIRON, V112, P127, DOI 10.1016/j.jaridenv.2013.11.004; Ram A, 2007, CATENA, V70, P437, DOI 10.1016/j.catena.2006.11.012; Rodriguez-Caballero E, 2012, GEOMORPHOLOGY, V145, P81, DOI 10.1016/j.geomorph.2011.12.042; Sinoga JDR, 2009, GEOMORPHOLOGY, V108, P234, DOI 10.1016/j.geomorph.2009.01.012; Shi ZH, 2012, J HYDROL, V454, P123, DOI 10.1016/j.jhydrol.2012.06.004; Shi ZH, 2010, CATENA, V81, P240, DOI 10.1016/j.catena.2010.04.007; Sole-Benet A, 1997, CATENA, V31, P23, DOI 10.1016/S0341-8162(97)00032-5; Summer ME, 1992, ADV SOIL SCI; Svircev Z, 2013, QUATERN INT, V296, P206, DOI 10.1016/j.quaint.2012.10.048; Viles HA, 2008, GEOGR COMPASS, V2, P899, DOI 10.1111/j.1749-8198.2008.00099.x; Wei W, 2014, J HYDROL, V513, P115, DOI 10.1016/j.jhydrol.2014.03.022; Wei W, 2010, CATENA, V81, P24, DOI 10.1016/j.catena.2010.01.002; Wei W, 2009, PROG PHYS GEOG, V33, P307, DOI 10.1177/0309133309341426; Whisenant SG, 1999, REPAIRING DAMAGED WI, P1; Williams JD, 1999, ARID SOIL RES REHAB, V13, P145, DOI 10.1080/089030699263384; Wuest SB, 2006, J SOIL WATER CONSERV, V61, P218; Xiao Bo, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P35; Xiao B, 2011, APPL SOIL ECOL, V48, P11, DOI 10.1016/j.apsoil.2011.02.006; Xu XL, 2008, FOREST ECOL MANAG, V256, P656, DOI 10.1016/j.foreco.2008.05.015; YANG XH, 2001, ACTA ECOLOGICA SINIC, V21, P474; Zaady E, 2007, J ARID ENVIRON, V70, P463, DOI 10.1016/j.jaridenv.2007.01.004; [赵允格 ZHAO Yunge], 2006, [自然资源学报, Journal of Natural Resources], V21, P441	54	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133565	10.1371/journal.pone.0133565	http://dx.doi.org/10.1371/journal.pone.0133565			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207757	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000100
J	Karch, S; Keeser, D; Hummer, S; Paolini, M; Kirsch, V; Karali, T; Kupka, M; Rauchmann, BS; Chrobok, A; Blautzik, J; Koller, G; Ertl-Wagner, B; Pogarell, O				Karch, Susanne; Keeser, Daniel; Huemmer, Sebastian; Paolini, Marco; Kirsch, Valerie; Karali, Temmuz; Kupka, Michael; Rauchmann, Boris-Stephan; Chrobok, Agnieszka; Blautzik, Janusch; Koller, Gabi; Ertl-Wagner, Birgit; Pogarell, Oliver			Modulation of Craving Related Brain Responses Using Real-Time fMRI in Patients with Alcohol Use Disorder	PLOS ONE			English	Article							CINGULATE CORTEX ACTIVITY; SLOW CORTICAL POTENTIALS; COMPUTER COMMUNICATION; PREFRONTAL CORTEX; SELF-REGULATION; ACTIVATION; NEUROFEEDBACK; REDUCTION; FEASIBILITY; ADDICTION	Literature One prominent symptom in addiction disorders is the strong desire to consume a particular substance or to display a certain behaviour (craving). Especially the strong association between craving and the probability of relapse emphasises the importance of craving in the therapeutic process. Neuroimaging studies have shown that craving is associated with increased responses, predominantly in fronto-striatal areas. Aim and Methods The aim of the present study is the modification of craving-related neuronal responses in patients with alcohol addiction using fMRI real-time neurofeedback. For that purpose, patients with alcohol use disorder and healthy controls participated once in neurofeedback training; during the sessions neuronal activity within an individualized cortical region of interest (ROI) (anterior cingulate cortex, insula, dorsolateral prefrontal cortex) was evaluated. In addition, variations regarding the connectivity between brain regions were assessed in the resting state. Results and Discussion The results showed a significant reduction of neuronal activity in patients at the end of the training compared to the beginning, especially in the anterior cingulate cortex, the insula, the inferior temporal gyrus and the medial frontal gyrus. Furthermore, the results show that patients were able to regulate their neuronal activities in the ROI, whereas healthy subjects achieved no significant reduction. However, there was a wide variability regarding the effects of the training within the group of patients. After the neurofeedback-sessions, individual craving was slightly reduced compared to baseline. The results demonstrate that it seems feasible for patients with alcohol dependency to reduce their neuronal activity using rtfMRI neurofeedback. In addition, there is some evidence that craving can be influenced with the help of this technique. Future Prospects In future, real-time fMRI might be a complementary neurophysiological-based strategy for the psychotherapy of patients with psychiatric or psychosomatic diseases. For that purpose, the stability of this effect and the generalizability needs to be assessed.	[Karch, Susanne; Keeser, Daniel; Huemmer, Sebastian; Chrobok, Agnieszka; Koller, Gabi; Pogarell, Oliver] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Keeser, Daniel; Paolini, Marco; Karali, Temmuz; Kupka, Michael; Rauchmann, Boris-Stephan; Blautzik, Janusch; Ertl-Wagner, Birgit] Univ Munich, Inst Clin Radiol, Munich, Germany; [Kirsch, Valerie] Univ Munich, Dept Neurol, D-80539 Munich, Germany	University of Munich; University of Munich; University of Munich	Karch, S (corresponding author), Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany.	Susanne.Karch@med.uni-muenchen.de	Rauchmann, Boris-Stephan/GLQ-9798-2022; Ertl-Wagner, Birgit/AAD-5708-2020; Keeser, Daniel/C-8888-2016	Rauchmann, Boris-Stephan/0000-0003-4547-6240; Keeser, Daniel/0000-0002-0244-1024; Kirsch, Valerie/0000-0002-9397-436X; Ertl-Wagner, Birgit/0000-0002-7896-7049				Arnold LE, 2012, J ATTEN DISORD; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Canterberry M, 2013, NICOTINE TOB RES, V15, P2120, DOI 10.1093/ntr/ntt122; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Caria A, 2012, NEUROSCIENTIST, V18, P487, DOI 10.1177/1073858411407205; Caria A, 2010, BIOL PSYCHIAT, V68, P425, DOI 10.1016/j.biopsych.2010.04.020; Chapin H, 2012, NEUROSCI LETT, V520, P174, DOI 10.1016/j.neulet.2012.02.076; de Ruiter MA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-581; Decharms RC, 2007, TRENDS COGN SCI, V11, P473, DOI 10.1016/j.tics.2007.08.014; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Dyck M, 2011, NEUROIMAGE, V54, P2503, DOI 10.1016/j.neuroimage.2010.10.013; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fagerstrom K, 2008, ADDICTION, V103, P841, DOI 10.1111/j.1360-0443.2008.02190.x; George MS, 2001, ARCH GEN PSYCHIAT, V58, P345, DOI 10.1001/archpsyc.58.4.345; Gevensleben H, 2012, EXPERT REV NEUROTHER, V12, P447, DOI [10.1586/ERN.12.22, 10.1586/ern.12.22]; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; Hanlon CA, 2013, PSYCHIAT RES-NEUROIM, V213, P79, DOI 10.1016/j.pscychresns.2013.03.003; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Heinz A, 2009, ADDICT BIOL, V14, P108, DOI 10.1111/j.1369-1600.2008.00136.x; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Johnston S, 2011, COGN AFFECT BEHAV NE, V11, P44, DOI 10.3758/s13415-010-0010-1; Kaiser J, 2001, CLIN NEUROPHYSIOL, V112, P551, DOI 10.1016/S1388-2457(01)00470-9; Kotchoubey B, 2001, EPILEPSIA, V42, P406, DOI 10.1046/j.1528-1157.2001.22200.x; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Lee S, 2011, NEUROREHAB NEURAL RE, V25, P259, DOI 10.1177/1545968310385128; Li XB, 2013, ADDICT BIOL, V18, P739, DOI 10.1111/j.1369-1600.2012.00449.x; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; McCaig RG, 2011, NEUROIMAGE, V55, P1298, DOI 10.1016/j.neuroimage.2010.12.016; Myrick H, 2004, J CLIN PSYCHOPHARM, V30, P365; Nazari MA, 2012, CLIN EEG NEUROSCI, V43, P315, DOI 10.1177/1550059412451880; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Posse S, 2001, HUM BRAIN MAPP, V12, P25, DOI 10.1002/1097-0193(200101)12:1<25::AID-HBM30>3.0.CO;2-H; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Schmidt T, 2012, BIOMED TECH BERL; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007; WHO, 2010, INT STAT CLASS DIS R; Wrase J, 2002, EUR PSYCHIAT, V17, P287, DOI 10.1016/S0924-9338(02)00676-4; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Yoo SS, 2002, NEUROREPORT, V13, P1377, DOI 10.1097/00001756-200208070-00005; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	50	56	56	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133034	10.1371/journal.pone.0133034	http://dx.doi.org/10.1371/journal.pone.0133034			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204262	Green Published, gold			2022-12-26	WOS:000358621000017
J	Niven, J; Hoare, J; McGowan, D; Devarajan, G; Itohara, S; Gannage, M; Teismann, P; Crane, I				Niven, Jennifer; Hoare, Joseph; McGowan, Debbie; Devarajan, Gayathri; Itohara, Shigeyoshi; Gannage, Monique; Teismann, Peter; Crane, Isabel			S100B Up-Regulates Macrophage Production of IL1 beta and CCL22 and Influences Severity of Retinal Inflammation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; GLYCATION END-PRODUCTS; GUANYLATE-CYCLASE; CA2+ SENSOR; ACTIVATION; EXPRESSION; RECEPTOR; RAGE; PROTEIN; ENCEPHALOMYELITIS	S100B is a Ca2+ binding protein and is typically associated with brain and CNS disorders. However, the role of S100B in an inflammatory situation is not clear. The aim of the study was to determine whether S100B is likely to influence inflammation through its effect on macrophages. A murine macrophage cell line (RAW 264.7) and primary bone marrow derived macrophages were used for in vitro studies and a model of retinal inflammatory disease in which pathogenesis is highly dependent on macrophage infiltration, Experimental Autoimmune Uveoretinitis, for in vitro study. Experimental Autoimmune Uveoretinitis is a model for the human disease posterior endogenous uveoretinitis, a potentially blinding condition, with an autoimmune aetiology, that mainly affects the working age group. To date the involvement of S100B in autoimmune uveoretinitis has not been investigated. Real-time PCR array analysis on RAW 246.7 cells indicated up-regulation of gene expression for various cytokines/chemokines in response to S100B, IL-1 beta and CCL22 in particular and this was confirmed by real-time PCR. In addition flow cytometry and ELISA confirmed up-regulation of protein production in response to S100B for pro-IL-1 beta and CCL22 respectively. This was the case for both RAW 264.7 cells and bone marrow derived macrophages. Induction of EAU with retinal antigen in mice in which S100B had been deleted resulted in a significantly reduced level of disease compared to wild-type mice, as determined by topical endoscopic fundus imaging and histology grading. Macrophage infiltration was also significantly reduced in S100B deleted mice. Real-time PCR analysis indicated that this was associated with reduction in CCL22 and IL-1 beta in retinas from S100B knock-out mice. In conclusion S100B augments the inflammatory response in uveoretinitis and this is likely to be, at least in part, via a direct effect on macrophages.	[Niven, Jennifer; Hoare, Joseph; McGowan, Debbie; Devarajan, Gayathri; Teismann, Peter; Crane, Isabel] Univ Aberdeen, Inst Med Sci, Div Appl Med, Aberdeen, Scotland; [Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Niven, Jennifer; Gannage, Monique] Univ Geneva, Sch Med, Div Rheumatol, CH-1211 Geneva, Switzerland; [Niven, Jennifer; Gannage, Monique] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland	University of Aberdeen; RIKEN; University of Geneva; University of Geneva	Crane, I (corresponding author), Univ Aberdeen, Inst Med Sci, Div Appl Med, Foresterhill, Aberdeen, Scotland.	i.j.crane@abdn.ac.uk	Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989; Gannage, Monique/0000-0003-3533-1937	National Eye Research Centre, Bristol, UK [SCIAD 058]; NHS Grampian Endowment Trust [10/16]	National Eye Research Centre, Bristol, UK; NHS Grampian Endowment Trust	This work was supported by funding awards to Dr Isabel Crane from the National Eye Research Centre, Bristol, UK (Grant ref. SCIAD 058); and NHS Grampian Endowment Trust (Grant ref. 10/16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJB, 2009, CLIN OPHTHALMOL, V3, P235; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Bryan NB, 2014, J INFLAMM, V7, P23; Chen MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109214; Copland DA, 2008, INVEST OPHTH VIS SCI, V49, P5458, DOI 10.1167/iovs.08-2348; Dagkalis A, 2009, INVEST OPHTH VIS SCI, V50, P4288, DOI 10.1167/iovs.09-3434; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dogan RNE, 2011, J LEUKOCYTE BIOL, V89, P93, DOI 10.1189/jlb.0810442; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Duda T, 1996, BIOCHEMISTRY-US, V35, P6263, DOI 10.1021/bi960007m; Duda T, 2002, EMBO J, V21, P2547, DOI 10.1093/emboj/21.11.2547; Esposito G, 2006, LIFE SCI, V78, P2707, DOI 10.1016/j.lfs.2005.10.023; Forde EA, 2011, J NEUROIMMUNOL, V236, P17, DOI 10.1016/j.jneuroim.2011.04.008; Forrester JV, 1998, CURR EYE RES, V17, P426, DOI 10.1080/02713689808951224; Foxman EF, 2002, J IMMUNOL, V168, P2483, DOI 10.4049/jimmunol.168.5.2483; Fujiya A, 2014, OBESITY, V22, P371, DOI 10.1002/oby.20532; Fukami N, 2009, J IMMUNOL, V182, P309, DOI 10.4049/jimmunol.182.1.309; Gasparotto J, 2013, SCI TOTAL ENVIRON, V463, P743, DOI 10.1016/j.scitotenv.2013.06.086; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hu JR, 1999, BRAIN RES, V842, P46, DOI 10.1016/S0006-8993(99)01804-1; Huang SM, 2006, MOL NUTR FOOD RES, V50, P1129, DOI 10.1002/mnfr.200600075; Kerr EC, 2008, PROG RETIN EYE RES, V27, P527, DOI 10.1016/j.preteyeres.2008.07.001; Kim SH, 2004, NEUROBIOL AGING, V25, P431, DOI 10.1016/S0197-4580(03)00126-X; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Mrak RE, 2011, NEUROBIOL AGING, V22, P915; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Poppensieker K, 2012, P NATL ACAD SCI USA, V109, P3897, DOI 10.1073/pnas.1114153109; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sathe K, 2012, BRAIN, V135, P3336, DOI 10.1093/brain/aws250; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Steiner J, 2011, BRAIN BEHAV IMMUN, V25, P1233, DOI 10.1016/j.bbi.2011.03.015; Trujillo G, 2008, AM J PATHOL, V172, P1209, DOI 10.2353/ajpath.2008.070832; Tsuchiya K, 2014, CRIT REV IMMUNOL, V34, P41, DOI 10.1615/CritRevImmunol.2013008686; Watanabe T, 2009, INVEST OPHTH VIS SCI, V50, P2283, DOI 10.1167/iovs.08-2709; Wen XH, 2012, CELL PHYSIOL BIOCHEM, V29, P417, DOI 10.1159/000338496; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	49	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132688	10.1371/journal.pone.0132688	http://dx.doi.org/10.1371/journal.pone.0132688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204512	gold, Green Published, Green Submitted			2022-12-26	WOS:000358621000012
J	Islam, FMA; Chakrabarti, R; Islam, SZ; Finger, RP; Critchley, C				Islam, Fakir M. Amirul; Chakrabarti, Rahul; Islam, Silvia Z.; Finger, Robert P.; Critchley, Christine			Factors Associated with Awareness, Attitudes and Practices Regarding Common Eye Diseases in the General Population in a Rural District in Bangladesh: The Bangladesh Population-based Diabetes and Eye Study (BPDES)	PLOS ONE			English	Article							LOW-VISION SURVEY; NATIONAL BLINDNESS; RISK-FACTORS; KNOWLEDGE; RETINOPATHY; PREVALENCE; ADULTS; HEALTH; INDIA; COMMUNITY	Background To assess the awareness, attitudes, and practices associated with common eye diseases and eye care utilization in a rural district of Bangladesh. Methods Data were collected using a multilevel cluster random sampling technique from 3104 adults aged >= 30 years from the Banshgram union with a questionnaire assessing the awareness, attitudes and practice about diabetes and common eye diseases, educational attainment, socio-economic status, and medical history. Results Participants were aged between 30 and 89 years with a mean (SD) age of 51 (12) years and 65% were female. The majority of participants had heard of cataracts (90%), trachoma (86%) and Pterygium (84%), yet only 4% had heard of diabetic retinopathy (DR), 7% of glaucoma and 8% of Age-related macular degeneration (AMD). However, 58% of participants did not know vision loss could be prevented. Factors associated with lower awareness regarding common eye diseases were increasing age, lack of formal schooling, and lower socio-economic status. A lower proportion (57%) of people with no schooling compared to those who had attained at least secondary school certificate education (72%) reported that they knew that vision loss could be prevented (p<0.001). Overall 51% of people had heard of at least six (67%) out of nine items relating to awareness of common eye diseases. This included 41% of participants aged 65 years or older compared to 61% of those aged 30-35 years (p<0.001). Only 4% had an eye check at least once a year and higher education and better SES were associated with higher frequency of eye checks. Conclusions In rural Bangladesh awareness of cataract, trachoma and pterygium was good but limited in relation to the potentially blinding conditions of glaucoma, DR, and AMD. The results show a large gap between public awareness and treatment practices about common eye diseases. Public health promotion should be designed to address these knowledge gaps.	[Islam, Fakir M. Amirul; Critchley, Christine] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Hawthorn, Vic 3122, Australia; [Islam, Fakir M. Amirul; Chakrabarti, Rahul; Islam, Silvia Z.] Org Rural Community Dev, Dariapur, Narail, Bangladesh; [Chakrabarti, Rahul; Finger, Robert P.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Islam, Silvia Z.] RMIT Univ Technol, Sch Econ Finance & Mkt, Melbourne, Vic, Australia	Swinburne University of Technology; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Islam, FMA (corresponding author), Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Hawthorn, Vic 3122, Australia.	fislam@swin.edu.au	Islam, Fakir M Amirul/P-6665-2015	Islam, Fakir M Amirul/0000-0003-3897-3302; Finger, Robert P/0000-0003-4253-7597				Aitaoto Nia, 2012, Prev Chronic Dis, V9, pE82; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; Alam DS, 2013, B WORLD HEALTH ORGAN, V91, P757, DOI 10.2471/BLT.13.120196; Attebo K, 1997, AUST NZ J OPHTHALMOL, V25, P283, DOI 10.1111/j.1442-9071.1997.tb01516.x; Bangladesh Bureau of Statistics, 2010, POP HOUS CENS; Basgram Union Parisad Office, 2011, EL LIST; Bhowmik B, 2013, DIABETES METAB J, V37, P46, DOI 10.4093/dmj.2013.37.1.46; Bourne RRA, 2004, OPHTHALMOLOGY, V111, P1150, DOI 10.1016/j.ophtha.2003.09.046; Bylsma GW, 2004, CLIN EXP OPHTHALMOL, V32, P573, DOI 10.1111/j.1442-9071.2004.00905.x; Chakrabarti R, 2015, BANGLADESH J MED SCI, V14; Cheng YH, 2002, SOC SCI MED, V55, P1415, DOI 10.1016/S0277-9536(01)00271-4; Dandona R, 2001, B WORLD HEALTH ORGAN, V79, P96; Demaio AR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-236; Dineen BP, 2003, BRIT J OPHTHALMOL, V87, P820, DOI 10.1136/bjo.87.7.820; Huang OS, 2013, OPHTHAL EPIDEMIOL, V20, P52, DOI 10.3109/09286586.2012.751429; Huang OS, 2009, ANN ACAD MED SINGAP, V38, P1048; Islam FMA, 2016, J DIABETES, V8, P260, DOI 10.1111/1753-0407.12294; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Muhit M A, 2011, Mymensingh Med J, V20, P671; Muller A, 2006, CLIN EXP OPHTHALMOL, V34, P445, DOI 10.1111/j.1442-9071.2006.01234.x; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Ormsby GM, 2012, ASIA-PAC J OPHTHALMO, V1, P331, DOI 10.1097/APO.0b013e31826d9e06; Rani PK, 2008, RURAL REMOTE HEALTH, V8; Shrestha MK, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-2; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI DOI 10.1016/J.0PHTHA.2013.05.025; Varma R, 2011, AM J OPHTHALMOL, V152, P515, DOI 10.1016/j.ajo.2011.06.004; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Zafar S, 2012, JCR-J CLIN RHEUMATOL, V18, P279, DOI 10.1097/RHU.0b013e3182676975; Zaman MJ, 2012, INT J EPIDEMIOL, V41, P1302, DOI 10.1093/ije/dyr226	31	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133043	10.1371/journal.pone.0133043	http://dx.doi.org/10.1371/journal.pone.0133043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200458	Green Published, gold			2022-12-26	WOS:000358597100051
J	Lopez, G; Bill, KLJ; Bid, HK; Braggio, D; Constantino, D; Prudner, B; Zewdu, A; Batte, K; Lev, D; Pollock, RE				Lopez, Gonzalo; Bill, Kate Lynn J.; Bid, Hemant Kumar; Braggio, Danielle; Constantino, Dylan; Prudner, Bethany; Zewdu, Abeba; Batte, Kara; Lev, Dina; Pollock, Raphael E.			HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)	PLOS ONE			English	Article							HISTONE DEACETYLASE; PROTEIN; ACETYLATION; INHIBITOR; COHESIN	Introduction HDAC isoform-specific inhibitors may improve the therapeutic window while limiting toxicities. Developing inhibitors against class I isoforms poses difficulties as they share high homology among their catalytic sites; however, HDAC8 is structurally unique compared to other class I isoforms. HDAC8 inhibitors are novel compounds and have affinity for class I HDAC isoforms demonstrating anti-cancer effects; little is known about their activity in malignant peripheral nerve sheath tumors (MPNST). Recently, we demonstrated anti-MPNST efficacy of HDAC8i in human and murine-derived MPNST pre-clinical models; we now seek to consider the potential therapeutic inhibition of HDAC8 in MPNST. Methods Four Human MPNST cell lines, a murine-derived MPNST cell line, and two HDAC8 inhibitors (PCI-34051, PCI-48012; Pharmacyclics, Inc. Sunnyvale, CA) were studied. Proliferation was determined using MTS and clonogenic assays. Effects on cell cycle were determined via PI FACS analysis; effects on apoptosis were determined using Annexin VPI FACS analysis and cleaved caspase 3 expression. In vivo growth effects of HDAC8i were evaluated using MPNST xenograft models. 2D gel electrophoresis and mass spectrometry were used to identify potential HDAC8 deacetylation substrates. Results HDAC8i induced cell growth inhibition and marked S-phase cell cycle arrest in human and murine-derived MPNST cells. Relative to control, HDAC8i induced apoptosis in both human and murine-derived MPNST cells. HDAC8i exhibited significant effects on MPNST xenograft growth (p=0.001) and tumor weight (p=0.02). Four potential HDAC8 substrate targets were identified using a proteomic approach: PARK7, HMGB1, PGAM1, PRDX6. Conclusions MPNST is an aggressive sarcoma that is notoriously therapy-resistant, hence the urgent need for improved anti-MPNST therapies. HDAC8 inhibition may be useful for MPNST by improving efficacy while limiting toxicities as compared to pan-HDACis.	[Lopez, Gonzalo; Bill, Kate Lynn J.; Bid, Hemant Kumar; Braggio, Danielle; Constantino, Dylan; Prudner, Bethany; Zewdu, Abeba; Batte, Kara] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Lev, Dina] Sheba Med Ctr, Surg B, Tel Aviv, Israel; [Pollock, Raphael E.] Ohio State Univ, Surg Oncol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Chaim Sheba Medical Center; University System of Ohio; Ohio State University	Pollock, RE (corresponding author), Ohio State Univ, Surg Oncol, Columbus, OH 43210 USA.	raphael.pollock@osumc.edu		Pollock, Raphael/0000-0002-0443-1583	National Cancer Institute of the National Institutes of Health [U54CA168512]; NATIONAL CANCER INSTITUTE [P30CA016058, U54CA168512] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health: U54CA168512 (RP) (https://urldefense.proofpoint.com/v2/url?u=http-3A_gsspubssl.nci.nih.gov_nciportfolio_search_details-3Bjsessionid-3DE09B3BF14FB00F6638F7736412CC4FB8-3Faction-3Dabstract-26grantNum- 3D5U54CA1 68512- 2D02- 26grantID- 3D8551649- 26grtSCDC3DFY-25202013-26absID-3D8551649-26absSCDC3DPUB2013&d=BQIGaQ&c=k9MF1d71ITtkuJxPdWme51dKbmfPEvxwt8SFEkBfs4&r=WlCJiS 1JcGqgTnM0Ltj2R6XxIkYTI7SdcJwmuK5r PJw&m=4-wHTbdb1Z326N6PEYFZuqHX_WU1 zqO7GvpeQng0UbE&s=QWOz6wxh3BZDapHEcz WiWKWvGqZrukK5GITFr-T-keg&e=). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; DAHLBERG WK, 1993, INT J RADIAT BIOL, V63, P191, DOI 10.1080/09553009314550251; de Leval L, 2006, AM J SURG PATHOL, V30, P319; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; FLETCHER JA, 1991, NEW ENGL J MED, V324, P436, DOI 10.1056/NEJM199102143240702; Frahm S, 2004, NEUROBIOL DIS, V16, P85, DOI 10.1016/j.nbd.2004.01.006; Gao JX, 2009, BIOCHEM BIOPH RES CO, V379, P1, DOI 10.1016/j.bbrc.2008.11.135; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Jeong J, 2012, PROTEOMICS, V12, P1452, DOI 10.1002/pmic.201100558; Jo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091508; Karolczak-Bayatti M, 2011, J BIOL CHEM, V286, P34346, DOI 10.1074/jbc.M111.278549; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kramer OH, 2014, TRENDS PHARMACOL SCI, V35, P501, DOI 10.1016/j.tips.2014.08.001; KrennHrubec K, 2007, BIOORG MED CHEM LETT, V17, P2874, DOI 10.1016/j.bmcl.2007.02.064; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Lopez G, 2011, CANCER RES, V71, P185, DOI 10.1158/0008-5472.CAN-10-2799; Lopez G, 2009, CLIN CANCER RES, V15, P3472, DOI 10.1158/1078-0432.CCR-08-2714; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Oehme I, 2009, EXPERT OPIN INV DRUG, V18, P1605, DOI 10.1517/14728220903241658; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ross PJ, 1997, ANN ONCOL, V8, P111, DOI 10.1023/A:1008274522483; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; van Pelt K, 2005, EXP HEMATOL, V33, P226, DOI 10.1016/j.exphem.2004.10.013; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zou CYY, 2009, MOL CANCER THER, V8, P1157, DOI 10.1158/1535-7163.MCT-08-1008	41	30	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133302	10.1371/journal.pone.0133302	http://dx.doi.org/10.1371/journal.pone.0133302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200462	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100059
J	Puerta, P; Hunsicker, ME; Quetglas, A; Alvarez-Berastegui, D; Esteban, A; Gonzalez, M; Hidalgo, M				Puerta, Patricia; Hunsicker, Mary E.; Quetglas, Antoni; Alvarez-Berastegui, Diego; Esteban, Antonio; Gonzalez, Mara; Hidalgo, Manuel			Spatially Explicit Modeling Reveals Cephalopod Distributions Match Contrasting Trophic Pathways in the Western Mediterranean Sea	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; SOUTH CATALAN SEA; ENVIRONMENTAL-CONDITIONS; POPULATION-DYNAMICS; FISH LARVAE; ECOLOGY; SQUID; VARIABILITY; CLIMATE; TEMPERATURE	Populations of the same species can experience different responses to the environment throughout their distributional range as a result of spatial and temporal heterogeneity in habitat conditions. This highlights the importance of understanding the processes governing species distribution at local scales. However, research on species distribution often averages environmental covariates across large geographic areas, missing variability in population-environment interactions within geographically distinct regions. We used spatially explicit models to identify interactions between species and environmental, including chlorophyll a (Chla) and sea surface temperature (SST), and trophic (prey density) conditions, along with processes governing the distribution of two cephalopods with contrasting life-histories (octopus and squid) across the western Mediterranean Sea. This approach is relevant for cephalopods, since their population dynamics are especially sensitive to variations in habitat conditions and rarely stable in abundance and location. The regional distributions of the two cephalopod species matched two different trophic pathways present in the western Mediterranean Sea, associated with the Gulf of Lion upwelling and the Ebro river discharges respectively. The effects of the studied environmental and trophic conditions were spatially variant in both species, with usually stronger effects along their distributional boundaries. We identify areas where prey availability limited the abundance of cephalopod populations as well as contrasting effects of temperature in the warmest regions. Despite distributional patterns matching productive areas, a general negative effect of Chla on cephalopod densities suggests that competition pressure is common in the study area. Additionally, results highlight the importance of trophic interactions, beyond other common environmental factors, in shaping the distribution of cephalopod populations. Our study presents a valuable approach for understanding the spatially variant ecology of cephalopod populations, which is important for fisheries and ecosystem management.	[Puerta, Patricia; Quetglas, Antoni; Hidalgo, Manuel] Inst Espanol Oceanog, Ctr Oceanog Baleares, Palma De Mallorca, Islas Baleares, Spain; [Hunsicker, Mary E.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Alvarez-Berastegui, Diego] Balear Isl Coastal Observing & Forecasting Syst, Palma De Mallorca, Islas Baleares, Spain; [Esteban, Antonio] Inst Espanol Oceanog, Ctr Oceanog Murcia, Murcia, Spain; [Gonzalez, Mara] Inst Espanol Oceanog, Ctr Oceanog Malaga, Malaga, Spain	Spanish Institute of Oceanography; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Spanish Institute of Oceanography; Spanish Institute of Oceanography	Puerta, P (corresponding author), Inst Espanol Oceanog, Ctr Oceanog Baleares, Palma De Mallorca, Islas Baleares, Spain.	patrix.puerta@gmail.com	Quetglas, Antoni/K-9089-2014; Puerta, Patricia/GPG-3786-2022; Hidalgo, Manuel/B-8023-2015	Quetglas, Antoni/0000-0002-1303-8003; Puerta, Patricia/0000-0003-4413-4601; Alvarez-Berastegui, Diego/0000-0003-1304-7185; Hidalgo, Manuel/0000-0002-3494-9658	project "ECLIPSAME" (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean) - Spanish Ministry of Economy and Competitiveness [CTM2012-37701]; European Commission; Directorate-General for Maritime Affairs and Fisheries (DG-MARE) of the European Commission; Spanish Institute of Oceanography; FPI grant from the Spanish Ministry of Economy and Competitiveness [BES-2010-030315]; Gordon and Betty Moore Foundation [2897.01]; European Community [289257]; Direccion General d'Educacio, Personal Docent, Universitats i Recerca - European Social Fund	project "ECLIPSAME" (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean) - Spanish Ministry of Economy and Competitiveness; European Commission(European CommissionEuropean Commission Joint Research Centre); Directorate-General for Maritime Affairs and Fisheries (DG-MARE) of the European Commission; Spanish Institute of Oceanography; FPI grant from the Spanish Ministry of Economy and Competitiveness(Spanish Government); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); European Community(European Commission); Direccion General d'Educacio, Personal Docent, Universitats i Recerca - European Social Fund	This research is supported by the project "ECLIPSAME" (Synergistics effects of Climate and Fishing on the demersal ecosystems of the North Atlantic and western Mediterranean, CTM2012-37701) co-financed by the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/) and the European Commission. Surveys were co-funded by the Directorate-General for Maritime Affairs and Fisheries (DG-MARE) of the European Commission (http://ec.europa.eu/dgs/maritimeaffairs_fisheries/index_en.htm) and the Spanish Institute of Oceanography (www.ieo.es). PP is supported by the funding of FPI grant BES-2010-030315 from the Spanish Ministry of Economy and Competitiveness. MEH's funding is provided by the Gordon and Betty Moore Foundation, grant number 2897.01, (www.moore.org) through the "Ocean Tipping Points" project (www.oceantippingpoints.org). MH is supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement MYFISH no 289257 (www.myfishproject.eu/) and a postdoctoral contract of the Direccion General d'Educacio, Personal Docent, Universitats i Recerca (http://dguni.caib.es/) funded by the European Social Fund 2014-2020 (http://ec.europa.eu/esf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy C, 2014, GLOBAL CHANGE BIOL, V20, P730, DOI 10.1111/gcb.12467; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Andre J, 2008, J EXP MAR BIOL ECOL, V354, P81, DOI 10.1016/j.jembe.2007.10.008; Andrews JM, 2006, CAN J FISH AQUAT SCI, V63, P1027, DOI 10.1139/F06-006; [Anonymous], 2014, R LANG ENV STAT COMP; Antoine D, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004472; Bacheler NM, 2012, DEEP-SEA RES PT II, V65-70, P208, DOI 10.1016/j.dsr2.2012.02.001; Bacheler NM, 2009, MAR ECOL PROG SER, V391, P1, DOI 10.3354/meps08259; Balbin R, 2014, J MARINE SYST, V138, P70, DOI 10.1016/j.jmarsys.2013.07.004; Balbin R, 2012, CONT SHELF RES, V47, P28, DOI 10.1016/j.csr.2012.06.008; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Bartolino V, 2011, ECOLOGY, V92, P189, DOI 10.1890/09-1129.1; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; Brown OB, 1999, UNDER CONTRACT NUMBE; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; Ciannelli L, 2004, ECOLOGY, V85, P3418, DOI 10.1890/03-0755; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Coll M, 2006, J MARINE SYST, V59, P63, DOI 10.1016/j.jmarsys.2005.09.001; Coll M, 2008, ECOL MODEL, V217, P95, DOI 10.1016/j.ecolmodel.2008.06.013; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Dahlhoff EP, 2002, INTEGR COMP BIOL, V42, P862, DOI 10.1093/icb/42.4.862; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Fanelli E, 2012, MAR FRESHWATER RES, V63, P264, DOI 10.1071/MF11157; Fauchald P, 2002, MAR ECOL PROG SER, V231, P279, DOI 10.3354/meps231279; Fernandez de Puelles ML, 2008, HYDROBIOLOGIA, V617, P3; Field JC, 2007, CAL COOP OCEAN FISH, V48, P131; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Friedland KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028945; Gruss A, 2014, FISH RES, V159, P11, DOI 10.1016/j.fishres.2014.05.005; Guijarro B, 2008, J MARINE SYST, V71, P385, DOI 10.1016/j.jmarsys.2007.04.003; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hidalgo M, 2009, ESTUAR COAST SHELF S, V83, P227, DOI 10.1016/j.ecss.2009.03.037; Hidalgo M, 2008, J MARINE SYST, V71, P367, DOI 10.1016/j.jmarsys.2007.03.005; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Koubbi P, 2006, SCI MAR, V70, P147, DOI 10.3989/scimar.2006.70s2147; Llope M, 2009, LIMNOL OCEANOGR, V54, P512, DOI 10.4319/lo.2009.54.2.0512; Llope M, 2012, GLOBAL CHANGE BIOL, V18, P106, DOI 10.1111/j.1365-2486.2011.02492.x; Lloret J, 2004, FISH OCEANOGR, V13, P102, DOI 10.1046/j.1365-2419.2003.00279.x; Lloret J, 2001, FISH OCEANOGR, V10, P33, DOI 10.1046/j.1365-2419.2001.00151.x; de Puelles MLF, 2007, PROG OCEANOGR, V74, P329, DOI 10.1016/j.pocean.2007.04.009; McCain C., 2006, EOS T AM GEOPHYSUNIO, V87, P337, DOI DOI 10.1029/2006EO340002; Millot C, 2005, SCI MAR, V69, P5, DOI 10.3989/scimar.2005.69s15; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Moreno A, 2002, B MAR SCI, V71, P515; Oguz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111482; OReilly J.E., 2000, SEAWIFS POSTLAUNCH C, P9; Otero J, 2009, MAR ECOL PROG SER, V386, P123, DOI 10.3354/meps08041; Palomera I, 2007, PROG OCEANOGR, V74, P377, DOI 10.1016/j.pocean.2007.04.012; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pertierra Juan Pablo, 2005, Phuket Marine Biological Center Research Bulletin, V66, P283; Phillips AJ, 2014, ICES J MAR SCI, V71, P1717, DOI 10.1093/icesjms/fst238; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Puerta P., 2014, 2014P02 ICES CM; Puerta P, 2014, MAR ECOL PROG SER, V514, P105, DOI 10.3354/meps10972; Quetglas A, 2011, ACTA OECOL, V37, P476, DOI 10.1016/j.actao.2011.06.002; Rodhouse PGK, 2014, ADV MAR BIOL, V67, P99, DOI 10.1016/B978-0-12-800287-2.00002-0; Sabates A, 2007, PROG OCEANOGR, V74, P355, DOI 10.1016/j.pocean.2007.04.017; Salat J, 1996, SCI MAR, V60, P21; Sanchez P, 2004, FISH RES, V68, P319, DOI 10.1016/j.fishres.2003.11.008; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Smith JM, 2013, DEEP-SEA RES PT II, V95, P145, DOI 10.1016/j.dsr2.2013.03.039; Sveegaard S, 2012, MAR ECOL PROG SER, V468, P245, DOI 10.3354/meps09959; Torres AP, 2011, J PLANKTON RES, V33, P1793, DOI 10.1093/plankt/fbr078; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y; Valls M, 2011, SCI MAR, V75, P633, DOI 10.3989/scimar.2011.75n4633; Vargas-Yanez M, 2009, FISH RES, V99, P159, DOI 10.1016/j.fishres.2009.05.013; Villanueva R, 2011, J EXP MAR BIOL ECOL, V407, P54, DOI 10.1016/j.jembe.2011.07.012; Walton CC, 1998, J GEOPHYS RES-OCEANS, V103, P27999, DOI 10.1029/98JC02370; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	75	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133439	10.1371/journal.pone.0133439	http://dx.doi.org/10.1371/journal.pone.0133439			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201075	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100064
J	Yang, W; Mok, MTS; Li, MSM; Kang, W; Wang, H; Chan, AW; Chou, JL; Chen, J; Ng, EKW; To, KF; Yu, J; Chan, MWY; Chan, FKL; Sung, JJY; Cheng, ASL				Yang, W.; Mok, M. T. S.; Li, M. S. M.; Kang, W.; Wang, H.; Chan, A. W.; Chou, J-L; Chen, J.; Ng, E. K. W.; To, K-F; Yu, J.; Chan, M. W. Y.; Chan, F. K. L.; Sung, J. J. Y.; Cheng, A. S. L.			Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development	ONCOGENE			English	Article							DIFFERENTIATION FACTOR-I; INTESTINAL METAPLASIA; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; GENE; EXPRESSION; RISK; RECEPTOR; CELLS; FOXD3	Accumulating evidence reveals the effectiveness of epigenetic therapy in gastric cancer. However, the molecular mechanisms and targets underlying such therapeutic responses remain elusive. Herein, we report an aberrant yet therapeutically rectifiable epigenetic signaling in gastric carcinogenesis. Administration of DNA-demethylating drug 5-aza-2'-deoxycytidine (5-aza-dC) reduced gastric cancer incidence by similar to 74% (P<0.05) in N-nitroso-N-methylurea-treated mice. Through genome-wide methylation scanning, novel promoter hypermethylation-silenced and drug-targeted genes were identified in the resected murine stomach tumors and tissues. We uncovered that growth/differentiation factor 1 (Gdf1), a member of the transforming growth factor-beta superfamily, was silenced by promoter hypermethylation in control tumor-bearing mice, but became reactivated in 5-aza-dCtreated mice (P<0.05). In parallel, the downregulated SMAD2/3 phosphorylation in gastric cancer was revived by 5-aza-dC in vivo. Such hypermethylation-dependent silencing and 5-aza-dC-mediated reactivation of GDF1-SMAD2/3 activity was conserved in human gastric cancer cells (Po0.05). Subsequent functional characterization further revealed the antiproliferative activity of GDF1, which was exerted through activation of SMAD2/3/4-mediated signaling, transcriptional controls on p15, p21 and c-Myc cell-cycle regulators and phosphorylation of retinoblastoma protein. Clinically, hypermethylation and loss of GDF1 was significantly associated with reduced phosphorylated-SMAD2/3 and poor survival in stomach cancer patients (Po0.05). Taken together, we demonstrated a causal relationship between DNA methylation and a tumor-suppressive pathway in gastric cancer. Epigenetic silencing of GDF1 abrogates the growth-inhibitory SMAD signaling and renders proliferation advantage to gastric epithelial cells during carcinogenesis. This study lends support to epigenetic therapy for gastric cancer chemoprevention and identifies a potential biomarker for prognosis.	[Yang, W.; Yu, J.; Chan, F. K. L.; Sung, J. J. Y.; Cheng, A. S. L.] Chinese Univ Hong Kong, State Key Lab Digest Dis, Shatin, Hong Kong, Peoples R China; [Yang, W.; Yu, J.; Chan, F. K. L.; Sung, J. J. Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Mok, M. T. S.; Li, M. S. M.; Cheng, A. S. L.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Mok, M. T. S.; Cheng, A. S. L.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Kang, W.; Chan, A. W.; To, K-F] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Wang, H.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chou, J-L; Chan, M. W. Y.] Natl Chung Cheng Univ, Dept Life Sci, Chiayi 621, Taiwan; [Chen, J.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Ng, E. K. W.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong; National Chung Cheng University; Sun Yat Sen University; Chinese University of Hong Kong	Cheng, ASL (corresponding author), Chinese Univ Hong Kong, State Key Lab Digest Dis, Shatin, Hong Kong, Peoples R China.; Cheng, ASL (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	alfredcheng@cuhk.edu.hk	Chan, Francis K. L./F-4851-2010; KANG, Wei/C-5451-2016; Chan, Anthony W.H./N-6719-2016; Chan, Anthony/U-7768-2019; Cheng, Alfred SL/C-3327-2014; Sung, Joseph J. Y./R-3203-2018; Yu, Jun/D-8569-2015; Mok, Myth/M-2958-2013; Chan, Michael/F-9615-2018; Wang, Maggie Haitian/F-5954-2017; Chan, Anthony Wing Hung/HGB-4311-2022; Ng, Enders Kwok-wai/E-8276-2016	Chan, Francis K. L./0000-0001-7388-2436; KANG, Wei/0000-0002-4651-677X; Chan, Anthony W.H./0000-0002-1771-163X; Chan, Anthony/0000-0002-1771-163X; Cheng, Alfred SL/0000-0003-2345-6951; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153; Mok, Myth/0000-0003-3156-4944; Chan, Michael/0000-0003-1431-322X; Wang, Maggie Haitian/0000-0003-1223-4595; Chan, Anthony Wing Hung/0000-0002-1771-163X; Chan, Michael/0000-0003-0314-2437; Ng, Enders Kwok-wai/0000-0001-7219-5810	Health and Medical Research Fund [08070172]; National Natural Science Foundation of China [373492, 81302167]; Chinese University of Hong Kong;  [1907301]	Health and Medical Research Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese University of Hong Kong(Chinese University of Hong Kong); 	This study was supported by the Health and Medical Research Fund (08070172), National Natural Science Foundation of China (373492, 81302167), Focused Investment Scheme - Scheme B (1907301) and the Direct Grant from the Chinese University of Hong Kong.	Andersson O, 2006, DEV BIOL, V293, P370, DOI 10.1016/j.ydbio.2006.02.002; Asada K, 2015, GUT, V64, P388, DOI 10.1136/gutjnl-2014-307094; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Burt David W., 1994, Progress in Growth Factor Research, V5, P99; Cheng ASL, 2013, GASTROENTEROLOGY, V144, P122, DOI 10.1053/j.gastro.2012.10.002; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; Cheung KF, 2012, CANCER-AM CANCER SOC, V118, P947, DOI 10.1002/cncr.26189; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Fuerer C, 2014, J BIOL CHEM, V289, P17854, DOI 10.1074/jbc.M114.550301; Geutjes EJ, 2012, ONCOGENE, V31, P3827, DOI 10.1038/onc.2011.552; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holbrook JD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-119; Ivanova T, 2013, GUT, V62, P22, DOI 10.1136/gutjnl-2011-301113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaasinen E, 2010, HUM MOL GENET, V19, P2747, DOI 10.1093/hmg/ddq164; Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Karkera JD, 2007, AM J HUM GENET, V81, P987, DOI 10.1086/522890; Katsuno Y, 2012, J PATHOL, V228, P391, DOI 10.1002/path.4020; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; LEE SJ, 1990, MOL ENDOCRINOL, V4, P1034, DOI 10.1210/mend-4-7-1034; Leung WK, 2008, CARCINOGENESIS, V29, P1648, DOI 10.1093/carcin/bgn156; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Li X, 2012, ONCOGENE, V31, P3419, DOI 10.1038/onc.2011.511; Liu J, 2012, ONCOL REP, V28, P545, DOI 10.3892/or.2012.1838; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Niwa T, 2013, CANCER PREV RES, V6, P263, DOI 10.1158/1940-6207.CAPR-12-0369; Qiu H, 2009, CANCER SCI, V100, P181, DOI 10.1111/j.1349-7006.2008.01004.x; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schmid CA, 2013, GASTROENTEROLOGY, V144, P22, DOI 10.1053/j.gastro.2012.11.014; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; Sun XW, 2013, MOL BIOL REP, V40, P1291, DOI 10.1007/s11033-012-2172-0; Sung JJY, 2000, GASTROENTEROLOGY, V119, P7, DOI 10.1053/gast.2000.8550; Wall NA, 2000, DEV BIOL, V227, P495, DOI 10.1006/dbio.2000.9926; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Yoda Y, 2015, GASTRIC CANCER, V18, P65, DOI 10.1007/s10120-014-0348-0; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zhang Y, 2014, BBA-MOL BASIS DIS, V1842, P232, DOI 10.1016/j.bbadis.2013.11.018; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	50	14	14	1	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2133	2144		10.1038/onc.2015.276	http://dx.doi.org/10.1038/onc.2015.276			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26212015				2022-12-26	WOS:000374505600012
J	Burtey, A; Wagner, M; Hodneland, E; Skaftnesmo, KO; Schoelermann, J; Mondragon, IR; Espedal, H; Golebiewska, A; Niclou, SP; Bjerkvig, R; Kogel, T; Gerdes, HH				Burtey, Anne; Wagner, Marek; Hodneland, Erlend; Skaftnesmo, Kai Ove; Schoelermann, Julia; Mondragon, Ivan Rios; Espedal, Heidi; Golebiewska, Anna; Niclou, Simone P.; Bjerkvig, Rolf; Kogel, Tanja; Gerdes, Hans-Hermann			Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes	FASEB JOURNAL			English	Article						cell-cell communication; organelle exchange; tumor microenvironment; endosomes	CANCER-CELLS; SIDE POPULATION; TNT FORMATION; KIDNEY-CELLS; RAB8 GTPASE; STEM-CELL; H-RAS; TRANSPORT; EXOSOMES; COMMUNICATION	Intercellular communication between cancer cells, especially between cancer and stromal cells, plays an important role in disease progression. We examined the intercellular transfer of organelles and proteins in vitro and in vivo and the role of tunneling nanotubes (TNTs) in this process. TNTs are membrane bridges that facilitate intercellular transfer of organelles of unclear origin. Using 3-dimensional quantitative and qualitative confocal microscopy, we showed that TNTs contain green fluorescent protein (GFP)-early endosome antigen (EEA) 1, GFP Rab5, GFP Rab11, GFP Rab8, transferrin (Tf), and Tf receptor (Tf-R) fused to mCherry (Tf-RmCherry). Tf-RmCherry was transferred between cancer cells by a contact-dependent but secretion-independent mechanism. Live cell imaging showed TNT formation preceding the transfer of Tf-RmCherry and involving the function of the small guanosine triphosphatase (GTPase) Rab8, which colocalized with Tf-RmCherry in the TNTs and was cotransferred to acceptor cells. Tf-RmCherry was transferred from cancer cells to fibroblasts, a noteworthy finding that suggests that this process occurs between tumor and stromal cells in vivo. We strengthened this hypothesis in a xenograft model of breast cancer using enhanced (e) GFP-expressing mice. Tf-RmCherry transferred from tumor to stromal cells and this process correlated with an increased opposite transfer of eGFP from stromal to tumor cells, together pointing toward complex intercellular communication at the tumor site.	[Burtey, Anne; Wagner, Marek; Skaftnesmo, Kai Ove; Schoelermann, Julia; Mondragon, Ivan Rios; Espedal, Heidi; Bjerkvig, Rolf; Kogel, Tanja; Gerdes, Hans-Hermann] Univ Bergen, Dept Biomed, Bergen, Norway; [Schoelermann, Julia] Univ Bergen, Biomat, Dept Clin Dent, Bergen, Norway; [Niclou, Simone P.; Bjerkvig, Rolf] Univ Bergen, KG Jebsen Brain Tumour Res Ctr, Bergen, Norway; [Wagner, Marek] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Hodneland, Erlend] Haukeland Hosp, Dept Clin Med, N-5021 Bergen, Norway; [Golebiewska, Anna; Niclou, Simone P.; Bjerkvig, Rolf] Luxembourg Inst Hlth, Dept Oncol, NorLux Neurooncol Lab, Luxembourg, Luxembourg	University of Bergen; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Luxembourg Institute of Health	Burtey, A (corresponding author), Univ Oslo, Sect Biochem & Mol Biol, Dept Biosci, Blindernveien 31, N-0371 Oslo, Norway.	a.p.burtey@ibv.uio.no	Golebiewska, Anna/E-1332-2015; Skaftnesmo, kai ove/AAF-6071-2021; Wagner, Marek/AAV-9589-2020; Niclou, Simone/P-2304-2018; Schoelermann, Julia/J-1593-2014; Espedal, Heidi/ABE-1829-2020	Golebiewska, Anna/0000-0002-4160-2521; Niclou, Simone/0000-0002-3417-9534; Schoelermann, Julia/0000-0001-5911-9688; Espedal, Heidi/0000-0002-0190-8999; Kogel, Tanja/0000-0002-3507-3395; Burtey, Anne/0000-0003-4548-8807; Wagner, Marek/0000-0003-3967-9527	Marie Sklodowska-Curie Individual European Fellowship FP7 TNTFUNCTION [209404]; MarieCurie Alumni Association [204921/F20, 102244]; Norwegian Research Council [642251]; Western Norway Regional Health Authority [303385, 911532, 911574, 911623]	Marie Sklodowska-Curie Individual European Fellowship FP7 TNTFUNCTION; MarieCurie Alumni Association; Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Regional Health Authority	The authors thank Dr. A. Benmerah and Prof. I. F. Pryme for critical reading of the manuscript. Imaging was performed at the Molecular Imaging Center, University of Bergen. A.B. was supported by a Marie Sklodowska-Curie Individual European Fellowship FP7 TNTFUNCTION (project 209404). This work was supported by a Micro Media grant from the MarieCurie Alumni Association (to A.B.); Grants 204921/F20, project 102244 (to T.K.) and 642251 (to I.R.M.) from The Norwegian Research Council; and Grants 303385 (to T.K.), 911532 (to M.W. and R.B.), and 911574 and 911623 (to H.-H.G.) from the Western Norway Regional Health Authority.	Ady JW, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00400; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Benmerah A, 1999, J CELL SCI, V112, P1303; Bloemendal S, 2013, NATURWISSENSCHAFTEN, V100, P3, DOI 10.1007/s00114-012-0988-z; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Calvo F, 2011, CURR OPIN CELL BIOL, V23, P621, DOI 10.1016/j.ceb.2011.04.010; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Golebiewska A, 2013, BRAIN, V136, P1462, DOI 10.1093/brain/awt025; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Gousset K, 2013, J CELL SCI, V126, P4424, DOI 10.1242/jcs.129239; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kadiu I, 2011, J PROTEOME RES, V10, P3225, DOI 10.1021/pr200262q; Kobayashi H, 2014, BIOL OPEN, V3, P803, DOI 10.1242/bio.20148771; Kucharzewska P., 2013, J EXTRACELL VESICLES, V5, P2; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Niclou SP, 2008, FASEB J, V22, P3120, DOI 10.1096/fj.08-109611; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt Bjorn, 2005, Sci STKE, V2005, ppe55, DOI 10.1126/stke.3132005pe55; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rainy N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.245; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rechavi O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001204; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SHIH YJ, 1990, J BIOL CHEM, V265, P19077; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stieber D, 2014, ACTA NEUROPATHOL, V127, P203, DOI 10.1007/s00401-013-1196-4; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Veranic P, 2008, BIOPHYS J, V95, P4416, DOI 10.1529/biophysj.108.131375; Vidulescu C, 2004, J CELL MOL MED, V8, P388, DOI 10.1111/j.1582-4934.2004.tb00328.x	46	36	38	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4695	4712		10.1096/fj.14-268615	http://dx.doi.org/10.1096/fj.14-268615			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26220176				2022-12-26	WOS:000364514700026
J	Kudryavtsev, DS; Shelukhina, IV; Son, LV; Ojomoko, LO; Kryukova, EV; Lyukmanova, EN; Zhmak, MN; Dolgikh, DA; Ivanov, IA; Kasheverov, IE; Starkov, VG; Ramerstorfer, J; Sieghart, W; Tsetlin, VI; Utkin, YN				Kudryavtsev, Denis S.; Shelukhina, Irina V.; Son, Lina V.; Ojomoko, Lucy O.; Kryukova, Elena V.; Lyukmanova, Ekaterina N.; Zhmak, Maxim N.; Dolgikh, Dmitry A.; Ivanov, Igor A.; Kasheverov, Igor E.; Starkov, Vladislav G.; Ramerstorfer, Joachim; Sieghart, Werner; Tsetlin, Victor I.; Utkin, Yuri N.			Neurotoxins from Snake Venoms and alpha-Conotoxin ImI Inhibit Functionally Active Ionotropic gamma-Aminobutyric Acid (GABA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; POSITIVE ALLOSTERIC MODULATION; CRYSTAL-STRUCTURE; NAJA-KAOUTHIA; WEAK TOXIN; ANTAGONIST; BINDING; BUNGAROTOXIN; PROTEIN; DERIVATIVES	Ionotropic receptors of gamma-aminobutyric acid (GABA(A)R) regulate neuronal inhibition and are targeted by benzodiazepines and general anesthetics. We show that a fluorescent derivative of alpha-cobratoxin (alpha-Ctx), belonging to the family of three-finger toxins from snake venoms, specifically stained the alpha 1 beta 3 gamma 2 receptor; and at 10 mu M alpha-Ctx completely blocked GABA-induced currents in this receptor expressed in Xenopus oocytes (IC50 = 236 nM) and less potently inhibited alpha 1 beta 2 gamma 2 approximate to alpha 2 beta 2 gamma 2 > alpha 5 beta 2 gamma 2 > alpha 2 beta 3 gamma 2 and alpha 1 beta 3 delta GABA(A)Rs. The alpha 1 beta 3 gamma 2 receptor was also inhibited by some other three-finger toxins, long alpha-neurotoxin Ls III and nonconventional toxin WTX. alpha-Conotoxin ImI displayed inhibitory activity as well. Electrophysiology experiments showed mixed competitive and noncompetitive alpha-Ctx action. Fluorescent alpha-Ctx, however, could be displaced by muscimol indicating that most of the alpha-Ctx-binding sites overlap with the orthosteric sites at the beta/alpha subunit interface. Modeling and molecular dynamic studies indicated that alpha-Ctx or alpha-bungarotoxin seem to interact with GABA(A)R in a way similar to their interaction with the acetylcholine-binding protein or the ligand-binding domain of nicotinic receptors. This was supported by mutagenesis studies and experiments with alpha-conotoxin ImI and a chimeric Naja oxiana alpha-neurotoxin indicating that the major role in alpha-Ctx binding to GABA(A)R is played by the tip of its central loop II accommodating under loop C of the receptors.	[Kudryavtsev, Denis S.; Shelukhina, Irina V.; Ojomoko, Lucy O.; Kryukova, Elena V.; Lyukmanova, Ekaterina N.; Zhmak, Maxim N.; Dolgikh, Dmitry A.; Ivanov, Igor A.; Kasheverov, Igor E.; Starkov, Vladislav G.; Tsetlin, Victor I.; Utkin, Yuri N.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Son, Lina V.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; [Zhmak, Maxim N.] Syneuro OOO, Moscow 117997, Russia; [Lyukmanova, Ekaterina N.; Dolgikh, Dmitry A.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Ramerstorfer, Joachim; Sieghart, Werner] Med Univ Vienna, Ctr Brain Res, Dept Mol Neurosci, A-1090 Vienna, Austria	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; Lomonosov Moscow State University; Medical University of Vienna	Utkin, YN (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	utkin@mx.ibch.ru	Lyukmanova, Ekaterina/F-2340-2014; Utkin, Yuri N./F-1958-2014; Ojomoko, Lucy/ABD-9910-2020; Shelukhina, Irina/AHE-5496-2022; Ivanov, Igor A/R-7543-2017; Kudryavtsev, Denis S/O-4811-2015; Dolgikh, Dmitry A/F-2369-2014; Sieghart, Werner/A-4877-2013; Tsetlin, Victor/X-2491-2018; Utkin, Yuri/L-2952-2019	Lyukmanova, Ekaterina/0000-0002-9728-9407; Utkin, Yuri N./0000-0002-4609-970X; Shelukhina, Irina/0000-0003-3476-1441; Kudryavtsev, Denis S/0000-0002-0313-9193; Sieghart, Werner/0000-0002-0443-0302; Utkin, Yuri/0000-0002-4609-970X; Dolgikh, Dmitry/0000-0002-9880-7202	Russian Science Foundation [14-24-00118, 14-14-00255]; Russian Foundation for Basic Research [14-04-00885]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Science Foundation Grant 14-24-00118. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Russian Foundation for Basic Research Grant 14-04-00885.; Supported by Russian Science Foundation Grant 14-14-00255 (NT II/I chimeric toxin was obtained with this grant).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alfonso J, 2012, CELL STEM CELL, V10, P76, DOI 10.1016/j.stem.2011.11.011; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Ashton H, 2005, CURR OPIN PSYCHIATR, V18, P249, DOI 10.1097/01.yco.0000165594.60434.84; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERG DK, 1972, P NATL ACAD SCI USA, V69, P147, DOI 10.1073/pnas.69.1.147; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Christian CA, 2013, NEURON, V78, P1063, DOI 10.1016/j.neuron.2013.04.026; CLARKE PBS, 1985, J NEUROSCI, V5, P1307; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dubovskii PV, 2014, CURR MED CHEM, V21, P270; Eastman P, 2010, COMPUT SCI ENG, V12, P34, DOI 10.1109/MCSE.2010.27; Gergalova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031361; GRISHIN EV, 1974, FEBS LETT, V45, P118, DOI 10.1016/0014-5793(74)80825-2; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hannan S, 2015, NEUROPHARMACOLOGY, V93, P28, DOI 10.1016/j.neuropharm.2015.01.001; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joshi S, 2013, MOL CELL NEUROSCI, V56, P201, DOI 10.1016/j.mcn.2013.05.003; Kasheverov IE, 2009, CURR PHARM DESIGN, V15, P2430, DOI 10.2174/138161209788682316; Krishek BJ, 1996, MOL PHARMACOL, V49, P494; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Maslennikov IV, 1999, FEBS LETT, V444, P275, DOI 10.1016/S0014-5793(99)00069-1; McCann CM, 2006, P NATL ACAD SCI USA, V103, P5149, DOI 10.1073/pnas.0600847103; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mirheydari P., 2014, NEUROCHEM RES, V39, P1057; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Olsen RW, 2006, P NATL ACAD SCI USA, V103, P6081, DOI 10.1073/pnas.0601121103; Osipov AV, 2012, J BIOL CHEM, V287, P6725, DOI 10.1074/jbc.M111.322313; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Razet R, 2000, BIOORG MED CHEM LETT, V10, P2579, DOI 10.1016/S0960-894X(00)00514-X; Rosso JP, 2015, P NATL ACAD SCI USA, V112, pE891, DOI 10.1073/pnas.1415488112; Shelukhina IV, 2009, J NEUROCHEM, V109, P1087, DOI 10.1111/j.1471-4159.2009.06033.x; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Starkov VG, 2009, RUSS J BIOORG CHEM+, V35, P10, DOI 10.1134/S1068162009010026; Tsetlin V, 2007, LIFE SCI, V80, P2202, DOI 10.1016/j.lfs.2007.01.007; TSETLIN VI, 1979, FEBS LETT, V106, P47, DOI 10.1016/0014-5793(79)80692-4; Utkin YN, 1998, EUR J BIOCHEM, V253, P229, DOI 10.1046/j.1432-1327.1998.2530229.x; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Wyrembek P, 2012, EUR J PHARMACOL, V683, P35, DOI 10.1016/j.ejphar.2012.03.005; Zhang L, 2012, NEUROPHARMACOLOGY, V62, P1062, DOI 10.1016/j.neuropharm.2011.10.017; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	46	35	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22747	22758		10.1074/jbc.M115.648824	http://dx.doi.org/10.1074/jbc.M115.648824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221036	Green Published, hybrid			2022-12-26	WOS:000361171500038
J	Amazit, L; Le Billan, F; Kolkhof, P; Lamribet, K; Viengchareun, S; Fay, MR; Khan, JA; Hillisch, A; Lombes, M; Rafestin-Oblin, ME; Fagart, J				Amazit, Larbi; Le Billan, Florian; Kolkhof, Peter; Lamribet, Khadija; Viengchareun, Say; Fay, Michel R.; Khan, Junaid A.; Hillisch, Alexander; Lombes, Marc; Rafestin-Oblin, Marie-Edith; Fagart, Jerome			Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; HEART-FAILURE; LIVING CELLS; BAY 94-8862; BINDING; SPIROLACTONES; ANTAGONISTS; KIDNEY; HYPERTENSION; RAT	Aldosterone regulates sodium homeostasis by activating the mineralocorticoid receptor (MR), a member of the nuclear receptor superfamily. Hyperaldosteronism leads to deleterious effects on the kidney, blood vessels, and heart. Although steroidal antagonists such as spironolactone and eplerenone are clinically useful for the treatment of cardiovascular diseases, they are associated with several side effects. Finerenone, a novel nonsteroidal MR antagonist, is presently being evaluated in two clinical phase IIb trials. Here, we characterized the molecular mechanisms of action of finerenone and spironolactone at several key steps of the MR signaling pathway. Molecular modeling and mutagenesis approaches allowed identification of Ser-810 and Ala-773 as key residues for the high MR selectivity of finerenone. Moreover, we showed that, in contrast to spironolactone, which activates the S810L mutant MR responsible for a severe form of early onset hypertension, finerenone displaysstrict antagonistic properties. Aldosterone-dependent phosphorylation and degradation of MR are inhibited by both finerenone and spironolactone. However, automated quantification of MR subcellular distribution demonstrated that finerenone delays aldosterone-induced nuclear accumulation of MR more efficiently than spironolactone. Finally, chromatin immunoprecipitation assays revealed that, as opposed to spironolactone, finerenone inhibits MR, steroid receptor coactivator-1, and RNA polymerase II binding at the regulatory sequence of the SCNN1A gene and also remarkably reduces basal MR and steroid receptor coactivator-1 recruitment, unraveling a specific and unrecognized inactivating mechanism on MR signaling. Overall, our data demonstrate that the highly potent and selective MR antagonist finerenone specifically impairs several critical steps of the MR signaling pathway and therefore represents a promising new generation MR antagonist.	[Amazit, Larbi; Le Billan, Florian; Lamribet, Khadija; Viengchareun, Say; Khan, Junaid A.; Lombes, Marc; Fagart, Jerome] INSERM, UMR S 1185, F-94276 Le Kremlin Bicetre, France; [Amazit, Larbi; Le Billan, Florian; Lamribet, Khadija; Viengchareun, Say; Khan, Junaid A.; Lombes, Marc; Fagart, Jerome] Univ Paris 11, Fac Med Paris Sud, UMR S 1185, F-94276 Le Kremlin Bicetre, France; [Amazit, Larbi] Inst Biomed Bicetre, UMS 32, F-94276 Le Kremlin Bicetre, France; [Kolkhof, Peter] Bayer Pharma AG, Global Drug Discovery, Dept Cardiol Res, D-42113 Wuppertal, Germany; [Hillisch, Alexander] Bayer Pharma AG, Global Drug Discovery, Dept Med Chem, D-42113 Wuppertal, Germany; [Fay, Michel R.; Rafestin-Oblin, Marie-Edith; Fagart, Jerome] Ctr Rech Biomed Bichat Beaujon, INSERM U773, CRB3, F-75890 Paris, France; [Fay, Michel R.; Rafestin-Oblin, Marie-Edith; Fagart, Jerome] Univ Paris Denis Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fagart, J (corresponding author), INSERM, Fac Med Paris Sud, UMR S 1185, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	jerome.fagart@inserm.fr	Viengchareun, Say/GOV-6812-2022; Fagart, Jerome/S-4581-2018; Khan, Junaid/AAE-3522-2019; Khan, Junaid Ali/ABG-6129-2020; Hillisch, Alexander/AAN-5872-2021; Khan, Junaid Ali/ABG-2756-2020; Lombes, Marc/L-5933-2018; Viengchareun, Say/M-6612-2017	Fagart, Jerome/0000-0002-7965-0553; Hillisch, Alexander/0000-0002-4228-2347; Khan, Junaid Ali/0000-0003-2630-1744; Lombes, Marc/0000-0003-3189-023X; viengchareun, say/0000-0003-4280-3250; Le Billan, Florian/0000-0002-3400-9295	INSERM; Universite Paris Sud Agence Nationale de la Recherche [11-BSV1-028-01]; Bayer Pharma AG [05112/A11 3, SCCV2395]; Ministere de l'Enseignement Superieur et de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Sud Agence Nationale de la Recherche(French National Research Agency (ANR)); Bayer Pharma AG; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by grants from INSERM, by Universite Paris Sud Agence Nationale de la Recherche Grant 11-BSV1-028-01, and by Bayer Pharma AG Grants 05112/A11 and SCCV2395. P. K. and A. H. are employees of Bayer Pharma AG.; Recipient of a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	Amazit L, 2011, MOL ENDOCRINOL, V25, P394, DOI 10.1210/me.2010-0458; Auzou G, 2000, MOL PHARMACOL, V58, P684, DOI 10.1124/mol.58.4.684; Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; BRASS EP, 1984, DRUGS, V27, P447, DOI 10.2165/00003495-198427050-00004; Cargnelli G, 2001, J CARDIOVASC PHARM, V37, P540, DOI 10.1097/00005344-200105000-00006; CASALSSTENZEL J, 1984, ARZNEIMITTEL-FORSCH, V34-1, P241; CHINN LJ, 1981, J MED CHEM, V24, P1103, DOI 10.1021/jm00141a020; CLAIRE M, 1978, FEBS LETT, V88, P295, DOI 10.1016/0014-5793(78)80197-5; Corvol P, 1977, Adv Nephrol Necker Hosp, V7, P199; CORVOL P, 1975, ENDOCRINOLOGY, V97, P52, DOI 10.1210/endo-97-1-52; COUSTAL S, 1995, TETRAHEDRON, V51, P3559, DOI 10.1016/0040-4020(95)00099-T; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DEGASPARO M, 1987, J PHARMACOL EXP THER, V240, P650; Deppe CE, 2002, ENDOCRINOLOGY, V143, P1932, DOI 10.1210/en.143.5.1932; Devin-Leclerc J, 1998, MOL ENDOCRINOL, V12, P842, DOI 10.1210/me.12.6.842; Epstein M, 2006, AM J MED, V119, P912, DOI 10.1016/j.amjmed.2006.03.038; Fagart J, 1998, EMBO J, V17, P3317, DOI 10.1093/emboj/17.12.3317; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Fagart J, 2005, MOL PHARMACOL, V67, P1714, DOI 10.1124/mol.104.010710; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Faresse N, 2012, FASEB J, V26, P4373, DOI 10.1096/fj.12-209924; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Funder JW, 2010, ENDOCRINOLOGY, V151, P5098, DOI 10.1210/en.2010-0465; Gekle M, 2014, STEROIDS, V81, P103, DOI 10.1016/j.steroids.2013.10.016; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; GOUILLEUX F, 1991, NUCLEIC ACIDS RES, V19, P1563, DOI 10.1093/nar/19.7.1563; Grossmann C, 2012, CHEM BIOL, V19, P742, DOI 10.1016/j.chembiol.2012.04.014; Huyet J, 2007, MOL PHARMACOL, V72, P563, DOI 10.1124/mol.107.036459; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Khan JA, 2013, MOL ENDOCRINOL, V27, P909, DOI 10.1210/me.2012-1328; Kolkhof P, 2014, J CARDIOVASC PHARM, V64, P69, DOI 10.1097/FJC.0000000000000091; Kolkhof P, 2012, MOL CELL ENDOCRINOL, V350, P310, DOI 10.1016/j.mce.2011.06.025; Le Billan F, 2015, FASEB J, V29, P3977, DOI 10.1096/fj.15-274266; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Liu Z, 2002, P NATL ACAD SCI USA, V99, P7940, DOI 10.1073/pnas.122225699; LOMBES M, 1994, BIOCHEM J, V302, P191, DOI 10.1042/bj3020191; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Rossi GP, 2006, HYPERTENSION, V48, P232, DOI 10.1161/01.HYP.0000230444.01215.6a; ROSSIER BC, 1983, AM J PHYSIOL, V244, pC24, DOI 10.1152/ajpcell.1983.244.1.C24; SCHANE HP, 1978, J CLIN ENDOCR METAB, V47, P691, DOI 10.1210/jcem-47-3-691; Shen TJ, 2001, MOL CELL BIOL, V21, P6122, DOI 10.1128/MCB.21.18.6122-6131.2001; Tirard M, 2007, MOL CELL ENDOCRINOL, V268, P20, DOI 10.1016/j.mce.2007.01.010; Tomaschitz A, 2010, NAT REV ENDOCRINOL, V6, P83, DOI 10.1038/nrendo.2009.263; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095; Williams RG, 2006, METHOD ENZYMOL, V414, P364, DOI 10.1016/S0076-6879(06)14021-5; Yokota K, 2004, ENDOCR RES, V30, P611, DOI 10.1081/ERC-200043783; Zhang JH, 2008, J STEROID BIOCHEM, V109, P279, DOI 10.1016/j.jsbmb.2008.03.018	57	71	74	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21876	21889		10.1074/jbc.M115.657957	http://dx.doi.org/10.1074/jbc.M115.657957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26203193	Green Published, hybrid			2022-12-26	WOS:000360968500010
J	Demelash, A; Pfannenstiel, LW; Tannenbaum, CS; Li, XX; Kalady, MF; DeVecchio, J; Gastman, BR				Demelash, Abeba; Pfannenstiel, Lukas W.; Tannenbaum, Charles S.; Li, Xiaoxia; Kalady, Matthew F.; DeVecchio, Jennifer; Gastman, Brian R.			Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; BH3 MIMETICS; LUNG-CANCER; BCL-XL; INHIBITORS; APOPTOSIS; THERAPY; P53; PHOSPHORYLATION; DEPENDENCY	Unlike other antiapoptotic Bcl-2 family members, Mcl-1 also mediates resistance to cancer therapy by uniquely inhibiting chemotherapy-induced senescence (CIS). In general, Bcl-2 family members regulate apoptosis at the level of the mitochondria through a common prosurvival binding groove. Through mutagenesis, we determined that Mcl-1 can inhibit CIS even in the absence of its apoptotically important mitochondrion-localizing domains. This finding prompted us to generate a series of Mcl-1 deletion mutants from both the N and C termini of the protein, including one that contained a deletion of all of the Bcl-2 homology domains, none of which impacted anti-CIS capabilities. Through subsequent structure-function analyses of Mcl-1, we identified a previously uncharacterized loop domain responsible for the anti-CIS activity of Mcl-1. The importance of the loop domain was confirmed in multiple tumor types, two in vivo models of senescence, and by demonstrating that a peptide mimetic of the loop domain can effectively inhibit the anti-CIS function of Mcl-1. The results from our studies appear to be highly translatable because we discerned an inverse relationship between the expression of Mcl-1 and of various senescence markers in cancerous human tissues. In summary, our findings regarding the unique structural properties of Mcl-1 provide new approaches for targeted cancer therapy.	[Demelash, Abeba; Pfannenstiel, Lukas W.; Tannenbaum, Charles S.; Li, Xiaoxia; Gastman, Brian R.] Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Kalady, Matthew F.; DeVecchio, Jennifer] Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Gastman, Brian R.] Taussig Canc Ctr, Inst Head & Neck Surg, Cleveland, OH 44195 USA; [Gastman, Brian R.] Taussig Canc Ctr, Inst Dermatol Surg, Cleveland, OH 44195 USA; [Gastman, Brian R.] Taussig Canc Ctr, Inst Plast Surg, Cleveland, OH 44195 USA; [Kalady, Matthew F.; DeVecchio, Jennifer] Cleveland Clin, Dept Colorectal Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Gastman, BR (corresponding author), Cleveland Clin, 9500 Euclid Ave NE60,NE6-303, Cleveland, OH 44195 USA.	gastmab@ccf.org						Baggstrom MQ, 2011, J THORAC ONCOL, V6, P1757, DOI 10.1097/JTO.0b013e31822e2941; Belmar J, 2015, PHARMACOL THERAPEUT, V145, P76, DOI 10.1016/j.pharmthera.2014.08.003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Billard C, 2013, MOL CANCER THER, V12, P1691, DOI 10.1158/1535-7163.MCT-13-0058; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Bolesta E, 2012, MOL CELL BIOL, V32, P1879, DOI 10.1128/MCB.06214-11; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cairney CJ, 2012, DRUG DISCOV TODAY, V17, P269, DOI 10.1016/j.drudis.2012.01.019; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; Demelash A, 2012, MOL BIOL CELL, V23, P2856, DOI 10.1091/mbc.E10-12-1010; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Elkholi Rana, 2011, Genes Cancer, V2, P523, DOI 10.1177/1947601911417177; Fire E, 2010, PROTEIN SCI, V19, P507, DOI 10.1002/pro.329; Germain M, 2007, J BIOL CHEM, V282, P32233, DOI 10.1074/jbc.M706408200; Giuliano S, 2011, PIGM CELL MELANOMA R, V24, P295, DOI 10.1111/j.1755-148X.2010.00820.x; Grabow S, 2014, BLOOD, V124, P3939, DOI 10.1182/blood-2014-09-601567; Haferkamp S, 2013, J INVEST DERMATOL, V133, P1601, DOI 10.1038/jid.2013.6; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Haugstetter AM, 2010, BRIT J CANCER, V103, P505, DOI 10.1038/sj.bjc.6605784; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Liu CN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001843; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Ng Samuel Y, 2014, Clin Adv Hematol Oncol, V12, P224; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2014, BIOORG MED CHEM LETT, V24, P1484, DOI 10.1016/j.bmcl.2014.02.010; Pfannenstiel LW, 2012, GENOME MED, V4, DOI 10.1186/gm352; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Placzek WJ, 2011, J BIOL CHEM, V286, P39829, DOI 10.1074/jbc.M111.305326; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Song JH, 2011, CANCER RES, V71, P506, DOI 10.1158/0008-5472.CAN-10-1977; Staub E, 2009, J MOL MED, V87, P633, DOI 10.1007/s00109-009-0467-y; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Varadarajan S, 2013, CELL DEATH DIFFER, V20, P1475, DOI 10.1038/cdd.2013.79; Warr MR, 2011, J BIOL CHEM, V286, P25098, DOI 10.1074/jbc.M111.218321; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	48	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21962	21975		10.1074/jbc.M115.663898	http://dx.doi.org/10.1074/jbc.M115.663898			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26205817	Green Published, hybrid			2022-12-26	WOS:000360968500017
J	Tikhanovich, I; Kuravi, S; Artigues, A; Villar, MT; Dorko, K; Nawabi, A; Roberts, B; Weinman, SA				Tikhanovich, Irina; Kuravi, Sudhakiranmayi; Artigues, Antonio; Villar, Maria T.; Dorko, Kenneth; Nawabi, Atta; Roberts, Benjamin; Weinman, Steven A.			Dynamic Arginine Methylation of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6 Regulates Toll-like Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATION; JMJD6; ACTIVATION; RESPONSES; SURVIVAL; CELLS; PRMT1; A20	Arginine methylation is a common post-translational modification, but its role in regulating protein function is poorly understood. This study demonstrates that, TNF receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase involved in innate immune signaling, is regulated by reversible arginine methylation in a range of primary and cultured cells. Under basal conditions, TRAF6 is methylated by the methyltransferase PRMT1, and this inhibits its ubiquitin ligase activity, reducing activation of toll-like receptor signaling. In response to toll-like receptor ligands, TRAF6 is demethylated by the Jumonji domain protein JMJD6. Demethylation is required for maximal activation of NF-kappa B. Loss of JMJD6 leads to reduced response, and loss of PRMT1 leads to basal pathway activation with subsequent desensitization to ligands. In human primary cells, variations in the PRMT1/JMJD6ratiosignificantlycorrelatewithTRAF6methylation, basal activation of NF-kappa B, and magnitude of response to LPS. Reversible arginine methylation of TRAF6 by the opposing effects of PRMT1 and JMJD6 is, therefore, a novel mechanism for regulation of innate immune pathways.	[Tikhanovich, Irina; Kuravi, Sudhakiranmayi; Roberts, Benjamin; Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA; [Nawabi, Atta] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66160 USA; [Artigues, Antonio; Villar, Maria T.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Dorko, Kenneth] Univ Kansas, Med Ctr, Dept Pharmacol & Toxicol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Weinman, SA (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Mailstop 1018, Kansas City, KS 66160 USA.	sweinman@kumc.edu	Tikhanovich, Irina/GOK-0267-2022		National Institute on Alcohol Abuse and Alcoholism [AA012863]; National Institutes of Health COBRE Grant [P20 RR021940]; Biomedical Research Training Program from The University of Kansas Medical Center; Hans Popper Memorial Postdoctoral Research Fellowship from the American Liver Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012863] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health COBRE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Training Program from The University of Kansas Medical Center; Hans Popper Memorial Postdoctoral Research Fellowship from the American Liver Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institute on Alcohol Abuse and Alcoholism Grant AA012863 and National Institutes of Health COBRE Grant P20 RR021940 (Center for Research Resources). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Biomedical Research Training Program from The University of Kansas Medical Center and a Hans Popper Memorial Postdoctoral Research Fellowship from the American Liver Foundation.	Anwar MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.28; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Choi YW, 2005, ADV EXP MED BIOL, V560, P77; Davies John Q, 2005, Methods Mol Biol, V290, P91; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Hahn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013769; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nakamoto N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00221; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Skvorak KJ, 2009, MOL THER, V17, P1266, DOI 10.1038/mt.2009.99; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tikhanovich I, 2014, HEPATOLOGY, V59, P58, DOI 10.1002/hep.26618; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zakharova L, 2009, J CELL PHYSIOL, V221, P84, DOI 10.1002/jcp.21829	29	47	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22236	22249		10.1074/jbc.M115.653543	http://dx.doi.org/10.1074/jbc.M115.653543			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26221041	Green Published, hybrid			2022-12-26	WOS:000360968500040
J	Zhou, T; Frabutt, DA; Moremen, KW; Zheng, YH				Zhou, Tao; Frabutt, Dylan A.; Moremen, Kelley W.; Zheng, Yong-Hui			ERManI (Endoplasmic Reticulum Class I alpha-Mannosidase) Is Required for HIV-1 Envelope Glycoprotein Degradation via Endoplasmic Reticulum-associated Protein Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; N-GLYCAN BIOSYNTHESIS; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS; EDEM; ALPHA-1,2-MANNOSIDASES; IDENTIFICATION; MITOCHONDRIA; EXPRESSION	Previously, we reported that the mitochondrial translocator protein (TSPO) induces HIV-1 envelope (Env) degradation via the endoplasmic reticulum (ER)-associated protein degradation (ERAD) pathway, but the mechanism was not clear. Here we investigated how the four ER-associated glycoside hydrolase family 47 (GH47) alpha-mannosidases, ERManI, and ER-degradation enhancing alpha-mannosidase-like (EDEM) proteins 1, 2, and 3, are involved in the Env degradation process. Ectopic expression of these four alpha-mannosidases uncovers that only ERManI inhibits HIV-1 Env expression in a dose-dependent manner. In addition, genetic knock-out of the ERManI gene MAN1B1 using CRISPR/Cas9 technology disrupts the TSPO-mediated Env degradation. Biochemical studies show that HIV-1 Env interacts with ERManI, and between the ERManI cytoplasmic, transmembrane, lumenal stem, and lumenal catalytic domains, the catalytic domain plays a critical role in the Env-ERManI interaction. In addition, functional studies show that inactivation of the catalytic sites by site-directed mutagenesis disrupts the ERManI activity. These studies identify ERManI as a critical GH47 alpha-mannosidase in the ER-associated protein degradation pathway that initiates the Env degradation and suggests that its catalytic domain and enzymatic activity play an important role in this process.	[Zhou, Tao; Zheng, Yong-Hui] Chinese Acad Agr Sci, Harbin Vet Res Inst, CAAS Michigan State Univ Joint Lab Innate Immun, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China; [Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zhou, Tao; Frabutt, Dylan A.; Zheng, Yong-Hui] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Zhou, Tao; Frabutt, Dylan A.; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University System of Georgia; University of Georgia; Michigan State University; Michigan State University	Zheng, YH (corresponding author), Rm 2215,567 Wilson Rd, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zhou, Tao/B-5757-2017; Regan, Clinton/E-6250-2012; Zheng, Yong-Hui/AAP-4492-2021; Moremen, Kelley/AAD-4661-2019	Zhou, Tao/0000-0002-3648-9923; Zheng, Yong-Hui/0000-0002-1098-7385; Frabutt, Dylan/0000-0002-8693-6656	National Institutes of Health [AI063944, P41GM103390, GM47533, DK075322]; "948" plan, Ministry of Agriculture, China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120189, R56AI063944, R01AI063944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM047533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "948" plan, Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063944 (to Y.- H. Z) and P41GM103390, GM47533, and DK075322 (to K. W. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a grant from the "948" plan, Ministry of Agriculture, China. To whom correspondence should be addressed: Rm. 2215, 567 Wilson Rd., East Lansing, MI 48824. Tel.: 517-884-5314; Fax: 517-353-8957; E-mail: zhengyo@msu.edu.	Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Benyair R, 2015, MOL BIOL CELL, V26, P172, DOI 10.1091/mbc.E14-06-1152; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Dellisanti C., 2015, NAT STRUCT MOL BIOL, V22, P184; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; FENNIE C, 1989, J VIROL, V63, P639, DOI 10.1128/JVI.63.2.639-646.1989; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; HALLENBERGER S, 1993, VIROLOGY, V193, P510, DOI 10.1006/viro.1993.1156; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Herscovics A, 2002, GLYCOBIOLOGY, V12, p14G; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Iannotti MJ, 2014, J BIOL CHEM, V289, P11844, DOI 10.1074/jbc.M114.552091; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Karaveg K, 2005, J BIOL CHEM, V280, P29837, DOI 10.1074/jbc.M505130200; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Lipari F, 1996, J BIOL CHEM, V271, P27615, DOI 10.1074/jbc.271.44.27615; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mast SW, 2006, METHOD ENZYMOL, V415, P31, DOI 10.1016/S0076-6879(06)15003-X; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Rafiq MA, 2011, AM J HUM GENET, V89, P176, DOI 10.1016/j.ajhg.2011.06.006; Rymen D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003989; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Tremblay LO, 1999, GLYCOBIOLOGY, V9, P1073, DOI 10.1093/glycob/9.10.1073; Vallee F, 2000, J BIOL CHEM, V275, P41287, DOI 10.1074/jbc.M006927200; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yang Y, 2007, P NATL ACAD SCI USA, V104, P10813, DOI 10.1073/pnas.0702027104; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhou T, 2014, J VIROL, V88, P3474, DOI 10.1128/JVI.03286-13; Zhou T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-31	43	20	20	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22184	22192		10.1074/jbc.M115.675207	http://dx.doi.org/10.1074/jbc.M115.675207			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26205822	hybrid, Green Published			2022-12-26	WOS:000360968500035
J	Bigna, JJR; Noubiap, JJN; Agbor, AA; Plottel, CS; Billong, SC; Ayong, APR; Koulla-Shiro, S				Bigna, Jean Joel R.; Noubiap, Jean Jacques N.; Agbor, Ako A.; Plottel, Claudia S.; Billong, Serge Clotaire; Ayong, Andre Patrick R.; Koulla-Shiro, Sinata			Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaounde Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013)	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; DOSING FREQUENCY; ADULTS; ADHERENCE; HAART; DEATH; START	Background Understanding contributors to mortality during the initial phase of tuberculosis (TB) treatment in patients co-infected with HIV would guide targeted interventions to improve survival. The aim of this study was to ascertain the incidence of death during the initial 2 months (new cases) and 3 months (retreatment cases) of TB treatment and to assess correlates of mortality in HIV co-infected patients. Methods We conducted a hospital-based retrospective cohort study from January 2006 to December 2013 at Yaounde Central Hospital, Cameroon. We reviewed medical records to identify co-infected TB/HIV inpatients aged 15 years and older who died during TB treatment. Death was defined as any death occurring during TB treatment, as per World Health Organization recommendations. We collected socio-demographic, clinical and laboratory data. We conducted multivariable logistic binary regression analysis to identify factors associated with death during the intensive phase of TB treatment. Magnitudes of associations were expressed by adjusted odds ratio (aOR) with 95% confidence interval. A p value < 0.05 was considered statistically significant. Results The 99 patients enrolled had a mean age of 39.5 (standard deviation 10.9) years and 53% were male. Patients were followed for 276.3 person-months of observation (PMO). Forty nine patients were died during intensive phase of TB treatment. Death incidence during the intensive phase of TB treatment was 32.2 per 100 PMO. Having a non-AIDS comorbidity (aOR 2.47, 95% CI 1.22-5.02, p = 0.012), having extra-pulmonary TB (aOR 1.89, 95% CI 1.05-3.43, p = 0.035), and one year increase in duration of known HIV infection (aOR 1.23, 95% CI 1.004-1.49) were independently associated with death during the intensive phase of TB treatment. Conclusions Mortality incidence during intensive phase of TB treatment was high among TB/HIV co-infected patients during TB treatment; and strongly associated with extra pulmonary TB suggesting advanced stage of immunosuppression and non-AIDS comorbidities. Early HIV diagnosis and care and good management of non-comorbidities can reduce this incidence.	[Bigna, Jean Joel R.] Pasteur Ctr Cameroon, Dept Epidemiol & Publ Hlth, Yaounde, Cameroon; [Noubiap, Jean Jacques N.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Noubiap, Jean Jacques N.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Noubiap, Jean Jacques N.] Med Diag Ctr, Yaounde, Cameroon; [Agbor, Ako A.; Billong, Serge Clotaire; Koulla-Shiro, Sinata] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Plottel, Claudia S.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Billong, Serge Clotaire] Minist Publ Hlth, Natl AIDS Control Comm, Yaounde, Cameroon; [Ayong, Andre Patrick R.] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Koulla-Shiro, Sinata] Yaounde Cent Hosp, Infect Dis Unit, Yaounde, Cameroon	University of Cape Town; University of Cape Town; University of Yaounde I; New York University; NYU Langone Medical Center	Bigna, JJR (corresponding author), Pasteur Ctr Cameroon, Dept Epidemiol & Publ Hlth, Yaounde, Cameroon.	bignarimjj@yahoo.fr	; Bigna, Jean Joel/A-1781-2015	Noubiap, Jean Jacques/0000-0002-7722-9757; Plottel, Claudia S./0000-0001-6088-6534; Bigna, Jean Joel/0000-0001-8018-6279				Agbor AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115211; Assawasuwannakit P, 2015, J CLIN PHARM THER, V40, P24, DOI 10.1111/jcpt.12219; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Coleman CI, 2012, J MANAGE CARE PHARM, V18, P527, DOI 10.18553/jmcp.2012.18.7.527; Cox JA, 2010, AIDS REV, V12, P183; Deribe Kebede, 2015, J Int Assoc Provid AIDS Care, V14, P269, DOI 10.1177/2325957413500528; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Feasey NA, 2013, J CLIN MICROBIOL, V51, P2311, DOI 10.1128/JCM.00330-13; Griffin J. P., 2009, TXB PHARM MED; Haddow LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040623; Heaney RP, 2001, J NUTR, V131, p1344S, DOI 10.1093/jn/131.4.1344S; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Jonnalagada S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-921; Little R. J. A., 1987, STAT ANAL MISSING DA; Luetkemeyer AF, 2014, JAIDS-J ACQ IMM DEF, V65, P423, DOI 10.1097/QAI.0000000000000030; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Mfinanga SG, 2014, LANCET INFECT DIS, V14, P563, DOI 10.1016/S1473-3099(14)70733-9; Mungrue Kameel, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P170, DOI 10.1177/1545109709331471; Naidoo K, 2013, CURR OPIN INFECT DIS, V26, P35, DOI 10.1097/QCO.0b013e32835ba8f9; Pokrovskaya AV, 2014, TERAPEVT ARKH, V86, P20; Programme National de lutte contre la Tuberculose, 2012, GUID PERS SANT YAOUN; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Saini SD, 2009, AM J MANAG CARE, V15, pE22; Sharma SK, 2011, INDIAN J MED RES, V134, P866, DOI 10.4103/0971-5916.92632; Shaweno Debebe, 2012, BMC Res Notes, V5, P682, DOI 10.1186/1756-0500-5-682; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Wilson EMP, 2013, IMMUNOL REV, V254, P343, DOI 10.1111/imr.12064; World Health Organization, 2014, CAM TUB PROF WHO; World Health Organization, 2014, WHO AFR REG CAM STAT; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0132394	10.1371/journal.pone.0132394	http://dx.doi.org/10.1371/journal.pone.0132394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214516	Green Submitted, Green Published, gold			2022-12-26	WOS:000358594300009
J	Chandrashekar, DS; Dey, P; Acharya, KK				Chandrashekar, Darshan Shimoga; Dey, Poulami; Acharya, Kshitish K.			GREAM: A Web Server to Short-List Potentially Important Genomic Repeat Elements Based on Over-/Under-Representation in Specific Chromosomal Locations, Such as the Gene Neighborhoods, within or across 17 Mammalian Species	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; DNA; MOUSE; TRANSCRIPTOME; EVOLUTION; INVERTEBRATES; METHYLATION; VERTEBRATES; EXPRESSION; LANDSCAPE	Background Genome-wide repeat sequences, such as LINEs, SINEs and LTRs share a considerable part of the mammalian nuclear genomes. These repeat elements seem to be important for multiple functions including the regulation of transcription initiation, alternative splicing and DNA methylation. But it is not possible to study all repeats and, hence, it would help to short-list before exploring their potential functional significance via experimental studies and/or detailed in silico analyses. Result We developed the 'Genomic Repeat Element Analyzer for Mammals' (GREAM) for analysis, screening and selection of potentially important mammalian genomic repeats. This web-server offers many novel utilities. For example, this is the only tool that can reveal a categorized list of specific types of transposons, retro-transposons and other genome-wide repetitive elements that are statistically over-/under-represented in regions around a set of genes, such as those expressed differentially in a disease condition. The output displays the position and frequency of identified elements within the specified regions. In addition, GREAM offers two other types of analyses of genomic repeat sequences: a) enrichment within chromosomal region(s) of interest, and b) comparative distribution across the neighborhood of orthologous genes. GREAM successfully short-listed a repeat element (MER20) known to contain functional motifs. In other case studies, we could use GREAM to short-list repetitive elements in the azoospermia factor a (AZFa) region of the human Y chromosome and those around the genes associated with rat liver injury. GREAM could also identify five over-represented repeats around some of the human and mouse transcription factor coding genes that had conserved expression patterns across the two species. Conclusion GREAM has been developed to provide an impetus to research on the role of repetitive sequences in mammalian genomes by offering easy selection of more interesting repeats in various contexts/regions. GREAM is freely available at http://resource.ibab.ac.in/GREAM/.	[Chandrashekar, Darshan Shimoga; Dey, Poulami; Acharya, Kshitish K.] Inst Bioinformat & Appl Biotechnol, Bangalore 560100, Karnataka, India; [Chandrashekar, Darshan Shimoga; Dey, Poulami] Manipal Univ, Manipal 576104, Karnataka, India; [Acharya, Kshitish K.] Shodhaka Life Sci Pvt Ltd, IBAB, Bangalore 560100, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Acharya, KK (corresponding author), Inst Bioinformat & Appl Biotechnol, Biotech Pk, Bangalore 560100, Karnataka, India.	kshitish@ibab.ac.in			Department of Electronics and Information Technology (DeitY), Government of India, under 'Centre of Excellence for Research and Teaching in Bioinformatics'	Department of Electronics and Information Technology (DeitY), Government of India, under 'Centre of Excellence for Research and Teaching in Bioinformatics'	This work was supported by an institutional grant to Institute of Bioinformatics and Biotechnology (IBAB) from Department of Electronics and Information Technology (DeitY), Government of India, under 'Centre of Excellence for Research and Teaching in Bioinformatics'.	Ade C, 2013, CURR OPIN VIROL, V3, P639, DOI 10.1016/j.coviro.2013.09.002; Belan E, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-22; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Chandrashekar DS, 2015, COMP NONCOMMERCIAL R; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Emery PTJ, 1999, P ROY SOC B-BIOL SCI, V266, P1677, DOI 10.1098/rspb.1999.0831; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Estecio MRH, 2010, GENOME RES, V20, P1369, DOI 10.1101/gr.107318.110; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Grandi Fiorella C, 2013, Mob Genet Elements, V3, pe25674; Haider S, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R90, 10.1186/gb-2012-13-10-r90]; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kamal M, 2006, P NATL ACAD SCI USA, V103, P2740, DOI 10.1073/pnas.0511238103; Krull M, 2007, GENOME RES, V17, P1139, DOI 10.1101/gr.6320607; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lerat E, 2010, HEREDITY, V104, P520, DOI 10.1038/hdy.2009.165; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; Li JF, 2012, GENOME RES, V22, P870, DOI 10.1101/gr.130740.111; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Makarevitch I, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1004915, 10.1371/journal.pgen.1005566]; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mattarucchi E, 2008, GENE CHROMOSOME CANC, V47, P625, DOI 10.1002/gcc.20568; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Newman MR, 2014, RADIAT RES, V181, P65, DOI 10.1667/RR13460.1; Ocalewicz K, 2013, CYTOGENET GENOME RES, V141, P114, DOI 10.1159/000354278; Ross SM, 2010, INTRO PROBABILITY ST, VFourth, P147; Schonbach C, 2004, BRIEF BIOINFORM, V5, P107, DOI 10.1093/bib/5.2.107; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Sela N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r59; Sela N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010907; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; Steinhoff C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-144; Tang W, 2000, P NATL ACAD SCI USA, V97, P6025, DOI 10.1073/pnas.110139897; Tawa GJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pope.0107230, DOI 10.1371/JOURNAL.POPE.0107230]; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649; Zabala G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111959	47	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133647	10.1371/journal.pone.0133647	http://dx.doi.org/10.1371/journal.pone.0133647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208093	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000114
J	Lei, Y; Yu, H; Dong, Y; Yang, J; Ye, W; Wang, Y; Chen, W; Jia, Z; Xu, Z; Li, Z; Zhang, F				Lei, Y.; Yu, H.; Dong, Y.; Yang, J.; Ye, W.; Wang, Y.; Chen, W.; Jia, Z.; Xu, Z.; Li, Z.; Zhang, F.			Characterization of N-Glycan Structures on the Surface of Mature Dengue 2 Virus Derived from Insect Cells	PLOS ONE			English	Article							DC-SIGN; LECTIN MICROARRAY; DENDRITIC CELLS; INFECTION; GLYCOSYLATION; GLYCOPROTEINS; EXPRESSION; VACCINES; DOMAIN; MODEL	DENV envelope glycoprotein (E) is responsible for interacting with host cell receptors and is the main target for the development of a dengue vaccine based on an induction of neutralizing antibodies. It is well known that DENV E glycoprotein has two potential N-linked glycosylation sites at Asn67 and Asn153. The N-glycans of E glycoprotein have been shown to influence the proper folding of the protein, its cellular localization, its interactions with receptors and its immunogenicity. However, the precise structures of the N-glycans that are attached to E glycoprotein remain elusive, although the crystal structure of DENV E has been determined. This study characterized the structures of envelope protein N-linked glycans on mature DENV-2 particles derived from insect cells via an integrated method that used both lectin microarray and MALDI-TOF-MS. By combining these methods, a high heterogeneity of DENV N-glycans was found. Five types of N-glycan were identified on DENV2, including mannose, GalNAc, GlcNAc, fucose and sialic acid; high mannose-type N-linked oligosaccharides and the galactosylation of N-glycans were the major structures that were found. Furthermore, a complex between a glycan on DENV and the carbohydrate recognition domain (CRD) of DC-SIGN was mimicked with computational docking experiments. For the first time, this study provides a comprehensive understanding of the N-linked glycan profile of whole DENV-2 particles derived from insect cells.	[Lei, Y.; Dong, Y.; Yang, J.; Ye, W.; Wang, Y.; Xu, Z.; Zhang, F.] Fourth Mil Med Univ, Dept Microbiol, Sch Preclin Med, Xian 710032, Shaanxi, Peoples R China; [Yu, H.; Chen, W.; Li, Z.] Northwest Univ, Lab Funct Glyc, Coll Life Sci, Xian 710069, Peoples R China; [Jia, Z.] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710038, Peoples R China; [Jia, Z.] Fourth Mil Med Univ, Tangdu Hosp, Ctr Liver Dis, Xian 710038, Peoples R China	Air Force Military Medical University; Northwest University Xi'an; Air Force Military Medical University; Air Force Military Medical University	Li, Z (corresponding author), Northwest Univ, Lab Funct Glyc, Coll Life Sci, 229 Taibai Beilu, Xian 710069, Peoples R China.	zhengli@nwu.edu.cn; flzhang@fmmu.edu.cn	Yu, Hanjie/E-7819-2016; lei, yingfeng/I-2986-2017	Yu, Hanjie/0000-0003-2684-8715; Ye, Wei/0000-0002-3980-8547	"Major infectious diseases such as AIDS and viral hepatitis prevention and control" technology major special projects grant [2013ZX10004609]; National Natural Science Foundation of China (NSFC) [31370193]	"Major infectious diseases such as AIDS and viral hepatitis prevention and control" technology major special projects grant; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a "Major infectious diseases such as AIDS and viral hepatitis prevention and control" technology major special projects grant to J.Z.S. (No. 2013ZX10004609) and a National Natural Science Foundation of China (NSFC) grant to Y.F.L. (No. 31370193).	Alen MMF, 2012, ANTIVIR RES, V96, P280, DOI 10.1016/j.antiviral.2012.10.007; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Christian EA, 2013, P NATL ACAD SCI USA, V110, P18662, DOI 10.1073/pnas.1310962110; Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0; Harrington J, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/756832; Hidari KIPJ, 2011, EXPERT REV ANTI-INFE, V9, P983, DOI [10.1586/ERI.11.115, 10.1586/eri.11.115]; Hu S, 2009, PROTEOM CLIN APPL, V3, P148, DOI 10.1002/prca.200800153; JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481; Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10; Kobayashi Y, 2014, ONCOL REP, V31, P1121, DOI 10.3892/or.2014.2979; Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09; Moi ML, 2010, J GEN VIROL, V91, P103, DOI 10.1099/vir.0.014829-0; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Qin YN, 2013, J PROTEOME RES, V12, P2742, DOI 10.1021/pr400096w; Rakus JF, 2011, ANNU REV ANAL CHEM, V4, P367, DOI 10.1146/annurev-anchem-061010-113951; Reiding KR, 2014, ANAL CHEM, V86, P5784, DOI 10.1021/ac500335t; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; SMITH GW, 1985, J GEN VIROL, V66, P559, DOI 10.1099/0022-1317-66-3-559; Tan ZQ, 2014, J PROTEOME RES, V13, P2783, DOI 10.1021/pr401185z; Thomas SJ, 2014, ANN NY ACAD SCI, V1323, P140, DOI 10.1111/nyas.12413; Urcuqui-Inchima S, 2010, ADV VIRUS RES, V77, P1, DOI 10.1016/S0065-3527(10)77001-9; van Kooyk Y, 2013, MOL IMMUNOL, V55, P143, DOI 10.1016/j.molimm.2012.10.031; Varga N, 2014, BIOMATERIALS, V35, P4175, DOI 10.1016/j.biomaterials.2014.01.014; Yauch LE, 2014, ADV VIRUS RES, V88, P315, DOI 10.1016/B978-0-12-800098-4.00007-6; Yu HJ, 2012, J PROTEOME RES, V11, P5277, DOI 10.1021/pr300484j; Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13	28	28	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132122	10.1371/journal.pone.0132122	http://dx.doi.org/10.1371/journal.pone.0132122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208004	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000023
J	Mou, LS; Xie, N; Yang, LH; Liu, YC; Diao, RY; Cai, ZM; Li, HG; Gui, YT				Mou, Lisha; Xie, Nie; Yang, Lihua; Liu, Yuchen; Diao, Ruiying; Cai, Zhiming; Li, Honggang; Gui, Yaoting			A Novel Mutation of DAX-1 Associated with Secretory Azoospermia	PLOS ONE			English	Article							ADRENAL HYPOPLASIA CONGENITA; ANDROGEN RECEPTOR; HYPOGONADOTROPIC HYPOGONADISM; SEX DETERMINATION; INFERTILITY; EXPRESSION; MALES	Secretory azoospermia is a severe form of male infertility caused by unknown factors. DAX-1 is predominantly expressed in mammalian reproductive tissues and plays an important role in spermatogenesis because Dax-1 knockout male mice show spermatogenesis defects. To examine whether DAX-1 is involved in the pathogenesis of secretory azoospermia in humans, we sequenced all of the exons of DAX-1 in 776 patients diagnosed with secretory azoospermia and 709 proven fertile men. A number of coding mutations unique to the patient group, including two synonymous mutations and six missense mutations, were identified. Of the missense mutations, our functional assay demonstrated that the V385L mutation caused the reduced functioning of DAX-1. This novel mutation (p. V385L) of DAX-1 is the first to be identified in association with secretory azoospermia, thereby highlighting the important role of DAX-1 in spermatogenesis.	[Mou, Lisha; Xie, Nie; Liu, Yuchen; Diao, Ruiying; Cai, Zhiming] Shenzhen Univ, Shenzhen Domesticated Organ Med Engn Res & Dev Ct, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Genitourinary Tumor,Affiliated H, Shenzhen 518035, Peoples R China; [Mou, Lisha; Xie, Nie; Yang, Lihua; Gui, Yaoting] Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen PKU HKUST Med Ctr, Biomed Res Inst,Shenzhen Hosp,Inst Urol, Shenzhen, Peoples R China; [Li, Honggang] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Wuhan 430030, Peoples R China	Shenzhen University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Huazhong University of Science & Technology	Li, HG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Wuhan 430030, Peoples R China.	lhgyx@hotmail.com; guiyaoting2007@aliyun.com	liu, yuchen/GYQ-6286-2022; Mou, Lisha/I-4739-2012; gui, yaoting/GLT-3684-2022	Mou, Lisha/0000-0001-6232-8341; 	National Natural Science Foundation of China [31271244, 81200465]; Shenzhen Foundation of Science and Technology [GJHZ20140414170821192, JCYJ20140414170821337, GJHZ20130412153906740]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Foundation of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (grant number 31271244 to YG, 81200465 to LM) and the Shenzhen Foundation of Science and Technology (grant number GJHZ20140414170821192 to NX, JCYJ20140414170821337 to NX, GJHZ20130412153906740 to NX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agoulnik IU, 2003, J BIOL CHEM, V278, P31136, DOI 10.1074/jbc.M305153200; Bae DS, 1996, ENDOCRINOLOGY, V137, P3921, DOI 10.1210/en.137.9.3921; Hirsh A, 2003, BMJ-BRIT MED J, V327, P669, DOI 10.1136/bmj.327.7416.669; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Ikeda Y, 1996, MOL ENDOCRINOL, V10, P1261, DOI 10.1210/me.10.10.1261; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Jadhav U, 2011, MOL CELL ENDOCRINOL, V346, P65, DOI 10.1016/j.mce.2011.04.017; Jarvi K, 2010, CUAJ-CAN UROL ASSOC, V4, P163, DOI 10.5489/cuaj.10050; Jouravel N, 2007, ACTA CRYSTALLOGR D, V63, P1198, DOI 10.1107/S0907444907045702; Li J, 2008, ANAL BIOCHEM, V373, P389, DOI 10.1016/j.ab.2007.10.034; Li ZS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08785; Mantovani G, 2005, FERTIL STERIL, V84, P1542, DOI 10.1016/j.fertnstert.2005.05.037; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P44, DOI 10.1210/jc.87.1.44; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Meeks JJ, 2003, NAT GENET, V34, P32, DOI 10.1038/ng1141; Mou LS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.103648; MULLERTZ A, 1990, LIPIDS, V25, P415, DOI 10.1007/BF02537987; Ozisik G, 2003, J CLIN ENDOCR METAB, V88, P417, DOI 10.1210/jc.2002-021034; Ponikwicka-Tyszko D, 2012, J ASSIST REPROD GEN, V29, P811, DOI 10.1007/s10815-012-9778-y; Raffin-Sanson ML, 2013, EUR J ENDOCRINOL, V168, pK45, DOI 10.1530/EJE-12-1055; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seminara SB, 1999, J CLIN ENDOCR METAB, V84, P4501, DOI 10.1210/jc.84.12.4501; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tabarin A, 2000, J CLIN INVEST, V105, P321, DOI 10.1172/JCI7212; Wu CM, 2011, J ENDOCRINOL INVEST, V34, pE235, DOI 10.3275/7484; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zuccarello D, 2008, CLIN ENDOCRINOL, V68, P580, DOI 10.1111/j.1365-2265.2007.03069.x	29	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133997	10.1371/journal.pone.0133997	http://dx.doi.org/10.1371/journal.pone.0133997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207377	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000188
J	Nishimatsu, H; Suzuki, E; Saito, Y; Niimi, A; Nomiya, A; Yamada, D; Homma, Y				Nishimatsu, Hiroaki; Suzuki, Etsu; Saito, Yasuho; Niimi, Aya; Nomiya, Akira; Yamada, Daisuke; Homma, Yukio			Neuromedin B Restores Erectile Function by Protecting the Cavernous Body and the Nitrergic Nerves from Injury in a Diabetic Rat Model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BOMBESIN-RELATED PEPTIDES; MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; APOPTOSIS SURVIVAL FACTOR; PREFERRING RECEPTORS; HYPERTHYROID RATS; GENE-TRANSFER; FOOD-INTAKE; AGED RAT	Erectile dysfunction (ED) is a major health problem worldwide and affects approximately 75% of diabetic patients, likely due to severely damaged cavernous body. While screening for cytokines produced by adipose tissue-derived stem cells, we detected neuromedin B (NMB). To explore a potential treatment option for ED, we examined whether NMB was capable of restoring erectile function. We also examined the potential mechanism by which NMB could restore erectile function. Male Wistar rats were injected with streptozotocin (STZ) to induce diabetes. An adenovirus expressing NMB (AdNMB) was injected into the penis 6 weeks after STZ administration. Four weeks after the injection of AdNMB, erectile function, penile histology, and protein expression were analyzed. As assessed by the measurement of intracavernous pressure, AdNMB injection significantly restored erectile function compared with the injection of an adenovirus expressing green fluorescent protein. This restoration was associated with conservation of the cavernous body structure and neural nitric oxide synthase (nNOS)-expressing nerves, together with recovery of a-smooth muscle actin, vascular endothelial-cadherin, and nNOS expression. Furthermore, NMB significantly stimulated the survival of SH-SY5Y cells derived from human neuroblastoma tissue with characteristics similar to neurons. Collectively, these results suggested that NMB restored erectile function via protection of the cavernous body from injury and stimulation of the survival of the associated nerves. NMB may be useful to treat ED patients with a severely damaged cavernous body.	[Nishimatsu, Hiroaki; Saito, Yasuho; Niimi, Aya; Nomiya, Akira; Yamada, Daisuke; Homma, Yukio] Univ Tokyo, Dept Urol, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; [Suzuki, Etsu] St Marianna Univ, Inst Med Sci, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168512, Japan	University of Tokyo; Saint Marianna University	Suzuki, E (corresponding author), St Marianna Univ, Inst Med Sci, Sch Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168512, Japan.	esuzuki-tky@umin.ac.jp			FUGAKU TRUST FOR MEDICINAL RESEARCH; Ministry of Education, Culture, Sports, Science and Technology of Japan [24592422, 24592423]	FUGAKU TRUST FOR MEDICINAL RESEARCH; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grants-in-aid of the FUGAKU TRUST FOR MEDICINAL RESEARCH (http://www.smtb.jp/personal/entrustment/management/public/example/list.html), a Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan #24592422 (http://www.jsps.go.jp), and a Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan #24592423 (http://www.jsps.go.jp).	Albersen M, 2010, J SEX MED, V7, P3331, DOI 10.1111/j.1743-6109.2010.01875.x; Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Bivalacqua TJ, 2001, BIOL REPROD, V65, P1371, DOI 10.1095/biolreprod65.5.1371; Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1278, DOI 10.1152/ajpheart.00685.2006; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; Champion HC, 1999, P NATL ACAD SCI USA, V96, P11648, DOI 10.1073/pnas.96.20.11648; Christ GJ, 1998, AM J PHYSIOL-HEART C, V275, pH600, DOI 10.1152/ajpheart.1998.275.2.H600; Dey J, 2002, MAYO CLIN PROC, V77, P276, DOI 10.4065/77.3.276; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Hedlund P, 1999, BRIT J PHARMACOL, V127, P349, DOI 10.1038/sj.bjp.0702556; Kato H, 1997, ENDOCRINOLOGY, V138, P2615, DOI 10.1210/en.138.6.2615; Kendirci M, 2010, J UROLOGY, V184, P1560, DOI 10.1016/j.juro.2010.05.088; KILGORE WR, 1993, NEUROPEPTIDES, V24, P43, DOI 10.1016/0143-4179(93)90039-D; Kim IG, 2013, TISSUE ENG PT A, V19, P14, DOI [10.1089/ten.TEA.2011.0654, 10.1089/ten.tea.2011.0654]; Kim W, 2003, FASEB J, V17, P1937, DOI 10.1096/fj.02-1209fje; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Ladenheim EE, 1997, AM J PHYSIOL-REG I, V272, pR433, DOI 10.1152/ajpregu.1997.272.1.R433; Magee TR, 2002, BIOL REPROD, V67, P20, DOI 10.1093/biolreprod/67.1.20; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Merali Z, 2002, CELL MOL LIFE SCI, V59, P272, DOI 10.1007/s00018-002-8422-x; Merali Z, 1999, NEUROPEPTIDES, V33, P376, DOI 10.1054/npep.1999.0054; Merali Z, 2006, J NEUROSCI, V26, P10387, DOI 10.1523/JNEUROSCI.1219-06.2006; Milusheva EA, 1998, PEPTIDES, V19, P549, DOI 10.1016/S0196-9781(97)00467-1; MINAMINO N, 1983, BIOCHEM BIOPH RES CO, V114, P541, DOI 10.1016/0006-291X(83)90814-8; Mishra SK, 2012, J NEUROSCI, V32, P8686, DOI 10.1523/JNEUROSCI.1533-12.2012; Nishimatsu H, 2001, PEPTIDES, V22, P1913, DOI 10.1016/S0196-9781(01)00521-6; Nishimatsu H, 2013, J SEX MED, V10, P1707, DOI 10.1111/jsm.12177; Nishimatsu H, 2012, J SEX MED, V9, P482, DOI 10.1111/j.1743-6109.2011.02469.x; Nykanen AI, 2006, CIRC RES, V98, P1373, DOI 10.1161/01.RES.0000225987.52765.13; Park HJ, 2011, CANCER LETT, V312, P117, DOI 10.1016/j.canlet.2011.08.014; Park HJ, 2009, EXP CELL RES, V315, P3359, DOI 10.1016/j.yexcr.2009.08.009; PazosMoura CC, 1996, P SOC EXP BIOL MED, V211, P353; Pu XY, 2007, ASIAN J ANDROL, V9, P83, DOI 10.1111/j.1745-7262.2007.00215.x; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; RETTORI V, 1992, P NATL ACAD SCI USA, V89, P3035, DOI 10.1073/pnas.89.7.3035; Ryu JK, 2012, J SEX MED, V9, P3051, DOI 10.1111/j.1743-6109.2012.02962.x; SEVERI C, 1991, AM J PHYSIOL, V260, pG683, DOI 10.1152/ajpgi.1991.260.5.G683; Siroky MB, 2003, J UROLOGY, V170, pS24, DOI 10.1097/01.ju.0000075361.35942.17; Sun C, 2012, INT J ANDROL, V35, P601, DOI 10.1111/j.1365-2605.2012.01250.x; Suzuki E, 2002, CIRC RES, V90, P1004, DOI 10.1161/01.RES.0000017629.70769.CC; Suzuki E, 2000, J BIOL CHEM, V275, P3637, DOI 10.1074/jbc.275.5.3637; Takahashi M, 2010, AM J PHYSIOL-HEART C, V298, pH415, DOI 10.1152/ajpheart.00391.2009; VIGNE P, 1995, EUR J BIOCHEM, V233, P414, DOI 10.1111/j.1432-1033.1995.414_2.x	43	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133874	10.1371/journal.pone.0133874	http://dx.doi.org/10.1371/journal.pone.0133874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207818	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000161
J	Pan, N; Liu, ZZ; He, JJ; Li, S; Lv, XW; Wang, LM; Liu, QL				Pan, Ning; Liu, Zhenzhen; He, Jinjing; Li, Song; Lv, Xiangwei; Wang, Liming; Liu, Qinlong			Comparison of Methods for the Reconstruction of the Hepatic Artery in Mouse Orthotopic Liver Transplantation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MODEL; MICE	Background The mouse model of arterialized orthotopic liver transplantation (AOLT) has played an important role in biomedical research. The available methods of sutured anastomosis for reconstruction of the hepatic artery are complicated, resulting in a high incidence of complications and failure. Therefore, we developed and evaluated a new model of AOLT in mice. Materials and methods Male inbred C57BL/6 mice were used in this study. A continuous suture approach was applied to connect the suprahepatic inferior vena cava (SHVC). The portal vein and infrahepatic inferior vena cava (IHVC) were connected according to the "two-cuff" method. The common bile duct was connected by a biliary stent. We used the stent (G3 group) or aortic trunk (G2 group) to reconstruct the hepatic artery. The patency of the hepatic artery was verified by transecting the artery near the graft after one week. The survival rate of the recipients and serum alanine aminotransferase (ALT) levels, hepatic pathologic alterations, apoptosis and necrosis were observed at one week postoperatively. Results The patency of the hepatic artery was verified in eight of ten mice in G3 and in six of ten mice in G2. The 7-day survival rate, extents of necrosis and apoptosis, and TGF-beta levels were not significantly different among the three groups (P>0.05). However, the serum ALT levels and operation time were markedly lower in G3 compared with G2 or G1 (both P<0.05). Conclusions Reconstruction of the hepatic artery using a stent can be performed quickly with a high rate of patency. This model simplifies hepatic artery anastomosis and should be promoted in the field of biomedical research.	[Pan, Ning] Dalian Med Univ, Dept Anesthesiol, Affiliated Hosp 2, Dalian, Liaoning Provin, Peoples R China; [Liu, Zhenzhen; He, Jinjing; Li, Song; Lv, Xiangwei; Wang, Liming; Liu, Qinlong] Dalian Med Univ, Dept Gen Surg, Affiliated Hosp 2, Dalian, Liaoning Provin, Peoples R China; [Liu, Zhenzhen; He, Jinjing; Li, Song; Lv, Xiangwei] Dalian Med Univ, Dalian, Liaoning Provin, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University	Liu, QL (corresponding author), Dalian Med Univ, Dept Gen Surg, Affiliated Hosp 2, Dalian, Liaoning Provin, Peoples R China.	qinlongliu@163.com			National Natural Science Foundation of China [81470878, 81272368, 81471755]; Industry and Technology Bureau of Dalian [2013J21DW022]; Supporting Plan for Talents in Colleges and Universities of Liaoning Province, Department of Education of Liaoning Province [LJQ2013099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Industry and Technology Bureau of Dalian; Supporting Plan for Talents in Colleges and Universities of Liaoning Province, Department of Education of Liaoning Province	This study was supported by: National Natural Science Foundation of China (81470878) http://npd.nsfc.gov.cn/fundingProjectSearchAction.action; The Industry and Technology Bureau of Dalian (Number 2013J21DW022) http://kjjh.dlinfo.gov.cn/index.shtml; Supporting Plan for Talents in Colleges and Universities of Liaoning Province, Department of Education of Liaoning Province Number: LJQ2013099 http://www.lnein.gov.cn/kj/web/index.asp; National Natural Science Foundation of China (81272368) http://npd.nsfc.gov.cn/fundingProjectSearchAction.action; and National Natural Science Foundation of China (81471755) http://npd.nsfc.gov.cn/fundingProjectSearchAction.action. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birsner JH, J SURG RES, V120, P97; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Huang DR, 2010, HEPATOB PANCREAT DIS, V9, P264; Humar B, 2013, J SURG RES, V184, pE1, DOI 10.1016/j.jss.2013.03.022; LEE S, 1973, TRANSPLANTATION, V16, P664, DOI 10.1097/00007890-197312000-00019; Ma Y, 2007, CHINESE MED J-PEKING, V120, P1914, DOI 10.1097/00029330-200711010-00013; QIAN SG, 1991, TRANSPLANTATION, V52, P562; Qian SG, 1997, J IMMUNOL, V158, P4654; Que XY, 2004, J SURG RES, V116, P262, DOI 10.1016/j.jss.2003.07.005; Rehman H, 2008, J PHARMACOL EXP THER, V327, P699, DOI 10.1124/jpet.108.143578; Rehman H, 2011, TRANSPLANTATION, V91, P406, DOI 10.1097/TP.0b013e318204bdb2; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steger U, 2003, TRANSPLANTATION, V76, P327, DOI 10.1097/01.TP.0000071521.36828.F7; Tian YH, 2002, TRANSPLANTATION, V74, P1242, DOI 10.1097/00007890-200211150-00008; TYGSTRUP N, 1962, J CLIN INVEST, V41, P447, DOI 10.1172/JCI104497; Ueki S, 2010, HEPATOLOGY, V51, P1692, DOI 10.1002/hep.23501; Yan S, 2009, HEPATOB PANCREAT DIS, V8, P575; Zhong Z, 2008, AM J PHYSIOL-GASTR L, V295, pG823, DOI 10.1152/ajpgi.90287.2008; Zhou ST, 2014, J SURG RES, V187, P297, DOI 10.1016/j.jss.2013.10.024	21	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133030	10.1371/journal.pone.0133030	http://dx.doi.org/10.1371/journal.pone.0133030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207367	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000058
J	Serra, N; Rosales, R; Masana, L; Vallve, JC				Serra, Noem; Rosales, Roser; Masana, Lluis; Vallve, Joan-Carles			Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition	PLOS ONE			English	Article							STATIN THERAPY; PLAQUE NEOVASCULARIZATION; ATHEROSCLEROTIC PLAQUES; PROTEIN FIBULIN-1; COLLAGEN CONTENT; MATRIX; MECHANISMS; DISEASE; BINDING; STABILIZATION	The composition and structure of the extracellular matrix (ECM) in the vascular wall and in the atherosclerotic plaque are important factors that determine plaque stability. Statins can stabilize atherosclerotic plaques by modulating ECM protein expression. Fibulins are important components of the ECM. We evaluated the in vitro effect of simvastatin on the expression of fibulin-1, -2, -4 and -5 in human coronary artery smooth muscle cells (SMCs) and the mechanisms involved. Cells were incubated with simvastatin (0.05-1 mu M), mevalonate (100 and 200 mu M), geranylgeranyl pyrophosphate (GGPP) (15 mu M), farnesyl pyrophosphate (FPP) (15 mu M), the Rho kinase (ROCK) inhibitor Y-27632 (15 and 20 mu M), the Rac-1 inhibitor (another member of Rho family) NSC23766 (100 mu M), arachidonic acid (a RhoA/ROCK activator, 25-100 mu M) and other fatty acids that are not activators of RhoA/ROCK (25100 mu M). Gene expression was analyzed by quantitative real-time PCR, and fibulin protein levels were analyzed by western blotting and ELISA. Simvastatin induced a significant increase in mRNA and protein levels of fibulin-2 at 24 hours of incubation (p<0.05), but it did not affect fibulin-1, -4, and -5 expression. Mevalonate and GGPP were able to reverse simvastatin's effect, while FPP did not. In addition, Y-27632, but not NSC23766, significantly increased fibulin-2 expression. Furthermore, activation of the RhoA/ROCK pathway with arachidonic acid decreased fibulin-2 mRNA. Simvastatin increased mRNA levels and protein expression of the ECM protein fibulin-2 through a RhoA and Rho-Kinase-mediated pathway. This increase could affect the composition and structure of the ECM.	[Serra, Noem; Rosales, Roser; Masana, Lluis; Vallve, Joan-Carles] Univ Rovira & Virgili, Fac Med, Unitat Recerca Lipids & Arteriosclerosi,Inst Inve, CIBER Diabet & Enfermedades Metab Asociadas CIBER, E-43201 Reus, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Rovira i Virgili	Vallve, JC (corresponding author), Univ Rovira & Virgili, Fac Med, Unitat Recerca Lipids & Arteriosclerosi,Inst Inve, CIBER Diabet & Enfermedades Metab Asociadas CIBER, C St Llorenc 21, E-43201 Reus, Catalonia, Spain.	jc.vallve@urv.cat	Vallvé, Joan-Carles/T-6742-2019; Rosales, Roser/AAF-9511-2021; MASANA, LUIS/M-7002-2019	Vallvé, Joan-Carles/0000-0001-8711-9618; Rosales, Roser/0000-0002-9386-7169; MASANA, LUIS/0000-0002-0789-4954; Serra, Noemi/0000-0002-2277-351X	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [FIS PI030786]; Centro de Investigacion Biomedica de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Centro de Investigacion Biomedica de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	This work was supported by a grant from the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, [FIS PI030786]; and Centro de Investigacion Biomedica de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM).	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Babelova A, 2013, CURR OPIN PHARMACOL, V13, P260, DOI 10.1016/j.coph.2013.01.004; Bellosta S, 1998, ARTERIOSCL THROM VAS, V18, P1671, DOI 10.1161/01.ATV.18.11.1671; Birnbaum Y, 2012, CURR ATHEROSCLER REP, V14, P135, DOI 10.1007/s11883-012-0232-5; Brown M, 2014, BRIT J CANCER, V110, P2099, DOI 10.1038/bjc.2014.99; Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Davies MJ, 2000, HEART, V83, P361, DOI 10.1136/heart.83.3.361; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Doyle B, 2007, J AM COLL CARDIOL, V49, P2073, DOI 10.1016/j.jacc.2007.01.089; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Fukumoto Y, 2001, CIRCULATION, V103, P993; Garcia MC, 2011, FEBS LETT, V585, P618, DOI 10.1016/j.febslet.2011.01.035; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Green J, 2014, ATHEROSCLEROSIS, V232, P277, DOI 10.1016/j.atherosclerosis.2013.11.052; Gu YC, 2000, BRIT J HAEMATOL, V109, P305, DOI 10.1046/j.1365-2141.2000.02011.x; Hattori K, 2012, JACC-CARDIOVASC IMAG, V5, P169, DOI 10.1016/j.jcmg.2011.11.012; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hu B, 2012, CANCER RES, V72, P3873, DOI 10.1158/0008-5472.CAN-12-1060; Jeziorska M, 1999, J PATHOL, V188, P189; Laugesen E, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-107; Li MX, 2008, EUR J PHARMACOL, V591, P219, DOI 10.1016/j.ejphar.2008.06.082; Libby P, 2003, AM J CARDIOL, V91, p4B, DOI 10.1016/S0002-9149(02)03267-8; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Longmate WM, 2014, J INVEST DERMATOL, V134, P1609, DOI 10.1038/jid.2014.10; Mackay J, 2004, WHO ATLAS HEART DIS; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Nakamura T, 2008, J CARDIOVASC PHARM, V51, P365, DOI 10.1097/FJC.0b013e318165dcad; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Noda K, 2013, P NATL ACAD SCI USA, V110, P2852, DOI 10.1073/pnas.1215779110; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Papke CL, 2014, MATRIX BIOL, V37, P142, DOI 10.1016/j.matbio.2014.02.004; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Sasaki T, 1996, J CELL SCI, V109, P2895; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Sawyer SL, 2013, AM J MED GENET A, V161A, P1148, DOI 10.1002/ajmg.a.35827; Schaar JA, 2004, EUR HEART J, V25, P1077, DOI 10.1016/j.ehj.2004.01.002; Scholze A, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-6; SHAH PK, 1995, CIRCULATION, V92, P1565; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Sideek MA, 2014, MATRIX BIOL, V34, P114, DOI 10.1016/j.matbio.2013.10.007; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Takarada S, 2009, ATHEROSCLEROSIS, V202, P491, DOI 10.1016/j.atherosclerosis.2008.05.014; ten Kate GL, 2010, CURR PROB CARDIOLOGY, V35, P556, DOI 10.1016/j.cpcardiol.2010.09.002; Utani A, 1997, J BIOL CHEM, V272, P2814, DOI 10.1074/jbc.272.5.2814; Vallve JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043051; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wu XJ, 1997, ARTERIOSCL THROM VAS, V17, P3347, DOI 10.1161/01.ATV.17.11.3347; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478	56	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133875	10.1371/journal.pone.0133875	http://dx.doi.org/10.1371/journal.pone.0133875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207907	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000162
J	Tanner, JJ; Mareci, TH; Okun, MS; Bowers, D; Libon, DJ; Price, CC				Tanner, Jared J.; Mareci, Thomas H.; Okun, Michael S.; Bowers, Dawn; Libon, David J.; Price, Catherine C.			Temporal Lobe and Frontal-Subcortical Dissociations in Non-Demented Parkinson's Disease with Verbal Memory Impairment	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DEMENTIA; CORTEX; NEUROPSYCHOLOGY; MICROSTRUCTURE; SEGMENTATION; PROGRESSION; NETWORKS; CRITERIA; ROBUST	Objective The current investigation examined verbal memory in idiopathic non-dementia Parkinson's disease and the significance of the left entorhinal cortex and left entorhinal-retrosplenial region connections (via temporal cingulum) on memory impairment in Parkinson's disease. Methods Forty non-demented Parkinson's disease patients and forty non-Parkinson's disease controls completed two verbal memory tests - a wordlist measure (Philadelphia repeatable Verbal Memory Test) and a story measure (Logical Memory). All participants received T1-weighted and diffusion magnetic resonance imaging (3T; Siemens) sequences. Left entorhinal volume and left entorhinal-retrosplenial connectivity (temporal cingulum edge weight) were the primary imaging variables of interest with frontal lobe thickness and subcortical structure volumes as dissociating variables. Results Individuals with Parkinson's disease showed worse verbal memory, smaller entorhinal volumes, but did not differ in entorhinal-retrosplenial connectivity. For Parkinson's disease entorhinal-retrosplenial edge weight had the strongest associations with verbal memory. A subset of Parkinson's disease patients (23%) had deficits (z-scores < -1.5) across both memory measures. Relative to non-impaired Parkinson's peers, this memory-impaired group had smaller entorhinal volumes. Discussion Although entorhinal cortex volume was significantly reduced in Parkinson's disease patients relative to non-Parkinson's peers, only white matter connections associated with the entorhinal cortex were significantly associated with verbal memory performance in our sample. There was also no suggestion of contribution from frontal-subcortical gray or frontal white matter regions. These findings argue for additional investigation into medial temporal lobe gray and white matter connectivity for understanding memory in Parkinson's disease.	[Tanner, Jared J.; Bowers, Dawn; Price, Catherine C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Mareci, Thomas H.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Okun, Michael S.] Univ Florida, Dept Neurol, UF Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Libon, David J.] Drexel Univ, Coll Med, Drexel Neurosci Inst, Philadelphia, PA 19104 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Drexel University	Price, CC (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	cep23@phhp.ufl.edu	Mareci, Thomas Harold/D-7745-2011	Mareci, Thomas Harold/0000-0003-4700-2364; Tanner, Jared/0000-0001-6821-0029; Okun, Michael/0000-0002-6247-9358; Price, Catherine/0000-0001-5994-0644	National Institutes of Health National Institute of Neurological Disorders and Stroke [K23NS60660, R01NR014810, R01NS082386]; Center for Movement Disorders and Neurorestoration; National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award [UL1TR000064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427, UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS060660, R01NS082386] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Movement Disorders and Neurorestoration; National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health National Institute of Neurological Disorders and Stroke K23NS60660 (CP), R01NR014810 (CP) and R01NS082386 (CP), and in part by the Center for Movement Disorders and Neurorestoration, and the National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award to the University of Florida UL1TR000064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondi MW, 2014, J ALZHEIMERS DIS, V42, P275, DOI 10.3233/JAD-140276; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Briggs GG, CORTEX, V11, P230; Bronnick K, 2011, NEUROPSYCHOLOGY, V25, P114, DOI 10.1037/a0020857; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Filoteo JV, 1997, J CLIN EXP NEUROPSYC, V19, P878, DOI 10.1080/01688639708403768; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Goldman JG, 2012, MOVEMENT DISORD, V27, P727, DOI 10.1002/mds.24938; Gratwicke J, 2015, BRAIN, V138, P1454, DOI 10.1093/brain/awv104; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; Heaton RK, 2004, PSYCHOL ASSESS RESOU; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Jak AJ, 2009, INT REV NEUROBIOL, V84, P81, DOI 10.1016/S0074-7742(09)00405-X; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jian B, 2007, NEUROIMAGE, V37, P164, DOI 10.1016/j.neuroimage.2007.03.074; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Kalaitzakis ME, 2009, PARKINSONISM RELAT D, V15, P196, DOI 10.1016/j.parkreldis.2008.05.007; Libon DJ, 2014, J ALZHEIMERS DIS, V42, P999, DOI 10.3233/JAD-132147; Libon DJ, 2011, J INT NEUROPSYCH SOC, V17, P905, DOI 10.1017/S1355617711000944; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Matteau E, 2011, AM J ALZHEIMERS DIS, V26, P389, DOI 10.1177/1533317511412046; McDonald CR, 2014, CORTEX, V58, P139, DOI 10.1016/j.cortex.2014.05.014; Osborne J.W., 2010, PRACTICAL ASSESS RES, V15, P1, DOI [10.7275/qbpc-gk17, DOI 10.7275/QBPC-GK17]; Price CC, 2010, J INT NEUROPSYCH SOC, V16, P846, DOI 10.1017/S135561771000072X; Price CC, 2009, CLIN NEUROPSYCHOL, V23, P944, DOI 10.1080/13854040802681664; Price CC, 2012, JINS, V18, P200; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Troster AI, 2011, J INT NEUROPSYCH SOC, V17, P393, DOI 10.1017/S1355617711000257; Vogt BA, 2000, TRENDS NEUROSCI, V23, P195, DOI 10.1016/S0166-2236(00)01579-4; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zahodne LB, 2011, CLIN NEUROPSYCHOL, V25, P348, DOI 10.1080/13854046.2011.562869; Zgaljardic Dennis J, 2003, Cogn Behav Neurol, V16, P193, DOI 10.1097/00146965-200312000-00001; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zheng Z, 2014, HUM BRAIN MAPP, V35, P1325, DOI 10.1002/hbm.22256	49	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133792	10.1371/journal.pone.0133792	http://dx.doi.org/10.1371/journal.pone.0133792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208170	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000145
J	Wang, N; Zheng, Y; Duan, NB; Zhang, ZY; Ji, XH; Jiang, SH; Sun, SS; Yang, L; Bai, Y; Fei, ZJ; Chen, XS				Wang, Nan; Zheng, Yi; Duan, Naibin; Zhang, Zongying; Ji, Xiaohao; Jiang, Shenghui; Sun, Shasha; Yang, Long; Bai, Yang; Fei, Zhangjun; Chen, Xuesen			Comparative Transcriptomes Analysis of Red- and White-Fleshed Apples in an F-1 Population of Malus sieversii f. niedzwetzkyana Crossed with M. domestica 'Fuji'	PLOS ONE			English	Article							GENE-EXPRESSION; MYB-GENE; ANTHOCYANIN BIOSYNTHESIS; ASCORBATE PEROXIDASE; CONFERS TOLERANCE; MOLECULAR-CLONING; ABIOTIC STRESS; SALT STRESS; FRUIT; DROUGHT	Transcriptome profiles of the red- and white-fleshed apples in an F-1 segregating population of Malus sieversii f. Niedzwetzkyana and M. domestica 'Fuji' were generated using the next-generation high-throughput RNA sequencing (RNA-Seq) technology and compared. A total of 114 differentially expressed genes (DEGs) were obtained, of which 88 were up-regulated and 26 were down-regulated in red-fleshed apples. The 88 up-regulated genes were enriched with those related to flavonoid biosynthetic process and stress responses. Further analysis identified 22 genes associated with flavonoid biosynthetic process and 68 genes that may be related to stress responses. Furthermore, the expression of 20 up-regulated candidate genes (10 related to flavonoid biosynthesis, two encoding MYB transcription factors and eight related to stress responses) and 10 down-regulated genes were validated by quantitative real-time PCR. After exploring the possible regulatory network, we speculated that flavonoid metabolism might be involved in stress responses in red-fleshed apple. Our findings provide a theoretical basis for further enriching gene resources associated with flavonoid synthesis and stress responses of fruit trees and for breeding elite apples with high flavonoid content and/or increased stress tolerances.	[Wang, Nan; Duan, Naibin; Zhang, Zongying; Ji, Xiaohao; Jiang, Shenghui; Sun, Shasha; Yang, Long; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Wang, Nan; Duan, Naibin; Zhang, Zongying; Ji, Xiaohao; Jiang, Shenghui; Sun, Shasha; Yang, Long; Chen, Xuesen] Shandong Agr Univ, Coll Hort Sci, Tai An, Shandong, Peoples R China; [Zheng, Yi; Bai, Yang; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Duan, Naibin] Shandong Acad Agr Sci, Shandong Ctr Crop Germplasm Resources, Jinan, Shandong, Peoples R China; [Yang, Long] Shandong Agr Univ, Tobacco Lab, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Cornell University; Boyce Thompson Institute for Plant Research; Shandong Academy of Agricultural Sciences; Shandong Agricultural University	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Zheng, Yi/F-6150-2016; Wang, Nan/GRY-3150-2022; Jiang, Shenghui/HHS-5691-2022; shi, zhensheng/GXN-3967-2022; Fei, Zhangjun/H-5152-2012	Zheng, Yi/0000-0002-8042-7770; Jiang, Shenghui/0000-0003-3550-9037; Duan, Naibin/0000-0003-0443-0406; Yang, Long/0000-0002-9990-8398	Special Fund for Agro-scientific Research in the Public Interest [201303093]; Natl. Natural Science Foundation of China [31171932]; National Key Basic Research Program of China from Ministry of Science and Technology and Agriculture of the People's Republic of China [2011CB100606]	Special Fund for Agro-scientific Research in the Public Interest; Natl. Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China from Ministry of Science and Technology and Agriculture of the People's Republic of China	This work was financially supported by Special Fund for Agro-scientific Research in the Public Interest (to XSC, grant no. 201303093, URL: http://www.most.gov.cn/), Natl. Natural Science Foundation of China (to XSC, grant no. 31171932, URL: http://www.nsfc.gov.cn/) and National Key Basic Research Program of China (to XSC, grant no. 2011CB100606, URL: http://www.most.gov.cn/) from Ministry of Science and Technology and Agriculture of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRITT BH, 2003, COMPACT FRUIT TREE, V36, P15; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt D, 2013, MOL BIOL REP, V40, P1155, DOI 10.1007/s11033-012-2157-z; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Cao H, 2008, ACTA HORTICULTURAE S, V35, P1351; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chen XS, 1994, J SHANDONG AGR U, V25, P36; [陈学森 Chen Xuesen], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P2193; Chen XueSen, 2010, Journal of Fruit Science, V27, P598; Chen Xuesen, 2007, Journal of Genetics and Genomics, V34, P171, DOI 10.1016/S1673-8527(07)60018-6; Chen YH, 2006, J INTEGR PLANT BIOL, V48, P1084, DOI 10.1111/j.1744-7909.2006.00311.x; Cho WK, 2014, MOL BIOL REP, V41, P1469, DOI 10.1007/s11033-013-2992-6; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; Conn S, 2008, J EXP BOT, V59, P3621, DOI 10.1093/jxb/ern217; Csiszar J, 2014, PLANT PHYSIOL BIOCH, V78, P15, DOI 10.1016/j.plaphy.2014.02.010; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; De Vos M, 2006, PLANT SIGNAL BEHAV, V1, P305, DOI 10.4161/psb.1.6.3512; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Feng Tao, 2007, Journal of Fruit Science, V24, P571; Feng TingTing, 2007, Journal of Fruit Science, V24, P199; Fini A, 2011, PLANT SIGNAL BEHAV, V168, P204; Galle Agnes, 2008, Acta Biologica Szegediensis, V52, P95; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Ithal N, 2004, PLANT SCI, V166, P1505, DOI 10.1016/j.plantsci.2004.02.002; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Ji XH, 2015, PLANT CELL TISS ORG, V120, P325, DOI 10.1007/s11240-014-0609-y; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Kussmaul L, 2015, PNAS, V103, P7607; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Liu ZH, 2013, BIOTECHNOL LETT, V35, P1765, DOI 10.1007/s10529-013-1277-4; Liu ZunChun, 2012, Journal of Fruit Science, V29, P722; Liu ZunChun, 2010, Scientia Agricultura Sinica, V43, P358; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mare C, 2004, PLANT MOL BIOL, V55, P399, DOI 10.1007/s11103-004-0906-7; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Moyano E, 1996, PLANT CELL, V8, P1519, DOI 10.1105/tpc.8.9.1519; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Patra B, 2013, BBA-GENE REGUL MECH, V1829, P1236, DOI 10.1016/j.bbagrm.2013.09.006; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Reddy AM, 2007, METAB ENG, V9, P95, DOI 10.1016/j.ymben.2006.09.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Sharma S, 2010, PLANT CELL ENVIRON, V33, P1838, DOI 10.1111/j.1365-3040.2010.02188.x; Shu HR, 1999, APPLE SCI, P26; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao F., 2006, J PLANT GENETIC RESO, V7, P270; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Umemura H, 2013, PLANTA, V238, P65, DOI 10.1007/s00425-013-1875-3; van Nocker S, 2012, EUPHYTICA, V185, P281, DOI 10.1007/s10681-011-0579-7; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang Y, 2012, NANO, V7, DOI 10.1142/S1793292012500427; Wang YanLing, 2010, Scientia Agricultura Sinica, V43, P2735; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; [吴传金 WU Chuanjin], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P243; [肖庆生 Xiao Qingsheng], 2012, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V34, P123; Xu F, 2008, MOL CELLS, V26, P536; Xu Qian, 2009, BMC GENOMICS, V10, P1; [许瑞瑞 Xu Ruirui], 2012, [园艺学报, Acta Horticulturae Sinica], V39, P2049; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Yu SW, 2008, ACTA BIOCH BIOPH SIN, V40, P1005, DOI 10.1111/j.1745-7270.2008.00489.x; Yu Y, 2003, PROGR BIOTECHNOLOGY, V2003; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang ChunYu, 2009, Acta Horticulturae Sinica, V36, P7; Zhang ChunYu, 2009, Scientia Agricultura Sinica, V42, P597; Zhang Chunyu, 2007, Journal of Genetics and Genomics, V34, P947, DOI 10.1016/S1673-8527(07)60106-4; Zhang JiYu, 2011, Scientia Agricultura Sinica, V44, P990; Zhang XiaoYan, 2008, Acta Horticulturae Sinica, V35, P1351; Zhang YanMin, 2009, Acta Horticulturae Sinica, V36, P447; Zhao LingLing, 2008, Journal of Fruit Science, V25, P151; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950	87	20	22	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133468	10.1371/journal.pone.0133468	http://dx.doi.org/10.1371/journal.pone.0133468			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207813	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000091
J	Lionetti, V; Raiola, A; Mattei, B; Bellincampi, D				Lionetti, Vincenzo; Raiola, Alessandro; Mattei, Benedetta; Bellincampi, Daniela			The Grapevine VvPMEI1 Gene Encodes a Novel Functional Pectin Methylesterase Inhibitor Associated to Grape Berry Development	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; CELL-WALL; METHYL-ESTERIFICATION; KIWI FRUIT; GLYCOPROTEIN INHIBITOR; DISEASE RESISTANCE; MODIFYING ENZYMES; EXPRESSION; POLYGALACTURONASE; HOMOGALACTURONAN	Pectin is secreted in a highly methylesterified form and partially de-methylesterified in the cell wall by pectin methylesterases (PMEs). PME activity is expressed during plant growth, development and stress responses. PME activity is controlled at the post-transcriptional level by proteins named PME inhibitors (PMEIs). We have identified, expressed and characterized VvPMEI1, a functional PME inhibitor of Vitis vinifera. VvPMEI1 typically affects the activity of plant PMEs and is inactive against microbial PMEs. The kinetics of PMEI-PME interaction, studied by surface plasmon resonance, indicates that the inhibitor strongly interacts with PME at apoplastic pH while the stability of the complex is reduced by increasing the pH. The analysis of VvPMEI1 expression in different grapevine tissues and during grape fruit development suggests that this inhibitor controls PME activity mainly during the earlier phase of berry development. A proteomic analysis performed at this stage indicates a PME isoform as possible target of VvPMEI1.	[Lionetti, Vincenzo; Mattei, Benedetta; Bellincampi, Daniela] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Raiola, Alessandro] Univ Padua, Dipartimento Terr & Sistemi Agroforestali, Legnaro, PD, Italy	Sapienza University Rome; University of Padua	Bellincampi, D (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	daniela.bellincampi@uniroma1.it	Mattei, Benedetta/C-3013-2019; Lionetti, Vincenzo/J-6145-2014; raiola, alessandro/K-8262-2015; Mattei, Benedetta/F-1504-2015; Raiola, Alessandro/AAV-7186-2020	Mattei, Benedetta/0000-0003-2927-6329; Lionetti, Vincenzo/0000-0002-2262-1479; raiola, alessandro/0000-0002-3635-9117; Mattei, Benedetta/0000-0003-2927-6329; Raiola, Alessandro/0000-0002-3635-9117	Ministero dell'Istruzione, dell'Universita e della Ricerca; PRIN [2010T7247Z]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca; PRIN Grant n. 2010T7247Z, http://www.istruzione.it/, to DB.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; An SH, 2008, PLANTA, V228, P61, DOI 10.1007/s00425-008-0719-z; Atkinson RG, 1998, PLANT MOL BIOL, V38, P449, DOI 10.1023/A:1006065926397; BALESTRIERI C, 1990, EUR J BIOCHEM, V193, P183, DOI 10.1111/j.1432-1033.1990.tb19321.x; Barnavon L, 2001, PHYTOCHEMISTRY, V58, P693, DOI 10.1016/S0031-9422(01)00274-6; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Bellincampi D, 2004, BBA-PROTEINS PROTEOM, V1696, P265, DOI 10.1016/j.bbapap.2003.10.011; Bellincampi D, 2004, Patent Application, Patent No. [PCT/IT2004/000390, 2004000390]; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Camardella L, 2000, EUR J BIOCHEM, V267, P4561, DOI 10.1046/j.1432-1327.2000.01510.x; CASTALDO D, 1991, J FOOD SCI, V56, P1632, DOI 10.1111/j.1365-2621.1991.tb08658.x; Ciardiello MA, 2008, PROTEINS, V71, P195, DOI 10.1002/prot.21681; da Silva FG, 2005, PLANT PHYSIOL, V139, P574, DOI 10.1104/pp.105.065748; Derbyshire P, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-31; Deytieux-Belleau C, 2008, PLANT PHYSIOL BIOCH, V46, P638, DOI 10.1016/j.plaphy.2008.04.008; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Dietrich DE, 2014, PEPTIDES, V53, P265, DOI 10.1016/j.peptides.2014.01.017; Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847; Ezaki N, 2005, PLANT CELL PHYSIOL, V46, P1831, DOI 10.1093/pcp/pci199; Fusada N, 2005, PLANT MOL BIOL, V59, P631, DOI 10.1007/s11103-005-0579-x; Geroyiannaki M, 2007, FOOD CONTROL, V18, P988, DOI 10.1016/j.foodcont.2006.06.005; GIOVANE A, 1995, EUR J BIOCHEM, V233, P926, DOI 10.1111/j.1432-1033.1995.926_3.x; Giovane A, 2004, BBA-PROTEINS PROTEOM, V1696, P245, DOI 10.1016/j.bbapap.2003.08.011; Hong MJ, 2010, GENES GENET SYST, V85, P97, DOI 10.1266/ggs.85.97; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Jolie RP, 2010, FOOD CHEM, V121, P207, DOI 10.1016/j.foodchem.2009.11.073; Kanellis AK, 1993, BIOCH FRUIT RIPENING, P189, DOI DOI 10.1007/978-94-011-1584-1_6; KLAVONS JA, 1986, J AGR FOOD CHEM, V34, P597, DOI 10.1021/jf00070a004; Lante A, PCTEP2008052347; LECAM B, 1994, PHYSIOL MOL PLANT P, V44, P187, DOI 10.1016/S0885-5765(05)80003-7; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Lionetti V, 2015, PHYTOCHEMISTRY, V112, P188, DOI 10.1016/j.phytochem.2014.07.025; Lionetti V, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0369-1; Lionetti V, 2014, MOL PLANT PATHOL, V15, P265, DOI 10.1111/mpp.12090; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; Luo H, 2005, PLANT BIOLOGY, V7, P459, DOI 10.1055/s-2005-865851; Mattei B, 2002, ROY SOC CH, P160, DOI 10.1039/9781847550323-00160; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Muller K, 2013, PLANT PHYSIOL, V161, P305, DOI 10.1104/pp.112.205724; Nunan KJ, 2001, PLANTA, V214, P257, DOI 10.1007/s004250100609; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Peaucelle A, 2008, CURR BIOL, V18, P1943, DOI 10.1016/j.cub.2008.10.065; Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raiola A, 2004, FEBS LETT, V557, P199, DOI 10.1016/S0014-5793(03)01491-1; Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157; Rausch T, 2004, BBA-PROTEINS PROTEOM, V1696, P253, DOI 10.1016/j.bbapap.2003.09.017; Reca IB, 2012, PLANT MOL BIOL, V79, P429, DOI 10.1007/s11103-012-9921-2; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Rocchi V, 2012, PLANT BIOLOGY, V14, P365, DOI 10.1111/j.1438-8677.2011.00508.x; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Saez-Aguayo S, 2013, PLANT CELL, V25, P308, DOI 10.1105/tpc.112.106575; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sorensen JF, 2004, BBA-PROTEINS PROTEOM, V1696, P275, DOI 10.1016/j.bbapap.2003.09.016; Srivastava Sudhakar, 2012, Physiology and Molecular Biology of Plants, V18, P191, DOI 10.1007/s12298-012-0102-1; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Volpi C, 2011, MOL PLANT MICROBE IN, V24, P1012, DOI 10.1094/MPMI-01-11-0021; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Wolf S, 2003, FEBS LETT, V555, P551, DOI 10.1016/S0014-5793(03)01344-9; Wolf S, 2012, CURR BIOL, V22, P1732, DOI 10.1016/j.cub.2012.07.036; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Xu NF, 1997, PLANT SCI, V126, P193, DOI 10.1016/S0168-9452(97)00110-6; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Zhang GY, 2010, PLANTA, V231, P1323, DOI 10.1007/s00425-010-1136-7; Zocca F, 2008, J I BREWING, V114, P262, DOI 10.1002/j.2050-0416.2008.tb00337.x; Zocca F, 2007, FOOD CHEM, V102, P59, DOI 10.1016/j.foodchem.2006.01.061	73	25	27	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133810	10.1371/journal.pone.0133810	http://dx.doi.org/10.1371/journal.pone.0133810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204516	Green Submitted, gold, Green Published			2022-12-26	WOS:000358621000040
J	Valdez-Tah, A; Huicochea-Gomez, L; Ortega-Canto, J; Nazar-Beutelspacher, A; Ramsey, JM				Valdez-Tah, Alba; Huicochea-Gomez, Laura; Ortega-Canto, Judith; Nazar-Beutelspacher, Austreberta; Ramsey, Janine M.			Social Representations and Practices Towards Triatomines and Chagas Disease in Calakmul, Mexico	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; RISK-FACTORS; AMERICAN TRYPANOSOMIASIS; YUCATAN PENINSULA; HOUSE INFESTATION; LATIN-AMERICA; VECTOR; INFECTION; TRANSMISSION; PALLIDIPENNIS	Vector-borne transmission of Trypanosoma cruzi (VBTTc) is dependent on the concomitant interaction between biological and environmental hazard over the entire landscape, and human vulnerability. Representations and practices of health-disease-care-seeking and territorial appropriation and use were analyzed for VBTTc in a qualitative ethnographic study in the Zoh-Laguna landscape, Campeche, Mexico. In-depth interviews and participatory observation explored representations and practices regarding ethno-ecological knowledge related to vector- transmission, health-disease-care-seeking, and land use processes. The population has a broad knowledge of biting insects, which they believe are all most abundant in the rainy season; the community ' s proximity to natural areas is perceived as a barrier to control their abundance. Triatomines are mostly recognized by men, who have detailed knowledge regarding their occurrence and association with mammals in non-domestic fragments, where they report being bitten. Women emphasize the dermal consequences of triatomine bites, but have little knowledge about the disease. Triatomine bites and the chinchoma are "normalized" events which are treated using home remedies, if at all. The neglected condition of Chagas disease in Mexican public health policies, livelihoods which are dependent on primary production, and gender-related knowledge (or lack thereof) are structural circumstances which influence the environment and inhabitants ' living conditions; in turn, these trigger triatomine-human contact. The most important landscape practices producing vulnerability are the activities and mobility within and between landscape fragments causing greater exposure of inhabitants primarily in the dry season. A landscape approach to understanding vulnerability components of VBTTc from health-disease-care-seeking perspectives and based on territorial appropriation and use, is essential where there is continuousmovement of vectors between and within all habitats. An understanding of the structural factors whichmotivate the population's perceptions, beliefs, and practices and which create and maintain vulnerability is essential to develop culturally relevant and sustainable community-based VBTTc prevention and control.	[Valdez-Tah, Alba; Huicochea-Gomez, Laura] El Colegio Frontera Sur, Dept Sociedad & Cultura, Campeche, Campeche, Mexico; [Valdez-Tah, Alba; Ramsey, Janine M.] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico; [Ortega-Canto, Judith] Univ Autonoma Yucatan, Ctr Reg Invest Biomed Dr Hideyo Noguchi, Merida, Yucatan, Mexico; [Nazar-Beutelspacher, Austreberta] El Colegio Frontera, Dept Salud, San Cristobal Las Casas, Chiapas, Mexico	El Colegio de la Frontera Sur (ECOSUR); Instituto Nacional de Salud Publica; Universidad Autonoma de Yucatan	Ramsey, JM (corresponding author), Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico.	jramsey@insp.mx	Ramsey, Janine M./AAS-2220-2021	Ramsey, Janine M./0000-0002-5950-0830	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [69997, 161405, 151816]; CONACYT [203790]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	JMR received financial support for this investigation from Consejo Nacional de Ciencia y Tecnologia (CONACYT) #69997, #161405 and #151816. AVT received a PhD scholarship from CONACYT #203790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2009, ACTA TROP, V110, P159, DOI 10.1016/j.actatropica.2008.06.005; Lopez-Cancino SA, 2015, ACTA TROP, V151, P58, DOI 10.1016/j.actatropica.2015.07.021; AZOGUE E, 1993, SOC SCI MED, V37, P503, DOI 10.1016/0277-9536(93)90285-C; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Briceno-Leon R, 2007, MEM I OSWALDO CRUZ, V102, P109, DOI 10.1590/S0074-02762007005000095; Caballero Zamora A, 1999, ENFERMEDAD CHAGAS BO; Carabarin-Lima A, 2013, ACTA TROP, V127, P126, DOI 10.1016/j.actatropica.2013.04.007; Cardona OD, NECESIDAD PENSAR MAN; Cecere MC, 1998, B WORLD HEALTH ORGAN, V76, P373; Ciannameo A., 1998, ARCHIVOS, V17, P39; Civetta A, 2003, PREC ARG ASS SPEC LA; Costa-Neto EM, 2002, HUM ECOL, V30, P245, DOI 10.1023/A:1015696830997; Coura JR, 1999, MEM I OSWALDO CRUZ, V94, P379, DOI 10.1590/S0074-02761999000700074; De Rego PI, 2006, PARASITE, V13, P237, DOI 10.1051/parasite/2006133237; DEANDRADE ALSS, 1995, AM J TROP MED HYG, V53, P443, DOI 10.4269/ajtmh.1995.53.443; Dell'Arciprete A, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-6; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Dumonteil E, 2007, AM J TROP MED HYG, V76, P930, DOI 10.4269/ajtmh.2007.76.930; Emperaire L, 2006, PARASITE, V13, P171, DOI 10.1051/parasite/2006132171; Enger KS, 2004, J MED ENTOMOL, V41, P760, DOI 10.1603/0022-2585-41.4.760; Farfán-García Ana E, 2011, Rev. salud pública, V13, P163, DOI 10.1590/S0124-00642011000100014; Freitas Simone Patrícia Carneiro, 2004, Cad. Saúde Pública, V20, P333, DOI 10.1590/S0102-311X2004000100052; Gomes TF, 2003, WORLD HLTH POPUL, V14, P14; Gottdenker NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001884; Grijalva MJ, 2010, MEM I OSWALDO CRUZ, V105, P677, DOI 10.1590/S0074-02762010000500013; Gurtler RE, 1998, AM J TROP MED HYG, V58, P748, DOI 10.4269/ajtmh.1998.58.748; Hammersley M., 2010, ETHNOGRAPHY PRINCIPL; Hashimoto K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-45; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Inhorn C, 1997, INT HLTH PERSPECTIVE; Instituto Nacional de Estadstica e Informatica, 2011, SIST EST NAC ANC COM; Jodelet D., 1986, PSICOLOGIA SOCIAL, P469; Kroeger A, 1999, TROP MED INT HEALTH, V4, P194, DOI 10.1046/j.1365-3156.1999.43370.x; Leon Canelon M, 2002, REV INTERAMERICANA P, V36, P21; Magnani C, 2009, CAD SAUDE PUBLICA, V25, P1624; Bustamante DM, 2009, CAD SAUDE PUBLICA, V25, pS83, DOI 10.1590/S0102-311X2009001300008; Mastrangelo A, 2009, RELACIONES SOCIALES; Mota J, 2007, VECTOR-BORNE ZOONOT, V7, P617, DOI 10.1089/vbz.2007.0106; Ramsey JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046013; Ramsey JM, 2005, MED VET ENTOMOL, V19, P219, DOI 10.1111/j.0269-283X.2005.00563.x; Ramsey JM, 2003, SALUD PUBLICA MEXICO, V45, P123, DOI 10.1590/S0036-36342003000200010; Ramsey JM, 2003, INICIATIVA VIGILANCI, P85; Reidpath DD, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-1; Rodriguez M, 2002, MEMORIAS ECLAT AMCHA; Rodriguez-Cerda O, 2003, RELACIONES INVIERNO, V93, P81; Rosecrans K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002763; Buitrago NLR, 2013, INFECT GENET EVOL, V19, P141, DOI 10.1016/j.meegid.2013.07.002; Roux E, 2011, GEOSPATIAL HEALTH, V6, P41, DOI 10.4081/gh.2011.156; SALAZARSCHETTINO PM, 1983, AM J TROP MED HYG, V32, P1179, DOI 10.4269/ajtmh.1983.32.1179; Sanmartino M, 2009, REV SALUD PUBLICA, VXIII, P74, DOI [DOI 10.31052/1853.1180.V13.N1.7112, 10.31052/1853.1180.v13.n1.7112]; Sanmartino M, 2009, REV BIOMED, V20, P216; Sanmartino M, 2005, HACER FRENTE CHAGAS; Silveira AC, 1999, MEM I OSWALDO CRUZ, V94, P405, DOI 10.1590/S0074-02761999000700080; Sosa-Estani S, 2006, CURR OPIN INFECT DIS, V19, P583, DOI 10.1097/01.qco.0000247592.21295.a5; Strauss A., 1990, BASICS QUALITATIVE R; Suárez Roberto, 2006, Antipod. Rev. Antropol. Arqueol., P123; Taylor StevenJ., 1994, INTRO METODOS CUALIT; Telleria J, 2010, ELSEV INSIGHT, P1, DOI 10.1016/B978-0-12-384876-5.00021-6; Valdez-Tah A, 2015, SALUD COLEC IN PRESS; Vazquez-Prokopec GM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001788; Velasco-Castrejon O, 1992, Salud Publica Mex, V34, P186; Ventura-Garcia L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002410; Vinas Albajar Pedro, 2003, Rev Soc Bras Med Trop, V36, P401; Waleckx E, 2015, MEM I OSWALDO CRUZ, V110, P324, DOI 10.1590/0074-02760140409; Walter Annie, 2005, Cad. Saúde Pública, V21, P974, DOI 10.1590/S0102-311X2005000300034; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; Xavier SCC, 2007, PARASITOL INT, V56, P119, DOI 10.1016/j.parint.2007.01.003	67	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132830	10.1371/journal.pone.0132830	http://dx.doi.org/10.1371/journal.pone.0132830			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NJ	26204555	Green Published, gold, Green Submitted			2022-12-26	WOS:000358621000013
J	Sanchez, MB; Decorosi, F; Viti, C; Oggioni, MR; Martinez, JL; Hernandez, A				Blanca Sanchez, Maria; Decorosi, Francesca; Viti, Carlo; Oggioni, Marco Rinaldo; Luis Martinez, Jose; Hernandez, Alvaro			Predictive Studies Suggest that the Risk for the Selection of Antibiotic Resistance by Biocides Is Likely Low in Stenotrophomonas maltophilia	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMP; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIONS; MUTATION FREQUENCIES; FUNCTIONAL-ANALYSIS; OXIDASE LEADS; TRICLOSAN; SMEDEF; OVEREXPRESSION; MECHANISMS	Biocides are used without restriction for several purposes. As a consequence, large amounts of biocides are released without any control in the environment, a situation that can challenge the microbial population dynamics, including selection of antibiotic resistant bacteria. Previous work has shown that triclosan selects Stenotrophomonas maltophilia antibiotic resistant mutants overexpressing the efflux pump SmeDEF and induces expression of this pump triggering transient low-level resistance. In the present work we analyze if two other common biocides, benzalkonium chloride and hexachlorophene, trigger antibiotic resistance in S. maltophilia. Bioinformatic and biochemical methods showed that benzalkonium chloride and hexachlorophene bind the repressor of smeDEF, SmeT. Only benzalkonium chloride triggers expression of smeD and its effect in transient antibiotic resistance is minor. None of the hexachlorophene-selected mutants was antibiotic resistant. Two benzalkonium chloride resistant mutants presented reduced susceptibility to antibiotics and were impaired in growth. Metabolic profiling showed they were more proficient than their parental strain in the use of some dipeptides. We can then conclude that although bio-informatic predictions and biochemical studies suggest that both hexachlorophene and benzalkonium chloride should induce smeDEF expression leading to transient S. maltophilia resistance to antibiotics, phenotypic assays showed this not to be true. The facts that hexachlorophene resistant mutants are not antibiotic resistant and that the benzalkonium chloride resistant mutants presenting altered susceptibility to antibiotics were impaired in growth suggests that the risk for the selection (and fixation) of S. maltophilia antibiotic resistant mutants by these biocides is likely low, at least in the absence of constant selection pressure.	[Blanca Sanchez, Maria; Luis Martinez, Jose; Hernandez, Alvaro] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid 28049, Spain; [Decorosi, Francesca; Viti, Carlo] Univ Florence, Dipartimento Sci Prod Agroalimentari & Ambiente, Florence, Italy; [Oggioni, Marco Rinaldo] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Florence; University of Leicester	Martinez, JL (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Darwin 3, Madrid 28049, Spain.	jlmtnez@cnb.csic.es; ahernandez@cicbiomagune.es	Sanchez, Maria Blanca/AAD-8294-2020; Ríos-Muñoz, Cesar A./J-9384-2012; Oggioni, Marco Rinaldo/K-3839-2016; Martinez, Jose L/A-4725-2013	Sanchez, Maria Blanca/0000-0002-5209-4518; Ríos-Muñoz, Cesar A./0000-0002-3423-8936; Oggioni, Marco Rinaldo/0000-0003-4117-793X; Martinez, Jose L/0000-0001-8813-7607; VITI, CARLO/0000-0001-7188-549X	Spanish Ministry of Economy and Competitivity; Madrid Autonomous Community [BIO2011-25255, S2010/BMD2414 (PROMPT)]; Instituto de Salud Carlos III (Spanish Network for Research on Infectious Diseases) [REIPI RD12/0015]; European Union [HEALTH-F3-2011-282004 (EVOTAR)]	Spanish Ministry of Economy and Competitivity(Spanish Government); Madrid Autonomous Community; Instituto de Salud Carlos III (Spanish Network for Research on Infectious Diseases)(Instituto de Salud Carlos III); European Union(European Commission)	This study was supported by grants from the Spanish Ministry of Economy and Competitivity; (BIO2011-25255) from Madrid Autonomous Community (S2010/BMD2414 (PROMPT)); from the Instituto de Salud Carlos III (Spanish Network for Research on Infectious Diseases (REIPI RD12/0015)); and from the European Union (HEALTH-F3-2011-282004 (EVOTAR)) to JLM.	Aiello AE, 2003, LANCET INFECT DIS, V3, P501, DOI 10.1016/S1473-3099(03)00723-0; Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Alonso A, 2000, ANTIMICROB AGENTS CH, V44, P3079, DOI 10.1128/AAC.44.11.3079-3086.2000; Alonso A, 2004, J ANTIMICROB CHEMOTH, V53, P432, DOI 10.1093/jac/dkh074; Alonso A, 1997, ANTIMICROB AGENTS CH, V41, P1140, DOI 10.1128/AAC.41.5.1140; Atlas R. M., 1993, HDB MICROBIOLOGICAL; Baquero F, 2009, ENV MICROBIOL REP, V1, P469, DOI 10.1111/j.1758-2229.2009.00053.x; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Turrientes MC, 2010, APPL ENVIRON MICROB, V76, P1746, DOI 10.1128/AEM.02817-09; Ceragioli M, 2010, APPL ENVIRON MICROB, V76, P3352, DOI 10.1128/AEM.03003-09; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; CORNER TR, 1971, J BACTERIOL, V108, P501, DOI 10.1128/JB.108.1.501-507.1971; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; De Muynck W, 2010, J APPL MICROBIOL, V108, P62, DOI 10.1111/j.1365-2672.2009.04395.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; FREDERICK JJ, 1974, ANTIMICROB AGENTS CH, V6, P712, DOI 10.1128/AAC.6.6.712; Garcia-Leon G, 2014, APPL ENVIRON MICROB, V80, P4559, DOI 10.1128/AEM.01058-14; Garcia-Leon G, 2014, ENVIRON MICROBIOL, V16, P1282, DOI 10.1111/1462-2920.12408; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Hernandez A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002103; Hernandez A, 2009, J BIOL CHEM, V284, P14428, DOI 10.1074/jbc.M809221200; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0; Karatzas KAG, 2007, J ANTIMICROB CHEMOTH, V60, P947, DOI 10.1093/jac/dkm314; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Lin YT, 2015, ANTIMICROB AGENTS CH; Lira F, 2012, J BACTERIOL, V194, P3563, DOI 10.1128/JB.00602-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez JL, 2011, CURR OPIN PHARMACOL, V11, P439, DOI 10.1016/j.coph.2011.07.005; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; McMurry LM, 1999, ANTIMICROB AGENTS CH, V43, P711, DOI 10.1128/AAC.43.3.711; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Morales G, 2006, ENVIRON MICROBIOL, V8, P1764, DOI 10.1111/j.1462-2920.2006.01061.x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Russell AD, 2002, J ANTIMICROB CHEMOTH, V49, P597, DOI 10.1093/jac/49.4.597; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Sanchez MB, 2009, FUTURE MICROBIOL, V4, P655, DOI 10.2217/FMB.09.45; Sanchez P, 2002, ANTIMICROB AGENTS CH, V46, P3386, DOI 10.1128/AAC.46.11.3386-3393.2002; Sanchez P, 2005, ANTIMICROB AGENTS CH, V49, P781, DOI 10.1128/AAC.49.2.781-782.2005; Sanchez P, 2004, ANTIMICROB AGENTS CH, V48, P2274, DOI 10.1128/AAC.48.6.2274-2276.2004; Tavankar GR, 2003, J BIOL CHEM, V278, P4524, DOI 10.1074/jbc.M210355200; Walsh SE, 2003, J HOSP INFECT, V55, P98, DOI 10.1016/S0195-6701(03)00240-8; Walsh SE, 2003, J APPL MICROBIOL, V94, P240, DOI 10.1046/j.1365-2672.2003.01825.x; Whitehead RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022833; Zinchenko AA, 2004, CHEMBIOCHEM, V5, P360, DOI 10.1002/cbic.200300797	58	28	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132816	10.1371/journal.pone.0132816	http://dx.doi.org/10.1371/journal.pone.0132816			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201074	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100048
J	Carson, DS; Garner, JP; Hyde, SA; Libove, RA; Berquist, SW; Hornbeak, KB; Jackson, LP; Sumiyoshi, RD; Howerton, CL; Hannah, SL; Partap, S; Phillips, JM; Hardan, AY; Parker, KJ				Carson, Dean S.; Garner, Joseph P.; Hyde, Shellie A.; Libove, Robin A.; Berquist, Sean W.; Hornbeak, Kirsten B.; Jackson, Lisa P.; Sumiyoshi, Raena D.; Howerton, Christopher L.; Hannah, Sadie L.; Partap, Sonia; Phillips, Jennifer M.; Hardan, Antonio Y.; Parker, Karen J.			Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism	PLOS ONE			English	Article							DIAGNOSTIC OBSERVATION SCHEDULE; INTRANASAL OXYTOCIN; SPECTRUM; INTERVIEW; BRAIN; INDIVIDUALS; ACTIVATION; PHENOTYPE; MULTIPLE; SIBLINGS	Brain arginine vasopressin (AVP) critically regulates normative social behavior in mammals, and experimental disruption of the AVP signaling pathway produces social impairments in rodent models. We therefore hypothesized that AVP signaling deficits may contribute to social impairments in children with autism spectrum disorder (ASD). Since blood measures (which are far easier to obtain than brain measures) of AVP are most meaningful if they are related to brain AVP activity, Study 1 tested the relationship between AVP concentrations in concomitantly collected blood and CSF samples from children and adults (N = 28) undergoing clinical procedures. Study 2 tested whether blood AVP concentrations: 1) differed between children with ASD (N = 57), their ASD discordant siblings (N = 47), and neurotypical controls (N = 55); and 2) predicted social functioning (using the NEPSY-II Theory of Mind and Affect Recognition tasks and the Social Responsiveness Scale) in this large, well-characterized child cohort. Blood AVP concentrations significantly and positively predicted CSF AVP concentrations (F-1,F-26 = 7.17, r = 0.46, p = 0.0127) in Study 1. In Study 2, blood AVP concentrations did not differ between groups or by sex, but significantly and positively predicted Theory of Mind performance, specifically in children with ASD, but not in non-ASD children (F-1,F-144 = 5.83, p = 0.017). Blood AVP concentrations can be used: 1) as a surrogate for brain AVP activity in humans; and 2) as a robust biomarker of theory of mind ability in children with ASD. These findings also suggest that AVP biology may be a promising therapeutic target by which to improve social cognition in individuals with ASD.	[Carson, Dean S.; Garner, Joseph P.; Hyde, Shellie A.; Libove, Robin A.; Berquist, Sean W.; Hornbeak, Kirsten B.; Jackson, Lisa P.; Sumiyoshi, Raena D.; Phillips, Jennifer M.; Hardan, Antonio Y.; Parker, Karen J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Garner, Joseph P.; Howerton, Christopher L.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Hannah, Sadie L.] Stanford Univ, Sch Med, Div Pediat Hematol Oncol SCT & Canc Biol, Dept Pediat, Stanford, CA 94305 USA; [Partap, Sonia] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Parker, KJ (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	kjparker@stanford.edu	Parker, Karen/G-1347-2012; Garner, Joseph P/C-8422-2009	Parker, Karen/0000-0002-6836-6338; Phillips, Jennifer/0000-0002-6360-2346; Partap, Sonia/0000-0001-5615-7689; Hornbeak, Kirsten/0000-0001-9859-2259	Simons Foundation Autism Research Initiative Pilot Award [93231]; National Institutes of Health [R21MH100387, UL1 RR025774, RR000167]; Katherine D. McCormick Fund; Mosbacher Family Fund for Autism Research; Stanford's Bio-X NeuroVentures Program; Weston Havens Foundation; Autism Speaks Meixner Fellowship in Translational Research [7895]; Stanford University School of Medicine; Stanford University Child Health Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167, UL1RR025774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH100387] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative Pilot Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Katherine D. McCormick Fund; Mosbacher Family Fund for Autism Research; Stanford's Bio-X NeuroVentures Program; Weston Havens Foundation; Autism Speaks Meixner Fellowship in Translational Research; Stanford University School of Medicine; Stanford University Child Health Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a Simons Foundation Autism Research Initiative Pilot Award (#93231), the National Institutes of Health (R21MH100387; UL1 RR025774; RR000167), the Katherine D. McCormick Fund, the Mosbacher Family Fund for Autism Research, Stanford's Bio-X NeuroVentures Program, the Weston Havens Foundation, the Stanford University Child Health Research Institute, an Autism Speaks Meixner Fellowship in Translational Research (#7895), and a Stanford University School of Medicine Dean's Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P47; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Auyeung B, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.146; Bishop DVM, 2006, AM J MED GENET B, V141B, P117, DOI 10.1002/ajmg.b.30267; Boso M, 2007, ARCH MED RES, V38, P70, DOI 10.1016/j.arcmed.2006.08.003; Bott NT, UNPUB; Carson DS, 2014, PEPTIDES, V61, P12, DOI 10.1016/j.peptides.2014.08.003; Carson DS, MOL PSYCHIA IN PRESS; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Dadds MR, 2014, J AUTISM DEV DISORD, V44, P521, DOI 10.1007/s10803-013-1899-3; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Donaldson ZR, 2010, BEHAV NEUROSCI, V124, P159, DOI 10.1037/a0018094; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Francis SM, 2014, BRAIN RES, V1580, P199, DOI 10.1016/j.brainres.2014.01.021; Freeman SM, 2014, PSYCHONEUROENDOCRINO, V45, P128, DOI 10.1016/j.psyneuen.2014.03.023; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Guastella AJ, 2011, PSYCHONEUROENDOCRINO, V36, P294, DOI 10.1016/j.psyneuen.2010.07.023; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P1220, DOI 10.1016/j.biopsych.2010.03.014; Guastella AJ, J CHILD PSY IN PRESS; Hall SS, 2012, PSYCHONEUROENDOCRINO, V37, P509, DOI 10.1016/j.psyneuen.2011.07.020; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kemp, 2007, NEPSY 2 CLIN INTERPR; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 1999, AUTISM DIAGNOSTIC OB; Miller M, 2013, AUTISM RES, V6, P91, DOI 10.1002/aur.1270; Nephew BC, 2008, PHYSIOL BEHAV, V95, P182, DOI 10.1016/j.physbeh.2008.05.016; Parker KJ, 2014, P NATL ACAD SCI USA, V111, P12258, DOI 10.1073/pnas.1402236111; Piven J, 1997, AM J PSYCHIAT, V154, P185; Rilling JK, 2012, PSYCHONEUROENDOCRINO, V37, P447, DOI 10.1016/j.psyneuen.2011.07.013; Roid G., 2003, TECHNICAL MANUAL; Webb S, 2010, NAT BIOTECHNOL, V28, P772, DOI 10.1038/nbt0810-772; Wingate M, 2014, MMWR SURVEILL SUMM, V63	40	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132224	10.1371/journal.pone.0132224	http://dx.doi.org/10.1371/journal.pone.0132224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200852	Green Submitted, Green Published, gold			2022-12-26	WOS:000358597100030
J	Gentili, C; Castor, D; Kaden, S; Lauterbach, D; Gysi, M; Steigemann, P; Gerlich, DW; Jiricny, J; Ferrari, S				Gentili, Christian; Castor, Dennis; Kaden, Svenja; Lauterbach, David; Gysi, Mario; Steigemann, Patrick; Gerlich, Daniel W.; Jiricny, Josef; Ferrari, Stefano			Chromosome Missegregation Associated with RUVBL1 Deficiency	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; MISMATCH REPAIR; ATPASE ACTIVITY; DNA HELICASE; ANAPHASE BRIDGES; COMPLEX; PONTIN; PROTEIN; MITOSIS; REPTIN	RUVBL1 (RuvB-like1) and RUVBL2 (RuvB-like 2) are integral components of multisubunit protein complexes involved in processes ranging from cellular metabolism, transcription and chromatin remodeling to DNA repair. Here, we show that although RUVBL1 and RUVBL2 are known to form heterodimeric complexes in which they stabilize each other, the subunits separate during cytokinesis. In anaphase-to-telophase transition, RUVBL1 localizes to structures of the mitotic spindle apparatus, where it partially co-localizes with polo-like kinase 1 (PLK1). The ability of PLK1 to phosphorylate RUVBL1-but not RUVBL2-in vitro and their physical association in vivo suggest that this kinase differentially regulates the function of the RuvB-like proteins during mitosis. We further show that siRNA-mediated knock-down of RuvB-like proteins causes severe defects in chromosome alignment and segregation. In addition, we show that the ATPase activity of RUVBL1 is indispensable for cell proliferation. Our data thus demonstrate that RUVBL1 is essential for efficient mitosis and proliferation.	[Gentili, Christian; Castor, Dennis; Kaden, Svenja; Lauterbach, David; Gysi, Mario; Jiricny, Josef; Ferrari, Stefano] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Gentili, Christian; Castor, Dennis; Kaden, Svenja; Lauterbach, David; Gysi, Mario; Jiricny, Josef; Ferrari, Stefano] ETH, CH-8057 Zurich, Switzerland; [Steigemann, Patrick; Gerlich, Daniel W.] Swiss Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch; sferrari@imcr.uzh.ch	Ferrari, Stefano/I-7357-2016; Gerlich, Daniel Wolfram W/A-6991-2016	Ferrari, Stefano/0000-0002-6607-215X; Gerlich, Daniel Wolfram W/0000-0003-1637-3365	Swiss National Science Foundation [3100/3A-144009/1, 3100A0-114120, 3100/068182.02/1]; European Community [241548, 258068]; Promedica Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); Promedica Foundation	The financial support of the Swiss National Science Foundation (SF, grant no. 3100/3A-144009/1; DG, grant no. 3100A0-114120; JJ, grant no. 3100/068182.02/1) is gratefully acknowledged. Research in the Gerlich laboratory has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreements no 241548 (MitoSys) and no 258068 (Systems Microscopy). CG was supported by a project grant from the Promedica Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bereshchenko O, 2012, HAEMATOL-HEMATOL J, V97, P1291, DOI 10.3324/haematol.2011.060251; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Broderick R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7572; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Ducat D, 2008, MOL BIOL CELL, V19, P3097, DOI 10.1091/mbc.E07-11-1202; Dufner P, 2000, J BIOL CHEM, V275, P36550, DOI 10.1074/jbc.M005987200; Elkaim J, 2012, BIOCHEM J, V443, P549, DOI 10.1042/BJ20111779; Ferrari S, 2006, CELL MOL LIFE SCI, V63, P781, DOI 10.1007/s00018-005-5515-3; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Gartner W, 2003, CELL MOTIL CYTOSKEL, V56, P79, DOI 10.1002/cm.10136; Gorynia S, 2011, J STRUCT BIOL, V176, P279, DOI 10.1016/j.jsb.2011.09.001; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Grigoletto A, 2013, MOL CANCER RES, V11, P133, DOI 10.1158/1541-7786.MCR-12-0455; Haurie V, 2009, HEPATOLOGY, V50, P1871, DOI 10.1002/hep.23215; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lakomek K, 2015, STRUCTURE, V23, P483, DOI 10.1016/j.str.2014.12.015; Lauscher JC, 2007, HUM PATHOL, V38, P978, DOI 10.1016/j.humpath.2007.01.005; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Magalska A, 2014, DEV CELL, V31, P305, DOI 10.1016/j.devcel.2014.09.001; Makino Y, 1999, J BIOL CHEM, V274, P15329, DOI 10.1074/jbc.274.22.15329; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Menard L, 2010, J HEPATOL, V52, P681, DOI 10.1016/j.jhep.2009.12.029; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Rajendra E, 2014, NUCLEIC ACIDS RES, V42, P13736, DOI 10.1093/nar/gku1230; Rieder CL, 2011, CHROMOSOME RES, V19, P291, DOI 10.1007/s10577-010-9178-z; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Rousseau B, 2007, HEPATOLOGY, V46, P1108, DOI 10.1002/hep.21770; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Sigala B, 2005, EXP CELL RES, V310, P357, DOI 10.1016/j.yexcr.2005.07.030; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; von Morgen P, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00069; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X	57	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133576	10.1371/journal.pone.0133576	http://dx.doi.org/10.1371/journal.pone.0133576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201077	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100072
J	Oniki, K; Saruwatari, J; Izuka, T; Kajiwara, A; Morita, K; Sakata, M; Otake, K; Ogata, Y; Nakagawa, K				Oniki, Kentaro; Saruwatari, Junji; Izuka, Tomoko; Kajiwara, Ayami; Morita, Kazunori; Sakata, Misaki; Otake, Koji; Ogata, Yasuhiro; Nakagawa, Kazuko			Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PRACTICE GUIDELINE; DIABETES-MELLITUS; GENE POLYMORPHISM; I148M VARIANT; PROGRESSION; METAANALYSIS; ASSOCIATION; PREVALENCE; MANAGEMENT	In normal weight subjects (body mass index < 25 kg/m(2)), non-alcoholic fatty liver disease (NAFLD) is likely to coexist with metabolic diseases. The patatin-like phospholipase 3 (PNPLA3) polymorphism rs738409 (c.444C>G) is associated with the risk of NAFLD and/or renal dysfunction; however, the influence of the weight status on the associations remains unknown. We aimed to clarify the associations of the PNPLA3 polymorphism with the risk of NAFLD and/or renal dysfunction, while also paying careful attention to the weight status of the subjects. Cross-sectional and retrospective longitudinal studies with 5.5 +/- 1.1 years of followup were conducted in 740 and 393 Japanese participants (61.2 +/- 10.5 and 67.5 +/- 6.0 years), respectively, during a health screening program. Among 591 subjects who did not have a habitual alcohol intake and/or hepatitis B or C virus infections, the PNPLA3 G/G genotype was associated with the risk for NAFLD in normal weight subjects [odds ratio (95% CI): 3.06 (1.11-8.43), P < 0.05]. Among all subjects, carriers of the PNPLA3 G/G genotype with a normal weight had a lower eGFR than those of the C/C genotype [partial regression coefficient (SE): -3.26 (1.48), P < 0.05]. These associations were replicated in the longitudinal analyses. Among the overweight subjects, none of the genotypes were significantly associated in the cross-sectional and longitudinal analyses; however, the power of the analyses was small, especially in the analyses among overweight subjects. The findings of this study suggest that carriers of the PNPLA3 G/G genotype with a normal weight status should nevertheless be carefully monitored for the presence of NAFLD and/or renal dysfunction.	[Oniki, Kentaro; Saruwatari, Junji; Izuka, Tomoko; Kajiwara, Ayami; Morita, Kazunori; Sakata, Misaki; Nakagawa, Kazuko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan; [Otake, Koji; Ogata, Yasuhiro] Japanese Red Cross Kumamoto Hlth Care Ctr, Kumamoto, Japan; [Nakagawa, Kazuko] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto, Japan	Kumamoto University; Kumamoto University	Saruwatari, J (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan.	junsaru@gpo.kumamoto-u.ac.jp	Saruwatari, Junji/Q-7748-2019	Saruwatari, Junji/0000-0001-6266-1347	Ministry of Education, Culture, Sports, Science and Technology, Japan; Smoking Research Foundation [25860117, 26360049, 15K18925]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	The work was supported in full by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan; http://www.jsps.go.jp/english/index.html; (Grant Numbers: 25860117, 26360049 and 15K18925), and in part by a grant from Smoking Research Foundation.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Dongiovanni P, 2013, WORLD J GASTROENTERO, V19, P6969, DOI 10.3748/wjg.v19.i41.6969; Feng RN, 2014, WORLD J GASTROENTERO, V20, P17932, DOI 10.3748/wjg.v20.i47.17932; Fung J, 2015, LIVER INT, V35, P542, DOI 10.1111/liv.12619; Garland JS, 2014, DIABET METAB SYND OB, V7, P347, DOI 10.2147/DMSO.S46674; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Hyysalo J, 2014, DIABETES, V63, P312, DOI 10.2337/db13-0774; Inker LA, 2014, AM J KIDNEY DIS, V64, P74, DOI 10.1053/j.ajkd.2014.02.020; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Kim NH, 2014, LIVER INT, V34, P604, DOI 10.1111/liv.12454; Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; Machado MV, 2012, LIVER INT, V32, P241, DOI 10.1111/j.1478-3231.2011.02623.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Musso G, 2015, HEPATOLOGY, V62, P658, DOI 10.1002/hep.27643; Musso G, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001680; Petta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074089; Pirazzi C, 2014, HUM MOL GENET, V23, P4077, DOI 10.1093/hmg/ddu121; Romeo S, 2015, HEPATOLOGY, V62, P660, DOI 10.1002/hep.27642; Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Shen J, 2014, ALIMENT PHARM THER, V39, P532, DOI 10.1111/apt.12609; Shen JH, 2015, J LIPID RES, V56, P167, DOI 10.1194/jlr.M048777; Shen JY, 2015, J GASTROEN HEPATOL, V30, P139, DOI 10.1111/jgh.12656; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Zhang L, 2015, J GASTROEN HEPATOL, V30, P821, DOI 10.1111/jgh.12889; Zhang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108381	37	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132640	10.1371/journal.pone.0132640	http://dx.doi.org/10.1371/journal.pone.0132640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200108	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100041
J	Azevedo, EP; Rochael, NC; Guimaraes-Costa, AB; de Souza-Vieira, TS; Ganilho, J; Saraiva, EM; Palhano, FL; Foguel, D				Azevedo, Estefania P.; Rochael, Natalia C.; Guimaraes-Costa, Anderson B.; de Souza-Vieira, Thiago S.; Ganilho, Juliana; Saraiva, Elvira M.; Palhano, Fernando L.; Foguel, Debora			A Metabolic Shift toward Pentose Phosphate Pathway Is Necessary for Amyloid Fibril-and Phorbol 12-Myristate 13-Acetate-induced Neutrophil Extracellular Trap (NET) Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HYDROGEN-PEROXIDE; INNATE IMMUNITY; NITRIC-OXIDE; LUNG INJURY; COMPLEX III; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; MYELOPEROXIDASE; MITOCHONDRIA; SUPEROXIDE	Neutrophils are the main defense cells of the innate immune system. Upon stimulation, neutrophils release their chromosomal DNA to trap and kill microorganisms and inhibit their dissemination. These chromatin traps are termed neutrophil extracellular traps (NETs) and are decorated with granular and cytoplasm proteins. NET release can be induced by several microorganism membrane components, phorbol 12-myristate 13-acetate as well as by amyloid fibrils, insoluble proteinaceous molecules associated with more than 40 different pathologies among other stimuli. The intracellular signaling involved in NET formation is complex and remains unclear for most tested stimuli. Herein we demonstrate that a metabolic shift toward the pentose phosphate pathway (PPP) is necessary for NET release because glucose-6-phosphate dehydrogenase (G6PD), an important enzyme from PPP, fuels NADPH oxidase with NADPH to produce superoxide and thus induce NETs. In addition, we observed that mitochondrial reactive oxygen species, which are NADPH-independent, are not effective in producing NETs. These data shed new light on how the PPP and glucose metabolism contributes to NET formation.	[Azevedo, Estefania P.; Ganilho, Juliana; Palhano, Fernando L.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, BR-21941902 Rio De Janeiro, Brazil; [Rochael, Natalia C.; Guimaraes-Costa, Anderson B.; de Souza-Vieira, Thiago S.; Saraiva, Elvira M.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21941970 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Saraiva, EM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21941970 Rio De Janeiro, Brazil.	esaraiva@micro.ufrj.br; palhano@bioqmed.ufrj.br; foguel@bioqmed.ufrj.br	Saraiva, Elvira M/L-2864-2017; Vieira, Thiago/AAB-7097-2022; Palhano, Fernando/AAB-3144-2021; Costa, Anderson G. B./K-1059-2012; Palhano, Fernando/C-2586-2008	Saraiva, Elvira M/0000-0002-6388-5286; Palhano, Fernando/0000-0001-5336-632X; Costa, Anderson G. B./0000-0003-4582-1980; Palhano, Fernando/0000-0001-5336-632X; Foguel, Debora/0000-0001-7312-7115	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)The authors declare that they have no conflicts of interest with the contents of this article.	Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Branzk N, 2013, SEMIN IMMUNOPATHOL, V35, P513, DOI 10.1007/s00281-013-0384-6; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; Cheng ML, 2013, FREE RADICAL RES, V47, P699, DOI 10.3109/10715762.2013.816420; Cooper PR, 2013, PERIODONTOL 2000, V63, P165, DOI 10.1111/prd.12025; Douda DN, 2014, BLOOD, V123, P597, DOI 10.1182/blood-2013-09-526707; GRAY GR, 1973, LANCET, V2, P530; Guimaraes-Costa Anderson B, 2012, J Parasitol Res, V2012, P929743, DOI 10.1155/2012/929743; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Gupte RS, 2011, ANTIOXID REDOX SIGN, V14, P543, DOI 10.1089/ars.2010.3207; Gyulkhandanyan AV, 2004, J NEUROCHEM, V90, P405, DOI 10.1111/j.1471-4159.2004.02489.x; HUANG FL, 1973, BIOCHIM BIOPHYS ACTA, V317, P394, DOI 10.1016/0005-2795(73)90233-X; Kirchner T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/849136; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; LITCHFIELD WJ, 1977, INFECT IMMUN, V16, P189, DOI 10.1128/IAI.16.1.189-197.1977; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; MARTIN SP, 1955, ANN NY ACAD SCI, V59, P996, DOI 10.1111/j.1749-6632.1955.tb45997.x; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Minucci A, 2009, IUBMB LIFE, V61, P27, DOI 10.1002/iub.137; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001; Perner A, 2003, INTENS CARE MED, V29, P642, DOI 10.1007/s00134-002-1628-4; Peyssonnaux C, 2004, CELL CYCLE, V3, P168; PLESNER L, 1974, J BIOL CHEM, V249, P1119; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; TOEWS ML, 1987, MOL PHARMACOL, V32, P737; Tsai KJ, 1998, FEBS LETT, V436, P411, DOI 10.1016/S0014-5793(98)01174-0; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Worthington K., 1988, WORTHINGTON MANUAL E, P159; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC; Zmijewski JW, 2009, AM J PHYSIOL-LUNG C, V296, pL624, DOI DOI 10.1152/ajplung.90522.2008	40	107	109	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22174	22183		10.1074/jbc.M115.640094	http://dx.doi.org/10.1074/jbc.M115.640094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198639	hybrid, Green Published			2022-12-26	WOS:000360968500034
J	Datta, D; Anbarasu, K; Rajabather, S; Priya, RS; Desai, P; Mahalingam, S				Datta, Debduti; Anbarasu, Kumaraswamy; Rajabather, Suryaraja; Priya, Rangasamy Sneha; Desai, Pavitra; Mahalingam, Sundarasamy			Nucleolar GTP-binding Protein-1 (NGP-1) Promotes G(1) to S Phase Transition by Activating Cyclin-dependent Kinase Inhibitor p21(Cip1/Waf1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; E2F transcription factor; mouse double minute 2 homolog (Mdm2); p53; tumor cell biology	HUMAN BREAST-CARCINOMA; HUMAN MYC PROMOTER; CELL-CYCLE; DNA-DAMAGE; TYROSINE PHOSPHORYLATION; STEM/PROGENITOR CELLS; ABERRANT EXPRESSION; HUMAN MALIGNANCIES; CDK INHIBITORS; GASTRIC-CANCER	Background: Breast cancer autoantigen nucleolar GTP-binding protein-1 (NGP-1) is overexpressed in cancers. Results: NGP-1 promotes G(1) to S phase transition by modulating the p53/p21 pathway. Conclusion: CDK inhibitor, p21, enhances cell proliferation in certain situations. Significance: This study provides evidence that p21 induces cell proliferation in addition to its traditional tumor suppressor function. Nucleolar GTP-binding protein (NGP-1) is overexpressed in various cancers and proliferating cells, but the functional significance remains unknown. In this study, we show that NGP-1 promotes G(1) to S phase transition of cells by enhancing CDK inhibitor p21(Cip-1/Waf1) expression through p53. In addition, our results suggest that activation of the cyclin D1-CDK4 complex by NGP-1 via maintaining the stoichiometry between cyclin D1-CDK4 complex and p21 resulted in hyperphosphorylation of retinoblastoma protein at serine 780 (p-RBSer-780) followed by the up-regulation of E2F1 target genes required to promote G(1) to S phase transition. Furthermore, our data suggest that ribosomal protein RPL23A interacts with NGP-1 and abolishes NGP-1-induced p53 activity by enhancing Mdm2-mediated p53 polyubiquitination. Finally, reduction of p-RBSer-780 levels and E2F1 target gene expression upon ectopic expression of RPL23a resulted in arrest at the G(1) phase of the cell cycle. Collectively, this investigation provides evidence that NGP-1 promotes cell cycle progression through the activation of the p53/p21(Cip-1/Waf1) pathway.	[Datta, Debduti; Anbarasu, Kumaraswamy; Rajabather, Suryaraja; Priya, Rangasamy Sneha; Desai, Pavitra; Mahalingam, Sundarasamy] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Lab Mol Virol & Cell Biol,Natl Canc Tissue Bioban, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Mahalingam, S (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Lab Mol Virol & Cell Biol,Natl Canc Tissue Bioban, Madras 600036, Tamil Nadu, India.	mahalingam@iitm.ac.in	Kumaraswamy, Anbarasu/Q-2208-2019	Kumaraswamy, Anbarasu/0000-0002-9997-7430; Mahalingam, Sundarasamy/0000-0003-4460-3949	Department of Science and Technology from the Government of India [VI-D&P/411/2012-2013/TDT(G)]; Council of Scientific and Industrial Research, Government of India	Department of Science and Technology from the Government of India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Science and Technology Grant VI-D&P/411/2012-2013/TDT(G) from the Government of India (to S. M.) and a graduate fellowship from the Council of Scientific and Industrial Research, Government of India (to D. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Aaltomaa S, 1999, PROSTATE, V39, P8; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Adrover E, 1999, BRIT J CANCER, V81, P122, DOI 10.1038/sj.bjc.6690660; An HX, 1999, AM J PATHOL, V154, P113, DOI 10.1016/S0002-9440(10)65257-1; Bahl R, 2000, ONCOGENE, V19, P323, DOI 10.1038/sj.onc.1203325; Balbin M, 1996, J BIOL CHEM, V271, P15782, DOI 10.1074/jbc.271.26.15782; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Biankin AV, 2001, CANCER RES, V61, P8830; Bockstaele L, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-25; BOOKSTEIN R, 1993, CANCER RES, V53, P3369; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cazier JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4756; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chennupati V, 2011, BIOCHEMISTRY-US, V50, P4521, DOI 10.1021/bi200425b; Cheung TH, 2001, CANCER LETT, V172, P93, DOI 10.1016/S0304-3835(01)00624-3; COLES C, 1992, CANCER RES, V52, P5291; Dai M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3441; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Du XM, 2006, MOL BIOL CELL, V17, P460, DOI 10.1091/mbc.E05-09-0848; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge R. M., 1998, PROGNOSTIC VARIABLES, P169; Essers PB, 2014, DEV BIOL, V385, P304, DOI 10.1016/j.ydbio.2013.10.029; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Ferrandina G, 2000, INT J ONCOL, V17, P1231; Geng Y, 1996, ONCOGENE, V12, P1173; GILLETT C, 1994, CANCER RES, V54, P1812; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; JAKESZ R, 1984, CANCER RES, V44, P619; Jinno S, 1999, ONCOGENE, V18, P565, DOI 10.1038/sj.onc.1202347; JUNG JM, 1995, ONCOGENE, V11, P2021; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Kumar PR, 2003, J MOL BIOL, V331, P1141, DOI 10.1016/s0022-2836(03)00853-3; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li J, 2006, J BIOL CHEM, V281, P16536, DOI 10.1074/jbc.M601386200; Liu SJ, 2004, WORLD J GASTROENTERO, V10, P1246; Llanos S, 2010, CELL CYCLE, V9, P4005, DOI 10.4161/cc.9.19.13299; Lo D, 2010, CELL CYCLE, V9, P3227, DOI 10.4161/cc.9.16.12605; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Meng L, 2011, ONCOGENE, V30, P1716, DOI 10.1038/onc.2010.550; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; Paridaen JTML, 2011, DEV BIOL, V355, P286, DOI 10.1016/j.ydbio.2011.04.028; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Racevskis J, 1996, CELL GROWTH DIFFER, V7, P271; Ralhan R, 2000, CLIN CANCER RES, V6, P2440; Rey MJ, 1998, J PATHOL, V184, P265, DOI 10.1002/(SICI)1096-9896(199803)184:3<265::AID-PATH8>3.0.CO;2-8; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shiohara M, 1997, LEUKEMIA LYMPHOMA, V26, P35, DOI 10.3109/10428199709109155; SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Takahashi Y, 2000, GENE DEV, V14, P804; TAMURA G, 1991, CANCER RES, V51, P3056; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; TERADA Y, 1995, NATURE, V376, P358, DOI 10.1038/376358a0; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zhang Y., 2011, ONCOTARGET, V2, P234	83	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21536	21552		10.1074/jbc.M115.637280	http://dx.doi.org/10.1074/jbc.M115.637280			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26203195	hybrid, Green Published			2022-12-26	WOS:000360637600028
J	Ju, H; Jones, M; Mishra, GD				Ju, Hong; Jones, Mark; Mishra, Gita D.			A U-Shaped Relationship between Body Mass Index and Dysmenorrhea: A Longitudinal Study	PLOS ONE			English	Article							WOMENS HEALTH AUSTRALIA; RISK-FACTORS; MENSTRUAL CYCLES; RIGHT WEIGHT; PAIN; MENARCHE; FAT; MAINTENANCE; PREVALENCE; SEVERITY	Background Both obesity and dysmenorrhea are prevalent among women. Few population-based longitudinal studies investigate the association between body mass index (BMI) and dysmenorrhea yielding mixed results, especially for obesity. This study aims to investigate the long-term association between BMI and dysmenorrhea. Methods 9,688 women from a prospective population-based cohort study were followed for 13 years. Data were collected through self-reported questionnaires. The longitudinal association between dysmenorrhea and BMI or BMI change was investigated by logistic regression analysis using generalized estimating equations to account for the repeated measures. Results When the women were aged 22 to 27 years, approximately 11% were obese, 7% underweight, and 25% reported dysmenorrhea. Compared to women with a normal weight, significantly higher odds of reporting dysmenorrhea were detected for both women who were underweight (odds ratio (OR) 1.34, 95% confidence interval (CI) 1.15, 1.57) and obese (OR 1.22, 95% CI 1.11, 1.35). Compared to women who remained at normal weight or overweight over time, significant risk was detected for women who: remained underweight or obese (OR 1.33, 95% CI 1.20, 1.48), were underweight despite weight gain (OR 1.33, 95% CI 1.12, 1.58), became underweight (OR 1.28, 95% CI 1.02, 1.61). However the higher risk among obese women disappeared when they lost weight (OR 1.06, 95% CI 0.85, 1.32). Conclusions A U-shaped association was revealed between dysmenorrhea and BMI, revealing a higher risk of dysmenorrhea for both underweight and obese women. Maintaining a healthy weight over time may be important for women to have pain-free periods.	[Ju, Hong; Jones, Mark; Mishra, Gita D.] Univ Queensland, Sch Publ Hlth, Ctr Longitudinal & Life Course Res, Brisbane, Qld, Australia	University of Queensland	Ju, H (corresponding author), Univ Queensland, Sch Publ Hlth, Ctr Longitudinal & Life Course Res, Brisbane, Qld, Australia.	h.ju@uq.edu.au	Jones, Mark/I-2720-2016	Jones, Mark/0000-0001-6858-9710; Mishra, Gita/0000-0001-6003-4884				Allen SS, 2014, ADDICT BEHAV, V39, P901, DOI 10.1016/j.addbeh.2014.01.029; Barnard K, 2003, J WOMENS HEALTH, V12, P911, DOI 10.1089/154099903770948140; Barnard ND, 2000, OBSTET GYNECOL, V95, P245, DOI 10.1016/S0029-7844(99)00525-6; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bettendorf B, 2008, OBSTET GYNECOL SURV, V63, P597, DOI 10.1097/OGX.0b013e31817f15ff; Brown WJ, 1999, J WOMEN HEALTH GEN-B, V8, P681, DOI 10.1089/jwh.1.1999.8.681; Brown WJ, 1998, WOMEN HEALTH, V28, P23; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FRISCH RE, 1990, BAILLIERE CLIN OB GY, V4, P419, DOI 10.1016/S0950-3552(05)80302-5; FRISCH RE, 1994, P NUTR SOC, V53, P113, DOI 10.1079/PNS19940015; FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949; Harlow SD, 1996, BRIT J OBSTET GYNAEC, V103, P1134, DOI 10.1111/j.1471-0528.1996.tb09597.x; Hassan S, 2014, PAIN, V155, P2448, DOI 10.1016/j.pain.2014.08.027; Hirata Mari, 2002, Nihon Koshu Eisei Zasshi, V49, P516; Jones M, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-32; Ju H, 2014, MATURITAS, V78, P99, DOI 10.1016/j.maturitas.2014.03.008; Ju H, 2014, EPIDEMIOL REV, V36, P104, DOI 10.1093/epirev/mxt009; Jukic AMZ, 2008, EPIDEMIOLOGY, V19, P846, DOI 10.1097/EDE.0b013e318187ac9e; Jungheim ES, 2012, OBSTET GYN CLIN N AM, V39, P479, DOI 10.1016/j.ogc.2012.09.002; Latthe P, 2006, BMJ-BRIT MED J, V332, P749, DOI 10.1136/bmj.38748.697465.55; Lentz G, 2012, COMPREHENSIVE GYNECO; Madhubala C, 2012, J OBSTET GYN INDIA, V62, P442, DOI 10.1007/s13224-012-0171-7; Montero P, 1996, J BIOSOC SCI, V28, P315, DOI 10.1017/S0021932000022380; MOORE JW, 1982, INT J CANCER, V29, P17, DOI 10.1002/ijc.2910290105; National Health Performance Authority, 2011, HLTH COMM OV OB RAT; Nohara M, 2011, IND HEALTH, V49, P228, DOI 10.2486/indhealth.MS1047; Ohde S, 2008, INT J GYNECOL OBSTET, V100, P13, DOI 10.1016/j.ijgo.2007.06.039; Ozerdogan N, 2009, INT J GYNECOL OBSTET, V107, P39, DOI 10.1016/j.ijgo.2009.05.010; SCOTT EC, 1982, J ADOLESCENT HEALTH, V2, P249, DOI 10.1016/S0197-0070(82)80059-4; Shillington AM, 2012, J CHILD ADOLES SUBST, V21, P333, DOI 10.1080/1067828X.2012.710026; SUNDELL G, 1990, BRIT J OBSTET GYNAEC, V97, P588, DOI 10.1111/j.1471-0528.1990.tb02545.x; Tworoger SS, 2006, CANCER EPIDEM BIOMAR, V15, P2494, DOI 10.1158/1055-9965.EPI-06-0671; ZAHRADNIK HP, 1984, ARCH GYNECOL, V236, P99, DOI 10.1007/BF02134006	33	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134187	10.1371/journal.pone.0134187	http://dx.doi.org/10.1371/journal.pone.0134187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218569	Green Submitted, gold, Green Published			2022-12-26	WOS:000358595900094
J	Ooi, CP; Rotureau, B; Gribaldo, S; Georgikou, C; Julkowska, D; Blisnick, T; Perrot, S; Subota, I; Bastin, P				Ooi, Cher-Pheng; Rotureau, Brice; Gribaldo, Simonetta; Georgikou, Christina; Julkowska, Daria; Blisnick, Thierry; Perrot, Sylvie; Subota, Ines; Bastin, Philippe			The Flagellar Arginine Kinase in Trypanosoma brucei Is Important for Infection in Tsetse Flies	PLOS ONE			English	Article							CELL MORPHOGENESIS; AFRICAN TRYPANOSOMES; PARAFLAGELLAR ROD; MIXED INFECTIONS; CREATINE-KINASE; PROTEIN; MOTILITY; LOCALIZATION; PARASITE; CYCLE	African trypanosomes are flagellated parasites that cause sleeping sickness. Parasites are transmitted from one mammalian host to another by the bite of a tsetse fly. Trypanosoma brucei possesses three different genes for arginine kinase (AK) including one (AK3) that encodes a protein localised to the flagellum. AK3 is characterised by the presence of a unique amino-terminal insertion that specifies flagellar targeting. We show here a phylogenetic analysis revealing that flagellar AK arose in two independent duplication events in T. brucei and T. congolense, the two species of African trypanosomes that infect the tsetse midgut. In T. brucei, AK3 is detected in all stages of parasite development in the fly (in the midgut and in the salivary glands) as well as in bloodstream cells, but with predominance at insect stages. Genetic knockout leads to a slight reduction in motility and impairs parasite infectivity towards tsetse flies in single and competition experiments, both phenotypes being reverted upon expression of an epitope-tagged version of AK3. We speculate that this flagellar arginine kinase is important for T. brucei infection of tsetse, especially in the context of mixed infections and that its flagellar targeting relies on a system equivalent to that discovered for calflagins, a family of trypanosome flagellum calcium binding proteins.	[Ooi, Cher-Pheng; Rotureau, Brice; Georgikou, Christina; Julkowska, Daria; Blisnick, Thierry; Perrot, Sylvie; Subota, Ines; Bastin, Philippe] Inst Pasteur, INSERM, Trypanosome Cell Biol Unit, U1201, F-75015 Paris, France; [Gribaldo, Simonetta] Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bastin, P (corresponding author), Inst Pasteur, INSERM, Trypanosome Cell Biol Unit, U1201, 25 Rue Dr Roux, F-75015 Paris, France.	pbastin@pasteur.fr	Rotureau, Brice/B-2460-2014; Ooi, Cher-Pheng/Q-9635-2018; Bastin, Philippe/O-4230-2019; Bastin, Philippe/E-6688-2017; gribaldo, simonetta/AAW-4377-2020	Rotureau, Brice/0000-0003-0671-8999; Ooi, Cher-Pheng/0000-0002-1503-1155; Bastin, Philippe/0000-0002-3042-8679; gribaldo, simonetta/0000-0002-7662-021X	Institut Pasteur; Centre National de la Recherche Scientifique (CNRS); DIM Ilede-France postdoctoral fellowship [DIM-MALINF-110071]; French Government Investissement d'Avenir programme, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Fonds National de la Recherche du Luxembourg fellowship [TR-PHD BFR 07-023]; Roux post-doctoral fellowship (Institut Pasteur)	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); DIM Ilede-France postdoctoral fellowship; French Government Investissement d'Avenir programme, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); Fonds National de la Recherche du Luxembourg fellowship(Luxembourg National Research Fund); Roux post-doctoral fellowship (Institut Pasteur)	This work was funded by the Institut Pasteur and by the Centre National de la Recherche Scientifique (CNRS). CPO was funded by a DIM Ilede-France postdoctoral fellowship (DIM-MALINF-110071) and by a French Government Investissement d'Avenir programme, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (ANR-10-LABX-62-IBEID). IS was funded by a Fonds National de la Recherche du Luxembourg (TR-PHD BFR 07-023) fellowship and DJ by a Roux post-doctoral fellowship (Institut Pasteur). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Bringaud F, ENERGY METABOLISM TR; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BRUN R, 1979, ACTA TROP, V36, P289; Buisson J, 2013, J CELL SCI, V126, P327, DOI 10.1242/jcs.117069; Canepa GE, 2011, COMP BIOCHEM PHYS B, V160, P40, DOI 10.1016/j.cbpb.2011.05.006; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Durand-Dubief M, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; EVANS DA, 1979, J PROTOZOOL, V26, P557, DOI 10.1111/j.1550-7408.1979.tb04195.x; Fernandez P, 2007, PROTEINS, V69, P209, DOI 10.1002/prot.21557; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Heddergott N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003023; Huet D, 2014, ELIFE, V3, DOI 10.7554/eLife.02419; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Jamonneau V, 2004, PARASITOLOGY, V129, P693, DOI 10.1017/S0031182004005876; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kubi C, 2005, J MED ENTOMOL, V42, P1035, DOI 10.1603/0022-2585(2005)042[1035:AOTTFD]2.0.CO;2; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lehane MJ, 2000, PARASITOLOGY, V120, P583, DOI 10.1017/S0031182099005983; LERAY D, 1977, ANN SOC BELG MED TR, V57, P369; Lopez MA, 2015, EUKARYOT CELL, V14, P104, DOI 10.1128/EC.00217-14; Maric D, 2011, J BIOL CHEM, V286, P33109, DOI 10.1074/jbc.M111.240895; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Miranda MR, 2009, PARASITOLOGY, V136, P1201, DOI 10.1017/S0031182009990448; Noguchi M, 2001, J EXP BIOL, V204, P1063; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Ooi Cher-Pheng, 2013, Front Cell Infect Microbiol, V3, P71, DOI 10.3389/fcimb.2013.00071; OVERATH P, 1986, EUR J BIOCHEM, V160, P175, DOI 10.1111/j.1432-1033.1986.tb09955.x; Overath P, ENDOCYTOSIS MEMBRANE; Peacock L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-109; Pereira CA, 2000, J BIOL CHEM, V275, P1495, DOI 10.1074/jbc.275.2.1495; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; REDDY SRR, 1992, EUR J BIOCHEM, V206, P251, DOI 10.1111/j.1432-1033.1992.tb16923.x; Rotureau B, 2014, CELL MICROBIOL, V16, P425, DOI 10.1111/cmi.12230; Rotureau B, 2014, J CELL SCI, V127, P204, DOI 10.1242/jcs.136424; Rotureau B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00053; Rotureau B, 2011, CELL MICROBIOL, V13, P705, DOI 10.1111/j.1462-5822.2010.01566.x; Rotureau B, 2009, CELL MICROBIOL, V11, P710, DOI 10.1111/j.1462-5822.2009.01295.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Sun SY, 2013, J CELL SCI, V126, P520, DOI 10.1242/jcs.113621; Sunter JD, 2015, J CELL SCI, V128, P1580, DOI 10.1242/jcs.166447; TETLEY L, 1985, J CELL SCI, V74, P1; TOMBES RM, 1987, BIOPHYS J, V52, P75, DOI 10.1016/S0006-3495(87)83190-9; TOMBES RM, 1995, METHOD CELL BIOL, V47, P467, DOI 10.1016/S0091-679X(08)60846-8; Urbaniak MD, GLOBAL QUANTITATIVE, DOI [10.1021/pr400086y, DOI 10.1021/PR400086Y]; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004493; Voncken F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065908; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Wingard Jennifer N, 2008, J Biol Chem, V283, P23388, DOI 10.1074/jbc.M803178200; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; Yanagisawa H, 2001, BIOCHEM BIOPH RES CO, V288, P443, DOI 10.1006/bbrc.2001.5776; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	72	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133676	10.1371/journal.pone.0133676	http://dx.doi.org/10.1371/journal.pone.0133676			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218532	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900039
J	Purser, A				Purser, Autun			A Time Series Study of Lophelia pertusa and Reef Megafauna Responses to Drill Cuttings Exposure on the Norwegian Margin	PLOS ONE			English	Article							COLD-WATER CORAL; PROPELLER MOUND; ROCKALL TROUGH; NORTH-SEA; DEEP; SEDIMENT; SCLERACTINIA; SIZE; DISCHARGE; COMMUNITY	As hotspots of local biodiversity in the deep sea, preservation of cold-water coral reef communities is of great importance. In European waters the most extensive reefs are found at depths of 300 - 500 m on the continental margin. In Norwegian waters many of these reefs are located in areas of interest for oil and gas exploration and production. In this study drilling was carried out in the Morvin drill field in proximity to a number of small Lophelia pertusa coral reefs (closest reefs 100 m upstream and 350 m downstream of point of waste drill material release). In a novel monitoring study, ROV video surveys of 9 reefs were conducted prior, during, immediately after and > 1 year after drilling operations. Behavior of coral polyps inhabiting reefs exposed to differing concentrations of drill cuttings and drilling fluids (waste drilling material) were compared. Levels of expected exposure to these waste materials were determined for each reef by modelling drill cutting transport following release, using accurate in-situ hydrodynamic data collected during the drilling period and drill cutting discharge data as parameters of a dispersal model. The presence / absence of associate reef species (Acesta excavata, Paragorgia arborea and Primnoa resedaeformis) were also determined from each survey video. There were no significant differences in Lophelia pertusa polyp behavior in corals modelled to have been exposed to pulses of > 25 ppm drill cutting material and those modelled to be exposed to negligible concentrations of material. From the video data collected, there were no observed degradations of reef structure over time, nor reductions of associate fauna abundance, regardless of modelled exposure concentration at any of the surveyed reefs. This study focused exclusively on adult fauna, and did not assess the potential hazard posed by waste drilling material to coral or other larvae. Video data was collected by various ROV's, using different camera and lighting setups throughout the survey campaign, making comparison of observations prior, during and post drilling problematic. A standardization of video monitoring in future monitoring campaigns is recommended.	Jacobs Univ Bremen, Oceanlab, D-28759 Bremen, Germany	Jacobs University	Purser, A (corresponding author), Jacobs Univ Bremen, Oceanlab, D-28759 Bremen, Germany.	a.purser@jacobs-university.de		Purser, Autun/0000-0001-5427-0151	Statoil	Statoil	This project was funded by Statoil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the author's 818 adherence to PLOS ONE policies on sharing data and materials.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allers E, 2013, MAR POLLUT BULL, V74, P132, DOI 10.1016/j.marpolbul.2013.07.016; Armstrong CW, 2008, MAR POLICY, V32, P66, DOI 10.1016/j.marpol.2007.04.007; Bell N, 1999, NATURE, V402, P601, DOI 10.1038/45127; Berov D., 2007, THESIS JACOBS U BREM; Beuck L, 2005, ERLANGEN EARTH C SER, P915, DOI 10.1007/3-540-27673-4_47; Beuck L, 2007, FACIES, V53, P157, DOI 10.1007/s10347-006-0094-9; Blanchard A, 2014, MAR POLICY, V43, P313, DOI 10.1016/j.marpol.2013.07.001; Briffa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021963; Brock R, 2009, MAR ECOL PROG SER, V397, P355, DOI 10.3354/meps08303; Bronner U, 2013, SPE EUR HSE C EXH C, DOI [10.2118/164949-MS, DOI 10.2118/164949-MS]; Brooke SD, 2009, MAR ECOL PROG SER, V390, P137, DOI 10.3354/meps08191; Brooke S, 2013, MAR BIOL, V160, P139, DOI 10.1007/s00227-012-2071-x; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Cairns SD, 2007, B MAR SCI, V81, P311; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Curran KJ, 2002, CONT SHELF RES, V22, P405, DOI 10.1016/S0278-4343(01)00082-6; Dahl MP, 2013, THESIS U GOTHENBURG; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Dodds LA, 2009, MAR ECOL PROG SER, V397, P113, DOI 10.3354/meps08143; Durell G, 2006, MAR ENVIRON RES, V62, P194, DOI 10.1016/j.marenvres.2006.03.013; Ellis JI, 2012, MAR ECOL PROG SER, V456, P285, DOI 10.3354/meps09622; Fossa JH, 2005, ERLANGEN EARTH C SER, P359, DOI 10.1007/3-540-27673-4_18; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Fossa Skjoldal H.R, 2010, HDB MARINE FISHERIES, P215; FREDERIKSEN R, 1992, SARSIA, V77, P157, DOI 10.1080/00364827.1992.10413502; Frost TK, 2014, SPE INT C HLTH SAF E; Gates AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044114; Godo OR, 2014, MAR POLLUT BULL, V84, P236, DOI 10.1016/j.marpolbul.2014.05.007; Guihen D, 2013, J SEA RES, V78, P36, DOI 10.1016/j.seares.2012.12.007; Guinan J, 2009, MAR ECOL PROG SER, V375, P125, DOI 10.3354/meps07739; Hauge KH, 2014, MAR POLICY, V44, P82, DOI 10.1016/j.marpol.2013.07.008; Henry LA, 2007, DEEP-SEA RES PT I, V54, P654, DOI 10.1016/j.dsr.2007.01.005; Hovland M, 2010, MAR PETROL GEOL, V27, P1190, DOI 10.1016/j.marpetgeo.2010.02.005; Hovland Martin, 2008, P1; Iversen P.E., 2011, GUIDELINES OFFSHORE; Jarnegren J, 2006, J EXP MAR BIOL ECOL, V334, P122, DOI 10.1016/j.jembe.2006.01.014; JENSEN A, 1992, SARSIA, V77, P53, DOI 10.1080/00364827.1992.10413492; Jonsson LG, 2004, MAR ECOL PROG SER, V284, P163, DOI 10.3354/meps284163; Kutti T, 2014, DEEP-SEA RES PT II, V99, P122, DOI 10.1016/j.dsr2.2013.07.021; Laberg JS, 2000, MAR GEOL, V171, P95, DOI 10.1016/S0025-3227(00)00112-2; Larsson AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102222; Larsson AI, 2013, MAR POLLUT BULL, V70, P176, DOI 10.1016/j.marpolbul.2013.02.033; Larsson AI, 2011, MAR POLLUT BULL, V62, P1159, DOI 10.1016/j.marpolbul.2011.03.041; Lepland A, 2008, ENVIRON GEOL, V56, P119, DOI 10.1007/s00254-007-1145-4; Lessard-Pilon SA, 2010, DEEP-SEA RES PT II, V57, P1882, DOI 10.1016/j.dsr2.2010.05.013; Lundalv T, 2008, 4 INT S DEEP SEA COR; Mortensen P, 2005, MAR BIOL, V147, P775, DOI 10.1007/s00227-005-1604-y; Mortensen P.B., 2006, P 10 INT COR REEF S, P1849; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Mortensen PB, 2001, J MAR BIOL ASSOC UK, V81, P581, DOI 10.1017/S002531540100426X; Mortensen PB, 1998, SARSIA, V83, P433, DOI 10.1080/00364827.1998.10413702; Neff J., 2011, PRODUCED WATER, P3, DOI DOI 10.1007/978-1-4614-0046-2_1; Neff J.M., 1987, P469; Netto SA, 2010, ENVIRON MONIT ASSESS, V167, P49, DOI 10.1007/s10661-010-1515-3; Orejas C, 2011, MAR ECOL PROG SER, V429, P57, DOI 10.3354/meps09104; Orejas C, 2009, MAR ECOL PROG SER, V397, P37, DOI 10.3354/meps08314; Pabortsava K, 2011, MAR POLLUT BULL, V62, P2170, DOI 10.1016/j.marpolbul.2011.07.002; Purser A, 2013, BIOGEOSCIENCES, V10, P5779, DOI 10.5194/bg-10-5779-2013; Purser A., 2013, METHODS OCEANOGR, V5, P1, DOI 10.1016/j.mio.2013.07.001; Purser A, 2013, CONT SHELF RES, V54, P37, DOI 10.1016/j.csr.2012.12.013; Purser A, 2012, MAR POLLUT BULL, V64, P2309, DOI 10.1016/j.marpolbul.2012.08.003; Purser A, 2010, J EXP MAR BIOL ECOL, V395, P55, DOI 10.1016/j.jembe.2010.08.013; Reed M., 2002, SPE INT C HLTH SAF E, DOI [10.2118/73856-MS, DOI 10.2118/73856-MS]; ROBERTS JM, 2009, COLDW COR BIOL GEOL, P1; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Ruggeberg A, 2007, INT J EARTH SCI, V96, P57, DOI 10.1007/s00531-005-0504-1; Rye H, 1998, ENVIRON MODELL SOFTW, V13, P431, DOI 10.1016/S1364-8152(98)00048-6; Rye Henrik, 2008, Integrated Environmental Assessment and Management, V4, P194, DOI 10.1897/IEAM_2007-039; Saasen A, 2013, PARTICUL SCI TECHNOL, V31, P85, DOI 10.1080/02726351.2011.648824; Safina C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001049; Santos MFL, 2010, ENVIRON MONIT ASSESS, V167, P65, DOI 10.1007/s10661-010-1518-0; Schaanning MT, 2008, J EXP MAR BIOL ECOL, V361, P49, DOI 10.1016/j.jembe.2008.04.014; Smit MGD, 2008, ENVIRON TOXICOL CHEM, V27, P1006, DOI 10.1897/07-339.1; STAFFORDSMITH MG, 1992, AUST J MAR FRESH RES, V43, P683, DOI 10.1071/MF9920683; Tenningen E, 2011, ENV MONITORING REPOR; Tracey DM, 2011, MAR ECOL PROG SER, V430, P1, DOI 10.3354/meps09164; Trannum HC, 2011, MAR ECOL PROG SER, V442, P23, DOI 10.3354/meps09340; Trannum HC, 2010, J EXP MAR BIOL ECOL, V383, P111, DOI 10.1016/j.jembe.2009.12.004; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; Weber M, 2006, J EXP MAR BIOL ECOL, V336, P18, DOI 10.1016/j.jembe.2006.04.007; Wesseling I, 1999, MAR ECOL PROG SER, V176, P11, DOI 10.3354/meps176011; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; White M, 2005, ERLANGEN EARTH CONF, P503, DOI 10.1007/3-540-27673-4_25; WILSON JB, 1979, J MAR BIOL ASSOC UK, V59, P165, DOI 10.1017/S0025315400046257	88	27	27	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134076	10.1371/journal.pone.0134076	http://dx.doi.org/10.1371/journal.pone.0134076			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218658	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900074
J	Tijchon, E; Schenau, DV; van Opzeeland, F; Tirone, F; Hoogerbrugge, PM; Van Leeuwen, FN; Scheijen, B				Tijchon, Esther; Schenau, Dorette van Ingen; van Opzeeland, Fred; Tirone, Felice; Hoogerbrugge, Peter M.; Van Leeuwen, Frank N.; Scheijen, Blanca			Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton	PLOS ONE			English	Article							POLYCOMB GROUP GENES; HOX GENES; ENDOCHONDRAL OSSIFICATION; EXPRESSION; MICE; SEGMENTATION; PROGRESSION; LEUKEMIA; E2F6; PATHOGENESIS	Btg1 and Btg2 encode highly homologous proteins that are broadly expressed in different cell lineages, and have been implicated in different types of cancer. Btg1 and Btg2 have been shown to modulate the function of different transcriptional regulators, including Hox and Smad transcription factors. In this study, we examined the in vivo role of the mouse Btg1 and Btg2 genes in specifying the regional identity of the axial skeleton. Therefore, we examined the phenotype of Btg1 and Btg2 single knockout mice, as well as novel generated Btg1(-/-); Btg2(-/-) double knockout mice, which were viable, but displayed a non-mendelian inheritance and smaller litter size. We observed both unique and overlapping phenotypes reminiscent of homeotic transformation along the anterior-posterior axis in the single and combined Btg1 and Btg2 knockout animals. Both Btg1(-/-) and Btg2(-/-) mice displayed partial posterior transformation of the seventh cervical vertebra, which was more pronounced in Btg1(-/-); Btg2(-/-) mice, demonstrating that Btg1 and Btg2 act in synergy. Loss of Btg2, but not Btg1, was sufficient for complete posterior transformation of the thirteenth thoracic vertebra to the first lumbar vertebra. Moreover, Btg2(-/-) animals displayed complete posterior transformation of the sixth lumbar vertebra to the first sacral vertebra, which was only partially present at a low frequency in Btg1(-/-) mice. The Btg1(-/-); Btg2(-/-) animals showed an even stronger phenotype, with L5 to S1 transformation. Together, these data show that both Btg1 and Btg2 are required for normal vertebral patterning of the axial skeleton, but each gene contributes differently in specifying the identity along the anterior-posterior axis of the skeleton.	[Tijchon, Esther; Schenau, Dorette van Ingen; Van Leeuwen, Frank N.; Scheijen, Blanca] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Oncol, NL-6525 ED Nijmegen, Netherlands; [van Opzeeland, Fred] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Tirone, Felice] CNR, Fdn Santa Lucia, Inst Cell Biol & Neurobiol, I-00143 Rome, Italy; [Hoogerbrugge, Peter M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); IRCCS Santa Lucia	Scheijen, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Oncol, NL-6525 ED Nijmegen, Netherlands.	Blanca.Scheijen@radboudumc.nl	Hoogerbrugge, Peter M./H-8049-2014; Tijchon, Esther/A-1679-2016; Scheijen, Blanca/E-3523-2016; van Leeuwen, Frank/AAQ-6799-2020; Tirone, Felice/P-6745-2014	Scheijen, Blanca/0000-0001-8029-9230; van Leeuwen, Frank/0000-0003-1107-6513; Tirone, Felice/0000-0002-0980-4377	Stichting Kinderen Kankervrij (KiKA) grant [77]	Stichting Kinderen Kankervrij (KiKA) grant	Funding provided by Stichting Kinderen Kankervrij (KiKA) grant-77; https://www.kika.nl/?gclid=CMW-652BlMQCFS7MtAod1H8AzA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bel S, 1998, DEVELOPMENT, V125, P3543; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; Casaca A, 2014, DEV DYNAM, V243, P24, DOI 10.1002/dvdy.24007; Cernilogar FM, 2005, BIOCHEM CELL BIOL, V83, P322, DOI 10.1139/o05-040; Core N, 1997, DEVELOPMENT, V124, P721; Courel M, 2008, DEV DYNAM, V237, P1232, DOI 10.1002/dvdy.21516; Ding M, 2012, J CELL PHYSIOL, V227, P3446, DOI 10.1002/jcp.24045; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Farioli-Vecchioli S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00124; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Hirsinger E, 2000, INT REV CYTOL, V198, P1; HORAN GSB, 1994, P NATL ACAD SCI USA, V91, P12644, DOI 10.1073/pnas.91.26.12644; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mallo M, 2009, INT J DEV BIOL, V53, P1469, DOI 10.1387/ijdb.072276mm; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Radulovic V, 2013, LEUKEMIA, V27, P523, DOI 10.1038/leu.2012.368; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Sheng SH, 2014, TUMOR BIOL, V35, P3317, DOI 10.1007/s13277-013-1437-0; Soung DY, 2012, J BONE MINER RES, V27, P1585, DOI 10.1002/jbmr.1601; Storre J, 2002, EMBO REP, V3, P695, DOI 10.1093/embo-reports/kvf141; Sun Q, 2013, TUMOR BIOL, V34, P4017, DOI 10.1007/s13277-013-0992-8; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Tschopp P, 2011, ANNU REV GENET, V45, P145, DOI 10.1146/annurev-genet-102209-163429; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Zhao Y, 2013, INT J MOL SCI, V14, P19670, DOI 10.3390/ijms141019670	41	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0131481	10.1371/journal.pone.0131481	http://dx.doi.org/10.1371/journal.pone.0131481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218146	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900002
J	Zhang, SJ; Chakrabarty, PK; Fleites, LA; Rayside, PA; Hopkins, DL; Gabriel, DW				Zhang, Shujian; Chakrabarty, Pranjib K.; Fleites, Laura A.; Rayside, Patricia A.; Hopkins, Donald L.; Gabriel, Dean W.			Three New Pierce's Disease Pathogenicity Effectors Identified Using Xylella fastidiosa Biocontrol Strain EB92-1	PLOS ONE			English	Article							ZONULA-OCCLUDENS TOXIN; ORYZAE PV. ORYZAE; 2-COMPONENT SYSTEM; VIRULENCE; SECRETION; PLANT; ENZYMES; GENOME; GACA; COLONIZATION	Xylella fastidiosa (X. fastidiosa) infects a wide range of plant hosts and causes economically serious diseases, including Pierce's Disease (PD) of grapevines. X. fastidiosa biocontrol strain EB92-1 was isolated from elderberry and is infectious and persistent in grapevines but causes only very slight symptoms under ideal conditions. The draft genome of EB92-1 revealed that it appeared to be missing genes encoding 10 potential PD pathogenicity effectors found in Temecula1. Subsequent PCR and sequencing analyses confirmed that EB92-1 was missing the following predicted effectors found in Temecula1: two type II secreted enzymes, including a lipase (LipA; PD1703) and a serine protease (PD0956); two identical genes encoding proteins similar to Zonula occludens toxins (Zot; PD0915 and PD0928), and at least one relatively short, hemagglutinin-like protein (PD0986). Leaves of tobacco and citrus inoculated with cell-free, crude protein extracts of E. coli BL21(DE3) overexpressing PD1703 exhibited a hypersensitive response (HR) in less than 24 hours. When cloned into shuttle vector pBBR1MCS-5, PD1703 conferred strong secreted lipase activity to Xanthomonas citri, E. coli and X. fastidiosa EB92-1 in plate assays. EB92-1/PD1703 transformants also showed significantly increased disease symptoms on grapevines, characteristic of PD. Genes predicted to encode PD0928 (Zot) and a PD0986 (hemagglutinin) were also cloned into pBBR1MCS-5 and moved into EB92-1; both transformants also showed significantly increased symptoms on V. vinifera vines, characteristic of PD. Together, these results reveal that PD effectors include at least a lipase, two Zot-like toxins and a possibly redundant hemagglutinin, none of which are necessary for parasitic survival of X. fastidiosa populations in grapevines or elderberry.	[Zhang, Shujian; Chakrabarty, Pranjib K.; Fleites, Laura A.; Rayside, Patricia A.; Gabriel, Dean W.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Hopkins, Donald L.] Univ Florida, Mid Florida Res & Educ Ctr, Apopka, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gabriel, DW (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	dgabr@ufl.edu	rolshausen, philippe/F-7999-2011		University of California Pierce's Disease Research Grants Program [2009-244]	University of California Pierce's Disease Research Grants Program	University of California Pierce's Disease Research Grants Program, project 2009-244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparna G, 2009, PLANT CELL, V21, P1860, DOI 10.1105/tpc.109.066886; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Cui Y, 2001, MOL PLANT MICROBE IN, V14, P516, DOI 10.1094/MPMI.2001.14.4.516; da Silva VS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-474; DAVIS MJ, 1980, PHYTOPATHOLOGY, V70, P425, DOI 10.1094/Phyto-70-425; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; GOODWIN PH, 1988, PHYSIOL MOL PLANT P, V32, P1, DOI 10.1016/S0885-5765(88)80002-X; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Guilhabert MR, 2001, MOL PLANT MICROBE IN, V14, P701, DOI 10.1094/MPMI.2001.14.6.701; Hagemann M, 2006, ARCH MICROBIOL, V185, P449, DOI 10.1007/s00203-006-0115-7; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hopkins DL, 2005, PLANT DIS, V89, P1348, DOI 10.1094/PD-89-1348; HOPKINS DL, 1985, PHYTOPATHOLOGY, V75, P713, DOI 10.1094/Phyto-75-713; Jha G, 2005, MOL PLANT MICROBE IN, V18, P891, DOI 10.1094/MPMI-18-0891; Jha G, 2007, MOL PLANT MICROBE IN, V20, P31, DOI 10.1094/MPMI-20-0031; Karyekar CS, 2003, J PHARM SCI-US, V92, P414, DOI 10.1002/jps.10310; Killiny N, 2009, APPL ENVIRON MICROB, V75, P521, DOI 10.1128/AEM.01921-08; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Matsumoto A, 2012, MICROBIOLOGYOPEN, V1, P33, DOI 10.1002/mbo3.6; Matsumoto A, 2010, APPL ENVIRON MICROB, V76, P4092, DOI 10.1128/AEM.03034-09; MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; MOLLENHAUER HH, 1974, J BACTERIOL, V119, P612, DOI 10.1128/JB.119.2.612-618.1974; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; Perez-Donoso AG, 2010, PLANT PHYSIOL, V152, P1748, DOI 10.1104/pp.109.148791; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Rajeshwari R, 2005, MOL PLANT MICROBE IN, V18, P830, DOI 10.1094/MPMI-18-0830; Reddy JD, 2007, MOL PLANT MICROBE IN, V20, P403, DOI 10.1094/MPMI-20-4-0403; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Roper MC, 2007, MOL PLANT MICROBE IN, V20, P411, DOI 10.1094/MPMI-20-4-0411; Rossi M, 2002, IMMUNOL LETT, V81, P217, DOI 10.1016/S0165-2478(02)00038-X; SAMAD MYA, 1989, J MICROBIOL METH, V9, P51, DOI 10.1016/0167-7012(89)90030-4; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x; Shi XY, 2009, APPL ENVIRON MICROB, V75, P2275, DOI 10.1128/AEM.01964-08; Stehr F, 2004, FEMS YEAST RES, V4, P401, DOI 10.1016/S1567-1356(03)00205-8; Stevenson JF, 2005, PLANT DIS, V89, P543, DOI 10.1094/PD-89-0543; Stevenson JF, 2004, AM J ENOL VITICULT, V55, P238; SWARUP S, 1991, PHYTOPATHOLOGY, V81, P802, DOI 10.1094/Phyto-81-802; Thorne ET, 2006, AM J ENOL VITICULT, V57, P1; Uzzau S, 1999, MICROB PATHOGENESIS, V27, P377, DOI 10.1006/mpat.1999.0312; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Voegel TM, 2010, MICROBIOL-SGM, V156, P2172, DOI 10.1099/mic.0.037564-0; Zhang S, 2011, J BACTERIOL, V193, P5576, DOI 10.1128/JB.05430-11	47	25	25	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133796	10.1371/journal.pone.0133796	http://dx.doi.org/10.1371/journal.pone.0133796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218423	Green Submitted, gold, Green Published			2022-12-26	WOS:000358595900048
J	Jathanna, D; Karanth, KU; Kumar, NS; Karanth, KK; Goswami, VR				Jathanna, Devcharan; Karanth, K. Ullas; Kumar, N. Samba; Karanth, Krithi K.; Goswami, Varun R.			Patterns and Determinants of Habitat Occupancy by the Asian Elephant in the Western Ghats of Karnataka, India	PLOS ONE			English	Article							RUHUNA-NATIONAL-PARK; LOXODONTA-AFRICANA; LANDSCAPE HETEROGENEITY; ESTIMATING ABUNDANCE; SPATIAL-DISTRIBUTION; RELATIVE ABUNDANCE; SPECIES OCCURRENCE; POPULATION-SIZE; SOUTHERN AFRICA; LARGE MAMMALS	Understanding species distribution patterns has direct ramifications for the conservation of endangered species, such as the Asian elephant Elephas maximus. However, reliable assessment of elephant distribution is handicapped by factors such as the large spatial scales of field studies, survey expertise required, the paucity of analytical approaches that explicitly account for confounding observation processes such as imperfect and variable detectability, unequal sampling probability and spatial dependence among animal detections. We addressed these problems by carrying out 'detection-non-detection' surveys of elephant signs across a c. 38,000-km(2) landscape in the Western Ghats of Karnataka, India. We analyzed the resulting sign encounter data using a recently developed modeling approach that explicitly addresses variable detectability across space and spatially dependent non-closure of occupancy, across sampling replicates. We estimated overall occupancy, a parameter useful to monitoring elephant populations, and examined key ecological and anthropogenic drivers of elephant presence. Our results showed elephants occupied 13,483 km(2) (SE = 847 km(2)) corresponding to 64% of the available 21,167 km(2) of elephant habitat in the study landscape, a useful baseline to monitor future changes. Replicate-level detection probability ranged between 0.56 and 0.88, and ignoring it would have underestimated elephant distribution by 2116 km(2) or 16%. We found that anthropogenic factors predominated over natural habitat attributes in determining elephant occupancy, underscoring the conservation need to regulate them. Human disturbances affected elephant habitat occupancy as well as site-level detectability. Rainfall is not an important limiting factor in this relatively humid bioclimate. Finally, we discuss cost-effective monitoring of Asian elephant populations and the specific spatial scales at which different population parameters can be estimated. We emphasize the need to model the observation and sampling processes that often obscure the ecological process of interest, in this case relationship between elephants to their habitat.	[Jathanna, Devcharan; Karanth, K. Ullas; Kumar, N. Samba; Karanth, Krithi K.; Goswami, Varun R.] Ctr Wildlife Studies, Bangalore, Karnataka, India; [Karanth, K. Ullas; Kumar, N. Samba; Goswami, Varun R.] Wildlife Conservat Soc, India Program, Bangalore, Karnataka, India; [Karanth, K. Ullas; Karanth, Krithi K.] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA; [Karanth, Krithi K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Wildlife Conservation Society; Duke University	Goswami, VR (corresponding author), Ctr Wildlife Studies, Bangalore, Karnataka, India.	varunr.goswami@gmail.com	Kumar, Samba/ADR-7829-2022; Goswami, Varun R/AAE-8780-2019; Jathanna, Devcharan/AAL-9107-2020	Kumar, Samba/0000-0002-1226-8552; Goswami, Varun R/0000-0003-2575-7301; Jathanna, Devcharan/0000-0002-7962-4582	Vision Group on Science and Technology, Government of Karnataka [Vi Ya Ei 170 Vi Tra Ma 2010]; Department of Biotechnology, Government of India [BT/PR13854/BCE/08/809/2010]	Vision Group on Science and Technology, Government of Karnataka; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by a grant to the Centre for Wildlife Studies, Bangalore from Vision Group on Science and Technology, Government of Karnataka vide G.O. No. Vi Ya Ei 170 Vi Tra Ma 2010 dated 19-4-2011, and from Department of Biotechnology, Government of India vide No. BT/PR13854/BCE/08/809/2010 dated 10-1-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfred R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031400; Amstrup SC, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P1; BARNES RFW, 1982, J APPL ECOL, V19, P411, DOI 10.2307/2403476; Barnes RFW, 2002, AFR J ECOL, V40, P159, DOI 10.1046/j.1365-2028.2002.00362.x; Barnes RFW, 1997, AFR J ECOL, V35, P39, DOI 10.1111/j.1365-2028.1997.061-89061.x; Baskaran N., 2010, Gajah, V32, P6; Baskaran N., 1993, WEEK ELEPHANTS, P298; Biru Y, 2009, THESIS ADIS ABABA U; Bist S., 2003, GAJAH, V22, P67; Bist S S, 2006, GAJAH, V25, P27; Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; Blake S., 2003, THESIS U EDINBURGH; Borowik T, 2013, EUR J WILDLIFE RES, V59, P675, DOI 10.1007/s10344-013-0720-0; Brandt PT, 2007, MSBVAR BAYESIAN VECT; Buckland S.T., 2001, pi; Buij R, 2007, BIOL CONSERV, V135, P189, DOI 10.1016/j.biocon.2006.10.028; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Daniels R. J. R., 2001, NATL BIODIVERS UNPUB; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; de Beer Y, 2008, J ARID ENVIRON, V72, P2017, DOI 10.1016/j.jaridenv.2008.07.002; de Silva S, 2011, BIOL CONSERV, V144, P1742, DOI 10.1016/j.biocon.2011.03.011; Diemer N., 2003, THESIS INT I GEOINFO; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Efron B., 1982, JACKNIFE BOOTSTRAP O; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Gaucherel C, 2010, J ZOOL, V280, P185, DOI 10.1111/j.1469-7998.2009.00652.x; Goswami VR, 2007, ANIM CONSERV, V10, P391, DOI 10.1111/j.1469-1795.2007.00124.x; Goswami VR, 2014, BIOL CONSERV, V177, P74, DOI 10.1016/j.biocon.2014.06.013; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Harris GM, 2008, ORYX, V42, P66, DOI 10.1017/S0030605308000483; Hedges S., 2012, MONITORING ELEPHANT, P61; Hedges S., 2012, MONITORING ELEPHANT; Hedges S, 2013, BIOL CONSERV, V159, P101, DOI 10.1016/j.biocon.2012.12.010; Hema EM, 2011, AFR J ECOL, V49, P141, DOI 10.1111/j.1365-2028.2010.01239.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines JE., 2006, PRESENCESOFTWARE EST; Hoare RE, 1999, CONSERV BIOL, V13, P633, DOI 10.1046/j.1523-1739.1999.98035.x; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jathanna D, 2015, BIOL CONSERV, V187, P212, DOI 10.1016/j.biocon.2015.04.030; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; KARANTH KU, 1992, J TROP ECOL, V8, P21, DOI 10.1017/S0266467400006040; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Krishnaswamy J, 2004, INT J REMOTE SENS, V25, P1185, DOI 10.1080/0143116031000149989; Krishnaswamy J, 2003, ECOCLIMATIC VEGETATI; Kumar MA, 2010, TROP CONSERV SCI, V3, P143, DOI 10.1177/194008291000300203; Kumar NS, 2011, THESIS MANIPAL U; Lakshminarayanan N, 2014, THESIS NATL CTR BIOL, P37; Leimgruber P, 2003, ANIM CONSERV, V6, P347, DOI 10.1017/S1367943003003421; Leuthold W., 1973, E AFR WILDL J, V11, P369; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Madhusudan MD, 2015, BIOL CONSERV, V187, P34, DOI 10.1016/j.biocon.2015.04.003; Martin J, 2010, ECOL APPL, V20, P1173, DOI 10.1890/09-0276.1; Menon V., 1997, GOD DISTRESS THREATS; Morley RC, 2007, J ZOOL, V271, P418, DOI 10.1111/j.1469-7998.2006.00225.x; MUELLERDOMBOIS D, 1972, ECOLOGY, V53, P208, DOI 10.2307/1934074; Mukeka JM, 2010, ANAL DISTRIBUTION AF; Murwira A, 2005, LANDSCAPE ECOL, V20, P217, DOI 10.1007/s10980-004-3159-6; Ntumi CP, 2005, S AFR J WILDL RES, V35, P139; OTTICHILO WK, 1986, AFR J ECOL, V24, P53, DOI 10.1111/j.1365-2028.1986.tb00342.x; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; R Development Core Team, 2012, R LANG ENV STAT COMP; Rangarajan M., 2010, GAJAH SECURING FUTUR; Redfern JV, 2002, THESIS U CALIFORNIA; Rood E, 2010, DIVERS DISTRIB, V16, P975, DOI 10.1111/j.1472-4642.2010.00704.x; Rota CT, 2011, ECOGRAPHY, V34, P659, DOI 10.1111/j.1600-0587.2010.06433.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; SANTIAPILLAI C, 1984, BIOL CONSERV, V29, P47, DOI 10.1016/0006-3207(84)90013-2; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098803; Sukumar R., 2012, REPORT KARNATAKA ELE; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Thomas B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003902; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; van Aarde RJ, 2007, BIOL CONSERV, V134, P289, DOI 10.1016/j.biocon.2006.08.027; Varma S, 2008, CURR SCI INDIA, V94, P501; VARMAN KS, 1995, J BIOSCIENCE, V20, P273, DOI 10.1007/BF02703274; Vidya TNC, 2005, HEREDITY, V94, P71, DOI 10.1038/sj.hdy.6800568; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Young KD, 2009, AUSTRAL ECOL, V34, P329, DOI 10.1111/j.1442-9993.2009.01934.x	97	21	24	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133233	10.1371/journal.pone.0133233	http://dx.doi.org/10.1371/journal.pone.0133233			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207378	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000068
J	Kim, IY; Kim, BR; Kim, YW				Kim, Ik Yong; Kim, Bo Ra; Kim, Young Wan			Impact of Prior Abdominal Surgery on Rates of Conversion to Open Surgery and Short-Term Outcomes after Laparoscopic Surgery for Colorectal Cancer	PLOS ONE			English	Article							MRC CLASICC TRIAL; RECTAL-CANCER; RESECTION; MULTICENTER; OPERATIONS; COLECTOMY	Purpose To evaluate the impact of prior abdominal surgery (PAS) on rates of conversion to open surgery and short-term outcomes after laparoscopic surgery for colon and rectal cancers. Methods We compared three groups as follows: colon cancer patients with no PAS (n = 272), major PAS (n = 24), and minor PAS (n = 33), and rectal cancer patients with no PAS (n = 282), major PAS (n = 16), and minor PAS (n = 26). Results In patients with colon and rectal cancers, the rate of conversion to open surgery was significantly higher in the major PAS group (25% and 25%) compared with the no PAS group (8.1% and 8.9%), while the conversion rate was similar between the no PAS and minor PAS groups (15.2% and 15.4%). The 30-day complication rate did not differ among the three groups (28.7% and 29.1% in the no PAS group, 29.2% and 25% in the major PAS group, and 27.3% and 26.9% in the minor PAS group). The mean operative time did not differ among the three groups (188 min and 227 min in the no PAS group, 191 min and 210 min in the major PAS group, and 192 min and 248 min in the minor PAS group). The rate of conversion to open surgery was significantly higher in patients with prior gastrectomy or colectomy compared with the no PAS group, while the conversion rate was similar between the no PAS group and patients with prior radical hysterectomy in patients with colon and rectal cancers. Conclusions Our results suggest that colorectal cancer patients with minor PAS or patients with prior radical hysterectomy can be effectively managed with a laparoscopic approach. In addition, laparoscopy can be selected as the primary surgical approach even in patients with major PAS (prior gastrectomy or colectomy) given the assumption of a higher conversion rate.	[Kim, Ik Yong; Kim, Young Wan] Yonsei Univ, Wonju Coll Med, Dept Surg, Div Gastrointestinal Surg, Wonju, South Korea; [Kim, Bo Ra] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Gastroenterol, Wonju, South Korea	Yonsei University; Yonsei University	Kim, YW (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Surg, Div Gastrointestinal Surg, Wonju, South Korea.	youngwkim@yonsei.ac.kr						Allaix ME, 2013, SURG ENDOSC, V27, P4596, DOI 10.1007/s00464-013-3072-7; Aytac E, 2015, SURG ENDOSC, V29, P537, DOI 10.1007/s00464-014-3719-z; Barleben A, 2009, AM SURGEON, V75, P1015; Beck DE, 2000, DIS COLON RECTUM, V43, P1749, DOI 10.1007/BF02236862; Belizon A, 2006, SURG ENDOSC, V20, P947, DOI 10.1007/s00464-005-0553-3; Braga M, 2007, DIS COLON RECTUM, V50, P464, DOI 10.1007/s10350-006-0798-5; Chan ACY, 2008, SURG ENDOSC, V22, P2625, DOI 10.1007/s00464-008-9813-3; Coleman MG, 2000, DIS COLON RECTUM, V43, P1297, DOI 10.1007/BF02237441; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Franko Jan, 2006, JSLS, V10, P169; Gervaz P, 2001, SURG ENDOSC, V15, P827, DOI 10.1007/s004640080062; Gonzalez IA, 2006, SURG LAPARO ENDO PER, V16, P8, DOI 10.1097/01.sle.0000202188.57537.07; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Hamel CT, 2000, SURG ENDOSC-ULTRAS, V14, P853, DOI 10.1007/s004640000218; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Kim YW, 2010, SURG LAPARO ENDO PER, V20, P36, DOI 10.1097/SLE.0b013e3181cdb762; Kumar AS, 2013, SURG CLIN N AM, V93, P217, DOI 10.1016/j.suc.2012.09.006; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Law WL, 2005, SURG ENDOSC, V19, P326, DOI 10.1007/s00464-004-8114-8; Marks JH, 2008, SURG ENDOSC, V22, P1899, DOI 10.1007/s00464-008-9828-9; Miskovic D, 2012, DIS COLON RECTUM, V55, P1300, DOI 10.1097/DCR.0b013e31826ab4dd; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Offodile AC, 2008, DIS COLON RECTUM, V51, P1669, DOI 10.1007/s10350-008-9278-4; Swank DJ, 2003, SURG LAPARO ENDO PER, V13, P88, DOI 10.1097/00129689-200304000-00006; van der Voort M, 2004, BRIT J SURG, V91, P1253, DOI 10.1002/bjs.4716; Vignali A, 2007, Tech Coloproctol, V11, P241, DOI 10.1007/s10151-007-0358-6; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yamamoto M, 2013, DIS COLON RECTUM, V56, P336, DOI 10.1097/DCR.0b013e31827ba103	30	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134058	10.1371/journal.pone.0134058	http://dx.doi.org/10.1371/journal.pone.0134058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207637	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000199
J	Lopez-Lopez, MT; Scionti, G; Oliveira, AC; Duran, JDG; Campos, A; Alaminos, M; Rodriguez, IA				Lopez-Lopez, Modesto T.; Scionti, Giuseppe; Oliveira, Ana C.; Duran, Juan D. G.; Campos, Antonio; Alaminos, Miguel; Rodriguez, Ismael A.			Generation and Characterization of Novel Magnetic Field-Responsive Biomaterials	PLOS ONE			English	Article							SCAFFOLDS; NANOPARTICLES; FIBRIN; BONE; REPAIR	We report the preparation of novel magnetic field-responsive tissue substitutes based on biocompatible multi-domain magnetic particles dispersed in a fibrin-agarose biopolymer scaffold. We characterized our biomaterials with several experimental techniques. First we analyzed their microstructure and found that it was strongly affected by the presence of magnetic particles, especially when a magnetic field was applied at the start of polymer gelation. In these samples we observed parallel stripes consisting of closely packed fibers, separated by more isotropic net-like spaces. We then studied the viability of oral mucosa fibroblasts in the magnetic scaffolds and found no significant differences compared to positive control samples. Finally, we analyzed the magnetic and mechanical properties of the tissue substitutes. Differences in microstructural patterns of the tissue substitutes correlated with their macroscopic mechanical properties. We also found that the mechanical properties of our magnetic tissue substitutes could be reversibly tuned by noncontact magnetic forces. This unique advantage with respect to other biomaterials could be used to match the mechanical properties of the tissue substitutes to those of potential target tissues in tissue engineering applications.	[Lopez-Lopez, Modesto T.; Duran, Juan D. G.] Univ Granada, Dept Appl Phys, Fac Sci, Granada, Spain; [Lopez-Lopez, Modesto T.; Scionti, Giuseppe; Oliveira, Ana C.; Duran, Juan D. G.; Campos, Antonio; Alaminos, Miguel; Rodriguez, Ismael A.] Inst Invest Biosanitaria Ibs GRANADA, Granada, Spain; [Scionti, Giuseppe; Oliveira, Ana C.; Campos, Antonio; Alaminos, Miguel; Rodriguez, Ismael A.] Univ Granada, Dept Histol, Fac Med, Granada, Spain; [Rodriguez, Ismael A.] Natl Univ Cordoba, Dept Histol, Sch Dent, Cordoba, Argentina	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; National University of Cordoba	Lopez-Lopez, MT (corresponding author), Univ Granada, Dept Appl Phys, Fac Sci, Granada, Spain.	modesto@ugr.es; ismaelrodriguez18@hotmail.com	Rodriguez, Ismael/C-7812-2019; Duran, Juan/GRZ-0839-2022; Lopez-Lopez, Modesto T/K-7327-2012; Oliveira, Ana Carolina/GRF-1435-2022; ALAMINOS, MIGUEL/N-9960-2016	Lopez-Lopez, Modesto T/0000-0002-9068-7795; ALAMINOS, MIGUEL/0000-0003-4876-2672; Scionti, Giuseppe/0000-0003-2128-0104; Campos, A/0000-0003-4061-8182	Spanish Ministry of Economy and Competitiveness - FEDER funds, EU [FIS2013-41821-R]; Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III - FEDER funds, EU) [FIS PI14/0955, FIS PI14/1343, PI11/01582]; Junta de Andalucia, Spain (Consejeria de Innovacion, Ciencia y Empleo-Proyectos de Excelencia) [P10-CTS-6060]	Spanish Ministry of Economy and Competitiveness - FEDER funds, EU; Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III - FEDER funds, EU); Junta de Andalucia, Spain (Consejeria de Innovacion, Ciencia y Empleo-Proyectos de Excelencia)(Junta de Andalucia)	This work was supported by FIS2013-41821-R (http://www.mineco.gob.es/): Spanish Ministry of Economy and Competitiveness (co-funded by FEDER funds, EU) to MTLL, GS, JDGD and IAR; FIS PI14/0955 (http://www.mineco.gob.es/): Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III-co-funded by FEDER funds, EU) to AC and MA; FIS PI14/1343 (http://www.mineco.gob.es/): Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III -co-funded by FEDER funds, EU) to AC and MA; PI11/01582 (http://www.mineco.gob.es/): Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III -co-funded by FEDER funds, EU) to AC and MA; and P10-CTS-6060 (http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html) Junta de Andalucia, Spain (Consejeria de Innovacion, Ciencia y Empleo-Proyectos de Excelencia) to AC and MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Baddour JA, 2012, BIRTH DEFECTS RES C, V96, P1, DOI 10.1002/bdrc.21006; Banobre-Lopez M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3561149; Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017; Bossis G, 2002, LECT NOTES PHYS, V594, P202; Capito RM, 2003, IEEE ENG MED BIOL, V22, P42, DOI 10.1109/MEMB.2003.1256271; Christensen R. M., 1991, MECH COMPOSITE MAT; Das B, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035003; De Santis R, 2011, J APPL POLYM SCI, V122, P3599, DOI 10.1002/app.34771; Dhandayuthapani B, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/290602; Ge L, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/11/115029; Getgood A, 2009, J BONE JOINT SURG BR, V91B, P565, DOI 10.1302/0301-620X.91B5.21832; Gloria A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0833; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Hu H, 2013, RSC ADV, V3, P879, DOI 10.1039/c2ra22726f; Hu SH, 2007, J MAGN MAGN MATER, V310, P2871, DOI 10.1016/j.jmmm.2006.11.081; Jiles D.C., 1998, INTRO MAGNETISM MAGN; Jolly MR, 1996, J INTEL MAT SYST STR, V7, P613, DOI 10.1177/1045389X9600700601; Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014; Lai KL, 2012, RSC ADV, V2, P13007, DOI 10.1039/c2ra22376g; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; Li YH, 2013, ADV FUNCT MATER, V23, P660, DOI 10.1002/adfm.201201708; Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015; Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x; Pabbruwe MB, 2009, BIOMATERIALS, V30, P4277, DOI 10.1016/j.biomaterials.2009.02.052; Panseri S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-32; Rodriguez IA, 2012, J TISSUE ENG REGEN M, V6, P636, DOI 10.1002/term.466; Rodriguez MA, 2013, CRYOBIOLOGY, V67, P355, DOI 10.1016/j.cryobiol.2013.10.003; Rosensweig RE, 1998, FERROHYDRODYNAMICS; Scionti G, 2014, J BIOMED MATER RES A, V102, P2573, DOI 10.1002/jbm.a.34929; Singh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091584; Skaat H, 2012, ADV HEALTHC MATER, V1, P168, DOI 10.1002/adhm.201100056; Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104; Tampieri A, 2012, ACTA BIOMATER, V8, P843, DOI 10.1016/j.actbio.2011.09.032; Thanikaivelan P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00230; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; Vinuela-Prieto JM, 2015, J PERIODONTAL RES, V50, P658, DOI 10.1111/jre.12247; Zeng XB, 2012, INT J NANOMED, V7, P3365, DOI 10.2147/IJN.S32264; Zeng XB, 2013, J INORG MATER, V28, P79, DOI 10.3724/SP.J.1077.2013.12107; Zhu YF, 2013, J MATER CHEM B, V1, P1279, DOI 10.1039/c2tb00262k; Ziv-Polat O, 2012, INT J NANOMED, V7, P1259, DOI 10.2147/IJN.S26533	41	40	41	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133878	10.1371/journal.pone.0133878	http://dx.doi.org/10.1371/journal.pone.0133878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207995	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000163
J	Samaniego, CS; Suh, JH; Chattopadhyay, A; Olivares, K; Guy, N; Sivils, JC; Dey, P; Yumoto, F; Fletterick, RJ; Strom, AM; Gustafsson, JA; Webb, P; Cox, MB				Samaniego, Cheryl Storer; Suh, Ji Ho; Chattopadhyay, Arundhati; Olivares, Karen; Guy, Naihsuan; Sivils, Jeffrey C.; Dey, Prasenjit; Yumoto, Fumiaki; Fletterick, Robert J.; Strom, Anders M.; Gustafsson, Jan-Ake; Webb, Paul; Cox, Marc B.			The FKBP52 Cochaperone Acts in Synergy with beta-Catenin to Potentiate Androgen Receptor Signaling	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; DOMAIN; WNT; ACTIVATION; PATHWAY; DISEASE; BINDING; ROLES; CELLS	FKBP52 and beta-catenin have emerged in recent years as attractive targets for prostate cancer treatment. beta-catenin interacts directly with the androgen receptor (AR) and has been characterized as a co-activator of AR-mediated transcription. FKBP52 is a positive regulator of AR in cellular and whole animal models and is required for the development of androgen-dependent tissues. We previously characterized an AR inhibitor termed MJC13 that putatively targets the AR BF3 surface to specifically inhibit FKBP52-regulated AR signaling. Predictive modeling suggests that beta-catenin interacts with the AR hormone binding domain on a surface that overlaps with BF3. Here we demonstrate that FKBP52 and beta-catenin interact directly in vitro and act in concert to promote a synergistic up-regulation of both hormone-independent and -dependent AR signaling. Our data demonstrate that FKBP52 promotes beta-catenin interaction with AR and is required for beta-catenin co-activation of AR activity in prostate cancer cells. MJC13 effectively blocks beta-catenin interaction with the AR LBD and the synergistic up-regulation of AR by FKBP52 and beta-catenin. Our data suggest that co-regulation of AR by FKBP52 and beta-catenin does not require FKBP52 PPIase catalytic activity, nor FKBP52 binding to Hsp90. However, the FKBP52 proline-rich loop that overhangs the PPIase pocket is critical for synergy.	[Samaniego, Cheryl Storer; Olivares, Karen; Guy, Naihsuan; Sivils, Jeffrey C.; Cox, Marc B.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Samaniego, Cheryl Storer; Olivares, Karen; Guy, Naihsuan; Sivils, Jeffrey C.; Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Samaniego, Cheryl Storer] Kettering Univ, Dept Chem & Biochem, Flint, MI USA; [Suh, Ji Ho; Chattopadhyay, Arundhati; Webb, Paul] Methodist Hosp, Res Inst, Genom Med, Houston, TX 77030 USA; [Dey, Prasenjit; Strom, Anders M.; Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Dey, Prasenjit; Strom, Anders M.; Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Yumoto, Fumiaki; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; Kettering University; The Methodist Hospital System; The Methodist Hospital - Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; University of California System; University of California San Francisco	Cox, MB (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	mbcox@utep.edu		Cox, Marc/0000-0001-7854-2676	National Institute on Minority Health and Health Disparities [2G12MD007592]; National Institutes of Health; American Recovery and Reinvestment Act (ARRA) funds through National Institute of General Medical Sciences [SC1GM084863]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110444-P1, RP110444-P2, RP110444-P3, RP110444-C2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM084863] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act (ARRA) funds through National Institute of General Medical Sciences; Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by grants to the Border Biomedical Research Center (http://science.utep.edu/bbrc/) from the National Institute on Minority Health and Health Disparities (grant number 2G12MD007592; http://www.nimhd.nih.gov/) from the National Institutes of Health. M.B.C. was supported in part by American Recovery and Reinvestment Act (ARRA) funds through grant number SC1GM084863 to M.B.C. from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/Pages/default.aspx). These studies were also supported in part by Cancer Prevention and Research Institute of Texas (CPRIT; http://www.cprit.state.tx.us/) grants to J.A.G. (RP110444-P1), M.B.C. (RP110444-P2), and P.W. (RP110444-P3 and RP110444-C2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cano LQ, 2013, MOL CELL ENDOCRINOL, V369, P52, DOI 10.1016/j.mce.2013.01.023; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Cluning C, 2013, MOL ENDOCRINOL, V27, P1020, DOI 10.1210/me.2012-1023; Cox MB, 2007, MOL ENDOCRINOL, V21, P2956, DOI 10.1210/me.2006-0547; Cronauer MV, 2005, INT J ONCOL, V26, P1033; De Leon JT, 2011, P NATL ACAD SCI USA, V108, P11878, DOI 10.1073/pnas.1105160108; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Erlejman AG, 2014, CURR PROTEIN PEPT SC, V15, P205, DOI 10.2174/1389203715666140331113753; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Jehle K, 2014, J BIOL CHEM, V289, P8839, DOI 10.1074/jbc.M113.534859; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Liang S, 2016, PHARM DEV TECHNOL, V21, P121, DOI 10.3109/10837450.2014.979946; Liang Su, 2014, Am J Mod Chromatogr, V1, P1; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Sivils JC, 2011, CURR OPIN PHARMACOL, V11, P314, DOI 10.1016/j.coph.2011.03.010; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Truica CI, 2000, CANCER RES, V60, P4709; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang Juan, 2011, Clinical Oncology and Cancer Research, V8, P85, DOI 10.1007/s11805-011-0564-x; Yamaoka M, 2010, CLIN CANCER RES, V16, P4319, DOI 10.1158/1078-0432.CCR-10-0255; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200; Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134015	10.1371/journal.pone.0134015	http://dx.doi.org/10.1371/journal.pone.0134015			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207810	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000191
J	Yan, JY; Zhang, L; Sultana, N; Park, DS; Shekhar, A; Bu, L; Hu, J; Razzaque, S; Cai, CL				Yan, Jianyun; Zhang, Lu; Sultana, Nishat; Park, David S.; Shekhar, Akshay; Bu, Lei; Hu, Jun; Razzaque, Shegufta; Cai, Chen-Leng			A Murine Myh6(MerCreMer) Knock-In Allele Specifically Mediates Temporal Genetic Deletion in Cardiomyocytes after Tamoxifen Induction	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; MYOSIN HEAVY-CHAIN; CRE-RECOMBINASE; TRANSGENIC MICE; SMOOTH-MUSCLE; EXPRESSION; MOUSE; CARDIOMYOPATHY; FAILURE; CELLS	A mouse model that mediates temporal, specific, and efficient myocardial deletion with Cre-LoxP technology will be a valuable tool to determine the function of genes during heart formation. Mhy6 encodes a cardiac muscle specific protein: alpha-myosin heavy chain. Here, we generated a new Myh6-MerCreMer (Myh6(MerCreMer/+)) inducible Cre knock-in mouse by inserting a MerCreMer cassette into the Myh6 start codon. By crossing knock-in mice with Rosa26 reporter lines, we found the Myh6(MerCreMer/+) mice mediate complete Cre-LoxP recombination in cardiomyocytes after tamoxifen induction. X-gal staining and immunohistochemistry analysis revealed that Myh6-driven Cre recombinase was specifically activated in cardiomyocytes at embryonic and adult stages. Furthermore, echocardiography showed that Myh6(MerCreMer/+) mice maintained normal cardiac structure and function before and after tamoxifen administration. These results suggest that the new Myh6(MerCreMer/+) mouse can serve as a robust tool to dissect the roles of genes in heart development and function. Additionally, myocardial progeny during heart development and after cardiac injury can be traced using this mouse line.	[Yan, Jianyun; Zhang, Lu; Sultana, Nishat; Hu, Jun; Razzaque, Shegufta; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Yan, Jianyun; Zhang, Lu; Sultana, Nishat; Hu, Jun; Razzaque, Shegufta; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Park, David S.; Shekhar, Akshay; Bu, Lei] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University	Cai, CL (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	chenleng.cai@mssm.edu	Yan, Jianyun/AAX-4510-2020	Yan, Jianyun/0000-0002-6962-1169; Razzaque, Shegufta/0000-0003-1220-5364; Shekhar, Akshay/0000-0002-9168-9987; BU, LEI/0000-0003-4476-2157	NHLBI [1R01HL095810, 1K02HL094688]; NYSTEM [C026426]; American Heart Association [15GRNT25710153]; March of Dimes Foundation [5-FY07-642]; NIH [T32 GM066704]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL094688, R01HL095810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066704] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NYSTEM; American Heart Association(American Heart Association); March of Dimes Foundation(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants to C.L.C. from the NHLBI (1R01HL095810 and 1K02HL094688), NYSTEM (C026426), the American Heart Association (15GRNT25710153) and the March of Dimes Foundation (5-FY07-642), and to A.S. from NIH T32 GM066704 (Bach). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SR, 2014, P NATL ACAD SCI USA, V111, P8850, DOI 10.1073/pnas.1408233111; Bersell K, 2013, DIS MODEL MECH, V6, P1459, DOI 10.1242/dmm.010447; Bruneau BG, 2014, CIRC RES, V114, P598, DOI 10.1161/CIRCRESAHA.113.303060; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Cai XQ, 2013, DEVELOPMENT, V140, P3176, DOI 10.1242/dev.092502; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gelb BD, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013953; Hall ME, 2011, AM J PHYSIOL-HEART C, V301, pH253, DOI 10.1152/ajpheart.00786.2010; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hougen K, 2010, AM J PHYSIOL-HEART C, V299, pH1671, DOI 10.1152/ajpheart.01155.2009; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Jaisser F, 2000, J AM SOC NEPHROL, V11, pS95; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Koyanagi M, 2007, CIRC RES, V101, P1139, DOI 10.1161/CIRCRESAHA.107.151381; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Mack CP, 1999, CIRC RES, V84, P852; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Molkentin JD, 2009, J MOL CELL CARDIOL, V46, P130, DOI 10.1016/j.yjmcc.2008.09.002; Nemir M, 2014, EUR HEART J, V35, P2174, DOI 10.1093/eurheartj/ehs269; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; Park EJ, 2008, DEV DYNAM, V237, P447, DOI 10.1002/dvdy.21415; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Pinkert CA., 2002, TRANSGENIC ANIMAL TE; Posch MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028872; Ram R, 2011, AM J PHYSIOL-HEART C, V301, pH1765, DOI 10.1152/ajpheart.00559.2011; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Robbins J, 2004, J MOL CELL CARDIOL, V36, P643, DOI 10.1016/j.yjmcc.2004.02.012; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thomas RL, 2013, GENE DEV, V27, P1365, DOI 10.1101/gad.215871.113; Tsuchihashi T, 2011, DEV BIOL, V351, P62, DOI 10.1016/j.ydbio.2010.12.023; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wolf M, 2010, CURR OPIN CARDIOL, V25, P192, DOI 10.1097/HCO.0b013e328337b4ce; Wu BR, 2010, GENESIS, V48, P63, DOI 10.1002/dvg.20573; Xie LL, 2012, DEV CELL, V23, P280, DOI 10.1016/j.devcel.2012.06.006; Yan JY, 2015, GENESIS, V53, P377, DOI 10.1002/dvg.22861; Yan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104503; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133472	10.1371/journal.pone.0133472	http://dx.doi.org/10.1371/journal.pone.0133472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204265	Green Submitted, Green Published, gold			2022-12-26	WOS:000358621000031
J	Bellinger, MR; Banks, MA; Bates, SJ; Crandall, ED; Garza, JC; Sylvia, G; Lawson, PW				Bellinger, M. Renee; Banks, Michael A.; Bates, Sarah J.; Crandall, Eric D.; Garza, John Carlos; Sylvia, Gil; Lawson, Peter W.			Geo-Referenced, Abundance Calibrated Ocean Distribution of Chinook Salmon (Oncorhynchus tshawytscha) Stocks across the West Coast of North America	PLOS ONE			English	Article							PACIFIC SALMON; COHO SALMON; TEMPORAL PATTERNS; BRITISH-COLUMBIA; GENETIC DATA; IDENTIFICATION; CALIFORNIA; MANAGEMENT; FISHERIES; DNA	Understanding seasonal migration and localized persistence of populations is critical for effective species harvest and conservation management. Pacific salmon (genus Oncorhynchus) forecasting models predict stock composition, abundance, and distribution during annual assessments of proposed fisheries impacts. Most models, however, fail to account for the influence of biophysical factors on year-to-year fluctuations in migratory distributions and stock-specific survival. In this study, the ocean distribution and relative abundance of Chinook salmon (O. tshawytscha) stocks encountered in the California Current large marine ecosystem, U.S. A were inferred using catch-per-unit effort (CPUE) fisheries and genetic stock identification data. In contrast to stock distributions estimated through coded-wire-tag recoveries (typically limited to hatchery salmon), stock-specific CPUE provides information for both wild and hatchery fish. Furthermore, in contrast to stock composition results, the stock-specific CPUE metric is independent of other stocks and is easily interpreted over multiple temporal or spatial scales. Tests for correlations between stock-specific CPUE and stock composition estimates revealed these measures diverged once proportional contributions of locally rare stocks were excluded from data sets. A novel aspect of this study was collection of data both in areas closed to commercial fisheries and during normal, open commercial fisheries. Because fishing fleet efficiency influences catch rates, we tested whether CPUE differed between closed area (non-retention) and open area (retention) data sets. A weak effect was indicated for some, but not all, analyzed cases. Novel visualizations produced from stock-specific CPUE-based ocean abundance facilitates consideration of how highly refined, spatial and genetic information could be incorporated in ocean fisheries management systems and for investigations of biogeographic factors that influence migratory distributions of fish.	[Bellinger, M. Renee; Banks, Michael A.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Coastal Oregon Marine Expt Stn, Newport, OR 97365 USA; [Bates, Sarah J.] Calif Salmon Council, Oakland, CA USA; [Crandall, Eric D.; Garza, John Carlos] Natl Marine Fisheries Serv, Natl Oceanog & Atmospher Adm, Southwest Fisheries Sci Ctr, Santa Cruz, CA USA; [Garza, John Carlos] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Sylvia, Gil] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Appl Econ, Coastal Oregon Marine Expt Stn, Newport, OR 97365 USA; [Lawson, Peter W.] Natl Marine Fisheries Serv, Natl Oceanog & Atmospher Adm, Northwest Fisheries Sci Ctr, Newport, OR USA	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Bellinger, MR (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Coastal Oregon Marine Expt Stn, Newport, OR 97365 USA.	reneebellinger@gmail.com	CRANDALL, EDWARD/AAD-8382-2020	Crandall, Eric/0000-0001-8580-3651	National Oceanic and Atmospheric Administration (NOAA); NOAA [NA07NMF4540337]; California Salmon Council;  [NA07NMF4540337 NA08NMF4720662 NA09NMF4720381];  [NA08NMF4270421]	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); California Salmon Council; ; 	This study was designed and conducted as an industry-science collaboration between industry partners California Salmon Council and OregonSalmon Commission and scientific investigators affiliated with academic and federal institutions. Major funding originated from the National Oceanic and Atmospheric Administration (NOAA). Funds were awarded to Nancy Fitzpatrick, Oregon Salmon Commission and David Goldenberg, California Salmon Council NA07NMF4540337 NA08NMF4720662 NA09NMF4720381, Saltonstall Kennedy Grant Program NA08NMF4270421. NOAA scientists and university scientists were co-Principal Investigators on all major grants except the Saltonstall-Kennedy Grant (University only). Pacific States Marine Fisheries Commission acted via contract with NOAA to help distribute Klamath Disaster funds (NA07NMF4540337) to the states. The California Salmon Council and Oregon Salmon Commission helped to facilitate the industry partnership and distributed funds to industry for their participation in at-sea sampling and data collection. The California Salmon Council provided support in the form of salary for author SJB, who was hired to manage California at-sea sample collections and contribute to manuscript preparation. The specific role of this author is articulated in the 'author contributions' section.	Allison P.D., 2008, P SAS GLOBAL FORUM, V360, P1; Anderson EC, 2008, CAN J FISH AQUAT SCI, V65, P1475, DOI 10.1139/F08-049; Beacham TD, 2004, CONSERV GENET, V5, P411, DOI 10.1023/B:COGE.0000031140.41379.73; BEACHAM TD, 2012, DYNAMICS MANAGE ECOS, P1, DOI DOI 10.1080/19425120.2011.649391; Beacham TD, 2008, N AM J FISH MANAGE, V28, P849, DOI 10.1577/M06-167.1; Beacham TD, 2006, T AM FISH SOC, V135, P861, DOI 10.1577/T05-241.1; Clemento AJ, 2011, MOL ECOL RESOUR, V11, P50, DOI 10.1111/j.1755-0998.2010.02972.x; Clemento AJ, 2014, FISH B-NOAA, V112, P112, DOI 10.7755/FB.112.2-3.2; Dann TH, 2013, CAN J FISH AQUAT SCI, V70, P785, DOI 10.1139/cjfas-2012-0449; Drenner SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031311; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Garza JC, CALIFORNIA GENETIC S; GRANT WS, 1980, CAN J FISH AQUAT SCI, V37, P1236, DOI 10.1139/f80-159; Heard William R., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P77; Hedgecock D., 2001, APPLICATIONS OF POPU, V179, P45; Hess JE, 2011, MOL ECOL RESOUR, V11, P137, DOI 10.1111/j.1755-0998.2010.02958.x; Hinke JT, 2005, MAR ECOL PROG SER, V285, P181, DOI 10.3354/meps285181; Hobday AJ, 2001, CAN J FISH AQUAT SCI, V58, P2021, DOI 10.1139/cjfas-58-10-2021; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JEFFERTS KB, 1963, NATURE, V198, P460, DOI 10.1038/198460a0; Johnson KJ, 2004, REGIONAL OVERVIEW OF; Kalinowsi ST, 2007, ONCOR A COMPUTER PRO; Kallio-Nyberg I, 1999, CAN J FISH AQUAT SCI, V56, P853, DOI 10.1139/cjfas-56-5-853; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; MCDONALD J, 1981, CAN J FISH AQUAT SCI, V38, P1657, DOI 10.1139/f81-214; MILNER GB, 1985, MAR FISH REV, V47, P1; Moran P, 2013, CAN J FISH AQUAT SCI, V70, P415, DOI 10.1139/cjfas-2012-0135; Natural Resources Consultants Inc. Northwest Emergency Assistance Plan at-sea Research Programs, 1998, FINAL REPORT; O'Malley KG, 2013, EVOL APPL, V6, P1184, DOI 10.1111/eva.12095; Pacific Fishery Management Council, 2010, PRESEASON REPORT III; Pacific Fishery Management Council A, 2007, FISHERIES REGULATION; Park SDE, 2001, THESIS; Pearcy WG, 1992, OCEAN ECOLOGY OF NOR; Peyronnet A, 2008, J FISH BIOL, V73, P945, DOI 10.1111/j.1095-8649.2008.01984.x; Satterthwaite WH, 2013, CAN J FISH AQUAT SCI, V70, P574, DOI 10.1139/cjfas-2012-0395; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2; Shaklee JB, 1999, FISH RES, V43, P45, DOI 10.1016/S0165-7836(99)00066-1; Shaul Leon, 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P93; Steele CA, 2013, CAN J FISH AQUAT SCI, V70, P1046, DOI 10.1139/cjfas-2012-0451; Theriault V, 2011, MOL ECOL, V20, P1860, DOI 10.1111/j.1365-294X.2011.05058.x; Tufte ER, 1986, THE VISUAL DISPLAY O; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Waples RS, 2008, EVOL APPL, V1, P189, DOI 10.1111/j.1752-4571.2008.00023.x; Waples RS, 2001, J FISH BIOL, V59, P1, DOI 10.1006/jfbi.2001.1764; Weitkamp LA, 2010, T AM FISH SOC, V139, P147, DOI 10.1577/T08-225.1; Wells BK, 2008, FISH OCEANOGR, V17, P101, DOI 10.1111/j.1365-2419.2008.00467.x; Wessa P., 2012, FREE STATISTICS SOFT; Winans Gary A., 2001, Reviews in Fisheries Science, V9, P213, DOI 10.1080/20016491101753	50	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131276	10.1371/journal.pone.0131276	http://dx.doi.org/10.1371/journal.pone.0131276			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200779	Green Submitted, Green Published, gold			2022-12-26	WOS:000358597100013
J	Gentry, LR; Nishimura, A; Cox, AD; Martin, TD; Tsygankov, D; Nishida, M; Elston, TC; Der, CJ				Gentry, Leanna R.; Nishimura, Akiyuki; Cox, Adrienne D.; Martin, Timothy D.; Tsygankov, Denis; Nishida, Motohiro; Elston, Timothy C.; Der, Channing J.			Divergent Roles of CAAX Motif-signaled Posttranslational Modifications in the Regulation and Subcellular Localization of Ral GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-RAS; CARBOXYL METHYLATION; ACTIVATING PROTEINS; ENDOPROTEASE RCE1; GAMMA-SUBUNIT; CELL-GROWTH; CANCER; DEFICIENCY; PHOSPHORYLATION; IDENTIFICATION	The Ras-like small GTPases RalA and RalB are well validated effectors of RAS oncogene-driven human cancer growth, and pharmacologic inhibitors of Ral function may provide an effective anti-Ras therapeutic strategy. Intriguingly, although RalA and RalB share strong overall amino acid sequence identity, exhibit essentially identical structural and biochemical properties, and can utilize the same downstream effectors, they also exhibit divergent and sometimes opposing roles in the tumorigenic and metastatic growth of different cancer types. These distinct biological functions have been attributed largely to sequence divergence in their carboxyl-terminal hypervariable regions. However, the role of posttranslational modifications signaled by the hypervariable region carboxyl-terminal tetrapeptide CAAX motif (C = cysteine, A = aliphatic amino acid, X = terminal residue) in Ral isoform-selective functions has not been addressed. We determined that these modifications have distinct roles and consequences. Both RalA and RalB require Ras converting CAAX endopeptidase 1 (RCE1) for association with the plasma membrane, albeit not with endomembranes, and loss of RCE1 caused mislocalization as well as sustained activation of both RalA and RalB. In contrast, isoprenylcysteine carboxylmethyltransferase (ICMT) deficiency disrupted plasma membrane localization only of RalB, whereas RalA depended on ICMT for efficient endosomal localization. Furthermore, the absence of ICMT increased stability of RalB but not RalA protein. Finally, palmitoylation was critical for subcellular localization of RalB but not RalA. In summary, we have identified striking isoform-specific consequences of distinct CAAX-signaled posttranslational modifications that contribute to the divergent subcellular localization and activity of RalA and RalB.	[Gentry, Leanna R.; Cox, Adrienne D.; Martin, Timothy D.; Tsygankov, Denis; Elston, Timothy C.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Nishimura, Akiyuki; Nishida, Motohiro] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cardiocirculatory Signaling, Okazaki, Aichi 4448787, Japan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB)	Der, CJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Tsygankov, Denis/L-4672-2019; Regan, Clinton/E-6250-2012	Nishida, Motohiro/0000-0002-2587-5458; Tsygankov, Denis/0000-0002-1180-3584; Der, Channing/0000-0002-7751-2747; Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health [R01 CA042978, T32 GM007040]; NATIONAL CANCER INSTITUTE [R01CA042978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079271, T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA042978 (to C. J. D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health T32 GM007040.	Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; CHARDIN P, 1989, NUCLEIC ACIDS RES, V17, P4380, DOI 10.1093/nar/17.11.4380; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Court H, 2013, J CLIN INVEST, V123, P4681, DOI 10.1172/JCI65764; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; FUKADA Y, 1994, J BIOL CHEM, V269, P5163; Gentry LR, 2014, BBA-MOL CELL RES, V1843, P2976, DOI 10.1016/j.bbamcr.2014.09.004; Kashatus DF, 2013, EXP CELL RES, V319, P2337, DOI 10.1016/j.yexcr.2013.06.020; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; KINSELLA BT, 1991, J BIOL CHEM, V266, P9786; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Martin TD, 2014, MOL CELL, V53, P209, DOI 10.1016/j.molcel.2013.12.004; Martin TD, 2012, J BIOL CHEM, V287, P14827, DOI 10.1074/jbc.M112.344986; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; Maske CP, 2003, J CELL BIOL, V162, P1223, DOI 10.1083/jcb.200303113; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Mitin N, 2012, METHODS MOL BIOL, V827, P87, DOI 10.1007/978-1-61779-442-1_6; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Neyraud V, 2012, J BIOL CHEM, V287, P29397, DOI 10.1074/jbc.M112.357764; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; PARISH CA, 1995, BIOCHEMISTRY-US, V34, P7722, DOI 10.1021/bi00023a019; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Tsygankov D, 2014, J CELL BIOL, V204, P443, DOI 10.1083/jcb.201306067; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wahlstrom AM, 2007, BLOOD, V109, P763, DOI 10.1182/blood-2006-05-024752; Wang H, 2010, CANCER RES, V70, P8760, DOI 10.1158/0008-5472.CAN-10-0952; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Yu YH, 2003, ANN NY ACAD SCI, V983, P268, DOI 10.1111/j.1749-6632.2003.tb05981.x	53	29	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22851	22861		10.1074/jbc.M115.656710	http://dx.doi.org/10.1074/jbc.M115.656710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216878	Green Published, hybrid			2022-12-26	WOS:000361171500047
J	Sun, XL; He, GZ; Wang, XY; Xu, SJ; Ju, JS; Xu, XL				Sun, Xiaoliang; He, Guangzheng; Wang, Xiaoyan; Xu, Shujing; Ju, Jiansong; Xu, Xiaoling			Crystal Structure of a Thermostable Alanine Racemase from Thermoanaerobacter tengcongensis MB4 Reveals the Role of Gln360 in Substrate Selection	PLOS ONE			English	Article							D-AMINO ACIDS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; X-RAY; BACILLUS-STEAROTHERMOPHILUS; SALMONELLA-TYPHIMURIUM; CYCLOSERINE; SITE; PURIFICATION; TUBERCULOSIS	Pyridoxal 5'-phosphate (PLP) dependent alanine racemase catalyzes racemization of L-Ala to D-Ala, a key component of the peptidoglycan network in bacterial cell wall. It has been extensively studied as an important antimicrobial drug target due to its restriction in eukaryotes. However, many marketed alanine racemase inhibitors also act on eukaryotic PLP-dependent enzymes and cause side effects. A thermostable alanine racemase (Alr(Tt)) from Thermoanaerobacter tengcongensis MB4 contains an evolutionarily non-conserved residue Gln360 in inner layer of the substrate entryway, which is supposed to be a key determinant in substrate specificity. Here we determined the crystal structure of Alr(Tt) in complex with L-Ala at 2.7 angstrom resolution, and investigated the role of Gln360 by saturation mutagenesis and kinetic analysis. Compared to typical bacterial alanine racemase, presence of Gln360 and conformational changes of active site residues disrupted the hydrogen bonding interactions necessary for proper PLP immobilization, and decreased both the substrate affinity and turnover number of Alr(Tt). However, it could be complemented by introduction of hydrophobic amino acids at Gln360, through steric blocking and interactions with a hydrophobic patch near active site pocket. These observations explained the low racemase activity of Alr(Tt), revealed the essential role of Gln360 in substrate selection, and its preference for hydrophobic amino acids especially Tyr in bacterial alanine racemization. Our work will contribute new insights into the alanine racemization mechanism for antimicrobial drug development.	[Sun, Xiaoliang; Wang, Xiaoyan; Xu, Xiaoling] Hangzhou Normal Univ, Sch Med, Inst Ageing Res, Hangzhou, Zhejiang, Peoples R China; [He, Guangzheng; Xu, Shujing; Ju, Jiansong] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China	Hangzhou Normal University; Hebei Normal University	Ju, JS (corresponding author), Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China.	jujiansong@hotmail.com; xuxl@hznu.edu.cn	Xu, Xiaoling/ABC-2449-2021; Jiansong, Ju/R-2177-2019	Xu, Xiaoling/0000-0001-8995-1213; 	National Natural Science Foundation of China [31400630]; Zhejiang Provincial Natural Science Foundation of China [LY14C050002]; Natural Science Foundation of Hebei Province [C2015205212]; Starting Foundation for Natural Science from Hangzhou Normal University [PE13002004007]; HZNUARI-Pilot Research Grant [PD11001006007011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Starting Foundation for Natural Science from Hangzhou Normal University; HZNUARI-Pilot Research Grant	This work is supported by the National Natural Science Foundation of China under Grant No. 31400630(XLX), Zhejiang Provincial Natural Science Foundation of China under Grant No. LY14C050002 (XLX), Natural Science Foundation of Hebei Province (No. C2015205212, JSJ), the Starting Foundation for Natural Science from Hangzhou Normal University (No. PE13002004007, XLX), and the HZNUARI-Pilot Research Grant(No. PD11001006007011, XLX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asojo OA, 2014, ACTA CRYSTALLOGR D, V70, P1922, DOI 10.1107/S1399004714009419; Au K, 2008, ACTA CRYSTALLOGR F, V64, P327, DOI 10.1107/S1744309108007252; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; COPIE V, 1988, BIOCHEMISTRY-US, V27, P4966, DOI 10.1021/bi00414a002; Counago RM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-53; Davis E, 2014, ACTA CRYSTALLOGR F, V70, P1199, DOI 10.1107/S2053230X14017725; Dong H, 2013, ACTA CRYSTALLOGR F, V69, P660, DOI 10.1107/S1744309113011743; Drsata J, 2005, J PHARMACEUT BIOMED, V37, P1173, DOI 10.1016/j.jpba.2004.10.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espaillat A, 2014, ACTA CRYSTALLOGR D, V70, P79, DOI 10.1107/S1399004713024838; Fenn TD, 2003, BIOCHEMISTRY-US, V42, P5775, DOI 10.1021/bi027022d; HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F; Im H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-116; Ju JS, 2011, J BIOCHEM, V149, P83, DOI 10.1093/jb/mvq120; Ju JS, 2009, J BIOSCI BIOENG, V107, P225, DOI 10.1016/j.jbiosc.2008.11.005; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; LAMBERT MP, 1972, J BACTERIOL, V110, P978, DOI 10.1128/JB.110.3.978-987.1972; LeMagueres P, 2005, BIOCHEMISTRY-US, V44, P1471, DOI 10.1021/bi0486583; LeMagueres P, 2003, BIOCHEMISTRY-US, V42, P14752, DOI 10.1021/bi030165v; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milligan DL, 2007, J BACTERIOL, V189, P8381, DOI 10.1128/JB.01201-07; Morollo AA, 1999, BIOCHEMISTRY-US, V38, P3293, DOI 10.1021/bi9822729; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ono K, 2006, PHYTOCHEMISTRY, V67, P856, DOI 10.1016/j.phytochem.2006.02.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palani K, 2013, ACTA CRYSTALLOGR F, V69, P15, DOI 10.1107/S1744309112047276; Patrick WM, 2002, CHEMBIOCHEM, V3, P789, DOI 10.1002/1439-7633(20020802)3:8<789::AID-CBIC789>3.0.CO;2-D; Priyadarshi A, 2009, BBA-PROTEINS PROTEOM, V1794, P1030, DOI 10.1016/j.bbapap.2009.03.006; Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c; Silverman R B, 1988, J Enzyme Inhib, V2, P73, DOI 10.3109/14756368809040714; SODA K, 1968, ANAL BIOCHEM, V25, P228, DOI 10.1016/0003-2697(68)90095-X; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Strych U, 2002, J BACTERIOL, V184, P4321, DOI 10.1128/JB.184.15.4321-4325.2002; Strych U, 2000, CURR MICROBIOL, V41, P290, DOI 10.1007/s002840010136; Uo T, 2001, J BACTERIOL, V183, P2226, DOI 10.1128/JB.183.7.2226-2233.2001; WALSH CT, 1989, J BIOL CHEM, V264, P2393; WASSERMAN SA, 1983, J BACTERIOL, V153, P1439, DOI 10.1128/JB.153.3.1439-1450.1983; WASSERMAN SA, 1984, BIOCHEMISTRY-US, V23, P5182, DOI 10.1021/bi00317a015; Watanabe A, 2002, J BIOL CHEM, V277, P19166, DOI 10.1074/jbc.M201615200; WILD J, 1985, MOL GEN GENET, V198, P315, DOI 10.1007/BF00383013; Wu DL, 2008, PROTEIN SCI, V17, P1066, DOI 10.1110/ps.083495908; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Xue ZW, 2013, EXTREMOPHILES, V17, P611, DOI 10.1007/s00792-013-0545-5; YEW WW, 1993, CLIN INFECT DIS, V17, P288, DOI 10.1093/clinids/17.2.288; Yokoigawa K, 2003, FEMS MICROBIOL LETT, V221, P263, DOI 10.1016/S0378-1097(03)00216-7; Yoshikawa N, 2002, COMP BIOCHEM PHYS B, V133, P445, DOI 10.1016/S1096-4959(02)00187-2	46	2	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133516	10.1371/journal.pone.0133516	http://dx.doi.org/10.1371/journal.pone.0133516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218070	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900034
J	Reil, D; Imholt, C; Eccard, JA; Jacob, J				Reil, Daniela; Imholt, Christian; Eccard, Jana Anja; Jacob, Jens			Beech Fructification and Bank Vole Population Dynamics - Combined Analyses of Promoters of Human Puumala Virus Infections in Germany	PLOS ONE			English	Article							FAGUS-SYLVATICA L.; HANTAVIRUS INFECTION; NEPHROPATHIA-EPIDEMICA; LYME-DISEASE; RISK-FACTORS; CLETHRIONOMYS-GLAREOLUS; RODENT POPULATIONS; TEMPORAL DYNAMICS; RENAL-FAILURE; OUTBREAKS	The transmission of wildlife zoonoses to humans depends, amongst others, on complex interactions of host population ecology and pathogen dynamics within host populations. In Europe, the Puumala virus (PUUV) causes nephropathia epidemica in humans. In this study we investigated complex interrelations within the epidemic system of PUUV and its rodent host, the bank vole (Myodes glareolus). We suggest that beech fructification and bank vole abundance are both decisive factors affecting human PUUV infections. While rodent host dynamics are expected to be directly linked to human PUUV infections, beech fructification is a rather indirect predictor by serving as food source for PUUV rodent hosts. Furthermore, we examined the dependence of bank vole abundance on beech fructification. We analysed a 12-year (2001-2012) time series of the parameters: beech fructification (as food resource for the PUUV host), bank vole abundance and human incidences from 7 Federal States of Germany. For the first time, we could show the direct interrelation between these three parameters involved in human PUUV epidemics and we were able to demonstrate on a large scale that human PUUV infections are highly correlated with bank vole abundance in the present year, as well as beech fructification in the previous year. By using beech fructification and bank vole abundance as predictors in one model we significantly improved the degree of explanation of human PUUV incidence. Federal State was included as random factor because human PUUV incidence varies considerably among states. Surprisingly, the effect of rodent abundance on human PUUV infections is less strong compared to the indirect effect of beech fructification. Our findings are useful to facilitate the development of predictive models for host population dynamics and the related PUUV infection risk for humans and can be used for plant protection and human health protection purposes.	[Reil, Daniela; Imholt, Christian; Jacob, Jens] Inst Plant Protect Hort & Forests Vertebrate Res, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Munster, Germany; [Reil, Daniela; Eccard, Jana Anja] Univ Potsdam, Inst Biochem & Biol Anim Ecol, Potsdam, Germany	Julius Kuhn-Institut; University of Potsdam	Reil, D (corresponding author), Inst Plant Protect Hort & Forests Vertebrate Res, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Munster, Germany.	daniela.reil@jki.bund.de	Jacob, Jens/AAZ-7850-2020; Jacob, Jens/C-2189-2013	Jacob, Jens/0000-0002-5136-6606; 	Federal Environment Agency (UBA) within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) [3709 41 401]	Federal Environment Agency (UBA) within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB)	This study was commissioned and funded by the Federal Environment Agency (UBA) within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) (grant number 3709 41 401). The funders had no role in study design, data collection and analysis, or decision to publish. An employee of UBA provided comments and authorised the manuscript.	Abu Sin M, 2007, EMERG INFECT DIS, V13, P1364, DOI 10.3201/eid1309.070552; ANDRZEJEWSKI R, 1975, Acta Theriologica, V20, P23; Bennett E, 2010, EPIDEMIOL INFECT, V138, P91, DOI 10.1017/S095026880999029X; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; Clement J, 1987, Adv Exp Med Biol, V212, P251; Clement J, 1996, LANCET, V347, P336, DOI 10.1016/S0140-6736(96)90519-X; Clement J, 2010, NEPHROL DIAL TRANSPL, V25, P1740, DOI 10.1093/ndt/gfq122; Clement J, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-1; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; Crowcroft NS, 1999, BMJ-BRIT MED J, V318, P1737, DOI 10.1136/bmj.318.7200.1737; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; Eccard JA, 2001, CAN J ZOOL, V79, P1743, DOI 10.1139/cjz-79-10-1743; Eichhorn J, 2010, MANUAL METHODS CRITE; Escutenaire S, 2000, VIRUS RES, V67, P91, DOI 10.1016/S0168-1702(00)00136-2; Faulde M, 2000, NEPHROL DIAL TRANSPL, V15, P751, DOI 10.1093/ndt/15.6.751; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; Hansson Lennart, 2000, Polish Journal of Ecology, V48, P163; Haredasht SA, 2013, ZOONOSES PUBLIC HLTH, V60, P461, DOI 10.1111/zph.12021; Heyman P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00237; Imholt C, 2015, PEST MANAG SCI, V71, P166, DOI 10.1002/ps.3838; Jacob J., 2010, RODENT OUTBREAKS ECO, P207; JENSEN TS, 1982, OECOLOGIA, V54, P184, DOI 10.1007/BF00378391; JENSEN TS, 1985, OIKOS, V44, P149, DOI 10.2307/3544056; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kallio ER, 2007, ECOLOGY, V88, P1911, DOI 10.1890/06-1620.1; Kallio ER, 2006, P ROY SOC B-BIOL SCI, V273, P2771, DOI 10.1098/rspb.2006.3645; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; Kang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006149; Khalil H, 2014, VECTOR-BORNE ZOONOT, V14, P537, DOI 10.1089/vbz.2013.1562; Killilea ME, 2008, ECOHEALTH, V5, P167, DOI 10.1007/s10393-008-0171-3; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Makary P, 2010, EPIDEMIOL INFECT, V138, P1484, DOI 10.1017/S0950268810000087; Mertens M, 2011, MED MICROBIOL IMMUN, V200, P263, DOI 10.1007/s00430-011-0203-4; Meyer BJ, 2000, TRENDS MICROBIOL, V8, P61, DOI 10.1016/S0966-842X(99)01658-3; Mills James N., 2006, BIODIVERSITY-OTTAWA, V7, P9; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; Olsson GE, 2003, EMERG INFECT DIS, V9, P1395, DOI 10.3201/eid0911.030275; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Overgaard R, 2007, FORESTRY, V80, P553, DOI 10.1093/forestry/cpm020; Piechotowski I, 2008, PARASITOL RES, V103, pS131, DOI 10.1007/s00436-008-1055-8; Piovesan G, 2001, CAN J BOT, V79, P1039, DOI 10.1139/cjb-79-9-1039; PUCEK Z, 1993, ACTA THERIOL, V38, P199, DOI 10.4098/AT.arch.93-18; R Development Core team, 2014, R A LANGUAGE AND ENV; Sauvage F, 2007, EPIDEMIOL INFECT, V135, P46, DOI 10.1017/S0950268806006595; Schauber EM, 2005, ECOL APPL, V15, P575, DOI 10.1890/03-5370; Schlegel M, 2014, ROLE OF ANIMALS IN EMERGING VIRAL DISEASES, P235, DOI 10.1016/B978-0-12-405191-1.00010-7; Schlegel M, 2012, VIRUS GENES, V45, P48, DOI 10.1007/s11262-012-0736-7; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; SCHMALJOHN CS, 1985, SCIENCE, V227, P1041, DOI 10.1126/science.2858126; Schmidt W, 2006, ALLG FORST JAGDZTG, V177, P9; Schmitz F, 2004, DIE ZWEITE BUNDESWAL; Schwarz AC, 2009, EMERG INFECT DIS, V15, P1032, DOI 10.3201/eid1507.081413; Selas V, 2006, OECOLOGIA, V147, P625, DOI 10.1007/s00442-005-0326-7; Sumibcay L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-34; Tersago K, 2009, EPIDEMIOL INFECT, V137, P250, DOI 10.1017/S0950268808000940; Vaheri A, 2013, REV MED VIROL, V23, P35, DOI 10.1002/rmv.1722; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Verhagen Ron, 2000, Polish Journal of Ecology, V48, P113; VIRO P, 1985, ACTA THERIOL, V30, P259, DOI 10.4098/AT.arch.85-17; ZEIER M, 1986, DEUT MED WOCHENSCHR, V111, P207, DOI 10.1055/s-2008-1068427	63	38	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134124	10.1371/journal.pone.0134124	http://dx.doi.org/10.1371/journal.pone.0134124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214509	Green Submitted, gold, Green Published			2022-12-26	WOS:000358594300051
J	Cohen, EN; Gao, H; Anfossi, S; Mego, M; Reddy, NG; Debeb, B; Giordano, A; Tin, SD; Wu, Q; Garza, RJ; Cristofanilli, M; Mani, SA; Croix, DA; Ueno, NT; Woodward, WA; Luthra, R; Krishnamurthy, S; Reuben, JM				Cohen, Evan N.; Gao, Hui; Anfossi, Simone; Mego, Michal; Reddy, Neelima G.; Debeb, Bisrat; Giordano, Antonio; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Cristofanilli, Massimo; Mani, Sendurai A.; Croix, Denise A.; Ueno, Naoto T.; Woodward, Wendy A.; Luthra, Raja; Krishnamurthy, Savitri; Reuben, James M.			Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells	PLOS ONE			English	Article							E-CADHERIN; CYTOKINE SYNTHESIS; EXPRESSION; INVADOPODIA; VIRUS; PLAYS; ALPHA; LINES	Inflammatory breast cancer (IBC) is the most insidious form of locally advanced breast cancer; about a third of patients have distant metastasis at initial staging. Emerging evidence suggests that host factors in the tumor microenvironment may interact with underlying IBC cells to make them aggressive. It is unknown whether immune cells associated to the IBC microenvironment play a role in this scenario to transiently promote epithelial to mesenchymal transition (EMT) in these cells. We hypothesized that soluble factors secreted by activated immune cells can induce an EMT in IBC and thus promote metastasis. In a pilot study of 16 breast cancer patients, TNF-alpha production by peripheral blood T cells was correlated with the detection of circulating tumor cells expressing EMT markers. In a variety of IBC model cell lines, soluble factors from activated T cells induced expression of EMT-related genes, including FN1, VIM, TGM2, ZEB1. Interestingly, although IBC cells exhibited increased invasion and migration following exposure to immune factors, the expression of E-cadherin (CDH1), a cell adhesion molecule, increased uniquely in IBC cell lines but not in non-IBC cell lines. A combination of TNF-alpha, IL-6, and TGF-beta was able to recapitulate EMT induction in IBC, and conditioned media preloaded with neutralizing antibodies against these factors exhibited decreased EMT. These data suggest that release of cytokines by activated immune cells may contribute to the aggressiveness of IBC and highlight these factors as potential target mediators of immune-IBC interaction.	[Cohen, Evan N.; Gao, Hui; Anfossi, Simone; Reddy, Neelima G.; Giordano, Antonio; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Luthra, Raja; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Mani, Sendurai A.; Krishnamurthy, Savitri] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Debeb, Bisrat; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Cohen, Evan N.; Gao, Hui; Anfossi, Simone; Debeb, Bisrat; Giordano, Antonio; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Ueno, Naoto T.; Woodward, Wendy A.; Krishnamurthy, Savitri; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Cohen, Evan N.; Anfossi, Simone; Tin, Sanda; Mani, Sendurai A.; Ueno, Naoto T.; Woodward, Wendy A.; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Mego, Michal] Natl Canc Inst, Bratislava, Slovakia; [Cristofanilli, Massimo] Thomas Jefferson Univ, Med Oncol, Philadelphia, PA 19107 USA; [Croix, Denise A.] Roche Diagnost, Indianapolis, IN USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institute of Oncology (NOU); Jefferson University; Roche Holding	Reuben, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	jreuben@mdanderson.org	Cohen, Evan N/AFP-3323-2022; Giordano, Antonio/AAU-1201-2020; Woodward, Wendy/AAX-6593-2020; Mani, Sendurai A./A-7244-2009	Cohen, Evan N/0000-0003-4192-9644; Giordano, Antonio/0000-0002-5959-016X; Mani, Sendurai A./0000-0002-5918-4276; Woodward, Wendy/0000-0002-7935-739X; Anfossi, Simone/0000-0001-5745-7587	Human Breast Cancer Stem Cell Surrogates, National Institutes of Health/National Cancer Institute [CA138239-02]; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, US Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP) [W81XWH-09-1-0031 01]; NIH/NCI [P30CA016672]; NATIONAL CANCER INSTITUTE [R01CA138239, P30CA016672] Funding Source: NIH RePORTER	Human Breast Cancer Stem Cell Surrogates, National Institutes of Health/National Cancer Institute; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, US Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by: Human Breast Cancer Stem Cell Surrogates, CA138239-02, National Institutes of Health/National Cancer Institute (MC, WAW, JMR); State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic (NTU, MC); Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, W81XWH-09-1-0031 01, US Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP) (ENC). FACS analysis was performed in MD Anderson's Flow Cytometry and Cellular Imaging core facility supported by the NIH/NCI under award number P30CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalay I, 2013, CANCER RES, V73, P2418, DOI 10.1158/0008-5472.CAN-12-2432; Alpaugh ML, 1999, CANCER RES, V59, P5079; Anfossi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083113; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bertucci F, 2014, ANN ONCOL, V25, P358, DOI 10.1093/annonc/mdt496; BONNIER P, 1995, INT J CANCER, V62, P382, DOI 10.1002/ijc.2910620404; Brewer TM, 2013, BRIT J CANCER, V109, P318, DOI 10.1038/bjc.2013.342; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dawood S, 2011, ANN ONCOL, V22, P515, DOI 10.1093/annonc/mdq345; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Eckert MA, 2011, ONCOTARGET, V2, P562; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gao H, 2005, LEUKEMIA, V19, P1905, DOI 10.1038/sj.leu.2403933; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Hajra KM, 2002, CANCER RES, V62, P1613; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Jung U, 2003, BLOOD, V102, P3439, DOI 10.1182/blood-2002-12-3936; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Kurebayashi J, 1999, BRIT J CANCER, V79, P707, DOI 10.1038/sj.bjc.6690114; Lacerda L, 2014, STEM CELL TRANSL MED, V3, P849, DOI 10.5966/sctm.2013-0204; Lefer DJ, 2002, CIRCULATION, V106, P2041, DOI 10.1161/01.CIR.0000033635.42612.88; Levine PH, 2014, WORLD J CLIN ONCOL, V5, P539, DOI 10.5306/wjco.v5.i3.539; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Medler TR, 2014, J INVEST DERMATOL, V134, pE23, DOI 10.1038/skinbio.2014.5; Mego M, 2012, INT J CANCER, V130, P808, DOI 10.1002/ijc.26037; Mohamed MM, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-3; Mohamed MM, 2008, BIOL CHEM, V389, P1117, DOI 10.1515/BC.2008.117; MOURALI N, 1978, INT J CANCER, V22, P1, DOI 10.1002/ijc.2910220102; Pogo BGT, 2010, CANCER-AM CANCER SOC, V116, P2741, DOI 10.1002/cncr.25179; Reuben JM, 2006, CANCER, V106, P2437, DOI 10.1002/cncr.21854; Reuben JM, 2002, J ALLERGY CLIN IMMUN, V110, P255, DOI 10.1067/mai.2002.125979; Reuben JM, 2000, CLIN CANCER RES, V6, P1671; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Singh R, 2014, CELL SIGNAL, V26, P1604, DOI 10.1016/j.cellsig.2014.03.028; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Starsichova A, 2009, BIOL PROCED ONLINE, V11, P316, DOI 10.1007/s12575-009-9017-9; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Takkouche B, 2008, JNCI-J NATL CANCER I, V100, P1439, DOI 10.1093/jnci/djn324; Tomlinson JS, 2001, CANCER RES, V61, P5231; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; van Golen Kenneth L, 2013, Breast Cancer Res, V15, P318, DOI 10.1186/bcr3571; Yamauchi H, 2012, ONCOLOGIST, V17, P891, DOI 10.1634/theoncologist.2012-0039; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	56	71	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132710	10.1371/journal.pone.0132710	http://dx.doi.org/10.1371/journal.pone.0132710			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207636	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000039
J	Sanchez-Montes, S; Espinosa-Martinez, DV; Rios-Munoz, CA; Berzunza-Cruz, M; Becker, I				Sanchez-Montes, Sokani; Espinosa-Martinez, Deborah V.; Rios-Munoz, Cesar A.; Berzunza-Cruz, Miriam; Becker, Ingeborg			Leptospirosis in Mexico: Epidemiology and Potential Distribution of Human Cases	PLOS ONE			English	Article							UNITED-STATES; NICHE; VECTORS; DISEASE; HAWAII; MODELS; FEVER; HOSTS; SETS	Background Leptospirosis is widespread in Mexico, yet the potential distribution and risk of the disease remain unknown. Methodology/Principal Findings We analysed morbidity and mortality according to age and gender based on three sources of data reported by the Ministry of Health and the National Institute of Geography and Statics of Mexico, for the decade 2000-2010. A total of 1,547 cases were reported in 27 states, the majority of which were registered during the rainy season, and the most affected age group was 25-44 years old. Although leptospirosis has been reported as an occupational disease of males, analysis of morbidity in Mexico showed no male preference. A total number of 198 deaths were registered in 21 states, mainly in urban settings. Mortality was higher in males (61.1%) as compared to females (38.9%), and the case fatality ratio was also increased in males. The overall case fatality ratio in Mexico was elevated (12.8%), as compared to other countries. We additionally determined the potential disease distribution by examining the spatial epidemiology combined with spatial modeling using ecological niche modeling techniques. We identified regions where leptospirosis could be present and created a potential distribution map using bioclimatic variables derived from temperature and precipitation. Our data show that the distribution of the cases was more related to temperature (75%) than to precipitation variables. Ecological niche modeling showed predictive areas that were widely distributed in central and southern Mexico, excluding areas characterized by extreme climates. Conclusions/Significance In conclusion, an epidemiological surveillance of leptospirosis is recommended in Mexico, since 55.7% of the country has environmental conditions fulfilling the criteria that favor the presence of the disease.	[Sanchez-Montes, Sokani; Rios-Munoz, Cesar A.; Berzunza-Cruz, Miriam; Becker, Ingeborg] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Mexico City 04510, DF, Mexico; [Sanchez-Montes, Sokani; Rios-Munoz, Cesar A.; Berzunza-Cruz, Miriam; Becker, Ingeborg] Univ Nacl Autonoma Mexico, Fac Med, Ctr Med Trop, Mexico City 04510, DF, Mexico; [Espinosa-Martinez, Deborah V.; Rios-Munoz, Cesar A.] Univ Nacl Autonoma Mexico, Fac Ciencias, Museo Zool Alfonso L Herrera, Dept Biol Evolut, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Becker, I (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Mexico City 04510, DF, Mexico.	becker@unam.mx	Sanchez, Maria Blanca/AAD-8294-2020; Ríos-Muñoz, Cesar A./J-9384-2012; Oggioni, Marco Rinaldo/K-3839-2016; Martinez, Jose L/A-4725-2013	Sanchez, Maria Blanca/0000-0002-5209-4518; Ríos-Muñoz, Cesar A./0000-0002-3423-8936; Oggioni, Marco Rinaldo/0000-0003-4117-793X; Martinez, Jose L/0000-0001-8813-7607; VITI, CARLO/0000-0001-7188-549X	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN217515]; Consejo Nacional de Ciencia y Tecnologia CONACyT [221405]; CONACyT	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Consejo Nacional de Ciencia y Tecnologia CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funded by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT No IN217515) and Consejo Nacional de Ciencia y Tecnologia CONACyT 221405 to IB. Daniel Sokani Sanchez Montes was supported by a PhD fellowship from CONACyT and is a doctoral student of (Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico UNAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 2003, ZOONOSES COMMUNICABL, V1, P157; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Centro Nacional de Vigilancia Epidemiologica y Control de Enfermedades (CENAVECE), 2013, AN MORB 1984 2011; Ciceroni L, 1995, EUR J EPIDEMIOL, V11, P707, DOI 10.1007/BF01720308; Ciceroni L, 2000, EUR J EPIDEMIOL, V16, P79, DOI 10.1023/A:1007658607963; Costa J, 2012, ADV EXP MED BIOL, V710, P59, DOI 10.1007/978-1-4419-5638-5_7; Cuervo-Robayo AP, 2014, INT J CLIMATOL, V34, P2427, DOI 10.1002/joc.3848; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Espinosa-Martinez DV, 2015, REV INST MED TROP SP, V57, P181, DOI 10.1590/S0036-46652015000200015; EVERARD COR, 1995, EUR J EPIDEMIOL, V11, P311, DOI 10.1007/BF01719436; GADM database Global Administrative Areas (GADM), 2014, ADM AR WORLD VER 2 0; GALTON MM, 1959, PUBLIC HEALTH REP, V74, P141, DOI 10.2307/4590398; Gavaldon D, 1988, GAC MED MEX, V131, P289; GEISTFELD JG, 1975, J INFECT DIS, V131, P743, DOI 10.1093/infdis/131.6.743; Giles J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000925; Hartskeerl R A, 2006, Indian J Med Microbiol, V24, P309; HEATH CW, 1965, NEW ENGL J MED, V273, P915, DOI 10.1056/NEJM196510212731706; Hervada Vidal Xurxo, 2004, Rev. Esp. Salud Publica, V78, P277, DOI 10.1590/s1135-57272004000200013; Holveck JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-6; IBM Corp, 2011, IBM SPSS STAT WIND V; INEGI (Instituto Nacional de Geografia y Estadistica), 2013, CAT UN CLAV AR GEOES; Instituto de Diagnostico y Referencia Epidemiologicos [InDRE], 2014, LIN DIAGN LEPT MED A; Instituto Nacional de Estadistica y Geografia (INEGI), 2013, MEX CIFR INF NAC POR; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; Jansen A, 2005, EMERG INFECT DIS, V11, P1048, DOI 10.3201/eid1107.041172; Jimenez-Sastre A, 2010, REV CHIL INFECTOL, V29, P32; Katz AR, 2011, EMERG INFECT DIS, V17, P221, DOI 10.3201/eid1702.101109; Katz AR, 2002, AM J TROP MED HYG, V66, P61, DOI 10.4269/ajtmh.2002.66.61; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Machado-Machado EA, 2012, APPL GEOGR, V33, P82, DOI 10.1016/j.apgeog.2011.06.011; Maher SP, 2010, AM J TROP MED HYG, V83, P736, DOI 10.4269/ajtmh.2010.10-0042; Mak S, 2010, ENVIRON HEALTH PERSP, V118, P653, DOI 10.1289/ehp.0901448; Meslin FX, 1997, EMERG INFECT DIS, V3, P223, DOI 10.3201/eid0302.970220; Mohammed H., 2011, Asian Journal of Epidemiology, V4, P17, DOI 10.3923/aje.2011.17.22; Mohan ARM, 2009, ACTA TROP, V112, P260, DOI 10.1016/j.actatropica.2009.08.007; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; Noguchi H, 1920, J EXP MED, V32, P627, DOI 10.1084/jem.32.5.627; Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; R Core Team, 2012, R LANG ENV STAT COMP; Rios-Munoz CA, 2009, ORNITOL NEOTROP, V20, P491; Sánchez-Cordero Víctor, 2005, Acta Zool. Mex, V21, P79; SAS Institute Inc, 2010, JMP 9 MOD MULT METH; Scachetti-Pereira R, 2001, DESKTOP GARP 1 1 3; Servicio Meteorologico Nacional de Mexico. Comision Nacional Del Agua [SMNCONAGUA], 2011, AN TEMP CICL TROP 20; SHENBERG E, 1982, AM J EPIDEMIOL, V115, P352, DOI 10.1093/oxfordjournals.aje.a113312; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; VARELA G, 1958, Rev Inst Salubr Enferm Trop, V18, P31; VARELA G., 1961, REV INST SALUBRIDAD Y ENFERMEDADES TROP, V21, P49; VARELA GERARDO, 1965, SALUD PUBLICA MEX, V7, P189; Vieira ML, 2006, INT J INFECT DIS, V10, P378, DOI 10.1016/j.ijid.2005.07.006; World Health Organization, 2008, ICD 10 INT STAT CLAS; Zavala J, 1967, SALUD PUBLICA MEXICO, V18, P989; Zavala Velazquez J, 1984, Salud Publica Mex, V26, P254; ZAVALAVELAZQUEZ J, 1985, REV INVEST CLIN, V37, P353; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1; Zuniga-Carrasco IR, 2013, ENF INF MICROBIOL, V33, P71	68	28	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133720	10.1371/journal.pone.0133720	http://dx.doi.org/10.1371/journal.pone.0133720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26201074	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000121
J	Tocchetti, A; Bordoni, R; Gallo, G; Petiti, L; Corti, G; Alt, S; Cruz, JCS; Salzano, AM; Scaloni, A; Puglia, AM; De Bellis, G; Peano, C; Donadio, S; Sosio, M				Tocchetti, Arianna; Bordoni, Roberta; Gallo, Giuseppe; Petiti, Luca; Corti, Giorgio; Alt, Silke; Cruz, Joao C. S.; Salzano, Anna Maria; Scaloni, Andrea; Puglia, Anna Maria; De Bellis, Gianluca; Peano, Clelia; Donadio, Stefano; Sosio, Margherita			A Genomic, Transcriptomic and Proteomic Look at the GE2270 Producer Planobispora rosea, an Uncommon Actinomycete	PLOS ONE			English	Article							SP NOV.; PATHWAYS; INHIBITOR; SEQUENCE	We report the genome sequence of Planobispora rosea ATCC 53733, a mycelium-forming soil-dweller belonging to one of the lesser studied genera of Actinobacteria and producing the thiopeptide GE2270. The P. rosea genome presents considerable convergence in gene organization and function with other members in the family Streptosporangiaceae, with a significant number (44%) of shared orthologs. Patterns of gene expression in P. rosea cultures during exponential and stationary phase have been analyzed using whole transcriptome shotgun sequencing and by proteome analysis. Among the differentially abundant proteins, those involved in protein metabolism are particularly represented, including the GE2270-insensitive EF-Tu. Two proteins from the pbt cluster, directing GE2270 biosynthesis, slightly increase their abundance values over time. While GE2270 production starts during the exponential phase, most pbt genes, as analyzed by qRT-PCR, are down-regulated. The exception is represented by pbtA, encoding the precursor peptide of the ribosomally synthesized GE2270, whose expression reached the highest level at the entry into stationary phase.	[Tocchetti, Arianna; Alt, Silke; Donadio, Stefano; Sosio, Margherita] NAICONS Srl, Milan, Italy; [Tocchetti, Arianna; Cruz, Joao C. S.; Donadio, Stefano; Sosio, Margherita] KtedoGen Srl, Milan, Italy; [Bordoni, Roberta; Petiti, Luca; Corti, Giorgio; De Bellis, Gianluca; Peano, Clelia] CNR, Inst Biomed Technol, Segrate, Italy; [Gallo, Giuseppe; Puglia, Anna Maria] Univ Palermo, Dept STEBICEF, Palermo, Italy; [Salzano, Anna Maria] CNR, ISPAAM, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Peano, C (corresponding author), CNR, Inst Biomed Technol, Segrate, Italy.	clelia.peano@itb.cnr.it; msosio@naicons.com	Peano, Clelia/C-4015-2018; Gallo, Giuseppe/O-4920-2015; Salzano, Anna Maria/C-7139-2012; De Bellis, Gianluca/H-9725-2013	Peano, Clelia/0000-0001-7055-3629; Gallo, Giuseppe/0000-0003-4727-5653; Salzano, Anna Maria/0000-0001-7192-8760; Sosio, Margherita/0000-0003-4297-6936; De Bellis, Gianluca/0000-0002-1622-4477; Scaloni, Andrea/0000-0001-9362-8515; Tocchetti, Arianna/0000-0001-7004-7582; Corti, Giorgio/0000-0001-6379-4117	Regione Lombardia [13810096]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); European Union [289285]	Regione Lombardia(Regione Lombardia); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was supported by Regione Lombardia (ID project 13810096) and by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (project). J.C. was supported by funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No 289285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [AT, JC, SD and MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aigle B, 2014, J IND MICROBIOL BIOT, V41, P251, DOI 10.1007/s10295-013-1379-y; Alduina R, 2003, FEMS MICROBIOL LETT, V218, P181, DOI 10.1111/j.1574-6968.2003.tb11516.x; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Corre C, 2009, NAT PROD REP, V26, P977, DOI 10.1039/b713024b; Donadio S, 2010, APPL MICROBIOL BIOT, V88, P1261, DOI 10.1007/s00253-010-2877-8; Fischer S., 2011, CURRENT PROTOCOLS BI; Flinspach K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090499; Gallo G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-152; Gallo G, 2012, APPL MICROBIOL BIOT, V94, P1289, DOI 10.1007/s00253-012-4046-8; GOODFELLOW M, 1990, J GEN MICROBIOL, V136, P19, DOI 10.1099/00221287-136-1-19; Hiller K, 2003, NUCLEIC ACIDS RES, V31, P3862, DOI 10.1093/nar/gkg536; Jabes D, 2011, ANTIMICROB AGENTS CH, V55, P1671, DOI 10.1128/AAC.01288-10; LaMarche MJ, 2011, J MED CHEM, V54, P2517, DOI 10.1021/jm101602q; Ludwig WEJ, 2012, BERGEYS MANUAL SYS A; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Ngaemthao W, 2014, INT J SYST EVOL MICR, V64, P1180, DOI 10.1099/ijs.0.057968-0; Ngaemthao W, 2013, INT J SYST EVOL MICR, V63, P2649, DOI 10.1099/ijs.0.046946-0; Nolan M, 2010, STAND GENOMIC SCI, V2, P29, DOI 10.4056/sigs.631049; Peano C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093009; Peano Clelia, 2013, Microb Inform Exp, V3, P1, DOI 10.1186/2042-5783-3-1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SELVA E, 1991, J ANTIBIOT, V44, P693, DOI 10.7164/antibiotics.44.693; Sosio E, 2000, MOL GEN GENET, V264, P213; Sosio M, 1996, MOL MICROBIOL, V22, P43, DOI 10.1111/j.1365-2958.1996.tb02654.x; Sosio M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01198-13; Sosio M, 2006, J IND MICROBIOL BIOT, V33, P569, DOI 10.1007/s10295-006-0124-1; Talamo F, 2003, PROTEOMICS, V3, P440, DOI 10.1002/pmic.200390059; THIEMAN J. E., 1970, The Actinomycetales". Jena International Symposium on Taxonomy, 1968., P245; THIEMANN JE, 1968, ARCH MIKROBIOL, V62, P157, DOI 10.1007/BF00410402; Tocchetti A, 2013, CHEM BIOL, V20, P1067, DOI 10.1016/j.chembiol.2013.07.005; Vobis G, 2012, BERGEYS MANUAL SYSTE, V5, P1861; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444	35	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133705	10.1371/journal.pone.0133705	http://dx.doi.org/10.1371/journal.pone.0133705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207753	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000120
J	Witkowski, W; Vermeire, J; Landi, A; Naessens, E; Vanderstraeten, H; Nauwynck, H; Favoreel, H; Verhasselt, B				Witkowski, Wojciech; Vermeire, Jolien; Landi, Alessia; Naessens, Evelien; Vanderstraeten, Hanne; Nauwynck, Hans; Favoreel, Herman; Verhasselt, Bruno			Vpx-Independent Lentiviral Transduction and shRNA-Mediated Protein Knock-Down in Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							SAMHD1 RESTRICTS; HIV-1 INFECTION; MACROPHAGES; PATHOGENESIS; ACTIVATION	The function of dendritic cells (DCs) in the immune system is based on their ability to sense and present foreign antigens. Powerful tools to research DC function and to apply in cell-based immunotherapy are either silencing or overexpression of genes achieved by lentiviral transduction. To date, efficient lentiviral transduction of DCs or their monocyte derived counterparts (MDDCs) required high multiplicity of infection (MOI) or the exposure to the HIV-2/SIV protein Vpx to degrade viral restriction factor SAM domain and HD domain-containing protein 1 (SAMHD1). Here we present a Vpx-independent method for efficient (>95%) transduction of MDDCs at lower MOI. The protocol can be used both for ectopic gene expression and knock-down. Introducing shRNA targeting viral entry receptor CD4 and restriction factor SAMHD1 into MDDCs resulted in down-regulation of targeted proteins and, consequently, expected impact on HIV infection. This protocol for MDDCs transduction is robust and free of the potential risk arising from the use of Vpx which creates a virus infection-prone environment, potentially dangerous in clinical setting.	[Witkowski, Wojciech; Vermeire, Jolien; Landi, Alessia; Naessens, Evelien; Vanderstraeten, Hanne; Verhasselt, Bruno] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Nauwynck, Hans] Univ Ghent, Virol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Favoreel, Herman] Univ Ghent, Immunol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Verhasselt, B (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, De Pintelaan 185, B-9000 Ghent, Belgium.	bruno.verhasselt@ugent.be	; Favoreel, Herman/H-8712-2013	Verhasselt, Bruno/0000-0002-4645-1144; Nauwynck, Hans/0000-0001-5470-0713; Favoreel, Herman/0000-0003-4993-6857	Research Foundation-Flanders (FWO); Ghent University (Geconcerteerde Onderzoeksactie) [BOF11/GOA/013]	Research Foundation-Flanders (FWO)(FWO); Ghent University (Geconcerteerde Onderzoeksactie)	The authors are supported by grants to BV from the Research Foundation-Flanders (FWO) and to BV, HN and HF from Ghent University (Geconcerteerde Onderzoeksactie BOF11/GOA/013). WW, JV and AL are PhD Fellows and BV is a Senior Clinical Investigator of the FWO.	Anguille S, 2014, LANCET ONCOL, V15, pE257, DOI 10.1016/S1470-2045(13)70585-0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Breckpot K, 2004, HUM GENE THER, V15, P562, DOI 10.1089/104303404323142015; Breckpot K, 2007, HUM GENE THER, V18, P536, DOI 10.1089/hum.2007.006; Chauveau L, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-014-0131-7; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Dornadula G, 1999, VIROLOGY, V253, P10, DOI 10.1006/viro.1998.9465; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Imbeault M, 2009, VIROLOGY, V393, P160, DOI 10.1016/j.virol.2009.07.009; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Landi A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0118-4; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Metelo J, 2011, CYTOSKELETON, V68, P434, DOI 10.1002/cm.20521; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; Piguet V, 2002, J INVEST DERMATOL, V119, P365, DOI 10.1046/j.1523-1747.2002.01840.x; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Rouas R, 2002, CANCER GENE THER, V9, P715, DOI 10.1038/sj.cgt.7700500; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Schnell T, 2000, HUM GENE THER, V11, P439, DOI 10.1089/10430340050015905; Schroers R, 2000, MOL THER, V1, P171, DOI 10.1006/mthe.2000.0027; Smits ELJM, 2009, HUM GENE THER, V20, P1106, DOI 10.1089/hum.2009.145; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859	30	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133651	10.1371/journal.pone.0133651	http://dx.doi.org/10.1371/journal.pone.0133651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208151	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000115
J	Ahmad, A; Cai, YF; Chen, XQ; Shuai, JW; Han, AD				Ahmad, Ashfaq; Cai, Yongfei; Chen, Xingqiang; Shuai, Jianwei; Han, Aidong			Conformational Dynamics of Response Regulator RegX3 from Mycobacterium tuberculosis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; RECEIVER DOMAIN; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; 2-COMPONENT SYSTEM; ESCHERICHIA-COLI; STRUCTURAL BASIS; PROTEIN; DIMERIZATION; TRANSITION	Two-component signal transduction systems (TCS) are vital for adaptive responses to various environmental stresses in bacteria, fungi and even plants. A TCS typically comprises of a sensor histidine kinase (SK) with its cognate response regulator (RR), which often has two domains-N terminal receiver domain (RD) and C terminal effector domain (ED). The histidine kinase phosphorylates the RD to activate the ED by promoting dimerization. However, despite significant progress on structural studies, how RR transmits activation signal from RD to ED remains elusive. Here we analyzed active to inactive transition process of OmpR/PhoB family using an active conformation of RegX3 from Mycobacterium tuberculosis as a model system by computational approaches. An inactive state of RegX3 generated from 150 ns molecular dynamic simulation has rotameric conformations of Thr(79) and Tyr(98) that are generally conserved in inactive RRs. Arg(81) in loop beta 4 alpha 4 acts synergistically with loop beta 1 alpha 1 to change its interaction partners during active to inactive transition, potentially leading to the N-terminal movement of RegX3 helix alpha 1. Global conformational dynamics of RegX3 is mainly dependent on alpha 4 beta 5 region, in particular seven 'hot-spot' residues (Tyr(98) to Ser(104)), adjacent to which several coevolved residues at dimeric interface, including Ile(76)-Asp(96), Asp(97)-Arg(111) and Glu(24)-Arg(113) pairs, are critical for signal transduction. Taken together, our computational analyses suggest a molecular linkage between Asp phosphorylation, proximal loops and alpha 4 beta 5 alpha 5 dimeric interface during RR active to inactive state transition, which is not often evidently defined from static crystal structures.	[Ahmad, Ashfaq; Cai, Yongfei; Han, Aidong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Chen, Xingqiang; Shuai, Jianwei] Xiamen Univ, Dept Phys, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University	Han, AD (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China.	ahan@xmu.edu.cn	Cai, Yongfei/ABI-7748-2020; Cai, Yongfei/J-1167-2019; AHMED, Ashfaq/AAP-4828-2020	Cai, Yongfei/0000-0002-3628-3802; Cai, Yongfei/0000-0002-3628-3802; AHMED, Ashfaq/0000-0003-4949-0808	National Science Foundation of China [31070647, 31370723, 31370830, 11125419]; National Key Basic Research Program [2013CB910603]; Project 985 [2011121028]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Project 985	This work was supported by National Science Foundation of China (31070647 and 31370723 to AH; 31370830 and 11125419 to JS), National Key Basic Research Program (2013CB910603 to AH.), Project 985 (2011121028 to AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Banerjee R, 2014, J PHYS CHEM B, V118, P4727, DOI 10.1021/jp4122968; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Best RB, 2005, STRUCTURE, V13, P1755, DOI 10.1016/j.str.2005.08.009; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Bobay Benjamin G, 2012, Biomol Concepts, V3, P175; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Cerutti DS, 2008, BIOCHEMISTRY-US, V47, P12065, DOI 10.1021/bi800894u; Choudhury HG, 2013, PROTEIN SCI, V22, P1287, DOI 10.1002/pro.2311; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Gao R, 2008, MOL MICROBIOL, V69, P1358, DOI 10.1111/j.1365-2958.2008.06355.x; Gao R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003927; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gardino AK, 2003, J MOL BIOL, V331, P245, DOI 10.1016/S0022-2836(03)00733-2; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hickey JM, 2011, J BIOL CHEM, V286, P32606, DOI 10.1074/jbc.M111.220574; Jeong KW, 2013, MOL CELLS, V35, P158, DOI 10.1007/s10059-013-2303-z; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; King-Scott J, 2007, J BIOL CHEM, V282, P37717, DOI 10.1074/jbc.M705081200; Knaggs MH, 2007, BIOPHYS J, V92, P2062, DOI 10.1529/biophysj.106.081950; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; McDonald LR, 2013, J MOL BIOL, V425, P2372, DOI 10.1016/j.jmb.2013.04.029; Menon S, 2011, BIOCHEMISTRY-US, V50, P5948, DOI 10.1021/bi2005575; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; NEEDHAM JV, 1993, BIOCHEMISTRY-US, V32, P3363, DOI 10.1021/bi00064a020; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Park S, 2002, FASEB J, V16, P1964, DOI 10.1096/fj.02-0395fje; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pioszak AA, 2004, J BACTERIOL, V186, P5730, DOI 10.1128/JB.186.17.5730-5740.2004; Porter SL, 2006, J BIOL CHEM, V281, P32694, DOI 10.1074/jbc.M606016200; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Roberts G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021090; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Smith JG, 2004, MOL MICROBIOL, V51, P887, DOI 10.1046/j.1365-2958.2003.03882.x; Sola M, 1999, J MOL BIOL, V285, P675, DOI 10.1006/jmbi.1998.2326; Stephenson SJ, 2002, MOL MICROBIOL, V44, P1455, DOI 10.1046/j.1365-2958.2002.02974.x; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zheng WJ, 2007, PROTEINS, V69, P43, DOI 10.1002/prot.21465; Zheng WJ, 2005, STRUCTURE, V13, P565, DOI 10.1016/j.str.2005.01.017; Zheng WJ, 2005, J MOL BIOL, V346, P745, DOI 10.1016/j.jmb.2004.12.020	59	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133389	10.1371/journal.pone.0133389	http://dx.doi.org/10.1371/journal.pone.0133389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201027	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100063
J	Pal, R; Ramdzan, ZM; Kaur, S; Duquette, PM; Marcotte, R; Leduy, L; Davoudi, S; Lamarche-Vane, N; Iulianella, A; Nepveu, A				Pal, Ranjana; Ramdzan, Zubaidah M.; Kaur, Simran; Duquette, Philippe M.; Marcotte, Richard; Leduy, Lam; Davoudi, Sayeh; Lamarche-Vane, Nathalie; Iulianella, Angelo; Nepveu, Alain			CUX2 Protein Functions as an Accessory Factor in the Repair of Oxidative DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; AP-ENDONUCLEASE; CUT REPEATS; TRANSCRIPTION FACTORS; GLYCOSYLASE ACTIVITY; MOUSE MODELS; STIMULATION; EXPRESSION; BRAIN; GENE	CUX1 and CUX2 proteins are characterized by the presence of three highly similar regions called Cut repeats 1, 2, and 3. Although CUX1 is ubiquitously expressed, CUX2 plays an important role in the specification of neuronal cells and continues to be expressed in postmitotic neurons. Cut repeats from the CUX1 protein were recently shown to stimulate 8-oxoguanine DNA glycosylase 1 (OGG1), an enzyme that removes oxidized purines from DNA and introduces a single strand break through its apurinic/apyrimidinic lyase activity to initiate base excision repair. Here, we investigated whether CUX2 plays a similar role in the repair of oxidative DNA damage. Cux2 knockdown in embryonic cortical neurons increased levels of oxidative DNA damage. In vitro, Cut repeats from CUX2 increased the binding of OGG1 to 7,8-dihydro-8-oxoguanine-containing DNA and stimulated both the glycosylase and apurinic/apyrimidinic lyase activities of OGG1. Genetic inactivation in mouse embryo fibroblasts or CUX2 knockdown in HCC38 cells delayed DNA repair and increased DNA damage. Conversely, ectopic expression of Cut repeats from CUX2 accelerated DNA repair and reduced levels of oxidative DNA damage. These results demonstrate that CUX2 functions as an accessory factor that stimulates the repair of oxidative DNA damage. Neurons produce a high level of reactive oxygen species because of their dependence on aerobic oxidation of glucose as their source of energy. Our results suggest that the persistent expression of CUX2 in postmitotic neurons contributes to the maintenance of genome integrity through its stimulation of oxidative DNA damage repair.	[Pal, Ranjana; Ramdzan, Zubaidah M.; Kaur, Simran; Leduy, Lam; Nepveu, Alain] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kaur, Simran; Davoudi, Sayeh; Nepveu, Alain] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Duquette, Philippe M.; Lamarche-Vane, Nathalie] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Marcotte, Richard] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Iulianella, Angelo] Dalhousie Univ, Life Sci Res Inst, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Dalhousie University	Nepveu, A (corresponding author), Goodman Canc Res Ctr, 1160 Pine Ave West,Rm 414, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020	Pal, Ranjana/0000-0002-9824-6337; Iulianella, Angelo/0000-0003-0712-4295; Kaur, Simran/0000-0003-1510-928X	Canadian Foundation for Innovation; Ministere du Developpement economique, innovation et exportation Quebec	Canadian Foundation for Innovation(Canada Foundation for Innovation); Ministere du Developpement economique, innovation et exportation Quebec	We are grateful to Drs. N. Noren Hooten and M. K. Evans (GST-OGG1) and Dr. G. Sauvageau (His-HOXB3) for generously providing plasmids. We are indebted to Drs. T. Paz-Elizur and Z. Livneh for the protocol on cleavage assays. Infrastructure support and technical assistance were made possible with funds from the Canadian Foundation for Innovation and the Ministere du Developpement economique, innovation et exportation Quebec.	Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Bachy I, 2011, DEV BIOL, V360, P77, DOI 10.1016/j.ydbio.2011.09.007; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; Bruckner BA, 1999, METABOLISM, V48, P422, DOI 10.1016/S0026-0495(99)90098-7; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15; CARADONNA SJ, 1982, MOL CELL BIOCHEM, V46, P49; Chen LW, 2002, CHEM BIOL, V9, P345, DOI 10.1016/S1074-5521(02)00120-5; Conforto TL, 2012, MOL CELL BIOL, V32, P4611, DOI 10.1128/MCB.00886-12; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Cubelos B, 2008, DEV NEUROBIOL, V68, P917, DOI 10.1002/dneu.20626; Cubelos B, 2015, DEV NEUROBIOL, V75, P163, DOI 10.1002/dneu.22215; Cubelos Beatriz, 2010, Commun Integr Biol, V3, P483, DOI 10.4161/cib.3.6.12755; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Englander EW, 2008, MECH AGEING DEV, V129, P475, DOI 10.1016/j.mad.2008.02.001; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P169; Gingras N, 2005, GENE, V344, P273, DOI 10.1016/j.gene.2004.11.008; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; HARADA R, 1994, J BIOL CHEM, V269, P2062; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hirano T, 1996, J GERONTOL A-BIOL, V51, pB303, DOI 10.1093/gerona/51A.5.B303; Hulea L, 2012, GENE, V497, P18, DOI 10.1016/j.gene.2012.01.039; Iulianella A, 2003, GENE EXPR PATTERNS, V3, P571, DOI 10.1016/S1567-133X(03)00123-6; Iulianella A, 2008, DEVELOPMENT, V135, P729, DOI 10.1242/dev.013276; Iulianella A, 2009, DEVELOPMENT, V136, P2329, DOI 10.1242/dev.032128; Jacobs AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081667; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7; Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067; Laz EV, 2007, ENDOCRINOLOGY, V148, P3327, DOI 10.1210/en.2006-1192; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Li Z, 2015, NUCLEIC ACIDS RES, V43, P3986, DOI 10.1093/nar/gkv283; Lindahl T, 1979, Prog Nucleic Acid Res Mol Biol, V22, P135; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Magistretti PJ, 1996, CEREB CORTEX, V6, P50, DOI 10.1093/cercor/6.1.50; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Marenstein DR, 2001, J BIOL CHEM, V276, P21242, DOI 10.1074/jbc.M101594200; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mokkapati SK, 2004, BIOCHEMISTRY-US, V43, P11596, DOI 10.1021/bi049097i; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Moore AW, 2008, CELL ADHES MIGR, V2, P81, DOI 10.4161/cam.2.2.6395; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Nakae D, 2000, LAB INVEST, V80, P249, DOI 10.1038/labinvest.3780028; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noren Hooten N, 2012, AGING-US, V4, P674, DOI 10.18632/aging.100492; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816; Paz-Elizur T, 2007, DNA REPAIR, V6, P45, DOI 10.1016/j.dnarep.2006.08.003; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Quaggin SE, 1996, J BIOL CHEM, V271, P22624, DOI 10.1074/jbc.271.37.22624; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramdzan ZM, 2015, ONCOTARGET, V6, P3613, DOI 10.18632/oncotarget.2919; Ramdzan ZM, 2014, NAT REV CANCER, V14, P673, DOI 10.1038/nrc3805; Ramdzan ZM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001807; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Shen S, 2001, MUTAT RES-FUND MOL M, V480, P153, DOI 10.1016/S0027-5107(01)00179-8; Shen WF, 1996, NUCLEIC ACIDS RES, V24, P898, DOI 10.1093/nar/24.5.898; Vadnais C, 2012, NUCLEIC ACIDS RES, V40, P4483, DOI 10.1093/nar/gks041; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Viswanathan A, 1999, SCIENCE, V284, P159, DOI 10.1126/science.284.5411.159; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson DM, 2007, NEUROSCIENCE, V145, P1187, DOI 10.1016/j.neuroscience.2006.07.011; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Wittmann W, 2014, DEV BIOL, V388, P35, DOI 10.1016/j.ydbio.2014.01.026; Yamada M, 2015, HIPPOCAMPUS, V25, P253, DOI 10.1002/hipo.22370	88	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22520	22531		10.1074/jbc.M115.651042	http://dx.doi.org/10.1074/jbc.M115.651042			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221032	Green Published, hybrid			2022-12-26	WOS:000361171500019
J	Heidegger, I; Fritz, J; Klocker, H; Pichler, R; Bektic, J; Horninger, W				Heidegger, Isabel; Fritz, Josef; Klocker, Helmut; Pichler, Renate; Bektic, Jasmin; Horninger, Wolfgang			Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program	PLOS ONE			English	Article							ANTIGEN; MEN; MORTALITY; NG/ML	Objective To reduce the number of unnecessary biopsies in patients with benign prostatic disease, however, without missing significant PCa the present study re-evaluates the age-dependent PSA cut-offs in the Tyrol Prostate Cancer (PCa) early detection program. Patients and Methods The study population included 2225 patients who underwent prostate biopsy due to elevated PSA levels at our department. We divided our patient collective into four age groups: <= 49 years (n = 178), 50-59 years (n = 597), 60-69 years (n = 962) and >= 70 years (n = 488). We simulated different scenarios for PSA cut-off values between 1.25 and 6 ng/mL and fPSA% between 15 and 21% for all four age groups and calculated sensitivity, specificity, confidence intervals and predictive values. Results PCa was detected in 1218 men (54.7%). We found that in combination with free PSA <= 21% the following PSA cut-offs had the best cancer specificity: 1.75 ng/ml for men <= 49 years and 50-59 years, 2.25 ng/ml for men aged 60-69 years and 3.25 ng/ml for men >= 70 years. Using these adjusted PSA cut-off values all significant tumors are recognized in all age groups, yet the number of biopsies is reduced. Overall, one biopsy is avoided in 13 to 14 men (number needed to screen = 13.3, reduction of biopsies = 7.5%) when decision regarding biopsy is done according to the "new" cut-off values instead of the "old" ones. For the different age groups the number needed to screen to avoid one biopsy varied between 9.2 (<= 49 years) and 17.4 (50-59 years). Conclusion With "new", fine-tuned PSA cut-offs we detect all relevant PCa with a significant reduction of biopsies compared to the "old" cut-off values. Optimization of age-specific PSA cut-offs is one step towards a smarter strategy in the Tyrol PCa Early Detection Program.	[Heidegger, Isabel; Pichler, Renate; Bektic, Jasmin; Horninger, Wolfgang] Med Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria; [Fritz, Josef] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Heidegger, Isabel; Klocker, Helmut] Med Univ Innsbruck, Div Expt Urol, Dept Urol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Horninger, W (corresponding author), Med Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria.	wolfgang.horninger@uki.at	Bektic, Jasmin/AAB-3952-2021; Klocker, Helmut/AAI-7130-2020; Fritz, Josef/P-9587-2016	Fritz, Josef/0000-0003-1342-3435				Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Astigueta JC, 2010, ACTAS UROL ESP, V34, P327, DOI 10.1016/S2173-5786(10)70078-0; AUA guidlines prostate cancer, 2014, AUA GUIDLINES PROSTA; Bartsch G, 2008, BJU INT, V101, P809, DOI 10.1111/j.1464-410X.2008.07502.x; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Candas B, 2000, PROSTATE, V45, P19; Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452; CHRISTENSSON A, 1993, J UROLOGY, V150, P100, DOI 10.1016/S0022-5347(17)35408-3; Cuzick J, 2014, LANCET ONCOL, V15, pE484, DOI 10.1016/S1470-2045(14)70211-6; D'Elia C, 2014, MOL CLIN ONCOL, V2, P1145, DOI 10.3892/mco.2014.370; Djavan B, 2010, EUR UROL, V57, P928, DOI 10.1016/j.eururo.2010.03.002; Heidegger I, 2012, ANTICANCER RES, V32, P5481; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Horninger W, 2001, J UROLOGY, V165, P1143, DOI 10.1016/S0022-5347(05)66451-8; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Junker D, 2014, AM J ROENTGENOL, V202, pW263, DOI 10.2214/AJR.13.11061; Loeb S, 2012, BJU INT, V110, P381, DOI 10.1111/j.1464-410X.2011.10943.x; Oberaigner W, 2012, INT J PUBLIC HEALTH, V57, P57, DOI 10.1007/s00038-011-0266-4; Parker PM, 2011, UROLOGY, V78, P110, DOI 10.1016/j.urology.2010.12.046; Phillips Robert, 2014, Nat Rev Urol, V11, P483, DOI 10.1038/nrurol.2014.210; Schroder FH, 2014, LANCET; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Sokoll LJ, 2003, UROLOGY, V61, P274, DOI 10.1016/S0090-4295(02)02398-1; Strope SA, 2010, NAT REV UROL, V7, P487, DOI 10.1038/nrurol.2010.120; Wolters T, 2009, EUR UROL, V55, P385, DOI 10.1016/j.eururo.2008.02.046	25	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134134	10.1371/journal.pone.0134134	http://dx.doi.org/10.1371/journal.pone.0134134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218594	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900084
J	Koukou, D; Chatzichristou, P; Trimis, G; Siahanidou, T; Skiathitou, AV; Koutouzis, EI; Syrogiannopoulos, GA; Lourida, A; Michos, AG; Syriopoulou, VP				Koukou, Dimitra; Chatzichristou, Panagiota; Trimis, Georgios; Siahanidou, Tania; Skiathitou, Anna-Venetia; Koutouzis, Emmanouil I.; Syrogiannopoulos, George A.; Lourida, Athanasia; Michos, Athanasios G.; Syriopoulou, Vassiliki P.			Rotavirus Gastroenteritis in a Neonatal Unit of a Greek Tertiary Hospital: Clinical Characteristics and Genotypes	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; NOSOCOMIAL ROTAVIRUS; TRYPSIN-INHIBITORS; RISK-FACTORS; INFECTION; DIARRHEA; INFANTS; STRAIN; INDIA; SURVEILLANCE	Introduction Rotavirus (RV) infection in neonatal age can be mild or even asymptomatic. Several studies have reported that RV is responsible for 31%-87% of pediatric nosocomial diarrhea and causes gastroenteritis outbreaks in pediatric and neonatal units. Objectives Study clinical characteristics, genotypes and risk factors of RV infection in neonatal age. Methods A prospective study was conducted from April 2009 till April 2013 in the neonatal special care unit of the largest tertiary pediatric hospital of Greece. Fecal samples and epidemiological data were collected from each neonate with gastrointestinal symptoms. RV antigen was detected with a rapid immunochromatography test. RV positive samples were further genotyped with RT PCR and sequencing using specific VP7 and VP4 primers. Results Positive for RV were 126/415 samples (30.4%). Mean age of onset was 18 days. Seventy four cases (58%) were hospital acquired. Seasonality of RV infection did not differ significantly throughout the year with the exception of 4 outbreaks. Genotypes found during the study period were G4P[8] (58.7%), G1P[8] (14.7%), G12P[8] (9.3%), G3P[8] (9.3%), G12P [6] (5.3%), G9P[8] (1.3%) and G2P[4] (1.3%). RV cases presented with: diarrhea (81%), vomiting (26.2%), fever (34.9%), dehydration (28.6%), feeding intolerance (39.7%), weight loss (54%), whilst 19% of cases were asymptomatic. Comparing community with hospital acquired cases differences in clinical manifestations were found. Conclusions Significant incidence of nosocomially transmitted RV infection in neonatal age including asymptomatic illness exists. Genotypes causing nosocomial outbreaks are not different from community strains. Circulating vaccines can be effective in prevention of nosocomial RV infection through herd immunity.	[Koukou, Dimitra; Chatzichristou, Panagiota; Siahanidou, Tania; Skiathitou, Anna-Venetia; Lourida, Athanasia; Michos, Athanasios G.; Syriopoulou, Vassiliki P.] Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece; [Trimis, Georgios] VIANEX Sanofi Pasteur MSD, Vaccine Unit, Athens, Greece; [Koutouzis, Emmanouil I.] Aghia Sophia Childrens Hosp, Dept Microbiol, Athens, Greece; [Syrogiannopoulos, George A.] Univ Thessaly, Gen Univ Hosp Larissa, Dept Pediat, Larisa, Greece	National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Sanofi-Aventis; The Aghia Sophia Children's Hospital; General University Hospital of Larissa; University of Thessaly	Syriopoulou, VP (corresponding author), Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece.	vsyriop@med.uoa.gr	Michos, Athanasios/H-2389-2012; Siahanidou, Tania/AAC-3850-2020	Siahanidou, Tania/0000-0001-8991-0649; Michos, Athanasios/0000-0003-1745-1118	GlaxoSmithKline Biologicals; Sanofi Pasteur MSD through the Centre for Infections, Health Protection Agency, London, United Kingdom; Vaccine Unit of VIANEX Athens-Greece; VIANEX/Sanofi Pasteur MSD	GlaxoSmithKline Biologicals(GlaxoSmithKline); Sanofi Pasteur MSD through the Centre for Infections, Health Protection Agency, London, United Kingdom; Vaccine Unit of VIANEX Athens-Greece; VIANEX/Sanofi Pasteur MSD	The study was supported by grants jointly from GlaxoSmithKline Biologicals and Sanofi Pasteur MSD through the Centre for Infections, Health Protection Agency, London, United Kingdom and from Vaccine Unit of VIANEX Athens-Greece. VIANEX/Sanofi Pasteur MSD provided support in the form of a salary for author GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the 'author contributions' section.	AKINCI A, 1991, TURKISH J PEDIATR, V33, P153; Arvay ML, 2009, J INFECT DIS, V200, pS85, DOI 10.1086/605062; BANATVALA JE, 1978, J AM VET MED ASSOC, V173, P527; Bass ES, 2007, PEDIATR REV, V28, P183, DOI 10.1542/pir.28-5-183; BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282; Bishop RF, 1997, J PAEDIATR CHILD H, V33, P80, DOI 10.1111/j.1440-1754.1997.tb00998.x; BLAKE PA, 1993, J INFECT DIS, V167, P627, DOI 10.1093/infdis/167.3.627; CAMERON DJS, 1975, LANCET, V2, P124; Chandran A, 2006, J PEDIATR-US, V149, P441, DOI 10.1016/j.jpeds.2006.04.054; CICIRELLO HG, 1994, PEDIATR INFECT DIS J, V13, P720, DOI 10.1097/00006454-199408000-00008; Civardi E, 2013, AM J INFECT CONTROL, V41, P854, DOI 10.1016/j.ajic.2013.01.026; CUNNINGHAM AS, 1987, J PEDIATR-US, V110, P658, DOI 10.1016/S0022-3476(87)80574-7; Das BK, 1994, J CLIN MICROBIOL, V32, P1820; de Rougemont A, 2009, PATHOL BIOL, V57, P86, DOI 10.1016/j.patbio.2008.08.004; DEARLOVE J, 1983, BRIT MED J, V286, P1473, DOI 10.1136/bmj.286.6376.1473; DUFFY LC, 1986, AM J DIS CHILD, V140, P1164, DOI 10.1001/archpedi.1986.02140250090041; DUNN SJ, 1993, J CLIN MICROBIOL, V31, P165, DOI 10.1128/JCM.31.1.165-169.1993; Ford-Jones EL, 2000, ARCH PEDIAT ADOL MED, V154, P586, DOI 10.1001/archpedi.154.6.586; Gentsch JR, 1996, J INFECT DIS, V174, pS30, DOI 10.1093/infdis/174.Supplement_1.S30; Gianino P, 2002, J HOSP INFECT, V50, P13, DOI 10.1053/jhin.2001.1129; GLASS RI, 1986, ACTA PAEDIATR SCAND, V75, P713, DOI 10.1111/j.1651-2227.1986.tb10279.x; Gomara MI, 2004, J CLIN MICROBIOL, V42, P2541, DOI 10.1128/JCM.42.6.2541-2547.2004; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; JAYASHREE S, 1988, J MED VIROL, V26, P333, DOI 10.1002/jmv.1890260313; KAPIKIAN AZ, 1993, JAMA-J AM MED ASSOC, V269, P627, DOI 10.1001/jama.269.5.627; Kilgore PE, 1996, PEDIATR INFECT DIS J, V15, P672, DOI 10.1097/00006454-199608000-00007; Kim CR, 2009, INFECT CONT HOSP EP, V30, P893, DOI 10.1086/599285; Konstantopoulos A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003570; Koukou D, 2011, J MED VIROL, V83, P165, DOI 10.1002/jmv.21945; Lebenthal A, 1999, JPEN-PARENTER ENTER, V23, pS3, DOI 10.1177/014860719902300502; Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637; Linhares AC, 2002, J MED VIROL, V67, P418, DOI 10.1002/jmv.10089; Malek MA, 2006, PEDIATRICS, V117, P1887, DOI 10.1542/peds.2005-2351; Marshall J, 2003, J CLIN VIROL, V28, P331, DOI 10.1016/S1386-6532(03)00081-7; MCLEAN BS, 1981, J CLIN MICROBIOL, V13, P22, DOI 10.1128/JCM.13.1.22-29.1981; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 1998, J INFECT DIS, V177, P13, DOI 10.1086/513808; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Ramachandran M, 1996, J CLIN MICROBIOL, V34, P436, DOI 10.1128/JCM.34.2.436-439.1996; Ramani S, 2008, PEDIATR INFECT DIS J, V27, P719, DOI 10.1097/INF.0b013e3181715170; Ratner AJ, 2001, INFECT CONT HOSP EP, V22, P299, DOI 10.1086/501904; Rogers M, 2000, AM J INFECT CONTROL, V28, P378, DOI 10.1067/mic.2000.109908; ROTBART HA, 1983, J PEDIATR-US, V103, P454, DOI 10.1016/S0022-3476(83)80427-2; SANTOSHAM M, 1982, LANCET, V1, P1070; Sharma R, 2002, PEDIATR INFECT DIS J, V21, P1099, DOI 10.1097/00006454-200212000-00003; Shim JO, 2012, PEDIATR NEONATOL, V53, P18, DOI 10.1016/j.pedneo.2011.11.005; Shim SY, 2010, J MED VIROL, V82, P700, DOI 10.1002/jmv.21698; STEELE AD, 1995, J CLIN MICROBIOL, V33, P1516, DOI 10.1128/JCM.33.6.1516-1519.1995; Syriopoulou V, 2011, ACTA PAEDIATR, V100, P732, DOI 10.1111/j.1651-2227.2010.02127.x; Tai IC, 2012, J MICROBIOL IMMUNOL, V45, P15, DOI 10.1016/j.jmii.2011.09.023; TAM JSL, 1990, J CLIN MICROBIOL, V28, P1033, DOI 10.1128/JCM.28.5.1033-1038.1990; TIMENETSKY MDST, 1994, J CLIN MICROBIOL, V32, P2622, DOI 10.1128/JCM.32.10.2622-2624.1994; TOTTERDELL BM, 1976, ARCH DIS CHILD, V51, P924, DOI 10.1136/adc.51.12.924; Trimis G, 2011, VACCINE, V29, P7292, DOI 10.1016/j.vaccine.2011.07.092; WEINBERG RJ, 1984, PEDIATRICS, V74, P250; Widdowson MA, 2002, INFECT CONT HOSP EP, V23, P665, DOI 10.1086/501991	56	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133891	10.1371/journal.pone.0133891	http://dx.doi.org/10.1371/journal.pone.0133891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214830	Green Published, Green Submitted, gold			2022-12-26	WOS:000358594300039
J	Ounap, K; Leetsi, L; Matsoo, M; Kurg, R				Ounap, Kadri; Leetsi, Lilian; Matsoo, Maarja; Kurg, Reet			The Stability of Ribosome Biogenesis Factor WBSCR22 Is Regulated by Interaction with TRMT112 via Ubiquitin-Proteasome Pathway	PLOS ONE			English	Article							TRANSFER-RNA; PROTEIN; YEAST; TRM112; CANCER; METHYLTRANSFERASES; IDENTIFICATION; GENOME; GROWTH; TRANSLATION	The human WBSCR22 protein is a 18S rRNA methyltransferase involved in pre-rRNA processing and ribosome 40S subunit biogenesis. Recent studies have shown that the protein function in ribosome synthesis is independent of its enzymatic activity. In this work, we have studied the WBSCR22 protein interaction partners by SILAC-coupled co-immunoprecipitation assay and identified TRMT112 as the interaction partner of WBSCR22. Knock-down of TRMT112 expression decreased the WBSCR22 protein level in mammalian cells, suggesting that the stability of WBSCR22 is regulated through the interaction with TRMT112. The localization of the TRMT112 protein is determined by WBSCR22, and the WBSCR22-TRMT112 complex is localized in the cell nucleus. We provide evidence that the interaction between WBSCR22/Bud23 and TRMT112/Trm112 is conserved between mammals and yeast, suggesting that the function of TRMT112 as a co-activator of methyltransferases is evolutionarily conserved. Finally, we show that the transiently expressed WBSCR22 protein is ubiquitinated and degraded through the proteasome pathway, revealing the tight control of the WBSCR22 protein level in the cells.	[Ounap, Kadri; Leetsi, Lilian; Matsoo, Maarja; Kurg, Reet] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu	Kurg, R (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	reet.kurg@ut.ee	Kurg, Reet/J-2829-2015	Kurg, Reet/0000-0001-7188-9693; Ounap, Kadri/0000-0001-7397-3231	Estonian Ministry of Education and Research [IUT20-27]; European Regional Development Fund through the Center of Excellence in Chemical Biology	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund through the Center of Excellence in Chemical Biology(European Commission)	This work was supported by institutional research funding (IUT20-27) of the Estonian Ministry of Education and Research and by the European Regional Development Fund through the Center of Excellence in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Figaro S, 2012, MOL CELL BIOL, V32, P2254, DOI 10.1128/MCB.06623-11; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Gu TT, 2012, ACTA HISTOCHEM CYTOC, V45, P113, DOI 10.1267/ahc.11047; Haag S, 2015, RNA, V21, P180, DOI 10.1261/rna.047910.114; Han YH, 2009, ONCOL REP, V22, P215, DOI 10.3892/or_00000427; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hu ZB, 2010, PLANT J, V61, P600, DOI 10.1111/j.1365-313X.2009.04085.x; Jangani M, 2014, J BIOL CHEM, V289, P8931, DOI 10.1074/jbc.M113.540906; Letoquarta J, 2014, P NATL ACAD SCI USA, V111, pE5518, DOI 10.1073/pnas.1413089111; Liger D, 2011, NUCLEIC ACIDS RES, V39, P6249, DOI 10.1093/nar/gkr176; Mazauric MH, 2010, J BIOL CHEM, V285, P18505, DOI 10.1074/jbc.M110.113100; Montanaro L, 2012, BBA-REV CANCER, V1825, P101, DOI 10.1016/j.bbcan.2011.10.006; Nakazawa Y, 2011, CANCER RES, V71, P1146, DOI 10.1158/0008-5472.CAN-10-2695; Ohbayashi I, 2011, PLANT J, V67, P49, DOI 10.1111/j.1365-313X.2011.04574.x; Ounap K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075686; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Purushothaman SK, 2005, MOL CELL BIOL, V25, P4359, DOI 10.1128/MCB.25.11.4359-4370.2005; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Sardana R, 2012, MOL BIOL CELL, V23, P4313, DOI 10.1091/mbc.E12-05-0370; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Stefanska B, 2014, CLIN CANCER RES, V20, P3118, DOI 10.1158/1078-0432.CCR-13-0283; Studte P, 2008, MOL MICROBIOL, V69, P1266, DOI 10.1111/j.1365-2958.2008.06358.x; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Teng T, 2013, CURR OPIN GENET DEV, V23, P63, DOI 10.1016/j.gde.2013.02.001; Tiedemann RE, 2012, CANCER RES, V72, P757, DOI 10.1158/0008-5472.CAN-11-2781; Towns WL, 2012, DNA CELL BIOL, V31, P434, DOI 10.1089/dna.2011.1437; Varjak M, 2013, J VIROL, V87, P10295, DOI 10.1128/JVI.01105-13; von Mikecz Anna, 2008, V463, P191, DOI 10.1007/978-1-59745-406-3_14; Vosa L, 2012, J VIROL, V86, P348, DOI 10.1128/JVI.05606-11; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Zorbas C, 2015, MOL BIOL CELL, V26, P2080, DOI 10.1091/mbc.E15-02-0073	34	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133841	10.1371/journal.pone.0133841	http://dx.doi.org/10.1371/journal.pone.0133841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214185	Green Submitted, Green Published, gold			2022-12-26	WOS:000358594300035
J	DeLuca, S; Khar, K; Meiler, J				DeLuca, Samuel; Khar, Karen; Meiler, Jens			Fully Flexible Docking of Medium Sized Ligand Libraries with RosettaLigand	PLOS ONE			English	Article							MOLECULAR DOCKING; PROTEIN; PREDICTION; DESIGN	RosettaLigand has been successfully used to predict binding poses in protein-small molecule complexes. However, the RosettaLigand docking protocol is comparatively slow in identifying an initial starting pose for the small molecule (ligand) making it unfeasible for use in virtual High Throughput Screening (vHTS). To overcome this limitation, we developed a new sampling approach for placing the ligand in the protein binding site during the initial 'low-resolution' docking step. It combines the translational and rotational adjustments to the ligand pose in a single transformation step. The new algorithm is both more accurate and more time-efficient. The docking success rate is improved by 10-15% in a benchmark set of 43 protein/ligand complexes, reducing the number of models that typically need to be generated from 1000 to 150. The average time to generate a model is reduced from 50 seconds to 10 seconds. As a result we observe an effective 30-fold speed increase, making RosettaLigand appropriate for docking medium sized ligand libraries. We demonstrate that this improved initial placement of the ligand is critical for successful prediction of an accurate binding position in the 'high-resolution' full atom refinement step.	[DeLuca, Samuel; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37240 USA; [Khar, Karen] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66045 USA	Vanderbilt University; University of Kansas	Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37240 USA.	jens@meilerlab.org		Meiler, Jens/0000-0001-8945-193X	PhRMA foundation; NIH [R01 GM080403, R01 GM099842, R01 DK097376]; NSF [CHE 1305874]; Direct For Mathematical & Physical Scien [1305874] Funding Source: National Science Foundation	PhRMA foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was funded by a Predoctoral fellowship from the PhRMA foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Work in the Meiler laboratory is supported through NIH (R01 GM080403, R01 GM099842, R01 DK097376) and NSF (CHE 1305874).	Bauer MR, 2013, J CHEM INF MODEL, V53, P1447, DOI [10.1021/ci400115b, 10.1021/ci400115bl]; BYSTROFF C, 1991, BIOCHEMISTRY-US, V30, P2227, DOI 10.1021/bi00222a028; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Davis IW, 2009, PROTEIN SCI, V18, P1998, DOI 10.1002/pro.192; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2036, DOI 10.1021/ci200082t; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Hindle SA, 2002, J COMPUT AID MOL DES, V16, P129, DOI 10.1023/A:1016399411208; Kaufmann KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050769; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Lemmon G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067536; Lemmon G, 2012, CHEM BIOL DRUG DES, V79, P888, DOI 10.1111/j.1747-0285.2012.01356.x; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Reymond JL, 2012, WIRES COMPUT MOL SCI, V2, P717, DOI 10.1002/wcms.1104; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Turlington M, 2013, J MED CHEM, V56, P7976, DOI 10.1021/jm401028t; Zhang XH, 2013, J COMPUT CHEM, V34, P915, DOI 10.1002/jcc.23214	27	59	59	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132508	10.1371/journal.pone.0132508	http://dx.doi.org/10.1371/journal.pone.0132508			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207742	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000030
J	Doggett, K; Turkel, N; Willoughby, LF; Ellul, J; Murray, MJ; Richardson, HE; Brumby, AM				Doggett, Karen; Turkel, Nezaket; Willoughby, Lee F.; Ellul, Jason; Murray, Michael J.; Richardson, Helena E.; Brumby, Anthony M.			BTB-Zinc Finger Oncogenes Are Required for Ras and Notch-Driven Tumorigenesis in Drosophila	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; EYE DEVELOPMENT; IMAGINAL DISCS; TEMPORAL IDENTITY; TUMOR-SUPPRESSOR; JAK/STAT PATHWAY; FEEDBACK LOOP; JNK ACTIVITY; PROTEIN	During tumorigenesis, pathways that promote the epithelial-to-mesenchymal transition (EMT) can both facilitate metastasis and endow tumor cells with cancer stem cell properties. To gain a greater understanding of how these properties are interlinked in cancers we used Drosophila epithelial tumor models, which are driven by orthologues of human oncogenes (activated alleles of Ras and Notch) in cooperation with the loss of the cell polarity regulator, scribbled (scrib). Within these tumors, both invasive, mesenchymal-like cell morphology and continual tumor overgrowth, are dependent upon Jun N-terminal kinase (JNK) activity. To identify JNK-dependent changes within the tumors we used a comparative microarray analysis to define a JNK gene signature common to both Ras and Notch-driven tumors. Amongst the JNK-dependent changes was a significant enrichment for BTB-Zinc Finger (ZF) domain genes, including chronologically inappropriate morphogenesis (chinmo). chinmo was upregulated by JNK within the tumors, and overexpression of chinmo with either Ras(V12) or N-intra was sufficient to promote JNK-independent epithelial tumor formation in the eye/antennal disc, and, in cooperation with Ras(V12), promote tumor formation in the adult midgut epithelium. Chinmo primes cells for oncogene-mediated transformation through blocking differentiation in the eye disc, and promoting an escargot-expressing stem or enteroblast cell state in the adult midgut. BTB-ZF genes are also required for Ras and Notch-driven overgrowth of scrib mutant tissue, since, although loss of chinmo alone did not significantly impede tumor development, when loss of chinmo was combined with loss of a functionally related BTB-ZF gene, abrupt, tumor overgrowth was significantly reduced. abrupt is not a JNK-induced gene, however, Abrupt is present in JNK-positive tumor cells, consistent with a JNK-associated oncogenic role. As some mammalian BTB-ZF proteins are also highly oncogenic, our work suggests that EMT-promoting signals in human cancers could similarly utilize networks of these proteins to promote cancer stem cell states.	[Doggett, Karen; Turkel, Nezaket; Willoughby, Lee F.; Richardson, Helena E.; Brumby, Anthony M.] Peter MacCallum Canc Ctr, Div Res, Cell Cycle & Dev Lab, Melbourne, Vic, Australia; [Ellul, Jason] Peter MacCallum Canc Ctr, Bioinformat Core Facil, Div Res, Melbourne, Vic, Australia; [Murray, Michael J.; Brumby, Anthony M.] Univ Melbourne, Sch Biosci, Melbourne, Vic 3052, Australia; [Richardson, Helena E.] Peter MacCallum Canc Ctr, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Richardson, Helena E.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3052, Australia; [Richardson, Helena E.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3052, Australia; [Richardson, Helena E.] La Trobe Univ, Sch Mol Sci, Bundoora, Vic 3086, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; La Trobe University	Doggett, K (corresponding author), Walter & Eliza Hall Inst Med Res, Dev & Canc Div, Melbourne, Vic 3052, Australia.	karen.doggett@wehi.edu.au	Richardson, Helena E/A-8080-2013	Richardson, Helena E/0000-0003-3852-4953; Ellul, Jason/0000-0002-6046-5139; Turkel, Nezaket/0000-0002-4480-7282	National Health and Medical Research Council Australia [509051, 400211]; Peter MacCallum Internal funds; National Health and Medical Research Council Australia	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Peter MacCallum Internal funds; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council Australia #509051 to AMB and #400211 to HER and AMB, and Peter MacCallum Internal funds to HER. HER is supported by a Senior Research Fellowship from the National Health and Medical Research Council Australia.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Bolstad B., 2004, LOW LEVEL ANALYSIS O; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Brumby AM, 2011, GENETICS; Bunker BD, 2015, ELIFE, V4, DOI 10.7554/eLife.03189; Campbell K, 2011, DEV CELL, V21, P1051, DOI 10.1016/j.devcel.2011.10.005; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; Davie K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004994; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; Flaherty MS, 2009, DEV DYNAM, V238, P2235, DOI 10.1002/dvdy.21989; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Go MJ, 1998, DEVELOPMENT, V125, P2031; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jal Wu, R WITH CONTRIBUTIONS; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karim FD, 1998, DEVELOPMENT, V125, P1; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; Kulshammer E, 2012, J CELL SCI; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; Lee JD, 2001, DEVELOPMENT, V128, P1519; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Manhire-Heath R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3790; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Rousset R, 2010, DEVELOPMENT, V137, P2177, DOI 10.1242/dev.050781; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song HJ, 2002, GENETICS, V162, P1703; Spradling AC, 1999, GENETICS, V153, P135; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Sustar A, 2011, DEV BIOL, V356, P576, DOI 10.1016/j.ydbio.2011.06.018; Team RC, 2014, R A LANGUAGE AND ENV; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Turkel N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003627; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; VanZomeren-Dohm A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-41; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Wu KJ, 2011, BIOSCIENCE REP, V31, P449, DOI 10.1042/BSR20100114; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Wu YC, 2012, DEV CELL, V23, P202, DOI 10.1016/j.devcel.2012.05.013; Xie G, 2011, INT J ONCOL; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	87	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132987	10.1371/journal.pone.0132987	http://dx.doi.org/10.1371/journal.pone.0132987			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207831	Green Published, gold			2022-12-26	WOS:000358622000051
J	Maama-Maime, LB; Mareka, M; Ershova, JV; Tlali, TE; Kao, K; Phalatse, M; Polansky, L; Beres, LK; Letsie, M; Holtz, TH				Maama-Maime, Llang B.; Mareka, Mathabo; Ershova, Julia V.; Tlali, Thabong E.; Kao, Kekeletso; Phalatse, Mamakhetha; Polansky, Lauren; Beres, Laura K.; Letsie, Moselinyane; Holtz, Timothy H.			Antituberculosis Drug Resistance Survey in Lesotho, 2008-2009: Lessons Learned	PLOS ONE			English	Article							TUBERCULOSIS	Setting Drug resistance is an increasing threat to tuberculosis (TB) control worldwide. The World Health Organization advises monitoring for drug resistance, with either ongoing surveillance or periodic surveys. Methods The antituberculosis drug resistance survey was conducted in Lesotho in 2008-2009. Basic demographic and TB history information was collected from individuals with positive sputum smear results at 17 diagnostic facilities. Additional sputum sample was sent to the national TB reference laboratory for culture and drug susceptibility testing. Results Among 3441 eligible smear-positive persons, 1121 (32.6%) were not requested to submit sputum for culture. Among 2320 persons submitted sputum, 1164 (50.2%) were not asked for clinical information or did not have valid sputum samples for testing. In addition, 445/ 2320 (19.2%) were excluded from analysis because of other laboratory or data management reasons. Among 984/3441 (28.6%) persons who had data available for analysis, MDR-TB was present in 24/773 (3.1%) of new and 25/195 (12.8%) of retreatment TB cases. Logistical, operational and data management challenges affected survey results. Conclusion MDR-TB is prevalent in Lesotho, but limitations reduced the reliability of our findings. Multiple lessons learned during this survey can be applied to improve the next drug resistance survey in Lesotho and other resource constrained countries may learn how to avoid these bottlenecks.	[Maama-Maime, Llang B.] Minist Hlth, Natl TB Programme, Maseru, Lesotho; [Mareka, Mathabo; Tlali, Thabong E.; Kao, Kekeletso; Phalatse, Mamakhetha] Minist Hlth, Lab Serv, Maseru, Lesotho; [Ershova, Julia V.; Polansky, Lauren; Holtz, Timothy H.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Beres, Laura K.] Emory Univ, Atlanta, GA 30322 USA; [Letsie, Moselinyane] Minist Hlth, Dis Control, Maseru, Lesotho	Centers for Disease Control & Prevention - USA; Emory University	Ershova, JV (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	jhe3@cdc.gov		Beres, Laura/0000-0002-4731-7828				[Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2007, KINGD LES ANN REP 20; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Kingdom of Lesotho, 2014, MILL DEV GOASL STAT; Moodley P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017513; ODonnell MR, 2013, EMERGING INFECT DIS, V19; Satti H, 2008, EMERG INFECT DIS, V14, P992, DOI 10.3201/eid1406.071654; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 4 WHO; World Health Organization, WHOHTMTB2009422	13	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133808	10.1371/journal.pone.0133808	http://dx.doi.org/10.1371/journal.pone.0133808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207630	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000149
J	Siryani, I; Jama, M; Rumman, N; Marzouqa, H; Kannan, M; Lyon, E; Hindiyeh, M				Siryani, Issa; Jama, Mohamed; Rumman, Nisreen; Marzouqa, Hiyam; Kannan, Moein; Lyon, Elaine; Hindiyeh, Musa			Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine	PLOS ONE			English	Article							GENE; IDENTIFICATION; DIAGNOSIS; SPECTRUM	Cystic fibrosis (CF) is an autosomal recessive inherited life-threatening disorder that causes severe damage to the lungs and the digestive system. In Palestine, mutations in the Cystic Fibrosis Transmembrane Conductance Regulator gene (CFTR) that contributes to the clinical presentation of CF are ill defined. A cohort of thirty three clinically diagnosed CF patients from twenty one different Palestinian families residing in the central and southern part of Palestine were incorporated in this study. Sweat chloride testing was performed using the Sweat Chek Conductivity Analyzer (ELITECH Group, France) to confirm the clinical diagnosis of CF. In addition, nucleic acid from the patients' blood samples was extracted and the CFTR mutation profiles were assessed by direct sequencing of the CFTR 27 exons and the intron-exon boundaries. For patient's DNA samples where no homozygous or two heterozygous CFTR mutations were identified by exon sequencing, DNA samples were tested for deletions or duplications using SALSA MLPA probemix P091-D1 CFTR assay. Sweat chloride testing confirmed the clinical diagnosis of CF in those patients. All patients had NaCl conductivity > 60 mmol/l. In addition, nine different CFTR mutations were identified in all 21 different families evaluated. These mutations were c.1393-1G>A, F508del, W1282X, G85E, c.313delA, N1303K, deletion exons 17a-17b-18, deletion exons 17a-17b and Q1100P. c.1393-1G>A was shown to be the most frequent occurring mutation among tested families. We have profiled the underling mutations in the CFTR gene of a cohort of 21 different families affected by CF. Unlike other studies from the Arab countries where F508del was reported to be the most common mutation, in southern/central Palestine, the c.1393-1G>A appeared to be the most common. Further studies are needed per sample size and geographic distribution to account for other possible CFTR genetic alterations and their frequencies. Genotype/phenotype assessments are also recommended and finally carrier frequency should be ascertained.	[Siryani, Issa; Rumman, Nisreen; Marzouqa, Hiyam; Hindiyeh, Musa] Caritas Baby Hosp, Bethlehem, Palestine; [Siryani, Issa; Kannan, Moein; Hindiyeh, Musa] Bethlehem Univ, Bethlehem, Palestine; [Siryani, Issa; Hindiyeh, Musa] Palestinian Forum Med Res, Ramallah, Palestine; [Jama, Mohamed; Lyon, Elaine] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84112 USA; [Lyon, Elaine] Univ Utah, Dept Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Lyon, E (corresponding author), ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84112 USA.	lyone@aruplab.com; mousa.hindiyeh@crb-mail.org			Caritas Baby Hospital Medical Research Fund [MRC-04]	Caritas Baby Hospital Medical Research Fund	This study was supported by Caritas Baby Hospital Medical Research Fund (MRC-04).	Chiba-Falek O, 1998, EUR J HUM GENET, V6, P181, DOI 10.1038/sj.ejhg.5200174; Chou LS, 2005, J MOL DIAGN, V7, P111, DOI 10.1016/S1525-1578(10)60016-5; des Georges Marie, 2004, J Cyst Fibros, V3, P265, DOI 10.1016/j.jcf.2004.04.008; Diana A, 2012, GENE, V497, P90, DOI 10.1016/j.gene.2012.01.061; DORK T, 1993, GENOMICS, V15, P688, DOI 10.1006/geno.1993.1127; Farra C, 2010, J CYST FIBROS, V9, P406, DOI 10.1016/j.jcf.2010.08.001; Laufer-Cahana A, 1999, Hum Mutat, V14, P543, DOI 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU16>3.0.CO;2-V; LeGrys VA, 2007, J PEDIATR-US, V151, P85, DOI 10.1016/j.jpeds.2007.03.002; Lerer I, 1999, Hum Mutat, V13, P337, DOI 10.1002/(SICI)1098-1004(1999)13:4<337::AID-HUMU13>3.0.CO;2-C; Lezana Jose Luis, 2003, J Cyst Fibros, V2, P1, DOI 10.1016/S1569-1993(02)00146-7; Mall MA, 2014, EUR RESPIR J, V44, P1042, DOI 10.1183/09031936.00228013; Nikolic A, 2014, J CYST FIBROS, V13, P111, DOI 10.1016/j.jcf.2013.07.001; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Padoa C, 1999, J MED GENET, V36, P41; Paracchini V, 2012, JIMD REP, V4, P17, DOI 10.1007/8904_2011_55; Quint A, 2005, AM J MED GENET A, V136A, P246, DOI 10.1002/ajmg.a.30823; Rohlfs EM, 2011, CLIN CHEM, V57, P841, DOI 10.1373/clinchem.2010.159285; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Schrijver I, 2005, J MOL DIAGN, V7, P375, DOI 10.1016/S1525-1578(10)60567-3; Shah U, 2009, TROP MED INT HEALTH, V14, P542, DOI 10.1111/j.1365-3156.2009.02253.x; Sharma N, 2009, ANN HUM GENET, V73, P26, DOI 10.1111/j.1469-1809.2008.00477.x; Stern RC, 1997, NEW ENGL J MED, V336, P487, DOI 10.1056/NEJM199702133360707; Svensson AM, 2010, GENET TEST MOL BIOMA, V14, P171, DOI 10.1089/gtmb.2009.0099; Wahab A, 2004, J TROP PEDIATRICS, V50, P120, DOI 10.1093/tropej/50.2.120	24	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133890	10.1371/journal.pone.0133890	http://dx.doi.org/10.1371/journal.pone.0133890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208274	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000166
J	Yang, CY; Powell, CA; Duan, YP; Shatters, R; Zhang, MQ				Yang, Chuanyu; Powell, Charles A.; Duan, Yongping; Shatters, Robert; Zhang, Muqing			Antimicrobial Nanoemulsion Formulation with Improved Penetration of Foliar Spray through Citrus Leaf Cuticles to Control Citrus Huanglongbing	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER-ASIATICUS; SAO-PAULO-STATE; GREENING DISEASE; DELIVERY-SYSTEMS; PLANT CUTICLES; SURFACTANTS; PERMEABILITY; SINENSIS; NANOPARTICLES; MOLECULES	Huanglongbing (HLB) is the most serious disease affecting the citrus industry worldwide to date. The causal agent, Candidatus Liberibacter asiaticus (Las), resides in citrus phloem, which makes it difficult to effectively treat with chemical compounds. In this study, a transcuticular nanoemulsion formulation was developed to enhance the permeation of an effective antimicrobial compound (ampicillin; Amp) against HLB disease through the citrus cuticle into the phloem via a foliar spray. The results demonstrated that efficiency of cuticle isolation using an enzymatic method (pectinase and cellulase) was dependent on the citrus cultivar and Las-infection, and it was more difficult to isolate cuticles from valencia orange (Citrus sinensis) and HLB-symptomatic leaves. Of eight adjuvants tested, Brij 35 provided the greatest increase in permeability of the HLB-affected cuticle with a 3.33-fold enhancement of cuticular permeability over water control. An in vitro assay using Bacillus subtilis showed that nanoemulsion formulations containing Amp (droplets size = 5.26 +/- 0.04 nm and 94 +/- 1.48 nm) coupled with Brij 35 resulted in greater inhibitory zone diameters (5.75 mm and 6.66 mm) compared to those of Brij 35 (4.34 mm) and Amp solution (2.83 mm) alone. Furthermore, the nanoemulsion formulations eliminated Las bacteria in HLB-affected citrus in planta more efficiently than controls. Our study shows that a water in oil (W/O) nanoemulsion formulation may provide a useful model for the effective delivery of chemical compounds into citrus phloem via a foliar spray for controlling citrus HLB.	[Yang, Chuanyu; Zhang, Muqing] Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Peoples R China; [Yang, Chuanyu; Powell, Charles A.; Zhang, Muqing] Univ Florida, Indian River Res & Educ Ctr, IFAS, Ft Pierce, FL USA; [Duan, Yongping; Shatters, Robert] USDA ARS, Hort Res Lab, Ft Pierce, FL USA; [Zhang, Muqing] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agri B, Nanning 530004, Peoples R China	Fujian Agriculture & Forestry University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Guangxi University	Zhang, MQ (corresponding author), Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Peoples R China.	mqzhang@ufl.edu		yang, chuanyu/0000-0003-1194-208X; Shatters, Robert/0000-0002-3903-772X; zhang, muqing/0000-0003-3138-3422	Citrus Research and Development Foundation [584, 617]; Guangxi Natural Science Foundation [2013GXNSFCB1902]; Guangxi international Cooperation Project [1347004-7]; ARS [ARS-0423073] Funding Source: Federal RePORTER	Citrus Research and Development Foundation; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi international Cooperation Project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support was provided by Citrus Research and Development Foundation (project#584, #617 and their enhancement), Guangxi Natural Science Foundation (project 2013GXNSFCB1902) and Guangxi international Cooperation Project (project 1347004-7).	Adjonu R, 2014, FOOD HYDROCOLLOID, V41, P169, DOI 10.1016/j.foodhyd.2014.04.007; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; [Anonymous], 2012, ECONOMIC IMPACTS OF; BAKER EA, 1975, J SCI FOOD AGR, V26, P1093, DOI 10.1002/jsfa.2740260807; Bell TA, 1958, BOT GAZ, P192; Bondada BR, 2006, J HORTIC SCI BIOTECH, V81, P219; Bondada BR, 2001, HORTSCIENCE, V36, P1061, DOI 10.21273/HORTSCI.36.6.1061; Bouchemal K, 2004, INT J PHARM, V280, P241, DOI 10.1016/j.ijpharm.2004.05.016; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; BREUER MM, 1979, J SOC COSMET CHEM, V30, P41; Castella M, 2013, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2013-62; Fan J, 2010, PLANT PATHOL, V59, P1037, DOI 10.1111/j.1365-3059.2010.02328.x; Fisher R. A., 1946, Statistical methods for research workers.; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Hull H M, 1970, Residue Rev, V31, P1; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jo YK, 2009, PLANT DIS, V93, P1037, DOI 10.1094/PDIS-93-10-1037; Jones B, 2009, J QUAL TECHNOL, V41, P340, DOI 10.1080/00224065.2009.11917790; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; KOLATTUKUDY PE, 1985, ANNU REV PHYTOPATHOL, V23, P223, DOI 10.1146/annurev.py.23.090185.001255; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li Y, 2012, FOOD HYDROCOLLOID, V27, P517, DOI 10.1016/j.foodhyd.2011.08.017; Lopes SA, 2008, PLANT DIS, V92, P21, DOI 10.1094/PDIS-92-1-0021; Lovelyn C., 2011, J BIOMATERIALS NANOB, V2, P626, DOI [DOI 10.4236/JBNB.2011.225075, 10.4236/jbnb.2011.225075]; Martinelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074256; Mason TG, 2006, J PHYS-CONDENS MAT, V18, pR635, DOI 10.1088/0953-8984/18/41/R01; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mohammed AR, 2007, J AGRON CROP SCI, V193, P324, DOI 10.1111/j.1439-037X.2007.00268.x; NARIANI TK, 1973, CURR SCI INDIA, V42, P513; Ocsoy I, 2013, ACS NANO, V7, P8972, DOI 10.1021/nn4034794; Orbovic V, 2007, HORTSCIENCE, V42, P1405, DOI 10.21273/HORTSCI.42.6.1405; Ozturk B, 2014, J FOOD ENG, V142, P57, DOI 10.1016/j.jfoodeng.2014.06.015; Park ES, 2000, INT J PHARM, V209, P109, DOI 10.1016/S0378-5173(00)00559-7; Pathan IB, 2009, TROP J PHARM RES, V8, P173; ROE JH, 1955, J BIOL CHEM, V212, P335; Roy S, 1996, J AM SOC HORTIC SCI, V121, P1179, DOI 10.21273/JASHS.121.6.1179; Saftner RA, 1997, J AM SOC HORTIC SCI, V122, P386, DOI 10.21273/JASHS.122.3.386; SCHONHERR J, 1986, PLANT CELL ENVIRON, V9, P459, DOI 10.1111/j.1365-3040.1986.tb01761.x; SCHONHERR J, 1979, PLANTA, V144, P391, DOI 10.1007/BF00391583; Schreiber L, 1995, J EXP BOT, V46, P1915, DOI 10.1093/jxb/46.12.1915; SKOSS JESSE D., 1955, BOT GAZ, V117, P55, DOI 10.1086/335891; SOLEL Z, 1973, PHYTOPATHOLOGY, V63, P505, DOI 10.1094/Phyto-63-505; STOCK D, 1993, PESTIC SCI, V38, P165, DOI 10.1002/ps.2780380211; Texeira DC, 2005, PLANT DIS, V89, P107, DOI 10.1094/PD-89-0107A; WALTERS KA, 1988, J PHARM PHARMACOL, V40, P525, DOI 10.1111/j.2042-7158.1988.tb05295.x; Young JA, 2002, J CHEM EDUC, V79, P1202, DOI 10.1021/ed079p1202.2; Zhang MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111032; Zhang MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076331; Zhang MQ, 2012, PHYTOPATHOLOGY, V102, P567, DOI 10.1094/PHYTO-09-11-0265; Zhang MQ, 2011, PHYTOPATHOLOGY, V101, P1097, DOI 10.1094/PHYTO-09-10-0262; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239	52	34	38	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133826	10.1371/journal.pone.0133826	http://dx.doi.org/10.1371/journal.pone.0133826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207823	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000151
J	Reuter, M; Wiedl, T; Piller, WE				Reuter, Markus; Wiedl, Thomas; Piller, Werner E.			Parascolymia (Scleractinia: Lobophylliidae) in the Central Paratethys Sea (Vienna Basin, Austria) and its possible biogeographic implications	PLOS ONE			English	Article							CARBONATE PLATFORM; LEITHA LIMESTONE; MIOCENE REEFS; OLIGOCENE; CORALS; PACIFIC; EVOLUTION; ATLANTIC; FACIES; TRENDS	Palaeobiogeographical and palaeodiversity patterns of scleractinian reef corals are generally biased due to uncertain taxonomy and a loss of taxonomic characters through dissolution and recrystallization of the skeletal aragonite in shallow marine limestones. Herein, we describe a fossil lobophylliid coral in mouldic preservation from the early middle Miocene Leitha Limestone of the Central Paratethys Sea (Vienna Basin, Austria). By using grey-scale image inversion and silicone rubber casts for the visualization of the original skeletal anatomy and the detection of distinct micromorphological characters (i.e. shape of septal teeth, granulation of septocostae) Parascolymia bracherti has been identified as a new species in spite of the dissolved skeleton. In the recent era, Parascolymia like all Lobophylliidae is restricted to the Indo-Pacific region, where it is represented by a single species. The new species proves the genus also in the Miocene Mediterranean reef coral province. A review of the spatio-temporal relationships of fossil corals related to Parascolymia indicates that the genus was probably rooted in the Eastern Atlantic-Western Tethys region during the Paleocene to Eocene and reached the Indo-Pacific region not before the Oligocene. The revealed palaeobiogeographical pattern shows an obvious congruence with that of Acropora and tridacnine bivalves reflecting a gradual equatorwards retreat of the marine biodiversity center parallel to the Cenozoic climate deterioration.	[Reuter, Markus; Wiedl, Thomas; Piller, Werner E.] Graz Univ, Inst Earth Sci, Graz, Austria	University of Graz	Reuter, M (corresponding author), Graz Univ, Inst Earth Sci, Graz, Austria.	markus.reuter@uni-graz.at			Austrian Science Fund [P 23492-B17]; NAWI Graz Advanced School of Science; Austrian Science Fund (FWF) [P 23492] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); NAWI Graz Advanced School of Science; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work received funding from the Austrian Science Fund (https://www.fwf.ac.at) by grant P 23492-B17 to WEP and the NAWI Graz Advanced School of Science (http://www.nawigraz.at).	Alvarez G., 1994, Courier Forschungsinstitut Senckenberg, V172, P249; BARTA-CALMUS S, 1969, Bulletin du Museum National d'Histoire Naturelle, V41, P817; Barta-Calmus S, 1973, THESIS U PARIS 6; Bellwood D. R., 2012, BIOTIC EVOLUTION ENV, P216, DOI [10.1017/CBO9780511735882.011, DOI 10.1017/CBO9780511735882.011]; Beydoun ZR, 1970, Q J GEOL SOC LOND, V125, P413, DOI DOI 10.1144/GSJGS.125.1.0413; Bosellini FR, 2008, PALAEOGEOGR PALAEOCL, V258, P71, DOI 10.1016/j.palaeo.2007.10.028; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Budd AF, 2009, ACTA ZOOL-STOCKHOLM, V90, P142, DOI 10.1111/j.1463-6395.2008.00345.x; Cahuzac Bruno, 1996, Concepts in Sedimentology and Paleontology, V5, P105; Chaix Christian, 2001, Annales de Paleontologie, V87, P3, DOI 10.1016/S0753-3969(01)88001-0; CHEVALIER JEAN- PIERRE, 1961, MEM SOC GEOL FRANCE, V93, P1; Dai C, 2009, SCLERACTINIA FAUNA T; Dullo W., 1983, FACIES, V8, P1, DOI DOI 10.1007/BF02536740; Duncan PM., 1884, J LINNEAN SOC LONDON, V18, P1, DOI [10.1111/j.1096-3642.1884.tb02013.x, DOI 10.1111/J.1096-3642.1884.TB02013.X]; Esteban Mateu, 1996, Concepts in Sedimentology and Paleontology, V5, P3; Filliozat M., 1915, Bulletin de la Societe des Sciences Naturelles Nantes, V4; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Gerth H., 1933, Wetenschappelijke Mededeelingen, V25, P1; Gerth H, 1923, SAMMLUNGEN GEOLOGISC, V10, P37; Gerth H., 1921, FOSSILIEN JAVA GRUND, P387; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Gregory J.W., 1916, GEOLOGICAL MAGAZINE, V3, P481, DOI 10.1017/s0016756800208297; Hall R., 2012, BIOTIC EVOLUTION ENV, P32, DOI DOI 10.1017/CBO9780511735882.005; Hardenbol J., 1998, MESOZOIC CENOZOIC SE, V60, P3; Harzhauser M, 2008, PALAEONTOLOGY, V51, P199, DOI 10.1111/j.1475-4983.2007.00742.x; Harzhauser M, 2007, ZOOL ANZ, V246, P241, DOI 10.1016/j.jcz.2007.05.001; Harzhauser M, 2007, PALAEONTOGR ABT A, V280, P75, DOI 10.1127/pala/280/2007/75; Harzhauser M, 2014, PALAEONTOGR ABT A, V302, P73; Harzhauser M, 2013, RIV ITAL PALEONTOL S, V119, P351, DOI 10.13130/2039-4942/6044; Harzhauser M, 2009, PALAEONTOGR ABT A, V289, P123; Harzhauser M, 2009, PALAEONTOL Z, V83, P333, DOI 10.1007/s12542-009-0025-5; Helm Carsten, 2003, Palaeontologische Zeitschrift, V77, P77; Hoeksema B, 2014, SCOLYMIA VITIENSIS B; Hoeksema B, 2014, LITHOPHYLLIA M EDWAR; Hoeksema B.W., 2014, WORLD REGISTER MARIN; Hoeksma B, 2014, ACANTHOPHYLLIA WELLS; Kolosvary, 1967, GEOLOGIJA, V10, P205; KOLOSVARY GABOR. A., 1956, FOLDTANI KOZLONY, V86, P67; Kroh A, 2011, ACTA GEOL POL, V61, P419; Kuhn O., 1933, Palaeontographica Stuttgart, V79, P143; KUHN OTHMAR, 1926, JAHRB GEOL BUNDESANST, V76, P65; LATHAM MH, 1929, T ROY SOC EDINBURGH, V56, P273; Maddaleni P., 1997, Gortania Atti del Museo Friulano di Storia Naturale, V19, P61; McCall Joe, 1994, Facies, V31, P141, DOI 10.1007/BF02536938; Milne Edwards H., 1850, MONOGRAPH BRIT FOSSI; Milne-Edwards H., 1848, MONOGRAPHIE ASTEREID, V3, P209; Oosberger R, 1954, N JB GEOL PALAONT AB, V100, P119; Oosterbaan A.F.F., 1990, Contributions to Tertiary and Quaternary Geology, V27, P3; Perrin C, 2012, EARTH-SCI REV, V111, P1, DOI 10.1016/j.earscirev.2011.12.007; PILLAI C S G, 1976, Zoologica (Stuttgart), V43, P1; Piller WE, 2007, STRATIGRAPHY, V4, P151; R/gl F., 1998, ANN NATURHIST MUS A, V99A, P279, DOI DOI 10.2307/41702129; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Reuss von A.E.R., 1871, DENKSCHR K AKAD W MN, V2, P1; Reuter M, 2013, CLIM PAST, V9, P2101, DOI 10.5194/cp-9-2101-2013; Reuter M, 2011, CORAL REEFS, V30, P889, DOI 10.1007/s00338-011-0798-3; Reuter M, 2009, INT J EARTH SCI, V98, P627, DOI 10.1007/s00531-007-0269-9; Reuter M, 2012, PALAEOGEOGR PALAEOCL, V350, P198, DOI 10.1016/j.palaeo.2012.06.032; Reuter M, 2012, PERSPECT PLANT ECOL, V14, P303, DOI 10.1016/j.ppees.2012.03.003; Reuter M, 2008, SEDIMENT GEOL, V212, P12, DOI 10.1016/j.sedgeo.2008.09.001; Riegl B, 2000, PALAIOS, V15, P399, DOI 10.2307/3515512; RIEGL B. M., 2002, P 9 INT COR REEF S B, V1, P211; Rus Monica, 2008, Acta Palaeontologica Romaniae, V6, P325; Schouppe A., 1949, Mitteilungen der Naturwissenschaftlichen Vereins fuer Steiermark, V1949, P142; Schuster F, 1999, INT J EARTH SCI, V88, P571, DOI 10.1007/s005310050285; Stolarski J, 2001, J PALEONTOL, V75, P1090, DOI 10.1666/0022-3360(2001)075<1090:TANSOE>2.0.CO;2; Tomascik T, 1997, ECOLOGY INDONESIAN S; UMBGROVE J. H. F., 1926, WETENSCHAPPELIJKE MEDEDEEL, VNo. 4, P25; Umbgrove JHF, 1945, P R SOC AMSTERDAM, V48, P244; Veron J.E.N., 1988, Memoir of the Association of Australasian Palaeontologists, V6, P1; VERON JEN, 1995, CORALS SPACE TIME BI; Veron JEN, 2000, CORALS WORLD, V3; Veron J, 2013, ZOOL J LINN SOC-LOND, V169, P485, DOI 10.1111/zoj.12076; Wallace CC, 2008, J PALEONTOL, V82, P313, DOI 10.1666/06-091.1; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; Wells J. W., 1964, Zoologische Mededeelingen Leiden, V39, P375; Wells J. W., 1956, pf328; White C.H., 2008, P 11 INT COR REEF S, P7; Wiedl T, 2013, PALAEOGEOGR PALAEOCL, V370, P232, DOI 10.1016/j.palaeo.2012.12.015; Wiedl T, 2012, FACIES, V58, P523, DOI 10.1007/s10347-011-0290-0; Wilson Moyra E. J., 1998, P165; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	85	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132243	10.1371/journal.pone.0132243	http://dx.doi.org/10.1371/journal.pone.0132243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201071	Green Submitted, Green Published, gold			2022-12-26	WOS:000358597100032
J	Ho, SR; Lee, YJ; Lin, WC				Ho, Shiuh-Rong; Lee, Yu-Ju; Lin, Weei-Chin			Regulation of RNF144A E3 Ubiquitin Ligase Activity by Self-association through Its Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING-FINGER PROTEIN; JUVENILE PARKINSONISM; LINEAR UBIQUITINATION; MUTATIONAL LANDSCAPE; ANTIVIRAL RESPONSE; IMMUNE-SYSTEM; GXXXG MOTIF; ACTIVATION; APOPTOSIS; FAMILY	RNF144A, an E3 ubiquitin ligase for DNA-dependent protein kinase catalytic subunit (DNA-PKcs), can promote DNA damage-induced cell apoptosis. Here we characterize an important regulation of RNF144A through its transmembrane (TM) domain. The TM domain of RNF144A is highly conserved among species. Deletion of the TM domain abolishes its membrane localization and also significantly reduces its ubiquitin ligase activity. Further evidence shows that the TM domain is required for RNF144A self-association and that the self-association may be partially mediated through a classic GXXXG interaction motif. A mutant RNF144A-G252L/G256L (in the G252XXXG256 motif) preserves membrane localization but is defective in self-association and ubiquitin ligase activity. On the other hand, a membrane localization loss mutant of RNF144A still retains self-association and E3 ligase activity, which can be blocked by additional G252L/G256L mutations. Therefore, our data demonstrate that the TM domain of RNF144A has at least two independent roles, membrane localization and E3 ligase activation, to regulate its physiological function. This regulatory mechanism may be applicable to other RBR (RING1-IBRRING2) E3 ubiquitin ligases because, first, RNF144B also self-associates. Second, all five TM-containing RBR E3 ligases, including RNF144A and RNF144B, RNF19A/Dorfin, RNF19B, and RNF217, have the RBR-TM(GXXXG) superstructure. Mutations of the GXXXG motifs in RNF144A and RNF217 have also be found in human cancers, including a G252D mutation of RNF144A. Interestingly, RNF144A-G252D still preserves self-association and ubiquitin ligase activity but loses membrane localization and is turned over rapidly. In conclusion, both proper membrane localization and self-association are important for RNF144A function.	[Ho, Shiuh-Rong; Lin, Weei-Chin] Baylor Coll Med, Dept Med, Hematol Oncol Sect, Houston, TX 77030 USA; [Lee, Yu-Ju; Lin, Weei-Chin] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lin, WC (corresponding author), One Baylor Plaza,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.edu	Regan, Clinton/E-6250-2012; HO, SHIUH-RONG/M-4728-2019	HO, SHIUH-RONG/0000-0002-9612-722X	National Institutes of Health [R01CA100857, R01CA138641]; Department of Defense [W81XWH-14-1-0339, W81XWH-14-1-0306]; Howard Hughes Medical Institute through the Med into Grad Initiative;  [T32DK60445]; NATIONAL CANCER INSTITUTE [T32CA174647, R01CA100857, R01CA138641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Howard Hughes Medical Institute through the Med into Grad Initiative(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA100857 and R01CA138641. This work was also supported by Department of Defense Grants W81XWH-14-1-0339 and W81XWH-14-1-0306. The authors declare that they have no conflicts of interest with the contents of this article.; S. R. H. was supported by T32 Fellowship T32DK60445.; Y. J. L. is in the Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, which was supported, in part, by a grant from the Howard Hughes Medical Institute through the Med into Grad Initiative.	Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chong IY, 2013, J PATHOL, V231, P301, DOI 10.1002/path.4247; Conforti F, 2013, ONCOGENE, V32, P4758, DOI 10.1038/onc.2012.497; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Du W, 2010, J BIOL CHEM, V285, P37436, DOI 10.1074/jbc.M110.113209; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho SR, 2014, P NATL ACAD SCI USA, V111, pE2646, DOI 10.1073/pnas.1323107111; Huang J, 2006, FEBS LETT, V580, P940, DOI 10.1016/j.febslet.2005.09.105; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Lin AE, 2013, NAT IMMUNOL, V14, P27, DOI 10.1038/ni.2478; Liu K, 2013, MOL CELL BIOL, V33, P4685, DOI 10.1128/MCB.00373-13; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Matsumine H, 1997, AM J HUM GENET, V60, P588; Nakamura N, 2011, MEMBRANES-BASEL, V1, P354, DOI 10.3390/membranes1040354; Ng CC, 2003, ONCOGENE, V22, P4449, DOI 10.1038/sj.onc.1206586; Niwa J, 2001, BIOCHEM BIOPH RES CO, V281, P706, DOI 10.1006/bbrc.2001.4414; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Polgar O, 2004, BIOCHEMISTRY-US, V43, P9448, DOI 10.1021/bi0497953; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Smit JJ, 2014, EMBO REP, V15, P142, DOI 10.1002/embr.201338166; Sparr E, 2005, J BIOL CHEM, V280, P39324, DOI 10.1074/jbc.M502810200; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Taebunpakul P, 2012, APOPTOSIS, V17, P762, DOI 10.1007/s10495-012-0720-7; Wang YY, 2012, CELL HOST MICROBE, V12, P129, DOI 10.1016/j.chom.2012.07.006	37	18	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23026	23038		10.1074/jbc.M115.645499	http://dx.doi.org/10.1074/jbc.M115.645499			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26216882	Green Published, hybrid			2022-12-26	WOS:000361685500017
J	Johnson, AC; Nagle, KJ; Tremble, SM; Cipolla, MJ				Johnson, Abbie Chapman; Nagle, Keith J.; Tremble, Sarah M.; Cipolla, Marilyn J.			The Contribution of Normal Pregnancy to Eclampsia	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GABA(A) RECEPTORS; OVARIAN CYCLE; PREECLAMPSIA; EXCITABILITY; AUTOREGULATION; PLASTICITY; RELEVANCE; CHILDREN; FLOW	Eclampsia, clinically defined as unexplained seizure in a woman with preeclampsia, is a life threatening complication unique to the pregnant state. However, a subpopulation of women with seemingly uncomplicated pregnancies experience de novo seizure without preeclamptic signs or symptoms, suggesting pregnancy alone may predispose the brain to seizure. Here, we hypothesized that normal pregnancy lowers seizure threshold and investigated mechanisms by which pregnancy may affect seizure susceptibility, including neuroinflammation and plasticity of gamma-aminobutyric acid type A receptor (GABA(A)R) subunit expression. Seizure threshold was determined by quantifying the amount of pentylenetetrazole (PTZ) required to elicit electrical seizure in Sprague Dawley rats that were either nonpregnant (Nonpreg, n = 7) or pregnant (Preg; d20, n = 6). Seizure-induced vasogenic edema was also measured. Further, activation of microglia, a measure of neuroinflammation (n = 6-8/group), and GABA(A)R delta- and gamma 2-subunit protein expression in the cerebral cortex and hippocampus (n = 6/group) was determined. Seizure threshold was lower in Preg compared to Nonpreg rats (36.7 +/- 9.6 vs. 65.0 +/- 14.5 mg/kg PTZ; p<0.01) that was associated with greater vasogenic edema formation (78.55 +/- 0.11 vs. 78.04 +/- 0.19% water; p<0.05). The % of active microglia was similar between groups; however, pregnancy was associated with downregulation of cortical GABA(A)R-delta and hippocampal GABA(A)R-gamma 2 expression. Overall, pregnancy appears to be a state of increased seizure susceptibility that is not due to neuroinflammation, but rather is associated with reduced expression of GABA(A)R subunits and greater edema. Understanding neurophysiological changes occurring in normal pregnancy could allow for better prevention and management of de novo seizure, including pathologic states such as eclampsia.	[Johnson, Abbie Chapman; Nagle, Keith J.; Tremble, Sarah M.; Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Obstet Gynecol & Reprod Sci, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Cipolla, MJ (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	Marilyn.Cipolla@uvm.edu			National Institutes of Health, National Institute of Neurologic Disorders and Stroke [RO1 NS045940]; National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement [RO1 NS 045940-06S1]; American Heart Association [14PRE18590005]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045940] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, National Institute of Neurologic Disorders and Stroke grant RO1 NS045940 to MJC (URL: http://www.ninds.nih.gov/); National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement RO1 NS 045940-06S1 to MJC (URL: http://www.ninds.nih.gov/); and the American Heart Association Fellowship 14PRE18590005 to ACJ (URL: http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos E, 2014, BJOG-INT J OBSTET GY, V121, P14, DOI 10.1111/1471-0528.12629; Aukes AM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.033; Aukes AM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.044; Biggio G, 2009, INT REV NEUROBIOL, V85, P73, DOI 10.1016/S0074-7742(09)85006-X; Brewer J, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.015; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; Cipolla MJ, 2012, HYPERTENSION, V60, P705, DOI 10.1161/HYPERTENSIONAHA.112.198952; Cipolla MJ, 2012, EXP NEUROL, V234, P398, DOI 10.1016/j.expneurol.2012.01.005; Cipolla MJ, 2011, J APPL PHYSIOL, V110, P329, DOI 10.1152/japplphysiol.01159.2010; Cipolla MJ, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000196948.15019.28; Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8; Donaldson J O, 1994, Adv Neurol, V64, P25; DONALDSON JO, 1994, HYPERTENS PREGNANCY, V13, P115, DOI 10.3109/10641959409009565; Donaldson JO, 1989, NEUROLOGY PREGNANCY, P269; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Euser AG, 2007, HYPERTENSION, V49, P334, DOI 10.1161/01.HYP.0000255791.54655.29; Herd MB, 2007, PHARMACOL THERAPEUT, V116, P20, DOI 10.1016/j.pharmthera.2007.03.007; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Johnson AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113670; Kanayama N, 1997, J HYPERTENS, V15, P383, DOI 10.1097/00004872-199715040-00009; Katz VL, 2000, AM J OBSTET GYNECOL, V182, P1389, DOI 10.1067/mob.2000.106178; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Maguire Jamie, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS84, DOI 10.1016/j.psyneuen.2009.06.019; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Olson DM, 2001, PEDIATRICS, V108, P163, DOI 10.1542/peds.108.1.163; Oztas B, 2003, PROG NEURO-PSYCHOPH, V27, P701, DOI 10.1016/S0278-5846(03)00084-8; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rich-Edwards JW, 2014, CHESLEYS HYPERTENSIV; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; SCHWARTZ RB, 1992, AM J ROENTGENOL, V159, P379, DOI 10.2214/ajr.159.2.1632361; SIBAI BM, 1990, AM J OBSTET GYNECOL, V163, P1049, DOI 10.1016/0002-9378(90)91123-T; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Thoresen M, 1997, ELECTROEN CLIN NEURO, V102, P152, DOI 10.1016/S0921-884X(96)96509-1; Zeeman GG, 2004, AM J OBSTET GYNECOL, V190, P714, DOI 10.1016/j.ajog.2003.09.015	42	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133953	10.1371/journal.pone.0133953	http://dx.doi.org/10.1371/journal.pone.0133953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218425	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900059
J	Julian, MW; Strange, HR; Ballinger, MN; Hotchkiss, RS; Papenfuss, TL; Crouser, ED				Julian, Mark W.; Strange, Heather R.; Ballinger, Megan N.; Hotchkiss, Richard S.; Papenfuss, Tracey L.; Crouser, Elliott D.			Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and-9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes	PLOS ONE			English	Article							HUMANS IN-VIVO; DENDRITIC CELLS; ENDOTOXIN TOLERANCE; IMMUNE-SYSTEM; SEPTIC SHOCK; T-CELLS; CPG-DNA; MYCOBACTERIUM-TUBERCULOSIS; TLR2-MEDIATED TOLERANCE; PROGRAMMED DEATH-1	Objective Immune suppression during critical illness predisposes to serious infections. We sought to determine the mechanisms regulating tolerance and cross-tolerance to common pro-inflammatory danger signals in a model that recapitulates the intact in vivo immune response. Materials and Methods Flt3-expanded splenocytes obtained from wild-type or matching IRAK-M knockout (IRAK-M-/-), C57BL/6, male mice (8-10 weeks old) were treated repeatedly or alternately with either LPS or CpGA DNA, agonists of Toll-like receptor (TLR)-4 and -9, respectively, over successive 24-hour periods. Supernatants were collected following each 24-hour period with cytokine release (ELISA) and splenocyte IRAK-M expression (Western blot) determined. Tolerance and cross-tolerance were assessed in the absence or presence of programmed death receptor (PD)-1 blocking antibody or IL-7 pre-treatment. Main Results Splenocytes notably exhibited both tolerance and cross-tolerance to subsequent treatments with either LPS or CpGA DNA. The character of tolerance and cross-tolerance in this model was distinct following initial LPS or CpGA treatment in that TNF alpha and IFN gamma release (not IL-10) were suppressed following LPS; whereas, initial CpGA treatment suppressed TNF alpha, IFN gamma and IL-10 release in response to subsequent stimulation (LPS or CpGA). Tolerance and cross-tolerance were unrelated to IL-10 release or PD-1 but were attenuated in IRAK-M-/-splenocytes. IL-7 significantly suppressed IRAK-M expression and restored TNF alpha and IFN gamma production without influencing IL-10 release. Conclusions In summary, acute immune tolerance and cross-tolerance in response to LPS or CpGA were distinct in that LPS selectively suppressed pro-inflammatory cytokine responses; whereas, CpGA suppressed both pro- and anti-inflammatory responses. The induction of tolerance and cross-tolerance in response to common danger signals was mechanistically unrelated to IL-10 or PD-1 but was directly influenced by IRAK-M expression. IL-7 reduced IRAK-M expression and attenuated immune tolerance induced by either LPS or CpGA, and thus may be useful for reversal of immune tolerance in the setting of critical illness.	[Julian, Mark W.; Ballinger, Megan N.; Crouser, Elliott D.] Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Strange, Heather R.; Papenfuss, Tracey L.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, Dept Med, St Louis, MO USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Washington University (WUSTL); Washington University (WUSTL)	Crouser, ED (corresponding author), Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	Elliott.Crouser@osumc.edu	Crouser, Elliott/ABC-2602-2021; Crouser, Elliott/E-2933-2011	Ballinger, Megan/0000-0002-2202-3049	National Institutes of Health [R21-AI083912, RO3-AI62740]; DHLRI Davis Developmental Grant; Wexner Medical Center at The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083912, R03AI062740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHLRI Davis Developmental Grant; Wexner Medical Center at The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by National Institutes of Health R21-AI083912 (EDC), National Institutes of Health RO3-AI62740 (EDC), and DHLRI Davis Developmental Grant, Wexner Medical Center at The Ohio State University (EDC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Ballinger MN, 2012, J IMMUNOL, V189, P356, DOI 10.4049/jimmunol.1103124; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; Boomer JS, 2014, VIRULENCE, V5, P45, DOI [10.4161/viru.26516, 10.4161/viru.27794]; Castegren M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053221; Chang K, 2014, CRIT CARE, V18, DOI 10.1186/cc13176; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cho HY, 2009, IMMUNOL LETT, V127, P39, DOI 10.1016/j.imlet.2009.08.011; Cook CH, 2007, J INFECT DIS, V196, P1273, DOI 10.1086/522433; Dalpke AH, 2005, IMMUNOLOGY, V116, P203, DOI 10.1111/j.1365-2567.2005.02211.x; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Dolgachev VA, 2012, J TRAUMA ACUTE CARE, V72, P614, DOI 10.1097/TA.0b013e318243d9b1; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Faust SM, 2013, J CLIN INVEST, V123, P2994, DOI 10.1172/JCI68205; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Guillerey C, 2012, BLOOD, V120, P90, DOI 10.1182/blood-2012-02-410936; Heagy W, 2000, SHOCK, V14, P271, DOI 10.1097/00024382-200014030-00005; Heagy Wyrta, 2003, Surg Infect (Larchmt), V4, P171, DOI 10.1089/109629603766956960; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hutchins NIA, 2014, TRENDS MOL MED, V20, P224, DOI 10.1016/j.molmed.2014.01.002; Ilyinskii PO, 2006, J VIROL, V80, P7146, DOI 10.1128/JVI.02745-05; Iversen AC, 2009, J IMMUNOL, V182, P5672, DOI 10.4049/jimmunol.0801268; Jiang HR, 2002, J LEUKOCYTE BIOL, V72, P978; Julian MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072354; Julian MW, 2012, J IMMUNOL, V189, P433, DOI 10.4049/jimmunol.1101375; Kawasaki T, 2001, ANESTH ANALG, V92, P1322; Kim YI, 2008, J BIOL CHEM, V283, P15258, DOI 10.1074/jbc.M709549200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi T, 2012, J IMMUNOL, V189, P1792, DOI 10.4049/jimmunol.1200042; Koenen P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2719; KROEMER G, 1993, ADV IMMUNOL, V53, P157, DOI 10.1016/S0065-2776(08)60500-3; Lee N, 2013, INFLUENZA OTHER RESP, V7, P666, DOI 10.1111/irv.12109; Leentjens J, 2013, AM J RESP CRIT CARE, V187, P1287, DOI 10.1164/rccm.201301-0036CP; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Li LQ, 2000, SCAND J IMMUNOL, V51, P361; Liu ZJ, 2008, J SURG RES, V150, P34, DOI 10.1016/j.jss.2007.12.759; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Mach N, 2000, CANCER RES, V60, P3239; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; Miller ML, 2014, P NATL ACAD SCI USA, V111, P7397, DOI 10.1073/pnas.1315398111; Nahid MA, 2013, J IMMUNOL, V190, P1250, DOI 10.4049/jimmunol.1103060; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nalos M, 2012, AM J RESP CRIT CARE, V185, P110, DOI 10.1164/ajrccm.185.1.110; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Papenfuss TL, 2007, J LEUKOCYTE BIOL, V82, P1510, DOI 10.1189/jlb.0406257; Parra M, 2009, CLIN VACCINE IMMUNOL, V16, P1025, DOI 10.1128/CVI.00067-09; Perona-Wright G, 2006, EUR J IMMUNOL, V36, P2367, DOI 10.1002/eji.200535722; Rixen D, 1996, J TRAUMA, V41, P581, DOI 10.1097/00005373-199610000-00001; Shindo Y, 2015, SHOCK, V43, P334, DOI 10.1097/SHK.0000000000000317; Sieben M, 2013, INT J CANCER, V132, P2548, DOI 10.1002/ijc.27938; Sly LM, 2004, IMMUNITY, P21; Souza-Fonseca-Guimaraes F, 2012, J IMMUNOL, V188, P5850, DOI 10.4049/jimmunol.1103616; Techasaensiri B, 2010, PEDIATR INFECT DIS J, V29, P519, DOI 10.1097/INF.0b013e3181cdafc2; Torcia MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039853; Turner DJ, 2002, MICROBIOL-SGM, V148, P2929, DOI 10.1099/00221287-148-10-2929; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Weijer S, 2002, J INFECT DIS, V186, P1748, DOI 10.1086/345675; Wurzel DF, 2014, CLIN INFECT DIS, V59, P34, DOI 10.1093/cid/ciu225; Xiong YB, 2013, J LEUKOCYTE BIOL, V94, P291, DOI 10.1189/jlb.0812401; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Yeo SJ, 2003, J IMMUNOL, V170, P1052, DOI 10.4049/jimmunol.170.2.1052; Yue SC, 2010, J IMMUNOL, V184, P268, DOI 10.4049/jimmunol.0800924; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354; Zhou F, 2012, EUR J IMMUNOL, V42, P1449, DOI 10.1002/eji.201141733; Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	72	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132921	10.1371/journal.pone.0132921	http://dx.doi.org/10.1371/journal.pone.0132921			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218271	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900014
J	Koffman, JS; Arnspang, EC; Marlar, S; Nejsum, LN				Koffman, Jennifer S.; Arnspang, Eva C.; Marlar, Saw; Nejsum, Lene N.			Opposing Effects of cAMP and T259 Phosphorylation on Plasma Membrane Diffusion of the Water Channel Aquaporin-5 in Madin-Darby Canine Kidney Cells	PLOS ONE			English	Article							ACINAR-CELLS; TRAFFICKING; SALIVARY; TRANSLOCATION; LOCALIZATION; PERMEABILITY; ENDOCYTOSIS; INHIBITION; EXPRESSION; SECRETION	Aquaporin-5 (AQP5) facilitates passive water transport in glandular epithelia in response to secretory stimuli via intracellular pathways involving calcium release, cAMP and protein kinase A (PKA). In epithelial plasma membranes, AQP5 may be acutely regulated to facilitate water transport in response to physiological stimuli by changes in protein modifications, interactions with proteins and lipids, nanoscale membrane domain organization, and turnover rates. Such regulatory mechanisms could potentially be associated with alteration of diffusion behavior, possibly resulting in a change in the plasma membrane diffusion coefficient of AQP5. We aimed to test the short-term regulatory effects of the above pathways, by measuring lateral diffusion of AQP5 and an AQP5 phospho-mutant, T259A, using k-space Image Correlation Spectroscopy of quantum dot-and EGFP-labeled AQP5. Elevated cAMP and PKA inhibition significantly decreased lateral diffusion of AQP5, whereas T259A mutation showed opposing effects; slowing diffusion without stimulation and increasing diffusion to basal levels after cAMP elevation. Thus, lateral diffusion of AQP5 is significantly regulated by cAMP, PKA, and T259 phosphorylation, which could be important for regulating water flow in glandular secretions.	[Nejsum, Lene N.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; Aarhus Univ, Interdisciplinary Nanosci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University	Nejsum, LN (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	nejsum@mbg.au.dk	Arnspang, Eva C/Y-1132-2018	Arnspang, Eva C/0000-0002-3095-4070; Nejsum, Lene Niemann/0000-0003-4368-8821	Graduate School of Science and Technology (GSST), AU; Lundbeck Junior Group Leader Fellowship from the Lundbeck Foundation	Graduate School of Science and Technology (GSST), AU; Lundbeck Junior Group Leader Fellowship from the Lundbeck Foundation	This work was supported by a Lundbeck Junior Group Leader Fellowship to LNN from the Lundbeck Foundation (http://www. lundbeckfoundation.com/). Additionally, this work was funded by the Graduate School of Science and Technology (GSST), AU, to JSK and SM (http://talent.au.dk/phd/scienceandtechnology/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnspang EC, 2014, JOVE-J VIS EXP, DOI 10.3791/51074; BAUM BJ, 1993, ANN NY ACAD SCI, V694, P17; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Delporte C, 1996, J BIOL CHEM, V271, P22070, DOI 10.1074/jbc.271.36.22070; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Ganguly S, 2008, BIOPHYS J, V95, P451, DOI 10.1529/biophysj.107.125732; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Gresz V, 2004, AM J PHYSIOL-GASTR L, V287, pG151, DOI 10.1152/ajpgi.00480.2003; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Hasegawa T, 2011, AM J PHYSIOL-CELL PH, V301, pC667, DOI 10.1152/ajpcell.00058.2011; He XJ, 1997, PFLUG ARCH EUR J PHY, V433, P260; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Inoue R, 2013, J DERMATOL SCI, V70, P26, DOI 10.1016/j.jdermsci.2013.01.013; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V265, P94, DOI 10.1006/bbrc.1999.1630; Ishikawa Y, 2000, FEBS LETT, V477, P253, DOI 10.1016/S0014-5793(00)01763-4; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Ishikawa Y, 1998, BIOCHEM BIOPH RES CO, V245, P835, DOI 10.1006/bbrc.1998.8395; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kolin DL, 2006, BIOPHYS J, V91, P3061, DOI 10.1529/biophysj.106.082768; Kosugi-Tanaka C, 2006, BBA-MOL CELL RES, V1763, P337, DOI 10.1016/j.bbamcr.2006.02.005; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Kusumi A, 2014, NAT CHEM BIOL, V10, P524, DOI [10.1038/NCHEMBIO.1558, 10.1038/nchembio.1558]; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Marlar S, 2014, BBA-BIOMEMBRANES, V1838, P2404, DOI 10.1016/j.bbamem.2014.06.005; Marlar S, 2014, AM J PHYSIOL-CELL PH, V306, pC598, DOI 10.1152/ajpcell.00132.2013; Moeller HB, 2014, J CELL SCI, V127, P3174, DOI 10.1242/jcs.150680; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Song YL, 2002, J PHYSIOL-LONDON, V541, P561, DOI 10.1113/jphysiol.2001.020180; Song YL, 2001, J BIOL CHEM, V276, P41288, DOI 10.1074/jbc.M107257200; Tada J, 1999, BIOCHEM BIOPH RES CO, V266, P443, DOI 10.1006/bbrc.1999.1828; Tham DKL, 2011, AM J PHYSIOL-RENAL, V301, pF396, DOI 10.1152/ajprenal.00315.2010; Umenishi F, 2000, BIOPHYS J, V78, P1024, DOI 10.1016/S0006-3495(00)76661-6; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Wellner RB, 2001, BIOCHEM BIOPH RES CO, V285, P1253, DOI 10.1006/bbrc.2001.5287; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Woo J, 2008, BIOCHEM BIOPH RES CO, V366, P321, DOI 10.1016/j.bbrc.2007.11.078; Yang F, 2003, J BIOL CHEM, V278, P32173, DOI 10.1074/jbc.M305149200; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200	51	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133324	10.1371/journal.pone.0133324	http://dx.doi.org/10.1371/journal.pone.0133324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218429	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900027
J	Chatziandreou, I; Tsioli, P; Sakellariou, S; Mourkioti, I; Giannopoulou, I; Levidou, G; Korkolopoulou, P; Patsouris, E; Saetta, AA				Chatziandreou, Ilenia; Tsioli, Panagiota; Sakellariou, Stratigoula; Mourkioti, Ioanna; Giannopoulou, Ioanna; Levidou, Georgia; Korkolopoulou, Penelope; Patsouris, Efstratios; Saetta, Angelica A.			Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations	PLOS ONE			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; KRAS MUTATIONS; ACTIVATING MUTATIONS; CLINICAL-FEATURES; EGFR MUTATIONS; MET; BRAF; INHIBITORS	Background Selection of NSCLC patients for targeted therapy is currently based upon the presence of sensitizing mutations in EGFR and EML4/ALK translocations. The heterogeneity of molecular alterations in lung cancer has led to the ongoing discovery of potential biomarkers and targets in order to improve survival. Aim This study aimed to detect alterations in EGFR, KRAS, BRAF, PIK3CA, MET-gene copy number and ALK rearrangements in a large cohort of 956 NSCLC patients of Hellenic origin using highly sensitive techniques and correlations with clinicopathological characteristics. Results Mutations were detected in EGFR 10.6%(101 out of 956 samples), KRAS 26.5% (191 out of 720 samples), BRAF 2.5% (12 out of 471 samples), PIK3CA 3.8% (7 out of 184 samples), MET gene amplification was detected in 18% (31 out of 170) and ALK rearrangements in 3.7% (4 out of 107 samples). EGFR mutations were detected in exon 19 (61.4% of mutant cases), exon 21 p.Leu858Arg (19.8%), exon 20 (15.8%), exon 18 (2.9%) and were correlated with gender histology, smoking status and TTF1 staining. p.Thr790Met mutant cases (3.9%) displayed concurrent mutations in exons 19 or 21. Negative TTF-1 staining showed strong negative predictive value for the presence of EGFR mutations. KRAS mutations were associated with histology, the most common mutation being p.Gly12Cys (38%). Discussion In conclusion, only 89 patients were eligible for EGFR-TKIs and ALK inhibitors therapy, whereas 257 patients showed other alterations, highlighting the necessity for a detailed molecular profiling potentially leading to more efficient individualized therapies for NSCLC patients.	[Chatziandreou, Ilenia; Tsioli, Panagiota; Sakellariou, Stratigoula; Mourkioti, Ioanna; Giannopoulou, Ioanna; Levidou, Georgia; Korkolopoulou, Penelope; Patsouris, Efstratios; Saetta, Angelica A.] Univ Athens, Sch Med, Dept Pathol 1, Laikon Gen Hosp, GR-11527 Athens, Greece	Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens	Chatziandreou, I (corresponding author), Univ Athens, Sch Med, Dept Pathol 1, Laikon Gen Hosp, GR-11527 Athens, Greece.	hchatzian@med.uoa.gr		CHATZIANDREOU, ILENIA/0000-0002-4940-5581; Saetta, Angelica A./0000-0002-4862-3413				Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Cai YR, 2011, ONCOL LETT, V2, P257, DOI 10.3892/ol.2010.229; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Cardarella S, 2013, CLIN CANCER RES, V19, P4532, DOI 10.1158/1078-0432.CCR-13-0657; Cardarella S, 2012, J THORAC ONCOL, V7, P1767, DOI 10.1097/JTO.0b013e3182745bcb; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Cheng Liang, 2012, Chinese Journal of Pathology, V41, P715, DOI 10.3760/cma.j.issn.0529-5807.2012.10.019; Cortes-Funes H, 2005, ANN ONCOL, V16, P1081, DOI 10.1093/annonc/mdi221; Carpeno JD, 2013, TRANSL LUNG CANCER R, V2, P142, DOI 10.3978/j.issn.2218-6751.2013.02.07; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dimou Anastasios, 2011, Patholog Res Int, V2011, P312346, DOI 10.4061/2011/312346; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Garassino MC, 2011, ANN ONCOL, V22, P235, DOI 10.1093/annonc/mdq680; Go H, 2010, J THORAC ONCOL, V5, P305, DOI 10.1097/JTO.0b013e3181ce3d1d; Gruber K, 2015, J THORAC ONCOL, V10, P713, DOI 10.1097/JTO.0000000000000427; Han CB, 2012, CANCER LETT, V314, P63, DOI 10.1016/j.canlet.2011.09.012; Hantson Inge, 2014, Transl Respir Med, V2, P9, DOI 10.1186/s40247-014-0009-0; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Herreros-Villanueva M, 2011, MOL BIOL REP, V38, P1315, DOI 10.1007/s11033-010-0232-x; Hirsch FR, 2013, J THORAC ONCOL, V8, P373, DOI 10.1097/JTO.0b013e31827ed0ff; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Korkolopoulou P, 2012, BJU INT, V110, pE1237, DOI 10.1111/j.1464-410X.2012.11569.x; Kubo T, 2009, INT J CANCER, V124, P1778, DOI 10.1002/ijc.24150; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Langer C, 2011, PHARMACOL THERAPEUT, P36; Leary AF, 2012, EUR J CANCER, V48, P61, DOI 10.1016/j.ejca.2011.09.022; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Levidou G, 2012, WORLD JOURNAL OF SUR, P47, DOI [10.1186/PREACCEPT-1032136556616351, DOI 10.1186/PREACCEPT-1032136556616351]; Li CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107276; Li S, 2014, BRIT J CANCER, V110, P2812, DOI 10.1038/bjc.2014.210; Li YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054369, 10.1371/journal.pone.0055108, 10.1371/journal.pone.0062036, 10.1371/journal.pone.0052093, 10.1371/journal.pone.0063648, 10.1371/journal.pone.0066567, 10.1371/journal.pone.0077685, 10.1371/journal.pone.0071994]; Ludovini V, 2012, CANCER CHEMOTH PHARM, V69, P1289, DOI 10.1007/s00280-012-1829-7; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Sanchez-Torres JM, 2013, TRANSL LUNG CANCER R, V2, P244, DOI 10.3978/j.issn.2218-6751.2013.04.01; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Munfus-McCray D, 2011, HUM PATHOL, V42, P1447, DOI 10.1016/j.humpath.2010.12.011; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Okuda K, 2008, CANCER SCI, V99, P2280, DOI 10.1111/j.1349-7006.2008.00916.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Reungwetwattana T, 2012, CLIN LUNG CANCER, V13, P252, DOI 10.1016/j.cllc.2011.09.004; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Roberts PJ, 2010, J CLIN ONCOL, V28, P4769, DOI 10.1200/JCO.2009.27.4365; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Serizawa M, 2014, CANCER-AM CANCER SOC, V120, P1471, DOI 10.1002/cncr.28604; Shan L, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-3; Shaw AT, 2011, J NATL COMPR CANC NE, V9, P1335, DOI 10.6004/jnccn.2011.0115; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soria JC, 2012, CANCER TREAT REV, V38, P416, DOI 10.1016/j.ctrv.2011.10.003; Sun PL, 2012, J THORAC ONCOL, V7, P323, DOI 10.1097/JTO.0b013e3182381515; Tasioudi KE, 2012, PATHOL RES PRACT, V208, P398, DOI 10.1016/j.prp.2012.05.009; Thunnissen E, 2012, VIRCHOWS ARCH, V461, P245, DOI 10.1007/s00428-012-1281-4; Vincenten J, 2012, J THORAC ONCOL, V7, P1522, DOI 10.1097/JTO.0b013e3182635a91; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110617; Wu JY, 2011, MEDICINE, V90, P159, DOI 10.1097/MD.0b013e31821a16f4; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zhang Xiaozhu, 2008, Int J Med Sci, V5, P209; Zhao FZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117333	74	23	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133859	10.1371/journal.pone.0133859	http://dx.doi.org/10.1371/journal.pone.0133859			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208325	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000157
J	Chen, XQ; Lin, ZH; Xue, M; Si, JM; Chen, SJ				Chen, Xueqin; Lin, Zhenghua; Xue, Meng; Si, Jianmin; Chen, Shujie			Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ABERRANT METHYLATION; GENE-EXPRESSION; SERUM; MARKERS	Gastric cancer (GC) remains one of the most common digestive cancers worldwide; however, most patients present at an advanced stage at initial diagnosis. Zic1 is a novel candidate tumor suppressor gene that is epigenetically silenced in GC. In this study, we investigated Zic1 promoter methylation in plasma DNA as a novel molecular marker for the early diagnosis and monitoring of GC. Methylation-specific polymerase chain reaction (MSP) assay was performed to detect Zic1 promoter methylation in plasma DNA from 20 healthy subjects, 50 gastric intraepithelial neoplasia patients, and 104 GC patients. The Zic1 promoter methylation rate in the plasma samples from the healthy control group was 0%, but it reached 54.0% in the intraepithelial neoplasia group and 60.6% in the GC group. The latter two values were significantly higher than that found in the healthy control group (p < 0.05), with a 100% specificity for intraepithelial neoplasia and GC diagnosis. The positive predictive value of plasma Zic1 promoter methylation for the diagnosis of intraepithelial neoplasia and GC was 100%. Methylation status in the GC group was not significantly associated with tumor size, tumor differentiation, lymph node metastasis, TNM staging, or tumor invasion (p > 0.05). Assessment of the significance of detection of the carcino-embryonic antigen (CEA) level and Zic1 promoter methylation rate for GC diagnosis revealed that the sensitivity of Zic1 promoter methylation was significantly higher than that of the CEA level as a marker and that the combined measurement of these two indices (parallel testing) improved sensitivity. Taken together, our results suggest that the Zic1 promoter methylation rate in plasma-derived DNA is of great significance for the early screening of GC and monitoring of tumorigenesis. Zic1 promoter methylation may serve as a novel non-invasive plasma biomarker for the early detection of GC and for risk assessment in high-risk populations. The combined measurement of the Zic1 promoter methylation rate and CEA level (parallel testing) may enhance the current guidelines for the early diagnosis of GC.	[Chen, Xueqin; Lin, Zhenghua; Xue, Meng; Si, Jianmin; Chen, Shujie] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Xueqin; Lin, Zhenghua; Xue, Meng; Si, Jianmin; Chen, Shujie] Zhejiang Univ, Inst Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, SJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	chensj77@hotmail.com			National Natural Science Foundation of China [81302070, 81372623]; Zhejiang Provincial Medical and health general research plan [2014KYB121]; Zhejiang Provincial Department of Education research plan [Y201327398]; Zhejiang province key science and technology innovation team [2013TD13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Medical and health general research plan; Zhejiang Provincial Department of Education research plan; Zhejiang province key science and technology innovation team	This work was funded by the National Natural Science Foundation of China (81302070, 81372623) (http://www.nsfc.gov.cn), Zhejiang Provincial Medical and health general research plan (2014KYB121) (http://www.zjwst.gov.cn/), Zhejiang Provincial Department of Education research plan (Y201327398) (http://www.zjedu.gov.cn), and Zhejiang province key science and technology innovation team (2013TD13) (http://www.zjkjt.gov.cn/). The funder Shujie Chen conceived and designed the experiments for this manuscript.	Brill E, 2010, CANCER RES, V70, P6891, DOI 10.1158/0008-5472.CAN-10-0745; Chen L, 2012, DIS MARKERS, V32, P195, DOI [10.1155/2012/473251, 10.3233/DMA-2011-0877]; Fock KM, 2014, ALIMENT PHARM THER, V40, P250, DOI 10.1111/apt.12814; Harder J, 2006, Praxis (Bern 1994), V95, P1021; Ichikawa D, 2004, ANTICANCER RES, V24, P2477; Ikoma H, 2007, HEPATO-GASTROENTEROL, V54, P946; Ikoma H, 2006, ANTICANCER RES, V26, P2313; Koike H, 2005, HEPATO-GASTROENTEROL, V52, P1293; Koike H, 2004, J SURG ONCOL, V87, P182, DOI 10.1002/jso.20106; Nakamura J, 2014, WORLD J GASTROENTERO, V20, P11991, DOI 10.3748/wjg.v20.i34.11991; Pourebrahim R, 2007, FEBS LETT, V581, P5122, DOI 10.1016/j.febslet.2007.09.061; Rashid A, 2001, AM J PATHOL, V159, P1129, DOI 10.1016/S0002-9440(10)61789-0; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Wang LJ, 2009, BIOCHEM BIOPH RES CO, V379, P959, DOI 10.1016/j.bbrc.2008.12.180; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Yamanaka M, 2003, INT J CANCER, V106, P382, DOI 10.1002/ijc.11227; Yokota N, 1996, CANCER RES, V56, P377; Zheng YA, 2011, CLIN BIOCHEM, V44, P1405, DOI 10.1016/j.clinbiochem.2011.09.006; Zhong J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-290	20	4	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133906	10.1371/journal.pone.0133906	http://dx.doi.org/10.1371/journal.pone.0133906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207911	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000172
J	Chen, YP; Wei, QQ; Ou, RW; Cao, B; Chen, XP; Zhao, B; Guo, XY; Yang, Y; Chen, K; Wu, Y; Song, W; Shang, HF				Chen, YongPing; Wei, Qian-Qian; Ou, RuWei; Cao, Bei; Chen, XuePing; Zhao, Bi; Guo, XiaoYan; Yang, Yuan; Chen, Ke; Wu, Ying; Song, Wei; Shang, Hui-Fang			Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; POLYMORPHISM; RISK; LOCI; PD	Background The polymorphisms of alpha-synuclein (SNCA), rs3775444, rs3822086 and rs11931074 that are strongly associated with Parkinson's disease (PD) in Caucasian populations, were examined in this study to elucidate the role of polymorphisms in different ethnic backgrounds. The possible associations of these three polymorphisms were also investigated in PD, amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in a Chinese population based on the overlapping of clinical manifestations and pathological characteristics of these three neurodegenerative diseases. Methods A total of 1276 PD, 885 sporadic ALS (SALS), 364 MSA patients, and 846 healthy controls (HCs) were included. All subjects were genotyped for the three polymorphisms using Sequenom iPLEX Assay technology. Results Significant differences in the genotype distributions (p = 5.99E-06 and p = 4.98E-06, respectively) and the minor allele frequency (MAF) (p = 2.16E-06 and p = 2.15E-06, respectively) of SNCA rs3822086 (C) and rs11931074 (G) were observed between PD and HCs. However, no differences were found in the genotype distributions and MAF of SNCA rs3775444 (T) between PD and HCs. Haplotype that incorporated the three SNPs further strengthened the association with PD (best haplotype, p = 9.62E-005). No significant differences in the genotype distributions and MAF of the SNPs were found between SALS and HCs, MSA and HCs, and subgroups of PD and SALS. However, the MAF of SNCA rs3775444 (T) was significantly higher in MSA patients with frontal lobe dysfunction than MSA patients without dysfunction (p = 0.0002, OR 2.53, 95% CI: 1.55-4.15). Conclusion Our results suggest that the rs3822086 (C) allele and rs11931074 (G) allele in SNCA decrease the risk for PD, and SNCA rs11931074 may affect frontal lobe dysfunction of MSA in the Chinese population. However, these SNCA polymorphisms are not likely a common cause of SALS or MSA.	[Chen, YongPing; Wei, Qian-Qian; Ou, RuWei; Cao, Bei; Chen, XuePing; Zhao, Bi; Guo, XiaoYan; Chen, Ke; Wu, Ying; Song, Wei; Shang, Hui-Fang] Sichuan Univ, Dept Neurol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Chen, YongPing; Wei, Qian-Qian; Ou, RuWei; Cao, Bei; Chen, XuePing; Zhao, Bi; Guo, XiaoYan; Chen, Ke; Wu, Ying; Song, Wei; Shang, Hui-Fang] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Chen, YongPing; Wei, Qian-Qian; Ou, RuWei; Cao, Bei; Chen, XuePing; Zhao, Bi; Guo, XiaoYan; Chen, Ke; Wu, Ying; Song, Wei; Shang, Hui-Fang] Sichuan Univ, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China; [Yang, Yuan] Sichuan Univ, Dept Med Genet, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Shang, HF (corresponding author), Sichuan Univ, Dept Neurol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	hfshang2002@163.com	Chen, Yong-Ping/ABC-4645-2021	yang, yuan/0000-0002-9206-0312	National Science Fund of China [81371394]; National Basic Research Program of China [2015CB856400]; Science and Technology Bureau Fund of Sichuan Province [2014FZ0072]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Bureau Fund of Sichuan Province	The present study was supported by the funding of the National Science Fund of China (Grant No. 81371394), supported in part by the National Basic Research Program of China (No: 2015CB856400), and the Science and Technology Bureau Fund of Sichuan Province (2014FZ0072).	Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Chiba-Falek O, 2005, AM J HUM GENET, V76, P478, DOI 10.1086/428655; Chung SJ, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.05.022; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gouras Gunnar K, 2013, Int J Cell Biol, V2013, P141083, DOI 10.1155/2013/141083; Guo XY, 2014, EUR J NEUROL, V21, P1337, DOI 10.1111/ene.12490; Guo XY, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.014; Hermosura MC, 2007, BBA-MOL BASIS DIS, V1772, P822, DOI 10.1016/j.bbadis.2007.02.008; Hu YC, 2012, J NEUROL, V259, P497, DOI 10.1007/s00415-011-6209-4; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Liu J, 2013, MOVEMENT DISORD, V28, P1892, DOI 10.1002/mds.25599; MAJOORKRAKAUER D, 1994, NEUROLOGY, V44, P1872, DOI 10.1212/WNL.44.10.1872; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Ozansoy M, 2013, MOL NEUROBIOL, V47, P460, DOI 10.1007/s12035-012-8369-3; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sun ZF, 2015, INT J NEUROSCI, V125, P612, DOI 10.3109/00207454.2014.990013; Wu-Chou YH, 2013, PARKINSONISM RELAT D, V19, P251, DOI 10.1016/j.parkreldis.2012.10.019	24	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133776	10.1371/journal.pone.0133776	http://dx.doi.org/10.1371/journal.pone.0133776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208350	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000137
J	Gillespie, D				Gillespie, Dirk			Algorithm for the Time-Propagation of the Radial Diffusion Equation Based on a Gaussian Quadrature	PLOS ONE			English	Article								The numerical integration of the time-dependent spherically-symmetric radial diffusion equation from a point source is considered. The flux through the source can vary in time, possibly stochastically based on the concentration produced by the source itself. Fick's one-dimensional diffusion equation is integrated over a time interval by considering a source term and a propagation term. The source term adds new particles during the time interval, while the propagation term diffuses the concentration profile of the previous time step. The integral in the propagation term is evaluated numerically using a combination of a new diffusion-specific Gaussian quadrature and interpolation on a diffusion-specific grid. This attempts to balance accuracy with the least number of points for both integration and interpolation. The theory can also be extended to include a simple reaction-diffusion equation in the limit of high buffer concentrations. The method is unconditionally stable. In fact, not only does it converge for any time step Delta t, the method offers one advantage over other methods because Delta t can be arbitrarily large; it is solely defined by the timescale on which the flux source turns on and off.	Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Rush University	Gillespie, D (corresponding author), Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, 1750 West Harrison St,Suite 1289, Chicago, IL 60612 USA.	dirk_gillespie@rush.edu			American Heart Association [14GRNT20380691]	American Heart Association(American Heart Association)	This work was done during the term of Award 14GRNT20380691 from the American Heart Association (www.heart.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton G., 1989, ELEMENTS GREENS FUNC; Bers DM, 2001, EXCITATION CONTRACTI; Conlisk A.T., 2012, ESSENTIALS MICRO NAN; Crank J, 1980, MATH DIFFUSION; Cussler E. L, 2009, DIFFUSION MASS TRANS; Fick, 1855, PHILOS MAG, V170, P59, DOI [10.1080/14786445508641925, DOI 10.1080/14786445508641925, 10.1016/0376-7388(94)00230-V]; Fick A., 1855, ANN PHYS-NEW YORK, V170, P59, DOI [10.1002/andp.18551700105, DOI 10.1002/ANDP.18551700105]; FORNBERG B, 1988, MATH COMPUT, V51, P699, DOI 10.1090/S0025-5718-1988-0935077-0; GOLUB GH, 1969, MATH COMPUT, V23, P221, DOI 10.2307/2004418; Gradshteyn I. S., 2014, TABLE INTEGRALS SERI; GREENGARD L, 1991, SIAM J SCI STAT COMP, V12, P79, DOI 10.1137/0912004; Li JR, 2007, J COMPUT PHYS, V226, P1891, DOI 10.1016/j.jcp.2007.06.021; Neher E., 1986, CALCIUM ELECTROGENES, V14, P80; Press W. H., 1992, ART SCI COMPUTING; Stern MD, 2013, J GEN PHYSIOL, V142, P257, DOI 10.1085/jgp.201311034	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132273	10.1371/journal.pone.0132273	http://dx.doi.org/10.1371/journal.pone.0132273			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208111	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000024
J	Hirano, T; Murakami, T; Ono, H; Sakurai, A; Tominaga, T; Takahashi, T; Nagai, K; Doi, T; Abe, H				Hirano, Takahiro; Murakami, Taichi; Ono, Hiroyuki; Sakurai, Akiko; Tominaga, Tatsuya; Takahashi, Toshikazu; Nagai, Kojiro; Doi, Toshio; Abe, Hideharu			A Novel Interaction between FLICE-Associated Huge Protein (FLASH) and E2A Regulates Cell Proliferation and Cellular Senescence via Tumor Necrosis Factor (TNF)-Alpha-p21WAF1/CIP1 Axis	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; GLOMERULAR MESANGIAL CELLS; KINASE INHIBITOR P21; HUMAN FIBROBLASTS; MATRIX EXPANSION; IN-VIVO; EXPRESSION; RAT; GLOMERULONEPHRITIS; APOPTOSIS	Dysregulation of the cell proliferation has been implicated in the pathophysiology of a number of diseases. Cellular senescence limits proliferation of cancer cells, preventing tumorigenesis and restricting tissue damage. However, the role of cellular senescence in proliferative nephritis has not been determined. The proliferative peak in experimental rat nephritis coincided with a peak in E2A expression in the glomeruli. Meanwhile, E12 (an E2A-encoded transcription factor) did not promote proliferation of Mesangial cells (MCs) by itself. We identified caspase-8-binding protein FLICE-associated huge protein (FLASH) as a novel E2A-binding partner by using a yeast two-hybrid screening. Knockdown of FLASH suppressed proliferation of MCs. This inhibitory effect was partially reversed by the knockdown of E2A. In addition, the knockdown of FLASH induced cyclin-dependent kinase inhibitor p21WAF1/CIP1 (p21) expression, but did not affect p53 expression. Furthermore, overexpression of E12 and E47 induced p21, but not p53 in MCs, in the absence of FLASH. We also demonstrated that E2A and p21 expression at the peak of proliferation was followed by significant induction of FLASH in mesangial areas in rat proliferative glomerulonephritis. Moreover, we revealed that FLASH negatively regulates cellular senescence via the interaction with E12. We also demonstrated that FLASH is involved in the TNF-alpha-induced p21 expressions. These results suggest that the functional interaction of E2A and FLASH play an important role in cell proliferation and cellular senescence via regulation of p21 expression in experimental glomerulonephritis.	[Hirano, Takahiro; Murakami, Taichi; Ono, Hiroyuki; Sakurai, Akiko; Tominaga, Tatsuya; Takahashi, Toshikazu; Nagai, Kojiro; Doi, Toshio; Abe, Hideharu] Univ Tokushima, Dept Nephrol, Grad Sch, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University	Abe, H (corresponding author), Univ Tokushima, Dept Nephrol, Grad Sch, Inst Hlth Biosci, Tokushima 770, Japan.	abeabe@tokushima-u.ac.jp			Kidney Foundation of Japan [JKFB09-41]; Kidney Foundation, Japan [JKFB13-34];  [24659279];  [2459120]	Kidney Foundation of Japan; Kidney Foundation, Japan(Kidney Foundation, Japan); ; 	This work was supported by a grant from The Kidney Foundation of Japan (JKFB09-41), by funds from The Kidney Foundation, Japan (JKFB13-34), and by Grants-in-Aid for Scientific Research (24659279 and 2459120).	Abe H, 2012, J BIOL CHEM, V287, P20430, DOI 10.1074/jbc.M111.275610; AUSIELLO DA, 1980, J CLIN INVEST, V65, P754, DOI 10.1172/JCI109723; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14802, DOI 10.1073/pnas.0604225103; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; CHEVREMONT M, 1951, NATURE, V167, P772, DOI 10.1038/167772a0; Coates SSA, 2007, J PHARMACOL EXP THER, V322, P70, DOI 10.1124/jpet.106.118018; Conlon Thomas M., 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-11; DAVIES M, 1994, KIDNEY INT, V45, P320, DOI 10.1038/ki.1994.41; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; ENG E, 1994, KIDNEY INT, V45, pS45; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; FOGO A, 1989, SEMIN NEPHROL, V9, P329; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Jefferson JA, 1999, J NEPHROL, V12, P297; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; JOHNSON RJ, 1992, J EXP MED, V175, P1413, DOI 10.1084/jem.175.5.1413; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Ledent Valerie, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-6-RESEARCH0030; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Makibayashi K, 2001, AM J PATHOL, V158, P1733, DOI 10.1016/S0002-9440(10)64129-6; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Monkawa T, 2006, NEPHRON EXP NEPHROL, V102, pE8, DOI 10.1159/000088311; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Pagliuca A, 2000, CANCER RES, V60, P1376; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Roninson IB, 2003, CANCER RES, V63, P2705; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rowe SJ, 2002, J IMMUNOL, V169, P6401, DOI 10.4049/jimmunol.169.11.6401; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rutherford MN, 1998, AM J PATHOL, V153, P165, DOI 10.1016/S0002-9440(10)65557-5; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; Serhan CN, 2004, HISTOCHEM CELL BIOL, V122, P305, DOI 10.1007/s00418-004-0695-8; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SIMONSON MS, 1993, NUCLEIC ACIDS RES, V21, P5767, DOI 10.1093/nar/21.24.5767; STRIKER LJ, 1989, SEMIN NEPHROL, V9, P318; Takahashi T, 2005, J BIOL CHEM, V280, P7100, DOI 10.1074/jbc.M411064200; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; YAMAMOTO T, 1994, KIDNEY INT, V45, P916, DOI 10.1038/ki.1994.122; YAMAMOTO T, 1987, J IMMUNOL, V138, P3758	56	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133205	10.1371/journal.pone.0133205	http://dx.doi.org/10.1371/journal.pone.0133205			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208142	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000065
J	Kreizinger, Z; Sulyok, KM; Pasztor, A; Erdelyi, K; Felde, O; Povazsan, J; Korosi, L; Gyuranecz, M				Kreizinger, Zsuzsa; Sulyok, Kinga Maria; Pasztor, Alexandra; Erdelyi, Karoly; Felde, Orsolya; Povazsan, Janos; Korosi, Laszlo; Gyuranecz, Miklos			Rapid, Simple and Cost-Effective Molecular Method to Differentiate the Temperature Sensitive (ts(+)) MS-H Vaccine Strain and Wild-Type Mycoplasma synoviae Isolates	PLOS ONE			English	Article							FIELD; ABNORMALITIES; POLYMORPHISM	Mycoplasma synoviae infection in chickens and turkeys can cause respiratory disease, infectious synovitis and eggshell apex abnormality; thus it is an economically important pathogen. Control of M. synoviae infection comprises eradication, medication or vaccination. The differentiation of the temperature sensitive (ts(+)) MS-H vaccine strain from field isolates is crucial during vaccination programs. Melt-curve and agarose gel based mismatch amplification mutation assays (MAMA) are provided in the present study to distinguish between the ts(+) MS-H vaccine strain, its non-temperature sensitive re-isolates and wildtype M. synoviae isolates based on the single nucleotide polymorphisms at nt367 and nt629 of the obg gene. The two melt-MAMAs and the two agarose-MAMAs clearly distinguish the ts(+) MS-H vaccine strain genotype from its non-temperature sensitive re-isolate genotype and wild-type M. synoviae isolate genotype, and no cross-reactions with other Mycoplasma species infecting birds occur. The sensitivity of the melt-MAMAs and agarose-MAMAs was 103 and 104 copy numbers, respectively. The assays can be performed directly on clinical samples and they can be run simultaneously at the same annealing temperature. The assays can be performed in laboratories with limited facilities, using basic real-time PCR machine or conventional thermocycler coupled with agarose gel electrophoresis. The advantages of the described assays compared with previously used methods are simplicity, sufficient sensitivity, time and cost effectiveness and specificity.	[Kreizinger, Zsuzsa; Sulyok, Kinga Maria; Pasztor, Alexandra; Felde, Orsolya; Gyuranecz, Miklos] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, H-1581 Budapest, Pest, Hungary; [Erdelyi, Karoly] Natl Food Chain Safety Off, Vet Diagnost Directorate, Budapest, Hungary; [Povazsan, Janos; Korosi, Laszlo] Rhone Vet Kft, Herceghalom, Pest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Gyuranecz, M (corresponding author), Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, H-1581 Budapest, Pest, Hungary.	m.gyuranecz@gmail.com	Erdélyi, Károly/A-9600-2016; Erdélyi, Károly/AAB-6540-2022	Gyuranecz, Miklos/0000-0002-5698-5713	Lendulet program of the Hungarian Academy of Sciences [LP2012-22]	Lendulet program of the Hungarian Academy of Sciences	This work was supported by the Lendulet (Momentum; http://mta.hu/articles/momentum-program- of-the-hungarian-academy-of-sciences-130009) program (LP2012-22) of the Hungarian Academy of Sciences dedicated to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayatzadeh MA, 2014, BRIT POULTRY SCI, V55, P148, DOI 10.1080/00071668.2013.878781; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Catania S, 2010, AVIAN DIS, V54, P961, DOI 10.1637/9121-110309-Case.1; Dijkman R, 2014, AVIAN PATHOL, V43, P465, DOI 10.1080/03079457.2014.958980; Feberwee A, 2009, AVIAN PATHOL, V38, P77, DOI 10.1080/03079450802662772; Harada K, 2009, AVIAN DIS, V53, P538, DOI 10.1637/8934-052309-Reg.1; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Kleven S., 2008, DIS POULTRY, P845; Kleven SH, 2008, AVIAN DIS, V52, P367, DOI 10.1637/8323-041808-Review.1; Marois C, 2000, VET MICROBIOL, V73, P311, DOI 10.1016/S0378-1135(00)00178-4; Morrow CJ, 1998, AVIAN DIS, V42, P667, DOI 10.2307/1592700; Ogino S, 2011, AVIAN DIS, V55, P187, DOI 10.1637/9461-071310-Reg.1; Shahid MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092215; Shahid MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073954; Shahid MA, 2013, AVIAN PATHOL, V42, P185, DOI 10.1080/03079457.2013.779363	15	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133554	10.1371/journal.pone.0133554	http://dx.doi.org/10.1371/journal.pone.0133554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207635	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000358622000099
J	Thielen, J; van den Broek, P; Farquhar, J; Desain, P				Thielen, Jordy; van den Broek, Philip; Farquhar, Jason; Desain, Peter			Broad-Band Visually Evoked Potentials: Re (con)volution in Brain-Computer Interfacing	PLOS ONE			English	Article								Brain-Computer Interfaces (BCIs) allow users to control devices and communicate by using brain activity only. BCIs based on broad-band visual stimulation can outperform BCIs using other stimulation paradigms. Visual stimulation with pseudo-random bit-sequences evokes specific Broad-Band Visually Evoked Potentials (BBVEPs) that can be reliably used in BCI for high-speed communication in speller applications. In this study, we report a novel paradigm for a BBVEP-based BCI that utilizes a generative framework to predict responses to broad-band stimulation sequences. In this study we designed a BBVEP-based BCI using modulated Gold codes to mark cells in a visual speller BCI. We defined a linear generative model that decomposes full responses into overlapping single-flash responses. These single- flash responses are used to predict responses to novel stimulation sequences, which in turn serve as templates for classification. The linear generative model explains on average 50% and up to 66% of the variance of responses to both seen and unseen sequences. In an online experiment, 12 participants tested a 6 x 6 matrix speller BCI. On average, an online accuracy of 86% was reached with trial lengths of 3.21 seconds. This corresponds to an Information Transfer Rate of 48 bits per minute (approximately 9 symbols per minute). This study indicates the potential to model and predict responses to broad-band stimulation. These predicted responses are proven to be well-suited as templates for a BBVEP-based BCI, thereby enabling communication and control by brain activity only.	[Thielen, Jordy; van den Broek, Philip; Farquhar, Jason; Desain, Peter] Radboud Univ Nijmegen, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Thielen, J (corresponding author), Radboud Univ Nijmegen, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands.	jordy.thielen@gmail.com	Desain, Peter/D-1267-2012; Thielen, Jordy/AAD-3685-2021; Thielen, Jordy/Q-8599-2018	Thielen, Jordy/0000-0002-6264-0367; 	BrainGain Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science [SSM06011]	BrainGain Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	This work was supported by BrainGain Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science (SSM06011, P. Desain).	Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Capilla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014543; DESAIN P, 2008, 4 INT BCI WORKSH TRA; Desain P, 2014, NL Patent, Patent No. 2013245; Desain P, 2015, DANS; Desain P, 2009, US Patent, Patent No. [US20110251511, 20110251511]; Farquhar J., 2008, P 4 INT BCI WORKSH T, P50; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Gao SK, 2014, IEEE T BIO-MED ENG, V61, P1436, DOI 10.1109/TBME.2014.2300164; GOLD R, 1967, IEEE T INFORM THEORY, V13, P619, DOI 10.1109/TIT.1967.1054048; Golomb SW, 1982, SHIFT REGISTER SEQUE, P78; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Lalor EC, 2006, NEUROIMAGE, V32, P1549, DOI 10.1016/j.neuroimage.2006.05.054; Schreuder M, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036025; Schreuder M, 2011, IEEE ENG MED BIO, P4580, DOI 10.1109/IEMBS.2011.6091134; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; Spuler M, 2012, P 20 EUR S ART NEUR, P103, DOI [10.13140/2.1.2186.7526, DOI 10.13140/2.1.2186.7526]; Sutter E. E., 1984, Proceedings of the Symposium on Biosensors (Cat. No. 84CH2068-5), P95; SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7; Tan P., 2006, INTRO DATA MINING; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231	25	28	38	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133797	10.1371/journal.pone.0133797	http://dx.doi.org/10.1371/journal.pone.0133797			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208328	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000147
J	Weng, J; Dong, SS; He, HJ; Chen, FY; Peng, XG				Weng, Jian; Dong, Shanshan; He, Hongjian; Chen, Feiyan; Peng, Xiaogang			Reducing Individual Variation for fMRI Studies in Children by Minimizing Template Related Errors	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; SPATIAL NORMALIZATION; FUNCTIONAL MRI; DECISION-MAKING; WORKING-MEMORY; HEAD SIZE; BRAIN; IMAGES; ADULTS; REGISTRATION	Spatial normalization is an essential process for group comparisons in functional MRI studies. In practice, there is a risk of normalization errors particularly in studies involving children, seniors or diseased populations and in regions with high individual variation. One way to minimize normalization errors is to create a study-specific template based on a large sample size. However, studies with a large sample size are not always feasible, particularly for children studies. The performance of templates with a small sample size has not been evaluated in fMRI studies in children. In the current study, this issue was encountered in a working memory task with 29 children in two groups. We compared the performance of different templates: a study-specific template created by the experimental population, a Chinese children template and the widely used adult MNI template. We observed distinct differences in the right orbitofrontal region among the three templates in between-group comparisons. The study-specific template and the Chinese children template were more sensitive for the detection of between-group differences in the orbitofrontal cortex than the MNI template. Proper templates could effectively reduce individual variation. Further analysis revealed a correlation between the BOLD contrast size and the norm index of the affine transformation matrix, i.e., the SFN, which characterizes the difference between a template and a native image and differs significantly across subjects. Thereby, we proposed and tested another method to reduce individual variation that included the SFN as a covariate in group-wise statistics. This correction exhibits outstanding performance in enhancing detection power in group-level tests. A training effect of abacus-based mental calculation was also demonstrated, with significantly elevated activation in the right orbitofrontal region that correlated with behavioral response time across subjects in the trained group.	[Weng, Jian; Dong, Shanshan; Chen, Feiyan] Zhejiang Univ, Dept Phys, Bio X Lab, Hangzhou 310003, Zhejiang, Peoples R China; [He, Hongjian] Zhejiang Univ, Dept Biomed Engn, Ctr Brain Imaging Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China; [Peng, Xiaogang] First Hosp Qiqihar, Qiqihar, Heilongjiang, Peoples R China	Zhejiang University; Zhejiang University	He, HJ (corresponding author), Zhejiang Univ, Dept Biomed Engn, Ctr Brain Imaging Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China.	hehongj@gmail.com	Chen, Feiyan/AAD-8940-2022	Chen, Feiyan/0000-0003-3730-1651	863 Program [2012AA011603, 2012AA011602]; National Natural Science Foundation of China [030900389, 31270026]; Fundamental Research Funds for the Central Universities [2014QNA3005, JS 7-15-2015, SF 04042242]	863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work has been funded by grants included: the 863 Program (2012AA011603, 2012AA011602), the National Natural Science Foundation of China (No. 030900389, No. 31270026), and the Fundamental Research Funds for the Central Universities (Program No. 2014QNA3005) by Dr. Feiyan Chen who has the role in data collecting." (JS 7-15-2015, SF 04042242)	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Chen FY, 2006, NEUROSCI LETT, V403, P46, DOI 10.1016/j.neulet.2006.04.041; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Frindel C, 2009, MED IMAGE ANAL, V13, P405, DOI 10.1016/j.media.2009.01.002; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Geng XJ, 2009, NEUROIMAGE, V47, P1341, DOI 10.1016/j.neuroimage.2009.04.024; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; Hoeksma MR, 2005, CLIN NEUROPHYSIOL, V116, P1188, DOI 10.1016/j.clinph.2004.12.021; Huang CM, 2010, J NEUROSCI METH, V189, P257, DOI 10.1016/j.jneumeth.2010.03.021; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Li YX, 2013, BRAIN RES, V1539, P24, DOI 10.1016/j.brainres.2013.09.030; LoPresti ML, 2008, J NEUROSCI, V28, P3718, DOI 10.1523/JNEUROSCI.0464-08.2008; Luo YS, 2014, HUM BRAIN MAPP, V35, P3880, DOI 10.1002/hbm.22444; MATHALON DH, 1993, PSYCHIAT RES-NEUROIM, V50, P121, DOI 10.1016/S0165-1781(05)80006-X; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; Pollari M, 2007, I S BIOMED IMAGING, P768, DOI 10.1109/ISBI.2007.356965; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Schon K, 2008, NEUROIMAGE, V39, P857, DOI 10.1016/j.neuroimage.2007.09.023; Shen S, 2007, MAGN RESON IMAGING, V25, P1385, DOI 10.1016/j.mri.2007.03.025; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Uchiyama HT, 2013, BRAIN DEV-JPN, V35, P228, DOI 10.1016/j.braindev.2012.04.005; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wang ZZ, 2004, PROC CVPR IEEE, P228; Weisstein E. W., MATRIX NORM MATHWORL; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Yeo BTT, 2010, IEEE T MED IMAGING, V29, P1424, DOI 10.1109/TMI.2010.2049497; Yoon U, 2009, NEUROIMAGE, V45, P769, DOI 10.1016/j.neuroimage.2008.12.046	36	3	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134195	10.1371/journal.pone.0134195	http://dx.doi.org/10.1371/journal.pone.0134195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207985	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000213
J	Bauer, R; Garnica, S; Oberwinkler, F; Riess, K; Weiss, M; Begerow, D				Bauer, Robert; Garnica, Sigisfredo; Oberwinkler, Franz; Riess, Kai; Weiss, Michael; Begerow, Dominik			Entorrhizomycota: A New Fungal Phylum Reveals New Perspectives on the Evolution of Fungi	PLOS ONE			English	Article							SMUT FUNGI; PHYLOGENETIC INFERENCE; SEQUENCE ALIGNMENT; CASPARYANA; POSITION; MEIOSIS; LINEAGE; LIGHT; DNA	Entorrhiza is a small fungal genus comprising 14 species that all cause galls on roots of Cyperaceae and Juncaceae. Although this genus was established 130 years ago, crucial questions on the phylogenetic relationships and biology of this enigmatic taxon are still unanswered. In order to infer a robust hypothesis about the phylogenetic position of Entorrhiza and to evaluate evolutionary trends, multiple gene sequences and morphological characteristics of Entorrhiza were analyzed and compared with respective findings in Fungi. In our comprehensive five-gene analyses Entorrhiza appeared as a highly supported monophyletic lineage representing the sister group to the rest of the Dikarya, a phylogenetic placement that received but moderate maximum likelihood and maximum parsimony boot-strap support. An alternative maximum likelihood tree with the constraint that Entorrhiza forms a monophyletic group with Basidiomycota could not be rejected. According to the first phylogenetic hypothesis, the teliospore tetrads of Entorrhiza represent the prototype of the dikaryan meiosporangium. The alternative hypothesis is supported by similarities in septal pore structure, cell wall and spindle pole bodies. Based on the isolated phylogenetic position of Entorrhiza and its peculiar combination of features related to ultrastructure and reproduction mode, we propose a new phylum Entorrhizomycota, for the genus Entorrhiza, which represents an apparently widespread group of inconspicuous fungi.	[Bauer, Robert; Garnica, Sigisfredo; Oberwinkler, Franz; Riess, Kai] Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, D-72076 Tubingen, Germany; [Weiss, Michael] Univ Tubingen, Dept Biol, D-72076 Tubingen, Germany; [Weiss, Michael] Inst Organismal Mycol & Microbiol, D-72076 Tubingen, Germany; [Begerow, Dominik] Univ Bochum, AG Geobot, D-44780 Bochum, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ruhr University Bochum	Riess, K (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, Morgenstelle 1, D-72076 Tubingen, Germany.	kai.riess@uni-tuebingen.de; dominik.begerow@rub.de	Weiß, Michael/F-6206-2012; Sigisfredo, Garnica/P-6506-2014; Riess, Kai/B-5491-2015	Weiß, Michael/0000-0002-4869-9186; Riess, Kai/0000-0002-8804-0175; Begerow, Dominik/0000-0002-8286-1597	German Research Foundation, DFG [BA 75/3-1]; Open Access Publishing Fund of Tuebingen University	German Research Foundation, DFG(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This research was funded by the German Research Foundation, DFG (BA 75/3-1) and the Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDONI RJ, 1984, T MYCOL SOC JPN, V25, P489; BAUER R, 1991, CAN J BOT, V69, P245, DOI 10.1139/b91-035; BAUER R, 1988, BOT ACTA, V101, P272, DOI 10.1111/j.1438-8677.1988.tb00044.x; BAUER R, 1986, Zeitschrift fuer Mykologie, V52, P259; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; BAUER R, 1994, CAN J BOT, V72, P1229, DOI 10.1139/b94-151; Bauer R, 2001, MYCOTA, V7, P57; Begerow D, 2004, MYCOL RES, V108, P1257, DOI 10.1017/S0953756204001066; Begerow D, 1997, CAN J BOT, V75, P2045, DOI 10.1139/b97-916; Begerow D, 2006, MYCOLOGIA, V98, P906, DOI 10.3852/mycologia.98.6.906; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; DEML G, 1981, MYCOLOGIA, V73, P392, DOI 10.2307/3759592; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FINERAN JM, 1982, CAN J BOT, V60, P2903, DOI 10.1139/b82-351; FINERAN JM, 1980, NOVA HEDWIGIA, V32, P265; FINERAN JM, 1978, NOVA HEDWIGIA, V30, P1; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; GERSTERBERGER P, 1979, BER DEUT BOT GES, V91, P381; HEATH IB, 1981, INT REV CYTOL, V69, P191; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Humber RA, 2012, MYCOTAXON, V120, P477, DOI 10.5248/120.477; INGOLD CT, 1979, AM J BOT, V66, P218, DOI 10.2307/2442527; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KREGERVA.NJ, 1971, J GEN MICROBIOL, V68, P87, DOI 10.1099/00221287-68-1-87; Le SQ, 2012, MOL BIOL EVOL, V29, P2921, DOI 10.1093/molbev/mss112; Liu YJJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-74; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Matheny PB, 2006, CAN J BOT, V84, P1794, DOI 10.1139/B06-128; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; NAGLER A, 1989, MYCOLOGIA, V81, P884, DOI 10.2307/3760107; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Oberwinkler, 2012, ANDRIAS, V19, P23; OBERWINKLER F, 1981, CAN J BOT, V59, P1034, DOI 10.1139/b81-141; Oberwinkler F., 2012, STAPFIA, V96, P45; Piepenbring M, 1998, PROTOPLASMA, V204, P155, DOI 10.1007/BF01280322; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salichos L, 2014, MOL BIOL EVOL, V31, P1261, DOI 10.1093/molbev/msu061; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Vanky K, 2012, SMUT FUNGI OF THE WO; Weber C, 1884, BOT ZTG BERLIN, V42, P369; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	50	31	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0128183	10.1371/journal.pone.0128183	http://dx.doi.org/10.1371/journal.pone.0128183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200112	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100001
J	Carey, M; Xiao, JJ; Farias, JG; Meharg, AA				Carey, Manus; Xiao Jiujin; Farias, Julia Gomes; Meharg, Andrew A.			Rethinking Rice Preparation for Highly Efficient Removal of Inorganic Arsenic Using Percolating Cooking Water	PLOS ONE			English	Article							COOKED RICE; WHITE	A novel way of cooking rice to maximize the removal of the carcinogen inorganic arsenic (As-i) is presented here. In conventional rice cooking water and grain are in continuous contact, and it is known that the larger the water: rice cooking ratio, the more As-i removed by cooking, suggesting that the As-i in the grain is mobile in water. Experiments were designed where rice is cooked in a continual stream of percolating near boiling water, either low in As-i, or As-i free. This has the advantage of not only exposing grain to large volumes of cooking water, but also physically removes any As-i leached from the grain into the water receiving vessel. The relationship between cooking water volume and As-i removal in conventional rice cooking was demonstrated for the rice types under study. At a water-to-rice cooking ratio of 12:1, 57 +/- 5% of As-i could be removed, average of 6 wholegrain and 6 polished rice samples. Two types of percolating technology were tested, one where the cooking water was recycled through condensing boiling water steam and passing the freshly distilled hot water through the grain in a laboratory setting, and one where tap water was used to cook the rice held in an off-the-shelf coffee percolator in a domestic setting. Both approaches proved highly effective in removing As-i from the cooking rice, with up to 85% of As-i removed from individual rice types. For the recycled water experiment 59 +/- 8% and 69 +/- 10% of As-i was removed, on average, compared to uncooked rice for polished (n=27) and wholegrain (n=13) rice, respectively. For coffee percolation there was no difference between wholegrain and polished rice, and the effectiveness of As-i removal was 49 +/- 7% across 6 wholegrain and 6 polished rice samples. The manuscript explores the potential applications and further optimization of this percolating cooking water, high As-i removal, discovery.	[Carey, Manus; Xiao Jiujin; Farias, Julia Gomes; Meharg, Andrew A.] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Xiao Jiujin] Sichuan Agr Univ, Chengdu, Sichuan, Peoples R China; [Farias, Julia Gomes] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Biol, BR-97119900 Santa Maria, RS, Brazil	Queens University Belfast; Sichuan Agricultural University; Universidade Federal de Santa Maria (UFSM)	Meharg, AA (corresponding author), Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland.	aa.meharg@qub.ac.uk	Meharg, Andrew Alexander/F-8182-2014; Carey, Manus/K-8180-2015	Meharg, Andrew Alexander/0000-0003-2019-0449; Carey, Manus/0000-0002-1065-4943; Farias, Julia/0000-0002-2268-5501				[Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Bae M, 2002, LANCET, V360, P1839, DOI 10.1016/S0140-6736(02)11738-7; Juhasz AL, 2006, ENVIRON HEALTH PERSP, V114, P1826, DOI 10.1289/ehp.9322; Meharg A.A., 2012, ARSENIC RICE; Meharg AA, 2008, ENVIRON POLLUT, V152, P746, DOI 10.1016/j.envpol.2008.01.043; Meharg AA, 2008, J ENVIRON MONITOR, V10, P428, DOI 10.1039/b800981c; Meharg AA, 2008, ENVIRON SCI TECHNOL, V42, P1051, DOI 10.1021/es702212p; Raab A, 2009, J ENVIRON MONITOR, V11, P41, DOI 10.1039/b816906c; Sengupta MK, 2006, FOOD CHEM TOXICOL, V44, P1823, DOI 10.1016/j.fct.2006.06.003; Sharma S, 2013, NUTR J, V12, P65; Signes-Pastor AJ, 2015, FOOD CHEM IN PRESS; Sun GX, 2008, ENVIRON SCI TECHNOL, V42, P7542, DOI 10.1021/es801238p; Watanabe T, 1999, J JPN SOC FOOD SCI, V46, P731	14	35	35	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131608	10.1371/journal.pone.0131608	http://dx.doi.org/10.1371/journal.pone.0131608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200355	gold, Green Published, Green Submitted			2022-12-26	WOS:000358597100018
J	Higashiyama, Y; Takeda, K; Someya, Y; Kuroiwa, Y; Tanaka, F				Higashiyama, Yuichi; Takeda, Katsuhiko; Someya, Yoshiaki; Kuroiwa, Yoshiyuki; Tanaka, Fumiaki			The Neural Basis of Typewriting: A Functional MRI Study	PLOS ONE			English	Article							WRITTEN WORD PRODUCTION; LESION LOCALIZATION; CORTEX INVOLVEMENT; MENTAL ROTATION; PREMOTOR CORTEX; AGRAPHIA; FMRI; MEMORY; MOTOR; ACTIVATIONS	To investigate the neural substrate of typewriting Japanese words and to detect the difference between the neural substrate of typewriting and handwriting, we conducted a functional magnetic resonance imaging (fMRI) study in 16 healthy volunteers. All subjects were skillful touch typists and performed five tasks: a typing task, a writing task, a reading task, and two control tasks. Three brain regions were activated during both the typing and the writing tasks: the left superior parietal lobule, the left supramarginal gyrus, and the left premotor cortex close to Exner's area. Although typing and writing involved common brain regions, direct comparison between the typing and the writing task revealed greater left posteromedial intraparietal cortex activation in the typing task. In addition, activity in the left premotor cortex was more rostral in the typing task than in the writing task. These findings suggest that, although the brain circuits involved in Japanese typewriting are almost the same as those involved in handwriting, there are brain regions that are specific for typewriting.	[Higashiyama, Yuichi; Kuroiwa, Yoshiyuki; Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 232, Japan; [Higashiyama, Yuichi; Takeda, Katsuhiko] Int Univ Hlth & Welf, Mita Hosp, Dept Neurol, Tokyo, Japan; [Someya, Yoshiaki] Keio Univ, Ctr Adv Res Log & Sensibil, Tokyo, Japan	Yokohama City University; International University of Health & Welfare; Keio University	Tanaka, F (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 232, Japan.	ftanaka@yokohama-cu.ac.jp						ALEXANDER MP, 1992, ARCH NEUROL-CHICAGO, V49, P246, DOI 10.1001/archneur.1992.00530270060019; ALEXANDER MP, 1992, BRAIN LANG, V43, P83, DOI 10.1016/0093-934X(92)90022-7; Amano S., 2000, NTT DATABASE SERIES; BEAUVOIS MF, 1981, BRAIN, V104, P21, DOI 10.1093/brain/104.1.21; Beeson PM, 2003, APHASIOLOGY, V17, P647, DOI 10.1080/02687030344000067; Buchwald A, 2009, COGN NEUROPSYCHOL, V26, P724, DOI 10.1080/02643291003707332; Cloutman L, 2009, ANN NEUROL, V66, P249, DOI 10.1002/ana.21693; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Cook Fabian Alexander Blyth, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-200257; Dejerine JJ, 1892, CONTRIBUTION A LETUD; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Exner S., 1881, UNTERSUCHUNGEN UBER; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Fujii N, 2000, J NEUROPHYSIOL, V83, P1764, DOI 10.1152/jn.2000.83.3.1764; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Katanoda K, 2001, HUM BRAIN MAPP, V13, P34, DOI 10.1002/hbm.1023; Magrassi L, 2010, BRAIN RES, V1346, P145, DOI 10.1016/j.brainres.2010.05.046; Menon V, 2001, COGNITIVE BRAIN RES, V12, P337, DOI 10.1016/S0926-6410(01)00063-5; Neggers SFW, 2006, NEUROIMAGE, V31, P320, DOI 10.1016/j.neuroimage.2005.12.028; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otsuki M, 2002, EUR NEUROL, V47, P136, DOI 10.1159/000047971; Purcell JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00239; Purcell JJ, 2011, NEUROIMAGE, V55, P750, DOI 10.1016/j.neuroimage.2010.11.042; Rapp B, 2002, COGN NEUROPSYCHOL, V19, P1, DOI 10.1080/0264329014300060; Rapp B, 2011, J COGNITIVE NEUROSCI, V23, P4067, DOI 10.1162/jocn_a_00109; Rapp B, 2011, J COGNITIVE NEUROSCI, V23, P1180, DOI 10.1162/jocn.2010.21507; ROELTGEN DP, 1984, BRAIN, V107, P811, DOI 10.1093/brain/107.3.811; Roux FE, 2014, CORTEX, V50, P64, DOI 10.1016/j.cortex.2013.09.012; Roux FE, 2010, CORTEX, V46, P1204, DOI 10.1016/j.cortex.2010.03.001; Roux FE, 2009, ANN NEUROL, V66, P537, DOI 10.1002/ana.21804; Ryu DW, 2012, ALZ DIS ASSOC DIS, V26, P285, DOI 10.1097/WAD.0b013e318231e614; Sakurai Y, 2007, BEHAV NEUROL, V18, P99, DOI 10.1155/2007/906417; SALTHOUSE TA, 1986, PSYCHOL BULL, V99, P303, DOI 10.1037/0033-2909.99.3.303; Sato M, 1983, No To Shinkei, V35, P1145; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; SHALLICE T, 1981, BRAIN, V104, P413, DOI 10.1093/brain/104.3.413; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Sugihara G, 2006, NEUROIMAGE, V32, P1837, DOI 10.1016/j.neuroimage.2006.05.035; TANAKA Y, 1987, CORTEX, V23, P679, DOI 10.1016/S0010-9452(87)80058-8; TOHGI H, 1995, J NEUROL NEUROSUR PS, V58, P629, DOI 10.1136/jnnp.58.5.629; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vingerhoets G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00151; Voyer D, 1995, BRAIN COGNITION, V29, P326, DOI 10.1006/brcg.1995.1285	47	10	10	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134131	10.1371/journal.pone.0134131	http://dx.doi.org/10.1371/journal.pone.0134131			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218431	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900082
J	Kirsten, TB; Chaves-Kirsten, GP; Bernardes, S; Scavone, C; Sarkis, JE; Bernardi, MM; Felicio, LF				Kirsten, Thiago Berti; Chaves-Kirsten, Gabriela P.; Bernardes, Suene; Scavone, Cristoforo; Sarkis, Jorge E.; Bernardi, Maria Martha; Felicio, Luciano F.			Lipopolysaccharide Exposure Induces Maternal Hypozincemia, and Prenatal Zinc Treatment Prevents Autistic-Like Behaviors and Disturbances in the Striatal Dopaminergic and mTOR Systems of Offspring	PLOS ONE			English	Article							IMMUNE ACTIVATION; ORGANOPHOSPHATE PESTICIDE; NEURODEVELOPMENTAL DAMAGE; INDUCED TERATOGENICITY; SPECTRUM DISORDERS; SOCIAL-BEHAVIOR; AMNIOTIC-FLUID; RODENT MODELS; BRAIN-INJURY; DOUBLE-BLIND	Autism is characterized by social deficits, repetitive behaviors, and cognitive inflexibility. The risk factors appear to include genetic and environmental conditions, such as prenatal infections and maternal dietary factors. Previous investigations by our group have demonstrated that prenatal exposure to lipopolysaccharide (LPS), which mimics infection by gram-negative bacteria, induces autistic-like behaviors. To understand the causes of autistic-like behaviors, we evaluated maternal serum metal concentrations, which are involved in intrauterine development and infection/inflammation. We identified reduced maternal levels of zinc, magnesium, selenium and manganese after LPS exposure. Because LPS induced maternal hypozincemia, we treated dams with zinc in an attempt to prevent or ease the impairments in the offspring. We evaluated the social and cognitive autistic-like behaviors and brain tissues of the offspring to identify the central mechanism that triggers the development of autism. Prenatal LPS exposure impaired play behaviors and T-maze spontaneous alternations, i.e., it induced autistic-like behaviors. Prenatal LPS also decreased tyrosine hydroxylase levels and increased the levels of mammalian target of rapamycin (mTOR) in the striatum. Thus, striatal dopaminergic impairments may be related to autism. Moreover, excessive signaling through the mTOR pathway has been considered a biomarker of autism, corroborating our rat model of autism. Prenatal zinc treatment prevented these autistic-like behaviors and striatal dopaminergic and mTOR disturbances in the offspring induced by LPS exposure. The present findings revealed a possible relation between maternal hypozincemia during gestation and the onset of autism. Furthermore, prenatal zinc administration appears to have a beneficial effect on the prevention of autism.	[Kirsten, Thiago Berti; Felicio, Luciano F.] Univ Sao Paulo, Dept Pathol, Sch Vet Med, Sao Paulo, Brazil; [Kirsten, Thiago Berti; Bernardi, Maria Martha] Univ Paulista, Environm & Expt Pathol, Sao Paulo, Brazil; [Chaves-Kirsten, Gabriela P.; Scavone, Cristoforo] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Bernardes, Suene] Univ Sao Paulo, Inst Phys, Sao Paulo, Brazil; [Sarkis, Jorge E.] Univ Sao Paulo, Inst Energy & Nucl Res IPEN, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo	Kirsten, TB (corresponding author), Univ Sao Paulo, Dept Pathol, Sch Vet Med, Sao Paulo, Brazil.	thik@outlook.com	Bernardi, Maria/T-6813-2019; Kirsten, Thiago Berti/AAS-2166-2021; Scavone, Cristoforo/C-1580-2012; Bernardi, M. M./H-8418-2012; Scavone, Cristoforo/AFK-9950-2022; Felicio, Luciano F/C-1083-2012; Scavone, Cristoforo/ABB-8279-2021	Kirsten, Thiago Berti/0000-0002-4032-4355; Scavone, Cristoforo/0000-0002-1206-0882; Bernardi, M. M./0000-0002-6860-9416; Scavone, Cristoforo/0000-0002-1206-0882; Felicio, Luciano F/0000-0002-9068-8317; Scavone, Cristoforo/0000-0002-1206-0882	Sao Paulo Research Foundation (FAPESP) [2012/07007-8, 2013/01610-7, 2009/51886-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio)	This research was supported by the Sao Paulo Research Foundation (FAPESP grant 2012/ 07007-8, 2013/01610-7 and thematic grant 2009/51886-3) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi OO, 2012, AFR HEALTH SCI, V12, P153, DOI 10.4314/ahs.v12i2.12; Akhondzadeh S, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-9; Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P155; Anwary S A, 2011, Mymensingh Med J, V20, P252; Anzolin DG, 2012, MAR POLLUT BULL, V64, P1402, DOI 10.1016/j.marpolbul.2012.04.018; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Barrington JW, 1996, BRIT J OBSTET GYNAEC, V103, P130, DOI 10.1111/j.1471-0528.1996.tb09663.x; Bilici M, 2004, PROG NEURO-PSYCHOPH, V28, P181, DOI 10.1016/j.pnpbp.2003.09.034; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013; Carey LC, 2003, BIRTH DEFECTS RES A, V67, P240, DOI 10.1002/bdra.10035; Caulfield LE, 2010, AM J CLIN NUTR, V92, P130, DOI 10.3945/ajcn.2010.29407; Chaves GP, 2008, J NEUROSCI RES, V86, P1626, DOI 10.1002/jnr.21613; Chua JSC, 2012, BRAIN BEHAV IMMUN, V26, P326, DOI 10.1016/j.bbi.2011.10.002; Chua JSC, 2006, PEDIATR RES, V59, P355, DOI 10.1203/01.pdr.0000199906.37619.9c; Coyle P, 2009, BEHAV BRAIN RES, V197, P210, DOI 10.1016/j.bbr.2008.08.022; DSM-IV, 1994, PERV DEV DIS, P65; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002; Fernell Elisabeth, 2013, Clin Epidemiol, V5, P33, DOI 10.2147/CLEP.S41714; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; FOSTER HD, 1993, MED HYPOTHESES, V40, P61, DOI 10.1016/0306-9877(93)90198-Y; Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023; GUVENC H, 1995, PEDIATRICS, V95, P879; Herbert MR, 2010, CURR OPIN NEUROL, V23, P103, DOI 10.1097/WCO.0b013e328336a01f; Johnson NL, 2013, J NURS SCHOLARSHIP, V45, P69, DOI 10.1111/j.1547-5069.2012.01483.x; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Kim S, 2000, J BIOL CHEM, V275, P25979, DOI 10.1074/jbc.M001975200; King JC, 2000, AM J CLIN NUTR, V71, p1334S, DOI 10.1093/ajcn/71.5.1334s; Kirsten TB, 2008, THESIS U SAO PAULO S; Kirsten TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082244; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Kirsten TB, 2010, NEUROIMMUNOMODULAT, V17, P240, DOI 10.1159/000290040; Kirsten TB, 2011, PHYSIOL BEHAV, V104, P417, DOI 10.1016/j.physbeh.2011.04.049; Kirsten TB, 2011, LIFE SCI, V89, P15, DOI 10.1016/j.lfs.2011.04.023; Kirsten TB, 2010, BEHAV BRAIN RES, V211, P77, DOI 10.1016/j.bbr.2010.03.009; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; KYNAST G, 1986, GYNECOL OBSTET INVES, V21, P117, DOI 10.1159/000298940; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Maywald M, 2015, J TRACE ELEM MED BIO, V29, P24, DOI 10.1016/j.jtemb.2014.06.003; McGuire SO, 2001, EXP NEUROL, V169, P219, DOI 10.1006/exnr.2001.7688; McPheeters ML, 2011, PEDIATRICS, V127, pE1312, DOI 10.1542/peds.2011-0427; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003; Meyer U, 2012, NEUROPHARMACOLOGY, V62, P1308, DOI 10.1016/j.neuropharm.2011.01.009; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Munhoz CD, 2003, NEUROPHARMACOLOGY, V45, P1151, DOI 10.1016/S0028-3908(03)00278-8; Nakasato A, 2008, BRAIN RES, V1193, P128, DOI 10.1016/j.brainres.2007.11.043; Narita N, 2002, PEDIATR RES, V52, P576, DOI 10.1203/01.PDR.0000028406.01104.76; Okada Y, 2013, J TOXICOL SCI, V38, P363, DOI 10.2131/jts.38.363; PANKSEPP J, 1980, BEHAV NEURAL BIOL, V30, P197, DOI 10.1016/S0163-1047(80)91077-8; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pletnikov MV, 1999, BEHAV BRAIN RES, V100, P43, DOI 10.1016/S0166-4328(98)00111-9; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; Rong YQ, 1996, J NEUROCHEM, V67, P662; Ryu JM, 2009, J CELL PHYSIOL, V218, P558, DOI 10.1002/jcp.21628; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Santos SB, 2012, VIABILIDADE MEDIDA E; SCHOLL TO, 1993, AM J EPIDEMIOL, V137, P1115, DOI 10.1093/oxfordjournals.aje.a116615; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Soto AMS, 2013, LIFE SCI, V92, P852, DOI 10.1016/j.lfs.2013.03.003; Spatling L, 1989, Magnes Res, V2, P271; Summers BL, 2006, PEDIATR RES, V59, P66, DOI 10.1203/01.pdr.0000190573.23893.13; Theoharides TC, 2009, EXPERT OPIN PHARMACO, V10, P2127, DOI 10.1517/14656560903107789; Timofeeva OA, 2008, NEUROTOXICOL TERATOL, V30, P38, DOI 10.1016/j.ntt.2007.10.002; Timofeeva OA, 2008, BRAIN RES BULL, V77, P404, DOI 10.1016/j.brainresbull.2008.08.019; Tuerk MJ, 2009, CURR OPIN GASTROEN, V25, P136, DOI 10.1097/MOG.0b013e328321b395; Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3; Veenstra-VanderWeele J, 2012, NEUROPSYCHOPHARMACOL, V37, P196, DOI 10.1038/npp.2011.185; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; Wang HS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00028; Wink LK, 2010, EXPERT OPIN EMERG DR, V15, P481, DOI 10.1517/14728214.2010.487860; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Wood RJ, 2009, NUTR REV, V67, P416, DOI 10.1111/j.1753-4887.2009.00214.x	87	34	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134565	10.1371/journal.pone.0134565	http://dx.doi.org/10.1371/journal.pone.0134565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218250	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900124
J	Wang, GL; Sun, S; Xing, GM; Wu, XJ; Wang, F; Xiong, AS				Wang, Guang-Long; Sun, Sheng; Xing, Guo-Ming; Wu, Xue-Jun; Wang, Feng; Xiong, Ai-Sheng			Morphological Characteristics, Anatomical Structure, and Gene Expression: Novel Insights into Cytokinin Accumulation during Carrot Growth and Development	PLOS ONE			English	Article							HISTIDINE PHOSPHOTRANSFER PROTEINS; DAUCUS-CAROTA L.; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; PLANT DEVELOPMENT; CELL-DIVISION; KINASE CKI1; BIOSYNTHESIS; PERCEPTION; SENESCENCE	Cytokinins have been implicated in normal plant growth and development. These bioactive molecules are essential for cell production and expansion in higher plants. Carrot is an Apiaceae vegetable with great value and undergoes significant size changes over the process of plant growth. However, cytokinin accumulation and its potential roles in carrot growth have not been elucidated. To address this problem, carrot plants at five stages were collected, and morphological and anatomical characteristics and expression profiles of cytokinin-related genes were determined. During carrot growth and development, cytokinin levels were the highest at the second stage in the roots, whereas relatively stable levels were observed in the petioles and leaves. DcCYP735A2 showed high expression at stage 2 in the roots, which may contribute largely to the higher cytokinin level at this stage. However, expression of most metabolic genes did not follow a pattern similar to that of cytokinin accumulation, indicating that cytokinin biosynthesis was regulated through a complex network. Genes involved in cytokinin signal perception and transduction were also integrated to normal plant growth and development. The results from the present work suggested that cytokinins may regulate plant growth in a stage-dependent manner. Our work would shed novel insights into cytokinin accumulation and its potential roles during carrot growth. Further studies regarding carrot cytokinins may be achieved by modification of the genes involved in cytokinin biosynthesis, inactivation, and perception.	[Wang, Guang-Long; Wu, Xue-Jun; Wang, Feng; Xiong, Ai-Sheng] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Sun, Sheng; Xing, Guo-Ming] Shanxi Agr Univ, Coll Hort, Taigu 030801, Peoples R China	Nanjing Agricultural University; Shanxi Agricultural University	Xiong, AS (corresponding author), Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	xiongaisheng@njau.edu.cn	Wang, Guang-Long/ABC-2687-2020	Xiong, Ai-Sheng/0000-0002-7900-5001	New Century Excellent Talents in University [NCET-11-0670]; Jiangsu Natural Science Foundation [BK20130027]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Shanxi Province Coal Based Key Scientific and Technological Project [FT201402-07]	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions; Shanxi Province Coal Based Key Scientific and Technological Project	The research was supported by the New Century Excellent Talents in University (NCET-11-0670); Jiangsu Natural Science Foundation (BK20130027); Priority Academic Program Development of Jiangsu Higher Education Institutions; and Shanxi Province Coal Based Key Scientific and Technological Project (FT201402-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Carimi F, 2004, PLANT SCI, V166, P963, DOI 10.1016/j.plantsci.2003.12.016; CHEN CM, 1985, PLANT PHYSIOL, V78, P510, DOI 10.1104/pp.78.3.510; Cheng C.-Y, 2014, MOL BIOL PLANT SCI 2, P269, DOI [10.1007/978-1-4614-7570-5_14, DOI 10.1007/978-1-4614-7570-5_14]; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Deng Y, 2010, PLANT CELL, V22, P1232, DOI 10.1105/tpc.108.065128; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; El-Showk S, 2013, DEVELOPMENT, V140, P1373, DOI 10.1242/dev.086371; Frebort I, 2011, J EXP BOT, V62, P2431, DOI 10.1093/jxb/err004; Galichet A, 2008, PLANT PHYSIOL, V146, P1155, DOI 10.1104/pp.107.107425; Gapper NE, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.34; Guo YF, 2011, PLANT PHYSIOL, V156, P1612, DOI 10.1104/pp.111.177022; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Heyl A, 2003, CURR OPIN PLANT BIOL, V6, P480, DOI 10.1016/S1369-5266(03)00087-6; Houba-Herin N, 1999, PLANT J, V17, P615, DOI 10.1046/j.1365-313X.1999.00408.x; Hradilova J, 2007, J PLANT GROWTH REGUL, V26, P229, DOI 10.1007/s00344-007-9011-x; Huang Y, 2015, MOL BIOL REP, V42, P893, DOI 10.1007/s11033-014-3826-x; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Jeon J, 2013, PLANT PHYSIOL, V161, P408, DOI 10.1104/pp.112.207621; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kieber JJ, 2010, PLANT PHYSIOL, V154, P487, DOI 10.1104/pp.110.161596; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Luby CH, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.15; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Moreira S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056370; Moreno JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058144; Ordaz-Ortiz JJ, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.2; Pekarova B, 2011, PLANT J, V67, P827, DOI 10.1111/j.1365-313X.2011.04637.x; Ren B, 2009, CELL RES, V19, P1178, DOI 10.1038/cr.2009.88; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Shimizu-Sato S, 2001, PLANT PHYSIOL, V127, P1405, DOI 10.1104/pp.010841; Sieberer T, 2003, CURR BIOL, V13, P837, DOI 10.1016/S0960-9822(03)00327-0; Song JC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-78; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Takei K, 2002, J EXP BOT, V53, P971, DOI 10.1093/jexbot/53.370.971; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Tian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117569; Tokuji Y, 2003, J PLANT PHYSIOL, V160, P133, DOI 10.1078/0176-1617-00892; Veach YK, 2003, PLANT PHYSIOL, V131, P1374, DOI 10.1104/pp.017210; Wang GL, 2015, PLANT PHYSIOL BIOCH, V94, P10, DOI 10.1016/j.plaphy.2015.04.014; Wang GL, 2015, MOL GENET GENOMICS, V290, P1379, DOI 10.1007/s00438-015-0999-5; Wang YP, 2011, PLANT J, V68, P249, DOI 10.1111/j.1365-313X.2011.04683.x; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Wingler A, 1998, PLANT PHYSIOL, V116, P329, DOI 10.1104/pp.116.1.329; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Xu ZS, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau096; Xu ZS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0262-y; Yang YM, 2001, PLANT GROWTH REGUL, V35, P233; Zhang KR, 2005, PLANT PHYSIOL, V137, P308, DOI 10.1104/pp.104.051938; Zhang WJ, 2013, CURR BIOL, V23, P1979, DOI 10.1016/j.cub.2013.08.008	54	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134166	10.1371/journal.pone.0134166	http://dx.doi.org/10.1371/journal.pone.0134166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218147	Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900090
J	Yoo, HS; Yun, HJ; Chung, SJ; Sunwoo, MK; Lee, JM; Sohn, YH; Lee, PH				Yoo, Han Soo; Yun, Hyuk Jin; Chung, Seok Jong; Sunwoo, Mun Kyung; Lee, Jong-Min; Sohn, Young Ho; Lee, Phil Hyu			Patterns of Neuropsychological Profile and Cortical Thinning in Parkinson's Disease with Punding	PLOS ONE			English	Article							IMPULSE CONTROL DISORDERS; AUTOMATED 3-D EXTRACTION; DOPAMINE; BEHAVIOR; CORTEX; MRI; DYSREGULATION; DEMENTIA; SURFACES; INSIGHTS	Background Punding, one of dopamine replacement treatment related complications, refers to aimless and stereotyped behaviors. To identify possible neural correlates of punding behavior in patients with Parkinson's disease (PD), we investigated the patterns of cognitive profiles and cortical thinning. Methods Of the 186 subjects with PD screened during the study period, we prospectively enrolled 10 PD patients with punding and 43 without punding on the basis of a structured interview. We performed comprehensive neuropsychological tests and voxel-based and regions-of-interest (ROIs)-based cortical thickness analysis between PD patients with and without punding. Results The prevalence of punding in patients with PD was 5.4%. Punding behaviors were closely related to previous occupations or hobbies and showed a temporal relationship to changes of levodopa-equivalent dose (LED). Significant predisposing factors were a long duration of PD and intake of medications of PD, high total daily LED, dyskinesia, and impulse control disorder. Punding severity was correlated with LED (p = 0.029). The neurocognitive assessment revealed that PD patients with punding showed more severe cognitive deficits in the color Stroop task than did those without punding (p = 0.022). Voxel-based analysis showed that PD-punders had significant cortical thinning in the dorsolateral prefrontal area relative to controls. Additionally, ROI-based analysis revealed that cortical thinning in PD-punders relative to PD-nonpunders was localized in the prefrontal cortices, extending into orbitofrontal area. Conclusions We demonstrated that PD patients with punding performed poorly on cognitive tasks in frontal executive functions and showed severe cortical thinning in the dorsolateral prefrontal and orbitofrontal areas. These findings suggest that prefrontal modulation may be an essential component in the development of punding behavior in patients with PD.	[Yoo, Han Soo; Chung, Seok Jong; Sunwoo, Mun Kyung; Sohn, Young Ho; Lee, Phil Hyu] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Yoo, Han Soo; Chung, Seok Jong; Sunwoo, Mun Kyung; Sohn, Young Ho; Lee, Phil Hyu] Yonsei Univ, Coll Med, Brain Res Inst, Seoul, South Korea; [Yun, Hyuk Jin; Lee, Jong-Min] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Lee, Phil Hyu] Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University	Lee, PH (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	phisland@chol.net		Yoo, Han Soo/0000-0001-7846-6271; Sohn, Young H./0000-0001-6533-2610; Yun, Hyuk Jin/0000-0002-9876-314X; Lee, Phil Hyu/0000-0001-9931-8462; Chung, Seok Jong/0000-0001-6086-3199	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea [HI14C0093]	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C0093). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SW, 2005, BRAIN, V128, P201, DOI 10.1093/brain/awh329; Avila A, 2011, NEUROLOGIA, V26, P166, DOI 10.1016/j.nrl.2010.09.007; Bathgate D, 2001, ACTA NEUROL SCAND, V103, P367, DOI 10.1034/j.1600-0404.2001.2000236.x; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Best M, 2002, P NATL ACAD SCI USA, V99, P8448, DOI 10.1073/pnas.112604099; CHRISTENSON GA, 1994, J CLIN PSYCHIAT, V55, P5; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Evans AH, 2006, ANN NEUROL, V59, P852, DOI 10.1002/ana.20822; Evans AH, 2004, CURR OPIN NEUROL, V17, P393, DOI 10.1097/01.wco.0000137528.23126.41; Fasano A, 2010, MOL PSYCHIATR, V15, P560, DOI 10.1038/mp.2009.95; Fasano A, 2008, DRUG ALCOHOL DEPEN, V96, P178, DOI 10.1016/j.drugalcdep.2008.02.005; Forstmann BU, 2008, J COGNITIVE NEUROSCI, V20, P1854, DOI 10.1162/jocn.2008.20122; Giovannoni G, 2000, J NEUROL NEUROSUR PS, V68, P423, DOI 10.1136/jnnp.68.4.423; Hayashi T, 2013, P NATL ACAD SCI USA, V110, P4422, DOI 10.1073/pnas.1212185110; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kang Y., 2012, SEOUL NEUROPSYCHOLOG, V2nd; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kulisevsky J, 2009, J NEUROL, V256, P816, DOI 10.1007/s00415-009-5001-1; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Miwa H, 2007, J NEUROL, V254, P61, DOI 10.1007/s00415-007-5010-x; Miyasaki JM, 2007, MOVEMENT DISORD, V22, P1179, DOI 10.1002/mds.21296; Muresanu DF, 2012, J NEUROL SCI, V316, P15, DOI 10.1016/j.jns.2012.01.016; Park A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/485063; Pontone G, 2006, NEUROLOGY, V67, P1258, DOI 10.1212/01.wnl.0000238401.76928.45; Ray N, 2010, CLIN EEG NEUROSCI, V41, P87, DOI 10.1177/155005941004100208; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smeding HMM, 2005, J NEUROL, V252, P176, DOI 10.1007/s00415-005-0628-z; Spencer AH, 2011, MOVEMENT DISORD, V26, P578, DOI 10.1002/mds.23508; STUSS DT, 1986, BRAIN LANG, V28, P66, DOI 10.1016/0093-934X(86)90091-X; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volle E, 2002, NEUROLOGY, V58, P488, DOI 10.1212/WNL.58.3.488; Zijdenbos A, 1996, LECT NOTES COMPUT SC, V1131, P439, DOI 10.1007/BFb0046984	37	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134468	10.1371/journal.pone.0134468	http://dx.doi.org/10.1371/journal.pone.0134468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218765	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900119
J	Yu, GW; Tan, MJ; Chong, YX; Long, XX				Yu, Guangwei; Tan, Meijuan; Chong, Yunxiao; Long, Xinxian			Spatial Variation of Phosphorous Retention Capacity in Subsurface Flow Constructed Wetlands: Effect of Wetland Type and Inflow Loading	PLOS ONE			English	Article							REMOVAL; WATER; VEGETATION; NITROGEN; LONGEVITY; MEDIA; REDOX	For verification of spatial distribution of phosphorous retention capacity in constructed wetlands systems(CWs), two horizontal subsurface flow(HSSF) CWs and two vertical subsurface flow(VSSF) CWs, using sand as substrate and Typha latifolia as wetland plants, were constructed and put into use for synthetic wastewater treatment. Five months later, significant spatial variations of TP and inorganic phosphorus(Ca-P, Fe-P and Al-P) were observed, which were found to be greatly affected by CWs type and hydraulic loading. The results revealed that though spatial distribution of Fe-P and Al-P displayed a similar order of substrate content as "rhizosphere" > "near-rhizosphere" > "non-rhizosphere" and "inflow section" > "outflow section" regardless of types and loading, the distribution of Ca-P was positively correlated to that of Fe-P and Al-P in HSSF CWs, while negative correlation was shown in VSSF CWs. As a result, TP spatial distribution in HSSF CWs demonstrated a greater dissimilarity than that in VSSF CWs. For HSSF CWs with low hydraulic loading, the lowest TP content was found in non-rhizosphere substrate of outflow section, while the highest one was discovered in rhizonsphere substrate of inflow section. The values in 6 parts of areas ranged from 0.138 g.kg(-1) to 2.710 g.kg(-1), which also were from -33.5% to 1209% compared to the control value. On contrast, spatial difference of TP content in substrates of VSSF CWs was insignificant, with a variation ranging from 0.776 g.kg(-1) to 1.080 g.kg(-1), that was 275% to 421% higher than the control value. In addition, when hydraulic loading was increased, TP content in VSSF CWs sharply decreased, ranging from 0.210 g.kg(-1) to 0.634 g.kg(-1). Meanwhile, dissimilarity of TP spatial distribution in HSSF CWs was reduced, with TP content ranging from 0.258 g.kg(-1) to 2.237 g.kg(-1). The results suggested that P spatial distribution should be taken into account for CWs design and operation.	[Yu, Guangwei; Tan, Meijuan; Chong, Yunxiao; Long, Xinxian] South China Agr Univ, Coll Nat Resource & Environm, Dept Environm Sci & Engn, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Chong, YX (corresponding author), South China Agr Univ, Coll Nat Resource & Environm, Dept Environm Sci & Engn, Guangzhou 510642, Guangdong, Peoples R China.	cyx04@scau.edu.cn			National Natural Science Foundation of China [50908090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by National Natural Science Foundation of China (No. 50908090). It had an important role in study design, data collection and analysis.	Ann Y, 2000, ECOL ENG, V14, P157; Arias CA, 2001, WATER RES, V35, P1159, DOI 10.1016/S0043-1354(00)00368-7; Babatunde AO, 2009, CHEM ENG J, V152, P8, DOI 10.1016/j.cej.2009.03.020; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Bezbaruah AN, 2004, BIOTECHNOL BIOENG, V88, P60, DOI 10.1002/bit.20208; Bryhn AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005417; Cao Xue-ying, 2012, Huanjing Kexue, V33, P4033; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093130; Dickopp J, 2011, ECOL ENG, V37, P1647, DOI 10.1016/j.ecoleng.2011.06.030; Ding Y, 2014, ECOL ENG, V70, P446, DOI 10.1016/j.ecoleng.2014.06.008; Drizo A, 1999, WATER RES, V33, P3595, DOI 10.1016/S0043-1354(99)00082-2; Drizo A, 2002, ENVIRON SCI TECHNOL, V36, P4642, DOI 10.1021/es011502v; Erler DV, 2011, SCI TOTAL ENVIRON, V409, P5359, DOI 10.1016/j.scitotenv.2011.08.052; Faulwetter JL, 2009, ECOL ENG, V35, P987, DOI 10.1016/j.ecoleng.2008.12.030; Garcia J, 2003, ECOL ENG, V21, P129, DOI 10.1016/j.ecoleng.2003.10.001; Golterman HL, 1995, HYDROBIOLOGIA, V315, P39, DOI 10.1007/BF00028629; Headley TR, 2005, ECOL ENG, V25, P567, DOI 10.1016/j.ecoleng.2005.07.012; Herrmann I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069017; Li LF, 2008, BIORESOURCE TECHNOL, V99, P1656, DOI 10.1016/j.biortech.2007.04.001; Liu CX, 2009, FRONT ENVIRON SCI EN, V3, P477, DOI 10.1007/s11783-009-0155-8; Maine MA, 2007, SCI TOTAL ENVIRON, V380, P75, DOI 10.1016/j.scitotenv.2006.11.036; Martin M, 2013, ECOL ENG, V61, P34, DOI 10.1016/j.ecoleng.2013.09.046; Moustafa MZ, 2012, ECOL ENG, V42, P134, DOI 10.1016/j.ecoleng.2012.01.028; Munch C, 2005, WATER SCI TECHNOL, V51, P185, DOI 10.2166/wst.2005.0316; O'Neill A, 2011, BIORESOURCE TECHNOL, V102, P5024, DOI 10.1016/j.biortech.2011.01.075; Reddy KR, 1999, CRIT REV ENV SCI TEC, V29, P83, DOI 10.1080/10643389991259182; Reddy KR, 1997, WATER SCI TECHNOL, V35, P1, DOI 10.1016/S0273-1223(97)00046-2; Richardson J, 2000, WETLAND SOILS THEIR; Seo DC, 2005, WATER RES, V39, P2445, DOI 10.1016/j.watres.2005.04.032; SEPA of PRC, 2002, TECHN SPEC REQ MON S; Tietz A, 2007, SCI TOTAL ENVIRON, V380, P163, DOI 10.1016/j.scitotenv.2006.11.034; Trang N.T.D., 2010, ECOL ENG, V36, P527, DOI DOI 10.1016/J.ECOLENG.2009.11.022; Truu M, 2009, SCI TOTAL ENVIRON, V407, P3958, DOI 10.1016/j.scitotenv.2008.11.036; van Diggelen JMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111106; Vohla C, 2011, ECOL ENG, V37, P70, DOI 10.1016/j.ecoleng.2009.08.003; Vymazal J, 2007, SCI TOTAL ENVIRON, V380, P48, DOI 10.1016/j.scitotenv.2006.09.014; Westholm LJ, 2006, WATER RES, V40, P23, DOI 10.1016/j.watres.2005.11.006; White JR, 2006, SOIL SCI SOC AM J, V70, P1242, DOI 10.2136/sssaj2003.0339; White JR, 2004, HYDROL PROCESS, V18, P343, DOI [10.1002/hyp.1379, 10.1002/hyp,1379]; Yang Y, 2012, WATER SCI TECHNOL, V66, P1022, DOI 10.2166/wst.2012.277; Yates CR, 2009, ECOL ENG, V35, P1693, DOI 10.1016/j.ecoleng.2009.05.005	41	7	7	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134010	10.1371/journal.pone.0134010	http://dx.doi.org/10.1371/journal.pone.0134010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218872	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900064
J	Certad, G; Dupouy-Camet, J; Gantois, N; Hammouma-Ghelboun, O; Pottier, M; Guyot, K; Benamrouz, S; Osman, M; Delaire, B; Creusy, C; Viscogliosi, E; Dei-Cas, E; Aliouat-Denis, CM; Follet, J				Certad, Gabriela; Dupouy-Camet, Jean; Gantois, Nausicaa; Hammouma-Ghelboun, Ourida; Pottier, Muriel; Guyot, Karine; Benamrouz, Sadia; Osman, Marwan; Delaire, Baptiste; Creusy, Colette; Viscogliosi, Eric; Dei-Cas, Eduardo; Aliouat-Denis, Cecile Marie; Follet, Jerome			Identification of Cryptosporidium Species in Fish from Lake Geneva (Lac Leman) in France	PLOS ONE			English	Article							N. SP APICOMPLEXA; SPARUS-AURATA L.; SUBTYPE ANALYSIS; EXPOSURE; CALVES; EPIDEMIOLOGY; BALTIMORE; GENOTYPES; BACTERIA; MOLNARI	Cryptosporidium, a protozoan parasite that can cause severe diarrhea in a wide range of vertebrates including humans, is increasingly recognized as a parasite of a diverse range of wildlife species. However, little data are available regarding the identification of Cryptosporidium species and genotypes in wild aquatic environments, and more particularly in edible freshwater fish. To evaluate the prevalence of Cryptosporidiumspp. in fish from Lake Geneva (Lac Leman) in France, 41 entire fish and 100 fillets (cuts of fish flesh) were collected from fishery suppliers around the lake. Nested PCR using degenerate primers followed by sequence analysis was used. Five fish species were identified as potential hosts of Cryptosporidium: Salvelinus alpinus, Esox lucius, Coregonus lavaretus, Perca fluviatilis, and Rutilus rutilus. The presence of Cryptosporidium spp. was found in 15 out of 41 fish (37%), distributed as follows: 13 (87%) C. parvum, 1 (7%) C. molnari, and 1 (7%) mixed infection (C. parvum and C. molnari). C. molnari was identified in the stomach, while C. parvum was found in the stomach and intestine. C. molnari was also detected in 1 out of 100 analyzed fillets. In order to identify Cryptosporidium subtypes, sequencing of the highly polymorphic 60-kDa glycoprotein (gp60) was performed. Among the C. parvum positive samples, three gp60 subtypes were identified: IIaA15G2R1, IIaA16G2R1, and IIaA17G2R1. Histological examination confirmed the presence of potential developmental stages of C. parvum within digestive epithelial cells. These observations suggest that C. parvum is infecting fish, rather than being passively carried. Since C. parvum is a zoonotic species, fish potentially contaminated by the same subtypes found in terrestrial mammals would be an additional source of infection for humans and animals, and may also contribute to the contamination of the environment with this parasite. Moreover, the risk of human transmission is strengthened by the observation of edible fillet contamination.	[Certad, Gabriela; Gantois, Nausicaa; Guyot, Karine; Benamrouz, Sadia; Osman, Marwan; Viscogliosi, Eric; Dei-Cas, Eduardo; Aliouat-Denis, Cecile Marie] Univ Lille, Biol & Div Pathogenes Eucaryotes Emergents BDEEP, Ctr Infect & Immunite Lille, Inst Pasteur Lille,INSERM U1019,CNRS UMR 8402, Lille, France; [Dupouy-Camet, Jean] Univ Paris 05, Hop Cochin, AP HP, Parasitol Mycol, Paris, France; [Hammouma-Ghelboun, Ourida; Follet, Jerome] Inst Super Agr Lille, Lab Biotechnol & Gest Agents Pathogenes Agr, Lille, France; [Pottier, Muriel; Aliouat-Denis, Cecile Marie] Univ Lille, Fac Pharm, Lille, France; [Benamrouz, Sadia] Univ Catholique Lille, Fac Libre Sci & Technol Lille, Ecol & Biodiversite, Lille, France; [Osman, Marwan] Univ Libanaise, Ctr AZM Rech Biotechnol & Ses Applicat, Lab Microbiol Sante & Environm, Tripoli, Lebanon; [Delaire, Baptiste; Creusy, Colette] Grp Hosp Univ Catholique Lille, Serv Anat & Cytol Pathol, Lille, France; [Dei-Cas, Eduardo] Univ Lille Nord France, Ctr Hosp Reg & Univ Lille, Lille, France; [Follet, Jerome] Univ Valenciennes, Laboratoire BioMEMS, Univ Lille, CNRS,ISEN,IEMN,Inst Elect Microelect & Nanotechno, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Universite Catholique de Lille; Lebanese University; Universite Catholique de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Centrale Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite Polytechnique Hauts-de-France	Certad, G (corresponding author), Univ Lille, Biol & Div Pathogenes Eucaryotes Emergents BDEEP, Ctr Infect & Immunite Lille, Inst Pasteur Lille,INSERM U1019,CNRS UMR 8402, Lille, France.	gabriela.certad@pasteur-lille.fr	Osman, Marwan/AAD-3784-2021; Aliouat-Denis, Cecile-Marie/P-1934-2016	Osman, Marwan/0000-0002-6235-2760; FOLLET, Jerome/0000-0001-8992-6819; Aliouat-Denis, Cecile-Marie/0000-0001-8388-4662; Viscogliosi, Eric/0000-0002-5805-7179	French National Research Agency [ANR-10-ALIA-004]; regional competitiveness center, AQUIMER (Boulogne s/mer, France)	French National Research Agency(French National Research Agency (ANR)); regional competitiveness center, AQUIMER (Boulogne s/mer, France)	This work was supported by the French National Research Agency (grant no. ANR-10-ALIA-004) and the regional competitiveness center, AQUIMER (Boulogne s/mer, France).	Alvarez-Pellitero P, 2004, DIS AQUAT ORGAN, V62, P133, DOI 10.3354/dao062133; Alvarez-Pellitero P, 2002, INT J PARASITOL, V32, P1007, DOI 10.1016/S0020-7519(02)00058-9; Barugahare R, 2011, APPL ENVIRON MICROB, V77, P1878, DOI 10.1128/AEM.02691-10; Certad G, 2010, INT J PARASITOL, V40, P1469, DOI 10.1016/j.ijpara.2010.07.007; Diaz P, 2010, PARASITOLOGY, V137, P1187, DOI 10.1017/S0031182010000181; Fayer R, 2004, TRENDS PARASITOL, V20, P531, DOI 10.1016/j.pt.2004.08.008; Follet J, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-116; Fuchslin HP, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13683; Garcia-Presedo I, 2013, VET PARASITOL, V196, P497, DOI 10.1016/j.vetpar.2013.04.017; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Gofti-Laroche L, 2003, OUTBREAK GASTROENTER; Graczyk TK, 2007, APPL ENVIRON MICROB, V73, P4069, DOI 10.1128/AEM.00166-07; Koinari M, 2013, VET PARASITOL, V198, P1, DOI 10.1016/j.vetpar.2013.08.031; McOliver CC, 2009, AM J PUBLIC HEALTH, V99, P1116, DOI 10.2105/AJPH.2008.151654; Morine M, 2012, VET PARASITOL, V190, P578, DOI 10.1016/j.vetpar.2012.06.036; Murphy BG, 2009, J VET DIAGN INVEST, V21, P722, DOI 10.1177/104063870902100523; Ng J, 2008, EXP PARASITOL, V119, P192, DOI 10.1016/j.exppara.2008.01.010; Pote J, 2009, ENVIRON MONIT ASSESS, V154, P337, DOI 10.1007/s10661-008-0401-8; Quilez J, 2008, PARASITOLOGY, V135, P1613, DOI 10.1017/S0031182008005088; Reid A, 2010, VET PARASITOL, V168, P190, DOI 10.1016/j.vetpar.2009.11.015; Roberts JD, 2007, J TOXICOL ENV HEAL A, V70, P1568, DOI 10.1080/15287390701384791; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Ryan U, 2015, EXP PARASITOL, V150, P31, DOI 10.1016/j.exppara.2015.01.009; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Ryan U, 2012, PARASITOLOGY, V139, P1673, DOI 10.1017/S0031182012001151; Sitja-Bobadilla A, 2005, APPL ENVIRON MICROB, V71, P131, DOI 10.1128/AEM.71.1.131-139.2005; Thevenon F, 2012, ECOTOX ENVIRON SAFE, V78, P50, DOI 10.1016/j.ecoenv.2011.11.005; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	29	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133047	10.1371/journal.pone.0133047	http://dx.doi.org/10.1371/journal.pone.0133047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213992	Green Published, Green Submitted, gold			2022-12-26	WOS:000358594300013
J	Lombard, C; Andre, F; Paul, J; Wanty, C; Vosters, O; Bernard, P; Pilette, C; Dupont, P; Sokal, EM; Smets, F				Lombard, Catherine; Andre, Floriane; Paul, Jerome; Wanty, Catherine; Vosters, Olivier; Bernard, Pierre; Pilette, Charles; Dupont, Pierre; Sokal, Etienne M.; Smets, Francoise			Clinical Parameters vs Cytokine Profiles as Predictive Markers of IgE-Mediated Allergy in Young Children	PLOS ONE			English	Article							T-CELLS; IMMUNOGLOBULIN-E; FOOD ALLERGY; SENSITIZATION; PREVALENCE; DISTINCT; LINEAGE; IL-15	Background Allergy afflicts one third of children, negatively impacting their quality of life and generating a significant socio-economic burden. To this day, this disorder remains difficult to diagnose early in young patients, with no predictive test available. Objective This study was designed to correlate cytokine profiles with clinical phenotypes of allergy development. Methods Three hundred patients were recruited and followed from birth to 18 months of age. They were given a clinical exam at birth and at 2, 6, 12, and 18 months of age, with skin prick tests at 6, and 18 months, in order to have a record of their medical history and determine their allergic status. In addition, mononuclear cells from 131 patients were isolated from cord blood and from peripheral blood samples at 2, 6 and 18 months of age, to analyse their cytokine and chemokine production. Results Cord blood mononuclear cells (CBMCs) from future Immunoglobulin (Ig) E-mediated allergic children produced significantly less Interleukin (IL)-12p70 and IL-15 than cells from the rest of the cohort. Multivariate analyses revealed that the best predictive model of allergy was built on cytokine data, whereas the best predictive model of IgE-mediated allergy was built on clinical parameters. Conclusions and clinical relevance Although univariate analyses can yield interesting information regarding the immune responses of allergic children, finding predictive markers of the disorder will likely rely on monitoring multiple parameters. Nonetheless these analyses suggest a potential key role for IL-15 in the development of atopic disease. In addition, the study highlights the importance of clinical parameters in predicting the development of IgE-mediated allergy.	[Lombard, Catherine; Andre, Floriane; Sokal, Etienne M.; Smets, Francoise] Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Pediat Hepatol & Cell Therapy, B-1200 Brussels, Belgium; [Paul, Jerome; Dupont, Pierre] Louvain Sch Engn, ICTEAM Inst, Machine Learning Grp, INGI Dept, Louvain La Neuve, Belgium; [Wanty, Catherine; Sokal, Etienne M.; Smets, Francoise] Clin Univ St Luc, Paediat Gastroenterol & Hepatol Unit, B-1200 Brussels, Belgium; [Vosters, Olivier] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; [Dupont, Pierre] Clin Univ St Luc, Obstetr Unit, B-1200 Brussels, Belgium; [Pilette, Charles] Catholic Univ Louvain, Pole Pneumol ENT & Dermatol, IREC, Clin Univ St Luc,Pneumol Dept, B-1200 Brussels, Belgium; [Pilette, Charles] Ctr Allergy, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Lombard, C (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Pediat Hepatol & Cell Therapy, B-1200 Brussels, Belgium.	catherine.lombard@uclouvain.be		Lombard, Catherine/0000-0002-5653-9545; Sokal, Etienne/0000-0001-5597-4708	government of the Walloon Region; GlaxoSmithKline Biologicals [FIRST 051/6261-CRISTALL study]	government of the Walloon Region; GlaxoSmithKline Biologicals(GlaxoSmithKline)	This work was supported by a grant from the government of the Walloon Region and GlaxoSmithKline Biologicals (FIRST 051/6261-CRISTALL study). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Aoi N, 2006, J ALLERGY CLIN IMMUN, V117, P1359, DOI 10.1016/j.jaci.2006.02.018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Chen CM, 2010, INT J HYG ENVIR HEAL, V213, P1, DOI 10.1016/j.ijheh.2009.12.003; Daemen A, 2009, IEEE ENG MED BIO, P5913, DOI 10.1109/IEMBS.2009.5334847; Dhami S, 2015, J ROY SOC MED, V108, P229, DOI 10.1177/0141076814562982; Costa AJF, 2011, PEDIAT ALLERG IMM-UK, V22, pe133, DOI 10.1111/j.1399-3038.2010.00988.x; Fiocchi A, 2006, ALLERGY ASTHMA PROC, V27, P178, DOI 10.2500/aap.2006.27.2850; Guyon I., 2006, FEATURE EXTRACTION F, V207; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris KM, 2010, CLIN IMMUNOL, V135, P430, DOI 10.1016/j.clim.2010.01.003; Husby S, 2008, J PEDIATR GASTR NUTR, V47, pS49, DOI 10.1097/01.mpg.0000338813.97803.16; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; KINIWA M, 1992, J CLIN INVEST, V90, P262, DOI 10.1172/JCI115846; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Lifschitz C, 2015, EUR J PEDIATR, V174, P141, DOI 10.1007/s00431-014-2422-3; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nadeau C, 2003, MACH LEARN, V52, P239, DOI 10.1023/A:1024068626366; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; Nilsson C, 2004, CLIN EXP ALLERGY, V34, P373, DOI 10.1111/j.1365-2222.2004.01896.x; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Pandiyan P, 2012, J IMMUNOL, V189, P4237, DOI 10.4049/jimmunol.1201476; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PATRICK EA, 1970, INFORM CONTROL, V16, P128, DOI 10.1016/S0019-9958(70)90081-1; Piippo-Savolainen E, 2008, ACTA PAEDIATR, V97, P5, DOI 10.1111/j.1651-2227.2007.00558.x; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	36	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0132753	10.1371/journal.pone.0132753	http://dx.doi.org/10.1371/journal.pone.0132753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214693	Green Submitted, gold, Green Published			2022-12-26	WOS:000358594300010
J	Chiodo, L; Malliavin, TE; Maragliano, L; Cottone, G; Ciccotti, G				Chiodo, Letizia; Malliavin, Therese E.; Maragliano, Luca; Cottone, Grazia; Ciccotti, Giovanni			A Structural Model of the Human alpha 7 Nicotinic Receptor in an Open Conformation	PLOS ONE			English	Article							GATED ION-CHANNEL; ACETYLCHOLINE-BINDING-PROTEIN; X-RAY-STRUCTURE; MOLECULAR-DYNAMICS SIMULATION; AGONIST BINDING; STRUCTURE VALIDATION; CRYSTAL-STRUCTURES; GATING MECHANISM; OPEN-STATE; LOOP	Nicotinic acetylcholine receptors (nAchRs) are ligand-gated ion channels that regulate chemical transmission at the neuromuscular junction. Structural information is available at low resolution from open and closed forms of an eukaryotic receptor, and at high resolution from other members of the same structural family, two prokaryotic orthologs and an eukaryotic GluCl channel. Structures of human channels however are still lacking. Homology modeling and Molecular Dynamics simulations are valuable tools to predict structures of unknown proteins, however, for the case of human nAchRs, they have been unsuccessful in providing a stable open structure so far. This is due to different problems with the template structures: on one side the homology with prokaryotic species is too low, while on the other the open eukaryotic GluCl proved itself unstable in several MD studies and collapsed to a dehydrated, non-conductive conformation, even when bound to an agonist. Aim of this work is to obtain, by a mixing of state-of-the-art homology and simulation techniques, a plausible prediction of the structure (still unknown) of the open state of human alpha 7 nAChR complexed with epibatidine, from which it is possible to start structural and functional test studies. To prevent channel closure we employ a restraint that keeps the transmembrane pore open, and obtain in this way a stable, hydrated conformation. To further validate this conformation, we run four long, unbiased simulations starting from configurations chosen at random along the restrained trajectory. The channel remains stable and hydrated over the whole runs. This allows to assess the stability of the putative open conformation over a cumulative time of 1 mu s, 800 ns of which are of unbiased simulation. Mostly based on the analysis of pore hydration and size, we suggest that the obtained structure has reasonable chances to be (at least one of the possible) structures of the channel in the open conformation.	[Chiodo, Letizia] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Malliavin, Therese E.] Inst Pasteur, Paris, France; [Malliavin, Therese E.] CNRS, UMR 3528, Unite Bioinformat Struct, Paris, France; [Maragliano, Luca] Ist Italiano Tecnol, Ctr Synapt Neurosci, Genoa, Italy; [Cottone, Grazia] Univ Palermo, Dept Chem & Phys, Palermo, Italy; [Cottone, Grazia; Ciccotti, Giovanni] Univ Coll Dublin, Sch Phys, Dublin 2, Ireland; [Ciccotti, Giovanni] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	Istituto Italiano di Tecnologia - IIT; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Istituto Italiano di Tecnologia - IIT; University of Palermo; University College Dublin; Sapienza University Rome	Cottone, G (corresponding author), Univ Palermo, Dept Chem & Phys, Palermo, Italy.	grazia.cottone@unipa.it	Maragliano, Luca/A-8294-2010; Chiodo, Letizia/G-9609-2012; Cottone, Grazia/E-8734-2012	Maragliano, Luca/0000-0002-5705-6967; Chiodo, Letizia/0000-0002-8278-7075; Cottone, Grazia/0000-0001-6923-6394; Malliavin, Therese/0000-0002-3276-3366	Science Foundation of Ireland (SFI) [08-IN.1-I1869]; Istituto Italiano di Tecnologia (IIT) [N.259SIMBEDD]; University of Palermo (FFR program)	Science Foundation of Ireland (SFI)(Science Foundation Ireland); Istituto Italiano di Tecnologia (IIT)(Istituto Italiano di Tecnologia - IIT); University of Palermo (FFR program)	This work was supported by Science Foundation of Ireland (SFI, grant 08-IN.1-I1869, G. Ciccotti, http://www.sfi.ie/), Istituto Italiano di Tecnologia (IIT, seed project grant N.259SIMBEDD, G. Ciccotti, http://www.iit.it/it/home.html), and University of Palermo (FFR program 2012/2013, www.unipa.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Amiri S, 2007, PROTEIN ENG DES SEL, V20, P353, DOI 10.1093/protein/gzm029; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Baptista-Hon DT, 2013, J BIOL CHEM, V288, P21558, DOI 10.1074/jbc.M113.481689; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Bondarenko V, 2014, BBA-BIOMEMBRANES, V1838, P1389, DOI 10.1016/j.bbamem.2013.12.018; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bourne Y, 2006, J MOL NEUROSCI, V30, P103, DOI 10.1385/JMN:30:1:103; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng MH, 2012, J PHYS CHEM B, V116, P13637, DOI 10.1021/jp3074915; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; Cheng XL, 2006, J MOL BIOL, V355, P310, DOI 10.1016/j.jmb.2005.10.039; Costa V, 2003, BRIT J PHARMACOL, V140, P921, DOI 10.1038/sj.bjp.0705498; CZERMINSKI R, 1990, INT J QUANTUM CHEM, P167; DeLano WL, 2002, THE PYMOL MOLECULAR; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Edink E, 2011, J AM CHEM SOC, V133, P5363, DOI 10.1021/ja110571r; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Gao F, 2003, J BIOL CHEM, V278, P23020, DOI 10.1074/jbc.M301151200; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Grazioso G, 2008, J COMPUT CHEM, V29, P2593, DOI 10.1002/jcc.21019; Haddadian EJ, 2008, J PHYS CHEM B, V112, P13981, DOI 10.1021/jp804868s; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Henchman RH, 2003, BIOPHYS J, V85, P3007, DOI 10.1016/S0006-3495(03)74720-1; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Hung A, 2005, BIOPHYS J, V88, P3321, DOI 10.1529/biophysj.104.052878; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kinde MN, 2015, STRUCTURE, V23, P995, DOI 10.1016/j.str.2015.03.017; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Lindert S, 2013, J CHEM THEORY COMPUT, V9, P3843, DOI 10.1021/ct400260c; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Murail S, 2011, BIOPHYS J, V100, P1642, DOI 10.1016/j.bpj.2011.02.032; Naveh ZMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088555; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Quigley D, 2004, J CHEM PHYS, V120, P11432, DOI 10.1063/1.1755657; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samson AO, 2008, BIOCHEMISTRY-US, V47, P4065, DOI 10.1021/bi702272j; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Shahsavar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040757; Song C, 2010, BIOPHYS J, V98, P404, DOI 10.1016/j.bpj.2009.10.032; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tsetlin V, 2009, CURR OPIN PHARMACOL, V9, P306, DOI 10.1016/j.coph.2009.03.005; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Ulens C, 2009, J MED CHEM, V52, P2372, DOI 10.1021/jm801400g; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whatley VJ, 1996, INT REV NEUROBIOL, V39, P113, DOI 10.1016/S0074-7742(08)60665-0; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Yaffe E, 2008, NUCLEIC ACIDS RES, V36, pW210, DOI 10.1093/nar/gkn223; Yan D, 2005, MOL PHARMACOL, V68, P365, DOI 10.1124/mol.105.011957; Yoluk O, 2013, BIOPHYS J, V105, P640, DOI 10.1016/j.bpj.2013.06.037; Yu RL, 2014, BIOCHEMISTRY-US, V53, P6041, DOI 10.1021/bi500815f; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	109	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133011	10.1371/journal.pone.0133011	http://dx.doi.org/10.1371/journal.pone.0133011			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208301	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000056
J	Hafiane, A; Bielicki, JK; Johansson, JO; Genest, J				Hafiane, Anouar; Bielicki, John K.; Johansson, Jan O.; Genest, Jacques			Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of pre beta-1 HDL In Vitro	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEINS; MIMETIC PEPTIDE; CELLULAR CHOLESTEROL; LIPID EFFLUX; BIDIRECTIONAL FLUX; METABOLISM; ATHEROSCLEROSIS; ACYLTRANSFERASE; MECHANISMS	Apolipoprotein (apo) mimetic peptides replicate some aspects of HDL function. We have previously reported the effects of compound ATI-5261 on its ability to replicate many functions of native apo A-I in the process of HDL biogenesis. ATI-5261 induced muscle toxicity in wild type C57Bl/6 mice, increased CPK, ALT and AST and increase in triglyceride (Tg) levels. Aromatic phenylalanine residues on the non-polar face of ATI-5261, together with positively charged arginine residues at the lipid-water interface were responsible for these effects. This information was used to create a novel analog (CS-6253) that was non-toxic. We evaluated this peptide designed from the carboxyl terminus of apo E, in its ability to mimic apo A-I functionality. Our data shows that the lipidated particles generated by incubating cells overexpressing ABCA1 with lipid free CS-6253 enhances the rate of ABCA1 lipid efflux with high affinity interactions with native ABCA1 oligomeric forms and plasma membrane micro-domains. Interaction between ABCA1 and lipid free CS-6253 resulted in formation of nascent HDL-CS-6253 particles that are actively remodeled in plasma. Mature HDL-CS-6253 particles deliver cholesterol to liver cells via SR-BI in-vitro. CS-6253 significantly increases cholesterol efflux in murine macrophages and in human THP-1 macrophage-derived foam cells expressing ABCA1. Addition of CS-6253 to plasma dose-dependently displaced apo A-I from alpha-HDL particles and led to de novo formation of pre beta-1 HDL that stimulates ABCA1 dependent cholesterol efflux efficiently. When incubated with human plasma CS-6253 was also found to bind with HDL and LDL and promoted the transfer of cholesterol from HDL to LDL predominantly. Our data shows that CS-6253 mimics apo A-I in its ability to promote ABCA1-mediated formation of nascent HDL particles, and enhances formation of pre beta-1 HDL with increase in the cycling of apo A-I between the pre beta and alpha-HDL particles in-vitro. These mechanisms are potentially anti-atherogenic.	[Hafiane, Anouar; Genest, Jacques] McGill Univ, Cardiovasc Res Labs Lab, Res Inst, Ctr Hlth, Montreal, PQ H4A 3J1, Canada; [Bielicki, John K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Donner Lab, Berkeley, CA 94720 USA; [Johansson, Jan O.] Artery Therapeut, San Ramon, CA USA	McGill University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Genest, J (corresponding author), McGill Univ, Cardiovasc Res Labs Lab, Res Inst, Ctr Hlth, Montreal, PQ H4A 3J1, Canada.	Jacques.genest@mcgill.ca	Hafiane, Anouar/AAE-3481-2020	Hafiane, Anouar/0000-0001-7494-722X; Johansson, Jan/0000-0002-3576-2748	Canadian Institutes of Health Research (CIHR) fund [MOP 15042]; Artery Therapeutics; NATIONAL CANCER INSTITUTE [R33CA094304] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR) fund; Artery Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is funded by the Canadian Institutes of Health Research (CIHR) fund MOP 15042 (JG). Artery Therapeutics provided support in the form of salaries for authors JJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Alexander ET, 2011, ARTERIOSCL THROM VAS, V31, P320, DOI 10.1161/ATVBAHA.110.216226; Amar MJA, 2010, J PHARMACOL EXP THER, V334, P634, DOI 10.1124/jpet.110.167890; ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Bailey D, 2010, J LIPID RES, V51, P785, DOI 10.1194/jlr.M001875; Bielicki JK, 2010, J LIPID RES, V51, P1496, DOI 10.1194/jlr.M003665; Bolin DJ, 1996, J BIOL CHEM, V271, P19152, DOI 10.1074/jbc.271.32.19152; Calabresi L, 2010, TRENDS CARDIOVAS MED, V20, P50, DOI 10.1016/j.tcm.2010.03.007; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Chen X, 2009, INT J BIOL SCI, V5, P489; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; de Souza JA, 2008, ATHEROSCLEROSIS, V197, P84, DOI 10.1016/j.atherosclerosis.2007.08.009; Denis M, 2004, J BIOL CHEM, V279, P41529, DOI 10.1074/jbc.M406881200; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Dergunov AD, 2013, MOL CELL BIOCHEM, V378, P283, DOI 10.1007/s11010-013-1619-5; Diditchenko S, 2013, ARTERIOSCL THROM VAS, V33, P2202, DOI 10.1161/ATVBAHA.113.301981; Doonan RJ, 2014, ARTERIOSCL THROM VAS, V34, P921, DOI 10.1161/ATVBAHA.113.302590; Favari E, 2009, BIOCHEMISTRY-US, V48, P11067, DOI 10.1021/bi901564g; GARBER DW, 1992, ARTERIOSCLER THROMB, V12, P886, DOI 10.1161/01.ATV.12.8.886; Getz GS, 2014, CURR OPIN ENDOCRINOL, V21, P129, DOI 10.1097/MED.0000000000000045; Getz GS, 2010, CURR ATHEROSCLER REP, V12, P96, DOI 10.1007/s11883-010-0097-4; Getz GS, 2009, CURR OPIN LIPIDOL, V20, P171, DOI 10.1097/MOL.0b013e32832ac051; Hafiane A, 2014, BIOCH BIOPHYS ACTA; Hafiane A, 2014, BBA-MOL CELL BIOL L, V1841, P1498, DOI 10.1016/j.bbalip.2014.07.018; Hafiane A, 2014, CURR OPIN ENDOCRINOL, V21, P134, DOI 10.1097/MED.0000000000000049; Hafiane A, 2014, AM J CARDIOL, V113, P249, DOI 10.1016/j.amjcard.2013.09.006; Hafiane A, 2013, CHOLESTEROL, DOI 10.1155/2013/891403; Hassan HH, 2008, J BIOL CHEM, V283, P11164, DOI 10.1074/jbc.M707720200; Hassan HH, 2006, CAN J CARDIOL, V22, p35B, DOI 10.1016/S0828-282X(06)70985-0; Hatch F T, 1968, Adv Lipid Res, V6, P1; Iatan I, 2011, J LIPID RES, V52, P2043, DOI 10.1194/jlr.M016196; KAWANO M, 1993, BIOCHEMISTRY-US, V32, P5025, DOI 10.1021/bi00070a008; Kee P, 2002, ARTERIOSCL THROM VAS, V22, P1912, DOI 10.1161/01.ATV.0000038485.94020.7F; Krimbou L, 1997, J LIPID RES, V38, P35; Krimbou L, 2005, J LIPID RES, V46, P1668, DOI 10.1194/jlr.M500038-JLR200; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Kritharides L, 1998, ARTERIOSCL THROM VAS, V18, P1589, DOI 10.1161/01.ATV.18.10.1589; LAW SW, 1983, BIOCHEM BIOPH RES CO, V112, P257, DOI 10.1016/0006-291X(83)91824-7; Leman LJ, 2014, J MED CHEM, V57, P2169, DOI 10.1021/jm4005847; Liu RJ, 2007, ARTERIOSCL THROM VAS, V27, P190, DOI 10.1161/01.ATV.0000249721.96666.e5; Liu XH, 2010, J CARDIOVASC PHARM, V56, P309, DOI 10.1097/FJC.0b013e3181edaf69; Liu YH, 2012, BBA-MOL CELL BIOL L, V1821, P522, DOI 10.1016/j.bbalip.2011.08.015; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lund-Katz S, 2013, J BIOL CHEM, V288, P23150, DOI 10.1074/jbc.M113.495523; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mazzone T, 1996, CURR OPIN LIPIDOL, V7, P303, DOI 10.1097/00041433-199610000-00008; Miyazaki O, 2014, J LIPID RES, V55, P214, DOI 10.1194/jlr.M041038; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Nandi S, 2009, J LIPID RES, V50, P456, DOI 10.1194/jlr.M800345-JLR200; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Nordskog BK, 1999, J LIPID RES, V40, P1806; Oram JF, 1996, J LIPID RES, V37, P2473; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Remaley Alan T, 2008, Expert Rev Cardiovasc Ther, V6, P1203, DOI 10.1586/14779072.6.9.1203; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Sethi AA, 2008, J BIOL CHEM, V283, P32273, DOI 10.1074/jbc.M804461200; Smith JD, 2010, CURR OPIN INVEST DR, V11, P989; Smythies LE, 2010, AM J PHYSIOL-CELL PH, V298, pC1538, DOI 10.1152/ajpcell.00467.2009; Song XL, 2009, INT J BIOL SCI, V5, P637; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Sviridov DO, 2013, J PHARMACOL EXP THER, V344, P50, DOI 10.1124/jpet.112.198143; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Tang CK, 2004, ACTA BIOCH BIOPH SIN, V36, P218, DOI 10.1093/abbs/36.3.218; Tardy C, 2014, ATHEROSCLEROSIS, V232, P110, DOI 10.1016/j.atherosclerosis.2013.10.018; Tavori H, 2015, J LIPID RES; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; Troutt JS, 2008, J LIPID RES, V49, P581, DOI 10.1194/jlr.M700385-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Waksman R, 2010, J AM COLL CARDIOL, V55, P2727, DOI 10.1016/j.jacc.2009.12.067; White CR, 2012, ARTERIOSCL THROM VAS, V32, P2631, DOI 10.1161/ATVBAHA.112.300167; Wool GD, 2008, J LIPID RES, V49, P1268, DOI 10.1194/jlr.M700552-JLR200; Wroblewska M, 2011, ACTA BIOCHIM POL, V58, P275; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200; Zheng Y, 2011, BIOCHEMISTRY-US, V50, P4068, DOI 10.1021/bi2002955; Zimetti F, 2006, J LIPID RES, V47, P605, DOI 10.1194/jlr.M500466-JLR200	84	37	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131997	10.1371/journal.pone.0131997	http://dx.doi.org/10.1371/journal.pone.0131997			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207756	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000020
J	Kinoshita, S; Kiyama, R; Yoshimoto, Y				Kinoshita, Satomi; Kiyama, Ryoji; Yoshimoto, Yoichi			Effect of Handrail Height on Sit-To-Stand Movement	PLOS ONE			English	Article							LOWER-LIMB MOVEMENT; BIOMECHANICAL ANALYSIS; SAGITTAL SPINE; HEALTHY; SUPPORT; WALKING; YOUNG; DETERMINANTS; POSITION; RISK	Background Care-needing older adults and disabled individuals often require handrails for assistance of movements, such as sit-to-stand movements. Handrails must be set at the appropriate position; however, the effects of handrail height on joint movement and center-of-gravity movements during sit-to-stand movement remain unclear. In the present study, we sought to clarify the effects of handrail height on joint movement, center-of-gravity, and floor reaction force during sit-to-stand movement. Methods Subjects included 16 healthy young adults and 25 older adults who require long-term care. Kinetic and kinematic measurements during sit-to-stand movement of young adults were conducted using a 3-D motion analyzer and a force plate. Trunk forward tilt angle during sit-to- stand movement of older adults was measured using a still image from a video recording. Results Using low handrails, sit-to-stand movement resulted in an increased hip flexion angle, ankle dorsiflexion angle, and trunk forward tilt angle and a greater forward center-of-gravity shift than when not using handrails in young adults during seat-off. In contrast, using high handrails resulted in a smaller hip flexion angle and trunk forward tilt angle in young adults. The backward force on the floor was decreased in the low handrail condition, and was increased in the high handrail condition rather than that of sit-to-stand movement without handrails in young adults. The effect of handrail height on trunk forward tilt angle was the same in both healthy young adults and care-needing older adults during seat-off. Conclusion Because handrail height affects joint movement and shift in the center-of-gravity during sitto- stand movement, handrail position should be selected to match the status of older adults with functional impairment.	[Kinoshita, Satomi] Kagoshima Univ, Grad Sch Hlth Sci, Doctor Course, Kagoshima 890, Japan; [Kiyama, Ryoji; Yoshimoto, Yoichi] Kagoshima Univ, Sch Hlth Sci, Course Phys Therapy, Fac Med, Kagoshima 890, Japan	Kagoshima University; Kagoshima University	Kinoshita, S (corresponding author), Kagoshima Univ, Grad Sch Hlth Sci, Doctor Course, Kagoshima 890, Japan.	monko@giga.ocn.ne.jp						ALEXANDER NB, 1991, J GERONTOL, V46, pM91, DOI 10.1093/geronj/46.3.M91; BAER GD, 1995, ARCH PHYS MED REHAB, V76, P844, DOI 10.1016/S0003-9993(95)80550-8; Bahrami F, 2000, CLIN BIOMECH, V15, P123, DOI 10.1016/S0268-0033(99)00044-3; Bernardi M, 2004, J ELECTROMYOGR KINES, V14, P401, DOI 10.1016/j.jelekin.2003.09.001; Chen G, 2005, GAIT POSTURE, V22, P57, DOI 10.1016/j.gaitpost.2004.06.008; Cheng PT, 2004, AM J PHYS MED REHAB, V83, P10, DOI 10.1097/01.PHM.0000104665.34557.56; Chihara T, 2014, APPL ERGON, V45, P261, DOI 10.1016/j.apergo.2013.04.006; Chou SW, 2003, AM J PHYS MED REHAB, V82, P42, DOI 10.1097/01.PHM.0000043769.93584.4D; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; DeVincenzo DK, 2012, REHABIL NURS, V12, P248; Edlich Richard F, 2003, J Long Term Eff Med Implants, V13, P31, DOI 10.1615/JLongTermEffMedImplants.v13.i1.40; GARDNER AW, 1991, AM J CARDIOL, V68, P99, DOI 10.1016/0002-9149(91)90719-2; IJmker T, 2013, ARCH PHYS MED REHAB, V94, P2255, DOI 10.1016/j.apmr.2013.04.022; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Kinoshita S, 2012, J BACK MUSCULOSKELET, V25, P33, DOI 10.3233/BMR-2012-0308; Kuo YL, 2010, SPINE, V35, pE1, DOI 10.1097/BRS.0b013e3181c47a0e; Mak MKY, 2003, CLIN BIOMECH, V18, P197, DOI 10.1016/S0268-0033(02)00191-2; Maki BE, 2011, J SAFETY RES, V42, P473, DOI 10.1016/j.jsr.2011.02.002; MANFRE MJ, 1994, CLIN CARDIOL, V17, P445, DOI 10.1002/clc.4960170808; Mazza C, 2004, J AM GERIATR SOC, V52, P1750, DOI 10.1111/j.1532-5415.2004.52472.x; MILLINGTON PJ, 1992, ARCH PHYS MED REHAB, V73, P609; Mion LC, 2013, REHABIL NURS, V14, P17; NYBERG L, 1995, STROKE, V26, P838, DOI 10.1161/01.STR.26.5.838; O'Connor SE, 2000, REHABILITATION NURSI, V25, P224; O'Meara DM, 2006, HUM MOVEMENT SCI, V25, P257, DOI 10.1016/j.humov.2005.11.003; O'Meara DM, 2005, J APPL BIOMECH, V21, P57, DOI 10.1123/jab.21.1.57; Papa E, 2000, J BIOMECH, V33, P1113, DOI 10.1016/S0021-9290(00)00046-4; Ploutz-Snyder LL, 2002, J GERONTOL A-BIOL, V57, pB144, DOI 10.1093/gerona/57.4.B144; RODOSKY MW, 1989, J ORTHOPAED RES, V7, P266, DOI 10.1002/jor.1100070215; ROEBROECK ME, 1994, CLIN BIOMECH, V9, P235, DOI 10.1016/0268-0033(94)90004-3; Sato S, 2012, JPN J COMPR REHABIL, V3, P6; Scarborough DM, 2007, J REHABIL RES DEV, V44, P33, DOI 10.1682/JRRD.2005.08.0134; Schenkman M, 1996, CLIN BIOMECH, V11, P153, DOI 10.1016/0268-0033(95)00060-7; Talis VL, 2008, CLIN BIOMECH, V23, P424, DOI 10.1016/j.clinbiomech.2007.11.010; Tully EA, 2005, GAIT POSTURE, V22, P338, DOI 10.1016/j.gaitpost.2004.11.007; VANDERLINDEN DW, 1994, ARCH PHYS MED REHAB, V75, P653, DOI 10.1016/0003-9993(94)90188-0; Yamada T, 2009, ARCH GERONTOL GERIAT, V48, P73, DOI 10.1016/j.archger.2007.10.006	37	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133747	10.1371/journal.pone.0133747	http://dx.doi.org/10.1371/journal.pone.0133747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207755	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000130
J	Murphy, JN; Harris, KD; Buriak, JM				Murphy, Jeffrey N.; Harris, Kenneth D.; Buriak, Jillian M.			Automated Defect and Correlation Length Analysis of Block Copolymer Thin Film Nanopatterns	PLOS ONE			English	Article							LINE-EDGE ROUGHNESS; ORDER-DISORDER TRANSITION; DIBLOCK COPOLYMERS; ORIENTATION; DENSITY; IMPACT; LITHOGRAPHY; FEATURES; PHASE; NANOLITHOGRAPHY	Line patterns produced by lamellae- and cylinder-forming block copolymer (BCP) thin films are of widespread interest for their potential to enable nanoscale patterning over large areas. In order for such patterning methods to effectively integrate with current technologies, the resulting patterns need to have low defect densities, and be produced in a short timescale. To understand whether a given polymer or annealing method might potentially meet such challenges, it is necessary to examine the evolution of defects. Unfortunately, few tools are readily available to researchers, particularly those engaged in the synthesis and design of new polymeric systems with the potential for patterning, to measure defects in such line patterns. To this end, we present an image analysis tool, which we have developed and made available, to measure the characteristics of such patterns in an automated fashion. Additionally we apply the tool to six cylinder-forming polystyrene-block- poly(2-vinylpyridine) polymers thermally annealed to explore the relationship between the size of each polymer and measured characteristics including line period, linewidth, defect density, line-edge roughness (LER), line-width roughness (LWR), and correlation length. Finally, we explore the line-edge roughness, line-width roughness, defect density, and correlation length as a function of the image area sampled to determine each in a more rigorous fashion.	[Murphy, Jeffrey N.; Buriak, Jillian M.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Murphy, Jeffrey N.; Harris, Kenneth D.; Buriak, Jillian M.] Natl Inst Nanotechnol NINT, Edmonton, AB, Canada	University of Alberta; National Research Council Canada	Murphy, JN (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB, Canada.	jnmurphy@ualberta.ca; jburiak@ualberta.ca	Murphy, Jeffrey N./F-1119-2010	Murphy, Jeffrey N./0000-0001-9180-9187; Buriak, Jillian Mary/0000-0002-9567-4328	NSERC; Izaak Walton Killam Memorial Scholarship, Killam Trusts; Canada Research Chair of Nanomaterials	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Izaak Walton Killam Memorial Scholarship, Killam Trusts; Canada Research Chair of Nanomaterials	JNM: NSERC Postgraduate Doctoral Scholarship, 2010-2013 (http://www.nserc-crsng.gc.ca) JNM: Izaak Walton Killam Memorial Scholarship, Killam Trusts, 2012-2014 (http://www.killamlaureates. ca) JMB: NSERC Discovery Grant, 2008-2014, 2014-2019 (http://www.nserc-crsng.gc.ca) JMB: Canada Research Chair of Nanomaterials (http://www.chairschaires.gc.ca/home-accueil-eng. aspx) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir NM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063025; Adutler-Lieber S, 2014, J AUTOIMMUN, V54, P100, DOI 10.1016/j.jaut.2014.05.003; [Anonymous], 2013, EMERGING RESEARCH MA; [Anonymous], 2011, EMERGING RESEARCH MA; [Anonymous], 2011, TEMPLATETYPEDEF ANSW; Asenov A, 2003, IEEE T ELECTRON DEV, V50, P1254, DOI 10.1109/TED.2003.813457; Bates CM, 2014, MACROMOLECULES, V47, P2, DOI 10.1021/ma401762n; Bates CM, 2012, SCIENCE, V338, P775, DOI 10.1126/science.1226046; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Beardsley TM, 2011, MACROMOLECULES, V44, P6209, DOI 10.1021/ma200966a; Bencher C, 2012, PROC SPIE, V8323, DOI 10.1117/12.917993; Berry BC, 2007, NANO LETT, V7, P2789, DOI 10.1021/nl071354s; Bita I, 2008, SCIENCE, V321, P939, DOI 10.1126/science.1159352; Black CT, 2001, APPL PHYS LETT, V79, P409, DOI 10.1063/1.1383805; Brillinger DR, 2011, INTERNATIONAL ENCYCL, P531; Campbell IP, 2013, MACROMOLECULES, V46, P9599, DOI 10.1021/ma401704m; Campbell IP, 2013, ACS MACRO LETT, V2, P918, DOI 10.1021/mz400269k; Chai J, 2007, NAT NANOTECHNOL, V2, P500, DOI 10.1038/nnano.2007.227; Chang MY, 2002, MACROMOLECULES, V35, P4437, DOI 10.1021/ma0201025; Cushen JD, 2012, ACS NANO, V6, P3424, DOI 10.1021/nn300459r; Deeg JA, 2011, NANO LETT, V11, P1469, DOI 10.1021/nl104079r; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Faas FGA, 2012, J CELL BIOL, V198, P457, DOI 10.1083/jcb.201201140; Fukukawa K, 2005, MACROMOLECULES, V38, P263, DOI 10.1021/ma049217u; Garetz BA, 1996, MACROMOLECULES, V29, P4675, DOI 10.1021/ma9600724; Gopalan P, 2006, MATERIAL MATTERS, V1, P6; Harrison C, 2000, SCIENCE, V290, P1558, DOI 10.1126/science.290.5496.1558; Harrison C, 2000, MACROMOLECULES, V33, P857, DOI 10.1021/ma991551g; Harrison CK, 1999, BLOCK COPOLYMER MICR; Hawker CJ, 2005, SCIENCE, V309, P1200, DOI 10.1126/science.1109778; Hawker CJ, 2001, CHEM REV, V101, P3661, DOI 10.1021/cr990119u; Hawker CJ, 1997, ACCOUNTS CHEM RES, V30, P373, DOI 10.1021/ar960248m; Hong SW, 2013, ACS NANO, V7, P9684, DOI 10.1021/nn402639g; Horvat A, 2008, ACS NANO, V2, P1143, DOI 10.1021/nn800181m; Hu XC, 2005, FARADAY DISCUSS, V128, P103, DOI 10.1039/b403881a; In I, 2006, LANGMUIR, V22, P7855, DOI 10.1021/la060748g; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Isawa M, 2013, PROC SPIE, V8681, DOI 10.1117/12.2010915; Jeong CK, 2014, NANO LETT, V14, P7031, DOI 10.1021/nl503402c; Jin C, 2014, ACS NANO, V8, P3979, DOI 10.1021/nn5009098; Jung YS, 2007, NANO LETT, V7, P2046, DOI 10.1021/nl070924l; Kim E, 2013, ACS NANO, V7, P1952, DOI 10.1021/nn3051264; Kim HW, 2004, IEEE T ELECTRON DEV, V51, P1984, DOI 10.1109/TED.2004.839115; Kim SO, 2003, NATURE, V424, P411, DOI 10.1038/nature01775; Kim Y, 2005, LANGMUIR, V21, P10444, DOI 10.1021/la047122f; Kleman M., 1983, POINTS LINES AND WAL; Kruss S, 2010, ADV MATER, V22, P5499, DOI 10.1002/adma.201003055; Landini G, 2013, AUTO LOCAL THRESHOLD; Lynd NA, 2005, MACROMOLECULES, V38, P8803, DOI 10.1021/ma051025r; Lynd NA, 2007, MACROMOLECULES, V40, P8050, DOI 10.1021/ma070962r; Majewski PW, 2015, ACS NANO, V9, P3896, DOI 10.1021/nn5071827; Mansky P, 1997, PHYS REV LETT, V79, P237, DOI 10.1103/PhysRevLett.79.237; Mistark PA, 2009, ACS NANO, V3, P3987, DOI 10.1021/nn901245w; Nagpal U, 2012, ACS MACRO LETT, V1, P418, DOI 10.1021/mz200245s; Niemeyer K., 2012, ARS TECHNICA; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Park S, 2008, ADV MATER, V20, P681, DOI 10.1002/adma.200701997; Patrone PN, 2012, MACROMOLECULES, V45, P9507, DOI 10.1021/ma301421j; Patrone PN, 2012, PROC SPIE, V8323, DOI 10.1117/12.918038; Peters AJ, 2013, PROC SPIE, V8680, DOI 10.1117/12.2021443; Poelma JE, 2012, ACS NANO, V6, P10845, DOI 10.1021/nn304217y; Qiang Z, 2014, SOFT MATTER, V10, P6068, DOI 10.1039/c4sm00875h; Qiang Z, 2014, MACROMOLECULES, V47, P1109, DOI 10.1021/ma402131j; Rasband W., 2006, IMAGEJ; Rehse S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051805; Ross CA, 2008, J VAC SCI TECHNOL B, V26, P2489, DOI 10.1116/1.2981079; Ruiz R, 2008, SCIENCE, V321, P936, DOI 10.1126/science.1157626; Ruiz R, 2011, ACS NANO, V5, P79, DOI 10.1021/nn101561p; Scherdel S, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2747598; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Steinhogl W, 2004, MICROELECTRON ENG, V76, P126, DOI 10.1016/j.mee.2004.07.005; Stoykovich MP, 2007, ACS NANO, V1, P168, DOI 10.1021/nn700164p; Stoykovich MP, 2005, SCIENCE, V308, P1442, DOI 10.1126/science.1111041; Stucchi M, 2007, MICROELECTRON ENG, V84, P2733, DOI 10.1016/j.mee.2007.05.038; Sweat DP, 2014, MACROMOLECULES, V47, P6687, DOI 10.1021/ma501597g; Takahashi H, 2012, MACROMOLECULES, V45, P6253, DOI 10.1021/ma300993x; Tavakkoli KGA, 2012, SCIENCE, V336, P1294, DOI 10.1126/science.1218437; Tseng YC, 2010, POLYMERS-BASEL, V2, P470, DOI 10.3390/polym2040470; Vigild ME, 1998, MACROMOLECULES, V31, P5702, DOI 10.1021/ma9716746; Williams EH, 2012, J CELL BIOL, V198, P271, DOI 10.1083/jcb.201207117; Windows Minesweeper, 2013, WINDOWS MINESWEEPER; Wu N., 2014, THESIS; Wu NLY, 2013, ACS NANO, V7, P5595, DOI 10.1021/nn401968t; Wu NLY, 2012, NANO LETT, V12, P264, DOI 10.1021/nl203488a; Yang XM, 2009, ACS NANO, V3, P1844, DOI 10.1021/nn900073r; ZHANG TY, 1984, COMMUN ACM, V27, P236, DOI 10.1145/357994.358023; Zhang XJ, 2011, MACROMOLECULES, V44, P9752, DOI 10.1021/ma202064t; Zhang XJ, 2010, ACS NANO, V4, P7021, DOI 10.1021/nn102387c	89	53	54	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133088	10.1371/journal.pone.0133088	http://dx.doi.org/10.1371/journal.pone.0133088			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207990	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000063
J	Gao, B; Wang, YQ; Liu, WB; Chen, ZY; Zhou, H; Yang, JY; Cohen, Z; Zhu, YH; Zang, YF				Gao, Bin; Wang, Yiquan; Liu, Weibo; Chen, Zhiyu; Zhou, Heshan; Yang, Jinyu; Cohen, Zachary; Zhu, Yihong; Zang, Yufeng			Spontaneous Activity Associated with Delusions of Schizophrenia in the Left Medial Superior Frontal Gyrus: A Resting-State fMRI Study	PLOS ONE			English	Article							1ST-EPISODE PSYCHOTIC DISORDERS; TEMPORAL-LOBE EPILEPSY; REGIONAL HOMOGENEITY; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; ALZHEIMERS-DISEASE; POSITIVE SYMPTOMS; DEFAULT MODE; CORTEX; MRI	Delusions of schizophrenia have been found to be associated with alterations of some brain regions in structure and task-induced activation. However, the relationship between spontaneously occurring symptoms and spontaneous brain activity remains unclear. In the current study, 14 schizophrenic patients with delusions and 14 healthy controls underwent a resting-state functional magnetic resonance imaging (RS-fMRI) scan. Patients with delusions of schizophrenia patients were rated with Positive and Negative Syndrome Scale (PANSS) and Characteristics of Delusional Rating Scale (CDRS). Regional homogeneity (ReHo) was calculated to measure the local synchronization of the spontaneous activity in a voxel-wise way. A two-sample t-test showed that ReHo of the right anterior cingulate gyrus and left medial superior frontal gyrus were higher in patients, and ReHo of the left superior occipital gyrus was lower, compared to healthy controls. Further, among patients, correlation analysis showed a significant difference between delusion scores of CRDS and ReHo of brain regions. ReHo of the left medial superior frontal gyrus was negatively correlated with patients' CDRS scores but not with delusional PANSS scores. These results suggested that altered local synchronization of spontaneous brain activity may be related to the pathophysiology of delusion in schizophrenia.	[Gao, Bin; Liu, Weibo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Psychiat, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yiquan; Chen, Zhiyu] Hangzhou Seventh Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Zhou, Heshan] Hangzhou First Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Yang, Jinyu; Zhu, Yihong] Zhejiang Univ, Sch Med, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Cohen, Zachary] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Zhu, Yihong] Zhejiang Univ, Mental Hlth Educ & Counseling Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zang, Yufeng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Zang, Yufeng] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Wang, Yiquan] Zhejiang Univ, Sch Med, Mental Hlth Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Brown University; Zhejiang University; Hangzhou Normal University; Zhejiang University	Zhu, YH (corresponding author), Zhejiang Univ, Sch Med, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	zhyh@zju.edu.cn			Key Specialty Project of Hangzhou Science and Technology Bureau [20100733Q19]; Type A Project of Hangzhou Health Bureau [2010A019]	Key Specialty Project of Hangzhou Science and Technology Bureau; Type A Project of Hangzhou Health Bureau	This work was supported by the Key Specialty Project of Hangzhou Science and Technology Bureau (No. 20100733Q19, http://www.hzst.gov.cn/), and the Type A Project of Hangzhou Health Bureau (No. 2010A019, http://www.hzwsjsw.gov.cn/index/index.jhtml).	Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Barch DM, 2014, SCHIZOPHRENIA BULL, V40, P1200, DOI 10.1093/schbul/sbu076; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; GARETY PA, 1987, EUR ARCH PSY CLIN N, V236, P294, DOI 10.1007/BF00380955; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hashimoto R, 2010, CEREB CORTEX, V20, P46, DOI 10.1093/cercor/bhp079; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Holzel BK, 2007, NEUROSCI LETT, V421, P16, DOI 10.1016/j.neulet.2007.04.074; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Kronmuller KT, 2011, COMPR PSYCHIAT, V52, P102, DOI 10.1016/j.comppsych.2010.04.014; Lahti AC, 2006, NEUROPSYCHOPHARMACOL, V31, P221, DOI 10.1038/sj.npp.1300837; Liu HH, 2012, SCHIZOPHRENIA BULL, V38, P285, DOI 10.1093/schbul/sbq074; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Menon M, 2011, BIOL PSYCHIAT, V70, P1127, DOI 10.1016/j.biopsych.2011.05.037; Nagahama Y, 2010, BRAIN, V133, P557, DOI 10.1093/brain/awp295; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Palaniyappan L, 2011, PSYCHOL MED, V41, P1701, DOI 10.1017/S0033291710002205; Park IH, 2011, ACTA PSYCHIAT SCAND, V123, P43, DOI 10.1111/j.1600-0447.2010.01597.x; Prasad KMR, 2004, AM J PSYCHIAT, V161, P1612, DOI 10.1176/appi.ajp.161.9.1612; Prasad KMR, 2004, PROG NEURO-PSYCHOPH, V28, P651, DOI 10.1016/j.pnpbp.2004.01.017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sabri O, 1997, LANCET, V349, P1735, DOI 10.1016/S0140-6736(96)08380-8; SARTORIUS N, 1986, PSYCHOL MED, V16, P909, DOI 10.1017/S0033291700011910; Schlagenhauf F, 2009, BIOL PSYCHIAT, V65, P1032, DOI 10.1016/j.biopsych.2008.12.016; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spencer MD, 2007, NEUROIMAGE, V35, P1181, DOI 10.1016/j.neuroimage.2007.01.008; Steel C, 2007, INT J METH PSYCH RES, V16, P88, DOI 10.1002/mpr.203; Suga M, 2010, EUR ARCH PSY CLIN N, V260, P465, DOI 10.1007/s00406-009-0094-1; Sumich A, 2005, BIOL PSYCHIAT, V57, P947, DOI 10.1016/j.biopsych.2004.12.041; Sun YY, 2014, CHINESE MENTAL HEALT; Szeszko PR, 1999, PSYCHIAT RES-NEUROIM, V90, P1, DOI 10.1016/S0925-4927(99)00002-5; Takahashi T, 2011, PROG NEURO-PSYCHOPH, V35, P177, DOI 10.1016/j.pnpbp.2010.10.023; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Turner JA, 2012, TWIN RES HUM GENET, V15, P324, DOI 10.1017/thg.2012.1; Weaver KE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00043; Whitford TJ, 2009, PSYCHIAT RES-NEUROIM, V172, P175, DOI 10.1016/j.pscychresns.2008.07.011; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xi Q, 2012, CHINESE MED J-PEKING, V125, P858, DOI 10.3760/cma.j.issn.0366-6999.2012.05.023; Yamasaki S, 2007, EUR ARCH PSY CLIN N, V257, P318, DOI 10.1007/s00406-007-0723-5; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng HW, 2013, EPILEPSIA, V54, P658, DOI 10.1111/epi.12066; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063477	55	27	30	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133766	10.1371/journal.pone.0133766	http://dx.doi.org/10.1371/journal.pone.0133766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204264	Green Published, gold, Green Submitted			2022-12-26	WOS:000358621000038
J	Li, J; Zhao, LN; You, Y; Lu, TL; Jia, MX; Yu, H; Ruan, YY; Yue, WH; Liu, J; Lu, L; Zhang, D; Wang, LF				Li, Jun; Zhao, Linnan; You, Yang; Lu, Tianlan; Jia, Meixiang; Yu, Hao; Ruan, Yanyan; Yue, Weihua; Liu, Jing; Lu, Lin; Zhang, Dai; Wang, Lifang			Schizophrenia Related Variants in CACNA1C also Confer Risk of Autism	PLOS ONE			English	Article							SCAFFOLDING PROTEIN SHANK3; GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; SUBUNIT GENE; COPY NUMBER; SPECTRUM; CONNECTIVITY; MUTATIONS; DISORDER; CA(V)1.2	Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders with a strong genetic component. Many lines of evidence indicated that ASD shares common genetic variants with other psychiatric disorders (for example, schizophrenia). Previous studies detected that calcium channels are involved in the etiology of many psychiatric disorders including schizophrenia and autism. Significant association between CACNA1C (calcium channel, voltage-dependent, L type, alpha 1C subunit) and schizophrenia was detected. Furthermore, rare mutation in CACNA1C is suggested to cause Timothy syndrome, a multisystem disorder including autism-associated phenotype. However, there is no evidence for association between CACNA1C and autism in Chinese Han population. To investigate the association between single nucleotide polymorphisms (SNP) in CACNA1C and autism, we first performed a family-based association study between eighteen SNPs in CACNA1C and autism in 239 trios. All SNPs were genotyped by using Sequenom genotyping platform. Two SNPs (rs1006737 and rs4765905) have a trend of association with autism. To further confirm the association between these two SNPs with autism, we expanded the sample size to 553 trios by adding 314 trios. Association analyses for SNPs and haplotype were performed by using family-based association test (FBAT) and Haploview software. Permutation tests were used for multiple testing corrections of the haplotype analyses (n=10,000). The significance level for all statistical tests was two-tailed (p<0.05). The results demonstrated that G allele of rs1006737 and G allele of rs4765905 showed a preferential transmission to affected offspring in 553 trios (p=0.035). Haplotype analyses showed that two haplotypes constructed from rs1006737 and rs4765905 were significantly associated with autism (p=0.030, 0.023, respectively; Global p=0.046). These results were still significant after permutation correction (n=10,000, p=0.027). Our research suggests that CACNA1C might play a role in the genetic etiology of autism in Chinese Han population.	[Li, Jun; Zhao, Linnan; You, Yang; Lu, Tianlan; Jia, Meixiang; Yu, Hao; Ruan, Yanyan; Yue, Weihua; Liu, Jing; Lu, Lin; Zhang, Dai; Wang, Lifang] Peking Univ, Inst Mental Hlth, Hosp 6, Beijing 100871, Peoples R China; [Li, Jun; Zhao, Linnan; You, Yang; Lu, Tianlan; Jia, Meixiang; Yu, Hao; Ruan, Yanyan; Yue, Weihua; Liu, Jing; Lu, Lin; Zhang, Dai; Wang, Lifang] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Li, Jun; Zhao, Linnan; You, Yang; Lu, Tianlan; Jia, Meixiang; Yu, Hao; Ruan, Yanyan; Yue, Weihua; Liu, Jing; Lu, Lin; Zhang, Dai; Wang, Lifang] Peking Univ, Natl Clin Res Ctr Mental Disorders, Beijing 100871, Peoples R China; [Yu, Hao; Zhang, Dai] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Lu, Lin; Zhang, Dai] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Zhang, D (corresponding author), Peking Univ, Inst Mental Hlth, Hosp 6, Beijing 100871, Peoples R China.	daizhang@bjmu.edu.cn; lifangwang@bjmu.edu.cn	Jia, Mei/GXZ-9967-2022; You, Yang/AEF-1080-2022; Yu, Hao/GYD-8698-2022	You, Yang/0000-0003-0574-7827; Yu, Hao/0000-0002-9785-8489	National Natural Science Foundation [81471383, 81471360]; Beijing Municipal Science & Technology Commission [Z131107002213100]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This research was supported by research grants from the National Natural Science Foundation (grant numbers 81471383 and 81471360) (http://www.nsfc.gov.cn/), and Beijing Municipal Science & Technology Commission (No. Z131107002213100) (http://mis.bjkw.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Suzuki M, 2005, BIOL PSYCHIAT, V57, P382, DOI 10.1016/j.biopsych.2004.11.022; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhat S, 2012, PROG NEUROBIOL, V99, P1, DOI 10.1016/j.pneurobio.2012.06.001; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Boersma M, 2013, BRAIN CONNECT, V3, P41, DOI 10.1089/brain.2012.0127; Breitenkamp AFS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095579; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; COON H, 1994, AM J MED GENET, V54, P12, DOI 10.1002/ajmg.1320540105; Craddock N, 2010, BRIT J PSYCHIAT, V197, P158, DOI 10.1192/bjp.197.2.158; Dima D, 2013, JAMA PSYCHIAT, V70, P1303, DOI 10.1001/jamapsychiatry.2013.2099; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Gauderman WJ, 2006, QUANTO 1 1 A COMPUTE; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Jurinke C, 2001, Methods Mol Biol, V170, P103; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Kakinuma H, 2008, AM J MED GENET B, V147B, P973, DOI 10.1002/ajmg.b.30663; Kenny EM, 2014, MOL PSYCHIATR, V19, P872, DOI 10.1038/mp.2013.127; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; King BH, 2011, BRAIN RES, V1380, P34, DOI 10.1016/j.brainres.2010.11.031; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Krug A, 2010, NEUROIMAGE, V49, P1831, DOI 10.1016/j.neuroimage.2009.09.028; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Leung RC, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-51; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lu ATH, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-18; Ivorra JL, 2014, SCHIZOPHR RES, V159, P107, DOI 10.1016/j.schres.2014.07.004; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin ER, 2000, AM J MED GENET, V96, P43, DOI 10.1002/(SICI)1096-8628(20000207)96:1<43::AID-AJMG9>3.0.CO;2-3; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Radulescu E, 2013, NEUROIMAGE-CLIN, V2, P716, DOI 10.1016/j.nicl.2013.05.010; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saus E, 2010, J PSYCHIATR RES, V44, P971, DOI 10.1016/j.jpsychires.2010.03.007; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Shukla DK, 2010, J AM ACAD CHILD PSY, V49, P1269, DOI 10.1016/j.jaac.2010.08.018; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Storm N, 2003, METHOD MOL BIOL, V212, P241; Strom SP, 2010, MOL PSYCHIATR, V15, P996, DOI 10.1038/mp.2009.41; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Verly M, 2014, NEUROIMAGE-CLIN, V4, P374, DOI 10.1016/j.nicl.2014.01.008; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	65	25	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133247	10.1371/journal.pone.0133247	http://dx.doi.org/10.1371/journal.pone.0133247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204268	gold, Green Published, Green Submitted			2022-12-26	WOS:000358621000024
J	Rojas, F; Hernandez, ME; Silva, M; Li, LH; Subramanian, S; Wilson, MJ; Liu, P				Rojas, Fausto; Hernandez, Maria E.; Silva, Milagros; Li, Lihua; Subramanian, Subbaya; Wilson, Michael J.; Liu, Ping			The Oncogenic Response to MiR-335 Is Associated with Cell Surface Expression of Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP) Activity	PLOS ONE			English	Article							UP-REGULATION; LUNG-CANCER; TUMOR-CELLS; INVASION; METASTASIS; MIGRATION; GROWTH; PROLIFERATION; ACTIVATION; MICRORNAS	MicroRNA miR-335 has been reported to have both tumor suppressor and oncogenic activities. In order to determine possible tissue and cell type differences in response to miR-335, we examined the effect of miR-335 on cell expression of MT1-MMP, a proteinase commonly expressed in tumors and associated with cell proliferation and migration. miR-335 increased cell surface expression of MT1-MMP in fibrosarcoma HT-1080 and benign prostate BPH-1 cells, but not in prostate LNCaP or breast MCF-7 tumor cells. miR-335 stimulated proliferation and cell migration in a wound healing in vitro assay in HT-1080, BPH-1, and U87 glioblastoma cells, cells which demonstrated significant cell surface expression of MT1-MMP. In contrast, miR-335 did not affect proliferation or migration in cells without a prominent plasma membrane associated MT1-MMP activity. Our data suggest that differences in response to miR-335 by tumor cells may lie in part in the mechanism of regulation of MT1-MMP production.	[Rojas, Fausto; Hernandez, Maria E.; Silva, Milagros] Univ Veracruzana, Ctr Invest Cerebrales, Xalapa 91000, Veracruz, Mexico; [Rojas, Fausto; Hernandez, Maria E.; Silva, Milagros; Wilson, Michael J.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Li, Lihua; Subramanian, Subbaya] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Subramanian, Subbaya; Wilson, Michael J.; Liu, Ping] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Wilson, Michael J.; Liu, Ping] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Wilson, Michael J.] Minneapolis VA Med Ctr, Minneapolis, MN USA	Universidad Veracruzana; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Wilson, MJ (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	Wilso042@umn.edu		Hernandez, Maria Elena/0000-0002-1617-5636; Rojas-Duran, Fausto/0000-0003-4497-0909; Subramanian, Subbaya/0000-0002-2544-480X; Silva Morales, Milagros/0000-0002-0794-2362	National Institutes Health [CA114418-01A2]; Karen Wyckoff Sarcoma Foundation; CONACyT [106531, 35159, 165708]; Sabbatical Support [159818]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NATIONAL CANCER INSTITUTE [R01CA114418] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karen Wyckoff Sarcoma Foundation; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Sabbatical Support; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for these studies was provided through National Institutes Health grant number: CA114418-01A2 (MJW), the Karen Wyckoff Sarcoma Foundation (SS), Sabbatical Support: 159818 (MEH), CONACyT grant 106531 (MEH), CONACyT Predoctoral Fellowship 35159 (MS), CONCyT Postdoctoral Fellowship 165708 (FR), and Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (MJW). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Cheng Q, 2014, MOL MED REP, V10, P399, DOI 10.3892/mmr.2014.2150; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Di Gregoli K, 2014, ARTERIOSCL THROM VAS, V34, P1990, DOI 10.1161/ATVBAHA.114.304088; Frittoli E, 2011, EUR J CELL BIOL, V90, P108, DOI 10.1016/j.ejcb.2010.04.007; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Heyn H, 2011, INT J CANCER, V129, P2797, DOI 10.1002/ijc.25962; Jiang J, 2012, MED ONCOL, V29, P3472, DOI 10.1007/s12032-012-0259-z; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Ma J, 2014, J BIOL CHEM, V289, P8442, DOI 10.1074/jbc.M113.516039; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; Nakayama I, 2013, INT J ONCOL, V43, P63, DOI 10.3892/ijo.2013.1935; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Ronchetti D, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-37; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Shi L, 2012, J NEURO-ONCOL, V110, P155, DOI 10.1007/s11060-012-0951-z; Shu MF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-59; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Takino T, 2013, BIOCHEM BIOPH RES CO, V436, P503, DOI 10.1016/j.bbrc.2013.05.134; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167; Vickers MM, 2012, CLIN EXP METASTAS, V29, P123, DOI 10.1007/s10585-011-9435-3; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang HQ, 2013, TUMOR BIOL, V34, P3101, DOI 10.1007/s13277-013-0878-9; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Wang X, 2009, J ANDROL, V30, P259, DOI 10.2164/jandrol.108.006494; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Willis AL, 2013, J MICROSC-OXFORD, V251, P250, DOI 10.1111/jmi.12064; Xiao HB, 2014, ONCOL REP, V31, P1832, DOI 10.3892/or.2014.3048; Xu M, 2013, ONCOL REP, V30, P1398, DOI 10.3892/or.2013.2548; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yan JL, 2013, BRIT J HAEMATOL, V163, P93, DOI 10.1111/bjh.12489; Yan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040037; Zhang H, 2014, ONCOGENE, V33, P387, DOI 10.1038/onc.2012.574; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	51	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132026	10.1371/journal.pone.0132026	http://dx.doi.org/10.1371/journal.pone.0132026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204513	Green Published, Green Submitted, gold			2022-12-26	WOS:000358621000005
J	Kurogochi, M; Mori, M; Osumi, K; Tojino, M; Sugawara, S; Takashima, S; Hirose, Y; Tsukimura, W; Mizuno, M; Amano, J; Matsuda, A; Tomita, M; Takayanagi, A; Shoda, SI; Shirai, T				Kurogochi, Masaki; Mori, Masako; Osumi, Kenji; Tojino, Mami; Sugawara, Shu-ichi; Takashima, Shou; Hirose, Yuriko; Tsukimura, Wataru; Mizuno, Mamoru; Amano, Junko; Matsuda, Akio; Tomita, Masahiro; Takayanagi, Atsushi; Shoda, Shin-Ichiro; Shirai, Takashi			Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for Fc gamma RIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; HUMAN IGG1; TRANSGENIC SILKWORMS; TRANSGLYCOSYLATION ACTIVITY; MEDIATED CYTOTOXICITY; RECOMBINANT ANTIBODY; EFFECTOR FUNCTIONS; CRYSTAL-STRUCTURE; RECEPTOR-BINDING; IN-VITRO	Many therapeutic antibodies have been developed, and IgG antibodies have been extensively generated in various cell expression systems. IgG antibodies contain N-glycans at the constant region of the heavy chain (Fc domain), and their N-glycosylation patterns differ during various processes or among cell expression systems. The Fc N-glycan can modulate the effector functions of IgG antibodies, such as antibody-dependent cellular cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC). To control Fc N-glycans, we performed a rearrangement of Fc N-glycans from a heterogeneous N-glycosylation pattern to homogeneous N-glycans using chemoenzymatic approaches with two types of endo-beta-N-acetyl glucosaminidases (ENG'ases), one that works as a hydrolase to cleave all heterogeneous N-glycans, another that is used as a glycosynthase to generate homogeneous N-glycans. As starting materials, we used an anti-Her2 antibody produced in transgenic silkworm cocoon, which consists of non-fucosylated pauci-mannose type (Man(2-3)GlcNAc(2)), high-mannose type (Man(4-9)GlcNAc(2)), and complex type (Man(3)GlcNAc(3-4)) N-glycans. As a result of the cleavage of several ENG'ases (endoS, endoM, endoD, endoH, and endoLL), the heterogeneous glycans on antibodies were fully transformed into homogeneous-GlcNAc by a combination of endoS, endoD, and endoLL. Next, the desired N-glycans (M-3; Man(3)-GlcNAc(1), G0; GlcNAc(2)Man(3)GlcNAc(1), G2; Gal(2)GlcNAc(2)Man(3)GlcNAc(1), A2; NeuAc(2)Gal(2)Glc-NAc(2)Man(3)GlcNAc(1)) were transferred from the corresponding oxazolines to the GlcNAcresidue on the intact anti-Her2 antibody with an ENG'ase mutant (endoS-D233Q), and the glycoengineered anti-Her2 antibody was obtained. The binding assay of anti-Her2 antibody with homogenous N-glycans with Fc gamma RIIIa-V158 showed that the glycoform influenced the affinity for Fc gamma RIIIa-V158. In addition, the ADCC assay for the glycoengineered anti-Her2 antibody (mAb-M3, mAb-G0, mAb-G2, and mAb-A2) was performed using SKBR-3 and BT-474 as target cells, and revealed that the glycoform influenced ADCC activity.	[Kurogochi, Masaki; Takashima, Shou; Amano, Junko; Shirai, Takashi] Noguchi Inst, Lab Glycobiol, Itabashi Ku, Tokyo, Japan; [Mori, Masako; Tsukimura, Wataru; Matsuda, Akio; Shirai, Takashi] Noguchi Inst, Lab Glycobioengn, Itabashi Ku, Tokyo, Japan; [Osumi, Kenji; Tojino, Mami; Sugawara, Shu-ichi; Hirose, Yuriko; Mizuno, Mamoru; Shirai, Takashi] Noguchi Inst, Lab Glycoorgan Chem, Itabashi Ku, Tokyo, Japan; [Tomita, Masahiro] Immunobiol Labs Co Ltd, Fujioka, Gunma, Japan; [Takayanagi, Atsushi] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo, Japan; [Shoda, Shin-Ichiro] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 980, Japan	Immuno-Biological Laboratories Co. Ltd.; Keio University; Tohoku University	Shirai, T (corresponding author), Noguchi Inst, Lab Glycobiol, Itabashi Ku, 1-8-1 Kaga, Tokyo, Japan.	shirai.tb@noguchi.or.jp	Amano, Junko/ABA-6890-2020; Amano, Junko/ABA-6882-2020	Amano, Junko/0000-0001-7602-0794; 	Immuno-Biological Laboratories Co. Ltd.	Immuno-Biological Laboratories Co. Ltd.	The authors received no specific funding for this work. Co-author Masahiro Tomita is employed by Immuno-Biological Laboratories Co. Ltd. Immuno-Biological Laboratories Co. Ltd. provided support in the form of salary for author MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adachi T, 2010, BIOTECHNOL BIOENG, V106, P860, DOI 10.1002/bit.22752; Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Ahmed AA, 2014, J MOL BIOL, V426, P3166, DOI 10.1016/j.jmb.2014.07.006; Barb AW, 2011, NAT CHEM BIOL, V7, P147, DOI 10.1038/NCHEMBIO.511; Baruah K, 2012, J MOL BIOL, V420, P1, DOI 10.1016/j.jmb.2012.04.002; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Crispin M, 2009, J MOL BIOL, V387, P1061, DOI 10.1016/j.jmb.2009.02.033; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Goodfellow JJ, 2012, J AM CHEM SOC, V134, P8030, DOI 10.1021/ja301334b; Green MC, 2000, CANCER TREAT REV, V26, P269, DOI 10.1053/ctrv.2000.0176; Ha S, 2011, GLYCOBIOLOGY, V21, P1087, DOI 10.1093/glycob/cwr047; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Hodoniczky J, 2005, BIOTECHNOL PROGR, V21, P1644, DOI 10.1021/bp050228w; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Iannello A, 2005, CANCER METAST REV, V24, P487, DOI 10.1007/s10555-005-6192-2; Iizuka M, 2008, J BIOSCI BIOENG, V105, P595, DOI 10.1263/jbb.105.595; Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Junttila TT, 2010, CANCER RES, V70, P4481, DOI 10.1158/0008-5472.CAN-09-3704; KADOWAKI S, 1990, AGR BIOL CHEM TOKYO, V54, P97, DOI 10.1080/00021369.1990.10869923; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kurogochi M, 2014, MOLECULES, V19, P9944, DOI 10.3390/molecules19079944; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Loos A, 2012, ARCH BIOCHEM BIOPHYS, V526, P167, DOI 10.1016/j.abb.2012.05.011; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Parekh BS, 2012, MABS-AUSTIN, V4, P310, DOI 10.4161/mabs.19873; PAULSEN H, 1984, LIEBIGS ANN CHEM, P951; Prang N, 2005, BRIT J CANCER, V92, P342, DOI 10.1038/sj.bjc.6602310; Ricart AD, 2007, NAT CLIN PRACT ONCOL, V4, P245, DOI 10.1038/ncponc0774; SARMA VR, 1971, J BIOL CHEM, V246, P3753; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Smith EL, 2014, BIOCONJUGATE CHEM, V25, P788, DOI 10.1021/bc500061s; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; STRECKER G, 1977, EUR J BIOCHEM, V81, P165, DOI 10.1111/j.1432-1033.1977.tb11937.x; Sun BY, 2014, CARBOHYD RES, V396, P62, DOI 10.1016/j.carres.2014.07.013; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Tada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095787; TAI T, 1975, J BIOL CHEM, V250, P8569; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; TARENTINO AL, 1974, J BIOL CHEM, V249, P818; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Wang SY, 2010, J CHROMATOGR A, V1217, P6496, DOI 10.1016/j.chroma.2010.08.044; Wei YD, 2008, BIOCHEMISTRY-US, V47, P10294, DOI 10.1021/bi800874y; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; Wright A, 2000, GLYCOBIOLOGY, V10, P1347, DOI 10.1093/glycob/10.12.1347; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yoshikawa M, 2013, BLOOD, V121, P2804, DOI 10.1182/blood-2012-12-468363; Zhang NY, 2011, MABS-AUSTIN, V3, P289, DOI 10.4161/mabs.3.3.15532; Zhou Q, 2008, BIOTECHNOL BIOENG, V99, P652, DOI 10.1002/bit.21598; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	72	77	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132848	10.1371/journal.pone.0132848	http://dx.doi.org/10.1371/journal.pone.0132848			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200113	gold, Green Submitted, Green Published			2022-12-26	WOS:000358597100049
J	Schauerte, B; Stiefelhagen, R				Schauerte, Boris; Stiefelhagen, Rainer			On the Distribution of Salient Objects in Web Images and Its Influence on Salient Object Detection	PLOS ONE			English	Article								In recent years it has become apparent that a Gaussian center bias can serve as an important prior for visual saliency detection, which has been demonstrated for predicting human eye fixations and salient object detection. Tseng et al. have shown that the photographer's tendency to place interesting objects in the center is a likely cause for the center bias of eye fixations. We investigate the influence of the photographer's center bias on salient object detection, extending our previous work. We show that the centroid locations of salient objects in photographs of Achanta and Liu's data set in fact correlate strongly with a Gaussian model. This is an important insight, because it provides an empirical motivation and justification for the integration of such a center bias in salient object detection algorithms and helps to understand why Gaussian models are so effective. To assess the influence of the center bias on salient object detection, we integrate an explicit Gaussian center bias model into two state-of-the-art salient object detection algorithms. This way, first, we quantify the influence of the Gaussian center bias on pixel- and segment-based salient object detection. Second, we improve the performance in terms of F-1 score, F-beta score, area under the recall-precision curve, area under the receiver operating characteristic curve, and hit-rate on the well-known data set by Achanta and Liu. Third, by debiasing Cheng et al.'s region contrast model, we exemplarily demonstrate that implicit center biases are partially responsible for the outstanding performance of state-of-the-art algorithms. Last but not least, we introduce a non-biased salient object detection method, which is of interest for applications in which the image data is not likely to have a photographer's center bias (e.g., image data of surveillance cameras or autonomous robots).	[Schauerte, Boris; Stiefelhagen, Rainer] Karlsruhe Inst Technol, Inst Anthropomat & Robot, Baden, Switzerland		Schauerte, B (corresponding author), Karlsruhe Inst Technol, Inst Anthropomat & Robot, Baden, Switzerland.	boris.schauerte@kit.edu			Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology.	Achanta R, 2010, P INT C IM PROC; Achanta R, 2009, P INT C COMP VIS PAT; Alexe B, 2010, P INT C COMP VIS PAT; Borji A, 2012, P INT C COMP VIS PAT; Borji A., 2012, P EUR C COMP VIS; Busswell G., 1935, PEOPLE LOOK PICTURES; Cheng MM, 2011, PROC CVPR IEEE, P409, DOI 10.1109/CVPR.2011.5995344; Davis J, 2006, PROC INT CONF MACHIN; Einhauser W, 2008, J VISION, V8; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Goferman S., 2012, IEEE T PATTERN ANAL; Goferman S, 2010, P INT C COMP VIS PAT; Guthrie W. F, 2020, NISTSEMATECH E HDB S, V151, DOI DOI 10.18434/M32189; Harel Jonathan, 2007, GRAPH BASED VISUAL S, V1, P4; Hou X, 2007, P INT C COMP VIS PAT; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L., 2006, ADV NEURAL INFORM PR; Jiang HZ, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.110; Judd T., 2009, P INT C COMP VIS; Klein D., 2011, P INT C COMP VIS; Liu T, 2007, P INT C COMP VIS PAT; Luo Y., 2008, P EUR C COMP VIS; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Parkhurst DJ, 2003, SPATIAL VISION, V16, P125, DOI 10.1163/15685680360511645; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Scharfenberger C, 2013, P INT C COMP VIS PAT; Schauerte B, 2014, P INT C INT ROB SYST; Schauerte B, 2012, P WORKSH APPL COMP V; Schauerte B, 2009, P INT C MULT INT; Schauerte B, 2011, SPECTRAL VISUAL SALI; Schauerte B, 2013, P INT C IM PROC; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Tseng PH, 2009, J VISION, V9, DOI 10.1167/9.7.4; Tsotsos JK, 2011, COMPUTATIONAL PERSPECTIVE ON VISUAL ATTENTION, P1; VOGEL RM, 1989, J WATER RES PL-ASCE, V115, P338, DOI 10.1061/(ASCE)0733-9496(1989)115:3(338); Yang Y, 2010, P EUR C COMP VIS	38	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0130316	10.1371/journal.pone.0130316	http://dx.doi.org/10.1371/journal.pone.0130316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201078	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100008
J	Wagner, F; Wimmer, W; Leidolt, L; Vischer, M; Weder, S; Wiest, R; Mantokoudis, G; Caversaccio, MD				Wagner, Franca; Wimmer, Wilhelm; Leidolt, Lars; Vischer, Mattheus; Weder, Stefan; Wiest, Roland; Mantokoudis, Georgios; Caversaccio, Marco D.			Significant Artifact Reduction at 1.5T and 3T MRI by the Use of a Cochlear Implant with Removable Magnet: An Experimental Human Cadaver Study	PLOS ONE			English	Article							CLINICAL-APPLICATION; INTERNAL MAGNET; SAFETY ASPECTS; COMPATIBILITY; CONTRAINDICATION; DISPLACEMENT; SCHWANNOMAS; EAR	Objective Cochlear implants (CIs) are standard treatment for postlingually deafened individuals and prelingually deafened children. This human cadaver study evaluated diagnostic usefulness, image quality and artifacts in 1.5T and 3T magnetic resonance (MR) brain scans after CI with a removable magnet. Methods Three criteria (diagnostic usefulness, image quality, artifacts) were assessed at 1.5T and 3T in five cadaver heads with CI. The brain magnetic resonance scans were performed with and without the magnet in situ. The criteria were analyzed by two blinded neuroradiologists, with focus on image distortion and limitation of the diagnostic value of the acquired MR images. Results MR images with the magnet in situ were all compromised by artifacts caused by the CI. After removal of the magnet, MR scans showed an unequivocal artifact reduction with significant improvement of the image quality and diagnostic usefulness, both at 1.5T and 3T. Visibility of the brain stem, cerebellopontine angle, and parieto-occipital lobe ipsilateral to the CI increased significantly after magnet removal. Conclusions The results indicate the possible advantages for 1.5T and 3T MR scanning of the brain in CI carriers with removable magnets. Our findings support use of CIs with removable magnets, especially in patients with chronic intracranial pathologies.	[Wagner, Franca; Leidolt, Lars; Wiest, Roland] Inselspital Bern, Univ Dept Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Wimmer, Wilhelm; Vischer, Mattheus; Weder, Stefan; Mantokoudis, Georgios; Caversaccio, Marco D.] Inselspital Bern, Univ Dept Otorhinolaryngol Head & Neck Surg, CH-3010 Bern, Switzerland; [Wimmer, Wilhelm; Caversaccio, Marco D.] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Wagner, F (corresponding author), Inselspital Bern, Univ Dept Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland.	franca.wagner@insel.ch	Mantokoudis, Georgios/J-6318-2013	Mantokoudis, Georgios/0000-0003-2268-7811; Wimmer, Wilhelm/0000-0001-5392-2074	MEDEL Corporation [MED-EL Corporation, Innsbruck, Austria]; MED-EL Corporation [MED-EL Corporation, Innsbruck, Austria]	MEDEL Corporation [MED-EL Corporation, Innsbruck, Austria]; MED-EL Corporation [MED-EL Corporation, Innsbruck, Austria]	The authors of this manuscript declare that they thank the MEDEL Corporation [MED-EL Corporation, Innsbruck, Austria] for loan of the cochlear implants and funding that study [total amount 15 000(sic)]. The authors state that this work has received funding from MED-EL Corporation [MED-EL Corporation, Innsbruck, Austria] in the amount of 15 000(sic). Additionally, the authors confirm that the funders had no role in our study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS HL, 1989, JAMA-J AM MED ASSOC, V261, P46, DOI 10.1001/jama.1989.03420010056027; Alberty J, 2002, HNO, V50, P739, DOI 10.1007/s00106-001-0601-9; Baumgartner WD, 2000, WIEN KLIN WOCHENSCHR, V112, P512; Baumgartner WD, 2000, ADV OTO-RHINO-LARYNG, V57, P28; Baumgartner WD, 2001, OTOL NEUROTOL, V22, P818, DOI 10.1097/00129492-200111000-00018; Bittencourt AG, 2014, INT ARCH OTORHINOLAR, V18, P322, DOI 10.1055/s-0033-1364170; CHOU CK, 1995, BIOELECTROMAGNETICS, V16, P307, DOI 10.1002/bem.2250160507; Crane BT, 2010, OTOL NEUROTOL, V31, P1215, DOI 10.1097/MAO.0b013e3181ec1d61; Czerny C, 2001, EUR J RADIOL, V40, P105, DOI 10.1016/S0720-048X(01)00378-3; Deneuve S, 2008, OTOL NEUROTOL, V29, P789, DOI 10.1097/MAO.0b013e3181825695; Dubrulle F, 2013, EUR RADIOL, V23, P1510, DOI 10.1007/s00330-012-2760-3; Fritsch Michael H, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P335, DOI 10.1097/MOO.0b013e328270b8b4; Fruauff K, 2015, TOP MAGN RESON IMAG, V24, P55; Graham J, 1999, J LARYNGOL OTOL, V113, P458, DOI 10.1017/S0022215100144214; Gubbels SP, 2006, LARYNGOSCOPE, V116, P865, DOI 10.1097/01.MLG.0000216807.03225.CE; Heller JW, 1996, AM J OTOL, V17, P724; Hochmair E S, 2001, Cochlear Implants Int, V2, P98, DOI 10.1179/cim.2001.2.2.98; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; Majdani O, 2008, OTOLARYNG HEAD NECK, V139, P833, DOI 10.1016/j.otohns.2008.07.026; Migirov L, 2013, ORL J OTO-RHINO-LARY, V75, P1, DOI 10.1159/000346239; Schmerber S, 2003, EUR ARCH OTO-RHINO-L, V260, P293, DOI 10.1007/s00405-002-0568-5; Teissl C, 1998, RADIOLOGY, V208, P700, DOI 10.1148/radiology.208.3.9722849; Teissl C, 1999, J MAGN RESON IMAGING, V9, P26, DOI 10.1002/(SICI)1522-2586(199901)9:1<26::AID-JMRI4>3.0.CO;2-H; Tieleman A, 2008, AM J NEURORADIOL, V29, P898, DOI 10.3174/ajnr.A1026; Todt I, 2015, OTOL NEUROTOL, DOI [10.1097/MAO.0000000000000720, DOI 10.1097/MA0.0000000000000720]; Tysome JR, 2012, OTOL NEUROTOL, V33, P466, DOI 10.1097/MAO.0b013e318248eaaa; Wackym PA, 2004, LARYNGOSCOPE, V114, P1355, DOI 10.1097/00005537-200408000-00007; Wagner J, 2014, 13 INT C COCHL IMPL; Weber BP, 1999, ANN OTO RHINOL LARYN, V108, P22; Youssefzadeh S, 1998, J COMPUT ASSIST TOMO, V22, P346, DOI 10.1097/00004728-199805000-00002; Yun JM, 2005, OTOLARYNG HEAD NECK, V133, P275, DOI 10.1016/j.otohns.2005.02.018	31	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132483	10.1371/journal.pone.0132483	http://dx.doi.org/10.1371/journal.pone.0132483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200775	gold, Green Published			2022-12-26	WOS:000358597100037
J	Yamazoe, K; Yoshida, S; Yasuda, M; Hatou, S; Inagaki, E; Ogawa, Y; Tsubota, K; Shimmura, S				Yamazoe, Katsuya; Yoshida, Satoru; Yasuda, Miyuki; Hatou, Shin; Inagaki, Emi; Ogawa, Yoko; Tsubota, Kazuo; Shimmura, Shigeto			Development of a Transgenic Mouse with R124H Human TGFBI Mutation Associated with Granular Corneal Dystrophy Type 2	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; JAPANESE PATIENTS; OXIDATIVE STRESS; GENE-MUTATIONS; BIGH3 GENE; PROTEIN; FIBROBLASTS; DEPOSITS	Purpose To investigate the phenotype and predisposing factors of a granular corneal dystrophy type 2 transgenic mouse model. Methods Human TGFBI cDNA with R124H mutation was used to make a transgenic mouse expressing human protein (TGFBI(R124H) mouse). Reverse transcription PCR (RT-PCR) was performed to analyze TGFBI(R124H) expression. A total of 226 mice including 23 homozygotes, 106 heterozygotes and 97 wild-type mice were examined for phenotype. Affected mice were also examined by histology, immunohistochemistry and electron microcopy. Results RT-PCR confirmed the expression of TGFBI(R124H) in transgenic mice. Corneal opacity defined as granular and lattice deposits was observed in 45.0% of homozygotes, 19.4% of heterozygotes. The incidence of corneal opacity was significantly higher in homozygotes than in heterozygotes (p = 0.02). Histology of affected mice was similar to histology of human disease. Lesions were Congo red and Masson Trichrome positive, and were observed as a deposit of amorphous material by electron microscopy. Subepithelial stroma was also stained with thioflavin T and LC3, a marker of autophagy activation. The incidence of corneal opacity was higher in aged mice in each group. Homozygotes were not necessarily more severe than heterozygotes, which deffers from human cases. Conclusions We established a granular corneal dystrophy type 2 mouse model caused by R124H mutation of human TGFBI. Although the phenotype of this mouse model is not equivalent to that in humans, further studies using this model may help elucidate the pathophysiology of this disease.	[Yamazoe, Katsuya; Yoshida, Satoru; Yasuda, Miyuki; Hatou, Shin; Inagaki, Emi; Ogawa, Yoko; Tsubota, Kazuo; Shimmura, Shigeto] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Keio University	Shimmura, S (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	shige@z8.keio.jp	Inagaki, Emi/GXG-8422-2022	Hatou, Shin/0000-0001-9273-5909	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the project for realization of regenerative medicine and support for the core institutes for iPS cell research from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Abazi Z, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-30; Awwad ST, 2008, AM J OPHTHALMOL, V145, P656, DOI 10.1016/j.ajo.2007.12.008; Basaiawmoit RV, 2011, J MOL BIOL, V408, P503, DOI 10.1016/j.jmb.2011.02.052; Cao WP, 2009, MOL VIS, V15, P70; Choi SI, 2012, AUTOPHAGY, V8, P1782, DOI 10.4161/auto.22067; Choi SI, 2011, J PINEAL RES, V51, P94, DOI 10.1111/j.1600-079X.2011.00866.x; Choi SI, 2011, INVEST OPHTH VIS SCI, V52, P3293, DOI 10.1167/iovs.10-6405; Choi SI, 2009, AM J PATHOL, V175, P248, DOI 10.2353/ajpath.2009.081001; de Sousa L, 2011, CORNEA, V3rd, P826; FOLBERG R, 1988, OPHTHALMOLOGY, V95, P46; Fujiki K, 2001, J HUM GENET, V46, P431, DOI 10.1007/s100380170041; Grothe HL, 2013, MOL VIS, V19, P593; Han KE, 2012, MOL VIS, V18, P1755; HOLLAND EJ, 1992, OPHTHALMOLOGY, V99, P1564; Jun RM, 2004, OPHTHALMOLOGY, V111, P463, DOI 10.1016/j.ophtha.2003.06.026; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Kato Y, 2013, J BIOL CHEM, V288, P25109, DOI 10.1074/jbc.M113.477695; Kim TI, 2011, AM J PATHOL, V179, P684, DOI 10.1016/j.ajpath.2011.04.005; Konishi M, 1999, CORNEA, V18, P424, DOI 10.1097/00003226-199907000-00006; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Mashima Y, 1998, BRIT J OPHTHALMOL, V82, P1280, DOI 10.1136/bjo.82.11.1280; Mashima Y, 2000, AM J OPHTHALMOL, V130, P516, DOI 10.1016/S0002-9394(00)00571-7; Okada M, 1998, INVEST OPHTH VIS SCI, V39, P1947; Wan XH, 2002, CORNEA, V21, P223, DOI 10.1097/00003226-200203000-00021; Yamamoto S, 2000, CORNEA, V19, pS21, DOI 10.1097/00003226-200005001-00005; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648	26	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133397	10.1371/journal.pone.0133397	http://dx.doi.org/10.1371/journal.pone.0133397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197481	Green Submitted, Green Published, gold			2022-12-26	WOS:000358547600094
J	Zhu, G; Li, X; Guo, B; Ke, Q; Dong, M; Li, F				Zhu, G.; Li, X.; Guo, B.; Ke, Q.; Dong, M.; Li, F.			PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer	ONCOGENE			English	Article							COLORECTAL-CANCER; E-CADHERIN; TRANSCRIPTION FACTORS; GASTRIC-CANCER; DOWN-REGULATION; CELL-ADHESION; E2A PROTEINS; KINASE; MIGRATION; INVASION	The p21-activated kinase 5 (PAK5) is overexpressed in advanced cancer and the transcription factor E47 is a direct repressor of E-cadherin and inducer of epithelial-mesenchymal transition (EMT). However, the relationship between PAK5 and E47 has not been explored. In this study, we found that PAK5-mediated E47 phosphorylation promoted EMT in advanced colon cancer. PAK5 interacted with E47 and phosphorylated E47 on Ser39 under hepatocyte growth factor (HGF) stimulation, which decreased cell-cell cohesion, increased cell migration and invasion in vitro and promoted metastasis in a xenograft model. Furthermore, phosphorylation of E47 facilitated its accumulating in nucleus in an importin a-dependent manner, and enhanced E47 binding to E-cadherin promoter directly, leading to inhibition of E-cadherin transcription. In contrast, PAK5-knockdown resulted in blockage of HGF-induced E47 phosphorylation, attenuated association of E47 with importin a and decreased E47 binding to E-cadherin promoter. In addition, we demonstrated a close correlation between PAK5 and phospho-Ser39 E47 expression in colon cancer specimens. More importantly, high expression of phospho-E47 was associated with an aggressive phenotype of colon cancer and nuclear phospho-E47 staining was found in certain cases of colon cancer with metastasis. Collectively, E47 is a novel substrate of PAK5, and PAK5-mediated phosphorylation of E47 promotes EMT and metastasis of colon cancer, suggesting that phosphorylated E47 on Ser39 may be a potential therapeutic target in progressive colon cancer.	China Med Univ, Dept Cell Biol, Key Lab Cell Biol, Minist Publ Hlth, Shenyang 110122, Peoples R China; China Med Univ, Key Lab Med Cell Biol, Minist Educ, Shenyang 110122, Peoples R China; Hangzhou Normal Univ, Sch Med, Dept Diagnost, Hangzhou, Zhejiang, Peoples R China; China Med Univ, Hosp 1, Gastrointestinal Surg, Dept Gen Surg, Shenyang 110122, Peoples R China	China Medical University; China Medical University; Hangzhou Normal University; China Medical University	Li, F (corresponding author), China Med Univ, Dept Cell Biol, Key Lab Cell Biol, Minist Publ Hlth,Shenyang North New Area, 77 Puhe Rd, Shenyang 110122, Peoples R China.; Li, F (corresponding author), China Med Univ, Key Lab Med Cell Biol, Minist Educ, 77 Puhe Rd, Shenyang 110122, Peoples R China.	fli@mail.cmu.edu.cn		Li, Feng/0000-0001-5868-7456	National Natural Science Foundation of China [90813038, 31371424, 31171360, 31000627, 81201659, 81230077]; Ministry of Education of China [20102104110016, IRT 13101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	We are grateful to Drs Stephen J Brandt and Akira Kato for providing essential expression vectors. We also thank Dr Funan Liu for technical assistance. This work was supported by grants from the National Natural Science Foundation of China (Nos 90813038, 31371424, 31171360, 31000627, 81201659 and 81230077), Doctoral fund of Ministry of Education of China (No. 20102104110016) and Ministry of Education of China (IRT 13101).	BERCHUCK A, 1989, CANCER RES, V49, P2091; Chen XS, 2012, J NEUROSCI RES, V90, P925, DOI 10.1002/jnr.22826; Chiaro C, 2012, BIOCHEM BIOPH RES CO, V428, P121, DOI 10.1016/j.bbrc.2012.10.018; Cochrane SW, 2009, BLOOD, V113, P1016, DOI 10.1182/blood-2008-06-164996; Coma S, 2010, CANCER RES, V70, P3823, DOI 10.1158/0008-5472.CAN-09-3048; Fang ZP, 2014, ACTA PHARMACOL SIN, V35, P82, DOI 10.1038/aps.2013.31; Fawdar S, 2013, P NATL ACAD SCI USA, V110, P12426, DOI 10.1073/pnas.1305207110; Giroux V, 2009, PANCREATOLOGY, V9, P738, DOI 10.1159/000199435; Gong W, 2009, INT J CANCER, V125, P548, DOI 10.1002/ijc.24428; Gu J, 2013, FEBS J, V280, P46, DOI 10.1111/febs.12048; Guo Q, 2014, ONCOGENE, V33, P3277, DOI 10.1038/onc.2013.296; He H, 2013, BBA-MOL CELL RES, V1833, P33, DOI 10.1016/j.bbamcr.2012.10.015; Hwang-Verslues WW, 2011, ONCOGENE, V30, P2463, DOI 10.1038/onc.2010.618; Johnson SE, 1996, MOL CELL BIOL, V16, P1604; Le Bras GF, 2012, CELL ADHES MIGR, V6, P365, DOI 10.4161/cam.21326; Lee SH, 2011, MOL CANCER RES, V9, P782, DOI 10.1158/1541-7786.MCR-10-0535; Li XD, 2010, EXPERT OPIN THER TAR, V14, P419, DOI 10.1517/14728221003642019; Li XD, 2010, INT J BIOCHEM CELL B, V42, P70, DOI 10.1016/j.biocel.2009.09.008; Li Y, 2012, BBA-MOL CELL RES, V1823, P465, DOI 10.1016/j.bbamcr.2011.11.013; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Mehmood R, 2011, MOL BIOL CELL, V22, P3715, DOI 10.1091/mbc.E10-10-0809; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; OGO A, 1995, J BIOL CHEM, V270, P25340, DOI 10.1074/jbc.270.43.25340; Patel D, 2012, BIOCHEM BIOPH RES CO, V422, P146, DOI 10.1016/j.bbrc.2012.04.126; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Shao YG, 2010, NUCLEIC ACIDS RES, V38, P2813, DOI 10.1093/nar/gkq006; Shapira S, 2014, CURR MED CHEM, V21, P2410, DOI 10.2174/0929867321666140205134616; Slattery C, 2008, INT J BIOCHEM CELL B, V40, P1431, DOI 10.1016/j.biocel.2007.05.014; Slattery C, 2006, FEBS LETT, V580, P4021, DOI 10.1016/j.febslet.2006.06.039; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; Spender LC, 2014, CANCER MANAG RES, V6, P27, DOI 10.2147/CMAR.S37745; Teachenor R, 2012, MOL CELL BIOL, V32, P1671, DOI 10.1128/MCB.06452-11; Teng Y, 2014, CLIN EXP METASTAS, V31, P367, DOI 10.1007/s10585-013-9621-6; Tijchon E, 2013, LEUKEMIA, V27, P541, DOI 10.1038/leu.2012.293; Wang X, 2010, TUMOR BIOL, V31, P575, DOI 10.1007/s13277-010-0071-3; Wang XX, 2013, TUMOR BIOL, V34, P2721, DOI 10.1007/s13277-013-0824-x; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Zhao HC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-317	45	31	33	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					1943	1954		10.1038/onc.2015.259	http://dx.doi.org/10.1038/onc.2015.259			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26212009				2022-12-26	WOS:000374010300007
J	Hanes, MS; Salanga, CL; Chowdry, AB; Comerford, I; McColl, SR; Kufareva, I; Handel, TM				Hanes, Melinda S.; Salanga, Catherina L.; Chowdry, Arnab B.; Comerford, Iain; McColl, Shaun R.; Kufareva, Irina; Handel, Tracy M.			Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-DERIVED FACTOR-1-ALPHA; CRYSTAL-STRUCTURE; SMALL-MOLECULE; HIGHLY POTENT; PHAGE DISPLAY; BETA-ARRESTIN; BINDING; CXCL12; ANTAGONIST	The chemokine CXCL12 and its G protein-coupled receptors CXCR4 and ACKR3 are implicated in cancer and inflammatory and autoimmune disorders and are targets of numerous antagonist discovery efforts. Here, we describe a series of novel, high affinity CXCL12-based modulators of CXCR4 and ACKR3 generated by selection of N-terminal CXCL12 phage libraries on live cells expressing the receptors. Twelve of 13 characterized CXCL12 variants are full CXCR4 antagonists, and four have K-d values <5 nM. The new variants also showed high affinity for ACKR3. The variant with the highest affinity for CXCR4, LGGG-CXCL12, showed efficacy in a murine model for multiple sclerosis, demonstrating translational potential. Molecular modeling was used to elucidate the structural basis of binding and antagonism of selected variants and to guide future designs. Together, this work represents an important step toward the development of therapeutics targeting CXCR4 and ACKR3.	[Hanes, Melinda S.; Salanga, Catherina L.; Chowdry, Arnab B.; Kufareva, Irina; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Comerford, Iain; McColl, Shaun R.] Univ Adelaide, Sch Mol & Biomed Sci, Chemokine Biol Grp, Adelaide, SA 5005, Australia	University of California System; University of California San Diego; University of Adelaide	Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,MC 0684, La Jolla, CA 92093 USA.	thandel@ucsd.edu	Regan, Clinton/E-6250-2012	Kufareva, Irina/0000-0001-9083-7039; Comerford, Iain/0000-0001-8753-4774	National Institutes of Health [R01 AI037113, U01 GM094612, R01 GM071872, U54 GM094618, R01 AI118985]; National Health and Medical Research Council [APP1066781]; Multiple Sclerosis Research Australia Grant [12-001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118985, R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, R01GM071872, U01GM094612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI037113 and U01 GM094612 (to T. M. H.), R01 GM071872 and U54 GM094618 (to I. K.), and R01 AI118985 (to T. M. H. and I. K.). This work was also supported by National Health and Medical Research Council Grant APP1066781 and Multiple Sclerosis Research Australia Grant 12-001 (to S. R. M. and I. C.). The authors declare that they have no conflicts of interest with the contents of this article.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Allen SJ, 2011, CYTOKINE, V55, P168, DOI 10.1016/j.cyto.2011.05.002; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berahovich RD, 2014, IMMUNOLOGY, V141, P111, DOI 10.1111/imm.12176; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chevigne A, 2011, BIOCHEM PHARMACOL, V82, P1438, DOI 10.1016/j.bcp.2011.07.091; Chevigne A, 2011, FEBS J, V278, P2867, DOI 10.1111/j.1742-4658.2011.08208.x; Choi WT, 2005, J VIROL, V79, P15398, DOI 10.1128/JVI.79.24.15398-15404.2005; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DUFFAUD G, 1988, J BIOL CHEM, V263, P10224; Eldridge B, 2009, PROTEIN ENG DES SEL, V22, P691, DOI 10.1093/protein/gzp052; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Hattermann K, 2013, ANN ANAT, V195, P103, DOI 10.1016/j.aanat.2012.10.013; Heitner T, 2001, J IMMUNOL METHODS, V248, P17, DOI 10.1016/S0022-1759(00)00340-9; Hori T, 1998, J IMMUNOL, V160, P180; Houimel M, 2012, CYTOKINE, V57, P322, DOI 10.1016/j.cyto.2011.11.022; Houimel M, 2009, J LEUKOCYTE BIOL, V85, P728, DOI 10.1189/jlb.0608380; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kawamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081454; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051813; Kohler RE, 2008, BRAIN PATHOL, V18, P504, DOI 10.1111/j.1750-3639.2008.00154.x; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; McDermott DH, 2011, BLOOD, V118, P4957, DOI 10.1182/blood-2011-07-368084; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Murphy JW, 2010, PROTEINS, V78, P1331, DOI 10.1002/prot.22666; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Ohnishi Y, 2000, J INTERF CYTOK RES, V20, P691, DOI 10.1089/10799900050116390; Patrussi L, 2011, CURR MED CHEM, V18, P497, DOI 10.2174/092986711794480159; Puchert M, 2014, CELL TISSUE RES, V355, P239, DOI 10.1007/s00441-013-1747-y; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; Ravn P, 2013, J BIOL CHEM, V288, P19760, DOI 10.1074/jbc.M112.426288; Sarchio SNE, 2014, J INVEST DERMATOL, V134, P1091, DOI 10.1038/jid.2013.424; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Smith EW, 2014, J MED CHEM, V57, P9693, DOI 10.1021/jm501194p; Steinberg M, 2010, CLIN THER, V32, P821, DOI 10.1016/j.clinthera.2010.05.007; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tan Y, 2009, CARDIOVASC RES, V82, P513, DOI 10.1093/cvr/cvp044; Tian SM, 2005, J VIROL, V79, P12667, DOI 10.1128/JVI.79.20.12667-12673.2005; Vabeno J, 2006, CHEM BIOL DRUG DES, V67, P346, DOI 10.1111/j.1747-0285.2006.00387.x; Veazey RS, 2009, J INFECT DIS, V199, P1525, DOI 10.1086/598685; Walters MJ, 2014, BRIT J CANCER, V110, P1179, DOI 10.1038/bjc.2013.830; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Werner L, 2013, THERANOSTICS, V3, P40, DOI 10.7150/thno.5135; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xia XM, 2010, WORLD J GASTROENTERO, V16, P2873, DOI 10.3748/wjg.v16.i23.2873; Yang OO, 1999, J VIROL, V73, P4582, DOI 10.1128/JVI.73.6.4582-4589.1999; Zhao B, 2011, J BIOL CHEM, V286, P28370, DOI 10.1074/jbc.M111.234799; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200	74	30	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22385	22397		10.1074/jbc.M115.675108	http://dx.doi.org/10.1074/jbc.M115.675108			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216880	Green Published, hybrid			2022-12-26	WOS:000361171500006
J	Nie, MH; Boddy, MN				Nie, Minghua; Boddy, Michael N.			Pli1(PIAS1) SUMO Ligase Protected by the Nuclear Pore-associated SUMO Protease Ulp1(SENP1/2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-SELECTIVE SEGREGASE; E3 LIGASE; LOCALIZATION; SUMOYLATION; ISOPEPTIDASE; COMPLEX; ULP2; RNF4; ACCUMULATION; MAINTENANCE	Covalent modification of the proteome by SUMO is critical for genetic stability and cell growth. Equally crucial to these processes is the removal of SUMO from its targets by the Ulp1 (HuSENP1/2) family of SUMO proteases. Ulp1 activity is normally spatially restricted, because it is localized to the nuclear periphery via interactions with the nuclear pore. Delocalization of Ulp1 causes DNA damage and cell cycle defects, phenotypes thought to be caused by inappropriate desumoylation of nucleoplasmic targets that are normally spatially protected from Ulp1. Here, we define a novel consequence of Ulp1 deregulation, with a major impact onSUMOpathway function. In fission yeast lacking Nup132 (Sc/HuNUP133), Ulp1 is delocalized and can no longer antagonize sumoylation of the PIAS family SUMO E3 ligase, Pli1. Consequently, SUMO chain-modified Pli1 is targeted for proteasomal degradation by the concerted action of a SUMO-targeted ubiquitin ligase (STUbL) and Cdc48-Ufd1Npl4. Pli1 degradation causes the profound SUMO pathway defects and associated centromere dysfunction in cells lacking Nup132. Thus, perhaps counterintuitively, Ulp1-mediated desumoylation can promote SUMO modification by stabilizing a SUMO E3 ligase.	[Nie, Minghua; Boddy, Michael N.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Boddy, MN (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nboddy@scripps.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM068608, GM081840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068608, R01GM081840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068608 and GM081840 (to M.N.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Asakawa H, 2014, NUCLEUS-PHILA, V5, P149, DOI 10.4161/nucl.28487; Bai SW, 2004, MOL CELL BIOL, V24, P6379, DOI 10.1128/MCB.24.14.6379-6392.2004; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Bukata L, 2013, CURR OPIN CELL BIOL, V25, P378, DOI 10.1016/j.ceb.2013.03.002; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Felberbaum R, 2008, CELL CYCLE, V7, P52, DOI 10.4161/cc.7.1.5218; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Goeres J, 2011, MOL BIOL CELL, V22, P4868, DOI 10.1091/mbc.E10-12-0953; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jongjitwimol J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094182; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kohler JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080442; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lewis A, 2007, J CELL BIOL, V178, P813, DOI 10.1083/jcb.200702154; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Liu NN, 2010, CELL RES, V20, P963, DOI 10.1038/cr.2010.107; Maison C, 2012, NAT STRUCT MOL BIOL, V19, P458, DOI 10.1038/nsmb.2244; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Miyagawa K, 2014, P NATL ACAD SCI USA, V111, P5950, DOI 10.1073/pnas.1401359111; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Mullen JR, 2011, GENETICS, V187, P73, DOI 10.1534/genetics.110.124347; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Palancade B, 2008, TRENDS CELL BIOL, V18, P174, DOI 10.1016/j.tcb.2008.02.001; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Skilton A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006750; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Taylor DL, 2002, J CELL SCI, V115, P1113; Texari L, 2013, MOL CELL, V51, P807, DOI 10.1016/j.molcel.2013.08.047; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Watts FZ, 2007, BIOCHEM SOC T, V35, P1379, DOI 10.1042/BST0351379; Westerbeck JW, 2014, MOL BIOL CELL, V25, P1, DOI 10.1091/mbc.E13-05-0291; Xhemalce B, 2004, EMBO J, V23, P3844, DOI 10.1038/sj.emboj.7600394; Xhemalce B, 2007, P NATL ACAD SCI USA, V104, P893, DOI 10.1073/pnas.0605442104; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	63	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22678	22685		10.1074/jbc.M115.673038	http://dx.doi.org/10.1074/jbc.M115.673038			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221037	hybrid, Green Published			2022-12-26	WOS:000361171500032
J	Badal, S; Her, YF; Maher, LJ				Badal, Sujan; Her, Yeng F.; Maher, L. James, III			Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL HYDROXYLASE REACTION; ACHILLES-TENDON RUPTURE; ACUTE-RENAL-FAILURE; CIPROFLOXACIN THERAPY; BACTERICIDAL ACTIVITY; COLLAGEN-SYNTHESIS; ANTIBACTERIAL USE; METAL-COMPLEXES; CANCER-CELLS; 4-HYDROXYLASES	Fluoroquinolones (FQ) are powerful broad-spectrum antibiotics whose side effects include renal damage and, strangely, tendinopathies. The pathological mechanisms underlying these toxicities are poorly understood. Here, we show that the FQ drugs norfloxacin, ciprofloxacin, and enrofloxacin are powerful iron chelators comparable with deferoxamine, a clinically useful iron-chelating agent. We show that iron chelation by FQ leads to epigenetic effects through inhibition of alpha-ketoglutarate-dependent dioxygenases that require iron as a co-factor. Three dioxygenases were examined in HEK293 cells treated with FQ. At sub-millimolar concentrations, these antibiotics inhibited jumonji domain histone demethylases, TET DNA demethylases, and collagen prolyl 4-hydroxylases, leading to accumulation of methylated histones and DNA and inhibition of proline hydroxylation in collagen, respectively. These effects may explain FQ-induced nephrotoxicity and tendinopathy. By the same reasoning, dioxygenase inhibition by FQ was predicted to stabilize transcription factor HIF-1 alpha by inhibition of the oxygen-dependent hypoxia-inducible transcription factor prolyl hydroxylation. In dramatic contrast to this prediction, HIF-1 alpha protein was eliminated by FQ treatment. We explored possible mechanisms for this unexpected effect and show that FQ inhibit HIF-1 alpha mRNA translation. Thus, FQ antibiotics induce global epigenetic changes, inhibit collagen maturation, and block HIF-1 alpha accumulation. We suggest that these mechanisms explain the classic renal toxicities and peculiar tendinopathies associated with FQ antibiotics.	[Badal, Sujan; Her, Yeng F.; Maher, L. James, III] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Maher, LJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	Maher@mayo.edu	Badal, Sujan/ABF-8294-2020; Regan, Clinton/E-6250-2012	Badal, Sujan/0000-0003-2271-7814; 	National Institutes of Health [1F31CA180698, 5T32GM065841, R25 GM55252, R25 GM075148]; Mayo Graduate School; Mayo Foundation; NATIONAL CANCER INSTITUTE [F31CA180698, R01CA166025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075148, R25GM055252, T32GM065841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F31CA180698 (to Y. F. H.), 5T32GM065841 (to Mayo Clinic), R25 GM55252 (to Mayo Clinic), and R25 GM075148 (to Mayo Clinic). This work was also supported by the Mayo Graduate School and the Mayo Foundation. The authors declare that they have no conflict of interest with the contents of this article.	Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872; BAILEY JR, 1992, AM J NEPHROL, V12, P271, DOI 10.1159/000168458; Bird ST, 2013, CAN MED ASSOC J, V185, pE475, DOI 10.1503/cmaj.121730; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; BURKHARDT JE, 1993, FUND APPL TOXICOL, V20, P257, DOI 10.1006/faat.1993.1034; Cameron EJ, 2012, CLIN EXP ALLERGY, V42, P1302, DOI 10.1111/j.1365-2222.2012.03979.x; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908; Chohan ZH, 2005, J ENZYM INHIB MED CH, V20, P303, DOI 10.1080/14756360310001624948; Corps AN, 2005, RHEUMATOLOGY, V44, P1514, DOI 10.1093/rheumatology/kei087; Corps AN, 2002, ARTHRITIS RHEUM, V46, P3034, DOI 10.1002/art.10617; Corrao G, 2006, DRUG SAFETY, V29, P889, DOI 10.2165/00002018-200629100-00006; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dharnidharka VR, 1998, AM J KIDNEY DIS, V31, P710, DOI 10.1053/ajkd.1998.v31.pm9531191; Ferry T, 2005, INFECTION, V33, P151, DOI 10.1007/s15010-005-4057-9; Gong LY, 2012, BIOORG MED CHEM LETT, V22, P7381, DOI 10.1016/j.bmcl.2012.10.066; Griffin MO, 2011, PHARMACOL RES, V63, P102, DOI 10.1016/j.phrs.2010.10.004; Griffin MO, 2010, AM J PHYSIOL-CELL PH, V299, pC539, DOI 10.1152/ajpcell.00047.2010; HACKBARTH CJ, 1986, ANTIMICROB AGENTS CH, V29, P611, DOI 10.1128/AAC.29.4.611; Hadimeri H, 1997, SCAND J UROL NEPHROL, V31, P481, DOI 10.3109/00365599709030647; Hall MM, 2011, PM&R, V3, P132, DOI 10.1016/j.pmrj.2010.10.003; Harrell RM, 1999, SOUTHERN MED J, V92, P622, DOI 10.1097/00007611-199906000-00014; Herath SC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009764.pub2; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hobson-Webb LD, 2006, J CHILD NEUROL, V21, P429, DOI 10.1177/08830738060210051201; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; HOOTKINS R, 1989, CLIN NEPHROL, V32, P75; Johannes CB, 2007, DRUG SAFETY, V30, P705, DOI 10.2165/00002018-200730080-00007; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kennedy J. F., 2003, CHEM FUNCTIONAL PROP; Khaliq Y, 2003, CLIN INFECT DIS, V36, P1404, DOI 10.1086/375078; Kim Grace K, 2010, J Clin Aesthet Dermatol, V3, P49; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Lim S, 2003, RENAL FAILURE, V25, P647, DOI 10.1081/JDI-120022557; Lipsky BA, 1999, CLIN INFECT DIS, V28, P352, DOI 10.1086/515104; Ma HHM, 1997, PHARMACEUT RES, V14, P366, DOI 10.1023/A:1012014608733; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Marti HP, 1998, BRIT J RHEUMATOL, V37, P343; Martin SJ, 1998, ANN PHARMACOTHER, V32, P320, DOI 10.1345/aph.17178; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Melhus Asa, 2005, Expert Opin Drug Saf, V4, P299, DOI 10.1517/14740338.4.2.299; Montagnac Richard, 2005, Nephrol Ther, V1, P44, DOI 10.1016/j.nephro.2005.02.005; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; MYLLYLA R, 1977, EUR J BIOCHEM, V80, P349, DOI 10.1111/j.1432-1033.1977.tb11889.x; Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455; Peters JP, 2013, NUCLEIC ACIDS RES, V41, P10593, DOI 10.1093/nar/gkt808; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierfitte C, 1996, THERAPIE, V51, P419; Psomas G, 2008, J INORG BIOCHEM, V102, P1798, DOI 10.1016/j.jinorgbio.2008.05.012; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Reece RJ, 1996, NEPHROL DIAL TRANSPL, V11, P393, DOI 10.1093/oxfordjournals.ndt.a027281; Rosenblat G, 1998, CONNECT TISSUE RES, V37, P303, DOI 10.3109/03008209809002447; Sadarangani SP, 2015, MAYO CLIN PROC, V90, P109, DOI 10.1016/j.mayocp.2014.09.006; Sandhu J, 2009, J CHROMATOGR B, V877, P1957, DOI 10.1016/j.jchromb.2009.05.032; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Simonin MA, 1999, ANTIMICROB AGENTS CH, V43, P2915, DOI 10.1128/AAC.43.12.2915; Simonin MA, 2000, ANTIMICROB AGENTS CH, V44, P867, DOI 10.1128/AAC.44.4.867-872.2000; Sode J, 2007, EUR J CLIN PHARMACOL, V63, P499, DOI 10.1007/s00228-007-0265-9; Stahlmann R, 1999, DRUGS, V58, P37, DOI 10.2165/00003495-199958002-00007; Steel HC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/584262; Stegeman CA, 1996, NEW ENGL J MED, V335, P16, DOI 10.1056/NEJM199607043350103; Stratta P, 2007, AM J KIDNEY DIS, V50, P330, DOI 10.1053/j.ajkd.2007.05.014; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; TUDERMAN L, 1977, EUR J BIOCHEM, V80, P341, DOI 10.1111/j.1432-1033.1977.tb11888.x; Uivarosi V, 2013, MOLECULES, V18, P11153, DOI 10.3390/molecules180911153; van der Linden PD, 2003, ARCH INTERN MED, V163, P1801, DOI 10.1001/archinte.163.15.1801; Wagenlehner FME, 2006, INT J ANTIMICROB AG, V28, P551, DOI 10.1016/j.ijantimicag.2006.07.026; Walker RC, 1999, MAYO CLIN PROC, V74, P1030; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; Williams RJ, 2000, AM J SPORT MED, V28, P364, DOI 10.1177/03635465000280031401; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; YAMAMOTO I, 1992, J NUTR, V122, P871, DOI 10.1093/jn/122.4.871; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448	79	52	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22287	22297		10.1074/jbc.M115.671222	http://dx.doi.org/10.1074/jbc.M115.671222			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26205818	Green Published, hybrid			2022-12-26	WOS:000360968500044
J	Lauer, ME; Majors, AK; Comhair, S; Ruple, LM; Matuska, B; Subramanian, A; Farver, C; Dworski, R; Grandon, D; Laskowski, D; Dweik, RA; Erzurum, SC; Hascall, VC; Aronica, MA				Lauer, Mark E.; Majors, Alana K.; Comhair, Suzy; Ruple, Lisa M.; Matuska, Brittany; Subramanian, Ahila; Farver, Carol; Dworski, Ryszard; Grandon, Deepa; Laskowski, Dan; Dweik, Raed A.; Erzurum, Serpil C.; Hascall, Vincent C.; Aronica, Mark A.			Hyaluronan and Its Heavy Chain Modification in Asthma Severity and Experimental Asthma Exacerbation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; INTER-ALPHA-INHIBITOR; SMOOTH-MUSCLE-CELLS; STIMULATED GENE-6; TSG-6 ACTIVITY; MURINE MODEL; INFLAMMATION; ACID; EXPRESSION; DEPOSITION	Hyaluronan (HA) is a large (>1500 kDa) polysaccharide of the extracellular matrix that has been linked to severity and inflammation in asthma. During inflammation, HA becomes covalently modified with heavy chains (HC-HA) from inter-alpha-inhibitor (I alpha I), which functions to increase its avidity for leukocytes. Our murine model of allergic pulmonary inflammation suggested that HC-HA may contribute to inflammation, adversely effecting lower airway remodeling and asthma severity. Our objective was to characterize the levels of HA and HC-HA in asthmatic subjects and to correlate these levels with asthma severity. We determined the levels and distribution of HA and HC-HA (i) from asthmatic and control lung tissue, (ii) in bron-choalveolar lavage fluid obtained from non-severe and severe asthmatics and controls, and (iii) in serum and urine from atopic asthmatics after an experimental asthma exacerbation. HC-HA distribution was observed (i) in the thickened basement membrane of asthmatic lower airways, (ii) around smooth muscle cells of the asthmatic submucosa, and (iii) around reserve cells of the asthmatic epithelium. Patients with severe asthma had increased HA levels in bronchoalveolar lavage fluid that correlated with pulmonary function and nitric oxide levels, whereas HC-HA was only observed in a patient with non-severe asthma. After an experimental asthma exacerbation, serum HA was increased within 4 h after challenge and remained elevated through 5 days after challenge. Urine HA and HC-HA were not significantly different. These data implicate HA and HC-HA in the pathogenesis of asthma severity that may occur in part due to repetitive asthma exacerbations over the course of the disease.	[Lauer, Mark E.] Cleveland Clin, Lerner Res Inst, Inst Pediat, Cleveland, OH 44195 USA; [Lauer, Mark E.; Matuska, Brittany; Hascall, Vincent C.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Majors, Alana K.; Comhair, Suzy; Ruple, Lisa M.; Grandon, Deepa; Laskowski, Dan; Dweik, Raed A.; Aronica, Mark A.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Farver, Carol] Cleveland Clin, Lerner Res Inst, Dept Anat Pathol, Cleveland, OH 44195 USA; [Subramanian, Ahila; Laskowski, Dan; Dweik, Raed A.; Erzurum, Serpil C.; Aronica, Mark A.] Cleveland Clin, Lerner Res Inst, Resp Inst, Cleveland, OH 44195 USA; [Dworski, Ryszard] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Vanderbilt University	Aronica, MA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol NB2 85, Cleveland, OH 44195 USA.	ARONICM@ccf.org	Regan, Clinton/E-6250-2012		National Institutes of Health [HL081064, HL103453]; Case Western Reserve University/Cleveland Clinic CTSA [UL1TR000439]; National Center for Advancing Translational Sciences (NCATS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123767, P01HL107147, P01HL081064, R01HL113325, P01HL103453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University/Cleveland Clinic CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081064 and HL103453 (NHLBI). This work was also supported in part by Case Western Reserve University/Cleveland Clinic CTSA Grant UL1TR000439 and the National Center for Advancing Translational Sciences (NCATS). The authors declare that they have no conflict of interest with the contents of this article.	[Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Ayars AG, 2013, INT ARCH ALLERGY IMM, V161, P65, DOI 10.1159/000343031; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Cheng G, 2013, GLYCOBIOLOGY, V23, P43, DOI 10.1093/glycob/cws122; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Comhair SAA, 2005, AM J RESP CRIT CARE, V172, P306, DOI 10.1164/rccm.200502-180OC; Comhair SAA, 2000, LANCET, V355, P624, DOI 10.1016/S0140-6736(99)04736-4; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; Forteza RM, 2012, J BIOL CHEM, V287, P42288, DOI 10.1074/jbc.M112.387795; FRASER JRE, 1989, CIBA F SYMP, V143, P41; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Ghosh Sudakshina, 2012, Drug Discov Today Dis Mech, V9, pe89; Haserodt S, 2011, GLYCOBIOLOGY, V21, P175, DOI 10.1093/glycob/cwq145; He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584; Khatri SB, 2003, J APPL PHYSIOL, V95, P436, DOI 10.1152/japplphysiol.01127.2002; Khatri SB, 2001, AM J RESP CRIT CARE, V164, P1844, DOI 10.1164/ajrccm.164.10.2106119; Lara A, 2008, AM J RESP CRIT CARE, V178, P673, DOI 10.1164/rccm.200710-1542OC; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2015, METHODS MOL BIOL, V1229, P543, DOI 10.1007/978-1-4939-1714-3_42; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Monzon ME, 2008, AM J RESP CELL MOL, V39, P289, DOI 10.1165/rcmb.2007-0361OC; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; SODERBERG M, 1989, INT ARCH ALLER A IMM, V88, P373, DOI 10.1159/000234719; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403, DOI 10.1164/ajrccm.157.2.96-08040; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Westergren-Thorsson G, 2002, INT J BIOCHEM CELL B, V34, P1256, DOI 10.1016/S1357-2725(02)00058-4; Wisniewski HG, 2014, OSTEOARTHR CARTILAGE, V22, P235, DOI 10.1016/j.joca.2013.12.004; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	40	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23124	23134		10.1074/jbc.M115.663823	http://dx.doi.org/10.1074/jbc.M115.663823			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26209637	Green Published, hybrid			2022-12-26	WOS:000361685500024
J	Gao, P; Liao, Z; Wang, XX; Bao, LF; Fan, MH; Li, XM; Wu, CW; Xia, SW				Gao, Peng; Liao, Zhi; Wang, Xin-xing; Bao, Lin-fei; Fan, Mei-hua; Li, Xiao-min; Wu, Chang-wen; Xia, Shu-wei			Layer-by-Layer Proteomic Analysis of Mytilus galloprovincialis Shell	PLOS ONE			English	Article								Bivalve shell is a biomineralized tissue with various layers/microstructures and excellent mechanical properties. Shell matrix proteins (SMPs) pervade and envelop the mineral crystals and play essential roles in biomineralization. Despite that Mytilus is an economically important bivalve, only few proteomic studies have been performed for the shell, and current knowledge of the SMP set responsible for different shell layers of Mytilus remains largely patchy. In this study, we observed that Mytilus galloprovincialis shell contained three layers, including nacre, fibrous prism, and myostracum that is involved in shell-muscle attachment. A parallel proteomic analysis was performed for these three layers. By combining LC-MS/ MS analysis with Mytilus EST database interrogations, a whole set of 113 proteins was identified, and the distribution of these proteins in different shell layers followed a mosaic pattern. For each layer, about a half of identified proteins are unique and the others are shared by two or all of three layers. This is the first description of the protein set exclusive to nacre, myostracum, and fibrous prism in Mytilus shell. Moreover, most of identified proteins in the present study are novel SMPs, which greatly extended biomineralization-related protein data of Mytilus. These results are useful, on one hand, for understanding the roles of SMPs in the deposition of different shell layers. On the other hand, the identified protein set of myostracum provides candidates for further exploring the mechanism of adductor muscle-shell attachment.	[Gao, Peng; Xia, Shu-wei] Ocean Univ Chinese, Coll Chem & Chem Engn, Qingdao, Peoples R China; [Gao, Peng; Liao, Zhi; Wang, Xin-xing; Bao, Lin-fei; Fan, Mei-hua; Wu, Chang-wen] Zhejiang Ocean Univ, Lab Marine Biol Prot Engn, Zhoushan, Zhejiang, Peoples R China; [Li, Xiao-min] Chinese Acad Fishery Sci, Ctr Biotechnol, Beijing, Peoples R China	Ocean University of China; Zhejiang Ocean University; Chinese Academy of Fishery Sciences	Xia, SW (corresponding author), Ocean Univ Chinese, Coll Chem & Chem Engn, Qingdao, Peoples R China.	shuweixia@yahoo.com	Wang, Xinxing/AAU-6356-2021	Liao, Zhi/0000-0003-0688-7346	Natural Science Foundation of Zhejiang [LY14C100001]; Open Foundation from Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education [2015DF02]; National College Students' Innovative Entrepreneurial Training Plan [201410340002]	Natural Science Foundation of Zhejiang(Natural Science Foundation of Zhejiang Province); Open Foundation from Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education; National College Students' Innovative Entrepreneurial Training Plan	This work was supported by the Natural Science Foundation of Zhejiang under Grant LY14C100001; The Open Foundation from Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education under Grant 2015DF02; and The National College Students' Innovative Entrepreneurial Training Plan under Grant 201410340002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck S, 1996, CONNECT TISSUE RES, V35, P365, DOI 10.3109/03008209609029213; Blank S, 2003, J MICROSC, V212; Caroline J, 2010, BMC GENOMICS, P11; Carriker MR, 1996, THE E OYSTER; Carter JG, 1990, SKELETAL BIOMINERALI, P1; Checa A, 2005, BIOMATERIALS, V26; Estevez-Calvar N, 2011, DEV COMP IMMUNOLOGY, V35; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; Falini G, 1996, SCIENCE, P271; Ferjani I, 2010, BIOCH BIOPHYSICA ACT, V1804; Funabara D, 2001, FISH SCI, V67; Galtsoff PA, 1964, THE AM OYSTER; Gregoie C, 1961, J BIOPHYSICAL BIOCH, P9; HARE PE, 1963, SCIENCE, V139, P216, DOI 10.1126/science.139.3551.216; Hofmann SL, 1989, J BIOL CHEM, V264; Huang J, 2007, BIOCH BIOPHYS ACTA, V1770; Jackson DJ, 2010, MOL BIOL EVOLUTION, V27; Kouchinsky A, 2000, ACTA PALAEONTOLOGICA, V45; Lee SW, 2007, MICRON, V38, P58, DOI 10.1016/j.micron.2006.03.018; Lee SW, 2011, MICRON, V42, P60, DOI 10.1016/j.micron.2010.08.001; Lowenstam HA, 1989, BIOMINERALIZATION; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Mann S., 2011, BIOMINERALIZATION PR; Marie B, 2012, P NATL ACAD SCI, V109; Marie B, 2011, MARINE BIOTECHNOLOGY, V13; Marie B, 2011, J MOL EVOL, V72, P531, DOI 10.1007/s00239-011-9451-6; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Oaki Y, 2005, ANGEW CHEM INT ED, V44; Peters W, 1972, COMP BIOCH PHYSL B, P41; Schonitzer V, 2007, BMC STRUCTURAL BIOL, P7; Sellinger A, 1998, NATURE, P394; Shen X, 1997, J BIOL CHEM, V272; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2007, BIOSCIENCE BIOTECHNO, V71; Suzuki M, 2011, CHEMBIOCHEM, V12, P2478, DOI 10.1002/cbic.201100317; TAYLOR JD, 1990, HYDROBIOLOGIA, V193, P199, DOI 10.1007/BF00028077; Weiss IM, 2001, BIOCH BIOPHYSICAL RE, V285; Weiss IM, 2006, J STRUCTURAL BIOL, V153; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; Yin Y, 2005, BIOCHEMISTRY, V44; Zhang G., 2012, NATURE, V490; Zhao H, 2006, J BIOL CHEM, V281	44	52	57	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133913	10.1371/journal.pone.0133913	http://dx.doi.org/10.1371/journal.pone.0133913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218932	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900054
J	Lean, QY; Eri, RD; Randall-Demllo, S; Sohal, SS; Stewart, N; Peterson, GM; Gueven, N; Patel, RP				Lean, Qi Ying; Eri, Rajaraman D.; Randall-Demllo, Sarron; Sohal, Sukhwinder Singh; Stewart, Niall; Peterson, Gregory M.; Gueven, Nuri; Patel, Rahul P.			Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses	PLOS ONE			English	Article							LOW-MOLECULAR-WEIGHT; ACTIVE ULCERATIVE-COLITIS; DEXTRAN SULFATE SODIUM; BOWEL-DISEASE; HEPARIN ENOXAPARIN; INTESTINAL INFLAMMATION; CYTOKINE PRODUCTION; ADJUVANT THERAPY; CROHNS-DISEASE; LICHEN-PLANUS	Inflammatory bowel diseases, such as ulcerative colitis, cause significant morbidity and decreased quality of life. The currently available treatments are not effective in all patients, can be expensive and have potential to cause severe side effects. This prompts the need for new treatment modalities. Enoxaparin, a widely used antithrombotic agent, is reported to possess anti-inflammatory properties and therefore we evaluated its therapeutic potential in a mouse model of colitis. Acute colitis was induced in male C57BL/6 mice by administration of dextran sulfate sodium (DSS). Mice were treated once daily with enoxaparin via oral or intraperitoneal administration and monitored for colitis activities. On termination (day 8), colons were collected for macroscopic evaluation and cytokine measurement, and processed for histology and immunohistochemistry. Oral but not intraperitoneal administration of enoxaparin significantly ameliorated DSS-induced colitis. Oral enoxaparin-treated mice retained their body weight and displayed less diarrhea and fecal blood loss compared to the untreated colitis group. Colon weight in enoxaparin-treated mice was significantly lower, indicating reduced inflammation and edema. Histological examination of untreated colitis mice showed a massive loss of crypt architecture and goblet cells, infiltration of immune cells and the presence of edema, while all aspects of this pathology were alleviated by oral enoxaparin. Reduced number of macrophages in the colon of oral enoxaparin-treated mice was accompanied by decreased levels of pro-inflammatory cytokines. Oral enoxaparin significantly reduces the inflammatory pathology associated with DSS-induced colitis in mice and could therefore represent a novel therapeutic option for the management of ulcerative colitis.	[Lean, Qi Ying; Stewart, Niall; Peterson, Gregory M.; Gueven, Nuri; Patel, Rahul P.] Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia; [Lean, Qi Ying] Univ Teknol MARA, Fac Pharm, Puncak Alam, Selangor, Malaysia; [Eri, Rajaraman D.; Randall-Demllo, Sarron; Sohal, Sukhwinder Singh] Univ Tasmania, Fac Hlth, Sch Hlth Sci, Hobart, Tas, Australia; [Sohal, Sukhwinder Singh; Peterson, Gregory M.] Univ Tasmania, Fac Hlth, Breathe Well Ctr Res Excellence Chron Resp Dis &, Sch Med, Hobart, Tas, Australia; [Peterson, Gregory M.] Univ Tasmania, Fac Hlth, Sch Med, Hlth Serv Innovat Tasmania, Hobart, Tas, Australia	University of Tasmania; Universiti Teknologi MARA; University of Tasmania; University of Tasmania; University of Tasmania	Patel, RP (corresponding author), Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia.	Rahul.Patel@utas.edu.au	Eri, Raj/AAD-1185-2020; Lean, Qi Ying/G-1680-2019; Randall-Demllo, Sarron Y/B-3326-2018; Eri, Rajaraman/AAM-3214-2020	Eri, Raj/0000-0003-1688-8043; Lean, Qi Ying/0000-0003-0331-8607; Peterson, Gregory/0000-0002-6764-3882; Patel, Rahul/0000-0001-9344-1013; Sohal, Sukhwinder Singh/0000-0001-9627-6498; Guven, Nuri/0000-0003-3782-767X	Royal Hobart Hospital Research Foundation, Hobart, Tasmania, Australia; University of Tasmania, Australia; Pharmacy, School of Medicine - Medicines Australia	Royal Hobart Hospital Research Foundation, Hobart, Tasmania, Australia; University of Tasmania, Australia; Pharmacy, School of Medicine - Medicines Australia	This study was supported by The Royal Hobart Hospital Foundation's Research Grant (RHHRF) from Royal Hobart Hospital Research Foundation, Hobart, Tasmania, Australia; and Faculty of Health Science Strategic Seed Funding Grant and Research Enhancement Grants Scheme from University of Tasmania, Australia. Qi Ying Lean is supported by a Scholarship from Pharmacy, School of Medicine, funded by Medicines Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Belmiro CLR, 2009, J BIOL CHEM, V284, P11267, DOI 10.1074/jbc.M807211200; Bento AF, 2011, AM J PATHOL, V178, P1153, DOI 10.1016/j.ajpath.2010.11.052; Bisio A, 2009, THROMB HAEMOSTASIS, V102, P865, DOI 10.1160/TH09-02-0081; Bloom S, 2004, ALIMENT PHARM THER, V19, P871, DOI 10.1111/j.1365-2036.2004.01926.x; Celasco G, 2010, ALIMENT PHARM THER, V31, P375, DOI 10.1111/j.1365-2036.2009.04194.x; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Day R, 1999, DIGEST DIS SCI, V44, P2508, DOI 10.1023/A:1026647308089; de Bievre MA, 2007, INFLAMM BOWEL DIS, V13, P753, DOI 10.1002/ibd.20085; Dotan I, 2001, DIGEST DIS SCI, V46, P2239, DOI 10.1023/A:1011979418914; Dotan I, 2001, ALIMENT PHARM THER, V15, P1687, DOI 10.1046/j.1365-2036.2001.01079.x; Eri R, 2012, METHODS MOL BIOL, V844, P261, DOI 10.1007/978-1-61779-527-5_19; Fareed J, 2004, CURR PHARM DESIGN, V10, P983, DOI 10.2174/1381612043452811; Ferrante M, 2008, J CROHNS COLITIS, V2, P219, DOI 10.1016/j.crohns.2008.03.004; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; GAFFNEY PR, 1995, AM J GASTROENTEROL, V90, P220; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Hayashi Y, 2009, SCAND J GASTROENTERO, V44, P1323, DOI 10.3109/00365520903262414; Heinsbroek SEM, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001069; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Hodak E, 1998, J AM ACAD DERMATOL, V38, P564, DOI 10.1016/S0190-9622(98)70118-5; Ishiguro Y, 1999, J GASTROENTEROL, V34, P66, DOI 10.1007/s005350050218; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Kaya S, 2004, SCAND J GASTROENTERO, V39, P613, DOI 10.1080/00365520410004622; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Korzenik JR, 1998, DIGEST DIS SCI, V43, P1800, DOI 10.1023/A:1018800207063; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; Lever Rebecca, 2012, Handb Exp Pharmacol, P281, DOI 10.1007/978-3-642-23056-1_12; Lever R, 2010, EUR J PHARMACOL, V630, P137, DOI 10.1016/j.ejphar.2009.12.015; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; Luo JY, 2011, BIOMED PHARMACOTHER, V65, P111, DOI 10.1016/j.biopha.2010.12.013; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Oshima T, 2008, J GASTROEN HEPATOL, V23, pS146, DOI 10.1111/j.1440-1746.2008.05405.x; Paliwal R, 2012, MED RES REV, V32, P388, DOI 10.1002/med.20217; Panes J, 2000, GASTROENTEROLOGY, V119, P903, DOI 10.1053/gast.2000.18159; Pastorelli L, 2008, ALIMENT PHARM THER, V28, P581, DOI 10.1111/j.1365-2036.2008.03757.x; Patel RP, 2008, J PHARMACEUT BIOMED, V46, P30, DOI 10.1016/j.jpba.2007.10.009; Pellequer Y, 2007, J PHARMACOL EXP THER, V321, P726, DOI 10.1124/jpet.106.117226; Queiroz KCS, 2011, MOL MED, V17, P1119, DOI 10.2119/molmed.2011.00138; Rai R, 2002, J AM ACAD DERMATOL, V46, P141, DOI 10.1067/mjd.2002.117389; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rose WA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-41; Sands BE, 2007, J CLIN PHARMACOL, V47, P930, DOI 10.1177/0091270007301623; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Steinbach EC, 2014, INFLAMM BOWEL DIS, V20, P166, DOI 10.1097/MIB.0b013e3182a69dca; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Torkvist L, 1999, ALIMENT PHARM THERAP, V13, P1323; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Vrij AA, 2001, SCAND J GASTROENTERO, V36, P41, DOI 10.1080/003655201753265091; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Wang X, 2011, DIGEST DIS SCI, V56, P1047, DOI 10.1007/s10620-010-1398-8; Weisser SB, 2011, J LEUKOCYTE BIOL, V90, P483, DOI 10.1189/jlb.0311124; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Yang SK, 2002, AM J GASTROENTEROL, V97, P126; Ye HP, 2013, J PHARMACEUT BIOMED, V85, P99, DOI 10.1016/j.jpba.2013.06.033; Zezos P, 2006, ALIMENT PHARM THER, V23, P1443, DOI 10.1111/j.1365-2036.2006.02870.x; Zheng B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095441; Zhu W, 2014, IMMUNOL INVEST, V43, P638, DOI 10.3109/08820139.2014.909456	63	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134259	10.1371/journal.pone.0134259	http://dx.doi.org/10.1371/journal.pone.0134259			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218284	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900103
J	Locatelli, D; Terao, M; Kurosaki, M; Zanellati, MC; Pletto, DR; Finardi, A; Colciaghi, F; Garattini, E; Battaglia, GS				Locatelli, Denise; Terao, Mineko; Kurosaki, Mami; Zanellati, Maria Clara; Pletto, Daniela Rita; Finardi, Adele; Colciaghi, Francesca; Garattini, Enrico; Battaglia, Giorgio Stefano			Different Stability and Proteasome-Mediated Degradation Rate of SMN Protein Isoforms	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL MOTOR-NEURON; ACTIN MESSENGER-RNA; DETERMINING GENE; DISEASE SEVERITY; AXONAL-SURVIVAL; A-SMN; COMPLEX; LOCALIZATION; IDENTIFICATION	The key pathogenic steps leading to spinal muscular atrophy (SMA), a genetic disease characterized by selective motor neuron degeneration, are not fully clarified. The full-length SMN protein (FL-SMN), the main protein product of the disease gene SMN1, plays an established role in the cytoplasm in snRNP biogenesis ultimately leading to mRNA splicing within the nucleus. It is also involved in the mRNA axonal transport. However, to what extent the impairment of these two SMN functions contributes to SMA pathogenesis remains unknown. A shorter SMN isoform, axonal-SMN or a-SMN, with more specific axonal localization, has been discovered, but whether it might act in concert with FL-SMN in SMA pathogenesis is not known. As a first step in defining common or divergent intracellular roles of FL-SMN vs a-SMN proteins, we here characterized the turn-over of both proteins and investigated which pathway contributed to a-SMN degradation. We performed real time western blot and confocal immunofluorescence analysis in easily controllable in vitro settings. We analyzed co-transfected NSC34 and HeLa cells and cell clones stably expressing both a-SMN and FL-SMN proteins after specific blocking of transcript or protein synthesis and inhibition of known intracellular degradation pathways. Our data indicated that whereas the stability of both FL-SMN and a-SMN transcripts was comparable, the a-SMN protein was characterized by a much shorter half-life than FL-SMN. In addition, as already demonstrated for FL-SMN, the Ub/proteasome pathway played a major role in the a-SMN protein degradation. We hypothesize that the faster degradation rate of a-SMN vs FL-SMN is related to the protection provided by the protein complex in which FL-SMN is assembled. The diverse a-SMN vs FL-SMN C-terminus may dictate different protein interactions and complex formation explaining the different localization and role in the neuronal compartment, and the lower expression and stability of a-SMN.	[Locatelli, Denise; Zanellati, Maria Clara; Pletto, Daniela Rita; Finardi, Adele; Colciaghi, Francesca; Battaglia, Giorgio Stefano] IRCCS Neurol Inst C Besta, Mol Neuroanat & Pathogenesis Unit, Milan, Italy; [Terao, Mineko; Kurosaki, Mami; Garattini, Enrico] IRCCS, Ist Ric Farmacol Mario Negri, Mol Biol Lab, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Locatelli, D (corresponding author), IRCCS Neurol Inst C Besta, Mol Neuroanat & Pathogenesis Unit, Milan, Italy.	denise.locatelli@istituto-besta.it	Colciaghi, Francesca/J-8772-2016; terao, mineko/AAU-8089-2020; Finardi, Adele/K-3970-2016; Garattini, Enrico/AAI-1998-2019; Terao, Mineko/AAA-6415-2020; KUROSAKI, Mami/ABG-2224-2020; Locatelli, Denise/J-8655-2016	Colciaghi, Francesca/0000-0002-6487-380X; Finardi, Adele/0000-0001-6156-975X; Terao, Mineko/0000-0002-9976-9869; KUROSAKI, Mami/0000-0001-8231-713X; Locatelli, Denise/0000-0001-9783-7111; Garattini, Enrico/0000-0001-8983-886X	Telethon-Italy Foundation [GGP13081]; Girotondo/ONLUS association; Smarathon-ONLUS association; Italian Ministry of Health	Telethon-Italy Foundation(Fondazione Telethon); Girotondo/ONLUS association; Smarathon-ONLUS association; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by financial supports from Telethon-Italy Foundation (GGP13081), Girotondo/ONLUS and Smarathon-ONLUS associations and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Battaglia G, 1997, HUM MOL GENET, V6, P1961, DOI 10.1093/hmg/6.11.1961; Brichta L, 2008, HUM GENET, V123, P141, DOI 10.1007/s00439-007-0455-7; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Fuentes JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015769; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Han KJ, 2012, J BIOL CHEM, V287, P43741, DOI 10.1074/jbc.M112.372318; Heier CR, 2007, J CHILD NEUROL, V22, P1013, DOI 10.1177/0883073807305669; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Kwon JE, 2011, FEBS LETT, V585, P1287, DOI 10.1016/j.febslet.2011.04.011; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Locatelli D, 2012, J BIOL CHEM, V287, P25782, DOI 10.1074/jbc.M112.362830; Locatelli D, 2012, J NEUROCHEM, V121, P465, DOI 10.1111/j.1471-4159.2012.07689.x; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; PEARN J, 1980, LANCET, V1, P919; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.33474; Robbins KL, 2014, HUM MOL GENET, V23, P4559, DOI 10.1093/hmg/ddu169; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Sleigh JN, 2011, DIS MODEL MECH, V4, P457, DOI 10.1242/dmm.007245; Sun Y, 2005, HUM MUTAT, V25, P64, DOI 10.1002/humu.20111; Todd AG, 2010, J MOL BIOL, V401, P681, DOI 10.1016/j.jmb.2010.06.058; Twombly R, 2003, J NATL CANCER I, V95, P845, DOI 10.1093/jnci/95.12.845; Vitali T, 1999, HUM MOL GENET, V8, P2525, DOI 10.1093/hmg/8.13.2525; Vitte J, 2007, AM J PATHOL, V171, P1269, DOI 10.2353/ajpath.2007.070399; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Yamada H, 2015, PEDIATR NEUROL, V52, P638, DOI 10.1016/j.pediatrneurol.2015.02.023; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134163	10.1371/journal.pone.0134163	http://dx.doi.org/10.1371/journal.pone.0134163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214005	gold, Green Published, Green Submitted			2022-12-26	WOS:000358594300055
J	Doria, MS; de Sousa, AO; Barbosa, CD; Costa, MGC; Gesteira, AD; Souza, RM; Freitas, ACO; Pirovani, CP				Doria, Milena Santos; de Sousa, Aurizangela Oliveira; Barbosa, Cristiane de Jesus; Cardoso Costa, Marcio Gilberto; Gesteira, Abelmon da Silva; Souza, Regina Martins; Oliveira Freitas, Ana Camila; Pirovani, Carlos Priminho			Citrus tristeza virus (CTV) Causing Proteomic and Enzymatic Changes in Sweet Orange Variety "Westin"	PLOS ONE			English	Article							SUPEROXIDE DISMUTASES; PLANT CHITINASES; OXIDATIVE STRESS; MOSAIC-VIRUS; INFECTION; PROTEINS; WATER; SUPPRESSION; METABOLISM; EXPRESSION	Citrus Tristeza disease, caused by CTV (Citrus tristeza virus), committs citrus plantations around the world and specifically attacks phloem tissues of the plant. The virus exists as a mixture of more or less severe variants, which may or may not cause symptoms of Tristeza. The objective of this study was to analyze the changes caused by CTV in the proteome of stems of sweet orange, as well as in the activity and gene expression of antioxidant enzymes. The CTV-infected sweet orange displayed mild symptoms, which were characterized by the presence of sparse stem pitting throughout their stems. The presence of virus was confirmed by RT-PCR. Proteomic analysis by 2DE-PAGE-MS / MS revealed the identity of 40 proteins differentially expressed between CTV-infected and -non-infected samples. Of these, 33 were up-regulated and 7 were down-regulated in CTV-infected samples. Among the proteins identified stands out a specific from the virus, the coat protein. Other proteins identified are involved with oxidative stress and for this their enzymatic activity was measured. The activity of superoxide dismutase (SOD) was higher in CTV-infected samples, as catalase (CAT) showed higher activity in uninfected samples. The activity of guaiacol peroxidase (GPX) did not vary significantly between samples. However, ascorbate peroxidase (APX) was more active in the infected samples. The relative expression of the genes encoding CAT, SOD, APX and GPX was analyzed by quantitative real time PCR (RT-qPCR). The CTV-infected samples showed greater accumulation of transcripts, except for the CAT gene. This gene showed higher expression in the uninfected samples. Taken together, it can be concluded that the CTV affects the protein profile and activity and gene expression of antioxidant enzymes in plants infected by this virus.	[Doria, Milena Santos; de Sousa, Aurizangela Oliveira; Cardoso Costa, Marcio Gilberto; Souza, Regina Martins; Oliveira Freitas, Ana Camila; Pirovani, Carlos Priminho] Univ Estadual Santa Cruz, Ctr Biotechnol & Genet, BR-45662000 Ilheus, BA, Brazil; [Barbosa, Cristiane de Jesus; Gesteira, Abelmon da Silva] Embrapa Mandioca & Fruticultura, BR-44380000 Cruz Das Almas, BA, Brazil	Universidade Estadual de Santa Cruz; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Pirovani, CP (corresponding author), Univ Estadual Santa Cruz, Ctr Biotechnol & Genet, Rodovia Ilheus Itabuna,Km 16, BR-45662000 Ilheus, BA, Brazil.	pirovani@uesc.br	Costa, Marcio/AAG-3285-2020; Pirovani, Carlos P/J-3426-2017; Pirovani, Carlos Priminho/N-1153-2019; da Silva Gesteira, Abelmon/I-2136-2013	Costa, Marcio/0000-0002-4358-5489; Pirovani, Carlos P/0000-0002-6176-4069; Pirovani, Carlos Priminho/0000-0002-6176-4069; da Silva Gesteira, Abelmon/0000-0002-7590-0455	Coordenacao de perfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305309/2012-9]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); Programa de Pos-graduacao em Biologia e Biotecnologia de Micro-organismos; CNPq (PRONEM) [PNE0005/2011]	Coordenacao de perfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Programa de Pos-graduacao em Biologia e Biotecnologia de Micro-organismos; CNPq (PRONEM)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	MSD was supported by the Coordenacao de perfeicoamento de Pessoal de Nivel Superior (CAPES). CPP was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(http://www.cnpq.br, Process number 305309/2012-9). The authors thank Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) and Programa de Pos-graduacao em Biologia e Biotecnologia de Micro-organismos (http;//http://www.fapesb.ba.gov.br/) and the and CNPq (PRONEM, Process number PNE0005/2011) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiach-Marti MR, 2000, J VIROL, V74, P6856, DOI 10.1128/JVI.74.15.6856-6865.2000; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177; BARJOSEPH M, 1989, ANNU REV PHYTOPATHOL, V27, P291, DOI 10.1146/annurev.py.27.090189.001451; Bordignon Rita, 2003, Bragantia, V62, P345, DOI 10.1590/S0006-87052003000300002; Bulbovas Patricia, 2005, Braz. J. Bot., V28, P687, DOI 10.1590/S0100-84042005000400004; BUTTNER M, 1992, P NATL ACAD SCI USA, V89, P8135, DOI 10.1073/pnas.89.17.8135; Cantu MD, 2008, PHYTOPATHOLOGY, V98, P1084, DOI 10.1094/PHYTO-98-10-1084; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; CordobaPedregosa MD, 1996, PLANT PHYSIOL, V112, P1119, DOI 10.1104/pp.112.3.1119; de Oliveira GAP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045620; Di Carli M, 2010, J PROTEOME RES, V9, P5684, DOI 10.1021/pr100487x; Feichtenberger E, 1997, MANUAL FITOPATOLOGIA, V2, P706; Garavaglia Betiana S, 2010, Commun Integr Biol, V3, P382; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Giribaldi M, 2011, J PROTEOMICS, V75, P306, DOI 10.1016/j.jprot.2011.08.006; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Elvira MI, 2008, J EXP BOT, V59, P1253, DOI 10.1093/jxb/ern032; Kalifa Y, 2004, PLANT CELL ENVIRON, V27, P1459, DOI 10.1111/j.1365-3040.2004.01251.x; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Kerbauy GB., 2004, FISIOLOGIA VEGETAL; KHAN AA, 1994, FOOD CHEM, V49, P407, DOI 10.1016/0308-8146(94)90013-2; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Liu XY, 2014, BIOTECHNOL BIOTEC EQ, V28, P408, DOI 10.1080/13102818.2014.925317; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meissner Filho Paulo E., 2002, Fitopatologia Brasileira, V27, P312, DOI 10.1590/S0100-41582002000300014; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Moreno P, 2008, MOL PLANT PATHOL, V9, P251, DOI 10.1111/J.1364-3703.2007.00455.X; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NWUGO CC, 2013, PLANT BIOLOGY, V13, P1; Nwugo CC, 2011, J PROTEOME RES, V10, P518, DOI 10.1021/pr100716h; Tanaka Francisco André Ossamu, 2009, Summa phytopathol., V35, P316, DOI 10.1590/S0100-54052009000400010; Owens RA, 2001, MOL PLANT MICROBE IN, V14, P905, DOI 10.1094/MPMI.2001.14.7.905; Pineda M, 2010, PHOTOSYNTH RES, V103, P31, DOI 10.1007/s11120-009-9499-y; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; READ SM, 1983, EUR J BIOCHEM, V134, P561, DOI 10.1111/j.1432-1033.1983.tb07603.x; Rehem BC., 2011, ENVIRON EXP BOT, V56, P158, DOI DOI 10.1016/J.ENVEXPB0T.2005.01.012; Roy A, 2005, VIRUS RES, V113, P132, DOI 10.1016/j.virusres.2005.04.023; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh BK, 2010, SCI HORTIC-AMSTERDAM, V124, P9, DOI 10.1016/j.scienta.2009.12.011; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Wang ZL, 2013, ENVIRON MICROBIOL, V15, P409, DOI 10.1111/j.1462-2920.2012.02848.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Wu LJ, 2013, J PROTEOMICS, V89, P124, DOI 10.1016/j.jprot.2013.06.005; Zhang Z, 2004, MOL PLANT PATHOL, V5, P537, DOI [10.1111/j.1364-3703.2004.00251.x, 10.1111/J.1364-3703.2004.00251.X]	50	17	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130950	10.1371/journal.pone.0130950	http://dx.doi.org/10.1371/journal.pone.0130950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207751	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000010
J	Kumar, MAS; Peluso, M; Chaudhary, P; Dhawan, J; Beheshti, A; Manickam, K; Thapar, U; Pena, L; Natarajan, M; Hlatky, L; Demple, B; Naidu, M				Kumar, M. A. Suresh; Peluso, Michael; Chaudhary, Pankaj; Dhawan, Jasbeer; Beheshti, Afshin; Manickam, Krishnan; Thapar, Upasna; Pena, Louis; Natarajan, Mohan; Hlatky, Lynn; Demple, Bruce; Naidu, Mamta			Fractionated Radiation Exposure of Rat Spinal Cords Leads to Latent Neuro-Inflammation in Brain, Cognitive Deficits, and Alterations in Apurinic Endonuclease 1	PLOS ONE			English	Article							BASE EXCISION; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; STEM/PROGENITOR CELLS; OBJECT RECOGNITION; CLUSTERED LESIONS; INDUCED APOPTOSIS; DNA-REPAIR; IRRADIATION; DIFFERENTIATION; NEUROINFLAMMATION	Ionizing radiation causes degeneration of myelin, the insulating sheaths of neuronal axons, leading to neurological impairment. As radiation research on the central nervous system has predominantly focused on neurons, with few studies addressing the role of glial cells, we have focused our present research on identifying the latent effects of single/fractionated -low dose of low/high energy radiation on the role of base excision repair protein Apurinic Endonuclease-1, in the rat spinal cords oligodendrocyte progenitor cells' differentiation. Apurinic endonuclease-1 is predominantly upregulated in response to oxidative stress by low-energy radiation, and previous studies show significant induction of Apurinic Endonuclease-1 in neurons and astrocytes. Our studies show for the first time, that fractionation of protons cause latent damage to spinal cord architecture while fractionation of HZE (Si-28) induce increase in APE1 with single dose, which then decreased with fractionation. The oligodendrocyte progenitor cells differentiation was skewed with increase in immature oligodendrocytes and astrocytes, which likely cause the observed decrease in white matter, increased neuro-inflammation, together leading to the observed significant cognitive defects.	[Kumar, M. A. Suresh] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; [Peluso, Michael; Beheshti, Afshin; Hlatky, Lynn; Naidu, Mamta] Tufts Univ, Sch Med, GeneSys Res Inst, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Chaudhary, Pankaj] Queens Univ, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Dhawan, Jasbeer] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Manickam, Krishnan; Natarajan, Mohan] UTHSCSA, Dept Pathol, San Antonio, TX USA; [Thapar, Upasna; Demple, Bruce] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Pena, Louis] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA	Columbia University; Tufts University; Queens University Belfast; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Health San Antonio; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Naidu, M (corresponding author), Tufts Univ, Sch Med, GeneSys Res Inst, Ctr Canc Syst Biol, Boston, MA 02111 USA.	mamta@cancer-systems-biology.org	Beheshti, Afshin/AAH-7267-2019; Beheshti, Afshin/N-2241-2014	Beheshti, Afshin/0000-0003-4643-531X; Chaudhary, Pankaj/0000-0002-0381-3635	NASA [NNX11AO89G, NNAX13AD74G, NNX13AJ01G]	NASA(National Aeronautics & Space Administration (NASA))	NASA grants, NNX11AO89G and NNAX13AD74G to MN; NASA grant NNX13AJ01G to LH.	Abzullaouf S., 2006, AUSTRAL ASIAN J CANC, V5, P297; ALLEN JC, 1991, NEUROLOGY, V41, P148, DOI 10.1212/WNL.41.1.148; Beckendorf V, 2004, INT J RADIAT ONCOL, V60, P1056, DOI 10.1016/j.ijrobp.2004.05.033; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Butler Jerome M, 2006, Curr Treat Options Oncol, V7, P517, DOI 10.1007/s11864-006-0026-5; Chang PW, 2005, INT J RADIAT BIOL, V81, P115, DOI 10.1080/09553000500103009; Dhawan J, 2011, FUTUR NEUROL, V6, P823, DOI 10.2217/FNL.11.55; Dianov GL, 2001, BIOESSAYS, V23, P745, DOI 10.1002/bies.1104; Druzhyna NM, 2003, GLIA, V42, P370, DOI 10.1002/glia.10230; Englander EW, 2008, MECH AGEING DEV, V129, P475, DOI 10.1016/j.mad.2008.02.001; Ennaceur A, 2005, BEHAV BRAIN RES, V159, P247, DOI 10.1016/j.bbr.2004.11.006; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fike JR, 2011, REV NEUROL-FRANCE, V167, P746, DOI 10.1016/j.neurol.2011.07.005; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; Fukuda A, 2005, J NEUROCHEM, V92, P569, DOI 10.1111/j.1471-4159.2004.02894.x; Fung H, 2011, J BIOL CHEM, V286, P4968, DOI 10.1074/jbc.M110.146498; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Giedzinski E, 2005, RADIAT RES, V164, P540, DOI 10.1667/RR3369.1; Grossman R, 2012, FUTUR NEUROL, V7, P329, DOI 10.2217/FNL.12.25; Harrison JF, 2005, NUCLEIC ACIDS RES, V33, P4660, DOI 10.1093/nar/gki759; HELLER MJ, 1974, BIOCHEMISTRY-US, V13, P1623, DOI 10.1021/bi00705a011; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jedinak A, 2011, ANTICANCER RES, V31, P379; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kovalchuk O, 2004, MOL CANCER RES, V2, P567; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Malyarchuk S, 2008, NUCLEIC ACIDS RES, V36, P4872, DOI 10.1093/nar/gkn450; Mettler FA, 1985, MED EFFECTS IONIZING, P172; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Naidu MD, 2010, J RADIAT RES, V51, P393, DOI 10.1269/jrr.09077; Paap B, 2008, NUCLEIC ACIDS RES, V36, P2717, DOI 10.1093/nar/gkn118; Pannu R, 2004, J NEUROSCI, V24, P5942, DOI 10.1523/JNEUROSCI.1271-04.2004; Philippo H, 2005, RADIAT RES, V163, P636, DOI 10.1667/0033-7587(2005)163[0636:RCOGPA]2.0.CO;2; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rabin BM, 2009, ADV SPACE RES, V43, P1193, DOI 10.1016/j.asr.2009.01.015; Raji NS, 2002, INT J DEV NEUROSCI, V20, P491, DOI 10.1016/S0736-5748(02)00079-5; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Shukitt-Hale B, 2004, ADV SPACE RES-SERIES, V33, P1334, DOI 10.1016/j.asr.2003.10.038; Tsujii H, 2004, RADIOTHER ONCOL, V73, pS41, DOI 10.1016/S0167-8140(04)80012-4; VRDOLJAK E, 1992, INT J RADIAT BIOL, V62, P475, DOI 10.1080/09553009214552361; Xie JY, 2010, CL LYMPH MYELOM LEUK, V10, P385, DOI 10.3816/CLML.2010.n.072; Zaky A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-26; Zou GM, 2007, BLOOD, V109, P1917, DOI 10.1182/blood-2006-08-044172	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133016	10.1371/journal.pone.0133016	http://dx.doi.org/10.1371/journal.pone.0133016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208353	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000057
J	Lee, YC; Lee, CH; Tsai, HP; An, HW; Lee, CM; Wu, JC; Chen, CS; Huang, SH; Hwang, J; Cheng, KT; Leiw, PL; Chen, CL; Lin, CM				Lee, Yu-Chieh; Lee, Chii-Hong; Tsai, Hsiang-Ping; An, Herng-Wei; Lee, Chi-Ming; Wu, Jen-Chine; Chen, Chien-Shu; Huang, Shih-Hao; Hwang, Jaulang; Cheng, Kur-Ta; Leiw, Phui-Ly; Chen, Chi-Long; Lin, Chun-Mao			Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer	PLOS ONE			English	Article							CYCLIN D1; COLORECTAL-CANCER; CARCINOMA-CELLS; EVODIAMINE; APOPTOSIS; INHIBITION; TUMORS; EXPRESSION; AUTOPHAGY; VITRO	DNA topoisomerase I (TOP1) levels of several human neoplasms are higher than those of normal tissues. TOP1 inhibitors are widely used in treating conventional therapy-resistant ovarian cancers. However, patients may develop resistance to TOP1 inhibitors, hampering chemotherapy success. In this study, we examined the mechanisms associated with the development of camptothecin (CPT) resistance in ovarian cancers and identified evodiamine (EVO), a natural product with TOP1 inhibiting activity that overcomes the resistance. The correlations among TOP1 levels, cancer staging, and overall survival (OS) were analyzed. The effect of EVO on CPT-resistant ovarian cancer was evaluated in vitro and in vivo. TOP1 was associated with poor prognosis in ovarian cancers (p = 0.024). EVO induced apoptosis that was detected using flow cytometry and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. The tumor size decreased significantly in the EVO treatment group compared with the control group (p < 0.01) in a xenograft mouse model. Effects of drugs targeting TOP1 for prognosis and therapy in CPT-resistant ovarian cancer are anticipated. EVO with TOP1 can be developed as an antiproliferative agent for overcoming CPT resistance in ovarian cancers.	[Lee, Yu-Chieh; An, Herng-Wei; Lee, Chi-Ming] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Lee, Chii-Hong; Leiw, Phui-Ly] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, New Taipei City, Taiwan; [Tsai, Hsiang-Ping; Hwang, Jaulang; Cheng, Kur-Ta; Lin, Chun-Mao] Taipei Med Univ, Sch Med, Dept Biochem, Taipei, Taiwan; [Wu, Jen-Chine] Chang Gung Mem Hosp, Ctr Stem Cells & Translat Canc Res, Gueishan, Taoyuan County, Taiwan; [Chen, Chien-Shu] China Med Univ, Sch Pharm, Taichung, Taiwan; [Huang, Shih-Hao] Taipei Coll Maritime Technol, Dept Food & Beverage Management, Taipei, Taiwan; [Chen, Chi-Long] Taipei Med Univ, Dept Pathol, Coll Med, Taipei, Taiwan; [Chen, Chi-Long] Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Chang Gung Memorial Hospital; China Medical University Taiwan; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lin, CM (corresponding author), Taipei Med Univ, Sch Med, Dept Biochem, Taipei, Taiwan.	cmlin@tmu.edu.tw		Lin, Chun-Mao/0000-0002-8366-4026	National Science Council, Taiwan [NSC101-2320-B-038-023]; Ministry of Health Welfare [MOHW104-TDU-B-212-113001]; Taipei Medical University-Shuang Ho Hospital [101TMU-SHH-10]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health Welfare; Taipei Medical University-Shuang Ho Hospital	This study was supported by grants from the National Science Council, Taiwan (NSC101-2320-B-038-023), the Ministry of Health & Welfare (MOHW104-TDU-B-212-113001), and Taipei Medical University-Shuang Ho Hospital (101TMU-SHH-10).	Al Sawah E, 2015, J CANCER RES CLIN, V141, P237, DOI 10.1007/s00432-014-1797-x; Barbieri F, 1999, CLIN CANCER RES, V5, P1837; Batey MA, 2013, MOL CANCER THER, V12, P959, DOI 10.1158/1535-7163.MCT-12-0707; Bhutia SK, 2010, P NATL ACAD SCI USA, V107, P22243, DOI 10.1073/pnas.1009479107; Bonneau C, 2015, GYNECOL ONCOL, V136, P112, DOI 10.1016/j.ygyno.2014.10.024; Chan KKL, 2011, ANN ONCOL, V22, P2241, DOI 10.1093/annonc/mdq749; Chen Y, 2014, ASIAN PAC J CANCER P, V15, P10351, DOI 10.7314/APJCP.2014.15.23.10351; Chiou JF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep228; Dai JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042706; Day CP, 2009, PIGM CELL MELANOMA R, V22, P283, DOI 10.1111/j.1755-148X.2009.00545.x; Dong GQ, 2012, J MED CHEM, V55, P7593, DOI 10.1021/jm300605m; Dou J, 2011, CELL BIOL INT, V35, P227, DOI 10.1042/CBI20100347; Du J, 2013, ONCOL REP, V30, P685, DOI 10.3892/or.2013.2498; Hunakova L, 2014, TOXICOL LETT, V230, P479, DOI 10.1016/j.toxlet.2014.08.018; Ikeguchi M, 2011, SURG TODAY, V41, P1196, DOI 10.1007/s00595-011-4546-7; Jiao J, 2013, ONCOTARGETS THER, V6, P667, DOI 10.2147/OTT.S44177; Kim HS, 2012, APOPTOSIS, V17, P938, DOI 10.1007/s10495-012-0719-0; Lee JC, 2015, CANCER LETT, V360, P310, DOI 10.1016/j.canlet.2015.02.034; Li DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045058; Li J, 2009, ONCOL REP, V21, P1605, DOI 10.3892/or_00000394; Liang Xiaobing, 2011, Chemother Res Pract, V2011, P715469, DOI 10.1155/2011/715469; Matrone A, 2010, INT J GYNECOL CANCER, V20, P203, DOI 10.1111/IGC.0b013e3181c8ca12; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Nguyen HG, 2014, ONCOGENE, V33, P4521, DOI 10.1038/onc.2014.25; Olszewski U, 2012, NEOPLASIA, V14, P813, DOI 10.1593/neo.12962; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pan XB, 2012, PHYTOMEDICINE, V19, P618, DOI 10.1016/j.phymed.2012.02.003; Perego P, 2012, BIOCHEM PHARMACOL, V83, P27, DOI 10.1016/j.bcp.2011.09.021; Proszek J, 2014, SENSORS-BASEL, V14, P1195, DOI 10.3390/s140101195; Rasul A, 2012, ONCOL REP, V27, P1481, DOI 10.3892/or.2012.1694; Ryan D, 2010, PIGM CELL MELANOMA R, V23, P542, DOI 10.1111/j.1755-148X.2010.00720.x; Sereno M, 2012, INT J ONCOL, V40, P2104, DOI 10.3892/ijo.2012.1378; Siu WY, 2004, MOL CANCER THER, V3, P621; Surowiak P, 2006, HISTOL HISTOPATHOL, V21, P713, DOI 10.14670/HH-21.713; Tsai HP, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-49; Tsunetoh S, 2010, CANCER BIOL THER, V10, P1138, DOI 10.4161/cbt.10.11.13443; Wang KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067297; Wang LF, 1997, CANCER RES, V57, P1516; Worsley SD, 1997, GYNECOL ONCOL, V64, P189, DOI 10.1006/gyno.1996.4569; Wu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112220; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791; Yang J, 2013, CANCER LETT, V328, P243, DOI 10.1016/j.canlet.2012.09.019; Yang L, 2014, MOL MED REP, V9, P1147, DOI 10.3892/mmr.2014.1924; Yu H, 2013, MOLECULES, V18, P1826, DOI 10.3390/molecules18021826; Yu SH, 2011, PLANTA MED, V77, P907, DOI 10.1055/s-0030-1250682; Yue GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065164; Zhang JW, 2014, BIOCHEM PHARMACOL, V90, P265, DOI 10.1016/j.bcp.2014.05.009; Zhang Y, 2004, J ASIAN NAT PROD RES, V6, P19, DOI 10.1080/1028602031000119772; Zhang YX, 2011, CANCER LETT, V304, P21, DOI 10.1016/j.canlet.2011.01.022	49	23	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132579	10.1371/journal.pone.0132579	http://dx.doi.org/10.1371/journal.pone.0132579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207989	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000033
J	Piersanti, S; Burla, R; Licursi, V; Brito, C; La Torre, M; Alves, PM; Simao, D; Mottini, C; Salinas, S; Negri, R; Tagliafico, E; Kremer, EJ; Saggio, I				Piersanti, Stefania; Burla, Romina; Licursi, Valerio; Brito, Catarina; La Torre, Mattia; Alves, Paula M.; Simao, Daniel; Mottini, Carla; Salinas, Sara; Negri, Rodolfo; Tagliafico, Enrico; Kremer, Eric J.; Saggio, Isabella			Transcriptional Response of Human Neurospheres to Helper-Dependent CAV-2 Vectors Involves the Modulation of DNA Damage Response, Microtubule and Centromere Gene Groups	PLOS ONE			English	Article							CANINE ADENOVIRUS TYPE-2; CELLULAR TRANSCRIPTION; RECEPTOR; COMPLEX; COXSACKIEVIRUS; INFECTION; THERAPY; NEURONS	Brain gene transfer using viral vectors will likely become a therapeutic option for several disorders. Helper-dependent (HD) canine adenovirus type 2 vectors (CAV-2) are well suited for this goal. These vectors are poorly immunogenic, efficiently transduce neurons, are retrogradely transported to afferent structures in the brain and lead to long-term transgene expression. CAV-2 vectors are being exploited to unravel behavior, cognition, neural networks, axonal transport and therapy for orphan diseases. With the goal of better understanding and characterizing HD-CAV-2 for brain therapy, we analyzed the transcriptomic modulation induced by HD-CAV-2 in human differentiated neurospheres derived from mid-brain progenitors. This 3D model system mimics several aspects of the dynamic nature of human brain. We found that differentiated neurospheres are readily transduced by HD-CAV- 2 and that transduction generates two main transcriptional responses: a DNA damage response and alteration of centromeric and microtubule probes. Future investigations on the biochemistry of processes highlighted by probe modulations will help defining the implication of HD-CAV-2 and CAR receptor binding in enchaining these functional pathways. We suggest here that the modulation of DNA damage genes is related to viral DNA, while the alteration of centromeric and microtubule probes is possibly enchained by the interaction of the HD-CAV-2 fibre with CAR.	[Piersanti, Stefania; Burla, Romina; Licursi, Valerio; La Torre, Mattia; Mottini, Carla; Negri, Rodolfo; Saggio, Isabella] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, I-00185 Rome, Italy; [Licursi, Valerio; Negri, Rodolfo; Saggio, Isabella] Cenci Bolognetti Fdn, Inst Pasteur, Rome, Italy; [Brito, Catarina; Alves, Paula M.; Simao, Daniel] Inst Biol Expt & Tecnol, P-2780901 Oeiras, Portugal; [Brito, Catarina; Alves, Paula M.; Simao, Daniel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Tagliafico, Enrico] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Salinas, Sara; Kremer, Eric J.] CNRS, Inst Genet Mol Montpellier, UMR 5535, Montpellier, France; [Salinas, Sara; Kremer, Eric J.] Univ Montpellier, F-34059 Montpellier, France; [Saggio, Isabella] CNR, Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Universidade Nova de Lisboa; Universita di Modena e Reggio Emilia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Saggio, I (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	isabella.saggio@uniroma1.it	Saggio, Isabella/H-2417-2015; Simão, Daniel/AAF-2747-2021; Tagliafico, Enrico/C-9079-2009; Salinas, Sara/O-1856-2013; Kremer, EJ/P-9838-2019; Alves, Paula M/C-1070-2008; La Torre, Mattia/AAR-2612-2021; Brito, Catarina/A-2389-2009; La Torre, Mattia/AHD-9999-2022; Salinas, Sara/O-1150-2019; Kremer, Eric J/D-3734-2013	Simão, Daniel/0000-0002-7532-8081; Tagliafico, Enrico/0000-0003-0981-2542; Salinas, Sara/0000-0003-4492-2093; Kremer, EJ/0000-0001-6114-7530; Alves, Paula M/0000-0003-1445-3556; Brito, Catarina/0000-0002-8926-279X; La Torre, Mattia/0000-0002-1178-6948; Salinas, Sara/0000-0003-4492-2093; Licursi, Valerio/0000-0002-8172-1437; saggio, isabella/0000-0002-9497-7415; Burla, Romina/0000-0002-5640-4464	EU [222992, 286071]; Fundacao para a Ciencia eTecnologia (FCT), Portugal [PTD/EBBBIO/119243/2010]; FCT, Portugal [SFRH/BD/78308/2011]	EU(European Commission); Fundacao para a Ciencia eTecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by EU FP7 grants BrainCAV (n. 222992) and BrainVectors (n. 286071) and by PTD/EBBBIO/119243/2010, funded by Fundacao para a Ciencia eTecnologia (FCT), Portugal. DS was the recipient of a PhD fellowship from FCT, Portugal (SFRH/BD/78308/2011).	Brito C, 2012, METHODS, V56, P452, DOI 10.1016/j.ymeth.2012.03.005; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Carson CT, 2009, EMBO J, V28, P652, DOI 10.1038/emboj.2009.15; Coelho PA, 2013, DEV CELL, V27, P586, DOI 10.1016/j.devcel.2013.09.029; Costantini LC, 2000, GENE THER, V7, P93, DOI 10.1038/sj.gt.3301119; Dermody TS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000481; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Fernandes P, 2013, GENE THER, V20, P353, DOI 10.1038/gt.2012.52; Fernandes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060342; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Fok PT, 2007, J BIOL CHEM, V282, P7512, DOI 10.1074/jbc.M607230200; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gudimchuk N, 2013, NAT CELL BIOL, V15, P1079, DOI 10.1038/ncb2831; Haberberger TC, 2000, GENE THER, V7, P903, DOI 10.1038/sj.gt.3301181; Ibanes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071032; Junyent F, 2015, CURRENT OPI IN PRESS; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Lowenstein PR, 2003, GENE THER, V10, P946, DOI 10.1038/sj.gt.3302048; Martina Y, 2007, VIRUS RES, V130, P71, DOI 10.1016/j.virusres.2007.05.019; McMenamin MM, 2010, GENE THER, V17, P448, DOI 10.1038/gt.2010.2; Milosevic J, 2007, STEM CELLS DEV, V16, P625, DOI 10.1089/scd.2006.0113; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; Mitchell R, 2003, MOL THER, V8, P674, DOI 10.1016/S1525-0016(03)00215-6; Patzke C, 2010, J NEUROSCI, V30, P2897, DOI 10.1523/JNEUROSCI.5725-09.2010; Piersanti Stefania, 2004, Am J Pharmacogenomics, V4, P345, DOI 10.2165/00129785-200404060-00002; Piersanti S, 2014, METHODS MOL BIOL, V1089, P89, DOI 10.1007/978-1-62703-679-5_7; Piersanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069808; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Salinas S, 2014, J BIOL CHEM, V289, P680, DOI 10.1074/jbc.M113.518365; Salinas S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000442; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Simao D, 2014, TISSUE ENG A; Simao Daniel, 2011, BMC Proc, V5 Suppl 8, pP53, DOI 10.1186/1753-6561-5-S8-P53; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soudais C, 2003, FASEB J, V17, P391, DOI 10.1096/fj.03-0438fje; Stilwell JL, 2003, J VIROL, V77, P12881, DOI 10.1128/JVI.77.23.12881-12885.2003; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Warren JC, 2006, MOL BIOL CELL, V17, P3557, DOI 10.1091/mbc.E05-09-0850; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106; Zhao HX, 2003, J VIROL, V77, P11006, DOI 10.1128/JVI.77.20.11006-11015.2003	46	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133607	10.1371/journal.pone.0133607	http://dx.doi.org/10.1371/journal.pone.0133607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207738	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000110
J	Sadot, E; Simpson, AL; Do, RKG; Gonen, M; Shia, J; Allen, PJ; D'Angelica, MI; DeMatteo, RP; Kingham, TP; Jarnagin, WR				Sadot, Eran; Simpson, Amber L.; Do, Richard K. G.; Gonen, Mithat; Shia, Jinru; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Kingham, T. Peter; Jarnagin, William R.			Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PRIMARY LIVER-CANCER; INTRAHEPATIC CHOLANGIOCARCINOMA; REGIONAL CHEMOTHERAPY; PROGNOSTIC-FACTOR; CD24 EXPRESSION; BREAST-CANCER; CARCINOMA; GENE; SURVIVAL	Purpose To investigate associations between imaging features of cholangiocarcinoma by visual assessment and texture analysis, which quantifies heterogeneity in tumor enhancement patterns, with molecular profiles based on hypoxia markers. Methods The institutional review board approved this HIPAA-compliant retrospective study of CT images of intrahepatic cholangiocarcinoma, obtained before surgery. Immunostaining for hypoxia markers (EGFR, VEGF, CD24, P53, MDM2, MRP-1, HIF-1 alpha, CA-IX, and GLUT1) was performed on pre-treatment liver biopsies. Quantitative imaging phenotypes were determined by texture analysis with gray level co-occurrence matrixes. The correlations between quantitative imaging phenotypes, qualitative imaging features (measured by radiographic inspection alone), and expression levels of the hypoxia markers from the 25 tumors were assessed. Results Twenty-five patients were included with a median age of 62 years (range: 54-84). The median tumor size was 10.2 cm (range: 4-14), 10 (40%) were single tumors, and 90% were moderately differentiated. Positive immunostaining was recorded for VEGF in 67% of the cases, EGFR in 75%, and CD24 in 55%. On multiple linear regression analysis, quantitative imaging phenotypes correlated significantly with EGFR and VEGF expression levels (R-2 = 0.4, p<0.05 and R-2 = 0.2, p<0.05, respectively), while a trend was demonstrated with CD24 expression (R-2 = 0.33, p = 0.1). Three qualitative imaging features correlated with VEGF and CD24 expression (P<0.05), however, none of the qualitative features correlated with the quantitative imaging phenotypes. Conclusion Quantitative imaging phenotypes, as defined by texture analysis, correlated with expression of specific markers of hypoxia, regardless of conventional imaging features.	[Sadot, Eran; Simpson, Amber L.; Allen, Peter J.; D'Angelica, Michael I.; DeMatteo, Ronald P.; Kingham, T. Peter; Jarnagin, William R.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Simpson, Amber L.; Do, Richard K. G.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Shia, Jinru] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jarnagin, WR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	jarnagiw@mskcc.org	Gonen, Mithat/E-4826-2012	Gonen, Mithat/0000-0001-8683-8477; Kingham, T Peter/0000-0002-3359-3186; Do, Richard/0000-0002-6554-0310; Shia, Jinru/0000-0002-4351-2511; Simpson, Amber/0000-0002-4387-8417	National Institutes of Health Cancer Center Support Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Institutes of Health Cancer Center Support Grant P30 CA008748 (MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, J GASTROINTEST SURG, V11, P445, DOI 10.1007/s11605-007-0091-5; Cleven AHG, 2007, CELL ONCOL, V29, P229; Cui CY, 2011, EUR RADIOL, V21, P2318, DOI 10.1007/s00330-011-2182-7; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Davenport MS, 2014, RADIOLOGY, V272, P132, DOI 10.1148/radiol.14131963; Di T, 2006, ONCOL REP, V15, P525; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Ding ZY, 2010, J CANCER RES CLIN, V136, P1697, DOI 10.1007/s00432-010-0828-5; Ganeshan B, 2013, CANCER IMAGING, V13, P140, DOI 10.1102/1470-7330.2013.0015; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gwak GY, 2005, J CANCER RES CLIN, V131, P649, DOI 10.1007/s00432-005-0016-1; Haralick, 1973, IEEE T SYST MAN CYB, V3, P610; Huang YL, 2006, ACAD RADIOL, V13, P713, DOI 10.1016/j.acra.2005.07.014; Ito Y, 2001, PATHOL RES PRACT, V197, P95, DOI 10.1078/0344-0338-00016; Jarnagin WR, 2009, ANN ONCOL, V20, P1589, DOI 10.1093/annonc/mdp029; Keeratichamroen S, 2011, INT J ONCOL, V39, P873, DOI 10.3892/ijo.2011.1088; Kemeny NE, 2011, ONCOLOGY-BASEL, V80, P153, DOI 10.1159/000324704; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Konstantinidis IT, 2014, ANN SURG ONCOL, V21, P2675, DOI 10.1245/s10434-014-3649-y; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Lee JH, 2012, J BIOL CHEM, V287, P20898, DOI 10.1074/jbc.M111.336875; Leone F, 2006, CLIN CANCER RES, V12, P1680, DOI 10.1158/1078-0432.CCR-05-1692; Marme D., 2008, TUMOR ANGIOGENESIS B; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mascaux C, 2011, CLIN CANCER RES, V17, P7796, DOI 10.1158/1078-0432.CCR-11-0209; National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines&REG;), 2014, NCCN CLIN PRACT GUID; Perez-Sayans M, 2013, J ORAL PATHOL MED, V42, P1, DOI 10.1111/j.1600-0714.2012.01144.x; Russ JC, 2011, IMAGE PROCESSING HDB, Vxviii; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Shia J, 2005, MODERN PATHOL, V18, P1350, DOI 10.1038/modpathol.3800417; Simpson AL, 2014, J AM COLL SURG; Simpson AL, 2014, J AM COLL SURGEONS, V219, P199, DOI 10.1016/j.jamcollsurg.2014.02.027; Skogen K, 2013, J NEURO-ONCOL, V111, P213, DOI 10.1007/s11060-012-1010-5; Su MC, 2006, CANCER LETT, V235, P34, DOI 10.1016/j.canlet.2005.03.059; Thelen A, 2010, AM J GASTROENTEROL, V105, P1123, DOI 10.1038/ajg.2009.674; Thomas S, 2012, CANCER RES, V72, P5600, DOI 10.1158/0008-5472.CAN-11-3666; Tortora G, 2008, NAT CLIN PRACT ONCOL, V5, P521, DOI 10.1038/ncponc1161; Yopp AC, 2011, ANN SURG ONCOL, V18, P2192, DOI 10.1245/s10434-011-1570-1; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Yousef GM., 2014, MOL TESTING CANC; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11	41	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132953	10.1371/journal.pone.0132953	http://dx.doi.org/10.1371/journal.pone.0132953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207380	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000048
J	Srivastava, G; Somasundaram, RT; Walfish, PG; Ralhan, R				Srivastava, Gunjan; Somasundaram, Raj Thani; Walfish, Paul G.; Ralhan, Ranju			Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy	PLOS ONE			English	Article							SUPERFICIAL BLADDER-CANCER; CLINICAL-STUDIES GROUP; NECK-CANCER; ADVANCED HEAD; PHASE-II; INTRAPERITONEAL THERAPY; INDUCTION CHEMOTHERAPY; MOLECULAR TARGET; HIGH-RISK; EO9	Oral squamous cell carcinoma (OSCC) patients diagnosed in late stages have limited chemotherapeutic options underscoring the great need for development of new anticancer agents for more effective disease management. We aimed to investigate the anticancer potential of Apaziquone, [EOquin, USAN, E09, 3-hydroxy-5-aziridinyl-1-methyl-2(1H-indole- 4,7-dione)-prop-beta-en-alpha-ol], a pro-drug belonging to a class of anti-cancer agents called bioreductive alkylating agents, for OSCC. Apaziquone treatment inhibited cell proliferation and induced apoptosis in OSCC cells in vitro. Apaziquone treated OSCC cells showed increased activation of Caspase 9 and Caspase 3, and Poly (ADP ribose) polymerase (PARP) cleavage suggesting induction of apoptosis by apaziquone in oral cancer cells. Importantly, apaziquone treatment significantly reduced oral tumor xenograft volume in immunocompromised NOD/SCID/Crl mice without causing apparent toxicity to normal tissues. In conclusion, our in vitro and in vivo studies identified and demonstrated the pre-clinical efficacy of Apaziquone, as a potential novel anti-cancer therapeutic candidate for oral cancer management.	[Srivastava, Gunjan; Somasundaram, Raj Thani; Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Alex & Simona Shnaider Res Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.] Univ Toronto, Toronto, ON, Canada; [Walfish, Paul G.; Ralhan, Ranju] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Ralhan, R (corresponding author), Mt Sinai Hosp, Alex & Simona Shnaider Res Lab Mol Oncol, Toronto, ON M5G 1X5, Canada.	rralhan@mtsinai.on.ca			Spectrum Pharmaceuticals Inc. (Irvine, CA)	Spectrum Pharmaceuticals Inc. (Irvine, CA)	The financial support of this work was provided by Spectrum Pharmaceuticals Inc. (Irvine, CA). The funders approved the study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics (RR), and Alex and Simona Shnaider Chair in Thyroid Cancer (PGW).	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bhide SA, 2008, BRIT J CANCER, V99, P57, DOI 10.1038/sj.bjc.6604444; Brana I, 2012, ANN ONCOL, V23, P178, DOI 10.1093/annonc/mds322; Budach W, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-28; Ceelen WP, 2010, NAT REV CLIN ONCOL, V7, P108, DOI 10.1038/nrclinonc.2009.217; Choudry GA, 2001, BRIT J CANCER, V85, P1137, DOI 10.1054/bjoc.2001.2056; COLLARD J, 1995, BRIT J CANCER, V71, P1199, DOI 10.1038/bjc.1995.233; Denaro N, 2014, RADIOTHER ONCOL, V110, P16, DOI 10.1016/j.radonc.2013.08.016; Dirix LY, 1996, EUR J CANCER, V32A, P2019, DOI 10.1016/0959-8049(96)00226-2; El Deen DAS, 2012, MED ONCOL, V29, P3367, DOI 10.1007/s12032-012-0269-x; Ferlay J., 2013, IARC CANCERBASE, V11; Gibson MK, 2005, J CLIN ONCOL, V23, P3562, DOI 10.1200/JCO.2005.01.057; Gomez DR, 2009, INT J RADIAT ONCOL, V73, P1096, DOI 10.1016/j.ijrobp.2008.05.024; Harari PM, 2009, SEMIN RADIAT ONCOL, V19, P63, DOI 10.1016/j.semradonc.2008.09.009; Hendricksen K, 2012, J UROLOGY, V187, P1195, DOI 10.1016/j.juro.2011.11.101; HENDRIKS HR, 1993, EUR J CANCER, V29A, P897, DOI 10.1016/S0959-8049(05)80434-4; Kaur J, 2003, ORAL ONCOL, V39, P806, DOI 10.1016/S1368-8375(03)00084-8; Kaur J, 2014, INT J CANCER, V134, P1379, DOI 10.1002/ijc.28473; Le Tourneau C, 2008, CURR OPIN ONCOL, V20, P256, DOI 10.1097/CCO.0b013e3282f9b575; Li ZL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1227-8; Lu Z, 2010, FUTURE ONCOL, V6, P1625, DOI 10.2217/FON.10.100; Macha MA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-655; Major AG, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/319489; Martens-de Kemp SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061555; Matta A, 2010, MOL CANCER THER, V9, P2676, DOI 10.1158/1535-7163.MCT-10-0312; Matta A, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-6; Nagao T, 2011, J ONCOL, V2011, DOI 10.1155/2011/318145; Pavlidis N, 1996, ANN ONCOL, V7, P529; Phillips RM, 2013, BRIT J PHARMACOL, V168, P11, DOI 10.1111/j.1476-5381.2012.01996.x; Pignon JP, 2007, INT J RADIAT ONCOL, V69, pS112, DOI 10.1016/j.ijrobp.2007.04.088; Puri R, 2006, J UROLOGY, V176, P1344, DOI 10.1016/j.juro.2006.06.047; Rousseau A, 2012, ATLAS GENET CYTOGENE, V16, P145, DOI DOI 10.4267/2042/46948; SCHELLENS JHM, 1994, J NATL CANCER I, V86, P906, DOI 10.1093/jnci/86.12.906; Scully C, 2008, ORAL ONCOL, V44, P211, DOI 10.1016/j.oraloncology.2008.01.006; van der Heijden AG, 2006, J UROLOGY, V176, P1349, DOI 10.1016/j.juro.2006.06.007; Wu CF, 2008, HEAD NECK-J SCI SPEC, V30, P611, DOI 10.1002/hed.20751; Yunaiyama D, 2014, JPN J RADIOL, V32, P708, DOI 10.1007/s11604-014-0370-5; Yutkin V, 2012, EXPERT OPIN INV DRUG, V21, P251, DOI 10.1517/13543784.2012.646081	38	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133735	10.1371/journal.pone.0133735	http://dx.doi.org/10.1371/journal.pone.0133735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208303	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000126
J	Sun, JJ; Wu, Y; Lu, YM; Zhang, HZ; Wang, T; Yang, XQ; Sun, MH; Wang, CF				Sun, Juan-Juan; Wu, Yong; Lu, Yong-Ming; Zhang, Hui-Zhi; Wang, Tao; Yang, Xiao-Qun; Sun, Meng-Hong; Wang, Chao-Fu			Immunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; COMMON CLONAL ORIGIN; URINARY-BLADDER; CYCLIN D1; CANCER; EXPRESSION; TRACT; P53; TUMOR; MICRODISSECTION	Urothelial carcinoma (UC) comprises a heterogeneous group of epithelial neoplasms with diverse biological behaviors and variable clinical outcomes. Distinguishing UC histological subtypes has become increasingly important because prognoses and therapy can dramatically differ among subtypes. In clinical work, overlapping morphological findings between low-grade noninvasive UC (LGNUC), which exhibits an inverted growth pattern, and inverted urothelial papilloma (IUP) can make subclassification difficult. We propose a combination of immunohistochemistry (IHC) and molecular cytogenetics for subtyping these clinical entities. In our study, tissue microarray immunohistochemical profiles of Ki-67, p53, cytokeratin 20 (CK20) and cyclinD1 were assessed. Molecular genetic alterations such as the gain of chromosomes 3, 7 or 17 or the homozygous loss of 9p21 were also assessed for their usefulness in differentiating these conditions. Based on our analysis, Ki-67 and CK20 may be useful for the differential diagnosis of these two tumor types. Fluorescence in situ hybridization (FISH) can also provide important data in cases in which the malignant nature of an inverted urothelial neoplasm is unclear. LGNUC with an inverted growth pattern that is negative for both Ki-67 and CK20 can be positively detected using FISH.	[Sun, Juan-Juan; Wu, Yong; Lu, Yong-Ming; Zhang, Hui-Zhi; Wang, Tao; Yang, Xiao-Qun; Sun, Meng-Hong; Wang, Chao-Fu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Sun, Juan-Juan; Wu, Yong; Zhang, Hui-Zhi; Wang, Tao; Sun, Meng-Hong; Wang, Chao-Fu] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Sun, Juan-Juan; Wu, Yong; Wang, Tao; Yang, Xiao-Qun; Sun, Meng-Hong; Wang, Chao-Fu] Fudan Univ, Inst Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, CF (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China.	wangchaofu@126.com	Wang, Chao/GXF-8353-2022	Wu, Yong/0000-0003-3764-3846				Amin MB, 1997, AM J SURG PATHOL, V21, P1057, DOI 10.1097/00000478-199709000-00010; ANDERSTROM C, 1982, J UROLOGY, V127, P1132, DOI 10.1016/S0022-5347(17)54266-4; Broussard JN, 2004, HUM PATHOL, V35, P1499, DOI 10.1016/j.humpath.2004.09.010; CAMERON KM, 1976, BRIT J UROL, V48, P567, DOI 10.1111/j.1464-410X.1976.tb06703.x; Cheng L, 2005, AM J PATHOL, V166, P1533, DOI 10.1016/S0002-9440(10)62369-3; Cheng L, 2004, CANCER-AM CANCER SOC, V101, P183, DOI 10.1002/cncr.20343; Cheng L, 2002, CANCER-AM CANCER SOC, V94, P104, DOI 10.1002/cncr.10151; Cheon Jun, 1995, Journal of Korean Medical Science, V10, P103; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; DEMEESTER LJ, 1975, CANCER, V36, P505, DOI 10.1002/1097-0142(197508)36:2<505::AID-CNCR2820360229>3.0.CO;2-L; Drew PA, 1996, MODERN PATHOL, V9, P989; EBLE JN, WHO CLASSIFICATION T; ESRIG D, 1993, AM J PATHOL, V143, P1389; Harnden P, 1999, LANCET, V353, P974, DOI 10.1016/S0140-6736(98)05383-5; HENDERSON DW, 1975, VIRCHOWS ARCH A, V366, P177, DOI 10.1007/BF00427408; Ho H, 2006, UROLOGY, V68, P333, DOI 10.1016/j.urology.2006.03.014; Humphrey Peter A, 2004, Ann Diagn Pathol, V8, P380, DOI 10.1053/j.anndiagpath.2004.08.012; Jones P A, 1993, Semin Urol, V11, P177; Jones TD, 2005, CANCER-AM CANCER SOC, V104, P1901, DOI 10.1002/cncr.21466; Jones TD, 2005, CLIN CANCER RES, V11, P6512, DOI 10.1158/1078-0432.CCR-05-0891; Jones TD, 2007, AM J SURG PATHOL, V31, P1861, DOI 10.1097/PAS.0b013e318060cb9d; KIMURA G, 1987, UROL INT, V42, P30, DOI 10.1159/000281846; KNOWLES MA, 1994, CANCER RES, V54, P531; KUNIMI K, 1994, EUR UROL, V26, P149; KUNZE E, 1983, CANCER-AM CANCER SOC, V51, P348, DOI 10.1002/1097-0142(19830115)51:2<348::AID-CNCR2820510231>3.0.CO;2-O; Lee K, 2010, J KOREAN MED SCI, V25, P1449, DOI 10.3346/jkms.2010.25.10.1449; Mallofre C, 2003, MODERN PATHOL, V16, P187, DOI 10.1097/01.MP.0000056628.38714.5D; MATTELAER J, 1988, UROLOGY, V32, P192, DOI 10.1016/0090-4295(88)90383-4; PALVIO DHB, 1985, SCAND J UROL NEPHROL, V19, P299, DOI 10.3109/00365598509180275; Perez-Montiel D, 2008, DIAGN HISTOPATHOL, V14, P48; Picozzi S, 2013, UROL ONCOL-SEMIN ORI, V31, P1584, DOI 10.1016/j.urolonc.2012.03.009; POTTS IF, 1963, J UROLOGY, V90, P175, DOI 10.1016/S0022-5347(17)64384-2; RISIO M, 1988, EUR UROL, V14, P333; ROMANELLI R, 1986, Pathologica (Genoa), V78, P89; ROSIN MP, 1995, CANCER RES, V55, P5213; Rozanski TA, 1996, J UROLOGY, V155, P1391, DOI 10.1016/S0022-5347(01)66280-3; RUPPERT JM, 1993, CANCER RES, V53, P5093; Sgambato A, 2002, INT J CANCER, V97, P671, DOI 10.1002/ijc.10055; Shariat SF, 2006, HUM PATHOL, V37, P1568, DOI 10.1016/j.humpath.2006.05.017; Shariat SF, 2010, BJU INT, V105, P489, DOI 10.1111/j.1464-410X.2009.08742.x; SPEVACK L, 1995, J UROLOGY, V153, P1202, DOI 10.1016/S0022-5347(01)67552-9; SPRUCK CH, 1994, CANCER RES, V54, P784; Sudo Toshio, 2003, Urology, V61, P837, DOI 10.1016/S0090-4295(02)02521-9; Sung MT, 2007, J PATHOL, V211, P420, DOI 10.1002/path.2129; Sung MT, 2006, CANCER, V107, P2622, DOI 10.1002/cncr.22311; Sung MT, 2006, MODERN PATHOL, V19, P1289, DOI 10.1038/modpathol.3800667; Urakami S, 1996, BRIT J UROL, V77, P55, DOI 10.1046/j.1464-410X.1996.08209.x; Valero PJA, 1995, ARCH ESP UROL, V48, P887; Wasco MJ, 2010, HUM PATHOL, V41, P163, DOI 10.1016/j.humpath.2009.07.015; Witjes JA, 1997, J UROLOGY, V158, P1500, DOI 10.1016/S0022-5347(01)64253-8; Ye YK, 2010, CLIN EXP MED, V10, P153, DOI 10.1007/s10238-009-0088-3	51	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133530	10.1371/journal.pone.0133530	http://dx.doi.org/10.1371/journal.pone.0133530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208279	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000096
J	Zhang, K; Gao, BS; Wang, YT; Wang, G; Wang, WG; Zhu, YX; Yao, LY; Gu, YM; Chen, M; Zhou, HL; Fu, YW				Zhang, Kun; Gao, Baoshan; Wang, Yuantao; Wang, Gang; Wang, Weigang; Zhu, Yaxiang; Yao, Liyu; Gu, Yiming; Chen, Mo; Zhou, Honglan; Fu, Yaowen			Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate Analysis	PLOS ONE			English	Article							CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; GLOMERULAR HYPERTENSION; CELL-PROLIFERATION; GRAFT-SURVIVAL; NITRIC-OXIDE; RISK-FACTOR	Since the association of serum uric acid and kidney transplant graft outcome remains disputable, we sought to evaluate the predictive value of uric acid level for graft survival/function and the factors could affect uric acid as time varies. A consecutive cohort of five hundred and seventy three recipients transplanted during January 2008 to December 2011 were recruited. Data and laboratory values of our interest were collected at 1, 3, 6, 12, 24 and 36 months post-transplant for analysis. Cox proportional hazard model, and multiple regression equation were built to adjust for the possible confounding variables and meet our goals as appropriate. The current cohort study lasts for 41.86 +/- 15.49 months. Uric acid level is proven to be negatively associated with eGFR at different time point after adjustment for age, body mass index and male gender (standardized beta ranges from -0.15 to -0.30 with all P<0.001). Males with low eGFR but high level of TG were on CSA, diuretics and RAS inhibitors and experienced at least one episode of acute rejection and diabetic issue were associated with a higher mean uric acid level. Hyperuricemia was significantly an independent predictor of pure graft failure (hazard ratio=4.01, 95% CI: 1.25-12.91, P=0.02) after adjustment. But it was no longer an independent risk factor for graft loss after adjustment. Interestingly, higher triglyceride level can make incidence of graft loss (hazard ratio=1.442, for each unit increase millimoles per liter 95% CI: 1.008-2.061, P=0.045) and death (hazard ratio=1.717, 95% CI: 1.105-2.665, P=0.016) more likely. The results of our study suggest that post-transplant elevated serum uric acid level is an independent predictor of long-term graft survival and graft function. Together with the high TG level impact on poor outcomes, further investigations for therapeutic effect are needed.	[Zhang, Kun; Gao, Baoshan; Wang, Yuantao; Wang, Gang; Wang, Weigang; Zhu, Yaxiang; Yao, Liyu; Gu, Yiming; Chen, Mo; Zhou, Honglan; Fu, Yaowen] Jilin Univ, Dept Urol, Transplant Ctr, Hosp 1, Changchun 130023, Jilin, Peoples R China	Jilin University	Zhou, HL (corresponding author), Jilin Univ, Dept Urol, Transplant Ctr, Hosp 1, Changchun 130023, Jilin, Peoples R China.	walkerzhouhl@163.com; fuyaowen@medmail.com.cn	deng, qiongxia/A-3206-2017					Akalin E, 2008, TRANSPLANTATION, V86, P652, DOI 10.1097/TP.0b013e3181814f5b; Akgul A, 2007, TRANSPL P, V39, P1023, DOI 10.1016/j.transproceed.2007.03.028; Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Feig DI, 2006, CURR HYPERTENS REP, V8, P111, DOI 10.1007/s11906-006-0005-z; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; Gerhardt U, 1999, CLIN TRANSPLANT, V13, P375, DOI 10.1034/j.1399-0012.1999.130502.x; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Haririan A, 2011, AM J TRANSPLANT, V11, P1943, DOI 10.1111/j.1600-6143.2011.03613.x; Haririan A, 2010, TRANSPLANTATION, V89, P573, DOI 10.1097/TP.0b013e3181c73c18; Hong Q, 2012, CELL CALCIUM, V51, P402, DOI 10.1016/j.ceca.2012.01.003; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039457; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Kasiske BL, 1998, AM J KIDNEY DIS, V32, pS142, DOI 10.1053/ajkd.1998.v32.pm9820472; Kato M, 2005, AM J CARDIOL, V96, P1576, DOI 10.1016/j.amjcard.2005.07.068; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Lapsia V, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.06.021; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy AR, 2014, VALUE HEALTH, V17, P254, DOI 10.1016/j.jval.2014.01.001; LINDHOLM A, 1995, TRANSPLANTATION, V60, P451, DOI 10.1097/00007890-199509000-00008; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079675; Mazali FC, 2011, SEMIN NEPHROL, V31, P466, DOI 10.1016/j.semnephrol.2011.08.012; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Mazzali M, 2001, TRANSPLANTATION, V71, P900, DOI 10.1097/00007890-200104150-00014; Meier-Kriesche HU, 2009, CLIN J AM SOC NEPHRO, V4, P1655, DOI 10.2215/CJN.02700409; Navaneethan SD, 2009, NEPHROL DIAL TRANSPL, V24, P1260, DOI 10.1093/ndt/gfn621; Numakura K, 2012, TRANSPLANTATION, V94, P145, DOI 10.1097/TP.0b013e318254391b; Paul LC, 1999, KIDNEY INT, V56, P783, DOI 10.1046/j.1523-1755.1999.00611.x; Ray C, 2009, NEW ENGL J MED, V360, P1460, DOI 10.1056/NEJMc090170; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Sanchez-Lozada LG, 2002, AM J PHYSIOL-RENAL, V283, pF1105, DOI 10.1152/ajprenal.00170.2002; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Short Robert A, 2005, Am J Nephrol, V25, P36, DOI 10.1159/000084073; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Svensson M, 2012, CURR OPIN ORGAN TRAN, V17, P393, DOI 10.1097/MOT.0b013e3283560a3b; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075	46	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133834	10.1371/journal.pone.0133834	http://dx.doi.org/10.1371/journal.pone.0133834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208103	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000154
J	Gan, JY; Sonntag, HJ; Tang, MK; Cai, DQ; Lee, KKH				Gan, Jingyi; Sonntag, Hans-Joachim; Tang, Mei Kuen; Cai, Dongqing; Lee, Kenneth Ka Ho			Integrative Analysis of the Developing Postnatal Mouse Heart Transcriptome	PLOS ONE			English	Article							CARDIAC STEM-CELLS; TERMINAL DIFFERENTIATION; CYCLE EXIT; CARDIOMYOCYTES; EXPRESSION; GATA4; FIBROBLASTS; WITHDRAWAL; MYOCYTES; MEF2C	In mammals, cardiomyocytes rapidly proliferate in the fetus and continue to do so for a few more days after birth. These cardiomyocytes then enter into growth arrest but the detailed molecular mechanisms involved have not been fully elucidated. We have addressed this issue by comparing the transcriptomes of 2-day-old (containing dividing cardiomyocytes) with 13-day-old (containing growth arrested cardiomyocytes) postnatal mouse hearts. We performed comparative microarray analysis on the heart tissues and then conducted Functional annotation, Gene ontology, KEGG pathway and Gene Set enrichment analyses on the differentially expressed genes. The bioinformatics analysis revealed that gene ontology categories associated with the "cell cycle", "DNA replication", "chromosome segregation" and "microtubule cytoskeleton" were down-regulated. Inversely, "immune response", "extracellular matrix", "cell differentiation" and "cell membrane" were up-regulated. Ingenuity Pathways Analysis (IPA) has revealed that GATA4, MYH7 and IGF1R were the key drivers of the gene interaction networks. In addition, Regulator Effects network analysis suggested that TASP1, TOB1, C1orf61, AIF1, ROCK1, TFF2 and miR503-5p may be acting on the cardiomyocytes in 13-day-old mouse hearts to inhibit cardiomyocyte proliferation and G1/S phase transition. RT-qPCR was used to validate genes which were differentially expressed and genes that play a prominent role in the pathways and interaction networks that we identified. In sum, our integrative analysis has provided more insights into the transcriptional regulation of cardiomyocyte exit from the cell cycle during postnatal heart development. The results also pinpoint potential regulators that could be used to induce growth arrested cardiomyocytes to proliferate in the infarcted heart.	[Gan, Jingyi; Tang, Mei Kuen; Lee, Kenneth Ka Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China; [Sonntag, Hans-Joachim] Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cai, Dongqing; Lee, Kenneth Ka Ho] Ji Nan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou 510632, Guangdong, Peoples R China	Chinese University of Hong Kong; University of Edinburgh; Jinan University	Lee, KKH (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China.	kaholee@cuhk.edu.hk	Tang, Florence/AAW-4103-2021; Lee, Kenneth Ka Ho/H-6698-2013	Lee, Kenneth Ka Ho/0000-0002-6520-304X	 [CUHK469313]		This study was supported by General Research Fund (CUHK469313). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaiz O, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-547; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Burton PBJ, 1999, DEV BIOL, V216, P659, DOI 10.1006/dbio.1999.9524; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067896; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; D'Amario D, 2011, CIRC RES, V108, P1467, DOI 10.1161/CIRCRESAHA.111.240648; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Giudice J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4603; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gupta V, 2013, CURR BIOL, V23, P1221, DOI 10.1016/j.cub.2013.05.028; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067266; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kawaguchi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014297; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liu Y, 2007, PROTEOMICS, V7, P23, DOI 10.1002/pmic.200600456; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Marshall-Clarke S, 2000, IMMUNOL TODAY, V21, P35, DOI 10.1016/S0167-5699(99)01548-0; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; O'Meara CC, 2015, CIRC RES, V116, P804, DOI 10.1161/CIRCRESAHA.116.304269; Paradis AN, 2014, DRUG DISCOV TODAY, V19, P602, DOI 10.1016/j.drudis.2013.10.019; Parmacek MS, 2009, NEW ENGL J MED, V361, P86, DOI 10.1056/NEJMcibr0903347; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tane S, 2014, J BIOL CHEM, V289, P18033, DOI 10.1074/jbc.M113.541953; Tane S, 2014, BIOCHEM BIOPH RES CO, V443, P1105, DOI 10.1016/j.bbrc.2013.12.109; Tang MK, 2004, CELL TISSUE RES, V316, P339, DOI 10.1007/s00441-004-0881-y; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; Wang F, 2013, J MOL CELL CARDIOL, V62, P122, DOI 10.1016/j.yjmcc.2013.05.016; YOSHIZUMI M, 1995, J CLIN INVEST, V95, P2275, DOI 10.1172/JCI117918; Yu XY, 2009, MOL CELL BIOCHEM, V332, P25, DOI 10.1007/s11010-009-0170-x; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048028	40	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133288	10.1371/journal.pone.0133288	http://dx.doi.org/10.1371/journal.pone.0133288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200114	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100057
J	Potter, AW; Gonzalez, JA; Karis, AJ; Xu, XJ				Potter, Adam W.; Gonzalez, Julio A.; Karis, Anthony J.; Xu, Xiaojiang			Biophysical Assessment and Predicted Thermophysiologic Effects of Body Armor	PLOS ONE			English	Article							HEAT STRAIN; EXERCISE; PERFORMANCE; RESISTANCES; MECHANISMS; STRESS; HOT	Introduction Military personnel are often required to wear ballistic protection in order to defend against enemies. However, this added protection increases mass carried and imposes additional thermal burden on the individual. Body armor (BA) is known to reduce combat casualties, but the effects of BA mass and insulation on the physical performance of soldiers are less well documented. Until recently, the emphasis has been increasing personal protection, with little consideration of the adverse impacts on human performance. Objective The purpose of this work was to use sweating thermal manikin and mathematical modeling techniques to quantify the tradeoff between increased BA protection, the accompanying mass, and thermal effects on human performance. Methods Using a sweating thermal manikin, total insulation (I-T, clo) and vapor permeability indexes (i(m)) were measured for a baseline clothing ensemble with and without one of seven increasingly protective U.S. Army BA configurations. Using mathematical modeling, predictions were made of thermal impact on humans wearing each configuration while working in hot/dry (desert), hot/humid (jungle), and temperate environmental conditions. Results In nearly still air (0.4 m/s), IT ranged from 1.57 to 1.63 clo and i(m) from 0.35 to 0.42 for the seven BA conditions, compared to IT and i(m) values of 1.37 clo and 0.45 respectively, for the baseline condition (no BA). Conclusion Biophysical assessments and predictive modeling show a quantifiable relationship exists among increased protection and increased thermal burden and decreased work capacity. This approach enables quantitative analysis of the tradeoffs between ballistic protection, thermal-work strain, and physical work performance.	[Potter, Adam W.; Gonzalez, Julio A.; Karis, Anthony J.; Xu, Xiaojiang] US Army, Environm Med Res Inst, Biophys & Biomed Modeling Div, Natick, MA 01760 USA		Potter, AW (corresponding author), US Army, Environm Med Res Inst, Biophys & Biomed Modeling Div, Natick, MA 01760 USA.	adam.w.potter.civ@mail.mil	Potter, Adam/D-9893-2014	Potter, Adam/0000-0003-4980-8353				American Society of Testing and Materials International (ASTM), 2010, F237010 ASTM; American Society of Testing and Materials International (ASTM), 2010, F129110 ASTM; Buller MJ, 2008, T0901 US ARM NAT SOL; Cadarette BS, 2001, T019 US ARM NAT SOLD; Caldwell JN, 2011, MIL MED, V176, P488, DOI 10.7205/MILMED-D-10-00010; Cheuvront SN, 2010, J APPL PHYSIOL, V109, P1989, DOI 10.1152/japplphysiol.00367.2010; Dorman LE, 2009, EUR J APPL PHYSIOL, V105, P463, DOI 10.1007/s00421-008-0924-2; EPSTEIN Y, 1988, EUR J APPL PHYSIOL O, V57, P243, DOI 10.1007/BF00640670; Gagge AP, 1941, SCIENCE, V94, P428, DOI 10.1126/science.94.2445.428; GIVONI B, 1972, J APPL PHYSIOL, V32, P812, DOI 10.1152/jappl.1972.32.6.812; Goldman R. F., 2001, MED ASPECTS HARSH EN, V1, P3; Gonzalez RR, 1997, J APPL PHYSIOL, V83, P1017, DOI 10.1152/jappl.1997.83.3.1017; Loverro KL, 2015, APPL ERGON, V46, P168, DOI 10.1016/j.apergo.2014.07.015; Maciejczyk M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095797; Matthew WT, 2001, T0113 US ARM RES I E; Mazurek Michael T, 2006, J Am Acad Orthop Surg, V14, pS18; Mitchell KB, 2013, T13033 US ARM NAT SO; O'Brien C, 2011, J OCCUP ENVIRON HYG, V8, P588, DOI 10.1080/15459624.2011.613291; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Pang TY, 2014, APPL ERGON, V45, P300, DOI 10.1016/j.apergo.2013.04.011; Parsons Ken., 2002, HUMAN THERMAL ENV EF, V3rd; Potter A., 2013, J SPORT HUMAN PERFOR, V1, P34, DOI [10.12922/9, DOI 10.12922/9, DOI 10.12922/JSHP.0009.2013]; Potter AW, 2014, T147 US ARM RES I EN; Pyke AJ, 2015, APPL ERGON, V47, P11, DOI 10.1016/j.apergo.2014.08.016; Sawka MN, 2011, COMPR PHYSIOL, V1, P1883, DOI 10.1002/cphy.c100082; Sawka MN, 2001, MED SCI SPORT EXER, V33, P422, DOI 10.1097/00005768-200103000-00014; Smith CJ, 2011, EUR J APPL PHYSIOL, V111, P1391, DOI 10.1007/s00421-010-1744-8; Stewart IB, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-22; Tharion WJ, 2005, APPETITE, V44, P47, DOI 10.1016/j.appet.2003.11.010; Welles AP, 2013, MIL MED, V178, P1141, DOI 10.7205/MILMED-D-12-00538; Woodcock A.H., 1962, TEXT RES J, V32, P628, DOI DOI 10.1177/004051756203200802; Woodcock AH, 1961, TREP149; Xu XJ, 2014, J OCCUP ENVIRON HYG, V11, pD187, DOI 10.1080/15459624.2014.946517	33	18	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132698	10.1371/journal.pone.0132698	http://dx.doi.org/10.1371/journal.pone.0132698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200906	gold, Green Published, Green Submitted			2022-12-26	WOS:000358597100046
J	Zhou, JJ; Yu, XL; Deng, YF; Yan, HF; Lin, ZL				Zhou, Jian-Jun; Yu, Xun-Lin; Deng, Yun-Fei; Yan, Hai-Fei; Lin, Zhe-Li			Lysimachia huangsangensis (Primulaceae), a New Species from Hunan, China	PLOS ONE			English	Article							SP-NOV PRIMULACEAE; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; DABIESHAN MOUNTAIN; TRNL-F; MYRSINACEAE; ERICALES; L.; EVOLUTION; ANAGALLIS	A new species, Lysimachia huangsangensis (Primulaceae), from Hunan, China is described and illustrated. The new species is closely related to L. carinata because of the crested calyx, but differs in the leaf blades that are ovate to elliptic and (3-)4.5-9 x 2-3.4 cm, 2-5-flowered racemes, and the calyx lobes that are ovate-lanceolate and 5-6 x 3-4 mm. The systematic placement and conservation status are also discussed.	[Zhou, Jian-Jun; Yu, Xun-Lin] Cent South Univ Forestry & Technol, Sch Forestry, Changsha 410004, Hunan, Peoples R China; [Deng, Yun-Fei; Yan, Hai-Fei; Lin, Zhe-Li] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Lin, Zhe-Li] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Central South University of Forestry & Technology; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, XL (corresponding author), Cent South Univ Forestry & Technol, Sch Forestry, Changsha 410004, Hunan, Peoples R China.	csfuyuxl@163.com; yfdeng@scbg.ac.cn			major special foundation of Science and Technology Department of Hunan Province [2012FJ1005]; special program of scientific investigation from the Huangsang National Natural Reserve; National Natural Science Foundation of China [30900160, 31270247, 31470302]	major special foundation of Science and Technology Department of Hunan Province; special program of scientific investigation from the Huangsang National Natural Reserve; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the major special foundation of Science and Technology Department of Hunan Province (Gran no. 2012FJ1005, www.hnst.gov.cn) and special program of scientific investigation from the Huangsang National Natural Reserve (grant no. N/A) to Xun-Lin Yu, and the National Natural Science Foundation of China (grant no. 30900160, 31270247, 31470302, www.nsfc.gov.cn) to Hai-Fei Yan and Yun-Fei Deng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderberg AA, 2002, AM J BOT, V89, P677, DOI 10.3732/ajb.89.4.677; Anderberg AA, 1998, PLANT SYST EVOL, V211, P93, DOI 10.1007/BF00984914; ANDERBERG AA, 1995, CAN J BOT, V73, P1699, DOI 10.1139/b95-184; Anderberg Arne A., 2007, Willdenowia, V37, P407, DOI 10.3372/wi.37.37202; Banfi E., 2005, ATTI SOC ITALIANA SC, V146, P219; Barthlott W., 1984, CURRENT CONCEPTPLA, P95; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; BENNELL A P, 1983, Notes from the Royal Botanic Garden Edinburgh, V40, P425; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chen F.H., 1979, ACTA PHYTOTAXON SIN, V17, P21; Chen FH, 1989, FLORA REIPUBLICAE PO; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cronquist A, 1981, INTEGRATED SYSTEM CL; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; DONOGHUE MJ, 1985, BRYOLOGIST, V88, P172, DOI 10.2307/3243026; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Erdtman G, 1972, PLANT MORPHOLOGY PLA; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; HANDEL-MAZZETTI H., 1928, NOTES ROY BOT GARD EDINBURGH, V16, P51; Hao G, 2004, MOL PHYLOGENET EVOL, V31, P323, DOI 10.1016/S1055-7903(03)00286-0; Hao Gang, 2001, Journal of Tropical and Subtropical Botany, V9, P93; Heywood V. H., 2007, FLOWERING PLANT FAMI; Hu C.M., 1996, FLORA CHINA, V15, P39, DOI DOI 10.2307/2656725; Huang T.-C, 1972, POLLEN FLORA TAIWAN; HUYNH K-L, 1971, Candollea, V26, P279; HUYNH K-L, 1970, Candollea, V25, P267; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN Standards and Pertition Subcommittee, 2014, GUID US IUCN RED LIS; Juan R, 2000, ANN BOT-LONDON, V86, P323, DOI 10.1006/anbo.2000.1188; Judd WS, 1994, HARVARD PAPERS BOTAN, V5, P1; Judd WS, 2008, PLANT SYSTEMATIC PHY; Kallersjo M, 2000, AM J BOT, V87, P1325, DOI 10.2307/2656725; Kao MT, 1998, FLORA OF TAIWAN, P59; Klatt F.W., 1866, ABHANDLUNGEN GEBIETE, V4, P1; Liu K, 2014, PLANT SYST EVOL, V300, P1615, DOI 10.1007/s00606-014-0986-z; Liu K, 2014, PHYTOTAXA, V174, P119, DOI 10.11646/phytotaxa.174.2.8; Mabberley D. J., 2008, MABBERLEYS PLANT BOO; Manns U, 2005, INT J PLANT SCI, V166, P1019, DOI 10.1086/449318; Manns Ulrika, 2009, Willdenowia, V39, P49, DOI 10.3372/wi.39.39103; Martins L, 2003, PLANT SYST EVOL, V237, P75, DOI 10.1007/s00606-002-0258-1; Mast AR, 2001, INT J PLANT SCI, V162, P1381, DOI 10.1086/323444; Nowicke J.W., 1977, SMITHSON CONTRIB BOT, V37, P1; Oh IC, 2008, PLANT SYST EVOL, V271, P177, DOI 10.1007/s00606-007-0625-z; Pax F, 1905, PFLANZENREICH, V22; Peng CI, 1999, BOT BULL ACAD SINICA, V40, P49; Loc PK, 2011, NORD J BOT, V29, P601, DOI 10.1111/j.1756-1051.2011.01174.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PUNT W, 1974, REV PALAEOBOT PALYNO, V17, P31, DOI 10.1016/0034-6667(74)90037-2; Qian YY, 1998, GUIHAIA, V18, P354; RAY JAMES DAVE, 1956, ILLINOIS BIOL MONOGR, V24, P1; Ren XF, 1994, J ANHUI NORM U NAT S, V17, P61; Reveal JL, 2011, PHYTOTAXA, V19, P71, DOI 10.11646/phytotaxa.19.1.4; Reveal JL., 2012, PHYTONEURON, V37, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouhan G, 2014, METHODS MOL BIOL, V1115, P1, DOI 10.1007/978-1-62703-767-9_1; Shao JW, 2006, ACTA PHYTOTAXON SIN, V44, P589, DOI 10.1360/aps050135; Shao Jian-Wen, 2006, Acta Botanica Yunnanica, V28, P378; [邵剑文 Shao Jianwen], 2005, [微体古生物学报, Acta Micropalaeontologica Sinica], V22, P78; [邵剑文 Shao Jianwen], 2004, [植物研究, Bulletin of Botanical Research], V24, P389; Stahl B, 2004, FA GE VAS P, V6, P266; Stevens P.F., 2012, ANGIOSPERM PHYLOGENY; Stuessy TF, 2014, PLANT SYSTEMATIC ORI; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Takhtajan A, 1997, DIVERSITY CLASSIFICA; Thiers B., 2015, INDEX HERBARIORUM GL; Wettstein R, 1935, HDB SYSTEMATISCHEN B; Willis J. C., 1973, DICT FLOWERING PLANT; Yan HF, 2012, NORD J BOT, V30, P443, DOI 10.1111/j.1756-1051.2012.01401.x; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zhang MD, 2006, ANN BOT FENN, V43, P317; Zhao ZE, 2000, J WUHAN BOT RES, V18, P283; [赵子恩 Zhao Zien], 2002, [武汉植物学研究, Journal of Wuhan Botanical Research], V20, P263; Zwickl D. J, 2006, GENETIC ALGORITHM AP	76	7	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132713	10.1371/journal.pone.0132713	http://dx.doi.org/10.1371/journal.pone.0132713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201028	Green Submitted, Green Published, gold			2022-12-26	WOS:000358597100047
J	Ferreira, S; Karali, B				Ferreira, Susana; Karali, Berna			Do Earthquakes Shake Stock Markets?	PLOS ONE			English	Article							NATURAL DISASTERS; HETEROSCEDASTICITY; AFTERMATH; CONTAGION; VARIANCE; RETURNS; PRICES; IMPACT; INCOME; EVENT	This paper examines how major earthquakes affected the returns and volatility of aggregate stock market indices in thirty-five financial markets over the last twenty years. Results show that global financial markets are resilient to shocks caused by earthquakes even if these are domestic. Our analysis reveals that, in a few instances, some macroeconomic variables and earthquake characteristics (gross domestic product per capita, trade openness, bilateral trade flows, earthquake magnitude, a tsunami indicator, distance to the epicenter, and number of fatalities) mediate the impact of earthquakes on stock market returns, resulting in a zero net effect. However, the influence of these variables is market-specific, indicating no systematic pattern across global capital markets. Results also demonstrate that stock market volatility is unaffected by earthquakes, except for Japan.	[Ferreira, Susana; Karali, Berna] Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Karali, B (corresponding author), Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA.	bkarali@uga.edu		Karali, Berna/0000-0001-7969-7506; Ferreira, Susana/0000-0002-9049-4408				Anbarci N, 2005, J PUBLIC ECON, V89, P1907, DOI 10.1016/j.jpubeco.2004.08.002; [Anonymous], 2013, AFR DEV IND 2012 201; [Anonymous], 1985, THEORY PRACTICE ECON; BAILLIE RT, 1989, J BUS ECON STAT, V7, P297, DOI 10.2307/1391527; BAILLIE RT, 1990, J FINANC QUANT ANAL, V25, P203, DOI 10.2307/2330824; Beyer H. L, 2012, GEOSPATIAL MODELLING; Binder, 1998, REV QUANT FINAN ACC, V11, P111, DOI [10.1023/A:1008295500105, DOI 10.1023/A:1008295500105]; BOLLERSLEV T, 1988, J POLIT ECON, V96, P116, DOI 10.1086/261527; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; BOLLERSLEV T, 1987, REV ECON STAT, V69, P542, DOI 10.2307/1925546; Brenner RJ, 1996, J FINANC QUANT ANAL, V31, P85, DOI 10.2307/2331388; Cavallo E, 2011, INT REV ENVIRON RESO, V5, P63, DOI 10.1561/101.00000039; Cavallo E, 2010, ECON J, V120, pF298, DOI 10.1111/j.1468-0297.2010.02378.x; CIESIN/SEDAC/CIAT. Center for International Earth Science Information Network NASA Socioeconomic Data and Applications Center (SEDAC) Inter-American Development Bank International Food Policy Research Institute to the Centro Internacional de Agricultura Tropical (CIAT), 2013, GRIDD POP WORLD GPW; CRED/OFDA, 2011, INT DIS DAT; CUTLER DM, 1989, J PORTFOLIO MANAGE, V15, P4, DOI 10.3905/jpm.1989.409212; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Fama E.F., 1969, INT ECON REV, V10, P1, DOI [10.2307/2525569, DOI 10.2307/2525569]; Ferreira S, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011701; Field CB, 2012, SPECIAL REPORT WORKI; Fomby T, 2013, J APPL ECONOMET, V28, P412, DOI 10.1002/jae.1273; Forbes KJ, 2002, J FINANC, V57, P2223, DOI 10.1111/0022-1082.00494; Forbes KJ, 2004, J INT ECON, V63, P59, DOI 10.1016/S0022-1996(03)00044-8; Forbes KJ, 2002, NBER CONF R, P77; FRENCH KR, 1987, J FINANC ECON, V19, P3, DOI 10.1016/0304-405X(87)90026-2; GIACCOTTO C, 1982, J FINANC, V37, P1247, DOI 10.2307/2327848; Hatase M, 2013, VANDERBIT U DEP EC W, V13-00007; HSIEH DA, 1989, J BUS ECON STAT, V7, P307, DOI 10.2307/1391528; IPCC, 2007, INT PAN CLIM CHANG I; Kahn ME, 2005, REV ECON STAT, V87, P271, DOI 10.1162/0034653053970339; Kajitani Y, 2013, EARTHQ SPECTRA, V29, pS457, DOI 10.1193/1.4000108; Keefer P, 2011, WORLD DEV, V39, P1530, DOI 10.1016/j.worlddev.2011.02.010; Kousky C, 2014, ENERG ECON, V46, P576, DOI 10.1016/j.eneco.2013.09.029; Lee HY, 2007, RES INT BUS FINANC, V21, P281, DOI 10.1016/j.ribaf.2006.05.001; LEE TH, 1994, J INT MONEY FINANC, V13, P375, DOI 10.1016/0261-5606(94)90034-5; Lo AW, 1988, REV FINANC STUD, V1, P41, DOI 10.1093/rfs/1.1.41; MacKinlay AC, 1997, J ECON LIT, V35, P13; NOAA, 2013, NAT GEOPH DAT CTR WO; Noy I, 2009, J DEV ECON, V88, P221, DOI 10.1016/j.jdeveco.2008.02.005; Odell KA, 2004, J ECON HIST, V64, P1002, DOI 10.1017/S0022050704043062; Raddatz C, 2009, POLICY RES WORKING P; Raddatz C, 2007, J DEV ECON, V84, P155, DOI 10.1016/j.jdeveco.2006.11.001; Scholtens B, 2013, EARTHQ SPECTRA, V29, P325, DOI 10.1193/1.4000103; SHELOR RM, 1992, J RISK INSUR, V59, P476, DOI 10.2307/253059; Skidmore M, 2002, ECON INQ, V40, P664, DOI 10.1093/ei/40.4.664; Tao ZR, 2014, NAT HAZARDS, V70, P1247, DOI 10.1007/s11069-013-0871-z; Worthington A, 2004, APPL ECON, V36, P2177, DOI 10.1080/0003684042000282489; Yamori N, 2002, J JPN INT ECON, V16, P92, DOI 10.1006/jjie.2001.0477; Yang CC, 2008, J RISK FINANC, V9, P232, DOI 10.1108/15265940810875568	49	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0133319	10.1371/journal.pone.0133319	http://dx.doi.org/10.1371/journal.pone.0133319			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN6LZ	26197482	gold, Green Published, Green Submitted			2022-12-26	WOS:000358547600084
J	Pizzolato, J; Mukherjee, S; Scharer, OD; Jiricny, J				Pizzolato, Julia; Mukherjee, Shivam; Schaerer, Orlando D.; Jiricny, Josef			FANCD2-associated Nuclease 1, but Not Exonuclease 1 or Flap Endonuclease 1, Is Able to Unhook DNA Interstrand Cross-links in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANEMIA-ASSOCIATED NUCLEASE; STALLED REPLICATION FORKS; FANCONI-ANEMIA; REPAIR; FAN1; KIAA1018/FAN1; MECHANISM; CELLS; IDENTIFICATION; MUTATIONS	Cisplatin and its derivatives, nitrogen mustards and mitomycin C, are used widely in cancer chemotherapy. Their efficacy is linked primarily to their ability to generate DNA interstrand cross-links (ICLs), which effectively block the progression of transcription and replication machineries. Release of this block, referred to as unhooking, has been postulated to require endonucleases that incise one strand of the duplex on either side of the ICL. Here we investigated how the 5' flap nucleases FANCD2-associated nuclease 1 (FAN1), exonuclease 1 (EXO1), and flap endonuclease 1 (FEN1) process a substrate reminiscent of a replication fork arrested at an ICL. We now show that EXO1 and FEN1 cleaved the substrate at the boundary between the single-stranded 5' flap and the duplex, whereas FAN1 incised it three to four nucleotides in the double-stranded region. This affected the outcome of processing of a substrate containing a nitrogen mustard-like ICL two nucleotides in the duplex region because FAN1, unlike EXO1 and FEN1, incised the substrate predominantly beyond the ICL and, therefore, failed to release the 5' flap. We also show that FAN1 was able to degrade a linear ICL substrate. This ability of FAN1 to traverse ICLs in DNA could help to elucidate its biological function, which is currently unknown.	[Pizzolato, Julia; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Jiricny, Josef] Swiss Inst Technol ETH Zurich, Dept Biol, CH-8057 Zurich, Switzerland; [Mukherjee, Shivam; Schaerer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch	Schärer, Orlando D./AAF-8613-2021; Scharer, Orlando/B-8908-2008	Scharer, Orlando/0000-0003-2425-2715	Swiss National Science Foundation [310030B-133123, 31003A-149989]; Advanced ERC Grant MIRIAM; University of Zurich; NATIONAL CANCER INSTITUTE [R01CA165911] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Advanced ERC Grant MIRIAM; University of Zurich; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Swiss National Science Foundation Grants 310030B-133123 and 31003A-149989 and by Advanced ERC Grant MIRIAM (to J. J.). Funding for open access charge was from the University of Zurich. The authors declare that they have no conflicts of interest with the contents of this article.	Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bregenhorn S, 2014, NUCLEIC ACIDS RES, V42, P7096, DOI 10.1093/nar/gku419; Chaudhury I, 2014, MOL CELL BIOL, V34, P3939, DOI 10.1128/MCB.00457-14; Clauson C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012732; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Fontebasso Y, 2013, DNA REPAIR, V12, P1011, DOI 10.1016/j.dnarep.2013.10.003; Guainazzi A, 2010, CHEM-EUR J, V16, P12100, DOI 10.1002/chem.201002041; Gwon GH, 2014, GENE DEV, V28, P2276, DOI 10.1101/gad.248492.114; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Hinz JM, 2010, ENVIRON MOL MUTAGEN, V51, P582, DOI 10.1002/em.20577; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mukherjee S, 2014, NUCLEIC ACIDS RES, V42, P7429, DOI 10.1093/nar/gku328; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Munoz IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109752; Nair N, 2014, DNA REPAIR, V24, P131, DOI 10.1016/j.dnarep.2014.08.004; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Pennell S, 2014, CELL REP, V8, P84, DOI 10.1016/j.celrep.2014.06.001; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; Wang R, 2014, SCIENCE, V346, P1127, DOI 10.1126/science.1258973; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Zhang JQ, 2015, NAT STRUCT MOL BIOL, V22, P242, DOI 10.1038/nsmb.2956; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018; Zhao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6726; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	37	29	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22602	22611		10.1074/jbc.M115.663666	http://dx.doi.org/10.1074/jbc.M115.663666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221031	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000361171500026
J	Radhakrishnan, R; Li, YX; Xiang, SY; Yuan, FH; Yuan, ZG; Telles, E; Fang, J; Coppola, D; Shibata, D; Lane, WS; Zhang, YB; Zhang, XH; Seto, E				Radhakrishnan, Rangasudhagar; Li, Yixuan; Xiang, Shengyan; Yuan, Fenghua; Yuan, Zhigang; Telles, Elphine; Fang, Jia; Coppola, Domenico; Shibata, David; Lane, William S.; Zhang, Yanbin; Zhang, Xiaohong; Seto, Edward			Histone Deacetylase 10 Regulates DNA Mismatch Repair and May Involve the Deacetylation of MutS Homolog 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; DAMAGE RESPONSE; PROTEIN; ALPHA; CELLS; CANCER; MSH2; INHIBITION; CHROMATIN; DEFECTS	MutS homolog 2 (MSH2) is an essential DNA mismatch repair (MMR) protein. It interacts with MSH6 or MSH3 to form the MutS alpha or MutS beta complex, respectively, which recognize base-base mispairs and insertions/deletions and initiate the repair process. Mutation or dysregulation of MSH2 causes genomic instability that can lead to cancer. MSH2 is acetylated at its C terminus, and histone deacetylase (HDAC6) deacetylates MSH2. However, whether other regions of MSH2 can be acetylated and whether other histone deacetylases (HDACs) and histone acetyltransferases (HATs) are involved in MSH2 deacetylation/acetylation is unknown. Here, we report that MSH2 can be acetylated at Lys-73 near the N terminus. Lys-73 is highly conserved across many species. Although several Class I and II HDACs interact with MSH2, HDAC10 is the major enzyme that deacetylates MSH2 at Lys-73. Histone acetyltransferase HBO1 might acetylate this residue. HDAC10 overexpression in HeLa cells stimulates cellular DNA MMR activity, whereas HDAC10 knockdown decreases DNA MMR activity. Thus, our study identifies an HDAC10-mediated regulatory mechanism controlling the DNA mismatch repair function of MSH2.	[Radhakrishnan, Rangasudhagar; Li, Yixuan; Yuan, Zhigang; Telles, Elphine; Fang, Jia; Zhang, Xiaohong; Seto, Edward] Dept Mol Oncol, Tampa, FL 33612 USA; [Coppola, Domenico; Shibata, David] Dept Gastroenterol, Tampa, FL 33612 USA; [Coppola, Domenico; Shibata, David] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Xiang, Shengyan; Zhang, Xiaohong] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Yuan, Fenghua; Zhang, Yanbin] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Lane, William S.] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Miami; Harvard University	Zhang, XH (corresponding author), USF Morsani Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	xzhang1@health.usf.edu; ed.seto@moffitt.org	li, yixuan/P-5376-2016; radhakrishnan, rangasudhagar/B-8557-2016; Regan, Clinton/E-6250-2012; XIANG, SHENGYAN/C-3176-2013; Zhang, Yanbin/F-2998-2011	radhakrishnan, rangasudhagar/0000-0001-6616-8525; XIANG, SHENGYAN/0000-0002-6940-3559; Zhang, Yanbin/0000-0002-7263-5510; Fang, Jia/0000-0001-8583-1652; Li, Yixuan/0000-0002-3550-8192	National Institutes of Health [R01CA169210, R01HL105631]; Bank-head Coley Biomedical Research Program; NATIONAL CANCER INSTITUTE [R01CA172774, R01CA169210] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bank-head Coley Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by National Institutes of Health grants R01CA169210 (to E. S.) and R01HL105631 (to Y. Z.), an endowment from the Kaul Foundation (to E. S.), and a postdoctoral fellowship from the Bank-head Coley Biomedical Research Program (to R. R.) The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Hafiz HA, 2014, J STEROID BIOCHEM, V140, P80, DOI 10.1016/j.jsbmb.2013.12.008; Christmann M, 2002, NUCLEIC ACIDS RES, V30, P1959, DOI 10.1093/nar/30.9.1959; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Fink D, 1998, CLIN CANCER RES, V4, P1; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gu Liya, 2012, Methods Mol Biol, V920, P135, DOI 10.1007/978-1-61779-998-3_10; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Masih PJ, 2008, NUCLEIC ACIDS RES, V36, P67, DOI 10.1093/nar/gkm943; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Smith JA, 2007, MOL CELL BIOL, V27, P7816, DOI 10.1128/MCB.00455-07; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan Fenghua, 2012, Methods Mol Biol, V920, P149, DOI 10.1007/978-1-61779-998-3_11; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	29	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22795	22804		10.1074/jbc.M114.612945	http://dx.doi.org/10.1074/jbc.M114.612945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26221039	Green Published, hybrid			2022-12-26	WOS:000361171500042
J	Thiemann, S; Man, JH; Chang, MH; Lee, B; Baum, LG				Thiemann, Sandra; Man, Jeanette H.; Chang, Margaret H.; Lee, Benhur; Baum, Linda G.			Galectin-1 Regulates Tissue Exit of Specific Dendritic Cell Populations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHATIC ENDOTHELIUM; O-GLYCANS; IN-VIVO; T-CELLS; DIFFERENTIAL GLYCOSYLATION; LEUKOCYTE TRAFFICKING; MEMBRANE TRAFFICKING; EXTRACELLULAR-MATRIX; LYMPHOMA-CELLS; EMERGING ROLE	During inflammation, dendritic cells emigrate from inflamed tissue across the lymphatic endothelium into the lymphatic vasculature and travel to regional lymph nodes to initiate immune responses. However, the processes that regulate dendritic cell tissue egress and migration across the lymphatic endothelium are not well defined. The mammalian lectin galectin-1 is highly expressed by vascular endothelial cells in inflamed tissue and has been shown to regulate immune cell tissue entry into inflamed tissue. Here, we show that galectin-1 is also highly expressed by human lymphatic endothelial cells, and deposition of galectin-1 in extracellular matrix selectively regulates migration of specific human dendritic cell subsets. The presence of galectin-1 inhibits migration of immunogenic dendritic cells through the extracellular matrix and across lymphatic endothelial cells, but it has no effect on migration of tolerogenic dendritic cells. The major galectin-1 counter-receptor on both dendritic cell populations is the cell surface mucin CD43; differential core 2 O-glycosylation of CD43 between immunogenic dendritic cells and tolerogenic dendritic cells appears to contribute to the differential effect of galectin-1 on migration. Binding of galectin-1 to immunogenic dendritic cells reduces phosphorylation and activity of the protein-tyrosine kinase Pyk2, an effect that may also contribute to reduced migration of this subset. In a murine lymphedema model, galectin-1(-/-) animals had increased numbers of migratory dendritic cells in draining lymph nodes, specifically dendritic cells with an immunogenic phenotype. These findings define a novel role for galectin-1 in inhibiting tissue emigration of immunogenic, but not tolerogenic, dendritic cells, providing an additional mechanism by which galectin-1 can dampen immune responses.	[Thiemann, Sandra; Man, Jeanette H.; Lee, Benhur; Baum, Linda G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Chang, Margaret H.; Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Lee, Benhur] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Icahn School of Medicine at Mount Sinai	Baum, LG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	lbaum@mednet.ucla.edu	Lee, Benhur/A-8554-2016; Regan, Clinton/E-6250-2012	Lee, Benhur/0000-0003-0760-1709; 	National Institutes of Health [R21HL102989]; Ruth L. Kirschstein National Research Award [T32 CA 009120, AI-28697, CA-16042]; Mizutani Glycoscience Foundation [120083]; NATIONAL CANCER INSTITUTE [T32CA009120, P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096392, R21HL102989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Glycoscience Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21HL102989, Ruth L. Kirschstein National Research Award T32 CA 009120 (to S.T.), Grant AI-28697 (to the Center for AIDS Research Virology Core Laboratory), and Grants CA-16042 and AI-28697 (to the Jonsson Comprehensive Cancer Center and Center for AIDS Research Flow Cytometry Core Facility). This work was also supported by Mizutani Glycoscience Foundation Research Grant 120083 (to L.G.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed H, 1996, J BIOCHEM, V120, P1007; Akbari O, 1999, J EXP MED, V189, P169, DOI 10.1084/jem.189.1.169; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Angeli Veronique, 2006, Lymphatic Research and Biology, V4, P217, DOI 10.1089/lrb.2006.4406; Balatoni CE, 2009, AM J PATHOL, V175, P1653, DOI 10.2353/ajpath.2009.090091; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BAUM LG, 1995, GLYCOCONJUGATE J, V12, P63, DOI 10.1007/BF00731870; Baum LG, 2003, CLIN IMMUNOL, V109, P295, DOI 10.1016/j.clim.2003.08.003; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; BIERHUIZEN MFA, 1994, J BIOL CHEM, V269, P4473; Boltjes A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00131; Braccia A, 2003, J BIOL CHEM, V278, P15679, DOI 10.1074/jbc.M211228200; Breiteneder-Geleff S, 1999, Verh Dtsch Ges Pathol, V83, P270; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Cabrera PV, 2006, BLOOD, V108, P2399, DOI 10.1182/blood-2006-04-018556; Card CM, 2014, J CLIN INVEST, V124, P943, DOI 10.1172/JCI73316; CARLSSON SR, 1986, J BIOL CHEM, V261, P2779; Cattaneo V, 2014, GLYCOBIOLOGY, V24, P966, DOI 10.1093/glycob/cwu060; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Cheng DE, 2014, BBA-GEN SUBJECTS, V1840, P1965, DOI 10.1016/j.bbagen.2014.01.026; Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722; Clark MC, 2012, BLOOD, V120, P4635, DOI 10.1182/blood-2012-06-438234; Clark MC, 2012, ANN NY ACAD SCI, V1253, P58, DOI 10.1111/j.1749-6632.2011.06304.x; Clement CC, 2013, J PROTEOMICS, V78, P172, DOI 10.1016/j.jprot.2012.11.013; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Cooper D, 2012, ANN NY ACAD SCI, V1253, P181, DOI 10.1111/j.1749-6632.2011.06291.x; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; Delacour D, 2008, J CELL SCI, V121, P458, DOI 10.1242/jcs.020800; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dudek AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00438; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Elola MT, 2005, J BIOMED SCI, V12, P13, DOI 10.1007/s11373-004-8169-5; Erbacher A, 2009, HUM IMMUNOL, V70, P308, DOI 10.1016/j.humimm.2009.02.005; Fautsch MP, 2003, EXP EYE RES, V77, P11, DOI 10.1016/S0014-4835(03)00107-6; FUKUDA M, 1991, Glycobiology, V1, P347, DOI 10.1093/glycob/1.4.347; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Fulcher JA, 2009, J BIOL CHEM, V284, P26860, DOI 10.1074/jbc.M109.037507; Galvan M, 2000, J BIOL CHEM, V275, P16730, DOI 10.1074/jbc.M001117200; Gandhi MK, 2007, BLOOD, V110, P1326, DOI 10.1182/blood-2007-01-066100; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Gil CD, 2006, INFLAMM RES, V55, P99, DOI 10.1007/s00011-005-0059-4; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; He JL, 2006, METHOD ENZYMOL, V417, P247, DOI 10.1016/S0076-6879(06)17017-2; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Ilarregui JM, 2010, NEUROIMMUNOMODULAT, V17, P157, DOI 10.1159/000258712; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Iqbal AJ, 2013, J IMMUNOL, V191, P171, DOI 10.4049/jimmunol.1203291; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Kuo PL, 2011, J IMMUNOL, V186, P1521, DOI 10.4049/jimmunol.1002940; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu Fu-Tong, 2002, Expert Opin Ther Targets, V6, P461, DOI 10.1517/14728222.6.4.461; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811; Luo YC, 2014, P NATL ACAD SCI USA, V111, P15178, DOI 10.1073/pnas.1416714111; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Maquoi E, 1997, PLACENTA, V18, P433, DOI 10.1016/S0143-4004(97)80044-6; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Moiseeva EP, 1999, J VASC RES, V36, P47, DOI 10.1159/000025625; Moiseeva EP, 2003, BIOCHEM BIOPH RES CO, V310, P1010, DOI 10.1016/j.bbrc.2003.09.112; Moreau A, 2012, EUR J IMMUNOL, V42, P2881, DOI 10.1002/eji.201142325; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morelli AE, 2010, APOPTOSIS, V15, P1083, DOI 10.1007/s10495-010-0469-9; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Mukasa R, 1999, INT IMMUNOL, V11, P259, DOI 10.1093/intimm/11.2.259; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Norling LV, 2008, FASEB J, V22, P682, DOI 10.1096/fj.07-9268com; Ohtsubo K, 2013, BIOCHEM BIOPH RES CO, V434, P346, DOI 10.1016/j.bbrc.2013.03.076; OZEKI Y, 1995, GLYCOBIOLOGY, V5, P255, DOI 10.1093/glycob/5.2.255; Pace KE, 1999, J IMMUNOL, V163, P3801; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Pace KE, 2002, GLYCOCONJUGATE J, V19, P607, DOI 10.1023/B:GLYC.0000014092.86763.2f; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Perone MJ, 2006, J IMMUNOL, V176, P7207, DOI 10.4049/jimmunol.176.12.7207; Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167; POIRIER F, 1993, DEVELOPMENT, V119, P1229; QUN Z, 1993, ARCH BIOCHEM BIOPHYS, V300, P6, DOI 10.1006/abbi.1993.1002; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2000, EUR J IMMUNOL, V30, P1331, DOI 10.1002/(SICI)1521-4141(200005)30:5<1331::AID-IMMU1331>3.3.CO;2-8; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Randolph GJ, 2005, SPRINGER SEMIN IMMUN, V26, P273, DOI 10.1007/s00281-004-0168-0; Renkawitz J, 2010, EMBO REP, V11, P744, DOI 10.1038/embor.2010.147; Rhee I, 2014, MOL CELL BIOL, V34, P888, DOI 10.1128/MCB.01369-13; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Russo E, 2013, LYMPHAT RES BIOL, V11, P172, DOI 10.1089/lrb.2013.0008; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; SMITH JB, 1970, J ANAT, V107, P87; Sparwasser T, 2000, EUR J IMMUNOL, V30, P3591, DOI 10.1002/1521-4141(200012)30:12<3591::AID-IMMU3591>3.0.CO;2-J; Stannard KA, 2010, CANCER LETT, V299, P95, DOI 10.1016/j.canlet.2010.08.005; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; STROSS WP, 1989, J CLIN PATHOL, V42, P953, DOI 10.1136/jcp.42.9.953; Svajger U, 2010, INT REV IMMUNOL, V29, P574, DOI 10.3109/08830185.2010.522280; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Tanikawa R, 2008, J BONE MINER RES, V23, P278, DOI 10.1359/JBMR.071008; Teijeira A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00433; Thiemann S, 2015, METHODS MOL BIOL, V1207, P215, DOI 10.1007/978-1-4939-1396-1_14; Thiemann S, 2011, J CLIN IMMUNOL, V31, P2, DOI 10.1007/s10875-010-9460-z; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; van der Leij J, 2004, J PATHOL, V204, P511, DOI 10.1002/path.1671; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Walzel H, 2006, GLYCOBIOLOGY, V16, P1262, DOI 10.1093/glycob/cwl037; Wollina U, 1999, HISTOL HISTOPATHOL, V14, P779, DOI 10.14670/HH-14.779; Wright RD, 2014, GLYCOBIOLOGY, V24, P1242, DOI 10.1093/glycob/cwu101; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010	147	32	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22662	22677		10.1074/jbc.M115.644799	http://dx.doi.org/10.1074/jbc.M115.644799			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216879	Green Published, hybrid			2022-12-26	WOS:000361171500031
J	Deudero, S; Vazquez-Luis, M; Alvarez, E				Deudero, Salud; Vazquez-Luis, Maite; Alvarez, Elvira			Human Stressors Are Driving Coastal Benthic Long-Lived Sessile Fan Mussel Pinna nobilis Population Structure More than Environmental Stressors	PLOS ONE			English	Article							SHELL; BIVALVE; IMPACTS; DENSITY; GULF; SEAGRASSES; MOLLUSCA; FORCES; GROWTH; SIZE	Coastal degradation and habitat disruption are severely compromising sessile marine species. The fan shell Pinna nobilis is an endemic, vulnerable species and the largest bivalve in the Mediterranean basin. In spite of species legal protection, fan shell populations are declining. Models analyzed the contributions of environmental (mean depth, wave height, maximum wave height, period of waves with high energy and mean direction of wave source) versus human-derived stressors (anchoring, protection status, sewage effluents, fishing activity and diving) as explanatory variables depicting Pinna nobilis populations at a mesoscale level. Human stressors were explaining most of the variability in density spatial distribution of fan shell, significantly disturbing benthic communities. Habitat protection affected P. nobilis structure and physical aggression by anchoring reveals a high impact on densities. Environmental variables instead played a secondary role, indicating that global change processes are not so relevant in coastal benthic communities as human-derived impacts.	[Deudero, Salud; Vazquez-Luis, Maite] Ctr Oceanog Baleares, IEO, Palma De Mallorca, Spain; [Alvarez, Elvira] Govern Illes Balears, Direccio Gen Medi Rural & Mari, Palma De Mallorca, Spain	Spanish Institute of Oceanography	Deudero, S (corresponding author), Ctr Oceanog Baleares, IEO, Palma De Mallorca, Spain.	salud.deudero@ba.ieo.es	Luis, Maite Vázquez/R-5189-2018; Deudero, Salud/I-1883-2015	Deudero, Salud/0000-0001-5584-2801; Vazquez-Luis, M. (Maite)/0000-0002-2733-2801	Organismo Autonomo Parques Nacionales, Ministerio de Medio Ambiente for the project "Estado de conservacion del bivalvo amenazado Pinna nobilis en el Parque Nacional del Archipielago de Cabrera" [024/2010]; European Community [287844]	Organismo Autonomo Parques Nacionales, Ministerio de Medio Ambiente for the project "Estado de conservacion del bivalvo amenazado Pinna nobilis en el Parque Nacional del Archipielago de Cabrera"; European Community(European Commission)	Funding was from Organismo Autonomo Parques Nacionales, Ministerio de Medio Ambiente for the project "Estado de conservacion del bivalvo amenazado Pinna nobilis en el Parque Nacional del Archipielago de Cabrera" (024/2010)", and partly funded from European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 287844 project 'Towards Coast to COast NETworks of marine protected areas (from the shore to the high and deep sea), coupled with sea-based wind energy potential' (COCONET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis P, 2009, SCI MAR, V73, P143, DOI 10.3989/scimar.2009.73n1143; Alomar C, 2015, J EXP MAR BIOL ECOL, V467, P77, DOI 10.1016/j.jembe.2015.03.006; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson M.J., 2004, PERMANOVA 2 FACTOR F; [Anonymous], WANA PROV TEMP SER N; Balaguer P, 2011, OCEAN COAST MANAGE, V54, P241, DOI 10.1016/j.ocecoaman.2010.12.002; Basso L, 2015, ADV MARINE IN PRESS; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Butler Alan, 1994, Marine Life, V3, P37; Cabanellas-Reboredo Miguel, 2009, Marine Biodiversity Records, V2, pe126, DOI 10.1017/S1755267209001274; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Coppa S, 2010, J MAR BIOL ASSOC UK, V90, P885, DOI 10.1017/S002531540999141X; Coppa S, 2013, J SEA RES, V76, P201, DOI 10.1016/j.seares.2012.09.007; Deudero S, 2011, ATLAS BIODIVERSIDAD; Fraschetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081838; Garcia-March JR, 2007, J EXP MAR BIOL ECOL, V342, P202, DOI 10.1016/j.jembe.2006.09.007; Gorley C.K., 2006, GETTING STARTED PRIM; Hendriks IE, 2013, BIOL CONSERV, V160, P105, DOI 10.1016/j.biocon.2013.01.012; Hendriks IE, 2011, ESTUAR COAST, V34, P60, DOI 10.1007/s12237-010-9309-y; Katsanevakis S, 2011, MEDITERR MAR SCI, V12, P429, DOI 10.12681/mms.42; Katsanevakis S, 2007, MAR BIOL, V152, P1319, DOI 10.1007/s00227-007-0781-2; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lemer S, 2014, MOL PHYLOGENET EVOL, V75, P11, DOI 10.1016/j.ympev.2014.02.008; Luna B, 2009, ICES J MAR SCI, V66, P517, DOI 10.1093/icesjms/fsp020; Marba N, 2005, ESTUARIES, V28, P53, DOI 10.1007/BF02732753; Milazzo M, 2002, MAR ECOL-P S Z N I, V23, P280, DOI 10.1111/j.1439-0485.2002.tb00026.x; Prado P, 2014, SCI MAR, V78, P555, DOI 10.3989/scimar.04087.03A; Procaccini G., 2003, WORLD ATLAS SEAGRASS, P48; Rabaoui L, 2010, J MOLLUS STUD, V76, P340, DOI 10.1093/mollus/eyq023; Richardson CA, 2004, J EXP MAR BIOL ECOL, V299, P1, DOI 10.1016/j.jembe.2003.08.012; Schultz Peter W.W., 2013, Acta Conchyliorum, V13, P1; SPA/BD Protocol, 1995, ANN 2 SPA BIOD PROT; Vazquez-Luis M, 2014, MEDITERR MAR SCI, V15, P626, DOI 10.12681/mms.796; Vazquez-Luis M, 2015, INFLUENCE BOAT ANCHO, DOI [10.1071/MF14285, DOI 10.1071/MF14285]; VICENTE N, 1991, ESPECES MARINES PROT, P159; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zavodnik Dusan, 1991, P169	39	26	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134530	10.1371/journal.pone.0134530	http://dx.doi.org/10.1371/journal.pone.0134530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218134	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900123
J	Herweijer, E; Feldman, AL; Ploner, A; Arnheim-Dahlstrom, L; Uhnoo, I; Netterlid, E; Dillner, J; Sparen, P; Sundstrom, K				Herweijer, Eva; Feldman, Adina L.; Ploner, Alexander; Arnheim-Dahlstrom, Lisen; Uhnoo, Ingrid; Netterlid, Eva; Dillner, Joakim; Sparen, Par; Sundstrom, Karin			The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; YOUNG-WOMEN; CANCER; ASSOCIATION; BEHAVIOR; MODEL	Background Concerns have been raised that HPV-vaccination might affect women's cervical screening behavior. We therefore investigated the association between opportunistic HPV-vaccination and attendance after invitation to cervical screening. Methods A cohort of all women resident in Sweden, born 1977-1987 (N=629,703), and invited to cervical screening, was followed October 2006 - December 2012. Invitations to screening were identified via the National Quality Register for Cervical Cancer Prevention, as was the primary outcome of a registered smear. Vaccination status was obtained from two nationwide health data registers. Hazard ratios (HR) were estimated using Cox regression adjusted for age, education level and income (HRadj). Women were individually followed for up to 6 years, of which the first and second screening rounds were analyzed separately. Results Screening attendance after three years of follow-up was 86% in vaccinated women (N=4,897) and 75% in unvaccinated women (N=625,804). The crude HR of screening attendance in vaccinated vs. unvaccinated women was 1.31 (95% CI 1.27-1.35) in the first screening round. Adjustment for education and income reduced but did not erase this difference (HRadj=1.09, 95% CI 1.05-1.13). In the second screening round, attendance was likewise higher in HPV-vaccinated women (crude HR=1.26, 95% CI 1.21-1.32; HRadj=1.15, 95% CI 1.10-1.20). Conclusions HPV-vaccination is so far associated with equal or higher attendance to cervical screening in Sweden in a cohort of opportunistically vaccinated young women. Most but not all of the difference in attendance was explained by socioeconomic differences between vaccinated and unvaccinated women. HPV vaccine effectiveness studies should consider screening attendance of HPV-vaccinated women when assessing incidence of screen-detected cervical lesions.	[Herweijer, Eva; Feldman, Adina L.; Ploner, Alexander; Arnheim-Dahlstrom, Lisen; Dillner, Joakim; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Feldman, Adina L.] Univ Cambridge, Epidemiol Unit, MRC, Cambridge, England; [Uhnoo, Ingrid; Netterlid, Eva] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Netterlid, Eva] Lund Univ, Fac Med, Dept Clin Sci, Malmo, Sweden; [Netterlid, Eva] Skane Univ Hosp, Dept Occupat & Environm Dermatol, Malmo, Sweden; [Dillner, Joakim; Sundstrom, Karin] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; University of Cambridge; Public Health Agency of Sweden; Lund University; Lund University; Skane University Hospital; Karolinska Institutet	Sundstrom, K (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	karin.sundstrom@ki.se	Sundström, Karin/V-5714-2017	Sundström, Karin/0000-0002-6865-0224; Sparen, Par/0000-0002-5184-8971; Ploner, Alexander/0000-0002-5042-8326	Swedish Foundation for Strategic Research; MRC [MC_UU_12015/4, MC_U106179474] Funding Source: UKRI; Medical Research Council [MC_U106179474, MC_UU_12015/4] Funding Source: researchfish	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Swedish Foundation for Strategic Research. All research was conducted entirely independent of the study funder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrae B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e900; Baldur-Felskov B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt460; Beer H, 2014, VACCINE, V32, P1828, DOI 10.1016/j.vaccine.2014.01.087; Bowyer HL, 2014, VACCINE, V32, P4310, DOI 10.1016/j.vaccine.2014.06.011; Bowyer HL, 2013, VACCINE, V31, P1051, DOI 10.1016/j.vaccine.2012.12.038; Budd AC, 2014, MED J AUSTRALIA, V201, P279, DOI 10.5694/mja14.00021; Elfstrom KM, 2014, CURR OPIN ONCOL, V26, P120, DOI 10.1097/CCO.0000000000000034; Folkhalsomyndigheten. [Public Health Agency of Sweden: Description of the Swedish Vaccination Register (SVEVAC)], 2014, PUBL HLTH AG SWED DE; Haupt RM, 2011, INT J CANCER, V129, P2632, DOI 10.1002/ijc.25940; Herweijer E, 2014, JAMA-J AM MED ASSOC, V311, P597, DOI 10.1001/jama.2014.95; Juraskova I, 2011, WOMEN HEALTH ISS, V21, P71, DOI 10.1016/j.whi.2010.08.004; Kulasingam SL, 2007, VACCINE, V25, P8110, DOI 10.1016/j.vaccine.2007.09.035; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mather T, 2012, VACCINE, V30, P3196, DOI 10.1016/j.vaccine.2012.02.081; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Robbins SCC, 2010, VACCINE, V28, P3398, DOI 10.1016/j.vaccine.2010.02.078; Sauer AG, 2015, CANCER EPIDEMIOL, V39, P650, DOI 10.1016/j.canep.2015.05.002; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sundstrom K, 2010, VACCINE, V28, P7492, DOI 10.1016/j.vaccine.2010.09.007; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	22	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134185	10.1371/journal.pone.0134185	http://dx.doi.org/10.1371/journal.pone.0134185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218492	Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900093
J	Liu, CY; Chou, YC; Chao, JCJ; Hsu, CY; Cha, TL; Tsao, CW				Liu, Chin-Yu; Chou, Yu-Ching; Chao, Jane C. -J.; Hsu, Chien-Yeh; Cha, Tai-Lung; Tsao, Chih-Wei			The Association between Dietary Patterns and Semen Quality in a General Asian Population of 7282 Males	PLOS ONE			English	Article							REPRODUCTIVE HORMONE-LEVELS; OXIDATIVE STRESS; FOOD-INTAKE; MEN; DETERIORATION; INFERTILITY; DECLINE; FAT	Objective To explore the associations between different dietary patterns and semen quality in a general Asian male population. Methods Cross-sectional study. Healthy Taiwanese men aged 18 years or older who participated in a standard medical screening program from 2008-2013 run by a private firm were included in this study. Semen parameters including sperm concentration (SC), total sperm motility (TSM), progressive motility (PRM) and normal sperm morphology (NSM) were recorded. A dietary questionnaire was used to categorize the participants into 5 groups: "Healthy diet", "Western diet", "High-carbohydrate diet", "High sweet snacks & sugar-sweetened drinks" and "High-sodium diet". Results A total of 7282 men completed the questionnaire regarding dietary pattern, and examination of anthropometric indexes was performed and laboratory data were obtained. A high intake of a "Western diet" resulted in statistically linear declines of SC and NSM (P < 0.001 and P < 0.001). Similarly, a greater intake of "High sweet snacks & sugar-sweetened drinks" was associated with a lower SC (P = 0.001). Increased intake of a "High-carbohydrate diet" was related to higher prevalences of abnormal TSM and PRM (P = 0.012 and P = 0.025). Similarly, a greater intake of a "High-sodium diet" was correlated with an elevated prevalence of abnormal NSM (P = 0.035). Conclusions This study showed that a greater intake of a "Western diet" is associated with poorer SC and NSM, a "High sweet snacks and sugar-sweetened drinks" intake is correlated with a lower SC, and high-carbohydrate food is related to elevated prevalences of abnormal TSM and PRM.	[Liu, Chin-Yu] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei City, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chao, Jane C. -J.] Taipei Med Univ, Sch Nutr & Hlth Sci, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Chao, Jane C. -J.; Hsu, Chien-Yeh] Taipei Med Univ, Master Program Global Hlth & Dev, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Chao, Jane C. -J.] Taipei Med Univ Hosp, Nutr Res Ctr, Taipei, Taiwan; [Hsu, Chien-Yeh] Natl Taipei Univ Nursing & Hlth Sci, Dept Informat Management, Taipei, Taiwan; [Cha, Tai-Lung; Tsao, Chih-Wei] Triserv Gen Hosp, Natl Def Med Ctr, Div Urol, Dept Surg, Taipei, Taiwan	Fu Jen Catholic University; National Defense Medical Center; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Taipei University of Nursing & Health Science (NTUNHS); National Defense Medical Center; Tri-Service General Hospital	Tsao, CW (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Div Urol, Dept Surg, Taipei, Taiwan.	weisurger@gmail.com		Tsao, Chih-Wei/0000-0001-7214-8766				Afeiche M, 2013, HUM REPROD, V28, P2265, DOI 10.1093/humrep/det133; Afeiche MC, 2014, FERTIL STERIL, V101, P1280, DOI 10.1016/j.fertnstert.2014.02.003; Akmal M, 2006, J MED FOOD, V9, P440, DOI 10.1089/jmf.2006.9.440; Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Chavarro JE, 2008, HUM REPROD, V23, P2584, DOI 10.1093/humrep/den243; Chavarro JE, 2014, HUM REPROD, V29, P429, DOI 10.1093/humrep/det464; Chen SJ, 2013, ARCH GYNECOL OBSTET, V288, P191, DOI 10.1007/s00404-013-2801-4; Chiu YH, 2014, HUM REPROD, V29, P1575, DOI 10.1093/humrep/deu102; Choy CMY, 2002, BJOG-INT J OBSTET GY, V109, P1121, DOI 10.1111/j.1471-0528.2002.02084.x; Eisenberg ML, 2014, HUM REPROD, V29, P193, DOI 10.1093/humrep/det428; Eskenazi B, 2005, HUM REPROD, V20, P1006, DOI 10.1093/humrep/deh725; Eslamian G, 2016, J AM COLL NUTR, V35, P50, DOI 10.1080/07315724.2014.936983; Eslamian G, 2012, HUM REPROD, V27, P3328, DOI 10.1093/humrep/des311; Fisch H, 1996, FERTIL STERIL, V65, P1009, DOI 10.1016/S0015-0282(16)58278-8; Gaskins AJ, 2012, HUM REPROD, V27, P2899, DOI 10.1093/humrep/des298; Irvine S, 1996, BMJ-BRIT MED J, V312, P467, DOI 10.1136/bmj.312.7029.467; Jensen TK, 2013, AM J CLIN NUTR, V97, P411, DOI 10.3945/ajcn.112.042432; Jensen TK, 2010, AM J EPIDEMIOL, V171, P883, DOI 10.1093/aje/kwq007; Keskes-Ammar L, 2003, ARCH ANDROLOGY, V49, P83, DOI 10.1080/713828100; Kondaki K, 2013, PUBLIC HEALTH NUTR, V16, P479, DOI 10.1017/S1368980012002613; Meeker JD, 2008, ENVIRON HEALTH PERSP, V116, P1473, DOI 10.1289/ehp.11490; Meeker JD, 2010, SYST BIOL REPROD MED, V56, P122, DOI 10.3109/19396360903443658; Mendiola J, 2010, FERTIL STERIL, V93, P1128, DOI 10.1016/j.fertnstert.2008.10.075; Mendiola J, 2009, FERTIL STERIL, V91, P812, DOI 10.1016/j.fertnstert.2008.01.020; Park K, 2009, DIABETES CARE, V32, P1302, DOI 10.2337/dc09-0259; Paulsen CA, 1996, FERTIL STERIL, V65, P1015; Robbins WA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101634; Rolland M, 2013, HUM REPROD, V28, P462, DOI 10.1093/humrep/des415; Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3; Safarinejad MR, 2012, ASIAN J ANDROL, V14, P514, DOI 10.1038/aja.2012.46; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; Vujkovic M, 2009, HUM REPROD, V24, P1304, DOI 10.1093/humrep/dep024; Wong WY, 2000, FERTIL STERIL, V73, P435, DOI 10.1016/S0015-0282(99)00551-8; Zou ZK, 2011, FERTIL STERIL, V95, P2018, DOI 10.1016/j.fertnstert.2011.02.052	35	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134224	10.1371/journal.pone.0134224	http://dx.doi.org/10.1371/journal.pone.0134224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218796	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900097
J	Morgan, D; Warburton, B; Nugent, G				Morgan, David; Warburton, Bruce; Nugent, Graham			Aerial Prefeeding Followed by Ground Based Toxic Baiting for More Efficient and Acceptable Poisoning of Invasive Small Mammalian Pests	PLOS ONE			English	Article							POSSUMS TRICHOSURUS-VULPECULA; NEW-ZEALAND	Introduced brushtail possums (Trichosurus vulpecula) and rat species (Rattus spp.) are major vertebrate pests in New Zealand, with impacts on conservation and agriculture being managed largely through poisoning operations. Aerial distribution of baits containing sodium fluoroacetate (1080) has been refined to maximise cost effectiveness and minimise environmental impact, but this method is strongly opposed by some as it is perceived as being indiscriminate. Although ground based control enables precise placement of baits, operations are often more than twice as costly as aerial control, mainly due to the high labour costs. We investigated a new approach to ground based control that combined aerial distribution of non.toxic 'prefeed' baits followed by sparse distribution of toxic baits at regular intervals along the GPS tracked prefeeding flight paths. This approach was tested in two field trials in which both 1080 baits and cholecalciferol baits were used in separate areas. Effectiveness of the approach, assessed primarily using 'chewcards', was compared with that of scheduled aerial 1080 operations that were conducted in outlying areas of both trials. Contractors carrying out ground based control were able to follow the GPS tracks of aerial prefeeding flight lines very accurately, and with 1080 baits achieved very high levels of kill of possums and rats similar to those achieved by aerial 1080 baiting. Cholecalciferol was less effective in the first trial, but by doubling the amount of cholecalciferol bait used in the second trial, few possums or rats survived. By measuring the time taken to complete ground baiting from GPS tracks, we predicted that the method (using 1080 baits) would be similarly cost effective to aerial 1080 operations for controlling possums and rats, and considerably less expensive than typical current costs of ground based control. The main limitations to the use of the method will be access to, and size of, the operational site, along with topography and vegetation density.	[Morgan, David; Warburton, Bruce; Nugent, Graham] Landcare Res, Dept Wildlife Ecol & Management, Lincoln 7640, New Zealand	Landcare Research - New Zealand	Morgan, D (corresponding author), Landcare Res, Dept Wildlife Ecol & Management, POB 40, Lincoln 7640, New Zealand.	morgand@landcareresearch.co.nz		Nugent, Graham/0000-0001-6223-8450	TBfree New Zealand (AHB project) [R-10721]	TBfree New Zealand (AHB project)	This study was supported by a research project grant from TBfree New Zealand (AHB project number R-10721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, BRUSHTAIL POSSUM BIO; Caughley G., 1977, ANAL VERTEBRATE POPU; Eason CT, 2001, DEP CONSERVATION TEC, V23; ERMA, 2009, COMM GUID AER 1080 O; Fox K., 2013, VETERANS DAY SOLAR F; Green W, 2012, J ROY SOC NEW ZEAL, V42, P185, DOI 10.1080/03036758.2011.556130; Innes J., 1990, HDB NZ MAMMALS; Innes J.G., 1990, P206; Morgan DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070683; Morgan DR, 1990, NZ J ECOL, V9, P167; Morgan DR, 2000, POSSUMS NZ BIOL IMPA, P143; MORGAN DR, 2004, THESIS LINCOLN U NZ; NPCA, 2011, AER 1080 PEST CONTR; NPCA (National Pest Control Agencies), 2011, POSS POP MON US TRAP; Nugent G, 2011, INT J PEST MANAGE, V57, P51, DOI 10.1080/09670874.2010.522265; Nugent G, 2009, NEW ZEAL J ZOOL, V36, P473, DOI 10.1080/03014223.2009.9651479; Nugent G, 2010, LC0910174 LANDC RES; Nugent G, 2013, NEW ZEAL J ECOL, V37, P246; Nugent G, 2012, PEST MANAG SCI, V68, P1374, DOI 10.1002/ps.3315; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; SPURR E, 1997, SCI CONSERVATION, V62, P20; Sweetapple P, 2011, NEW ZEAL J ECOL, V35, P153; Thompson J., 2013, DANGERS SOLAR STORMS; Warburton B, 2015, NEW ZEAL VET J, V63, P77, DOI 10.1080/00480169.2014.981315; Warburton B, 2009, WILDLIFE RES, V36, P659, DOI 10.1071/WR09047	25	5	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134032	10.1371/journal.pone.0134032	http://dx.doi.org/10.1371/journal.pone.0134032			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218095	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900068
J	Hansen, K; Schussel, K; Kieble, M; Werning, J; Schulz, M; Friis, R; Pohlau, D; Schmitz, N; Kugler, J				Hansen, Kerstin; Schuessel, Katrin; Kieble, Marita; Werning, Johanna; Schulz, Martin; Friis, Robert; Poehlau, Dieter; Schmitz, Norbert; Kugler, Joachim			Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study	PLOS ONE			English	Article							INTERFERON-BETA TREATMENT; LONG-TERM ADHERENCE; MEDICATION ADHERENCE; CLINICAL-TRIAL; RRMS PATIENTS; PERSISTENCE; THERAPY; PRESCRIPTION	Background Long-term therapies such as disease modifying therapy for Multiple Sclerosis (MS) demand high levels of medication adherence in order to reach acceptable outcomes. The objective of this study was to describe adherence to four disease modifying drugs (DMDs) among statutorily insured patients within two years following treatment initiation. These drugs were interferon beta-1a i.m. (Avonex), interferon beta-1a s.c. (Rebif), interferon beta-1b s.c. (Betaferon) and glatiramer acetate s.c. (Copaxone). Methods This retrospective cohort study used pharmacy claims data from the data warehouse of the German Institute for Drug Use Evaluation (DAPI) from 2001 through 2009. New or renewed DMD prescriptions in the years 2002 to 2006 were identified and adherence was estimated during 730 days of follow-up by analyzing the medication possession ratio (MPR) as proxy for compliance and persistence defined as number of days from initiation of DMD therapy until discontinuation or interruption. Findings A total of 52,516 medication profiles or therapy cycles (11,891 Avonex, 14,060 Betaferon, 12,353 Copaxone and 14,212 Rebif) from 50,057 patients were included into the analysis. Among the 4 cohorts, no clinically relevant differences were found in available covariates. The Medication Possession Ratio (MPR) measured overall compliance, which was 39.9% with a threshold MPR >= 0.8. There were small differences in the proportion of therapy cycles during which a patient was compliant for the following medications: Avonex (42.8%), Betaferon (40.6%), Rebif (39.2%), and Copaxone (37%). Overall persistence was 32.3% at the end of the 24 months observation period, i.e. during only one third of all included therapy cycles patients did not discontinue or interrupt DMD therapy. There were also small differences in the proportion of therapy cycles during which a patient was persistent as follows: Avonex (34.2%), Betaferon (33.4%), Rebif (31.7%) and Copaxone (29.8%). Conclusions Two years after initiating MS-modifying therapy, only 30-40% of patients were adherent to DMDs.	[Hansen, Kerstin; Kugler, Joachim] Tech Univ Dresden, Fak Med, Lehrstuhl Gesundheitswissensch Publ Hlth, Dresden, Germany; [Schuessel, Katrin; Kieble, Marita; Werning, Johanna; Schulz, Martin] Deutsch Arzneiprufungsinst eV DAPI, Berlin, Germany; [Friis, Robert] Calif State Univ Long Beach, Dept Hlth Sci, Long Beach, CA 90840 USA; [Poehlau, Dieter] Kamillus Klin, Asbach, Germany; [Schmitz, Norbert] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Hansen, Kerstin] Tech Univ Dresden, Fak Med, Bereich Allgemeinmed, Dresden, Germany	Technische Universitat Dresden; California State University System; California State University Long Beach; Technische Universitat Dresden	Kugler, J (corresponding author), Tech Univ Dresden, Fak Med, Lehrstuhl Gesundheitswissensch Publ Hlth, Dresden, Germany.	Joachim.Kugler@tu-dresden.de	Schmitz, Norbert/A-5177-2010; Schulz, Martin/HHT-0997-2022; Schmitz, Norbert/AAH-3624-2020; Schulz, Martin/AAA-6157-2020	Schmitz, Norbert/0000-0001-7777-6323; Schulz, Martin/0000-0002-5876-7322; Schuessel, Katrin/0000-0002-8377-2254				ABDATA Pharma Daten Service, 2001, ABDA DATABASE AND AB; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V.(AWMF), 2012, GUIDELINE ON MULTIPL; Arroyo E, 2011, EUR NEUROL, V65, P59, DOI 10.1159/000323216; Bruce JM, 2010, MULT SCLER, V16, P112, DOI 10.1177/1352458509351897; Bundesministerium fur Gesundheit und Soziale Sicherung, 2010, STATUTORY HEALTH INS; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; de Seze J, 2012, PATIENT PREFER ADHER, V6, P263, DOI 10.2147/PPA.S27038; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Enting RH, 2007, J PAIN SYMPTOM MANAG, V34, P523, DOI 10.1016/j.jpainsymman.2007.01.007; Evans C, 2012, CLIN THER, V34, P341, DOI 10.1016/j.clinthera.2012.01.006; Giovannoni G, 2012, MULT SCLER J, V18, P932, DOI 10.1177/1352458511433302; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Grimmsmann T, 2014, EUR J CLIN PHARMACOL, V70, P295, DOI 10.1007/s00228-013-1607-4; Grymonpre R, 2006, MED CARE, V44, P471, DOI 10.1097/01.mlr.0000207817.32496.cb; Haas J, 2005, EUR J NEUROL, V12, P425, DOI 10.1111/j.1468-1331.2005.00936.x; Halpern R, 2011, ADV THER, V28, P761, DOI 10.1007/s12325-011-0054-9; Hasford J, 2007, EUR J CLIN PHARMACOL, V63, P1055, DOI 10.1007/s00228-007-0340-2; Hein T, 2000, NERVENARZT, V71, P288, DOI 10.1007/s001150050559; Kleinman Nathan L, 2010, J Med Econ, V13, P633, DOI 10.3111/13696998.2010.527588; Lafata JE, 2008, J AM PHARM ASSOC, V48, P752, DOI 10.1331/JAPhA.2008.07116; Lopez-Mendez P, 2013, REV NEUROLOGIA, V56, P8, DOI 10.33588/rn.5601.2012593; Menning M, 2011, GESUNDHEITSWESEN, V73, pE84, DOI 10.1055/s-0030-1255055; Mesaros S, 2012, CLIN NEUROL NEUROSUR, V114, P1145, DOI 10.1016/j.clineuro.2012.02.043; Milanese C, 2005, NEUROL SCI, V26, pS171, DOI 10.1007/s10072-005-0509-3; Mohr DC, 1999, MULT SCLER, V5, P192, DOI 10.1191/135245899678846069; O'Rourke KET, 2005, MULT SCLER J, V11, P46, DOI 10.1191/1352458505ms1131oa; Portaccio E, 2008, EUR NEUROL, V59, P131, DOI 10.1159/000111875; Reynolds MW, 2010, CURR MED RES OPIN, V26, P663, DOI 10.1185/03007990903554257; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Ruggieri RM, 2003, NEUROL SCI, V24, P361, DOI 10.1007/s10072-003-0190-3; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Swart E, 2005, GESUNDHEITSWESEN, V67, P416, DOI 10.1055/s-2005-858356; Treadaway K, 2009, J NEUROL, V256, P568, DOI 10.1007/s00415-009-0096-y; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; Twork S, 2007, CURR MED RES OPIN, V23, P1209, DOI 10.1185/030079907X188125; Vicente Iturbe C, 2012, Farm Hosp, V36, P77, DOI 10.1016/j.farma.2010.12.006; World Health Organisation, 2003, ADHERENCE TO LONG TE	37	58	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133279	10.1371/journal.pone.0133279	http://dx.doi.org/10.1371/journal.pone.0133279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214805	Green Published, gold, Green Submitted			2022-12-26	WOS:000358594300018
J	Dominguez, E; Raoul, W; Calippe, B; Sahel, JA; Guillonneau, X; Paques, M; Sennlaub, F				Dominguez, Elisa; Raoul, William; Calippe, Bertrand; Sahel, Jose-Alain; Guillonneau, Xavier; Paques, Michel; Sennlaub, Florian			Experimental Branch Retinal Vein Occlusion Induces Upstream Pericyte Loss and Vascular Destabilization	PLOS ONE			English	Article							MULLER CELL RESPONSES; GENE-EXPRESSION; RAT MODEL; ANGIOGENESIS; RETINOPATHY; APOPTOSIS; DISEASE; HEALTH	Aims Branch retinal vein occlusion (BRVO) leads to extensive vascular remodeling and is important cause of visual impairment. Although the vascular morphological changes following experimental vein occlusion have been described in a variety of models using angiography, the underlying cellular events are ill defined. Methods and Results We here show that laser-induced experimental BRVO in mice leads to a wave of TUNEL-positive endothelial cell (EC) apoptosis in the upstream vascular network associated with a transient edema and hemorrhages. Subsequently, we observe an induction of EC proliferation within the dilated vein and capillaries, detected by EdU incorporation, and the edema resolves. However, the pericytes of the upstream capillaries are severely reduced, which was associated with continuing EC apoptosis and proliferation. The vascular remodeling was associated with increased expression of TGF beta, TSP-1, but also FGF2 expression. Exposure of the experimental animals to hypoxia, when pericyte (PC) dropout had occurred, led to a dramatic increase in endothelial cell proliferation, confirming the vascular instability induced by the experimental BRVO. Conclusion Experimental BRVO leads to acute endothelial cells apoptosis and increased permeability. Subsequently the upstream vascular network remains destabilized, characterized by pericyte dropout, un-physiologically high endothelial cells turnover and sensitivity to hypoxia. These early changes might pave the way for capillary loss and subsequent chronic ischemia and edema that characterize the late stage disease.	[Dominguez, Elisa; Calippe, Bertrand; Sahel, Jose-Alain; Guillonneau, Xavier; Paques, Michel; Sennlaub, Florian] INSERM, U968, F-75012 Paris, France; [Dominguez, Elisa; Calippe, Bertrand; Sahel, Jose-Alain; Guillonneau, Xavier; Paques, Michel; Sennlaub, Florian] Univ Paris 04, Univ Paris 06, UMR S 968, Inst Vis, F-75012 Paris, France; [Dominguez, Elisa; Calippe, Bertrand; Sahel, Jose-Alain; Guillonneau, Xavier; Paques, Michel; Sennlaub, Florian] CNRS, UMR 7210, F-75012 Paris, France; [Raoul, William] Univ Tours, CNRS, GICC UMR 7292, Tours, France; [Sahel, Jose-Alain; Paques, Michel] Ctr Hosp Natl Ophtalmol Quinze Vingts, DHU ViewMaintain, INSERM DHOS CIC 1423, F-75012 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Sennlaub, F (corresponding author), INSERM, U968, F-75012 Paris, France.	florian.sennlaub@inserm.fr	Raoul, William/H-2118-2018; Guillonneau, xavier/E-3995-2017; guillonneau, xavier/AAF-9495-2021; Sennlaub, Florian/F-2756-2017; Sahel, Jose-Alain/F-3172-2017	Raoul, William/0000-0002-5040-3372; Guillonneau, xavier/0000-0001-7379-3935; guillonneau, xavier/0000-0001-7379-3935; Sennlaub, Florian/0000-0003-4412-1341; Sahel, Jose-Alain/0000-0002-4831-1153	INSERM; Labex Lifesenses; Carnot; ERC starting Grant [ERC-2007 St.G. 210345]; Association de Prevoyance Sante de ALLIANZ; Berthe-Fouassier Foundation	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Labex Lifesenses; Carnot; ERC starting Grant(European Research Council (ERC)); Association de Prevoyance Sante de ALLIANZ; Berthe-Fouassier Foundation	This work was supported by grants from INSERM (http://www.inserm.fr/), Labex Lifesenses (http://cache.media.enseignementsup-recherche.gouv.fr/file/Fiches_Labex/91/3/LIFESENSES_171913.pdf), Carnot (http://www.instituts-carnot.eu/), and ERC starting Grant (ERC-2007 St.G. 210345) and by the Association de Prevoyance Sante de ALLIANZ. ED was a beneficiary of a scholarship from the Berthe-Fouassier Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Chatziralli IP, 2013, SEMIN OPHTHALMOL; Coscas G, 2011, OPHTHALMOLOGICA, V226, P4, DOI 10.1159/000327391; DANIS RP, 1987, OPHTHALMOLOGY, V94, P1213; Donati G, 2008, ACTA OPHTHALMOL, V86, P302, DOI [10.1111/j.1600-0420.2007.01044.x, 10.1111/j.600-0420.2007.01044.x]; Ehlers JP, 2011, SURV OPHTHALMOL, V56, P281, DOI 10.1016/j.survophthal.2010.11.006; Feenstra Derrick J, 2013, J Clin Exp Ophthalmol, V4, P298; Ferrari G, 2009, J CELL PHYSIOL, V219, P449, DOI 10.1002/jcp.21706; Genevois O, 2004, INVEST OPHTH VIS SCI, V45, P594, DOI 10.1167/iovs.03-0764; Hardy P, 2005, PHARMACOL REP, V57, P169; Im Chan Young, 2002, Korean J Ophthalmol, V16, P82; Jonas J, 2010, DEV OPHTHALMOL, V47, P111, DOI 10.1159/000320076; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Koferl P, 2014, GRAEF ARCH CLIN EXP, V252, P257, DOI 10.1007/s00417-013-2532-z; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; Petrella RJ, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/723169; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Rehak M, 2009, INVEST OPHTH VIS SCI, V50, P2359, DOI 10.1167/iovs.08-2332; Sennlaub F, 2003, CIRCULATION, V108, P198, DOI 10.1161/01.CIR.0000080735.93327.00; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; SLAVIN J, 1995, CELL BIOL INT, V19, P431, DOI 10.1006/cbir.1995.1087; Sun C, 2013, EXP EYE RES, V113, P105, DOI 10.1016/j.exer.2013.05.018; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	27	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132644	10.1371/journal.pone.0132644	http://dx.doi.org/10.1371/journal.pone.0132644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208283	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000036
J	Fan, XB; Macleod, K; Mustafi, D; Conzen, SD; Markiewicz, E; Zamora, M; Vosicky, J; Mueller, J; Karczmar, GS				Fan, Xiaobing; Macleod, Kay; Mustafi, Devkumar; Conzen, Suzanne D.; Markiewicz, Erica; Zamora, Marta; Vosicky, James; Mueller, Jeffrey; Karczmar, Gregory S.			Correlation of In Vivo and Ex Vivo ADC and T2 of In Situ and Invasive Murine Mammary Cancers	PLOS ONE			English	Article							BREAST-CONSERVING SURGERY; TRANSGENIC MOUSE MODEL; DIFFUSION-WEIGHTED MRI; MARGIN ASSESSMENT; TUMORS; LESIONS; VALUES	Ex vivo MRI may aid in the evaluation of surgical specimens, and provide valuable information regarding the micro-anatomy of mammary/breast cancer. The use of ex vivo MRI to study mouse mammary cancer would be enhanced if there is a strong correlation between parameters derived from in vivo and ex vivo scans. Here, we report the correlation between apparent diffusion coefficient (ADC) and T-2 values measured in vivo and ex vivo in mouse mammary glands with in situ cancers (mammary intraepithelial neoplasia (MIN)) and invasive cancers (those which spread outside the ducts into surrounding tissue). MRI experiments were performed on the Polyoma middle T oncoprotein breast cancer mouse model (n = 15) in a 9.4T scanner. For in vivo experiments, T-2-weighted (T2W) images were acquired to identify abnormal regions, then ADC and T-2 values were measured for nine selected slices. For ex vivo experiments, a midline incision was made along the spine, and then skin, glands, and tumors were gently peeled from the body. Tissue was fixed in formalin, placed around a mouse-sized sponge, and sutured together mimicking the geometry of the gland when attached to the mouse. The same pulse sequences used for in vivo experiments were repeated for ex vivo scans at room temperature. Regions of interest were manually traced on T2W images defining features that could be identified on in vivo and ex vivo images. The results demonstrate a strong positive correlations between in vivo and ex vivo invasive cancers for ADC (r = 0.89, p < 0.0001) and T-2 (r = 0.89, p < 0.0001) values; and weak to moderate positive correlations between in vivo and ex vivo in situ cancers for ADC (r = 0.61, p < 0.0001) and T-2 (r = 0.79, p < 0.0001) values. The average ex vivo ADC value was about 54% of the in vivo value; and the average ex vivo T-2 was similar to the in vivo value for cancers. Although motion, fixation, and temperature differences affect ADC and T-2, these results show a reliable relationship between ADC and T-2 in vivo and ex vivo. As result ex vivo images can provide valuable information with clinical and research applications.	[Fan, Xiaobing; Mustafi, Devkumar; Markiewicz, Erica; Zamora, Marta; Vosicky, James; Karczmar, Gregory S.] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Macleod, Kay] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Conzen, Suzanne D.] Univ Chicago, Med Hematol Oncol, Chicago, IL 60637 USA; [Mueller, Jeffrey] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Karczmar, GS (corresponding author), Univ Chicago, Dept Radiol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	gskarczm@uchicago.edu			National Institutes of Health grant [1R01CA133490-01A2]; University of Chicago Cancer Center; NATIONAL CANCER INSTITUTE [R01CA162405, R01CA131188, R01CA089208, R01CA133490] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Cancer Center(University of Chicago); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health grant (1R01CA133490-01A2) and by a core facilities grant from the University of Chicago Cancer Center.	Chagpar A, 2003, AM J SURG, V186, P371, DOI 10.1016/S0002-9610(03)00264-2; Chenevert TL, 2011, J MAGN RESON IMAGING, V34, P983, DOI 10.1002/jmri.22363; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Ihrai T, 2014, EJSO-EUR J SURG ONC, V40, P449, DOI 10.1016/j.ejso.2014.01.002; Jansen SA, 2008, PHYS MED BIOL, V53, P5481, DOI 10.1088/0031-9155/53/19/014; Jansen SA, 2011, NMR BIOMED, V24, P880, DOI 10.1002/nbm.1643; Jansen SA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2357; Kim SE, 2011, J MAGN RESON IMAGING, V34, P1167, DOI 10.1002/jmri.22736; Lee JH, 2003, MAGNET RESON MED, V49, P450, DOI 10.1002/mrm.10402; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091; Nilsen LB, 2013, EUR RADIOL, V23, P1027, DOI 10.1007/s00330-012-2687-8; Park MJ, 2007, KOREAN J RADIOL, V8, P390, DOI 10.3348/kjr.2007.8.5.390; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P562, DOI 10.1002/jmri.22078; Pfefferbaum A, 2004, NEUROIMAGE, V21, P1585, DOI 10.1016/j.neuroimage.2003.11.024; Santamaria G, 2010, RADIOGRAPHICS, V30, P533, DOI 10.1148/rg.302095044; Sun XH, 2009, J MAGN RESON IMAGING, V29, P621, DOI 10.1002/jmri.21675; Takano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052904; Tamura T, 2012, MAGN RESON MED, V68, P890, DOI 10.1002/mrm.23277; Westra C, 2014, AM J ROENTGENOL, V202, pW183, DOI 10.2214/AJR.13.11266; Xu JQ, 2009, MAGN RESON MED, V61, P842, DOI 10.1002/mrm.21896	21	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0129212	10.1371/journal.pone.0129212	http://dx.doi.org/10.1371/journal.pone.0129212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208092	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000004
J	Lao, Z; Kelly, CJ; Yang, XY; Jenkins, WT; Toorens, E; Ganguly, T; Evans, SM; Koch, CJ				Lao, Zheng; Kelly, Catherine J.; Yang, Xiang-Yang; Jenkins, W. Timothy; Toorens, Erik; Ganguly, Tapan; Evans, Sydney M.; Koch, Cameron J.			Improved Methods to Generate Spheroid Cultures from Tumor Cells, Tumor Cells & Fibroblasts or Tumor-Fragments: Microenvironment, Microvesicles and MiRNA	PLOS ONE			English	Article							CANCER STEM-CELLS; IN-VITRO; MAMMALIAN-CELLS; 2-NITROIMIDAZOLE EF5; POTENTIALLY LETHAL; GLIOMA SPHEROIDS; RADIATION-DAMAGE; SOLID TUMORS; OXYGEN; MODEL	Diagnostic and prognostic indicators are key components to achieve the goal of personalized cancer therapy. Two distinct approaches to this goal include predicting response by genetic analysis and direct testing of possible therapies using cultures derived from biopsy specimens. Optimally, the latter method requires a rapid assessment, but growing xenograft tumors or developing patient-derived cell lines can involve a great deal of time and expense. Furthermore, tumor cells have much different responses when grown in 2D versus 3D tissue environments. Using a modification of existing methods, we show that it is possible to make tumor-fragment (TF) spheroids in only 2-3 days. TF spheroids appear to closely model characteristics of the original tumor and may be used to assess critical therapy-modulating features of the microenvironment such as hypoxia. A similar method allows the reproducible development of spheroids from mixed tumor cells and fibroblasts (mixed-cell spheroids). Prior literature reports have shown highly variable development and properties of mixed-cell spheroids and this has hampered the detailed study of how individual tumor-cell components interact. In this study, we illustrate this approach and describe similarities and differences using two tumor models (U87 glioma and SQ20B squamous-cell carcinoma) with supporting data from additional cell lines. We show that U87 and SQ20B spheroids predict a key microenvironmental factor in tumors (hypoxia) and that SQ20B cells and spheroids generate similar numbers of microvesicles. We also present pilot data for miRNA expression under conditions of cells, tumors, and TF spheroids.	[Lao, Zheng; Yang, Xiang-Yang; Jenkins, W. Timothy; Evans, Sydney M.; Koch, Cameron J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Lao, Zheng] Fudan Univ, Eye & ENT Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Kelly, Catherine J.] Univ Oxford, Gray Inst Radiat Oncol, Oxford, England; [Toorens, Erik; Ganguly, Tapan] Univ Penn, Perelman Sch Med, Penn Genom Anal Core, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Fudan University; University of Oxford; University of Pennsylvania; Pennsylvania Medicine	Koch, CJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	kochc@mail.med.upenn.edu		Evans, Sydney M/0000-0002-0216-1014	Commonwealth of Pennsylvania, Health Research Formula Fund [4100062223]; Cancer Research UK [C48264/A16614]; visiting PhD student grant (program of China Scholarship Council) from the Science and Technology Commission of Shanghai [12JC1402102]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania, Health Research Formula Fund; Cancer Research UK(Cancer Research UK); visiting PhD student grant (program of China Scholarship Council) from the Science and Technology Commission of Shanghai; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was supported by a grant from the Commonwealth of Pennsylvania, 2013 Health Research Formula Fund (#4100062223). Dr. Kelly was supported by a visiting scholar travel-research grant from Cancer Research UK: C48264/A16614. ZL was supported by a visiting PhD student grant (program of China Scholarship Council) from the Science and Technology Commission of Shanghai (12JC1402102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; CARLSSON J, 1988, INT J CANCER, V42, P715, DOI 10.1002/ijc.2910420515; Cowan DSM, 1996, BRIT J CANCER, V74, pS28; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Durand RE, 2001, METHOD CELL BIOL, V64, P211; Evans SM, 1996, CANCER RES, V56, P405; FRANKO AJ, 1983, RADIAT RES, V96, P497, DOI 10.2307/3576116; FRANKO AJ, 1984, INT J RADIAT ONCOL, V10, P1333, DOI 10.1016/0360-3016(84)90343-2; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Giandomenico AR, 1997, FREE RADICAL BIO MED, V23, P426, DOI 10.1016/S0891-5849(97)00113-5; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hamer PCDW, 2009, CYTOM PART A, V75A, P528, DOI 10.1002/cyto.a.20716; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Horan AD, 2001, RADIAT RES, V156, P388, DOI 10.1667/0033-7587(2001)156[0388:TKMFRO]2.0.CO;2; Hovinga KE, 2005, J NEURO-ONCOL, V74, P99, DOI 10.1007/s11060-004-4204-7; IonTorrent, ION TORR WHIT PAP ME; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kelly CJ, 2014, RADIOTHER ONCOL, V111, P72, DOI 10.1016/j.radonc.2014.02.007; Koch CJ, 2008, RADIAT RES, V169, P677, DOI 10.1667/RR1305.1; Koch CJ, 2014, TRANSL ONCOL, V7, P752, DOI 10.1016/j.tranon.2014.10.004; Koch CJ, 2002, METHOD ENZYMOL, V352, P3; KOCH CJ, 1984, RADIAT RES, V97, P434, DOI 10.2307/3576294; KOCH CJ, 1977, RADIAT RES, V70, P542, DOI 10.2307/3574644; KOCH CJ, 1978, BRIT J CANCER, V37, P163; Koch CJ, 2012, TUMOR MICROENVIRON T, V1, P1, DOI DOI 10.2478/TUMOR-2012-001; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Kross KW, 2008, SCAND J IMMUNOL, V67, P392, DOI 10.1111/j.1365-3083.2008.02072.x; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LITTLE JB, 1973, RADIOLOGY, V106, P689, DOI 10.1148/106.3.689; Machida H, 2005, CANCER SCI, V96, P911, DOI 10.1111/j.1349-7006.2005.00125.x; Marotta D, 2011, CANCER RES, V71, P779, DOI 10.1158/0008-5472.CAN-10-3061; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Sundlisaester E, 2006, NEUROPATH APPL NEURO, V32, P419, DOI 10.1111/j.1365-2990.2006.00744.x; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; SUTHERLAND RM, 1974, CANCER RES, V34, P3501; SUTHERLAND RM, 1970, INT J RADIAT BIOL RE, V18, P491, DOI 10.1080/09553007014551401; WEICHSELBAUM RR, 1984, RADIOTHER ONCOL, V2, P41, DOI 10.1016/S0167-8140(84)80037-7; Yeon SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073345	44	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133895	10.1371/journal.pone.0133895	http://dx.doi.org/10.1371/journal.pone.0133895			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208323	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000167
J	Reardon, C; Tobin, DP; Delahunt, E				Reardon, Cillian; Tobin, Daniel P.; Delahunt, Eamonn			Application of Individualized Speed Thresholds to Interpret Position Specific Running Demands in Elite Professional Rugby Union: A GPS Study	PLOS ONE			English	Article							PHYSICAL DEMANDS; MOTION ANALYSIS; PERFORMANCE; ACCELERATION; RELIABILITY; VALIDITY; PLAYERS; TIME	A number of studies have used GPS technology to categorise rugby union locomotive demands. However, the utility of the results of these studies is confounded by small sample sizes, sub-elite player status and the global application of absolute speed thresholds to all player positions. Furthermore, many of these studies have used GPS units with low sampling frequencies. The aim of the present study was to compare and contrast the high speed running (HSR) demands of professional rugby union when utilizing micro-technology units sampling at 10 Hz and applying relative or individualised speed zones. The results of this study indicate that application of individualised speed zones results in a significant shift in the interpretation of the HSR demands of both forwards and backs and positional sub-categories therein. When considering the use of an absolute in comparison to an individualised HSR threshold, there was a significant underestimation for forwards of HSR distance (HSRD) (absolute = 269 +/- 172.02, individualised = 354.72 +/- 99.22, p < 0.001), HSR% (absolute = 5.15 +/- 3.18, individualised = 7.06 +/- 2.48, p < 0.001) and HSR efforts (HSRE) (absolute = 18.81 +/- 12.25; individualised = 24.78 +/- 8.30, p < 0.001). In contrast, there was a significant overestimation of the same HSR metrics for backs with the use of an absolute threshold (HSRD absolute = 697.79 +/- 198.11, individualised = 570.02 +/- 171.14, p < 0.001; HSR% absolute = 10.85 +/- 2.82, individualised = 8.95 +/- 2.76, p < 0.001; HSRE absolute = 41.55 +/- 11.25; individualised = 34.54 +/- 9.24, p < 0.001). This under-or overestimation associated with an absolute speed zone applies to varying degrees across the ten positional sub-categories analyzed and also to individuals within the same positional sub-category. The results of the present study indicated that although use of an individulised HSR threshold improves the interpretation of the HSR demands on a positional basis, inter-individual variability in maximum velocity within positional sub-categories means that players need to be considered on an individual basis to accurately gauge the HSR demands of rugby union.	[Reardon, Cillian; Tobin, Daniel P.] Leinster Rugby, Dublin, Ireland; [Reardon, Cillian; Delahunt, Eamonn] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [Delahunt, Eamonn] Univ Coll Dublin, Inst Sport & Hlth, Dublin 2, Ireland	University College Dublin; University College Dublin	Reardon, C (corresponding author), Leinster Rugby, Dublin, Ireland.	cillian.reardon@leinsterrugby.ie		Delahunt, Eamonn/0000-0001-5449-5932	Leinster Rugby	Leinster Rugby	There are no current funding sources for this study; Co-authors CR & DPT are employed by Leinster Rugby. Leinster Rugby provided support in the form of salaries for CR and DPT, but did not have any additional role in the study design, data collection & analysis, decision to publish or preparation of the manuscript. The specific role of each author is outlined in the "Author Contributions," section.	Akenhead R, 2013, J SCI MED SPORT, P925; Austin D, 2011, J SPORT SCI, V29, P1105, DOI 10.1080/02640414.2011.582508; Austin D, 2011, J SCI MED SPORT, V14, P259, DOI 10.1016/j.jsams.2011.01.003; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Coughlan GF, 2011, J ORTHOP SPORT PHYS, V41, P600, DOI 10.2519/jospt.2011.3508; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Cronin J, 2006, STRENGTH COND J, V28, P42, DOI 10.1519/1533-4295(2006)028[0042:RSTFTA]2.0.CO;2; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Duthie GM, 2006, J STRENGTH COND RES, V20, P208, DOI 10.1519/R-16784.1; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P2319, DOI 10.1519/JSC.0b013e318277fd21; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Jones MR, 2015, QUANTIFYING POSITION; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Spinks CD, 2007, J STRENGTH COND RES, V21, P77, DOI 10.1519/00124278-200702000-00015; Suarez-Arrones LJ, 2012, ISOKINET EXERC SCI, V20, P77, DOI 10.3233/IES-2012-0444; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Waldron M, 2011, J SPORT SCI, V29, P1223, DOI 10.1080/02640414.2011.587445	22	50	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133410	10.1371/journal.pone.0133410	http://dx.doi.org/10.1371/journal.pone.0133410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208315	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000087
J	Schyth, BD; Bela-ong, DB; Jalali, SAH; Kristensen, LBJ; Einer-Jensen, K; Pedersen, FS; Lorenzen, N				Schyth, Brian Dall; Bela-ong, Dennis Berbulla; Jalali, Seyed Amir Hossein; Kristensen, Lasse Bogelund Juel; Einer-Jensen, Katja; Pedersen, Finn Skou; Lorenzen, Niels			Two Virus-Induced MicroRNAs Known Only from Teleost Fishes Are Orthologues of MicroRNAs Involved in Cell Cycle Control in Humans	PLOS ONE			English	Article							HEMORRHAGIC SEPTICEMIA VIRUS; IMMUNE-RESPONSE; EMERGING PLAYER; MIRNA GENES; EXPRESSION; RNA; TRANSCRIPTION; PROTEIN; GAMMA; INFECTION	MicroRNAs (miRNAs) are similar to 22 base pair-long non-coding RNAs which regulate gene expression in the cytoplasm of eukaryotic cells by binding to specific target regions in mRNAs to mediate transcriptional blocking or mRNA cleavage. Through their fundamental roles in cellular pathways, gene regulation mediated by miRNAs has been shown to be involved in almost all biological phenomena, including development, metabolism, cell cycle, tumor formation, and host-pathogen interactions. To address the latter in a primitive vertebrate host, we here used an array platform to analyze the miRNA response in rainbow trout (Oncorhynchus mykiss) following inoculation with the virulent fish rhabdovirus Viral hemorrhagic septicaemia virus. Two clustered miRNAs, miR-462 and miR-731 (herein referred to as miR-462 cluster), described only in teleost fishes, were found to be strongly upregulated, indicating their involvement in fish-virus interactions. We searched for homologues of the two teleost miRNAs in other vertebrate species and investigated whether findings related to ours have been reported for these homologues. Gene synteny analysis along with gene sequence conservation suggested that the teleost fish miR-462 and miR-731 had evolved from the ancestral miR-191 and miR-425 (herein called miR-191 cluster), respectively. Whereas the miR-462 cluster locus is found between two protein-coding genes (intergenic) in teleost fish genomes, the miR-191 cluster locus is found within an intron of a protein-coding gene (intragenic) in the human genome. Interferon (IFN)-inducible and immune-related promoter elements found upstream of the teleost miR-462 cluster locus suggested roles in immune responses to viral pathogens in fish, while in humans, the miR-191 cluster functionally associated with cell cycle regulation. Stimulation of fish cell cultures with the IFN inducer poly I:C accordingly upregulated the expression of miR-462 and miR-731, while no stimulatory effect on miR-191 and miR-425 expression was observed in human cell lines. Despite high sequence conservation, evolution has thus resulted in different regulation and presumably also different functional roles of these orthologous miRNA clusters in different vertebrate lineages.	[Schyth, Brian Dall; Bela-ong, Dennis Berbulla; Kristensen, Lasse Bogelund Juel] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark; [Bela-ong, Dennis Berbulla; Lorenzen, Niels] Aarhus Univ, Dept Anim Sci, Fish Hlth Sect, Aarhus N, Denmark; [Jalali, Seyed Amir Hossein] Isfahan Univ Technol, Inst Biotechnol & Bioengn, Esfahan, Iran; [Kristensen, Lasse Bogelund Juel; Pedersen, Finn Skou] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Einer-Jensen, Katja] QIAGEN AAR, Aarhus C, Denmark	Technical University of Denmark; Aarhus University; Isfahan University of Technology; Aarhus University	Bela-ong, DB (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark.	dbelaong@alumni.nus.edu.sg; niels.lorenzen@anis.au.dk	Bela-ong, Dennis/H-6782-2019; Lorenzen, Niels/L-3967-2017	Bela-ong, Dennis/0000-0002-9483-3542; Lorenzen, Niels/0000-0002-6946-3252; Jalali, Seyed Amir Hossein/0000-0003-1381-0865	Danish Research Council for Technology and Production Sciences [26-03-0059, 274-05-0585]; Lundbeck Foundation [52/03]; European Commission [FP6007103 IMAQUANIM]; John Birthe Meyer Foundation	Danish Research Council for Technology and Production Sciences; Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre); John Birthe Meyer Foundation	This work was supported through grants to NL: Grant nos. 26-03-0059 and 274-05-0585 from the Danish Research Council for Technology and Production Sciences (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council-1/the-danish-council-for-independent-research-technology-and-production-sciences); grant no. 52/03 from the Lundbeck Foundation (http://www.lundbeckfoundation.com/Frontpage.327.aspx); the European Commission (http://ec.europa.eu/index_en.htm) through contract FP6007103 IMAQUANIM; and the John Birthe Meyer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson MK, 2001, P NATL ACAD SCI USA, V98, P553, DOI 10.1073/pnas.021478998; Andreassen R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-482; Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bela-ong DB, 2015, VACCINE, V33, P3215, DOI 10.1016/j.vaccine.2015.04.092; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Castro R, 2008, MOL IMMUNOL, V45, P3454, DOI 10.1016/j.molimm.2008.03.015; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cheng JC, 2012, CELL MOL LIFE SCI, V69, P2621, DOI 10.1007/s00018-012-0940-6; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; DALY C, 1993, MOL CELL BIOL, V13, P3756, DOI 10.1128/MCB.13.6.3756; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Di Leva G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003311; Einer-Jensen K, 2014, J GEN VIROL, V95, P307, DOI 10.1099/vir.0.057448-0; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Fender A., 2013, MICRORNAS MED; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153; Gao L, 2013, J VIROL, V87, P8808, DOI 10.1128/JVI.00718-13; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gong BD, 2010, INT J MOL MED, V25, P853, DOI 10.3892/ijmm_00000414; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Grinchuk OV, 2010, NUCLEIC ACIDS RES, V38, P534, DOI 10.1093/nar/gkp954; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He YH, 2011, NEOPLASIA, V13, P841, DOI 10.1593/neo.11698; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hu ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4263; ICTV, 2012, VIR TAX 2011 REL; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Isshiki T, 2001, DIS AQUAT ORGAN, V47, P87, DOI 10.3354/dao047087; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lena AM, 2012, BIOCHEM BIOPH RES CO, V423, P509, DOI 10.1016/j.bbrc.2012.05.153; Li SC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S8; Lin JM, 2013, MODERN PATHOL, V26, P148, DOI 10.1038/modpathol.2012.131; Liu X, 2012, IMMUNOL LETT, V143, P208, DOI 10.1016/j.imlet.2012.02.014; Lorenzen N, 2002, FISH SHELLFISH IMMUN, V12, P439, DOI 10.1006/fsim.2002.0422; Ma J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-40; Nagpal N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00099; Nagpal N, 2013, CARCINOGENESIS, V34, P1889, DOI 10.1093/carcin/bgt107; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Netterwald J, 2005, J VIROL, V79, P5035, DOI 10.1128/JVI.79.8.5035-5046.2005; Olesen NJ, 1998, J APPL ICHTHYOL, V14, P173, DOI 10.1111/j.1439-0426.1998.tb00638.x; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng WZ, 2014, INT J MOL SCI, V15, P4031, DOI 10.3390/ijms15034031; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Ribas L, 2008, FISH SHELLFISH IMMUN, V24, P35, DOI 10.1016/j.fsi.2007.07.009; RIO DC, 1985, SCIENCE, V227, P23, DOI 10.1126/science.2981116; Ross K., 1995, Bulletin of the European Association of Fish Pathologists, V14, P213; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Rust K, 1996, AM J RESP CELL MOL, V14, P121, DOI 10.1165/ajrcmb.14.2.8630261; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schyth BD, 2007, MOL THER, V15, P1366, DOI 10.1038/sj.mt.6300150; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shen J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-47; Shintani S, 2000, P NATL ACAD SCI USA, V97, P7417, DOI 10.1073/pnas.110505597; Sisk JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-95; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Smail DA, 1999, FISH DISEASES AND DISORDERS, VOL 3, P123; Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11; Sperling EA, 2008, ANIMAL EVOLUTION: GENOMES, FOSSILS, AND TREES, P157; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Swaminathan G, 2013, PHYSIOL GENOMICS, V45, P1035, DOI 10.1152/physiolgenomics.00112.2013; Tarver JE, 2013, MOL BIOL EVOL, V30, P2369, DOI 10.1093/molbev/mst133; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; Thoulouze MI, 2004, J VIROL, V78, P4098, DOI 10.1128/JVI.78.8.4098-4107.2004; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; USDA-APHIS, 2008, FED ORD PREV SPREAD; USDA-APHIS (US Department of Agriculture-Animal and Plant Health Inspection Service), 2008, REG SPEC SUSC VHSV U; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vestergard JOrgensen P. E., 1974, THESIS COPENHAGEN, P1; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu SS, 2015, DEV COMP IMMUNOL, V48, P124, DOI 10.1016/j.dci.2014.09.012; Xu J, 2013, GENOME RES, V23, P1810, DOI 10.1101/gr.148916.112; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Zhang JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081366; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhang Y, 2013, J ZHEJIANG UNIV-SC B, V14, P1, DOI 10.1631/jzus.B1200292; Zhuo Y, 2013, CELL PHYSIOL BIOCHEM, V32, P499, DOI 10.1159/000354455; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484	103	34	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132434	10.1371/journal.pone.0132434	http://dx.doi.org/10.1371/journal.pone.0132434			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207374	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000028
J	Vijayan, A; Garcia-Arriaza, J; Raman, SC; Conesa, JJ; Chichon, FJ; Santiago, C; Sorzano, COS; Carrascosa, JL; Esteban, M				Vijayan, Aneesh; Garcia-Arriaza, Juan; Raman, Suresh C.; Javier Conesa, Jose; Javier Chichon, Francisco; Santiago, Cesar; Sorzano, Carlos Oscar S.; Carrascosa, Jose L.; Esteban, Mariano			A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen	PLOS ONE			English	Article							T-CELL RESPONSES; NEUTRALIZING ANTIBODY-RESPONSE; HUMAN MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEINS; CD4-BINDING SITE; DENDRITIC CELLS; CENTRAL MEMORY; MVA-B; TYPE-1; EFFECTOR	In the HIV vaccine field, there is a need to produce highly immunogenic forms of the Env protein with the capacity to trigger broad B and T-cell responses. Here, we report the generation and characterization of a chimeric HIV-1 gp120 protein (termed gp120-14K) by fusing gp120 from clade B with the vaccinia virus (VACV) 14K oligomeric protein (derived from A27L gene). Stable CHO cell lines expressing HIV-1 gp120-14K protein were generated and the protein purified was characterized by size exclusion chromatography, electron microscopy and binding to anti-Env antibodies. These approaches indicate that gp120-14K protein is oligomeric and reacts with a wide spectrum of HIV-1 neutralizing antibodies. Furthermore, in human monocyte-derived dendritic cells (moDCs), gp120-14K protein upregulates the levels of several proinflammatory cytokines and chemokines associated with Th1 innate immune responses (IL-1 beta, IFN-gamma, IL-6, IL-8, IL-12, RANTES). Moreover, we showed in a murine model, that a heterologous prime/boost immunization protocol consisting of a DNA prime with a plasmid expressing gp120-14K protein followed by a boost with MVA-B [a recombinant modified vaccinia virus Ankara (MVA) expressing HIV-1 gp120, Gag, Pol and Nef antigens from clade B], generates stronger, more polyfunctional, and greater effector memory HIV-1-specific CD4(+) and CD8(+) T-cell immune responses, than immunization with DNA-gp120/MVA-B. The DNA/MVA protocol was superior to immunization with the combination of protein/MVA and the latter was superior to a prime/boost of MVA/MVA or protein/protein. In addition, these immunization protocols enhanced antibody responses against gp120 of the class IgG2a and IgG3, together favoring a Th1 humoral immune response. These results demonstrate that fusing HIV-1 gp120 with VACV 14K forms an oligomeric protein which is highly antigenic as it activates a Th1 innate immune response in human moDCs, and in vaccinated mice triggers polyfunctional HIV-1-specific adaptive and memory T-cell immune responses, as well as humoral responses. This novel HIV-1 gp120-14K immunogen might be considered as an HIV vaccine candidate for broad T and B-cell immune responses.	[Vijayan, Aneesh; Garcia-Arriaza, Juan; Raman, Suresh C.; Esteban, Mariano] CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Javier Conesa, Jose; Javier Chichon, Francisco; Carrascosa, Jose L.] CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Madrid, Spain; [Santiago, Cesar] CSIC, Ctr Nacl Biotecnol, Xray Crystallizat Unit, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Esteban, M (corresponding author), CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain.	mesteban@cnb.csic.es	VIJAYAN, ANEESH/K-1961-2014; GARCIA-ARRIAZA, JUAN/Q-6243-2017; S. Sorzano, Carlos Oscar/ABE-4884-2021; Sorzano, Carlos Oscar S S./F-2639-2016; Santiago, César/K-4240-2014; García, Francisco Javier Chichón/R-2167-2019; Conesa, Jose Javier/J-5878-2017; Esteban, Mariano/ABG-5375-2020; Vijayan, Aneesh/AAH-5640-2019; Chichón García, Francisco Javier/B-6029-2011	VIJAYAN, ANEESH/0000-0002-2828-5285; GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; Santiago, César/0000-0002-5149-1722; García, Francisco Javier Chichón/0000-0003-2766-0327; Conesa, Jose Javier/0000-0002-8440-5691; Esteban, Mariano/0000-0003-0846-2827; Vijayan, Aneesh/0000-0002-2828-5285; Chichón García, Francisco Javier/0000-0003-2766-0327	Spanish grants [SAF-2008-02036, SAF-2013-45232-R, RD12/0017/0038, BFU2011-29038]; La CAIXA fellowships	Spanish grants(Spanish Government); La CAIXA fellowships	This investigation was supported by Spanish grants, SAF-2008-02036, SAF-2013-45232-R, RD12/0017/0038 to ME and BFU2011-29038 to JLC. AV and SCR were supported by La CAIXA fellowships.	Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Buckheit RW, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-68; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chang TH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003563; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Daly LM, 2005, VACCINE, V23, P963, DOI 10.1016/j.vaccine.2004.03.072; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Fantuzzi L, 2004, J VIROL, V78, P9763, DOI 10.1128/JVI.78.18.9763-9772.2004; Fonseca SG, 2011, CURR OPIN HIV AIDS, V6, P188, DOI 10.1097/COH.0b013e32834589a1; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13; Garcia-Arriaza J, 2014, J VIROL, V88, P3392, DOI 10.1128/JVI.02723-13; Garcia-Arriaza J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066894; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; GORNY MK, 1993, J IMMUNOL, V150, P635; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Huang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093804; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; JEFFERIS R, 1994, ANN BIOL CLIN-PARIS, V52, P57; Jones NG, 2009, VACCINE, V27, P1136, DOI 10.1016/j.vaccine.2008.11.071; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; LAI CF, 1990, J BIOL CHEM, V265, P22174; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; MADASSERY JV, 1988, CLIN CHEM, V34, P1407; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; McFarland EJ, 2001, J INFECT DIS, V184, P1331, DOI 10.1086/323994; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McMichael AJ, 2014, NAT IMMUNOL, V15, P319, DOI 10.1038/ni.2844; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; PAGANIN C, 1995, J CLIN INVEST, V96, P1677, DOI 10.1172/JCI118209; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pennings PS, 2013, INFECT DIS REP, V5, P21, DOI 10.4081/idr.2013.s1.e5; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rao M, 2004, IMMUNOL CELL BIOL, V82, P523, DOI 10.1111/j.0818-9641.2004.01283.x; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sandgren KJ, 2013, J IMMUNOL, V191, P60, DOI 10.4049/jimmunol.1202489; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Vazquez MI, 1999, J VIROL, V73, P9098; Vazquez MI, 1998, J VIROL, V72, P10126; Vijayan A, 2012, J IMMUNOL, V188, P6407, DOI 10.4049/jimmunol.1102492; Visciano ML, 2008, VIROLOGY, V372, P409, DOI 10.1016/j.virol.2007.10.044; Visciano ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-4; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, J VIROL, V85, P12811, DOI 10.1128/JVI.05994-11; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	94	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133595	10.1371/journal.pone.0133595	http://dx.doi.org/10.1371/journal.pone.0133595			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208356	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000107
J	Gilca, R; Skowronski, DM; Douville-Fradet, M; Amini, R; Boulianne, N; Rouleau, I; Martineau, C; Charest, H; De Serres, G				Gilca, Rodica; Skowronski, Danuta M.; Douville-Fradet, Monique; Amini, Rachid; Boulianne, Nicole; Rouleau, Isabelle; Martineau, Christine; Charest, Hugues; De Serres, Gaston			Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015	PLOS ONE			English	Article							VIRUS; ASSOCIATION; INFECTION; EFFICACY	Background The 2014/15 influenza season in Canada was characterized by an early epidemic due to vaccine-mismatched influenza A(H3N2) viruses, disproportionately affecting elderly individuals >= 65-years-old. We assessed vaccine effectiveness (VE) against A(H3N2) hospitalization among elderly individuals during the peak weeks of the 2014/15 epidemic in Quebec, Canada. Methods Nasal specimens and clinical/epidemiological data were collected within 7 days of illness onset from elderly patients admitted with respiratory symptoms to one of four participating hospitals between November 30, 2014 and January 13, 2015. Cases tested RT-PCR positive for influenza A(H3N2) and controls tested negative for any influenza. VE was assessed by test-negative case-control design. Results There were 314 participants including 186 cases (62% vaccinated) and 128 controls (59% vaccinated) included in primary VE analysis. Median age was 81.5 years, two-thirds were admitted from the community and 91% had underlying comorbidity. Crude VE against A (H3N2) hospitalization was -17% (95% CI: -86% to 26%), decreasing to -23% (95% CI: -99 to 23%) with adjustment for age and comorbidity, and to -39% (95% CI: -142 to 20%) with additional adjustment for specimen collection interval, calendar time, type of residence and hospital. In sensitivity analyses, VE estimates were improved toward the null with restriction to participants admitted from the community (-2%; 95% CI: -105 to 49%) or with specimen collection <= 4 days since illness onset (-8%; 95% CI: -104 to 43%) but further from the null with restriction to participants with comorbidity (-51%; 95% CI: -169 to 15%). Conclusion The 2014/15 mismatched influenza vaccine provided elderly patients with no cross-protection against hospitalization with the A(H3N2) epidemic strain, reinforcing the need for adjunct protective measures among high-risk individuals and improved vaccine options.	[Gilca, Rodica; Douville-Fradet, Monique; Amini, Rachid; Boulianne, Nicole; De Serres, Gaston] Inst Natl Sante Publ Quebec, Biol Environm & Occupat Risks, Quebec City, PQ, Canada; [Gilca, Rodica; Boulianne, Nicole; De Serres, Gaston] CHU Quebec, Quebec City, PQ, Canada; [Gilca, Rodica; De Serres, Gaston] Univ Laval, Quebec City, PQ, Canada; [Skowronski, Danuta M.] British Columbia Ctr Dis Control, Influenza & Emerging Resp Pathogens, Vancouver, BC, Canada; [Rouleau, Isabelle] Minist Sante & Serv Sociaux Quebec, Bur Surveillance & Vigie, Quebec City, PQ, Canada; [Martineau, Christine; Charest, Hugues] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Montreal, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Laval University; Laval University; Institut national de sante publique du Quebec (INSPQ)	Gilca, R (corresponding author), Inst Natl Sante Publ Quebec, Biol Environm & Occupat Risks, Quebec City, PQ, Canada.	rodica.gilca@inspq.qc.ca		Martineau, Christine/0000-0003-2020-2657	Minsitry of Health of Quebec	Minsitry of Health of Quebec	The Minsitry of Health of Quebec provided financial support for this project. IR from the funding source contributed to the analysis and preparation of the manuscript.	BC Centre for Disease Control, INFL SURV REP BC INF; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; Centers for Disease Control and Prevention, 2005, REAL TIM RT PCR RRT; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; De Serres G, 2013, EURO SURVEILL, V18, P37; Dube E, 2015, ENQUETE QUEBECOISE V; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; Gilca R, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu086; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680; McNeil S, 2013, EFFECTIVENESS 2012 1; McNeil SA, 2015, EURO SURVEILL, V20, P21024; McNeil SA, 2014, EURO SURVEILL, V19; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Oughton M, 2011, DIAGN MICR INFEC DIS, V70, P213, DOI 10.1016/j.diagmicrobio.2010.12.013; Pabbaraju K, 2008, J CLIN MICROBIOL, V46, P3056, DOI 10.1128/JCM.00878-08; Pebody RG, 2015, EUROSURVEILLANCE, V20, P6, DOI [10.2807/1560-7917.ES2015.20.5.21025, 10.2807/1560-7917.ES.2015.20.36.30013]; Rondy M, 2015, EURO SURVEILL, V20; SKOWRONSKI D, 2015, EUROSURVEILLANCE, V20, P1, DOI DOI 10.2807/1560-7917.ES.2015.20.43.30047; Skowronski DM, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.5.20690; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086555; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skull SA, 2007, VACCINE, V25, P4775, DOI 10.1016/j.vaccine.2007.04.015; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tsuchihashi Y, 2012, CLIN INFECT DIS, V54, P381, DOI 10.1093/cid/cir787; van der Werf S, 2015, Euro Surveill, V20, P21030; World Health Organization (WHO), 2014, REC COMP INFL VIR VA	34	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132195	10.1371/journal.pone.0132195	http://dx.doi.org/10.1371/journal.pone.0132195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200655	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100028
J	Venn-Watson, SK; Parry, C; Baird, M; Stevenson, S; Carlin, K; Daniels, R; Smith, CR; Jones, R; Wells, RS; Ridgway, S; Jensen, ED				Venn-Watson, Stephanie K.; Parry, Celeste; Baird, Mark; Stevenson, Sacha; Carlin, Kevin; Daniels, Risa; Smith, Cynthia R.; Jones, Richard; Wells, Randall S.; Ridgway, Sam; Jensen, Eric D.			Increased Dietary Intake of Saturated Fatty Acid Heptadecanoic Acid (C17:0) Associated with Decreasing Ferritin and Alleviated Metabolic Syndrome in Dolphins	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; INSULIN-RESISTANCE; DIABETES-MELLITUS; DAIRY CONSUMPTION; FISH CONSUMPTION; ARACHIDONIC-ACID; SERUM FERRITIN; LIVER-DISEASE; JAPANESE MEN	Similar to humans, bottlenose dolphins (Tursiops truncatus) can develop metabolic syndrome and associated high ferritin. While fish and fish-based fatty acids may protect against metabolic syndrome in humans, findings have been inconsistent. To assess potential protective factors against metabolic syndrome related to fish diets, fatty acids were compared between two dolphin populations with higher (n = 30, Group A) and lower (n = 19, Group B) mean insulin (11 +/- 12 and 2 +/- 5 mu IU/ml, respectively; P < 0.0001) and their dietary fish. In addition to higher insulin, triglycerides, and ferritin, Group A had lower percent serum heptadecanoic acid (C17:0) compared to Group B (0.3 +/- 0.1 and 1.3 +/- 0.4%, respectively; P < 0.0001). Using multivariate stepwise regression, higher percent serum C17:0, a saturated fat found in dairy fat, rye, and some fish, was an independent predictor of lower insulin in dolphins. Capelin, a common dietary fish for Group A, had no detectable C17:0, while pin-fish and mullet, common in Group B's diet, had C17:0 (41 and 67 mg/100g, respectively). When a modified diet adding 25% pinfish and/or mullet was fed to six Group A dolphins over 24 weeks (increasing the average daily dietary C17:0 intake from 400 to 1700 mg), C17:0 serum levels increased, high ferritin decreased, and blood-based metabolic syndrome indices normalized toward reference levels. These effects were not found in four reference dolphins. Further, higher total serum C17:0 was an independent and linear predictor of lower ferritin in dolphins in Group B dolphins. Among off the shelf dairy products tested, butter had the highest C17:0 (423mg/100g); nonfat dairy products had no detectable C17:0. We hypothesize that humans' movement away from diets with potentially beneficial saturated fatty acid C17:0, including whole fat dairy products, could be a contributor to widespread low C17:0 levels, higher ferritin, and metabolic syndrome.	[Venn-Watson, Stephanie K.; Parry, Celeste; Baird, Mark; Stevenson, Sacha; Carlin, Kevin; Daniels, Risa; Smith, Cynthia R.; Ridgway, Sam] Natl Marine Mammal Fdn, Translat Med & Res Program, San Diego, CA 92106 USA; [Jones, Richard] Kennedy Krieger Inst, Baltimore, MD USA; [Wells, Randall S.] Chicago Zool Soc Mote Marine Lab, Sarasota, FL USA; [Jensen, Eric D.] US Navy Marine Mammal Program, San Diego, CA USA	Kennedy Krieger Institute; Mote Marine Laboratory & Aquarium; United States Department of Defense; United States Navy	Venn-Watson, SK (corresponding author), Natl Marine Mammal Fdn, Translat Med & Res Program, San Diego, CA 92106 USA.	stephanie.venn-watson@nmmf.org		Ridgway, Sam/0000-0001-7474-9880	Office of Naval Research Grant [N000141210294]	Office of Naval Research Grant(Office of Naval Research)	This study was funded by the Office of Naval Research Grant Number N000141210294. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MMH, 2015, BRIT J NUTR, V113, P435, DOI 10.1017/S0007114514003894; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Anderson AJC, 1954, MARGARINE; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Benatar JR, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-32; Berens McCabe Elizabeth J., 2010, Marine Biology (Berlin), V157, P931; Centers for Disease Control, 2020, NATL DIABETES STAT R; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Choi KM, 2005, METABOLISM, V54, P1510, DOI 10.1016/j.metabol.2005.05.018; Ellervik C, 2001, LANCET, V358, P1405, DOI 10.1016/S0140-6736(01)06526-6; Fernandes R, 2013, DIS MARKERS, V2013, P105, DOI 10.1155/2013/913715; Fernandez-Real JM, 2002, DIABETES, V51, P2348, DOI 10.2337/diabetes.51.8.2348; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; GIBSON RA, 1983, LIPIDS, V18, P743, DOI 10.1007/BF02534631; GLAUBER H, 1988, ANN INTERN MED, V108, P663, DOI 10.7326/0003-4819-108-5-663; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Johnson SP, 2009, JAVMA-J AM VET MED A, V235, P194, DOI 10.2460/javma.235.2.194; Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005; Lagerstedt SA, 2001, MOL GENET METAB, V73, P38, DOI 10.1006/mgme.2001.3170; Luzia LA, 2003, FOOD CHEM, V83, P93, DOI 10.1016/S0308-8146(03)00054-2; Magnusdottir OK, 2014, EUR J CLIN NUTR, V68, P453, DOI 10.1038/ejcn.2014.12; Mansson HL, 2008, FOOD NUTR RES, V52, P4; Maruyama C, 2008, J ATHEROSCLER THROMB, V15, P306, DOI 10.5551/jat.E564; Mazzaro LM, 2012, COMPARATIVE MED, V62, P508; Mennen LI, 2000, NUTR RES, V20, P335, DOI 10.1016/S0271-5317(00)00127-5; Nanri A, 2011, AM J CLIN NUTR, V94, P884, DOI 10.3945/ajcn.111.012252; Ozogul Y, 2007, FOOD CHEM, V103, P217, DOI 10.1016/j.foodchem.2006.08.009; Patel PS, 2009, DIABETES CARE, V32, P1857, DOI 10.2337/dc09-0116; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Pfeuffer M, 2007, OBES REV, V8, P109, DOI 10.1111/j.1467-789X.2006.00265.x; Phillips BE, 2014, J WILDLIFE DIS, V50, P891, DOI 10.7589/2013-08-212; POPPSNIJDERS C, 1987, DIABETES RES CLIN EX, V4, P141; Ruidavets JB, 2007, J EPIDEMIOL COMMUN H, V61, P810, DOI 10.1136/jech.2006.052126; Sandrou DK, 2000, CRIT REV FOOD SCI, V40, P427, DOI 10.1080/10408690091189211; Slifka KA, 2013, INTERNET J VET MED, V10, P1, DOI DOI 10.1638/2014-0064R1.1; Suresh Y, 2001, PROSTAG LEUKOTR ESS, V64, P37, DOI 10.1054/plef.2000.0236; Swaminathan S, 2007, DIABETES CARE, V30, P1926, DOI 10.2337/dc06-2625; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Venn-Watson S, 2008, J WILDLIFE DIS, V44, P318, DOI 10.7589/0090-3558-44.2.318; Venn-Watson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126538; Venn-Watson Stephanie, 2013, Front Endocrinol (Lausanne), V4, P136, DOI 10.3389/fendo.2013.00136; Venn-Watson S, 2012, J ZOO WILDLIFE MED, V43, pS35, DOI 10.1638/2011-0146.1; Venn-Watson S, 2011, GEN COMP ENDOCR, V170, P193, DOI 10.1016/j.ygcen.2010.10.005; Venn-Watson SK, 2015, JAVMA-J AM VET MED A, V246, P893, DOI 10.2460/javma.246.8.893; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Wells R.S., 2014, PRIMATES CETACEANS F, P149, DOI DOI 10.1007/978-4-431-54523-1_8; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells Randall S, 2013, Front Endocrinol (Lausanne), V4, P139, DOI 10.3389/fendo.2013.00139; Xun PC, 2012, DIABETES CARE, V35, P930, DOI 10.2337/dc11-1869	50	48	57	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132117	10.1371/journal.pone.0132117	http://dx.doi.org/10.1371/journal.pone.0132117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200116	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100025
J	Martin-Tumasz, S; Brow, DA				Martin-Tumasz, Stephen; Brow, David A.			Saccharomyces cerevisiae Sen1 Helicase Domain Exhibits 5 ' -to 3 '-Helicase Activity with a Preference for Translocation on DNA Rather than RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II; SPLICING ENDONUCLEASE; EARLY TERMINATION; BUDDING YEAST; GENE; PROTEIN; MUTATIONS; TRANSCRIPTION; SENATAXIN; BINDING	In the yeast Saccharomyces cerevisiae, the essential nuclear helicase Sen1 is required for efficient termination of transcription of short noncoding RNA genes by RNA polymerase II. However, the mechanism by which Sen1 promotes transcription termination is not known. Prior biochemical studies on the Sen1 homolog from Schizosaccharomyces pombe showed that it can bind and unwind both DNA and RNA, but the S. pombe protein is not essential and has not been demonstrated to function in transcription. Furthermore, Sen1 from either yeast has not previously been expressed as a recombinant protein, due to its large molecular mass (252 kDa in S. cerevisiae). Here, we report the purification and characterization of the 89-kDa S. cerevisiae Sen1 helicase domain (Sen1-HD) produced in Escherichia coli. Sen1-HD binds single-stranded RNA and DNA with similar affinity in the absence of ATP, but it binds RNA more stably than DNA in the presence of ATP, apparently due to a slower translocation rate on RNA. Translocation occurs in the 5' to 3'direction, as for the S. pombe protein. When purified from E. coli at a moderate salt concentration, Sen1-HD was associated with short RNAs that are enriched for the trinucleotide repeat (CAN) 4. We propose that Sen1 binds to RNA sand prevents their stable pairing with DNA, consistent with in vivo studies by others showing increased R-loop (RNA/DNA hybrid) formation when Sen1 activity is impaired by mutations. Our results are consistent with a model in which Sen1 promotes transcription termination by resolving R-loops.	[Martin-Tumasz, Stephen; Brow, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Brow, DA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	dabrow@wisc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 GM082956]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM082956 (to D. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Castelnuovo M, 2014, NUCLEIC ACIDS RES, V42, P4348, DOI 10.1093/nar/gku100; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010; Chan YJA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004288; Chen X, 2014, GENETICS, V198, P577, DOI 10.1534/genetics.114.167585; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; CZAPLINSKI K, 1995, RNA, V1, P610; DEMARINI DJ, 1992, MOL CELL BIOL, V12, P2154, DOI 10.1128/MCB.12.5.2154; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Guenther UP, 2009, HUM MOL GENET, V18, P1288, DOI 10.1093/hmg/ddp028; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Lee CD, 2008, PROTEIN SCI, V17, P1241, DOI 10.1110/ps.035188.108; Lim SC, 2012, NUCLEIC ACIDS RES, V40, P11009, DOI 10.1093/nar/gks792; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; Porrua O, 2013, NAT STRUCT MOL BIOL, V20, P884, DOI 10.1038/nsmb.2592; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; WINEY M, 1988, GENETICS, V118, P609	30	32	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22880	22889		10.1074/jbc.M115.674002	http://dx.doi.org/10.1074/jbc.M115.674002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26198638	Green Published, hybrid			2022-12-26	WOS:000361685500002
J	Napoli, E; Tassone, F; Wong, S; Angkustsiri, K; Simon, TJ; Song, G; Giulivi, C				Napoli, Eleonora; Tassone, Flora; Wong, Sarah; Angkustsiri, Kathleen; Simon, Tony J.; Song, Gyu; Giulivi, Cecilia			Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME; D-2-AND L-2-HYDROXYGLUTARIC ACIDURIA; CREATINE-KINASE ACTIVITY; RAT CEREBRAL-CORTEX; D-2-HYDROXYGLUTARIC ACID; GENE-EXPRESSION; ALPHA-KETOGLUTARATE; OXIDATIVE STRESS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; SPECTRUM DISORDERS	The congenital disorder 22q11.2 deletion syndrome (22qDS), characterized by a hemizygous deletion of 1.5-3 Mb on chromosome 22 at locus 11.2, is the most common microdeletion disorder (estimated prevalence of 1 in 4000) and the second risk factor for schizophrenia. Nine of similar to 30 genes involved in 22qDS have the potential of disrupting mitochondrial metabolism (COMT, UFD1L, DGCR8, MRPL40, PRODH, SLC25A1, TXNRD2, T10, and ZDHHC8). Deficits in bioenergetics during early postnatal brain development could set the basis for a disrupted neuronal metabolism or synaptic signaling, partly explaining the higher incidence in developmental and behavioral deficits in these individuals. Here, we investigated whether mitochondrial outcomes and metabolites from 22qDS children segregated with the altered dosage of one or several of these mitochondrial genes contributing to 22qDS etiology and/or morbidity. Plasma metabolomics, lymphocytic mitochondrial outcomes, and epigenetics (histone H3 Lys-4 trimethylation and 5-methylcytosine) were evaluated in samples from 11 22qDS children and 13 age-and sex-matched neurotypically developing controls. Metabolite differences between 22qDS children and controls reflected a shift from oxidative phosphorylation to glycolysis (higher lactate/pyruvate ratios) accompanied by an increase in reductive carboxylation of alpha-ketoglutarate (increased concentrations of 2-hydroxyglutaric acid, cholesterol, and fatty acids). Altered metabolism in 22qDS reflected a critical role for the haploinsufficiency of the mitochondrial citrate transporter SLC25A1, further enhanced by HIF-1 alpha, MYC, and metabolite controls. This comprehensive profiling served to clarify the biochemistry of this disease underlying its broad, complex phenotype.	[Napoli, Eleonora; Wong, Sarah; Song, Gyu; Giulivi, Cecilia] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Tassone, Flora; Angkustsiri, Kathleen; Simon, Tony J.; Giulivi, Cecilia] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA; [Angkustsiri, Kathleen] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA; [Simon, Tony J.] Univ Calif Davis, Med Ctr, Dept Psychiat, Sacramento, CA 95817 USA; [Tassone, Flora] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Giulivi, C (corresponding author), Sch Vet Med, Dept Mol Biosci, 1089 Vet Med Dr, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/ABB-7809-2020; Napoli, Eleonora/AAQ-6079-2021; Giulivi, Cecilia/AAV-6774-2021; Regan, Clinton/E-6250-2012	Giulivi, Cecilia/0000-0003-1033-7435; Napoli, Eleonora/0000-0001-8808-4242; 	National Institutes of Health [NIEHS020392, HD036071]; Simons Foundation [271406]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants NIEHS020392 and HD036071. This work was also supported by Simons Foundation Grant 271406. The authors declare that they have no conflicts of interest with the contents of this article.	Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Baldini A, 2006, THESCIENTIFICWORLDJO, V6, P1881, DOI 10.1100/tsw.2006.317; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Brauburger K, 2011, J INHERIT METAB DIS, V34, P477, DOI 10.1007/s10545-010-9268-2; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Campbell AM, 2002, BBA-BIOMEMBRANES, V1567, P123, DOI 10.1016/S0005-2736(02)00607-7; CASAZZA JP, 1990, TRENDS BIOCHEM SCI, V15, P26, DOI 10.1016/0968-0004(90)90127-W; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Chalmers R A, 1980, J Inherit Metab Dis, V3, P11, DOI 10.1007/BF02312516; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Correa-Cerro LS, 2005, J MED GENET, V42, P350, DOI 10.1136/jmg.2004.022749; da Silva CG, 2004, NEUROCHEM INT, V44, P45, DOI 10.1016/S0197-0186(03)00098-6; da Silva CG, 2002, BBA-MOL BASIS DIS, V1586, P81, DOI 10.1016/S0925-4439(01)00088-6; da Silva CG, 2003, EUR J CLIN INVEST, V33, P840, DOI 10.1046/j.1365-2362.2003.01237.x; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dean RT, 1997, BIOCHEM J, V324, P1; Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; Fine SE, 2005, J AUTISM DEV DISORD, V35, P461, DOI 10.1007/s10803-005-5036-9; Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Glatt SJ, 2012, J AM ACAD CHILD PSY, V51, P934, DOI 10.1016/j.jaac.2012.07.007; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hwang VJ, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0106-5; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Jurata LW, 2006, SCHIZOPHR RES, V88, P251, DOI 10.1016/j.schres.2006.07.017; Jurevics HA, 1997, J LIPID RES, V38, P723; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kim A, 2010, MAMM GENOME, V21, P534, DOI 10.1007/s00335-010-9299-x; Kolker S, 2002, EUR J NEUROSCI, V16, P21, DOI 10.1046/j.1460-9568.2002.02055.x; KOWALOFF EM, 1976, METABOLISM, V25, P1087, DOI 10.1016/0026-0495(76)90016-0; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; Latini A, 2003, J NEUROSCI RES, V74, P103, DOI 10.1002/jnr.10735; Latini A, 2003, EUR J NEUROSCI, V17, P2017, DOI 10.1046/j.1460-9568.2003.02639.x; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Liu YM, 2009, CANCER RES, V69, P6414, DOI 10.1158/0008-5472.CAN-09-1223; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Maynard TM, 2008, MOL CELL NEUROSCI, V39, P439, DOI 10.1016/j.mcn.2008.07.027; McComsey GA, 2008, HIV CLIN TRIALS, V9, P126, DOI 10.1310/hct0902-126; McDonald-McGinn DM, 2006, AM J MED GENET A, V140A, P906, DOI 10.1002/ajmg.a.31199; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Meechan DW, 2011, INT J DEV NEUROSCI, V29, P283, DOI 10.1016/j.ijdevneu.2010.08.005; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; MROCHEK JE, 1972, CLIN CHEM, V18, P821; Muhlhausen C, 2014, J INHERIT METAB DIS, V37, P775, DOI 10.1007/s10545-014-9702-y; MUNEKATA M, 1981, AGR BIOL CHEM TOKYO, V45, P2149, DOI 10.1080/00021369.1981.10864851; Muntau AC, 2000, NEUROPEDIATRICS, V31, P137, DOI 10.1055/s-2000-7497; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Napoli E, 2014, PEDIATRICS, V133, pE1405, DOI 10.1542/peds.2013-1545; Napoli E, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-2; Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503; Napoli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042504; Nota B, 2013, AM J HUM GENET, V92, P627, DOI 10.1016/j.ajhg.2013.03.009; Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006; PENG L, 1991, NEUROCHEM RES, V16, P29, DOI 10.1007/BF00965824; PHANG J M, 1975, Annals of Clinical and Laboratory Science, V5, P298; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Raimondi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069152; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Robertson M, 2004, DRUG DISCOV TODAY, V9, P684, DOI 10.1016/S1359-6446(04)03217-9; ROBINSON BH, 1993, BIOCHIM BIOPHYS ACTA, V1182, P231, DOI 10.1016/0925-4439(93)90064-8; Ross-Inta C, 2010, BIOCHEM J, V429, P545, DOI 10.1042/BJ20091960; Rutter M., 2003, SOCIAL COMMUNICATION; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schwichtenberg AJ, 2013, AUTISM RES, V6, P169, DOI 10.1002/aur.1278; Sellier C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103884; Strauss KA, 2010, BRAIN, V133, P76, DOI 10.1093/brain/awp297; Struys EA, 2005, J INHERIT METAB DIS, V28, P921, DOI 10.1007/s10545-005-0114-x; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Swanson JM., 1995, SNAP 4 SCALE; Tint GS, 2006, J LIPID RES, V47, P1535, DOI 10.1194/jlr.M600141-JLR200; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Turley SD, 1996, J LIPID RES, V37, P1953; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Wajner M, 2002, J INHERIT METAB DIS, V25, P28, DOI 10.1023/A:1015165212965; Washizuka S, 2009, NEUROSCI RES, V63, P199, DOI 10.1016/j.neures.2008.12.004; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang XJ, 2014, J PHARMACEUT BIOMED, V95, P85, DOI 10.1016/j.jpba.2014.02.014	98	32	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23240	23253		10.1074/jbc.M115.672360	http://dx.doi.org/10.1074/jbc.M115.672360			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26221035	Green Published, hybrid			2022-12-26	WOS:000361685500033
J	Chiang, CY; Lee, CC; Lo, SY; Wang, AHJ; Tsai, HJ				Chiang, Cheng-Yi; Lee, Cheng-Chung; Lo, Shin-Yi; Wang, Andrew H. -J.; Tsai, Huai-Jen			Chromophore Deprotonation State Alters the Optical Properties of Blue Chromoprotein	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; CRYSTAL-STRUCTURE; SEA-ANEMONE; STRUCTURAL BASIS; VARIANTS; HOMOLOG; CORAL	Chromoproteins (CPs) have unique colors and can be used in biological applications. In this work, a novel blue CP with a maximum absorption peak (lambda(max)) at 608 nm was identified from the carpet anemone Stichodactyla gigantea (sgBP). In vivo expression of sgBP in zebrafish would change the appearance of the fishes to have a blue color, indicating the potential biomarker function. To enhance the color properties, the crystal structure of sgBP at 2.25 angstrom resolution was determined to allow structure - based protein engineering. Among the mutations conducted in the Gln-Tyr-Gly chromophore and chromophore environment, a S157C mutation shifted the lambda(max) to 604 nm with an extinction coefficient (epsilon) of 58,029 M-1.cm(-1) and darkened the blue color expression. The S157C mutation in the sgBP chromophore environment could affect the color expression by altering the deprotonation state of the phenolic group in the chromophore. Our results provide a structural basis for the blue color enhancement of the biomarker development.	[Chiang, Cheng-Yi] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Lee, Cheng-Chung; Lo, Shin-Yi; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lee, Cheng-Chung; Lo, Shin-Yi; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Prod & Xray Struct Anal, Taipei, Taiwan; [Tsai, Huai-Jen] MacKay Med Coll, Inst Biomed Sci, New Taipei City, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Mackay Medical College	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw; hjtsai@ntu.edu.tw			National Science Council, Taiwan [NSC103-2313-B-002-048-MY2]; Academia Sinica from the National Science Council of Taiwan [NSC102-2319-B-001-003]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica from the National Science Council of Taiwan	This work was supported by the National Science Council, Taiwan (NSC103-2313-B-002-048-MY2). This work was also supported by Academia Sinica with grants from the National Science Council of Taiwan (NSC102-2319-B-001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Bulina ME, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-7; Chan MCY, 2006, J BIOL CHEM, V281, P37813, DOI 10.1074/jbc.M606921200; Chiang CY, 2014, MAR BIOTECHNOL, V16, P436, DOI 10.1007/s10126-014-9563-2; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2003, J BIOL CHEM, V278, P7215, DOI 10.1074/jbc.M211988200; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Dove SG, 1995, BIOL BULL, V189, P288, DOI 10.2307/1542146; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Molich A, 2005, J EXP BIOL, V208, P4137, DOI 10.1242/jeb.01878; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pakhomov AA, 2006, BIOCHEMISTRY-US, V45, P7256, DOI 10.1021/bi060207q; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pletnev S, 2012, J MOL BIOL, V417, P144, DOI 10.1016/j.jmb.2012.01.044; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shkrob MA, 2005, BIOCHEM J, V392, P649, DOI 10.1042/BJ20051314; Sniegowski JA, 2005, BIOCHEM BIOPH RES CO, V332, P657, DOI 10.1016/j.bbrc.2005.04.166; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462	37	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134108	10.1371/journal.pone.0134108	http://dx.doi.org/10.1371/journal.pone.0134108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218063	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900078
J	Chen, Q				Chen, Qun			An Optimization Model for the Selection of Bus-Only Lanes in a City	PLOS ONE			English	Article							NETWORK DESIGN PROBLEM; POWER MANAGEMENT; HYBRID BUS; ALGORITHM	The planning of urban bus-only lane networks is an important measure to improve bus service and bus priority. To determine the effective arrangement of bus-only lanes, a bi-level programming model for urban bus lane layout is developed in this study that considers accessibility and budget constraints. The goal of the upper-level model is to minimize the total travel time, and the lower-level model is a capacity-constrained traffic assignment model that describes the passenger flow assignment on bus lines, in which the priority sequence of the transfer times is reflected in the passengers' route-choice behaviors. Using the proposed bi-level programming model, optimal bus lines are selected from a set of candidate bus lines; thus, the corresponding bus lane network on which the selected bus lines run is determined. The solution method using a genetic algorithm in the bi-level programming model is developed, and two numerical examples are investigated to demonstrate the efficacy of the proposed model.	Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China	Central South University	Chen, Q (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	chenqun631@csu.edu.cn						Bagloee SA, 2011, TRANSPORT RES B-METH, V45, P1787, DOI 10.1016/j.trb.2011.07.005; Chiabaut N, 2012, TRANSPORT RES REC, P182, DOI 10.3141/2315-19; DAVIS GA, 1994, TRANSPORT RES B-METH, V28, P61, DOI 10.1016/0191-2615(94)90031-0; Fan W, 2006, J TRANSP ENG-ASCE, V132, P122, DOI 10.1061/(ASCE)0733-947X(2006)132:2(122); Gao ZY, 2005, TRANSPORT RES B-METH, V39, P479, DOI 10.1016/j.trb.2004.06.004; Herbert SL, 1998, TRANSP RES BOARD ANN; Hu XS, 2015, IEEE-ASME T MECH, V20, P457, DOI 10.1109/TMECH.2014.2336264; Hu XS, 2015, APPL ENERG, V137, P913, DOI 10.1016/j.apenergy.2014.05.013; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Khoo HL, 2014, ENG OPTIMIZ, V46, P987, DOI 10.1080/0305215X.2013.812728; Li SG, 2009, IEEE T INTELL TRANSP, V10, P236, DOI 10.1109/TITS.2009.2018326; Liu HX, 2015, TRANSPORT RES B-METH, V72, P20, DOI 10.1016/j.trb.2014.10.009; Luathep P, 2011, TRANSPORT RES B-METH, V45, P808, DOI 10.1016/j.trb.2011.02.002; Mauttone A, 2009, COMPUT OPER RES, V36, P2440, DOI 10.1016/j.cor.2008.09.014; Nayeem MA, 2014, TRANSPORT RES C-EMER, V46, P30, DOI 10.1016/j.trc.2014.05.002; Patankar VM, 2007, J URBAN PLAN D-ASCE, V133, P99, DOI 10.1061/(ASCE)0733-9488(2007)133:2(99); Sakamoto K, 2007, TRANSP RES RECORD, P103, DOI 10.3141/2034-12; Surprenant-Legault J, 2011, TRANSPORT RES REC, P10, DOI 10.3141/2218-02; Tse LY, 2014, TRANSPORTMETRICA A, V10, P140, DOI 10.1080/18128602.2012.724470; Uchida K, 2007, NETW SPAT ECON, V7, P213, DOI 10.1007/s11067-006-9010-7; Vijay KM, 1999, TRAFFIC CONGEST TRAF, V3, P319; Wang DZW, 2015, TRANSPORT RES E-LOG, V79, P213, DOI 10.1016/j.tre.2015.04.005; Wang DZW, 2010, TRANSPORT RES B-METH, V44, P482, DOI 10.1016/j.trb.2009.10.003; Wang SA, 2013, TRANSPORT RES B-METH, V50, P42, DOI 10.1016/j.trb.2013.01.006; Wang W, 2002, PLANNING METHOD MANA; Yang H, 1998, TRANSPORT REV, V18, P257, DOI 10.1080/01441649808717016; Yao BZ, 2014, TRANSPORT RES C-EMER, V43, P233, DOI 10.1016/j.trc.2013.12.005; Yao J, 2012, J TRANSP ENG-ASCE, V138, P1422, DOI 10.1061/(ASCE)TE.1943-5436.0000475; Zhu L, 2012, J PUBLIC TRANSPORT, V15, P111, DOI 10.5038/2375-0901.15.4.6	29	9	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133951	10.1371/journal.pone.0133951	http://dx.doi.org/10.1371/journal.pone.0133951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214001	Green Submitted, gold, Green Published			2022-12-26	WOS:000358594300041
J	Esteve-Turrillas, FA; Mercader, JV; Parra, J; Agullo, C; Abad-Somovilla, A; Abad-Fuentes, A				Esteve-Turrillas, Francesc A.; Mercader, Josep V.; Parra, Javier; Agullo, Consuelo; Abad-Somovilla, Antonio; Abad-Fuentes, Antonio			Ready Access to Proquinazid Haptens via Cross-Coupling Chemistry for Antibody Generation and Immunoassay Development	PLOS ONE			English	Article							COMPETITIVE IMMUNOASSAYS; REGIOISOMERIC HAPTENS; PICOXYSTROBIN; RESIDUES; AFFINITY; DESIGN	Bioconjugate preparation is a fundamental step for antibody generation and immunoassay development to small chemical compounds. For analytical targets holding in their structure an aryl halogen atom, cross-coupling reactions may be a simple and efficient way to obtain functionalized derivatives; thus offering great potential to elicit robust and selective immune responses after being coupled to immunogenic carrier proteins. However, substitution of the halogen atom by an aliphatic chain might eventually compromise the affinity and specificity of the resulting antibodies. In order to address this issue, proquinazid, a new-generation fungicide with outstanding performance, was chosen as model analyte. Two functionalized derivatives differing in spacer arm rigidity were synthesized by Sonogashira cross-coupling chemistry. These haptens were covalently coupled to bovine serum albumin and the resulting immunoconjugates were employed for rabbit vaccination. Antibodies were tested for proquinazid recognition by direct and indirect competitive immunoassay, and IC50 values in the low nanomolar range were found, thus demonstrating the suitability of this straightforward synthetic strategy for the generation of immunoreagents to compounds bearing an aryl halide. Following antibody characterization, competitive immunoassays were developed and employed to determine proquinazid residues in grape musts, and their analytical performance was satisfactorily validated by comparison with GC-MS. Besides having described the development of the first immunochemical method for proquinazid analysis, an efficient functionalization approach for analytes comprising aryl halides is reported.	[Esteve-Turrillas, Francesc A.; Mercader, Josep V.; Parra, Javier; Abad-Fuentes, Antonio] IATA CSIC, Dept Biotechnol, Valencia 46980, Spain; [Agullo, Consuelo; Abad-Somovilla, Antonio] Univ Valencia, Dept Organ Chem, E-46100 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia	Abad-Somovilla, A (corresponding author), Univ Valencia, Dept Organ Chem, Doctor Moliner 50, E-46100 Valencia, Spain.	antonio.abad@uv.es; aabad@iata.csic.es	Abad-Fuentes, Antonio/ABC-1805-2021; Esteve-Turrillas, Francesc/N-2976-2013; Agulló, Consuelo/F-9385-2015; Abad-Fuentes, Antonio/B-5716-2011; Somovilla, Antonio Abad/F-9217-2015; Mercader, Josep Vicent/H-2849-2012	Abad-Fuentes, Antonio/0000-0001-5672-1438; Esteve-Turrillas, Francesc/0000-0003-1543-1877; Agulló, Consuelo/0000-0001-6056-5087; Abad-Fuentes, Antonio/0000-0001-5672-1438; Somovilla, Antonio Abad/0000-0002-5599-3682; Mercader, Josep Vicent/0000-0002-1838-2647	Ministerio de Economia y Competitividad [AGL2012-39965-C02-01/02/ALI]; FEDER funds; Ministerio de Ciencia e Innovacion; European Social Fund	Ministerio de Economia y Competitividad(Spanish Government); FEDER funds(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Social Fund(European Social Fund (ESF))	The work was supported by Ministerio de Economia y Competitividad (AGL2012-39965-C02-01/02/ALI) and cofinanced by FEDER funds. FAET: JAE postdoctoral contract from Ministerio de Ciencia e Innovacion and the European Social Fund. JVM: Ramon y Cajal postdoctoral contract from Ministerio de Ciencia e Innovacion and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Fuentes A, 2012, FOOD CHEM, V135, P276, DOI 10.1016/j.foodchem.2012.04.090; APVMA, PUBL REL SUMM EV NEW; Bereznak JF, 1997, US Pat, Patent No. [6166208A, 6166208]; Ceballos-Alcantarilla E, 2014, ANALYST, V139, P5358, DOI 10.1039/c4an00828f; Chinchilla R, 2011, CHEM SOC REV, V40, P5084, DOI 10.1039/c1cs15071e; EFSA, 2009, EFSA J, V7, DOI [10.2903/j.efsa.2009.1350, DOI 10.2903/J.EFSA.2009.1350]; Esteve-Turrillas FA, 2014, ANALYST, V139, P3636, DOI 10.1039/c3an01104f; Esteve-Turrillas FA, 2013, ANALYST, V138, P3360, DOI 10.1039/c3an00228d; Esteve-Turrillas FA, 2010, ANAL CHIM ACTA, V682, P93, DOI 10.1016/j.aca.2010.09.042; Genet JL, 2009, PEST MANAG SCI, V65, P878, DOI 10.1002/ps.1768; Jeschke P., 2013, MODERN METHODS CROP, P73, DOI [DOI 10.1002/9783527655908.CH4, 10.1002/9783527655908]; Lehotay SJ, 2010, J CHROMATOGR A, V1217, P2548, DOI 10.1016/j.chroma.2010.01.044; Lopez-Moreno R, 2014, FOOD CHEM, V152, P230, DOI 10.1016/j.foodchem.2013.11.150; Lopez-Moreno R, 2013, ORG BIOMOL CHEM, V11, P7361, DOI 10.1039/c3ob41570h; Mercader JV, 2012, FOOD CONTROL, V26, P162, DOI 10.1016/j.foodcont.2012.01.021; Mercader JV, 2011, ORG BIOMOL CHEM, V9, P1443, DOI 10.1039/c0ob00686f; Parra J, 2011, TETRAHEDRON, V67, P624, DOI 10.1016/j.tet.2010.11.054; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Selby Thomas P., 2007, V948, P209; Suarez-Pantaleon C, 2010, J AGR FOOD CHEM, V58, P8502, DOI 10.1021/jf101660z	20	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134042	10.1371/journal.pone.0134042	http://dx.doi.org/10.1371/journal.pone.0134042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214507	gold, Green Published, Green Submitted			2022-12-26	WOS:000358594300044
J	Gruschus, JM				Gruschus, James M.			Did alpha-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease	PLOS ONE			English	Article							LONG-RANGE INTERACTIONS; CORRELATED MUTATIONS; GAUCHER-DISEASE; X-RAY; INFORMATION; COEVOLUTION; INTERACTS; SEQUENCE; PHOSPHORYLATION; AGGREGATION	Mutations in the GBA1 gene are associated with increased risk of Parkinson's disease, and the protein produced by the gene, glucocerebrosidase, interacts with alpha-synuclein, the protein at the center of the disease etiology. One possibility is that the mutations disrupt a beneficial interaction between the proteins, and a beneficial interaction would imply that the proteins have coevolved. To explore this possibility, a correlated mutation analysis has been performed for all 72 vertebrate species where complete sequences of alpha-synuclein and glucocerebrosidase are known. The most highly correlated pair of residue variations is alpha-synuclein A53T and glucocerebrosidase G115E. Intriguingly, the A53T mutation is a Parkinson's disease risk factor in humans, suggesting the pathology associated with this mutation and interaction with glucocerebrosidase might be connected. Correlations with beta-synuclein are also evaluated. To assess the impact of lowered species number on accuracy, intra and inter-chain correlations are also calculated for hemoglobin, using mutual information Z-value and direct coupling analyses.	NHLBI, Lab Struct Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gruschus, JM (corresponding author), NHLBI, Lab Struct Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	gruschuj@helix.nih.gov			Intramural Research Program at the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)	Intramural Research Program at the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)	This work was supported by the Intramural Research Program at the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Ashenberg O, 2013, METHOD ENZYMOL, V523, P191, DOI 10.1016/B978-0-12-394292-0.00009-6; Ashkenazy H, 2010, PROTEIN ENG DES SEL, V23, P321, DOI 10.1093/protein/gzp078; Bellani Serena, 2010, Commun Integr Biol, V3, P106; Beutler E, 1996, P ASSOC AM PHYSICIAN, V108, P179; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Brighina L, 2007, NEUROSCI LETT, V420, P229, DOI 10.1016/j.neulet.2007.05.021; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Chen RHC, 2013, J BIOL CHEM, V288, P7438, DOI 10.1074/jbc.M112.439497; Cho MK, 2009, PROTEIN SCI, V18, P1840, DOI 10.1002/pro.194; Choi P, 2001, NEUROREPORT, V12, P2839, DOI 10.1097/00001756-200109170-00017; Cookson MR, 2012, CURR BIOL, V22, pR753, DOI 10.1016/j.cub.2012.07.008; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Di Lena P, 2012, BIOINFORMATICS, V28, P2449, DOI 10.1093/bioinformatics/bts475; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; El-Agnaf OMA, 1998, EUR J BIOCHEM, V258, P157, DOI 10.1046/j.1432-1327.1998.2580157.x; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Gruschus JM, 2015, BIOCHEM BIOPH RES CO, V457, P561, DOI 10.1016/j.bbrc.2015.01.024; Gruschus JM, 2013, BIOCHEMISTRY-US, V52, P3436, DOI 10.1021/bi400199p; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Jeong CS, 2012, PROTEIN ENG DES SEL, V25, P705, DOI 10.1093/protein/gzs081; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Knaggs MH, 2007, BIOPHYS J, V92, P2062, DOI 10.1529/biophysj.106.081950; Kosciolek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092197; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Lee BC, 2009, BIOINFORMATICS, V25, P2506, DOI 10.1093/bioinformatics/btp455; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Neystat M, 2002, NEUROSCI LETT, V325, P119, DOI 10.1016/S0304-3940(02)00253-7; Noivirt-Brik O, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-4; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pele J, 2014, PROTEINS, V82, P2141, DOI 10.1002/prot.24570; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Sybertz E, 2014, J LIPID RES, V55, P1996, DOI 10.1194/jlr.R047381; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uemura N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005065; Vargas KJ, 2014, J NEUROSCI, V34, P9364, DOI 10.1523/JNEUROSCI.4787-13.2014; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wei RR, 2011, J BIOL CHEM, V286, P299, DOI 10.1074/jbc.M110.150433; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Yap TL, 2013, BIOCHEMISTRY-US, V52, P7161, DOI 10.1021/bi401191v; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	70	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133863	10.1371/journal.pone.0133863	http://dx.doi.org/10.1371/journal.pone.0133863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214314	gold, Green Published, Green Submitted			2022-12-26	WOS:000358594300036
J	Tachi, Y; Hirai, T; Toyoda, H; Tada, T; Hayashi, K; Honda, T; Ishigami, M; Goto, H; Kumada, T				Tachi, Yoshihiko; Hirai, Takanori; Toyoda, Hidenori; Tada, Toshifumi; Hayashi, Kazuhiko; Honda, Takashi; Ishigami, Masatoshi; Goto, Hidemi; Kumada, Takashi			Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; SIMPLE NONINVASIVE INDEX; HEPATOCELLULAR-CARCINOMA; INTERFERON THERAPY; RISK-FACTORS; LONG-TERM; HISTOLOGIC IMPROVEMENT; CIRRHOSIS; MORBIDITY; MORTALITY	Liver fibrosis remains an important risk factor for hepatocarcinogenesis in patients with chronic hepatitis C even after the eradication of hepatitis C virus (HCV). However, it is difficult to estimate liver fibrosis based on liver biopsy after the eradication of HCV. We investigated the ability of laboratory indices to predict liver fibrosis in patients with sustained virologic response (SVR) to antiviral therapy. Three laboratory liver fibrosis indices (aspartate aminotransferase-platelet ratio index (APRI), FIB-4 index, and Forns index) were calculated based on data at the time of initial pretreatment liver biopsy and at second liver biopsy performed approximately 5 years after SVR in 115 patients who underwent serial liver biopsies. The indices at the time of initial biopsy were compared to histological degree of liver fibrosis in initial biopsy, and laboratory indices at the time of second liver biopsy were compared to the degree of fibrosis in second biopsy. In both comparisons, there were significant increases in all 3 indices with the increase of liver fibrosis grade as assessed in liver biopsy specimens. All 3 indices at the time of second biopsy were able to predict moderate to advanced (METAVIR score F2-4) and advanced (F3-4) fibrosis on liver biopsy, with the area under the receiver-operating characteristics curve >0.8 and the accuracy >70%. All 3 laboratory indices of fibrosis accurately reflected liver fibrosis in patients with SVR for 5 years despite the normalization of serum liver transaminase activity and the lack of liver inflammation.	[Tachi, Yoshihiko; Hirai, Takanori] Komaki City Hosp, Dept Gastroenterol, Komaki, Japan; [Toyoda, Hidenori; Tada, Toshifumi; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan; [Hayashi, Kazuhiko; Honda, Takashi; Ishigami, Masatoshi; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan	Ogaki Municipal Hospital; Nagoya University	Toyoda, H (corresponding author), Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan.	tkumada@he.mirai.ne.jp	Honda, Takashi/I-7268-2014; Hayashi, Kazuhiko/I-7382-2014	Hayashi, Kazuhiko/0000-0002-7919-6071				Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Degasperi E, 2014, J HEPATOL, V60, pS418, DOI 10.1016/S0168-8278(14)61192-2; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Guzelbulut F, 2011, TURK J GASTROENTEROL, V22, P279, DOI 10.4318/tjg.2011.0213; Halfon Philippe, 2002, Comp Hepatol, V1, P3, DOI 10.1186/1476-5926-1-3; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005; Iwasaki Y, 2004, LIVER INT, V24, P603, DOI 10.1111/j.1478-3231.2004.0956.x; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Makiyama A, 2004, CANCER-AM CANCER SOC, V101, P1616, DOI 10.1002/cncr.20537; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Shiffman ML, 1997, HEPATOLOGY, V26, P780, DOI 10.1002/hep.510260335; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tachi Y, 2015, HEPATOL RES, V45, P238, DOI 10.1111/hepr.12331; Tokita H, 2005, J GASTROEN HEPATOL, V20, P752, DOI 10.1111/j.1440-1746.2005.03800.x; Toyoda H, J GASTROENTEROL HEPA; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	37	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133515	10.1371/journal.pone.0133515	http://dx.doi.org/10.1371/journal.pone.0133515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214180	gold, Green Published, Green Submitted			2022-12-26	WOS:000358594300021
J	Andoh, M; Sakata, A; Takano, A; Kawabata, H; Fujita, H; Une, Y; Goka, K; Kishimoto, T; Ando, S				Andoh, Masako; Sakata, Akiko; Takano, Ai; Kawabata, Hiroki; Fujita, Hiromi; Une, Yumi; Goka, Koichi; Kishimoto, Toshio; Ando, Shuji			Detection of Rickettsia and Ehrlichia spp. in Ticks Associated with Exotic Reptiles and Amphibians Imported into Japan	PLOS ONE			English	Article							CANDIDATUS NEOEHRLICHIA-MIKURENSIS; IXODES-OVATUS TICKS; COWDRIA-RUMINANTIUM; WILD RODENTS; INFECTION; ANAPLASMATACEAE; IDENTIFICATION; IXODIDAE; ISLAND; ACARI	One of the major routes of transmission of rickettsial and ehrlichial diseases is via ticks that infest numerous host species, including humans. Besides mammals, reptiles and amphibians also carry ticks that may harbor Rickettsia and Ehrlichia strains that are pathogenic to humans. Furthermore, reptiles and amphibians are exempt from quarantine in Japan, thus facilitating the entry of parasites and pathogens to the country through import. Accordingly, in the current study, we examined the presence of Rickettsia and Ehrlichia spp. genes in ticks associated with reptiles and amphibians originating from outside Japan. Ninety-three ticks representing nine tick species (genera Amblyomma and Hyalomma) were isolated from at least 28 animals spanning 10 species and originating from 12 countries (Ghana, Jordan, Madagascar, Panama, Russia, Sri Lanka, Sudan, Suriname, Tanzania, Togo, Uzbekistan, and Zambia). None of the nine tick species are indigenous in Japan. The genes encoding the common rickettsial 17-kDa antigen, citrate synthase (gltA), and outer membrane protein A (ompA) were positively detected in 45.2% (42/93), 40.9% (38/93), and 23.7% (22/93) of the ticks, respectively, by polymerase chain reaction (PCR). The genes encoding ehrlichial heat shock protein (groEL) and major outer membrane protein (omp-1) were PCR-positive in 7.5% (7/93) and 2.2% (2/93) of the ticks, respectively. The p44 gene, which encodes the Anaplasma outer membrane protein, was not detected. Phylogenetic analysis showed that several of the rickettsial and ehrlichial sequences isolated in this study were highly similar to human pathogen genes, including agents not previously detected in Japan. These data demonstrate the global transportation of pathogenic Rickettsia and Ehrlichia through reptile-and amphibian-associated ticks. These imported animals have potential to transfer pathogens into human life. These results highlight the need to control the international transportation of known and potential pathogens carried by ticks in reptiles, amphibians, and other animals, in order to improve national and international public health.	[Andoh, Masako; Sakata, Akiko; Kishimoto, Toshio; Ando, Shuji] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Andoh, Masako] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Publ Hlth, Kagoshima 890, Japan; [Takano, Ai; Kawabata, Hiroki] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Takano, Ai] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Yamaguchi, Japan; [Fujita, Hiromi] Mahara Inst Med Acarol, Tokushima, Japan; [Une, Yumi] Azabu Univ, Sch Vet Med, Lab Vet Pathol, Sagamihara, Kanagawa, Japan; [Goka, Koichi] Natl Inst Environm Studies, Ibaraki, Japan; [Kishimoto, Toshio] Okayama Prefectural Inst Environm Sci & Publ Hlth, Okayama, Japan	National Institute of Infectious Diseases (NIID); Kagoshima University; National Institute of Infectious Diseases (NIID); Yamaguchi University; Azabu University; National Institute for Environmental Studies - Japan	Ando, S (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.	shuando@nih.go.jp		TAKANO, Ai/0000-0002-5919-3738	Japanese Ministry of Health, Labor and Welfare [H21-Shinkou-Ippan-006, H24-Shinkou-Ippan-008]; Global Environment Research Fund of the Ministry of the Environment and Japan [F-3, F-081]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Global Environment Research Fund of the Ministry of the Environment and Japan; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by a grant of the Japanese Ministry of Health, Labor and Welfare (H21-Shinkou-Ippan-006 and H24-Shinkou-Ippan-008) (http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h25/gaiyo/19.html) and the Global Environment Research Fund (F-3 and F-081) of the Ministry of the Environment and Japan 2008 (http://www.env.go.jp/policy/kenkyu/suishin/english/index.html)(http://www.env.go.jp/policy/kenkyu/suishin/kadai_hyouka/h23/detail.html#D-0801). This research was partially supported by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp BA, 2010, VET PARASITOL, V167, P123, DOI 10.1016/j.vetpar.2009.09.014; ANDERSON BE, 1989, J BACTERIOL, V171, P5199, DOI 10.1128/jb.171.9.5199-5201.1989; Bermudez SE, 2012, EXP APPL ACAROL, V58, P81, DOI 10.1007/s10493-012-9564-7; Burridge MJ, 2000, J PARASITOL, V86, P1135, DOI 10.1645/0022-3395(2000)086[1135:EOCRIH]2.0.CO;2; Dantas-Torres F, 2008, REV BRAS PARASITOL V, V17, P218, DOI 10.1590/S1984-29612008000400009; De Sousa R, 2012, APPL ENVIRON MICROB, V78, P3767, DOI 10.1128/AEM.07945-11; Duh D, 2010, INT J SYST EVOL MICR, V60, P977, DOI 10.1099/ijs.0.011049-0; Ekner A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-182; Imaoka K, 2011, CASE REP DERMATOL, V3, P68, DOI 10.1159/000326941; Inayoshi M, 2004, MICROBIOL IMMUNOL, V48, P737, DOI 10.1111/j.1348-0421.2004.tb03599.x; Jensenius M, 2003, LANCET INFECT DIS, V3, P557, DOI 10.1016/S1473-3099(03)00739-4; Kar S, 2013, EXP APPL ACAROL, V61, P349, DOI 10.1007/s10493-013-9698-2; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Kawahara M, 2009, EMERG INFECT DIS, V15, P1991, DOI 10.3201/eid1512.081667; Kim HY, 2002, CLIN DIAGN LAB IMMUN, V9, P1079, DOI 10.1128/CDLI.9.5.1079-1084.2002; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Li H, 2012, EMERG INFECT DIS, V18, P1636, DOI 10.3201/eid1810.120594; Naitou H, 2006, MICROBIOL IMMUNOL, V50, P45, DOI 10.1111/j.1348-0421.2006.tb03769.x; Nieto NC, 2009, J PARASITOL, V95, P1165, DOI 10.1645/GE-1983.1; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; NORVAL RAI, 1981, VET PARASITOL, V8, P189, DOI 10.1016/0304-4017(81)90047-9; OLIVER JH, 1993, J PARASITOL, V79, P786, DOI 10.2307/3283624; Pacheco RC, 2007, BIOMEDICA, V27, P364, DOI 10.7705/biomedica.v27i3.199; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Parola P, 2009, EMERG INFECT DIS, V15, P1105, DOI 10.3201/eid1507.081449; Randolph SE, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P40, DOI 10.1017/CBO9780511551802.003; Reeves WK, 2006, J MED ENTOMOL, V43, P1099, DOI 10.1603/0022-2585(2006)43[1099:ASFGRF]2.0.CO;2; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Rikihisa Y, 1999, MICROBES INFECT, V1, P367, DOI 10.1016/S1286-4579(99)80053-7; Shibata S, 2000, J CLIN MICROBIOL, V38, P1331, DOI 10.1128/JCM.38.4.1331-1338.2000; Stenos J, 2003, AM J TROP MED HYG, V69, P314, DOI 10.4269/ajtmh.2003.69.314; Switaj Karolina, 2012, Przegl Epidemiol, V66, P347; Tabara K, 2007, MICROBIOL IMMUNOL, V51, P359, DOI 10.1111/j.1348-0421.2007.tb03923.x; Takano A, 2010, ENVIRON MICROBIOL, V12, P134, DOI 10.1111/j.1462-2920.2009.02054.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ushijima Y, 2003, J PARASITOL, V89, P196, DOI 10.1645/0022-3395(2003)089[0196:MSVICC]2.0.CO;2; Vaclav R, 2011, MICROB ECOL, V61, P245, DOI 10.1007/s00248-010-9736-0	37	41	41	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133700	10.1371/journal.pone.0133700	http://dx.doi.org/10.1371/journal.pone.0133700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207382	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000118
J	Beltran-Pardo, E; Jonsson, KI; Harms-Ringdahl, M; Haghdoost, S; Wojcik, A				Beltran-Pardo, Eliana; Jonsson, K. Ingemar; Harms-Ringdahl, Mats; Haghdoost, Siamak; Wojcik, Andrzej			Tolerance to Gamma Radiation in the Tardigrade Hypsibius dujardini from Embryo to Adult Correlate Inversely with Cellular Proliferation	PLOS ONE			English	Article							DNA-DAMAGE; IONIZING-RADIATION; RESISTANCE; INDUCTION; DESICCATION; REPAIR; SPACE; CELLS; MODEL	Tardigrades are highly tolerant to desiccation and ionizing radiation but the mechanisms of this tolerance are not well understood. In this paper, we report studies on dose responses of adults and eggs of the tardigrade Hypsibius dujardini exposed to gamma radiation. In adults the LD50/48h for survival was estimated at similar to 4200 Gy, and doses higher than 100 Gy reduced both fertility and hatchability of laid eggs drastically. We also evaluated the effect of radiation (doses 50 Gy, 200 Gy, 500 Gy) on eggs in the early and late embryonic stage of development, and observed a reduced hatchability in the early stage, while no effect was found in the late stage of development. Survival of juveniles from irradiated eggs was highly affected by a 500 Gy dose, both in the early and the late stage. Juveniles hatched from eggs irradiated at 50 Gy and 200 Gy developed into adults and produced offspring, but their fertility was reduced compared to the controls. Finally we measured the effect of low temperature during irradiation at 4000 Gy and 4500 Gy on survival in adult tardigrades, and observed a slight delay in the expressed mortality when tardigrades were irradiated on ice. Since H. dujardini is a freshwater tardigrade with lower tolerance to desiccation compared to limno-terrestrial tardigrades, the high radiation tolerance in adults, similar to limno-terrestrial tardigrades, is unexpected and seems to challenge the idea that desiccation and radiation tolerance rely on the same molecular mechanisms. We suggest that the higher radiation tolerance in adults and late stage embryos of H. dujardini (and in other studied tardigrades) compared to early stage embryos may partly be due to limited mitotic activity, since tardigrades have a low degree of somatic cell division (eutely), and dividing cells are known to be more sensitive to radiation.	[Beltran-Pardo, Eliana; Jonsson, K. Ingemar; Harms-Ringdahl, Mats; Haghdoost, Siamak; Wojcik, Andrzej] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Jonsson, K. Ingemar] Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden	Stockholm University; Kristianstad University	Beltran-Pardo, E (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	elianabeltran@yahoo.com		Levine, Eliana/0000-0002-0609-3944	Swedish National Space Board [87/11]	Swedish National Space Board	This study was funded by the Swedish National Space Board (http://www.rymdstyrelsen.se/en/Home/Home/), from grant 87/11 to AW.	ALEXANDER ML, 1955, P NATL ACAD SCI USA, V41, P1046, DOI 10.1073/pnas.41.12.1046; Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; Beltran-Pardo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072098; Beltran-Pardo EA, 2013, J LIMNOL, V72, P80, DOI 10.4081/jlimnol.2013.s1.e10; Bergonie J, 1906, CR HEBD ACAD SCI, V143, P983; BERTOLAN.R, 1970, ATTI ACCAD NAZ LIN, V48, P739; Dartnell LR, 2010, ASTROBIOLOGY, V10, P717, DOI 10.1089/ast.2009.0439; de Carvalho RC, 2012, ANN BOT-LONDON, V110, P1007, DOI 10.1093/aob/mcs180; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Erkut C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082473; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gobbel GT, 1998, J NEUROSCI, V18, P147; Gusev O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014008; Hejnol A, 2005, DEVELOPMENT, V132, P1349, DOI 10.1242/dev.01701; Holway AH, 2006, J CELL BIOL, V172, P999, DOI 10.1083/jcb.200512136; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Horikawa DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064793; Horikawa DD, 2012, ASTROBIOLOGY, V12, P283, DOI 10.1089/ast.2011.0669; Jonsson I, 2013, J LIMNOL, V72, P73, DOI 10.4081/jlimnol.2013.s1.e9; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, ASTROBIOLOGY, V7, P757, DOI 10.1089/ast.2006.0088; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Jonsson KI, 2003, PHYSIOL BIOCHEM ZOOL, V76, P429; Kappas NC, 2000, MOL BIOL CELL, V11, P3101, DOI 10.1091/mbc.11.9.3101; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Krisko A, 2012, P NATL ACAD SCI USA, V109, P2354, DOI 10.1073/pnas.1119762109; Lisowska H, 2014, INT J RADIAT BIOL, V90, P318, DOI 10.3109/09553002.2014.887233; McLennan AG, 2009, J EXP BIOL, V212, P785, DOI 10.1242/jeb.023663; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; Nilsson EJC, 2010, INT J RADIAT BIOL, V86, P420, DOI 10.3109/09553000903568001; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Santos-Ahmed J, 2011, REPROD TOXICOL, V31, P17, DOI 10.1016/j.reprotox.2010.09.012; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092663; Widel M, 2014, FREE RADICAL BIO MED, V68, P278, DOI 10.1016/j.freeradbiomed.2013.12.021; WRIGHT JC, 1989, J EXP BIOL, V142, P267	38	27	27	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133658	10.1371/journal.pone.0133658	http://dx.doi.org/10.1371/journal.pone.0133658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208275	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000116
J	Callol, A; Reyes-Lopez, FE; Roig, FJ; Goetz, G; Goetz, FW; Amaro, C; MacKenzie, SA				Callol, Agnes; Reyes-Lopez, Felipe E.; Roig, Francisco J.; Goetz, Giles; Goetz, Frederick W.; Amaro, Carmen; MacKenzie, Simon A.			An Enriched European Eel Transcriptome Sheds Light upon Host-Pathogen Interactions with Vibrio vulnificus	PLOS ONE			English	Article							DUPLEX-SPECIFIC NUCLEASE; IMMUNE-RELATED GENES; EXPRESSION PROFILE; VIRULENCE PLASMID; CELL-DEATH; SEROVAR-E; RESPONSES; GILLS; IMMUNOGENOMICS; IDENTIFICATION	Infectious diseases are one of the principal bottlenecks for the European eel recovery. The aim of this study was to develop a new molecular tool to be used in host-pathogen interaction experiments in the eel. To this end, we first stimulated adult eels with different pathogen-associated molecular patterns (PAMPs), extracted RNA from the immune-related tissues and sequenced the transcriptome. We obtained more than 2x10(6) reads that were assembled and annotated into 45,067 new descriptions with a notable representation of novel transcripts related with pathogen recognition, signal transduction and the immune response. Then, we designed a DNA-microarray that was used to analyze the early immune response against Vibrio vulnificus, a septicemic pathogen that uses the gills as the portal of entry into the blood, as well as the role of the main toxin of this species (RtxA1(3)) on this early interaction. The gill transcriptomic profiles obtained after bath infecting eels with the wild type strain or with a mutant deficient in rtxA1(3) were analyzed and compared. Results demonstrate that eels react rapidly and locally against the pathogen and that this immuneresponse is rtxA1(3)-dependent as transcripts related with cell destruction were highly up-regulated only in the gills from eels infected with the wild-type strain. Furthermore, significant differences in the immune response against the wild type and the mutant strain also suggest that host survival after V. vulnificus infection could depend on an efficient local phagocytic activity. Finally, we also found evidence of the presence of an interbranchial lymphoid tissue in European eel gills although further experiments will be necessary to identify such tissue.	[Callol, Agnes; Roig, Francisco J.; Amaro, Carmen] Univ Valencia, Dept Microbiol & Ecol, E-46100 Burjassot, Spain; [Callol, Agnes; Reyes-Lopez, Felipe E.; MacKenzie, Simon A.] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Reyes-Lopez, Felipe E.] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol Anim & Immunol, Bellaterra, Spain; [Goetz, Giles; Goetz, Frederick W.] NW Fisheries Sci Ctr, Seattle, WA USA; [MacKenzie, Simon A.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland	University of Valencia; Autonomous University of Barcelona; Autonomous University of Barcelona; National Oceanic Atmospheric Admin (NOAA) - USA; University of Stirling	MacKenzie, SA (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain.	simon.mackenzie@stir.ac.uk	Amaro, Carmen/K-7873-2014; Reyes-López, Felipe E./S-1760-2018; MacKenzie, Simon/Q-2362-2019	Amaro, Carmen/0000-0003-1323-6330; Reyes-López, Felipe E./0000-0002-5001-457X; MacKenzie, Simon/0000-0003-1845-6826; Roig Molina, Francisco Jose/0000-0002-8853-2428	FEDER funds [AGL2011-29639]; MICINN of Spanish Government [CSD2009-00006, CSD2007-00002]; MICINN [BES-2009-024776]; CONICYT [BCH 4311/2013]	FEDER funds(European Commission); MICINN of Spanish Government(Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by AGL2011-29639 (co-funded with FEDER funds), and Consolider-Ingenio Programs CSD2009-00006 and CSD2007-00002 from MICINN of Spanish Government. Grant support to Agnes Callol (BES-2009-024776, MICINN) and Felipe E. Reyes-Lopez (BCH 4311/2013, CONICYT) are thankfully acknowledged.	Aachoui Y, 2013, CURR OPIN MICROBIOL, V16, P319, DOI 10.1016/j.mib.2013.04.004; Adams A, 2006, TRENDS BIOTECHNOL, V24, P201, DOI 10.1016/j.tibtech.2006.03.004; Amaro C, 1996, APPL ENVIRON MICROB, V62, P1454, DOI 10.1128/AEM.62.4.1454-1457.1996; Aoyama J, 2001, MOL PHYLOGENET EVOL, V20, P450, DOI 10.1006/mpev.2001.0959; Austin B., 2012, BACTERIAL FISH PATHO; Baillon L, 2015, ECOTOXICOLOGY, V24, P71, DOI 10.1007/s10646-014-1356-x; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bright MD, 2011, INT J BIOCHEM CELL B, V43, P1776, DOI 10.1016/j.biocel.2011.08.015; Buonaguro L, 2011, IMMUNOL REV, V239, P197, DOI 10.1111/j.1600-065X.2010.00971.x; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Callol A, 2015, FISH SHELLFISH IMMUN, V43, P502, DOI 10.1016/j.fsi.2015.01.009; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Cummings RD, 2009, ESSENTIALS GLYCOBIOL; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Douglas SE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-144; Douglas SE, 2006, OMICS, V10, P474, DOI 10.1089/omi.2006.10.474; Esteve-Gassent MD, 2003, FISH SHELLFISH IMMUN, V15, P51, DOI 10.1016/S1050-4648(02)00138-9; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Garlanda C, 2013, SEMIN IMMUNOL, V25, P408, DOI 10.1016/j.smim.2013.10.019; Gerdol M, 2015, MAR GENOM, V20, P13, DOI 10.1016/j.margen.2014.12.005; Gu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09836; Haugarvoll E, 2008, J ANAT, V213, P202, DOI 10.1111/j.1469-7580.2008.00943.x; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kalujnaia S, 2007, PHYSIOL GENOMICS, V31, P385, DOI 10.1152/physiolgenomics.00059.2007; Kim YR, 2013, J INFECT DIS, V207, P1406, DOI 10.1093/infdis/jis746; Kirkegaard E, 2010, DTU AQUA REPORT NO 2; Koppang EO, 2010, J ANAT, V217, P728, DOI 10.1111/j.1469-7580.2010.01305.x; Lee CT, 2008, J BACTERIOL, V190, P1638, DOI 10.1128/JB.01484-07; Lee CT, 2013, ENVIRON MICROBIOL, V15, P419, DOI 10.1111/j.1462-2920.2012.02854.x; Lee JH, 2007, J MICROBIOL, V45, P146; Li YW, 2011, PARASITE IMMUNOL, V33, P679, DOI 10.1111/j.1365-3024.2011.01337.x; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Marco-Noales E, 2001, APPL ENVIRON MICROB, V67, P4717, DOI 10.1128/AEM.67.10.4717-4725.2001; Mayank G, 2009, INT J PHARM RES DEV, V1, P1; Minegishi Y, 2012, MAR BIOTECHNOL, V14, P583, DOI 10.1007/s10126-012-9444-5; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Mohd-Shaharuddin N, 2013, FISH SHELLFISH IMMUN, V34, P762, DOI 10.1016/j.fsi.2012.11.052; Nielsen T., 2008, FAO Fisheries Technical Paper, P141; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ohara O, 2009, FEBS LETT, V583, P1662, DOI 10.1016/j.febslet.2009.04.021; Ortiz NN, 2014, DEV COMP IMMUNOL, V47, P309, DOI 10.1016/j.dci.2014.07.015; Pajuelo D, 2015, ENVIRON MICROBIOL, DOI [10.1111/1462-2920.1278, DOI 10.1111/1462-2920.1278]; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Press C, 1999, FISH SHELLFISH IMMUN; Rebl A, 2014, MAR BIOTECHNOL, V16, P333, DOI 10.1007/s10126-013-9552-x; Ribas L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-180; Ricciardi-Castagnoli P, 2002, NAT REV IMMUNOL, V2, P881, DOI 10.1038/nri936; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sainz J, 2007, ARTERIOSCL THROM VAS, V27, P263, DOI 10.1161/01.ATV.0000256727.34148.e2; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Thebault P, 2009, J IMMUNOL, V183, P3099, DOI 10.4049/jimmunol.0803767; Valiente E, 2008, FISH SHELLFISH IMMUN, V24, P134, DOI 10.1016/j.fsi.2007.10.007; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-356; Yufera M, 2012, MAR BIOTECHNOL, V14, P423, DOI 10.1007/s10126-011-9422-3; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	61	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133328	10.1371/journal.pone.0133328	http://dx.doi.org/10.1371/journal.pone.0133328			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207370	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000078
J	Hwang, S; Aronov, A; Bar-Peled, M				Hwang, Soyoun; Aronov, Avi; Bar-Peled, Maor			The Biosynthesis of UDP-D-QuiNAc in Bacillus cereus ATCC 14579	PLOS ONE			English	Article							O-ANTIGENIC POLYSACCHARIDE; IN-VITRO BIOSYNTHESIS; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL-CHARACTERIZATION; RHIZOBIUM-PHASEOLI; H-1-NMR SPECTRA; D-QUINOVOSAMINE; LIPOPOLYSACCHARIDE; 4,6-DEHYDRATASE; IDENTIFICATION	N-acetylquinovosamine (2-acetamido-2,6-di-deoxy-D-glucose, QuiNAc) is a relatively rare amino sugar residue found in glycans of few pathogenic gram-negative bacteria where it can play a role in infection. However, little is known about QuiNAc-related polysaccharides in gram-positive bacteria. In a routine screen for bacillus glycan grown at defined medium, it was surprising to identify a QuiNAc residue in polysaccharides isolated from this gram-positive bacterium. To gain insight into the biosynthesis of these glycans, we report the identification of an operon in Bacillus cereus ATCC 14579 that contains two genes encoding activities not previously described in gram-positive bacteria. One gene encodes a UDP-N-acetylglucosamine C4,6-dehydratase, (abbreviated Pdeg) that converts UDP-GlcNAc to UDP-4-keto-4,6-D-deoxy-GlcNAc (UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-4-hexulose); and the second encodes a UDP-4-reductase (abbr. Preq) that converts UDP-4-keto-4,6-D-deoxy-GlcNAc to UDP-N-acetyl-quinovosamine in the presence of NADPH. Biochemical studies established that the sequential Pdeg and Preq reaction product is UDP-D-QuiNAc as determined by mass spectrometry and one- and two-dimensional NMR experiments. Also, unambiguous evidence for the conversions of the dehydratase product, UDP-alpha-D-4-keto-4,6-deoxy-GlcNAc, to UDP-alpha-D-QuiNAc was obtained using real-time H-1-NMR spectroscopy and mass spectrometry. The two genes overlap by 4 nucleotides and similar operon organization and identical gene sequences were also identified in a few other Bacillus species suggesting they may have similar roles in the lifecycle of this class of bacteria important to human health. Our results provide new information about the ability of Bacilli to form UDP-QuiNAc and will provide insight to evaluate their role in the biology of Bacillus.	[Hwang, Soyoun; Aronov, Avi; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu		Aronov, Avi/0000-0003-1781-6068	US Department of Energy [UG1021RR549475]	US Department of Energy(United States Department of Energy (DOE))	This works was supported by UG1021RR549475, US Department of Energy, (http://energy.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard STM, 2000, ACTA CRYSTALLOGR D, V56, P222, DOI 10.1107/S0907444999016200; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; BOWSER DV, 1974, INFECT IMMUN, V9, P772, DOI 10.1128/IAI.9.4.772-774.1974; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Bretthauer RK, 2009, CURR DRUG TARGETS, V10, P477, DOI 10.2174/138945009788488369; Bubb WA, 2003, CONCEPT MAGN RESON A, V19A, P1, DOI 10.1002/cmr.a.10080; CARLSON RW, 1987, J BACTERIOL, V169, P4923, DOI 10.1128/jb.169.11.4923-4928.1987; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; De Castro C, 2013, P NATL ACAD SCI USA, V110, P13956, DOI 10.1073/pnas.1313005110; Forsberg LS, 2003, J BIOL CHEM, V278, P51347, DOI 10.1074/jbc.M309016200; Forsberg LS, 2000, J BIOL CHEM, V275, P18851, DOI 10.1074/jbc.M001090200; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Hartley MD, 2011, BIOCHEMISTRY-US, V50, P4936, DOI 10.1021/bi2003372; HRABAK EM, 1981, J BACTERIOL, V148, P697, DOI 10.1128/JB.148.2.697-711.1981; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; ITO M, 1993, CARBOHYD RES, V242, P173, DOI 10.1016/0008-6215(93)80032-A; King JD, 2009, FEBS J, V276, P2686, DOI 10.1111/j.1742-4658.2009.06993.x; Li TZ, 2014, J BIOL CHEM, V289, P18110, DOI 10.1074/jbc.M114.555862; Li Z, 2015, J BIOL CHEM, V290, P691, DOI 10.1074/jbc.M114.612747; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Martinez V, 2012, J BIOL CHEM, V287, P879, DOI 10.1074/jbc.M111.287367; Miyafusa T, 2013, BIOSCIENCE REP, V33; Morrison MJ, 2014, BIOCHEMISTRY-US, V53, P624, DOI 10.1021/bi401546r; Morrison MJ, 2013, ARCH BIOCHEM BIOPHYS, V536, P72, DOI 10.1016/j.abb.2013.05.011; NOEL KD, 1986, J BACTERIOL, V168, P1392, DOI 10.1128/jb.168.3.1392-1401.1986; Olivier NB, 2006, BIOCHEMISTRY-US, V45, P13659, DOI 10.1021/bi061456h; Osipiuk J, PDB 3PVZ UNPUB; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SHARON N, 1964, BIOCHEM J, V93, P210, DOI 10.1042/bj0930210; SONESSON A, 1989, ARCH MICROBIOL, V153, P72, DOI 10.1007/BF00277544; Stanley P SH, 2009, ESSENTIALS GLYCOBIOL	37	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133790	10.1371/journal.pone.0133790	http://dx.doi.org/10.1371/journal.pone.0133790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207987	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000143
J	Rubtsova, SN; Zhitnyak, IY; Gloushankova, NA				Rubtsova, Svetlana N.; Zhitnyak, Irina Y.; Gloushankova, Natalya A.			A Novel Role of E-Cadherin-Based Adherens Junctions in Neoplastic Cell Dissemination	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL BARRIER; BREAST-CANCER; ACTIN CYTOSKELETON; ALPHA-CATENIN; BETA-CATENIN; EXPRESSION; CARCINOMA; INVASION; METASTASIS	Using confocal microscopy, we analyzed the behavior of IAR-6-1, IAR1170, and IAR1162 transformed epithelial cells seeded onto the confluent monolayer of normal IAR-2 epithelial cells. Live-cell imaging of neoplastic cells stably expressing EGFP and of normal epithelial cells stably expressing mKate2 showed that transformed cells retaining expression of E-cadherin were able to migrate over the IAR-2 epithelial monolayer and invade the monolayer. Transformed IAR cells invaded the IAR-2 monolayer at the boundaries between normal cells. Studying interactions of IAR-6-1 transformed cells stably expressing GFP-E-cadherin with the IAR-2 epithelial monolayer, we found that IAR-6-1 cells established E-cadherin-based adhesions with normal epithelial cells: dot-like dynamic E-cadherin-based adhesions in protrusions and large adherens junctions at the cell sides and rear. A comparative study of a panel of transformed IAR cells that differ by their ability to form E-cadherin-based AJs, either through loss of E-cadherin expression or through expression of a dominant negative E-cadherin mutant, demonstrated that E-cadherin-based AJs are key mediators of the interactions between neoplastic and normal epithelial cells. IAR-6-1DNE cells expressing a dominant-negative mutant form of E-cadherin with the mutation in the first extracellular domain practically lost the ability to adhere to IAR-2 cells and invade the IAR-2 epithelial monolayer. The ability of cancer cells to form E-cadherin-based AJs with the surrounding normal epithelial cells may play an important role in driving cancer cell dissemination in the body.	[Rubtsova, Svetlana N.; Zhitnyak, Irina Y.; Gloushankova, Natalya A.] NN Blokhin Russian Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia	N.N. Blokhin Russian Cancer Research Center	Gloushankova, NA (corresponding author), NN Blokhin Russian Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia.	natglu@hotmail.com	Zhitnyak, Irina Y/I-2967-2015; Rubtsova, Svetlana/R-7178-2019; Gloushankova, Natalya/S-2577-2019	Zhitnyak, Irina Y/0000-0002-6717-3745; Rubtsova, Svetlana/0000-0003-4620-7851; Gloushankova, Natalya/0000-0002-2044-2063	Russian Foundation for Basic Research [13-04-01423a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Foundation for Basic Research grant #13-04-01423a to NAG (http://www.rfbr.ru/rffi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayollo DV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008027; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bukholm IK, 2000, J PATHOL, V190, P15; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Garcia-Roman J, 2013, CANCER LETT, V335, P259, DOI 10.1016/j.canlet.2013.03.005; Gavard Julie, 2014, Cell Adh Migr, V8, P158; Gavert N, 2011, MOL CANCER RES, V9, P14, DOI 10.1158/1541-7786.MCR-10-0406; Hashizume R, 1996, HISTOPATHOLOGY, V29, P139, DOI 10.1046/j.1365-2559.1996.d01-499.x; Heyder C, 2002, J CANCER RES CLIN, V128, P533, DOI 10.1007/s00432-002-0377-7; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kartenbeck J, 2005, EUR J CELL BIOL, V84, P417, DOI 10.1016/j.ejcb.2005.01.005; Kenny HA, 2009, CANCER TREAT RES, V149, P335, DOI 10.1007/978-0-387-98094-2_16; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Klingelhofer J, 2002, MOL CELL BIOL, V22, P7449, DOI 10.1128/MCB.22.21.7449-7458.2002; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Mazurov D, 2012, J VIROL, V86, P2447, DOI 10.1128/JVI.06993-11; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; MONTESANO R, 1975, INT J CANCER, V16, P550, DOI 10.1002/ijc.2910160405; Oda H, 2011, J CELL BIOL, V193, P1137, DOI 10.1083/jcb.201008173; Oldenburg J, 2014, CELL TISSUE RES, V355, P545, DOI 10.1007/s00441-013-1792-6; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rakha EA, 2013, HISTOPATHOLOGY, V62, P695, DOI 10.1111/his.12066; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vasioukhin Valeri, 2012, Subcell Biochem, V60, P379, DOI 10.1007/978-94-007-4186-7_16; Vered M, 2012, HISTOL HISTOPATHOL, V27, P141, DOI 10.14670/HH-27.141; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Voura EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078413; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wu C, 2008, DIFFERENTIATION, V76, P193, DOI 10.1111/j.1432-0436.2007.00193.x; Zhitnyak IY, 2011, RUSS J DEV BIOL+, V42, P402, DOI 10.1134/S1062360411050110	44	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133578	10.1371/journal.pone.0133578	http://dx.doi.org/10.1371/journal.pone.0133578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207916	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000102
J	Ryo, M; Iwasaki, Y; Yoshimura, C; Oliver, VOC				Ryo, Masahiro; Iwasaki, Yuichi; Yoshimura, Chihiro; Saavedra, Oliver C., V			Evaluation of Spatial Pattern of Altered Flow Regimes on a River Network Using a Distributed Hydrological Model	PLOS ONE			English	Article							MANAGEMENT; FRAMEWORK; CRITERIA; SCIENCE; DAMS	Alteration of the spatial variability of natural flow regimes has been less studied than that of the temporal variability, despite its ecological importance for river ecosystems. Here, we aimed to quantify the spatial patterns of flow regime alterations along a river network in the Sagami River, Japan, by estimating river discharge under natural and altered flow conditions. We used a distributed hydrological model, which simulates hydrological processes spatiotemporally, to estimate 20-year daily river discharge along the river network. Then, 33 hydrologic indices (i.e., Indicators of Hydrologic Alteration) were calculated from the simulated discharge to estimate the spatial patterns of their alterations. Some hydrologic indices were relatively well estimated such as the magnitude and timing of maximum flows, monthly median flows, and the frequency of low and high flow pulses. The accuracy was evaluated with correlation analysis (r > 0.4) and the Kolmogorov-Smirnov test (alpha = 0.05) by comparing these indices calculated from both observed and simulated discharge. The spatial patterns of the flow regime alterations varied depending on the hydrologic indices. For example, both the median flow in August and the frequency of high flow pulses were reduced by the maximum of approximately 70%, but these strongest alterations were detected at different locations (i.e., on the mainstream and the tributary, respectively). These results are likely caused by different operational purposes of multiple water control facilities. The results imply that the evaluation only at discharge gauges is insufficient to capture the alteration of the flow regime. Our findings clearly emphasize the importance of evaluating the spatial pattern of flow regime alteration on a river network where its discharge is affected by multiple water control facilities.	[Ryo, Masahiro; Yoshimura, Chihiro; Saavedra, Oliver C., V] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 152, Japan; [Iwasaki, Yuichi] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	Tokyo Institute of Technology; Colorado State University	Ryo, M (corresponding author), Eawag, Dept Aquat Ecol, Dubendorf, Switzerland.	masahiroryo@gmail.com	Iwasaki, Yuichi/A-4634-2009; Ryo, Masahiro/AAL-7294-2020	Iwasaki, Yuichi/0000-0001-7006-8113; Ryo, Masahiro/0000-0002-5271-3446; Saavedra, Oliver/0000-0002-1674-7737	Japan Society for the Promotion of Science [26.11771]; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japan Society for the Promotion of Science, grant Number 26.11771 (http://www.jsps.go.jp/english/index.html) to MR, and Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, grant Number not allocated (http://www.jst.go.jp/kisoken/crest/en/index.html) to CY.	[Anonymous], 2014, R LANG ENV STAT COMP; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Brocca L, 2010, HYDROL EARTH SYST SC, V14, P1881, DOI 10.5194/hess-14-1881-2010; Brutsaert W., 1982, EVAPORATION ATMOSPHE, P302, DOI [10.1007/978-94-017-1497-6, DOI 10.1007/978-94-017-1497-6]; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Carlisle DM, 2010, RIVER RES APPL, V26, P118, DOI 10.1002/rra.1247; Commission on Dams in Kanto region, 2011, REG REP EV MIYAG; DUAN QY, 1994, J HYDROL, V158, P265, DOI 10.1016/0022-1694(94)90057-4; Gan TY, 1997, J HYDROL, V192, P81, DOI 10.1016/S0022-1694(96)03114-9; Graf WL, 2006, GEOMORPHOLOGY, V79, P336, DOI 10.1016/j.geomorph.2006.06.022; Ishidaira H, 2000, P JAP SOC CIV ENG AN, P11; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Kiffney PM, 2006, CAN J FISH AQUAT SCI, V63, P2518, DOI 10.1139/F06-138; Larned ST, 2010, J AM WATER RESOUR AS, V46, P541, DOI 10.1111/j.1752-1688.2010.00433.x; Larned ST, 2011, ECOHYDROLOGY, V4, P532, DOI 10.1002/eco.126; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Magilligan FJ, 2005, GEOMORPHOLOGY, V71, P61, DOI 10.1016/j.geomorph.2004.08.017; Maidment D.R., 1993, HDB HYDROLOGY; Murphy JC, 2013, RIVER RES APPL, V29, P660, DOI 10.1002/rra.2570; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; Postel S, 2003, RIVERS LIFE MANAGING; Pushpalatha R, 2012, J HYDROL, V420, P171, DOI 10.1016/j.jhydrol.2011.11.055; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Richter BD, 1998, REGUL RIVER, V14, P329; Richter BD, 1997, FRESHWATER BIOL, V37, P231, DOI 10.1046/j.1365-2427.1997.00153.x; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Robinson JS, 1996, HYDROL PROCESS, V10, P845, DOI 10.1002/(SICI)1099-1085(199606)10:6&lt;845::AID-HYP375&gt;3.0.CO;2-7; Ryo M, 2011, ANN J HYDRAUL ENG, V55, P1459; Ryo M, 2014, J HYDROMETEOROL, V15, P563, DOI 10.1175/JHM-D-13-052.1; Shrestha RR, 2014, HYDROL PROCESS, V28, P4294, DOI 10.1002/hyp.9997; Snelder TH, 2009, J HYDROL, V373, P57, DOI 10.1016/j.jhydrol.2009.04.011; Stanford JA, 2001, REGUL RIVER, V17, P303, DOI 10.1002/rrr.659; Suen JP, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004314; The Nature Conservancy, 2009, IND HYDR ALT VERS 7; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Verdin KL, 1999, J HYDROL, V218, P1, DOI 10.1016/S0022-1694(99)00011-6; Wohling T, 2013, ENVIRON EARTH SCI, V69, P453, DOI 10.1007/s12665-013-2306-2; Yang D, 2002, HYDROLOG SCI J, V47, P49, DOI 10.1080/02626660209492907; Yang D, 2000, HYDROL PROCESS, V14, P403, DOI 10.1002/(SICI)1099-1085(20000228)14:3&lt;403::AID-HYP945&gt;3.0.CO;2-3	44	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133833	10.1371/journal.pone.0133833	http://dx.doi.org/10.1371/journal.pone.0133833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207997	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000153
J	Smerlak, M; Stoll, B; Gupta, A; Magdanz, JS				Smerlak, Matteo; Stoll, Brady; Gupta, Agam; Magdanz, James S.			Mapping Systemic Risk: Critical Degree and Failures Distribution in Financial Networks	PLOS ONE			English	Article							DEFAULT CASCADES; TOPOLOGY; MODEL; INSURANCE; EVOLUTION; MARKET	The financial crisis illustrated the need for a functional understanding of systemic risk in strongly interconnected financial structures. Dynamic processes on complex networks being intrinsically difficult to model analytically, most recent studies of this problem have relied on numerical simulations. Here we report analytical results in a network model of interbank lending based on directly relevant financial parameters, such as interest rates and leverage ratios. We obtain a closed-form formula for the "critical degree" (the number of creditors per bank below which an individual shock can propagate throughout the network), and relate failures distributions to network topologies, in particular scalefree ones. Our criterion for the onset of contagion turns out to be isomorphic to the condition for cooperation to evolve on graphs and social networks, as recently formulated in evolutionary game theory. This remarkable connection supports recent calls for a methodological rapprochement between finance and ecology.	[Smerlak, Matteo] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Stoll, Brady] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA; [Gupta, Agam] Indian Inst Management Calcutta, Kolkata 700104, W Bengal, India; [Magdanz, James S.] Univ Alaska Fairbanks, Resilience & Adaptat Program, Fairbanks, AK 99775 USA	Perimeter Institute for Theoretical Physics; University of Texas System; University of Texas Austin; Indian Institute of Management (IIM System); Indian Institute of Management Calcutta; University of Alaska System; University of Alaska Fairbanks	Smerlak, M (corresponding author), Perimeter Inst Theoret Phys, 31 Caroline St North, Waterloo, ON N2L 2Y5, Canada.	msmerlak@perimeterinstitute.ca	Magdanz, James S/C-9348-2011; Smerlak, Matteo/AAA-5639-2022	Magdanz, James S/0000-0002-2412-2788; Smerlak, Matteo/0000-0002-0844-8868	Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation	Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	Research at the Perimeter Institute is supported in part by the Government of Canada through Industry Canada and by the Province of Ontario through the Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D., 2013, 134 COL BUS SCH; Aghion P, 2000, EUR ECON REV, V44, P713, DOI 10.1016/S0014-2921(00)00058-1; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Allen F, 2009, ANNU REV FINANC ECON, V1, P97, DOI 10.1146/annurev.financial.050808.114321; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P18338, DOI 10.1073/pnas.1213767109; Ashcraft AB, 2007, AM ECON REV, V97, P221, DOI 10.1257/aer.97.2.221; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Basel III Basel C., 2010, BASEL; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Battiston S, 2012, J FINANC STABIL, V8, P138, DOI 10.1016/j.jfs.2012.01.002; Bech ML, 2010, PHYSICA A, V389, P5223, DOI 10.1016/j.physa.2010.05.058; Billio M, 2012, J FINANC ECON, V104, P535, DOI 10.1016/j.jfineco.2011.12.010; Bisias D, 2012, ANNU REV FINANC ECON, V4, P255, DOI 10.1146/annurev-financial-110311-101754; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; Caccioli F., 2012, 201210018 SFI; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; de Bandt, 2000, EUROPEAN CENTRAL BAN; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; Eisenberg L, 2001, MANAGE SCI, V47, P236, DOI 10.1287/mnsc.47.2.236.9835; Fotouhi B, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40920-6; Freixas X., 2010, 371 FRB NEW YORK STA, V371; Furfine C., 1999, FINANCIAL MARKETS IN, V8, P24, DOI DOI 10.1111/1468-0416.00031; Furfine CH, 2003, J MONEY CREDIT BANK, V35, P111, DOI 10.1353/mcb.2003.0004; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; Garlaschelli D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268701; Haldane A., 2009, BIS REV, V18; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Inoguchi M, 2013, PAC-BASIN FINANC J, V25, P136, DOI 10.1016/j.pacfin.2013.08.006; Kambhu J., 2007, NEW DIRECTIONS UNDER; Markose S, 2012, J ECON BEHAV ORGAN, V83, P627, DOI 10.1016/j.jebo.2012.05.016; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; May RM, 2010, J R SOC INTERFACE, V7, P823, DOI 10.1098/rsif.2009.0359; Minoiu C, 2013, J FINANC STABIL, V9, DOI 10.1016/j.jfs.2013.03.001; Mistrulli PE, 2011, J BANK FINANC, V35, P1114, DOI 10.1016/j.jbankfin.2010.09.018; Musmeci N, 2013, J STAT PHYS, V151, P720, DOI 10.1007/s10955-013-0720-1; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016132, 10.1103/PhysRevE.64.026118]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nguyen G., 2007, INT J CENTRAL BANKIN, V3, P123, DOI DOI 10.2139/ssrn.1691645; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; POSTLEWAITE A, 1987, J POLIT ECON, V95, P485, DOI 10.1086/261468; Propper M., 2008, NETWORK DESCRIPTION, V177, P1; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roukny T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02759; Soramaki K, 2007, PHYSICA A, V379, P317, DOI 10.1016/j.physa.2006.11.093; Stiglitz JE, 2010, AM ECON REV, V100, P388, DOI 10.1257/aer.100.2.388; Taylor J. B., 2008, 13943 NBER, P36; Temme NM, 2003, J COMPUT APPL MATH, V153, P441, DOI 10.1016/S0377-0427(02)00627-1; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	54	10	11	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130948	10.1371/journal.pone.0130948	http://dx.doi.org/10.1371/journal.pone.0130948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26207631	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000009
J	Tsang, SY; Mei, LL; Wan, WQ; Li, J; Li, Y; Zhao, CY; Ding, XF; Pun, FW; Hu, XX; Wang, JM; Zhang, JY; Luo, RC; Cheung, ST; Leung, GKK; Poon, WS; Ng, HK; Zhang, LW; Xue, H				Tsang, Shui-Ying; Mei, Lingling; Wan, Weiqing; Li, Jun; Li, Yi; Zhao, Cunyou; Ding, Xiaofan; Pun, Frank W.; Hu, Xiaoxia; Wang, Jianmin; Zhang, Junyi; Luo, Rongcheng; Cheung, Siu-Tim; Leung, Gilberto K. K.; Poon, Wai-Sang; Ng, Ho-Keung; Zhang, Liwei; Xue, Hong			Glioma Association and Balancing Selection of ZFPM2	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; GENE; FOG-2; POLYMORPHISMS; EXPRESSION; COFACTOR; HEART; MICE; EPIDEMIOLOGY; RESISTANCE	ZFPM2, encoding a zinc finger protein and abundantly expressed in the brain, uterus and smooth muscles, plays important roles in cardiac and gonadal development. Abnormal expression of ZFPM2 in ovarian tumors and neuroblastoma has been reported but hitherto its genetic association with cancer and effects on gliomas have not been studied. In the present study, the hexamer insertion-deletion polymorphism rs71305152, located within a large haplotype block spanning intron 1 to intron 3 of ZFPM2, was genotyped in Chinese cohorts of glioma (n = 350), non-glioma cancer (n = 354) and healthy control (n = 463) by direct sequencing and length polymorphism in gel electrophoresis, and ZFPM2 expression in glioma tissues (n = 69) of different grades was quantified by real-time RT-PCR. Moreover, potential natural selection pressure acting on the gene was investigated. Disease-association analysis showed that the overall genotype of rs71305152 was significantly associated with gliomas (P = 0.016), and the heterozygous genotype compared to the combined homozygous genotypes was less frequent in gliomas than in controls (P = 0.005) or non-glioma cancers (P = 0.020). ZFPM2 mRNA expression was negatively correlated with the grades of gliomas (P = 0.002), with higher expression levels in the low-grade gliomas. In the astrocytoma subtype, higher ZFPM2 expression was also correlated with the rs71305152 heterozygous genotype (P = 0.028). In addition, summary statistics tests gave highly positive values, demonstrating that the gene is under the influence of balancing selection. These findings suggest that ZFPM2 is a glioma susceptibility gene, its genotype and expression showing associations with incidence and severity, respectively. Moreover, the balancing selection acting on ZFPM2 may be related to the important roles it has to play in multiple organ development or associated disease etiology.	[Tsang, Shui-Ying; Mei, Lingling; Zhao, Cunyou; Ding, Xiaofan; Pun, Frank W.; Xue, Hong] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Tsang, Shui-Ying; Mei, Lingling; Zhao, Cunyou; Ding, Xiaofan; Pun, Frank W.; Xue, Hong] Hong Kong Univ Sci & Technol, Appl Genom Ctr, Clear Water Bay, Hong Kong, Peoples R China; [Wan, Weiqing; Zhang, Liwei] Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, Beijing, Peoples R China; [Li, Jun; Li, Yi; Poon, Wai-Sang] Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Hu, Xiaoxia; Wang, Jianmin] Second Mil Med Univ, Dept Hematol, Inst Hematol, PLA,Changhai Hosp, Shanghai, Peoples R China; [Zhang, Junyi; Luo, Rongcheng] Southern Med Univ, Nanfang Hosp, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Cheung, Siu-Tim; Leung, Gilberto K. K.] Univ Hong Kong, Div Neurosurg, Dept Surg, Li Ka Shing Fac Med,Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Ng, Ho-Keung] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Capital Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Naval Medical University; Southern Medical University - China; University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Zhang, LW (corresponding author), Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, Beijing, Peoples R China.	zlwtt@yahoo.com.cn; hxue@ust.hk	DING, Xiaofan/GLS-2274-2022; Poon, Wai Sang/F-1558-2011; Cheung, Siu-Tim/C-4238-2009; Poon, Wai S/HGD-3084-2022; ZHAO, Cunyou/Q-5076-2016; Ng, Ho Keung/I-3952-2015; wang, jian/GVS-0711-2022; Leung, Gilberto Ka Kit/C-4337-2009	Cheung, Siu-Tim/0000-0003-2147-315X; ZHAO, Cunyou/0000-0001-6116-4584; Leung, Gilberto Ka Kit/0000-0003-3147-3057; DING, Xiaofan/0000-0003-2565-7757; Xue, Hong/0000-0002-8133-9828	University Grants Council of Hong Kong SAR [VPRDO09/10.SC08, VPRDO14SC01, DG14SC02, SRFI11SC06, SRFI11SC06PG]; 863 Program, Ministry of Science and Technology, China [2012AA02A201]	University Grants Council of Hong Kong SAR; 863 Program, Ministry of Science and Technology, China(National High Technology Research and Development Program of China)	The study was supported by grants to HX from the University Grants Council of Hong Kong SAR (VPRDO09/10.SC08, VPRDO14SC01, DG14SC02, SRFI11SC06 and SRFI11SC06PG) and a grant to LZ from 863 Program, Ministry of Science and Technology, China (2012AA02A201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; Andersson U, 2010, ACTA ONCOL, V49, P767, DOI 10.3109/0284186X.2010.480980; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Chakrabarti I, 2005, CANCER-AM CANCER SOC, V104, P2798, DOI 10.1002/cncr.21539; Chen HY, 2011, AM J EPIDEMIOL, V173, P915, DOI 10.1093/aje/kwq457; Chen ZJ, 2013, TECHNOL CANCER RES T, V12, P91, DOI 10.7785/tcrt.2012.500250; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dobbins SE, 2011, INT J CANCER, V128, P1736, DOI 10.1002/ijc.25483; Dubrow R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-325; Fan WW, 2011, J NEURO-ONCOL, V105, P211, DOI 10.1007/s11060-011-0586-5; Fazeny-Dorner B, 2003, ANTI-CANCER DRUG, V14, P305, DOI 10.1097/00001813-200304000-00008; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Finelli P, 2007, CLIN GENET, V71, P195, DOI 10.1111/j.1399-0004.2007.00752.x; FU YX, 1993, GENETICS, V133, P693; Garnatz AS, 2014, DEV BIOL, V395, P50, DOI 10.1016/j.ydbio.2014.08.030; Hamm D, 2007, AM J HUM GENET, V81, P44, DOI 10.1086/518695; Hedrick P.W., 2011, GENETICS POPULATIONS; Hoene V, 2009, BRIT J CANCER, V101, P1481, DOI 10.1038/sj.bjc.6605276; Hou WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037531; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kabat GC, 2010, CANCER EPIDEM BIOMAR, V19, P2421, DOI 10.1158/1055-9965.EPI-10-0658; Key FM, 2014, CURR OPIN GENET DEV, V29, P45, DOI 10.1016/j.gde.2014.08.001; Koika V, 2012, EUR J ENDOCRINOL, V166, P695, DOI 10.1530/EJE-11-0894; Laitinen MPE, 2000, J CLIN ENDOCR METAB, V85, P3476, DOI 10.1210/jc.85.9.3476; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li G, 2012, CANCER EPIDEMIOL, V36, P525, DOI 10.1016/j.canep.2012.06.008; Li R, 2011, INT J CANCER, V128, P166, DOI 10.1002/ijc.25306; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu WD, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-76; Lopez C, 2010, GENE, V467, P1, DOI 10.1016/j.gene.2010.07.008; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Manuylov NL, 2007, ONCOGENE, V26, P5204, DOI 10.1038/sj.onc.1210333; Mei LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-564; Ng SK, 2010, PLOS ONE, V5, pA18, DOI 10.1371/journal.pone.0009547; Ng SK, 2006, GENE, V368, P110, DOI 10.1016/j.gene.2005.10.034; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Schulz S, 2010, J PERIODONTAL RES, V45, P396, DOI 10.1111/j.1600-0765.2009.01251.x; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Sipos L, 1998, Pathol Oncol Res, V4, P267; Song X, 2012, CARCINOGENESIS, V33, P1065, DOI 10.1093/carcin/bgs117; Sun C, 2011, HUM GENET, V130, P767, DOI 10.1007/s00439-011-1025-6; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; TAJIMA F, 1989, GENETICS, V123, P585; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Wang J, 2008, AM J HUM GENET, V83, P53, DOI 10.1016/j.ajhg.2008.06.010; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhao YJ, 2012, INT J CANCER, V131, P1569, DOI 10.1002/ijc.27417	50	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133003	10.1371/journal.pone.0133003	http://dx.doi.org/10.1371/journal.pone.0133003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207917	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000052
J	Branchini, S; Meschini, M; Covi, C; Piccinetti, C; Zaccanti, F; Goffredo, S				Branchini, Simone; Meschini, Marta; Covi, Claudia; Piccinetti, Corrado; Zaccanti, Francesco; Goffredo, Stefano			Participating in a Citizen Science Monitoring Program: Implications for Environmental Education	PLOS ONE			English	Article							EGYPTIAN RED-SEA; CORAL-REEFS; COASTAL TOURISM; DIVING IMPACTS; SCUBA-DIVERS; MANAGEMENT; BRIEFINGS; DAMAGE; FORCE; AREAS	Tourism is of growing economical importance to many nations, in particular for developing countries. Although tourism is an important economic vehicle for the host country, its continued growth has led to on-going concerns about its environmental sustainability. Coastal and marine tourism can directly affect the environment through direct and indirect tourist activities. For these reasons tourism sector needs practical actions of sustainability. Several studies have shown how education minimizes the impact on and is proactive for, preserving the natural resources. This paper evaluates the effectiveness of a citizen science program to improve the environmental education of the volunteers, by means of questionnaires provided to participants to a volunteer-based Red Sea coral reef monitoring program (STEproject). Fifteen multiple-choice questions evaluated the level of knowledge on the basic coral reef biology and ecology and the awareness on the impact of human behaviour on the environment. Volunteers filled in questionnaires twice, once at the beginning, before being involved in the project and again at the end of their stay, after several days participation in the program. We found that the participation in STEproject significantly increased both the knowledge of coral reef biology and ecology and the awareness of human behavioural impacts on the environment, but was more effective on the former. We also detected that tourists with a higher education level have a higher initial level of environmental education than less educated people and that the project was more effective on divers than snorkelers. This study has emphasized that citizen science projects have an important and effective educational value and has suggested that tourism and diving stakeholders should increase their commitment and efforts to these programs	[Branchini, Simone; Meschini, Marta; Covi, Claudia; Zaccanti, Francesco; Goffredo, Stefano] Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, Marine Sci Grp,Citizen Sci Lab, I-40126 Bologna, Italy; [Piccinetti, Corrado] Univ Bologna, Lab Fisheries & Marine Biol Fano, I-61032 Fano, PU, Italy	University of Bologna; University of Bologna	Goffredo, S (corresponding author), Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, Marine Sci Grp,Citizen Sci Lab, Via F Selmi 3, I-40126 Bologna, Italy.	s.goffredo@unibo.it	Meschini, Marta/AAM-3264-2020	goffredo, stefano/0000-0002-5022-9503; MESCHINI, MARTA/0000-0001-6575-6384; BRANCHINI, SIMONE/0000-0001-6374-8161	Italian Government (Ministry of the Education, University and Research); Egyptian Government (Ministry of Tourism of the Arab Republic of Egypt, Egyptian Tourist Authority); tour operator Settemari; diving agency SNSI, Scuba Nitrox Safety International; diving centers Viaggio nel Blu; Project Aware Foundation	Italian Government (Ministry of the Education, University and Research); Egyptian Government (Ministry of Tourism of the Arab Republic of Egypt, Egyptian Tourist Authority); tour operator Settemari; diving agency SNSI, Scuba Nitrox Safety International; diving centers Viaggio nel Blu; Project Aware Foundation	"STE: Scuba Tourism for the Environment" was funded by the Italian Government (Ministry of the Education, University and Research; www.istruzione.it), the Egyptian Government (Ministry of Tourism of the Arab Republic of Egypt, Egyptian Tourist Authority; www.egypt.travel), the tour operator Settemari (www.settemari.it), the diving agency SNSI, Scuba Nitrox Safety International (www.scubasnsi.com), the diving centers Viaggio nel Blu (www.viaggionelblu.org) and the Project Aware Foundation (www.projectaware.org). In-kind support was provided by the airline Neos (www.neosair.it), the diving center Holiday Service (www.holidaydiving.org), the diving agency SSI, Scuba School International (www.divessi.com) and the association Underwater Life Project (www.underwaterlifeproject.it). The project has also had the patronage of the Ministry of the Environment and Land and Sea Protection (www.minambiente.it) and of the ASTOI (Association of Italian Tour Operators; www.astoi.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WR, 1996, CORAL REEFS, V15, P215, DOI 10.1007/s003380050045; Ammar Mohammed S.A., 2006, Egyptian Journal of Aquatic Research, V32, P184; Barker N, 2003, THESIS U YORK W INDI; Barker NHL, 2004, BIOL CONSERV, V120, P481, DOI 10.1016/j.biocon.2004.03.021; Barradas JI, 2012, ARQUIVOS CIENCIAS MA; BEEKHUIS JV, 1981, AMBIO, V10, P325; Bellan GL, 2001, AQUAT CONSERV, V11, P325, DOI 10.1002/aqc.461; Branchini S, 2014, BIODIVERS C IN PRESS; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Camp E, 2012, OCEAN COAST MANAGE, V61, P30, DOI 10.1016/j.ocecoaman.2012.02.002; Cohen R., 2000, GLOBAL SOCIOLOGY; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fulton D.C., 1996, HUMAN DIMENSIONS WIL, V1, P24, DOI DOI 10.1080/10871209609359060; Goffredo S, 2004, CONSERV BIOL, V18, P1492, DOI 10.1111/j.1523-1739.2004.00015.x; Goffredo S, 2010, ECOL APPL, V20, P2170, DOI 10.1890/09-1546.1; Hall CM, 2001, OCEAN COAST MANAGE, V44, P601, DOI 10.1016/S0964-5691(01)00071-0; Hasler H, 2008, MAR POLLUT BULL, V56, P1788, DOI 10.1016/j.marpolbul.2008.06.002; Hawkins JP, 1999, CONSERV BIOL, V13, P888, DOI 10.1046/j.1523-1739.1999.97447.x; Higgins-Desbiolles F, 2006, TOURISM MANAGE, V27, P1192, DOI 10.1016/j.tourman.2005.05.020; Jameson S. C., 2007, Journal of Sustainable Tourism, V15, P309, DOI 10.2167/jost719.0; Jennings S, 2004, ANN TOURISM RES, V31, P899, DOI 10.1016/j.annals.2004.02.005; Lansing P, 2007, J BUS ETHICS, V72, P77, DOI 10.1007/s10551-006-9157-7; Lynn NA, 2003, LANDSCAPE URBAN PLAN, V64, P77, DOI 10.1016/S0169-2046(02)00202-5; Marshall NA, 2011, CURR ISSUES TOUR, V14, P507, DOI 10.1080/13683500.2010.512075; Mathieson A., 1982, TOURISM EC PHYS SOCI; Medio D, 1997, BIOL CONSERV, V79, P91, DOI 10.1016/S0006-3207(96)00074-2; Milazzo M, 2002, MAR ECOL-P S Z N I, V23, P280, DOI 10.1111/j.1439-0485.2002.tb00026.x; MILLER ML, 1991, MAR POLICY, V15, P75, DOI 10.1016/0308-597X(91)90008-Y; Moufaddal WM, 2005, ENVIRON MONIT ASSESS, V107, P427, DOI 10.1007/s10661-005-3576-2; Needham MD, 2010, J SUSTAIN TOUR, V18, P757, DOI 10.1080/09669581003690486; Orams Mark, 1999, MARINE TOURISM DEV I; ORAMS MB, 1998, J ENVIRON EDUC, V29, P33, DOI DOI 10.1080/00958969809599116; Plathong S, 2000, CONSERV BIOL, V14, P1821, DOI [10.1046/j.1523-1739.2000.99301.x, 10.1111/j.1523-1739.2000.99301.x]; Rouphael AB, 1997, BIOL CONSERV, V82, P329, DOI 10.1016/S0006-3207(97)00047-5; Russell D., 2003, Pacific island tourism, P38; Smith Kirby, 2009, Journal and Proceedings of the Royal Society of New South Wales, V142, P31; UNEP, 2009, SUST COAST TOUR INT; UNWTO, 2018, UNWTO TOUR HIGHL 201, Vxxx; UNWTO, 2011, UNWTO TOUR 2030 GLOB; Zakai D, 2002, BIOL CONSERV, V105, P179, DOI 10.1016/S0006-3207(01)00181-1	41	35	36	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131812	10.1371/journal.pone.0131812	http://dx.doi.org/10.1371/journal.pone.0131812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7EO	26200660	gold, Green Submitted, Green Published			2022-12-26	WOS:000358597100020
J	Gormley-Gallagher, AM; Douglas, RW; Rippey, B				Gormley-Gallagher, Aine Marie; Douglas, Richard William; Rippey, Brian			The Applicability of the Distribution Coefficient, K-D, Based on Non-Aggregated Particulate Samples from Lakes with Low Suspended Solids Concentrations	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; TRACE-ELEMENTS; FRESH-WATER; SEDIMENT; METALS; CU; PH; ZN; REDISTRIBUTION; VARIABILITY	Separate phases of metal partitioning behaviour in freshwater lakes that receive varying degrees of atmospheric contamination and have low concentrations of suspended solids were investigated to determine the applicability of the distribution coefficient, K-D. Concentrations of Pb, Ni, Co, Cu, Cd, Cr, Hg and Mn were determined using a combination of filtration methods, bulk sample collection and digestion and Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). Phytoplankton biomass, suspended solids concentrations and the organic content of the sediment were also analysed. By distinguishing between the phyto-plankton and (inorganic) lake sediment, transient variations in K-D were observed. Suspended solids concentrations over the 6-month sampling campaign showed no correlation with the K-D (n = 15 for each metal, p > 0.05) for Mn (r(2) = 0.0063), Cu (r(2) = 0.0002, Cr (r(2) = 0.021), Ni (r(2) = 0.0023), Cd (r(2) = 0.00001), Co (r(2) = 0.096), Hg (r(2) = 0.116) or Pb (r(2) = 0.164). The results implied that colloidal matter had less opportunity to increase the dissolved (filter passing) fraction, which inhibited the spurious lowering of K-D. The findings conform to the increasingly documented theory that the use of K-D in modelling may mask true information on metal partitioning behaviour. The root mean square error of prediction between the directly measured total metal concentrations and those modelled based on the separate phase fractions were +/- 3.40, 0.06, 0.02, 0.03, 0.44, 484.31, 80.97 and 0.1 mu g/L for Pb, Cd, Mn, Cu, Hg, Ni, Cr and Co respectively. The magnitude of error suggests that the separate phase models for Mn and Cu can be used in distribution or partitioning models for these metals in lake water.	[Gormley-Gallagher, Aine Marie; Douglas, Richard William; Rippey, Brian] Univ Ulster, Sch Environm Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Gormley-Gallagher, Aine Marie] Cranfield Univ, Sch Appl Sci, Cranfield MK43 0AL, Beds, England	Ulster University; Cranfield University	Gormley-Gallagher, AM (corresponding author), Univ Ulster, Sch Environm Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	aine.gormley@cranfield.ac.uk	Gormley-Gallagher, Aine/M-2855-2016	Gormley-Gallagher, Aine/0000-0003-2080-2134; douglas, richard/0000-0001-8156-0920	Department for Employment and Learning (DEL) Northern Ireland	Department for Employment and Learning (DEL) Northern Ireland	This work was funded by the Department for Employment and Learning (DEL) Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, GEOCHEM T, DOI [DOI 10.1039/B104809K, DOI 10.1186/1467-4866-2-57]; APHA, 1995, STANDARD METHODS EXA; Arain MB, 2008, CHEMOSPHERE, V70, P1845, DOI 10.1016/j.chemosphere.2007.08.005; Atkinson CA, 2007, CHEMOSPHERE, V69, P1428, DOI 10.1016/j.chemosphere.2007.04.068; Baldwin DS, 2008, WATER RES, V42, P4711, DOI 10.1016/j.watres.2008.08.020; BALISTRIERI LS, 1994, GEOCHIM COSMOCHIM AC, V58, P3993, DOI 10.1016/0016-7037(94)90262-3; BALLS PW, 1989, NETH J SEA RES, V23, P7, DOI 10.1016/0077-7579(89)90037-9; Bennion H, 1996, ENVIRON SCI TECHNOL, V30, P2004, DOI 10.1021/es9508030; BENOIT G, 1994, MAR CHEM, V45, P307, DOI 10.1016/0304-4203(94)90076-0; BIRKS HJB, 1990, PHILOS T R SOC B, V327, P263, DOI 10.1098/rstb.1990.0062; Bock R, 1979, HDB DECOMPOSITION ME; Boyer JN, 2009, ECOL INDIC, V9, pS56, DOI 10.1016/j.ecolind.2008.11.013; Caddick MX, 1998, SOC GEN MICROBIOLOGY, P56; Chen CY, 2005, ENVIRON SCI TECHNOL, V39, P115, DOI 10.1021/es0403007; Croteau MN, 2007, AQUAT TOXICOL, V83, P116, DOI 10.1016/j.aquatox.2007.03.016; DANIELSSON LG, 1983, ESTUAR COAST SHELF S, V17, P73, DOI 10.1016/0272-7714(83)90046-X; Douglas RW, 2000, LIMNOL OCEANOGR, V45, P686, DOI 10.4319/lo.2000.45.3.0686; Douglas RW, 2003, FRESHWATER BIOL, V48, P512, DOI 10.1046/j.1365-2427.2003.01027.x; Gagnon C, 2003, ENVIRON POLLUT, V124, P47, DOI 10.1016/S0269-7491(02)00433-5; Gaiero DM, 2003, GEOCHIM COSMOCHIM AC, V67, P3603, DOI 10.1016/S0016-7037(03)00211-4; Hart GL, 1997, SOIL SCI SOC AM J, V61, P1765, DOI 10.2136/sssaj1997.03615995006100060031x; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Henderson GM, 1999, DEEP-SEA RES PT I, V46, P1861, DOI 10.1016/S0967-0637(99)00030-8; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; HILTON J, 1985, LIMNOL OCEANOGR, V30, P1131, DOI 10.4319/lo.1985.30.6.1131; Ho TY, 2007, LIMNOL OCEANOGR, V52, P1776, DOI 10.4319/lo.2007.52.5.1776; Hurley JP, 1996, ENVIRON SCI TECHNOL, V30, P2093, DOI 10.1021/es9509543; Jiang L, 2005, AM NAT, V166, P496, DOI 10.1086/444442; Juggins S, 1996, FRESHWATER BIOL, V36, P203, DOI 10.1046/j.1365-2427.1996.00079.x; Kogut MB, 2003, ENVIRON SCI TECHNOL, V37, P509, DOI 10.1021/es020723d; Kozelka PB, 1998, MAR CHEM, V60, P267, DOI 10.1016/S0304-4203(97)00107-2; Last W. M., 2001, TRACKING ENV CHANGE, V1; Lepparanta M., 2015, FREEZING LAKES EVOLU; Lindsay W.L., 1979, CHEM EQUILIBRIA SOIL; Lindstrom M., 2000, THESIS ACTA U UPSALI; Long SE, 1990, 2008 US ENV PROT AG; MacIntyre S, 2009, LIMNOL OCEANOGR, V54, P2255, DOI 10.4319/lo.2009.54.6.2255; McKergow LA, 2010, NEW ZEAL J MAR FRESH, V44, P53, DOI 10.1080/00288331003721471; Meylan S, 2004, ANAL CHIM ACTA, V510, P91, DOI 10.1016/j.aca.2003.12.052; MONISMITH SG, 2009, ENCY INLAND WATERS, V1, P636, DOI DOI 10.1016/B978-012370626-3.00078-8; MURRAY JW, 1987, ADV CHEM SER, P153; Nguyen TH, 2005, ENVIRON SCI TECHNOL, V39, P913, DOI 10.1021/es048839s; Olrik K, 1998, 4860 SWED ENV PROT A; Opuene K, 2008, INT J ENVIRON RES, V2, P343; Palleiro L, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1651-9; PATRICK S, 1995, UK ACID WATERS MONIT; Pham MK, 1998, ENVIRON SCI TECHNOL, V32, P440, DOI 10.1021/es970183y; REYNOLDS GL, 1992, LIMNOL OCEANOGR, V37, P1759, DOI 10.4319/lo.1992.37.8.1759; Rippey B, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002305; Rippey B, 2004, LIMNOL OCEANOGR, V49, P2256, DOI 10.4319/lo.2004.49.6.2256; Shafer MM, 1997, CHEM GEOL, V136, P71, DOI 10.1016/S0009-2541(96)00139-8; SMITH VH, 1985, WATER RESOUR BULL, V21, P433; Sykes JM, 1999, UK ENV CHANGE NETWOR; Tack FM, 1996, ENVIRON POLLUT, V91, P199, DOI 10.1016/0269-7491(95)00049-6; Turner A, 2007, ENVIRON SCI TECHNOL, V41, P3977, DOI 10.1021/es0620336; Tyler G., 2001, WATER AIR SOIL POLL, V3, P279, DOI DOI 10.1023/A:1017528826641; US. EPA, 2012, UND VAR PART COEFF K; Vesely J, 2001, APPL GEOCHEM, V16, P437, DOI 10.1016/S0883-2927(00)00041-X; Vignati DAL, 2005, ENVIRON SCI TECHNOL, V39, P489, DOI 10.1021/es049322j; Wang WX, 2006, ENVIRON POLLUT, V142, P303, DOI 10.1016/j.envpol.2005.10.005; Yu MQ, 2003, ANAL CHIM ACTA, V479, P225, DOI 10.1016/S0003-2670(02)01528-3; Zhang XB, 2004, GLOBAL PLANET CHANGE, V41, P221, DOI 10.1016/j.gloplacha.2004.01.008	62	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133069	10.1371/journal.pone.0133069	http://dx.doi.org/10.1371/journal.pone.0133069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200885	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100054
J	Tian, R; Yang, G; Tang, Y; Liu, XM; Li, R; Zhu, HL; Li, H				Tian, Rui; Yang, Gang; Tang, Ying; Liu, Xinmin; Li, Rui; Zhu, Hualing; Li, Hang			Origin of Hofmeister Effects for Complex Systems	PLOS ONE			English	Article							DENSITY DISTRIBUTION ANALYSIS; ELECTRON-DENSITY; COLLOIDAL PARTICLES; ION ADSORPTION; DOUBLE-LAYERS; CO-ION; SURFACE; ENERGY; AGGREGATION; KAOLINITE	Hofmeister effects have been recognized as important as Mendel's work was to genetics while remain largely controversial, especially for the mechanistic aspects. Here we demonstrated that complex colloids in electrolyte solutions show resembling aggregation kinetics as model colloid, and then quantitatively evaluated the resulting Hofmeister effects. Mechanism for the aggregation of complex colloids has been proposed that is closely associated with the charges of their constituents; despite that, electrostatic interactions play a minor role while polarization effect is evidenced to be the driving force for the aggregation processes. Polarization effect is further ascribed to arouse the resulting Hofmeister effects, which is supported by the fine correlation of activation energies vs. polarizability data of different alkali ions and the calculations of dipole moments for minerals with different charges and adsorbed alkali ions. Because of neglecting polarization effect, the prevailing DLVO theory is not sufficient to describe Hofmeister effects that are ubiquitous in nature. We speculate that polarization effect should also be responsible for Hofmeister effects of other charged systems such as proteins and membranes.	[Tian, Rui; Yang, Gang; Tang, Ying; Liu, Xinmin; Li, Rui; Zhu, Hualing; Li, Hang] Southwest Univ, Chongqing Key Lab Soil Multi Scale Interfacial Pr, Coll Resources & Environm, Chongqing, Peoples R China	Southwest University - China	Yang, G (corresponding author), Southwest Univ, Chongqing Key Lab Soil Multi Scale Interfacial Pr, Coll Resources & Environm, Chongqing, Peoples R China.	theobiochem@gmail.com; lihangswu@163.com	Yang, Gang/B-2616-2008; Yang, Gang/AAG-9666-2021	Yang, Gang/0000-0003-1032-6840; Yang, Gang/0000-0003-1032-6840; , Rui/0000-0002-8849-7706	National Natural Science Foundation of China [21473137]; Fourth Excellent Talents Program of Higher Education in Chongqing [2014-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fourth Excellent Talents Program of Higher Education in Chongqing	National Natural Science Foundation of China (21473137) and the Fourth Excellent Talents Program of Higher Education in Chongqing (2014-03) support this research.	BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Boncina M, 2008, BIOPHYS J, V95, P1285, DOI 10.1529/biophysj.108.128694; Bostrom M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168103; Bostrom M, 2003, EUROPHYS LETT, V63, P610, DOI 10.1209/epl/i2003-00559-8; Bradl HB, 2004, J COLLOID INTERF SCI, V277, P1, DOI 10.1016/j.jcis.2004.04.005; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; Dahirel V, 2010, CURR OPIN COLLOID IN, V15, P2, DOI 10.1016/j.cocis.2009.05.006; dos Santos AP, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.167801; Dubois M, 1998, J CHEM PHYS, V108, P7855, DOI 10.1063/1.476505; Duignan TT, 2013, J PHYS CHEM B, V117, P9412, DOI 10.1021/jp403595x; Elouear Z, 2014, SOIL SEDIMENT CONTAM, V23, P628, DOI 10.1080/15320383.2014.857640; Flegmann AW, 1969, P BR CERAM SOC, V13, P31; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; Frisch M.J., 2016, GAUSSIAN 16 REV C 01; Garcia-Garcia S, 2007, J COLLOID INTERF SCI, V315, P512, DOI 10.1016/j.jcis.2007.07.002; Gupta V, 2011, J COLLOID INTERF SCI, V359, P95, DOI 10.1016/j.jcis.2011.03.043; He YT, 2008, J NANOPART RES, V10, P321, DOI 10.1007/s11051-007-9255-1; HIRSHFELD FL, 1977, THEOR CHIM ACTA, V44, P129, DOI 10.1007/BF00549096; Hofmeister F., 1888, ARCH EXP PATHOL PHAR, V25, P1, DOI DOI 10.1007/BF01838161; Holthoff H, 1996, LANGMUIR, V12, P5541, DOI 10.1021/la960326e; Jungsuttiwong S, 2011, INT J QUANTUM CHEM, V111, P2275, DOI 10.1002/qua.22531; Jungwirth P, 2006, CHEM REV, V106, P1259, DOI 10.1021/cr0403741; Kim HK, 2001, EUR PHYS J E, V4, P411, DOI 10.1007/s101890170096; Kjellander R, 2001, J CHEM PHYS, V114, P9565, DOI 10.1063/1.1366639; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P19, DOI 10.1016/j.cocis.2004.05.005; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P1, DOI 10.1016/j.cocis.2004.05.004; Kunz W, 2010, CURR OPIN COLLOID IN, V15, P34, DOI 10.1016/j.cocis.2009.11.008; Laidler K. J., 1987, CHEM KINETICS; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Levin Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257802; Lima ERA, 2008, LANGMUIR, V24, P3944, DOI 10.1021/la7037069; LIN MY, 1989, NATURE, V339, P360, DOI 10.1038/339360a0; Liu XM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05047; Liu XM, 2014, RSC ADV, V4, P1189, DOI 10.1039/c3ra44984j; Liu XM, 2013, J PHYS CHEM C, V117, P6245, DOI 10.1021/jp312682u; Peula-Garcia JM, 2010, J PHYS CHEM C, V114, P11133, DOI 10.1021/jp912035v; Marcus Y., 1997, ION PROPERTIES; Moller J, 2014, PHYS CHEM CHEM PHYS, V16, P7423, DOI 10.1039/c3cp55278k; Nihonyanagi S, 2014, J AM CHEM SOC, V136, P6155, DOI 10.1021/ja412952y; Ninham BW, 1997, LANGMUIR, V13, P2097, DOI 10.1021/la960974y; Parsons DF, 2011, PHYS CHEM CHEM PHYS, V13, P12352, DOI 10.1039/c1cp20538b; Parsons DF, 2009, COLLOID SURFACE A, V343, P57, DOI 10.1016/j.colsurfa.2009.01.029; PASHLEY RM, 1986, J PHYS CHEM-US, V90, P1637, DOI 10.1021/j100399a037; Petrache HI, 2006, P NATL ACAD SCI USA, V103, P7982, DOI 10.1073/pnas.0509967103; RITCHIE JP, 1987, J COMPUT CHEM, V8, P499, DOI 10.1002/jcc.540080430; RITCHIE JP, 1985, J AM CHEM SOC, V107, P1829, DOI 10.1021/ja00293a005; Salis A, 2014, CHEM SOC REV, V43, P7358, DOI 10.1039/c4cs00144c; Scheu R, 2014, J AM CHEM SOC, V136, P2040, DOI 10.1021/ja4120117; Solans-Monfort X, 2002, J PHYS CHEM B, V106, P10220, DOI 10.1021/jp026303s; Stumm W., 1996, AQUATIC CHEMISTRY CH; Sumner ME, 2000, HANDBOOK OF SOIL SCI; Tian R, 2015, J PHYS CHEM C, V119, P4856, DOI 10.1021/jp512078v; Tian R, 2014, PHYS CHEM CHEM PHYS, V16, P8828, DOI 10.1039/c3cp54813a; Tobias DJ, 2008, SCIENCE, V319, P1197, DOI 10.1126/science.1152799; Van Olphen H, 1951, DISCUSS FARADAY SOC, V11, P82; Vasconcelos IF, 2007, J PHYS CHEM C, V111, P6753, DOI 10.1021/jp065687+; Whittinghill KA, 2012, BIOGEOCHEMISTRY, V111, P569, DOI 10.1007/s10533-011-9688-6; WILLIAMS DJA, 1978, J COLLOID INTERF SCI, V65, P79, DOI 10.1016/0021-9797(78)90260-6; Yang G, 2014, SCI REP-UK, V4, DOI 10.1038/srep06594; Yang G, 2011, CHEM-EUR J, V17, P1614, DOI 10.1002/chem.201002241	60	13	13	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0128602	10.1371/journal.pone.0128602	http://dx.doi.org/10.1371/journal.pone.0128602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200350	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100002
J	Wang, L; Wang, QM				Wang, Long; Wang, Qi-Ming			Molecular Phylogenetic Analysis of Ballistoconidium-Forming Yeasts in Trichosporonales (Tremellomycetes): A Proposal for Takashimella gen. nov and Cryptotrichosporon tibetense sp nov.	PLOS ONE			English	Article							BASIDIOMYCETOUS YEASTS; PLANT-LEAVES; BALLISTOSPOROUS YEASTS; CRYPTOCOCCUS; SYSTEMATICS; SPOROBOLOMYCES; PERFORMANCE; SEQUENCES; SOFTWARE; D1/D2	Bullera species in the Trichosporonales (Tremellomycetes, Agaricomycotina) are phylogenetically distinct from Bullera alba (teleomorph: Bulleromyces albus), the type species of Bullera that belongs to Tremellales. In the present study, the three Bullera species, namely Bullera formosensis, Bullera koratensis and Bullera lagerstroemiae, and Cryptococcus tepidarius belonging to the Trichosporonales are transferred into a new genus Takashimella gen. nov. (MycoBank No. MB 810672) based on sequence analysis of the small subunit (SSU) rRNA gene, the D1/D2 domains of large subunit (LSU) rRNA gene and the ITS+5.8S rRNA gene sequences. In addition, the genus Cryptotrichosporon is emended to accommodate a novel ballistoconidium-forming species of the Trichosporonales, which is named as Cryptotrichosporon tibetense (type strain CGMCC 2.02614(T) = CBS 10455(T)). The MycoBank number of this new species is MB 810688.	[Wang, Long; Wang, Qi-Ming] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, QM (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	wangqm@im.ac.cn			National Natural Science Foundation of China (NSFC) [30700001, 30970013]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants No. 30700001 and No. 30970013 from the National Natural Science Foundation of China (NSFC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai FY, 2002, INT J SYST EVOL MICR, V52, P2309, DOI [10.1099/ijs.0.02297-0, 10.1099/00207713-52-6-2309]; Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1623, DOI 10.1016/B978-0-444-52149-1.00137-3; Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1339, DOI 10.1016/B978-0-444-52149-1.00100-2; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; Derx HG, 1930, ANN MYCOL, V28, P1; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Fungsin B, 2006, J GEN APPL MICROBIOL, V52, P73, DOI 10.2323/jgam.52.73; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; NAKASE T, 1987, STUD MYCOL, P375; NAKASE T, 1993, J GEN APPL MICROBIOL, V39, P107, DOI 10.2323/jgam.39.107; Nakase T, 2002, J GEN APPL MICROBIOL, V48, P345, DOI 10.2323/jgam.48.345; NAKASE T, 1991, J GEN APPL MICROBIOL, V37, P175, DOI 10.2323/jgam.37.175; NAKASE T, 1992, FEMS MICROBIOL LETT, V100, P497, DOI 10.1111/j.1574-6968.1992.tb05746.x; Nakase T, 2000, J GEN APPL MICROBIOL, V46, P189, DOI 10.2323/jgam.46.189; NAKASE T, 1989, YEAST, V5, P511; Nakase T, 1993, RIKEN REV, V3, P33; Okoli I, 2007, FEMS YEAST RES, V7, P339, DOI 10.1111/j.1567-1364.2006.00164.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rodrigues de Miranda L., 1984, YEASTS TAXONOMIC STU, P577; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; STADELMANN F, 1975, A VAN LEEUW J MICROB, V41, P575, DOI 10.1007/BF02565099; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoll M, 2005, MYCOL RES, V109, P342, DOI 10.1017/S0953756204002229; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Takashima M, 2001, J GEN APPL MICROBIOL, V47, P75, DOI 10.2323/jgam.47.75; Takashima M, 2009, INT J SYST EVOL MICR, V59, P181, DOI 10.1099/ijs.0.004515-0; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Vogelmann SA, 2012, INT J SYST EVOL MICR, V62, P1715, DOI 10.1099/ijs.0.032748-0; Wang QM, 2008, FEMS YEAST RES, V8, P799, DOI 10.1111/j.1567-1364.2008.00403.x; Wang QM, 2011, INT J SYST EVOL MICR, V61, P210, DOI 10.1099/ijs.0.019299-0; Wang QM, 2003, INT J SYST EVOL MICR, V53, P2085, DOI 10.1099/ijs.0.02736-0; WEISS M, 2014, MYCOTA SYSTEMATICS A, V7, P331; YAMADA Y, 1973, J GEN APPL MICROBIOL, V19, P59, DOI 10.2323/jgam.19.59	36	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132653	10.1371/journal.pone.0132653	http://dx.doi.org/10.1371/journal.pone.0132653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200459	Green Submitted, Green Published, gold			2022-12-26	WOS:000358597100043
J	Grevengoed, TJ; Cooper, DE; Young, PA; Ellis, JM; Coleman, RA				Grevengoed, Trisha J.; Cooper, Daniel E.; Young, Pamela A.; Ellis, Jessica M.; Coleman, Rosalind A.			Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation	FASEB JOURNAL			English	Article						heart metabolism; glucose metabolism; lipid metabolism; beta-oxidation; ATP synthase	FATTY-ACID OXIDATION; ISCHEMIA-REPERFUSION INJURY; INDUCED HEART-FAILURE; ATP SYNTHASE BETA; PRESSURE-OVERLOAD; MAMMALIAN TARGET; PATHOLOGICAL HYPERTROPHY; RECEPTOR-ALPHA; MOUSE HEARTS; MTOR	Because hearts with a temporally induced knockout of acyl-CoA synthetase 1 (Acsl1(T-/-)) are virtually unable to oxidize fatty acids, glucose use increases 8-fold to compensate. This metabolic switch activates mechanistic target of rapamycin complex 1 (mTORC1), which initiates growth by increasing protein and RNA synthesis and fatty acid metabolism, while decreasing autophagy. Compared with controls, Acsl1(T-/-) hearts contained 3 times more mitochondria with abnormal structure and displayed a 35-43% lower respiratory function. To study the effects of mTORC1 activation on mitochondrial structure and function, mTORC1 was inhibited by treating Acsl1(T-/-) and littermate control mice with rapamycin or vehicle alone for 2 wk. Rapamycin treatment normalized mitochondrial structure, number, and the maximal respiration rate in Acsl1(T-/-) hearts, but did not improve ADP-stimulated oxygen consumption, which was likely caused by the 33-51% lower ATP synthase activity present in both vehicle-and rapamycin-treated Acsl1(T-/-) hearts. The turnover of microtubule associated protein light chain 3b in Acsl1(T-/-) hearts was 88% lower than controls, indicating a diminished rate of autophagy. Rapamycin treatment increased autophagy to a rate that was 3.1-fold higher than in controls, allowing the formation of autophagolysosomes and the clearance of damaged mitochondria. Thus, long-chain acyl-CoA synthetase isoform 1 (ACSL1) deficiency in the heart activated mTORC1, thereby inhibiting autophagy and increasing the number of damaged mitochondria.	[Grevengoed, Trisha J.; Cooper, Daniel E.; Young, Pamela A.; Ellis, Jessica M.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Coleman, RA (corresponding author), Univ N Carolina, MHRC, Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Grevengoed, Trisha/AAA-3980-2021	Grevengoed, Trisha/0000-0003-4433-3950	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK59935]; University of North Carolina Nutrition Obesity Research Center [DK056350]; NIH Heart, Lung, and Blood Institute [T32HL069768, T32-HL069768, 13PRE16910109, 0815054E]; American Heart Association Mid-Atlantic Division [12GRNT12030144]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK059935] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of North Carolina Nutrition Obesity Research Center; NIH Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Mid-Atlantic Division(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK59935 (to R.A.C.) and the University of North Carolina Nutrition Obesity Research Center DK056350, NIH Heart, Lung, and Blood Institute Predoctoral Training Grants T32HL069768 (to T.J.G.) and T32-HL069768 (to J.M.E.), predoctoral fellowships 13PRE16910109 (to T.J.G.) and 0815054E (to J.M.E.), and 12GRNT12030144 from the American Heart Association Mid-Atlantic Division (to R.A.C.). The authors declare no conflicts of interest.	Allard MF, 1997, CIRCULATION, V96, P676; Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; ASCHENBRENNER V, 1970, BIOCHEM J, V119, P157, DOI 10.1042/bj1190157; Barger PM, 1999, AM J MED SCI, V318, P36, DOI 10.1097/00000441-199907000-00006; Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Choi JC, 2013, AUTOPHAGY, V9, P110, DOI 10.4161/auto.22403; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Das A, 2012, J MOL CELL CARDIOL, V53, P858, DOI 10.1016/j.yjmcc.2012.09.007; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971; Dyck JRB, 2006, CIRCULATION, V114, P1721, DOI 10.1161/CIRCULATIONAHA.106.642009; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Fullekrug J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00401; Goo CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045806; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; He L, 2012, CIRCULATION, V126, P1705, DOI 10.1161/CIRCULATIONAHA.111.075978; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; Jaishy B, 2015, J LIPID RES, V56, P546, DOI 10.1194/jlr.M055152; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kane LA, 2010, CIRC RES, V106, P504, DOI 10.1161/CIRCRESAHA.109.214155; Kane LA, 2009, J BIOENERG BIOMEMBR, V41, P145, DOI 10.1007/s10863-009-9218-6; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paul DS, 2014, BBA-MOL CELL BIOL L, V1841, P880, DOI 10.1016/j.bbalip.2014.03.001; Pereira RO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000301; Rahman M, 2014, J CELL BIOL, V206, P289, DOI 10.1083/jcb.201404118; Ramos FJ, 2013, AUTOPHAGY, V9, P108, DOI 10.4161/auto.22401; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schwarzer M, 2013, AM J PHYSIOL-HEART C, V304, pH529, DOI 10.1152/ajpheart.00699.2012; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Sen S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.004796; Sharma S, 2007, CARDIOVASC RES, V76, P71, DOI 10.1016/j.cardiores.2007.05.004; Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Thomas RL, 2013, GENE DEV, V27, P1365, DOI 10.1101/gad.215871.113; Tian R, 2003, CURR HYPERTENS REP, V5, P454, DOI 10.1007/s11906-003-0052-7; Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420; Willis MS, 2012, CIRC RES, V111, pE111, DOI 10.1161/CIRCRESAHA.112.265587; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Xu XH, 2014, HYPERTENSION, V63, P490, DOI 10.1161/HYPERTENSIONAHA.113.02219; Yan J, 2009, CIRCULATION, V119, P2818, DOI 10.1161/CIRCULATIONAHA.108.832915; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhu Y, 2013, AM J PHYSIOL-HEART C, V305, pH41, DOI 10.1152/ajpheart.00877.2012; Zhu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054221, 10.1371/journal.pone.0071727]	66	24	26	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4641	4653		10.1096/fj.15-272732	http://dx.doi.org/10.1096/fj.15-272732			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26220174	Green Published			2022-12-26	WOS:000364514700022
J	Shaik, MM; Lombardi, C; Trindade, DM; Fenel, D; Schoehn, G; Di Guilmi, AM; Dessen, A				Shaik, Md Munan; Lombardi, Charlotte; Trindade, Daniel Maragno; Fenel, Daphna; Schoehn, Guy; Di Guilmi, Anne Marie; Dessen, Andrea			A Structural Snapshot of Type II Pilus Formation in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; PROTEIN SECRETION; CRYSTAL-STRUCTURE; ISOPEPTIDE BONDS; SORTING SIGNAL; PILIN PROTEIN; SORTASE-B; CELL-WALL; TRANSPEPTIDASE	Pili are fibrous appendages expressed on the surface of a vast number of bacterial species, and their role in surface adhesion is important for processes such as infection, colonization, and biofilm formation. The human pathogen Streptococcus pneumoniae expresses two different types of pili, PI-1 and PI-2, both of which require the concerted action of structural proteins and sortases for their polymerization. The type PI-1 streptococcal pilus is a complex, well studied structure, but the PI-2 type, present in a number of invasive pneumococcal serotypes, has to date remained less well understood. The PI-2 pilus consists of repeated units of a single protein, PitB, whose covalent association is catalyzed by cognate sortase SrtG-1 and partner protein SipA. Here we report the high resolution crystal structures of PitB and SrtG1 and use molecular modeling to visualize a "trapped" 1:1 complex between the two molecules. X-ray crystallography and electron microscopy reveal that the pneumococcal PI-2 backbone fiber is formed by PitB monomers associated in head-to-tail fashion and that short, flexible fibers can be formed even in the absence of coadjuvant proteins. These observations, obtained with a simple pilus biosynthetic system, are likely to be applicable to other fiber formation processes in a variety of Gram-positive organisms.	[Shaik, Md Munan; Lombardi, Charlotte; Fenel, Daphna; Schoehn, Guy; Di Guilmi, Anne Marie; Dessen, Andrea] Univ Grenoble Alpes, Inst Biol Struct, F-38044 Grenoble, France; [Shaik, Md Munan; Lombardi, Charlotte; Fenel, Daphna; Schoehn, Guy; Di Guilmi, Anne Marie; Dessen, Andrea] CNRS, IBS, F-38044 Grenoble, France; [Shaik, Md Munan; Lombardi, Charlotte; Fenel, Daphna; Schoehn, Guy; Di Guilmi, Anne Marie; Dessen, Andrea] CEA, IBS, Grenoble, France; [Trindade, Daniel Maragno; Dessen, Andrea] Brazilian Natl Lab Biosci LNBio, CNPEM, BR-13083 Campinas, SP, Brazil	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Dessen, A (corresponding author), Inst Biol Struct, Bacterial Pathogenesis Grp, 71 Ave Martyrs, Grenoble, France.	andrea.dessen@ibs.fr	Trindade, Daniel Maragno/J-6085-2012	Trindade, Daniel Maragno/0000-0002-8005-8784; Dessen, Andrea/0000-0001-6487-4020; Di Guilmi, Anne Marie/0000-0001-7335-3470; Schoehn, Guy/0000-0002-1459-3201	FRISBI [ANR-10-INSB-05-02]; GRAL within Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	FRISBI; GRAL within Grenoble Partnership for Structural Biology (PSB)	We thank J. Marquez and the HTX Laboratory team for access to and help with high throughput crystallization and the ESRF for access to beamlines. This project used the platforms of the Grenoble Instruct Center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). The electron microscope facility is supported by the Rhone-Alpes Region, the Fondation pour la Recherche Medicale (FRM), and the FEDER funds.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bogaert D, 2004, VACCINE, V22, P2209, DOI 10.1016/j.vaccine.2003.11.038; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cozzi R, 2013, FASEB J, V27, P3144, DOI 10.1096/fj.13-227793; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; El Mortaji L, 2012, BIOCHEMISTRY-US, V51, P342, DOI 10.1021/bi201591n; El Mortaji L, 2012, BIOCHEM J, V441, P833, DOI 10.1042/BJ20111397; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feldman Charles, 2014, F1000Prime Rep, V6, P82, DOI 10.12703/P6-82; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Hament JM, 2003, EUR J CLIN INVEST, V33, P169, DOI 10.1046/j.1365-2362.2002.01109.x; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Khare B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022995; Khare B, 2011, J MOL BIOL, V414, P563, DOI 10.1016/j.jmb.2011.10.017; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mehr S, 2012, PAEDIATR RESPIR REV, V13, P258, DOI 10.1016/j.prrv.2011.12.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nielsen HV, 2013, J BACTERIOL, V195, P4484, DOI 10.1128/JB.00451-13; Paterson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022095; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Shaik MM, 2014, J BIOL CHEM, V289, P16988, DOI 10.1074/jbc.M114.555854; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Solovyova AS, 2010, EUR BIOPHYS J BIOPHY, V39, P469, DOI 10.1007/s00249-009-0432-2; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wu CG, 2012, J BACTERIOL, V194, P2531, DOI 10.1128/JB.00093-12; Young PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099135; Zahner D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025124; Zahner D, 2010, EMERG INFECT DIS, V16, P955, DOI 10.3201/eid1606.091820; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001	69	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22581	22592		10.1074/jbc.M115.647834	http://dx.doi.org/10.1074/jbc.M115.647834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26198632	Green Published, hybrid			2022-12-26	WOS:000361171500024
J	Gerzova, L; Babak, V; Sedlar, K; Faldynova, M; Videnska, P; Cejkova, D; Jensen, AN; Denis, M; Kerouanton, A; Ricci, A; Cibin, V; Osterberg, J; Rychlik, I				Gerzova, Lenka; Babak, Vladimir; Sedlar, Karel; Faldynova, Marcela; Videnska, Petra; Cejkova, Darina; Jensen, Annette Nygaard; Denis, Martine; Kerouanton, Annaelle; Ricci, Antonia; Cibin, Veronica; Osterberg, Julia; Rychlik, Ivan			Characterization of Antibiotic Resistance Gene Abundance and Microbiota Composition in Feces of Organic and Conventional Pigs from Four EU Countries	PLOS ONE			English	Article							REAL-TIME PCR; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; TETRACYCLINE RESISTANCE; EUROPEAN COUNTRIES; FOOD ANIMALS; PREVALENCE; POULTRY; FARMS; SALMONELLA	One of the recent trends in animal production is the revival of interest in organic farming. The increased consumer interest in organic animal farming is mainly due to concerns about animal welfare and the use of antibiotics in conventional farming. On the other hand, providing animals with a more natural lifestyle implies their increased exposure to environmental sources of different microorganisms including pathogens. To address these concerns, we determined the abundance of antibiotic resistance and diversity within fecal microbiota in pigs kept under conventional and organic farming systems in Sweden, Denmark, France and Italy. The abundance of sul1, sul2, strA, tet(A), tet(B) and cat antibiotic resistance genes was determined in 468 samples by real-time PCR and the fecal microbiota diversity was characterized in 48 selected samples by pyrosequencing of V3/V4 regions of 16S rRNA. Contrary to our expectations, there were no extensive differences between the abundance of tested antibiotic resistance genes in microbiota originating from organic or conventionally housed pigs within individual countries. There were also no differences in the microbiota composition of organic and conventional pigs. The only significant difference was the difference in the abundance of antibiotic resistance genes in the samples from different countries. Fecal microbiota in the samples originating from southern European countries (Italy, France) exhibited significantly higher antibiotic resistance gene abundance than those from northern parts of Europe (Denmark, Sweden). Therefore, the geographical location of the herd influenced the antibiotic resistance in the fecal microbiota more than farm's status as organic or conventional.	[Gerzova, Lenka; Babak, Vladimir; Faldynova, Marcela; Videnska, Petra; Cejkova, Darina; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic; [Sedlar, Karel] Brno Univ Technol, CS-61090 Brno, Czech Republic; [Jensen, Annette Nygaard] Tech Univ Denmark, Natl Food Inst, Copenhagen, Denmark; [Denis, Martine; Kerouanton, Annaelle] Anses, Hyg & Qual Poultry & Pig Prod Unit, Ploufragan, France; [Ricci, Antonia; Cibin, Veronica] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy; [Osterberg, Julia] Natl Vet Inst SVA, Uppsala, Sweden	Czech Veterinary Research Institute; Brno University of Technology; Technical University of Denmark; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); IZS delle Venezie; National Veterinary Institute SVA	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	Cejkova, Darina/AAA-5820-2022; Sedlar, Karel/K-1120-2014; , Ivan/GPS-9674-2022; Ricci, Antonia/AAA-9473-2019	Cejkova, Darina/0000-0002-6989-6330; Sedlar, Karel/0000-0002-8269-4020; , Ivan/0000-0001-7995-6483; Ricci, Antonia/0000-0002-4774-9655; Jensen, Annette Nygaard/0000-0001-9681-7258	Ministry of Agriculture of the Czech Republic [CZ1.05/2.1.00/01.0006-ED 0006/01/01, MZE0002716202]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work has been supported by the SafeOrganic project, AdmireVet CZ1.05/2.1.00/01.0006-ED 0006/01/01 project and MZE0002716202 project from the Ministry of Agriculture of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez E, 2012, J FOOD PROTECT, V75, P847, DOI 10.4315/0362-028X.JFP-11-182; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Christensen Ellen Gerd, 2014, BMC Res Notes, V7, P660, DOI 10.1186/1756-0500-7-660; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; Dransfield E, 2005, MEAT SCI, V69, P61, DOI 10.1016/j.meatsci.2004.06.006; European Medicines Agency, 2014, EMA3339212014; Faldynova M, 2013, VET MED-CZECH, V58, P298, DOI 10.17221/6865-VETMED; Gerzova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103865; Grave K, 2014, J ANTIMICROB CHEMOTH, V69, P2284, DOI 10.1093/jac/dku106; Grsboll K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100458; Hellweger FL, 2013, FEMS MICROBIOL ECOL, V83, P622, DOI 10.1111/1574-6941.12019; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Miranda JN, 2008, J FOOD PROTECT, V71, P2537, DOI 10.4315/0362-028X-71.12.2537; Mollenkopf DF, 2014, FOODBORNE PATHOG DIS, V11, P920, DOI 10.1089/fpd.2014.1808; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Ngapo TM, 2004, MEAT SCI, V66, P125, DOI 10.1016/S0309-1740(03)00076-7; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Roesch M, 2006, J DAIRY SCI, V89, P989, DOI 10.3168/jds.S0022-0302(06)72164-6; Sapkota AR, 2014, SCI TOTAL ENVIRON, V476, P387, DOI 10.1016/j.scitotenv.2013.12.005; Sato K, 2004, APPL ENVIRON MICROB, V70, P1442, DOI 10.1128/AEM.70.3.1442-1447.2004; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Soonthornchaikul N, 2006, INT J ANTIMICROB AG, V27, P125, DOI 10.1016/j.ijantimicag.2005.09.020; Szmolka A, 2012, VET MICROBIOL, V156, P110, DOI 10.1016/j.vetmic.2011.09.030; Tseng CP, 2003, CLIN CHEM, V49, P306, DOI 10.1373/49.2.306; Videnska P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115142; Videnska P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110076; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Yu ZT, 2005, APPL ENVIRON MICROB, V71, P6926, DOI 10.1128/AEM.71.11.6926-6933.2005; Zheng DM, 2007, LIVEST SCI, V106, P189, DOI 10.1016/j.livsci.2006.08.003; Zhou XL, 2012, J ANIM SCI, V90, P37, DOI 10.2527/jas.50269	35	31	31	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132892	10.1371/journal.pone.0132892	http://dx.doi.org/10.1371/journal.pone.0132892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218075	Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900012
J	Cho, KI; Ann, SH; Singh, GB; Her, AY; Shin, ES				Cho, Kyoung Im; Ann, Soe Hee; Singh, Gillian Balbir; Her, Ae-Young; Shin, Eun-Seok			Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ALL-CAUSE MORTALITY; NEUTROPHIL/LYMPHOCYTE RATIO; CLINICAL-OUTCOMES; ARTERY-DISEASE; ATHEROSCLEROSIS; COUNT; INFLAMMATION; ANGIOGRAPHY; SEVERITY	Objectives The aim of this study was to investigate the combined usefulness of platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention (PCI) with a drug-eluting stent (DES). Methods 798 patients with stable angina, unstable angina and non-ST elevated myocardial infarction (NSTEMI) who underwent elective successful PCI with DES were consecutively enrolled. The value of PLR and NLR in predicting adverse coronary artery disease (CAD) events and the correlations between these markers and adverse events (all-cause mortality, cardiac death, and nonfatal myocardial infarction) were analyzed. Results The follow-up period was 62.8 +/- 28.8 months. When patients were classified into four groups according to the optimal cut-off values for the PLR and NLR on receiver operating characteristic analysis, patients with a high PLR (>128) and high NLR (>2.6) had the highest occurrence of adverse events among the groups. On Cox multivariate analysis, the NLR >2.6 [hazard ratio (HR) 2.352, 95% confidence interval (CI) 1.286 to 4.339, p = 0.006] and the PLR >128 (HR 2.372, 95% CI 1.305 to 3.191, p = 0.005) were independent predictors of long-term adverse events after adjusting for cardiovascular risk factors. Moreover, both a PLR >128 and a NLR >2.6 were the strongest predictors of adverse events (HR 2.686, 95% CI 1.452 to 4.970, p = 0.002). Conclusion High pre-intervention PLR and NLR, especially when combined, are independent predictors of long-term adverse clinical outcomes such as all-cause mortality, cardiac death, and myocardial infarction in patients with unstable angina and NSTEMI who have undergone successful PCI with DES.	[Cho, Kyoung Im] Kosin Univ, Sch Med, Dept Cardiol, Busan, South Korea; [Ann, Soe Hee; Singh, Gillian Balbir; Shin, Eun-Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan 680749, South Korea; [Her, Ae-Young] Kangwon Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Chunchon, South Korea	University of Ulsan; Ulsan University Hospital; Kangwon National University	Shin, ES (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan 680749, South Korea.	sesim1989@gmail.com						Acar G, 2015, CLIN APPL THROMB-HEM, V21, P462, DOI 10.1177/1076029613508599; Al Suwaidi J, 2002, CIRCULATION, V106, P974, DOI 10.1161/01.CIR.0000027560.41358.B3; Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.009; Azab B, 2012, J THROMB THROMBOLYS, V34, P326, DOI 10.1007/s11239-012-0718-6; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Balta S, 2013, HEMODIAL INT, V17, P668, DOI 10.1111/hdi.12058; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; D'Ascenzo F, 2014, THROMB RES, V134, P558, DOI 10.1016/j.thromres.2014.05.037; Damas JK, 2003, CIRCULATION, V107, P2670, DOI 10.1161/01.CIR.0000070542.18001.87; Fowler AJ, 2013, ATHEROSCLEROSIS, V228, P44, DOI 10.1016/j.atherosclerosis.2013.02.008; Gary T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067688; Gurm HS, 2003, AM HEART J, V146, P692, DOI 10.1016/S0002-8703(03)00230-8; Han YC, 2013, KOREAN CIRC J, V43, P93, DOI 10.4070/kcj.2013.43.2.93; Iijima R, 2007, THROMB HAEMOSTASIS, V98, P852, DOI 10.1160/TH07-04-0285; Kurtul A, 2014, AM J CARDIOL, V114, P342, DOI 10.1016/j.amjcard.2014.04.045; Lee JM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-65; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Luft FC, 2000, BASIC RES CARDIOL, V95, P72; Nikolsky E, 2007, AM J CARDIOL, V99, P1055, DOI 10.1016/j.amjcard.2006.11.066; Ommen SR, 1997, AM J CARDIOL, V79, P812, DOI 10.1016/S0002-9149(96)00878-8; Park JJ, 2013, AM J CARDIOL, V111, P636, DOI 10.1016/j.amjcard.2012.11.012; Poludasu Shyam, 2009, Clin Cardiol, V32, pE6, DOI 10.1002/clc.20503; Prasad A, 2007, AM J CARDIOL, V99, P1067, DOI 10.1016/j.amjcard.2006.11.063; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Smith C, 2006, J AM COLL CARDIOL, V48, P1591, DOI 10.1016/j.jacc.2006.06.060; Sunbul M, 2014, CLIN EXP HYPERTENS, V36, P217, DOI 10.3109/10641963.2013.804547; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Thygesen K, 2007, EUR HEART J, V28, P2525; Tsiara S, 2003, CLIN APPL THROMB-HEM, V9, P177, DOI 10.1177/107602960300900301; Waehre T, 2004, THROMB HAEMOSTASIS, V92, P1358, DOI 10.1160/TH04-03-0146; Wang XD, 2014, ATHEROSCLEROSIS, V234, P206, DOI 10.1016/j.atherosclerosis.2014.03.003; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	33	53	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133934	10.1371/journal.pone.0133934	http://dx.doi.org/10.1371/journal.pone.0133934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207383	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000178
J	Kidd, AR; Muniz-Medina, V; Der, CJ; Cox, AD; Reiner, DJ				Kidd, Ambrose R., III; Muniz-Medina, Vanessa; Der, Channing J.; Cox, Adrienne D.; Reiner, David J.			The C-elegans Chp/Wrch Ortholog CHW-1 Contributes to LIN-18/Ryk and LIN-17/Frizzled Signaling in Cell Polarity	PLOS ONE			English	Article							FAMILY SMALL GTPASE; CAENORHABDITIS-ELEGANS; TISSUE POLARITY; RHO-GTPASES; VULVAL DEVELOPMENT; PLANAR POLARITY; WNT; PATHWAYS; MIGRATION; WRCH-1	Wnt signaling controls various aspects of developmental and cell biology, as well as contributing to certain cancers. Expression of the human Rho family small GTPase Wrch/RhoU is regulated by Wnt signaling, and Wrch and its paralog Chp/RhoV are both implicated in oncogenic transformation and regulation of cytoskeletal dynamics. We performed developmental genetic analysis of the single Caenorhabditis elegans ortholog of Chp and Wrch, CHW-1. Using a transgenic assay of the distal tip cell migration, we found that wild-type CHW-1 is likely to be partially constitutively active and that we can alter ectopic CHW-1-dependent migration phenotypes with mutations predicted to increase or decrease intrinsic GTP hydrolysis rate. The vulval P7.p polarity decision balances multiple antagonistic Wnt signals, and also uses different types of Wnt signaling. Previously described cooperative Wnt receptors LIN-17/Frizzled and LIN-18/Ryk orient P7.p posteriorly, with LIN-17/Fz contributing approximately two-thirds of polarizing activity. CHW-1 deletion appears to equalize the contributions of these two receptors. We hypothesize that CHW-1 increases LIN-17/Fz activity at the expense of LIN-18/Ryk, thus making the contribution of these signals unequal. For P7.p to polarize correctly and form a proper vulva, LIN-17/Fz and LIN-18/Ryk antagonize other Wnt transmembrane systems VANG-1/VanGogh and CAM-1/Ror. Our genetic data suggest that LIN-17/Fz represses both VANG-1/VanGogh and CAM-1/Ror, while LIN-18/Ryk represses only VANG-1. These data expand our knowledge of a sophisticated signaling network to control P7.p polarity, and suggests that CHW-1 can alter ligand gradients or receptor priorities in the system.	[Kidd, Ambrose R., III; Muniz-Medina, Vanessa; Der, Channing J.; Cox, Adrienne D.; Reiner, David J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Der, Channing J.; Cox, Adrienne D.; Reiner, David J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA; [Reiner, David J.] Texas A&M Hlth Sci Ctr & Coll Med, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Reiner, DJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	dreiner@ibt.tamhsc.edu		Cox, Adrienne D./0000-0002-4901-2454; Der, Channing/0000-0002-7751-2747; Reiner, David/0000-0002-0344-7161	NRSA postdoctoral fellowship [5F32CA138142]; National Institutes of Health [R01 GM085309]; NATIONAL CANCER INSTITUTE [F32CA138142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085309] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NRSA postdoctoral fellowship 5F32CA138142 to A. R. K. and National Institutes of Health grant R01 GM085309 (D. J. R.). http://www.nigms.nih.gov/, http://grants.nih.gov/training/nrsa.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley BD, 2014, DEV NEUROBIOL, V74, P781, DOI 10.1002/dneu.22146; Alan JK, 2010, MOL CELL BIOL, V30, P4324, DOI 10.1128/MCB.01646-09; Aronheim A, 1998, CURR BIOL, V8, P1125, DOI 10.1016/S0960-9822(98)70468-3; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Berzat AC, 2005, J BIOL CHEM, V280, P33055, DOI 10.1074/jbc.M507362200; Bhavsar PJ, 2013, ONCOGENE, V32, P198, DOI 10.1038/onc.2012.42; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Brady DC, 2009, MOL CELL BIOL, V29, P1035, DOI 10.1128/MCB.00336-08; BRENNER S, 1974, GENETICS, V77, P71; Chenette EJ, 2005, J BIOL CHEM, V280, P13784, DOI 10.1074/jbc.M411300200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Fujisawa K, 2007, SCIENCE, V317, P1934, DOI 10.1126/science.1144874; GAO DL, 1995, P NATL ACAD SCI USA, V92, P9839, DOI 10.1073/pnas.92.21.9839; Gleason JE, 2006, DEV BIOL, V298, P442, DOI 10.1016/j.ydbio.2006.06.050; Goh KY, 2012, P NATL ACAD SCI USA, V109, P15853, DOI 10.1073/pnas.1120795109; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Hoffmann M, 2010, DEV BIOL, V339, P268, DOI 10.1016/j.ydbio.2009.12.002; Hubsman MW, 2007, BIOCHEM J, V404, P487, DOI 10.1042/BJ20061696; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Levy-Strumpf N, 2007, NAT NEUROSCI, V10, P161, DOI 10.1038/nn1835; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; MacNeil LT, 2009, NAT NEUROSCI, V12, P150, DOI 10.1038/nn.2256; McNeill H, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003376; Minor PJ, 2013, DEVELOPMENT, V140, P3882, DOI 10.1242/dev.095687; Modzelewska K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001465; Myers TR, 2007, P NATL ACAD SCI USA, V104, P20368, DOI 10.1073/pnas.0709989104; Najarro EH, 2013, DEV BIOL, V377, P224, DOI 10.1016/j.ydbio.2013.01.014; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Nishiwaki K, 1999, GENETICS, V152, P985; Peters EC, 2013, G3-GENES GENOM GENET, V3, P181, DOI 10.1534/g3.112.004416; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Schiavone D, 2009, BIOCHEM J, V421, P283, DOI 10.1042/BJ20090061; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shutes A, 2004, CURR BIOL, V14, P2052, DOI 10.1016/j.cub.2004.11.011; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Tay HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010125; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Zand TP, 2011, DEV CELL, V20, P84, DOI 10.1016/j.devcel.2010.12.004	57	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133226	10.1371/journal.pone.0133226	http://dx.doi.org/10.1371/journal.pone.0133226			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208319	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000067
J	Wang, XQ; Wei, DP; Ma, YB; McLaughlin, MJ				Wang, Xiaoqing; Wei, Dongpu; Ma, Yibing; McLaughlin, Mike J.			Derivation of Soil Ecological Criteria for Copper in Chinese Soils	PLOS ONE			English	Article							SPECIES SENSITIVITY DISTRIBUTIONS; RISK-ASSESSMENT; TOXICITY; NICKEL; PLANTS; METALS; ZINC; BIOAVAILABILITY; ACCUMULATION; WHEAT	Considerable information on copper (Cu) ecotoxicity as affected by biological species and abiotic properties of soils has been collected from the last decade in the present study. The information on bioavailability/ecotoxicity, species sensitivity and differences in laboratory and field ecotoxicity of Cu in different soils was collated and integrated to derive soil ecological criteria for Cu in Chinese soils, which were expressed as predicted no effect concentrations (PNEC). First, all ecotoxicity data of Cu from bioassays based on Chinese soils were collected and screened with given criteria to compile a database. Second, the compiled data were corrected with leaching and aging factors to minimize the differences between laboratory and field conditions. Before Cu ecotoxicity data were entered into a species sensitivity distribution (SSD), they were normalized with Cu ecotoxicity predictive models to modify the effects of soil properties on Cu ecotoxicity. The PNEC value was set equal to the hazardous concentration for x% of the species (HCx), which could be calculated from the SSD curves, without an additional assessment factor. Finally, predictive models for HCx based on soil properties were developed. The soil properties had a significant effect on the magnitude of HCx, with HC5 varying from 13.1 mg/kg in acidic soils to 51.9 mg/kg in alkaline non-calcareous soils. The two-factor predictive models based on soil pH and cation exchange capacity could predict HCx with determination coefficients (R-2) of 0.82-0.91. The three-factor predictive models - that took into account the effect of soil organic carbon were more accurate than two-factor models, with R-2 of 0.85-0.99. The predictive models obtained here could be used to calculate soil-specific criteria. All results obtained here could provide a scientific basis for revision of current Chinese soil environmental quality standards, and the approach adopted in this study could be used as a pragmatic framework for developing soil ecological criteria for other trace elements in soils.	[Wang, Xiaoqing] Luoyang Inst Sci & Technol, Dept Environm Engn & Chem, Luoyang, Peoples R China; [Wang, Xiaoqing; Wei, Dongpu; Ma, Yibing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China; [Ma, Yibing] Univ Jinan, Sch Resources & Environm, Jinan, Peoples R China; [McLaughlin, Mike J.] CSIRO Land & Water, Ctr Environm Contaminant Res, Adelaide, SA, Australia; [McLaughlin, Mike J.] Univ Adelaide, Sch Agr Food & Wine, Waite Res Inst, Soil Sci, Adelaide, SA, Australia	Luoyang Institute of Science & Technology; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; University of Jinan; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide	Ma, YB (corresponding author), 12 Southern St Zhongguancun, Beijing 100081, Peoples R China.	mayibing@caas.cn	McLaughlin, Mike J/F-2931-2010; McLaughlin, Michael J/N-5888-2017	McLaughlin, Mike J/0000-0001-6796-4144; McLaughlin, Michael J/0000-0001-6796-4144; Ma, Yibing/0000-0002-9340-8181	Special Fund for Environmental Protection Scientific Research in the Public Interest [201509032]; International Copper Association; Rio Tinto Pty Ltd	Special Fund for Environmental Protection Scientific Research in the Public Interest; International Copper Association; Rio Tinto Pty Ltd	The authors are thankful for the financial support provided by the Special Fund for Environmental Protection Scientific Research in the Public Interest (Project no. 201509032), the International Copper Association and Rio Tinto Pty Ltd. There are no patents, products in development or marketed products to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva AK, 2000, SOIL SCI SOC AM J, V64, P955, DOI 10.2136/sssaj2000.643955x; [Anonymous], [No title captured]; BCMOE (British Columbia Ministry of Environment), 2005, BACKGROUND SOIL QUAL, V17; Bongers M, 2004, ENVIRON TOXICOL CHEM, V23, P195, DOI 10.1897/02-508; Chang A. C., 2000, California Agriculture, V54, P49, DOI 10.3733/ca.v054n02p49; Conesa HM, 2007, ENVIRON POLLUT, V145, P700, DOI 10.1016/j.envpol.2006.06.002; Crommentuijn T, 2000, ENVIRON TOXICOL CHEM, V19, P1692, DOI 10.1002/etc.5620190628; CSIRO (Australia's Commonwealth Scientific and Industrial Research Organisation), 2008, FLEX APPR SPEC PROT; Daoust CM, 2006, J ENVIRON QUAL, V35, P558, DOI 10.2134/jeq2005.0107; Department for Environment Food and Rural Affairs and the Environment Agency, 2002, CONT LAND EXP ASS CL; Domene X, 2008, ENVIRON POLLUT, V155, P227, DOI 10.1016/j.envpol.2007.12.001; Duboudin C, 2004, ENVIRON TOXICOL CHEM, V23, P1774, DOI [10.1897/1551-5028(2004)023&lt;1774:ASSDE&gt;2.0.CO;2, 10.1002/etc.5620230723]; European Chemicals Agency, 2008, GUID INF REQ CHEM SA; European Union (EU), 2006, DRAFT RISK ASS REP N; Goldhaber SB, 2003, REGUL TOXICOL PHARM, V38, P232, DOI 10.1016/S0273-2300(02)00020-X; Grist EPM, 2006, ENVIRON SCI TECHNOL, V40, P395, DOI 10.1021/es050871e; Guo XY, 2010, PLANT SOIL, V333, P365, DOI 10.1007/s11104-010-0351-0; HAANSTRA L, 1985, PLANT SOIL, V84, P293, DOI 10.1007/BF02143194; Huang J., 2012, THESIS CHINESE ACAD; Huang Jin-sun, 2012, Huanjing Kexue, V33, P1369; Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017; Kabata P.A, 2001, TRACE ELEMENTS SOILS, V3rd; KOOIJMAN SALM, 1987, WATER RES, V21, P269, DOI 10.1016/0043-1354(87)90205-3; Li B, 2010, THESIS CHINESE ACAD; Li B, 2013, ENVIRON TOXICOL CHEM, V32, P2372, DOI 10.1002/etc.2312; Li B, 2010, ENVIRON TOXICOL CHEM, V29, P835, DOI 10.1002/etc.108; Li X., 2009, THESIS CHINESE ACAD; Li XF, 2010, ENVIRON TOXICOL CHEM, V29, P294, DOI 10.1002/etc.51; Lock K, 2003, ENVIRON TOXICOL CHEM, V22, P1162, DOI [10.1897/1551-5028(2003)022&lt;1162:IOAOCB&gt;2.0.CO;2, 10.1002/etc.5620220527]; Ma YB, 2006, ENVIRON SCI TECHNOL, V40, P6310, DOI 10.1021/es060306r; National Environmental Protection Council, 2011, GUID SOIL QUAL GUID; Oorts K, 2006, ENVIRON TOXICOL CHEM, V25, P845, DOI 10.1897/04-673R.1; Oorts K, 2007, ENVIRON TOXICOL CHEM, V26, P1130, DOI 10.1897/06-533R.1; Pedersen MB, 2000, ARCH ENVIRON CON TOX, V39, P431, DOI 10.1007/s002440010124; Posthuma L., 2002, SPECIES SENSITIVITY; Rooney CP, 2006, ENVIRON TOXICOL CHEM, V25, P726, DOI 10.1897/04-602R.1; Schlekat CE, 2010, SCI TOTAL ENVIRON, V408, P6148, DOI 10.1016/j.scitotenv.2010.09.012; Scott-Fordsmand Janeck J., 2000, Environmental Toxicology and Chemistry, V19, P1774, DOI 10.1897/1551-5028(2000)019&lt;1774:IOCHFU&gt;2.3.CO;2; Scott-Fordsmand JJ, 2000, ENVIRON TOXICOL CHEM, V19, P1297, DOI [10.1897/1551-5028(2000)019&lt;1297:ROFFCI&gt;2.3.CO;2, 10.1002/etc.5620190511]; Smolders E, 2009, ENVIRON TOXICOL CHEM, V28, P1633, DOI 10.1897/08-592.1; Stevens DP, 2003, ENVIRON TOXICOL CHEM, V22, P3017, DOI 10.1897/02-290; Struijs J, 1997, ECOTOX ENVIRON SAFE, V37, P112, DOI 10.1006/eesa.1997.1534; Van Sprang PA, 2009, SCI TOTAL ENVIRON, V407, P5373, DOI 10.1016/j.scitotenv.2009.06.029; [王小庆 Wang Xiaoqing], 2012, [农业环境科学学报, Journal of Agro-Environment Science], V31, P92; Warne MSJ, 2008, ENVIRON TOXICOL CHEM, V27, P786, DOI 10.1897/07-294.1; Wei DP, 2010, THESIS CHINESE ACAD; Wheeler JR, 2002, MAR POLLUT BULL, V45, P192, DOI 10.1016/S0025-326X(01)00327-7; Xiong Y, 1987, THE SOILS OF CHINA; Zhou Juan, 2008, Asian Journal of Ecotoxicology, V3, P394	49	11	13	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133941	10.1371/journal.pone.0133941	http://dx.doi.org/10.1371/journal.pone.0133941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207783	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000180
J	Yokomichi, H; Tanaka, T; Suzuki, K; Akiyama, T; Yamagata, Z				Yokomichi, Hiroshi; Tanaka, Taichiro; Suzuki, Kohta; Akiyama, Tomoki; Yamagata, Zentaro		Okinawa Child Hlth Study Grp	Macrosomic Neonates Carry Increased Risk of Dental Caries in Early Childhood: Findings from a Cohort Study, the Okinawa Child Health Study, Japan	PLOS ONE			English	Article							MATERNAL WEIGHT-GAIN; LOW-BIRTH-WEIGHT; OFFSPRING ADIPOSITY; FETAL MACROSOMIA; UNITED-STATES; BORN SMALL; FOLLOW-UP; OBESITY; ASSOCIATION; GROWTH	Background Although many studies have discussed health risks in neonates with a low birth weight, few studies have focused on the risks in neonates with a high birth weight. The objective of this study was to determine whether differences in the incidence of dental caries in early childhood are associated with birth weight status. Methods A total of 117,175 children born in Okinawa Prefecture, Japan from 1997 to 2007 were included in this study. Medical professionals collected information about birth records, growth and development, parental child-rearing practices and dental health at 3 months, 18 months and 3 years of age. The risk of dental caries among neonates with macrosomia (birth weight >= 4000 g) was compared with that among neonates with normal weight (2500-3999 g). Sensitivity analyses included 'large for gestational age' (LGA, birth weight above the 90th percentile for gestational age), which was relative to 'appropriate for gestational age' (birth weight between 10th and 90th percentiles). Relative risks and relative risk increases were estimated by multivariate Poisson regression. Results At 3 years of age, the relative risk increases for dental caries after adjusting for confounding factors were 19% [95% confidence interval (CI), 11%-28%, P < 0.001] for macrosomic neonates and 12% (95% CI, 9%-16%, P < 0.001) for LGA neonates. Conclusion Macrosomia and LGA were associated with an increased risk of dental caries in early childhood. Particular attention should be paid to abnormally large neonates.	[Yokomichi, Hiroshi; Suzuki, Kohta; Akiyama, Tomoki; Yamagata, Zentaro] Univ Yamanashi, Dept Hlth Sci, Div Med, Grad Sch,Dept Interdisciplinary Res, Chuo City, Yamanashi, Japan; [Tanaka, Taichiro] Toho Univ, Fac Med, Dept Social Med, Tokyo, Japan	University of Yamanashi; Toho University	Yokomichi, H (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, New Radcliffe House,Woodstock Rd, Oxford, Oxon, England.	hyokomichi@yamanashi.ac.jp; zenymgt@yamanashi.ac.jp	Yokomichi, Hiroshi/B-2816-2013	Yokomichi, Hiroshi/0000-0001-7369-155X	Ministry of Health, Labour and Welfare of Japan [Jisedai-Ippan] [H25-002]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24790614, 15K08730]	Ministry of Health, Labour and Welfare of Japan [Jisedai-Ippan]; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Health, Labour and Welfare of Japan [Jisedai-Ippan (H25-002, http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h25/gaiyo/08.html) to ZY] and by the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid for Young Scientists (B) 24790614, https://kaken.nii.ac.jp/d/p/24790614.en.html) and Grant-in-Aid for Scientific Research (C) (15K08730, https://kaken.nii.ac.jp/d/p/15K08730.en.html) to HY]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS L, 1977, J ENDOCRINOL, V73, P339, DOI 10.1677/joe.0.0730339; Aligne CA, 2003, JAMA-J AM MED ASSOC, V289, P1258, DOI 10.1001/jama.289.10.1258; ANDERSON TD, 2004, PEDIATRICS, V113, P152; BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; BOYD ME, 1983, OBSTET GYNECOL, V61, P715; Burt B A, 2001, J Dent Educ, V65, P1024; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; ERIKSSON U, 1982, BIOL NEONATE, V42, P239; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Gibson S, 1999, CARIES RES, V33, P101, DOI 10.1159/000016503; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Harris Rebecca, 2004, Community Dent Health, V21, P71; Hediger ML, 1998, ARCH PEDIAT ADOL MED, V152, P1225; Hediger ML, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.3.e33; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; HOEGSBERG B, 1993, DIABETES CARE, V16, P32, DOI 10.2337/diacare.16.1.32; Hong L, 2008, J PUBLIC HEALTH DENT, V68, P227, DOI 10.1111/j.1752-7325.2008.00083.x; Iida H, 2007, PEDIATRICS, V120, pE944, DOI 10.1542/peds.2006-0124; Japanese Society of Pediatric Dentistry, WAY THINK US PAC 200; Ji Y, 2006, PEDIATR DENT J, V16, P91, DOI 10.1016/S0917-2394(06)70070-2; Kantovitz Kamila Rosamilia, 2006, Oral Health Prev Dent, V4, P137; Kay EJ, 2010, COMMUNITY DENT ORAL, V38, P408, DOI 10.1111/j.1600-0528.2010.00548.x; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Lai P. Y., 1997, Pediatric Dentistry, V19, P42; Lawlor DA, 2011, AM J CLIN NUTR, V94, P142, DOI 10.3945/ajcn.110.009324; McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855; Ministry of Health Labour and Welfare of Japan, 2007, SUPP GUID BREASTF AB; Ministry of Health Labour and Welfare of Japan, CHILDR CHILDR 2014; Morikawa M, 2013, J OBSTET GYNAECOL RE, V39, P960, DOI 10.1111/j.1447-0756.2012.02059.x; Moyer VA, 2014, PEDIATRICS, V133, P1102, DOI 10.1542/peds.2014-0483; Ogawa Y, 1998, ACTA NEONATOLOGICA J, V34, P624; Ohsuka Keiko, 2009, Environmental Health and Preventive Medicine, V14, P103, DOI 10.1007/s12199-008-0065-6; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Saraiva MCD, 2007, COMMUNITY DENT ORAL, V35, P364, DOI 10.1111/j.1600-0528.2006.00345.x; Shulman JD, 2005, CARIES RES, V39, P161, DOI 10.1159/000084792; Strauss RS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e85; SUSA JB, 1979, DIABETES, V28, P1058, DOI 10.2337/diab.28.12.1058; Tanaka K, 2009, J PEDIATR-US, V155, P410, DOI 10.1016/j.jpeds.2009.03.032; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; The Okinawa Society of Child Health, SEC REP HLTH EX INF; Warren JJ, 2009, COMMUNITY DENT ORAL, V37, P116, DOI 10.1111/j.1600-0528.2008.00447.x; World Health Organization, 1987, CONS DEF STAND REL M; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	51	12	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133872	10.1371/journal.pone.0133872	http://dx.doi.org/10.1371/journal.pone.0133872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207737	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000160
J	Shao, ZR; Bao, Q; Jiang, FZ; Qian, H; Fang, Q; Hu, XQ				Shao, Zheren; Bao, Qi; Jiang, Fangzhen; Qian, Huan; Fang, Quan; Hu, Xueqing			VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo	PLOS ONE			English	Article							EFFICIENTLY INDUCES APOPTOSIS; PROSTATE-CANCER; BCL-XL; PATHWAY; MTOR; TARGETS; ABT-737; PI3K	Melanomas cause over 76% of skin cancer deaths annually. Phosphatidylinositol 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) signaling pathway is important for melanoma initiation and progression. In the current study, we evaluated the potential anti-melanoma effect of VS-5584, a novel and highly potent PI3K-mTOR dual inhibitor. We demonstrated that VS-5584 potently inhibited survival and proliferation of established (A375, A-2058 and SK-MEL-3 lines) and primary human melanoma cells, but was non-cytotoxic to non-cancerous human skin keratinocytes and B10BR murine melanocytes. At the meantime, VS-5584 induced caspase-dependent apoptotic death in melanoma cells, and its cytotoxicity was alleviated by the caspase inhibitors. At the molecular level, VS-5584 blocked AKT-mTOR activation and downregulated cyclin D1 expression in melanoma cells, while the expressions of Bcl-xL and Bcl-2 were not affected by VS-5584 treatment. On the other hand, a BH-3 mimetic Bcl-xL/Bcl-2 inhibitor ABT-737, as well as siRNA-mediated knockdown of Bcl-xL or Bcl-2, enhanced the activity of VS-5584 in melanoma cells. In vivo, oral administration of VS-5584 suppressed A375 melanoma xenograft growth in nude mice, and its activity was further enhanced by co-administration of ABT-737. These results provide the rationale for the clinical assessment of VS-5584 in melanoma patients and development of ABT-737 and other Bcl-xL/Bcl-2 inhibitors as the possible adjuvants.	[Shao, Zheren; Bao, Qi; Jiang, Fangzhen; Qian, Huan; Fang, Quan; Hu, Xueqing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Plast Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, XQ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Plast Surg, Hangzhou 310003, Zhejiang, Peoples R China.	huxueqing163@126.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Davies MA, 2012, CANCER J, V18, P142, DOI 10.1097/PPO.0b013e31824d448c; Dienstmann R, 2014, MOL CANCER THER, V13, P1021, DOI 10.1158/1535-7163.MCT-13-0639; Edlind MP, 2014, ASIAN J ANDROL, V16, P378, DOI 10.4103/1008-682X.122876; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hart S, 2013, MOL CANCER THER, V12, P151, DOI 10.1158/1535-7163.MCT-12-0466; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Hutchinson Lisa, 2015, Nat Rev Clin Oncol, V12, P1, DOI 10.1038/nrclinonc.2014.219; Hutchinson L, 2014, NAT REV CLIN ONCOL, V11, P299, DOI [10.1038/nrclinonc.2014.87, 10.1038/nrclinonc.2014.132]; Kolev VN, 2015, CANCER RES, V75, P446, DOI 10.1158/0008-5472.CAN-14-1223; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Populo H, 2012, EXPERT OPIN THER TAR, V16, P689, DOI 10.1517/14728222.2012.691472; Risberg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024012; Russo AE, 2009, INT J ONCOL, V34, P1481, DOI 10.3892/ijo_00000277; Schadendorf D, 2014, NAT REV CLIN ONCOL, V11, P75, DOI 10.1038/nrclinonc.2013.246; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun SY, 2013, CANCER LETT, V340, P1, DOI 10.1016/j.canlet.2013.06.017; Tang KD, 2014, CURR MED CHEM, V21, P3048, DOI 10.2174/0929867321666140414100127; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Webster RM, 2014, NAT REV DRUG DISCOV, V13, P491, DOI 10.1038/nrd4326	26	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132655	10.1371/journal.pone.0132655	http://dx.doi.org/10.1371/journal.pone.0132655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204252	gold, Green Submitted, Green Published			2022-12-26	WOS:000358621000010
J	Takao, Y; Tomaru, Y; Nagasaki, K; Honda, D				Takao, Yoshitake; Tomaru, Yuji; Nagasaki, Keizo; Honda, Daiske			Ecological Dynamics of Two Distinct Viruses Infecting Marine Eukaryotic Decomposer Thraustochytrids (Labyrinthulomycetes, Stramenopiles)	PLOS ONE			English	Article							HETEROSIGMA-AKASHIWO RAPHIDOPHYCEAE; SCHIZOCHYTRIUM SP; FUNGOID PROTIST; HETEROCAPSA-CIRCULARISQUAMA; PHYTOPLANKTON; BLOOM; SEA; ABUNDANCE; BACTERIA; IMPACTS	Thraustochytrids are cosmopolitan osmotrophic or heterotrophic microorganisms that are considered as important decomposers in coastal ecosystems. However, because of a lack of estimation method for each genus or systematic group of them, relatively little is known about their ecology in situ. Previously, we reported two distinct types of virus infecting thraustochytrids (AuRNAV: reported as SssRNAV, and SmDNAV) suggesting they have wide distributions in the host-virus systems of coastal environments. Here we conducted a field survey from 2004 through 2005 to show the fluctuation pattern of thraustochytrids and their viruses in Hiroshima Bay, Japan. During the field survey, we monitored the dynamics of the two types of thraustochytrid-infecting virus: small viruses causing lysis of Aurantiochytrium sp. NIBH N1-27 (identified as AuRNAV) and the large viruses of Sicyoidochytrium minutum NBRC 102975 (similar to SmDNAV in physiology and morphology). Fluctuation patterns of the two distinct types of virus were different from each other. This may reflect the difference in the preference of organic substrates; i.e., it may be likely the host of AuRNAV (Aurantiochytrium sp.) increases utilizing algal dead bodies or feeble cells as the virus shows a large increase in abundance following raphidophyte blooms; whereas, the trophic nutrient supply for S. minutum may primarily depend on other constantly-supplied organic compounds because it did not show any significant change in abundance throughout the survey. Further study concerning the population composition of thraustochytrids and their viruses may demonstrate the microbial ecology (especially concerning the detrital food web) of marine environments.	[Takao, Yoshitake] Fukui Prefectural Univ, Dept Marine Biosci, Obama, Fukui 9170003, Japan; [Tomaru, Yuji; Nagasaki, Keizo] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hatsukaichi, Hiroshima 7390452, Japan; [Honda, Daiske] Konan Univ, Dept Biol, Fac Sci & Engn, Higashinada Ku, Kobe, Hyogo 6588501, Japan	Fukui Prefectural University; Japan Fisheries Research & Education Agency (FRA); Konan University	Takao, Y (corresponding author), Fukui Prefectural Univ, Dept Marine Biosci, 1-1 Gakuencho, Obama, Fukui 9170003, Japan.	takyoshi@fpu.ac.jp		Honda, Daiske/0000-0002-3436-4561; Takao, Yoshitake/0000-0002-0741-7445	Asahi Glass Foundation; Kato Memorial Bioscience Foundation	Asahi Glass Foundation; Kato Memorial Bioscience Foundation	This work was partially supported by the Asahi Glass Foundation and Kato Memorial Bioscience Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bongiorni L, 2002, AQUAT MICROB ECOL, V25, P355; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; GAERTNER A, 1979, Veroeffentlichungen des Instituts fuer Meeresforschung in Bremerhaven, V18, P29; GAERTNER A, 1968, VEROFF I MEERESFORSC, V3, P75; Honda D, 1998, MYCOL RES, V102, P439, DOI 10.1017/S0953756297005170; Kimura H, 2001, AQUAT MICROB ECOL, V25, P293, DOI 10.3354/ame025293; Kimura H, 1999, MAR ECOL PROG SER, V189, P27, DOI 10.3354/meps189027; Lewis TE, 1999, MAR BIOTECHNOL, V1, P580, DOI 10.1007/PL00011813; Naganuma T, 1998, MAR ECOL PROG SER, V162, P105, DOI 10.3354/meps162105; Nagasaki K, 1997, AQUAT MICROB ECOL, V13, P135, DOI 10.3354/ame013135; Nagasaki K, 2008, J MICROBIOL, V46, P235, DOI 10.1007/s12275-008-0098-y; Nakahara T, 1996, J AM OIL CHEM SOC, V73, P1421, DOI 10.1007/BF02523506; NISHIHARA T, 1986, EISEI KAGAKU, V32, P226, DOI 10.1248/jhs1956.32.226; PORTER D, 1989, HDB PROTOCTISTA, P388; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Raghukumar S, 2002, EUR J PROTISTOL, V38, P127, DOI 10.1078/0932-4739-00832; RAGHUKUMAR S, 1992, MAR BIOL, V113, P165, DOI 10.1007/BF00367650; Raghukumar S, 2001, AQUAT MICROB ECOL, V24, P175, DOI 10.3354/ame024175; Raghukumar S, 1996, ADV ZOOSPORIC FUNGI, P35; Suttle C. A., 1993, HDB METHODS AQUATIC, P121; Takao Y, 2006, J GEN VIROL, V87, P723, DOI 10.1099/vir.0.81204-0; Takao Y, 2005, APPL ENVIRON MICROB, V71, P4516, DOI 10.1128/AEM.71.8.4516-4522.2005; Takao Y, 2007, AQUAT MICROB ECOL, V49, P101, DOI 10.3354/ame01141; Tarutani K, 2000, APPL ENVIRON MICROB, V66, P4916, DOI 10.1128/AEM.66.11.4916-4920.2000; Tomaru Y, 2004, AQUAT MICROB ECOL, V34, P227, DOI 10.3354/ame034227; Tomaru Y, 2004, AQUAT MICROB ECOL, V34, P207, DOI 10.3354/ame034207; Tomaru Y, 2007, ENVIRON MICROBIOL, V9, P1376, DOI 10.1111/j.1462-2920.2007.01252.x; Ueda M, 2015, AQUAT MICROB ECOL, V74, P187, DOI 10.3354/ame01736; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Yokoyama Rinka, 2007, Mycoscience, V48, P199, DOI 10.1007/s10267-006-0362-0	31	2	2	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133395	10.1371/journal.pone.0133395	http://dx.doi.org/10.1371/journal.pone.0133395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203654	Green Published, Green Submitted, gold			2022-12-26	WOS:000358621000028
J	Bao, KS; Shen, J; Wang, GP; Gao, CY				Bao, Kunshan; Shen, Ji; Wang, Guoping; Gao, Chuanyu			Anthropogenic Black Carbon Emission Increase during the Last 150 Years at Coastal Jiangsu, China	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SURFACE SEDIMENTS; HISTORICAL TRENDS; PYROGENIC CARBON; ELEMENTAL CARBON; LAKE-SEDIMENTS; SOILS; LAND; SEA; QUANTIFICATION	Black carbon (BC) is one of the major drivers of climate change and a useful indicator of environmental pollution from industrialization, and thus it is essential to reconstruct the historical trend in BC flux to better understand its impact. The Yancheng coastal wetland reserve in Jiangsu province is an area sensitive to global sea level change and is also located in the most developed as well as most polluted region of China. We investigated the concentration and historical flux of BC over the past 150 years through geochemical analysis of two Pb-210-dated sediment cores from Yancheng coastal wetland. Measured BC contents ranged from 0.24 mg g(-1) to 1.41 mg g(-1) with average values of 0.51mg g(-1)-0.69 mg g(-1), and BC fluxes ranged from 0.69 g m(-2) yr(-1) to 11.80 g m(-2) yr(-1) with averages of 2.94g m(-2) yr-1-3.79 g m(-2) yr(-1). These values are consistent with other records worldwide. Both BC content and flux show a gradual and continuous increase over time and clearly reflect increased emissions from anthropogenic activities. The BC records have a significant peak in recent years (from 2000 to 2007), which is accompanied by the sharp increase of energy consumption and total carbon emission in the region. It is reasonable to conclude that changes in BC from increasing human activities have controlled BC fluxes during the last 150 years. Industrial contamination, especially BC emission, in the coastal region of eastern China should be taken into account when developing management strategies for protecting the natural environment.	[Bao, Kunshan; Shen, Ji] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Wang, Guoping; Gao, Chuanyu] Chinese Acad Sci, Key Lab Wetland Ecol & Environm, Northeast Inst Geog & Agroecol, Changchun, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Bao, KS (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	ksbao@niglas.ac.cn	Gao, Chuanyu/O-3946-2019; Bao, Kunshan/HGC-3930-2022; Bao, Kunshan/AFP-8998-2022; Wang, Guoping/A-8140-2008	Bao, Kunshan/0000-0002-7668-1522; Gao, Chuanyu/0000-0003-2792-5022; Wang, Guoping/0000-0002-8350-812X	Natural Science Foundation of Jiangsu Province, China [BK20131058]; National Natural Science Foundation of China [41301215]; National Basic Research Program of China [2012CB956100]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This research was supported by the Natural Science Foundation of Jiangsu Province, China (no. BK20131058), the National Natural Science Foundation of China (no. 41301215), and the National Basic Research Program of China (no. 2012CB956100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby PG, 2008, HOLOCENE, V18, P83, DOI 10.1177/0959683607085598; BALDWIN B, 1985, AAPG BULL, V69, P622; Bao K, 2010, J ENVIRON RADIOACTIV, V101, P773, DOI 10.1016/j.jenvrad.2010.05.004; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Bogdal C, 2011, J ENVIRON MONITOR, V13, P1316, DOI 10.1039/c0em00655f; Bond TC, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002840; Cao GL, 2006, ATMOS ENVIRON, V40, P6516, DOI 10.1016/j.atmosenv.2006.05.070; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Choi YH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002261; Chuai XW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05667; Cong ZY, 2013, ENVIRON SCI TECHNOL, V47, P2579, DOI 10.1021/es3048202; Cordeiro RC, 2002, SCI TOTAL ENVIRON, V293, P247, DOI 10.1016/S0048-9697(02)00045-1; CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669; DeLaune RD, 2012, CLIMATIC CHANGE, V110, P297, DOI 10.1007/s10584-011-0089-6; Elmquist M, 2007, ENVIRON SCI TECHNOL, V41, P6926, DOI 10.1021/es070546m; Fang SB, 2010, J HAZARD MATER, V184, P375, DOI 10.1016/j.jhazmat.2010.08.046; [方引 Fang Yin], 2014, [海洋学报, Acta Oceanologica Sinica], V36, P98; Gao CA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05723; Gao JH, 2012, J COASTAL RES, V28, P486, DOI 10.2112/JCOASTRES-D-11-00062.1; Gustafsson O, 2001, GLOBAL BIOGEOCHEM CY, V15, P881, DOI 10.1029/2000GB001380; Gustafsson O, 1998, GEOCHIM COSMOCHIM AC, V62, P465, DOI 10.1016/S0016-7037(97)00370-0; Hammes K, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002914; Hammes K, 2006, ORG GEOCHEM, V37, P1629, DOI 10.1016/j.orggeochem.2006.07.003; Han YM, 2011, ENVIRON SCI TECHNOL, V45, P5287, DOI 10.1021/es103518c; [韩永明 Han Yongming], 2010, [第四纪研究, Quaternary Sciences], V30, P550; Husain L, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009398; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Jiang X, 2009, ECO ENV SCI, V19, P1617; Jiangsu Provincial Bureau of Statistics, 2013, JIANGS STAT YB; Kang YJ, 2009, CHIN J OCEANOL LIMN, V27, P297, DOI 10.1007/s00343-009-9151-x; Kapicka A, 1999, J GEOCHEM EXPLOR, V66, P291, DOI 10.1016/S0375-6742(99)00008-4; Ke CQ, 2011, REG ENVIRON CHANGE, V11, P161, DOI 10.1007/s10113-010-0130-8; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; KUHLBUSCH TAJ, 1995, GLOBAL BIOGEOCHEM CY, V9, P491, DOI 10.1029/95GB02742; Lal R, 2003, CRIT REV PLANT SCI, V22, P151, DOI 10.1080/713610854; Lim B, 1996, CHEM GEOL, V131, P143, DOI 10.1016/0009-2541(96)00031-9; Lin Tian, 2012, Huanjing Kexue, V33, P2335; Liu ZY, 2010, J GEOGR SCI, V20, P91, DOI 10.1007/s11442-010-0091-3; Lohmann R, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003253; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Muri G, 2002, CHEMOSPHERE, V46, P1225, DOI 10.1016/S0045-6535(01)00295-8; Pennings SC, 2012, NATURE, V490, P352, DOI 10.1038/490352a; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Qin Y, 2012, ATMOS CHEM PHYS, V12, P4825, DOI 10.5194/acp-12-4825-2012; Qiu JN, 2011, NATURE, V471, P19, DOI 10.1038/471019a; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; Sanchez-Garcia L, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003956; Schwarz JP, 2013, SCI REP-UK, V3, DOI 10.1038/srep01356; Singh BP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03687; SMITH DM, 1973, NATURE, V241, P268, DOI 10.1038/241268a0; Song JZ, 2002, ENVIRON SCI TECHNOL, V36, P3960, DOI 10.1021/es025502m; Song ML, 2015, J CLEAN PROD, V103, P620, DOI 10.1016/j.jclepro.2014.05.095; SPSS, 2002, STAT PROD SERV SOL V; Streets DG, 2001, ATMOS ENVIRON, V35, P4281, DOI 10.1016/S1352-2310(01)00179-0; Sun XS, 2008, APPL GEOCHEM, V23, P3464, DOI 10.1016/j.apgeochem.2008.08.006; Thevenon F, 2010, GLOBAL PLANET CHANGE, V72, P381, DOI 10.1016/j.gloplacha.2010.01.014; [王爱军 Wang Aijun], 2005, [地理学报, Acta Geographica Sinica], V60, P61; Wang R, 2012, ENVIRON SCI TECHNOL, V46, P7595, DOI 10.1021/es3003684; Wang X, 2013, QUATERNARY SCI REV, V59, P18, DOI 10.1016/j.quascirev.2012.10.033; Wang XC, 2007, CHINESE SCI BULL, V52, P3155, DOI 10.1007/s11434-007-0452-1	61	9	11	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0129680	10.1371/journal.pone.0129680	http://dx.doi.org/10.1371/journal.pone.0129680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200665	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100004
J	Chen, ZJ; Han, HQ; Ren, W; Huang, GJ				Chen, Zejun; Han, Huiquan; Ren, Wei; Huang, Guangjie			Heat Transfer Modeling of an Annular On-Line Spray Water Cooling Process for Electric-Resistance-Welded Steel Pipe	PLOS ONE			English	Article							AIR-ATOMIZED SPRAY	On-line spray water cooling (OSWC) of electric-resistance-welded (ERW) steel pipes can replace the conventional off-line heat treatment process and become an important and critical procedure. The OSWC process improves production efficiency, decreases costs, and enhances the mechanical properties of ERW steel pipe, especially the impact properties of the weld joint. In this paper, an annular OSWC process is investigated based on an experimental simulation platform that can obtain precise real-time measurements of the temperature of the pipe, the water pressure and flux, etc. The effects of the modes of annular spray water cooling and related cooling parameters on the mechanical properties of the pipe are investigated. The temperature evolutions of the inner and outer walls of the pipe are measured during the spray water cooling process, and the uniformity of mechanical properties along the circumferential and longitudinal directions is investigated. A heat transfer coefficient model of spray water cooling is developed based on measured temperature data in conjunction with simulation using the finite element method. Industrial tests prove the validity of the heat transfer model of a steel pipe undergoing spray water cooling. The research results can provide a basis for the industrial application of the OSWC process in the production of ERW steel pipes.	[Chen, Zejun; Ren, Wei; Huang, Guangjie] Chongqing Univ, Coll Mat Sci & Engn, State Key Lab Mech Transmiss, Chongqing 400044, Peoples R China; [Han, Huiquan] CISDI Engn Co Ltd, Chongqing 400013, Peoples R China	Chongqing University	Chen, ZJ (corresponding author), Chongqing Univ, Coll Mat Sci & Engn, State Key Lab Mech Transmiss, Chongqing 400044, Peoples R China.	zjchen@cqu.edu.cn	chen, zejun/AAC-7734-2021	chen, zejun/0000-0002-8633-5842	Fundamental Research Funds for the Central Universities [CDJZR14135504]; National Natural Science Foundation of China [51421001]; CISDI Engineering Co., Ltd.	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CISDI Engineering Co., Ltd.	The authors would like to acknowledge the project is supported by the Fundamental Research Funds for the Central Universities (No. CDJZR14135504), and supported by National Natural Science Foundation of China (No. 51421001). Coauthor Huiquan Han is employed by CISDI Engineering Co., Ltd. CISDI Engineering Co., Ltd. provided support in the form of salary for author HH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abdalrahman KHM, 2014, INT J HEAT MASS TRAN, V78, P76, DOI 10.1016/j.ijheatmasstransfer.2014.06.070; Al-Ahmadi HM, 2008, EXP HEAT TRANSFER, V21, P38, DOI 10.1080/08916150701647827; [Anonymous], 2004, 11960 ISO; Buckland B, 2005, KAWASAKI STEEL TECHN, V1, P26; Buckland B, 2005, KAWASAKI STEEL TECHN, V1, P20; Dou RF, 2014, APPL THERM ENG, V62, P738, DOI 10.1016/j.applthermaleng.2013.10.037; [韩会全 Han Huiquan], 2014, [钢铁, Iron and Steel], V49, P55; Kim JH, 2007, INT J HEAT FLUID FL, V28, P753, DOI 10.1016/j.ijheatfluidflow.2006.09.003; Liu SC, 2011, THESIS YANSHAN U; Liu ZH, 2001, INT J HEAT MASS TRAN, V44, P2475, DOI 10.1016/S0017-9310(00)00281-7; Masamura K., 2006, JFE TECH REP, V7, P1; Mohapatra SS, 2012, EXP HEAT TRANSFER, V25, P111, DOI 10.1080/08916152.2011.582567; Mohapatra SS, 2012, J ENHANC HEAT TRANSF, V19, P397, DOI 10.1615/JEnhHeatTransf.2012004285; Rosado DB, 2013, SUSTAINABLE CONSTRUC, V4, DOI 10.13140/2.1.4498.5287; Sarkocevic Z., 2010, ZAVARIVANHE ZAVARENE, V55, P137; Toyooka T, 2002, KAWASAKI STEEL TECHN, V47, P1; Pedrosa IRV, 2013, MATER RES-IBERO-AM J, V16, P489, DOI [10.1590/S1516-14392013005000024, 10.1590/S1516-14392013000200026]; Wang F, 2008, INT J ADV MANUF TECH, V38, P38, DOI 10.1007/s00170-007-1085-x; Wang HM, 2012, J MATER PROCESS TECH, V212, P1825, DOI 10.1016/j.jmatprotec.2012.04.008; Wendelstorf J, 2008, INT J HEAT MASS TRAN, V51, P4902, DOI 10.1016/j.ijheatmasstransfer.2008.01.032; Wendelstorf R, 2008, INT J HEAT MASS TRAN, V51, P4892, DOI 10.1016/j.ijheatmasstransfer.2008.01.033; Zhang X, 2014, APPL THERM ENG, V71, P43, DOI 10.1016/j.applthermaleng.2014.06.026	22	2	2	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131574	10.1371/journal.pone.0131574	http://dx.doi.org/10.1371/journal.pone.0131574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201073	Green Submitted, gold, Green Published			2022-12-26	WOS:000358597100016
J	Venturutti, L; Romero, LV; Urtreger, AJ; Chervo, MF; Russo, RIC; Mercogliano, MF; Inurrigarro, G; Pereyra, MG; Proietti, CJ; Izzo, F; Flaque, MCD; Sundblad, V; Roa, JC; Guzman, P; Joffe, EDBD; Charreau, EH; Schillaci, R; Elizalde, PV				Venturutti, L.; Romero, L. V.; Urtreger, A. J.; Chervo, M. F.; Cordo Russo, R. I.; Mercogliano, M. F.; Inurrigarro, G.; Pereyra, M. G.; Proietti, C. J.; Izzo, F.; Diaz Flaque, M. C.; Sundblad, V.; Roa, J. C.; Guzman, P.; Bal de Kier Joffe, E. D.; Charreau, E. H.; Schillaci, R.; Elizalde, P. V.			Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis	ONCOGENE			English	Article							PROGESTERONE-RECEPTOR; MICRORNA EXPRESSION; SIGNAL TRANSDUCER; TRANSGENIC MICE; MAMMARY-TUMORS; UP-REGULATION; TRANSCRIPTIONAL COMPLEX; TISSUE INHIBITOR; ACTIVATION; GROWTH	Membrane overexpression of the receptor tyrosine kinase ErbB-2 (MErbB-2) accounts for a clinically aggressive breast cancer (BC) subtype (ErbB-2-positive) with increased incidence of metastases. We and others demonstrated that nuclear ErbB-2 (NErbB-2) also plays a key role in BC and is a poor prognostic factor in ErbB-2-positive tumors. The signal transducer and activator of transcription 3 (Stat3), another player in BC, has been recognized as a downstream mediator of MErbB-2 action in BC metastasis. Here, we revealed an unanticipated novel direction of the ErbB-2 and Stat3 interaction underlying BC metastasis. We found that Stat3 binds to its response elements (GAS) at the ErbB-2 promoter to upregulate ErbB-2 transcription in metastatic, ErbB-2-positive BC. We validated these results in several BC subtypes displaying metastatic and non-metastatic ability, highlighting Stat3 general role as upstream regulator of ErbB-2 expression in BC. Moreover, we showed that Stat3 co-opts NErbB-2 function by recruiting ErbB-2 as its coactivator at the GAS sites in the promoter of microRNA-21 (miR-21), a metastasis-promoting microRNA (miRNA). Using an ErbB-2 nuclear localization domain mutant and a constitutively activated ErbB-2 variant, we found that NErbB-2 role as a Stat3 coactivator and also its direct role as transcription factor upregulate miR-21 in BC. This reveals a novel function of NErbB-2 as a regulator of miRNAs expression. Increased levels of miR-21, in turn, downregulate the expression of the metastasis-suppressor protein programmed cell death 4 (PDCD4), a validated miR-21 target. Using an in vivo model of metastatic ErbB-2-postive BC, in which we silenced Stat3 and reconstituted ErbB-2 or miR-21 expression, we showed that both are downstream mediators of Stat3-driven metastasis. Supporting the clinical relevance of our results, we found an inverse correlation between ErbB-2/Stat3 nuclear co-expression and PDCD4 expression in ErbB-2-positive primary invasive BCs. Our findings identify Stat3 and NErbB-2 as novel therapeutic targets to inhibit ErbB-2-positive BC metastasis.	[Venturutti, L.; Romero, L. V.; Chervo, M. F.; Cordo Russo, R. I.; Mercogliano, M. F.; Pereyra, M. G.; Proietti, C. J.; Izzo, F.; Diaz Flaque, M. C.; Sundblad, V.; Charreau, E. H.; Schillaci, R.; Elizalde, P. V.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Mol Mech Carcinogenesis, RA-1033 Buenos Aires, DF, Argentina; [Urtreger, A. J.; Bal de Kier Joffe, E. D.] Univ Buenos Aires, Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina; [Inurrigarro, G.] Sanatorio Mater Dei, Serv Patol, Buenos Aires, DF, Argentina; [Roa, J. C.; Guzman, P.] Univ La Frontera, Dept Anat Patol BIOREN, Temuco, Chile; [Roa, J. C.] Pontificia Univ Catolica Chile, Escuela Med, Dept Anat Patol, Santiago, Chile; [Roa, J. C.] Pontificia Univ Catolica Chile, Adv Ctr Chron Dis ACCDIS, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; Universidad de La Frontera; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Schillaci, R; Elizalde, PV (corresponding author), Inst Biol & Med Expt IBYME, Lab Mol Mech Carcinogenesis, Vuelta de Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	rschillaci@ibyme.conicet.gov.ar; patriciaelizalde@ibyme.conicet.gov.ar	Roa, Juan C./K-4749-2014; Russo, Rosalia Cordo/O-9149-2017	Roa, Juan C./0000-0001-8313-8774; Russo, Rosalia Cordo/0000-0002-5984-9717; Mercogliano, Maria Florencia/0000-0003-1094-9247; Chervo, Maria Florencia/0000-0001-8878-5591; BAL de KIER JOFFE, ELISA DORA/0000-0001-6952-0029; Elizalde, Patricia V./0000-0002-5923-9898; Diaz Flaque, Maria Celeste/0000-0003-4167-6149	Susan G Komen for the Cure [KG090250]; National Agency of Scientific Promotion of Argentina [IDB/PICT 2012-668, PID 2012-066, IDB/PICT 2012-0382]; Oncomed-Reno CONICET from Henry Moore Institute of Argentina [1819/03]	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Agency of Scientific Promotion of Argentina(ANPCyT); Oncomed-Reno CONICET from Henry Moore Institute of Argentina	We thank MC Hung (MD Anderson Cancer Center, Houston, TX, USA) for his generous gift of the hErbB-2.NLS, which indeed made this work possible, AA Molinolo (NIH, Bethesda, MD, USA) for his constant help and support and V Chiauzzi for her technical assistance. This work was supported by the Susan G Komen for the Cure KG090250 investigator-initiated research Grant, and IDB/PICT 2012-668 and PID 2012-066 from the National Agency of Scientific Promotion of Argentina, all of them awarded to PVE, IDB/PICT 2012-0382 (awarded to RS) and Oncomed-Reno CONICET 1819/03, from the Henry Moore Institute of Argentina (awarded to PVE and RS).	AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; Alonso DF, 1999, BREAST CANCER RES TR, V57, P271, DOI 10.1023/A:1006291607871; Balana ME, 2001, ONCOGENE, V20, P34, DOI 10.1038/sj.onc.1204050; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Barbieri I, 2010, MOL CARCINOGEN, V49, P114, DOI 10.1002/mc.20605; Bates NP, 1997, ONCOGENE, V15, P473, DOI 10.1038/sj.onc.1201368; Beguelin W, 2010, MOL CELL BIOL, V30, P5456, DOI 10.1128/MCB.00012-10; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carnevale RP, 2007, MOL ENDOCRINOL, V21, P1335, DOI 10.1210/me.2006-0304; Chen J, 2014, CLIN TRANSL ONCOL, V16, P225, DOI 10.1007/s12094-013-1132-z; Russo RIC, 2015, ONCOGENE, V34, P3413, DOI 10.1038/onc.2014.272; Delacroix L, 2005, DNA CELL BIOL, V24, P582, DOI 10.1089/dna.2005.24.582; Flaque MCD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3587; Flaque MCD, 2013, STEROIDS, V78, P559, DOI 10.1016/j.steroids.2012.11.003; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; Freudenberg JA, 2009, EXP MOL PATHOL, V87, P1, DOI 10.1016/j.yexmp.2009.05.001; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Gomez-Martin C, 2014, CANCER LETT, V351, P30, DOI 10.1016/j.canlet.2014.05.019; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Han ML, 2012, MOL CELL BIOCHEM, V363, P427, DOI 10.1007/s11010-011-1195-5; Henderson IC, 1998, BREAST CANCER RES TR, V52, P261, DOI 10.1023/A:1006141703224; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Izzo F, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0491-x; Kamran MZ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421821; Kang HJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07201; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Landgraf R, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1633; Li CH, 2014, EUR J CANCER, V50, P2560, DOI 10.1016/j.ejca.2014.07.008; Li LY, 2011, CANCER RES, V71, P4269, DOI 10.1158/0008-5472.CAN-10-3504; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Marino ALF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-739; Meric-Bernstam F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3343; Mitsui K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-863; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nieves-Alicea R, 2009, BREAST CANCER RES TR, V114, P203, DOI 10.1007/s10549-008-9993-5; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Ou HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109929; Peters MG, 2003, BREAST CANCER RES TR, V80, P221, DOI 10.1023/A:1024549729256; Petrovic N, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0867-x; Proietti C, 2005, MOL CELL BIOL, V25, P4826, DOI 10.1128/MCB.25.12.4826-4840.2005; Proietti CJ, 2009, MOL CELL BIOL, V29, P1249, DOI 10.1128/MCB.00853-08; Puricelli L, 2002, INT J CANCER, V100, P642, DOI 10.1002/ijc.10533; Qian L, 2006, BIOCHEM BIOPH RES CO, V345, P660, DOI 10.1016/j.bbrc.2006.04.153; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Rivas MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3187; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Schillaci R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-74; Shishodia G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-996; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Urtreger AJ, 1997, INT J ONCOL, V11, P489; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Wen YH, 2007, ONCOL REP, V18, P1387; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yan M, 2014, CANCER TREAT REV, V40, P770, DOI 10.1016/j.ctrv.2014.02.008; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Zhang J, 2012, BRIT J CANCER, V107, P352, DOI 10.1038/bjc.2012.251; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhou X, 2014, ONCOL REP, V31, P2173, DOI 10.3892/or.2014.3114; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	79	45	47	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2208	2222		10.1038/onc.2015.281	http://dx.doi.org/10.1038/onc.2015.281			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26212010	Green Published			2022-12-26	WOS:000374986000007
J	Gulati, S; Balderes, D; Kim, C; Guo, ZMA; Wilcox, L; Area-Gomez, E; Snider, J; Wolinski, H; Stagljar, I; Granato, JT; Ruggles, KV; DeGiorgis, JA; Kohlwein, SD; Schon, EA; Sturley, SL				Gulati, Sonia; Balderes, Dina; Kim, Christine; Guo, Zhongmin A.; Wilcox, Lisa; Area-Gomez, Estela; Snider, Jamie; Wolinski, Heimo; Stagljar, Igor; Granato, Juliana T.; Ruggles, Kelly V.; DeGiorgis, Joseph A.; Kohlwein, Sepp D.; Schon, Eric A.; Sturley, Stephen L.			ATP-binding cassette transporters and sterol O-acyltransferases interact at membrane microdomains to modulate sterol uptake and esterification	FASEB JOURNAL			English	Article						cholesteryl ester; sterol transport; ABC transporter; lipid droplet	A-CHOLESTEROL ACYLTRANSFERASE; YEAST SACCHAROMYCES-CEREVISIAE; HUMAN ABCG1 TRANSPORTER; ACYL-COENZYME; PLASMA-MEMBRANE; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; PROTEINS; COA	A key component of eukaryotic lipid homeostasis is the esterification of sterols with fatty acids by sterol O-acyltransferases (SOATs). The esterification reactions are allosterically activated by their sterol substrates, the majority of which accumulate at the plasma membrane. We demonstrate that in yeast, sterol transport from the plasma membrane to the site of esterification is associated with the physical interaction of the major SOAT, acylcoenzyme A: cholesterol acyltransferase (ACAT)-related enzyme (Are) 2p, with 2 plasma membrane ATP-binding cassette (ABC) transporters: Aus1p and Pdr11p. Are2p, Aus1p, and Pdr11p, unlike the minor acyltransferase, Are1p, colocalize to sterol and sphingolipid-enriched, detergent-resistant microdomains (DRMs). Deletion of either ABC transporter results in Are2p relocalization to detergent-soluble membrane domains and a significant decrease (53-36%) in esterification of exogenous sterol. Similarly, in murine tissues, the SOAT1/Acat1 enzyme and activity localize to DRMs. This subcellular localization is diminished upon deletion of murine ABC transporters, such as Abcg1, which itself is DRM associated. We propose that the close proximity of sterol esterification and transport proteins to each other combined with their residence in lipid-enriched membrane microdomains facilitates rapid, high-capacity sterol transport and esterification, obviating any requirement for soluble intermediary proteins.	[Gulati, Sonia; Balderes, Dina; Guo, Zhongmin A.; Wilcox, Lisa; Ruggles, Kelly V.; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Area-Gomez, Estela; Schon, Eric A.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Schon, Eric A.] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Kim, Christine] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Kim, Christine] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Snider, Jamie; Stagljar, Igor] Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Wolinski, Heimo; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, BioTechMed Graz, Graz, Austria; [Granato, Juliana T.; DeGiorgis, Joseph A.] Providence Coll, KDepartment Biol, Providence, RI 02918 USA; [Granato, Juliana T.; DeGiorgis, Joseph A.; Sturley, Stephen L.] Marine Biol Lab, Woods Hole, MA 02543 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of Toronto; University of Graz; Providence College; Marine Biological Laboratory - Woods Hole	Sturley, SL (corresponding author), Columbia Univ, Med Ctr, 630 West 168th St, New York, NY 10032 USA.	sls37@columbia.edu		Kohlwein, Sepp Dieter/0000-0002-1030-0598; Moon, Christine/0000-0001-8717-2435; Wolinski, Heimo/0000-0002-1583-6092; Area, Estela/0000-0002-0962-1570; Ruggles, Kelly/0000-0002-0152-0863	American Heart Association; Ara Parseghian Medical Research Foundation; University of Notre Dame; U.S. National Institutes of Health (NIH) [DK54320]; John Douglas French Alzheimer Foundation; NIH [K01AG045335]; American Health Assistance Foundation; Ellison Medical Foundation; Alzheimer Drug Discovery Foundation; U.S. Department of Defense [W911NF-12-1-9159, W911F-15-1-0169]; Canadian Foundation for Innovation; Canadian Institutes of Health Research; Canadian Cancer Society Research Institute; Heart and Stroke Foundation; Cystic Fibrosis Foundation; Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada; Novartis; NIH National Institute of General Medical Sciences [2 P20 GM103430]; Austrian Science Funds; Fonds zur Forderung der Wissenschaftlichen Forschung [F3005 LIPOTOX]; Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG045335] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Ara Parseghian Medical Research Foundation; University of Notre Dame; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Douglas French Alzheimer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Alzheimer Drug Discovery Foundation; U.S. Department of Defense(United States Department of Defense); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Novartis(Novartis); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Funds(Austrian Science Fund (FWF)); Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors appreciate the technical assistance of Abraham Sturley and provision of reagents or helpful discussions with Andrew Munkacsi, Liz Miller, Elisabeth Tarling, and Peter Edwards. This work was supported by the American Heart Association, Ara Parseghian Medical Research Foundation, University of Notre Dame, and U.S. National Institutes of Health (NIH) Grant DK54320 (to S.L.S.); the John Douglas French Alzheimer Foundation and NIH Grant K01AG045335 (to E.A.-G.); American Health Assistance Foundation, Ellison Medical Foundation, Alzheimer Drug Discovery Foundation, U.S. Department of Defense Grants W911NF-12-1-9159 and W911F-15-1-0169 (to E.A.S.); Canadian Foundation for Innovation, Canadian Institutes of Health Research, Canadian Cancer Society Research Institute, Heart and Stroke Foundation, Cystic Fibrosis Foundation, Ontario Genomics Institute, Natural Sciences and Engineering Research Council of Canada, and Novartis (to J.S. and I.S.); the Canadian Institutes of Health Research (to L.W.); an Institutional Development Award from the NIH National Institute of General Medical Sciences, Grant 2 P20 GM103430 (to J.A.D. and J.T.G.); and the Austrian Science Funds, Fonds zur Forderung der Wissenschaftlichen Forschung [Project F3005 LIPOTOX (to S.D.K.)].	Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; BILLHEIMER JT, 1990, J BIOL CHEM, V265, P8632; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; CHENG D, 1995, J BIOL CHEM, V270, P685, DOI 10.1074/jbc.270.2.685; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Finley Jr R. L., 1995, GENE PROBES PRACTICA, P169; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Gulati S., 2011, THESIS, P84; Gulati S, 2010, PROG LIPID RES, V49, P353, DOI 10.1016/j.plipres.2010.03.003; Guo ZM, 2001, J LIPID RES, V42, P1282; Jensen-Pergakes K, 2001, J BACTERIOL, V183, P4950, DOI 10.1128/JB.183.17.4950-4957.2001; Kawasaki T, 1998, BIOCHEM BIOPH RES CO, V244, P347, DOI 10.1006/bbrc.1998.8268; Khelef N, 1998, J BIOL CHEM, V273, P11218, DOI 10.1074/jbc.273.18.11218; Khelef N, 2000, ARTERIOSCL THROM VAS, V20, P1769; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Koh JLY, 2010, NUCLEIC ACIDS RES, V38, pD502, DOI 10.1093/nar/gkp820; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lei XF, 2010, J ATHEROSCLER THROMB, V17, P740, DOI 10.5551/jat.4416; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; LISCUM L, 1995, J BIOL CHEM, V270, P15443, DOI 10.1074/jbc.270.26.15443; Marek M, 2011, J BIOL CHEM, V286, P21835, DOI 10.1074/jbc.M111.244525; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Neufeld Edward B, 2014, Biology (Basel), V3, P866, DOI 10.3390/biology3040866; Neufeld Edward B, 2014, Biology (Basel), V3, P781, DOI 10.3390/biology3040781; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; RAYMOND CK, 1992, INT REV CYTOL, V139, P59, DOI 10.1016/S0074-7696(08)61410-2; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sano O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109886; Scheffer GL, 2000, CANCER RES, V60, P2589; Schneiter R, 2007, BIOCHIMIE, V89, P255, DOI 10.1016/j.biochi.2006.07.022; Skiba PJ, 1996, J BIOL CHEM, V271, P13392, DOI 10.1074/jbc.271.23.13392; Snider J, 2013, NAT CHEM BIOL, V9, P565, DOI [10.1038/NCHEMBIO.1293, 10.1038/nchembio.1293]; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; Tarling EJ, 2012, BBA-MOL CELL BIOL L, V1821, P386, DOI 10.1016/j.bbalip.2011.07.011; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; TAVANI DM, 1982, J LIPID RES, V23, P774; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Vaughan AM, 2009, J LIPID RES, V50, P285, DOI 10.1194/jlr.M800366-JLR200; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang HY, 1997, J BIOL CHEM, V272, P3980, DOI 10.1074/jbc.272.7.3980; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	55	18	18	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4682	4694		10.1096/fj.14-264796	http://dx.doi.org/10.1096/fj.14-264796			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26220175	Green Published			2022-12-26	WOS:000364514700025
J	Little, DJ; Milek, S; Bamford, NC; Ganguly, T; DiFrancesco, BR; Nitz, M; Deora, R; Howell, PL				Little, Dustin J.; Milek, Sonja; Bamford, Natalie C.; Ganguly, Tridib; DiFrancesco, Benjamin R.; Nitz, Mark; Deora, Rajendar; Howell, P. Lynne			The Protein BpsB Is a Poly-beta-1,6-N-acetyl-D-glucosamine Deacetylase Required for Biofilm Formation in Bordetella bronchiseptica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PGAB; DE-N-ACETYLATION; STAPHYLOCOCCUS-EPIDERMIDIS; CARBOHYDRATE ESTERASE; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; POLYSACCHARIDE; PERTUSSIS; COLONIZATION; SYSTEM	Bordetella pertussis and Bordetella bronchiseptica are the causative agents of whooping cough in humans and a variety of respiratory diseases in animals, respectively. Bordetella species produce an exopolysaccharide, known as the Bordetella polysaccharide (Bps), which is encoded by the bpsABCD operon. Bps is required for Bordetella biofilm formation, colonization of the respiratory tract, and confers protection from complement-mediated killing. In this report, we have investigated the role of BpsB in the biosynthesis of Bps and biofilm formation by B. bronchiseptica. BpsB is a two-domain protein that localizes to the periplasm and outer membrane. BpsB displays metal-and length-dependent deacetylation on poly-beta-1,6-N-acetyl-D-glucosamine (PNAG) oligomers, supporting previous immunogenic data that suggests Bps is a PNAG polymer. BpsB can use a variety of divalent metal cations for deacetylase activity and showed highest activity in the presence of Ni2+ and Co2+. The structure of the BpsB deacetylase domain is similar to the PNAG deacetylases PgaB and IcaB and contains the same circularly permuted family four carbohydrate esterase motifs. Unlike PgaB from Escherichia coli, BpsB is not required for polymer export and has unique structural differences that allow the N-terminal deacetylase domain to be active when purified in isolation from the C-terminal domain. Our enzymatic characterizations highlight the importance of conserved active site residues in PNAG deacetylation and demonstrate that the C-terminal domain is required for maximal deacetylation of longer PNAG oligomers. Furthermore, we show that BpsB is critical for the formation and complex architecture of B. bronchiseptica biofilms.	[Little, Dustin J.; Bamford, Natalie C.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Little, Dustin J.; Bamford, Natalie C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Milek, Sonja; Ganguly, Tridib; Deora, Rajendar] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; [DiFrancesco, Benjamin R.; Nitz, Mark] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Wake Forest University; University of Toronto	Deora, R (corresponding author), Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA.	rdeora@wakehealth.edu	ganguly, tridib/H-8767-2019	ganguly, tridib/0000-0002-5283-5689; Bamford, Natalie/0000-0003-1959-856X	Canadian Institutes of Health Research [43998, 89708]; University of Toronto; Ontario Graduate Scholarship Program; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Canadian Institutes of Health Research Grants 43998 and 89708 (to P. L. H. and M. N., respectively). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by graduate scholarships from the University of Toronto, the Ontario Graduate Scholarship Program, and Canadian Institutes of Health Research.; Supported in part by a graduate scholarship from the Natural Sciences and Engineering Research Council of Canada and Mary H. Beatty and Dr. James A. and Connie P. Dickson Scholarships from the University of Toronto.	Abu Khweek A, 2010, MICROBIOL-SGM, V156, P1424, DOI 10.1099/mic.0.036640-0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres E, 2014, ANGEW CHEM INT EDIT, V53, P6882, DOI 10.1002/anie.201400220; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Conover MS, 2012, J BACTERIOL, V194, P233, DOI 10.1128/JB.06020-11; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Deora R, 2002, J BACTERIOL, V184, P6942, DOI 10.1128/JB.184.24.6942-6951.2002; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganguly T, 2014, CELL MICROBIOL, V16, P1105, DOI 10.1111/cmi.12264; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Irie Y, 2007, FEMS MICROBIOL LETT, V275, P191, DOI 10.1111/j.1574-6968.2007.00852.x; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jakinovich A, 2014, CURR OPIN PEDIATR, V26, P597, DOI 10.1097/MOP.0000000000000139; Janecek S, 2014, CELL MOL LIFE SCI, V71, P1149, DOI 10.1007/s00018-013-1388-z; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Laganowsky A, 2011, PROTEIN SCI, V20, P1876, DOI 10.1002/pro.727; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leung C, 2009, CARBOHYD RES, V344, P570, DOI 10.1016/j.carres.2008.12.021; Little D. J., 2014, ENCY INORGANIC BIOIN, P1; Little DJ, 2014, J BIOL CHEM, V289, P35907, DOI 10.1074/jbc.M114.611400; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Little DJ, 2012, ACTA CRYSTALLOGR F, V68, P842, DOI 10.1107/S1744309112022075; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nishiyama T, 2013, ACTA CRYSTALLOGR D, V69, P44, DOI 10.1107/S0907444912042059; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pokrovskaya V, 2013, BIOCHEMISTRY-US, V52, P5463, DOI 10.1021/bi400836g; Serra DO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028811; Serra DO, 2008, PROTEOMICS, V8, P4995, DOI 10.1002/pmic.200800218; Sisti F, 2013, MICROBIOL-SGM, V159, P869, DOI 10.1099/mic.0.064345-0; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0; Sukumar N, 2007, J BACTERIOL, V189, P3695, DOI 10.1128/JB.00009-07; Sukumar N, 2014, INFECT IMMUN, V82, P1627, DOI 10.1128/IAI.01453-13; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001	68	26	30	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22827	22840		10.1074/jbc.M115.672469	http://dx.doi.org/10.1074/jbc.M115.672469			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26203190	Green Published, hybrid			2022-12-26	WOS:000361171500045
J	Cai, HY; Li, Y; Zhao, MJ; Fu, GW; Lai, J; Feng, FQ				Cai, Haiying; Li, Yang; Zhao, Minjie; Fu, Guanwen; Lai, Jia; Feng, Fengqin			Immobilization, Regiospecificity Characterization and Application of Aspergillus oryzae Lipase in the Enzymatic Synthesis of the Structured Lipid 1,3-Dioleoyl-2-Palmitoylglycerol	PLOS ONE			English	Article							MILK FAT SUBSTITUTES; CANDIDA-RUGOSA LIPASE; SOLVENT-FREE SYSTEM; HYDROPHOBIC SUPPORTS; ORGANIC-SOLVENTS; RHIZOPUS-ORYZAE; CEPACIA LIPASE; BIOCATALYTIC SYNTHESIS; PSEUDOMONAS-CEPACIA; MICROBIAL LIPASES	The enzymatic synthesis of 1,3-dioleoyl-2-palmitoylglycerol (OPO), one of the main components of human milk fats, has been hindered by the relatively high cost of sn-1,3-specific lipases and the deficiency in biocatalyst stability. The sn-1,3-specific lipase from Aspergillus oryzae (AOL) is highly and efficiently immobilized with the polystyrene-based hydrophobic resin D3520, with a significant 49.54-fold increase in specific lipase activity compared with the AOL powder in catalyzing the synthesis of OPO through the acidolysis between palm stearin and oleic acid (OA). The optimal immobilization conditions were investigated, including time course, initial protein concentration and solution pH. The sn-1,3 specificity of lipases under different immobilization conditions was evaluated and identified as positively associated with the lipase activity, and the pH of the immobilization solution influenced the regiospecificity and synthetic activity of these lipases. Immobilized AOL D3520, as the biocatalyst, was used for the enzymatic synthesis of the structured lipid OPO through the acidolysis between palm stearin and OA. The following conditions were optimized for the synthesis of structured lipid OPO: 65 degrees C temperature; 1:8 substrate molar ratio between palm stearin and OA; 8% (w/w) enzyme load; 3.5% water content of the immobilized lipase; and 1 h reaction time. Under these conditions, highly efficient C52 production (45.65%) was achieved, with a tripalmitin content of 2.75% and a sn-2 palmitic acid (PA) proportion of 55.08% in the system.	[Cai, Haiying; Li, Yang; Zhao, Minjie; Lai, Jia; Feng, Fengqin] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Cai, Haiying; Li, Yang; Zhao, Minjie; Lai, Jia; Feng, Fengqin] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Guanwen] Hangzhou Kangyuan Food Technol Co Ltd, Hangzhou, Zhejiang, Peoples R China; [Feng, Fengqin] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Feng, FQ (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fengfq@zju.edu.cn	Cai, Haiying/AAQ-6456-2021		Key Science and Technology Programs in Zhejiang Province [2012C12005-2]; Hangzhou Kangyuan Food Technology Co., Ltd	Key Science and Technology Programs in Zhejiang Province; Hangzhou Kangyuan Food Technology Co., Ltd	This work was supported by the Key Science and Technology Programs in Zhejiang Province (No. 2012C12005-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hangzhou Kangyuan Food Technology Co., Ltd provided support in the form of salaries for author Guanwen Fu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adlercreutz P, 2013, CHEM SOC REV, V42, P6406, DOI 10.1039/c3cs35446f; Aggett P, 2003, NUTRITION, V19, P375, DOI 10.1016/S0899-9007(02)00999-1; Alles M. S., 2004, CURRENT PAEDIAT, V14, P51; Bastida A, 1998, BIOTECHNOL BIOENG, V58, P486, DOI 10.1002/(SICI)1097-0290(19980605)58:5<486::AID-BIT4>3.0.CO;2-9; Blanco RM, 2007, J MOL CATAL B-ENZYM, V47, P13, DOI 10.1016/j.molcatb.2007.03.003; Cao XW, 2009, PROCESS BIOCHEM, V44, P177, DOI 10.1016/j.procbio.2008.10.003; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Contesini FJ, 2010, J MOL CATAL B-ENZYM, V67, P163, DOI 10.1016/j.molcatb.2010.07.021; Esteban L, 2011, BIOCHEM ENG J, V54, P62, DOI 10.1016/j.bej.2011.01.009; Fernandez-Lorente G, 2007, ENZYME MICROB TECH, V41, P565, DOI 10.1016/j.enzmictec.2007.05.004; Gustafsson H, 2012, COLLOID SURFACE B, V100, P22, DOI 10.1016/j.colsurfb.2012.04.042; Herbst D, 2012, J BIOTECHNOL, V162, P398, DOI 10.1016/j.jbiotec.2012.03.011; Hou C, 2014, PROCESS BIOCHEM, V49, P244, DOI 10.1016/j.procbio.2013.10.019; Jegannathan KR, 2008, CRIT REV BIOTECHNOL, V28, P253, DOI [10.1080/07388550802428392, 10.1080/07388550802428392 ]; Jensen RG, 1999, LIPIDS, V34, P1243, DOI 10.1007/s11745-999-0477-2; JENSEN RG, 1992, J PEDIATR GASTR NUTR, V15, P232, DOI 10.1097/00005176-199210000-00002; Kim BH, 2005, J AGR FOOD CHEM, V53, P8033, DOI 10.1021/jf0509761; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Koseki T, 2013, APPL MICROBIOL BIOT, V97, P5351, DOI 10.1007/s00253-012-4391-7; Kruger NJ, 2009, SPRINGER PROTOC HAND, P17, DOI 10.1007/978-1-59745-198-7_4; Lam MK, 2010, BIOTECHNOL ADV, V28, P500, DOI 10.1016/j.biotechadv.2010.03.002; Lang DA, 1998, EUR J BIOCHEM, V254, P333, DOI 10.1046/j.1432-1327.1998.2540333.x; Liu T, 2011, J MOL CATAL B-ENZYM, V71, P45, DOI 10.1016/j.molcatb.2011.03.007; Manoel EA, 2015, ENZYME MICROB TECH, V71, P53, DOI 10.1016/j.enzmictec.2015.02.001; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Nishizawa K., 1997, J CHEM SOC P2, V26, P1293; No DS, 2013, J AGR FOOD CHEM, V61, P8934, DOI 10.1021/jf402953n; Okobira T, 2015, J BIOSCI BIOENG, V9; Pahujani S, 2008, BIORESOURCE TECHNOL, V99, P2566, DOI 10.1016/j.biortech.2007.04.042; Pencreach G, 1997, BIOTECHNOL BIOENG, V56, P181, DOI 10.1002/(SICI)1097-0290(19971020)56:2<181::AID-BIT7>3.0.CO;2-L; Perignon M, 2013, J AM OIL CHEM SOC, V90, P1151, DOI 10.1007/s11746-013-2256-6; Pleiss J, 2000, BIOCHIMIE, V82, P1043, DOI 10.1016/S0300-9084(00)01181-0; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Simoes T, 2014, J AM OIL CHEM SOC, V91, P411, DOI 10.1007/s11746-013-2379-9; STADLER P, 1995, EUR J BIOCHEM, V227, P335, DOI 10.1111/j.1432-1033.1995.tb20394.x; Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012; Tecelao C, 2012, BIOCHEM ENG J, V67, P104, DOI 10.1016/j.bej.2012.06.001; Toida J, 1998, BIOSCI BIOTECH BIOCH, V62, P759, DOI 10.1271/bbb.62.759; Wei W, 2015, LWT-FOOD SCI TECHNOL, V60, P1187, DOI 10.1016/j.lwt.2014.09.013; Wu XY, 1996, ENZYME MICROB TECH, V19, P226, DOI 10.1016/0141-0229(95)00239-1; Xu XB, 2000, EUR J LIPID SCI TECH, V102, P287; Yadav GD, 2004, CHEM ENG SCI, V59, P373, DOI 10.1016/j.ces.2003.09.034; Yan HD, 2014, CATAL COMMUN, V45, P59, DOI 10.1016/j.catcom.2013.10.018; Yang TK, 2003, J AM OIL CHEM SOC, V80, P881, DOI 10.1007/s11746-003-0789-7; ZAKS A, 1985, P NATL ACAD SCI USA, V82, P3192, DOI 10.1073/pnas.82.10.3192; Zhang YHP, 2011, J MATER CHEM, V21, P18877, DOI 10.1039/c1jm12078f; Zheng MM, 2012, BIORESOURCE TECHNOL, V115, P141, DOI 10.1016/j.biortech.2011.11.128; Zou XQ, 2011, J AGR FOOD CHEM, V59, P6055, DOI 10.1021/jf200619v	48	29	32	15	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133857	10.1371/journal.pone.0133857	http://dx.doi.org/10.1371/journal.pone.0133857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218640	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900051
J	Hiraoka, T; Hoshi, S; Okamoto, Y; Okamoto, F; Oshika, T				Hiraoka, Takahiro; Hoshi, Sujin; Okamoto, Yoshifumi; Okamoto, Fumiki; Oshika, Tetsuro			Mesopic Functional Visual Acuity in Normal Subjects	PLOS ONE			English	Article							LASER PHOTOREFRACTIVE KERATECTOMY; IN-SITU KERATOMILEUSIS; DRY EYE PATIENTS; CONTRAST SENSITIVITY; TONIC ACCOMMODATION; MEASUREMENT SYSTEM; REACTION-TIMES; HIGH MYOPIA; VISION; LUMINANCE	To evaluate mesopic functional visual acuity (FVA) with a newly developed system in normal subjects and to compare the results with photopic FVA, sixty-eight healthy volunteers (24.03 +/- 4.42 [mean +/- standard deviation] years) were enrolled in this study. A commercially available FVA measurement system (AS-28; Kowa, Aichi, Japan) was modified to measure FVA under mesopic conditions as well as photopic conditions. Measurements were performed monocularly in photopic conditions during 60 seconds. After dark adaptation for 15 minutes, the same measurements were repeated in mesopic conditions. Outcomes included starting visual acuity (VA), FVA (the average of VAs), visual maintenance ratio (VMR), maximum VA, minimum VA, and numbers of blinks during the 60-second measurement session, and were compared between mesopic and photopic conditions. Starting VA was -0.11 +/- 0.08 and 0.39 +/- 0.12 logarithm of the minimum angle of resolution (logMAR) in photopic and mesopic conditions, respectively. FVA was -0.06 +/- 0.09 and 0.52 +/- 0.14 logMAR, VMR was 0.98 +/- 0.02 and 0.94 +/- 0.04, maximum VA was -0.15 +/- 0.06 and 0.33 +/- 0.12 logMAR, the minimum VA was 0.05 +/- 0.12 and 0.78 +/- 0.20 logMAR, and the number of blinks was 8.23 +/- 7.54 and 7.23 +/- 6.20, respectively. All these parameters except the number of blinks were significantly different between the two conditions (P < 0.001). Besides, the difference between maximum and minimum VAs and standard deviation of VA were significantly larger in mesopic than in photopic conditions (P < 0.001). This study revealed that not only overall visual function decline but also instability of vision under mesopic conditions even in healthy subjects.	[Hiraoka, Takahiro; Hoshi, Sujin; Okamoto, Yoshifumi; Okamoto, Fumiki; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Ibaraki, Japan	University of Tsukuba	Hiraoka, T (corresponding author), Univ Tsukuba, Fac Med, Dept Ophthalmol, Ibaraki, Japan.	thiraoka@md.tsukuba.ac.jp			JSPS KAKENHI grant [24592619]	JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant number 24592619. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERN M, 1958, J OPT SOC AM, V48, P193, DOI 10.1364/JOSA.48.000193; Arumi P, 1997, OPHTHAL PHYSL OPT, V17, P291, DOI 10.1111/j.1475-1313.1997.tb00060.x; Bella F, 2014, J SAFETY RES, V49, P45, DOI 10.1016/j.jsr.2014.02.007; Brunette I, 2000, OPHTHALMOLOGY, V107, P1790, DOI 10.1016/S0161-6420(00)00267-0; CAMPBELL FW, 1959, J PHYSIOL-LONDON, V145, P579, DOI 10.1113/jphysiol.1959.sp006164; CAMPBELL FW, 1958, J OPT SOC AM, V48, P669, DOI 10.1364/JOSA.48.000669; CHARMAN WN, 1988, OPHTHAL PHYSL OPT, V8, P153, DOI 10.1111/j.1475-1313.1988.tb01031.x; Charman WN, 1997, OPHTHAL PHYSL OPT, V17, P371, DOI 10.1111/j.1475-1313.1997.tb00070.x; CHARMAN WN, 1978, AM J OPTOM PHYS OPT, V55, P84; Collins G., 1937, BR J PHYSL OPT, V11, P30, DOI [10.1111/j.1444-0938.1939.tb01569.x, DOI 10.1111/J.1444-0938.1939.TB01569.X]; Community Road Accident Database, ANN STAT REP 2011; DAVISON PA, 1985, OPHTHAL PHYSL OPT, V5, P195, DOI 10.1111/j.1475-1313.1985.tb00656.x; DOMA H, 1988, VISION RES, V28, P915, DOI 10.1016/0042-6989(88)90100-9; FENDER DH, 1964, SCI AM, V211, P24, DOI 10.1038/scientificamerican0764-24; Goto E, 2003, AM J OPHTHALMOL, V135, P704, DOI 10.1016/S0002-9394(02)02147-5; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; GRAY LS, 1993, OPHTHAL PHYSL OPT, V13, P258, DOI 10.1111/j.1475-1313.1993.tb00468.x; HALLIDAY BL, 1995, BRIT J OPHTHALMOL, V79, P881, DOI 10.1136/bjo.79.10.881; Hamberg-Nystrom H, 1995, J Refract Surg, V11, pS335; Hiraoka T, 2013, J OCUL PHARMACOL TH, V29, P770, DOI 10.1089/jop.2013.0024; Hofstetter H W, 1976, J Am Optom Assoc, V47, P887; HUMPHRISS D, 1987, OPHTHAL PHYSL OPT, V7, P73, DOI 10.1016/0275-5408(87)90183-9; International Road Traffic and Accident Database, ROAD SAF ANN REP 201; Ishida R, 2005, AM J OPHTHALMOL, V139, P253, DOI 10.1016/j.ajo.2004.08.075; Ishioka M, 2009, ACTA OPHTHALMOL, V87, P574, DOI 10.1111/j.1755-3768.2008.01230.x; Johnson CA, 2005, OPTOMETRY VISION SCI, V82, P779, DOI 10.1097/01.opx.0000174767.13915.40; JOHNSON CA, 1976, J OPT SOC AM, V66, P138, DOI 10.1364/JOSA.66.000138; Kaido M, 2008, OPTOMETRY VISION SCI, V85, P758, DOI 10.1097/OPX.0b013e3181819f0a; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Kaido M, 2014, INVEST OPHTH VIS SCI, V55, P3275, DOI 10.1167/iovs.13-13000; Kaido M, 2011, JPN J OPHTHALMOL, V55, P183, DOI 10.1007/s10384-011-0026-2; Kaido M, 2006, AM J OPHTHALMOL, V142, P917, DOI 10.1016/j.ajo.2006.07.055; Lee HK, 2006, J REFRACT SURG, V22, P647; LEIBOWITZ HW, 1978, DOC OPHTHALMOL, V46, P133; MCBRIEN NA, 1987, INVEST OPHTH VIS SCI, V28, P997; McGhee CNJ, 2000, J CATARACT REFR SURG, V26, P497, DOI 10.1016/S0886-3350(00)00312-6; Nishi Y, 2013, ACTA OPHTHALMOL, V91, pE353, DOI 10.1111/aos.12060; Owens DA, 1996, HUM FACTORS, V38, P680, DOI 10.1518/001872096778827233; OWENS DA, 1996, IATSS RES, V20, P57; Owsley C, 1999, SURV OPHTHALMOL, V43, P535, DOI 10.1016/S0039-6257(99)00035-1; OWSLEY C, 1994, OPTOMETRY VISION SCI, V71, P727, DOI 10.1097/00006324-199412000-00002; Piovella M, 1997, OPHTHALMOLOGY, V104, P1554, DOI 10.1016/S0161-6420(97)30096-7; Plainis S, 2000, NEUROPSYCHOLOGIA, V38, P1555, DOI 10.1016/S0028-3932(00)00100-7; Plainis S, 2002, OPHTHAL PHYSL OPT, V22, P409, DOI 10.1046/j.1475-1313.2002.00076.x; Puell MC, 2004, J REFRACT SURG, V20, P484, DOI 10.3928/1081-597X-20040901-12; Rassow B, 1999, KLIN MONATSBL AUGENH, V214, P401, DOI 10.1055/s-2008-1034820; RICHARDS OW, 1966, AMER J OPT ARCH AM A, V43, P313; Rubin GS, 2007, INVEST OPHTH VIS SCI, V48, P1483, DOI 10.1167/iovs.06-0474; Schlote T, 1997, J CATARACT REFR SURG, V23, P718, DOI 10.1016/S0886-3350(97)80280-5; SCHOR CM, 1984, OPHTHAL PHYSL OPT, V4, P133, DOI 10.1111/j.1475-1313.1984.tb00346.x; Subzwari S, 2009, COCHRANE DB SYST REV, V21; Tanaka M, 2004, J CATARACT REFR SURG, V30, P2311, DOI 10.1016/j.jcrs.2004.02.086; Wakamatsu TH, 2011, J CATARACT REFR SURG, V37, P258, DOI 10.1016/j.jcrs.2010.08.048; Watanabe K, 2014, CONTACT LENS ANTERIO, V37, P203, DOI 10.1016/j.clae.2013.11.009; Williams AF, 2003, J SAFETY RES, V34, P5, DOI 10.1016/S0022-4375(02)00075-0; WINN B, 1992, OPHTHAL PHYSL OPT, V12, P252; Yamaguchi T, 2009, J REFRACT SURG, V25, P410, DOI 10.3928/1081597X-20090422-02	57	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134505	10.1371/journal.pone.0134505	http://dx.doi.org/10.1371/journal.pone.0134505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218066	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900122
J	Liu, W; Peng, LP; Liu, HM; Hua, SC				Liu, Wei; Peng, Liping; Liu, Hongmei; Hua, Shucheng			Pulmonary Function and Clinical Manifestations of Patients Infected with Mild Influenza A Virus Subtype H1N1: A One-Year Follow-Up	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; EXERCISE CAPACITY; LUNG-FUNCTION; SURVIVORS; HUMANS	Objective To investigate the long-term effects of mild H1N1 influenza infection on the pulmonary function of a cohort of patients. Methods Forty-eight patients, all diagnosed with influenza A virus subtype H1N1 in 2009, were retrospectively included in this study. Each patient in the study was monitored for 11-13 months by standard pulmonary function examination. The examination included monitoring respiratory tract infection symptoms (cough, expectoration or gasping) and vital signs. Long-term changes in symptoms and changes in vital signs were correlated back to and compared with the severity of the initial H1N1 influenza infection. Results One year post discharge, mild to moderate pulmonary dysfunction was observed in the majority of patients. Further, 54.2% of patients had signs of severe abnormal pulmonary function, including diffusion disorder (33.3%) and small airway dysfunction (33.3%). Fourteen patients presented with respiratory tract infection symptoms; 12 with abnormal pulmonary function and two with normal pulmonary function. Our results indicated that the change in pulmonary function at one year post discharge was not significantly correlated with the severity of H1N1 influenza. Conclusion Signs and symptoms of abnormal pulmonary function accompanied by respiratory tract infection symptoms remain for some patients after one year following discharge from the hospital for mild influenza A virus subtype H1N1 infection. These patients should continue to be monitored for any changes in condition and symptoms and rehabilitation treatment should be provided when necessary.	[Liu, Wei; Peng, Liping; Liu, Hongmei; Hua, Shucheng] Jilin Univ, Hosp 1, Dept Resp Med, Changchun 130021, Jilin Province, Peoples R China	Jilin University	Hua, SC (corresponding author), Jilin Univ, Hosp 1, Dept Resp Med, Changchun 130021, Jilin Province, Peoples R China.	shuchenghua@eyou.com						Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Goka EA, 2014, ARCH VIROL, V159, P3167, DOI 10.1007/s00705-014-2179-z; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Luyt CE, 2012, CHEST, V142, P583, DOI 10.1378/chest.11-2196; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; McMullen SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040190; Neff TA, 2003, CHEST, V123, P845, DOI 10.1378/chest.123.3.845; Ngai JC, 2010, RESPIROLOGY, V15, P543, DOI 10.1111/j.1440-1843.2010.01720.x; PETERS JI, 1989, AM REV RESPIR DIS, V139, P1163, DOI 10.1164/ajrccm/139.5.1163; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rios FG, 2011, CRIT CARE, V15, DOI 10.1186/cc10369; Schmidt R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-55; Su MC, 2007, RESPIRATION, V74, P511, DOI 10.1159/000095673; SUCHYTA MR, 1993, RESPIRATION, V60, P103	15	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133698	10.1371/journal.pone.0133698	http://dx.doi.org/10.1371/journal.pone.0133698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218647	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900041
J	Nakajima, M; Arimatsu, K; Kato, T; Matsuda, Y; Minagawa, T; Takahashi, N; Ohno, H; Yamazaki, K				Nakajima, Mayuka; Arimatsu, Kei; Kato, Tamotsu; Matsuda, Yumi; Minagawa, Takayoshi; Takahashi, Naoki; Ohno, Hiroshi; Yamazaki, Kazuhisa			Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PERIODONTAL-DISEASE; DIABETES-MELLITUS; INFLAMMATION; HEALTH; METAANALYSIS; PATHOGENS; OBESITY; MICE	Although periodontitis has been implicated as a risk factor for various systemic diseases, the precise mechanisms by which periodontitis induces systemic disease remain to be elucidated. We have previously revealed that repeated oral administration of Porphyromonas gingivalis elicits endotoxemia via changes in the gut microbiota of the ileum, and thereby induces systemic inflammation and insulin resistance. However, it is not clear to what extent a single administration of P. gingivalis could affect gut microbiota composition, gut barrier function, and subsequent influx of gut microbiota into the liver. Therefore, in the present study, C57BL/6 mice were orally administered P. gingivalis (strain W83) once and compared to sham-inoculated mice. The phylogenetic structure and diversity of microbial communities in the gut and liver were analyzed by pyrosequencing the 16S ribosomal RNA genes. Serum endotoxin activity was determined by a Limulus amebocyte lysate test. Gene expression in the intestine and expression of 16S rRNA genes in the blood and liver were examined by quantitative polymerase chain reaction. Administration of P. gingivalis significantly altered gut microbiota, with an increased proportion of phylum Bacteroidetes, a decreased proportion of phylum Firmicutes, and increased serum endotoxin levels. In the intestinal tissues, gene expression of tjp-1 and occludin, which are involved in intestinal permeability, were downregulated. Higher amounts of bacterial DNA were detected in the liver of infected mice. Importantly, changes in gut microbiota preceded systemic inflammatory changes. These results further support the idea that disturbance of the gut microbiota composition by orally derived periodontopathic bacteria may be a causal mechanism linking periodontitis and systemic disease.	[Nakajima, Mayuka; Arimatsu, Kei; Matsuda, Yumi; Minagawa, Takayoshi; Takahashi, Naoki; Yamazaki, Kazuhisa] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Lab Periodontol & Immunol, Niigata, Japan; [Nakajima, Mayuka; Arimatsu, Kei; Matsuda, Yumi; Minagawa, Takayoshi; Takahashi, Naoki] Niigata Univ, Div Periodontol, Dept Oral Biol Sci, Grad Sch Med & Dent Sci, Niigata, Japan; [Kato, Tamotsu; Ohno, Hiroshi] RIKEN, Lab Intestinal Ecosyst, Ctr Integrat Med Sci IMS, Yokohama, Kanagawa, Japan; [Ohno, Hiroshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Niigata University; Niigata University; RIKEN; Japan Science & Technology Agency (JST)	Yamazaki, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Lab Periodontol & Immunol, Niigata, Japan.	kaz@dent.niigata-u.ac.jp	Ohno, Hiroshi/L-7899-2014	Ohno, Hiroshi/0000-0001-8776-9661; Kato, Tamotsu/0000-0002-8407-4327; Nakajima, Mayuka/0000-0002-2875-2111	Japan Society for the Promotion of Science KAKENHI [23390476, 25670882, 15H02578]; Japan Science and Technology Agency; Sunstar Inc.	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Sunstar Inc.	This work was supported by the Japan Society for the Promotion of Science KAKENHI 23390476, 25670882, and 15H02578 (KY); The Japan Science and Technology Agency (HO); and Sunstar Inc. (KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Armingohar Z, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23408; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Boutaga K, 2007, J PERIODONTOL, V78, P79, DOI 10.1902/jop.2007.060078; Brinkman BM, 2013, INFLAMM BOWEL DIS, V19, P2560, DOI 10.1097/MIB.0b013e3182a8759a; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cullinan MP, 2013, PERIODONTOL 2000, V62, P271, DOI 10.1111/prd.12007; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fukuda S, 2014, SEMIN IMMUNOPATHOL, V36, P103, DOI 10.1007/s00281-013-0399-z; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Kato T, 2014, DNA RES, V21, P469, DOI 10.1093/dnares/dsu013; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Chavarry NGM, 2009, ORAL HLTH PREV DENT, V7, P107; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salvi GE, 2008, J CLIN PERIODONTOL, V35, P398, DOI 10.1111/j.1600-051X.2008.01282.x; Saygun I, 2011, J PERIODONTAL RES, V46, P235, DOI 10.1111/j.1600-0765.2010.01335.x; Seekatz AM, 2014, J CLIN INVEST, V124, P4182, DOI 10.1172/JCI72336; Vaziri ND, 2012, NEPHROL DIAL TRANSPL, V27, P2686, DOI 10.1093/ndt/gfr624; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; vonTroilLinden B, 1995, J DENT RES, V74, P1789, DOI 10.1177/00220345950740111201; Wang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01843	36	170	185	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134234	10.1371/journal.pone.0134234	http://dx.doi.org/10.1371/journal.pone.0134234			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218067	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900100
J	Olah, G; Szczesny, B; Brunyanszki, A; Lopez-Garcia, IA; Gero, D; Radak, Z; Szabo, C				Olah, Gabor; Szczesny, Bartosz; Brunyanszki, Attila; Lopez-Garcia, Isabel A.; Geroe, Domokos; Radak, Zsolt; Szabo, Csaba			Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress	PLOS ONE			English	Article							MUSCLE DIFFERENTIATION; SATELLITE CELLS; POTENTIAL ROLE; DNA-DAMAGE; MITOCHONDRIAL; INHIBITION; EXERCISE; METABOLISM; REPAIR; MODULATION	Poly(ADP-ribose) polymerase 1 (PARP-1), the major isoform of the poly (ADP-ribose) polymerase family, is a constitutive nuclear and mitochondrial protein with well-recognized roles in various essential cellular functions such as DNA repair, signal transduction, apoptosis, as well as in a variety of pathophysiological conditions including sepsis, diabetes and cancer. Activation of PARP-1 in response to oxidative stress catalyzes the covalent attachment of the poly (ADP-ribose) (PAR) groups on itself and other acceptor proteins, utilizing NAD(+) as a substrate. Overactivation of PARP-1 depletes intracellular NAD(+) influencing mitochondrial electron transport, cellular ATP generation and, if persistent, can result in necrotic cell death. Due to their high metabolic activity, skeletal muscle cells are particularly exposed to constant oxidative stress insults. In this study, we investigated the role of PARP-1 in a well-defined model of murine skeletal muscle differentiation (C2C12) and compare the responses to oxidative stress of undifferentiated myoblasts and differentiated myotubes. We observed a marked reduction of PARP-1 expression as myoblasts differentiated into myotubes. This alteration correlated with an increased resistance to oxidative stress of the myotubes, as measured by MTT and LDH assays. Mitochondrial function, assessed by measuring mitochondrial membrane potential, was preserved under oxidative stress in myotubes compared to myoblasts. Moreover, basal respiration, ATP synthesis, and the maximal respiratory capacity of mitochondria were higher in myotubes than in myoblasts. Inhibition of the catalytic activity of PARP-1 by PJ34 (a phenanthridinone PARP inhibitor) exerted greater protective effects in undifferentiated myoblasts than in differentiated myotubes. The above observations in C2C12 cells were also confirmed in a rat-derived skeletal muscle cell line (L6). Forced overexpression of PARP1 in C2C12 myotubes sensitized the cells to oxidant-induced injury. Taken together, our data indicate that the reduction of PARP-1 expression during the process of the skeletal muscle differentiation serves as a protective mechanism to maintain the cellular functions of skeletal muscle during oxidative stress.	[Olah, Gabor; Szczesny, Bartosz; Brunyanszki, Attila; Lopez-Garcia, Isabel A.; Geroe, Domokos; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Radak, Zsolt] Semmelweis Univ, Fac Phys Educ & Sport Sci, H-1085 Budapest, Hungary; [Szczesny, Bartosz; Szabo, Csaba] Shriners Hosp Children, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; Semmelweis University; University of Physical Education	Szabo, C (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	szabocsaba@aol.com	Gero, Domokos/F-7853-2017; Szabo, Csaba/ABG-2644-2021	Gero, Domokos/0000-0002-3132-3465; Radak, Zsolt/0000-0003-1297-6804	US National Institutes of Health [2P50 GM060338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM060338] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health 2P50 GM060338 to C.S.	Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Aoi W, 2014, SUBCELL BIOCHEM, V77, P175, DOI 10.1007/978-94-007-7920-4_15; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brunyanszki A, 2014, MOL PHARMACOL, V86, P450, DOI 10.1124/mol.114.094318; Chen M, 2004, CARDIOVASC RES, V63, P682, DOI 10.1016/j.cardiores.2004.04.018; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Diaz EC, 2015, BURNS, V41, P649, DOI 10.1016/j.burns.2014.10.010; Ding YC, 2001, BRAIN RES, V915, P210, DOI 10.1016/S0006-8993(01)02852-9; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Erdelyi K, 2009, FASEB J, V23, P3553, DOI 10.1096/fj.09-133264; Ferri P, 2009, J CELL BIOCHEM, V108, P1302, DOI 10.1002/jcb.22360; Frederick DW, 2015, J BIOL CHEM, V290, P1546, DOI 10.1074/jbc.M114.579565; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gero D, 2014, MOL MED, V20, P313, DOI 10.2119/molmed.2014.00102; Gero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065994; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HELLER B, 1995, J BIOL CHEM, V270, P11176, DOI 10.1074/jbc.270.19.11176; Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jagtap P, 2002, CRIT CARE MED, V30, P1071, DOI 10.1097/00003246-200205000-00019; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Modis K, 2013, BIOCHEM PHARMACOL, V86, P1311, DOI 10.1016/j.bcp.2013.08.064; Modis K, 2012, BIOCHEM PHARMACOL, V83, P633, DOI 10.1016/j.bcp.2011.12.014; Mohamed JS, 2014, DIABETES, V63, P1546, DOI 10.2337/db13-1364; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Pieper AA, 2000, MOL MED, V6, P271, DOI 10.1007/BF03401936; Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002; Radak Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Radak Z, 2011, FREE RADICAL BIO MED, V51, P417, DOI 10.1016/j.freeradbiomed.2011.04.018; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Sakellariou GK, 2014, FREE RADICAL RES, V48, P12, DOI 10.3109/10715762.2013.830718; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; Szczesny B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075201; Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009; Thibault R, 2011, CURR OPIN CLIN NUTR, V14, P261, DOI 10.1097/MCO.0b013e3283455d60; Wang YX, 2014, J CELL SCI, V127, P4543, DOI 10.1242/jcs.151209; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	54	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134227	10.1371/journal.pone.0134227	http://dx.doi.org/10.1371/journal.pone.0134227			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218895	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900098
J	Wu, JN; Li, SR; Jia, WJ; Deng, HR; Chen, K; Zhu, LL; Yu, FY; Su, FX				Wu, Jiannan; Li, Shunrong; Jia, Weijuan; Deng, Heran; Chen, Kai; Zhu, Liling; Yu, Fengyan; Su, Fengxi			Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; TUMOR; CHEMOTHERAPY; DOXORUBICIN; MICRORNAS	Chemotherapy resistance remains an important problem in the breast cancer clinic. The ability to predict the patients who would respond to a distinct therapy would help to optimize tailored treatment options. miRNAs can mediate a number of genes in response to druginduced acute cellular stress. Several studies suggest that let-7 miRNA may be involved in the chemosensitivity of cancer cell lines in vitro. However, it is not known whether this phenomenon occurs in clinical breast tumors. The present study showed that lower let-7a expression was associated with epirubicin resistance in primary breast tumors. Moreover, upregulation of let-7a expression sensitized resistant breast tumor cell lines to epirubicin by enhancing cellular apoptosis in vitro. Collectively, these findings indicate that lower expression of let-7a miRNA can induce chemoresistance in breast cancer by enhancing cellular apoptosis and suggest that let-7a may be used as a therapeutic target to modulate epirubicin-based chemotherapy resistance.	[Wu, Jiannan; Yu, Fengyan; Su, Fengxi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China; [Wu, Jiannan; Li, Shunrong; Jia, Weijuan; Deng, Heran; Chen, Kai; Zhu, Liling; Yu, Fengyan; Su, Fengxi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yu, FY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China.	fengyanyu_summer@163.com; fengxisu@vip.163.com	Wu, Jiannan/AAD-9358-2019		National Natural Science Foundation of China [81472731]; Guangdong Natural Science Funds for Distinguished Young Scholars [S20120011199]; Program for New Century Excellent Talents in University of the Ministry of Education of China; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD); Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013] 163]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes [KLB09001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholars; Program for New Century Excellent Talents in University of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China); Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes	This work was supported by the National Natural Science Foundation of China (81472731), the Guangdong Natural Science Funds for Distinguished Young Scholars (S20120011199), the Program for New Century Excellent Talents in University of the Ministry of Education of China and the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD). This work was also supported by Grant [2013] 163 from the Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology and Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes.	Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Helleman J, 2010, INT J BIOCHEM CELL B, V42, P25, DOI 10.1016/j.biocel.2009.10.016; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaufmann M, 2007, ANN ONCOL, V18, P1927, DOI 10.1093/annonc/mdm201; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Serguienko A, 2015, ONCOTARGET, V6, P2451, DOI 10.18632/oncotarget.3235; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; van Jaarsveld MTM, 2010, INT J BIOCHEM CELL B, V42, P1282, DOI 10.1016/j.biocel.2010.01.014; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	16	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133643	10.1371/journal.pone.0133643	http://dx.doi.org/10.1371/journal.pone.0133643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218285	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900037
J	Isosaka, M; Niinuma, T; Nojima, M; Kai, M; Yamamoto, E; Maruyama, R; Nobuoka, T; Nishida, T; Kanda, T; Taguchi, T; Hasegawa, T; Tokino, T; Hirata, K; Suzuki, H; Shinomura, Y				Isosaka, Mai; Niinuma, Takeshi; Nojima, Masanori; Kai, Masahiro; Yamamoto, Eiichiro; Maruyama, Reo; Nobuoka, Takayuki; Nishida, Toshirou; Kanda, Tatsuo; Taguchi, Takahiro; Hasegawa, Tadashi; Tokino, Takashi; Hirata, Koichi; Suzuki, Hiromu; Shinomura, Yasuhisa			A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							TARGETING BCL-W; HEPATOCELLULAR-CARCINOMA; INHIBITS MIGRATION; COLORECTAL-CANCER; PANCREATIC-CANCER; DNA METHYLATION; GASTRIC-CANCER; OVARIAN-CANCER; ANATOMIC SITE; BREAST-CANCER	Background Dysregulation of microRNA (miRNA) has been implicated in gastrointestinal stromal tumors (GISTs) but the mechanism is not fully understood. In this study, we aimed to explore the involvement of epigenetic alteration of miRNA genes in GISTs. Methods GIST-T1 cells were treated with 5-aza-2'-deoxycytidine (5-aza-dC) and 4-phenylbutyric acid (PBA), after which miRNA expression profiles were analyzed using TaqMan miRNA arrays. DNA methylation was then analyzed using bisulfite pyrosequencing. The functions of miRNAs were examined using MTT assays, wound-healing assays, Boyden chamber assays and Matrigel invasion assays. Gene expression microarrays were analyzed to assess effect of ectopic miRNA expression in GIST-T1 cells. Results Of the 754 miRNAs analyzed, 61 were significantly upregulated in GIST-T1 cells treated with 5-aza-dC plus PBA. Among those, 21 miRNA genes were associated with an upstream CpG island (CGI), and the CGIs of miR-34a and miR-335 were frequently methylated in GIST-T1 cells and primary GIST specimens. Transfection of miR-34a or miR-335 mimic molecules into GIST-T1 cells suppressed cell proliferation, and miR-34a also inhibited migration and invasion by GIST-T1 cells. Moreover, miR-34a downregulated a number of predicted target genes, including PDGFRA. RNA interference-mediated knockdown of PDGFRA in GIST-T1 cells suppressed cell proliferation, suggesting the tumor suppressive effect of miR-34a is mediated, at least in part, through targeting PDGFRA. Conclusions Our results suggest that miR-34a and miR-335 are candidate tumor suppressive miRNAs in GISTs, and that they are frequent targets of epigenetic silencing in GISTs.	[Isosaka, Mai; Yamamoto, Eiichiro; Maruyama, Reo; Shinomura, Yasuhisa] Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan; [Niinuma, Takeshi; Kai, Masahiro; Yamamoto, Eiichiro; Suzuki, Hiromu] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Nojima, Masanori] Univ Tokyo, Inst Med Sci, Ctr Translat Res, Tokyo, Japan; [Nobuoka, Takayuki; Hirata, Koichi] Sapporo Med Univ, Sch Med, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan; [Nishida, Toshirou] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; [Kanda, Tatsuo] Sanjo Gen Hosp, Dept Surg, Sanjo City, Niigata, Japan; [Taguchi, Takahiro] Kochi Univ, Grad Sch Kuroshio Sci, Div Human Hlth & Med Sci, Nankoku, Kochi, Japan; [Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Tokino, Takashi] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Med Genome Sci, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; University of Tokyo; Sapporo Medical University; National Cancer Center - Japan; Kochi University; Sapporo Medical University; Sapporo Medical University	Suzuki, H (corresponding author), Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido, Japan.	hsuzuki@sapmed.ac.jp	ravegnini, gloria/K-1330-2016; Tokino, Takashi/AAI-9887-2021; Nojima, Masanori/ABE-2237-2020	ravegnini, gloria/0000-0002-7774-402X; Nojima, Masanori/0000-0002-8788-2522	Japan Society for Promotion of Science [25670371, 26860514]; Takeda Science Foundation [2011]; Project for Developing Innovative Research on Cancer Therapeutics (P-DIRECT) [11093014]; Grants-in-Aid for Scientific Research [25430115] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Project for Developing Innovative Research on Cancer Therapeutics (P-DIRECT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grant-in-Aid for Challenging Exploratory Research from the Japan Society for Promotion of Science (No 25670371), Grant-in-Aid for Young Scientists (B) from the Japan Society for Promotion of Science (No 26860514), the Takeda Science Foundation (No 2011), and the Project for Developing Innovative Research on Cancer Therapeutics (P-DIRECT) (No 11093014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2014, ONCOTARGET, V5, P872, DOI 10.18632/oncotarget.1825; Assamaki R, 2007, GENE CHROMOSOME CANC, V46, P564, DOI 10.1002/gcc.20439; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Cao J, 2013, ONCOL REP, V30, P701, DOI 10.3892/or.2013.2482; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chim CS, 2010, CARCINOGENESIS, V31, P745, DOI 10.1093/carcin/bgq033; Choi HJ, 2010, INT J CANCER, V126, P1640, DOI 10.1002/ijc.24897; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; de la Rosa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3268; Dohi O, 2013, INT J ONCOL, V42, P411, DOI 10.3892/ijo.2012.1724; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fan R, 2014, TUMOR BIOL, V35, P4209, DOI 10.1007/s13277-013-1551-z; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Gao L, 2014, TUMOR BIOL, V35, P8309, DOI 10.1007/s13277-014-2092-9; Gao Y, 2015, TUMOR BIOL, V36, P2875, DOI 10.1007/s13277-014-2917-6; Garofalo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067581; Gong M, 2014, MOL CANCER RES, V12, P101, DOI 10.1158/1541-7786.MCR-13-0136; Guan XY, 2001, CANCER RES, V61, P3806; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He LR, 2011, INT J CANCER, V129, P143, DOI 10.1002/ijc.25669; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heyn H, 2011, INT J CANCER, V129, P2797, DOI 10.1002/ijc.25962; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S0016-5085(03)01046-1; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jiang J, 2012, MED ONCOL, V29, P3472, DOI 10.1007/s12032-012-0259-z; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li Y, 2014, GASTROENTEROLOGY, V146, P1701, DOI 10.1053/j.gastro.2014.02.029; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu S, 2014, TUMOR BIOL, V35, P9131, DOI 10.1007/s13277-014-2177-5; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Nakatani H, 2005, CANCER SCI, V96, P116, DOI 10.1111/j.1349-7006.2005.00018.x; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Okamoto Y, 2012, GUT, V61, P392, DOI 10.1136/gut.2011.241034; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Peng Y, 2014, BIOSCIENCE REP, V34, P247, DOI 10.1042/BSR20140020; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Shimizu T, 2013, EUR UROL, V63, P1091, DOI 10.1016/j.eururo.2012.11.030; Shu MF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-59; Silber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033844; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Wang HQ, 2013, TUMOR BIOL, V34, P3101, DOI 10.1007/s13277-013-0878-9; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wozniak A, 2007, GENE CHROMOSOME CANC, V46, P261, DOI 10.1002/gcc.20408; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040037; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	60	16	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133754	10.1371/journal.pone.0133754	http://dx.doi.org/10.1371/journal.pone.0133754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214687	Green Published, gold, Green Submitted			2022-12-26	WOS:000358594300031
J	Awad, AS; You, HN; Gao, T; Gvritishvili, A; Cooper, TK; Tombran-Tink, J				Awad, Alaa S.; You, Hanning; Gao, Ting; Gvritishvili, Anzor; Cooper, Timothy K.; Tombran-Tink, Joyce			Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EXPRESSION; RECEPTOR; NEPHROPATHY; IDENTIFICATION; INFLAMMATION; MACROPHAGES; ACTIVATION; PODOCYTES; INCREASE	Our recent publication showed that a small bioactive pigment epithelium derived factor (PEDF) peptide (P78-PEDF) prevents the development of diabetic nephropathy (DN). However, its effects on the progression of established DN were not clear. Therefore, the purpose of this study was to determine the effect of P78-PEDF in the progression of DN and to compare the effects of P78-PEDF and an ACE inhibitor (ACEi), a standard of care in DN. Experiments were conducted in Ins2(Akita) mice treated with P78-PEDF or captopril starting at 6 wks of age for 12 wks (early treatment) or starting at 12 wks of age for 6 wks (late treatment). We first established the optimal dose of the P78-PEDF peptide to ameliorate DN in Ins2(Akita) mouse for a 6 wk study period and found that the peptide was effective at 0.1-0.5 mu g/g/day. We next showed that early or late treatment with P78-PEDF resulted in protection from DN as indicated by reduced albuminuria, kidney macrophage recruitment, histological changes, inflammatory cytokines and fibrotic markers (kidney TNF-alpha, fibronectin, VEGFA and EGFR), and restored nephrin expression compared with vehicle-treated Ins2(Akita) mice. Interestingly, only early but not late treatment with captopril was as effective as P78-PEDF in reducing most DN complications, despite its lack of effect on nephrin, VEGFA and EGFR expression. These findings highlight the importance of P78-PEDF peptide as a potential therapeutic modality in both the development and progression of diabetic renal injury.	[Awad, Alaa S.; You, Hanning; Gao, Ting] Penn State Univ, Coll Med, Dept Med, Div Nephrol, Hershey, PA 17033 USA; [Gvritishvili, Anzor; Tombran-Tink, Joyce] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Cooper, Timothy K.] Penn State Univ, Coll Med, Dept Comparat Med, Hershey, PA USA; [Tombran-Tink, Joyce] Penn State Univ, Coll Med, Dept Ophthalmol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Awad, AS (corresponding author), Penn State Univ, Coll Med, Dept Med, Div Nephrol, Hershey, PA 17033 USA.	asa17@psu.edu			NIH [DK094930, DK094930S1]; Novo Nordisk; JDRF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009493, R01DK094930] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk(Novo Nordisk); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH Grants DK094930 and DK094930S1, and grants from Novo Nordisk and JDRF. The PI only received grant money from Novo Nordisk to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman EM, 2012, J GEN INTERN MED, V27, P458, DOI 10.1007/s11606-011-1912-5; Awad AS, 2013, AM J PHYSIOL-RENAL, V305, pF891, DOI 10.1152/ajprenal.00149.2013; Awad AS, 2011, AM J PHYSIOL-RENAL, V301, pF1358, DOI 10.1152/ajprenal.00332.2011; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; BREYER MD, 1990, AM J PHYSIOL, V259, pF553, DOI 10.1152/ajprenal.1990.259.4.F553; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chen HB, 2010, AM J NEPHROL, V32, P47, DOI 10.1159/000314326; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Gattu AK, 2014, ENDOCRINOLOGY, V155, P1373, DOI 10.1210/en.2013-1785; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; HARRIS RC, 1988, J CLIN INVEST, V82, P1028, DOI 10.1172/JCI113659; Kalantarinia K, 2003, KIDNEY INT, V64, P1208, DOI 10.1046/j.1523-1755.2003.00237.x; Li H, 2006, EXP EYE RES, V83, P824, DOI 10.1016/j.exer.2006.04.014; Liu E, 2007, J AM SOC NEPHROL, V18, P2094, DOI 10.1681/ASN.2006010075; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; Liu YL, 2012, MOL MED, V18, P1387, DOI 10.2119/molmed.2012.00008; Morris SM, 2011, DIABETES, V60, P3015, DOI 10.2337/db11-0901; Motomiya Y, 2006, CLIN CHEM, V52, P1970, DOI 10.1373/clinchem.2006.073171; Nakamura K, 2010, INT J CARDIOL, V143, P96, DOI 10.1016/j.ijcard.2008.11.169; NAKAMURA T, 1993, CLIN IMMUNOL IMMUNOP, V66, P33, DOI 10.1006/clin.1993.1005; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Pina AL, 2007, CELL TISSUE RES, V329, P329, DOI 10.1007/s00441-007-0420-8; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Tesch GH, 2007, CLIN EXP PHARMACOL P, V34, P1016, DOI 10.1111/j.1440-1681.2007.04729.x; Tombran-Tink J, 2005, FRONT BIOSCI-LANDMRK, V10, P2131, DOI 10.2741/1686; Tombran-Tink J, 2003, TRENDS MOL MED, V9, P244, DOI 10.1016/S1471-4914(03)00074-1; Tombran-Tink J, 2010, CURR MOL MED, V10, P267, DOI 10.2174/156652410791065336; Veron D, 2011, DIABETOLOGIA, V54, P1227, DOI 10.1007/s00125-010-2034-z; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wang JJ, 2005, DIABETES, V54, P243, DOI 10.2337/diabetes.54.1.243; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; You H, 2013, KIDNEY INT, DOI [10.1038/ki2013.215, DOI 10.1038/KI2013.215]; You HN, 2013, AM J PHYSIOL-RENAL, V305, pF1719, DOI 10.1152/ajprenal.00141.2013; You HN, 2013, KIDNEY INT, V84, P1189, DOI 10.1038/ki.2013.215; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279	37	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133777	10.1371/journal.pone.0133777	http://dx.doi.org/10.1371/journal.pone.0133777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207369	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000138
J	Huang, PC; Tsai, CH; Liang, WY; Li, SS; Pan, WH; Chiang, HC				Huang, Po-Chin; Tsai, Chih-Hsin; Liang, Wei-Yen; Li, Sih-Syuan; Pan, Wen-Harn; Chiang, Hung-Che			Age and Gender Differences in Urinary Levels of Eleven Phthalate Metabolites in General Taiwanese Population after a DEHP Episode	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; EXPOSURE; CHILDREN; ASSOCIATION; ADOLESCENTS; HORMONES; SAMPLES; ADULTS; RISK	Introduction In 2011, the Taiwan FDA disclosed illegal di(2-ethylhexyl phthalate) (DEHP) and dibutyl phthalate (DBP) use in beverage and nutrition supplements. We aim to determine phthalate exposure and other relevant factors in a sample of the general Taiwanese population in order to evaluate actual phthalate exposure levels after this disclosure of DEHP use. Method We selected subjects aged 7 years old and older in 2013 from the general Taiwanese population. First morning urine samples from each participant were collected to analyze 11 phthalate metabolites representing 7 parent phthalates using on-line liquid chromatography/tandem mass spectrometry. An interview questionnaire was applied to obtain participant demographic characteristics, lifestyle, and other relevant factors. Results The median levels of metabolites of DEHP, including mono-ethylhexyl phthalate (MEHP), mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP), DBP (DnBP and DiBP), including mono-n-butyl phthalate (MnBP) and mono-iso-butyl phthalate (MiBP), and monoethyl phthalate (MEP) in urine samples of 290 adults/97 minors (<18 years) were 7.9/6.1, 12.6/17.8, 22.0/25.8, 25.4/30.8, 18.1/23.6, 9.4/13.6 and 14.5/12.4 mu g/g creatinine, respectively. Women (. 18 years) were exposed to significantly higher levels of MEHHP (P=0.011), MECPP (P=0.01), MnBP (P=0.001) and MEP (P<0.001) than men (>= 18 years), whereas no gender difference was observed in minors. We found significant higher level of MEP (creatinine-unadjusted) in subject aged between 18 to 40 years old (P<0.001), especially for women. Exposure levels of MEOHP (P<0.001), MECPP (P=0.002) and MnBP (P=0.044) in minors were significantly higher than those of adults. High frequency usage of food preservation film and bags, and personal care products are potential sources of phthalates exposure in general Taiwanese. Conclusion Our findings indicated that DEHP and DBP exposure in a sample of the general Taiwanese population varied by age and gender, possibly affected by different lifestyles, and continuing bio-monitoring surveillance is warranted.	[Huang, Po-Chin; Tsai, Chih-Hsin; Liang, Wei-Yen; Li, Sih-Syuan; Chiang, Hung-Che] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Natl Environm Hlth Res Ctr, Miaoli, Taiwan; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan; [Chiang, Hung-Che] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Div Environm Hlth & Occupat Med, Miaoli, Taiwan	National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Pan, WH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	pan@ibms.sinica.edu.tw; hcchiang@nhri.org.tw	Pan, Wen-Harn/F-9972-2010	Pan, Wen-Harn/0000-0001-9136-0658; Huang, Po-Chin/0000-0002-9243-0838	National Health Research Institutes [102-EH-PP05, 103-EH-PP05, 104-EH-PP05]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	Support was provided by National Health Research Institutes grant, 102-EH-PP05, 103-EH-PP05, 104-EH-PP05 [http://nehrc.nhri.org.tw/toxic/project_research_en.php]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122140; Bao J, 2015, ARCH ENVIRON CON TOX, V69, P202, DOI 10.1007/s00244-015-0146-7; Becker K, 2014, INT J HYG ENVIR HEAL, V217, P312, DOI 10.1016/j.ijheh.2013.07.004; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Calafat AM, 2011, ENVIRON HEALTH PERSP, V119, P50, DOI 10.1289/ehp.1002316; CDC, 2012, 4 CDC; Chen CY, 2015, SCI TOTAL ENVIRON, V517, P125, DOI 10.1016/j.scitotenv.2015.02.021; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Dewalque L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/649314; Frederiksen H, 2014, REPRODUCTION, V147, P555, DOI 10.1530/REP-13-0522; Ha M, 2014, INT J HYG ENVIR HEAL, V217, P260, DOI 10.1016/j.ijheh.2013.06.001; Huang PC, 2012, INT SOC EXP SCI C P; Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205; Huang PC, 2014, ENVIRON SCI POLLUT R, V21, P13964, DOI 10.1007/s11356-014-3260-6; Huang PC, 2012, J FOOD DRUG ANAL, V20, P719, DOI 10.6227/jfda.2012200401; Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Kobrosly RW, 2014, ENVIRON HEALTH PERSP, V122, P521, DOI 10.1289/ehp.1307063; Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7; Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009; Ku HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123309; Li JH, 2012, KAOHSIUNG J MED SCI, V28, pS17, DOI 10.1016/j.kjms.2012.05.005; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Mendiola J, 2012, J ANDROL, V33, P488, DOI 10.2164/jandrol.111.013557; Pan WH, 2011, ASIA PAC J CLIN NUTR, V20, P238; Parlett LE, 2013, J EXPO SCI ENV EPID, V23, P197, DOI 10.1038/jes.2012.105; Philippat C, 2015, ENVIRON RES, V140, P369, DOI 10.1016/j.envres.2015.04.009; Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x; Saravanabhavan G, 2013, INT J HYG ENVIR HEAL, V216, P652, DOI 10.1016/j.ijheh.2012.12.009; Sathyanarayana S, 2014, REPRODUCTION, V147, P401, DOI 10.1530/REP-13-0415; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Schindler BK, 2014, INT J HYG ENVIR HEAL, V217, P653, DOI 10.1016/j.ijheh.2013.12.002; Schutze A, 2014, INT J HYG ENVIR HEAL, V217, P421, DOI 10.1016/j.ijheh.2013.08.004; Schulz C, 2011, INT J HYG ENVIR HEAL, V215, P26, DOI 10.1016/j.ijheh.2011.06.007; Smerieri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117831; Swan SH, 2015, HUM REPROD, V30, P963, DOI 10.1093/humrep/deu363; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; Toft G, 2012, ENVIRON HEALTH PERSP, V120, P458, DOI 10.1289/ehp.1103552; Wang IJ, 2014, ENVIRON INT, V62, P48, DOI 10.1016/j.envint.2013.09.002; Wu MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055005, 10.1371/journal.pone.0055044]; Wu MT, 2012, ENVIRON INT, V44, P75, DOI 10.1016/j.envint.2012.01.014; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104852; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	46	58	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133782	10.1371/journal.pone.0133782	http://dx.doi.org/10.1371/journal.pone.0133782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207744	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000140
J	Hurren, B; Collins, JJP; Duxson, MJ; Deries, M				Hurren, Bradley; Collins, Jennifer J. P.; Duxson, Marilyn J.; Deries, Marianne			First Neuromuscular Contact Correlates with Onset of Primary Myogenesis in Rat and Mouse Limb Muscles	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; SKELETAL-MUSCLE; CHICK HINDLIMB; PROJECTION PATTERNS; PATHWAY SELECTION; VERTEBRATE LIMB; SOLEUS MUSCLE; SPINAL-CORD; INNERVATION; DIFFERENTIATION	Skeletal muscle development has been the focus of intensive study for many decades. Recent advances in genetic manipulation of the mouse have increased our understanding of the cell signalling involved in the development of muscle progenitors which give rise to adult skeletal muscles and their stem cell populations. However, the influence of a vital tissue type - the peripheral nerve-has largely been ignored since its earliest descriptions. Here we carefully describe the timing in which myogenic progenitors expressing Pax3 and Pax7 (the earliest markers of myogenic cells) enter the limb buds of rat and mouse embryos, as well as the spatiotemporal relationship between these progenitors and the ingrowing peripheral nerve. We show that progenitors expressing Pax3 enter the limb bud one full day ahead of the first neurites and that Pax7-expressing progenitors (associated with secondary myogenesis in the limb) are first seen in the limb bud at the time of nerve entry and in close proximity to the nerve. The initial entry of the nerve also coincides with the first expression of myosin heavy chain showing that the first contact between nerves and myogenic cells correlates with the onset of myogenic differentiation. Furthermore, as the nerve grows into the limb, Pax3 expression is progressively replaced by Pax7 expression in myogenic progenitors. These findings indicate that the ingrowing nerve enters the limb presumptive muscle masses earlier than what was generally described and raises the possibility that nerve may influence the differentiation of muscle progenitors in rodent limbs.	[Hurren, Bradley; Duxson, Marilyn J.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Collins, Jennifer J. P.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Deries, Marianne] Univ Lisbon, Fac Ciencias, Ctr Evol Ecol & Alteracoes Ambientais, Lisbon, Portugal	University of Otago; University of Ottawa; Ottawa Hospital Research Institute; Universidade de Lisboa	Deries, M (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Evol Ecol & Alteracoes Ambientais, Lisbon, Portugal.	mederies@fc.ul.pt		Collins, Jennifer/0000-0002-7556-0526	Department of Anatomy, University of Otago; Fundacao para a Ciencia e a Tecnologia (Portugal) [SFRH / BPD / 65370 / 2009]	Department of Anatomy, University of Otago; Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	This work was funded by the postgraduate student funding from the Department of Anatomy, University of Otago. MD holds a post doc grant SFRH / BPD / 65370 / 2009 from Fundacao para a Ciencia e a Tecnologia (Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; ASHBY PR, 1993, DEV BIOL, V156, P519, DOI 10.1006/dbio.1993.1098; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Bardeen Charles R., 1900, JOHNS HOPKINS HOSP R, V9, P367; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; BRAITHWAITE AW, 1979, NATURE, V279, P549, DOI 10.1038/279549a0; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Burden SJ, 2002, J NEUROBIOL, V53, P501, DOI 10.1002/neu.10137; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; CAMERON J, 1982, J ANAT, V134, P795; COHEN SA, 1980, P NATL ACAD SCI-BIOL, V77, P644, DOI 10.1073/pnas.77.1.644; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DENNIS MJ, 1981, DEV BIOL, V81, P266, DOI 10.1016/0012-1606(81)90290-6; Deries M, 2008, EVOL DEV, V10, P746, DOI 10.1111/j.1525-142X.2008.00289.x; ENTWISTLE A, 1988, J CELL BIOL, V106, P1703, DOI 10.1083/jcb.106.5.1703; Florini JR, 1996, J BIOL CHEM, V271, P12699, DOI 10.1074/jbc.271.22.12699; FREDETTE BJ, 1991, DEV BIOL, V143, P19, DOI 10.1016/0012-1606(91)90051-4; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HARRIS AJ, 1981, PHILOS T ROY SOC B, V293, P257, DOI 10.1098/rstb.1981.0076; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; HOLLYDAY M, 1995, J COMP NEUROL, V357, P242, DOI 10.1002/cne.903570205; Hollyday M, 1983, DEV REGENERATION A, P183; HUGHES DS, 1992, DEV DYNAM, V193, P164, DOI 10.1002/aja.1001930208; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Kardon G, 2002, DEV CELL, V3, P533, DOI 10.1016/S1534-5807(02)00291-5; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kardon G, 2011, DEVELOPMENT, V138, P2855, DOI 10.1242/dev.067181; Kim DG, 1999, J BIOL CHEM, V274, P15395, DOI 10.1074/jbc.274.22.15395; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P559; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LANDMESSER L, 1986, DEV BIOL, V118, P511, DOI 10.1016/0012-1606(86)90023-0; LANDMESSER L, 1975, J PHYSIOL-LONDON, V249, P301, DOI 10.1113/jphysiol.1975.sp011017; Lee ASJ, 2013, DEV DYNAM, V242, P1043, DOI 10.1002/dvdy.23998; Lewis WH, 1902, AM J ANAT, V1, P145, DOI 10.1002/aja.1000010204; Luria V, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-13; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; MCLENNAN IS, 1983, DEV BIOL, V98, P287, DOI 10.1016/0012-1606(83)90359-7; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; ONTELL M, 1988, AM J ANAT, V181, P267, DOI 10.1002/aja.1001810305; ONTELL M, 1984, AM J ANAT, V171, P149, DOI 10.1002/aja.1001710203; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; POURQUIE O, 1993, P NATL ACAD SCI USA, V90, P5242, DOI 10.1073/pnas.90.11.5242; Pownall ME, 1996, DEVELOPMENT, V122, P1475; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; REYNOLDS ML, 1991, NEUROSCIENCE, V41, P201, DOI 10.1016/0306-4522(91)90210-F; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; VALLETTE FM, 1987, DEV BIOL, V120, P77, DOI 10.1016/0012-1606(87)90105-9; Van Ho AT, 2011, DEV CELL, V21, P273, DOI 10.1016/j.devcel.2011.06.019; VRBOVA G, 1963, J PHYSIOL-LONDON, V169, P513, DOI 10.1113/jphysiol.1963.sp007276; Wang GY, 2000, J NEUROSCI, V20, P5358, DOI 10.1523/JNEUROSCI.20-14-05358.2000; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	60	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133811	10.1371/journal.pone.0133811	http://dx.doi.org/10.1371/journal.pone.0133811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207754	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000150
J	Ma, YY; Liu, Y; Song, HM; Sun, JY; Lei, Y; Wang, YC				Ma, Yongyong; Liu, Yu; Song, Huiming; Sun, Junyan; Lei, Ying; Wang, Yanchao			A Standardized Precipitation Evapotranspiration Index Reconstruction in the Taihe Mountains Using Tree-Ring Widths for the Last 283 Years	PLOS ONE			English	Article							DROUGHT RECONSTRUCTION; INNER-MONGOLIA; CHINA; VARIABILITY; PACIFIC; DATASET; RECORDS; GROWTH; 1920S	Tree-ring samples from Chinese Pine (Pinus tabulaeformis Carr.) that were collected in the Taihe Mountains on the western Loess Plateau, China, were used to analyze the effects of climate and drought on radial growth and to reconstruct the mean April-June Standardized Precipitation Evapotranspiration Index (SPEI) during the period 1730-2012 AD. Precipitation positively affected tree growth primarily during wet seasons, while temperature negatively affected tree growth during dry seasons. Tree growth responded positively to SPEI at long time scales most likely because the trees were able to withstand water deficits but lacked a rapid response to drought. The 10-month scale SPEI was chosen for further drought reconstruction. A calibration model for the period 1951-2011 explained 51% of the variance in the modeled SPEI data. Our SPEI reconstruction revealed long-term patterns of drought variability and captured some significant drought events, including the severe drought of 1928-1930 and the clear drying trend since the 1950s which were widespread across northern China. The reconstruction was also consistent with two other reconstructions on the western Loess Plateau at both interannual and decadal scales. The reconstructed SPEI series showed synchronous variations with the drought/wetness indices and spatial correlation analyses indicated that this reconstruction could be representative of large-scale SPEI variability in northern China. Period analysis discovered 128-year, 25-year, 2.62-year, 2.36-year, and 2.04-year cycles in this reconstruction. The time-dependency of the growth response to drought should be considered in further studies of the community dynamics. The SPEI reconstruction improves the sparse network of long-term climate records for an enhanced understanding of climatic variability on the western Loess Plateau, China.	[Ma, Yongyong; Liu, Yu; Song, Huiming; Sun, Junyan; Lei, Ying] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710061, Peoples R China; [Ma, Yongyong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Liu, Yu; Song, Huiming] Beijing Normal Univ, Joint Ctr Global Change Studies, Beijing 100875, Peoples R China; [Wang, Yanchao] Xingtai Univ, Dept Geog, Xingtai 054001, Peoples R China	Chinese Academy of Sciences; Institute of Earth Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Normal University; Xingtai University	Liu, Y (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710061, Peoples R China.	liuyu@loess.llqg.ac.cn	Wang, Yanchao/GZH-3084-2022; Wang, Yanchao/V-9700-2019; Liu, Yu/AAA-6165-2019	Wang, Yanchao/0000-0003-3316-0177; liu, yu/0000-0002-1402-0737	National Basic Research Program of China [2013CB955900]; Chinese Academy of Sciences [KZZD-EW-04-01]; Project of State Key Laboratory of Loess and Quaternary Geology Institute of Earth Environment, CAS [SKLLQG1314]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Project of State Key Laboratory of Loess and Quaternary Geology Institute of Earth Environment, CAS	This study was supported by grants from the National Basic Research Program of China (no. 2013CB955900), the Chinese Academy of Sciences (KZZD-EW-04-01) and the Project of State Key Laboratory of Loess and Quaternary Geology Institute of Earth Environment, CAS (SKLLQG1314). This research is an initiative of the Sino-Swedish Tree-Ring Research Center (SISTRR): Contribution (No. 024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun BJ, 2013, CLIM DYNAM, V41, P277, DOI 10.1007/s00382-012-1523-9; Allan R., 1997, OCEANOGR LIT REV, V6, P555; Allen KJ, 2011, CLIM DYNAM, V37, P1799, DOI 10.1007/s00382-011-1011-7; Cai Q, 2014, CLIM PAST, V10, P509, DOI 10.5194/cp-10-509-2014; Central Meteorological Bureau of China, 1981, YEARL CHARTS DRYN WE; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107501; Cook E.R., 2013, METHODS DENDROCHRONO; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Fang KY, 2010, INT J CLIMATOL, V30, P1137, DOI 10.1002/joc.1974; Feng S, 2004, J CLIMATE, V17, P4871, DOI 10.1175/JCLI-3245.1; FRITTS H C, 1986, Tree-Ring Bulletin, V46, P31; Fritts H. C., 1976, TREE RINGS CLIMATE; Gou XH, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005705; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Li JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025803; Li JB, 2007, INT J CLIMATOL, V27, P903, DOI 10.1002/joc.1450; Li WeiGuang, 2012, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V20, P643, DOI 10.3724/SP.J.1011.2012.00643; Liang EY, 2006, CLIMATIC CHANGE, V79, P403, DOI 10.1007/s10584-006-9082-x; Liang EY, 2003, ANN FOREST SCI, V60, P145, DOI 10.1051/forest:2003007; Libiseller C, 2002, ENVIRONMETRICS, V13, P71, DOI 10.1002/env.507; Liu Y, 2003, CHINESE SCI BULL, V48, P1140, DOI 10.1360/02wd0455; Liu Y, 1996, SCI CHINA SER D, V39, P152; Liu Y, 2001, EARTH SCI FRONT, V8, P91; Liu Y, 2007, TREE-RING RES, V63, P3, DOI 10.3959/1536-1098-63.1.3; Liu Y, 2013, DENDROCHRONOLOGIA, V31, P290, DOI 10.1016/j.dendro.2013.02.001; Liu Y, 2013, INT J BIOMETEOROL, V57, P927, DOI 10.1007/s00484-012-0618-7; Liu Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012330; Liu Y, 2009, PALAEOGEOGR PALAEOCL, V282, P81, DOI 10.1016/j.palaeo.2009.08.012; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Martin-Benito D, 2013, EUR J FOREST RES, V132, P33, DOI 10.1007/s10342-012-0652-3; MEEHL GA, 1987, MON WEATHER REV, V115, P27, DOI 10.1175/1520-0493(1987)115<0027:TACAIV>2.0.CO;2; MEKO D, 1995, WATER RESOUR BULL, V31, P605; Mendivelso HA, 2014, AGR FOREST METEOROL, V188, P13, DOI 10.1016/j.agrformet.2013.12.010; Searcy J.K., 1960, CYCL DATA, DOI [10.3133/wsp1541B, DOI 10.3133/WSP1541B]; Song HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093504; Song HM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016220; Stokes M.A., 1996, INTRO TREE RING DATI; Vicente-Serrano SM, 2010, J HYDROMETEOROL, V11, P1033, DOI 10.1175/2010JHM1224.1; Vicente-Serrano SM, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000434.1; Vicente-Serrano SM, 2013, P NATL ACAD SCI USA, V110, P52, DOI 10.1073/pnas.1207068110; Vicente-Serrano SM, 2011, ADV GLOB CHANGE RES, V46, P23, DOI 10.1007/978-94-007-1372-7_3; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Wang Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023344; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Xu GC., 1997, CLIMATE CHANGE ARID; Xu GB, 2014, THEOR APPL CLIMATOL, V116, P385, DOI 10.1007/s00704-013-0958-1; YANG WJ, 2003, SOIL WATER CONSERVAT, V12, P24; Zhang Q, 2004, SCI TECHNOLOGY REV, V7, P21; Zou XK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021853	53	17	19	7	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133605	10.1371/journal.pone.0133605	http://dx.doi.org/10.1371/journal.pone.0133605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207621	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000109
J	Musilova, I; Kutova, R; Pliskova, L; Stepan, M; Menon, R; Jacobsson, B; Kacerovsky, M				Musilova, Ivana; Kutova, Radka; Pliskova, Lenka; Stepan, Martin; Menon, Ramkumar; Jacobsson, Bo; Kacerovsky, Marian			Intraamniotic Inflammation in Women with Preterm Prelabor Rupture of Membranes	PLOS ONE			English	Article							AMNIOTIC-FLUID INTERLEUKIN-6; PREMATURE RUPTURE; MICROBIAL INVASION; DIAGNOSTIC PERFORMANCE; OXIDATIVE STRESS; RACIAL DISPARITY; BACTERIA; LATENCY; CAVITY; DAMAGE	Objective To characterize subgroups of preterm prelabor rupture of membranes (PPROM) and short-term neonatal outcomes based on the presence and absence of intraamniotic inflammation (IAI) and/or microbial invasion of the amniotic cavity (MIAC). Methods One hundred and sixty-six Caucasian women with singleton pregnancies were included in this study. Amniotic fluid samples were obtained by transabdominal amniocentesis (n=166) and were assayed for interleukin-6 levels by a lateral flow immunoassay. The presence of Ureaplasma species, Mycoplasma hominis, Chlamydia trachomatis, and 16S rRNA was evaluated in the amniotic fluid. IAI was defined as amniotic fluid IL-6 values, measured by a point of care test, higher than 745 pg/mL. Results Microbial-associated IAI (IAI with MIAC) and sterile intraamniotic inflammation (IAI alone) were found in 21% and 4%, respectively, of women with PPROM. Women with microbial-associated IAI had higher microbial loads of Ureaplasma species in the amniotic fluid than women with MIAC alone. No differences in the short-term neonatal morbidity with respect to the presence of microbial-associated IAI, sterile IAI and MIAC alone were found after adjusting for the gestational age at delivery in women with PPROM. Conclusions Microbial-associated but not sterile intraamniotic inflammation is common in Caucasian women with PPROM. The gestational age at delivery but not the presence of inflammation affects the short-term neonatal morbidity of newborns from PPROM pregnancies.	[Musilova, Ivana; Stepan, Martin; Kacerovsky, Marian] Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Charles Univ Prague, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Kutova, Radka; Pliskova, Lenka] Univ Hosp Hradec Kralove, Inst Clin Biochem, Hradec Kralove, Czech Republic; [Menon, Ramkumar] Sahlgrens Acad, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Norwegian Inst Publ Hlth, Dept Genes & Environm, Div Epidemiol, Oslo, Norway; [Jacobsson, Bo] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA; [Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; University of Gothenburg; Norwegian Institute of Public Health (NIPH); University of Texas System; University of Texas Medical Branch Galveston; University Hospital Hradec Kralove	Kacerovsky, M (corresponding author), Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Charles Univ Prague, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic.	kacermar@fnhk.cz	Kacerovsky, Marian/ABE-3437-2020; Musilová, Ivana Kacerovská/I-6204-2017; Jacobsson, Bo/O-8007-2014; Kacerovsky, Marian/A-7586-2011	Musilová, Ivana Kacerovská/0000-0002-6960-8319; Jacobsson, Bo/0000-0001-5079-2374; Kacerovsky, Marian/0000-0001-9858-7900	Ministry of Health of the Czech Republic [NS 13461-4/2012]; Charles University in Prague, the Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK" [P37/10]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Charles University in Prague, the Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK"	This work was supported by 1) a grant from the Ministry of Health of the Czech Republic (NS 13461-4/2012), and 2) Charles University in Prague, the Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK" P37/10.	Bredeson S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113799; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P349, DOI 10.3109/14767058.2015.1006620; Chaemsaithong P, 2015, J MATERN-FETAL NEO M, V28, P1510, DOI 10.3109/14767058.2014.961417; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Fortunato SJ, 2004, AM J OBSTET GYNECOL, V190, P1557, DOI 10.1016/j.ajog.2004.03.053; Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355; Frenette P, 2013, J OBSTET GYNAECOL CA, V35, P710, DOI 10.1016/S1701-2163(15)30861-6; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P423, DOI 10.1034/j.1600-0412.2003.00157.x; Jacobsson B, 2009, ACTA OBSTET GYN SCAN, V88, P63, DOI 10.1080/00016340802572646; Kacerovsky M, 2015, AM J OBSTET GYNECOL, V213, P435, DOI 10.1016/j.ajog.2015.05.039; Kacerovsky M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.069; Kacerovsky M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060399; Kacerovsky M, 2012, J MATERN-FETAL NEO M, V25, P2014, DOI 10.3109/14767058.2012.671873; Kacerovsky M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.004; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012; Menon R, 2007, REPROD SCI, V14, P253, DOI 10.1177/1933719107301336; Menon R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00567; Menon R, 2014, AM J REPROD IMMUNOL, V72, P75, DOI 10.1111/aji.12220; Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011; Nayot D, 2012, J PERINATOL, V32, P970, DOI 10.1038/jp.2012.15; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; ROMERO R, 1991, CLIN OBSTET GYNECOL, V34, P769, DOI 10.1097/00003081-199112000-00013; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839, DOI 10.1016/0002-9378(93)90014-A; ROMERO R, 1993, AM J REPROD IMMUNOL, V30, P167, DOI 10.1111/j.1600-0897.1993.tb00618.x; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463; Romero R, 2014, J MATERN-FETAL NEO M, V27, P757, DOI 10.3109/14767058.2013.844123; Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383	34	70	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133929	10.1371/journal.pone.0133929	http://dx.doi.org/10.1371/journal.pone.0133929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208287	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000176
J	Tokuhisa, M; Ichikawa, Y; Kosaka, N; Ochiya, T; Yashiro, M; Hirakawa, K; Kosaka, T; Makino, H; Akiyama, H; Kunisaki, C; Endo, I				Tokuhisa, Motohiko; Ichikawa, Yasushi; Kosaka, Nobuyoshi; Ochiya, Takahiro; Yashiro, Masakazu; Hirakawa, Kosei; Kosaka, Takashi; Makino, Hirochika; Akiyama, Hirotoshi; Kunisaki, Chikara; Endo, Itaru			Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer	PLOS ONE			English	Article							MICRORNA; CELLS; PROFILES; SERUM	Peritoneal metastasis is the most frequent type of recurrence in patients with gastric cancer (GC) and is associated with poor prognosis. Peritoneal lavage cytology, used to evaluate the risk of peritoneal metastasis, has low sensitivity. Here, we assessed the diagnostic potential of exosomal miRNA profiles in peritoneal fluid for the prediction of peritoneal dissemination in GC. Total RNA was extracted from exosomes isolated from six gastric malignant ascites (MA) samples, 24 peritoneal lavage fluid (PLF) samples, and culture supernatants (CM) of two human gastric carcinoma cell lines that differ in their potential for peritoneal metastasis. Expression of exosomal miRNAs was evaluated with Agilent Human miRNA microarrays and quantitative reverse transcription polymerase chain reaction (qRT-PCR). The microarray analysis indicated a low variability in the number and signal intensity of miRNAs detected among the samples. In the six MA fluids, miR-21 showed the highest signal intensity. We identified five miRNAs (miR-1225-5p, miR-320c, miR-1202, miR-1207-5p, and miR-4270) with high expression in MA samples, the PLF of serosa-invasive GC, and the CM of a highly metastatic GC cell line; these candidate miRNA species appear to be related to peritoneal dissemination. Differential expression of miR-21, miR-320c, and miR-1225-5p was validated in the PLF of serosa-invasive and non-invasive GC by qRT-PCR and miR-21 and miR-1225-5p were confirmed to be associated with serosal invasion in GC. PLF can be used to profile the expression of exosomal miRNAs. Our findings suggest that miR-21 and miR-1225-5p may serve as biomarkers of peritoneal recurrence after curative GC resection, thus providing a novel approach to early diagnosis of peritoneal dissemination of GC.	[Tokuhisa, Motohiko; Kosaka, Takashi; Makino, Hirochika; Akiyama, Hirotoshi; Kunisaki, Chikara; Endo, Itaru] Yokohama City Univ, Dept Surg Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Ichikawa, Yasushi] Yokohama City Univ, Dept Clin Oncol, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 104, Japan; [Yashiro, Masakazu; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan	Yokohama City University; Yokohama City University; National Cancer Center - Japan; Osaka Metropolitan University	Tokuhisa, M (corresponding author), Yokohama City Univ, Dept Surg Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	tokuhisa@yokohama-cu.ac.jp	Ochiya, Takahiro/AAH-7585-2019					Bando E, 1999, AM J SURG, V178, P256, DOI 10.1016/S0002-9610(99)00162-2; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kim DW, 2011, J KOREAN MED SCI, V26, P875, DOI 10.3346/jkms.2011.26.7.875; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Li QL, 2008, CLIN MED INSIGHTS-ON, V2, P461; Li Z, 2012, MOL MED REP, V6, P558, DOI 10.3892/mmr.2012.951; Lim JS, 2006, RADIOGRAPHICS, V26, P143, DOI 10.1148/rg.261055078; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Liu J, 2014, INT J MOL SCI, V15, P758, DOI 10.3390/ijms15010758; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maehara Y, 1999, ONCOLOGY-BASEL, V56, P322, DOI 10.1159/000011986; Olszewski WL, 2007, SURGERY, V141, P212, DOI 10.1016/j.surg.2006.06.031; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Sanyukta R, 2013, NEOPLASIA, V15, P281; Tamura S, 2014, J SURG ONCOL, V109, P75, DOI 10.1002/jso.23472; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685	33	118	126	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130472	10.1371/journal.pone.0130472	http://dx.doi.org/10.1371/journal.pone.0130472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208314	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000007
J	Wang, J; Zhao, XM; Yuan, P; Fang, TF; Ouyang, NY; Li, RQ; Ou, SB; Wang, WJ				Wang, Jing; Zhao, Xiaomiao; Yuan, Ping; Fang, Tingfeng; Ouyang, Nengyong; Li, Ruiqi; Ou, Songbang; Wang, Wenjun			Clinical Outcomes of In Vitro Fertilization among Chinese Infertile Couples Treated for Syphilis Infection	PLOS ONE			English	Article							TREPONEMA-PALLIDUM; PREGNANCY OUTCOMES; RELIABILITY; DIAGNOSIS; WOMEN	To compare the clinical outcomes of infertile patients with and without syphilis after in vitro fertilization and embryo transfer (IVF-ET), in this case-control study, 320 infertile couples were enrolled and divided into syphilis (n = 160) and control groups (n = 160). The primary IVF outcomes were the clinical pregnancy rate and the birth of a healthy baby. All syphilis patients received the standard anti-syphilis treatment before undergoing IVF/ICSI. Our results showed that the endometrial thickness of the syphilis group was greater than that of the control group following hCG injection (16.9 +/- 5.4 vs. 13.0 +/- 4.7 mm, P<0.001). The numbers of normally fertilized eggs and normally cleaved fertilized eggs and the implantation rate were 6.8 +/- 4.8, 6.3 +/- 4.7 and 24.2%, respectively, for the syphilis group and 8.3 +/- 4.6, 8.1 +/- 4.6 and 34.4%, respectively, for the control group, and these values were significantly different between the groups. The clinical pregnancy rate was lower in the syphilis group compared with that in the control group (43.8% vs. 55.6%, P = 0.03). Lower offspring birth weight was observed in the infected male group compared with those in the infected female (2.7 +/- 0.4 vs. 3.0 +/- 0.4 kg, P = 0.01) and infected couple groups (2.7 +/- 0.4 vs. 3.1 +/- 0.5 kg, P = 0.007). Therefore, syphilis infection reduces the clinical pregnancy rate after IVF/ICSI.	[Wang, Jing; Zhao, Xiaomiao; Yuan, Ping; Fang, Tingfeng; Ouyang, Nengyong; Li, Ruiqi; Ou, Songbang; Wang, Wenjun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Reprod Med Ctr, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University	Wang, WJ (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Reprod Med Ctr, 107 Yanjiang Xi Rd, Guangzhou 510120, Guangdong, Peoples R China.	wenjungzcn@163.com			National Science Technology Research Projects of China [81100402]; Specialized Research Funds for New Teachers Program of the Chinese Ministry of Education [20110171120083]	National Science Technology Research Projects of China; Specialized Research Funds for New Teachers Program of the Chinese Ministry of Education	This study was funded by The National Science Technology Research Projects of China (81100402) and The Specialized Research Funds for New Teachers Program of the Chinese Ministry of Education(20110171120083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almobarak AO, 2013, J CYTOL, V30, P100, DOI 10.4103/0970-9371.112651; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Arroll TW, 1999, INFECT IMMUN, V67, P4757, DOI 10.1128/IAI.67.9.4757-4763.1999; Askienazy-Elbhar M, 2005, Gynecol Obstet Fertil, V33, P691, DOI 10.1016/j.gyobfe.2005.07.008; Bhattacharya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082249; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Borkhardt HL, 1997, J MED MICROBIOL, V46, P965, DOI 10.1099/00222615-46-11-965; Calonge N, 2009, ANN INTERN MED, V150, P705; Casper RF, 2011, FERTIL STERIL, V96, P519, DOI 10.1016/j.fertnstert.2011.07.1096; Chen H, 2011, J ASSIST REPROD GEN, V28, P797, DOI 10.1007/s10815-011-9600-2; Chen XS, 2013, CHINESE MED J-PEKING, V126, P2774, DOI 10.3760/cma.j.issn.0366-6999.20123559; Chen XS, 2011, FUTURE MICROBIOL, V6, P1131, DOI [10.2217/fmb.11.99, 10.2217/FMB.11.99]; Cicinelli E, 2009, GYNECOL OBSTET INVES, V68, P108, DOI 10.1159/000223819; Deiss RG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-426; Di Simone N, 2000, ARTHRITIS RHEUM-US, V43, P140, DOI 10.1002/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P; Fang J, 2007, STAT METHODS BIOMEDI, P266; Hammadeh ME, 2002, AM J REPROD IMMUNOL, V47, P82, DOI 10.1034/j.1600-0897.2002.1o024.x; Jiang CH, 2013, CLIN VACCINE IMMUNOL, V20, P1563, DOI 10.1128/CVI.00122-13; Jin X, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/179098; Karimzade MA, 2010, ARCH GYNECOL OBSTET, V281, P499, DOI 10.1007/s00404-009-1166-1; Kasius JC, 2012, HUM REPROD, V27, P153, DOI 10.1093/humrep/der341; Kiguli-Malwadde Elsie, 2004, Afr Health Sci, V4, P178; Knudsen A, 2009, SEX TRANSM DIS, V36, P300, DOI 10.1097/OLQ.0b013e318193ca26; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lam PM, 2010, FERTIL STERIL, V93, P480, DOI 10.1016/j.fertnstert.2009.01.137; Lee SH, 2014, ACTA DERM-VENEREOL, V94, P321, DOI 10.2340/00015555-1703; Lee V, 2008, CLIN MED, V8, P330, DOI 10.7861/clinmedicine.8-3-330; Munkhzul B, 2012, WEST PAC SURVEILL RE, V3, P48, DOI [10.5365/WPSAR.2012.3.4.003, 10.5365/wpsar.2012.3.4.003]; Okohue J E, 2009, Afr J Reprod Health, V13, P113; Quentin R, 2012, J GYNECOL OBST BIO R, V41, P850, DOI 10.1016/j.jgyn.2012.09.015; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832; Smit PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075327; Tong ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070102; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; Wang BX, 2014, INT J STD AIDS, V25, P550, DOI 10.1177/0956462413515444; Wilkinson D, 1997, GENITOURIN MED, V73, P558; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization, 2010, WHO LAB MAN EX PROC, V5th, P224; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Xiao Z, 2013, SHANGDONG MED J, V17, P18; Yang LG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-793; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084950; Zhao J, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-100; Zhao WH, 2014, GYNECOL OBSTET INVES, V77, P169, DOI 10.1159/000358393	44	2	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133726	10.1371/journal.pone.0133726	http://dx.doi.org/10.1371/journal.pone.0133726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208116	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000124
J	Suita, K; Fujita, T; Hasegawa, N; Cai, WQ; Jin, HL; Hidaka, Y; Prajapati, R; Umemura, M; Yokoyama, U; Sato, M; Okumura, S; Ishikawa, Y				Suita, Kenji; Fujita, Takayuki; Hasegawa, Nozomi; Cai, Wenqian; Jin, Huiling; Hidaka, Yuko; Prajapati, Rajesh; Umemura, Masanari; Yokoyama, Utako; Sato, Motohiko; Okumura, Satoshi; Ishikawa, Yoshihiro			Norepinephrine-Induced Adrenergic Activation Strikingly Increased the Atrial Fibrillation Duration through beta 1-and alpha 1-Adrenergic Receptor-Mediated Signaling in Mice	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; HEART-FAILURE; LIFETIME RISK; PATHOPHYSIOLOGY; TACHYCARDIA; PREVALENCE; OVEREXPRESSION; MECHANISMS; INDUCTION; PROTEINS	Background Atrial fibrillation (AF) is the most common arrhythmias among old people. It causes serious long-term health problems affecting the quality of life. It has been suggested that the autonomic nervous system is involved in the onset and maintenance of AF in human. However, investigation of its pathogenesis and potential treatment has been hampered by the lack of suitable AF models in experimental animals. Objectives Our aim was to establish a long-lasting AF model in mice. We also investigated the role of adrenergic receptor (AR) subtypes, which may be involved in the onset and duration of AF. Methods and Results Trans-esophageal atrial burst pacing in mice could induce AF, as previously shown, but with only a short duration (29.0 +/- 8.1 sec). We found that adrenergic activation by intraperitoneal norepinephrine (NE) injection strikingly increased the AF duration. It increased the duration to more than 10 minutes, i.e., by more than 20-fold (656.2 +/- 104.8 sec; P<0.001). In this model, a prior injection of a specific beta 1-AR blocker metoprolol and an alpha 1-AR blocker prazosin both significantly attenuated NE-induced elongation of AF. To further explore the mechanisms underlying these receptors' effects on AF, we assessed the SR Ca2+ leak, a major trigger of AF, and consequent spontaneous SR Ca2+ release (SCR) in atrial myocytes. Consistent with the results of our in-vivo experiments, both metoprolol and prazosin significantly inhibited the NE-induced SR Ca2+ leak and SCR. These findings suggest that both beta 1-AR and alpha 1-AR may play important roles in the development of AF. Conclusions We have established a long-lasting AF model in mice induced by adrenergic activation, which will be valuable in future AF study using experimental animals, such as transgenic mice. We also revealed the important role of beta 1- and alpha 1-AR-mediated signaling in the development of AF through in-vivo and in-vitro experiments.	[Suita, Kenji; Fujita, Takayuki; Hasegawa, Nozomi; Cai, Wenqian; Jin, Huiling; Hidaka, Yuko; Prajapati, Rajesh; Umemura, Masanari; Yokoyama, Utako; Sato, Motohiko; Okumura, Satoshi; Ishikawa, Yoshihiro] Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan; [Sato, Motohiko] Aichi Med Univ, Sch Med, Dept Physiol, Nagakute, Aichi, Japan; [Okumura, Satoshi] Tsurumi Univ, Sch Dent Med, Dept Physiol, Yokohama, Kanagawa, Japan	Yokohama City University; Aichi Medical University; Tsurumi University	Fujita, T (corresponding author), Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan.	fujitaka@yokohama-cu.ac.jp; yishikaw@med.yokohama-cu.ac.jp	Cai, Wenqian/GXV-1498-2022; Yokoyama, Utako/AAD-1404-2022; Umemura, Masanari/D-3607-2018	Cai, Wenqian/0000-0002-3876-1185; Yokoyama, Utako/0000-0003-1803-0155; Umemura, Masanari/0000-0002-1812-5720; Prajapati, Rajesh/0000-0002-3252-0073	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grant for Strategic Research Promotion of Yokohama City University; Ministry of Health, Labor and Welfare; Kitsuen Kagaku Research Foundation; Japan Space Forum; Takeda Science Foundation; Yokohama Foundation for Advancement of Medical Science; Mitsubishi Pharma Research Foundation; Suzuken Memorial Foundation; Yokohama Academic Foundation; Commercialization Promotion Program for Biotechnology-related Studies; Grants for Research and Development Project II from Yokohama City University; Research Foundation for Community Medicine	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant for Strategic Research Promotion of Yokohama City University; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Kitsuen Kagaku Research Foundation; Japan Space Forum; Takeda Science Foundation(Takeda Science Foundation (TSF)); Yokohama Foundation for Advancement of Medical Science; Mitsubishi Pharma Research Foundation; Suzuken Memorial Foundation; Yokohama Academic Foundation; Commercialization Promotion Program for Biotechnology-related Studies; Grants for Research and Development Project II from Yokohama City University; Research Foundation for Community Medicine	This study was supported in part by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KS, TF, SO, YI), a Grant for Strategic Research Promotion of Yokohama City University (TF, SO), the Ministry of Health, Labor and Welfare (YI), a Grant-in-Aid for Scientific Research on Innovative Areas (YI), the Kitsuen Kagaku Research Foundation (YI), the Japan Space Forum (YI), Takeda Science Foundation (YI), Yokohama Foundation for Advancement of Medical Science (SO), Mitsubishi Pharma Research Foundation (SO), Suzuken Memorial Foundation (SO), Yokohama Academic Foundation (SO), 2010 Commercialization Promotion Program for Biotechnology-related Studies (SO), Grants for Research and Development Project II from Yokohama City University (SO, YI), and Research Foundation for Community Medicine (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Armour JA, 1997, CAN J CARDIOL, V13, P277; Armour JA, 2005, AUTON NEUROSCI-BASIC, V118, P68, DOI 10.1016/j.autneu.2005.01.006; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; Chen PS, 2014, CIRC RES, V114, P1500, DOI 10.1161/CIRCRESAHA.114.303772; Fukui A, 2013, CIRC-ARRHYTHMIA ELEC, V6, P402, DOI 10.1161/CIRCEP.111.000104; Grimm M, 2007, J MOL CELL CARDIOL, V42, P643, DOI 10.1016/j.yjmcc.2006.12.010; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; Haugan K, 2004, J CARDIOVASC PHARM, V44, P125, DOI 10.1097/00005344-200407000-00017; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Hirose M, 2009, HEART RHYTHM, V6, P78, DOI 10.1016/j.hrthm.2008.10.018; Ishibashi H, 2003, J PHYSIOL-LONDON, V548, P111, DOI 10.1113/jphysiol.2002.033100; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Katritsis DG, 2013, J AM COLL CARDIOL, V62, P2318, DOI 10.1016/j.jacc.2013.06.053; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Muller FU, 2005, J BIOL CHEM, V280, P6906, DOI 10.1074/jbc.M407864200; O-Uchi J, 2008, CIRC RES, V102, P1378, DOI 10.1161/CIRCRESAHA.107.167734; Ogrodnik J, 2010, J PHYSIOL-LONDON, V588, P225, DOI 10.1113/jphysiol.2009.181800; ORTIZ J, 1994, CIRC RES, V74, P882, DOI 10.1161/01.RES.74.5.882; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Pretorius L, 2009, AM J PATHOL, V175, P998, DOI 10.2353/ajpath.2009.090126; Rathore SS, 2000, CIRCULATION, V101, P969, DOI 10.1161/01.CIR.101.9.969; Riley G, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00296; Rose RA, 2007, CIRC RES, V101, P1274, DOI 10.1161/CIRCRESAHA.107.158428; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Sapra G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6705; SATO R, 1995, J MEMBRANE BIOL, V148, P185; Sato S, 2008, AM J PHYSIOL-HEART C, V294, pH1708, DOI 10.1152/ajpheart.01122.2007; Schrickel JW, 2002, BASIC RES CARDIOL, V97, P452, DOI 10.1007/s003950200052; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Stavrakis S, 2009, J AM COLL CARDIOL, V54, P1309, DOI 10.1016/j.jacc.2009.07.015; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; Van Noord T, 2004, EUROPACE, V6, P343, DOI 10.1016/j.eupc.2004.04.001; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wakimoto H, 2001, CARDIOVASC RES, V50, P463, DOI 10.1016/S0008-6363(01)00264-4; Wang HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094005; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Yoshioka I, 2009, THORAC CARDIOV SURG, V57, P464, DOI 10.1055/s-0029-1186069; Zeng Z, 2014, J PHARMACOL SCI, V126, P37, DOI 10.1254/jphs.14029FP; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	45	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133664	10.1371/journal.pone.0133664	http://dx.doi.org/10.1371/journal.pone.0133664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203906	Green Published, Green Submitted, gold			2022-12-26	WOS:000358621000036
J	Tie, SR; McCarthy, DJ; Kendrick, TS; Louw, A; Le, C; Satiaputra, J; Kucera, N; Phillips, M; Ingley, E				Tie, S. R.; McCarthy, D. J.; Kendrick, T. S.; Louw, A.; Le, C.; Satiaputra, J.; Kucera, N.; Phillips, M.; Ingley, E.			Regulation of sarcoma cell migration, invasion and invadopodia formation by AFAP1L1 through a phosphotyrosine-dependent pathway	ONCOGENE			English	Article							ERYTHROPOIETIN-INDUCED DIFFERENTIATION; PODOSOME FORMATION; ERYTHROID-CELLS; TYROSINE KINASE; ADAPTER PROTEIN; ACTIN DYNAMICS; SRC SUBSTRATE; TUMOR-CELLS; N-WASP; CORTACTIN	Invasion and metastasis are controlled by the invadopodia, which delivers matrix-degrading enzymes to the invasion interface permitting cancer cell penetration and spread into healthy tissue. We have identified a novel pathway that directs Lyn/Src family tyrosine kinase signals to the invadopodia to regulate sarcoma cell invasion via the molecule AFAP-1-like-1 (AFAP1L1), a new member of the AFAP (actin filament-associated protein) family. We show that AFAP1L1 can transform cells, promote migration and co-expression with active Lyn profoundly influences cell morphology and movement. AFAP1L1 intersects several invadopodia pathway components through its multiple domains and motifs, including the following (i) pleckstrin homology domains that bind phospholipids generated at the plasma membrane by phosphoinositide 3-kinase, (ii) a direct filamentous-actin binding domain and (iii) phospho-tyrosine motifs (pY136 and pY566) that specifically bind Vav2 and Nck2 SH2 domains, respectively. These phosphotyrosine motifs are essential for AFAP1L1-mediated cytoskeleton regulation. Through its interaction with Vav2, AFAP1L1 regulates Rac activity and downstream control of PAK1/2/3 (p21-activated kinases) phosphorylation of myosin light chain (MLC) kinase and MLC2. AFAP1L1 interaction with Nck2 recruits actin-nucleating complexes. Significantly, in osteosarcoma cell lines, knockdown of AFAP1L1 inhibits phosphorylated MLC2 recruitment to filamentous-actin structures, disrupts invadopodia formation, cell attachment, migration and invasion. These data define a novel pathway that directs Lyn/Src family tyrosine kinase signals to sarcoma cell invadopodia through specific recruitment of Vav2 and Nck2 to phosphorylated AFAP1L1, to control cell migration and invasion.	[Tie, S. R.; McCarthy, D. J.; Kendrick, T. S.; Louw, A.; Le, C.; Satiaputra, J.; Kucera, N.; Ingley, E.] Univ Western Australia, Harry Perkins Inst Med Res, Cell Signalling Grp, Nedlands, WA 6009, Australia; [Tie, S. R.; McCarthy, D. J.; Kendrick, T. S.; Louw, A.; Le, C.; Satiaputra, J.; Kucera, N.; Ingley, E.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Louw, A.] Royal Perth Hosp, Med Res Fdn, Perth, WA 6001, Australia; [Phillips, M.] Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA 6009, Australia; [Phillips, M.] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Royal Perth Hospital; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Ingley, E (corresponding author), Univ Western Australia, Harry Perkins Inst Med Res, Cell Signalling Grp, QEII Med Ctr, Level 7,QQ Block,6 Verdun St, Nedlands, WA 6009, Australia.; Ingley, E (corresponding author), Univ Western Australia, Med Res Ctr, QEII Med Ctr, Level 7,QQ Block,6 Verdun St, Nedlands, WA 6009, Australia.	evan.ingley@uwa.edu.au	Ingley, Evan/C-2401-2013	Ingley, Evan/0000-0002-8112-9134; Phillips, Michael/0000-0002-0252-9085	National Health and Medical Research Council [513714, 634352]; Medical Research Foundation of Royal Perth Hospital; Cancer Council of Western Australia; Harry Perkins Institute of Medical Research; Sock-it-to-Sarcoma; Hollywood Private Hospital Research Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Foundation of Royal Perth Hospital; Cancer Council of Western Australia(Cancer Council Western Australia); Harry Perkins Institute of Medical Research; Sock-it-to-Sarcoma; Hollywood Private Hospital Research Foundation	We thank Janice Lam, Matt Lee, Rebecca Shapiro, Morgane Davies, Irma Larma and Kevin Li for technical assistance. This work was supported by grants from the National Health and Medical Research Council (513714 and 634352), the Medical Research Foundation of Royal Perth Hospital and the Cancer Council of Western Australia. EI received support from the Cancer Council of Western Australia, The Harry Perkins Institute of Medical Research, Sock-it-to-Sarcoma and the Hollywood Private Hospital Research Foundation.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; Barrio-Real L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003543; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; CHAUHAN AK, 1993, P NATL ACAD SCI USA, V90, P679, DOI 10.1073/pnas.90.2.679; CHEN WT, 1985, NATURE, V316, P156, DOI 10.1038/316156a0; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Crimaldi L, 2009, EXP CELL RES, V315, P2581, DOI 10.1016/j.yexcr.2009.06.012; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Dorfleutner A, 2008, J CELL SCI, V121, P2394, DOI 10.1242/jcs.026187; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Furu M, 2011, ONCOGENE, V30, P4015, DOI 10.1038/onc.2011.108; Gatesman A, 2004, MOL CELL BIOL, V24, P7578, DOI 10.1128/MCB.24.17.7578-7597.2004; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Ingley E, 2001, J BIOL CHEM, V276, P43428, DOI 10.1074/jbc.M106645200; Ingley E, 2000, J BIOL CHEM, V275, P7887, DOI 10.1074/jbc.275.11.7887; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Kaipparettu BA, 2008, BIOTECHNIQUES, V45, P165, DOI 10.2144/000112883; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Lodyga M, 2010, J CELL SCI, V123, P4156, DOI 10.1242/jcs.071050; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Moshfegh Y, 2014, NAT CELL BIOL, V16, P571, DOI 10.1038/ncb2972; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nakahara H, 2003, GENES CELLS, V8, P1019, DOI 10.1111/j.1365-2443.2003.00695.x; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Samuels AL, 2009, BLOOD, V113, P3845, DOI 10.1182/blood-2008-04-153452; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Snyder BN, 2011, EUR J CELL BIOL, V90, P376, DOI 10.1016/j.ejcb.2010.11.016; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Takahashi R, 2014, CANCER MED-US, V3, P759, DOI 10.1002/cam4.237; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wells CM, 2005, EXP CELL RES, V310, P303, DOI 10.1016/j.yexcr.2005.07.015; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126	57	4	4	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2098	2111		10.1038/onc.2015.272	http://dx.doi.org/10.1038/onc.2015.272			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26212012	Green Submitted			2022-12-26	WOS:000374505600009
J	Lee, CK; Yang, Y; Chen, C; Liu, J				Lee, C. K.; Yang, Y.; Chen, C.; Liu, J.			Syk-mediated tyrosine phosphorylation of mule promotes TNF-induced JNK activation and cell death	ONCOGENE			English	Article							NF-KAPPA-B; ARF TUMOR-SUPPRESSOR; E3 UBIQUITIN LIGASE; RECEPTOR GAMMA-CHAIN; DNA-DAMAGE; PROTEIN-KINASE; JUN KINASES; APOPTOSIS; MIZ1; P53	The transcription factor Miz1 negatively regulates TNF-induced JNK activation and cell death by suppressing TRAF2 K63-polyubiquitination; upon TNF stimulation, the suppression is relieved by Mule/ARF-BP1-mediated Miz1 ubiquitination and subsequent degradation. It is not known how Mule is activated by TNF. Here we report that TNF activates Mule by inducing the dissociation of Mule from its inhibitor ARF. ARF binds to and thereby inhibits the E3 ligase activity of Mule in the steady state. TNF induces tyrosine phosphorylation of Mule, which subsequently dissociates from ARF and becomes activated. Inhibition of Mule phosphorylation by silencing of the Spleen Tyrosine Kinase (Syk) prevents its dissociation from ARF, thereby inhibiting Mule E3 ligase activity and TNF-induced JNK activation and cell death. Our data provides a missing link in TNF signaling pathway that leads to JNK activation and cell death.	[Lee, C. K.; Chen, C.; Liu, J.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, McGaw Pavil Suite M-300,240 E Huron, Chicago, IL 60611 USA; [Yang, Y.] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Northwestern University; Feinberg School of Medicine; Fudan University	Liu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, McGaw Pavil Suite M-300,240 E Huron, Chicago, IL 60611 USA.	jing@northwestern.edu			National Institutes of Health [GM081603-03, HL114763-01A1]; Lung Science Training Program [2T32HL076139-11A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114763, T32HL076139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung Science Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anning Lin (University of Chicago) for valuable reagents that made this work possible. We thank Jie Yan (University of Chicago), Hong Kuang (Northwestern University) and Chi Do (Northwestern University) for excellent technical assistance. This work was partially supported by National Institutes of Health (GM081603-03, HL114763-01A1) (JL), and the Lung Science Training Program (2T32HL076139-11A1) (CL).	Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Do-Umehara HC, 2013, NAT IMMUNOL, V14, P461, DOI 10.1038/ni.2566; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; GU J, 1994, MOL BRAIN RES, V24, P77, DOI 10.1016/0169-328X(94)90120-1; GU J, 1995, ONCOGENE, V11, P2175; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Khan SH, 2000, P NATL ACAD SCI USA, V97, P3266, DOI 10.1073/pnas.050560997; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu J, 2012, P NATL ACAD SCI USA, V109, P191, DOI 10.1073/pnas.1105176108; Liu J, 2009, P NATL ACAD SCI USA, V106, P18279, DOI 10.1073/pnas.0906328106; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Parsons JL, 2009, EMBO J, V28, P3207, DOI 10.1038/emboj.2009.243; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Takada Y, 2004, J IMMUNOL, V173, P1066, DOI 10.4049/jimmunol.173.2.1066; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Yang Y, 2010, P NATL ACAD SCI USA, V107, P13444, DOI 10.1073/pnas.0913690107; Yeh KW, 1997, PLANT MOL BIOL, V33, P565, DOI 10.1023/A:1005764702510; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	54	15	15	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					1988	1995		10.1038/onc.2015.275	http://dx.doi.org/10.1038/onc.2015.275			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26212014	Green Accepted			2022-12-26	WOS:000374010300011
J	de Araujo, ED; Alvarez, CP; Lopez-Alonso, JP; Sooklal, CR; Stagljar, M; Kanelis, V				de Araujo, Elvin D.; Alvarez, Claudia P.; Lopez-Alonso, Jorge P.; Sooklal, Clarissa R.; Stagljar, Marijana; Kanelis, Voula			Phosphorylation- dependent Changes in Nucleotide Binding, Conformation, and Dynamics of the First Nucleotide Binding Domain (NBD1) of the Sulfonylurea Receptor 2B (SUR2B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; SENSITIVE POTASSIUM CHANNEL; ABC TRANSPORTER; P-GLYCOPROTEIN; MEDIATED PHOSPHORYLATION; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; MOLECULAR-BASIS; DRUG-BINDING	The sulfonylurea receptor 2B (SUR2B) forms the regulatory subunit of ATP-sensitive potassium (K-ATP) channels in vascular smooth muscle. Phosphorylation of the SUR2B nucleotide binding domains (NBD1 and NBD2) by protein kinase A results in increased channel open probability. Here, we investigate the effects of phosphorylation on the structure and nucleotide binding properties of NBD1. Phosphorylation sites in SUR2B NBD1 are located in an N-terminal tail that is disordered. Nuclear magnetic resonance (NMR) data indicate that phosphorylation of the N-terminal tail affects multiple residues in NBD1, including residues in the NBD2-binding site, and results in altered conformation and dynamics of NBD1. NMR spectra of NBD1 lacking the N-terminal tail, NBD1-Delta N, suggest that phosphorylation disrupts interactions of the N-terminal tail with the core of NBD1, a model supported by dynamic light scattering. Increased nucleotide binding of phosphorylated NBD1 and NBD1-Delta N, compared with non-phosphorylated NBD1, suggests that by disrupting the interaction of theNBDcore with the N-terminal tail, phosphorylation also exposes the MgATP-binding site on NBD1. These data provide insights into the molecular basis by which phosphorylation of SUR2BNBD1activates K-ATP channels.	[de Araujo, Elvin D.; Alvarez, Claudia P.; Lopez-Alonso, Jorge P.; Sooklal, Clarissa R.; Stagljar, Marijana; Kanelis, Voula] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; [de Araujo, Elvin D.; Alvarez, Claudia P.; Lopez-Alonso, Jorge P.; Sooklal, Clarissa R.; Stagljar, Marijana; Kanelis, Voula] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Lopez-Alonso, Jorge P.; Stagljar, Marijana; Kanelis, Voula] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University of Toronto	Kanelis, V (corresponding author), Univ Toronto, DV Dept Chem & Phys Sci 4042, 3359 Mississauga Rd N, Mississauga, ON L5L 1C6, Canada.	voula.kanelis@utoronto.ca	López-Alonso, Jorge Pedro/U-5551-2018	López-Alonso, Jorge Pedro/0000-0003-2081-2607	Canadian Institutes of Health Research [MOP-106470]; Natural Sciences and Engineering Council of Canada [RGPIN 357118-09]; Ontario Postdoctoral Fellowship; Ontario Ministry of Economic Development and Innovation; Canadian Institutes of Health Research New Investigator Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Postdoctoral Fellowship; Ontario Ministry of Economic Development and Innovation; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-106470 and the Natural Sciences and Engineering Council of Canada Grant RGPIN 357118-09 (to V.K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Ontario Postdoctoral Fellowship. Present address: CIC bio-GUNE, Edificio 800, Parque Tecnologico de Bizkaia, 48160 Derio (Bizkaia), Spain.; Supported by an Early Researcher Award from the Ontario Ministry of Economic Development and Innovation and a Canadian Institutes of Health Research New Investigator Award.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; [Anonymous], [No title captured]; Arakel EC, 2014, J CELL SCI, V127, P2106, DOI 10.1242/jcs.141440; Atreya HS, 2012, ADV EXP MED BIOL, V992, pV; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Chutkow WA, 1996, DIABETES, V45, P1439, DOI 10.2337/diabetes.45.10.1439; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Cuthbertson JM, 2005, PROTEIN ENG DES SEL, V18, P295, DOI 10.1093/protein/gzi032; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Araujo ED, 2014, PROTEIN EXPRES PURIF, V103, P38, DOI 10.1016/j.pep.2014.08.006; de Araujo ED, 2011, BIOCHEMISTRY-US, V50, P6655, DOI 10.1021/bi200434d; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deber C. M., 2010, PROLINE RESIDUES PRO; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Fang K, 2006, J PHYSIOL-LONDON, V576, P379, DOI 10.1113/jphysiol.2006.112748; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Grifman M, 1997, MOL BRAIN RES, V51, P179, DOI 10.1016/S0169-328X(97)00246-5; Guarnieri MT, 2011, ASSAY DRUG DEV TECHN, V9, P174, DOI 10.1089/adt.2010.0289; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hu D, 2014, INT J CARDIOL, V171, P431, DOI 10.1016/j.ijcard.2013.12.084; Hudson RP, 2012, J BIOL CHEM, V287, P28480, DOI 10.1074/jbc.M112.371138; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Kanelis V, 2011, METHODS MOL BIOL, V741, P377, DOI 10.1007/978-1-61779-117-8_25; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Karger AB, 2008, J GEN PHYSIOL, V131, P185, DOI 10.1085/jgp.200709852; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krishnarjuna B, 2011, J BIOMOL NMR, V49, P39, DOI 10.1007/s10858-010-9459-z; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Lin YF, 2008, NEUROSCIENCE, V152, P371, DOI 10.1016/j.neuroscience.2008.01.003; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Lopez-Alonso JP, 2012, BIOCHEMISTRY-US, V51, P9211, DOI 10.1021/bi301019e; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Minoretti P, 2006, CLIN CHIM ACTA, V370, P124, DOI 10.1016/j.cca.2006.02.007; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Olson TM, 2007, NAT CLIN PRACT CARD, V4, P110, DOI 10.1038/ncpcardio0792; Ortiz D, 2013, J BIOL CHEM, V288, P18894, DOI 10.1074/jbc.M113.476887; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Ribalet B, 2000, J GEN PHYSIOL, V116, P391, DOI 10.1085/jgp.116.3.391; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Roosbeek S, 2004, J BIOL CHEM, V279, P37779, DOI 10.1074/jbc.M401821200; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Shi Y, 2008, J BIOL CHEM, V283, P7523, DOI 10.1074/jbc.M709941200; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Smith KJ, 2013, INT J CARDIOL, V168, P3506, DOI 10.1016/j.ijcard.2013.04.210; Smith SP, 1997, PROTEIN SCI, V6, P1110, DOI 10.1002/pro.5560060518; Stolarczyk EI, 2011, CURR PHARM BIOTECHNO, V12, P621; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P10925, DOI 10.1021/bi00202a011; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yamada M, 2004, MOL PHARMACOL, V66, P807, DOI 10.1124/mol.104.002717; Yuan Y. R., 2001, J BIOL CHEM, V276, P32313; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	96	11	11	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22699	22714		10.1074/jbc.M114.636233	http://dx.doi.org/10.1074/jbc.M114.636233			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26198630	hybrid, Green Published			2022-12-26	WOS:000361171500034
J	Niizuma, K; Tahara-Hanaoka, S; Noguchi, E; Shibuya, A				Niizuma, Kouta; Tahara-Hanaoka, Satoko; Noguchi, Emiko; Shibuya, Akira			Identification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; MAST-CELL; ACTIVATING RECEPTOR; SOLUBLE FORM; CMRF-35-LIKE MOLECULE-1; FCR-GAMMA; MAIR-II; MONOCYTES; EXPRESSION; INFECTION	Recruitment of circulating monocytes and neutrophils to infection sites is essential for host defense against infections. Here, we identified a previously unannotated gene that encodes an immunoglobulin-like receptor, designated CD300H, which is located in the CD300 gene cluster. CD300H has a short cytoplasmic tail and associates with the signaling adaptor proteins, DAP12 and DAP10. CD300H is expressed on CD16(+) monocytes and myeloid dendritic cells. Ligation of CD300H on CD16(+) monocytes and myeloid dendritic cells with anti-CD300H monoclonal antibody induced the production of neutrophil chemoattractants. Interestingly, CD300H expression varied among healthy subjects, who could be classified into two groups according to "positive" and "negative" expression. Genomic sequence analysis revealed a single-nucleotide substitution (rs905709 (G -> A)) at a splice donor site on intron 1 on either one or both alleles. The International HapMap Project database has demonstrated that homozygosity for the A allele of single nucleotide polymorphism (SNP) rs905709 ("negative" expression) is highly frequent in Han Chinese in Beijing, Japanese in Tokyo, and Europeans (A/A genotype frequencies 0.349, 0.167, and 0.138, respectively) but extremely rare in Sub-Saharan African populations. Together, these results suggest that CD300H may play an important role in innate immunity, at least in populations that carry the G/G or G/A genotype of CD300H.	[Niizuma, Kouta; Tahara-Hanaoka, Satoko; Shibuya, Akira] Univ Tsukuba, Dept Immunol, Tsukuba, Ibaraki 3058575, Japan; [Noguchi, Emiko] Univ Tsukuba, Dept Med Genet, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Tahara-Hanaoka, Satoko; Shibuya, Akira] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance TARA, Tsukuba, Ibaraki 3058575, Japan; [Tahara-Hanaoka, Satoko; Noguchi, Emiko; Shibuya, Akira] Univ Tsukuba, Japan Sci & Technol Agcy, CREST, Tsukuba, Ibaraki 3058575, Japan; [Niizuma, Kouta] Univ Tsukuba, PhD Program Human Biol, Sch Integrat & Global Majors, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba	Tahara-Hanaoka, S (corresponding author), Univ Tsukuba, Dept Immunol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tokothr@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [15K15659, 15J08253] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Can I, 2008, J IMMUNOL, V180, P207, DOI 10.4049/jimmunol.180.1.207; Can I, 2008, HYBRIDOMA, V27, P59, DOI 10.1089/hyb.2007.0534; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Comas-Casellas E, 2012, J BIOL CHEM, V287, P9682, DOI 10.1074/jbc.M111.279224; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Enomoto Y, 2010, J BIOL CHEM, V285, P35274, DOI 10.1074/jbc.M110.137166; Frankenberger M, 2013, IMMUNOBIOLOGY, V218, P169, DOI 10.1016/j.imbio.2012.02.013; Fujimoto M, 2006, INT IMMUNOL, V18, P1499, DOI 10.1093/intimm/dxl083; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2014, J ALLERGY CLIN IMMUN, V133, P270, DOI 10.1016/j.jaci.2013.08.008; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; LANTZ M, 1990, J CLIN INVEST, V86, P1396, DOI 10.1172/JCI114853; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martinez-Barriocanal A, 2010, J BIOL CHEM, V285, P41781, DOI 10.1074/jbc.M110.140889; Moshkovits I, 2014, MUCOSAL IMMUNOL, V7, P292, DOI 10.1038/mi.2013.47; Nakahashi C, 2007, J IMMUNOL, V178, P765, DOI 10.4049/jimmunol.178.2.765; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Nakahashi-Oda C, 2012, BIOCHEM BIOPH RES CO, V417, P646, DOI 10.1016/j.bbrc.2011.12.025; Nakano T, 2008, MOL IMMUNOL, V45, P289, DOI 10.1016/j.molimm.2007.04.011; Nakano-Yokomizo T, 2011, J EXP MED, V208, P1661, DOI 10.1084/jem.20101623; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Phongsisay V, 2014, MOL IMMUNOL, V62, P169, DOI 10.1016/j.molimm.2014.06.012; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shibuya Akira, 2009, Immune Netw, V9, P41, DOI 10.4110/in.2009.9.2.41; Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2012, J IMMUNOL, V189, P1773, DOI 10.4049/jimmunol.1201139; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zhou YH, 1998, J IMMUNOL, V160, P4018; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V289, P135, DOI 10.1016/j.cellimm.2014.03.019; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	50	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22298	22308		10.1074/jbc.M115.643361	http://dx.doi.org/10.1074/jbc.M115.643361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26221034	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000360968500045
J	Xu, GF; Shang, D; Zhang, ZP; Shaw, TS; Ran, YL; Lopez, JA; Peng, YD				Xu, Guofeng; Shang, Dan; Zhang, Zuping; Shaw, Tanner S.; Ran, Yali; Lopez, Jose A.; Peng, Yuandong			The Transmembrane Domains of beta and IX Subunits Mediate the Localization of the Platelet Glycoprotein Ib-IX Complex to the Glycosphingolipid-enriched Membrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; BERNARD-SOULIER-SYNDROME; RECEPTOR GAMMA-CHAIN; LIPID RAFTS; V COMPLEX; CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; ALPHA; ACTIVATION; BINDING	We have previously reported that the structural elements of the GP Ib-IX complex required for its localization to glycosphingolipid- enriched membranes (GEMs) reside in the Ib beta and IX subunits. To identify them, we generated a series of cell lines expressing mutant GP Ib beta and GP IX where 1) the cytoplasmic tails (CTs) of either or both GP Ib beta and IX are truncated, and 2) the transmembrane domains (TMDs) of GP Ib beta and GP IX were swapped with the TMD of a non-GEMs associating molecule, human transferrin receptor. Sucrose density fractionation analysis showed that the removal of either or both of the CTs from GP Ib beta and GP IX does not alter GP Ib beta-GEMs association when compared with the wild type. In contrast, swapping of the TMDs of either GP Ib beta or GP IX with that of transferrin receptor results in a significant loss (similar to 50%) of GP Ib beta from the low density GEMs fractions, with the largest effect seen in the dual TMD-replaced cells (>80% loss) when compared with the wild type cells (100% of GP Ib beta present in the GEMs fractions). Under high shear flow, the TMD-swapped cells adhere poorly to a von Willebrand factor-immobilized surface to a much lesser extent than the previously reported disulfide linkage dysfunctional GP Ib beta-expressing cells. Thus, our data demonstrate that the bundle of GP Ib beta and GP IX TMDs instead of their individual CTs is the structural element that mediates the beta/IX complex localization to the membrane GEMs, which through the alpha/beta disulfide linkage brings GP Ib beta into the GEMs.	[Xu, Guofeng] Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Shanghai 200092, Peoples R China; [Shang, Dan] Huazhong Univ Sci & Technol, Dept Vasc Surg, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China; [Zhang, Zuping] Cent S Univ, Sch Basic Med, Changsha 410013, Hunan, Peoples R China; [Lopez, Jose A.] Univ Washington, Dept Med, Puget Sound Blood Ctr, Div Hematol, Seattle, WA 98195 USA; [Xu, Guofeng; Shang, Dan; Zhang, Zuping; Shaw, Tanner S.; Ran, Yali; Peng, Yuandong] Baylor Coll Med, Dept Med, Cardiovasc Res Sect, Houston, TX 77030 USA	Shanghai Jiao Tong University; Huazhong University of Science & Technology; Central South University; Puget Sound Blood Center; University of Washington; University of Washington Seattle; Baylor College of Medicine	Peng, YD (corresponding author), Baylor Coll Med, Dept Med, One Baylor Plaza,Alkek N1317-06, Houston, TX 77030 USA.	Yuandong@bcm.edu		Zhang, Zuping/0000-0002-3295-2861	American Heart Association [0635155N]; National Institute of Health [HL095676]; Alkek Endowment Fund; Fondren Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095676] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alkek Endowment Fund; Fondren Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by American Heart Association Scientist Development Grant 0635155N (to Y. P.), National Institute of Health Grant HL095676 (to Y. P.), and funds from the Alkek Endowment Fund (to Y. P.) and the Fondren Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Andrews RK, 2001, BLOOD, V98, P681, DOI 10.1182/blood.V98.3.681; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chen ZZ, 2008, BIOPHYS J, V95, P1303, DOI 10.1529/biophysj.108.132324; DU XP, 1994, J BIOL CHEM, V269, P18287; DU XP, 1987, BLOOD, V69, P1524; Falati S, 1999, BLOOD, V94, P1648, DOI 10.1182/blood.V94.5.1648.417k31_1648_1656; Fredrickson BJ, 1998, BLOOD, V92, P3684, DOI 10.1182/blood.V92.10.3684.422k39_3684_3693; Geng HQ, 2011, J BIOL CHEM, V286, P21315, DOI 10.1074/jbc.M110.202549; Gosse JA, 2005, J IMMUNOL, V175, P2123, DOI 10.4049/jimmunol.175.4.2123; Jin W, 2007, J THROMB HAEMOST, V5, P1034, DOI 10.1111/j.1538-7836.2007.02476.x; Kasirer-Friede A, 2002, J BIOL CHEM, V277, P11949, DOI 10.1074/jbc.M108727200; Li R, 2013, J THROMB HAEMOST, V11, P605, DOI 10.1111/jth.12144; LOPEZ JA, 1995, BLOOD, V85, P1254, DOI 10.1182/blood.V85.5.1254.bloodjournal8551254; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; Lou JZ, 2008, P NATL ACAD SCI USA, V105, P13847, DOI 10.1073/pnas.0801965105; McEwan PA, 2011, BLOOD, V118, P5292, DOI 10.1182/blood-2011-05-356253; Mo X, 2009, J THROMB HAEMOST, V7, P1533, DOI 10.1111/j.1538-7836.2009.03536.x; Mo X, 2008, FEBS LETT, V582, P3270, DOI 10.1016/j.febslet.2008.08.036; Mo X, 2006, J BIOL CHEM, V281, P23050, DOI 10.1074/jbc.M600924200; Mo X, 2010, J BIOL CHEM, V285, P32096, DOI 10.1074/jbc.M110.111864; Mu FT, 2010, J THROMB HAEMOST, V8, P324, DOI 10.1111/j.1538-7836.2009.03672.x; Peng YD, 2005, BLOOD, V106, P1982, DOI 10.1182/blood-2005-02-0514; Peng YD, 2004, BLOOD, V104, P3971, DOI 10.1182/blood-2004-07-2544; PERSCHL A, 1995, J CELL SCI, V108, P1033; Pradhan S, 2013, J THROMB HAEMOST, V11, P1612, DOI 10.1111/jth.12329; Quinton TM, 2005, J THROMB HAEMOST, V3, P1036, DOI 10.1111/j.1538-7836.2005.01325.x; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Shen Y, 2006, J BIOL CHEM, V281, P26419, DOI 10.1074/jbc.M604296200; Shrimpton CN, 2002, J EXP MED, V196, P1057, DOI 10.1084/jem.20020143; Sullam PM, 1998, J BIOL CHEM, V273, P5331, DOI 10.1074/jbc.273.9.5331; van der Wal DE, 2010, THROMB HAEMOSTASIS, V103, P1033, DOI 10.1160/TH09-11-0751; Vial C, 2006, BIOCHEM BIOPH RES CO, V343, P415, DOI 10.1016/j.bbrc.2006.02.174; Wu Y, 2001, BLOOD, V97, P3836, DOI 10.1182/blood.V97.12.3836; Zhang W, 2015, BLOOD, V125, P562, DOI 10.1182/blood-2014-07-589507; Zhou L, 2014, J THROMB HAEMOST, V12, P82, DOI 10.1111/jth.12437	38	2	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22155	22162		10.1074/jbc.M115.668145	http://dx.doi.org/10.1074/jbc.M115.668145			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26203189	Green Published, hybrid			2022-12-26	WOS:000360968500032
J	Chen, G; Yang, LH; Jin, MJ; Du, PF; Zhang, C; Wang, J; Shao, H; Jin, F; Zheng, LF; Wang, SS; She, YX; Wang, J				Chen, Ge; Yang, Lihua; Jin, Maojun; Du, Pengfei; Zhang, Chan; Wang, Jian; Shao, Hua; Jin, Fen; Zheng, Lufei; Wang, Shanshan; She, Yongxin; Wang, Jing			The Rapid Screening of Triazophos Residues in Agricultural Products by Chemiluminescent Enzyme Immunoassay	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY PRODUCTION; LINKED-IMMUNOSORBENT-ASSAY; HAPTEN SYNTHESIS; SPECTROMETRY	A highly sensitive chemiluminescent enzyme immunoassay (CLEIA) method was developed in this study for efficient screening of triazophos residues in a large number of samples. Based on the maximum residue limits (MRLs) set by China and CAC for triazophos in different agro-products, the representative apple, orange, cabbage, zucchini, and rice samples were selected as spiked samples, and the triazophos at the concentrations of the MRL values were spiked to blank samples. Subsequently, the five samples with the spiked triazophos standard were measured by CLEIA 100 times, and the detection results indicated that the correction factors of the apple, orange, cabbage, zucchini, and rice were determined as 0.79, 0.66, 0.85, 0.76, and 0.91, respectively. In this experiment, 1500 real samples were detected by both the CLEIA and the GC-MS methods. With the GC-MS method, 1462 samples were identified as negative samples and 38 samples as positive samples. Based on the correction factors, the false positive rate of the CLEIA method was 0.13%, and false negative rate was 0. The results showed that the established CLEIA method could be used to screen a large number of real samples.	[Chen, Ge; Yang, Lihua; Jin, Maojun; Du, Pengfei; Zhang, Chan; Wang, Jian; Shao, Hua; Jin, Fen; Zheng, Lufei; Wang, Shanshan; She, Yongxin; Wang, Jing] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Jin, MJ (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100081, Peoples R China.	katonking@163.com; w_jing2001@126.com		Jin, Maojun/0000-0002-9102-8572	National Natural Science Foundation of China [31201371]; National key foundation for exploring scientific instrument [2013YQ140371]; Chinese Public Interest Industrial Science & Technology Project [201203094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key foundation for exploring scientific instrument; Chinese Public Interest Industrial Science & Technology Project	This study was supported by the National Natural Science Foundation of China (31201371), National key foundation for exploring scientific instrument (2013YQ140371), Chinese Public Interest Industrial Science & Technology Project (201203094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2015, FOOD AGR IMMUNOL, V26, P1, DOI 10.1080/09540105.2013.858663; [楚金申 CHU Jinshen], 2011, [食品科学, Food Science], V32, P124; [龚云飞 Gong Yunfei], 2014, [食品工业科技, Science & Technology of Food Industry], V35, P66; He ZY, 2015, FOOD CHEM, V169, P372, DOI 10.1016/j.foodchem.2014.07.102; Jiang JQ, 2012, J FOOD SCI, V77, pT63, DOI 10.1111/j.1750-3841.2011.02578.x; Jin MaoJun, 2014, Journal of Food Safety and Quality, V5, P840; Jin MJ, 2013, FOOD AGR IMMUNOL, V24, P345, DOI 10.1080/09540105.2012.694096; Jin MJ, 2012, J FOOD SCI, V77, pT99, DOI 10.1111/j.1750-3841.2012.02659.x; Jin RenYao, 2006, Journal of Zhejiang University (Agriculture and Life Sciences), V32, P591; Kim BM, 2007, B KOREAN CHEM SOC, V28, P929; Li PL, 2013, CHIN RES PERSP SOC, V1, P1; [李培武 Li Peiwu], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P3618; Liang CZ, 2013, FOOD AGR IMMUNOL, V24, P9, DOI 10.1080/09540105.2011.639065; Liu YH, 2013, J FOOD SCI, V78, pT372, DOI 10.1111/1750-3841.12017; Ruan ED, 2014, RAPID COMMUN MASS SP, V28, P2723, DOI 10.1002/rcm.7058; STARRATT AN, 1977, CAN J CHEM, V55, P4238, DOI 10.1139/v77-601; Tao XQ, 2014, LUMINESCENCE, V29, P301, DOI 10.1002/bio.2544; Tian Jie, 2013, Journal of Zhejiang University (Agriculture and Life Sciences), V39, P513; Torres OB, 2014, ANAL BIOANAL CHEM, V406, P5927, DOI 10.1007/s00216-014-8035-x; Wang ZH, 2015, FOOD CHEM, V171, P98, DOI 10.1016/j.foodchem.2014.08.104; Wijaya W, 2014, J FOOD SCI, V79, pT743, DOI 10.1111/1750-3841.12391; Wu J, 2014, J AGR FOOD CHEM, V62, P7078, DOI 10.1021/jf5015395; Wu YJ, 2011, SPECTROCHIM ACTA A, V81, P544, DOI 10.1016/j.saa.2011.06.047; [杨丽华 Yang Lihua], 2014, [分析测试学报, Journal of Instrumental Analysis], V33, P758; Yu F, 2014, FOOD CHEM, V149, P71, DOI 10.1016/j.foodchem.2013.10.024; Zhao JY, 2014, FOOD AGR IMMUNOL, V25, P350, DOI 10.1080/09540105.2013.797385	26	14	14	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133839	10.1371/journal.pone.0133839	http://dx.doi.org/10.1371/journal.pone.0133839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218576	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900050
J	Ladur, AN; Colvin, CJ; Stinson, K				Ladur, Alice Norah; Colvin, Christopher J.; Stinson, Kathryn			Perceptions of Community Members and Healthcare Workers on Male Involvement in Prevention of Mother-To-Child Transmission Services in Khayelitsha, Cape Town, South Africa	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; FOLLOW-UP; HIV; PROGRAMS; WOMEN	Involving male partners of pregnant women accessing PMTCT programs has the potential to improve health outcomes for women and children. This study explored community members' (men and women) and healthcare workers' perceptions of male involvement in the prevention of mother-to-child transmission of HIV in Khayelitsha, South Africa. Two focus group discussions were held with 25 men of unknown HIV status and one focus group discussion held with 12 HIV-positive women in the community. In depth interviews were conducted with four HIV-positive couples and five service providers purposely sampled from the community and a health facility, respectively. Both men and women interviewed in this study were receptive towards male involvement in PMTCT. However, men were reluctant to engage with health services due to stigma and negative attitudes from nurses. This study also found HIV testing, disclosure and direct health worker engagement with men increases male involvement in PMTCT. Using men in the media and community to reach out to fellow men with prevention messages tailored to suit specific audiences may reduce perceptions of antenatal care as being a woman's domain.	[Ladur, Alice Norah; Colvin, Christopher J.; Stinson, Kathryn] Univ Cape Town, CIDER, ZA-7925 Cape Town, South Africa; [Ladur, Alice Norah] Africa Renewal Univ, Dept Community Hlth, Kampala, Uganda	University of Cape Town	Ladur, AN (corresponding author), Univ Cape Town, CIDER, ZA-7925 Cape Town, South Africa.	aliceladur@gmail.com	Colvin, Christopher/AAQ-1607-2021; Colvin, Christopher/AAB-8276-2019	Colvin, Christopher/0000-0002-8930-7863				Abrams EJ, 2007, AM J OBSTET GYNECOL, V197, pS101, DOI 10.1016/j.ajog.2007.03.068; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; [Anonymous], 2011, MED SANS FRONTIERES; [Anonymous], 2013, 2012 NAT ANT SENT HI; Bolu O, 2007, AM J OBSTET GYNECOL, V197, pS17, DOI 10.1016/j.ajog.2007.03.082; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Dawson S, 1993, FOCUS GROUPS MANUAL; Ditekemena J, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-32; Dorrington R, 2002, POPULATION PROJECTIO; Falnes EF, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-21; Garson P., 2005, MEN THINK WE BRING D; Goga A, 2010, EVALUATION EFFECTIVE; Greenwood N, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-107; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Homsy J, 2006, JAIDS-J ACQ IMM DEF, V42, P149, DOI 10.1097/01.qai.0000225032.52766.c2; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Larsson EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037590; Larsson EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-769; Montgomery CM, 2006, SOC SCI MED, V62, P2411, DOI 10.1016/j.socscimed.2005.10.026; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Msuya Sia E, 2006, AIDS Res Ther, V3, P27, DOI 10.1186/1742-6405-3-27; National Department of Health of South Africa, 2014, NAT CONS GUID PREV M; National Department of Health [South Africa], 2008, POL GUID IMPL PMTCT; Peacock D., 2004, International Journal of Men's Health, V3, P173, DOI 10.3149/jmh.0303.173; Peacock D, 2003, JOINT UN PROGR HIV A; Peacock D., 2008, MEN CARE CONTEXT HIV; Peltzer K, 2008, J ASSOC NURSE AIDS C, V19, P450, DOI 10.1016/j.jana.2008.05.006; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Technau KG, 2014, JAIDS-J ACQ IMM DEF, V65, pE170, DOI 10.1097/QAI.0000000000000068; Theuring S, 2009, AIDS CARE, P1562; Traore AT, 2009, SOC SCI MED, V69, P830, DOI 10.1016/j.socscimed.2009.06.001; Trieu Nguyen Ngoc, 2010, MALE INVOLVEMENT PMT; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; Van Rossem R, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-352; Yin R.K., 2017, APPL CASE STUDY RES	37	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133239	10.1371/journal.pone.0133239	http://dx.doi.org/10.1371/journal.pone.0133239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218065	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900023
J	Siu, MKY; Kong, DSH; Ngai, SYP; Chan, HY; Jiang, LL; Wong, ESY; Liu, SS; Chan, KKL; Ngan, HYS; Cheung, ANY				Siu, Michelle K. Y.; Kong, Daniel S. H.; Ngai, Sheila Y. P.; Chan, Hoi Yan; Jiang, Lili; Wong, Esther S. Y.; Liu, Stephanie S.; Chan, Karen K. L.; Ngan, Hextan Y. S.; Cheung, Annie N. Y.			p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GROUP-II PAKS; CYCLIN D1; PHOSPHORYLATION; EXPRESSION; ACTIVATION; CARCINOMA; MIGRATION; INVASION; CONTRIBUTES	p21-activated kinases (Paks) are serine/threonine protein kinases involved in biological events linked to malignant tumor progression. In this study, expression of Pak1, p-Pak2 Ser(20), Pak4, pPak4 Ser(474) in 21 normal endometrium, 16 hyperplastic endometrium without atypia, 17 atypical complex hyperplasia and 67 endometrial cancers was assessed by immunohistochemistry and correlated with clinicopathological parameters. We also accessed the proliferative role and downstream targets of Pak1 in endometrial cancer. Pak1 was expressed in cytoplasm whereas Pak4 and p-Pak4 were expressed in both cytoplasm and nucleus of endometrial tissues. In normal endometrium, significantly higher Pak1 (P = 0.028) and cytoplasmic p-Pak2 (P = 0.048) expression was detected in proliferative endometrium than secretory endometrium. Pak1, cytoplasmic and nuclear Pak4 and nuclear p-Pak4 was significantly overexpressed in endometrial cancer when compared to atrophic endometrium (all P<0.05). Moreover, type I endometrioid carcinomas showed significantly higher Pak1 expression than type II non-endometrioid carcinomas (P<0.001). On the other hand, Pak1, Pak4 and p-Pak4 expression negatively correlated with histological grade (all P<0.05) while p-Pak2 and cytoplasmic Pak4 expression inversely correlated with myometrial invasion (all P<0.05). Furthermore, patients with endometrial cancers with lower cytoplasmic Pak4 expression showed poorer survival (P = 0.026). Multivariate analysis showed cytoplasmic Pak4 is an independent prognostic factor. Functionally, knockdown of Pak1, but not Pak4, in endometrial cancer cell line led to reduced cell proliferation along with reduced cyclin D1, estrogen receptor (ER alpha) and progestogen receptor (PR) expression. Significant correlation between Pak1 and PR expression was also detected in clinical samples. Our findings suggest that Pak1 and cytoplasmic p-Pak2 may promote cell proliferation in normal endometrium during menstral cycle. Pak1, cytoplasmic and nuclear Pak4 and nuclear p-Pak4 are involved in the pathogenesis of endometrial cancer especially in postmenopausal women. Pak1 promote endometrial cancer cell proliferation, particular in type I endometrioid carcinoma. Cytoplasmic Pak4 can be potential prognostic marker in endometrial cancer.	[Siu, Michelle K. Y.; Kong, Daniel S. H.; Ngai, Sheila Y. P.; Chan, Hoi Yan; Jiang, Lili; Wong, Esther S. Y.; Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Siu, Michelle K. Y.; Liu, Stephanie S.; Chan, Karen K. L.; Ngan, Hextan Y. S.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Siu, MKY (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	mkysiu@hkucc.hku.hk; anycheun@hkucc.hku.hk	Cheung, Annie Nga Yin/C-4231-2009	Cheung, Annie Nga Yin/0000-0002-1584-7568; Ngan, Hextan Y S/0000-0003-3945-159X	Hong Kong Anti-Cancer Society Grant; University of Hong Kong Small Project Funding; Conference and Research Council Grant	Hong Kong Anti-Cancer Society Grant; University of Hong Kong Small Project Funding; Conference and Research Council Grant	This study was supported by the Hong Kong Anti-Cancer Society Grant, the University of Hong Kong Small Project Funding and the Conference and Research Council Grant.	Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025; Balasenthil S, 2004, FEBS LETT, V567, P243, DOI 10.1016/j.febslet.2004.04.071; Begum A, 2009, CANCER SCI, V100, P1908, DOI 10.1111/j.1349-7006.2009.01252.x; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Jiang LL, 2011, CLIN CANCER RES, V17, P6924, DOI 10.1158/1078-0432.CCR-11-0588; Kamelle S, 2002, FERTIL STERIL, V78, P596, DOI 10.1016/S0015-0282(02)03302-2; Kim SH, 2009, HUM REPROD, V24, P1133, DOI 10.1093/humrep/den484; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Liao XY, 2009, MODERN PATHOL, V22, P839, DOI 10.1038/modpathol.2009.45; Mazumdar A, 2003, FEBS LETT, V535, P6, DOI 10.1016/S0014-5793(02)03846-2; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Nikaido T, 1996, CANCER, V78, P1248, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1248::AID-CNCR12>3.3.CO;2-U; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Shabani N, 2007, EUR J CANCER, V43, P2434, DOI 10.1016/j.ejca.2007.08.014; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Siu MKY, 2013, ONCOGENE, V32, P3500, DOI 10.1038/onc.2012.363; Siu MKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047201; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Siu MKY, 2010, AM J PATHOL, V176, P3015, DOI 10.2353/ajpath.2010.091263; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Tao J, 2011, MOL ENDOCRINOL, V25, P1565, DOI 10.1210/me.2011-0062; Thiel DA, 2002, CURR BIOL, V12, P1227, DOI 10.1016/S0960-9822(02)00931-4; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wong OG, 2010, OBSTET GYNECOL INT, DOI [10.1155/2010/682504, DOI 10.1155/2010/682504]; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	36	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133467	10.1371/journal.pone.0133467	http://dx.doi.org/10.1371/journal.pone.0133467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218748	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900031
J	Zhang, TW; Zhang, L; Fan, SQ; Zhang, MZ; Fu, HH; Liu, YJ; Yin, XL; Chen, H; Xie, L; Zhang, JC; Gavine, PR; Gu, Y; Ni, XZ; Su, XY				Zhang, Tianwei; Zhang, Lin; Fan, Shuqiong; Zhang, Meizhuo; Fu, Haihua; Liu, Yuanjie; Yin, Xiaolu; Chen, Hao; Xie, Liang; Zhang, Jingchuan; Gavine, Paul R.; Gu, Yi; Ni, Xingzhi; Su, Xinying			Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity	PLOS ONE			English	Article							CELL LUNG-CANCER; POTENTIAL THERAPEUTIC TARGET; FGFR2 GENE AMPLIFICATION; GROWTH-FACTOR RECEPTORS; C-MET INHIBITOR; JUNCTION ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE; ESTABLISHMENT; HER2; EXPRESSION	Patient-derived cancer xenografts (PDCX) generally represent more reliable models of human disease in which to evaluate a potential drugs preclinical efficacy. However to date, only a few patient-derived gastric cancer xenograft (PDGCX) models have been reported. In this study, we aimed to establish additional PDGCX models and to evaluate whether these models accurately reflected the histological and genetic diversities of the corresponding patient tumors. By engrafting fresh patient gastric cancer (GC) tissues into immune-compromised mice (SCID and/or nude mice), thirty two PDGCX models were established. Histological features were assessed by a qualified pathologist based on H&E staining. Genomic comparison was performed for several biomarkers including ERBB1, ERBB2, ERBB3, FGFR2, MET and PTEN. These biomarkers were profiled to assess gene copy number by fluorescent in situ hybridization (FISH) and/or protein expression by immunohistochemistry (IHC). All 32 PDGCX models retained the histological features of the corresponding human tumors. Furthermore, among the 32 models, 78% (25/32) highly expressed ERBB1 (EGFR), 22% (7/32) were ERBB2 (HER2) positive, 78% (25/32) showed ERBB3 (HER3) high expression, 66% (21/32) lost PTEN expression, 3% (1/32) harbored FGFR2 amplification, 41% (13/32) were positive for MET expression and 16% (5/32) were MET gene amplified. Between the PDGCX models and their parental tumors, a high degree of similarity was observed for FGFR2 and MET gene amplification, and also for ERBB2 status (agreement rate = 94 similar to 100%; kappa value = 0.81 similar to 1). Protein expression of PTEN and MET also showed moderate agreement (agreement rate = 78%; kappa value = 0.46 similar to 0.56), while ERBB1 and ERBB3 expression showed slight agreement (agreement rate = 59 similar to 75%; kappa value = 0.18 similar to 0.19). ERBB2 positivity, FGFR2 or MET gene amplification was all maintained until passage 12 in mice. The stability of the molecular profiles observed across subsequent passages within the individual models provides confidence in the utility and translational significance of these models for in vivo testing of personalized therapies.	[Zhang, Tianwei; Zhang, Lin; Fan, Shuqiong; Fu, Haihua; Liu, Yuanjie; Yin, Xiaolu; Xie, Liang; Zhang, Jingchuan; Gavine, Paul R.; Gu, Yi; Su, Xinying] AstraZeneca R&D, Asia & Emerging Markets iMed, Shanghai, Peoples R China; [Zhang, Meizhuo] AstraZeneca R&D, Res & Dev Informat, Shanghai, Peoples R China; [Chen, Hao; Ni, Xingzhi] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China	AstraZeneca; AstraZeneca; Shanghai Jiao Tong University	Ni, XZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China.	georgeniwjc@163.com; Xinying.Su@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	This study is fully funded by AstraZeneca. To clarify, AstraZeneca authors were fully involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CANCER DISCOV, V4, P752, DOI 10.1158/2159-8290.CD-NB2014-069; Asaoka Y, 2011, EXPERT OPIN INV DRUG, V20, P595, DOI 10.1517/13543784.2011.566863; Bang YJ, 2010, LANCET, V376, P1302; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Burgenske DM, 2014, AM J CANCER RES, V4, P824; Carneiro F, 2000, CANCER, V88, P238, DOI 10.1002/(SICI)1097-0142(20000101)88:1<238::AID-CNCR31>3.0.CO;2-F; Chen H, 2015, PATHOL ONCO IN PRESS; Cho EY, 2013, MODERN PATHOL, V26, P677, DOI 10.1038/modpathol.2012.205; Cho YB, 2014, J SURG RES, V187, P502, DOI 10.1016/j.jss.2013.11.010; Chong ML, 2014, INT J CANCER, V134, P1232, DOI 10.1002/ijc.28444; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; de Mello RA, 2013, WORLD J GASTROENTERO, V19, P6165, DOI 10.3748/wjg.v19.i37.6165; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Gavine PR, 2015, MOL ONCOL, V9, P323, DOI 10.1016/j.molonc.2014.08.015; Ha SY, 2013, MODERN PATHOL, V26, P1632, DOI 10.1038/modpathol.2013.108; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Hong L, 2013, EXPERT REV GASTROENT, V7, P759, DOI 10.1586/17474124.2013.837804; Ilie M, 2014, CANC MED IN PRESS; Iveson T, 2014, LANCET ONCOL, V15, P1007, DOI 10.1016/S1470-2045(14)70023-3; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Jin KT, 2012, ONCOL LETT, V3, P1052, DOI 10.3892/ol.2012.603; Jin KT, 2011, HEPATO-GASTROENTEROL, V58, P1814, DOI 10.5754/hge11136; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kang YK, 2014, INVEST NEW DRUG, V32, P355, DOI 10.1007/s10637-013-0057-2; Kawakami H, 2013, ONCOTARGET, V4, P9, DOI 10.18632/oncotarget.718; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee HE, 2013, EUR J CANCER, V49, P1448, DOI 10.1016/j.ejca.2012.10.018; Li J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-241; Lin D, 2014, ASIAN J ANDROL, V16, P407, DOI 10.4103/1008-682X.125394; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; Lu J, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0398-z; Matsumoto K, 2012, BRIT J CANCER, V106, P727, DOI 10.1038/bjc.2011.603; Mattie Mike, 2013, Neoplasia, V15, P1138; Milne ANA, 2007, HUM PATHOL, V38, P903, DOI 10.1016/j.humpath.2006.12.010; Okamoto W, 2012, MOL CANCER THER, V11, P1557, DOI 10.1158/1535-7163.MCT-11-0934; Power DG, 2010, CANCER TREAT REV, V36, P384, DOI 10.1016/j.ctrv.2010.01.005; Salgia R, 2014, CLIN CANCER RES, V20, P1666, DOI 10.1158/1078-0432.CCR-13-2070; Scott CL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00295; Stahl P, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0231-4; Su X, 2014, BRIT J CANCER, V110, P967, DOI 10.1038/bjc.2013.802; Tajiri R, 2014, HUM PATHOL, V45, P725, DOI 10.1016/j.humpath.2013.11.004; Teng LS, 2013, INT J MOL MED, V32, P1247, DOI 10.3892/ijmm.2013.1531; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Tran TN, 2013, J SURG ONCOL, V108, P113, DOI 10.1002/jso.23357; Wu XH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-180; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Yang JY, 2012, CELL BIOCHEM BIOPHYS, V62, P221, DOI 10.1007/s12013-011-9286-1; Zhang HY, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3640; Zhang JC, 2014, LAB INVEST, V94, P917, DOI 10.1038/labinvest.2014.77; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694; Zhang XC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-168; Zhu M, 2015, BRIT J CANCER, V112, P429, DOI 10.1038/bjc.2014.649; Zhu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08542	59	24	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134493	10.1371/journal.pone.0134493	http://dx.doi.org/10.1371/journal.pone.0134493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217940	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900121
J	Labedz-Maslowska, A; Lipert, B; Berdecka, D; Kedracka-Krok, S; Jankowska, U; Kamycka, E; Sekula, M; Madeja, Z; Dawn, B; Jura, J; Zuba-Surma, EK				Labedz-Maslowska, Anna; Lipert, Barbara; Berdecka, Dominika; Kedracka-Krok, Sylwia; Jankowska, Urszula; Kamycka, Elzbieta; Sekula, Malgorzata; Madeja, Zbigniew; Dawn, Buddhadeb; Jura, Jolanta; Zuba-Surma, Ewa K.			Monocyte Chemoattractant Protein-Induced Protein 1 (MCPIP1) Enhances Angiogenic and Cardiomyogenic Potential of Murine Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							INHIBITORS DECREASE PROLIFERATION; ZINC-FINGER PROTEIN; OXIDATIVE STRESS; MYOCARDIAL DYSFUNCTION; PROMOTES ANGIOGENESIS; ENDOTHELIAL-CELLS; SDF-1-CXCR4 AXIS; GENE-TRANSFER; NITRIC-OXIDE; IN-VITRO	The current evidence suggests that beneficial effects of mesenchymal stem cells (MSCs) toward myocardial repair are largely due to paracrine actions of several factors. Although Monocyte chemoattractant protein-induced protein 1 (MCPIP1) is involved in the regulation of inflammatory response, apoptosis and angiogenesis, whether MCPIP1 plays any role in stem cell-induced cardiac repair has never been examined. By employing retroviral (RV)transduced overexpression of MCPIP1, we investigated the impact of MCPIP1 on viability, apoptosis, proliferation, metabolic activity, proteome, secretome and differentiation capacity of murine bone marrow (BM) - derived MSCs. MCPIP1 overexpression enhanced angiogenic and cardiac differentiation of MSCs compared with controls as indicated by elevated expression of genes accompanying angiogenesis and cardiomyogenesis in vitro. The proangiogenic activity of MCPIP1-overexpressing MSCs (MCPIP1-MSCs) was also confirmed by increased capillary-like structure formation under several culture conditions. This increase in differentiation capacity was associated with decreased proliferation of MCPIP1-MSCs when compared with controls. MCPIP1-MSCs also expressed increased levels of proteins involved in angiogenesis, autophagy, and induction of differentiation, but not adverse inflammatory agents. We conclude that MCPIP1 enhances endothelial and cardiac differentiation of MSCs. Thus, modulating MCPIP1 expression may be a novel approach useful for enhancing the immune-regulatory, anti-apoptotic, anti-inflammatory and regenerative capacity of BM-derived MSCs for myocardial repair and regeneration of ischemic tissues.	[Labedz-Maslowska, Anna; Berdecka, Dominika; Kamycka, Elzbieta; Sekula, Malgorzata; Madeja, Zbigniew; Zuba-Surma, Ewa K.] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Krakow, Poland; [Lipert, Barbara; Jura, Jolanta] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Gen Biochem, Krakow, Poland; [Kedracka-Krok, Sylwia; Jankowska, Urszula] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland; [Kedracka-Krok, Sylwia; Jankowska, Urszula; Sekula, Malgorzata] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland; [Dawn, Buddhadeb] Univ Kansas, Med Ctr, Cardiovasc Res Inst, Div Cardiovasc Dis, Kansas City, KS 66103 USA	Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; University of Kansas; University of Kansas Medical Center	Zuba-Surma, EK (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Krakow, Poland.	ewa.zuba-surma@uj.edu.pl	Jankowska, Urszula/C-4898-2015; Jura, Jolanta/F-8889-2015; Zuba-Surma, Ewa/GZM-7140-2022; Sekuła, Małgorzata/AAA-8305-2021; Berdecka, Dominika/A-2391-2017; Berdecka, Dominika/AAP-5200-2020	Jankowska, Urszula/0000-0002-7165-8964; Jura, Jolanta/0000-0002-0816-3475; Berdecka, Dominika/0000-0003-1035-2520; Berdecka, Dominika/0000-0003-1035-2520; Labedz-Maslowska, Anna/0000-0002-8088-6221; Madeja, Zbigniew/0000-0002-5523-1215; Zuba-Surma, Ewa/0000-0001-6814-6127	National Science Centre (NCN) [N N302 177338]; Foundation for Polish Science (FNP) [TEAM-2012/9-6]; Ministry of Science and Higher Education [POIG.01.01.02-00-109/09]	National Science Centre (NCN)(National Science Centre, Poland); Foundation for Polish Science (FNP)(Foundation for Polish Science); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by 1) Grant no. N N302 177338 from National Science Centre (NCN; https://www.ncn.gov.pl) to EZS, 2) Grant no. TEAM-2012/9-6 from Foundation for Polish Science (FNP; http://www.fnp.org.pl) to EZS, and 3) Grant no. POIG.01.01.02-00-109/09 from Ministry of Science and Higher Education (http://www.nauka.gov.pl) to EZS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008576; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Baumgarten G, 2006, SHOCK, V25, P43, DOI 10.1097/01.shk.0000196498.57306.a6; Cho J, 2011, CIRC RES, V108, P478, DOI 10.1161/CIRCRESAHA.110.229658; Chugh A R, 2009, Minerva Cardioangiol, V57, P185; Davis T, 2000, CLIN CANCER RES, V6, P4334; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Fan L, 2009, EUR J HEART FAIL, V11, P1023, DOI 10.1093/eurjhf/hfp135; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hattan N, 2005, CARDIOVASC RES, V65, P334, DOI 10.1016/j.cardiores.2004.10.004; Ho TK, 2010, J VASC SURG, V51, P689, DOI 10.1016/j.jvs.2009.10.044; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Huang F, 2013, CARDIOLOGY, V125, P18, DOI 10.1159/000347081; Huang F, 2013, INT J MOL MED, V31, P484, DOI 10.3892/ijmm.2012.1200; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ikezoe T, 2000, BLOOD, V96, P3553; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kawai T, 2015, CYTOTHERAPY, V17, P369, DOI 10.1016/j.jcyt.2014.11.009; Khadour FH, 2002, AM J PHYSIOL-HEART C, V283, pH1108, DOI 10.1152/ajpheart.00549.2001; Kim JH, 2014, KOREAN J UROL, V55, P228, DOI 10.4111/kju.2014.55.4.228; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Lipert B, 2014, BBA-MOL CELL RES, V1843, P780, DOI 10.1016/j.bbamcr.2014.01.001; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; McGinley LM, 2013, HUM GENE THER, V24, P840, DOI 10.1089/hum.2011.009; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mizgalska D, 2009, FEBS J, V276, P7386, DOI 10.1111/j.1742-4658.2009.07452.x; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Morimoto H, 2008, CARDIOVASC RES, V78, P554, DOI 10.1093/cvr/cvn035; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Murphy MK, 2015, STEM CELLS, V33, P762, DOI 10.1002/stem.1890; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Niu JL, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0483-8; Niu JL, 2013, J PHARMACOL EXP THER, V347, P288, DOI 10.1124/jpet.113.207316; Niu JL, 2011, J MOL CELL CARDIOL, V51, P177, DOI 10.1016/j.yjmcc.2011.04.018; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Piao WH, 2010, ANGIOGENESIS, V13, P203, DOI 10.1007/s10456-010-9169-x; Qi DF, 2011, J BIOL CHEM, V286, P41692, DOI 10.1074/jbc.M111.276006; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Ratajczak MZ, 2006, EXP HEMATOL, V34, P986, DOI 10.1016/j.exphem.2006.03.015; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Roy A, 2012, CELL SIGNAL, V24, P2123, DOI 10.1016/j.cellsig.2012.07.014; Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200; Shi B, 2014, EXP BIOL MED, V239, P356, DOI 10.1177/1535370213517619; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Solchaga LA, 2011, METHODS MOL BIOL, V698, P253, DOI 10.1007/978-1-60761-999-4_20; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tatsumi T, 2004, J MOL CELL CARDIOL, V37, P775, DOI 10.1016/j.yjmcc.2004.06.014; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu JW, 2012, NUCLEIC ACIDS RES, V40, P6957, DOI 10.1093/nar/gks359; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111246; Zhang W, 2013, CORONARY ARTERY DIS, V24, P549, DOI 10.1097/MCA.0b013e3283640f00; Zuba-Surma EK, 2012, CIRCULATION, V126	68	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133746	10.1371/journal.pone.0133746	http://dx.doi.org/10.1371/journal.pone.0133746			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214508	gold, Green Submitted, Green Published			2022-12-26	WOS:000358594300030
J	Ahn, SY; Chang, YS; Sung, DK; Sung, SI; Yoo, HS; Im, GH; Choi, SJ; Park, WS				Ahn, So Yoon; Chang, Yun Sil; Sung, Dong Kyung; Sung, Se In; Yoo, Hye Soo; Im, Geun Ho; Choi, Soo Jin; Park, Won Soon			Optimal Route for Mesenchymal Stem Cells Transplantation after Severe Intraventricular Hemorrhage in Newborn Rats	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; MARROW STROMAL CELLS; TRAUMATIC BRAIN INJURY; BONE-MARROW; AGE; HYDROCEPHALUS; RECOVERY; OUTCOMES; THERAPY; INFANTS	Recently, we showed that intracerebroventricular (IC) transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) significantly attenuates post-hemorrhagic hydrocephalus (PHH) and brain damage after severe IVH in newborn rats. This study was performed to determine the optimal route for transplanting MSCs for severe IVH by comparing IC transplantation, intravenous (IV) transplantation, and IV transplantation plus mannitol infusion. Severe IVH was induced by injecting 100 uL of blood into each ventricle of Sprague-Dawley rats on postnatal day 4 (P4). After confirming severe IVH with brain magnetic resonance imaging (MRI) at P5, human UCB-derived MSCs were transplanted at P6 by an IC route (1x10(5)), an IV route (5x10(5)), or an IV route with mannitol infused. Follow-up brain MRIs and rotarod tests were performed. At P32, brain tissue samples were obtained for biochemical and histological analyses. Although more MSCs localized to the brain after IC than after IV delivery, both methods were equally effective in preventing PHH; attenuating impaired rotarod test; increasing the number of TUNEL-positive cells, inflammatory cytokines, and astrogliosis; and reducing corpus callosal thickness and myelin basic protein expression after severe IVH regardless of mannitol co-infusion. Despite the superior delivery efficacy with IC than with the IV route, both IC and IV transplantation of MSCs had equal therapeutic efficacy in protecting against severe IVH. These findings suggest that the less invasive IV route might be a good alternative for clinically unstable, very preterm infants that cannot tolerate a more invasive IC delivery of MSCs.	[Ahn, So Yoon; Chang, Yun Sil; Sung, Dong Kyung; Sung, Se In; Yoo, Hye Soo; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Im, Geun Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Choi, Soo Jin] MEDIPOST Co Ltd, Biomed Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; MEDIPOST	Park, WS (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea.	ws123.park@samsung.com			Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A110445]; Samsung Biomedical Research Institute grant [SMX1131761, SMX1132321]	Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Samsung Biomedical Research Institute grant(Samsung)	This work was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Number; A110445, Author; Won Soon Park) (https://www.htdream.kr/) and by a Samsung Biomedical Research Institute grant (Number; SMX1131761, Author; Won Soon Park, SMX1132321, Author; So Yoon Ahn) (http://www.skkusm.ac.kr/academics/ri.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and do not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Ahn SY, 2013, STROKE, V44, P497, DOI 10.1161/STROKEAHA.112.679092; AMTORP O, 1974, J PHYSIOL-LONDON, V243, P387, DOI 10.1113/jphysiol.1974.sp010759; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; BRAUN LD, 1980, J NEUROCHEM, V34, P147, DOI 10.1111/j.1471-4159.1980.tb04633.x; Chang YS, 2014, J PEDIATR-US, V164, P966, DOI 10.1016/j.jpeds.2013.12.011; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Choi YJ, 2010, J NEUROL SCI, V298, P28, DOI 10.1016/j.jns.2010.09.003; Delo DM, 2008, STEM CELLS DEV, V17, P1185, DOI 10.1089/scd.2008.0028; Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Hudgins RJ, 1997, PEDIATR NEUROSURG, V26, P281, DOI 10.1159/000121207; Jang YK, 2006, ANN HEMATOL, V85, P212, DOI 10.1007/s00277-005-0047-3; Kawabori M, 2012, NEUROPATHOLOGY, V32, P217, DOI 10.1111/j.1440-1789.2011.01260.x; Kennedy C, 1998, LANCET, V352, P433; Kim ES, 2012, PEDIATR RES, V72, P277, DOI 10.1038/pr.2012.71; Kingham PJ, 2014, STEM CELLS DEV, V23, P741, DOI 10.1089/scd.2013.0396; Kuchroo P, 2015, STEM CELLS DEV, V24, P437, DOI 10.1089/scd.2014.0184; LARROCHE JC, 1972, BIOL NEONATE, V20, P287; Lee JK, 2007, CELL TRANSPLANT, V16, P849, DOI 10.3727/000000007783465271; LEVENE MI, 1982, ARCH DIS CHILD, V57, P410, DOI 10.1136/adc.57.6.410; Liu R, 2013, STEM CELLS DEV, V22, P1053, DOI 10.1089/scd.2012.0463; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; MUJSCE DJ, 1990, STROKE, V21, P1210, DOI 10.1161/01.STR.21.8.1210; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Payne AH, 2013, JAMA PEDIATR, V167, P451, DOI 10.1001/jamapediatrics.2013.866; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Thorp JA, 2001, AM J OBSTET GYNECOL, V185, P859, DOI 10.1067/mob.2001.117355; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; van Velthoven CTJ, 2009, BRAIN RES REV, V61, P1, DOI 10.1016/j.brainresrev.2009.03.003; Vinukonda G, 2010, BRAIN, V133, P2264, DOI 10.1093/brain/awq107; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI 10.1111/j.1582-4934.2008.00671.x; Zawadzka M, 2009, ACTA NEUROBIOL EXP, V69, P46; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479; 1990, ARCH DIS CHILDHOOD, V65, P3	40	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132919	10.1371/journal.pone.0132919	http://dx.doi.org/10.1371/journal.pone.0132919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208299	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000046
J	Byabagambi, J; Marks, P; Megere, H; Karamagi, E; Byakika, S; Opio, A; Calnan, J; Njeuhmeli, E				Byabagambi, John; Marks, Pamela; Megere, Humphrey; Karamagi, Esther; Byakika, Sarah; Opio, Alex; Calnan, Jacqueline; Njeuhmeli, Emmanuel			Improving the Quality of Voluntary Medical Male Circumcision through Use of the Continuous Quality Improvement Approach: A Pilot in 30 PEPFAR-Supported Sites in Uganda	PLOS ONE			English	Article							HEALTH-CARE; SAFETY	Background Uganda adopted voluntary medical male circumcision (VMMC) (also called Safe Male Circumcision in Uganda), as part of its HIV prevention strategy in 2010. Since then, the Ministry of Health (MOH) has implemented VMMC mostly with support from the United States President's Emergency Plan for AIDS Relief (PEPFAR) through its partners. In 2012, two PEPFAR-led external quality assessments evaluated compliance of service delivery sites with minimum quality standards. Quality gaps were identified, including lack of standardized forms or registers, lack of documentation of client consent, poor preparedness for emergencies and use of untrained service providers. In response, PEPFAR, through a USAID-supported technical assistance project, provided support in quality improvement to the MOH and implementing partners to improve quality and safety in VMMC services and build capacity of MOH staff to continuously improve VMMC service quality. Methods and Findings Sites were supported to identify barriers in achieving national standards, identify possible solutions to overcome the barriers and carry out improvement plans to test these changes, while collecting performance data to objectively measure whether they had bridged gaps. A 53-indicator quality assessment tool was used by teams as a management tool to measure progress; teams also measured client-level indicators through self-assessment of client records. At baseline (February-March 2013), less than 20 percent of sites scored in the "good" range (>80%) for supplies and equipment, patient counseling and surgical procedure; by November 2013, the proportion of sites scoring "good" rose to 67 percent, 93 percent and 90 percent, respectively. Significant improvement was noted in post-operative follow-up at 48 hours, sexually transmitted infection assessment, informed consent and use of local anesthesia but not rate of adverse events. Conclusion Public sector providers can be engaged to address the quality of VMMC using a continuous quality improvement approach.	[Byabagambi, John; Megere, Humphrey; Karamagi, Esther] Univ Res Co LLC URC, USAID Applying Sci Strengthen & Improve Syst ASSI, Kampala, Uganda; [Marks, Pamela] Univ Res Co LLC URC, USAID Applying Sci Strengthen & Improve Syst ASSI, Bethesda, MD USA; [Byakika, Sarah; Opio, Alex] Minist Hlth, Kampala, Uganda; [Calnan, Jacqueline] US Agcy Int Dev, Hlth Team, Kampala, Uganda; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Off HIV AIDS, Global Hlth Bur, Washington, DC 20523 USA	United States Agency for International Development (USAID); United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Njeuhmeli, E (corresponding author), US Agcy Int Dev, Off HIV AIDS, Global Hlth Bur, Washington, DC 20523 USA.	enjeuhmeli@usaid.gov	Byabagambi, MD, MPH, MMS, FISQua, John/GWC-7323-2022; Byabagambi, John/GVU-6682-2022	Byabagambi, John/0000-0002-1456-3387	American people through the United States Agency for International Development (USAID); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work described in this article was supported by the American people through the United States Agency for International Development (USAID) with funding support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). It was implemented under the USAID Applying Science to Strengthen and Improve Systems (ASSIST) Project, managed by URC under the terms of Cooperative Agreement Number AIDOAAA1200101. Donor staff played an important role in the study design, data analysis, decision to publish and review of the manuscript.	Bertrand JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082518; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Franco LM, 2011, BMJ QUAL SAF, V20, P658, DOI 10.1136/bmjqs.2010.044388; Heiby JR, 2014, BJOG-INT J OBSTET GY, V121, P4, DOI 10.1111/1471-0528.12903; Herman-Roloff A, 2012, B WORLD HEALTH ORGAN, V90, P773, DOI 10.2471/BLT.12.106112; Institute for Healthcare Improvement, 2003, I HEALTHC IMPR INN S; Jennings L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079524; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Ministry of Health, 2011, MIN STAND PROC SAF M; Ministry of Health, 2011, HLTH SECT QUAL IMPR; Ministry of Health (MOH) [Uganda] and ORC Macro, 2006, UG HIV AIDS SER BEH; Ministry of Health Uganda, 2010, SAF MAL CIRC POL; Muula Adamson S, 2007, BMC Urol, V7, P4, DOI 10.1186/1471-2490-7-4; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Perla RJ, 2011, BMJ QUAL SAF, V20, P46, DOI 10.1136/bmjqs.2009.037895; Presidential Emergency Plan For AIDS Relief (PEPFAR), 2012, PREL FIND EXT QUAL A; Rech D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084271; Taylor MJ, 2014, BMJ QUAL SAF, V23, P290, DOI 10.1136/bmjqs-2013-001862; Uganda Ministry of Health and ICF International, 2012, 2011 UG AIDS IND SUR; WHO/UNAIDS Technical Consultation, 2007, MAL CIRC HIV PREV RE; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85; World Health Organization, 2009, MAL CIRC SERV QUAL A	22	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133369	10.1371/journal.pone.0133369	http://dx.doi.org/10.1371/journal.pone.0133369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207986	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000083
J	Kang, HR; Lee, YA; Kim, YH; Lee, DG; Kim, BJ; Kim, KJ; Kim, BG; Oh, MG; Han, CK; Lee, S; Ryu, BY				Kang, Hye-Ryun; Lee, Yong-An; Kim, Yong-Hee; Lee, Dong Gu; Kim, Bang-Jin; Kim, Ki-Jung; Kim, Byung-Gak; Oh, Myeong-Geun; Han, Chan Kyu; Lee, Sanghyun; Ryu, Buom-Yong			Petasites japonicus Stimulates the Proliferation of Mouse Spermatogonial Stem Cells	PLOS ONE			English	Article							JAPANESE HERBAL MEDICINE; FUNCTIONAL-CHARACTERISTICS; SELF-RENEWAL; EXTRACTS	Oriental natural plants have been used as medical herbs for the treatment of various diseases for over 2,000 years. In this study, we evaluated the effect of several natural plants on the preservation of male fertility by assessing the ability of plant extracts to stimulate spermatogonial stem cell (SSC) proliferation by using a serum-free culture method. In vitro assays showed that Petasites japonicus extracts, especially the butanol fraction, have a significant effect on germ cells proliferation including SSCs. The activity of SSCs cultured in the presence of the Petasites japonicus butanol fraction was confirmed by normal colony formation and spermatogenesis following germ cell transplantation of the treated SSCs. Our findings could lead to the discovery of novel factors that activate SSCs and could be useful for the development of technologies for the prevention of male infertility.	[Kang, Hye-Ryun; Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Ki-Jung; Oh, Myeong-Geun; Ryu, Buom-Yong] Chung Ang Univ, Dept Anim Sci & Technol, Ansong, South Korea; [Lee, Dong Gu; Lee, Sanghyun] Chung Ang Univ, Dept Integrat Plant Sci, Ansong, South Korea; [Kim, Byung-Gak] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Van Andel Inst, Grand Rapids, MI USA; [Han, Chan Kyu] Korea Food Res Inst, Songnam, South Korea	Chung Ang University; Chung Ang University; Michigan State University; Van Andel Institute; Korea Food Research Institute (KFRI)	Ryu, BY (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Ansong, South Korea.	byryu@cau.ac.kr		Lee, Yong-An/0000-0001-7253-2397	Korea Food Research Institute, Republic of Korea [ER142023887]; Excellent Student Scholarship (CAU) from Chung-Ang University, Republic of Korea	Korea Food Research Institute, Republic of Korea; Excellent Student Scholarship (CAU) from Chung-Ang University, Republic of Korea	This work was supported by the fund of Korea Food Research Institute (ER142023887), Republic of Korea. HRK YAL YHK DGL BJK KJK BGK MGO CKH SL BYR received the funding above for this work. MGO was supported by the Excellent Student Scholarship 2015 (CAU2015) from Chung-Ang University, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte PM, 2005, APMIS, V113, P727, DOI 10.1111/j.1600-0463.2005.apm_302.x; Bickford PC, 2006, STEM CELLS DEV, V15, P118, DOI 10.1089/scd.2006.15.118; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chignell CF, 2007, PHOTOCHEM PHOTOBIOL, V83, P938, DOI 10.1111/j.1751-1097.2007.00086.x; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cui HS, 2005, J AGR FOOD CHEM, V53, P8526, DOI 10.1021/jf051595q; de Kretser DM, 1998, HUM REPROD, V13, P1; Debrunner B, 1998, Pharm Acta Helv, V72, P359, DOI 10.1016/S0031-6865(97)00027-7; Deters AM, 2012, J ETHNOPHARMACOL, V142, P438, DOI 10.1016/j.jep.2012.05.014; Engel N, 2011, J ETHNOPHARMACOL, V137, P1003, DOI 10.1016/j.jep.2011.07.023; Grabowska-Joachimiak A, 2011, CYTOGENET GENOME RES, V132, P203, DOI 10.1159/000321584; Hisha H, 1997, BLOOD, V90, P1022, DOI 10.1182/blood.V90.3.1022.1022_1022_1030; Hisha H, 2002, STEM CELLS, V20, P311, DOI 10.1634/stemcells.20-4-311; Holehouse EL, 1998, BBA-LIPID LIPID MET, V1390, P52, DOI 10.1016/S0005-2760(97)00176-8; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lee DY, 2009, J ETHNOPHARMACOL, V123, P149, DOI 10.1016/j.jep.2009.02.009; Lee JS, 2011, J ETHNOPHARMACOL, V133, P551, DOI 10.1016/j.jep.2010.10.038; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Nembo EN, 2014, J ETHNOPHARMACOL, V156, P73, DOI 10.1016/j.jep.2014.07.046; Ng TB, 2003, COMP BIOCHEM PHYS C, V136, P109, DOI 10.1016/S1532-0456(03)00170-4; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Paul C, 2013, NAT REV UROL, V10, P227, DOI 10.1038/nrurol.2013.18; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Schmidt S, 2013, J ETHNOPHARMACOL, V150, P85, DOI 10.1016/j.jep.2013.08.013; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132; vanPelt AMM, 1996, BIOL REPROD, V55, P439, DOI 10.1095/biolreprod55.2.439; Wang SN, 2013, FOOD CHEM, V141, P2075, DOI 10.1016/j.foodchem.2013.04.116; Yeap SK, 2007, J ETHNOPHARMACOL, V114, P406, DOI 10.1016/j.jep.2007.08.020	36	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133077	10.1371/journal.pone.0133077	http://dx.doi.org/10.1371/journal.pone.0133077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207817	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000061
J	Raman, K; Wang, HQ; Troncone, MJ; Khan, WI; Pare, G; Terry, J				Raman, Kripa; Wang, Huaqing; Troncone, Michael J.; Khan, Waliul I.; Pare, Guillaume; Terry, Jefferson			Overlap Chronic Placental Inflammation Is Associated with a Unique Gene Expression Pattern	PLOS ONE			English	Article							B-CELL DEVELOPMENT; UNKNOWN ETIOLOGY; FETOMATERNAL INTERFACE; IMMUNE-SYSTEM; VILLITIS; CHORIOAMNIONITIS; MICROARRAY; TOLERANCE; PREGNANCY; REJECTION	Breakdown of the balance between maternal pro- and anti-inflammatory pathways is thought to allow an anti-fetal maternal immune response that underlies development of chronic placental inflammation. Chronic placental inflammation is manifested by the influx of maternal inflammatory cells, including lymphocytes, histiocytes, and plasma cells, into the placental membranes, villi, and decidua. These infiltrates are recognized pathologically as chronic chorioamnionitis, chronic villitis of unknown etiology, and chronic deciduitis. Each of these histological entities is associated with adverse fetal outcomes including intrauterine growth restriction and preterm birth. Studying the gene expression patterns in chronically inflamed placenta, particularly when overlapping histologies are present, may lead to a better understanding of the underlying mechanism(s). Therefore, this study compared tissue with and without chronic placental inflammation, manifested as overlapping chronic chorioamnionitis, chronic villitis of unknown etiology, and chronic deciduitis. RNA expression profiling was conducted on formalin fixed, paraffin embedded placental tissue using Illumina microarrays. IGJ was the most significant differentially expressed gene identified and had increased expression in the inflamed tissue. In addition, IGLL1, CXCL13, CD27, CXCL9, ICOS, and KLRC1 had increased expression in the inflamed placental samples. These differentially expressed genes are associated with T follicular helper cells, natural killer cells, and B cells. Furthermore, these genes differ from those typically associated with the individual components of chronic placental inflammation, such as chronic villitis, suggesting that the inflammatory infiltrate associated with overlapping chronic chorioamnionitis, chronic villitis of unknown etiology, and chronic deciduitis differs is unique. To further explore and validate gene expression findings, we conducted immunohistochemical assessment of protein level expression and demonstrate that IgJ expression was largely attributable to the presence of plasma cells as part of chronic deciduitis and that IgA positive plasma cells are associated with chronic deciduitis occurring in combination with chronic chorioamnionitis and chronic villitis of unknown etiology but not with isolated chronic deciduitis.	[Raman, Kripa; Pare, Guillaume] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Raman, Kripa; Wang, Huaqing; Troncone, Michael J.; Khan, Waliul I.; Pare, Guillaume; Terry, Jefferson] McMaster Univ, Hamilton, ON, Canada; [Raman, Kripa; Pare, Guillaume] Hamilton Hlth Sci, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Wang, Huaqing; Khan, Waliul I.; Pare, Guillaume] Hamilton Hlth Sci, Famcombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Wang, Huaqing; Troncone, Michael J.; Khan, Waliul I.; Terry, Jefferson] Hamilton Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University	Terry, J (corresponding author), Hamilton Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada.	terryj@hhsc.ca	Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760; Terry, Jefferson/0000-0001-5464-8679	Hamilton Health Sciences New Investigator Fund	Hamilton Health Sciences New Investigator Fund	Funding for this work is provided by the Hamilton Health Sciences New Investigator Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Ben-Hur H, 2001, IN VIVO, V15, P429; Billingham RE, 2010, J IMMUNOL, V184, P5, DOI 10.4049/jimmunol.0990109; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85; Edmondson N, 2009, PEDIATR DEVEL PATHOL, V12, P16, DOI 10.2350/07-04-0270.1; El Costa H, 2009, J REPROD IMMUNOL, V82, P142, DOI 10.1016/j.jri.2009.06.123; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Munoz-Fernandez R, 2012, HUM REPROD, V27, P2775, DOI 10.1093/humrep/des198; Nagamatsu T, 2011, IMMUNOL CELL BIOL, V89, P417, DOI 10.1038/icb.2010.101; Nutku E, 2003, BLOOD, V101, P5014, DOI 10.1182/blood-2002-10-3058; Ohnishi K, 2000, J BIOL CHEM, V275, P31134, DOI 10.1074/jbc.M005901200; Pinar H, 1996, PEDIATR PATHOL LAB M, V16, P901, DOI 10.1080/15513819609168713; Plancade S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-329; Redline RW, 2007, HUM PATHOL, V38, P1439, DOI 10.1016/j.humpath.2007.05.025; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; REDLINE RW, 1993, AM J PATHOL, V143, P473; Redline RW, 2004, PEDIATR DEVEL PATHOL, V7, P443, DOI 10.1007/s10024-004-2020-x; Riella LV, 2013, AM J PATHOL, V182, P2204, DOI 10.1016/j.ajpath.2013.02.014; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tamblyn JA, 2013, PLACENTA, V34, P846, DOI 10.1016/j.placenta.2013.07.002; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Waddell N, 2010, J PATHOL, V221, P452, DOI 10.1002/path.2728; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360	33	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133738	10.1371/journal.pone.0133738	http://dx.doi.org/10.1371/journal.pone.0133738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207633	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000129
J	Reed, MD; Wilder, JA; Mega, WM; Hutt, JA; Kuehl, PJ; Valderas, MW; Chew, LL; Liang, BC; Squires, CH				Reed, Matthew D.; Wilder, Julie A.; Mega, William M.; Hutt, Julie A.; Kuehl, Philip J.; Valderas, Michelle W.; Chew, Lawrence L.; Liang, Bertrand C.; Squires, Charles H.			Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; VACCINE; IMMUNOGENICITY; TOXIN; ANTIBODIES; THERAPY; ASSAY; MODEL	Protective antigen (PA), one of the components of the anthrax toxin, is the major component of human anthrax vaccine (Biothrax). Human anthrax vaccines approved in the United States and Europe consist of an alum-adsorbed or precipitated (respectively) supernatant material derived from cultures of toxigenic, non-encapsulated strains of Bacillus anthracis. Approved vaccination schedules in humans with either of these vaccines requires several booster shots and occasionally causes adverse injection site reactions. Mutant derivatives of the protective antigen that will not form the anthrax toxins have been described. We have cloned and expressed both mutant (PA SNKE167-Delta FF-315-E308D) and native PA molecules recombinantly and purified them. In this study, both the mutant and native PA molecules, formulated with alum (Alhydrogel), elicited high titers of anthrax toxin neutralizing anti-PA antibodies in New Zealand White rabbits. Both mutant and native PA vaccine preparations protected rabbits from lethal, aerosolized, B. anthracis spore challenge subsequent to two immunizations at doses of less than 1 mu g.	[Reed, Matthew D.; Wilder, Julie A.; Mega, William M.; Hutt, Julie A.; Kuehl, Philip J.; Valderas, Michelle W.] Lovelace Biomed & Environm Res Inst, Preclin Drug Dev, Albuquerque, NM USA; [Chew, Lawrence L.; Liang, Bertrand C.; Squires, Charles H.] Pfenex Inc, San Diego, CA 92121 USA	Lovelace Respiratory Research Institute	Liang, BC (corresponding author), Pfenex Inc, 10790 Roselle St, San Diego, CA 92121 USA.	bl@pfenex.com		Kuehl, Philip/0000-0002-7567-3002	BARDA contract [HHS0100201000045C]; Pfenex Inc.; United States Government's (USG) Health and Human Services Biomedical Advanced Research and Development Authority	BARDA contract; Pfenex Inc.; United States Government's (USG) Health and Human Services Biomedical Advanced Research and Development Authority	Funding was provided by BARDA contract HHS0100201000045C (http://www.phe.gov/about/barda/Pages/default.aspx). Pfenex Inc. provided support in the form of salaries for authors LLC, BCL and CHS. The specific technology focus of this U.S. Government contract necessitated scientific input from the technology provider, Pfenex Inc. The specific roles of these authors are articulated in the 'author contributions' section. Pfenex was provided funding under a technology-focused contract from the United States Government's (USG) Health and Human Services Biomedical Advanced Research and Development Authority.	Aulinger BA, 2005, INFECT IMMUN, V73, P3408, DOI 10.1128/IAI.73.6.3408-3414.2005; Bellanti JA, 2012, CLIN VACCINE IMMUNOL, V19, P140, DOI 10.1128/CVI.05556-11; Brown BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013849; Campbell JD, 2007, HUM VACCINES, V3, P205, DOI 10.4161/hv.3.5.4459; Cote CK, 2005, MICROB PATHOGENESIS, V38, P209, DOI 10.1016/j.micpath.2005.02.001; Cybulski RJ, 2009, MOL ASPECTS MED, V30, P490, DOI 10.1016/j.mam.2009.08.006; Gorse GJ, 2006, VACCINE, V24, P5950, DOI 10.1016/j.vaccine.2006.05.044; Gutting BW, 2013, J THEOR BIOL, V329, P20, DOI 10.1016/j.jtbi.2013.03.020; Gutting BW, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00087; Hering D, 2004, BIOLOGICALS, V32, P17, DOI 10.1016/j.biologicals.2003.09.003; Little SF, 2007, VACCINE, V25, P2771, DOI 10.1016/j.vaccine.2006.12.043; Little SF, 2004, VACCINE, V22, P2843, DOI 10.1016/j.vaccine.2003.12.027; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Pitt MLM, 2001, VACCINE, V19, P4768, DOI 10.1016/S0264-410X(01)00234-1; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; Retallack DM, 2012, PROTEIN EXPRES PURIF, V81, P157, DOI 10.1016/j.pep.2011.09.010; Rhie GE, 2005, FEMS IMMUNOL MED MIC, V45, P341, DOI 10.1016/j.femsim.2005.05.009; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Taft SC, 2008, CLIN VACCINE IMMUNOL, V15, P71, DOI 10.1128/CVI.00321-07; Verma A, 2013, INFECT IMMUN, V81, P278, DOI 10.1128/IAI.00863-12; Yan M, 2008, VACCINE, V26, P947, DOI 10.1016/j.vaccine.2007.11.087; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	24	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130952	10.1371/journal.pone.0130952	http://dx.doi.org/10.1371/journal.pone.0130952			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207820	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000011
J	Shi, WJ; Xu, XH; Zhang, Y; Guo, S; Wang, J; Wang, J				Shi, Wenjun; Xu, Xiaohang; Zhang, Yi; Guo, Sa; Wang, Jing; Wang, Jianjun			Epidemiology and Risk Factors of Functional Constipation in Pregnant Women	PLOS ONE			English	Article							QUALITY-OF-LIFE; UNITED-STATES; POPULATION; PREVALENCE; DEPRESSION; DEFECATION; DISORDERS; SYMPTOMS	Aim To understand the prevalence of functional constipation in pregnant women and to analyze the impact of its risk factors. Methods We searched hospital databases for women who were 37-41 weeks pregnant (1698 cases) from July 2012 to January 2014 in four hospitals in Shanghai. We reviewed factors including general data, living and eating habits, psychological history, past history of defecation in the 6 months before pregnancy and defecation after pregnancy. Data were analyzed using SPSS software. Results Pregnant women who were more than 35 years old, with a pre-pregnancy body mass index >24, who were highly educated and employed in a sedentary occupation, showed a higher prevalence of functional constipation. Multivariate logistic regression analysis indicated that the prevalence of functional constipation among pregnant women was related to age, pre-pregnancy body mass index, diet, exercise, occupation, psychological factors, threatened abortion in early pregnancy and constipation history. Conclusion The prevalence rate of functional constipation in pregnant women was significantly higher than in the general population.	[Shi, Wenjun; Xu, Xiaohang] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China; [Shi, Wenjun] Huangpu Dist Matern & Infant Hosp, Shanghai, Peoples R China; [Xu, Xiaohang; Zhang, Yi; Guo, Sa; Wang, Jing; Wang, Jianjun] Tongji Univ, Tongji Hosp, Dept Obstet & Gynaecol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Wang, J (corresponding author), Tongji Univ, Tongji Hosp, Dept Obstet & Gynaecol, Shanghai 200092, Peoples R China.	18918513937@163.com; jjwang0524@sina.com	Zhang, Yi/ABD-4822-2020					American Gastroenterological Association, 2013, Gastroenterology, V144, P211, DOI 10.1053/j.gastro.2012.10.029; Barbezat Gil, 2002, N Z Med J, V115, pU220; Bradley CS, 2007, OBSTET GYNECOL, V110, P1351, DOI 10.1097/01.AOG.0000295723.94624.b1; Chen L. Y., 2000, SMJ, V41, P255; Cheng C, 2003, ALIMENT PHARM THERAP, V18, P319, DOI 10.1046/j.1365-2036.2003.01663.x; Dennison C, 2005, PHARMACOECONOMICS, V23, P461, DOI 10.2165/00019053-200523050-00006; Devanarayana NM, 2010, J TROP PEDIATRICS, V56, P144, DOI 10.1093/tropej/fmp077; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Fishman L, 2004, J PEDIATR-US, V145, P253, DOI 10.1016/j.jpeds.2004.04.022; [付朝伟 FU Chaowei], 2006, [中华消化杂志, Chinese Journal of Digestion], V26, P151; Garrigues V, 2004, AM J EPIDEMIOL, V159, P520, DOI 10.1093/aje/kwh072; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; Jin J. J., 2009, CHINA PRACTICAL MED, V4, P106; Jun DW, 2006, DIGEST DIS SCI, V51, P1471, DOI 10.1007/s10620-006-9087-3; Jung Hye-Kyung, 2003, Korean J Intern Med, V18, P181; Kil SY, 2010, J CLIN NURS, V19, P1307, DOI 10.1111/j.1365-2702.2009.03053.x; Li Z. J., 2000, CHINA J CENTR S FOR, V20, P1; Liu W, 2010, CHIN J GASTROENTEROL, V15, P95; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Nakaji S, 2002, EUR J NUTR, V41, P244, DOI 10.1007/s00394-002-0380-4; Pare P, 2001, AM J GASTROENTEROL, V96, P3130, DOI 10.1111/j.1572-0241.2001.05259.x; Peppas G, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-5; SANDLER RS, 1990, AM J PUBLIC HEALTH, V80, P185, DOI 10.2105/AJPH.80.2.185; Siproudhis L, 2006, DIS COLON RECTUM, V49, P219, DOI 10.1007/s10350-005-0249-8; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Tuteja AK, 2005, AM J GASTROENTEROL, V100, P124, DOI 10.1111/j.1572-0241.2005.40516.x; Wei XQ, 2001, CHIN J GASTROENTEROL, V10, P150; Wu Jia-Xuan, 2009, Zhonghua Yi Xue Za Zhi, V89, P1255; Wuhan J, 2013, CHIN J DIG, V33, P291; [阚志超 Xian Zhichao], 2004, [中华消化杂志, Chinese Journal of Digestion], V24, P612; Xin HW, 2012, CHIN J GASTROENTEROL, V17, P87; You JS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S41; Zhao YF, 2011, ALIMENT PHARM THER, V34, P1020, DOI 10.1111/j.1365-2036.2011.04809.x; 郭晓峰, 2002, [中华消化杂志, Chinese Journal of Digestion], V22, P637; 刘智勇, 2004, [中华消化杂志, Chinese Journal of Digestion], V24, P435	36	14	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133521	10.1371/journal.pone.0133521	http://dx.doi.org/10.1371/journal.pone.0133521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208169	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000095
J	Arif, M; Kattan, A				Arif, Muhammad; Kattan, Ahmed			Physical Activities Monitoring Using Wearable Acceleration Sensors Attached to the Body	PLOS ONE			English	Article							ACTIVITY RECOGNITION; ROTATION FOREST; CLASSIFICATION; ACCELEROMETRY; EXERCISE; OVERWEIGHT; WEIGHT; DIET	Monitoring physical activities by using wireless sensors is helpful for identifying postural orientation and movements in the real-life environment. A simple and robust method based on time domain features to identify the physical activities is proposed in this paper; it uses sensors placed on the subjects' wrist, chest and ankle. A feature set based on time domain characteristics of the acceleration signal recorded by acceleration sensors is proposed for the classification of twelve physical activities. Nine subjects performed twelve different types of physical activities, including sitting, standing, walking, running, cycling, Nordic walking, ascending stairs, descending stairs, vacuum cleaning, ironing clothes and jumping rope, and lying down (resting state). Their ages were 27.2 +/- 3.3 years and their body mass index (BMI) is 25.11 +/- 2.6 Kg/m(2). Classification results demonstrated a high validity showing precision (a positive predictive value) and recall (sensitivity) of more than 95% for all physical activities. The overall classification accuracy for a combined feature set of three sensors is 98%. The proposed framework can be used to monitor the physical activities of a subject that can be very useful for the health professional to assess the physical activity of healthy individuals as well as patients.	[Arif, Muhammad; Kattan, Ahmed] Umm Alqura Univ, Dept Comp Sci, Coll Comp & Informat Syst, Mecca, Saudi Arabia	Umm Al Qura University	Arif, M (corresponding author), Umm Alqura Univ, Dept Comp Sci, Coll Comp & Informat Syst, Mecca, Saudi Arabia.	syedmarif2003@yahoo.com	Kattan, Ahmed/AAN-8954-2020	Arif, Muhammad/0000-0003-0513-9872	National Plan for Science, Technology and Innovation (MAARIFAH) King Abdul Aziz city for science and Technology, Kingdom of Saudi Arabia [12-INF2290-10]	National Plan for Science, Technology and Innovation (MAARIFAH) King Abdul Aziz city for science and Technology, Kingdom of Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH) King Abdul Aziz city for science and Technology, the Kingdom of Saudi Arabia, award number (12-INF2290-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Alves N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-23; Atallah L, 2011, IEEE T BIOMED CIRC S, V5, P320, DOI 10.1109/TBCAS.2011.2160540; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Chuy OY, 2007, IEEE T ROBOT, V23, P899, DOI 10.1109/TRO.2007.907920; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Ermes M, 2008, IEEE T INF TECHNOL B, V12, P20, DOI 10.1109/TITB.2007.899496; Fausett LV, 2006, FUNDAMENTALS NEURAL; Forster M, 2011, INT J OBESITY, V35, P1071, DOI 10.1038/ijo.2010.246; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Glover J, 2004, IEEE INT CONF ROBOT, P3306, DOI 10.1109/ROBOT.2004.1308764; Gubbi J, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-33; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Hall M.A, 1999, CORRELATION BASED FE; Hanai Y, 2009, 2009 IEEE 13TH DIGITAL SIGNAL PROCESSING WORKSHOP & 5TH IEEE PROCESSING EDUCATION WORKSHOP, VOLS 1 AND 2, PROCEEDINGS, P675, DOI 10.1109/DSP.2009.4786008; Himes CL, 2012, J AM GERIATR SOC, V60, P124, DOI 10.1111/j.1532-5415.2011.03767.x; Ibata Y, 2013, IEEE ENG MED BIO, P4891, DOI 10.1109/EMBC.2013.6610644; Khan M, 2011, FEATURE EXTRACTION M; Kuncheva LI, 2007, LECT NOTES COMPUT SC, V4472, P459; Kwapisz JR., 2011, ACM SIGKDD EXPLORATI, V12, P74, DOI [10.1145/1964897.1964918, DOI 10.1145/1964897.1964918]; Vinh LT, 2011, APPL INTELL, V35, P226, DOI 10.1007/s10489-010-0216-5; Lara OD, 2013, IEEE COMMUN SURV TUT, V15, P1192, DOI 10.1109/SURV.2012.110112.00192; Lester J, 2006, LECT NOTES COMPUT SC, V3968, P1; Lopez FG, 2006, EUR J OPER RES, V169, P477, DOI 10.1016/j.ejor.2004.08.010; Lyons GM, 2005, MED ENG PHYS, V27, P497, DOI 10.1016/j.medengphy.2004.11.006; Mannini A, 2010, SENSORS-BASEL, V10, P1154, DOI 10.3390/s100201154; Mantyla T.J., 2001, P IEEE INT C SYST MA, V3494, P747, DOI DOI 10.1109/ICSMC.2001.973004; Marti R, 2006, EUR J OPER RES, V169, P359, DOI 10.1016/j.ejor.2004.08.004; Mathie MJ, 2004, MED BIOL ENG COMPUT, V42, P679, DOI 10.1007/BF02347551; Mathie MJ, 2004, PHYSIOL MEAS, V25, pR1, DOI 10.1088/0967-3334/25/2/R01; Maurer U, 2006, BSN 2006: INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P113; McGlynn D, 2011, RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXVII: INCORPORATING APPLICATIONS AND INNOVATIONS IN INTELLIGENT SYSTEMS XVIII, P339, DOI 10.1007/978-0-85729-130-1_26; Minnen D, 2007, IFMBE PROC, V13, P236; Ohtaki Y., 2004, POWER, V100, P102; Parkka J, 2006, IEEE T INF TECHNOL B, V10, P119, DOI 10.1109/TITB.2005.856863; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Phinyomark A., 2009, ARXIV09123973; Preece SJ, 2009, IEEE T BIO-MED ENG, V56, P871, DOI 10.1109/TBME.2008.2006190; Reiss A, 2012, CREATING BENCHMARKIN, P40; Reiss A, 2012, IEEE INT SYM WRBL CO, P108, DOI 10.1109/ISWC.2012.13; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Sekine M, 2000, MED ENG PHYS, V22, P285, DOI 10.1016/S1350-4533(00)00041-2; Seon-Woo Lee, 2002, IEEE Pervasive Computing, V1, P24, DOI 10.1109/MPRV.2002.1037719; Shammas L, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-10; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; W.H.O, 2013, OB OV FACT SHEETS WH; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Zhu C, 2009, HUMAN DAILY ACTIVITY, P2154	50	64	64	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0130851	10.1371/journal.pone.0130851	http://dx.doi.org/10.1371/journal.pone.0130851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203909	Green Published, gold, Green Submitted			2022-12-26	WOS:000358621000001
J	Bailleul, F; Vacquie-Garcia, J; Guinet, C				Bailleul, Frederic; Vacquie-Garcia, Jade; Guinet, Christophe			Dissolved Oxygen Sensor in Animal-Borne Instruments: An Innovation for Monitoring the Health of Oceans and Investigating the Functioning of Marine Ecosystems	PLOS ONE			English	Article							ELEPHANT SEALS; SOUTHERN-OCEAN; INDIAN-OCEAN; WATER; CIRCULATION; TILETAMINE; SWORDFISH; ZOLAZEPAM; WHALES	The current decline in dissolved oxygen concentration within the oceans is a sensitive indicator of the effect of climate change on marine environment. However the impact of its declining on marine life and ecosystems' health is still quite unclear because of the difficulty in obtaining in situ data, especially in remote areas, like the Southern Ocean (SO). Southern elephant seals (Mirounga leonina) proved to be a relevant alternative to the traditional oceanographic platforms to measure physical and biogeochemical structure of oceanic regions rarely observed. In this study, we use a new stage of development in biologging technology to draw a picture of dissolved oxygen concentration in the SO. We present the first results obtained from a dissolved oxygen sensor added to Argos CTD-SRDL tags and deployed on 5 female elephant seals at Kerguelen. From October 2010 and October 2011, 742 oxygen profiles associated with temperature and salinity measurements were recorded. Whether a part of the data must be considered cautiously, especially because of offsets and temporal drifts of the sensors, the range of values recorded was consistent with a concomitant survey conducted from a research vessel (Keops-2 project). Once again, elephant seals reinforced the relationship between marine ecology and oceanography, delivering essential information about the water masses properties and the biological status of the Southern Ocean. But more than the presentation of a new stage of development in animal-borne instrumentation, this pilot study opens a new field of investigation in marine ecology and could be enlarged in a near future to other key marine predators, especially large fish species like swordfish, tuna or sharks, for which dissolved oxygen is expected to play a crucial role in distribution and behaviour.	[Bailleul, Frederic] South Australian Res & Dev Inst Aquat Sci, Adelaide, SA 5024, Australia; [Bailleul, Frederic; Vacquie-Garcia, Jade; Guinet, Christophe] Univ La Rochelle, CNRS, Ctr Etudes Biol Chize, UMR 7372, F-79360 Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Bailleul, F (corresponding author), South Australian Res & Dev Inst Aquat Sci, 2 Hamra Ave,West Beach, Adelaide, SA 5024, Australia.	fred.bailleul@sa.gov.au	Guinet, Christophe/AAR-8457-2020	VACQUIE GARCIA, Jade/0000-0002-3126-3423	French Polar Institute (Institut Paul Emile Victor, IPEV); Territoire des Terres Australes et Antarctiques Francaises (TAAF); Total Foundation	French Polar Institute (Institut Paul Emile Victor, IPEV); Territoire des Terres Australes et Antarctiques Francaises (TAAF); Total Foundation(Total SA)	This study is part of the National Research Program (no. 109, H. Weimerskirch and the observatory Mammiferes Explorateurs du Milieu Oceanique, MEMO SOERE CTD 02) supported by the French Polar Institute (Institut Paul Emile Victor, IPEV) and the Territoire des Terres Australes et Antarctiques Francaises (TAAF). This work was carried out in the framework of ANR TOPP-PATCHES and CNES-TOSCA programs and was supported by the Total Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2010, ICES J MAR SCI, V67, P466, DOI 10.1093/icesjms/fsp252; Bailleul Frederic, 2012, Endangered Species Research, V17, P27, DOI 10.3354/esr00420; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bindoff NL, 2000, J PHYS OCEANOGR, V30, P1207, DOI 10.1175/1520-0485(2000)030<1207:DCAAIO>2.0.CO;2; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Coppola L, 2012, WHITE PAPER DISSOLVE; Costa DP, 2008, DEEP-SEA RES PT II, V55, P323, DOI 10.1016/j.dsr2.2007.11.003; Dehairs F, 1990, GLOBAL BIOGEOCHEM CY, V4, P85, DOI 10.1029/GB004i001p00085; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dragon AC, 2010, PROG OCEANOGR, V87, P61, DOI 10.1016/j.pocean.2010.09.025; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Guinet C, 2013, EARTH SYST SCI DATA, V5, P15, DOI 10.5194/essd-5-15-2013; Joos F., 2003, EOS T AM GEOPHYS UN, V84, P197, DOI [10.1029/2003EO210001, DOI 10.1029/2003EO210001, DOI 10.1029/2003E0210001]; Jorgensen SJ, 2009, J FISH BIOL, V74, P1682, DOI 10.1111/j.1095-8649.2009.02230.x; Kortzinger A, 2005, J ATMOS OCEAN TECH, V22, P302, DOI 10.1175/JTECH1701.1; Lydersen C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015462; Matear RJ, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000086; Matear RJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001997; McGillicuddy DJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001987; McGillicuddy DJ, 1999, J GEOPHYS RES, V104, P13; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; PAPASTAVROU V, 1989, CAN J ZOOL, V67, P839, DOI 10.1139/z89-124; PARK YH, 1993, J GEOPHYS RES-OCEANS, V98, P12361, DOI 10.1029/93JC00938; Potier M, 2007, FISH RES, V83, P60, DOI 10.1016/j.fishres.2006.08.020; Riser SC, 2008, NATURE, V451, P323, DOI 10.1038/nature06441; Roquet F, 2013, GEOPHYS RES LETT, V40, P6176, DOI 10.1002/2013GL058304; Roquet F, 2011, J ATMOS OCEAN TECH, V28, P787, DOI 10.1175/2010JTECHO801.1; Roquet F, 2009, J MARINE SYST, V78, P377, DOI 10.1016/j.jmarsys.2008.11.017; Schmittner A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002953; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Sparrow MD, 1996, J GEOPHYS RES-OCEANS, V101, P6377, DOI 10.1029/95JC03750; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Vacquie-Garcia J, 2015, DEEP-SEA RES PT II, V113, P145, DOI 10.1016/j.dsr2.2014.10.029	39	11	11	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132681	10.1371/journal.pone.0132681	http://dx.doi.org/10.1371/journal.pone.0132681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200780	Green Published, gold			2022-12-26	WOS:000358597100045
J	Suzuki-Hashido, N; Hayakawa, T; Matsui, A; Go, Y; Ishimaru, Y; Misaka, T; Abe, K; Hirai, H; Satta, Y; Imai, H				Suzuki-Hashido, Nami; Hayakawa, Takashi; Matsui, Atsushi; Go, Yasuhiro; Ishimaru, Yoshiro; Misaka, Takumi; Abe, Keiko; Hirai, Hirohisa; Satta, Yoko; Imai, Hiroo			Rapid Expansion of Phenylthiocarbamide Non-Tasters among Japanese Macaques	PLOS ONE			English	Article							RECEPTOR GENE REPERTOIRE; HAPLOTYPE RECONSTRUCTION; POSITIVE SELECTION; STATISTICAL-METHOD; EVOLUTION; SENSITIVITY; POLYMORPHISM; HUMANS; ALLELE; MODEL	Bitter taste receptors (TAS2R proteins) allow mammals to detect and avoid ingestion of toxins in food. Thus, TAS2Rs play an important role in food choice and are subject to complex natural selection pressures. In our previous study, we examined nucleotide variation in TAS2R38, a gene expressing bitter taste receptor for phenylthiocarbamide (PTC), in 333 Japanese macaques (Macaca fuscata) from 9 local populations in Japan. We identified a PTC "non-taster" TAS2R38 allele in Japanese macaques that was caused by a loss of the start codon. This PTC non-taster allele was only found in a limited local population (the Kii area), at a frequency of 29%. In this study, we confirmed that this allele was present in only the Kii population by analyzing an additional 264 individuals from eight new populations. Using cellular and behavioral experiments, we found that this allele lost its receptor function for perceiving PTC. The nucleotide sequences of the allele including flanking regions (of about 10 kb) from 23 chromosomes were identical, suggesting that a non-taster allele arose and expanded in the Kii population during the last 13,000 years. Genetic analyses of non-coding regions in Kii individuals and neighboring populations indicated that the high allele frequency in the Kii population could not be explained by demographic history, suggesting that positive selection resulted in a rapid increase in PTC non-tasters in the Kii population. The loss-of-function that occurred at the TAS2R38 locus presumably provided a fitness advantage to Japanese macaques in the Kii population. Because TAS2R38 ligands are often found in plants, this functional change in fitness is perhaps related to feeding habit specificity. These findings should provide valuable insights for elucidating adaptive evolutionary changes with respect to various environments in wild mammals.	[Suzuki-Hashido, Nami; Hayakawa, Takashi; Matsui, Atsushi; Go, Yasuhiro; Hirai, Hirohisa; Imai, Hiroo] Kyoto Univ, Primate Res Inst, Mol Biol Sect, Dept Cellular & Mol Biol, Inuyama, Aichi 484, Japan; [Suzuki-Hashido, Nami; Hayakawa, Takashi] Japan Soc Promot Sci, Tokyo, Japan; [Ishimaru, Yoshiro; Misaka, Takumi; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Satta, Yoko] Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan	Kyoto University; Japan Society for the Promotion of Science; University of Tokyo; Graduate University for Advanced Studies - Japan	Satta, Y (corresponding author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan.	satta@soken.ac.jp; imai.hiroo.5m@kyoto-u.ac.jp	Hayakawa, Takashi/U-9518-2018; Ishimaru, Yoshiro/AAI-3049-2020; Imai, Hiroo/AAP-2393-2020; Go, Yasuhiro/AAD-3313-2020	Hayakawa, Takashi/0000-0002-1037-0350; Imai, Hiroo/0000-0003-0729-0322; Go, Yasuhiro/0000-0003-4581-0325; Satta, Yoko/0000-0002-5305-493X; Misaka, Takumi/0000-0002-9547-5767; Suzuki-Hashido, Nami/0000-0002-9934-7324	MEXT; JSPS KAKENHI [12J04300, 21370109, 24370096, 26117512]; Grants-in-Aid for Scientific Research [26304008, 26242007] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from MEXT and JSPS KAKENHI to NS (12J04300) and to HI (21370109, 24370096, and 26117512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; CHIARELLI B., 1963, FOLIA PRIMATOLOGICA [BASEL], V1, P88, DOI 10.1159/000165784; Conte C, 2003, PHYSIOL GENOMICS, V14, P73, DOI 10.1152/physiolgenomics.00060.2003; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Fisher RA, 1939, NATURE, V144, P750, DOI 10.1038/144750a0; Go Y, 2006, MOL BIOL EVOL, V23, P964, DOI 10.1093/molbev/msj106; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; Hayakawa T, 2014, MOL BIOL EVOL, V31, P2018, DOI 10.1093/molbev/msu144; Hayakawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043277; HIRAI M, 1990, J JPN SOC HORTIC SCI, V59, P1, DOI 10.2503/jjshs.59.1; Iwahori S, 1990, GENERAL REMARKS OF C; Kawamoto Y, 2007, PRIMATES, V48, P27, DOI 10.1007/s10329-006-0013-2; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KIMURA M, 1971, GENET RES, V18, P125, DOI 10.1017/S0016672300012520; KIMURA M, 1964, GENETICS, V49, P561; KIMURA M, 1973, GENETICS, V75, P199; Li DY, 2014, MOL BIOL EVOL, V31, P303, DOI 10.1093/molbev/mst219; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marmi J, 2004, MOL PHYLOGENET EVOL, V30, P676, DOI 10.1016/S1055-7903(03)00247-1; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; NEI M, 1977, AM J HUM GENET, V29, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NOZAWA K, 1982, Primates, V23, P252, DOI 10.1007/BF02381165; NOZAWA K, 1991, PRIMATES, V32, P411, DOI 10.1007/BF02381934; NOZAWA K, 1972, Primates, V13, P381, DOI 10.1007/BF01793658; Osada N, 2010, MOL ECOL, V19, P2884, DOI 10.1111/j.1365-294X.2010.04687.x; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Sandell MA, 2006, CURR BIOL, V16, pR792, DOI 10.1016/j.cub.2006.08.049; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shishikura M, 2013, GSJ CHISHITSU NEWS, V2, P201; Sivakumar K, 2010, HYSTRIX, V21, P35; Snyder LH, 1931, SCIENCE, V74, P151, DOI 10.1126/science.74.1910.151; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suzuki N, 2010, PRIMATES, V51, P285, DOI 10.1007/s10329-010-0209-3; TAJIMA F, 1989, GENETICS, V123, P585; Takaki A, 2012, IMMUNOGENETICS, V64, P15, DOI 10.1007/s00251-011-0556-2; Tsuji Yamato, 2012, Primate Research, V28, P109; Ueda T, 2003, J NEUROSCI, V23, P7376; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wooding S, 2006, NATURE, V440, P930, DOI 10.1038/nature04655; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Wooding S, 2011, J MOL EVOL, V73, P257, DOI 10.1007/s00239-011-9481-0; Wooding S, 2010, CHEM SENSES, V35, P685, DOI 10.1093/chemse/bjq061; Wright S, 1931, GENETICS, V16, P0097	53	8	9	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132016	10.1371/journal.pone.0132016	http://dx.doi.org/10.1371/journal.pone.0132016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201026	Green Submitted, gold, Green Published			2022-12-26	WOS:000358597100023
J	Zhang, G; Li, Q; Zhang, RR; Wei, X; Wang, JY; Qin, XY				Zhang, Gang; Li, Qi; Zhang, Rongrong; Wei, Xiao; Wang, Junyi; Qin, Xinyue			Subtypes and Prognosis of Guillain-Barre Syndrome in Southwest China	PLOS ONE			English	Article							BRAIN-STEM ENCEPHALITIS; RETROSPECTIVE ANALYSIS; CLINICAL-FEATURES; FISHER SYNDROME; MORTALITY	The proportion of different subtypes of Guillain-Barre syndrome (GBS) and their prognosis varied significantly among different regions. This study attempts to investigate the clinical subtypes and outcome of GBS in southwest China. Patients with GBS admitted to The First Affiliated Hospital of Chongqing Medical University from January 2006 to March 2013 were included in our study. Patients were classified into acute inflammatory demyelinating polyneuropathy (AIDP) group, acute motor axonal neuropathy (AMAN) group, Miller-Fisher syndrome (MFS) group, cranial nerve variants(CNV), Bickerstaff's brainstem encephalitis overlaps with GBS (BBE-GBS) group and unclassifiable group based on clinical features and electrophysiological findings. Hughes function grade score (HFGS) was used to assess the prognosis at 3 and 6 months. The prognosis of different subtypes and outcome predictors were analyzed. The most common subtype of GBS was AIDP (57%), followed by AMAN (22%) and MFS (7%). The prognosis of AMAN and BBE-GBS is similar at 3 month (P = 0.0704) and 6 month (P = 0.1614) follow-up. The prognosis of AMAN group was poorer than that of AIDP group at 3 month and 6 month follow-up (P<0.001). Outcome of MFS group and that of CNV group at 6 months were both good(Hughes <= 1). Hughes >= 3 (P<0.0001, OR = 6.650,95% CI = 2.865 to 15.023)) and dysautonomia (P = 0.043, OR = 2.820,95% CI = 1.031 to 7.715)) were associated with poor outcome at 6 month follow-up. AIDP is the most common subtype of GBS. Prognosis of AMAN group and BBE-GBS group is poorer than that of AIDP group at 3 month and 6 month follow-up. Hughes >= 3 at nadir and dysautonomia are predictors of poor prognosis at 6 month follow-up.	[Zhang, Gang; Li, Qi; Zhang, Rongrong; Wang, Junyi; Qin, Xinyue] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Wei, Xiao] Chongqing Med & Pharmaceut Coll, Dept Med Technol, Chongqing, Peoples R China	Chongqing Medical University	Qin, XY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	Qinxinyue@yahoo.com	wang, junyi/GYA-3213-2022; Li, Qi/ABE-4182-2021	Li, Qi/0000-0002-9144-148X	National Key Clinical Specialties Construction Program of China	National Key Clinical Specialties Construction Program of China	This study is supported by National Key Clinical Specialties Construction Program of China.	Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4; [Anonymous], 1978, Ann Neurol, V3, P565; [Anonymous], 1996, Brain, V119 ( Pt 6), P2053; Bai HX, 2013, J PERIPHER NERV SYST, V18, P195, DOI 10.1111/jns5.12030; Bhargava A, 2014, J NEUROSCI RURAL PRA, V5, pS43, DOI 10.4103/0976-3147.145200; Dhar R, 2008, J NEUROL SCI, V264, P121, DOI 10.1016/j.jns.2007.08.005; Drenthen J, 2011, J NEUROL NEUROSUR PS, V82, P300, DOI 10.1136/jnnp.2010.226639; Gonzalez-Suarez I, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-95; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758; HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Hughes RAC, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008630.pub3, DOI 10.1002/14651858.CD008630, 10.1002/14651858.CD008630]; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub5; Kalita J, 2014, J PERIPHER NERV SYST, V19, P36, DOI 10.1111/jns5.12050; Kokubun N, 2013, CLIN NEUROPHYSIOL, V124, P1671, DOI 10.1016/j.clinph.2013.02.010; Kuwabara S, 2002, J NEUROL SCI, V199, P89, DOI 10.1016/S0022-510X(02)00088-6; Lin JJ, 2012, PEDIATR NEUROL, V47, P91, DOI 10.1016/j.pediatrneurol.2012.05.011; Ma YM, 2010, PEDIATR INT, V52, P13, DOI 10.1111/j.1442-200X.2009.02951.x; Mitsui Y, 2015, J NEUROL NEUROSUR PS, V86, P110, DOI 10.1136/jnnp-2013-306509; Mori M, 2001, NEUROLOGY, V56, P1104, DOI 10.1212/WNL.56.8.1104; Ng YS, 2004, ANN ACAD MED SINGAP, V33, P314; Odaka M, 2003, BRAIN, V126, P2279, DOI 10.1093/brain/awg233; Omejec G, 2012, J PERIPHER NERV SYST, V17, P217, DOI 10.1111/j.1529-8027.2012.00397.x; Shahrizaila N, 2013, J NEUROL NEUROSUR PS, V84, P576, DOI 10.1136/jnnp-2012-302824; van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc; van Doorn PA, 2010, J CLIN IMMUNOL, V30, pS74, DOI 10.1007/s10875-010-9407-4; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; Visser LH, 1999, NEUROLOGY, V53, P598, DOI 10.1212/WNL.53.3.598; Vucic S, 2004, CLIN NEUROPHYSIOL, V115, P2329, DOI 10.1016/j.clinph.2004.05.009; Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138; Witsch J, 2013, J NEUROL, V260, P1367, DOI 10.1007/s00415-012-6806-x; Ye YQ, 2013, MUSCLE NERVE, V47, P68, DOI 10.1002/mus.23477; Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012; Yuki N, 1998, ANN NEUROL, V43, P546, DOI 10.1002/ana.410430424; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525	38	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133520	10.1371/journal.pone.0133520	http://dx.doi.org/10.1371/journal.pone.0133520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200903	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100070
J	Eshima, Y; Higuchi, Y; Kinoshita, T; Nakakita, SI; Takegawa, K				Eshima, Yasunari; Higuchi, Yujiro; Kinoshita, Takashi; Nakakita, Shin-Ichi; Takegawa, Kaoru			Transglycosylation Activity of Glycosynthase Mutants of Endo-beta-N-Acetylglucosaminidase from Coprinopsis cinerea	PLOS ONE			English	Article							CHEMOENZYMATIC SYNTHESIS; GLYCOPROTEINS; PURIFICATION; CLONING	Endo-beta-N-acetylglucosaminidase (ENGase), which catalyzes hydrolysis of N-linked oligosaccharides, is a useful tool for analyzing oligosaccharide contents of glycoproteins. However, there are only a few known ENGases that can catalyze the hydrolysis of human complex type oligosaccharides, and although commercially available, they are expensive. Here, we report the cloning of two ENGase encoding cDNAs from the basidiomycete fungus Coprinopsis cinerea, Endo-CC1 and Endo-CC2. We successfully expressed recombinant His(6)-tagged Endo-CC1 and Endo-CC2 in Escherichia coli and purified them for enzymatic characterization. Both Endo-CC1 and Endo-CC2 showed hydrolytic activity on high-mannose and complex type oligosaccharides. Since Endo-CC1 could be prepared more easily than Endo-CC2 from E. coli cultures, we examined the enzymatic properties of Endo-CC1 in detail. Our results showed that Endo-CC1 acted on both N-linked high-mannose type and sialobiantennary type complex oligosaccharides of glycoproteins RNase B and human transferrin, respectively, but not on the sialotriantennary type complex oligosaccharide of glycoprotein fetuin. Examination of the transglycosylation activity of Endo-CC1 revealed that the wild-type Endo-CC1 could not transfer the sialobiantennary type complex oligosaccharide onto the deglycosylated RNase B. To obtain an Endo-CC1 mutant with desired transglycosylation activity, we performed mutation analysis of the active site residue Asn 180 (N180), known to be important for catalysis, by individually replacing it with the remaining 19 amino acid residues. Transglycosylation analyses of these mutants led us to identify one mutant, namely Endo-CC1(N180H), which exhibited the desired transglycosylation activity. Taken together, we suggest that Endo-CC1 would potentially be a valuable tool for analyzing oligosaccharides on glycoproteins, as large quantities of it could be made available more easily and less expensively than the currently used enzyme, Endo-M.	[Eshima, Yasunari; Higuchi, Yujiro; Takegawa, Kaoru] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Kinoshita, Takashi] Fushimi Pharmaceut Co Ltd, Marugame, Kagawa, Japan; [Nakakita, Shin-Ichi] Kagawa Univ, Life Sci Res Ctr, Dept Funct Glyc, Kagawa, Japan	Kyushu University; Kagawa University	Takegawa, K (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, 6-10-1 Hakozaki, Fukuoka 812, Japan.	takegawa@agr.kyushu-u.ac.jp		Higuchi, Yujiro/0000-0001-7309-291X; Kinoshita, Takashi/0000-0002-3468-002X	JSPS KAKENHI [26292054]; Fushimi Pharmaceutical Co. Ltd.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fushimi Pharmaceutical Co. Ltd.	This study was supported in part by JSPS KAKENHI Grant Number 26292054 (KT). Fushimi Pharmaceutical Co. Ltd. provided support in the form of the salary for the author TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Fujita K, 2001, BIOCHEM BIOPH RES CO, V282, P678, DOI 10.1006/bbrc.2001.4631; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; IWASE H, 1981, ANAL BIOCHEM, V113, P93, DOI 10.1016/0003-2697(81)90048-8; KADOWAKI S, 1991, J BIOCHEM-TOKYO, V110, P17, DOI 10.1093/oxfordjournals.jbchem.a123536; KADOWAKI S, 1990, AGR BIOL CHEM TOKYO, V54, P97, DOI 10.1080/00021369.1990.10869923; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; TAKEGAWA K, 1995, J BIOL CHEM, V270, P3094, DOI 10.1074/jbc.270.7.3094; Takegawa K, 1997, ARCH BIOCHEM BIOPHYS, V338, P22, DOI 10.1006/abbi.1996.9803; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tharmalingam T, 2013, GLYCOCONJUGATE J, V30, P137, DOI 10.1007/s10719-012-9443-9; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wang LX, 2011, TRENDS GLYCOSCI GLYC, V23, P33, DOI 10.4052/tigg.23.33; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72	23	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0132859	10.1371/journal.pone.0132859	http://dx.doi.org/10.1371/journal.pone.0132859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197478	Green Published, Green Submitted, gold			2022-12-26	WOS:000358547600054
J	Harte, NP; Klyubin, I; McCarthy, EK; Min, S; Garrahy, SA; Xie, YJ; Davey, GP; Boland, JJ; Rowan, MJ; Mok, KH				Harte, Nial P.; Klyubin, Igor; McCarthy, Eoin K.; Min, Soyoung; Garrahy, Sarah Ann; Xie, Yongjing; Davey, Gavin P.; Boland, John J.; Rowan, Michael J.; Mok, K. Hun			Amyloid Oligomers and Mature Fibrils Prepared from an Innocuous Protein Cause Diverging Cellular Death Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; A-BETA; MOLECULAR-BASIS; PRION PROTEIN; TOXICITY; CELLS; CYTOTOXICITY; NEURODEGENERATION; PATHOGENESIS	Despite significant advances, the molecular identity of the cytotoxic species populated during in vivo arnyloid formation crucial for the understanding of neurodegenerative disorders is yet to be revealed. In this study lysozyme prefibrillar oligomers and fibrils in both mature and sonicated states have been isolated through an optimized ultrafiltration/ultracentrifugation method and characterized with various optical spectroscopic techniques, atomic force microscopy, and transmission electron microscopy. We examined their level and mode of toxicity on rat pheochromocytoma (PC12) cells in both differentiated and undifferentiated states. We find that oligomers and fibrils display cytotoxic capabilities toward cultured cells in vitro, with oligomers producing elevated levels of cellular injury toward undifferentiated PC 12 cells (PC2(undiff)), Furthermore, dual flow cytometry staining experiments demonstrate that the oligomers and mature fibrils induce divergent cellular death pathways (apoptosis and secondary necrosis, respectively) in these PC12 cells. We have also shown that oligomers but not sonicated mature fibrils inhibit hippocampal long term potentiation, a form of synaptic plasticity implicated in learning and memory, in vivo. We conclude that our in vitro and in vivo findings confer a level of resistance toward amyloid fibrils, and that the PC 12-based comparative cytotoxicity assay can provide insights into toxicity differences between differently aggregated protein species.	[Harte, Nial P.; Min, Soyoung; Xie, Yongjing; Davey, Gavin P.; Mok, K. Hun] Univ Dublin Trinity Coll, Sch Biochem & Immunol, TBSI, Dublin 2, Ireland; [Klyubin, Igor; Rowan, Michael J.] Univ Dublin Trinity Coll, TCIN, Dept Pharmacol & Therapeut, Dublin 2, Ireland; [McCarthy, Eoin K.; Boland, John J.] Univ Dublin Trinity Coll, Sch Chem, Dublin 2, Ireland; [McCarthy, Eoin K.; Boland, John J.; Mok, K. Hun] Univ Dublin Trinity Coll, CRANN, Dublin 2, Ireland; [Garrahy, Sarah Ann; Davey, Gavin P.] Univ Dublin Trinity Coll, TCIN, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Mok, KH (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, TBSI, 152-160 Pearse St, Dublin 2, Ireland.	mok1@tcd.ie	Boland, John J/P-9740-2016; Davey, Gavin/HGB-4233-2022; Boland, John/AAB-8498-2022	Boland, John J/0000-0002-3229-8038; Boland, John/0000-0002-3229-8038; Mok, K Hun/0000-0003-3663-2002; Xie, Yongjing/0000-0001-5482-5743; Rowan, Michael Joseph/0000-0002-3867-9536; Min, Soyoung/0000-0001-7511-1520	Health Research Board of Ireland; Science Foundation Ireland	Health Research Board of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported in part by grants from the Health Research Board of Ireland (to I. K.) and Science Foundation Ireland (to M. J. R). The authors declare that they have no conflicts of interest with the contents of this article.	Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Bucciantini M, 2004, FASEB J, V18, P437, DOI 10.1096/fj.04-3086fje; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cecchi C, 2005, J CELL SCI, V118, P3459, DOI 10.1242/jcs.02473; Cecchi C, 2008, NEUROCHEM RES, V33, P2516, DOI 10.1007/s11064-008-9627-7; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; IVERSEN LL, 1995, BIOCHEM J, V311, P1; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klyubin I., 2012, ALZHEIMERS DEMENT, V8, pP648; Klyubin I, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0147; Klyubin I, 2011, NEUROBIOL AGING, V32, P614, DOI 10.1016/j.neurobiolaging.2009.04.005; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Marzban L, 2003, EXP GERONTOL, V38, P347, DOI 10.1016/S0531-5565(03)00004-4; Merlini G, 2011, J CLIN ONCOL, V29, P1924, DOI 10.1200/JCO.2010.32.2271; Min SY, 2012, BIOCHEM SOC T, V40, P746, DOI 10.1042/BST20120029; Mossberg AK, 2010, FEBS J, V277, P4614, DOI 10.1111/j.1742-4658.2010.07890.x; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oberdoerster J, 1999, LIFE SCI, V64, pPL267, DOI 10.1016/S0024-3205(99)00166-6; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Olesen OF, 1998, MOL BRAIN RES, V57, P266, DOI 10.1016/S0169-328X(98)00096-5; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; SHIMADA K, 1989, MOL BIOL MED, V6, P333; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Wang XD, 2001, GENE DEV, V15, P2922; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c	48	19	19	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28343	28352		10.1074/jbc.M115.676072	http://dx.doi.org/10.1074/jbc.M115.676072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26221033	hybrid, Green Published			2022-12-26	WOS:000365761900026
J	Feng, X; Coulombe, PA				Feng, Xia; Coulombe, Pierre A.			Complementary Roles of Specific Cysteines in Keratin 14 toward the Assembly, Organization, and Dynamics of Intermediate Filaments in Skin Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; SULFHYDRYL OXIDASE; POINT MUTATIONS; DISULFIDE BONDS; DISEASE; EPITHELIA; DIFFERENTIATION; CYTOSKELETON; MECHANISMS; DISORDERS	We recently showed that inter-keratin disulfide bonding plays an important role in the assembly, organization, and dynamics of keratin intermediate filaments in skin keratinocytes. In particular, cysteine 367 located in the central alpha-helical rod domain of keratin 14 is necessary for the formation of a stable perinuclear network of keratin filaments (with type II partner keratin 5) in skin keratinocytes analyzed by static and live cell imaging. Here, we show that two additional cysteine residues located in the non-helical head domain of K14, Cys-4 and Cys-40, also participate in inter-keratin disulfide bonding and tandemly play a key role complementary to that of Cys-367 in the assembly, organization, and dynamics of keratin filaments in skin keratinocytes in primary culture. Analysis of K14 variants with single or multiple substitutions of cysteine residues points to a spatial and temporal hierarchy in how Cys-4/Cys-40 and Cys-367 regulate keratin assembly in vitro and filament dynamics in live keratinocytes in culture. Our findings substantiate the importance and complexity of a novel determinant, namely inter-keratin disulfide bonding, for the regulation of several aspects of keratin filaments in surface epithelia.	[Feng, Xia; Coulombe, Pierre A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	coulombe@jhu.edu	Regan, Clinton/E-6250-2012	Feng, Xia/0000-0003-2460-192X	National Institutes of Health [S10 OD016374]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042047] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to members of the Coulombe laboratory for support; to Jill Hakim and Janet Folmer for technical assistance; to the School of Medicine Microscope Facility for live cell imaging experiments (National Institutes of Health Grant S10 OD016374); and to Valeria Culotta, Michael Matunis, Andrew Ewald, and Ryan Hobbs for advice.	AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131; AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341; Clarke SJ, 2006, NAT MATER, V5, P409, DOI 10.1038/nmat1631; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; Darby N, 1995, Methods Mol Biol, V40, P219; Feng X, 2015, J CELL BIOL, V209, P59, DOI 10.1083/jcb.201408079; Feng X, 2013, J INVEST DERMATOL, V133, P850, DOI 10.1038/jid.2012.397; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hashimoto Y, 2000, ARCH DERMATOL RES, V292, P570, DOI 10.1007/s004030000171; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Kojer K, 2014, BBA-PROTEINS PROTEOM, V1844, P1383, DOI 10.1016/j.bbapap.2014.02.004; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; McLean WHI, 2011, HUM MOL GENET, V20, pR189, DOI 10.1093/hmg/ddr379; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Saaranen MJ, 2013, ANTIOXID REDOX SIGN, V19, P36, DOI 10.1089/ars.2012.4868; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STRICKLAND JE, 1988, CANCER RES, V48, P165; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; TAKAMORI K, 1980, BIOCHIM BIOPHYS ACTA, V615, P309, DOI 10.1016/0005-2744(80)90499-4; Thiele JJ, 2001, CURR PROBL DERMATOL, V29, P26; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Werner NS, 2004, MOL BIOL CELL, V15, P990, DOI 10.1091/mbc.E03-09-0687; Windoffer R, 2004, METHOD CELL BIOL, V78, P321; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095	39	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22507	22519		10.1074/jbc.M115.654749	http://dx.doi.org/10.1074/jbc.M115.654749			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216883	Green Published, hybrid			2022-12-26	WOS:000361171500018
J	Irimia, JM; Tagliabracci, VS; Meyer, CM; Segvich, DM; DePaoli-Roach, AA; Roach, PJ				Irimia, Jose M.; Tagliabracci, Vincent S.; Meyer, Catalina M.; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.			Muscle Glycogen Remodeling and Glycogen Phosphate Metabolism following Exhaustive Exercise of Wild Type and Laforin Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; SKELETAL-MUSCLE; INSULIN SENSITIVITY; POMPE DISEASE; AUTOPHAGY; GLUCOSE; SYNTHASE; ACCUMULATION; GRANULE; BODIES	Glycogen, the repository of glucose in many cell types, contains small amounts of covalent phosphate, of uncertain function and poorly understood metabolism. Loss-of-function mutations in the laforin gene cause the fatal neurodegenerative disorder, Lafora disease, characterized by increased glycogen phosphorylation and the formation of abnormal deposits of glycogen- like material called Lafora bodies. It is generally accepted that the phosphate is removed by the laforin phosphatase. To study the dynamics of skeletal muscle glycogen phosphorylation in vivo under physiological conditions, mice were subjected to glycogen-depleting exercise and then monitored while they resynthesized glycogen. Depletion of glycogen by exercise was associated with a substantial reduction in total glycogen phosphate and the newly resynthesized glycogen was less branched and less phosphorylated. Branching returned to normal on a time frame of days, whereas phosphorylation remained suppressed over a longer period of time. We observed no change in markers of autophagy. Exercise of 3-month-old laforin knockout mice caused a similar depletion of glycogen but no loss of glycogen phosphate. Furthermore, remodeling of glycogen to restore the basal branching pattern was delayed in the knockout animals. From these results, we infer that 1) laforin is responsible for glycogen dephosphorylation during exercise and acts during the cytosolic degradation of glycogen, 2) excess glycogen phosphorylation in the absence of laforin delays the normal remodeling of the branching structure, and 3) the accumulation of glycogen phosphate is a relatively slow process involving multiple cycles of glycogen synthesis-degradation, consistent with the slow onset of the symptoms of Lafora disease.	[Irimia, Jose M.; Tagliabracci, Vincent S.; Meyer, Catalina M.; Segvich, Dyann M.; DePaoli-Roach, Anna A.; Roach, Peter J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Roach, PJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	proach@iu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK27221, NS56454]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027221, R01DK027221, R56DK027221, P30DK097512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 and NS56454. The authors disclose no actual or perceived conflicts of interest.	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andrade D M, 2007, Acta Myol, V26, P83; Aschenbach WG, 2001, J BIOL CHEM, V276, P39959, DOI 10.1074/jbc.M105518200; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; COLLINS GH, 1968, ARCH PATHOL, V86, P239; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DePaoli-Roach AA, 2015, J BIOL CHEM, V290, P841, DOI 10.1074/jbc.M114.607796; DePaoli-Roach AA, 2012, HUM MOL GENET, V21, P1604, DOI 10.1093/hmg/ddr598; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; FONTANA JD, 1980, FEBS LETT, V109, P85, DOI 10.1016/0014-5793(80)81317-2; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Fukuda T, 2006, AUTOPHAGY, V2, P318, DOI 10.4161/auto.2984; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Garyali P, 2014, J BIOL CHEM, V289, P20606, DOI 10.1074/jbc.M114.580167; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x; Hawley JA, 1997, SPORTS MED, V24, P73, DOI 10.2165/00007256-199724020-00001; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hirschhorn R., 2000, METABOLIC MOL BASES, P3389; Irimia JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042453; Jensen TE, 2012, J PHYSIOL-LONDON, V590, P1069, DOI 10.1113/jphysiol.2011.224972; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; KIRKMAN B R, 1990, Biofactors, V2, P193; Knecht E, 2010, AUTOPHAGY, V6, P991, DOI [10.4161/auto.6.7.13308, 10.4161/auto6.7.13308]; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; LOMAKO J, 1994, BIOFACTORS, V4, P167; LOMAKO J, 1993, FEBS LETT, V329, P263, DOI 10.1016/0014-5793(93)80234-L; Marchand I, 2007, J PHYSIOL-LONDON, V580, P617, DOI 10.1113/jphysiol.2006.122457; Marchand I, 2002, J APPL PHYSIOL, V93, P1598, DOI 10.1152/japplphysiol.00585.2001; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Nielsen JN, 2003, ACTA PHYSIOL SCAND, V178, P309, DOI 10.1046/j.1365-201X.2003.01165.x; Nielsen J, 2011, J PHYSIOL-LONDON, V589, P2871, DOI 10.1113/jphysiol.2010.204487; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pederson BA, 2003, BIOCHEM BIOPH RES CO, V305, P826, DOI 10.1016/S0006-291X(03)00862-3; Pederson BA, 2013, ANN NEUROL, V74, P297, DOI 10.1002/ana.23899; Puri R, 2012, AUTOPHAGY, V8, P289, DOI 10.4161/auto.8.2.19010; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Roach P. J., 2013, ROTEIN TYROSINE PHOS, P239; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Turnbull J, 2014, ANN NEUROL, V75, P442, DOI 10.1002/ana.24104; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	55	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22686	22698		10.1074/jbc.M115.673897	http://dx.doi.org/10.1074/jbc.M115.673897			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26216881	Green Published, hybrid			2022-12-26	WOS:000361171500033
J	Lemonidis, K; Sanchez-Perez, MC; Chamberlain, LH				Lemonidis, Kimon; Sanchez-Perez, Maria C.; Chamberlain, Luke H.			Identification of a Novel Sequence Motif Recognized by the Ankyrin Repeat Domain of zDHHC17/13 S-Acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-STRING PROTEIN; HUNTINGTIN-INTERACTING PROTEIN-14; DHHC-PALMITOYL-TRANSFERASES; LEUCINE ZIPPER PROTEIN; SHORT LINEAR MOTIFS; CAENORHABDITIS-ELEGANS; SUBSTRATE RECOGNITION; MEMBRANE INTERACTIONS; REGION PREDICTIONS; STRUCTURAL BASIS	S-Acylation is a major post-translational modification affecting several cellular processes. It is particularly important for neuronal functions. This modification is catalyzed by a family of transmembrane S-acyltransferases that contain a conserved zinc finger DHHC (zDHHC) domain. Typically, eukaryote genomes encode for 7-24 distinct zDHHC enzymes, with two members also harboring an ankyrin repeat (AR) domain at their cytosolic N termini. The AR domain of zDHHC enzymes is predicted to engage in numerous interactions and facilitates both substrate recruitment and S-acylation-independent functions; however, the sequence/structural features recognized by this module remain unknown. The two mammalian AR-containing S-acyltransferases are the Golgi-localized zDHHC17 and zDHHC13, also known as Huntingtin-interacting proteins 14 and 14-like, respectively; they are highly expressed in brain, and their loss in mice leads to neuropathological deficits that are reminiscent of Huntington's disease. Here, we report that zDHHC17 and zDHHC13 recognize, via their AR domain, evolutionary conserved and closely related sequences of a [VIAP][VIT] XXQP consensus in SNAP25, SNAP23, cysteine string protein, Huntingtin, cytoplasmic linker protein 3, and microtubule-associated protein 6. This novel AR-binding sequence motif is found in regions predicted to be unstructured and is present in a number of zDHHC17 substrates and zDHHC17/13-interacting S-acylated proteins. This is the first study to identify a motif recognized by AR-containing zDHHCs.	[Lemonidis, Kimon; Sanchez-Perez, Maria C.; Chamberlain, Luke H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland	University of Strathclyde	Chamberlain, LH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	luke.chamberlain@strath.ac.uk		Lemonidis, Kimon/0000-0003-1332-6002	Wellcome Trust [WT094184MA]; Medical Research Council [0601597/2]; MRC [G0601597] Funding Source: UKRI; Medical Research Council [G0601597] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Wellcome Trust Grant WT094184MA and Medical Research Council Grant 0601597/2. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold C, 2004, J EXP BIOL, V207, P1323, DOI 10.1242/jeb.00898; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Bannan Barbra A, 2008, Fly (Austin), V2, P198; Bennett V, 2013, CURR TOP MEMBR, V72, P1, DOI 10.1016/B978-0-12-417027-8.00001-5; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Blaskovic S, 2014, CHEM PHYS LIPIDS, V180, P44, DOI 10.1016/j.chemphyslip.2014.02.001; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Butland SL, 2014, HUM MOL GENET, V23, P4142, DOI 10.1093/hmg/ddu137; Chamberlain LH, 1996, J BIOL CHEM, V271, P7320, DOI 10.1074/jbc.271.13.7320; Chen LS, 2001, J CELL BIOL, V154, P841, DOI 10.1083/jcb.200009004; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Edmonds MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-841; Frenal K, 2013, TRAFFIC, V14, P895, DOI 10.1111/tra.12081; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gao TY, 2009, PROTEINS, V76, P772, DOI 10.1002/prot.22452; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Gory-Faure S, 2006, J BIOL CHEM, V281, P28387, DOI 10.1074/jbc.M603380200; Gory-Faure S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114905; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Grefen Christopher, 2009, V479, P217, DOI 10.1007/978-1-59745-289-2_14; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Harada T, 2003, GENES CELLS, V8, P493, DOI 10.1046/j.1365-2443.2003.00650.x; Hemsley PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028799; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Lemonidis K, 2014, MOL BIOL CELL, V25, P3870, DOI 10.1091/mbc.E14-06-1169; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Liu ZR, 2014, PROTEIN SCI, V23, P539, DOI 10.1002/pro.2443; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Milde S, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582338; Milnerwood AJ, 2013, P NATL ACAD SCI USA, V110, P20296, DOI 10.1073/pnas.1222384110; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Ren WY, 2013, MOL CELL BIOL, V33, P4255, DOI 10.1128/MCB.00527-13; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sanders SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090669; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Song IW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092194; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Stowers RS, 2007, J NEUROSCI, V27, P12874, DOI 10.1523/JNEUROSCI.2464-07.2007; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tom CTMB, 2013, ACS CHEM BIOL, V8, P46, DOI 10.1021/cb300607e; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Wan JM, 2013, CHEM BIOL, V20, P1421, DOI 10.1016/j.chembiol.2013.09.018; Xu C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002979; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang G, 2012, CELL DEATH DIFFER, V19, P553, DOI 10.1038/cdd.2011.124; Yang G, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003727; Yang G, 2011, J NEUROSCI, V31, P11980, DOI 10.1523/JNEUROSCI.2510-11.2011; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002	72	45	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21939	21950		10.1074/jbc.M115.657668	http://dx.doi.org/10.1074/jbc.M115.657668			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198635	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000360968500015
J	Weston, C; Lu, J; Li, NC; Barkan, K; Richards, GO; Roberts, DJ; Skerry, TM; Poyner, D; Pardamwar, M; Reynolds, CA; Dowell, SJ; Willars, GB; Ladds, G				Weston, Cathryn; Lu, Jing; Li, Naichang; Barkan, Kerry; Richards, Gareth O.; Roberts, David J.; Skerry, Timothy M.; Poyner, David; Pardamwar, Meenakshi; Reynolds, Christopher A.; Dowell, Simon J.; Willars, Gary B.; Ladds, Graham			Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-RELATED PEPTIDE; CALCITONIN-RECEPTOR; COUPLED RECEPTORS; DIFFERENTIALLY MODULATE; ADENYLYL-CYCLASE; AMYLIN RECEPTORS; YEAST; OXYNTOMODULIN; AGONIST; ADRENOMEDULLIN	The glucagon and glucagon-like peptide-1 (GLP-1) receptors play important, opposing roles in regulating blood glucose levels. Consequently, these receptors have been identified as targets for novel diabetes treatments. However, drugs acting at the GLP-1 receptor, although having clinical efficacy, have been associated with severe adverse side-effects, and targeting of the glucagon receptor has yet to be successful. Here we use a combination of yeast reporter assays and mammalian systems to provide a more complete understanding of glucagon receptor signaling, considering the effect of multiple ligands, association with the receptor-interacting protein receptor activity-modifying protein-2 (RAMP2), and the role of individual G protein alpha-subunits. We demonstrate that RAMP2 alters both ligand selectivity and G protein preference of the glucagon receptor. Importantly, we also uncover novel cross-reactivity of therapeutically used GLP-1 receptor ligands at the glucagon receptor that is abolished by RAMP2 interaction. This study reveals the glucagon receptor as a previously unidentified target for GLP-1 receptor agonists and highlights a role for RAMP2 in regulating its pharmacology. Such previously unrecognized functions of RAMPs highlight the need to consider all receptor-interacting proteins in future drug development.	[Weston, Cathryn; Barkan, Kerry; Ladds, Graham] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Lu, Jing; Li, Naichang; Willars, Gary B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Richards, Gareth O.; Roberts, David J.; Skerry, Timothy M.] Univ Sheffield, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield S10 2RX, S Yorkshire, England; [Poyner, David] Aston Univ, Sch Life Sci, Birmingham B4 7ET, W Midlands, England; [Pardamwar, Meenakshi; Reynolds, Christopher A.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Dowell, Simon J.] GlaxoSmithKline, Dept Biol Sci, Mol Discovery Res, Stevenage SG1 2NY, Herts, England; [Ladds, Graham] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Warwick; University of Leicester; University of Sheffield; Aston University; University of Essex; GlaxoSmithKline; University of Cambridge	Weston, C (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England.	caw38@leicester.ac.uk; grl30@cam.ac.uk	; Reynolds, Christopher/G-1036-2010	Dowell, Simon/0000-0001-6499-7573; Richards, Gareth Owain/0000-0001-7984-6882; Skerry, Timothy/0000-0003-1319-5575; Poyner, David R/0000-0003-1590-112X; Ladds, Graham/0000-0001-7320-9612; Reynolds, Christopher/0000-0001-9267-5141	Warwick Impact Fund; Biotechnology and Biological Sciences Research Council [BB/G01227X/1, BB/F008392/1, BB/M007529/1, BB/M000176/1]; Warwick Research Development Fund [RD13301]; Birmingham Science City Research Alliance; BBSRC [BB/G01227X/1, BB/M00015X/1, BB/M006883/1, BB/F008392/1, BB/M00015X/2, BB/M007529/1, BB/M000176/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M00015X/2, BB/M00015X/1, BB/M006883/1] Funding Source: researchfish; Prostate Cancer UK [PA12-12] Funding Source: researchfish	Warwick Impact Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Warwick Research Development Fund; Birmingham Science City Research Alliance; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Prostate Cancer UK	This work was supported by the Warwick Impact Fund (to C. W. and G. L.), Biotechnology and Biological Sciences Research Council Grants BB/G01227X/1 (to G. L.), BB/F008392/1 (to T. S., G. R., and D. R.), and BB/M007529/1 and BB/M000176/1 (to D. P.); Warwick Research Development Fund Grant RD13301 (to C. W. and G. L.); and the Birmingham Science City Research Alliance (to G. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Ali S, 2015, MOL METAB, V4, P132, DOI 10.1016/j.molmet.2014.11.005; Bagger JI, 2011, DIABETES OBES METAB, V13, P965, DOI 10.1111/j.1463-1326.2011.01427.x; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Bertheleme N, 2013, BRIT J PHARMACOL, V169, P988, DOI 10.1111/bph.12165; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bond M, 2013, YEAST, V30, P145, DOI 10.1002/yea.2949; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brown AJ, 2011, J PHARMACOL EXP THER, V337, P236, DOI 10.1124/jpet.110.172650; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; Croft W, 2013, J BIOL CHEM, V288, P27327, DOI 10.1074/jbc.M113.497826; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GRADY T, 1987, J BIOL CHEM, V262, P15514; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hay DL, 2006, MOL PHARMACOL, V70, P1984, DOI 10.1124/mol.106.027953; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Husmann K, 2000, MOL CELL ENDOCRINOL, V162, P35, DOI 10.1016/S0303-7207(00)00212-4; Jorgensen R, 2007, J PHARMACOL EXP THER, V322, P148, DOI 10.1124/jpet.107.120006; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Marks J, 2003, CLIN SCI, V104, P253, DOI 10.1042/CS20020336; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Morfis M, 2008, ENDOCRINOLOGY, V149, P5423, DOI 10.1210/en.2007-1735; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Rudling JE, 1999, BRIT J PHARMACOL, V127, P877, DOI 10.1038/sj.bjp.0702614; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Schepp W, 1996, DIGESTION, V57, P398, DOI 10.1159/000201367; Scott DA, 2013, DIABETES OBES METAB, V15, P213, DOI 10.1111/dom.12007; Shen DM, 2011, EXPERT OPIN THER PAT, V21, P1211, DOI 10.1517/13543776.2011.587001; Shyu JF, 1999, EUR J BIOCHEM, V262, P95, DOI 10.1046/j.1432-1327.1999.00346.x; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; Stewart GD, 2009, J PHARMACOL EXP THER, V331, P277, DOI 10.1124/jpet.109.158667; Totsune K, 2000, CLIN SCI, V99, P541, DOI 10.1042/CS20000108; Udawela M, 2006, MOL PHARMACOL, V69, P1984, DOI 10.1124/mol.105.021915; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Usdin TB, 1999, NAT NEUROSCI, V2, P941, DOI 10.1038/14724; Watkins HA, 2014, BRIT J PHARMACOL, V171, P772, DOI 10.1111/bph.12508; Weston C, 2014, BRIT J PHARMACOL, V171, P3651, DOI 10.1111/bph.12716; Wootten D, 2013, BRIT J PHARMACOL, V168, P822, DOI 10.1111/j.1476-5381.2012.02202.x; Wynne K, 2005, DIABETES, V54, P2390, DOI 10.2337/diabetes.54.8.2390; Xu YZ, 2009, J RECEPT SIG TRANSD, V29, P318, DOI 10.3109/10799890903295150	50	42	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23009	23022		10.1074/jbc.M114.624601	http://dx.doi.org/10.1074/jbc.M114.624601			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26198634	hybrid, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000361685500013
J	Fleury, M; Marcelo, W; Vasquez, RA; Gonzalez, LA; Bustamante, RO				Fleury, Marina; Marcelo, Wara; Vasquez, Rodrigo A.; Alberto Gonzalez, Luis; Bustamante, Ramiro O.			Recruitment Dynamics of the Relict Palm, Jubaea chilensis: Intricate and Pervasive Effects of Invasive Herbivores and Nurse Shrubs in Central Chile	PLOS ONE			English	Article							ORYCTOLAGUS-CUNICULUS; SPATIAL-DISTRIBUTION; EUROPEAN RABBITS; TREE SAPLINGS; BIOTIC STRESS; FACILITATION; VEGETATION; PLANTS; PATTERNS; PREDATOR	Shrubs can have a net positive effect on the recruitment of other species, especially relict species in dry-stressful conditions. We tested the effects of nurse shrubs and herbivory defoliation on performance (survival and growth) of nursery-grown seedlings of the largest living palm, the relict wine palm Jubaea chilensis. During an 18-month period, a total of more than 300 seedlings were exposed to of four possible scenarios produced by independently weakening the effects of nurse shrubs and browsers. The experiment followed a two-way fully factorial design. We found consistent differences in survival between protected and unprotected seedlings (27.5% and 0.7%, respectively), and herbivory had a dramatic and overwhelmingly negative effect on seedling survival. The invasive rabbit (Oryctolagus cuniculus) is clearly creating a critical bottleneck in the regeneration process and might, therefore, partially explain the general lack of natural regeneration of wine palms under natural conditions. Apparently biotic filters mediated by ecological interactions are more relevant in the early stages of recruitment than abiotic, at least in invaded sites of central Chile. Our data reveal that plant-plant facilitation relationship may be modulated by plant-animal interactions, specifically by herbivory, a common and widespread ecological interaction in arid and semi-arid environments whose role has been frequently neglected. Treatments that protect young wine palm seedlings are mandatory to enable the seedlings to attain a height at which shoots are no longer vulnerable to browsing. Such protection is an essential first step toward the conservation and reintroduction of this emblematic and threatened species.	[Fleury, Marina; Alberto Gonzalez, Luis] Univ Chile, Fac Ciencias Forest & Conservac Nat, Santiago, Chile; [Fleury, Marina; Marcelo, Wara; Vasquez, Rodrigo A.; Bustamante, Ramiro O.] Univ Chile, Dept Ciencias Ecol, Inst Ecol & Biodiversidad, Santiago, Chile	Universidad de Chile; Universidad de Chile	Fleury, M (corresponding author), Univ Chile, Fac Ciencias Forest & Conservac Nat, Santiago, Chile.	marina.fleury@mac.com	BUSTAMANTE, RAMIRO/I-7353-2019		Fondecyt [1140548]; CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) [PFB-23]; Millennium Scientific Initiative [ICM-P05-002]; International Palm Society; CNPq; CONICYT-ICM	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Millennium Scientific Initiative; International Palm Society; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CONICYT-ICM	The authors thank Fondecyt (1140548), CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) (PFB-23), the Millennium Scientific Initiative (ICM-P05-002), and the International Palm Society for financial support. MF received a fellowship from CNPq, and WM, RV and RB received fellowships from CONICYT-ICM. In addition, MF would like to thank the Institutional Excellence Incentive/PEEI, Universidad de Chile. The sources of funding agencies have not affected the research design, the collection and interpretation of data, or the writing of the manuscript in any way.	Alberto Gonzalez Luis, 2009, Palms, V53, P68; Allcock KG, 2004, OECOLOGIA, V138, P231, DOI 10.1007/s00442-003-1420-3; Armesto J.J., 2007, PHYS GEOGRAPHY S AM, P184, DOI DOI 10.1093/OSO/9780195313413.003.0019; ARMESTO JJ, 1978, J ECOL, V66, P881, DOI 10.2307/2259301; Armesto JJ., 1995, ECOLOGY BIOGEOGRAPHY, P418; Arroyo MTK, 1995, ECOL STU AN, P43, DOI DOI 10.1007/978-1-4612-2490-7_; Baraza E, 2006, OIKOS, V113, P148, DOI 10.1111/j.0030-1299.2006.14265.x; Barrett MA, 2006, BIOL CONSERV, V129, P100, DOI 10.1016/j.biocon.2005.10.026; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bozinovic F, 1997, COMP BIOCHEM PHYS A, V118, P625, DOI 10.1016/S0300-9629(96)00480-X; Bustamante RO, 2000, PLANT ECOL, V147, P173, DOI 10.1023/A:1009852400814; Castro J, 2002, RESTOR ECOL, V10, P297, DOI 10.1046/j.1526-100X.2002.01022.x; Collett, 2003, MODELLING SURVIVAL D; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; COX DR, 1972, J R STAT SOC B, V34, P187; Davey C, 2006, ECOSYSTEMS, V9, P992, DOI 10.1007/s10021-004-0173-0; ElOrtegui S, 2002, CAMPANA NATL PARK OR; Fleury M, 2015, BASIC APPL ECOL, V16, P141, DOI 10.1016/j.baae.2014.11.006; FrancoPizana JG, 1996, J VEG SCI, V7, P257, DOI 10.2307/3236326; FUENTES ER, 1986, OECOLOGIA, V68, P358, DOI 10.1007/BF01036739; FUENTES ER, 1984, OECOLOGIA, V62, P405, DOI 10.1007/BF00384275; FUENTES ER, 1983, OECOLOGIA, V58, P411, DOI 10.1007/BF00385244; Garcia D, 2005, ECOSCIENCE, V12, P223, DOI 10.2980/i1195-6860-12-2-223.1; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Gomez JM, 2005, ECOL MONOGR, V75, P231, DOI 10.1890/04-0722; Gomez JM, 2003, FOREST ECOL MANAG, V180, P125, DOI 10.1016/S0378-1127(02)00608-4; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gomez-Aparicio L, 2008, J VEG SCI, V19, P161, DOI 10.3170/2008-8-18347; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Graff P, 2011, OIKOS, V120, P1023, DOI 10.1111/j.1600-0706.2010.19059.x; Hastwell GT, 2003, J ECOL, V91, P941, DOI 10.1046/j.1365-2745.2003.00832.x; Henriquez CA, 2001, BIOL CONSERV, V98, P69, DOI 10.1016/S0006-3207(00)00143-9; Holmgren M, 2000, PLANT ECOL, V147, P49, DOI 10.1023/A:1009804726307; Holmgren Milena, 2002, Biological Invasions, V4, P25, DOI 10.1023/A:1020535628776; JAKSIC FM, 1979, J MAMMAL, V60, P207, DOI 10.2307/1379775; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kissling WD, 2012, P NATL ACAD SCI USA, V109, P7379, DOI 10.1073/pnas.1120467109; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MACDONALD IAW, 1988, BIOL CONSERV, V44, P37, DOI 10.1016/0006-3207(88)90004-3; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; Maher CT, 2015, FOREST ECOL MANAG, V342, P76, DOI 10.1016/j.foreco.2015.01.015; Marcelo W., 2007, JUBAEA CHILENSIS MOL; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Perea R, 2014, EUR J FOREST RES, V133, P525, DOI 10.1007/s10342-014-0782-x; Perea R, 2014, FOREST ECOL MANAG, V312, P47, DOI 10.1016/j.foreco.2013.10.022; Pias B, 2014, FOREST ECOL MANAG, V329, P186, DOI 10.1016/j.foreco.2014.06.021; Pliscoff P, 2011, ENVIRON CONSERV, V38, P303, DOI 10.1017/S0376892911000208; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saiz H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040551; Schenk HJ, 2003, J ECOL, V91, P383, DOI 10.1046/j.1365-2745.2003.00782.x; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; SIMONETTI JA, 1982, OECOLOGIA, V54, P55, DOI 10.1007/BF00541107; Smit C, 2007, OECOLOGIA, V152, P265, DOI 10.1007/s00442-006-0650-6; Smit C, 2009, J ECOL, V97, P1215, DOI 10.1111/j.1365-2745.2009.01555.x; Spinoni J, 2014, INT J CLIMATOL, V34, P2792, DOI 10.1002/joc.3875; Svenning JC, 1999, J ECOL, V87, P55, DOI 10.1046/j.1365-2745.1999.00329.x; Terborgh J, 2006, J ECOL, V94, P253, DOI 10.1111/j.1365-2745.2006.01106.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Valiente-Banuet A, 2006, P NATL ACAD SCI USA, V103, P16812, DOI 10.1073/pnas.0604933103; Van Staalduinen MA, 2007, APPL VEG SCI, V10, P299, DOI 10.1111/j.1654-109X.2007.tb00428.x; Villasenor R, 1980, ATTI I BOT LAB CRITT, V6, P69	63	10	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133559	10.1371/journal.pone.0133559	http://dx.doi.org/10.1371/journal.pone.0133559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218100	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900035
J	Hoffmann, W; Bahr, J; Weitmann, K; Herold, R; Kohlmann, T; van den Berg, N				Hoffmann, Wolfgang; Bahr, Jeanette; Weitmann, Kerstin; Herold, Robert; Kohlmann, Thomas; van den Berg, Neeltje			Not Just the Demographic Change - The Impact of Trends in Risk Factor Prevalences on the Prediction of Future Cases of Myocardial Infarction	PLOS ONE			English	Article							HEALTH; POPULATION; MORTALITY; NUMBERS; EVENTS; REGION; CARE	Background Previous predictions of population morbidity consider demographic changes only. To model future morbidity, however, changes in prevalences of risk factors should be considered. We calculated the number of incident cases of first myocardial infarction (MI) in Mecklenburg-Western Pomerania in 2017 considering the effects of demographic changes and trends in the prevalences of major risk factors simultaneously. Methods Data basis of the analysis were two population-based cohorts of the German Study of Health in Pomerania (SHIP-baseline [1997-2001] and the 5-year follow-up and SHIP-Trend- baseline [2008-2011] respectively). SHIP-baseline data were used to calculate the initial coefficients for major risk factors for MI with a Poisson regression model. The dependent variable was the number of incident cases of MI between SHIP-baseline and SHIP-5-year follow-up. Explanatory variables were sex, age, a validated diagnosis of hypertension and/or diabetes, smoking, waist circumference (WC), increased blood levels of triglycerides (TG) and low-density-lipoprotein cholesterol (LDL), and low blood levels of high-density-lipoprotein cholesterol (HDL). Applying the coefficients determined for SHIP baseline to risk factor prevalences, derived from the new cohort SHIP-Trend together with population forecast data, we calculated the projected number of incident cases of MI in 2017. Results Except for WC and smoking in females, prevalences of risk factors in SHIP-Trend-baseline were lower compared to SHIP-baseline. Based on demographic changes only, the calculated incidence of MI for 2017 compared to the reference year 2006 yields an increase of MI (males: + 11.5%, females: + 8.0%). However, a decrease of MI (males: - 23.7%, females: -17.1%) is shown considering the changes in the prevalences of risk factors in the projection. Conclusions The predicted number of incident cases of MI shows large differences between models with and without considering changes in the prevalences of major risk factors. Hence, the prediction of incident MI should preferably not only be based on demographic changes.	[Hoffmann, Wolfgang; Bahr, Jeanette; Weitmann, Kerstin; Herold, Robert; Kohlmann, Thomas; van den Berg, Neeltje] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Hoffmann, Wolfgang; Weitmann, Kerstin; van den Berg, Neeltje] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany	Greifswald Medical School; German Centre for Cardiovascular Research	Hoffmann, W (corresponding author), Univ Med Greifswald, Inst Community Med, Greifswald, Germany.	wolfgang.hoffmann@uni-greifswald.de						[Anonymous], 2008, DEM WAND DEUTSCHL AU; Boateng S, 2013, DM-DIS MON, V59, P83, DOI 10.1016/j.disamonth.2012.12.004; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cassar A, 2009, MAYO CLIN PROC, V84, P1130, DOI 10.4065/mcp.2009.0391; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Fendrich K, 2007, J PUBLIC HEALTH-HEID, V15, P345, DOI 10.1007/s10389-007-0142-0; Foerch C, 2008, DTSCH ARZTEBL INT, V105, P467, DOI 10.3238/arztebl.2008.0467; Germano G, 2012, EUR HEART J, V33, P137; Guo J, 2013, CHINESE MED J-PEKING, V126, P464, DOI 10.3760/cma.j.issn.0366-6999.20113076; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS31, DOI 10.1055/s-2005-858241; Neumann T, 2009, DTSCH ARZTEBL INT, V106, P269, DOI 10.3238/arztebl.2009.0269; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Schulz E, 2004, HEALTH POLICY, V67, P57, DOI 10.1016/S0168-8510(03)00083-6; Schunkert H, 2010, EUR HEART J, V31, P918, DOI 10.1093/eurheartj/ehq038; Siewert U, 2010, DTSCH ARZTEBL INT, V107, P328, DOI 10.3238/arztebl.2010.0328; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Verschuren JJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056262; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0131256	10.1371/journal.pone.0131256	http://dx.doi.org/10.1371/journal.pone.0131256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214851	gold, Green Published, Green Submitted			2022-12-26	WOS:000358594300005
J	Legros, A; Modolo, J; Brown, S; Roberston, J; Thomas, AW				Legros, Alexandre; Modolo, Julien; Brown, Samantha; Roberston, John; Thomas, Alex W.			Effects of a 60 Hz Magnetic Field Exposure Up to 3000 mu T on Human Brain Activation as Measured by Functional Magnetic Resonance Imaging	PLOS ONE			English	Article							FREQUENCY-DEPENDENT CHANGES; CONSCIOUS RESTING STATE; CEREBRAL-BLOOD-FLOW; MENTAL ROTATION; ELECTROMAGNETIC-FIELDS; SYNAPTIC PLASTICITY; COGNITIVE FUNCTION; HEART-RATE; POWER; MEMORY	Several aspects of the human nervous system and associated motor and cognitive processes have been reported to be modulated by extremely low-frequency (ELF, < 300 Hz) time-varying Magnetic Fields (MF). Due do their worldwide prevalence; power-line frequencies (60 Hz in North America) are of particular interest. Despite intense research efforts over the last few decades, the potential effects of 60 Hz MF still need to be elucidated, and the underlying mechanisms to be understood. In this study, we have used functional Magnetic Resonance Imaging (fMRI) to characterize potential changes in functional brain activation following human exposure to a 60 Hz MF through motor and cognitive tasks. First, pilot results acquired in a first set of subjects (N=9) were used to demonstrate the technical feasibility of using fMRI to detect subtle changes in functional brain activation with 60 Hz MF exposure at 1800 mu T. Second, a full study involving a larger cohort of subjects tested brain activation during 1) a finger tapping task (N=20), and 2) a mental rotation task (N=21); before and after a one-hour, 60 Hz, 3000 mu T MF exposure. The results indicate significant changes in task-induced functional brain activation as a consequence of MF exposure. However, no impact on task performance was found. These results illustrate the potential of using fMRI to identify MF-induced changes in functional brain activation, suggesting that a one-hour 60 Hz, 3000 mu T MF exposure can modulate activity in specific brain regions after the end of the exposure period (i.e., residual effects). We discuss the possibility that MF exposure at 60 Hz, 3000 mu T may be capable of modulating cortical excitability via a modulation of synaptic plasticity processes.	[Legros, Alexandre; Modolo, Julien; Brown, Samantha; Roberston, John; Thomas, Alex W.] Lawson Hlth Res Inst, Human Threshold Res Grp, London, ON, Canada; [Legros, Alexandre; Modolo, Julien; Roberston, John; Thomas, Alex W.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Legros, Alexandre; Modolo, Julien; Thomas, Alex W.] Univ Western Ontario, Dept Med Imaging, London, ON, Canada; [Legros, Alexandre] Univ Western Ontario, Sch Kinesiol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Legros, A (corresponding author), Lawson Hlth Res Inst, Human Threshold Res Grp, London, ON, Canada.	alegros@lawsonimaging.ca	Modolo, Julien G/B-5714-2015; Modolo, Julien/M-5120-2018	Modolo, Julien G/0000-0002-5973-7571; Modolo, Julien/0000-0002-5973-7571; Legros, Alexandre/0000-0003-2532-6624	HydroQuebec (Canada); EDF-RTE (France); CIHR (Canada) [187204]; CFI/ORF (Canada, Biomedical Multimodality Hybrid Imaging) [11358]; Lawson Health Research Institute	HydroQuebec (Canada); EDF-RTE (France); CIHR (Canada)(Canadian Institutes of Health Research (CIHR)); CFI/ORF (Canada, Biomedical Multimodality Hybrid Imaging); Lawson Health Research Institute	This project was sponsored by: HydroQuebec (Canada) (http://www.hydroquebec.com/en/); EDF-RTE (France) (http://www.edf.com/the-edf-group-42667.html) (http://www.rte-france.com/fr/); CIHR (Canada, grant #187204) (http://www.cihr-irsc.gc.ca/e/193.html); CFI/ORF (Canada, Biomedical Multimodality Hybrid Imaging - grant #11358) (http://www.innovation.ca/en); and the Lawson Health Research Institute (http://www.lhrionhealth.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; [Anonymous], C956 IEEE; Beuter A, 2009, CHAOS, V19, DOI 10.1063/1.3127585; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Burton H, 1999, CEREB CORTEX, V9, P662, DOI 10.1093/cercor/9.7.662; Cash RF, 2014, CEREB CORTEX; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Cook CM, 2005, BIOELECTROMAGNETICS, V26, P367, DOI 10.1002/bem.20113; Cook CM, 2004, BIOELECTROMAGNETICS, V25, P196, DOI 10.1002/bem.10188; COOK MR, 1992, BIOELECTROMAGNETICS, V13, P261, DOI 10.1002/bem.2250130403; Corbacio M, 2011, BIOELECTROMAGNETICS, V32, P620, DOI 10.1002/bem.20676; Corballis MC, 1997, BRAIN LANG, V57, P100, DOI 10.1006/brln.1997.1835; Crasson M, 2003, RADIAT PROT DOSIM, V106, P333, DOI 10.1093/oxfordjournals.rpd.a006369; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Ghione S, 2005, NEUROSCI LETT, V382, P112, DOI 10.1016/j.neulet.2005.02.072; Ghione S, 2004, BIOELECTROMAGNETICS, V25, P167, DOI 10.1002/bem.10180; Gianni M, 2006, BIOL CYBERN, V94, P118, DOI 10.1007/s00422-005-0029-5; Graham C, 2000, BIOELECTROMAGNETICS, V21, P413, DOI 10.1002/1521-186X(200009)21:6<413::AID-BEM1>3.0.CO;2-1; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Heusser K, 1997, NEUROSCI LETT, V239, P57, DOI 10.1016/S0304-3940(97)00881-1; Horowitz AL, 1995, MRI PHYS RADIOLOGIST; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Johansen-Berg H, 2000, NEUROREPORT, V11, P1237, DOI 10.1097/00001756-200004270-00019; JOHNSON AM, 1990, PERCEPT MOTOR SKILL, V71, P803, DOI 10.2466/PMS.71.7.803-806; JONES B, 1982, CORTEX, V18, P501, DOI 10.1016/S0010-9452(82)80049-X; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Legros A, 2005, BIOELECTROMAGNETICS, V26, P657, DOI 10.1002/bem.20161; Legros A, 2010, REV ELECT ELECT REE, V5, P44; Legros A, 2011, EUR J APPL PHYSL; Legros A, 2006, MED ENG PHYS, V28, P827, DOI 10.1016/j.medengphy.2005.11.003; Legros A, 2006, NEUROTOXICOLOGY, V27, P534, DOI 10.1016/j.neuro.2006.02.007; LOVSUND P, 1980, MED BIOL ENG COMPUT, V18, P326, DOI 10.1007/BF02443387; LOVSUND P, 1979, ACTA OPHTHALMOL, V57, P812; Lyskov E, 2001, BIOELECTROMAGNETICS, V22, P457, DOI 10.1002/bem.73; LYSKOV E, 1993, INT J PSYCHOPHYSIOL, V14, P227, DOI 10.1016/0167-8760(93)90036-O; LYSKOV EB, 1993, BIOELECTROMAGNETICS, V14, P87, DOI 10.1002/bem.2250140202; Marino AA, 2004, CLIN NEUROPHYSIOL, V115, P1195, DOI 10.1016/j.clinph.2003.12.023; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Modolo J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00034; Modolo J, 2010, IEEE 5 INT C BIOINSP, P2010; Modolo J, 2013, ELECTROMAGN BIOL MED, V32, P137, DOI 10.3109/15368378.2013.776341; Mourao-Miranda J, 2009, J COGNITIVE NEUROSCI, V21, P890, DOI 10.1162/jocn.2009.21078; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Preece AW, 1998, INT J RADIAT BIOL, V74, P463, DOI 10.1080/095530098141339; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Richter W, 2000, J COGNITIVE NEUROSCI, V12, P310, DOI 10.1162/089892900562129; Riecker A, 2003, NEUROIMAGE, V18, P731, DOI 10.1016/S1053-8119(03)00003-X; Robertson JA, 2010, J R SOC INTERFACE, V7, P467, DOI 10.1098/rsif.2009.0205; Sadato N, 1997, J CEREBR BLOOD F MET, V17, P670; Sadato N, 1996, J CEREBR BLOOD F MET, V16, P23, DOI 10.1097/00004647-199601000-00003; Sait ML, 1999, MED ENG PHYS, V21, P361, DOI 10.1016/S1350-4533(99)00062-4; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sastre A, 2000, CLIN NEUROPHYSIOL, V111, P1942, DOI 10.1016/S1388-2457(00)00438-7; Sastre A, 1998, BIOELECTROMAGNETICS, V19, P98, DOI 10.1002/(SICI)1521-186X(1998)19:2<98::AID-BEM7>3.0.CO;2-Z; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Stodilka RZ, 2011, NEUROCOMPUTING, V74, P2164, DOI 10.1016/j.neucom.2011.01.025; Stuchly MA, 2002, HEALTH PHYS, V83, P333, DOI 10.1097/00004032-200209000-00003; Tabor Z, 2004, BIOELECTROMAGNETICS, V25, P474, DOI 10.1002/bem.20039; Thomas AW, 2001, NEUROSCI LETT, V297, P121, DOI 10.1016/S0304-3940(00)01688-8; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Toma Keiichiro, 2002, Magn Reson Med Sci, V1, P109, DOI 10.2463/mrms.1.109; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; Wexler BE, 1997, MAGN RESON IMAGING, V15, P385, DOI 10.1016/S0730-725X(96)00232-9; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	73	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0132024	10.1371/journal.pone.0132024	http://dx.doi.org/10.1371/journal.pone.0132024			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214312	Green Submitted, Green Published, gold			2022-12-26	WOS:000358594300008
J	Bidmos, FA; Chan, H; Praekelt, U; Tauseef, I; Ali, YM; Kaczmarski, EB; Feavers, I; Bayliss, CD				Bidmos, Fadil A.; Chan, Hannah; Praekelt, Uta; Tauseef, Isfahan; Ali, Youssif M.; Kaczmarski, Edward B.; Feavers, Ian; Bayliss, Christopher D.			Investigation into the Antigenic Properties and Contributions to Growth in Blood of the Meningococcal Haemoglobin Receptors, HpuAB and HmbR	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; TRANSFERRIN-BINDING PROTEINS; NEISSERIA-MENINGITIDIS; GROUP-B; PHASE VARIATION; BACTERICIDAL ANTIBODIES; IRON-METABOLISM; STRAIN COVERAGE; IGG SUBCLASS; WHOLE-BLOOD	Acquisition of iron from host complexes is mediated by four surface-located receptors of Neisseria meningitidis. The HmbR protein and heterodimeric HpuAB complex bind to haemoglobin whilst TbpBA and LbpBA bind iron-loaded transferrin and lactoferrin complexes, respectively. The haemoglobin receptors are unevenly distributed; disease-causing meningococcal isolates encode HmbR or both receptors while strains with only HpuAB are rarely-associated with disease. Both these receptors are subject to phase variation and 70-90% of disease isolates have one or both of these receptors in an ON expression state. The surface- expression, ubiquity and association with disease indicate that these receptors could be potential virulence factors and vaccine targets. To test for a requirement during disease, an hmbR deletion mutant was constructed in a strain (MC58) lacking HpuAB and in both a wild-type and TbpBA deletion background. The hmbR mutant exhibited an identical growth pattern to wild-type in whole blood from healthy human donors whereas growth of the tbpBA mutant was impaired. These results suggest that transferrin is the major source of iron for N. meningitidis during replication in healthy human blood. To examine immune responses, polyclonal antisera were raised against His-tagged purified-recombinant variants of HmbR, HpuA and HpuB in mice using monolipopolysaccharide as an adjuvant. Additionally, monoclonal antibodies were raised against outer membrane loops of HmbR presented on the surface of EspA, an E. coli fimbrial protein. All antisera exhibited specific reactivity in Western blots but HmbR and HpuA polyclonal sera were reactive against intactmeningococcal cells. None of the sera exhibited bactericidal activity against iron-induced wild-type meningococci. These findings suggest that the HmbR protein is not required during the early stages of disease and that immune responses against these receptors may not be protective.	[Bidmos, Fadil A.; Praekelt, Uta; Tauseef, Isfahan; Bayliss, Christopher D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Chan, Hannah; Feavers, Ian] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Ali, Youssif M.] Univ Leicester, Dept Infect Inflammat & Immun, Leicester, Leics, England; [Kaczmarski, Edward B.] Publ Hlth England, Meningococcal Reference Unit, Manchester, Lancs, England; [Ali, Youssif M.] Mansoura Univ, Fac Pharm, Dept Microbiol, Mansoura, Egypt	University of Leicester; National Institute for Biological Standards & Control; University of Leicester; Public Health England; Egyptian Knowledge Bank (EKB); Mansoura University	Bayliss, CD (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	cdb12@le.ac.uk	Bidmos, Fadil/AAD-8401-2020; Ali, Youssif M./P-9593-2018	Bidmos, Fadil/0000-0003-2843-409X; Ali, Youssif M./0000-0003-3124-9848; Bayliss, Christopher/0000-0002-5564-2145	Meningitis Research Foundation;  [1002.0]	Meningitis Research Foundation(Meningitis Research Foundation (MRF)); 	This work was funded by the Meningitis Research Foundation (http://www.meningitis.org/). Grant number 1002.0 entitled "Examination of meningococcal haemoglobin receptors as potential vaccine targets" was awarded to HC, EK, IF, and CDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase A, 1998, SCAND J IMMUNOL, V47, P388; Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11425; Alamro M, 2014, INFECT IMMUN, V82, P2472, DOI 10.1128/IAI.01521-14; Bidmos FA, 2011, J CLIN MICROBIOL, V49, P506, DOI 10.1128/JCM.01322-10; BOSLEGO J, 1995, VACCINE, V13, P821, DOI 10.1016/0264-410X(94)00037-N; Bridges KR, 1995, BLOOD PRINCIPLES PRA; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chen CJ, 2002, J BACTERIOL, V184, P420, DOI 10.1128/JB.184.2.420-426.2002; DANVE B, 1993, VACCINE, V11, P1214, DOI 10.1016/0264-410X(93)90045-Y; Deschemin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061050; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Evans NJ, 2010, MICROBIOL-SGM, V156, P1384, DOI 10.1099/mic.0.036475-0; FINNE J, 1983, LANCET, V2, P355; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Galloway Y, 2009, INT J EPIDEMIOL, V38, P413, DOI 10.1093/ije/dyn228; Giuntini S, 2012, INFECT IMMUN, V80, P187, DOI 10.1128/IAI.05956-11; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; GORRINGE AR, 1995, VACCINE, V13, P1207, DOI 10.1016/0264-410X(95)00055-6; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison OB, 2013, MICROBIOL-SGM, V159, P1920, DOI 10.1099/mic.0.068874-0; Harrison OB, 2009, J INFECT DIS, V200, P94, DOI 10.1086/599377; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; ISON CA, 1995, MICROB PATHOGENESIS, V18, P97, DOI 10.1016/S0882-4010(95)90093-4; Jack DL, 2005, J LEUKOCYTE BIOL, V77, P328, DOI 10.1189/jlb.0604342; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; LETENDRE ED, 1987, CANCER METAST REV, V6, P41, DOI 10.1007/BF00047608; Lewis LA, 1998, J BACTERIOL, V180, P6043, DOI 10.1128/JB.180.22.6043-6047.1998; Lewis LA, 1997, MOL MICROBIOL, V23, P737, DOI 10.1046/j.1365-2958.1997.2501619.x; Lewis LA, 1999, MOL MICROBIOL, V32, P977, DOI 10.1046/j.1365-2958.1999.01409.x; LONNERDAL B, 1995, ANNU REV NUTR, V15, P93, DOI 10.1146/annurev.nu.15.070195.000521; Lucidarme J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076932; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; Na N, 2005, CLIN CHEM, V51, P1754, DOI 10.1373/clinchem.2005.055657; Omer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017145; Pelicic V, 2000, J BACTERIOL, V182, P5391, DOI 10.1128/JB.182.19.5391-5398.2000; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Perkins-Balding D, 2003, MICROBIOL-SGM, V149, P3423, DOI 10.1099/mic.0.26448-0; Piet JR, 2011, J BACTERIOL, V193, P2371, DOI 10.1128/JB.01331-10; Praekelt U, 2014, J MED MICROBIOL, V63, P1595, DOI 10.1099/jmm.0.076323-0; Richardson AR, 1999, J BACTERIOL, V181, P2067, DOI 10.1128/JB.181.7.2067-2074.1999; Rohde KH, 2002, MOL MICROBIOL, V43, P335, DOI 10.1046/j.1365-2958.2002.02745.x; Rohde KH, 2004, INFECT IMMUN, V72, P2494, DOI 10.1128/IAI.72.5.2494-2506.2004; Rokbi B, 1997, INFECT IMMUN, V65, P55, DOI 10.1128/IAI.65.1.55-63.1997; ROSENQVIST E, 1995, INFECT IMMUN, V63, P4642, DOI 10.1128/IAI.63.12.4642-4652.1995; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; SCHRYVERS AB, 1990, CAN J MICROBIOL, V36, P145, DOI 10.1139/m90-026; SCHRYVERS AB, 1989, INFECT IMMUN, V57, P2425, DOI 10.1128/IAI.57.8.2425-2429.1989; Seib KL, 2009, INFECT IMMUN, V77, P292, DOI 10.1128/IAI.01071-08; Stojiljkovic I, 1996, J BACTERIOL, V178, P4670, DOI 10.1128/jb.178.15.4670-4678.1996; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Tauseef I, THESIS; Tauseef I, 2013, INFECT IMMUN, V81, P1374, DOI 10.1128/IAI.01358-12; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; Turner PC, 1998, INFECT IMMUN, V66, P5215, DOI 10.1128/IAI.66.11.5215-5223.1998; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Welsch JA, 2007, CLIN VACCINE IMMUNOL, V14, P1596, DOI 10.1128/CVI.00341-07; West D, 2001, INFECT IMMUN, V69, P1561, DOI 10.1128/IAI.69.3.1561-1567.2001; Wyngaarden JB, 1985, CECIL TEXTBOOK OF ME; Zarantonelli ML, 2007, INFECT IMMUN, V75, P5609, DOI 10.1128/IAI.00781-07; Zhao SM, 2010, INFECT IMMUN, V78, P1109, DOI 10.1128/IAI.00363-09; Zhu WM, 2000, J BACTERIOL, V182, P439, DOI 10.1128/JB.182.2.439-447.2000	63	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133855	10.1371/journal.pone.0133855	http://dx.doi.org/10.1371/journal.pone.0133855			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208277	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000156
J	Lee, U; Skinner, JJ; Reinitz, J; Rosner, MR; Kim, EJ				Lee, Unjin; Skinner, John J.; Reinitz, John; Rosner, Marsha Rich; Kim, Eun-Jin			Noise-Driven Phenotypic Heterogeneity with Finite Correlation Time in Clonal Populations	PLOS ONE			English	Article							BREAST-CANCER; TUMOR; MODEL; CANALIZATION; VARIABILITY; EMERGENCE; EVOLUTION; DYNAMICS	There has been increasing awareness in the wider biological community of the role of clonal phenotypic heterogeneity in playing key roles in phenomena such as cellular bet-hedging and decision making, as in the case of the phage-lambda lysis/lysogeny and B. Subtilis competence/vegetative pathways. Here, we report on the effect of stochasticity in growth rate, cellular memory/intermittency, and its relation to phenotypic heterogeneity. We first present a linear stochastic differential model with finite auto-correlation time, where a randomly fluctuating growth rate with a negative average is shown to result in exponential growth for sufficiently large fluctuations in growth rate. We then present a non-linear stochastic selfregulation model where the loss of coherent self-regulation and an increase in noise can induce a shift from bounded to unbounded growth. An important consequence of these models is that while the average change in phenotype may not differ for various parameter sets, the variance of the resulting distributions may considerably change. This demonstrates the necessity of understanding the influence of variance and heterogeneity within seemingly identical clonal populations, while providing a mechanism for varying functional consequences of such heterogeneity. Our results highlight the importance of a paradigm shift from a deterministic to a probabilistic view of clonality in understanding selection as an optimization problem on noise-driven processes, resulting in a wide range of biological implications, from robustness to environmental stress to the development of drug resistance.	[Lee, Unjin] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Skinner, John J.; Rosner, Marsha Rich] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Skinner, John J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Kim, Eun-Jin] Univ Sheffield, Sch Math & Stat, Sheffield, S Yorkshire, England	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Sheffield	Lee, U (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.	unjin@uchicago.edu	Kim, Eun-Jin/I-1261-2019	Kim, Eun-Jin/0000-0001-5607-6635; Lee, UnJin/0000-0003-2424-650X	National Institute of Health [GM 87630, RO1CA-184494]; NATIONAL CANCER INSTITUTE [R01CA184494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197, R01GM087630] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institute of Health grants GM 87630 and RO1CA-184494 to MRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Arkin A, 1998, GENETICS, V149, P1633; Bose T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051903; BUEHRING GC, 1976, CANCER RES, V36, P3742; CALDERON CP, 1991, MATH BIOSCI, V103, P97, DOI 10.1016/0025-5564(91)90093-X; d'Onofrio A, 2009, CHAOS SOLITON FRACT, V41, P875, DOI 10.1016/j.chaos.2008.04.014; Diego D, 2013, J MATH BIOL, V67, P657, DOI 10.1007/s00285-012-0565-2; Dingli D, 2007, CANCER BIOL THER, V6, P383, DOI 10.4161/cbt.6.3.3720; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Frank SA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001296; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Hart D, 1998, BRIT J CANCER, V78, P382, DOI 10.1038/bjc.1998.503; Hasegawa H, 2008, PHYSICA A, V387, P2697, DOI [10.1016/j.physa-2008.01.072, 10.1016/j.physa.2008.01.072]; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; HERNANDEZMACHADO A, 1984, PHYS REV A, V29, P3388, DOI 10.1103/PhysRevA.29.3388; HONEYCUTT RL, 1992, PHYS REV A, V45, P604, DOI 10.1103/PhysRevA.45.604; Kim E, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3033751; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Li DX, 2012, PHYS LETT A, V376, P1771, DOI 10.1016/j.physleta.2012.04.006; Loewenstein Y, 2011, J NEUROSCI, V31, P9481, DOI 10.1523/JNEUROSCI.6130-10.2011; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mombach JCM, 2002, EUROPHYS LETT, V59, P923, DOI 10.1209/epl/i2002-00244-6; Nevozhay D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002480; Newton APL, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4817955; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Royston P, 2001, STAT NEERL, V55, P89, DOI 10.1111/1467-9574.00158; Sahoo S, 2010, PHYSICA A, V389, P1197, DOI 10.1016/j.physa.2009.11.015; Schultz D, 2007, P NATL ACAD SCI USA, V104, P17582, DOI 10.1073/pnas.0707965104; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang NX, 2012, BRAZ J PHYS, V42, P253, DOI 10.1007/s13538-012-0082-1; Weedon-Fekjaer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2092; Whitesell L, 2014, P NATL ACAD SCI USA, V111, P18297, DOI 10.1073/pnas.1421323111; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	37	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0132397	10.1371/journal.pone.0132397	http://dx.doi.org/10.1371/journal.pone.0132397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203903	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358621000008
J	van Hoeven, L; Vergouwe, Y; de Buck, PDM; Luime, JJ; Hazes, JMW; Weel, AEAM				van Hoeven, Lonneke; Vergouwe, Yvonne; de Buck, P. D. M.; Luime, Jolanda J.; Hazes, Johanna M. W.; Weel, Angelique E. A. M.			External Validation of a Referral Rule for Axial Spondyloarthritis in Primary Care Patients with Chronic Low Back Pain	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; GLOBAL BURDEN; DISEASE; PREDICTION; IDENTIFICATION; PERFORMANCE; DISABILITY; DIAGNOSIS	Objectives To validate and optimize a referral rule to identify primary care patients with chronic low back pain (CLBP) suspected for axial spondyloarthritis (axSpA). Design Cross-sectional study with data from 19 Dutch primary care practices for development and 38 for validation. Participants Primary care patients aged 18-45 years with CLBP existing more than three months and onset of back pain started before the age of 45 years. Main Outcome The number of axSpA patients according to the ASAS criteria. Methods The referral rule (CaFaSpA referral rule) was developed using 364 CLBP patients from 19 primary care practices and contains four easy to use variables; inflammatory back pain, good response to nonsteriodal anti-inflammatory drugs, family history of spondyloarthritis and a back pain duration longer than five years. This referral rule is positive when at least two variables are present. Validation of the CaFaSpA rule was accomplished in 579 primary care CLBP patients from 38 practices from other areas. Performance of the referral rule was assessed by c-statistic and calibration plot. To fit the final referral rule the development and validation datasets were pooled leading to a total study population of 943 primary care participants. Results The referral rule was validated in 579 patients (41% male, mean age 36 (sd7.0). The percentage of identified axSpA patients was 16% (n=95). External validation resulted in satisfactory calibration and reasonable discriminative ability (c-statistics 0.70 [95% CI, 0.64-0.75]). In the pooled dataset sensitivity and specificity of the referral rule were 75% and 58%. Conclusions The CaFaSpA referral rule for axSpA consists of four easy to use predictors for primary care physicians and has a good predictive value in this validation study. The referral rule has the potential to be a screening tool for primary care by identifying CLBP patients suspected for axSpA.	[van Hoeven, Lonneke; Luime, Jolanda J.; Hazes, Johanna M. W.; Weel, Angelique E. A. M.] Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands; [van Hoeven, Lonneke; Weel, Angelique E. A. M.] Maasstad Hosp, Dept Rheumatol, Rotterdam, Netherlands; [Vergouwe, Yvonne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [de Buck, P. D. M.] MC Haaglanden, Dept Rheumatol, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; Maasstad Hospital; Erasmus University Rotterdam; Erasmus MC	van Hoeven, L (corresponding author), Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands.	l.vanhoeven@erasmusmc.nl	, Angelique/O-1699-2016		AbbVie Netherlands [IMM-10-0147]	AbbVie Netherlands(AbbVie)	An unrestricted research grant was provided by AbbVie Netherlands, grantnumber IMM-10-0147 (www.abbvie.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Boonen A, 2006, J RHEUMATOL, V33, P4; Brandt HC, 2007, ANN RHEUM DIS, V66, P1479, DOI 10.1136/ard.2006.068734; Braun A, 2013, RHEUMATOLOGY, V52, P1418, DOI 10.1093/rheumatology/ket115; Braun J, 2010, ANN RHEUM DIS, V69, P1264, DOI 10.1136/ard.2010.130559; Callhoff J, 2014, ANN RHEUM DIS; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gebel RS, 1997, ST HEAL T, V43, P421; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hermann J, 2009, RHEUMATOLOGY, V48, P812, DOI 10.1093/rheumatology/kep119; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; Molto A, 2014, ANN RHEUM DIS; Poddubnyy D, 2011, J RHEUMATOL, V38, P2452, DOI 10.3899/jrheum.110070; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Sieper J, 2013, ANN RHEUM DIS, V72, P1621, DOI 10.1136/annrheumdis-2012-201777; Sieper J, 2013, ANN RHEUM DIS, V72, P815, DOI 10.1136/annrheumdis-2012-201766; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; THE H S G, 1985, British Journal of Rheumatology, V24, P242; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Underwood MR, 1995, BRIT J RHEUMATOL, V34, P1074; van den Berg R, 2013, RHEUMATOLOGY, V52, P1492, DOI 10.1093/rheumatology/ket164; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van der Horst-Bruinsma IE, 2012, RHEUM DIS CLIN N AM, V38, P523, DOI 10.1016/j.rdc.2012.08.010; van Hoeven L, 2014, ARTHRIT CARE RES, V66, P446, DOI 10.1002/acr.22180; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Yazici H, 2009, BULL HOSP JT DIS, V67, P206	35	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0131963	10.1371/journal.pone.0131963	http://dx.doi.org/10.1371/journal.pone.0131963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200904	Green Published, Green Submitted, gold			2022-12-26	WOS:000358597100022
J	Zhang, MJ; Gilbert, M; Yuki, N; Cao, FF; Li, JJ; Liu, HY; Li, Q; Meng, FL; Zhang, JZ				Zhang, Maojun; Gilbert, Michel; Yuki, Nobuhiro; Cao, Fangfang; Li, Jianjun; Liu, Hongying; Li, Qun; Meng, Fanliang; Zhang, Jianzhong			Association of Anti-GT1a Antibodies with an Outbreak of Guillain-Barre Syndrome and Analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain	PLOS ONE			English	Article							STRUCTURAL-CHARACTERIZATION; FOODBORNE BOTULISM; MASS-SPECTROMETRY; BIOSYNTHESIS; EPIDEMIOLOGY; PATHOGEN; CLUSTERS; FEATURES; GENES	An outbreak of Guillain-Barre syndrome (GBS), subsequent to Campylobacter jejuni enteritis, occurred in China in 2007. Serum anti-ganglioside antibodies were measured in GBS patients and controls. Genome sequencing was used to determine the phylogenetic relationship among three C. jejuni strains from a patient with GBS (ICDCCJ07001), a patient with gastroenteritis (ICDCCJ07002) and a healthy carrier (ICDCCJ07004), which were all associated with the outbreak. The ganglioside-like structures of the lipo-oligosaccharides of these strains were determined by mass spectrometry. Seventeen (53%) of the GBS patients had anti-GT1a IgG antibodies. GT1a mimicry was found in the lipo-oligosaccharides of strain ICDCCJ07002 and ICDCCJ07004; but a combination of GM3/GD3 mimics was observed in ICDCCJ07001, although this patient had anti-GT1a IgG antibodies. A single-base deletion in a glycosyltransferase gene caused the absence of GT1a mimicry in ICDCCJ07001. The phylogenetic tree showed that ICDCCJ07002 and ICDCCJ07004 were genetically closer to each other than to ICDCCJ07001. C. jejuni, bearing a GT1a-like lipooligosaccharide, might have caused the GBS outbreak and the loss of GT1a mimicry may have helped ICDCCJ07001 to survive in the host.	Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Zhang, Maojun; Zhang, Jianzhong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Gilbert, Michel; Li, Jianjun] Natl Res Council Canada, Human Hlth Therapeut, Ottawa, ON K1A 0R6, Canada; [Yuki, Nobuhiro] Natl Neurosci Inst, Singapore 308433, Singapore; [Li, Qun] Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; National Research Council Canada; National Neuroscience Institute (NNI); Chinese Center for Disease Control & Prevention	Zhang, JZ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.	zhangjianzhong@icdc.cn	Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206; Gilbert, Michel/0000-0002-0204-4408; Li, Jianjun/0000-0002-6531-3687	General Program of National Natural Science Foundation of China [81071314, 81271789]; National Basic Research Program of China [2013CB127204]; Singapore National Medical Research Council [IRG 10nov086, CSA/047/2012]; Yong Loo Lin School of Medicine [R-172-000-264-733]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Singapore National Medical Research Council(National Medical Research Council, Singapore); Yong Loo Lin School of Medicine(National University of Singapore)	This work was supported by The General Program of National Natural Science Foundation of China (81071314 and 81271789), the National Basic Research Program of China (2013CB127204), Singapore National Medical Research Council (IRG 10nov086 and CSA/047/2012 to N.Y.) and Yong Loo Lin School of Medicine (R-172-000-264-733 to N.Y.).	Ang CW, 2000, J NEUROIMMUNOL, V111, P229, DOI 10.1016/S0165-5728(00)00369-6; Chen JH, 2003, FEMS MICROBIOL LETT, V224, P277, DOI 10.1016/S0378-1097(03)00470-1; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Davis MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3916; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Jackson BR, 2011, EPIDEMIOL INFECT, V7, P1; KAPLAN JE, 1983, JAMA-J AM MED ASSOC, V250, P2635; Kimoto K, 2006, NEUROLOGY, V67, P1837, DOI 10.1212/01.wnl.0000244468.22377.6b; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; Leclair D, 2013, EMERG INFECT DIS, V19, P961, DOI 10.3201/eid1906.120873; Li JJ, 2007, RAPID COMMUN MASS SP, V21, P952, DOI 10.1002/rcm.2916; Li JJ, 2007, MASS SPECTROM REV, V26, P35, DOI 10.1002/mas.20105; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; Nagashima T, 2007, ARCH NEUROL-CHICAGO, V64, P1519, DOI 10.1001/archneur.64.10.1519; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602; Prendergast MM, 1998, INFECT IMMUN, V66, P3649, DOI 10.1128/IAI.66.8.3649-3655.1998; Richards VP, 2013, INFECT GENET EVOL, V14, P200, DOI 10.1016/j.meegid.2012.12.010; SLIMAN NA, 1978, BMJ-BRIT MED J, V1, P751, DOI 10.1136/bmj.1.6115.751; Sun ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117912; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Susuki K, 2012, EXP NEUROL, V233, P534, DOI 10.1016/j.expneurol.2011.11.039; Takahashi M, 2005, J CLIN MICROBIOL, V43, P335, DOI 10.1128/JCM.43.1.335-339.2005; Wakerley BR, 2013, J NEUROL NEUROSUR PS, P1; Wangroongsarb P, 2013, JPN J INFECT DIS, V66, P353, DOI 10.7883/yoken.66.353; Ye YQ, 2010, MUSCLE NERVE, V42, P311, DOI 10.1002/mus.21701; YUKI N, 1995, J PEDIATR-US, V126, P162, DOI 10.1016/S0022-3476(95)70539-2; Yuki N, 1997, J NEUROIMMUNOL, V74, P30, DOI 10.1016/S0165-5728(96)00201-9; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Zhang MJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00256-13; Zhang MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015060; Zhang MJ, 2010, FOODBORNE PATHOG DIS, V7, P913, DOI 10.1089/fpd.2009.0493	41	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2015	10	7							e0131730	10.1371/journal.pone.0131730	http://dx.doi.org/10.1371/journal.pone.0131730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN6LZ	26197476	Green Published, gold, Green Submitted			2022-12-26	WOS:000358547600014
J	Mar, AC; Chu, CH; Lee, HJ; Chien, CW; Cheng, JJ; Yang, SH; Jiang, JK; Lee, TC				Mar, Ai-Chung; Chu, Chun-Ho; Lee, Hui-Ju; Chien, Chia-Wen; Cheng, Jing-Jy; Yang, Shung-Haur; Jiang, Jeng-Kai; Lee, Te-Chang			Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECTOPIC EXPRESSION; GENE-EXPRESSION; IL-1 RECEPTOR; PROTEINS; KERATINOCYTES; INFLAMMATION; ARSENITE; ANTIBODY; MODEL; STAT3	Interleukin-1 receptor type 2 (IL1R2) acts as a decoy receptor of exogenous IL-1; however, its intracellular activity is poorly understood. We previously demonstrated that IL1R2 intracellularly activates the expression of several proinflammatory cytokines and affects cell migration. In this study, we found that intracellular IL1R2 expression was increased in human colorectal cancer cells (CRCs) compared with normal colon cells. We also observed that the mRNA levels of IL1R2 were highly correlated with IL-6 in tumor tissues of CRC patients. By modulating its expression in CRC cells, we verified that enhanced IL1R2 expression transcriptionally activated the expression of IL-6 and VEGF-A. Conditioned medium harvested from IL1R2-over-expressing CRC cells contained higher levels of IL-6 and VEGF-A than that from vector control cells and significantly enhanced the proliferation, migration, and tube formation of cultured endothelial cells. We further demonstrated a positive association of intracellular IL1R2 levels with tumor growth and microvessel density in xenograft mouse models. These results revealed that IL1R2 activates the expression of angiogenic factors. Mechanistically, we revealed that IL1R2 complexes with c-Fos and binds to the AP-1 site at the IL-6 and VEGF-A promoters. Together, these results reveal a novel function of intracellular IL1R2 that acts with c-Fos to enhance the transcription of IL-6 and VEGF-A, which promotes angiogenesis in CRC.	[Mar, Ai-Chung] Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei 11529, Taiwan; [Mar, Ai-Chung] Acad Sinica, Taipei 11529, Taiwan; [Mar, Ai-Chung; Lee, Hui-Ju; Chien, Chia-Wen; Lee, Te-Chang] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chu, Chun-Ho] Natl Yang Ming Univ, Inst Pharmacol, Taipei 11221, Taiwan; [Yang, Shung-Haur; Jiang, Jeng-Kai] Natl Yang Ming Univ, Sch Med, Taipei 11221, Taiwan; [Chu, Chun-Ho] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Surg, Taipei 11221, Taiwan; [Cheng, Jing-Jy] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei 11221, Taiwan; [Yang, Shung-Haur; Jiang, Jeng-Kai] Taipei Vet Gen Hosp, Dept Surg, Div Colon & Rectal Surg, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine; Taipei Veterans General Hospital	Lee, TC (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sec 2,Acad Rd, Taipei 115, Taiwan.	bmtcl@ibms.sinica.edu.tw			Academia Sinica; Taiwan National Science Council [NSC-97-2314-B-0010MY3, MOST-104-2320-B-001-008-MY3]	Academia Sinica(Academia Sinica - Taiwan); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica and by Taiwan National Science Council Grants NSC-97-2314-B-0010MY3 and MOST-104-2320-B-001-008-MY3 (to T.-C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aceto N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3329; ALLEY MC, 1988, CANCER RES, V48, P589; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Buys TPH, 2007, GENE CHROMOSOME CANC, V46, P1069, DOI 10.1002/gcc.20492; Chang SY, 2009, CYTOKINE, V45, P32, DOI 10.1016/j.cyto.2008.10.013; Chen YJ, 2011, PROTEOMICS, V11, P4331, DOI 10.1002/pmic.201100329; Chien CW, 2004, ENVIRON HEALTH PERSP, V112, P1704, DOI 10.1289/ehp.7224; Chung YC, 2006, ANTICANCER RES, V26, P3905; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Duda Dan G, 2012, ISRN Cell Biol, V2012; Eldesoky A, 2011, SAUDI J GASTROENTERO, V17, P170, DOI 10.4103/1319-3767.80378; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P90, DOI 10.1038/sj.jcbfm.9600509; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Goto H, 2004, CLIN CANCER RES, V10, P7671, DOI 10.1158/1078-0432.CCR-04-1171; GROVES RW, 1995, J IMMUNOL, V154, P4065; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Huang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kawaguchi Y, 2006, P NATL ACAD SCI USA, V103, P14501, DOI 10.1073/pnas.0603545103; Kondera-Anasz Zdzislawa, 2003, Ginekol Pol, V74, P761; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-8; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lin KY, 2007, CANCER RES, V67, P1832, DOI 10.1158/0008-5472.CAN-06-3014; Lin SY, 2012, GENES IMMUN, V13, P214, DOI 10.1038/gene.2011.74; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martinetti A, 2014, CANCERS, V6, P1753, DOI 10.3390/cancers6031753; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; Murukesh N, 2010, BRIT J CANCER, V102, P8, DOI 10.1038/sj.bjc.6605483; Nagasaki T, 2014, BRIT J CANCER, V110, P469, DOI 10.1038/bjc.2013.748; Nakagawa K, 2007, J NUTR, V137, P1938, DOI 10.1093/jn/137.8.1938; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Nishida N, 2006, VASC HEALTH RISK MAN, V2, P213, DOI 10.2147/vhrm.2006.2.3.213; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Pou J, 2011, BBA-MOL CELL BIOL L, V1811, P556, DOI 10.1016/j.bbalip.2011.05.014; Ramadas RA, 2006, IMMUNOGENETICS, V58, P851, DOI 10.1007/s00251-006-0146-x; Rauschmayr T, 1997, P NATL ACAD SCI USA, V94, P5814, DOI 10.1073/pnas.94.11.5814; Ruckert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012243; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; SIMS JE, 1989, P NATL ACAD SCI USA, V86, P8946, DOI 10.1073/pnas.86.22.8946; Su PS, 2006, ENVIRON HEALTH PERSP, V114, P394, DOI 10.1289/ehp.8174; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Zhang YY, 2013, J BIOL CHEM, V288, P18961, DOI 10.1074/jbc.M113.458638; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	55	59	65	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					22212	22224		10.1074/jbc.M115.644823	http://dx.doi.org/10.1074/jbc.M115.644823			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26209639	Green Published, hybrid			2022-12-26	WOS:000360968500038
J	Wang, CD; Kam, RKT; Shi, WL; Xia, Y; Chen, XF; Cao, Y; Sun, JM; Du, YZ; Lu, G; Chen, ZJ; Chan, WY; Chan, SO; Deng, Y; Zhao, H				Wang, Chengdong; Kam, Richard Kin Ting; Shi, Weili; Xia, Yin; Chen, Xiongfong; Cao, Ying; Sun, Jianmin; Du, Yanzhi; Lu, Gang; Chen, Zijiang; Chan, Wood Yee; Chan, Sun On; Deng, Yi; Zhao, Hui			The Proto-oncogene Transcription Factor Ets1 Regulates Neural Crest Development through Histone Deacetylase 1 to Mediate Output of Bone Morphogenetic Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; XENOPUS-EMBRYOS; PARAXIAL MESODERM; BINDING-PROTEIN; INDUCTION; EXPRESSION; SPECIFICATION; WNT; ACTIVATION; MIGRATION	The neural crest (NC) is a transient, migratory cell population that differentiates into a large variety of tissues including craniofacial cartilage, melanocytes, and peripheral nervous system. NC is initially induced at the border of neural plate and non-neural ectoderm by balanced regulation of multiple signaling pathways among which an intermediate bone morphogenetic protein (BMP) signaling is essential for NC formation. ets1, a proto-oncogene playing important roles in tumor invasion, has also been implicated in delamination of NC cells. In this study, we investigated Ets1 function in NC formation using Xenopus. Overexpression of ets1 repressed NC formation through down-regulation of BMP signaling. Moreover, ets1 repressed the BMP-responsive gene id3 that is essential for NC formation. Conversely, overexpression of id3 can partially rescue the phenotype of NC inhibition induced by ectopic ets1. Mechanistically, we found that Ets1 binds to id3 promoter as well as histone deacetylase 1, suggesting that Ets1 recruits histone deacetylase 1 to the promoter of id3, thereby inducing histone deacetylation of the id3 promoter. Thus, our studies indicate that Ets1 regulates NC formation through attenuating BMP signaling epigenetically.	[Wang, Chengdong; Kam, Richard Kin Ting; Xia, Yin; Lu, Gang; Chan, Wood Yee; Chan, Sun On; Zhao, Hui] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Shi, Weili] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Deng, Yi] South Univ Sci & Technol China, Dept Biol, Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China; [Xia, Yin; Lu, Gang; Chan, Wood Yee; Chan, Sun On; Zhao, Hui] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Chen, Xiongfong] NCI, Adv Biomed Comp Ctr, NIH, Frederick, MD 21702 USA; [Cao, Ying] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Cao, Ying] Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Sun, Jianmin] Lund Univ, Dept Lab Med, Translat Canc Res & Stem Cell Ctr, S-22381 Lund, Sweden; [Du, Yanzhi; Chen, Zijiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Southern University of Science & Technology; Chinese University of Hong Kong, Shenzhen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nanjing University; Lund University; Shanghai Jiao Tong University	Zhao, H (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	zhaohui@cuhk.edu.hk	Chan, Sun-On/R-6547-2018; Chen, Zi-Jiang/GOE-6119-2022; Xia, Yin/M-5440-2018; Chan, Wood Yee/R-6692-2018; Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Zhao, Hui/B-8429-2016; Sun, Jianmin/AAX-5094-2021	Chan, Sun-On/0000-0002-3221-3786; Xia, Yin/0000-0003-0315-7532; Chan, Wood Yee/0000-0002-7114-1463; Zhao, Hui/0000-0001-8160-6415; Sun, Jianmin/0000-0003-2327-4285; Deng, Yi/0000-0003-1378-015X; Chen, Zi-Jiang/0000-0001-6637-6631; Wang, Chengdong/0000-0001-9891-8765	Research Grants Council of Hong Kong [CUHK413/12, CUHK480709, CUHK432/12]; Lo Kwee-Seong Biomedical Research Fund; National Basic Research Program of China [81200566]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Lo Kwee-Seong Biomedical Research Fund; National Basic Research Program of China(National Basic Research Program of China)	This work is supported by Research Grants Council of Hong Kong Grants N_CUHK413/12 and CUHK480709 (to H. Z.) and N_CUHK432/12 (to Y. X.), the Lo Kwee-Seong Biomedical Research Fund (to H. Z.), and National Basic Research Program of China Grant 81200566 (to Y. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Akkers Robert C, 2012, Methods Mol Biol, V917, P279, DOI 10.1007/978-1-61779-992-1_17; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; Barembaum M, 2013, DEV BIOL, V382, P567, DOI 10.1016/j.ydbio.2013.08.009; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; ESSEX LJ, 1993, DEV DYNAM, V198, P108, DOI 10.1002/aja.1001980205; Gao ZG, 2010, DEVELOPMENT, V137, P1543, DOI 10.1242/dev.047696; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Hong CS, 2008, DEVELOPMENT, V135, P3903, DOI 10.1242/dev.026229; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; Kee Y, 2005, GENE DEV, V19, P744, DOI 10.1101/gad.1257405; Kiyota Tomomi, 2007, Organogenesis, V3, P93; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Kos R, 2001, DEVELOPMENT, V128, P1467; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin N, 1999, NEURAL CREST, Vxxiii; Lee CG, 2012, J IMMUNOL, V188, P2244, DOI 10.4049/jimmunol.1101614; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lee PC, 2012, J CELL BIOL, V198, P799, DOI 10.1083/jcb.201204161; Light W, 2005, DEVELOPMENT, V132, P1831, DOI 10.1242/dev.01734; Luo T, 2003, P NATL ACAD SCI USA, V100, P532, DOI 10.1073/pnas.0237226100; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; MAYOR R, 1993, DEVELOPMENT, V119, P661; MAYOR R, 1995, DEVELOPMENT, V121, P767; Meyer D, 1997, INT J DEV BIOL, V41, P607; Milet C, 2013, P NATL ACAD SCI USA, V110, P5528, DOI 10.1073/pnas.1219124110; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nichane M, 2008, DEV BIOL, V322, P355, DOI 10.1016/j.ydbio.2008.08.003; Nichane M, 2010, EMBO J, V29, P55, DOI 10.1038/emboj.2009.313; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pasqualetti M, 2000, DEVELOPMENT, V127, P5367; Patthey C, 2009, DEVELOPMENT, V136, P73, DOI 10.1242/dev.025890; Pohl BS, 2001, MECH DEVELOP, V103, P93, DOI 10.1016/S0925-4773(01)00334-3; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schumacher JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027403; Spokony RF, 2002, DEVELOPMENT, V129, P421; Steventon B, 2005, SEMIN CELL DEV BIOL, V16, P647, DOI 10.1016/j.semcdb.2005.06.001; Steventon B, 2009, DEVELOPMENT, V136, P771, DOI 10.1242/dev.029017; Stuhlmiller TJ, 2012, CELL MOL LIFE SCI, V69, P3715, DOI 10.1007/s00018-012-0991-8; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; Theveneau E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001142; Tropepe V, 2006, DEV BIOL, V289, P517, DOI 10.1016/j.ydbio.2005.10.004; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Wang CD, 2011, DEV DYNAM, V240, P2028, DOI 10.1002/dvdy.22693; Wang YF, 2003, BIOESSAYS, V25, P317, DOI 10.1002/bies.10255; Wu MY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000593; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Zhao H, 2001, INT J DEV BIOL, V45, P817; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073	62	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21925	21938		10.1074/jbc.M115.644864	http://dx.doi.org/10.1074/jbc.M115.644864			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26198637	Green Published, hybrid			2022-12-26	WOS:000360968500014
J	Vinn, O; Wilson, MA; Toom, U				Vinn, Olev; Wilson, Mark A.; Toom, Ursula			Bioerosion of Inorganic Hard Substrates in the Ordovician of Estonia (Baltica)	PLOS ONE			English	Article							PALEOECOLOGY; HARDGROUNDS; MORPHOLOGY; ARAGONITE	The earliest bioeroded inorganic hard substrates in the Ordovician of Estonia appear in the Dapingian. Hardgrounds are also known from the Sandbian and Katian. Most of the bioerosion of inorganic hard substrates occurs as the boring Trypanites Magdefrau, 1932 along with some possible Gastrochaenolites borings. North American hardground borings are more diverse than those in Baltica. In contrast to a worldwide trend of increasing boring intensity, the Estonian record seems to show no increase in boring intensities during the Middle and Late Ordovician. Hardgrounds seem to be more common during the temperate climate interval of the Ordovician calcite sea in Estonia (seven hardgrounds during 15 my) than in the part with a tropical climate (four hardgrounds during 12 my). Bioerosion is mostly associated with carbonate hardgrounds, but cobbles and pebbles broken from the hardgrounds are also often penetrated by Trypanites borings. The general diversity of boring ichnotaxa in Baltica increased from one ichnospecies in the Cambrian to seven by the end of Ordovician, showing the effect of the GOBE on bioeroding ichnotaxa. The diversity of inorganic hard substrate borers increased by only two times. This difference can be explained by the wider environmental distribution of organic as compared to inorganic substrates in the Ordovician seas of Baltica, and their more continuous temporal availability, which may have caused increased specialization of several borers. The inorganic substrates may have been bioreroded only by the generalists among boring organisms.	[Vinn, Olev] Univ Tartu, Dept Geol, Tartu, Estonia; [Wilson, Mark A.] Coll Wooster, Dept Geol, Wooster, OH 44691 USA; [Toom, Ursula] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia	University of Tartu; College of Wooster; Tallinn University of Technology	Vinn, O (corresponding author), Univ Tartu, Dept Geol, Tartu, Estonia.	olev.vinn@ut.ee	Vinn, Olev/AAG-6806-2020	Vinn, Olev/0000-0002-2889-2544; Toom, Ursula/0000-0002-7782-6615	Palaeontological Association Research Grant; Estonian Research Council [ETF9064, IUT20-34]	Palaeontological Association Research Grant; Estonian Research Council	Financial support to O.V. was provided by the Palaeontological Association Research Grant, Estonian Research Council projects ETF9064 and IUT20-34.	Ainsaar L, 2004, PALAEOGEOGR PALAEOCL, V210, P119, DOI 10.1016/j.palaeo.2004.02.046; [Anonymous], 1997, GEOLOGY MINERAL RESO; Balthasar U, 2015, GEOLOGY, V43, P99, DOI 10.1130/G36293.1; BRETT CE, 1984, PALAEOGEOGR PALAEOCL, V46, P233, DOI 10.1016/0031-0182(84)90001-4; BRETT CE, 1978, PALEOBIOLOGY, V4, P329, DOI 10.1017/S0094837300006035; Dronov A., 2000, P EST ACAD SCI, V49, P3; Ekdale AA, 2001, LETHAIA, V34, P1; Hecker RF, 1960, T I GEOL AN ESTSSR, V5, P199; Hints L, 2008, EST J EARTH SCI, V57, P11, DOI 10.3176/earth.2008.1.02; Jackson PNW, 2007, LETHAIA, V40, P237, DOI 10.1111/j.1502-3931.2007.00021.x; Motus M-A, 2007, 10 INT S FOSS CNID P, P54; Nestor H., 1977, FACIES FAUNA SILURIA, P89; NORDLUND U, 1989, GEOL FORENING STOCK, V111, P161; Orviku K, 1940, LITHOLOGIE TALLINNA, VI, P1; Orviku K, 1961, GEOLOOGILINE KOGUMIK, P16; Orviku K, 1960, AK NAUK EST SSR GEOL, V5, P45; Orviku K, 1962, AKAD NAUK EST SSR GE, V10, P187; PALMER T, 1982, LETHAIA, V15, P309, DOI 10.1111/j.1502-3931.1982.tb01696.x; PALMER TJ, 1977, LETHAIA, V10, P179, DOI 10.1111/j.1502-3931.1977.tb00608.x; Palmer TJ, 2004, LETHAIA, V37, P417, DOI 10.1080/00241160410002135; Tapanila L, 2004, PALAIOS, V19, P292, DOI 10.1669/0883-1351(2004)019<0292:EASCOP>2.0.CO;2; Taylor PD, 2003, EARTH-SCI REV, V62, P1, DOI 10.1016/S0012-8252(02)00131-9; Vinn O., 2005, CARNETS GEOL, VCG2005, pA03; Vinn O, ESTONIAN J IN PRESS; Vinn O, CARNETS GEO IN PRESS; Vinn Olev, 2004, Proceedings of the Estonian Academy of Sciences Geology, V53, P257; Vinn O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099455; Vinn O, 2010, CARNETS GEOL; WILSON MA, 1988, J PALEONTOL, V62, P306, DOI 10.1017/S0022336000029978; WILSON MA, 1992, I EARTH STUDIES PUBL, V9, P1; Wilson Mark A., 2006, Ichnos, V13, P109, DOI 10.1080/10420940600850505	31	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134279	10.1371/journal.pone.0134279	http://dx.doi.org/10.1371/journal.pone.0134279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218582	Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900106
J	Rossi, L; Stevens, D; Pierga, JY; Lerebours, F; Reyal, F; Robain, M; Asselain, B; Rouzier, R				Rossi, Lea; Stevens, Denise; Pierga, Jean-Yves; Lerebours, Florence; Reyal, Fabien; Robain, Mathieu; Asselain, Bernard; Rouzier, Roman			Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population	PLOS ONE			English	Article							OLDER WOMEN; EPIDEMIOLOGY; MORTALITY; THERAPY	Background The impact of adjuvant chemotherapy on breast cancer prognosis has been demonstrated in randomized trials, but its impact is unknown in real-world populations. The aim of this study was to evaluate the effect of adjuvant chemotherapy on the survival of breast cancer patients in an unselected population. Methods This prospective cohort study included 32,502 women treated at the Institut Curie between 1981 and 2008 for a first invasive breast cancer without metastasis. The patients were matched based on their propensity score to receive adjuvant chemotherapy. Results The matching generated a subsample of 9,180 patients with an overlapping propensity score. In the group without chemotherapy, the overall survival (OS) rates at 5 and 10 years of follow-up were 87.6% (95% CI [86.7-88.6]) and 75.0% (95% CI [73.6-76.5]), respectively, versus 92.1% (95% CI [91.3-92.9]) and 81.9% (95% CI [80.6-83.2]), respectively, in the chemotherapy group. Distant disease-free survival (DDFS) was significantly improved in the five first years (absolute benefit of 3.5%). In a multivariate analysis, adjuvant chemotherapy was associated with better OS (HR = 0.75, 95% CI [0.69-0.83], p<0.0001) and DDFS (HR = 0.82, 95% CI [0.75-0.90], p<0.0001). Conclusion Adjuvant chemotherapy significantly improves OS and DDFS rates in an unselected population, in accordance with previous results reported by randomized trials.	[Rossi, Lea; Stevens, Denise; Pierga, Jean-Yves; Lerebours, Florence; Reyal, Fabien; Robain, Mathieu; Asselain, Bernard; Rouzier, Roman] Inst Curie, Paris, France; [Rossi, Lea; Rouzier, Roman] Univ Versailles St Quentin, Risk & Safety Clin Med Women & Perinatal Hlth, Equipe Accueil 7285, Montigny Le Bretonneux, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay	Rouzier, R (corresponding author), Inst Curie, Paris, France.	roman.rouzier@curie.fr	Rouzier, Roman/G-2953-2018	Rouzier, Roman/0000-0002-8167-6808	Fondation Curie; Fonds d'etude et de recherche du corps medical (FERCM)	Fondation Curie; Fonds d'etude et de recherche du corps medical (FERCM)	This work was supported by Fondation Curie and Fonds d'etude et de recherche du corps medical (FERCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Ban KA, 2014, SURG ONCOL CLIN N AM, V23, P409, DOI 10.1016/j.soc.2014.03.011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Brookhart M Alan, 2007, Int J Biostat, V3, P14; DRAKE C, 1995, INT J EPIDEMIOL, V24, P183, DOI 10.1093/ije/24.1.183; Elkin EB, 2006, J CLIN ONCOL, V24, P2757, DOI 10.1200/JCO.2005.03.6053; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Hassan MSU, 2010, ONCOL REP, V24, P1121, DOI 10.3892/or_00000963; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hery C, 2008, ANN ONCOL, V19, P1009, DOI 10.1093/annonc/mdm593; Kemeny MM, 2003, J CLIN ONCOL, V21, P2268, DOI 10.1200/JCO.2003.09.124; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Olszewski AJ, 2013, BREAST CANCER RES TR, V138, P215, DOI 10.1007/s10549-013-2423-3; Poole CJ, 2006, NEW ENGL J MED, V355, P1851, DOI 10.1056/NEJMoa052084; Schneider M, 2011, J AM GERIATR SOC, V59, P637, DOI 10.1111/j.1532-5415.2011.03351.x; Sorensen HT, 2006, HEPATOLOGY, V44, P1075, DOI 10.1002/hep.21404; Webb PM, 2004, BREAST, V13, P7, DOI 10.1016/S0960-9776(03)00129-2; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007	22	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0132853	10.1371/journal.pone.0132853	http://dx.doi.org/10.1371/journal.pone.0132853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214853	Green Submitted, Green Published, gold			2022-12-26	WOS:000358594300012
J	Hov, JR; Zhong, HZ; Qin, BC; Anmarkrud, JA; Holm, K; Franke, A; Lie, BA; Karlsen, TH				Hov, Johannes R.; Zhong, Huanzi; Qin, Bingcai; Anmarkrud, Jarl Andreas; Holm, Kristian; Franke, Andre; Lie, Benedicte A.; Karlsen, Tom H.			The Influence of the Autoimmunity-Associated Ancestral HLA Haplotype AH8.1 on the Human Gut Microbiota: A Cross-Sectional Study	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; INTESTINAL MICROBIOTA; DISEASE; GENES; SENSITIVITY; INDUCTION	Multiple immune-related genes are encoded in the HLA complex on chromosome 6p21. The 8.1 ancestral haplotype (AH8.1) include the classical HLA alleles HLA-B*08:01 and HLA-DRB1*03: 01, and has been associated with a large number of autoimmune diseases, but the underlying mechanisms for this association are largely unknown. Given the recently established links between the gut microbiota and inflammatory diseases, we hypothesized that the AH8.1 influences the host gut microbial community composition. To study this further, healthy individuals were selected from the Norwegian Bone Marrow Donor Registry and categorized as either I. AH8.1 homozygote (n=34), II. AH8.1 heterozygote (n=38), III. Non AH8.1 heterozygote or IV. HLA-DRB1 homozygote but non AH8.1 (n=15). Bacterial DNA from stool samples were subjected to sequencing of the V3-V5 region of the 16S rRNA gene on the 454 Life Sciences platform and data analyzed using Mothur and QIIME. The results showed that the abundances of different taxa were highly variable within all pre-defined AH8.1 genotype groups. Using univariate non-parametric statistics, there were no differences regarding alpha or beta diversity between AH8.1 carriers (categories I and II) and non-carriers (categories III and IV), however four different taxa (Prevotellaceae, Clostridium XVIII, Coprococcus, Enterorhabdus) had nominally significant lower abundances in AH8.1 carriers than non-carriers. After including possible confounders in a multivariate linear regression, only the two latter genera remained significantly associated. In conclusion, the overall contribution of the AH8.1 haplotype to the variation in gut microbiota profile of stool in the present study was small.	[Hov, Johannes R.; Anmarkrud, Jarl Andreas; Holm, Kristian; Karlsen, Tom H.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Hov, Johannes R.; Lie, Benedicte A.; Karlsen, Tom H.] Univ Oslo, Fac Med, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Hov, Johannes R.; Karlsen, Tom H.] Oslo Univ Hosp, Internal Med Res Inst, Rikshosp, Oslo, Norway; [Hov, Johannes R.; Karlsen, Tom H.] Oslo Univ Hosp, Gastroenterol Sect, Div Canc Med Surg & Transplantat, Dept Transplantat Med,Rikshosp, Oslo, Norway; [Zhong, Huanzi; Qin, Bingcai] BGI Shenzhen, Shenzhen, Peoples R China; [Qin, Bingcai] Shanghai Majorbio Biopharm Technol Co Ltd, Shanghai, Peoples R China; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Dept Immunol, Rikshosp, Oslo, Norway; [Karlsen, Tom H.] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Beijing Genomics Institute (BGI); University of Kiel; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Bergen	Hov, JR (corresponding author), Oslo Univ Hosp, Div Canc Med, Dept Transplantat Med, Norwegian PSC Res Ctr,Rikshosp, Oslo, Norway.	j.e.r.hov@medisin.uio.no	Anmarkrud, Jarl Andreas/R-1822-2019; Franke, Andre/B-2151-2010; Hov, Johannes R/J-1480-2019	Anmarkrud, Jarl Andreas/0000-0002-7496-4430; Franke, Andre/0000-0003-1530-5811; Hov, Johannes R/0000-0002-5900-8096	Norwegian PSC Research Center; Shanghai Majorbio Bio-pharm Technology Co. Ltd	Norwegian PSC Research Center; Shanghai Majorbio Bio-pharm Technology Co. Ltd	The study was funded by the Norwegian PSC Research Center. The funding sources of Norwegian PSC Research Center had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shanghai Majorbio Bio-pharm Technology Co. Ltd provided support in the form of salaries for authors BQ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHLQUIST DA, 1988, ANN INTERN MED, V108, P609, DOI 10.7326/0003-4819-108-4-609; Arumugam M, 2014, NATURE, V506, DOI 10.1038/nature13075; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Candore Giuseppina, 2002, Autoimmunity Reviews, V1, P29, DOI 10.1016/S1568-9972(01)00004-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Couturier-Maillard A, 2013, J CLIN INVEST; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Palma G, 2010, CURR ISSUES MOL BIOL, V12, P1; De Palma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030791; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Goyette P, 2015, NAT GENET; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Marild K, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-109; Morris DL, 2012, AM J HUM GENET, V91, P778, DOI 10.1016/j.ajhg.2012.08.026; Naess S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114486; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Olivares M., 2014, GUT; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Thorsby E, 2005, TRANSPL IMMUNOL, V14, P175, DOI 10.1016/j.trim.2005.03.021; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206	50	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133804	10.1371/journal.pone.0133804	http://dx.doi.org/10.1371/journal.pone.0133804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207384	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000148
J	Huh, JH; Choi, SI; Lim, JS; Chung, CH; Shin, JY; Lee, MY				Huh, Ji Hye; Choi, Soo In; Lim, Jung Soo; Chung, Choon Hee; Shin, Jang Yel; Lee, Mi Young			Lower Serum Creatinine Is Associated with Low Bone Mineral Density in Subjects without Overt Nephropathy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SURVEY KNHANES IV; MUSCLE MASS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; NATIONWIDE SURVEY; SARCOPENIA; WOMEN; MEN; OSTEOPOROSIS	Background Low skeletal muscle mass is associated with deterioration of bone mineral density. Because serum creatinine can serve as a marker of muscle mass, we evaluated the relationship between serum creatinine and bone mineral density in an older population with normal renal function. Methods Data from a total of 8,648 participants (4,573 men and 4,075 postmenopausal women) aged 45-95 years with an estimated glomerular filtration rate >60 ml/min/1.73 m2 were analyzed from the Fourth Korea National Health and Nutrition Examination Survey (2008-2010). Bone mineral density (BMD) and appendicular muscle mass (ASM) were measured using dual-energy X-ray absorptiometry. Receiver operating characteristic curve analysis revealed that the cut points of serum creatinine for sarcopenia were below 0.88 mg/dl in men and 0.75 mg/dl in women. Subjects were divided into two groups: low creatinine and upper normal creatinine according to the cut point value of serum creatinine for sarcopenia. Results In partial correlation analysis adjusted for age, serum creatinine was positively associated with both BMD and ASM. Subjects with low serum creatinine were at a higher risk for low BMD (T-score <= -1.0) at the femur neck, total hip and lumbar spine in men, and at the total hip and lumbar spine in women after adjustment for confounding factors. Each standard deviation increase in serum creatinine was significantly associated with reduction in the likelihood of low BMD at the total hip and lumbar spine in both sexes (men: odds ratio (OR) = 0.84 [95% CI = 0.74-0.96] at the total hip, OR = 0.8 [95% CI = 0.68-0.96] at the lumbar spine; women: OR = 0.83 [95% CI = 0.73-0.95] at the total hip, OR = 0.81 [95% CI = 0.67-0.99] at the lumbar spine). Conclusions Serum creatinine reflected muscle mass, and low serum creatinine was independently associated with low bone mineral density in subjects with normal kidney function.	[Huh, Ji Hye; Choi, Soo In; Lim, Jung Soo; Chung, Choon Hee; Shin, Jang Yel; Lee, Mi Young] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, Gangwon Do, South Korea	Yonsei University	Lee, MY (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, Gangwon Do, South Korea.	domoe46@yonsei.ac.kr		Chung, Choon/0000-0003-1144-7206	National Research Foundation (NRF) of Korea grant - Korean government (MEST) [20110001024]	National Research Foundation (NRF) of Korea grant - Korean government (MEST)	This work was supported by a National Research Foundation (NRF) of Korea grant funded by the Korean government (MEST) (No. 20110001024).	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Binkley N, 2013, OSTEOPOROSIS INT, V24, P2955, DOI 10.1007/s00198-013-2427-1; Bonewald LF, 2013, J BONE MINER RES, V28, P1857, DOI 10.1002/jbmr.1980; Cooper C, 2012, OSTEOPOROSIS INT, V23, P1839, DOI 10.1007/s00198-012-1913-1; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Di Monaco M, 2012, ARCH GERONTOL GERIAT, V55, pE48, DOI 10.1016/j.archger.2012.05.002; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Haderslev Kent Valentin, 2005, Dyn Med, V4, P1, DOI 10.1186/1476-5918-4-1; Harita N, 2009, DIABETES CARE, V32, P424, DOI 10.2337/dc08-1265; Hjelmesaeth J, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-6; Huh JH, 2014, OSTEOPOROSIS INT, V25, P1053, DOI 10.1007/s00198-013-2531-2; KESHAVIAH PR, 1994, J AM SOC NEPHROL, V4, P1475; Kim JE, 2014, OSTEOPOROSIS INT, V25, P2189, DOI 10.1007/s00198-014-2745-y; Kim KM, 2013, J BONE MINER METAB, V31, P144, DOI 10.1007/s00774-012-0386-9; Klein GL, 2014, WORLD J DIABETES, V5, P14, DOI 10.4239/wjd.v5.i1.14; Lee YH, 2014, J CLIN ENDOCR METAB, V99, P3879, DOI 10.1210/jc.2013-3764; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu-Ambrose T, 2003, J GERONTOL A-BIOL, V58, P862; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mo Chenglin, 2012, Recent Pat Biotechnol, V6, P223; Mudali S, 2004, MECH AGEING DEV, V125, P297, DOI 10.1016/j.mad.2004.01.004; Patel SS, 2013, J CACHEXIA SARCOPENI, V4, P19, DOI 10.1007/s13539-012-0079-1; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; Schoenau E, 2002, CALCIFIED TISSUE INT, V70, P405, DOI 10.1007/s00223-001-0048-8; SCHUTTE JE, 1981, J APPL PHYSIOL, V51, P762, DOI 10.1152/jappl.1981.51.3.762; Thomas T, 2002, J BONE MINER RES, V17, P1563, DOI 10.1359/jbmr.2002.17.9.1563; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yonemura K, 2004, KIDNEY INT, V65, P1395, DOI 10.1111/j.1523-1755.2004.00521.x; Yu R, 2014, J AM MED DIR ASSOC, V15, P551, DOI 10.1016/j.jamda.2014.02.005; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	31	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133062	10.1371/journal.pone.0133062	http://dx.doi.org/10.1371/journal.pone.0133062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207750	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000060
J	Inobe, T; Genmei, R				Inobe, Tomonao; Genmei, Reiko			N-Terminal Coiled-Coil Structure of ATPase Subunits of 26S Proteasome Is Crucial for Proteasome Function	PLOS ONE			English	Article							19 S REGULATOR; PROTEIN-DEGRADATION; MOLECULAR ARCHITECTURE; EUKARYOTIC PROTEASOME; SUBSTRATE ENTRY; CORE PARTICLE; AAA SUBUNITS; ROLES; YEAST; TRANSLOCATION	The proteasome is an essential proteolytic machine in eukaryotic cells, where it removes damaged proteins and regulates many cellular activities by degrading ubiquitinated proteins. Its heterohexameric AAA+ ATPase Rpt subunits play a central role in proteasome activity by the engagement of substrate unfolding and translocation for degradation; however, its detailed mechanism remains poorly understood. In contrast to AAA+ ATPase domains, their N-terminal regions of Rpt subunits substantially differ from each other. Here, to investigate the requirements and roles of the N-terminal regions of six Rpt subunits derived from Saccharomyces cerevisiae, we performed systematic mutational analysis using conditional knockdown yeast strains for each Rpt subunit and bacterial heterologous expression system of the base subcomplex. We showed that the formation of the coiled-coil structure was the most important for the N-terminal region of Rpt subunits. The primary role of coiled-coil structure would be the maintenance of the ring structure with the defined order. However, the coiled-coil region would be also be involved in substrate recognition and an interaction between lid and base subcomplexes.	[Inobe, Tomonao; Genmei, Reiko] Toyama Univ, Frontier Res Core Life Sci, Toyama 9308555, Japan	University of Toyama	Inobe, T (corresponding author), Toyama Univ, Frontier Res Core Life Sci, 3190 Gofuku, Toyama 9308555, Japan.	inobe@ctg.u-toyama.ac.jp		Inobe, Tomonao/0000-0002-5864-6889	KAKENHI [26870216, 15H01531]; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [15H01531] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (grant 26870216 and 15H01531 (T.I.)); and the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science and Technology (T.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Erales J, 2012, J BIOL CHEM, V287, P18535, DOI 10.1074/jbc.M112.357327; Farrell CM, 2007, MOL CELL, V25, P161, DOI 10.1016/j.molcel.2006.11.018; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fu HY, 1999, PLANT J, V18, P529, DOI 10.1046/j.1365-313X.1999.00479.x; Gautam AKS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034864; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kimura Y, 2013, PROTEOMICS, V13, P3167, DOI 10.1002/pmic.201300207; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134056	10.1371/journal.pone.0134056	http://dx.doi.org/10.1371/journal.pone.0134056			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208326	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000197
J	Kremsky, I; Bellora, N; Eyras, E				Kremsky, Isaac; Bellora, Nicolas; Eyras, Eduardo			A Quantitative Profiling Tool for Diverse Genomic Data Types Reveals Potential Associations between Chromatin and Pre-mRNA Processing	PLOS ONE			English	Article							SPLICING ENHANCER MOTIFS; NASCENT RNA; IDENTIFICATION; SPECIFICITIES; TRANSCRIPTION; TRANSLATION; METHYLATION; INCLUSION; PROTEIN	High-throughput sequencing, and genome-based datasets in general, are often represented as profiles centered at reference points to study the association of protein binding and other signals to particular regulatory mechanisms. Although these profiles often provide compelling evidence of these associations, they do not provide a quantitative assessment of the enrichment, which makes the comparison between signals and conditions difficult. In addition, a number of biases can confound profiles, but are rarely accounted for in the tools currently available. We present a novel computational method, ProfileSeq, for the quantitative assessment of biological profiles to provide an exact, nonparametric test that specific regions of the test profile have higher or lower signal densities than a control set. The method is applicable to high-throughput sequencing data (ChIP-Seq, GRO-Seq, CLIP-Seq, etc.) and to genome-based datasets (motifs, etc.). We validate ProfileSeq by recovering and providing a quantitative assessment of several results reported before in the literature using independent datasets. We show that input signal and mappability have confounding effects on the profile results, but that normalizing the signal by input reads can eliminate these biases while preserving the biological signal. Moreover, we apply ProfileSeq to ChIP-Seq data for transcription factors, as well as for motif and CLIP-Seq data for splicing factors. In all examples considered, the profiles were robust to biases in mappability of sequencing reads. Furthermore, analyses performed with ProfileSeq reveal a number of putative relationships between transcription factor binding to DNA and splicing factor binding to pre-mRNA, adding to the growing body of evidence relating chromatin and pre-mRNA processing. ProfileSeq provides a robust way to quantify genome-wide coordinate-based signal. Software and documentation are freely available for academic use at https://bitbucket.org/regulatorygenomicsupf/profileseq/.	[Kremsky, Isaac; Eyras, Eduardo] Univ Pompeu Fabra, Computat Genom Grp, E-08003 Barcelona, Spain; [Bellora, Nicolas] Univ Nacl Comahue, INIBIOMA CONICET UNComa, Ctr Reg Univ Bariloche, Lab Microbiol Aplicada & Biotecnol, San Carlos De Bariloche, Rio Negro, Argentina; [Eyras, Eduardo] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Pompeu Fabra University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; ICREA	Eyras, E (corresponding author), Univ Pompeu Fabra, Computat Genom Grp, E-08003 Barcelona, Spain.	eduardo.eyras@upf.edu	Eduardo, Eyras/L-1053-2014; Gasull, Martina/J-4076-2019; Eyras, Eduardo/ABG-7144-2020; Bellora, Nicolas/E-6356-2014	Eduardo, Eyras/0000-0003-0793-6218; Eyras, Eduardo/0000-0003-0793-6218; Bellora, Nicolas/0000-0001-6637-3465	Initial Training Network grant RNPNet from the European Commission [289007]; Ministerio de Economia y Competitividad (MINECO) from the Spanish Government [BIO2011-23920, CSD2009-00080]; Fundacion Sandra Ibarra de Solidaridad Frente al Cancer; ICREA Funding Source: Custom	Initial Training Network grant RNPNet from the European Commission; Ministerio de Economia y Competitividad (MINECO) from the Spanish Government; Fundacion Sandra Ibarra de Solidaridad Frente al Cancer; ICREA(ICREA)	Support was provided by an Initial Training Network grant RNPNet (289007) from the European Commission [http://ec.europa.eu/research/mariecurieactions/]; grants BIO2011-23920 and CSD2009-00080 from Ministerio de Economia y Competitividad (MINECO) from the Spanish Government [http://www.mineco.gob.es/portal/site/mineco/]; and Fundacion Sandra Ibarra de Solidaridad Frente al Cancer [http://www.fundacionsandraibarra.org/].	Allo M, 2014, P NATL ACAD SCI USA, V111, P15622, DOI 10.1073/pnas.1416858111; Althammer S, 2011, BIOINFORMATICS, V27, P3333, DOI 10.1093/bioinformatics/btr570; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blin K, 2015, NUCLEIC ACIDS RES, V43, pD160, DOI 10.1093/nar/gku1180; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Fu X, 2014, NATURE REV GENETICS, P1; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Acuna LIG, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.28726; Guillouf C, 2006, J BIOL CHEM, V281, P19145, DOI 10.1074/jbc.M512049200; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Kakaradov B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S11; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khan DH, 2014, NUCLEIC ACIDS RES, V42, P1656, DOI 10.1093/nar/gkt1134; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pervouchine DD, 2013, BIOINFORMATICS, V29, P273, DOI 10.1093/bioinformatics/bts678; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Richardson JE, 2006, J COMPUT BIOL, V13, P1457, DOI 10.1089/cmb.2006.13.1457; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Sharma S, 2011, MOL CELL, V41, P579, DOI 10.1016/j.molcel.2011.02.012; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Ye Z, 2013, NUCL ACIDS RES, P1; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132448	10.1371/journal.pone.0132448	http://dx.doi.org/10.1371/journal.pone.0132448			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207626	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000029
J	Ou, JP; Xing, WJ; Li, YB; Xu, YW; Zhou, CQ				Ou, Jianping; Xing, Weijie; Li, Yubin; Xu, Yanwen; Zhou, Canquan			Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; POOR RESPONDERS; INVITRO FERTILIZATION; EMBRYO QUALITY; AGONIST; STIMULATION; INDUCTION; OVULATION; IVF	Objective To compare the two GnRH-a protocols (long GnRH-a protocol and short GnRH-a protocol) for ovarian stimulation in IVF/ICSI cycles in patients of various age ranges. Methods A total of 5662 IVF-ET/ICSI cycles from 2010 to 2013 were retrospectively identified. The cycles were divided into two groups: a long protocol group and short protocol group. In each group, the patients were divided into four age ranges: <31 years, 31 to 35 years, 36 to 40 years, and >40 years. The duration of stimulation, total dose of Gn, implantation rate and pregnancy rate were compared. Results The total dose of Gn was significantly higher, and the duration of stimulation was significantly longer, in the long protocol group than in the short protocol group for all age ranges (P<0.05). If the patients were of the same age range, the number of oocytes retrieved, MII oocytes, and high-quality embryos in the long protocol group were all significantly greater than those in the short protocol group (P<0.05). In the long protocol group, the clinical pregnancy rates of the four age ranges were 52.76%, 44.33%, 36.15% and 13.33%, respectively, which were significantly higher than those in the short protocol group (33.33%, 24.58%, 22.49% and 8.72%, respectively; P<0.05). The same trend was also found in the implantation rates of the four age ranges. As the age increased, the clinical pregnancy and implantation rates, as well as the number of oocytes retrieved, MII oocytes, and high-quality embryos, of the long protocol group significantly decreased (P<0.05). Conclusions Our study demonstrated that regardless of patient age, the long protocol was superior to the short protocol in terms of the number of retrieved oocytes, as well as the implantation and pregnancy rates.	[Ou, Jianping; Xing, Weijie] Sun Yat Sen Univ, Affiliated Hosp 3, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yubin; Xu, Yanwen; Zhou, Canquan] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, CQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China.	zhoucanquan@hotmail.com						Berin I, 2010, FERTIL STERIL, V93, P360, DOI 10.1016/j.fertnstert.2008.11.007; Daya S, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001299, 10.1002/14641858.CD001299]; Dong XY, 2013, INT J CLIN EXP PATHO, V6, P1911; GARCIA JE, 1990, FERTIL STERIL, V53, P302; HUGHES EG, 1992, FERTIL STERIL, V58, P888; Kahraman K, 2009, FERTIL STERIL, V91, P2437, DOI 10.1016/j.fertnstert.2008.03.057; Maldonado LG, 2013, FERTIL STERIL, V99, P1615, DOI 10.1016/j.fertnstert.2013.01.095; Madani T, 2012, GYNECOL ENDOCRINOL, V28, P102, DOI 10.3109/09513590.2011.579206; Mahutte NG, 2002, CURR OPIN OBSTET GYN, V14, P275, DOI 10.1097/00001703-200206000-00005; Mao GH, 2014, ARCH MED SCI, V10, P161, DOI 10.5114/aoms.2014.40743; PORTER RN, 1984, LANCET, V2, P1284, DOI 10.1016/S0140-6736(84)92840-X; Shanbhag S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004379.pub2; Sunkara SK, 2014, FERTIL STERIL, V101, P147, DOI 10.1016/j.fertnstert.2013.09.035; Tarlatzis BC, 2003, HUM REPROD UPDATE, V9, P61, DOI 10.1093/humupd/dmg007; Tesarik Jan, 2003, Reprod Biomed Online, V7, P59; Toner JP, 2003, FERTIL STERIL, V79, P491, DOI 10.1016/S0015-0282(02)04840-9; van Rooij IAJ, 2003, FERTIL STERIL, V79, P482, DOI 10.1016/S0015-0282(02)04839-2	17	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133887	10.1371/journal.pone.0133887	http://dx.doi.org/10.1371/journal.pone.0133887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208150	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000165
J	Stewart, JE; Brooks, K; Brannen, PM; Cline, WO; Brewer, MT				Stewart, Jane E.; Brooks, Kyle; Brannen, Phillip M.; Cline, William O.; Brewer, Marin T.			Elevated Genetic Diversity in the Emerging Blueberry Pathogen Exobasidium maculosum	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; INTERNAL TRANSCRIBED SPACER; POPULATION EXPANSION; DNA; FUNGAL; PLANT; SEQUENCE; REVEALS; NUMBER; PHYLOGEOGRAPHY	Emerging diseases caused by fungi are increasing at an alarming rate. Exobasidium leaf and fruit spot of blueberry, caused by the fungus Exobasidium maculosum, is an emerging disease that has rapidly increased in prevalence throughout the southeastern USA, severely reducing fruit quality in some plantings. The objectives of this study were to determine the genetic diversity of E. maculosum in the southeastern USA to elucidate the basis of disease emergence and to investigate if populations of E. maculosum are structured by geography, host species, or tissue type. We sequenced three conserved loci from 82 isolates collected from leaves and fruit of rabbiteye blueberry (Vaccinium virgatum), highbush blueberry (V. corymbosum), and southern highbush blueberry (V. corymbosum hybrids) from commercial fields in Georgia and North Carolina, USA, and 6 isolates from lowbush blueberry (V. angustifolium) from Maine, USA, and Nova Scotia, Canada. Populations of E. maculosum from the southeastern USA and from lowbush blueberry in Maine and Nova Scotia are distinct, but do not represent unique species. No difference in genetic structure was detected between different host tissues or among different host species within the southeastern USA; however, differentiation was detected between populations in Georgia and North Carolina. Overall, E. maculosum showed extreme genetic diversity within the conserved loci with 286 segregating sites among the 1,775 sequenced nucleotides and each isolate representing a unique multilocus haplotype. However, 94% of the nucleotide substitutions were silent, so despite the high number of mutations, selective constraints have limited changes to the amino acid sequences of the housekeeping genes. Overall, these results suggest that the emergence of Exobasidium leaf and fruit spot is not due to a recent introduction or host shift, or the recent evolution of aggressive genotypes of E. maculosum, but more likely as a result of an increasing host population or an environmental change.	[Stewart, Jane E.; Brooks, Kyle; Brannen, Phillip M.; Brewer, Marin T.] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [Cline, William O.] N Carolina State Univ, Hort Crops Res Stn, Dept Plant Pathol, Castle Hayne, NC USA	University System of Georgia; University of Georgia; University of North Carolina; North Carolina State University	Brewer, MT (corresponding author), Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA.	mtbrewer@uga.edu			Georgia Blueberry Commission; U. S. Department of Agriculture, Specialty Crop Research Initiative grant [2008-51180-19579]; Southern Region Small Fruit Consortium grant [2012-01]	Georgia Blueberry Commission; U. S. Department of Agriculture, Specialty Crop Research Initiative grant; Southern Region Small Fruit Consortium grant	The study was supported by a grant to MTB and PMB from the Georgia Blueberry Commission, from the U. S. Department of Agriculture, Specialty Crop Research Initiative grant no. 2008-51180-19579 and by Southern Region Small Fruit Consortium grant 2012-01 to PMB.	Alexandrino J, 2002, HEREDITY, V88, P66, DOI 10.1038/sj.hdy.6800010; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Begerow D, 2014, MYCOTA A, V7; Begerow Dominik, 2002, Mycological Progress, V1, P187, DOI 10.1007/s11557-006-0018-7; Bell DJ, 2008, J AM SOC HORTIC SCI, V133, P701, DOI 10.21273/JASHS.133.5.701; Billiard S, 2012, J EVOLUTION BIOL, V25, P1020, DOI 10.1111/j.1420-9101.2012.02495.x; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Brewer MT, 2014, MYCOLOGIA, V106, P415, DOI 10.3852/13-202; Brewer MT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-268; Burt EA, 1915, ANN MISSOURI BOT GAR, V2, P627, DOI DOI 10.2307/2990117; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cline W. O., 1998, Plant Disease, V82, P1064, DOI 10.1094/PDIS.1998.82.9.1064B; Eaton CJ, 2011, PLANT SCI, V180, P190, DOI 10.1016/j.plantsci.2010.10.002; Fontaine MC, 2013, MOL ECOL, V22, P2771, DOI 10.1111/mec.12293; Fry W, 2015, REEMERGING PHYTOPHTH; FU YX, 1993, GENETICS, V133, P693; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Gattepaille LM, 2013, HEREDITY, V110, P409, DOI 10.1038/hdy.2012.120; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Gladieux P, 2015, MOL ECOL, V24, P1969, DOI 10.1111/mec.13028; GRAAFLAND W., 1960, ACTA BOT NEERLAND, V9, P347; Grunwald NJ, 2011, ANNU REV PHYTOPATHOL, V49, P249, DOI 10.1146/annurev-phyto-072910-095246; Harder CB, 2013, FUNGAL BIOL-UK, V117, P764, DOI 10.1016/j.funbio.2013.09.004; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Kauserud H, 2006, MOL ECOL, V15, P421, DOI 10.1111/j.1365-294X.2005.02768.x; Levi A, 1997, J AM SOC HORTIC SCI, V122, P74, DOI 10.21273/JASHS.122.1.74; Lucas JA, 2015, ADV APPL MICROBIOL, V90, P29, DOI 10.1016/bs.aambs.2014.09.001; Mahuku GS, 2004, PLANT MOL BIOL REP, V22, P71, DOI 10.1007/BF02773351; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Mikaberidze A, 2014, PHYTOPATHOLOGY, V104, P324, DOI 10.1094/PHYTO-07-13-0204-R; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; MIMS CW, 1987, BOT GAZ, V148, P228, DOI 10.1086/337651; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Mouli B. C., 2003, Annual Review of Plant Pathology, V2, P145; Nagao Hideyuki, 2006, Mycoscience, V47, P277, DOI 10.1007/s10267-006-0307-7; Nannfeldt J.A., 1981, SYMB BOT UPSAL, V23, P1; NEI M, 1981, GENETICS, V97, P145; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nei M., 1987, MOL EVOLUTIONARY GEN; Nickerson NL, 1997, CAN J PLANT PATHOL, V19, P66, DOI 10.1080/07060669709500575; Pelczar Jr MJ, 1958, LAB EXERCISES MICROB, P45; Piatek M, 2012, MYCOL PROG, V11, P361, DOI 10.1007/s11557-011-0751-4; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shen Q, 2002, MYCOLOGIA, V94, P472, DOI 10.2307/3761781; Smith B, 2012, MISSISSIPPI VACCINIU, V1, P10; Smith K., 2009, Outlooks on Pest Management, V20, P148, DOI 10.1564/20aug02; Stukenbrock EH, 2014, FUNGAL BIOL REV, V28, P1, DOI 10.1016/j.fbr.2014.02.001; SUNDSTROM K. R., 1964, Symbolae botanicae upsalienses, V18; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Symington LS, 2014, NATURE, V514, P39, DOI 10.1038/nature13751; TAJIMA F, 1989, GENETICS, V123, P597; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Van Kan JAL, 2014, MOL PLANT PATHOL, V15, P957, DOI 10.1111/mpp.12148; Vialle A, 2013, MOL PHYLOGENET EVOL, V66, P628, DOI 10.1016/j.ympev.2012.10.021; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	76	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132545	10.1371/journal.pone.0132545	http://dx.doi.org/10.1371/journal.pone.0132545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207812	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000031
J	Zheng, CB; Zhou, WB; Wang, TT; You, PP; Zhao, YL; Yang, YQ; Wang, X; Luo, J; Chen, YH; Liu, MY; Chen, HQ				Zheng, Chunbing; Zhou, Wenbo; Wang, Tongtong; You, Panpan; Zhao, Yongliang; Yang, Yiqing; Wang, Xin; Luo, Jian; Chen, Yihua; Liu, Mingyao; Chen, Huaqing			A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic beta-Cells in Type 2 Diabetic Mice	PLOS ONE			English	Article							BILE-ACID RECEPTOR; FASTING BLOOD-GLUCOSE; INSULIN-RESISTANCE; IN-VITRO; AGONISTS; POTENT; MASS; SITAGLIPTIN; DERIVATIVES; MELLITUS	The G protein-coupled receptor TGR5 is a membrane receptor for bile acids. Its agonism increases energy expenditure and controls blood glucose through secretion of glucagon-like peptide-1 in enteroendocrine cells. In this study, we explored the therapeutic potential of WB403, a small compound activating TGR5 which was identified by combining TGR5 targeted luciferase assay and active GLP-1 assay, in treating type 2 diabetes. After confirmation of TGR5 and GLP-1 stimulating activities in various cell systems, WB403 was examined in oral glucose tolerance test, and tested on different mouse models of type 2 diabetes for glycemic control and pancreatic beta-cell protection effect. As a result, WB403 exhibited a moderate TGR5 activation effect while promoting GLP-1 secretion efficiently. Interestingly, gallbladder filling effect, which was reported for some known TGR5 agonists, was not detected in this novel compound. In vivo results showed that WB403 significantly improved glucose tolerance and decreased fasting blood glucose, postprandial blood glucose and HbA1c in type 2 diabetic mice. Further analysis revealed that WB403 increased pancreatic beta-cells and restored the normal distribution pattern of alpha-cell and beta-cell in islets. These findings demonstrated that TGR5 activator WB403 effectively promoted GLP-1 release, improved hyperglycemia and preserved the mass and function of pancreatic beta-cells, whereas it did not show a significant side effect on gallbladder. It may represent a promising approach for future type 2 diabetes mellitus drug development.	[Zheng, Chunbing; Zhou, Wenbo; Wang, Tongtong; You, Panpan; Zhao, Yongliang; Yang, Yiqing; Wang, Xin; Luo, Jian; Chen, Yihua; Liu, Mingyao; Chen, Huaqing] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Zheng, Chunbing; Zhou, Wenbo; Wang, Tongtong; You, Panpan; Zhao, Yongliang; Yang, Yiqing; Wang, Xin; Luo, Jian; Chen, Yihua; Liu, Mingyao; Chen, Huaqing] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Dept Mol & Cellular Med, Houston, TX USA	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Liu, MY (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China.	myliu@bio.ecnu.edu.cn; hqchen@bio.ecnu.edu.cn	Chen, Yihua/A-4323-2013; Wang, Xin/B-6572-2011; Chen, Yihua/O-2743-2019; Luo, Jian/H-3362-2016	Chen, Yihua/0000-0003-1733-7980; Wang, Xin/0000-0001-8079-8638; Chen, Yihua/0000-0003-1733-7980; Liu, Mingyao/0000-0001-7339-5048; Luo, Jian/0000-0003-3583-0154	Ministry of Science and Technology of China [2013ZX09507001]; National Natural Science Foundation of China [31271468]; Science and Technology Commission of Shanghai Municipality [12ZR1408700]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grant funding from the Ministry of Science and Technology of China (http://www.most.gov.cn. 2013ZX09507001) to ML; the National Natural Science Foundation of China (http://isisn.nsfc.gov.cn. 31271468) to HC; and the Science and Technology Commission of Shanghai Municipality (http://www.stcsm.gov.cn. 12ZR1408700) to HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2001, Diabetes Care, V24, P775; Baggio LL, 2004, DIABETES, V53, pS205, DOI 10.2337/diabetes.53.suppl_3.S205; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Christiansen E, 2011, J MED CHEM, V54, P6691, DOI 10.1021/jm2005699; Duan HL, 2012, J MED CHEM, V55, P10475, DOI 10.1021/jm301071h; Evans KA, 2009, J MED CHEM, V52, P7962, DOI 10.1021/jm901434t; Eyre H, 2004, CIRCULATION, V109, P3244, DOI 10.1161/01.CIR.0000133321.00456.00; Gadsby Roger, 2007, Prim Care Diabetes, V1, P209, DOI 10.1016/j.pcd.2007.10.004; Gerich JE, 1999, DIABETES OBES METAB, V1, P257, DOI 10.1046/j.1463-1326.1999.00027.x; Goke B, 2008, INT J CLIN PRACT, V62, P2, DOI 10.1111/j.1742-1241.2007.01686.x; Hansen HS, 2012, TRENDS PHARMACOL SCI, V33, P374, DOI 10.1016/j.tips.2012.03.014; Herbert MR, 2010, BIOORG MED CHEM LETT, V20, P5718, DOI 10.1016/j.bmcl.2010.08.014; Holst JJ, 2012, CLIN DRUG INVEST, V32, P1, DOI 10.2165/11595370-000000000-00000; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Knop FK, 2010, AM J PHYSIOL-ENDOC M, V299, pE10, DOI 10.1152/ajpendo.00137.2010; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Maedler K, 2005, J CLIN ENDOCR METAB, V90, P501, DOI 10.1210/jc.2004-0699; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Masur K, 2005, MOL ENDOCRINOL, V19, P1373, DOI 10.1210/me.2004-0350; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moran BM, 2014, DIABETES OBES METAB, V16, P1128, DOI 10.1111/dom.12330; Motta M, 2010, ARCH GERONTOL GERIAT, V50, P60, DOI 10.1016/j.archger.2009.01.012; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Murakami M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-20; Nakashima K, 2012, MOL CELL ENDOCRINOL, V349, P281, DOI 10.1016/j.mce.2011.11.008; Poucher SM, 2012, DIABETES OBES METAB, V14, P918, DOI 10.1111/j.1463-1326.2012.01619.x; Qian J, 2014, CELL SIGNAL, V26, P2412, DOI 10.1016/j.cellsig.2014.07.019; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Renehan AG, 2005, LANCET, V365, P1449, DOI 10.1016/S0140-6736(05)66399-4; Ritzel RA, 2006, DIABETES CARE, V29, P717, DOI 10.2337/diacare.29.03.06.dc05-1538; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Shah P, 2013, J CLIN ENDOCR METAB, V98, pE1163, DOI 10.1210/jc.2013-1029; Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813; Stumvoll M, 2001, CLIN LAB MED, V21, P31; Tanaka H, 2014, LIFE SCI, V94, P115, DOI 10.1016/j.lfs.2013.11.010; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Valentine WJ, 2006, INT J CLIN PRACT, V60, P1138, DOI 10.1111/j.1742-1241.2006.01102.x; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhu JJ, 2013, EUR J MED CHEM, V69, P55, DOI 10.1016/j.ejmech.2013.07.050	45	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134051	10.1371/journal.pone.0134051	http://dx.doi.org/10.1371/journal.pone.0134051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208278	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000196
J	Zhang, C; Sanders, JPM; Xiao, TT; Bruins, ME				Zhang, Chen; Sanders, Johan P. M.; Xiao, Ting T.; Bruins, Marieke E.			How Does Alkali Aid Protein Extraction in Green Tea Leaf Residue: A Basis for Integrated Biorefinery of Leaves	PLOS ONE			English	Article							FUNCTIONAL-PROPERTIES; ANTIOXIDANT ACTIVITY; SUGAR-BEET; PECTINS; CELL; CELLULOSE; BIOMASS; ACID; POLYSACCHARIDES; DEGRADATION	Leaf protein can be obtained cost-efficiently by alkaline extraction, but overuse of chemicals and low quality of (denatured) protein limits its application. The research objective was to investigate how alkali aids protein extraction of green tea leaf residue, and use these results for further improvements in alkaline protein biorefinery. Protein extraction yield was studied for correlation to morphology of leaf tissue structure, protein solubility and hydrolysis degree, and yields of non-protein components obtained at various conditions. Alkaline protein extraction was not facilitated by increased solubility or hydrolysis of protein, but positively correlated to leaf tissue disruption. HG pectin, RGII pectin, and organic acids were extracted before protein extraction, which was followed by the extraction of cellulose and hemi-cellulose. RGI pectin and lignin were both linear to protein yield. The yields of these two components were 80% and 25% respectively when 95% protein was extracted, which indicated that RGI pectin is more likely to be the key limitation to leaf protein extraction. An integrated biorefinery was designed based on these results.	[Zhang, Chen; Sanders, Johan P. M.; Bruins, Marieke E.] AFSG, Biobased Chem & Technol Grp, NL-6708 WG Wageningen, Wageningen Ur, Netherlands; [Sanders, Johan P. M.; Bruins, Marieke E.] Food & Biobased Res Inst, NL-6708 WG Wageningen, Wageningen Ur, Netherlands; [Xiao, Ting T.] Mol Biol Lab, Dept Plant Sci, NL-6708 PB Wageningen, Wageningen Ur, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Zhang, C (corresponding author), AFSG, Biobased Chem & Technol Grp, Bornse Weilanden 9, NL-6708 WG Wageningen, Wageningen Ur, Netherlands.	chen.zhang@wur.nl	Zhang, Chen/AAB-1292-2021; Bruins, Marieke E/G-3226-2014; Zhang, Chen/ABG-7131-2020	Zhang, Chen/0000-0002-9461-1755	STW project (Netherlands); DSM; Mali Biocarburant; Agrifirm	STW project (Netherlands); DSM; Mali Biocarburant; Agrifirm	This research is funded by STW project (Netherlands), and it is co-funded by DSM (http://www.dsm.com/countrysites/dsmnl/nl_NL/home.html), Agrifirm (http://www.agrifirm.com/) and Mali Biocarburant (http://www.malibiocarburant.com/malibio/). CZ, JS, and MB have received this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKESON WR, 1965, J AGR FOOD CHEM, V13, P145, DOI 10.1021/jf60138a014; Badar K. V., 2011, Current Botany, V2, P5; Bals B, 2011, BIOTECHNOL BIOENG, V108, P530, DOI 10.1002/bit.22973; Brovko FA, 1998, PLANT PHYSIOL BIOCH, V36, P773, DOI 10.1016/S0981-9428(98)80029-6; Carvalheiro F, 2008, J SCI IND RES INDIA, V67, P849; Chen X, 2012, APPL MECH MATER, V138-139, P933, DOI 10.4028/www.scientific.net/AMM.138-139.933; Chiesa S, 2011, BIORESOURCE TECHNOL, V102, P427, DOI 10.1016/j.biortech.2010.07.125; Dashek W. V., 2006, PLANT CELL BIOL, P33; Dashek WV, 2006, PLANT CELL BIOL, P107; Durling NE, 2007, FOOD CHEM, V101, P1417, DOI 10.1016/j.foodchem.2006.03.050; Ele-Ekouna JP, 2011, CARBOHYD POLYM, V83, P1232, DOI 10.1016/j.carbpol.2010.09.028; ENGLYST HN, 1984, ANALYST, V109, P937, DOI 10.1039/an9840900937; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; GERLOFF ED, 1965, J AGR FOOD CHEM, V13, P139, DOI 10.1021/jf60138a012; Ghaly A. E., 2010, American Journal of Applied Sciences, V7, P331, DOI 10.3844/ajassp.2010.331.342; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154; HENRIQUES F, 1976, BIOCHIM BIOPHYS ACTA, V430, P312, DOI 10.1016/0005-2728(76)90087-6; Jamdar SN, 2010, FOOD CHEM, V121, P178, DOI 10.1016/j.foodchem.2009.12.027; JAYASURIYA MCN, 1978, ANIM FEED SCI TECH, V3, P219, DOI 10.1016/0377-8401(78)90029-9; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Knill CJ, 2003, CARBOHYD POLYM, V51, P281, DOI 10.1016/S0144-8617(02)00183-2; Kondo M, 2004, ANIM FEED SCI TECH, V113, P71, DOI 10.1016/j.anifeedsci.2003.10.018; Lamsal BP, 2007, LWT-FOOD SCI TECHNOL, V40, P1520, DOI 10.1016/j.lwt.2006.11.010; Li P, 2005, J FOOD ENG, V67, P253, DOI 10.1016/j.jfoodeng.2004.04.009; Maas RHW, 2008, APPL MICROBIOL BIOT, V78, P751, DOI 10.1007/s00253-008-1361-1; Mauseth JD, 2009, BOT INTRO PLANT BIOL, P120; Nielsen PM, 2001, J FOOD SCI, V66, P642, DOI 10.1111/j.1365-2621.2001.tb04614.x; Ozdal T, 2013, FOOD RES INT, V51, P954, DOI 10.1016/j.foodres.2013.02.009; Parajo JC, 1996, FOOD CHEM, V57, P531, DOI 10.1016/S0308-8146(96)00012-X; Renard CMGC, 1996, PROGR BIOTECHNOL, V14, P603, DOI 10.1016/S0921-0423(96)80292-9; RENARD CMGC, 1990, CARBOHYD POLYM, V12, P9, DOI 10.1016/0144-8617(90)90101-W; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Sanders J, 2007, MACROMOL BIOSCI, V7, P105, DOI 10.1002/mabi.200600223; Saulnier L, 1999, J SCI FOOD AGR, V79, P396, DOI [10.1002/(SICI)1097-0010(19990301)79:3<396::AID-JSFA262>3.0.CO;2-B, 10.1002/(SICI)1097-0010(19990301)79:3&lt;396::AID-JSFA262&gt;3.0.CO;2-B]; Shen L, 2008, FOOD CHEM, V107, P929, DOI 10.1016/j.foodchem.2007.08.047; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Testova L, 2014, CARBOHYD POLYM, V100, P185, DOI 10.1016/j.carbpol.2013.01.093; Thompson JE, 2000, PLANTA, V211, P275, DOI 10.1007/s004250000287; Turkmen N, 2006, FOOD CHEM, V99, P835, DOI 10.1016/j.foodchem.2005.08.034; Van Dongen FEM, 2011, CARBOHYD POLYM, V86, P722, DOI 10.1016/j.carbpol.2011.05.007; Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350; de Toledo NMV, 2013, FOOD CHEM, V138, P776, DOI 10.1016/j.foodchem.2012.11.079; Willats WGT, 2006, TRENDS FOOD SCI TECH, V17, P97, DOI 10.1016/j.tifs.2005.10.008; Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X; Yalcin E, 2007, FOOD CHEM, V104, P1641, DOI 10.1016/j.foodchem.2007.03.029; Zaidel DNA, 2012, BIOCATAL AGRIC BIOTE, V1, P207, DOI 10.1016/j.bcab.2012.03.007; Zhang C, 2014, BIOMASS BIOENERG, V67, P466, DOI 10.1016/j.biombioe.2014.05.020; Zykwinska A, 2006, CARBOHYD POLYM, V65, P510, DOI 10.1016/j.carbpol.2006.02.012; Zykwinska AW, 2005, PLANT PHYSIOL, V139, P397, DOI 10.1104/pp.105.065912	50	23	25	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133046	10.1371/journal.pone.0133046	http://dx.doi.org/10.1371/journal.pone.0133046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200774	gold, Green Published, Green Submitted			2022-12-26	WOS:000358597100053
J	Adada, MM; Canals, D; Jeong, N; Kelkar, AD; Hernandez-Corbacho, M; Pulkoski-Gross, MJ; Donaldson, JC; Hannun, YA; Obeid, LM				Adada, Mohamad M.; Canals, Daniel; Jeong, Nara; Kelkar, Ashwin D.; Hernandez-Corbacho, Maria; Pulkoski-Gross, Michael J.; Donaldson, Jane C.; Hannun, Yusuf A.; Obeid, Lina M.			Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth facetor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion	FASEB JOURNAL			English	Article						Spns2; cell adhesion; alkaline ceramidase 2	ERM PROTEINS; SPHINGOLIPID METABOLISM; PLASMA-MEMBRANE; RECEPTOR; MIGRATION; 1-PHOSPHATE; ACTIVATION; TRANSLOCATION; INHIBITOR; CARCINOMA	The bioactive sphingolipid sphingosine-1-phosphate (S1P) mediates cellular proliferation, mitogenesis, inflammation, and angiogenesis. These biologies are mediated through S1P binding to specific GPCRs [sphingosine-1-phosphate receptor (S1PR)1-5] and some other less well-characterized intracellular targets. Ezrinradixin- moesin (ERM) proteins, a family of adaptor molecules linking the cortical actin cytoskeleton to the plasma membrane, are emerging as critical regulators of cancer invasion via regulation of cell morphology and motility. Recently, we identified S1P as an acute ERM activator (via phosphorylation) through its action on S1PR2. In this work, we dissect the mechanism of S1P generation downstream of epidermal growth factor (EGF) leading to ERM phosphorylation and cancer invasion. Using pharmacologic inhibitors, small interfering RNA technologies, and genetic approaches, we demonstrate that sphingosine kinase (SK) 2, and not SK1, is essential and sufficient in EGF-mediated ERM phosphorylation in HeLa cells. In fact, knocking down SK2 decreased ERM activation 2.5-fold. Furthermore, we provide evidence that SK2 is necessary to mediate EGF-induced invasion. In addition, overexpressing SK2 causes a 2-fold increase in HeLa cell invasion. Surprisingly, and for the first time, we find that this event, although dependent on S1PR2 activation, does not generate and does not require extracellular S1P secretion, therefore introducing a potential novel model of autocrine/intracrine action of S1P that still involves its GPCRs. These results define new mechanistic insights for EGF-mediated invasion and novel actions of SK2, therefore setting the stage for novel targets in the treatment of growth factor-driven malignancies.	[Adada, Mohamad M.; Canals, Daniel; Jeong, Nara; Kelkar, Ashwin D.; Hernandez-Corbacho, Maria; Pulkoski-Gross, Michael J.; Donaldson, Jane C.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11784 USA; [Adada, Mohamad M.; Canals, Daniel; Jeong, Nara; Kelkar, Ashwin D.; Hernandez-Corbacho, Maria; Pulkoski-Gross, Michael J.; Donaldson, Jane C.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11784 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, North Port, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Obeid, LM (corresponding author), SUNY Stony Brook, Dept Med, Hlth Sci Ctr, L-4,179, Stony Brook, NY 11784 USA.	lina.obeid@stonybrookmedicine.edu	Canals, Daniel/AAW-1998-2021; Canals, Daniel/AAJ-8176-2021	Canals, Daniel/0000-0002-9293-5123; Pulkoski-Gross, Michael/0000-0003-4644-1795; Adada, Mohamad/0000-0002-2988-2081	U.S. Veterans Affairs Merit Award; U.S. National Institutes of Health [GM097741, PO1CA097132]; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA087584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518, R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	U.S. Veterans Affairs Merit Award; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank all the members of the Lipid Cancer Lab for their comments during data presentation. The authors also thank Mrs. Janet Allopenna for her help in tagging the WT sphingosine kinase 2 construct with the MYC tag, and Lpath for the generous gift of the Sphingomab antibody. The Sphingomab antibody was obtained through a material transfer agreement between LPath Inc. (San Diego, CA, USA) and the Research Foundation for the State University of New York. The authors also thank Dr. Cungui Mao and Ms. Ruijuan Xu for their generous gift of the ACER2 DNA construct, as well as the HeLa cells stably overexpressing ACER2. This work was supported by a U.S. Veterans Affairs Merit Award and U.S. National Institutes of Health Grants GM097741 (National Institute of General Medical Sciences) and PO1CA097132 (National Cancer Institute) all to L.M.O. M.M.A., D.C., Y.A.H., and L.M.O. participated in research design. M.M.A. and D.C. prepared the analytic tools. M.M.A., D.C., N.J., M.J.P.-G., M.H.-C., and A.D.K. conducted the experiments. M.M.A., D.C., Y.A.H., and L.M.O. wrote or contributed to the writing of the manuscript. The authors declare no conflicts of interest.	Adada M, 2014, BBA-MOL CELL BIOL L, V1841, P727, DOI 10.1016/j.bbalip.2013.07.002; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Beljanski V, 2011, INVEST NEW DRUG, V29, P1132, DOI 10.1007/s10637-010-9452-0; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Bradley E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110119; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Chen J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004688; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Don AS, 2009, BIOCHEM BIOPH RES CO, V380, P87, DOI 10.1016/j.bbrc.2009.01.075; Endo K, 2009, ONCOGENE, V28, P1725, DOI 10.1038/onc.2009.20; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Fukuhara Shigetomo, 2013, Seikagaku, V85, P269; Gandy KAO, 2013, FASEB J, V27, P3155, DOI 10.1096/fj.13-228460; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044543; Gillies L, 2009, CELL SIGNAL, V21, P675, DOI 10.1016/j.cellsig.2009.01.023; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2002, FEBS LETT, V532, P97, DOI 10.1016/S0014-5793(02)03636-0; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hisano Y, 2013, BIOL OPEN, V2, P789, DOI 10.1242/bio.20134994; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kitajiri S, 2004, J CELL BIOL, V166, P559, DOI 10.1083/jcb.200402007; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lai WQ, 2009, J IMMUNOL, V183, P2097, DOI 10.4049/jimmunol.0804376; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Maines Lynn W., 2010, Inflammopharmacology, V18, P73, DOI 10.1007/s10787-010-0032-x; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; O'Sullivan C, 2013, TRENDS PHARMACOL SCI, V34, P401, DOI 10.1016/j.tips.2013.05.002; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Siow D, 2011, CRIT REV BIOCHEM MOL, V46, P365, DOI 10.3109/10409238.2011.580097; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Sun DF, 2012, CANCER LETT, V319, P182, DOI 10.1016/j.canlet.2012.01.012; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Waters D, 2006, FASEB J, V20, pA1058; Weigert A, 2009, INT J CANCER, V125, P2114, DOI 10.1002/ijc.24594; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	61	52	56	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4654	4669		10.1096/fj.15-274340	http://dx.doi.org/10.1096/fj.15-274340			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26209696	Green Published			2022-12-26	WOS:000364514700023
J	Samuel, PP; Smith, LP; Phillips, GN; Olson, JS				Samuel, Premila P.; Smith, Lucian P.; Phillips, George N., Jr.; Olson, John S.			Apoglobin Stability Is the Major Factor Governing both Cell-free and in Vivo Expression of Holomyoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS SYSTEM; SITE-DIRECTED MUTAGENESIS; FOLDED APOMYOGLOBIN INTERMEDIATE; SPERM-WHALE MYOGLOBIN; ESCHERICHIA-COLI; MESSENGER-RNA; STRUCTURAL-CHARACTERIZATION; HEMIN DISSOCIATION; LIPID OXIDATION; AMYLOID FIBRILS	Expression levels in animal muscle tissues and in Escherichia coli vary widely for naturally occurring mammalian myoglobins (Mb). To explore this variation, we developed an in vitro transcription and wheat germ extract-based translation assay to examine quantitatively the factors that govern expression of holoMb. We constructed a library of naturally occurring Mbs from two terrestrial and four deep-diving aquatic mammals and three distal histidine mutants designed to enhance apoglobin stability but decrease hemin affinity. A strong linear correlation is observed between cell-free expression levels of holo-metMb variants and their corresponding apoglobin stabilities, which were measured independently by guanidine HCl-induced unfolding titrations using purified proteins. In contrast, there is little dependence of expression on hemin affinity. Our results confirm quantitatively that deep diving mammals have highly stable Mbs that express to higher levels in animal myocytes, E. coli, and the wheat germ cell-free system than Mbs from terrestrial mammals. Our theoretical analyses show that the rate of aggregation of unfolded apoMb is very large, and as a result, the key factor for high level expression of holoMb, and presumably other heme proteins, is an ultra high fraction of folded, native apoglobin that is capable of rapidly binding hemin. This fraction is determined by the overall equilibrium folding constant and not hemin affinity. These results also demonstrate that the cell-free transcription/translation system can be used as a high throughput platform to screen for apoglobin stability without the need to generate large amounts of protein for in vitro unfolding measurements.	[Samuel, Premila P.; Smith, Lucian P.; Phillips, George N., Jr.; Olson, John S.] Rice Univ, BioSci Rice, Houston, TX 77005 USA; [Phillips, George N., Jr.] Rice Univ, Dept Chem, Houston, TX 77005 USA	Rice University; Rice University	Olson, JS (corresponding author), Rice Univ, BioSci Rice, MS 140,6100 Main St, Houston, TX 77005 USA.	olson@rice.edu	Regan, Clinton/E-6250-2012	Olson, John/0000-0002-0760-5403; Samuel, Premila/0000-0001-6690-0886; Smith, Lucian/0000-0001-7002-6386	National Institutes of Health [P01 HL110900, U01 GM098248, HL47020, GM35649]; Robert A. Welch Foundation [C-0612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020, P01HL110900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, U01GM098248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL110900 (to J. S. O.). This work was also supported by Grant C-0612 from Robert A. Welch Foundation (to J. S. O.). The initial funds for setting up the cell-free technology at Rice University were supported by the National Institutes of Health Grant U01 GM098248 (Protein Structure Initiative) (to G. N. P., Jr.). The earlier work on holoMb expression in E. coli was supported by the National Institutes of Health Grants HL47020 and GM35649 (to J. S. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar M Kalim, 2014, Front Bioeng Biotechnol, V2, P30, DOI 10.3389/fbioe.2014.00030; Alayash AI, 2013, TRENDS BIOTECHNOL, V31, P2, DOI 10.1016/j.tibtech.2012.10.003; Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, V21; Ascoli F, 1981, Methods Enzymol, V76, P72; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Banci L., 2013, METALLOMICS CELL, P565; BARRICK D, 1994, J MOL BIOL, V237, P588, DOI 10.1006/jmbi.1994.1257; BARRICK D, 1993, BIOCHEMISTRY-US, V32, P3790, DOI 10.1021/bi00065a035; BASTOS RN, 1977, J MOL BIOL, V110, P205, DOI 10.1016/S0022-2836(77)80069-7; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Egan TJ, 2001, BIOCHEMISTRY-US, V40, P204, DOI 10.1021/bi0013501; Eliezer D, 2000, BIOCHEMISTRY-US, V39, P2894, DOI 10.1021/bi992545f; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; Elmer J, 2011, J CHROMATOGR B, V879, P131, DOI 10.1016/j.jchromb.2010.11.021; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; FLANAGAN MA, 1983, BIOCHEMISTRY-US, V22, P6027, DOI 10.1021/bi00294a051; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; Goren MA, 2009, METHOD ENZYMOL, V463, P647, DOI 10.1016/S0076-6879(09)63037-8; Graves PE, 2008, BBA-PROTEINS PROTEOM, V1784, P1471, DOI 10.1016/j.bbapap.2008.04.012; GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6; Grimsley GR, 1999, PROTEIN SCI, V8, P1843, DOI 10.1110/ps.8.9.1843; Grunwald EW, 2006, J AGR FOOD CHEM, V54, P4452, DOI 10.1021/jf0603228; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11300, DOI 10.1021/bi960372d; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Harnastai IN, 2006, PROTEIN EXPRES PURIF, V46, P47, DOI 10.1016/j.pep.2005.07.006; HUGHSON FM, 1989, BIOCHEMISTRY-US, V28, P4415, DOI 10.1021/bi00436a044; HUGHSON FM, 1991, BIOCHEMISTRY-US, V30, P4113, DOI 10.1021/bi00231a001; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; Imamura H, 2013, J SYNCHROTRON RADIAT, V20, P919, DOI 10.1107/S0909049513022772; INADA Y, 1962, BIOCHEM BIOPH RES CO, V9, P323, DOI 10.1016/0006-291X(62)90048-7; IRACE G, 1981, BIOCHEMISTRY-US, V20, P792, DOI 10.1021/bi00507a022; Itoh T, 2001, BIOCONJUGATE CHEM, V12, P3, DOI 10.1021/bc000055q; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Kelley C., 2013, GNUPLOT VERSION 4 5; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; KIRBY EP, 1970, J BIOL CHEM, V245, P6300; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lee SK, 2015, FOOD CHEM, V167, P258, DOI 10.1016/j.foodchem.2014.06.098; Lepeshkevich SV, 2009, BBA-PROTEINS PROTEOM, V1794, P103, DOI 10.1016/j.bbapap.2008.09.024; Light W. R., 1987, THESIS RICE U HOUSTO; Lo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060704; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Madin K, 2004, FEBS LETT, V562, P155, DOI 10.1016/S0014-5793(04)00221-2; Makino S, 2010, METHODS MOL BIOL, V607, P127, DOI 10.1007/978-1-60327-331-2_12; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022; MOORE RE, 1980, CANCER RES, V40, P1449; Nishimura C, 2006, J MOL BIOL, V355, P139, DOI 10.1016/j.jmb.2005.10.047; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; Robinson CR, 1997, BIOCHEMISTRY-US, V36, P16141, DOI 10.1021/bi971470h; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Scott EE, 2000, J BIOL CHEM, V275, P27129; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; SINGER RH, 1973, J MOL BIOL, V78, P321, DOI 10.1016/0022-2836(73)90119-8; SMERDON SJ, 1991, BIOCHEMISTRY-US, V30, P6252, DOI 10.1021/bi00239a025; Smith L., 2003, THESIS RICE U HOUSTO; Spirin AS, 2008, CELL FREE PROTEIN SY, P1; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SRINIVAS V, 1990, BIOCHEM INT, V21, P849; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Takai K, 2010, CURR PHARM BIOTECHNO, V11, P272, DOI 10.2174/138920110791111933; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tcherkasskaya O, 2000, BIOCHEMISTRY-US, V39, P1879, DOI 10.1021/bi992117+; Tcherkasskaya O, 2000, J BIOL CHEM, V275, P36285, DOI 10.1074/jbc.M003008200; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Tyler RC, 2005, PROTEINS, V59, P633, DOI 10.1002/prot.20436; Varnado CL, 2013, ANTIOXID REDOX SIGN, V18, P2314, DOI 10.1089/ars.2012.4917; WEDZICHA BL, 1988, FOOD CHEM, V27, P47, DOI 10.1016/0308-8146(88)90035-0; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443	89	21	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23479	23495		10.1074/jbc.M115.672204	http://dx.doi.org/10.1074/jbc.M115.672204			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26205820	hybrid, Green Published			2022-12-26	WOS:000361816500002
J	Kubic, JD; Lui, JW; Little, EC; Ludvik, AE; Konda, S; Salgia, R; Aplin, AE; Lang, D				Kubic, Jennifer D.; Lui, Jason W.; Little, Elizabeth C.; Ludvik, Anton E.; Konda, Sasank; Salgia, Ravi; Aplin, Andrew E.; Lang, Deborah			PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; B16 TUMOR-CELLS; NEURAL CREST; GENOMIC ORGANIZATION; ENDOTHELIAL-CELLS; MET RECEPTOR; METASTASIS; ACTIVATION; FUSION; DOMAIN	Metastatic melanoma is an aggressive and deadly disease. The chemokine receptor CXCR4 is active in melanoma metastasis, although the mechanism for the promotion and maintenance of CXCR4 expression in these cells is mostly unknown. Here, we find melanoma cells express two CXCR4 isoforms, the common version and a variant that is normally restricted to cells during development or to mature blood cells. CXCR4 expression is driven through a highly conserved intronic enhancer element by the transcription factors PAX3 and FOXD3. Inhibition of these transcription factors slows melanoma cell growth, migration, and motility, as well as reduces CXCR4 expression. Overexpression of these transcription factors drives the production of increased CXCR4 levels. Loss of PAX3 and FOXD3 transcription factor activity results in a reduction in cell motility, migration, and chemotaxis, all of which are rescued by CXCR4 overexpression. Here, we discover a molecular pathway wherein PAX3 and FOXD3 promote CXCR4 gene expression in melanoma.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lang, Deborah] Univ Chicago, Dermatol Sect, Chicago, IL 60637 USA; [Salgia, Ravi] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; [Aplin, Andrew E.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Aplin, Andrew E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Aplin, Andrew E.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Surg, Philadelphia, PA 19107 USA	University of Chicago; University of Chicago; University of Chicago; Jefferson University; Jefferson University; Jefferson University	Lang, D (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 5067, Chicago, IL 60637 USA.	dlang@medicine.bsd.uchicago.edu	Regan, Clinton/E-6250-2012	Lang, Deborah/0000-0003-1057-0923	National Institutes of Health [T32 GM007183, T35 DK062719, R01 CA160495, R01 CA130202, R01-AR062547, R01CA184001]; American Cancer Society [RSG-CSM-121505]; Friends of Dermatology-University of Chicago; Wendy Will Case Foundation; University of Chicago Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA130202, R01CA160495, R01CA184001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK062719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Friends of Dermatology-University of Chicago; Wendy Will Case Foundation; University of Chicago Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM007183 (to J. W. L.), T35 DK062719 (TO S. K.), R01 CA160495 (to A. E. A.), and R01 CA130202, R01-AR062547, and R01CA184001 (to D. L.), American Cancer Society Research Scholar Award RSG-CSM-121505 (to D. L.), Friends of Dermatology-University of Chicago, the Wendy Will Case Foundation, and the University of Chicago Comprehensive Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article.	Abel EV, 2010, CANCER RES, V70, P2891, DOI 10.1158/0008-5472.CAN-09-3139; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Basile KJ, 2012, ONCOGENE, V31, P2471, DOI 10.1038/onc.2011.424; Bonvin E, 2012, MOL CELL BIOL, V32, P4674, DOI 10.1128/MCB.01067-12; Cardones AR, 2003, CANCER RES, V63, P6751; Caruz A, 1998, FEBS LETT, V426, P271, DOI 10.1016/S0014-5793(98)00359-7; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P3685, DOI 10.1073/pnas.91.9.3685; CHALEPAKIS G, 1995, GENE, V162, P267, DOI 10.1016/0378-1119(95)00345-7; Duquenne C, 2014, J IMMUNOL, V193, P4188, DOI 10.4049/jimmunol.1303298; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gupta SK, 1999, J IMMUNOL, V163, P2368; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; He SJ, 2011, MELANOMA RES, V21, P24, DOI 10.1097/CMR.0b013e328341c7e0; Izraely S, 2010, IMMUNOL LETT, V130, P107, DOI 10.1016/j.imlet.2009.12.003; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Jun S, 1996, DEVELOPMENT, V122, P2639; Katiyar P, 2011, MOL CANCER RES, V9, P545, DOI 10.1158/1541-7786.MCR-10-0454; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Kubic JD, 2015, ONCOGENE, V34, P4964, DOI 10.1038/onc.2014.420; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Kubic JD, 2012, MOL CANCER RES, V10, P1065, DOI 10.1158/1541-7786.MCR-11-0387; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Lee CH, 2006, MOL CANCER THER, V5, P2592, DOI 10.1158/1535-7163.MCT-06-0310; Lee E, 2013, PIGM CELL MELANOMA R, V26, P58, DOI 10.1111/pcmr.12024; Li DJ, 2011, J VASC SURG, V53, P1668, DOI 10.1016/j.jvs.2011.01.044; Liedtke D, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12188; Liu F, 2013, PIGM CELL MELANOMA R, V26, P67, DOI 10.1111/pcmr.12029; Longo-Imedio MI, 2005, INT J CANCER, V117, P861, DOI 10.1002/ijc.21269; Mascarenhas JB, 2010, PIGM CELL MELANOMA R, V23, P225, DOI 10.1111/j.1755-148X.2010.00667.x; Murakami T, 2002, CANCER RES, V62, P7328; Nelms BL, 2011, GENESIS, V49, P10, DOI 10.1002/dvg.20686; O'Boyle G, 2013, BRIT J CANCER, V108, P1634, DOI 10.1038/bjc.2013.124; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; Plummer RS, 2008, MODERN PATHOL, V21, P525, DOI 10.1038/modpathol.3801019; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Sasai N, 2001, DEVELOPMENT, V128, P2525; Scala S, 2006, CLIN CANCER RES, V12, P2427, DOI 10.1158/1078-0432.CCR-05-1940; Scholl FA, 2001, CANCER RES, V61, P823; Sloane AJ, 2005, IMMUNOL CELL BIOL, V83, P129, DOI 10.1111/j.1440-1711.2004.01304.x; Sutton J, 1996, J BIOL CHEM, V271, P23126, DOI 10.1074/jbc.271.38.23126; Takekoshi T, 2012, MOL CANCER THER, V11, P2516, DOI 10.1158/1535-7163.MCT-12-0494; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Thompson JA, 2012, J NATL COMPR CANC NE, V10, P932, DOI 10.6004/jnccn.2012.0096; Tomescu O, 2004, LAB INVEST, V84, P1060, DOI 10.1038/labinvest.3700125; Ueno Y, 2008, INT J CANCER, V123, P340, DOI 10.1002/ijc.23465; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Vianello F, 2006, J IMMUNOL, V176, P2902, DOI 10.4049/jimmunol.176.5.2902; Wegner SA, 1998, J BIOL CHEM, V273, P4754, DOI 10.1074/jbc.273.8.4754; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Zhu ZB, 2004, GENE THER, V11, P645, DOI 10.1038/sj.gt.3302089	56	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21901	21914		10.1074/jbc.M115.670976	http://dx.doi.org/10.1074/jbc.M115.670976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26205821	Green Published, hybrid			2022-12-26	WOS:000360968500012
J	Catavitello, G; Ivanenko, YP; Lacquaniti, F				Catavitello, Giovanna; Ivanenko, Yuri P.; Lacquaniti, Francesco			Planar Covariation of Hindlimb and Forelimb Elevation Angles during Terrestrial and Aquatic Locomotion of Dogs	PLOS ONE			English	Article							KINEMATIC ANALYSIS; QUADRUPEDAL LOCOMOTION; HUMAN WALKING; SPINAL-CORD; PATTERN GENERATION; GAIT TRANSITIONS; DECEREBRATE CATS; CANIS-FAMILIARIS; NEURAL NETWORKS; MODULAR CONTROL	The rich repertoire of locomotor behaviors in quadrupedal animals requires flexible inter-limb and inter-segmental coordination. Here we studied the kinematic coordination of different gaits (walk, trot, gallop, and swim) of six dogs (Canis lupus familiaris) and, in particular, the planar covariation of limb segment elevation angles. The results showed significant variations in the relative duration of rearward limb movement, amplitude of angular motion, and inter-limb coordination, with gait patterns ranging from a lateral sequence of footfalls during walking to a diagonal sequence in swimming. Despite these differences, the planar law of inter-segmental coordination was maintained across different gaits in both forelimbs and hindlimbs. Notably, phase relationships and orientation of the covariation plane were highly limb specific, consistent with the functional differences in their neural control. Factor analysis of published muscle activity data also demonstrated differences in the characteristic timing of basic activation patterns of the forelimbs and hindlimbs. Overall, the results demonstrate that the planar covariation of inter-segmental coordination has emerged for both fore-and hindlimbs and all gaits, although in a limb-specific manner.	[Catavitello, Giovanna; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, I-00133 Rome, Italy; [Catavitello, Giovanna; Ivanenko, Yuri P.; Lacquaniti, Francesco] Santa Lucia Fdn, Lab Neuromotor Physiol, I-00179 Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, I-00133 Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Rome Tor Vergata	Catavitello, G (corresponding author), Univ Roma Tor Vergata, Ctr Space Biomed, I-00133 Rome, Italy.	g.catavitello@hsantalucia.it	Catavitello, Giovanna/AAQ-8737-2020; Lacquaniti, Francesco/J-9842-2016; Ivanenko, Yury/L-1599-2018	Lacquaniti, Francesco/0000-0003-0896-7315; Ivanenko, Yury/0000-0001-9363-9548	Italian University Ministry (PRIN project) [2010MEFNF7_002]; Italian Space Agency (COREA grant); PhD program in Neurosciences of the University of Rome Tor Vergata	Italian University Ministry (PRIN project); Italian Space Agency (COREA grant); PhD program in Neurosciences of the University of Rome Tor Vergata	This work was supported by grants from the Italian University Ministry (PRIN project grant 2010MEFNF7_002) and the Italian Space Agency (COREA grant). GC is supported by the PhD program in Neurosciences of the University of Rome Tor Vergata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFELT Z, 1983, ACTA NEUROBIOL EXP, V43, P235; Alexander R.M., 1982, LOCOMOTION ANIMALS; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; Arshavskii Iu I, 1965, Biofizika, V10, P665; Barliya A, 2009, EXP BRAIN RES, V193, P371, DOI 10.1007/s00221-008-1633-0; Beliez L, 2015, J NEUROSCI, V35, P6117, DOI 10.1523/JNEUROSCI.4145-14.2015; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bertram JEA, 2000, AM J VET RES, V61, P832, DOI 10.2460/ajvr.2000.61.832; Bianchi L, 1998, J NEUROPHYSIOL, V79, P2155, DOI 10.1152/jn.1998.79.4.2155; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Bohn HF, 2012, J COMP PHYSIOL A, V198, P465, DOI 10.1007/s00359-012-0723-4; Borghese NA, 1996, J PHYSIOL-LONDON, V494, P863, DOI 10.1113/jphysiol.1996.sp021539; Bush JWM, 2006, ANNU REV FLUID MECH, V38, P339, DOI 10.1146/annurev.fluid.38.050304.092157; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Carrier DR, 1998, J EXP BIOL, V201, P3185; CAVAGNA GA, 1988, J PHYSIOL-LONDON, V399, P81; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CHARTERIS J, 1979, J ANAT, V128, P803; Cheron G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/375148; Cheron G, 2001, EXP BRAIN RES, V137, P455, DOI 10.1007/s002210000663; Corazza S, 2010, IEEE T BIO-MED ENG, V57, P806, DOI 10.1109/TBME.2008.2002103; Courtine G, 2005, J NEUROPHYSIOL, V93, P3127, DOI 10.1152/jn.01073.2004; Deban SM, 2012, J EXP BIOL, V215, P287, DOI 10.1242/jeb.063230; DeCamp CE, 1997, VET CLIN N AM-SMALL, V27, P825, DOI 10.1016/S0195-5616(97)50082-9; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Dominici N, 2010, J NEUROPHYSIOL, V103, P1673, DOI 10.1152/jn.00945.2009; Dounskaia N, 2010, EXERC SPORT SCI REV, V38, P201, DOI 10.1097/JES.0b013e3181f45194; Drew T, 2008, J PHYSIOL-LONDON, V586, P1239, DOI 10.1113/jphysiol.2007.146605; Feeney LC, 2007, AM J VET RES, V68, P277, DOI 10.2460/ajvr.68.3.277; Fischer M.S., 2011, DOGS MOTION; Fischer MS, 2006, J EXP ZOOL PART A, V305A, P935, DOI 10.1002/jez.a.333; Fish FE, 2014, INTEGR COMP BIOL, V54, pE65; Fisher N.I., 1993, STAT ANAL SPHERICAL; Full R, 2003, CAN SIMPLE NEURAL OS; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gerasimenko Y, 2009, J NEUROSCI, V29, P5681, DOI 10.1523/JNEUROSCI.6058-08.2009; Giszter SF, 2010, EXP BRAIN RES, V200, P283, DOI 10.1007/s00221-009-2016-x; Goldner B, 2015, VET J IN PRESS; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GOSLOW GE, 1981, J EXP BIOL, V94, P15; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Grillner S, 2011, SCIENCE, V334, P912, DOI 10.1126/science.1214778; Guertin PA, 2013, MOVEMENT DISORD, V3, P183, DOI [10.3389/fneur.2012.00183, DOI 10.3389/FNEUR.2012.00183]; Hallemans A, 2009, EXP BRAIN RES, V198, P95, DOI 10.1007/s00221-009-1937-8; Hart CB, 2010, J NEUROSCI, V30, P1322, DOI 10.1523/JNEUROSCI.5894-08.2010; HILDEBRAND M, 1967, AM J PHYS ANTHROPOL, V26, P119, DOI 10.1002/ajpa.1330260203; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; Hsieh ST, 2004, P NATL ACAD SCI USA, V101, P16784, DOI 10.1073/pnas.0405736101; Hudson PE, 2012, J EXP BIOL, V215, P2425, DOI 10.1242/jeb.066720; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Ivanenko YP, 2008, EUR J NEUROSCI, V27, P3351, DOI 10.1111/j.1460-9568.2008.06289.x; Ivanenko YP, 2008, J NEUROPHYSIOL, V99, P1890, DOI 10.1152/jn.01308.2007; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Ivanenko YP, 2006, NEUROSCIENTIST, V12, P339, DOI 10.1177/1073858406287987; JAYES AS, 1978, J ZOOL, V185, P289, DOI 10.1111/j.1469-7998.1978.tb03334.x; Juvin L, 2012, J NEUROSCI, V32, P953, DOI 10.1523/JNEUROSCI.4640-11.2012; KELLY MF, 1990, IEEE T BIO-MED ENG, V37, P221, DOI 10.1109/10.52324; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kim J, 2008, AM J VET RES, V69, P1116, DOI 10.2460/ajvr.69.9.1116; Lacquaniti F, 1999, NEWS PHYSIOL SCI, V14, P168, DOI 10.1152/physiologyonline.1999.14.4.168; Lacquaniti F, 2002, ARCH ITAL BIOL, V140, P263; Lacquaniti F, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00061; Lacquaniti F, 2012, J PHYSIOL-LONDON, V590, P2189, DOI 10.1113/jphysiol.2011.215137; Laroche D, 2007, EXP BRAIN RES, V176, P85, DOI 10.1007/s00221-006-0597-1; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DV, 1999, J EXP BIOL, V202, P3565; Leong P, 1998, J NEUROSCI METH, V80, P191, DOI 10.1016/S0165-0270(97)00201-X; Leurs F, 2012, GAIT POSTURE, V35, P647, DOI 10.1016/j.gaitpost.2011.12.017; MacLellan MJ, 2014, J NEUROPHYSIOL, V111, P1541, DOI 10.1152/jn.00437.2013; MacLellan MJ, 2012, J NEUROPHYSIOL, V107, P114, DOI 10.1152/jn.00693.2011; MacLellan MJ, 2010, EXP BRAIN RES, V202, P307, DOI 10.1007/s00221-009-2133-6; Maes L, 2013, J EXP BIOL, V216, P2257, DOI 10.1242/jeb.082149; Maes LD, 2008, J EXP BIOL, V211, P138, DOI 10.1242/jeb.008243; MAH CD, 1994, J MOTOR BEHAV, V26, P83, DOI 10.1080/00222895.1994.9941664; Marsolais GS, 2003, J AM VET MED ASSOC, V222, P739, DOI 10.2460/javma.2003.222.739; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Meyns P, 2013, GAIT POSTURE, V38, P555, DOI 10.1016/j.gaitpost.2013.02.006; MILLER S, 1975, BRAIN RES, V91, P217, DOI 10.1016/0006-8993(75)90544-2; MISIASZEK JE, 1995, J NEUROPHYSIOL, V73, P2499, DOI 10.1152/jn.1995.73.6.2499; Muybridge Eadweard, 1902, ANIMALS MOTION, P20; Neptune RR, 2009, J BIOMECH, V42, P1282, DOI 10.1016/j.jbiomech.2009.03.009; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Noble JW, 2008, EXP BRAIN RES, V189, P249, DOI 10.1007/s00221-008-1464-z; OLREE KS, 1995, BIOL CYBERN, V73, P409, DOI 10.1007/BF00201475; ORLOVSKII G. N., 1965, BIOFIZIKA, V10, P847; ORLOVSKII G. N., 1966, BIOFIZKA, V11, P364; Patla AE, 1988, NEURAL CONTROL RHYTH, P455; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; PRENTICE SD, 1995, MED BIOL ENG COMPUT, V33, P317, DOI 10.1007/BF02510506; Prentice Stephen D, 2006, COMPUTATIONAL INTELL, P172; Prochazka A, 2012, COMPR PHYSIOL, V2, P2615, DOI 10.1002/cphy.c100086; Revzen S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051907; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Schilling N, 2009, J EXP BIOL, V212, P1036, DOI 10.1242/jeb.020255; Sefati S, 2013, P NATL ACAD SCI USA, V110, P18798, DOI 10.1073/pnas.1309300110; Shapiro LJ, 2005, AM J PHYS ANTHROPOL, V126, P205, DOI 10.1002/ajpa.20049; Shen L, 1995, J NEUROPHYSIOL, V74, P2266, DOI 10.1152/jn.1995.74.6.2266; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; SHIK M. L., 1965, BIOFIZIKA, V10, P1037; SRINIVASAN S, 1992, IEEE T BIO-MED ENG, V39, P716, DOI 10.1109/10.142646; Tan U, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00084; Walter RM, 2007, J EXP BIOL, V210, P208, DOI 10.1242/jeb.02645; Wannier T, 2001, EXP BRAIN RES, V141, P375, DOI 10.1007/s002210100875; WOOTTEN ME, 1990, J ORTHOPAED RES, V8, P247, DOI 10.1002/jor.1100080214; YAMAGUCHI T, 1986, BRAIN RES, V379, P125, DOI 10.1016/0006-8993(86)90264-7; Zelenin PV, 2011, J NEUROSCI, V31, P4636, DOI 10.1523/JNEUROSCI.6511-10.2011	110	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133936	10.1371/journal.pone.0133936	http://dx.doi.org/10.1371/journal.pone.0133936			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218076	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900056
J	Wang, SH; Lin, PY; Chiu, YC; Huang, JS; Kuo, YT; Wu, JC; Chen, CC				Wang, Shu-Huei; Lin, Pei-Ya; Chiu, Ya-Chen; Huang, Ju-Sui; Kuo, Yi-Tsen; Wu, Jen-Chine; Chen, Chin-Chuan			Curcumin-Mediated HDAC Inhibition Suppresses the DNA Damage Response and Contributes to Increased DNA Damage Sensitivity	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; HISTONE DEACETYLASE; SACCHAROMYCES-CEREVISIAE; SYNTHETICALLY LETHAL; RAD52 INACTIVATION; REPAIR PATHWAYS; CANCER-CELLS; AUTOPHAGY; CHECKPOINT	Chemo- and radiotherapy cause multiple forms of DNA damage and lead to the death of cancer cells. Inhibitors of the DNA damage response are candidate drugs for use in combination therapies to increase the efficacy of such treatments. In this study, we show that curcumin, a plant polyphenol, sensitizes budding yeast to DNA damage by counteracting the DNA damage response. Following DNA damage, the Mec1-dependent DNA damage checkpoint is inactivated and Rad52 recombinase is degraded by curcumin, which results in deficiencies in double-stand break repair. Additive effects on damage-induced apoptosis and the inhibition of damage-induced autophagy by curcumin were observed. Moreover, rpd3 mutants were found to mimic the curcumin-induced suppression of the DNA damage response. In contrast, hat1 mutants were resistant to DNA damage, and Rad52 degradation was impaired following curcumin treatment. These results indicate that the histone deacetylase inhibitor activity of curcumin is critical to DSB repair and DNA damage sensitivity.	[Wang, Shu-Huei] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Lin, Pei-Ya; Chiu, Ya-Chen; Huang, Ju-Sui; Kuo, Yi-Tsen; Chen, Chin-Chuan] Chang Gung Univ, Grad Inst Nat Prod, Taoyuan, Taiwan; [Wu, Jen-Chine] Chang Gung Mem Hosp, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan; [Chen, Chin-Chuan] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan	National Taiwan University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, CC (corresponding author), Chang Gung Univ, Grad Inst Nat Prod, Taoyuan, Taiwan.	chinchuan@mail.cgu.edu.tw	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209; WANG, SHU-HUEI/0000-0002-9208-3135	Chang Gung Memorial Hospital, Chang Gung University [CMRPD3C0011-3]; Ministry of Science and Technology of Taiwan [102-2320-B-182-012-MY3]	Chang Gung Memorial Hospital, Chang Gung University(Chang Gung Memorial Hospital); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	Support was provided by Chang Gung Memorial Hospital, Chang Gung University (CMRPD3C0011-3) for CCC, and by the Ministry of Science and Technology (102-2320-B-182-012-MY3) of Taiwan for CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Azad GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059003; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Biswas J, 2010, HUM EXP TOXICOL, V29, P513, DOI 10.1177/0960327109359020; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Bora-Tatar G, 2009, BIOORGAN MED CHEM, V17, P5219, DOI 10.1016/j.bmc.2009.05.042; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Choy JS, 2002, MOL CELL BIOL, V22, P8215, DOI 10.1128/MCB.22.23.8215-8225.2002; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Dietlein F, 2014, CLIN CANCER RES, V20, P5882, DOI 10.1158/1078-0432.CCR-14-1165; Dietlein F, 2014, TRENDS GENET, V30, P326, DOI 10.1016/j.tig.2014.06.003; DORNFELD KJ, 1991, MOL CELL BIOL, V11, P2013, DOI 10.1128/MCB.11.4.2013; Dubrana K, 2007, J CELL SCI, V120, P4209, DOI 10.1242/jcs.018366; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Hasima N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.467; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Javvadi P, 2010, CANCER RES, V70, P1941, DOI 10.1158/0008-5472.CAN-09-3025; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Ji ZY, 2010, BREAST CANCER-BASIC, V4, P1; Kim PM, 2001, NUCLEIC ACIDS RES, V29, P4352, DOI 10.1093/nar/29.21.4352; Ko JC, 2011, TOXICOL APPL PHARM, V255, P327, DOI 10.1016/j.taap.2011.07.012; Lee SJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-144; Li H, 2008, TOXICOL APPL PHARM, V227, P115, DOI 10.1016/j.taap.2007.10.002; Liou JS, 2014, TOXICOL APPL PHARM, V278, P249, DOI 10.1016/j.taap.2014.04.028; Liu HL, 2005, ACTA PHARMACOL SIN, V26, P603, DOI 10.1111/j.1745-7254.2005.00081.x; Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; Lu HF, 2009, NEUROCHEM RES, V34, P1491, DOI 10.1007/s11064-009-9936-5; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Ogiwara H, 2013, CARCINOGENESIS, V34, P2486, DOI 10.1093/carcin/bgt240; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Qin J, 2003, RADIAT RES, V159, P139, DOI 10.1667/0033-7587(2003)159[0139:MAOTDD]2.0.CO;2; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shehzad A, 2013, BIOFACTORS, V39, P27, DOI 10.1002/biof.1065; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shu LM, 2011, AAPS J, V13, P606, DOI 10.1208/s12248-011-9300-y; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Thoms J, 2010, SEMIN RADIAT ONCOL, V20, P217, DOI 10.1016/j.semradonc.2010.06.003; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zhou J, 2009, NUCLEIC ACIDS RES, V37, P3699, DOI 10.1093/nar/gkp233	60	34	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134110	10.1371/journal.pone.0134110	http://dx.doi.org/10.1371/journal.pone.0134110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218133	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900079
J	Zhang, JF; Shi, H; Xu, LY; Zhu, XY; Li, XQ				Zhang, Jinfeng; Shi, Hao; Xu, Linyu; Zhu, Xiaoyan; Li, Xiangqian			Site-Directed Mutagenesis of a Hyperthermophilic Endoglucanase Cel12B from Thermotoga maritima Based on Rational Design	PLOS ONE			English	Article							BETA-GLUCOSIDASE; SWISS-MODEL; ACTIVE-SITE; PROTEIN; CELLULOSE; IDENTIFICATION; ENVIRONMENT; CELLULASES; EXPRESSION; CELLOBIOSE	To meet the demand for the application of high activity and thermostable cellulases in the production of new-generation bioethanol from nongrain-cellulose sources, a hyperthermostable beta-1,4-endoglucase Cel12B from Thermotoga maritima was selected for further modification by gene site-directed mutagenesis method in the present study, based on homology modeling and rational design. As a result, two recombinant enzymes showed significant improvement in enzyme activity by 77% and 87%, respectively, higher than the parental enzyme TmCel12B. Furthermore, the two mutants could retain 80% and 90.5% of their initial activity after incubation at 80 degrees C for 8 h, while only 45% for 5 h to TmCel12B. The K-m and V-max of the two recombinant enzymes were 1.97 +/- 0.05 mM, 4.23 +/- 0.15 mu mol.mg(-1).min(-1) of TmCel12B-E225H-K207G-D37V, and 2.97 +/- 0.12 mM, 3.15 +/- 0.21 mu mol.mg(-1).min(-1) of TmCel12B-E225H-K207G, respectively, when using CMC-Na as the substrate. The roles of the mutation sites were also analyzed and evaluated in terms of electron density, hydrophobicity of the modeled protein structures. The recombinant enzymes may be used in the hydrolysis of cellulose at higher temperature in the future. It was concluded that the gene mutagenesis approach of a certain active residues may effectively improve the performance of cellulases for the industrial applications and contribute to the study the thermostable mechanism of thermophilic enzymes.	[Zhang, Jinfeng; Shi, Hao; Xu, Linyu; Zhu, Xiaoyan; Li, Xiangqian] Huaiyin Inst Technol, Jiangsu Prov Engn Lab Biomass Convers & Proc Inte, Huaian 223003, Jiangsu, Peoples R China; [Zhang, Jinfeng; Xu, Linyu; Zhu, Xiaoyan; Li, Xiangqian] Huaiyin Inst Technol, Sch Life Sci & Chem Engn, Huaian 223003, Jiangsu, Peoples R China; [Zhu, Xiaoyan] Huaiyin Normal Univ, Jiangsu Key Lab Biomass Based Energy & Enzyme Tec, Huaian 223300, Jiangsu, Peoples R China	Huaiyin Institute of Technology; Huaiyin Institute of Technology; Huaiyin Normal University	Li, XQ (corresponding author), Huaiyin Inst Technol, Jiangsu Prov Engn Lab Biomass Convers & Proc Inte, Huaian 223003, Jiangsu, Peoples R China.	lixq2002@126.com	zhang, jin/GXV-9154-2022; Dai, Kai/O-5669-2016	Dai, Kai/0000-0003-0056-5653	National Natural Science Foundation of China [20971050]; Opening Fund of the Jiangsu Provincial Engineering Laboratory for Biomass Conversion and Process Integration (Huaiyin Institute of Technology) [JPELBCPL2012001, 20130010]; Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology (Huaiyin Normal University) [JSBEET1304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Fund of the Jiangsu Provincial Engineering Laboratory for Biomass Conversion and Process Integration (Huaiyin Institute of Technology); Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology (Huaiyin Normal University)	The authors gratefully acknowledge the financial support of the National Natural Science Foundation of China (No. 20971050), Opening Fund of the Jiangsu Provincial Engineering Laboratory for Biomass Conversion and Process Integration (Huaiyin Institute of Technology) (No. JPELBCPL2012001, 20130010) and Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology (Huaiyin Normal University) (No. JSBEET1304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterbach-Bahl K, 2013, NATURE, V493, P483, DOI 10.1038/nature11853; Carstensen L, 2012, BIOCHEMISTRY-US, V51, P3420, DOI 10.1021/bi300189f; Charoenrat T, 2013, J BIOSCI BIOENG, V116, P193, DOI 10.1016/j.jbiosc.2013.02.020; Cheng YS, 2011, PROTEINS, V79, P1193, DOI 10.1002/prot.22953; Couturier M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-103; Crennell SJ, 2002, J MOL BIOL, V320, P883, DOI 10.1016/S0022-2836(02)00446-1; Forse GJ, 2011, PROTEIN SCI, V20, P168, DOI 10.1002/pro.550; Gao SH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-24; Geng J, 2012, BIOTECHNOL BIOENG, V109, P1508, DOI 10.1002/bit.24419; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jeon SD, 2012, NEW BIOTECHNOL, V29, P365, DOI 10.1016/j.nbt.2011.06.008; Karnaouri AC, 2014, APPL MICROBIOL BIOT, V98, P231, DOI 10.1007/s00253-013-4895-9; Kawai Y, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-45; Kojima M, 2013, APPL MICROBIOL BIOT, V97, P5137, DOI 10.1007/s00253-013-4874-1; Kufner K, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-11; Kumar R, 2014, BIOTECHNOL BIOENG, V111, P1341, DOI 10.1002/bit.25218; Levine SE, 2011, BIOTECHNOL BIOENG, V108, P2561, DOI 10.1002/bit.23249; Li Xiang-qian, 2006, Weishengwu Xuebao, V46, P726; Liebl W, 1996, MICROBIOL-SGM, V142, P2533, DOI 10.1099/00221287-142-9-2533; Liu M, 2013, CHEM COMMUN, V49, P7219, DOI 10.1039/c3cc42485e; Liu WJ, 2010, APPL ENVIRON MICROB, V76, P4914, DOI 10.1128/AEM.00958-10; Liu WJ, 2009, BIOTECHNOL BIOENG, V103, P1087, DOI 10.1002/bit.22340; MACARRON R, 1993, FEBS LETT, V316, P137, DOI 10.1016/0014-5793(93)81202-B; Merceron R, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394114; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nakazawa H, 2009, APPL MICROBIOL BIOT, V83, P649, DOI 10.1007/s00253-009-1901-3; Sambrook J., 2001, MOL CLONING LAB MANU; Sandgren M, 2005, PROG BIOPHYS MOL BIO, V89, P246, DOI 10.1016/j.pbiomolbio.2004.11.002; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi H, 2014, BIORESOURCES, V9, P3526; Shi H, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-8; Shi RR, 2013, BIORESOURCE TECHNOL, V142, P338, DOI 10.1016/j.biortech.2013.05.037; Skopec CE, 2003, PROTEIN ENG, V16, P1005, DOI 10.1093/protein/gzg115; Srikrishnan S, 2012, BIOTECHNOL BIOENG, V109, P1595, DOI 10.1002/bit.24414; Tishkov VI, 2013, BIOCHIMIE, V95, P1704, DOI 10.1016/j.biochi.2013.05.018; Worning P, 2000, NUCLEIC ACIDS RES, V28, P706, DOI 10.1093/nar/28.3.706; Ye XH, 2012, MOL BIOSYST, V8, P1815, DOI 10.1039/c2mb05492b; Yennamalli RM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-136; Yi ZL, 2011, BIORESOURCE TECHNOL, V102, P3636, DOI 10.1016/j.biortech.2010.11.043; Zhang F, 2011, BIORESOURCE TECHNOL, V102, P10143, DOI 10.1016/j.biortech.2011.08.019; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	44	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133824	10.1371/journal.pone.0133824	http://dx.doi.org/10.1371/journal.pone.0133824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218520	gold, Green Published, Green Submitted			2022-12-26	WOS:000358595900049
J	Lei, Y; Boinapally, V; Zoltowska, A; Adner, M; Hellman, L; Nilsson, G				Lei, Ying; Boinapally, Vamsi; Zoltowska, Anna; Adner, Mikael; Hellman, Lars; Nilsson, Gunnar			Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma	PLOS ONE			English	Article							ALLERGIC INFLAMMATION; MURINE MODEL; IGE; ASSOCIATION; INTERLEUKIN-33; IDENTIFICATION; EXACERBATION; INFECTIONS; PHENOTYPES; CHALLENGE	In several clinical and experimental studies IL-33 and its receptor have been found to play important roles in the development of asthma and allergic airway inflammation. We evaluated the effects of vaccination against IL-33 in a mouse model of airway inflammation induced by house dust mite (HDM) allergen. Balb/c mice received the IL-33 vaccine subcutaneously, followed by intranasal administration of HDM for up to six weeks. Vaccination against IL-33 induced high titers of specific anti-IL-33 IgG antibodies that inhibited HDM-induced airway hyperresponsiveness (AHR) in the conducting airways and tissue damping. The vaccination also attenuated the HDM-induced elevation in the numbers of eosinophils in bronchoalveolar lavage fluid (BALF) and suppressed the accumulation of inflammatory cells in the airways. Furthermore, the levels of IL-17A, IL-25, IL-33 and TSLP in lung tissue homogenates were reduced by vaccination against IL-33. These observations demonstrate that vaccination against IL-33 inhibits HDM-induced development of AHR, airway inflammation and production of inflammatory cytokines. The results also indicate an important role of IL-33 in the regulation of AHR of the distal lung compartments. Thus, administration of such a vaccine is potentially an effective therapeutic tool for treating allergic asthma.	[Lei, Ying; Zoltowska, Anna; Nilsson, Gunnar] Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden; [Lei, Ying; Zoltowska, Anna; Nilsson, Gunnar] Karolinska Univ Hosp, Stockholm, Sweden; [Boinapally, Vamsi; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Adner, Mikael] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Adner, Mikael; Nilsson, Gunnar] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Lei, Ying] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Pharm, Xian 710049, Peoples R China	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet; Karolinska Institutet; Xi'an Jiaotong University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	lars.hellman@icm.uu.se; gunnar.p.nilsson@ki.se		Nilsson, Gunnar/0000-0001-6795-5512	Swedish Research Council-Medicine and Health [521-2011-3286, 521-2011-2517]; Heart and Lung Foundation [20120345]; Ollie and Elof Ericsson's foundation; Konsul Th C Bergh's Foundation; Centre for Allergy Research at Karolinska Institutet; National Natural Science Foundation of China [81200001]	Swedish Research Council-Medicine and Health; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Ollie and Elof Ericsson's foundation; Konsul Th C Bergh's Foundation; Centre for Allergy Research at Karolinska Institutet(Karolinska Institutet); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Swedish Research Council-Medicine and Health; 521-2011-3286 (GN), 521-2011-2517 (LH) www.vr.se, the Heart and Lung Foundation; 20120345 (GN), www.hjart-lungfonden.se, the Ollie and Elof Ericsson's foundation; (GN) http://oestiftelse.se/, Konsul Th C Bergh's Foundation; (MA), www.konsulbergh.se, the Centre for Allergy Research at Karolinska Institutet (MA, GN), www.ki.se/cfa, National Natural Science Foundation of China; 81200001 (YL) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besnard AG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004607; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Borges MC, 2013, RESP PHYSIOL NEUROBI, V189, P144, DOI 10.1016/j.resp.2013.07.005; Brode SK, 2015, THORAX, V70, P677, DOI 10.1136/thoraxjnl-2014-206470; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; de Boer JD, 2013, AM J RESP CELL MOL, V48, P382, DOI 10.1165/rcmb.2012-0331OC; Ford AC, 2013, AM J GASTROENTEROL, V108, P1268, DOI 10.1038/ajg.2013.138; Fuchs B, 2012, AM J PHYSIOL-LUNG C, V303, pL1027, DOI 10.1152/ajplung.00227.2012; Fux M, 2014, ALLERGY, V69, P216, DOI 10.1111/all.12309; Gregory LG, 2009, CLIN EXP ALLERGY, V39, P1597, DOI 10.1111/j.1365-2222.2009.03302.x; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hellman L, 2008, EXPERT REV VACCINES, V7, P193, DOI 10.1586/14760584.7.2.193; Hellman L, 2007, BIOMED PHARMACOTHER, V61, P34, DOI 10.1016/j.biopha.2006.10.001; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Huijbers EJM, 2012, VACCINE, V30, P225, DOI 10.1016/j.vaccine.2011.11.010; Huijbers EJM, 2010, FASEB J, V24, P4535, DOI 10.1096/fj.10-163022; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Johansson J, 2004, VACCINE, V22, P2873, DOI 10.1016/j.vaccine.2003.12.029; Johansson J, 2007, VACCINE, V25, P1676, DOI 10.1016/j.vaccine.2006.10.055; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kim YH, 2012, J ASTHMA, V49, P738, DOI 10.3109/02770903.2012.702841; Lee HY, 2014, EXP LUNG RES, V40, P66, DOI 10.3109/01902148.2013.870261; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Mizutani N, 2014, J IMMUNOL, V192, P1372, DOI 10.4049/jimmunol.1301538; Mizutani N, 2013, IMMUNOLOGY, V139, P205, DOI 10.1111/imm.12071; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nandakumar KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013511; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Reijmerink NE, 2008, J ALLERGY CLIN IMMUN, V122, P651, DOI 10.1016/j.jaci.2008.06.030; Ringvall M, 2009, VACCINE, V28, P48, DOI 10.1016/j.vaccine.2009.09.122; Saglani S, 2009, AM J RESP CELL MOL, V41, P281, DOI 10.1165/rcmb.2008-0396OC; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Savenije OE, 2014, J ALLERGY CLIN IMMUN, V134, P170, DOI 10.1016/j.jaci.2013.12.1080; Silverpil E, 2012, EXPERT REV RESP MED, V6, P173, DOI [10.1586/ERS.12.12, 10.1586/ers.12.12]; Sjoberg LC, 2015, ALLERGY, V70, P514, DOI 10.1111/all.12590; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Volarevic V, 2012, J HEPATOL, V56, P26, DOI 10.1016/j.jhep.2011.03.022; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678	48	30	31	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133774	10.1371/journal.pone.0133774	http://dx.doi.org/10.1371/journal.pone.0133774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214807	gold, Green Published, Green Submitted			2022-12-26	WOS:000358594300032
J	Lugo, JE; Doti, R; Faubert, J				Lugo, J. E.; Doti, Rafael; Faubert, Jocelyn			Planckian Power Spectral Densities from Human Calves during Posture Maintenance and Controlled Isometric Contractions	PLOS ONE			English	Article							MEDIAN FREQUENCY; MOTOR UNITS; MUSCLE ARCHITECTURE; CONDUCTION-VELOCITY; MYOELECTRIC SIGNAL; ELECTRODE; SIZE; FORCE	Background The relationship between muscle anatomy and physiology and its corresponding electromyography activity (EMGA) is complex and not well understood. EMGA models may be broadly divided in stochastic and motor-unit-based models. For example, these models have successfully described many muscle physiological variables such as the value of the muscle fiber velocity and the linear relationship between median frequency and muscle fiber velocity. However they cannot explain the behavior of many of these variables with changes in intramuscular temperature, or muscle PH acidity, for instance. Here, we propose that the motor unit action potential can be treated as an electromagnetic resonant mode confined at thermal equilibrium inside the muscle. The motor units comprising the muscle form a system of standing waves or modes, where the energy of each mode is proportional to its frequency. Therefore, the power spectral density of the EMGA is well described and fit by Planck's law and from its distribution we developed theoretical relationships that explain the behavior of known physiological variables with changes in intramuscular temperature or muscle PH acidity, for instance. Methods EMGA of the calf muscle was recorded during posture maintenance in seven participants and during controlled isometric contractions in two participants. The power spectral density of the EMGA was then fit with the Planckian distribution. Then, we inferred nine theoretical relationships from the distribution and compared the theoretically derived values with experimentally obtained values. Results The power spectral density of EMGA was fit by Planckian distributions and all the theoretical relationships were validated by experimental results. Conclusions Only by considering the motor unit action potentials as electromagnetic resonant modes confined at thermal equilibrium inside the muscle suffices to predict known or new theoretical relationships for muscle physiological variables that other models have failed to do.	[Lugo, J. E.; Doti, Rafael; Faubert, Jocelyn] Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada	Universite de Montreal	Lugo, JE (corresponding author), Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada.	eduardo.lugo@gmail.com	Faubert, Jocelyn/E-2207-2011		Natural Sciences and Engineering Research Council of Canada operating grant	Natural Sciences and Engineering Research Council of Canada operating grant	This work was supported by a Natural Sciences and Engineering Research Council of Canada operating grant.	Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Basmajian JV, 1985, MUSCLES ALIVE THEIR, VFifth, P10; Bonato P, 2001, IEEE ENG MED BIOL, V20, P29, DOI 10.1109/MEMB.2001.982272; BRODY LR, 1991, J APPL PHYSIOL, V71, P1878, DOI 10.1152/jappl.1991.71.5.1878; Conwit RA, 1999, CLIN NEUROPHYSIOL, V110, P1270, DOI 10.1016/S1388-2457(99)00054-1; De Luca C. J., 2008, PRACTICUM USE SEMG S; DE LUCA CJ, 1979, IEEE T BIO-MED ENG, V26, P313, DOI 10.1109/TBME.1979.326534; Eben JC, 1936, AM J ANAT, V58, P259; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211, DOI 10.1152/jappl.1992.73.4.1211; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Heymsfield SB, 2002, AM J PHYSIOL-ENDOC M, V282, pE132, DOI 10.1152/ajpendo.2002.282.1.E132; LATEVA ZC, 1993, J ELECTROMYOGR KINES, V3, P195, DOI 10.1016/1050-6411(93)90008-K; Lee C T, 1998, SPUMS J, V28, P125; LINDSTROM LH, 1977, P IEEE, V65, P653, DOI 10.1109/PROC.1977.10544; McGill KC, 2004, MED BIOL ENG COMPUT, V42, P446, DOI 10.1007/BF02350985; MCPHEDRA.AM, 1965, J NEUROPHYSIOL, V28, P71, DOI 10.1152/jn.1965.28.1.71; MERLETTI R, 1984, EUR J APPL PHYSIOL, V52, P258, DOI 10.1007/BF01015206; MONSTER AW, 1977, J NEUROPHYSIOL, V40, P1432, DOI 10.1152/jn.1977.40.6.1432; MORE JJ, 1983, SIAM J SCI STAT COMP, V4, P553, DOI 10.1137/0904038; MORIMOTO S, 1980, JPN J PHYSIOL, V30, P71; Morse CI, 2005, ACTA PHYSIOL SCAND, V183, P291, DOI 10.1111/j.1365-201X.2004.01404.x; Petrofsky J., 2005, BASIC APPL MYOL, V15, P61; ROY SH, 1986, J APPL PHYSIOL, V61, P1510, DOI 10.1152/jappl.1986.61.4.1510; Saitou K, 2000, J Hum Ergol (Tokyo), V29, P35; Santillan M., 1998, European Journal of Physics, V19, P361, DOI 10.1088/0143-0807/19/4/008; Stulen EB, 1981, IEEE T BIOMED ENG, V28, P515; Vinciguerra M, 2010, ADV EXP MED BIOL, V694, P211; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WUERKER RB, 1965, J NEUROPHYSIOL, V28, P85, DOI 10.1152/jn.1965.28.1.85; Yamada H, 2000, J Hum Ergol (Tokyo), V29, P7; Yuan Y-x, 1994, C SCI COMP HONG KONG; Zubieta-Calleja G, 2004, NEW HUMAN PHYSL	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0131798	10.1371/journal.pone.0131798	http://dx.doi.org/10.1371/journal.pone.0131798			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214179	Green Published, gold, Green Submitted			2022-12-26	WOS:000358594300007
J	Stewart, EM; Michelutti, N; Shenstone-Harris, S; Grooms, C; Weseloh, C; Kimpe, LE; Blais, JM; Smol, JP				Stewart, Emily M.; Michelutti, Neal; Shenstone-Harris, Sarah; Grooms, Christopher; Weseloh, Chip; Kimpe, Linda E.; Blais, Jules M.; Smol, John P.			Tracking the History and Ecological Changes of Rising Double-Crested Cormorant Populations Using Pond Sediments from Islands in Eastern Lake Ontario	PLOS ONE			English	Article							GREAT-LAKES; STABLE-ISOTOPES; TRENDS; EUTROPHICATION; ACCUMULATION; MANAGEMENT; NUTRIENTS; TRANSPORT; GULLS; BASIN	In the Laurentian Great Lakes region, the double-crested cormorant (Phalacrocorax auritus) has seen a thousand-fold population increase in recent decades. These large colonies of birds now often conflict with socioeconomic interests, particularly due to perceived competition with fisheries and the destruction of terrestrial vegetation in nesting habitats. Here we use dated sediment cores from ponds on islands in eastern Lake Ontario that receive waste inputs from dense colonies of cormorants and ring-billed gulls (Larus delawarensis) to chronicle the population rise of these species and assess their long-term ecological impacts. Modern water chemistry sampling from these sites reveals drastically elevated nutrient and major ion concentrations compared to reference ponds not influenced by waterbirds. Geochemical tracers in dated sediment cores, particularly delta N-15 and chlorophyll-a concentrations, track waterbird influences over time. Fossil diatom assemblages were dominated by species tolerant of hyper-eutrophic and polluted systems, which is in marked contrast to assemblages in reference sites. In addition to establishing long-term ecological impacts, this multi-proxy paleoecological approach can be used to determine whether islands of concern have been long-term nesting sites or were only recently colonized by cormorant or ring-billed gull populations across the Great Lakes, facilitating informed management decisions about controversial culling programs.	[Stewart, Emily M.; Michelutti, Neal; Shenstone-Harris, Sarah; Grooms, Christopher; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Weseloh, Chip] Environm Canada, Canadian Wildlife Serv, Toronto, ON M3H 5T4, Canada; [Kimpe, Linda E.; Blais, Jules M.] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada	Queens University - Canada; Environment & Climate Change Canada; Canadian Wildlife Service; University of Ottawa	Stewart, EM (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	em.stewart16@gmail.com	Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598; Smol, John/0000-0002-2499-6696; Stewart, Emily/0000-0003-0243-9407	Natural Sciences and Engineering Research Council of Canada [2360-2009]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors' research was funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), grant number: 2360-2009 JPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ENVIRONMENT CANADA M, V1; [Anonymous], 1994, ENVIRONMENT CANADA M, V2; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Audubon JJ, 1844, THE BIRDS OF AMERICA, V7; Audubon JJ, 1843, THE BIRDS OF AMERICA, V6; Battarbee R. W., 2001, TRACKING ENV CHANGE, P155, DOI DOI 10.1007/0-306-47668-1_8; Belant JL, 1998, LANDSCAPE URBAN PLAN, V43, P11, DOI 10.1016/S0169-2046(98)00100-5; Blais JM, 2005, SCIENCE, V309, P445, DOI 10.1126/science.1112658; Blais JM, 2007, ENVIRON SCI TECHNOL, V41, P1075, DOI 10.1021/es061314a; Blokpoel H, 1991, TECHNICAL REPORT SER, V117; Boutin C, 2011, RESTOR ECOL, V19, P720, DOI 10.1111/j.1526-100X.2010.00769.x; Caron-Beaudoin E, 2013, CAN J ZOOL, V91, P689, DOI 10.1139/cjz-2013-0008; Cuthbert FJ, 2002, J GREAT LAKES RES, V28, P145, DOI 10.1016/S0380-1330(02)70572-8; Doucette JL, 2011, ECOL APPL, V21, P2987, DOI 10.1890/10-2384.1; Dove A, 2009, AQUAT ECOSYST HEALTH, V12, P281, DOI 10.1080/14634980903136388; EISENREICH SJ, 1989, ENVIRON SCI TECHNOL, V23, P1116, DOI 10.1021/es00067a009; Ellis JC, 2006, J ANIM ECOL, V75, P565, DOI 10.1111/j.1365-2656.2006.01077.x; Glahn JF, 1995, COLON WATERBIRD, V18, P137, DOI 10.2307/1521533; Glew J.R., 1989, J PALEOLIMNOL, V2, P241, DOI [DOI 10.1007/BF00195474, 10.1007/BF00195474]; Glew J.R., 1988, J PALEOLIMNOL, V1, P235, DOI DOI 10.1007/BF00177769; Hodell DA, 1998, LIMNOL OCEANOGR, V43, P200, DOI 10.4319/lo.1998.43.2.0200; Hyatt CV, 2010, THESIS; Kendall C, 1998, ISOTOPE TRACERS IN C; Korosi JB, 2015, DEV PALEOENVIRON RES, V18, P161, DOI 10.1007/978-94-017-9541-8_8; Krammer K., 1986, BACILLARIOPHYCEAE; Krummel EM, 2003, NATURE, V425, P255, DOI 10.1038/425255a; Lantry BF, 2002, J GREAT LAKES RES, V28, P193, DOI 10.1016/S0380-1330(02)70576-5; Ligeza S, 2003, CHEMOSPHERE, V52, P595, DOI 10.1016/S0045-6535(03)00241-8; LUDWIG JP, 1974, AUK, V91, P575, DOI 10.2307/4084477; Michelutti N, 2009, P ROY SOC B-BIOL SCI, V276, P591, DOI 10.1098/rspb.2008.1103; Michelutti N, 2010, J PALEOLIMNOL, V43, P205, DOI 10.1007/s10933-009-9325-8; Morris RD, 2011, WATERBIRDS, V34, P202, DOI 10.1675/063.034.0209; Robinson SA, 2009, CAN J ZOOL, V87, P740, DOI 10.1139/Z09-062; Rott E, 1998, CAN J FISH AQUAT SCI, V55, P1443, DOI 10.1139/cjfas-55-6-1443; SMOL JP, 1985, HYDROBIOLOGIA, V123, P199, DOI 10.1007/BF00034378; Smol JP, 2010, THE DIATOMS APPLICAT; Spaulding S, 2008, DATABASE DIATOMS OF; Stewart EM, 2014, HYDROBIOLOGIA, V721, P251, DOI 10.1007/s10750-013-1667-6; Van Dam Herman, 1994, Netherlands Journal of Aquatic Ecology, V28, P117; Wait DA, 2005, J ARID ENVIRON, V60, P681, DOI 10.1016/j.jaridenv.2004.07.001; Weir RD, 2008, BIRDS OF THE KINGSTO; Weseloh DVC, 2012, WATERBIRDS, V35, P1; Weseloh DV, 1995, COLON WATERBIRD, V18, P48, DOI 10.2307/1521523; Weseloh DVC, 2002, J GREAT LAKES RES, V28, P125; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273; Wires LR, 2006, WATERBIRDS, V29, P9, DOI 10.1675/1524-4695(2006)29[9:HPOTDC]2.0.CO;2; YAMAMURO M, 1995, LIMNOL OCEANOGR, V40, P1001, DOI 10.4319/lo.1995.40.5.1001	47	16	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134167	10.1371/journal.pone.0134167	http://dx.doi.org/10.1371/journal.pone.0134167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214177	Green Submitted, Green Published, gold			2022-12-26	WOS:000358594300056
J	Tamura, H; Goto, R; Akune, Y; Hiratsuka, Y; Hiragi, S; Yamada, M				Tamura, Hiroshi; Goto, Rei; Akune, Yoko; Hiratsuka, Yoshimune; Hiragi, Shusuke; Yamada, Masakazu			The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION SECONDARY; VISUAL IMPAIRMENT; UTILITY ANALYSIS; PHOTODYNAMIC THERAPY; CATARACT-SURGERY; EYE DISEASE; FELLOW EYES; RANIBIZUMAB; PREVALENCE; POPULATION	Objective To investigate the cost-effectiveness of screening and subsequent intervention for age-related macular degeneration (AMD) in Japan. Methods The clinical effectiveness and cost-effectiveness of screening and subsequent intervention for AMD were assessed using a Markov model. The Markov model simulation began at the age of 40 years and concluded at the age of 90 years. The first-eye and second-eye combined model assumed an annual state-transition probability, development of prodromal symptoms, choroidal neovascularization (CNV), and reduction in visual acuity. Anti-vascular-endothelial-growth-factor (anti-VEGF) intravitreal injection therapy and photodynamic therapy (PDT) were performed to treat CNV. Intake of supplements was recommended to patients who had prodromal symptoms and unilateral AMD. Data on prevalence, morbidity, transition probability, utility value of each AMD patient, and treatment costs were obtained from published clinical reports. Results In the base-case analysis, screening for AMD every 5 years, beginning at the age of 50 years, showed a decrease of 41% in the total number of blind patients. The screening program reduced the incidence of blindness more than did the additional intake of supplements. However, the incremental cost-effectiveness ratio (ICER) of screening versus no screening was 27,486,352 Japanese yen (JPY), or 259,942 US dollars (USD) per quality-adjusted life year (QALY). In the sensitivity analysis, prodromal symptom-related factors for AMD had great impacts on the cost-effectiveness of screening. The lowest ICER obtained from the best scenario was 4,913,717 JPY (46,470 USD) per QALY, which was approximately equal to the willingness to pay in Japan. Conclusions Ophthalmologic screening for AMD in adults is highly effective in reducing the number of patients with blindness but not cost-effective as demonstrated by a Markov model based on clinical data from Japan.	[Tamura, Hiroshi; Hiragi, Shusuke] Kyoto Univ Hosp, Div Med Informat Technol & Adm Planning, Sakyo Ku, Kyoto 6068507, Japan; [Tamura, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan; [Goto, Rei] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Goto, Rei] Kyoto Univ, Grad Sch Econ, Sakyo Ku, Kyoto 6068501, Japan; [Akune, Yoko] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan; [Hiratsuka, Yoshimune] Natl Inst Publ Hlth, Dept Hlth & Welf Serv, Wako, Saitama 3510197, Japan; [Yamada, Masakazu] Kyorin Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; National Institute of Public Health - Japan; Kyorin University	Tamura, H (corresponding author), Kyoto Univ Hosp, Div Med Informat Technol & Adm Planning, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	htamura@kuhp.kyoto-u.ac.jp	Hiragi, Shusuke/AAF-4310-2019; TAMURA, Hiroshi/H-1855-2011; HIRAGI, Shusuke/GYA-3171-2022	Hiragi, Shusuke/0000-0003-1629-6195; TAMURA, Hiroshi/0000-0002-7740-2732; 	Japan Society for the Promotion of Science, Tokyo, Japan [24592626]; Japan Ophthalmologists Association, Tokyo, Japan; Japan National Society for the Prevention of Blindness, Tokyo, Japan	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Ophthalmologists Association, Tokyo, Japan; Japan National Society for the Prevention of Blindness, Tokyo, Japan(Japan National Society for the Prevention of Blindness)	This study was supported in part by grants-in-aid for scientific research (Nos. 24592626) from the Japan Society for the Promotion of Science, Tokyo, Japan, http://www.jsps.go.jp/j-grantsinaid/index.html; the Japan Ophthalmologists Association, Tokyo, Japan, http://www.gankaikai.or.jp/; and the Japan National Society for the Prevention of Blindness, Tokyo, Japan, http://www.business1.jp/jnspb/pc/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Arch Ophthalmol, V117, P1329; Antoszyk AN, 2008, AM J OPHTHALMOL, V145, P862, DOI 10.1016/j.ajo.2007.12.029; Bloch SB, 2012, AM J OPHTHALMOL, V153, P209, DOI 10.1016/j.ajo.2011.10.016; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; Bonds DE, 2014, JAMA INTERN MED, V174, P763, DOI 10.1001/jamainternmed.2014.328; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown G C, 1999, Trans Am Ophthalmol Soc, V97, P473; Brown GC, 2007, OPHTHALMOLOGY, V114, P1170, DOI 10.1016/j.ophtha.2006.09.019; Brown GC, 2000, ARCH OPHTHALMOL-CHIC, V118, P47; Brown MM, 2008, OPHTHALMOLOGY, V115, P1039, DOI 10.1016/j.ophtha.2007.08.033; Cheung CSY, 2012, OPHTHALMOLOGY, V119, P1609, DOI 10.1016/j.ophtha.2012.02.014; Chew EY, 2014, OPHTHALMOLOGY, V121, P535, DOI 10.1016/j.ophtha.2013.10.027; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Cohen SY, 2008, GRAEF ARCH CLIN EXP, V246, P1527, DOI 10.1007/s00417-008-0890-8; Fletcher EC, 2008, OPHTHALMOLOGY, V115, P2192, DOI 10.1016/j.ophtha.2008.07.018; Hiratsuka Y, 2014, JPN J OPHTHALMOL, V58, P415, DOI 10.1007/s10384-014-0335-3; Hiratsuka Y, 2013, JPN J OPHTHALMOL, V57, P391, DOI 10.1007/s10384-013-0238-8; Hirneiss C, 2014, CLIN OPHTHALMOL, V8, P1703, DOI 10.2147/OPTH.S64200; Holden BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1731, DOI 10.1001/archopht.126.12.1731; Holz FG, 2015, BRIT J OPHTHALMOL, V99, P220, DOI 10.1136/bjophthalmol-2014-305327; Hurley Susan F, 2008, Cost Eff Resour Alloc, V6, P12, DOI 10.1186/1478-7547-6-12; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Japan Ophthalmologists Association, 2009, SOC BURD VIS DIST JA; Hernandez-Pastor LJ, 2010, GRAEF ARCH CLIN EXP, V248, P467, DOI 10.1007/s00417-009-1156-9; Hernandez-Pastor LJ, 2008, CLIN THER, V30, P2436, DOI 10.1016/j.clinthera.2008.12.025; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Kanagasingam Y, 2014, PROG RETIN EYE RES, V38, P20, DOI 10.1016/j.preteyeres.2013.10.002; Kawasaki R, 2015, OPHTHAL EPIDEMIOL, V22, P4, DOI 10.3109/09286586.2014.988876; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; Krishnadev N, 2010, CURR OPIN OPHTHALMOL, V21, P184, DOI 10.1097/ICU.0b013e32833866ee; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Mitchell P, 2011, PHARMACOECONOMICS, V29, P107, DOI 10.2165/11585520-000000000-00000; Miyazaki M, 2003, BRIT J OPHTHALMOL, V87, P469, DOI 10.1136/bjo.87.4.469; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Nakae K MK, 2006, GERIATR MED, V44, P1221; Nakata I, 2013, AM J OPHTHALMOL, V156, P1002, DOI 10.1016/j.ajo.2013.06.007; Neubauer AS, 2010, CLIN THER, V32, P1343, DOI 10.1016/j.clinthera.2010.07.010; Oshima Y, 2001, BRIT J OPHTHALMOL, V85, P1153, DOI 10.1136/bjo.85.10.1153; Pineles SL, 2011, AM J OPHTHALMOL, V152, P133, DOI 10.1016/j.ajo.2011.01.023; Pushpoth S, 2012, BRIT J OPHTHALMOL, V96, P1469, DOI 10.1136/bjophthalmol-2012-302167; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Sharma S, 2001, OPHTHALMOLOGY, V108, P2051, DOI 10.1016/S0161-6420(01)00764-3; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; Takahashi Kanji, 2012, Nippon Ganka Gakkai Zasshi, V116, P1150; Tamura H, 2012, AM J OPHTHALMOL, V154, P542, DOI 10.1016/j.ajo.2012.03.042; Tano Y, 2010, ACTA OPHTHALMOL, V88, P309, DOI 10.1111/j.1755-3768.2009.01843.x; Ueta T, 2008, AM J OPHTHALMOL, V146, P96, DOI 10.1016/j.ajo.2008.03.002; Uyama M, 2000, BRIT J OPHTHALMOL, V84, P1018, DOI 10.1136/bjo.84.9.1018; Wako Rina, 2014, Nippon Ganka Gakkai Zasshi, V118, P495; Wang JJ, 2000, CLIN EXP OPHTHALMOL, V28, P268, DOI 10.1046/j.1442-9071.2000.00315.x; Weih LM, 2000, ARCH OPHTHALMOL-CHIC, V118, P264; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x; Yanagi Yasuo, 2011, Nippon Ganka Gakkai Zasshi, V115, P825; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017	62	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133628	10.1371/journal.pone.0133628	http://dx.doi.org/10.1371/journal.pone.0133628			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214804	Green Submitted, Green Published, gold			2022-12-26	WOS:000358594300025
J	Bengtsen, M; Klepper, K; Gundersen, S; Cuervo, I; Drablos, F; Hovig, E; Sandve, GK; Gabrielsen, OS; Eskeland, R				Bengtsen, Mads; Klepper, Kjetil; Gundersen, Sveinung; Cuervo, Ignacio; Drablos, Finn; Hovig, Eivind; Sandve, Geir Kjetil; Gabrielsen, Odd Stokke; Eskeland, Ragnhild			c-Myb Binding Sites in Haematopoietic Chromatin Landscapes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR-BINDING; CHIP-SEQ DATA; DNA-BINDING; HUMAN GENOME; IN-VIVO; A-MYB; HISTONE METHYLTRANSFERASE; DEVELOPMENTAL REGULATORS; MYELOID PROGENITOR	Strict control of tissue-specific gene expression plays a pivotal role during lineage commitment. The transcription factor c-Myb has an essential role in adult haematopoiesis and functions as an oncogene when rearranged in human cancers. Here we have exploited digital genomic footprinting analysis to obtain a global picture of c-Myb occupancy in the genome of six different haematopoietic cell-types. We have biologically validated several c-Myb footprints using c-Myb knockdown data, reporter assays and DamID analysis. We show that our predicted conserved c-Myb footprints are highly dependent on the haematopoietic cell type, but that there is a group of gene targets common to all cell-types analysed. Furthermore, we find that c-Myb footprints co-localise with active histone mark H3K4me3 and are significantly enriched at exons. We analysed co-localisation of c-Myb footprints with 104 chromatin regulatory factors in K562 cells, and identified nine proteins that are enriched together with c-Myb footprints on genes positively regulated by c-Myb and one protein enriched on negatively regulated genes. Our data suggest that c-Myb is a transcription factor with multifaceted target regulation depending on cell type.	[Bengtsen, Mads; Cuervo, Ignacio; Gabrielsen, Odd Stokke; Eskeland, Ragnhild] Univ Oslo, Dept Biosci, Oslo, Norway; [Klepper, Kjetil; Drablos, Finn] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Gundersen, Sveinung; Hovig, Eivind; Sandve, Geir Kjetil] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Med Informat, Oslo, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo	Gabrielsen, OS (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	o.s.gabrielsen@ibv.uio.no; Ragnhild.Eskeland@ibv.uio.no	Eskeland, Ragnhild/AFM-2892-2022; Eskeland, Ragnhild/GSN-9383-2022; Drablos, Finn/L-4970-2019; Gundersen, Sveinung/HCI-0764-2022; Eskeland, Ragnhild/K-7018-2014; Hovig, Eivind/H-2474-2011	Eskeland, Ragnhild/0000-0003-2789-3171; Drablos, Finn/0000-0001-5794-828X; Eskeland, Ragnhild/0000-0003-2789-3171; Hovig, Eivind/0000-0002-9103-1077; Sandve, Geir Kjetil/0000-0002-4959-1409; Gundersen, Sveinung/0000-0001-9888-7954	 [231217/F20];  [3485238-2013];  [419436 107692-PR-2007-0148]	; ; 	Funding provided by (RE) https://www.forskningsradet.no/ (231217/F20)*, (RE) https://kreftforeningen.no (3485238-2013)* and (OSG) https://kreftforeningen.no (419436 107692-PR-2007-0148)*. *The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berge T, 2007, BLOOD CELL MOL DIS, V39, P278, DOI 10.1016/j.bcmd.2007.05.007; Bergholtz S, 2001, NUCLEIC ACIDS RES, V29, P3546, DOI 10.1093/nar/29.17.3546; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Chen XY, 2010, BIOINFORMATICS, V26, pi334, DOI 10.1093/bioinformatics/btq175; Clarke D, 2000, ONCOGENE, V19, P3343, DOI 10.1038/sj.onc.1203661; Dahle O, 2003, EUR J BIOCHEM, V270, P1338, DOI 10.1046/j.1432-1033.2003.03504.x; Deisenroth C, 2010, MOL CELL BIOL, V30, P3981, DOI 10.1128/MCB.01284-09; Dekker J, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-25; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Erwin GD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003677; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Garcia P, 2009, EMBO J, V28, P1492, DOI 10.1038/emboj.2009.97; GOLAY J, 1994, ONCOGENE, V9, P2469; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hooper J, 2008, IMMUNOLOGY, V123, P282, DOI 10.1111/j.1365-2567.2007.02697.x; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Klepper K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-9; Kulakovskiy IV, 2010, BIOINFORMATICS, V26, P2622, DOI 10.1093/bioinformatics/btq488; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li LK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005070; Lipsick JS, 1996, ONCOGENE, V13, P223; Lorenzo Petra Isabel, 2011, Genes Cancer, V2, P805, DOI 10.1177/1947601911428224; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Molvaersmyr AK, 2010, NUCLEIC ACIDS RES, V38, P4970, DOI 10.1093/nar/gkq245; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; MYRSET AH, 1993, EMBO J, V12, P4625, DOI 10.1002/j.1460-2075.1993.tb06151.x; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; Nakata Y, 2010, BLOOD, V116, P1280, DOI 10.1182/blood-2009-05-223255; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Oki S, 2014, GENES CELLS, V19, P919, DOI 10.1111/gtc.12190; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Pinson B, 2001, NUCLEIC ACIDS RES, V29, P527, DOI 10.1093/nar/29.2.527; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Sakamoto Y, 2007, J BIOL CHEM, V282, P16391, DOI 10.1074/jbc.M700011200; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sandve GK, 2013, NUCLEIC ACIDS RES, V41, pW133, DOI 10.1093/nar/gkt342; Sanghvi VR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005500; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; SHAPIRO LH, 1995, J BIOL CHEM, V270, P8763, DOI 10.1074/jbc.270.15.8763; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stenman G, 2010, CELL CYCLE, V9, P2986, DOI 10.4161/cc.9.15.12515; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tanikawa J, 2004, J BIOL CHEM, V279, P55393, DOI 10.1074/jbc.M411658200; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Tuteja G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003449; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; WESTON K, 1992, NUCLEIC ACIDS RES, V20, P3043, DOI 10.1093/nar/20.12.3043; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Ye P, 2013, LEUKEMIA RES, V37, P595, DOI 10.1016/j.leukres.2013.01.012; Zargarian L, 1999, BIOCHEMISTRY-US, V38, P1921, DOI 10.1021/bi981199j; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218; Zhao L, 2014, ONCOGENE, V33, P4442, DOI 10.1038/onc.2013.419; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024; Zhou Y, 2013, FRONT BIOSCI, V16, P1109	95	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133280	10.1371/journal.pone.0133280	http://dx.doi.org/10.1371/journal.pone.0133280			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208222	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000075
J	Broekman, MMTJ; Roelofs, HMJ; Hoentjen, F; Wiegertjes, R; Stoel, N; Joosten, LA; de Jong, DJ; Wanten, GJA				Broekman, Mark M. T. J.; Roelofs, Hennie M. J.; Hoentjen, Frank; Wiegertjes, Renske; Stoel, Nicole; Joosten, Leo A.; de Jong, Dirk J.; Wanten, Geert J. A.			LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; TNF-ALPHA; LIPOPOLYSACCHARIDE STIMULATION; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISMS; MONONUCLEAR-CELLS; INNATE PRODUCTION; INTERLEUKIN-10; ASSOCIATION	Introduction Crohn's disease (CD) is a chronic inflammatory disease in which cytokines play a pivotal role in the induction and maintenance of inflammation. Innate cytokine production is genetically determined and varies largely between individuals; this might impact the severity of inflammation. We aimed to assess whether ex-vivo endotoxin-stimulated levels of cytokines could be associated with disease phenotype. Methods Patients with quiescent CD (Harvey-Bradshaw Index <= 4 and negative inflammation markers) who were not using immunomodulating drugs or biologicals were eligible. Historical disease characteristics (localization, behavior, number of bowel resections, drug history, extra-intestinal symptoms) were extracted from medical records. We measured cytokine levels (tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6 and IL-10) in supernatants of lipopolysaccharide (LPS) -stimulated whole blood cultures and correlated these with disease characteristics and age- and sex-matched healthy controls. In addition, we analyzed whether single nucleotide polymorphisms (SNPs) in the promoter region of the TNF-alpha gene were related to TNF-alpha levels. Results We included 75 patients with CD and 24 healthy controls. Six patients were excluded because of increased inflammation markers resulting in a total of 69 patients. The mean age (SD) of patients with CD was 51.2 (12.3) years with a mean (SD) disease duration of 24.1 (11.5) years. Disease localization, peri-anal involvement and behavior were not related to LPS-stimulated TNF-alpha, IL-1 beta, IL-6 or IL-10 levels. In addition, combination of localization with behavior to differentiate mild from severe disease type showed no significant differences. TNF-alpha levels were higher in patients with CD (428 pg/ml IQR [267-468]) compared to healthy controls (459 pg/ml IQR [364-570], p=0.02). We found no associations between SNPs in the promoter region and TNF-alpha levels. Conclusion In this study, innate cytokine production of TNF-alpha, IL-1 beta, IL-6 and IL-10 was not related to historical disease characteristics or disease severity in patients with quiescent CD. These findings suggest that genetically determined levels of these cytokines obtained from LPS-stimulated whole blood cultures are not linked with disease behavior or severity.	[Broekman, Mark M. T. J.; Roelofs, Hennie M. J.; Hoentjen, Frank; Wiegertjes, Renske; Stoel, Nicole; de Jong, Dirk J.; Wanten, Geert J. A.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [Joosten, Leo A.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Broekman, MMTJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands.	mark.broekman@radboudumc.nl	Stoel, Nicole/V-8803-2018; de Jong, D.J./L-4417-2015; Hoentjen, F./L-4378-2015; Broekman, Mark/P-5697-2015; Joosten, Leo AB/H-3138-2015; Wanten, G.J.A./L-4742-2015; Wiegertjes, Renske/P-1696-2016	Joosten, Leo AB/0000-0001-6166-9830; Hoentjen, Frank/0000-0001-5314-4452				Ai WC, 2013, INT J ENV RES PUB HE, V10, P3834, DOI 10.3390/ijerph10093834; Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Botha-Scheepers S, 2008, ANN RHEUM DIS, V67, P1165, DOI 10.1136/ard.2007.084657; Brazova J, 2005, CLIN IMMUNOL, V115, P210, DOI 10.1016/j.clim.2005.01.013; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Castro-Santos P, 2006, AM J GASTROENTEROL, V101, P1039, DOI 10.1111/j.1572-0241.2006.00501.x; Correa I, 2009, J LEUKOCYTE BIOL, V85, P896, DOI 10.1189/jlb.1108698; Damsgaard CT, 2009, J IMMUNOL METHODS, V340, P95, DOI 10.1016/j.jim.2008.10.005; de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; de Jong DJ, 2003, GUT, V52, P547, DOI 10.1136/gut.52.4.547; Leal RF, 2015, GUT, V64, P233, DOI 10.1136/gutjnl-2013-306518; Gerards AH, 2003, RHEUMATOLOGY, V42, P1189, DOI 10.1093/rheumatology/keg323; Gresnigt MS, 2012, J IMMUNOL, V189, P4806, DOI 10.4049/jimmunol.1103551; Hildner K, 1998, ANN NY ACAD SCI, V859, P204, DOI 10.1111/j.1749-6632.1998.tb11129.x; Horton DL, 2010, CLIN VACCINE IMMUNOL, V17, P979, DOI 10.1128/CVI.00404-09; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kayakabe K, 2012, RHEUMATOLOGY, V51, P1639, DOI 10.1093/rheumatology/kes094; Koss K, 2000, GENES IMMUN, V1, P207, DOI 10.1038/sj.gene.6363658; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Larsen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066262; Louis E, 2011, BEST PRACT RES CL GA, V25, pS2, DOI 10.1016/S1521-6918(11)70003-8; Maranville JC, 2014, J CROHNS COLITIS, V8, P1539, DOI 10.1016/j.crohns.2014.06.013; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Meresse B, 2002, GUT, V50, P25, DOI 10.1136/gut.50.1.25; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nikolaus S, 1998, GUT, V42, P470, DOI 10.1136/gut.42.4.470; Ouyang Y, 2000, J ALLERGY CLIN IMMUN, V106, P280, DOI 10.1067/mai.2000.107751; Page TH, 2010, J IMMUNOL, V185, P3694, DOI 10.4049/jimmunol.1000906; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Riyazi N, 2005, ARTHRITIS RHEUM-US, V52, P1443, DOI 10.1002/art.21014; Schreiber S, 1999, LANCET, V353, P459, DOI 10.1016/S0140-6736(98)03339-X; Schwarzmaier D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062761; Sewell GW, 2012, INFLAMM BOWEL DIS, V18, P2120, DOI 10.1002/ibd.22952; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Somasundaram R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084521; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; van der Linden MW, 1998, J IMMUNOL METHODS, V218, P63, DOI 10.1016/S0022-1759(98)00108-2; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Vermeire S, 2013, GUT, V62, P1511, DOI 10.1136/gutjnl-2012-303958; Waldner MJ, 2014, SEMIN IMMUNOL, V26, P75, DOI 10.1016/j.smim.2013.12.003; Waschke KA, 2005, AM J GASTROENTEROL, V100, P1126, DOI 10.1111/j.1572-0241.2005.40534.x; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Wouters IM, 2002, TOXICOL IND HEALTH, V18, P15, DOI 10.1191/0748233702th126oa; Yamamoto T, 2004, ALIMENT PHARM THER, V19, P671, DOI 10.1111/j.1365-2036.2004.01899.x; Yaqoob P, 1999, CYTOKINE, V11, P600, DOI 10.1006/cyto.1998.0471	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133932	10.1371/journal.pone.0133932	http://dx.doi.org/10.1371/journal.pone.0133932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208333	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000177
J	Chuzel, T; Sanchez, V; Vandamme, M; Martin, S; Flety, O; Pager, A; Chabanel, C; Magnier, L; Foskolos, M; Petit, O; Rokbi, B; Chereul, E				Chuzel, Thomas; Sanchez, Violette; Vandamme, Marc; Martin, Stephane; Flety, Odile; Pager, Aurelie; Chabanel, Christophe; Magnier, Luc; Foskolos, Marie; Petit, Oceane; Rokbi, Bachra; Chereul, Emmanuel			Impact of Anesthesia Protocols on In Vivo Bioluminescent Bacteria Imaging Results	PLOS ONE			English	Article							INFECTIONS; MICE; HEMODYNAMICS; LUCIFERASE; MODELS	Infectious murine models greatly benefit from optical imaging using bioluminescent bacteria to non-invasively and repeatedly follow in vivo bacterial infection. In this context, one of the most critical parameters is the bioluminescence sensitivity to reliably detect the smallest number of bacteria. Another critical point is the anesthetic approaches that have been demonstrated to impact the bioluminescence flux emission in studies with luciferase-transfected tumor cells. However, this impact has never been assessed on bacteria bioluminescent models. To this end, we investigated the effects of four anesthesia protocols on the bioluminescence flux in a central venous catheter murine model (SKH1-hrhr mice) infected by a bioluminescent S. aureus Xen36 strain. Bioluminescence imaging was performed on mice anesthetized by either ketamine/xylazine (with or without oxygen supplementation), or isoflurane carried with air or oxygen. Total flux emission was determined in vivo daily for 3 days and ex vivo at the end of the study together with a CFU counting of the biofilm in the catheter. Bioluminescence flux differences appear between the different anesthetic protocols. Using a ketamine/xylazine anesthesia (with air), bacteria detection was impossible since the bioluminescence signal remains in the background signal. Mice anesthetized with isoflurane and oxygen led to a signal significantly higher to the background all along the kinetics. The use of isoflurane in air presents a bioluminescence signal similar to the use of ketamine/xylazine with oxygen. These data highlight the importance of oxygen to improve bioluminescence flux by bacteria with isoflurane as well as with ketamine/xylazine anesthetics. As a conclusion, we recommend the use of isoflurane anesthetic with oxygen to increase the bioluminescence sensitivity in this kind of study.	[Chuzel, Thomas; Vandamme, Marc; Martin, Stephane; Pager, Aurelie; Magnier, Luc; Foskolos, Marie; Petit, Oceane; Chereul, Emmanuel] Voxcan, Marcy Letoile, France; [Sanchez, Violette; Flety, Odile; Chabanel, Christophe; Rokbi, Bachra] Sanofi Pasteur, Marcy Letoile, France		Chereul, E (corresponding author), Voxcan, Marcy Letoile, France.	emmanuel.chereul@voxcan.fr			VOXCAN; SANOFI PASTEUR	VOXCAN; SANOFI PASTEUR	The authors received no specific funding for this work. VOXCAN provided support in the form of salaries for authors TC, MV, SM, AP, LM, MF, OP, and EC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. SANOFI PASTEUR provided support in the form of salaries for authors VS, OF, CC, and BR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Chauhan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037281; Cui KM, 2008, LUMINESCENCE, V23, P292, DOI 10.1002/bio.1032; Ebert T, 2011, HUM VACCINES, V7, P630, DOI 10.4161/hv.7.6.15407; Fish R, 2011, ANESTHESIA ANALGESIA; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; Guo Y, 2013, ANTIMICROB AGENTS CH, V57, P855, DOI 10.1128/AAC.01003-12; Hildebrandt IJ, 2008, ILAR J NATL RES COUN, P49; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Kadurugamuwa Jagath L., 2008, V431, P225; Keyaerts M, 2012, PLOS ONE, V7, P374, DOI 10.1371/journal.pone.0030061; Kuklin NA, 2003, ANTIMICROB AGENTS CH, V47, P2740, DOI 10.1128/AAC.47.9.2740-2748.2003; Lerondel S., 2013, CURRENT MOL IMAGING, V2, P18, DOI [10.2174/2211555211302010004, DOI 10.2174/2211555211302010004]; Lorenz U, 2008, MICROBES INFECT, V10, P217, DOI 10.1016/j.micinf.2007.11.006; Semprini S, 2012, J AM ASSOC LAB ANIM, V51, P820; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; Zuurbier CJ, 2002, AM J PHYSIOL-HEART C, V282, pH2099, DOI 10.1152/ajpheart.01002.2001	19	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134048	10.1371/journal.pone.0134048	http://dx.doi.org/10.1371/journal.pone.0134048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208168	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000195
J	Gariepy, G; Thombs, BD; Kestens, Y; Kaufman, JS; Blair, A; Schmitz, N				Gariepy, Genevieve; Thombs, Brett D.; Kestens, Yan; Kaufman, Jay S.; Blair, Alexandra; Schmitz, Norbert			The Neighbourhood Built Environment and Trajectories of Depression Symptom Episodes in Adults: A Latent Class Growth Analysis	PLOS ONE			English	Article							MENTAL-HEALTH; DISORDERS; DURATION; BENEFITS; RISK	Aim To investigate the effect of the neighbourhood built environment on trajectories of depression symptom episodes in adults from the general Canadian population. Research Design and Methods We used 10 years of data collection (2000/01-2010/11) from the Canadian National Population Health Study (n = 7114). Episodes of depression symptoms were identified using the Composite International Diagnostic Interview Short-Form. We assessed the presence of local parks, healthy food stores, fast food restaurants, health services and cultural services using geospatial data. We used latent class growth modelling to identify different trajectories of depression symptom episodes in the sample and tested for the effect of neighbourhood variables on the trajectories over time. Results We uncovered three distinct trajectories of depression symptom episodes: low prevalence (76.2% of the sample), moderate prevalence (19.2%) and high prevalence of depression symptom episodes (2.8%). The presence of any neighbourhood service (healthy food store, fast-food restaurant, health service, except for cultural service) was significantly associated with a lower probability of a depression symptom episode for those following a trajectory of low prevalence of depression symptom episodes. The presence of a local park was also a significant protective factor in trajectory groups with both low and moderate prevalence of depression symptom episodes. Neighbourhood characteristics did not significantly affect the trajectory of high prevalence of depression symptom episodes. Conclusions For individuals following a trajectory of low and moderate prevalence of depression symptom episodes, the neighbourhood built environment was associated with a shift in the trajectory of depression symptom episodes. Future intervention studies are recommended to make policy recommendations.	[Gariepy, Genevieve] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Thombs, Brett D.; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Kestens, Yan; Blair, Alexandra] Univ Montreal, Dept Social & Preventat Med, Montreal, PQ, Canada; [Kaufman, Jay S.; Schmitz, Norbert] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal; McGill University	Gariepy, G (corresponding author), McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada.	genevieve.gariepy@mail.mcgill.ca	Schmitz, Norbert/A-5177-2010; Kestens, Yan/D-1631-2012; Schmitz, Norbert/AAH-3624-2020	Schmitz, Norbert/0000-0001-7777-6323; Kestens, Yan/0000-0003-2619-5750; Kaufman, Jay/0000-0003-1606-401X	Canadian Institutes of Health Research [SEC-117118]; Canadian Institutes of Health; Fonds de Recherche en Sante du Quebec; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canada Research Chairs program(Canada Research Chairs)	This work was supported by Operating Grant SEC-117118 from the Canadian Institutes of Health Research. GG was supported by funding from the Canadian Institutes of Health. YK and AB were supported by the Fonds de Recherche en Sante du Quebec. JSK was funded by the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN 4; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; [Anonymous], DEPR; [Anonymous], 2014, CANADA POST; Berndt ER, 2000, AM J PSYCHIAT, V157, P940, DOI 10.1176/appi.ajp.157.6.940; Bow C Jennifer D, 2004, Int J Health Geogr, V3, P5, DOI 10.1186/1476-072X-3-5; Colman I, 2010, CAN J PSYCHIAT, V55, P622, DOI 10.1177/070674371005501002; DMTI Spatial Inc, 2010, DESKT MAPP TECHN INC; Evans GW, 2003, J URBAN HEALTH, V80, P536, DOI 10.1093/jurban/jtg063; Gariepy G, 2014, HEALTH PLACE, V30, P279, DOI 10.1016/j.healthplace.2014.10.009; Glymour MM, 2010, ANN EPIDEMIOL, V20, P856, DOI 10.1016/j.annepidem.2010.08.003; Holzel L, 2011, J AFFECT DISORDERS, V129, P1, DOI 10.1016/j.jad.2010.03.025; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kim J, 2009, J COMMUNITY PSYCHOL, V37, P725, DOI 10.1002/jcop.20327; Kubzansky LD, 2005, AM J EPIDEMIOL, V162, P253, DOI 10.1093/aje/kwi185; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Melchior M, 2013, MOL PSYCHIATR, V18, P112, DOI 10.1038/mp.2011.116; Nabi H, 2011, HYPERTENSION, V57, P710, DOI 10.1161/HYPERTENSIONAHA.110.164061; Paczkowski MM, 2010, CURR OPIN PSYCHIATR, V23, P337, DOI 10.1097/YCO.0b013e32833ad70b; Patten S B, 2000, Chronic Dis Can, V21, P68; Paykel ES, 2005, EUR NEUROPSYCHOPHARM, V15, P411, DOI 10.1016/j.euroneuro.2005.04.008; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Public Health Agency of Canada, 2013, WHAT IS DEPR; Renalds A, 2010, FAM COMMUNITY HEALTH, V33, P68, DOI 10.1097/FCH.0b013e3181c4e2e5; Sarkar C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-695; Sheline YI, 1999, J NEUROSCI, V19, P5034; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; Statistics Canada, 2011, NAT POP HLTH SURV HO; Statistics Canada, LOW INC MEAS 2009; Stockdale SE, 2007, SOC SCI MED, V65, P1867, DOI 10.1016/j.socscimed.2007.05.045; van Ham M, 2012, ENVIRON PLANN A, V44, P2787, DOI 10.1068/a45439	33	17	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133603	10.1371/journal.pone.0133603	http://dx.doi.org/10.1371/journal.pone.0133603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207368	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000108
J	Hayes, MA; Cryan, PM; Wunder, MB				Hayes, Mark A.; Cryan, Paul M.; Wunder, Michael B.			Seasonally-Dynamic Presence-Only Species Distribution Models for a Cryptic Migratory Bat Impacted by Wind Energy Development	PLOS ONE			English	Article							HOARY BAT; LASIURUS-CINEREUS; ROOST SELECTION; FATALITIES; THERMOREGULATION; CONSERVATION; POPULATIONS; PREDICTION; SOLITARY; BEHAVIOR	Understanding seasonal distribution and movement patterns of animals that migrate long distances is an essential part of monitoring and conserving their populations. Compared to migratory birds and other more conspicuous migrants, we know very little about the movement patterns of many migratory bats. Hoary bats (Lasiurus cinereus), a cryptic, wide-ranging, long-distance migrant, comprise a substantial proportion of the tens to hundreds of thousands of bat fatalities estimated to occur each year at wind turbines in North America. We created seasonally-dynamic species distribution models (SDMs) from 2,753 museum occurrence records collected over five decades in North America to better understand the seasonal geographic distributions of hoary bats. We used 5 SDM approaches: logistic regression, multivariate adaptive regression splines, boosted regression trees, random forest, and maximum entropy and consolidated outputs to generate ensemble maps. These maps represent the first formal hypotheses for sex-and season-specific hoary bat distributions. Our results suggest that North American hoary bats winter in regions with relatively long growing seasons where temperatures are moderated by proximity to oceans, and then move to the continental interior for the summer. SDMs suggested that hoary bats are most broadly distributed in autumn-the season when they are most susceptible to mortality from wind turbines; this season contains the greatest overlap between potentially suitable habitat and wind energy facilities. Comparing wind-turbine fatality data to model outputs could test many predictions, such as 'risk from turbines is highest in habitats between hoary bat summering and wintering grounds'. Although future field studies are needed to validate the SDMs, this study generated well-justified and testable hypotheses of hoary bat migration patterns and seasonal distribution.	[Hayes, Mark A.; Wunder, Michael B.] Univ Colorado, Dept Integrat Biol, Denver, CO 80204 USA; [Hayes, Mark A.; Cryan, Paul M.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA	University of Colorado System; University of Colorado Denver; United States Department of the Interior; United States Geological Survey	Hayes, MA (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80204 USA.	hayesm@usgs.gov		Cryan, Paul/0000-0002-2915-8894	U.S. Geological Survey; University of Colorado Denver	U.S. Geological Survey(United States Geological Survey); University of Colorado Denver	This study was supported by U.S. Geological Survey and University of Colorado Denver. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G. M., 1939, BATS BIOL BEHAV FOLK; Altringham John D., 2005, P280; [Anonymous], 2011, ECOLOGICAL NICHES GE; [Anonymous], 2011, MODIS VEGETATION CON; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett Edward B., 2013, P435; Baker R. R., 1978, EVOLUTIONARY ECOLOGY; Barbour R. W., 1969, BATS OF AM; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Berthold P, 2001, AUK, V2nd; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Carter TC, 2003, MONITORING TRENDS BA, P41; Cryan P. M., 2011, ENVIRON LAW, V41, P355; Cryan PM, 2007, BIOL CONSERV, V139, P1, DOI 10.1016/j.biocon.2007.05.019; Cryan PM, 2014, P NATL ACAD SCI USA, V111, P15126, DOI 10.1073/pnas.1406672111; Cryan PM, 2014, ECOL APPL, V24, P602, DOI 10.1890/13-0752.1; Cryan PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047586; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Cryan Paul M., 2009, P476; Cryan Paul M., 2007, P153; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Dalquest W. W., 1943, Murrelet Seattle, V24, P21, DOI 10.2307/3534418; Diffendorfer J. E., 2014, US GEOLOGICAL SURVEY; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellison L. E., 2012, 20121110 US GEOL SUR; Findley J. S., 1964, Journal of Mammalogy, V45, P461, DOI 10.2307/1377421; Fink D., 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1.; Fleming TH, 2003, BAT ECOLOGY, P156; Franklin J, 2009, MAPPING SPECIES DIST; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Griffin D.R., 1940, B MUS COMP ZOOL HARV, V86, P217; Grinnell H. W., 1918, U CALIFORNIA PUBLICA, V17, P223; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Illan JG, 2010, GLOBAL ECOL BIOGEOGR, V19, P159, DOI 10.1111/j.1466-8238.2009.00507.x; Hayes MA, 2013, BIOSCIENCE, V63, P975, DOI 10.1525/bio.2013.63.12.10; Hayes MA, 2011, J WILDLIFE MANAGE, V75, P137, DOI 10.1002/jwmg.6; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOFFMEISTER D F, 1970, Southwestern Naturalist, V15, P11, DOI 10.2307/3670197; Jimenez-Valverde A, 2013, GLOBAL ECOL BIOGEOGR, V22, P508, DOI 10.1111/geb.12007; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Klug BJ, 2013, J MAMMAL, V94, P477, DOI 10.1644/12-MAMM-A-178.1; Klug BJ, 2012, CAN J ZOOL, V90, P329, DOI 10.1139/Z11-139; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kunz TH, 2007, J WILDLIFE MANAGE, V71, P2449, DOI 10.2193/2007-270; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; Linsley JH, 1842, AM J SCI, V43, P345; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Merriam C.H., 1887, T ROY SOC CAN, V4, P85; Merriam CH, 1884, MAMMALS ADIRONDACK R; Miller J, 2010, GEOGR COMPASS, V4, P490, DOI 10.1111/j.1749-8198.2010.00351.x; Morisette JT, 2013, ECOGRAPHY, V36, P129, DOI 10.1111/j.1600-0587.2012.07815.x; Mumford R. E., 1963, Journal of Mammalogy, V44, P272, DOI 10.2307/1377465; ORR RT, 1950, J MAMMAL, V31, P456; PEARSON RG, 2007, SPECIES DISTRIBUTION; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Rodhouse TJ, 2012, ECOL APPL, V22, P1098, DOI 10.1890/11-1662.1; Ruf T, 2014, BIOL REV, DOI [10.1111/brv.12137:1-38, DOI 10.1111/BRV.12137:1-38]; Runge CA, 2014, FRONT ECOL ENVIRON, V12, P395, DOI 10.1890/130237; Seton Ernest T., 1909, LIFE HIST NO ANIMALS; Shump K.A. Jr, 1982, Mammalian Species, P1; Smallwood KS, 2013, WILDLIFE SOC B, V37, P19, DOI 10.1002/wsb.260; Strelkov P. P., 1969, Acta Zoologica Cracoviensia, V14, P393; Talbert CB, 2014, USER MANUAL SAHM PAC; Talbert MK, 2014, TUTORIAL SOFTWARE AS; Tan B, 2011, IEEE J-STARS, V4, P361, DOI 10.1109/JSTARS.2010.2075916; Vaughan T. A., 1954, Publications of the Museum of Natural History University of Kansas, V7, P513; VAUGHAN TA, 1954, J MAMMAL, V35, P431, DOI 10.2307/1375977; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WHITAKER J O JR, 1972, Proceedings of the Indiana Academy of Science, V81, P376; WHITAKER JO, 1967, J MAMMAL, V48, P663, DOI 10.2307/1377600; Willis CKR, 2005, J MAMMAL, V86, P85, DOI 10.1644/1545-1542(2005)086<0085:PAEAOR>2.0.CO;2; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; ZINN TL, 1979, J MAMMAL, V60, P634, DOI 10.2307/1380110	84	30	32	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132599	10.1371/journal.pone.0132599	http://dx.doi.org/10.1371/journal.pone.0132599			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208098	gold, Green Published			2022-12-26	WOS:000358622000034
J	Chung, YE; You, JS; Lee, HJ; Lim, JS; Lee, HS; Baek, SE; Kim, MJ				Chung, Yong Eun; You, Je Sung; Lee, Hye-Jeong; Lim, Joon Seok; Lee, Hye Sun; Baek, Song-Ee; Kim, Myeong-Jin			Possible Contrast Media Reduction with Low keV Monoenergetic Images in the Detection of Focal Liver Lesions: A Dual-Energy CT Animal Study	PLOS ONE			English	Article							LOW-TUBE-VOLTAGE; INDUCED NEPHROPATHY; DYNAMIC CT; KVP CT; ROW CT; AGENT; ENHANCEMENT; ANGIOGRAPHY; PROTOCOL; QUALITY	Objective To investigate the feasibility of dual-energy CT for contrast media (CM) reduction in the diagnosis of hypervascular and hypovascular focal liver lesions (FLL). Subjects and Methods The Institutional Animal Care and Use Committee approved this study. VX2 tumors were implanted in two different segments of the liver in 13 rabbits. After 2 weeks, two phase contrast enhanced CT scans including the arterial phase (AP) and portal-venous phase (PVP) were performed three times with 24-hour intervals with three different concentrations of iodine, 300 (I-300), 150 (I-150) and 75 mg I/mL (I-75). The mean HU and standard deviation (SD) were measured in the liver, the hypervascular portion of the VX2 tumor which represented hypervascular tumors, and the central necrotic area of the VX2 tumor which represented hypovascular tumors in 140kVp images with I-300 as a reference standard and in monoenergetic images (between 40keV and 140keV) with I-150 and I-75. The contrast-to-noise ratio (CNR) for FLLs and the ratio of the CNRs (CNRratio) between monoenergetic image sets with I-150 and I-75, and the reference standard were calculated. Results For hypervascular lesions, the CNRratio was not statistically different from 1.0 between 40keV and 70keV images with I-150, whereas the CNRratio was significantly lower than 1.0 in all keV images with I-75. For hypovascular lesions, the CNRratio was similar to or higher than 1.0 between 40keV and 80keV with I-150 and between 40keV and 70keV with I-75. Conclusions With dual-energy CT, the total amount of CM might be halved in the diagnosis of hypervascular FLLs and reduced to one-fourth in the diagnosis of hypovascular FLLs, while still preserving CNRs.	[Chung, Yong Eun; Lee, Hye-Jeong; Lim, Joon Seok; Baek, Song-Ee; Kim, Myeong-Jin] Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp,Res Inst Radiol Sci, Seoul, South Korea; [You, Je Sung] Yonsei Univ, Coll Med, Dept Emergency Med, Severance Hosp, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Dept Res Affairs, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp,Res Inst Radiol Sci, Seoul, South Korea.	yelv@yuhs.ac	Lim, Joon Seok/R-7753-2019; Lee, Hye Sun/J-2154-2015; Kim, Myeong-Jin/E-1623-2011	You, Je Sung/0000-0002-2074-6745; Chung, Yong Eun/0000-0003-0811-9578; Lee, Hye Sun/0000-0001-6328-6948; Lim, Joon seok/0000-0002-0334-5042; Lee, Hye-Jeong/0000-0003-4349-9174; Kim, Myeong-Jin/0000-0001-7949-5402	Yonsei University College of Medicine [6-2012-0039]; national research foundation of Korea - Ministry of Education [NRF-2014R1A1A2057091]	Yonsei University College of Medicine(General Electric); national research foundation of Korea - Ministry of Education	This work was supported by the faculty research grant of Yonsei University College of Medicine (6-2012-0039) and the national research foundation of Korea funded by the Ministry of Education (NRF-2014R1A1A2057091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACR Committee on Drugs, 2013, MAN CONTR MED VERS 9; Altenbernd J, 2011, EUR RADIOL, V21, P738, DOI 10.1007/s00330-010-1964-7; [Anonymous], 2009, CONTRAST MEDIA SAFET; Blake MA, 2011, RADIOGRAPHICS, V31, P1047, DOI 10.1148/rg.314105159; Chen CM, 2014, EUR RADIOL, V24, P460, DOI 10.1007/s00330-013-3027-3; Cho ES, 2015, EUR RADIOL, V25, P1421, DOI 10.1007/s00330-014-3540-z; Choi SH, 2010, INVEST RADIOL, V45, P427, DOI 10.1097/RLI.0b013e3181e07516; Dong J, 2013, J COMPUT ASSIST TOMO, V37, P618, DOI 10.1097/RCT.0b013e31828f5020; Dubourg B, 2014, EUR RADIOL, V24, P2659, DOI 10.1007/s00330-014-3263-1; European Society of Urogenital Radiology, 2012, ESUR GUID CONTR MED; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Kane GC, 2008, J AM COLL CARDIOL, V51, P89, DOI 10.1016/j.jacc.2007.09.019; Kim KW, 2011, AM J ROENTGENOL, V196, P102, DOI 10.2214/AJR.09.3971; Kim MJ, 2010, J COMPUT ASSIST TOMO, V34, P496, DOI 10.1097/RCT.0b013e3181d34532; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Machida H, 2014, JPN J RADIOL, V32, P217, DOI 10.1007/s11604-014-0288-y; Marenzi G, 2009, ANN INTERN MED, V150, P170, DOI 10.7326/0003-4819-150-3-200902030-00006; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; Nakaura T, 2012, RADIOLOGY, V264, P445, DOI 10.1148/radiol.12111082; Nakaura T, 2011, RADIOLOGY, V261, P467, DOI 10.1148/radiol.11110021; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Robinson E, 2010, INVEST RADIOL, V45, P413, DOI 10.1097/RLI.0b013e3181dfda78; Schindera ST, 2008, RADIOLOGY, V246, P125, DOI 10.1148/radiol.2461070307; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Solomon RJ, 2009, CLIN J AM SOC NEPHRO, V4, P1162, DOI 10.2215/CJN.00550109; Takahashi H, 2014, EUR J RADIOL, V83, P684, DOI 10.1016/j.ejrad.2013.12.014; Wu HP, 2009, ACAD RADIOL, V16, P1483, DOI 10.1016/j.acra.2009.09.009; Yamada Y, 2012, INVEST RADIOL, V47, P292, DOI 10.1097/RLI.0b013e318240a874; Yeh BM, 2009, AM J ROENTGENOL, V193, P47, DOI 10.2214/AJR.09.2592; Zhang D, 2011, MED PHYS, V38, P1178, DOI 10.1118/1.3551999	31	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133170	10.1371/journal.pone.0133170	http://dx.doi.org/10.1371/journal.pone.0133170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26203652	Green Published, gold, Green Submitted			2022-12-26	WOS:000358621000021
J	Hou, Q; Lin, JY; Huang, WT; Li, MY; Feng, JH; Mao, XM				Hou, Qi; Lin, Jinyan; Huang, Wentao; Li, Maoyin; Feng, Jianhua; Mao, Xiangming			CTRP3 Stimulates Proliferation and Anti-Apoptosis of Prostate Cells through PKC Signaling Pathways	PLOS ONE			English	Article							C1Q/TNF-RELATED PROTEIN-3 CTRP3; PROMOTES PROLIFERATION; ADIPOSE-TISSUE; CTRP3/CARTDUCIN; PARALOG; METABOLISM; EXPRESSION; CARTDUCIN; ADIPOKINE; CORS-26	C1q/TNF-related protein-3 (CTRP3) is a novel adipokine with roles in multiple cellular processes. However, little is known about its function in prostate cells. This study investigated the effects and mechanisms of CTRP3 in prostate cells. We first generated and purified CTRP3 protein in HEK 293T cells. Proliferation of RWPE-1 prostate cells was evaluated by MTT analyses under treatment with different concentrations of CTRP3 for various exposure times. The results revealed maximum enhancement of proliferation with 10 mu g/mL CTRP3 for 72 h. Cell apoptosis and cell cycle were determined by TUNEL staining and flow cytometry analysis. TUNEL assay showed decreased TUNEL-positive cells in RWPE-1 prostate cells treated with CTRP3, and flow cytometry showed significantly decreased apoptotic cells upon CTRP3 treatment (treated cells, 8.34 +/- 1.175 vs. controls, 20.163 +/- 0.35) (P < 0.01). Moreover, flow cytometry analysis also showed a significant decrease of cells in the G1 phase and an increase of cells in the S and G2 phase upon CTRP3 treatment (treated cells, 42.85 +/- 1.40 vs. control, 52.77 +/- 0.90; 28.41 +/- 0.57 vs. 23.49 +/- 1.13; 27.08 +/- 1.97 vs. 22.20 +/- 1.32, respectively) (all P < 0.05). Two-dimensional gel electrophoresis and mass spectrometry identified differentially expressed proteins, including cytokeratin-19, GLRX3 and DDAH1, which were upregulated in CTRP3 treated cells, and cytokeratin-17 and 14-3-3 sigma, which were downregulated. GLRX3, DDAH1 and 14-3-3 sigma were confirmed using western blot analysis. A PKC inhibitor, staurosporine, was used to inhibit PKC activity in CTRP3 treated RWPE-1 cells. Staurosporine completely abolished the CTRP3-induced increased phosphorylation of intracellular PKC substrates and CTRP3-stimulated effect by RWPE-1 cells. Our results provide the first evidence for a physiological role of the novel adipokine, CTRP3, in prostate cells. Our findings suggest that CTRP3 could improve proliferation and anti-apoptosis of prostate cells through protein kinase C signaling pathways.	[Hou, Qi; Feng, Jianhua] Longgang Dist Cent Hosp, Dept Urol, Shenzhen, Peoples R China; [Lin, Jinyan] Southern Med Univ, Nanfang Hosp, Hlth management Ctr, Guangzhou, Guangdong, Peoples R China; [Huang, Wentao; Li, Maoyin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Mao, Xiangming] Peking Univ, Shenzhen Hosp, Dept Urol, Shenzhen, Peoples R China	Southern Medical University - China; Sun Yat Sen University; Peking University	Feng, JH (corresponding author), Longgang Dist Cent Hosp, Dept Urol, Shenzhen, Peoples R China.	feng-jianhua@hotmail.com; 13691903635@126.com		Mao, Xiangming/0000-0002-3335-7263; Hou, Qi/0000-0002-4597-7013	Medical Science and Technology Program of Shenzhen Longgang district [201406093001004]	Medical Science and Technology Program of Shenzhen Longgang district	This work was supported by a grant from the Medical Science and Technology Program of Shenzhen Longgang district (No. 201406093001004).	Akiyama H, 2006, FEBS J, V273, P2257, DOI 10.1111/j.1742-4658.2006.05240.x; Akiyama H, 2007, MOL CELL BIOCHEM, V304, P243, DOI 10.1007/s11010-007-9506-6; Akiyama H, 2009, ONCOL REP, V21, P1477, DOI 10.3892/or_00000377; Cha MK, 2009, CANCER EPIDEMIOL, V33, P281, DOI 10.1016/j.canep.2009.08.006; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Hou M, 2014, INT J MOL MED, V33, P97, DOI 10.3892/ijmm.2013.1550; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Lodygin D, 2004, ONCOGENE, V23, P9034, DOI 10.1038/sj.onc.1208004; Maas R, 2009, PHARMACOL RES, V60, P475, DOI 10.1016/j.phrs.2009.07.012; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Maeda T, 2001, J BIOL CHEM, V276, P3628, DOI 10.1074/jbc.M007898200; Maeda T, 2010, CELL BIOL INT, V34, P261, DOI 10.1042/CBI20090043; Osada H, 2002, ONCOGENE, V21, P2418, DOI 10.1038/sj.onc.1205303; Otani M, 2012, CYTOKINE, V58, P238, DOI 10.1016/j.cyto.2012.01.018; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144; Rohaly G, 2005, CELL, V122, P21, DOI 10.1016/j.cell.2005.04.032; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Schaffler A, 2003, BBA-GENE STRUCT EXPR, V1630, P123, DOI 10.1016/j.bbaexp.2003.08.013; Ummanni R, 2008, CANCER LETT, V266, P171, DOI 10.1016/j.canlet.2008.02.047; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Zhang P, 2011, ARTERIOSCL THROM VAS, V31, P890, DOI 10.1161/ATVBAHA.110.215640	29	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134006	10.1371/journal.pone.0134006	http://dx.doi.org/10.1371/journal.pone.0134006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218761	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900063
J	Zhao, WT; Liu, JW; Xu, RX; Zhang, C; Pang, Q; Chen, X; Liu, SF; Hong, LX; Yuan, J; Li, XT; Chen, YX; Li, J; Su, XZ				Zhao, Wenting; Liu, Jianwen; Xu, Ruixue; Zhang, Cui; Pang, Qin; Chen, Xin; Liu, Shengfa; Hong, Lingxian; Yuan, Jing; Li, Xiaotong; Chen, Yixin; Li, Jian; Su, Xin-zhuan			The Gametocytes of Leucocytozoon sabrazesi Infect Chicken Thrombocytes, Not Other Blood Cells	PLOS ONE			English	Article							PLASMODIUM; PREVALENCE; PARASITES; AGGREGATION; MICROSCOPY; BIRDS	Leucocytozoon parasites infect a large number of avian hosts, including domestic chicken, and cause significant economical loss to the poultry industry. Although the transmission stages of the parasites were observed in avian blood cells more than a century ago, the specific host cell type(s) that the gametocytes infect remain uncertain. Because all the avian blood cells, including red blood cells (RBCs), are nucleated, and the developing parasites dramatically change the morphology of the infected host cells, it has been difficult to identify Leucocytozoon infected host cell(s). Here we use cell-type specific antibodies to investigate the identities of the host cells infected by Leucocytozoon sabrazesi gametocytes. Anti-RBC antibodies stained RBCs membrane strongly, but not the parasite-infected cells, ruling out the possibility of RBCs being the infected host cells. Antibodies recognizing various leukocytes including heterophils, monocytes, lymphocytes, and macrophages did not stain the infected cells either. Antisera raised against a peptide of the parasite cytochrome B (CYTB) stained parasite-infected cells and some leukocytes, particularly cells with a single round nucleus as well as clear/pale cytoplasm suggestive of thrombocytes. Finally, a monoclonal antibody known to specifically bind chicken thrombocytes also stained the infected cells, confirming that L. sabrazesi gametocytes develop within chicken thrombocytes. The identification of L. sabrazesi infected host cell solves a long unresolved puzzle and provides important information for studying parasite invasion of host cells and for developing reagents to interrupt parasite transmission.	[Zhao, Wenting; Liu, Jianwen; Xu, Ruixue; Zhang, Cui; Pang, Qin; Chen, Xin; Liu, Shengfa; Hong, Lingxian; Yuan, Jing; Li, Xiaotong; Chen, Yixin; Li, Jian; Su, Xin-zhuan] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Chen, Yixin] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Publ Hlth, Xiamen 361005, Fujian, Peoples R China; [Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Xiamen University; Xiamen University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Li, J (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	jianli_204@xmu.edu.cn; xsu@niaid.nih.gov	Li, xiaotong/GYV-4890-2022	Su, Xinzhuan/0000-0003-3246-3248	National Natural Science Foundation of China [81220108019, 81271858, 81201324]; Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China [B06016]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Natural Science Foundation of China #81220108019, 81271858, and #81201324, by Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China (B06016), and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2014, BLOOD, V123, P959, DOI 10.1182/blood-2013-08-520767; Argilla LS, 2013, PARASITOLOGY, V140, P672, DOI 10.1017/S0031182012002089; AWADHIYA RP, 1980, RES VET SCI, V29, P120, DOI 10.1016/S0034-5288(18)32701-2; BELAMARI.FA, 1966, NATURE, V212, P1579, DOI 10.1038/2121579a0; Bunbury N, 2007, PARASITOLOGY, V134, P797, DOI 10.1017/S0031182006002149; Campbell Terry W., 1994, P176; CARLSON HC, 1968, AVIAN DIS, V12, P700, DOI 10.2307/1588457; Dezfoulian O, 2013, IRAN J PARASITOL, V8, P171; Farfour E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-285; Ferdous F, 2008, POULTRY SCI, V87, P61, DOI 10.3382/ps.2007-00356; Genovese KJ, 2013, DEV COMP IMMUNOL, V41, P334, DOI 10.1016/j.dci.2013.03.021; GRANT RA, 1973, AM J PHYSIOL, V225, P340, DOI 10.1152/ajplegacy.1973.225.2.340; GRECCHI R, 1980, J PATHOL, V130, P23, DOI 10.1002/path.1711300104; HONG L, 1990, Acta Zoologica Sinica, V36, P123; Huff CG, 1942, J INFECT DIS, V71, P18, DOI 10.1093/infdis/71.1.18; Imura T, 2012, VET PARASITOL, V183, P244, DOI 10.1016/j.vetpar.2011.07.027; Ishak HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002304; KUNICKI TJ, 1985, P NATL ACAD SCI USA, V82, P7319, DOI 10.1073/pnas.82.21.7319; Meseguer J, 2002, MICROSC RES TECHNIQ, V57, P491, DOI 10.1002/jemt.10102; Pattaradilokrat S, 2014, GENES IMMUN, V15, P145, DOI 10.1038/gene.2013.74; Peirce MA, 2005, VET REC, V157, DOI 10.1136/vr.157.25.819-a; Seliger C, 2012, VET IMMUNOL IMMUNOP, V145, P86, DOI 10.1016/j.vetimm.2011.10.010; St Paul M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043381; STEELE EJ, 1993, J EUKARYOT MICROBIOL, V40, P384, DOI 10.1111/j.1550-7408.1993.tb04932.x; Steele EJ, 2001, J EUKARYOT MICROBIOL, V48, P118, DOI 10.1111/j.1550-7408.2001.tb00423.x; Swayne D E, 1986, Vet Clin Pathol, V15, P17, DOI 10.1111/j.1939-165X.1986.tb00639.x; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2008, J PARASITOL, V94, P1395, DOI 10.1645/GE-1570.1; Viertlboeck BC, 2007, VET IMMUNOL IMMUNOP, V119, P137, DOI 10.1016/j.vetimm.2007.06.017; Weng Z, 1998, FUJIAN J ANI HUSB VE, V2, P10; Wingstrand KG, 1947, SOME HAEMATOZOA SWED; Zhao WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094877; Garamszegi LZ, 2010, J PARASITOL, V96, P1197, DOI 10.1645/GE-2531.1	33	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133478	10.1371/journal.pone.0133478	http://dx.doi.org/10.1371/journal.pone.0133478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218846	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900032
J	Hermannsen, L; Tougaard, J; Beedholm, K; Nabe-Nielsen, J; Madsen, PT				Hermannsen, Line; Tougaard, Jakob; Beedholm, Kristian; Nabe-Nielsen, Jacob; Madsen, Peter Teglberg			Characteristics and Propagation of Airgun Pulses in Shallow Water with Implications for Effects on Small Marine Mammals	PLOS ONE			English	Article							PORPOISE PHOCOENA-PHOCOENA; WHALES PHYSETER-MACROCEPHALUS; TEMPORARY THRESHOLD SHIFTS; EQUAL-LOUDNESS CONTOURS; HARBOR PORPOISE; SPERM-WHALES; SEISMIC SURVEYS; NOISE; EXPOSURE; SOUNDS	Airguns used in seismic surveys are among the most prevalent and powerful anthropogenic noise sources in marine habitats. They are designed to produce most energy below 100 Hz, but the pulses have also been reported to contain medium-to-high frequency components with the potential to affect small marine mammals, which have their best hearing sensitivity at higher frequencies. In shallow water environments, inhabited by many of such species, the impact of airgun noise may be particularly challenging to assess due to complex propagation conditions. To alleviate the current lack of knowledge on the characteristics and propagation of airgun pulses in shallow water with implications for effects on small marine mammals, we recorded pulses from a single airgun with three operating volumes (10 in(3), 25 in(3) and 40 in(3)) at six ranges (6, 120, 200, 400, 800 and 1300 m) in a uniform shallow water habitat using two calibrated Reson 4014 hydrophones and four DSG-Ocean acoustic data recorders. We show that airgun pulses in this shallow habitat propagated out to 1300 meters in a way that can be approximated by a 18log(r) geometric transmission loss model, but with a high pass filter effect from the shallow water depth. Source levels were back-calculated to 192 dB re mu Pa(2)s (sound exposure level) and 200 dB re 1 mu Pa dB Leq-fast (rms over 125 ms duration), and the pulses contained substantial energy up to 10 kHz, even at the furthest recording station at 1300 meters. We conclude that the risk of causing hearing damage when using single airguns in shallow waters is small for both pinnipeds and porpoises. However, there is substantial potential for significant behavioral responses out to several km from the airgun, well beyond the commonly used shut-down zone of 500 meters.	[Hermannsen, Line; Tougaard, Jakob; Nabe-Nielsen, Jacob] Aarhus Univ, Dept Biosci, Sect Marine Mammal Res, Roskilde, Denmark; [Hermannsen, Line; Beedholm, Kristian; Madsen, Peter Teglberg] Aarhus Univ, Dept Biosci, Zoophysiol, Roskilde, Denmark; [Madsen, Peter Teglberg] Murdoch Univ, Sch Vet & Life Sci, Cetacean Res Unit, Perth, WA, Australia	Aarhus University; Aarhus University; Murdoch University	Hermannsen, L (corresponding author), Aarhus Univ, Dept Biosci, Sect Marine Mammal Res, Roskilde, Denmark.	line.hermannsen@gmail.com	Madsen, Peter T/K-5832-2013; Nabe-Nielsen, Jacob/A-5891-2010; Tougaard, Jakob/G-4948-2011; Vattenfall, Bioscience/AHA-7236-2022	Madsen, Peter T/0000-0002-5208-5259; Nabe-Nielsen, Jacob/0000-0002-0716-9525; Tougaard, Jakob/0000-0002-4422-7800; 	Danish Research Council; Vattenfall; Forewind; SMart Wind; ENECO Luchterduinen; East Anglia Offshore Wind	Danish Research Council(Det Frie Forskningsrad (DFF)); Vattenfall; Forewind; SMart Wind; ENECO Luchterduinen; East Anglia Offshore Wind	Some of the recording equipment was funded by a grant from the Danish Research Council (www.ufm.dk) to PTM (www.marinebioacoustics.com). This study is part of the DEPONS project (www.depons.au.dk) funded by the offshore wind developers Vattenfall, Forewind, SMart Wind, ENECO Luchterduinen and East Anglia Offshore Wind. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2000, SPR HDB AUD, V12, P1; Blackwell SB, 2004, J ACOUST SOC AM, V115, P2346, DOI 10.1121/1.1701899; Cerchio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086464; DeRuiter SL, 2006, J ACOUST SOC AM, V120, P4100, DOI 10.1121/1.2359705; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Dragoset W.H., 1990, LEAD EDGE, V9, P24, DOI [10.1190/1.1439671, DOI 10.1190/1.1439671]; Finneran JJ, 2011, J ACOUST SOC AM, V130, P3124, DOI 10.1121/1.3641449; Goold JC, 1998, J ACOUST SOC AM, V103, P2177, DOI 10.1121/1.421363; Goold JC, 2006, IWC SC, P1; Gordon J, 2003, MAR TECHNOL SOC J, V37, P16, DOI 10.4031/002533203787536998; Gordon J, 1998, INVESTIGATIONS EFFEC; GREENE CR, 1988, J ACOUST SOC AM, V83, P2246, DOI 10.1121/1.396354; Guerra M, 2011, J ACOUST SOC AM, V130, P3046, DOI 10.1121/1.3628326; Harris RE, 2001, MAR MAMMAL SCI, V17, P795, DOI 10.1111/j.1748-7692.2001.tb01299.x; Hermannsen L, 2014, J ACOUST SOC AM, V136, P1640, DOI 10.1121/1.4893908; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Joint Nature Conservation Committee (JNCC), 2010, JNCC GUID MIN RISK I, P1; Kastak D, 2005, J ACOUST SOC AM, V118, P3154, DOI 10.1121/1.2047128; Kastelein RA, 2002, J ACOUST SOC AM, V112, P334, DOI 10.1121/1.1480835; Kastelein RA, 2014, J ACOUST SOC AM, V136, P412, DOI 10.1121/1.4883596; Kastelein RA, 2013, J ACOUST SOC AM, V134, P13, DOI 10.1121/1.4808078; Kastelein RA, 2012, J ACOUST SOC AM, V132, P3525, DOI 10.1121/1.4757641; Kastelein RA, 2011, J ACOUST SOC AM, V129, P488, DOI 10.1121/1.3518779; Kastelein RA, 2010, J ACOUST SOC AM, V128, P3211, DOI 10.1121/1.3493435; Ketten DR, 2000, SPR HDB AUD, V12, P43; Lucke K, 2009, J ACOUST SOC AM, V125, P4060, DOI 10.1121/1.3117443; Madsen PT, 2006, J ACOUST SOC AM, V120, P2366, DOI 10.1121/1.2229287; Madsen P. T., 2002, Aquatic Mammals, V28, P231; Madsen PT, 2005, J ACOUST SOC AM, V117, P3952, DOI 10.1121/1.1921508; Malakoff D, 2002, SCIENCE, V298, P722, DOI 10.1126/science.298.5594.722; Medwin H., 1998, FUNDAMENTALS ACOUSTI; Miller PJO, 2009, DEEP-SEA RES PT I, V56, P1168, DOI 10.1016/j.dsr.2009.02.008; MOHL B, 1990, NATO ADV SCI I A-LIF, V196, P295; Moore S. E, 1995, MARINE MAMMALS NOISE, P136; National Oceanographic and Atmospheric Administration (NOAA), 2013, GUID ASS EF IN PRESS, P1; National Research Council, 2005, MAR MAMM POP OC NOIS; Nedwell JR, 2007, 534R1231 SUB, P1; Nieukirk SL, 2004, J ACOUST SOC AM, V115, P1832, DOI 10.1121/1.1675816; NRC, 2003, OC NOIS MAR MAMM; Pirotta E, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1090; Reichmuth C, 2013, J COMP PHYSIOL A, V199, P491, DOI 10.1007/s00359-013-0813-y; Richardson WJ, 1995, MARINE MAMMALS NOISE, P241, DOI DOI 10.1016/B978-012588440-2/50009-3; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Romano TA, 2004, CAN J FISH AQUAT SCI, V61, P1124, DOI [10.1139/f04-055, 10.1139/F04-055]; Smoorenburg GF, 1982, NEW PERSPECTIVES NOI, P471; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Stone Carolyn J., 2006, Journal of Cetacean Research and Management, V8, P255; Thompson D, 1998, C7940098 MAS2 EUR CO; Thompson PM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2001; Tougaard J, 2015, MAR POLLUT BULL, V90, P196, DOI 10.1016/j.marpolbul.2014.10.051; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Weilgart L., 2013, CBD EXPERT WORKSHOP, P1; Weir Caroline R., 2008, Aquatic Mammals, V34, P71, DOI 10.1578/AM.34.1.2008.71	54	20	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133436	10.1371/journal.pone.0133436	http://dx.doi.org/10.1371/journal.pone.0133436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214849	Green Published, Green Submitted, gold			2022-12-26	WOS:000358594300019
J	Yokogawa, N; Murakami, H; Demura, S; Kato, S; Yoshioka, K; Yamamoto, M; Iseki, S; Tsuchiya, H				Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Yamamoto, Miyuki; Iseki, Shoichi; Tsuchiya, Hiroyuki			Effects of Radiation on Spinal Dura Mater and Surrounding Tissue in Mice	PLOS ONE			English	Article							CORD COMPRESSION; INDUCED FIBROSIS; RISK-FACTORS; MOUSE; RADIOTHERAPY; PENTOXIFYLLINE; IRRADIATION; METASTASIS; MYELOPATHY; MECHANISMS	Purpose Spinal surgery in a previously irradiated field carries increased risk of perioperative complications, such as delayed wound healing or wound infection. In addition, adhesion around the dura mater is often observed clinically. Therefore, similar to radiation-induced fibrosisa major late-stage radiation injury in other tissue-epidural fibrosis is anticipated to occur after spinal radiation. In this study, we performed histopathologic assessment of postirradiation changes in the spinal dura mater and peridural tissue in mice. Materials and Methods The thoracolumbar transition of ddY mice was irradiated with a single dose of 10 or 20 Gy. After resection of the irradiated spine, occurrence of epidural fibrosis and expression of transforming growth factor beta 1 in the spinal dura mater were evaluated. In addition, microstructures in the spinal dura mater and peridural tissue were assessed using an electron microscope. Results In the 20-Gy irradiated mice, epidural fibrosis first occurred around 12 weeks postirradiation, and was observed in all cases from 16 weeks postirradiation. In contrast, epidural fibrosis was not observed in the nonirradiated mice. Compared with the nonirradiated mice, the 10- and 20-Gy irradiated mice had significantly more overexpression of transforming growth factor beta 1 at 1 week postirradiation and in the late stages after irradiation. In microstructural assessment, the arachnoid barrier cell layer was thinned at 12 and 24 weeks postirradiation compared with that in the nonirradiated mice. Conclusion In mice, spinal epidural fibrosis develops in the late stages after high-dose irradiation, and overexpression of transforming growth factor beta 1 occurs in a manner similar to that seen in radiation-induced fibrosis in other tissue. Additionally, thinning of the arachnoid barrier cell layer was observed in the late stages after irradiation. Thus, consideration should be given to the possibility that these phenomena can occur as radiation-induced injuries of the spine.	[Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan; [Yamamoto, Miyuki; Iseki, Shoichi] Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, Kanazawa, Ishikawa 9208641, Japan	Kanazawa University; Kanazawa University	Yokogawa, N (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	chakkun1981chakkun@yahoo.co.jp	DEMURA, Satoru/X-8589-2019	Kato, Satoshi/0000-0003-4762-5932	JSPS KAKENHI [26462233]; Radiation Effects Association	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Radiation Effects Association	This study was supported by JSPS KAKENHI Grant No. 26462233 to H.M. and N.Y., and a grant-in-aid for research from the Radiation Effects Association to N.Y. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GA, 2012, SPINE J, V12, P121, DOI 10.1016/j.spinee.2012.01.012; Bartels RHMA, 2008, CA-CANCER J CLIN, V58, P245, DOI 10.3322/CA.2007.0016; BATES T, 1992, INT J RADIAT ONCOL, V23, P217, DOI 10.1016/0360-3016(92)90565-Y; BERNARDS CM, 1990, ANESTHESIOLOGY, V73, P1214, DOI 10.1097/00000542-199012000-00020; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CAUCHOIX J, 1978, Spine, V3, P256; COUTURE D, 2003, NEUROSURG FOCUS, V15, P1; De Andres J, 2009, EUR J PAIN SUPP, P55, DOI 10.1016/j.eujps.2009.07.004; Delanian S, 2003, J CLIN ONCOL, V21, P2545, DOI 10.1200/JCO.2003.06.064; Delanian S, 2007, SEMIN RADIAT ONCOL, V17, P99, DOI 10.1016/j.semradonc.2006.11.006; Demura S, 2009, SPINE, V34, P635, DOI 10.1097/BRS.0b013e31819712ca; Devalia HL, 2008, INT WOUND J, V5, P40, DOI 10.1111/j.1742-481X.2007.00351.x; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; Dowd S.B., 1999, PRACTICAL RAD PROTEC; Gerszten PC, 2009, SPINE, V34, pS78, DOI 10.1097/BRS.0b013e3181b8b6f5; Ghogawala Z, 2001, SPINE, V26, P818, DOI 10.1097/00007632-200104010-00025; GOLDWEIN JW, 1987, MED PEDIATR ONCOL, V15, P89, DOI 10.1002/mpo.2950150208; Haubner F, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-162; He Y, 1995, SPINE, V1, P20; Janjan NA, 1996, J PAIN SYMPTOM MANAG, V11, P47, DOI 10.1016/0885-3924(95)00137-9; KEY JA, 1948, J BONE JOINT SURG AM, V30-A, P621, DOI 10.2106/00004623-194830030-00009; Lefaix JL, 1999, INT J RADIAT ONCOL, V43, P839, DOI 10.1016/S0360-3016(98)00419-2; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mozes MM, 1999, J IMMUNOL METHODS, V225, P87, DOI 10.1016/S0022-1759(99)00031-9; Nishioka A, 2004, INT J RADIAT ONCOL, V58, P1235, DOI 10.1016/j.ijrobp.2003.11.006; PATIN DJ, 1993, ANESTH ANALG, V76, P535; Rades D, 2010, NAT REV CLIN ONCOL, V7, P590, DOI 10.1038/nrclinonc.2010.137; Randall K, 1996, INT J RADIAT BIOL, V70, P351, DOI 10.1080/095530096145085; RODEMANN HP, 1995, RADIOTHER ONCOL, V35, P83, DOI 10.1016/0167-8140(95)01540-W; Ronnberg K, 2008, EUR SPINE J, V17, P1714, DOI 10.1007/s00586-008-0805-8; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; SCHULTHEISS TE, 1984, INT J RADIAT ONCOL, V10, P1109, DOI 10.1016/0360-3016(84)90184-6; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SHARPLIN J, 1989, RADIAT RES, V119, P15, DOI 10.2307/3577364; SIQUEIRA EB, 1983, SURG NEUROL, V19, P168, DOI 10.1016/0090-3019(83)90418-4; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; TAYLOR JMG, 1992, INT J RADIAT ONCOL, V23, P41, DOI 10.1016/0360-3016(92)90541-O; Vandenabeele F, 1996, J ANAT, V189, P417; Wang Junru, 2006, Hernia, V10, P502, DOI 10.1007/s10029-006-0150-y; Westbury CB, 2012, CLIN ONCOL-UK, V24, P657, DOI 10.1016/j.clon.2012.04.001; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002; Yokogawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098797; ZIDE BM, 1987, J NEUROSURG, V67, P59, DOI 10.3171/jns.1987.67.1.0059	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133806	10.1371/journal.pone.0133806	http://dx.doi.org/10.1371/journal.pone.0133806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214850	Green Submitted, Green Published, gold			2022-12-26	WOS:000358594300033
J	Zhu, LS; Lv, RT; Kong, LC; Cheng, HD; Lan, F; Li, XT				Zhu, Lisha; Lv, Ruitu; Kong, Lingchun; Cheng, Haidong; Lan, Fei; Li, Xiaotian			Genome-Wide Mapping of 5mC and 5hmC Identified Differentially Modified Genomic Regions in Late-Onset Severe Preeclampsia: A Pilot Study	PLOS ONE			English	Article							POLARITY PROTEIN PARD-3; CHRONIC KIDNEY-DISEASE; EMBRYONIC STEM-CELLS; PROMOTER HYPOMETHYLATION; DNA HYPOMETHYLATION; GROWTH-FACTOR; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; PLACENTAS; 5-METHYLCYTOSINE	Preeclampsia (PE) is a leading cause of perinatal morbidity and mortality. However, as a common form of PE, the etiology of late-onset PE is elusive. We analyzed 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) levels in the placentas of late-onset severe PE patients (n = 4) and normal controls (n = 4) using a (hydroxy) methylated DNA immunoprecipitation approach combined with deep sequencing ([h] MeDIP-seq), and the results were verified by (h) MeDIP-qPCR. The most significant differentially methylated regions (DMRs) were verified by MassARRAY EppiTYPER in an enlarged sample size (n = 20). Bioinformatics analysis identified 714 peaks of 5mC that were associated with 403 genes and 119 peaks of 5hmC that were associated with 61 genes, thus showing significant differences between the PE patients and the controls (>2-fold, p<0.05). Further, only one gene, PTPRN2, had both 5mC and 5hmC changes in patients. The ErbB signaling pathway was enriched in those 403 genes that had significantly different5mC level between the groups. This genome-wide mapping of 5mC and 5hmC in late-onset severe PE and normal controls demonstrates that both 5mC and 5hmC play epigenetic roles in the regulation of the disease, but work independently. We reveal the genome-wide mapping of DNA methylation and DNA hydroxymethylation in late-onset PE placentas for the first time, and the identified ErbB signaling pathway and the gene PTPRN2 may be relevant to the epigenetic pathogenesis of late-onset PE.	[Zhu, Lisha; Cheng, Haidong; Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Dept Obstet, Shanghai 200011, Peoples R China; [Lv, Ruitu; Kong, Lingchun; Lan, Fei] Fudan Univ, Key Lab Epigenet Shanghai, Minist Educ, Sch Basic Med, Shanghai 200032, Peoples R China; [Lv, Ruitu; Kong, Lingchun; Lan, Fei] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Lan, Fei] Fudan Univ, Childrens Hosp, Key Lab Birth Defect, Shanghai 201102, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Cheng, HD (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Obstet, Shanghai 200011, Peoples R China.	hdcheng2003@163.com; fei_lan@fudan.edu.cn; xiaotianli555@163.com	Lyu, Ruitu/ABU-6220-2022; Lyu, Ruitu/ABG-1437-2021; Li, Xiaotian/ABI-3309-2020	Lyu, Ruitu/0000-0003-4597-1604; Lyu, Ruitu/0000-0003-4597-1604; Li, Xiaotian/0000-0002-2051-4581	National Science Fund of China [81270712]	National Science Fund of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Science Fund of China, http://www.nsfc.gov.cn/ (81270712). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armant DR, 2006, DEVELOPMENT, V133, P751, DOI 10.1242/dev.02237; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Chen BS, 2010, AM J PHYSIOL-CELL PH, V299, pC968, DOI 10.1152/ajpcell.00154.2010; Chen JH, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/970435; Ching T, 2014, MOL HUM REPROD, V20, P885, DOI 10.1093/molehr/gau046; Choudhury M, 2012, CLIN EXP HYPERTENS, V34, P334, DOI 10.3109/10641963.2011.649931; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Figueroa-Romero C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052672; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Gould PS, 2010, HYPERTENSION, V56, P172, DOI 10.1161/HYPERTENSIONAHA.110.152074; Goyal R, 2010, PLACENTA, V31, P568, DOI 10.1016/j.placenta.2010.05.004; Haram K, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/910751; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang HS, 2012, EUR J OBSTET GYN R B, V160, P137, DOI 10.1016/j.ejogrb.2011.10.007; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Johansson A, 2011, EUR J HUM GENET, V19, P796, DOI 10.1038/ejhg.2011.19; Johnson MP, 2013, MOL HUM REPROD, V19, P423, DOI 10.1093/molehr/gat011; Kornacki J, 2014, GINEKOL POL, V85, P504; Kroeze LI, 2015, BBA-REV CANCER, V1855, P144, DOI 10.1016/j.bbcan.2015.01.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liao AH, 2009, AM J REPROD IMMUNOL, V61, P313, DOI 10.1111/j.1600-0897.2009.00697.x; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu Y, 2014, HYPERTENSION, V63, P827, DOI 10.1161/HYPERTENSIONAHA.113.02637; Loewendorf AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096723; Matsukawa R, 2013, AM J HYPERTENS, V26, P51, DOI 10.1093/ajh/hps005; Mbah AK, 2010, BJOG-INT J OBSTET GY, V117, P997, DOI 10.1111/j.1471-0528.2010.02593.x; Mendola P, 2015, EPIDEMIOLOGY, V26, P17, DOI 10.1097/EDE.0000000000000213; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Park SY, 2015, CANCER LETT, V357, P419, DOI 10.1016/j.canlet.2014.12.005; Parry S, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.035; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Schanz A, 2011, EUR J OBSTET GYN R B, V157, P32, DOI 10.1016/j.ejogrb.2011.02.023; Sharp AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087621; Smyth LJ, 2014, EPIGENETICS-US, V9, P366, DOI 10.4161/epi.27161; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt091; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tejera E, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-51; van Dijk Marie, 2013, Frontiers in Genetics, V4, P180, DOI 10.3389/fgene.2013.00180; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yao B, 2014, HUM MOL GENET, V23, P1095, DOI 10.1093/hmg/ddt504; Yazbek SN, 2011, GENOME RES, V21, P1065, DOI 10.1101/gr.120741.111; Yoshida T, 2010, EXP THER MED, V1, P137, DOI 10.3892/etm_00000023; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; Yung HW, 2014, J PATHOL, V234, P262, DOI 10.1002/path.4394; Zhao J, 2011, REPROD SCI, V18, P164, DOI 10.1177/1933719110382920; Zhao S, 2011, REPROD SCI, V18, P772, DOI 10.1177/1933719111398145	52	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134119	10.1371/journal.pone.0134119	http://dx.doi.org/10.1371/journal.pone.0134119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214307	Green Submitted, Green Published, gold			2022-12-26	WOS:000358594300050
J	Qi, Y; Qi, ZH; Li, ZC; Wong, CK; So, C; Lo, IC; Huang, Y; Yao, XQ; Tsang, SY				Qi, Yan; Qi, Zenghua; Li, Zhichao; Wong, Chun-Kit; So, Chun; Lo, Iek-Chi; Huang, Yu; Yao, Xiaoqiang; Tsang, Suk-Ying			Role of TRPV1 in the Differentiation of Mouse Embryonic Stem Cells into Cardiomyocytes	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; POTASSIUM CHANNELS; IDENTIFICATION; CARDIOGENESIS; ANTAGONIST; PATHWAY; MICE	Cytosolic Ca2+ ([Ca2+](i)) is an important signal that regulates cardiomyocyte differentiation during cardiogenesis. TRPV1 is a Ca2+-permeable channel that is expressed in cardiomyocytes. In the present study, we utilized mouse embryonic stem cell-derived cardiomyocytes (mESC-CMs) as a model to investigate the functional role of TRPV1 in cardiomyocyte differentiation. Induction of embryonic stem cells into cardiomyocytes was achieved using embryoid body (EB)-based differentiation method. Quantitative PCRs showed an increased TRPV1 expression during the differentiation process. In [Ca2+](i) measurement study, application of TRPV1 agonists, capsaicin and camphor, elicited a [Ca2+](i) rise in mESC-CMs, the effect of which was abolished by TRPV1-shRNA. In functional study, treatment of EBs with TRPV1 antagonists (capsazepine and SB366791) and TRPV1-shRNA reduced the size of the EBs and decreased the percentage of spontaneously beating EBs. TRPV1 antagonists and TRPV1-shRNA also suppressed the expression of cardiomyocyte marker genes, including cardiac actin, c-TnT, c-TnI, and alpha-MHC. Taken together, this study demonstrated an important functional role of TRPV1 channels in the differentiation of mESCs into cardiomyocytes.	[Qi, Yan; Li, Zhichao; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Qi, Yan; Li, Zhichao; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Qi, Zenghua; Wong, Chun-Kit; So, Chun; Lo, Iek-Chi; Tsang, Suk-Ying] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Tsang, Suk-Ying] Chinese Univ Hong Kong, Partner State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Tsang, Suk-Ying] Chinese Univ Hong Kong, Ctr Novel Biomat, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Yao, XQ (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk; fayetsang@cuhk.edu.hk	So, Chun/AAD-1181-2022; TSANG, Suk/Q-6402-2018; So, Chun/GPG-0333-2022; Huang, Yu/K-2866-2017; Yao, Xiaoqiang/I-5413-2016	So, Chun/0000-0003-3901-7654; TSANG, Suk/0000-0002-9992-5454; Huang, Yu/0000-0002-1277-6784; Yao, Xiaoqiang/0000-0002-0687-8186; Li, Zhichao/0000-0001-6803-6876	Hong Kong RGC [T13-706/11, AoE/M-05/12, CUHK2/CRF/11G, CUHK478710, CUHK478011, CUHK478413, CUHK474711, CUHK474412, CUHK474913]; National Science Foundation of China [31171100]; Innovative Technology Fund of Innovation Technology Commission	Hong Kong RGC(Hong Kong Research Grants Council); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Technology Fund of Innovation Technology Commission	This work was supported by T13-706/11 (XY), AoE/M-05/12 (XY), CUHK2/CRF/11G (XY), CUHK478710 (XY), CUHK478011 (XY, YH), CUHK478413 (XY), CUHK478413 (XY), CUHK474711 (SYT), CUHK474412 (SYT), and CUHK474913 (SYT) from the Hong Kong RGC; National Science Foundation of China grant 31171100 (XY); Innovative Technology Fund of Innovation Technology Commission: Funding Support to Partner State Key Laboratories in Hong Kong (SYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Gerges N, 2000, J PHYSIOL-LONDON, V523, P377, DOI 10.1111/j.1469-7793.2000.t01-2-00377.x; Banach K, 2003, AM J PHYSIOL-HEART C, V284, pH2114, DOI 10.1152/ajpheart.01106.2001; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Fijnvandraat AC, 2003, CARDIOVASC RES, V58, P399, DOI 10.1016/S0008-6363(03)00282-7; Guasch G, 2005, NAT GENET, V37, P1201, DOI 10.1038/ng1667; Gunthorpe MJ, 2004, NEUROPHARMACOLOGY, V46, P133, DOI 10.1016/S0028-3908(03)00305-8; Idris AI, 2010, BONE, V46, P1089, DOI 10.1016/j.bone.2010.01.368; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Law SK, 2013, INT J CARDIOL, V168, P3458, DOI 10.1016/j.ijcard.2013.04.178; Leuner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014716; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Ng SY, 2010, J CELL PHYSIOL, V224, P165, DOI 10.1002/jcp.22113; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Puceat M, 2005, CELL CALCIUM, V38, P383, DOI 10.1016/j.ceca.2005.06.016; Selescu T, 2013, CHEM SENSES, V38, P563, DOI 10.1093/chemse/bjt027; Shin HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010359; Toth BI, 2009, FEBS LETT, V583, P1619, DOI 10.1016/j.febslet.2009.04.031; Tsang SY, 2007, BIOCHEM BIOPH RES CO, V357, P480, DOI 10.1016/j.bbrc.2007.03.187; Wang K, 2005, STEM CELLS, V23, P1526, DOI 10.1634/stemcells.2004-0299; Wei WJ, 2012, J BIOL CHEM, V287, P35599, DOI 10.1074/jbc.M112.392530; Wobus A M, 2002, Methods Mol Biol, V185, P127; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Xia R, 2011, ADV EXP MED BIOL, V704, P637, DOI 10.1007/978-94-007-0265-3_34; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388; Yanagida E, 2004, CELL CALCIUM, V36, P135, DOI 10.1016/j.ceca.2004.01.022; Zhang YM, 2012, J MOL CELL BIOL, V4, P97, DOI 10.1093/jmcb/mjs002; Zhang YM, 2003, AM J PHYSIOL-HEART C, V285, pH2770, DOI 10.1152/ajpheart.01114.2002; Zhong BH, 2009, AM J PHYSIOL-REG I, V297, pR1681, DOI 10.1152/ajpregu.90746.2008	33	7	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133211	10.1371/journal.pone.0133211	http://dx.doi.org/10.1371/journal.pone.0133211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208267	gold, Green Published, Green Submitted			2022-12-26	WOS:000358622000066
J	Wortham, JM; Gray, J; Verani, J; Contreras, CL; Bernart, C; Moscoso, F; Moir, JC; Marroquin, ELR; Castellan, R; Arvelo, W; Lindblade, K; McCracken, JP				Wortham, Jonathan M.; Gray, Jennifer; Verani, Jennifer; Lucia Contreras, Carmen; Bernart, Chris; Moscoso, Fabiola; Carlos Moir, Juan; Reyes Marroquin, Emma Lissette; Castellan, Rigoberto; Arvelo, Wences; Lindblade, Kim; McCracken, John P.			Using Standardized Interpretation of Chest Radiographs to Identify Adults with Bacterial Pneumonia-Guatemala, 2007-2012	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCOCCAL CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD PNEUMONIA; CHILDREN YOUNGER; HERD-IMMUNITY; DIAGNOSIS; ETIOLOGY; ANTIGEN; EPIDEMIOLOGY	Background Bacterial pneumonia is a leading cause of illness and death worldwide, but quantifying its burden is difficult due to insensitive diagnostics. Although World Health Organization (WHO) protocol standardizes pediatric chest radiograph (CXR) interpretation for epidemiologic studies of bacterial pneumonia, its validity in adults is unknown. Methods Patients (age >= 15 years) admitted with respiratory infections to two Guatemalan hospitals between November 2007 and March 2012 had urine and nasopharyngeal/oropharyngeal (NP/OP) swabs collected; blood cultures and CXR were also performed at physician clinical discretion. 'Any bacterial infection' was defined as a positive urine pneumococcal antigen test, isolation of a bacterial pneumonia pathogen from blood culture, or detection of an atypical bacterial pathogen by polymerase chain reaction (PCR) of nasopharyngeal/oropharyngeal (NP/OP) specimens. 'Viral infection' was defined as detection of viral pathogens by PCR of NP/OP specimens. CXRs were interpreted according to the WHO protocol as having 'endpoint consolidation', 'other infiltrate', or 'normal' findings. We examined associations between bacterial and viral infections and endpoint consolidation. Findings Urine antigen and/or blood culture results were available for 721 patients with CXR interpretations; of these, 385 (53%) had endpoint consolidation and 253 (35%) had other infiltrate. Any bacterial infection was detected in 119 (17%) patients, including 106 (89%) pneumococcal infections. Any bacterial infection (Diagnostic Odds Ratio [DOR] = 2.9; 95% confidence Interval (CI): 1.3-7.9) and pneumococcal infection (DOR = 3.4; 95% CI: 1.5-10.0) were associated with 'endpoint consolidation', but not 'other infiltrate' (DOR = 1.7; 95% CI: 0.7-4.9, and 1.7; 95% CI: 0.7-4.9 respectively). Viral infection was not significantly associated with 'endpoint consolidation', 'other infiltrate,' or 'normal' findings. Interpretation 'Endpoint consolidation' was associated with 'any bacterial infection,' specifically pneumococcal infection. Therefore, endpoint consolidation may be a useful surrogate for studies measuring the impact of interventions, such as conjugate vaccines, against bacterial pneumonia.	[Wortham, Jonathan M.; Verani, Jennifer; Arvelo, Wences; Lindblade, Kim] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Gray, Jennifer; Lucia Contreras, Carmen; Bernart, Chris; Moscoso, Fabiola; Castellan, Rigoberto; McCracken, John P.] Univ Valle Guatemala, Guatemala City, Guatemala; [Carlos Moir, Juan; Reyes Marroquin, Emma Lissette] Minist Salud Publ & Asistencia Social, Guatemala City, Guatemala	Centers for Disease Control & Prevention - USA; Universidad del Valle de Guatemala	Wortham, JM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	vij5@cdc.gov		Lindblade, Kim/0000-0002-5593-0470	U.S Centers for Disease Control and Prevention (CDC) [UO1 GH000028-02]	U.S Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported in part by Cooperative Agreement Number UO1 GH000028-02 from the U.S Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Albaum MN, 1996, CHEST, V110, P343, DOI 10.1378/chest.110.2.343; Baqui AH, 2007, PEDIATR INFECT DIS J, V26, P565, DOI 10.1097/INF.0b013e31806166a0; Butler JC, 2003, J INFECT DIS, V187, P1416, DOI 10.1086/374623; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Corbo J, 2004, EMERG MED J, V21, P446, DOI 10.1136/emj.2003.005306; de la Hoz F, 2004, VACCINE, V23, P36, DOI 10.1016/j.vaccine.2004.05.017; Elberse KEM, 2012, VACCINE, V30, P7644, DOI 10.1016/j.vaccine.2012.04.021; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Ewig S, 2002, CHEST, V121, P1486, DOI 10.1378/chest.121.5.1486; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Fitzwater SP, 2012, PEDIATR INFECT DIS J, V31, P501, DOI 10.1097/INF.0b013e31824de9f6; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Gutierrez F, 2003, CLIN INFECT DIS, V36, P286, DOI 10.1086/345852; Haber M, 2007, VACCINE, V25, P5390, DOI 10.1016/j.vaccine.2007.04.088; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Heiskanen-Kosma T, 1998, PEDIATR INFECT DIS J, V17, P986, DOI 10.1097/00006454-199811000-00004; Javadi M, 2006, INT J INFECT DIS, V10, P129, DOI 10.1016/j.ijid.2005.01.007; Lynch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011989; Mendoza-Paredes A, 2013, CLIN MED INSIGHTS-PE, V7, P1, DOI 10.4137/CMPed.S8051; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; MIMICA I, 1971, AM J DIS CHILD, V122, P278, DOI 10.1001/archpedi.1971.02110040062002; Myers AL, 2013, PEDIAT INFECT DIS J; Nantanda R, 2008, ANN TROP PAEDIATR, V28, P253, DOI 10.1179/146532808X375404; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro SK, 2006, LANCET INFECT DIS, V6, P150, DOI 10.1016/S1473-3099(06)70411-X; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; SILVERMAN M, 1977, ARCH DIS CHILD, V52, P925, DOI 10.1136/adc.52.12.925; Sinclair A, 2013, J CLIN MICROBIOL, V51, P2303, DOI 10.1128/JCM.00137-13; Verani JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083600; Wang SA, 2013, MMWR-MORBID MORTAL W, V62, P308; Watt JP, 2010, EPIDEMIOL INFECT, V138, P1146, DOI 10.1017/S0950268809991464; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wiemken TL, 2012, SEMIN RESP CRIT CARE, V33, P213, DOI 10.1055/s-0032-1315633; World Health Organization, 2001, STAND INT CHEST RAD	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133257	10.1371/journal.pone.0133257	http://dx.doi.org/10.1371/journal.pone.0133257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207918	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000072
J	Zhu, Y; Wang, JL; He, ZY; Jin, F; Tang, L				Zhu, Ying; Wang, Jia-Lu; He, Zhi-Yi; Jin, Feng; Tang, Ling			Association of Altered Serum MicroRNAs with Perihematomal Edema after Acute Intracerebral Hemorrhage	PLOS ONE			English	Article							BRAIN EDEMA; INFLAMMATION; STROKE; EXPRESSION; PREDICTOR; MORTALITY; TARGETS; GROWTH; INJURY; VOLUME	Background and Purpose Perihematomal edema (PHE) contributes to secondary brain damage and aggravates patient outcomes after intracerebral hemorrhage (ICH). MicroRNAs (miRNAs) are stable in circulation, and their unique expression profiles have fundamental roles in modulating vascular disease. The objective of this study was to test the hypothesis that altered miRNA levels are associated with PHE in ICH patients. Methods Hematoma and PHE volumes of ICH patients were measured on admission and in follow-up computed tomography scans. Whole-genome miRNA profiles of ICH patients and healthy controls were determined using the Exiqon miRCURY LNA Array, and validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Bioinformatics analysis investigated dysregulated miRNA target genes and the signaling pathways involved. Results We identified 55 miRNAs that were differentially expressed in ICH patients compared with normal controls, of which 54 were down-regulated and one was up-regulated. qRT-PCR confirmation showed decreases in miR-126 (0.63-fold), miR-146a (0.64-fold), miR-let-7a (0.50-fold), and miR-26a (0.54-fold) in ICH patients relative to controls. Serum miR-126, but not miR-146a, miR-let-7a or miR-26a, levels were significantly correlated with relative PHE volume on days 3-4 (r = -0.714; P<0.001) in patients with ICH. Conclusions ICH patients appear to have a specific miRNA expression profile. Low expression of miR-126 was positively correlated with the extent of PHE, suggesting it may have a pathogenic role in the development of PHE after ICH.	[Zhu, Ying; Wang, Jia-Lu; He, Zhi-Yi; Jin, Feng; Tang, Ling] China Med Univ, Dept Neurol, Hosp 1, Shenyang, Peoples R China	China Medical University	He, ZY (corresponding author), China Med Univ, Dept Neurol, Hosp 1, Shenyang, Peoples R China.	he-zy@outlook.com			National Natural Science Foundation of China [81271291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81271291).	Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Bai YY, 2011, MED HYPOTHESES, V77, P488, DOI 10.1016/j.mehy.2011.06.017; Bao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106540; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; BRODERICK J, 1994, NEUROSURGERY, V34, P882, DOI 10.1227/00006123-199405000-00015; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; Guo D, 2013, STROKE, V44, P1739, DOI 10.1161/STROKEAHA.111.000835; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hu JZ, 2015, BRAIN RES, V1608, P191, DOI 10.1016/j.brainres.2015.02.036; Kim JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097946; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; McColl BW, 2007, BIOCHEM SOC T, V35, P1163, DOI 10.1042/BST0351163; Nikolic Iva, 2010, J Angiogenes Res, V2, P9, DOI 10.1186/2040-2384-2-9; Pogue AI, 2009, J INORG BIOCHEM, V103, P1591, DOI 10.1016/j.jinorgbio.2009.05.012; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan JR, 2011, CURR MOL MED, V11, P76; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wasserman JK, 2007, BRAIN RES, V1180, P140, DOI 10.1016/j.brainres.2007.08.058; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2002, NEUROSURG CLIN N AM, V13, P371, DOI 10.1016/S1042-3680(02)00007-4; Zheng HW, 2012, CNS NEUROSCI THER, V18, P1003, DOI 10.1111/cns.12019; Zhou QB, 2014, INFLAMMATION, V37, P107, DOI 10.1007/s10753-013-9717-9	33	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133783	10.1371/journal.pone.0133783	http://dx.doi.org/10.1371/journal.pone.0133783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207814	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000141
J	Castelli, A; Daidone, S; Jacobs, R; Kasteridis, P; Street, AD				Castelli, Adriana; Daidone, Silvio; Jacobs, Rowena; Kasteridis, Panagiotis; Street, Andrew David			The Determinants of Costs and Length of Stay for Hip Fracture Patients	PLOS ONE			English	Article							MORTALITY; RISK; OUTCOMES; MODELS; TRENDS; CARE	Background and Purpose An ageing population at greater risk of proximal femoral fracture places an additional clinical and financial burden on hospital and community medical services. We analyse the variation in i) length of stay (LoS) in hospital and ii) costs across the acute care pathway for hip fracture from emergency admission, to hospital stay and follow-up outpatient appointments. Patients and Methods We analyse patient-level data from England for 2009/10 for around 60,000 hip fracture cases in 152 hospitals using a random effects generalized linear multi-level model where the dependent variable is given by the patient's cost or length of stay (LoS). We control for socio-economic characteristics, type of fracture and intervention, co-morbidities, discharge destination of patients, and quality indicators. We also control for provider and social care characteristics. Results Older patients and those from more deprived areas have higher costs and LoS, as do those with specific co-morbidities or that develop pressure ulcers, and those transferred between hospitals or readmitted within 28 days. Costs are also higher for those having a computed tomography (CT) scan or cemented arthroscopy. Costs and LoS are lower for those admitted via a 24h emergency department, receiving surgery on the same day of admission, and discharged to their own homes. Interpretation Patient and treatment characteristics are more important as determinants of cost and LoS than provider or social care factors. A better understanding of the impact of these characteristics can support providers to develop treatment strategies and pathways to better manage this patient population.	[Castelli, Adriana; Jacobs, Rowena; Kasteridis, Panagiotis; Street, Andrew David] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Daidone, Silvio] UN, FAO, I-00153 Rome, Italy	University of York - UK; Food & Agriculture Organization of the United Nations (FAO)	Castelli, A (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	adriana.castelli@york.ac.uk	Daidone, Silvio/ABC-5526-2021; Daidone, Silvio/AAJ-4490-2021	Daidone, Silvio/0000-0002-1789-5635; 	Policy Research Programme in the English Department of Health from the Economics of Social and Health Care Research Unit (ESHCRU) [103/0001]	Policy Research Programme in the English Department of Health from the Economics of Social and Health Care Research Unit (ESHCRU)	The work was funded by the Policy Research Programme in the English Department of Health from the Economics of Social and Health Care Research Unit (ESHCRU) (Ref 103/0001). The funders have approved the manuscript for submission but had no role in the design or conduct of the study. The views expressed are those of the authors and not necessarily those of the funders.	Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Austin PC, 2002, HLTH SERV OUTCOME RE, V3, P107, DOI DOI 10.1023/A:1024260023851; Blough DK, 1999, J HEALTH ECON, V18, P153, DOI 10.1016/S0167-6296(98)00032-0; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Department of Health, 2008, NHS COST MAN 2009 10; Department of Health, 2009 10 2010 11 PCT; Draper B, 1998, INT J GERIATR PSYCH, V13, P1, DOI 10.1002/(SICI)1099-1166(199801)13:1<1::AID-GPS716>3.0.CO;2-V; Duan N, 1983, J BUS ECON STAT, V1, P115, DOI DOI 10.2307/1391852; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Frakt AB, 2011, MILBANK Q, V89, P90, DOI 10.1111/j.1468-0009.2011.00621.x; Garcia AE, 2012, J ORTHOP TRAUMA, V26, P620, DOI 10.1097/BOT.0b013e3182695416; Gehlbach SH, 2007, OSTEOPOROSIS INT, V18, P585, DOI 10.1007/s00198-006-0281-0; Holt G, 2009, INJURY, V40, P722, DOI 10.1016/j.injury.2008.11.004; Laudicella M, 2010, SOC SCI MED, V71, P1872, DOI 10.1016/j.socscimed.2010.06.049; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Marsh D, 2007, CARE PATIENTS FRAGIL; Moran JL, 2012, BMC MED RES METHODOL, V12, P1; National Clinical Guideline Centre, 2011, MAN HIP FRACT AD, P664; Nikkel LE, 2012, J BONE JOINT SURG AM, V94A, P9, DOI [10.2106/JBJS.J.01077, 10.2106/JBJS.K.01214]; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Richmond J, 2003, J ORTHOP TRAUMA, V17, P53, DOI 10.1097/00005131-200301000-00008; Rosen AB, 1999, AM HEART J, V138, P69, DOI 10.1016/S0002-8703(99)70249-8; Titler M, 2007, NURS OUTLOOK, V55, P5, DOI 10.1016/j.outlook.2006.06.006; White SM, 2011, INJURY, V42, P1230, DOI 10.1016/j.injury.2010.11.010	27	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133545	10.1371/journal.pone.0133545	http://dx.doi.org/10.1371/journal.pone.0133545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NJ	26204450	Green Submitted, Green Published, gold			2022-12-26	WOS:000358621000032
J	Kim, J; Chung, M; Kim, S; Jo, DH; Kim, JH; Jeon, NL				Kim, Jaerim; Chung, Minhwan; Kim, Sudong; Jo, Dong Hyun; Kim, Jeong Hun; Jeon, Noo Li			Engineering of a Biomimetic Pericyte-Covered 3D Microvascular Network	PLOS ONE			English	Article							IN-VITRO; TUMOR VASCULATURE; VESSEL MATURATION; ENDOTHELIAL-CELLS; ANGIOGENESIS; MICROVESSELS; IL-1	Pericytes enveloping the endothelium play an important role in the physiology and pathology of microvessels, especially in vessel maturation and stabilization. However, our understanding of fundamental pericyte biology is limited by the lack of a robust in vitro model system that allows researchers to evaluate the interactions among multiple cell types in perfusable blood vessels. The present work describes a microfluidic platform that can be used to investigate interactions between pericytes and endothelial cells (ECs) during the sprouting, growth, and maturation steps of neovessel formation. A mixture of ECs and pericytes was attached to the side of a pre-patterned three dimensional fibrin matrix and allowed to sprout across the matrix. The effects of intact coverage and EC maturation by the pericytes on the perfused EC network were confirmed using a confocal microscope. Compared with EC monoculture conditions, EC-pericyte co-cultured vessels showed a significant reduction in diameter, increased numbers of junctions and branches and decreased permeability. In response to biochemical factors, ECs and pericytes in the platform showed the similar features with previous reports from in vivo experiments, thus reflect various pathophysiological conditions of in vivo microvessels. Taken together, these results support the physiological relevancy of our three-dimensional microfluidic culture system but also that the system can be used to screen drug effect on EC-pericyte biology.	[Kim, Jaerim; Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Div WCU Multiscale Mech Design, Seoul, South Korea; [Chung, Minhwan; Kim, Sudong; Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul, South Korea; [Jo, Dong Hyun; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 110744, South Korea; [Jo, Dong Hyun; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Jo, Dong Hyun; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea; [Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Jeon, Noo Li] Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Jeon, NL (corresponding author), Seoul Natl Univ, Sch Mech & Aerosp Engn, Div WCU Multiscale Mech Design, Seoul, South Korea.	steph25@snu.ac.kr; njeon@snu.ac.kr	chung, minhwan/AAH-5541-2019; Jo, Dong Hyun/D-5962-2012	chung, minhwan/0000-0001-6720-7514; Jo, Dong Hyun/0000-0002-6320-6829; Kim, Jeong Hun/0000-0003-2957-1766	National Research Foundation - Ministry of Education [NRF-2015R1A2A1A09005662]; Seoul National University Hospital Research Fund [03-2014-0260]; Seoul National University Research Grant [800-20140542]; Seoul National University (SNU)	National Research Foundation - Ministry of Education; Seoul National University Hospital Research Fund; Seoul National University Research Grant; Seoul National University (SNU)	This work was supported by the National Research Foundation funded by the Ministry of Education (NRF-2015R1A2A1A09005662), Seoul National University Hospital Research Fund (03-2014-0260), Seoul National University Research Grant (800-20140542) and Research Grant for Foreign Professors through Seoul National University (SNU) in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005; Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007; Carrion B, 2010, BIOTECHNOL BIOENG, V107, P1020, DOI 10.1002/bit.22891; Chang WG, 2013, CARDIOVASC RES, V100, P492, DOI 10.1093/cvr/cvt215; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jeon JS, 2014, INTEGR BIOL-UK, V6, P555, DOI 10.1039/c3ib40267c; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; Lee H, 2014, MRS BULL, V39, P51, DOI 10.1557/mrs.2013.286; Lee H, 2014, MICROVASC RES, V91, P90, DOI 10.1016/j.mvr.2013.12.001; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Tarallo S, 2012, ACTA DIABETOL, V49, pS141, DOI 10.1007/s00592-012-0390-5; Tigges U, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-33; van der Meer AD, 2013, LAB CHIP, V13, P3562, DOI 10.1039/c3lc50435b; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Wang SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045499; Waters JP, 2013, J VASC RES, V50, P324, DOI 10.1159/000353303; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	40	73	76	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133880	10.1371/journal.pone.0133880	http://dx.doi.org/10.1371/journal.pone.0133880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204526	Green Published, gold, Green Submitted			2022-12-26	WOS:000358621000041
J	Jalbrzikowski, M; Lazaro, MT; Gao, FY; Huang, A; Chow, C; Geschwind, DH; Coppola, G; Bearden, CE				Jalbrzikowski, Maria; Lazaro, Maria T.; Gao, Fuying; Huang, Alden; Chow, Carolyn; Geschwind, Daniel H.; Coppola, Giovanni; Bearden, Carrie E.			Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; LOW-COPY REPEATS; PREFRONTAL CORTEX; GENE-EXPRESSION; MITOCHONDRIAL DYSFUNCTION; DIAGNOSTIC INTERVIEW; MICRORNA EXPRESSION; MENTAL-RETARDATION; WHITE-MATTER; SCHIZOPHRENIA	Background 22q11.2 Deletion Syndrome (22q11DS) represents one of the greatest known genetic risk factors for the development of psychotic illness, and is also associated with high rates of autistic spectrum disorders (ASD) in childhood. We performed integrated genomic analyses of 22q11DS to identify genes and pathways related to specific phenotypes. Methods We used a high-resolution aCGH array to precisely characterize deletion breakpoints. Using peripheral blood, we examined differential expression (DE) and networks of co-expressed genes related to phenotypic variation within 22q11DS patients. Whole-genome transcriptional profiling was performed using Illumina Human HT-12 microarrays. Data mining techniques were used to validate our results against independent samples of both peripheral blood and brain tissue from idiopathic psychosis and ASD cases. Results Eighty-five percent of 22q11DS individuals (N = 39) carried the typical 3 Mb deletion, with significant variability in deletion characteristics in the remainder of the sample (N = 7). DE analysis and weighted gene co-expression network analysis (WGCNA) identified expression changes related to psychotic symptoms in patients, including a module of co-expressed genes which was associated with psychosis in 22q11DS and involved in pathways associated with transcriptional regulation. This module was enriched for brain-expressed genes, was not related to antipsychotic medication use, and significantly overlapped with transcriptional changes in idiopathic schizophrenia. In 22q11DS-ASD, both DE and WGCNA analyses implicated dysregulation of immune response pathways. The ASD-associated module showed significant overlap with genes previously associated with idiopathic ASD. Conclusion These findings further support the use of peripheral tissue in the study of major mutational models of diseases affecting the brain, and point towards specific pathways dysregulated in 22q11DS carriers with psychosis and ASD.	[Jalbrzikowski, Maria; Gao, Fuying; Chow, Carolyn; Geschwind, Daniel H.; Coppola, Giovanni; Bearden, Carrie E.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Lazaro, Maria T.; Huang, Alden] Univ Calif Los Angeles, Interdept Neurosci Program, Los Angeles, CA USA; [Geschwind, Daniel H.; Coppola, Giovanni] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bearden, CE (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	cbearden@mednet.ucla.edu		Bearden, Carrie/0000-0002-8516-923X	ACE Center [5P50 HD055784]; National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics [P30 NS06269]; Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome [R01MH085953]; NINDS Training Grant [T32NS048004]; Heyler Research Award; National Science Foundation (NSF) Graduate Research Fellowship Program [NSF-GRFP DGE-0707424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048004, P30NS062691] Funding Source: NIH RePORTER	ACE Center; National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics; Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome; NINDS Training Grant; Heyler Research Award; National Science Foundation (NSF) Graduate Research Fellowship Program(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to acknowledge the following funding sources: 5P50 HD055784 ACE Center (Daniel H. Geschwind), P30 NS06269 National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics (Giovanni Coppola), R01MH085953 Neurodevelopment and Psychosis in the 22q11.2 Deletion Syndrome (Carrie E. Bearden), T32NS048004 NINDS Training Grant (Maria Jalbrzikowski), Heyler Research Award (Maria Jalbrzikowski), and NSF-GRFP DGE-0707424 National Science Foundation (NSF) Graduate Research Fellowship Program (Maria T. Lazaro). Dr. Bearden had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors contributed to and have approved the final manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkustsiri K, 2014, J AUTISM DEV DISORD, V44, P739, DOI 10.1007/s10803-013-1920-x; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Baker K, 2012, CURR OPIN NEUROL, V25, P131, DOI 10.1097/WCO.0b013e328352dd58; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Bertolino A, 2006, PSYCHIAT RES-NEUROIM, V147, P221, DOI 10.1016/j.pscychresns.2006.04.001; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Bittel DC, 2009, CYTOGENET GENOME RES, V124, P113, DOI 10.1159/000207515; Cai CC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-589; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Coppola G, 2011, ANN NEUROL, V70, P790, DOI 10.1002/ana.22526; Coppola G, 2011, METHODS MOL BIOL, V793, P417, DOI 10.1007/978-1-61779-328-8_28; Couture SM, 2010, PSYCHOL MED, V40, P569, DOI 10.1017/S003329170999078X; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eliez S, 2007, J AM ACAD CHILD PSY, V46, P433, DOI 10.1097/CHI.0b013e31802f5490; First MB, 2002, BIOMETRICS RESEARCH; Fung WLA, 2010, AM J PSYCHIAT, V167, P998, DOI 10.1176/appi.ajp.2010.09101463; Gadow KD, 2009, J AUTISM DEV DISORD, V39, P1542, DOI 10.1007/s10803-009-0794-4; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Goncalves VF, 2015, HUM GENET, V134, P13, DOI 10.1007/s00439-014-1491-8; Gothelf D, 2004, AM J MED GENET B, V126B, P99, DOI 10.1002/ajmg.b.20124; Gothelf D, 2007, AM J PSYCHIAT, V164, P663, DOI 10.1176/appi.ajp.164.4.663; Gothelf D, 2014, BIOL PSYCHIAT, V75, P406, DOI 10.1016/j.biopsych.2013.07.021; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Hiramoto T, 2011, HUM MOL GENET, V20, P4775, DOI 10.1093/hmg/ddr404; Ho JS, 2012, AUTISM RES, V5, P407, DOI 10.1002/aur.1252; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jolin EM, 2009, J AFFECT DISORDERS, V119, P177, DOI 10.1016/j.jad.2009.02.016; Jonas RK, 2013, BIOLOGICAL PSYCHIATR, P1; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kates WR, 2007, AM J MED GENET A, V143A, P2642, DOI 10.1002/ajmg.a.32012; Kikinis Z, 2012, SCHIZOPHR RES, V141, P35, DOI 10.1016/j.schres.2012.06.032; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Li Y, 2011, PSYCHIAT RES, V187, P457, DOI 10.1016/j.psychres.2010.04.019; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Maynard TM, 2008, MOL CELL NEUROSCI, V39, P439, DOI 10.1016/j.mcn.2008.07.027; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; McGlashan TH, 2001, EARLY INTERVENTION P, P135, DOI DOI 10.1007/978-94-010-0892-1_7; McKernan DP, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.37; Mikhail FM, 2011, AM J MED GENET A, V155A, P2386, DOI 10.1002/ajmg.a.34177; Morgan JT, 2012, BRAIN RES, V1456, P72, DOI 10.1016/j.brainres.2012.03.036; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Niklasson L, 2001, GENET MED, V3, P79, DOI 10.1097/00125817-200101000-00017; Niklasson L, 2009, RES DEV DISABIL, V30, P763, DOI 10.1016/j.ridd.2008.10.007; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Nott A, 2013, NAT NEUROSCI, V16, P1163, DOI 10.1038/nn.3506; Paemka L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080737; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Pasternak O, 2012, J NEUROSCI, V32, P17365, DOI 10.1523/JNEUROSCI.2904-12.2012; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prata DP, 2009, BIOL PSYCHIAT, V65, P473, DOI 10.1016/j.biopsych.2008.09.027; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Radoeva PD, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-38; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Schneider M, 2014, AM J PSYCHIAT; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shaikh TH, 2007, GENOME RES, V17, P482, DOI 10.1101/gr.5986507; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Toritsuka M, 2013, P NATL ACAD SCI USA, V110, P17552, DOI 10.1073/pnas.1312661110; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; van Beveren NJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033473; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Vorstman JAS, 2013, SCHIZOPHR RES, V143, P55, DOI 10.1016/j.schres.2012.10.010; Williams NM, 2008, HUM MOL GENET, V17, P555, DOI 10.1093/hmg/ddm330; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yoo HJ, 2013, J KOREAN MED SCI, V28, P1403, DOI 10.3346/jkms.2013.28.9.1403; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	99	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132542	10.1371/journal.pone.0132542	http://dx.doi.org/10.1371/journal.pone.0132542			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26201030	gold, Green Published, Green Submitted			2022-12-26	WOS:000358597100039
J	Yamauchi, S; Takeuchi, K; Chihara, K; Sun, XD; Honjoh, C; Yoshiki, H; Hotta, H; Sada, K				Yamauchi, Shota; Takeuchi, Kenji; Chihara, Kazuyasu; Sun, Xuedong; Honjoh, Chisato; Yoshiki, Hatsumi; Hotta, Hak; Sada, Kiyonao			Hepatitis C Virus Particle Assembly Involves Phosphorylation of NS5A by the c-Abl Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5A; DIFFERENTIAL PHOSPHORYLATION; RNA REPLICATION; CORE PROTEIN; LIFE-CYCLE; SRC FAMILY; BINDING; CANCER; DOMAIN; ASSOCIATION	Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is thought to regulate the replication of viral RNA and the assembly of virus particles in a serine/threonine phosphorylation-dependent manner. However, the host kinases that phosphorylate NS5A have not been fully identified. Here, we show that HCV particle assembly involves the phosphorylation of NS5A by the c-Abl tyrosine kinase. Pharmacological inhibition or knockdown of c-Abl reduces the production of infectious HCV (J6/JFH1) particles in Huh-7.5 cells without markedly affecting viral RNA translation and replication. NS5A is tyrosine-phosphorylated in HCV-infected cells, and this phosphorylation is also reduced by the knockdown of c-Abl. Mutational analysis reveals that NS5A tyrosine phosphorylation is dependent, at least in part, on Tyr(330) (Tyr(2306) in polyprotein numbering). Mutation of this residue to phenylalanine reduces the production of infectious HCV particles but does not affect the replication of the JFH1 subgenomic replicon. These findings suggest that c-Abl promotes HCV particle assembly by phosphorylating NS5A at Tyr(330).	[Yamauchi, Shota; Takeuchi, Kenji; Chihara, Kazuyasu; Sun, Xuedong; Honjoh, Chisato; Yoshiki, Hatsumi; Sada, Kiyonao] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Genome Sci & Microbiol, Fukui 9101193, Japan; [Honjoh, Chisato] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 9101193, Japan; [Yamauchi, Shota; Takeuchi, Kenji; Chihara, Kazuyasu; Sada, Kiyonao] Univ Fukui, Org Life Sci Adv Programs, Fukui 9101193, Japan; [Hotta, Hak] Kobe Univ, Grad Sch Med, Div Microbiol, Kobe, Hyogo 6500017, Japan	University of Fukui; University of Fukui; University of Fukui; Kobe University	Sada, K (corresponding author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Genome Sci & Microbiol, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan.	ksada@u-fukui.ac.jp	Sada, Kiyonao/H-7373-2015	Sada, Kiyonao/0000-0001-6124-3100	Japan Society for the Promotion of Science (JSPS) [15K19021, 25460383]; Research and Education Program for Life Science at the University of Fukui; Yakult Honsha Co., Ltd.	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research and Education Program for Life Science at the University of Fukui; Yakult Honsha Co., Ltd.	This work was supported by KAKENHI Grants 15K19021 (to S. Y.) and 25460383 (to K. S.) from the Japan Society for the Promotion of Science (JSPS), a grant from the Research and Education Program for Life Science at the University of Fukui (to S. Y.), and a grant from Yakult Honsha Co., Ltd. (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Baugh JM, 2013, ANTIVIR RES, V100, P555, DOI 10.1016/j.antiviral.2013.09.020; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Colpitts CC, 2015, BBA-PROTEINS PROTEOM, V1854, P1657, DOI 10.1016/j.bbapap.2015.04.011; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; deLemos AS, 2014, TRENDS MOL MED, V20, P315, DOI 10.1016/j.molmed.2014.02.002; Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Dubuisson J, 2014, J HEPATOL, V61, pS3, DOI 10.1016/j.jhep.2014.06.031; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Furlan A, 2011, CELL DEATH DIFFER, V18, P1608, DOI 10.1038/cdd.2011.23; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Inubushi S, 2008, J GEN VIROL, V89, P1231, DOI 10.1099/vir.0.83510-0; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Nakashima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046634; Okuda K, 2001, BLOOD, V97, P2440, DOI 10.1182/blood.V97.8.2440; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Reed KE, 1998, J VIROL, V72, P6199, DOI 10.1128/JVI.72.7.6199-6206.1998; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Ross-Thriepland D, 2013, J GEN VIROL, V94, P1009, DOI 10.1099/vir.0.050633-0; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Suzuki T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00038; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Yamauchi S, 2014, J CELL BIOL, V204, P1191, DOI 10.1083/jcb.201309107; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	57	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21857	21864		10.1074/jbc.M115.666859	http://dx.doi.org/10.1074/jbc.M115.666859			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26203192	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000360968500008
J	Chen, C; Shrestha, R; Jia, K; Gao, PF; Geisbrecht, BV; Bossmann, SH; Shi, JS; Li, P				Chen, Chao; Shrestha, Ruben; Jia, Kaimin; Gao, Philip F.; Geisbrecht, Brian V.; Bossmann, Stefan H.; Shi, Jishu; Li, Ping			Characterization of Dye-decolorizing Peroxidase (DyP) from Thermomonospora curvata Reveals Unique Catalytic Properties of A-type DyPs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; BASIDIOMYCETE PHANEROCHAETE-CHRYSOSPORIUM; SUBSTRATE-INTERACTION-SITES; EXTRACELLULAR HEME ENZYME; RHODOCOCCUS-JOSTII RHA1; HORSERADISH-PEROXIDASE; MANGANESE PEROXIDASE; LIGNIN PEROXIDASE; SPECTRAL CHARACTERIZATION; HYDROGEN-PEROXIDE	Dye-decolorizing peroxidases (DyPs) comprise a new family of heme peroxidases, which has received much attention due to their potential applications in lignin degradation. A new DyP from Thermomonospora curvata (TcDyP) was identified and characterized. Unlike other A-type enzymes, TcDyP is highly active toward a wide range of substrates including model lignin compounds, in which the catalytic efficiency with ABTS (k(cat)(app)/K-m(app) = (1.7 x 10(7)) M-1 s(-1)) is close to that of fungal DyPs. Stopped-flow spectroscopy was employed to elucidate the transient intermediates as well as the catalytic cycle involving wildtype (wt) and mutant TcDyPs. Although residues Asp(220) and Arg(327) are found necessary for compound I formation, His(312) is proposed to play roles in compound II reduction. Transient kinetics of hydroquinone (HQ) oxidation by wt-TcDyP showed that conversion of the compound II to resting state is a rate-limiting step, which will explain the contradictory observation made with the aspartate mutants of A-type DyPs. Moreover, replacement of His(312) and Arg(327) has significant effects on the oligomerization and redox potential (E degrees') of the enzyme. Both mutants were found to promote the formation of dimeric state and to shift E degrees' to a more negative potential. Not only do these results reveal the unique catalytic property of the A-type DyPs, but they will also facilitate the development of these enzymes as lignin degraders.	[Chen, Chao; Shrestha, Ruben; Jia, Kaimin; Bossmann, Stefan H.; Li, Ping] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA; [Geisbrecht, Brian V.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Shi, Jishu] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Gao, Philip F.] Univ Kansas, Prot Prod Grp, Lawrence, KS 66045 USA	Kansas State University; Kansas State University; Kansas State University; University of Kansas	Li, P (corresponding author), Kansas State Univ, CB 213, Manhattan, KS 66506 USA.	pli@ksu.edu	Shi, Jishu/AAJ-3664-2021; Regan, Clinton/E-6250-2012; Bossmann, Stefan/AAG-9881-2020	Chen, Chao/0000-0003-1028-3182	National Institutes of Health [P30GM110761]; Johnson Cancer Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Cancer Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant P30GM110761 and the Johnson Cancer Research Center. The authors declare that they have no conflicts of interest with the contents of this article.	Adak S, 1996, BIOCHEM J, V314, P985, DOI 10.1042/bj3140985; Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Baciocchi E, 2002, TETRAHEDRON, V58, P8087, DOI 10.1016/S0040-4020(02)00997-3; Banci L, 2003, J BIOL INORG CHEM, V8, P751, DOI 10.1007/s00775-003-0476-1; Banerjee S, 2010, BIOFUEL BIOPROD BIOR, V4, P77, DOI 10.1002/bbb.188; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y; Brown ME, 2011, J AM CHEM SOC, V133, P18006, DOI 10.1021/ja203972q; Chertkov O, 2011, STAND GENOMIC SCI, V4, P13, DOI 10.4056/sigs.1453580; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; CHOUDHURY K, 1994, J BIOL CHEM, V269, P20239; Colpa DI, 2014, J IND MICROBIOL BIOT, V41, P1, DOI 10.1007/s10295-013-1371-6; Dunford H. B., 2010, PEROXIDASES CATALASE; Efimov I, 2011, J AM CHEM SOC, V133, P15376, DOI 10.1021/ja2007017; FENNINGTON G, 1984, APPL ENVIRON MICROB, V47, P201, DOI 10.1128/AEM.47.1.201-204.1984; Fernandez-Fueyo E, 2012, J BIOL CHEM, V287, P16903, DOI 10.1074/jbc.M112.356378; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Hiner ANP, 2001, EUR J BIOCHEM, V268, P3091, DOI 10.1046/j.1432-1327.2001.02208.x; Johjima T, 2003, APPL MICROBIOL BIOT, V61, P220, DOI 10.1007/s00253-003-1236-4; Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029; Koua D, 2009, NUCLEIC ACIDS RES, V37, pD261, DOI 10.1093/nar/gkn680; Kroppenstedt RM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P682, DOI 10.1007/0-387-30743-5_27; KUAN IC, 1993, J BIOL CHEM, V268, P20064; LAMAR GN, 1992, BIOCHEMISTRY-US, V31, P9158, DOI 10.1021/bi00153a007; Li J, 2012, APPL BIOCHEM BIOTECH, V166, P774, DOI 10.1007/s12010-011-9466-x; Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7; Linde D, 2015, BIOCHEM J, V466, P253, DOI 10.1042/BJ20141211; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; Mcllvaine T. C., 1921, J BIOL CHEM, V49, P183; Min K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08245; MINO Y, 1988, J BIOL CHEM, V263, P7029; Morales M, 2012, J BIOL CHEM, V287, P41053, DOI 10.1074/jbc.M112.405548; Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09; Paliwal R, 2012, APPL BIOCHEM BIOTECH, V167, P1865, DOI 10.1007/s12010-012-9735-3; Petruccioli M, 2009, J BIOL INORG CHEM, V14, P1153, DOI 10.1007/s00775-009-0559-8; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; RENGANATHAN V, 1986, BIOCHEMISTRY-US, V25, P1626, DOI 10.1021/bi00355a027; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023; Sambrook J., 2006, CONDENSED PROTOCOLS; Santos A, 2014, APPL MICROBIOL BIOT, V98, P2053, DOI 10.1007/s00253-013-5041-4; Santucci R, 2000, BIOCHEM J, V349, P85, DOI 10.1042/0264-6021:3490085; SCHONBAUM GR, 1972, J BIOL CHEM, V247, P3353; Sezer M, 2013, BIOCHEMISTRY-US, V52, P3074, DOI 10.1021/bi301630a; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strittmatter E, 2015, ARCH BIOCHEM BIOPHYS, V574, P75, DOI 10.1016/j.abb.2014.12.016; Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176; STUTZENBERGER FJ, 1979, BIOTECHNOL BIOENG, V21, P909, DOI 10.1002/bit.260210514; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Sugano Y, 2009, BIODEGRADATION, V20, P433, DOI 10.1007/s10532-008-9234-y; ten Have R, 2001, CHEM REV, V101, P3397, DOI 10.1021/cr000115l; Tien M, 1997, J BIOL CHEM, V272, P8912; Torres E, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P1, DOI 10.1007/978-3-642-12627-7; van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x; VITELLO LB, 1993, BIOCHEMISTRY-US, V32, P9807, DOI 10.1021/bi00088a036; Wang WC, 1999, BIOCHEM J, V340, P329, DOI 10.1042/0264-6021:3400329; WARIISHI H, 1988, BIOCHEMISTRY-US, V27, P5365, DOI 10.1021/bi00414a061; Wei K, 2004, J MOL STRUC-THEOCHEM, V712, P197, DOI 10.1016/j.theochem.2004.10.032; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966; Zhang Z, 2002, ANAL CHEM, V74, P163, DOI 10.1021/ac010701u; Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673	70	72	72	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23447	23463		10.1074/jbc.M115.658807	http://dx.doi.org/10.1074/jbc.M115.658807			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26205819	Green Published, hybrid			2022-12-26	WOS:000361685500048
J	Dynnik, VV; Kononov, AV; Sergeev, AI; Teplov, IY; Tankanag, AV; Zinchenko, VP				Dynnik, Vladimir V.; Kononov, Alexey V.; Sergeev, Alexander I.; Teplov, Iliya Y.; Tankanag, Arina V.; Zinchenko, Valery P.			To Break or to Brake Neuronal Network Accelerated by Ammonium Ions?	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; HEPATIC-ENCEPHALOPATHY; NMDA RECEPTORS; SPINAL-CORD; N-ACETYLASPARTYLGLUTAMATE; PRIMARY CULTURES; LIVER-FAILURE; L-CARNITINE; IN-VITRO; RAT	Purpose The aim of present study was to investigate the effects of ammonium ions on in vitro neuronal network activity and to search alternative methods of acute ammonia neurotoxicity prevention. Methods Rat hippocampal neuronal and astrocytes co-cultures in vitro, fluorescent microscopy and perforated patch clamp were used to monitor the changes in intracellular Ca2+- and membrane potential produced by ammonium ions and various modulators in the cells implicated in neural networks. Results Low concentrations of NH4Cl (0.1-4 mM) produce short temporal effects on network activity. Application of 5-8 mM NH4Cl: invariably transforms diverse network firing regimen to identical burst patterns, characterized by substantial neuronal membrane depolarization at plateau phase of potential and high-amplitude Ca2+-oscillations; raises frequency and average for period of oscillations Ca2+-level in all cells implicated in network; results in the appearance of group of "run out" cells with high intracellular Ca2+ and steadily diminished amplitudes of oscillations; increases astrocyte Ca2+-signalling, characterized by the appearance of groups of cells with increased intracellular Ca2+-level and/or chaotic Ca2+-oscillations. Accelerated network activity may be suppressed by the blockade of NMDA or AMPA/kainate-receptors or by overactivation of AMPA/kainite-receptors. Ammonia still activate neuronal firing in the presence of GABA(A) receptors antagonist bicuculline, indicating that "disinhibition phenomenon" is not implicated in the mechanisms of networks acceleration. Network activity may also be slowed down by glycine, agonists of metabotropic inhibitory receptors, betaine, L-carnitine, L-arginine, etc. Conclusions Obtained results demonstrate that ammonium ions accelerate neuronal networks firing, implicating ionotropic glutamate receptors, having preserved the activities of group of inhibitory ionotropic and metabotropic receptors. This may mean, that ammonia neurotoxicity might be prevented by the activation of various inhibitory receptors (i.e. by the reinforcement of negative feedback control), instead of application of various enzyme inhibitors and receptor antagonists (breaking of neural, metabolic and signaling systems).	[Dynnik, Vladimir V.; Kononov, Alexey V.; Sergeev, Alexander I.; Teplov, Iliya Y.; Tankanag, Arina V.; Zinchenko, Valery P.] Russian Acad Sci, Inst Cell Biophys, Lab Intracellular Signaling, Pushchino 142292, Russia; [Dynnik, Vladimir V.] Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Bioenerget, Pushchino 142292, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Dynnik, VV (corresponding author), Russian Acad Sci, Inst Cell Biophys, Lab Intracellular Signaling, Pushchino 142292, Russia.	dynnik@rambler.ru	Tankanag, Arina/D-7222-2012; Teplov, Ilia Y./C-7050-2015	Tankanag, Arina/0000-0002-9538-1939; Teplov, Ilia Y./0000-0001-8333-2294	Russian Foundation of Basic Research [14-04-01597, 14-0401695]; Russian Science Foundation [14-14-00989]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Foundation of Basic Research (http://www.rfbr.ru/rffi/ru/) (projects No 14-04-01597, 14-0401695) and the Russian Science Foundation (http://www.rscf.ru/) (projects No 14-14-00989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahboucha S, 2012, NEUROCHEM INT, V60, P707, DOI 10.1016/j.neuint.2011.10.003; Al Sibae Mohamad Rasm, 2009, Ther Clin Risk Manag, V5, P617; Arnsten Amy F. T., 2012, Yale Journal of Biology and Medicine, V85, P45; BASILE AS, 1991, PHARMACOL REV, V43, P27; Bergeron R, 2005, NEUROPSYCHOPHARMACOL, V30, P7, DOI 10.1038/sj.npp.1300559; Bosoi CR, 2014, J HEPATOL, V60, P554, DOI 10.1016/j.jhep.2013.10.011; Braissant O, 2013, J INHERIT METAB DIS, V36, P595, DOI 10.1007/s10545-012-9546-2; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; BRUSILOW SW, 1986, NEW ENGL J MED, V314, P786; Butterworth RF, 2002, METAB BRAIN DIS, V17, P221, DOI 10.1023/A:1021989230535; Butterworth RF, 2010, NEUROCHEM INT, V57, P383, DOI 10.1016/j.neuint.2010.03.012; Calligaris L, 2013, PEDIATR ANESTH, V23, P202, DOI 10.1111/pan.12088; Cauli O, 2014, NEUROMOL MED, V16, P360, DOI 10.1007/s12017-013-8283-5; Cauli O, 2009, METAB BRAIN DIS, V24, P69, DOI 10.1007/s11011-008-9115-4; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; Chu CJ, 2006, J GASTROEN HEPATOL, V21, P1194, DOI 10.1111/j.1440-1746.2006.04310.x; COLOMBO JP, 1971, MONOGR PAEDIATRICA, V1, P1; Darbon P, 2002, J NEUROPHYSIOL, V88, P1461, DOI 10.1152/jn.2002.88.3.1461; Darbon P, 2002, EUR J NEUROSCI, V15, P671, DOI 10.1046/j.1460-9568.2002.01904.x; Eck NV, 1877, VOEN MED J, V130, P1; FALCHETTO S, 1971, CAN J PHYSIOL PHARM, V49, P1, DOI 10.1139/y71-001; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Fisher SK, 2010, J PHYSIOL-LONDON, V588, P3355, DOI 10.1113/jphysiol.2010.190777; Fricker AC, 2009, NEUROPHARMACOLOGY, V56, P1060, DOI 10.1016/j.neuropharm.2009.03.002; Gerova A, 2004, PHYSIOL RES, V53, P357; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Gonzalez-Usano A, 2013, J NEUROCHEM, V125, P133, DOI 10.1111/jnc.12119; Granata AR, 2001, NEUROSCI LETT, V300, P49, DOI 10.1016/S0304-3940(00)01673-6; Haack N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105832; Haussinger D, 2010, CURR OPIN CLIN NUTR, V13, P87, DOI 10.1097/MCO.0b013e328333b829; Hahn M, 1893, ARCH EXP PATHOL PH, V32, P161; HAWKINS RA, 1973, BIOCHEM J, V134, P1001, DOI 10.1042/bj1341001; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; Hertz L, 2015, NEUROCHEM RES, V40, P241, DOI 10.1007/s11064-014-1352-9; HINDFELT B, 1971, SCAND J CLIN LAB INV, V28, P365, DOI 10.3109/00365517109095711; ILES JF, 1980, BRAIN, V103, P555, DOI 10.1093/brain/103.3.555; Imre G, 2007, CNS DRUG REV, V13, P444; Izumi Y, 2013, NEUROSCIENCE, V233, P166, DOI 10.1016/j.neuroscience.2012.12.035; JANIRI L, 1991, J NEURAL TRANSM-GEN, V86, P135, DOI 10.1007/BF01250574; Jayakumar AR, 2014, J NEUROCHEM, V128, P890, DOI 10.1111/jnc.12516; Jayakumar AR, 2009, J NEUROCHEM, V109, P252, DOI 10.1111/j.1471-4159.2009.05842.x; Kelly T, 2005, PFLUG ARCH EUR J PHY, V451, P418, DOI 10.1007/s00424-005-1483-6; Kelly T, 2006, J NEUROPHYSIOL, V96, P2342, DOI 10.1152/jn.01269.2005; Kelly T, 2009, GLIA, V57, P921, DOI 10.1002/glia.20817; Kircheis G, 2002, METAB BRAIN DIS, V17, P453, DOI 10.1023/A:1021934607762; Kleiman-Weiner M, 2009, J NEUROPHYSIOL, V102, P203, DOI 10.1152/jn.91158.2008; KLOIBER O, 1988, TOXICOLOGY, V49, P83, DOI 10.1016/0300-483X(88)90178-3; Kononov AV, 2013, RECEPTORS INTRACELLU, P275; KOSENKO E, 1995, NEUROCHEM RES, V20, P451, DOI 10.1007/BF00973101; Kosenko EA, 1995, B EXP BIOL MED+, V120, P1111, DOI 10.1007/BF02445478; Langer SZ, 2008, NEUROCHEM INT, V52, P26, DOI 10.1016/j.neuint.2007.04.031; Lee CR, 2007, J NEUROSCI, V27, P6531, DOI 10.1523/JNEUROSCI.1678-07.2007; Legrand JC, 2004, EUR J NEUROSCI, V19, P521, DOI 10.1111/j.0953-816X.2003.03143.x; Lin BJ, 2007, J PHYSIOL-LONDON, V582, P163, DOI 10.1113/jphysiol.2006.125963; LUX HD, 1971, SCIENCE, V173, P555, DOI 10.1126/science.173.3996.555; MANZONI OJ, 1995, NEUROPHARMACOLOGY, V34, P965, DOI 10.1016/0028-3908(95)00060-J; MARCAIDA G, 1992, FEBS LETT, V296, P67, DOI 10.1016/0014-5793(92)80404-5; Marchetti C, 2002, EUR J NEUROSCI, V15, P975, DOI 10.1046/j.1460-9568.2002.01927.x; Masuda A, 1998, BRAIN RES, V807, P70, DOI 10.1016/S0006-8993(98)00737-9; McDERMOTT W V Jr, 1958, Bull N Y Acad Med, V34, P357; Minana MD, 1996, J PHARMACOL EXP THER, V279, P194; Mitchell VA, 2011, NEUROPSYCHOPHARMACOL, V36, P1801, DOI 10.1038/npp.2011.59; Neale SA, 2006, J PHYSIOL-LONDON, V577, P659, DOI 10.1113/jphysiol.2006.119073; Nencki M, 1896, ARCH EXP PATHOL PH, V37, P26; Nencki M, 1895, ARCH EXP PATHOL PHAR, V36, P385; Nguyen JH, 2012, NEUROCHEM INT, V60, P676, DOI 10.1016/j.neuint.2011.10.012; NICOLL RA, 1978, J PHYSIOL-LONDON, V283, P121, DOI 10.1113/jphysiol.1978.sp012491; OCONNOR JE, 1990, ADV EXP MED BIOL, V272, P183; OCONNOR JE, 1984, FEBS LETT, V166, P331, DOI 10.1016/0014-5793(84)80106-4; Onativia J, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046017; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Pflieger JF, 2002, BRAIN RES, V935, P81, DOI 10.1016/S0006-8993(02)02469-1; RAABE W, 1975, J NEUROPHYSIOL, V38, P347, DOI 10.1152/jn.1975.38.2.347; Rose C, 2005, J BIOL CHEM, V280, P20937, DOI 10.1074/jbc.M412448200; Rose CF, 2012, CLIN PHARMACOL THER, V92, P321, DOI 10.1038/clpt.2012.112; Sanchez-Blazquez P, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00169; Schwarz CS, 2012, EXP NEUROL, V235, P368, DOI 10.1016/j.expneurol.2012.02.019; SHERLOCK S, 1961, GASTROENTEROLOGY, V41, P1; Smith MD, 2008, EPILEPSY RES, V79, P6, DOI 10.1016/j.eplepsyres.2007.12.009; SNODGRASS SR, 1990, FASEB J, V4, P2755; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Stauffer VL, 2014, J CLIN PSYCHOPHARM, V34, P552, DOI 10.1097/JCP.0000000000000187; Sturgeon JP, 2014, EXPERT REV GASTROENT, V8, P83, DOI 10.1586/17474124.2014.858598; Tankanag A.V., 2013, MED PHYS, P85; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Turovskaya MV, 2012, NEUROSCI LETT, V516, P151, DOI 10.1016/j.neulet.2012.03.084; Turovsky EA, 2012, BIOCHEM MOSC SUPPL S, V6, P35, DOI 10.1134/S1990747811060158; Turovsky EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063483; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Walder KK, 2013, EUR J NEUROSCI, V37, P118, DOI 10.1111/ejn.12027; Wang F, 2015, ACTA PHYSIOL, V214, P261, DOI 10.1111/apha.12500; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; WARREN KS, 1964, J LAB CLIN MED, V64, P442; Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Xu TL, 2010, PROG NEUROBIOL, V91, P349, DOI 10.1016/j.pneurobio.2010.04.008; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Zuidema G D, 1964, Major Probl Clin Surg, V1, P102	99	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134145	10.1371/journal.pone.0134145	http://dx.doi.org/10.1371/journal.pone.0134145			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217943	Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900088
J	Hansen, R; Scott, KP; Khan, S; Martin, JC; Berry, SH; Stevenson, M; Okpapi, A; Munro, MJ; Hold, GL				Hansen, Richard; Scott, Karen P.; Khan, Shoaib; Martin, Jenny C.; Berry, Susan H.; Stevenson, Matthew; Okpapi, Augusta; Munro, Michael J.; Hold, Georgina L.			First-Pass Meconium Samples from Healthy Term Vaginally-Delivered Neonates: An Analysis of the Microbiota	PLOS ONE			English	Article							BACTERIA; BIFIDOBACTERIUM; PRETERM; MILK	Background Considerable effort has been made to categorise the bacterial composition of the human gut and correlate findings with gastrointestinal disease. The infant gut has long been considered sterile at birth followed by rapid colonisation; however, this view has recently been challenged. We examined first-pass meconium from healthy term infants to confirm or refute sterility. Methods Healthy mothers were approached following vaginal delivery. First-pass meconium stools within 24 hours of delivery were obtained from healthy, breastfed infants with tight inclusion/exclusion criteria including rejecting any known antibiotic exposure-mother within 7 days preceding delivery or infant after birth. Stools were processed in triplicate for fluorescent insitu hybridisation (FISH) with 16S rRNA-targeted probes including Bifidobacterium; Bacteroides- Prevotella; Lactobacillaceae/Enterococcaceae; Enterobacteriaceae; Streptococcaceae; Staphylococcaceae and Enterococcaceae. Absolute counts of all bacteria and proportional identification of each bacterial group were calculated. Confirmation of bacterial presence by PCR was undertaken on FISH-positive samples. Results The mothers of 31 newborn infants were recruited, 15 met inclusion/exclusion criteria and provided a sample within 24 hours of birth, processed in the lab within 4 hours. All babies were 37-40 weeks gestation. 8/15 were male, mean birth weight was 3.4kg and mean maternal age was 32 years. Meconium samples from 10/15 (66%) infants had evidence of bacteria based on FISH analysis. Of these, PCR was positive in only 1. Positive FISH counts ranged from 2.2-41.8 x 10(4) cells/g with a mean of 15.4 x 10(4) cells/g. (The limit of detection for automated counting is 106 cells/g). Cell counts were too low to allow formal diversity analysis. Amplification by PCR was not possible despite positive spiked samples demonstrating the feasibility of reaction. One baby was dominated by Enterobacteriaceae. The others contained 2-5 genera, with Bifidobacterium, Enterobacteriaceae, Enterococcaceae and Bacteroides-Prevotella the most prevalent. There was no association between bacterial counts and rupture of membrane duration, time to passage of meconium or time to lab. Conclusion This study provides evidence that low numbers of bacteria are present in first-pass meconium samples from healthy, vaginally-delivered, breastfed term infants. Only two-thirds of meconium samples had detectable bacteria, though at levels too low for automated counting or for reliable confirmation by PCR. This study suggests that gut bacterial colonisation is extremely limited at birth and occurs rapidly thereafter.	[Hansen, Richard; Khan, Shoaib; Okpapi, Augusta; Munro, Michael J.] Aberdeen Matern Hosp, Dept Neonatol, Aberdeen, Scotland; [Hansen, Richard; Berry, Susan H.; Stevenson, Matthew; Hold, Georgina L.] Univ Aberdeen, Gastrointestinal Res Grp, Aberdeen, Scotland; [Scott, Karen P.; Martin, Jenny C.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Hold, GL (corresponding author), Univ Aberdeen, Gastrointestinal Res Grp, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Scott, Karen/ABD-5484-2021; Hold, Georgina Louise/AAG-9923-2020	Scott, Karen/0000-0002-4608-0013; Hold, Georgina Louise/0000-0001-7573-3397; Hansen, Richard/0000-0002-3944-6646	NHS Grampian Neonatal Endowments; Rural and Environmental Science and Analytical Services programme of the Scottish Government	NHS Grampian Neonatal Endowments; Rural and Environmental Science and Analytical Services programme of the Scottish Government	This work was funded from NHS Grampian Neonatal Endowments. The Rowett Institute receives funding from the Rural and Environmental Science and Analytical Services programme of the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Bekkali N, 2008, ARCH DIS CHILD-FETAL, V93, pF376, DOI 10.1136/adc.2008.138024; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Gey A, 2013, J VET DIAGN INVEST, V25, P386, DOI 10.1177/1040638713486113; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Hold GL, 2003, APPL ENVIRON MICROB, V69, P4320, DOI 10.1128/AEM.69.7.4320-4324.2003; Hu JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078257; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005	22	98	108	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133320	10.1371/journal.pone.0133320	http://dx.doi.org/10.1371/journal.pone.0133320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218283	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000358595900026
J	Jung, YS; Lim, J; Jung, KW; Ryu, J; Won, YJ				Jung, Yuh-S; Lim, Jiwon; Jung, Kyu-Won; Ryu, Junsun; Won, Young-Joo			Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010)	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; PRIMARY TUMORS; UNITED-STATES; RISK-FACTORS; TRENDS; ASSOCIATION; PREVALENCE	Second primary malignancy (SPM) is the major long-term cause of patient mortality with head and neck squamous cell carcinoma (HNSCC). As the incidence of high-risk human papillomavirus (HPV)-related HNSCC is increasing globally, we analyzed the patterns of SPM occurrence, the effect of the index tumor site along with attributes to HPV, and the effect of SPM on survival in South Korean patients with head and neck cancer (HNC). Data were retrieved from the Korea Central Cancer Registry, a nationwide population-based cancer registry, from 1993 to 2010. Standardized incidence ratios were analyzed and compared between index tumor sites, particularly oropharyngeal vs. non-oropharyngeal sites. After adjustment for competing risks, 3- and 5-year SPM rates were calculated using the cumulative incidence function. The effects of SPM occurrence on overall survival (OS) were then analyzed. SPM rates were significantly lower for HPV-attributable oropharyngeal sites than for non-oropharyngeal sites, such as the larynx and hypopharynx (p<0.001). SPM rates were also lower for oral cavity first primary sites than for non-oropharyngeal first primary sites (p<0.001). SPMs typically occurred in the esophagus, lungs and the head and neck. Uterine cervical cancers occurred significantly more frequently after index oropharyngeal cancer in women. The 5-year and 10-year OS rates were 57.8 and 45.7% in all HNC patients, respectively. The OS after SPM occurrence was poor (5-year, 31.8%; 10-year, 20.8%) compared to after index HNC occurrence (5-year, 68.4%; 10-year, 41.2%). SPM occurrence in the esophagus and lung/bronchus showed a worse OS than SPM localized to the head and neck. South Korean HNC patient, the first primary cancer site affected SPM risk and distribution. The 5- and 10-year OS rates deteriorated after SPM occurrence, particularly in the esophagus and lungs. Further optimization of follow-up strategies for effective surveillance of SPM, particularly in the esophagus and lungs, is warranted.	[Jung, Yuh-S; Ryu, Junsun] Natl Canc Ctr, Res Inst & Hosp, Ctr Thyroid Canc, Specif Organs Canc Branch,Dept Otolaryngol, Goyang, South Korea; [Lim, Jiwon; Jung, Kyu-Won; Won, Young-Joo] Natl Canc Ctr, Canc Registrat & Stat Branch, Div Canc Registrat & Surveillance, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Won, YJ (corresponding author), Natl Canc Ctr, Canc Registrat & Stat Branch, Div Canc Registrat & Surveillance, Goyang, South Korea.	astra67@ncc.re.kr		Lim, Jiwon/0000-0002-3322-7792; Ryu, Junsun/0000-0002-6730-6755	National Cancer Center Grant [NCC-1310220]	National Cancer Center Grant	This work was supported by the National Cancer Center Grant (NCC-1310220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2012, CANCER-AM CANCER SOC, V118, P5783, DOI 10.1002/cncr.27609; Biron VL, 2011, J OTOLARYNGOL-HEAD N, V40, pS65, DOI 10.2310/7070.2010.100093; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Erkal HS, 2001, J CLIN ONCOL, V19, P1358, DOI 10.1200/JCO.2001.19.5.1358; Fritz AG, 2000, INTERNATIONAL CLASSI; Gan SJ, 2013, CANCER-AM CANCER SOC, V119, P2593, DOI 10.1002/cncr.28107; Garavello W, 2006, ARCH OTOLARYNGOL, V132, P762, DOI 10.1001/archotol.132.7.762; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Jain KS, 2013, CANCER-AM CANCER SOC, V119, P1832, DOI 10.1002/cncr.27988; Johnson-Obaseki S, 2012, OTOLARYNG HEAD NECK, V147, P74, DOI 10.1177/0194599812437332; JONES AS, 1995, CANCER, V75, P1343, DOI 10.1002/1097-0142(19950315)75:6<1343::AID-CNCR2820750617>3.0.CO;2-T; Joseph AW, 2013, ORAL ONCOL, V49, P244, DOI 10.1016/j.oraloncology.2012.09.009; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; Leon X, 1999, HEAD NECK-J SCI SPEC, V21, P204, DOI 10.1002/(SICI)1097-0347(199905)21:3<204::AID-HED4>3.0.CO;2-7; Lozza V, 2014, ARCH GYNECOL OBSTET, V290, P375, DOI 10.1007/s00404-014-3187-7; Meyer MF, 2014, ORAL ONCOL, V50, P27, DOI 10.1016/j.oraloncology.2013.10.009; Morris LGT, 2011, J CLIN ONCOL, V29, P739, DOI 10.1200/JCO.2010.31.8311; PANOSETTI E, 1989, LARYNGOSCOPE, V99, P1267; Park WS, 2012, HEAD NECK-J SCI SPEC, V34, P1408, DOI 10.1002/hed.21939; Peck BW, 2013, HEAD NECK-J SCI SPEC, V35, P794, DOI 10.1002/hed.23033; Roeser MM, 2010, LARYNGOSCOPE, V120, pS181, DOI 10.1002/lary.21645; SCHWARTZ LH, 1994, CANCER, V74, P1933, DOI 10.1002/1097-0142(19941001)74:7<1933::AID-CNCR2820740718>3.0.CO;2-X; Shin A, 2013, LARYNGOSCOPE, V123, pE30, DOI 10.1002/lary.24243; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Singhi AD, 2012, HEAD NECK-J SCI SPEC, V34, P213, DOI 10.1002/hed.21714; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; STURGIS EM, 1995, ANN OTO RHINOL LARYN, V104, P946, DOI 10.1177/000348949510401206; Tiwana MS, 2014, LARYNGOSCOPE, V124, P2287, DOI 10.1002/lary.24719; VIKRAM B, 1984, ARCH OTOLARYNGOL, V110, P564	30	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134160	10.1371/journal.pone.0134160	http://dx.doi.org/10.1371/journal.pone.0134160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218068	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900089
J	Robles-Rubio, CA; Bertolizio, G; Brown, KA; Kearney, RE				Robles-Rubio, Carlos Alejandro; Bertolizio, Gianluca; Brown, Karen A.; Kearney, Robert E.			Scoring Tools for the Analysis of Infant Respiratory Inductive Plethysmography Signals	PLOS ONE			English	Article							QUALITATIVE DIAGNOSTIC CALIBRATION; FORMER PRETERM INFANTS; POSTOPERATIVE APNEA; GENERAL-ANESTHESIA; PREMATURE-INFANTS; SLEEP; OBSTRUCTION; AGREEMENT; EVENTS; RISK	Infants recovering from anesthesia are at risk of life threatening Postoperative Apnea (POA). POA events are rare, and so the study of POA requires the analysis of long cardiorespiratory records. Manual scoring is the preferred method of analysis for these data, but it is limited by low intra-and inter-scorer repeatability. Furthermore, recommended scoring rules do not provide a comprehensive description of the respiratory patterns. This work describes a set of manual scoring tools that address these limitations. These tools include: (i) a set of definitions and scoring rules for 6 mutually exclusive, unique patterns that fully characterize infant respiratory inductive plethysmography (RIP) signals; (ii) RIPScore, a graphical, manual scoring software to apply these rules to infant data; (iii) a library of data segments representing each of the 6 patterns; (iv) a fully automated, interactive formal training protocol to standardize the analysis and establish intra-and inter-scorer repeatability; and (v) a quality control method to monitor scorer ongoing performance over time. To evaluate these tools, three scorers from varied backgrounds were recruited and trained to reach a performance level similar to that of an expert. These scorers used RIPScore to analyze data from infants at risk of POA in two separate, independent instances. Scorers performed with high accuracy and consistency, analyzed data efficiently, had very good intra-and inter-scorer repeatability, and exhibited only minor confusion between patterns. These results indicate that our tools represent an excellent method for the analysis of respiratory patterns in long data records. Although the tools were developed for the study of POA, their use extends to any study of respiratory patterns using RIP (e.g., sleep apnea, extubation readiness). Moreover, by establishing and monitoring scorer repeatability, our tools enable the analysis of large data sets by multiple scorers, which is essential for longitudinal and multicenter studies.	[Robles-Rubio, Carlos Alejandro; Kearney, Robert E.] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Bertolizio, Gianluca; Brown, Karen A.] McGill Univ, Ctr Hlth, Dept Anesthesia, Montreal, PQ, Canada	McGill University; McGill University	Robles-Rubio, CA (corresponding author), McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.	carlos.roblesrubio@mail.mcgill.ca	Brown, Karen/AAE-1816-2020; Bertolizio, Gianluca/AAM-7595-2020	Kearney, Robert/0000-0002-5107-6190	Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN 1051-13]; Queen Elizabeth Hospital of Montreal Foundation Chair in Pediatric Anesthesia, McGill University Faculty of Medicine; Mexican National Council for Science and Technology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen Elizabeth Hospital of Montreal Foundation Chair in Pediatric Anesthesia, McGill University Faculty of Medicine; Mexican National Council for Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca, grant NSERC RGPIN 1051-13), and in part by the Queen Elizabeth Hospital of Montreal Foundation Chair in Pediatric Anesthesia, McGill University Faculty of Medicine (www.mcgill.ca/medicine/faculty-medicine). CARR was supported in part by a scholarship for graduate studies from the Mexican National Council for Science and Technology (www.conacyt.gob.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JL, 1991, PEDIATR PULM, V11, P37, DOI 10.1002/ppul.1950110107; ALLEN JL, 1990, AM REV RESPIR DIS, V141, P337, DOI 10.1164/ajrccm/141.2.337; American Academy of Sleep M, 2001, INT CLASS SLEEP DIS; Aoude A, 2006, BIOMEDICAL ENG; Aoude A A, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4631; Aoude AA, 2011, IEEE T BIO-MED ENG, V58, P1724, DOI 10.1109/TBME.2011.2112657; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P133; BROUILLETTE RT, 1987, J PEDIATR-US, V111, P377, DOI 10.1016/S0022-3476(87)80457-2; Brown K, 1998, EUR RESPIR J, V12, P935, DOI 10.1183/09031936.98.12040935; Brown KA, 2008, CAN J ANAESTH, V55, P739, DOI 10.1007/BF03016346; Caples SM, 2007, J CLIN SLEEP MED, V3, P147; Cardillo G., 2007, FLEISSES KAPPA COMPU; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collop NA, 2002, SLEEP MED, V3, P43, DOI 10.1016/S1389-9457(01)00115-0; COTE CJ, 1995, ANESTHESIOLOGY, V82, P809, DOI 10.1097/00000542-199504000-00002; COTE CJ, 1990, ANESTHESIOLOGY, V72, P559, DOI 10.1097/00000542-199003000-00027; DallAva-Santucci J, 1991, PULMONARY FUNCTION M, P121; Davidson AJ, 2015, ANESTHESIOLOGY; De Groote A, 2001, J APPL PHYSIOL, V90, P1025, DOI 10.1152/jappl.2001.90.3.1025; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Flemons WW, 2004, AM J RESP CRIT CARE, V169, P668, DOI 10.1164/rccm.200308-1124PP; Grigg-Damberger M, 2007, J CLIN SLEEP MED, V3, P201; Hrynaszkiewicz I, 2010, BMJ, V340; Iber C, 2007, J CLIN SLEEP MED, V3, P107; KONNO K, 1967, J APPL PHYSIOL, V22, P407, DOI 10.1152/jappl.1967.22.3.407; KRANE EJ, 1995, ANESTH ANALG, V80, P7, DOI 10.1097/00000539-199501000-00003; KURTH CD, 1987, ANESTHESIOLOGY, V66, P483, DOI 10.1097/00000542-198704000-00006; KURTH CD, 1991, ANESTHESIOLOGY, V75, P22, DOI 10.1097/00000542-199107000-00005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Penzel T, 2007, J CLIN SLEEP MED, V3, P109; Precup D, 2012, IEEE ENG MED BIO, P5630, DOI 10.1109/EMBC.2012.6347271; Ramanathan R, 2001, JAMA-J AM MED ASSOC, V285, P2199, DOI 10.1001/jama.285.17.2199; Redline S, 2007, J CLIN SLEEP MED, V3, P169; Robles-Rubio CA, 2015, PEDIATR PULM, V50, P479, DOI 10.1002/ppul.23151; Robles-Rubio CA, 2011, 12 INT S SLEEP BREAT; Robles-Rubio CA, 2013, 13 INT S SLEEP BREAT; Robles-Rubio CA, 2013, IEEE ENG MED BIO, P2295, DOI 10.1109/EMBC.2013.6609996; Robles-Rubio CA, 2012, IEEE ENG MED BIO, P6333, DOI 10.1109/EMBC.2012.6347442; Robles-Rubio CA, 2011, IEEE ENG MED BIO, P3201, DOI 10.1109/IEMBS.2011.6090871; Semienchuk SM, 2005, P ANN INT IEEE EMBS, P4420, DOI 10.1109/IEMBS.2005.1615446; Silber MH, 2007, J CLIN SLEEP MED, V3, P22, DOI DOI 10.5664/jcsm.26814; STEWARD DJ, 1982, ANESTHESIOLOGY, V56, P304, DOI 10.1097/00000542-198204000-00013; Walters AS, 2007, J CLIN SLEEP MED, V3, P155; WELBORN LG, 1990, ANESTHESIOLOGY, V72, P838, DOI 10.1097/00000542-199005000-00012; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	47	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134182	10.1371/journal.pone.0134182	http://dx.doi.org/10.1371/journal.pone.0134182			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218351	Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900092
J	Supper, E; Tahir, S; Imai, T; Inoue, J; Minato, N				Supper, Emmanuelle; Tahir, Suhail; Imai, Takahiko; Inoue, Joe; Minato, Nagahiro			Modification of Gene Expression, Proliferation, and Function of OP9 Stroma Cells by Bcr-Abl-Expressing Leukemia Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; ACUTE MYELOID-LEUKEMIA; NICHE; PROGENITORS; CANCER; INFLAMMATION; PATHWAYS; RAP1	Expression of the Bcr-Abl fusion gene in hematopoietic progenitor cells (HPCs) results in the development of chronic myelogenous leukemia (CML), for which hematopoietic microenvironment plays an important role. We investigated the specific effects of an HPC line transduced with Bcr-Abl, KOBA, on BM-derived OP9 stroma cells. DNA microarray analysis revealed that OP9 cells co-cultured with KOBA cells (OP9/L) show diverse changes in the gene expression. OP9/L cells showed significant down-regulation of Cdkn genes and up-regulation of Icam1, leading to the increased proliferation capacity of OP9 cells and enhanced transmigration of leukemia cells through them. The effects were attributed to direct Notch activation of OP9 cells by KOBA cells. OP9/L cells also showed a markedly altered cytokine gene expression pattern, including a robust increase in a variety of proinflammatory genes and a decrease in hematopoietic cytokines such as Cxcl12, Scf, and Angpt1. Consequently, OP9/L cells promoted the proliferation of KOBA cells more efficiently than parental OP9 cells, whereas the activity supporting normal myelopoiesis was attenuated. In mice bearing KOBA leukemia, the characteristic genetic changes observed in OP9/L cells were reflected differentially in the endothelial cells (ECs) and mesenchymal stroma cells (MCs) of the BM. The ECs were markedly increased with Notch-target gene activation and decreased Cdkn expression, whereas the MCs showed a marked increase in proinflammatory gene expression and a profound decrease in hematopoietic genes. Human CML cell lines also induced essentially similar genetic changes in OP9 cells. Our results suggest that CML cells remodel the hematopoietic microenvironment by changing the gene expression patterns differentially in ECs and MCs of BM.	[Supper, Emmanuelle; Tahir, Suhail; Imai, Takahiko; Inoue, Joe; Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan	Kyoto University	Minato, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan.	minato@imm.med.kyoto-u.ac.jp			Ministry of Education, Culture, Science, Sports and Technology, Special Coordination Funds for Promoting Science and Technology of the Japanese Government [24111008]	Ministry of Education, Culture, Science, Sports and Technology, Special Coordination Funds for Promoting Science and Technology of the Japanese Government	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (24111008) (http://www.jsps.go.jp/j-grantsinaid/34_new_scientific/) and a grant-in-aid from the Ministry of Education, Culture, Science, Sports and Technology, Special Coordination Funds for Promoting Science and Technology of the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony BA, 2014, TRENDS IMMUNOL, V35, P32, DOI 10.1016/j.it.2013.10.002; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Bruns I, 2009, LEUKEMIA, V23, P892, DOI 10.1038/leu.2008.392; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Copland I, 2008, EXPER HEMATOL, V36, P93103; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Gao JA, 2010, J GENET GENOMICS, V37, P475, DOI 10.1016/S1673-8527(09)60067-9; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Guichet PO, 2015, STEM CELLS, V33, P21, DOI 10.1002/stem.1767; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ishida D, 2003, CANCER CELL, V4, P55, DOI 10.1016/S1535-6108(03)00163-6; Jamieson Catriona H, 2008, Hematology Am Soc Hematol Educ Program, P436, DOI 10.1182/asheducation-2008.1.436; Jin A, 2006, ONCOGENE, V25, P4332, DOI 10.1038/sj.onc.1209459; JUNEJA HS, 1993, EXP HEMATOL, V21, P444; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kometani K, 2006, CANCER RES, V66, P9967, DOI 10.1158/0008-5472.CAN-06-1346; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lo Celso C, 2011, J CELL SCI, V124, P3529, DOI 10.1242/jcs.074112; Mahadevan KK, 2014, J CLIN DIAGN RES, V8, pFC4, DOI 10.7860/JCDR/2014/7994.4405; Minato N, 2013, EXP CELL RES, V319, P2323, DOI 10.1016/j.yexcr.2013.04.009; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Priestley GV, 2006, BLOOD, V107, P2959, DOI 10.1182/blood-2005-07-2670; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145; Zalc A, 2014, DEVELOPMENT, V141, P2780, DOI 10.1242/dev.110155; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018	39	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134026	10.1371/journal.pone.0134026	http://dx.doi.org/10.1371/journal.pone.0134026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218064	gold, Green Submitted, Green Published			2022-12-26	WOS:000358595900067
J	Yamamoto, N; Hamaguchi, S; Akeda, Y; Santanirand, P; Kerdsin, A; Seki, M; Ishii, Y; Paveenkittiporn, W; Bonomo, RA; Oishi, K; Malathum, K; Tomono, K				Yamamoto, Norihisa; Hamaguchi, Shigeto; Akeda, Yukihiro; Santanirand, Pitak; Kerdsin, Anusak; Seki, Masafumi; Ishii, Yoshikazu; Paveenkittiporn, Wantana; Bonomo, Robert A.; Oishi, Kazunori; Malathum, Kumthorn; Tomono, Kazunori			Clinical Specimen-Direct LAMP: A Useful Tool for the Surveillance of bla(OXA-23)-Positive Carbapenem-Resistant Acinetobacter baumannii	PLOS ONE			English	Article							BETA-LACTAMASES; IDENTIFICATION; EMERGENCE; INFECTION	Healthcare-associated infections are a leading cause of morbidity and mortality worldwide. Treatment is increasingly complicated by the escalating incidence of antimicrobial resistance. Among drug-resistant pathogens, carbapenem-resistant Acinetobacter baumannii (CRAb) is of increasing concern because of the limited applicable therapies and its expanding global distribution in developed countries and newly industrialized countries. Therefore, a rapid detection method that can be used even in resource-poor countries is urgently required to control this global public health threat. Conventional techniques, such as bacterial culture and polymerase chain reaction (PCR), are insufficient to combat this threat because they are time-consuming and laborious. In this study, we developed a loop-mediated isothermal amplification (LAMP) method for detecting bla(OXA-23)-positive CRAb, the most prevalent form of CRAb in Asia, especially in Thailand, and confirmed its efficacy as a surveillance tool in a clinical setting. Clinical samples of sputum and rectal swabs were collected from patients in a hospital in Bangkok and used for LAMP assays. After boiling and centrifugation, the supernatants were used directly in the assay. In parallel, a culture method was used for comparison purposes to evaluate the specificity and sensitivity of LAMP. As a first step, a total of 120 sputum samples were collected. The sensitivity of LAMP was 88.6% (39/44), and its specificity was 92.1% (70/76) using the culture method as the "gold standard". When surveillance samples including sputum and rectal swabs were analyzed with the LAMP assay, its sensitivity was 100.0%. This method enables the direct analysis of clinical specimens and provides results within 40 minutes of sample collection, making it a useful tool for surveillance even in resource-poor countries.	[Yamamoto, Norihisa; Hamaguchi, Shigeto; Akeda, Yukihiro; Seki, Masafumi; Tomono, Kazunori] Osaka Univ, Grad Sch Med, Div Infect Control & Prevent, Osaka, Japan; [Yamamoto, Norihisa; Hamaguchi, Shigeto; Akeda, Yukihiro; Oishi, Kazunori] Osaka Univ, Microbial Dis Res Inst, Lab Clin Res Infect Dis, Osaka, Japan; [Santanirand, Pitak; Malathum, Kumthorn] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Kerdsin, Anusak; Paveenkittiporn, Wantana] Natl Inst Hlth, Dept Med Sci, Minist Publ Hlth, Gen Bacteriol Sect, Bangkok, Thailand; [Ishii, Yoshikazu] Toho Univ, Fac Med, Sch Med, Dept Microbiol & Infect Dis, Tokyo, Japan; [Bonomo, Robert A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Osaka University; Osaka University; Mahidol University; Ministry of Public Health - Thailand; Toho University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; National Institute of Infectious Diseases (NIID)	Tomono, K (corresponding author), Osaka Univ, Grad Sch Med, Div Infect Control & Prevent, Osaka, Japan.	tomono@hp-infect.med.osaka-u.ac.jp	はまぐち しげと, 濱口 重人/GQZ-8515-2022; Kerdsin, Anusak/H-5360-2019; Malathum, Kumthorn/AAD-7189-2020	Kerdsin, Anusak/0000-0003-1055-3656; Hamaguchi, Shigeto/0000-0003-2560-9982; Santanirand, Pitak/0000-0002-3914-1367	JSPS KAKENHI [24406022]; Grants-in-Aid for Scientific Research [25461524] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24406022 for KT [http://www.jsps.go.jp/english/e-grants/index.html]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Afzal-Shah M, 2001, ANTIMICROB AGENTS CH, V45, P583, DOI 10.1128/AAC.45.2.583-588.2001; Alvarez-Buylla A, 2012, INFECT GENET EVOL, V12, P345, DOI 10.1016/j.meegid.2012.01.002; Baraibar J, 1997, CHEST, V112, P1050, DOI 10.1378/chest.112.4.1050; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; De Luca F, 2011, P NATL ACAD SCI USA, V108, P18424, DOI 10.1073/pnas.1110530108; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Erbay A, 2009, INT J ANTIMICROB AG, V34, P575, DOI 10.1016/j.ijantimicag.2009.07.006; Evans BA, 2008, CLIN MICROBIOL INFEC, V14, P268, DOI 10.1111/j.1469-0691.2007.01919.x; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Hall AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073845; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kouyama Y, 2012, J INFECT CHEMOTHER, V18, P522, DOI 10.1007/s10156-012-0374-y; Latibeaudiere R, 2014, CLIN INFECT IN PRESS; Lemos EV, 2014, CLIN MICROBIOL INFEC, V20, P416, DOI 10.1111/1469-0691.12363; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Marchaim D, 2007, INFECT CONT HOSP EP, V28, P945, DOI 10.1086/518970; Marti S, 2008, ANTIMICROB AGENTS CH, V52, P2955, DOI 10.1128/AAC.00072-08; Mitsuda T, 1999, J CLIN MICROBIOL, V37, P2548, DOI 10.1128/JCM.37.8.2548-2552.1999; Mongkolrattanothai K, 2004, ANTIMICROB AGENTS CH, V48, P1823, DOI 10.1128/AAC.48.5.1823-1836.2004; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Niumsup PR, 2009, JPN J INFECT DIS, V62, P152; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Okada K, 2010, DIAGN MICR INFEC DIS, V66, P135, DOI 10.1016/j.diagmicrobio.2009.09.004; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2006, INFECT CONT HOSP EP, V27, P759, DOI 10.1086/507012; Romero-Steiner S, 2001, CLIN DIAGN LAB IMMUN, V8, P1115, DOI 10.1128/CDLI.8.6.1115-1119.2001; Soo PC, 2013, J MICROBIOL METH, V92, P197, DOI 10.1016/j.mimet.2012.11.020; Thapa B, 2009, THESIS U MAHIDOL BAN; Thapa B, 2010, SE ASIAN J TROP MED, V41, P625; Vergara A, 2014, ANTIMICROB AGENTS CH, V58, P7538, DOI 10.1128/AAC.03870-14; Wang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066406	36	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133204	10.1371/journal.pone.0133204	http://dx.doi.org/10.1371/journal.pone.0133204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218925	Green Submitted, Green Published, gold			2022-12-26	WOS:000358595900021
J	Yoshina, S; Mitani, S				Yoshina, Sawako; Mitani, Shohei			Loss of C. elegans GON-1, an ADAMTS9 Homolog, Decreases Secretion Resulting in Altered Lifespan and Dauer Formation	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; INSULIN-RESISTANCE; GENE-EXPRESSION; MUTANTS; DAF-16; LOCI; LONGEVITY; MEMBER; GLYCOSYLATION; MUTATIONS	ADAMTS9 is a metalloprotease that cleaves components of the extracellular matrix and is also implicated in transport from the endoplasmic reticulum (ER) to the Golgi. It has been reported that an ADAMTS9 gene variant is associated with type 2 diabetes. The underlying pathology of type 2 diabetes is insulin resistance and beta-cell dysfunction. However, the molecular mechanisms underlying ADAMTS9 function in beta cells and peripheral tissues are unknown. We show that loss of C. elegans GON-1, an ADAMTS9 homolog, alters lifespan and dauer formation. GON-1 loss impairs secretion of proteins such as insulin orthologs and TGF-beta, and additionally impacts insulin/IGF-1 signaling in peripheral tissues. The function of the GON domain, but not the protease domain, is essential for normal lifespan and dauer formation in these scenarios. We conclude that the GON domain is critical for ADAMTS9/GON-1 function across species, which should help the understanding of type 2 diabetes in humans.	[Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Mitani, Shohei] Tokyo Womens Med Univ, Inst Integrated Med Sci TIIMS, Tokyo 1628666, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Mitani, S (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan.	mitani.shohei@twmu.ac.jp			Program for Promoting the Establishment of Strategic Research Centers; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology (Japan); Uehara Memorial Foundation; Japan Society for the promotion of Science	Program for Promoting the Establishment of Strategic Research Centers; Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported partly by the Program for Promoting the Establishment of Strategic Research Centers; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology (Japan) (to S.M.), a grant from the Uehara Memorial Foundation (to S.M.), and grant-in-Aid for young scientists from Japan Society for the promotion of Science (to S.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailion M, 2003, GENETICS, V165, P127; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; BRENNER S, 1974, GENETICS, V77, P71; Clark ME, 2000, GENOMICS, V67, P343, DOI 10.1006/geno.2000.6246; Ewald CY, 2015, NATURE, V519, P97, DOI 10.1038/nature14021; Fares H, 2001, GENETICS, V159, P133; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Grarup N, 2008, DIABETES, V57, P2534, DOI 10.2337/db08-0436; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Inoue T, 2000, GENETICS, V156, P1035; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kitaoka S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068475; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; MALONE EA, 1994, GENETICS, V136, P879; Matsunaga Y, 2012, BIOCHEM BIOPH RES CO, V423, P478, DOI 10.1016/j.bbrc.2012.05.145; Maures TJ, 2014, SCIENCE, V343, P541, DOI 10.1126/science.1244160; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Trombetta M, 2013, ACTA DIABETOL, V50, P401, DOI 10.1007/s00592-012-0443-9; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Yoshina S, 2012, MOL BIOL CELL, V23, P1728, DOI 10.1091/mbc.E11-10-0857; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	41	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133966	10.1371/journal.pone.0133966	http://dx.doi.org/10.1371/journal.pone.0133966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218657	Green Published, gold, Green Submitted			2022-12-26	WOS:000358595900062
J	Bennett, JA; Singh, KP; Unnisa, Z; Welle, SL; Gasiewicz, TA				Bennett, John A.; Singh, Kameshwar P.; Unnisa, Zeenath; Welle, Stephen L.; Gasiewicz, Thomas A.			Deficiency in Aryl Hydrocarbon Receptor (AHR) Expression throughout Aging Alters Gene Expression Profiles in Murine Long-Term Hematopoietic Stem Cells	PLOS ONE			English	Article							GROWTH; QUIESCENCE; PATHWAY; PROLIFERATION; MAINTENANCE; ACTIVATION; LYMPHOMA; EXPOSURE; AGONIST; CANCER	Dysregulation of hematopoietic stem cell (HSC) signaling can contribute to the development of diseases of the blood system. Lack of aryl hydrocarbon receptor (AhR) has been associated with alterations in gene expression related to HSC function and the subsequent development of a myeloproliferative disorder in aging female mice. We sorted the most primitive population of HSCs with the highest stem cell potential (Long-term, or LT-HSCs) from 18-month-old AhR-null-allele (AhR-KO) and WT mice and analyzed gene expression using microarray to determine alterations in gene expression and cell signaling networks in HSCs that could potentially contribute to the aging phenotype of AhR-KO mice. Comparisons with previous array data from 8-week old mice indicated that aging alone is sufficient to alter gene expression. In addition, a significant number of gene expression differences were observed in aged LT-HSCs that are dependent on both aging and lack of AhR. Pathway analysis of these genes revealed networks related to hematopoietic stem cell activity or function. qPCR was used to confirm the differential expression of a subset of these genes, focusing on genes that may represent novel AhR targets due to the presence of a putative AhR binding site in their upstream regulatory region. We verified differential expression of PDGF-D, Smo, Wdfy1, Zbtb37 and Zfp382. Pathway analysis of this subset of genes revealed overlap between cellular functions of the novel AhR targets and AhR itself. Lentiviral-mediated knockdown of AhR in lineage-negative hematopoietic cells was sufficient to induce changes in all five of the candidate AhR targets identified. Taken together, these data suggest a role for AhR in HSC functional regulation, and identify novel HSC AhR target genes that may contribute to the phenotypes observed in AhR-KO mice.	[Bennett, John A.; Singh, Kameshwar P.; Unnisa, Zeenath; Gasiewicz, Thomas A.] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; [Welle, Stephen L.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Gasiewicz, TA (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA.	tom_gasiewicz@urmc.rochester.edu			National Institutes of Health [T32ES07026, ES004862, ES023068]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004862, R01ES023068, T32ES007026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health grants T32ES07026, ES004862 and ES023068. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 2012, VITAM HORM, V88, P25, DOI 10.1016/B978-0-12-394622-5.00002-X; Ahrenhoerster LS, 2015, TOXICOL APPL PHARM, V283, P99, DOI 10.1016/j.taap.2014.12.017; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bell DR, 2004, ONCOGENE, V23, P7290, DOI 10.1038/sj.onc.1207949; Bertazzi PA, 2001, AM J EPIDEMIOL, V153, P1031, DOI 10.1093/aje/153.11.1031; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bock KW, 2014, BIOCHEM PHARMACOL, V90, P1, DOI 10.1016/j.bcp.2014.04.009; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Boyd AL, 2013, EXP HEMATOL, V41, P858, DOI 10.1016/j.exphem.2013.05.287; Casado FL, 2011, MOL PHARMACOL, V80, P673, DOI 10.1124/mol.111.071381; Chaklader M, 2012, ARH HIG RADA TOKSIKO, V63, P271, DOI 10.2478/10004-1254-63-2012-2255; Charbord P, 2014, CELL STEM CELL, V15, P376, DOI 10.1016/j.stem.2014.06.005; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cooper CL, 2012, BLOOD, V119, P5438, DOI 10.1182/blood-2011-12-397976; Dorshkind K, 2009, CURR OPIN IMMUNOL, V21, P404, DOI 10.1016/j.coi.2009.07.001; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Faust D, 2013, TOXICOL LETT, V223, P73, DOI 10.1016/j.toxlet.2013.08.022; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Garrett RW, 2006, MOL PHARMACOL, V69, P2076, DOI 10.1124/mol.105.021006; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Hayes MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106955; Hecht E, 2014, TOXICOL APPL PHARM, V280, P511, DOI 10.1016/j.taap.2014.08.023; Hilpert M, 2014, STEM CELL REP, V3, P1085, DOI 10.1016/j.stemcr.2014.10.005; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Kim YR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-124; Kramer S, 2012, ENVIRON HEALTH PERSP, V120, P1067, DOI 10.1289/ehp.1104652; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Mar BG, 2011, LEUKEMIA, V25, P1665, DOI 10.1038/leu.2011.143; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Migasa AA, 2014, LEUKEMIA RES, V38, P1102, DOI 10.1016/j.leukres.2014.06.002; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; POLAND A, 1976, J BIOL CHEM, V251, P4936; Rimmele P, 2014, STEM CELL R IN PRESS, V3, P1, DOI DOI 10.1016/J.STEMCR.2014.04.015; Santos PM, 2014, J IMMUNOL, V192, P160, DOI 10.4049/jimmunol.1302502; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Singh KP, 2014, STEM CELLS DEV, V23, P95, DOI 10.1089/scd.2013.0346; Singh KP, 2011, STEM CELLS DEV, V20, P769, DOI 10.1089/scd.2010.0333; Singh KP, 2009, CARCINOGENESIS, V30, P11, DOI 10.1093/carcin/bgn224; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Tonks A, 2007, LEUKEMIA, V21, P2495, DOI 10.1038/sj.leu.2404961; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Vogel CFA, 2007, AM J PATHOL, V171, P1538, DOI 10.2353/ajpath.2007.070406; Ward A, 2015, LEUKEMIA LYMPHOMA, V56, P2123, DOI 10.3109/10428194.2014.971407	49	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133791	10.1371/journal.pone.0133791	http://dx.doi.org/10.1371/journal.pone.0133791			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208102	gold, Green Submitted, Green Published			2022-12-26	WOS:000358622000144
J	Collet, AC; Fize, D; VanRullen, R				Collet, Anne-Claire; Fize, Denis; VanRullen, Rufin			Contextual Congruency Effect in Natural Scene Categorization: Different Strategies in Humans and Monkeys (Macaca mulatta)	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; OBJECT RECOGNITION; NONHUMAN-PRIMATES; VISUAL-SEARCH; CEBUS-APELLA; PIGEONS; STIMULI; REPRESENTATIONS; DISCRIMINATION; ORGANIZATION	Rapid visual categorization is a crucial ability for survival of many animal species, including monkeys and humans. In real conditions, objects (either animate or inanimate) are never isolated but embedded in a complex background made of multiple elements. It has been shown in humans and monkeys that the contextual background can either enhance or impair object categorization, depending on context/object congruency (for example, an animal in a natural vs. man-made environment). Moreover, a scene is not only a collection of objects; it also has global physical features (i.e phase and amplitude of Fourier spatial frequencies) which help define its gist. In our experiment, we aimed to explore and compare the contribution of the amplitude spectrum of scenes in the context-object congruency effect in monkeys and humans. We designed a rapid visual categorization task, Animal versus Non-Animal, using as contexts both real scenes photographs and noisy backgrounds built from the amplitude spectrum of real scenes but with randomized phase spectrum. We showed that even if the contextual congruency effect was comparable in both species when the context was a real scene, it differed when the foreground object was surrounded by a noisy background: in monkeys we found a similar congruency effect in both conditions, but in humans the congruency effect was absent (or even reversed) when the context was a noisy background.	[Collet, Anne-Claire; Fize, Denis; VanRullen, Rufin] Univ Toulouse, Ctr Rech Cerveau & Cognit, UPS, Toulouse, France; [Collet, Anne-Claire; Fize, Denis; VanRullen, Rufin] CNRS, CerCo, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Collet, AC (corresponding author), Univ Toulouse, Ctr Rech Cerveau & Cognit, UPS, Toulouse, France.	collet@cerco.ups-tlse.fr	Fize, Denis/F-4525-2011; VanRullen, Rufin/B-2150-2008	VanRullen, Rufin/0000-0002-3611-7716				ASTLEY SL, 1992, J EXP PSYCHOL ANIM B, V18, P193, DOI 10.1037/0097-7403.18.2.193; Aust U, 2001, ANIM LEARN BEHAV, V29, P107, DOI 10.3758/BF03192820; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; CERELLA J, 1980, PATTERN RECOGN, V12, P1, DOI 10.1016/0031-3203(80)90048-5; DAMATO MR, 1988, J EXP PSYCHOL ANIM B, V14, P43, DOI 10.1037/0097-7403.14.1.43; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; EDWARDS CA, 1987, LEARN MOTIV, V18, P235, DOI 10.1016/0023-9690(87)90013-0; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Fagot J, 2000, PICTURE PERCEPTION A; Fagot J, 2010, P NATL ACAD SCI USA, V107, P519, DOI 10.1073/pnas.0913577107; Fize D, 2011, P NATL ACAD SCI USA, V108, P7635, DOI 10.1073/pnas.1016213108; GAFFAN D, 1993, J COGNITIVE NEUROSCI, V5, P118, DOI 10.1162/jocn.1993.5.1.118; Gronau N, 2008, J COGNITIVE NEUROSCI, V20, P371, DOI 10.1162/jocn.2008.20.3.371; Guyader N, 2004, CR BIOL, V327, P313, DOI 10.1016/j.crvi.2004.02.006; HERRNSTEIN RJ, 1964, SCIENCE, V146, P549, DOI 10.1126/science.146.3643.549; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Joubert OR, 2008, J VISION, V8, DOI 10.1167/8.13.11; Joubert OR, 2009, J VISION, V9, DOI 10.1167/9.1.2; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; KirkpatrickSteger K, 1996, J EXP ANAL BEHAV, V65, P465, DOI 10.1901/jeab.1996.65-465; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; Loschky LC, 2007, J EXP PSYCHOL HUMAN, V33, P1431, DOI 10.1037/0096-1523.33.6.1431; Mace MJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005927; Miller MB, 1998, NEUROPSYCHOLOGIA, V36, P513, DOI 10.1016/S0028-3932(97)00148-6; Neider MB, 2006, VISION RES, V46, P2217, DOI 10.1016/j.visres.2006.01.006; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Parron C, 2008, BEHAV PROCESS, V78, P351, DOI 10.1016/j.beproc.2008.01.019; Pokorny JJ, 2009, P NATL ACAD SCI USA, V106, P21539, DOI 10.1073/pnas.0912174106; ROBERTS WA, 1988, J EXP PSYCHOL ANIM B, V14, P247, DOI 10.1037/0097-7403.14.3.247; Rousselet GA, 2005, VIS COGN, V12, P852, DOI 10.1080/13506280444000553; SANDS SF, 1982, J EXP PSYCHOL GEN, V111, P369, DOI 10.1037/0096-3445.111.4.369; SCHRIER AM, 1984, J EXP PSYCHOL ANIM B, V10, P564, DOI 10.1037/0097-7403.10.4.564; SCHRIER AM, 1987, J EXP PSYCHOL ANIM B, V13, P136; SIEGEL S., 1956, NONPARAMETRIC STAT B; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Truppa V, 2009, BEHAV PROCESS, V82, P140, DOI 10.1016/j.beproc.2009.05.004; WASSERMAN EA, 1993, PSYCHOL SCI, V4, P336, DOI 10.1111/j.1467-9280.1993.tb00575.x; Wasserman EA, 1996, J EXP PSYCHOL ANIM B, V22, P205, DOI 10.1037/0097-7403.22.2.205; Wolfe JM, 2002, VISION RES, V42, P2985, DOI 10.1016/S0042-6989(02)00388-7	42	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133721	10.1371/journal.pone.0133721	http://dx.doi.org/10.1371/journal.pone.0133721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207915	Green Published, gold			2022-12-26	WOS:000358622000122
J	Deng, XQ; Li, YY; Zhou, L; Liu, CY; Liu, M; Ding, NC; Shao, JY				Deng, Xingqi; Li, Yanyan; Zhou, Ling; Liu, Chunyan; Liu, Mei; Ding, Nianchang; Shao, Jinyan			Gender Differences in the Symptoms, Signs, Disease History, Lesion Position and Pathophysiology in Patients with Pulmonary Embolism	PLOS ONE			English	Article							EUROPEAN-SOCIETY; CARDIOLOGY ESC; TASK-FORCE; MANAGEMENT; DIAGNOSIS; THROMBOEMBOLISM; GUIDELINES; THROMBOSIS	Advances in research relating to pulmonary embolisms (PE) can assist physicians in selecting the best management strategies for PE patients. However, the symptoms, signs, disease history, lesion position and pathophysiology linked to different genders in patients with PE have rarely been evaluated. One hundred and forty-nine PE patients (73 males and 76 females) were sequentially recruited to this study over the last five years whilst attending our Emergency Department. Data relating to the symptoms, signs, disease history, biochemical testing, cardiac electrophysiology, imaging detection, treatment and outcome were collected and the gender differences were analyzed. We found that embolisms occurred significantly more frequently in the right lung (89.7%) than in the left lung (42.6%). The presence of dyspnea, the number of patients presenting with tumors, the number of patients with chronic pulmonary disease, those with emboli in the right pulmonary artery and emboli in the right lung, as well as the average systolic and diastolic blood pressure were: 78.1%, 15.1%, 31.5%, 32.9%, 94.5%, 129.9+20.0 and 75.0+11.2 in the male patients and 59.2%, 1.3%, 14.5%, 17.1%, 69.7%, 125.1+14.6 and 69.3+11.0 in the female patients. These indicators were found to be significantly higher in male patients. In contrast, the rate of V1-V4 T-wave inversion and level of D-dimer in the blood were significantly lower in males than in females. No significant difference was observed in the remaining observational indicators. Gender differences regarding the symptoms, signs, disease history, lesion position and pathophysiology exist in patients with PE and should be considered in clinical practice.	[Deng, Xingqi] Fudan Univ, Dept Emergency Med, Shanghai 200433, Peoples R China; Fudan Univ, Ctr Hosp Minhang Dist, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Deng, XQ (corresponding author), Fudan Univ, Dept Emergency Med, Shanghai 200433, Peoples R China.	dengchengsheng@sina.com			Program for Development of Key Disciplines of Shanghai [ZK2012A23]	Program for Development of Key Disciplines of Shanghai	This work was supported by the Program for Development of Key Disciplines of Shanghai (grant number: ZK2012A23). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Borrero S, 2007, J WOMENS HEALTH, V16, P1165, DOI 10.1089/jwh.2006.0236; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jenab Y, 2013, J ULTRAS MED, V32, P1997, DOI 10.7863/ultra.32.11.1997; Keller K, 2014, DEUT MED WOCHENSCHR, V139, P2329, DOI 10.1055/s-0034-1387367; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Lapner ST, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f757; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Manfreda J, 2004, CHEST, V125, P1657, DOI 10.1378/chest.125.5.1657; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Siddique RM, 1998, AM J PUBLIC HEALTH, V88, P1476, DOI 10.2105/AJPH.88.10.1476; Silverman EK, 2000, AM J RESP CRIT CARE, V162, P2152, DOI 10.1164/ajrccm.162.6.2003112; Stein PD, 2004, AM J CARDIOL, V93, P1197, DOI 10.1016/j.amjcard.2004.01.058; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Tang YY, 2011, CIRCULATION, V123, P2219, DOI 10.1161/CIRCULATIONAHA.110.976134; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Yu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113076	20	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133993	10.1371/journal.pone.0133993	http://dx.doi.org/10.1371/journal.pone.0133993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208352	Green Submitted, Green Published, gold			2022-12-26	WOS:000358622000187
J	Ho, YJ; Wang, YM; Lu, JW; Wu, TY; Lin, LI; Kuo, SC; Lin, CC				Ho, Yi-Jung; Wang, Yu-Ming; Lu, Jeng-wei; Wu, Tzong-Yuan; Lin, Liang-In; Kuo, Szu-Cheng; Lin, Chang-Chi			Suramin Inhibits Chikungunya Virus Entry and Transmission	PLOS ONE			English	Article							CELL-TO-CELL; E2 GLYCOPROTEIN; MEMBRANE-FUSION; DENGUE VIRUS; INFECTION; PROTEIN; BINDING; EXPRESSION; GLYCOSAMINOGLYCAN; IDENTIFICATION	The mosquito-borne Chikungunya virus (CHIKV) is a profound global threat due to its high rate of contagion and the lack of vaccine or effective treatment. Suramin is a symmetric polyanionic naphthylurea that is widely used in the clinical treatment of parasite infections. Numerous studies have reported the broad antiviral activities of suramin; however, inhibition effects against CHIKV have not yet been demonstrated. The aim of this study was thus to investigate the antiviral effect of suramin on CHIKV infection and to elucidate the molecular mechanism underlying inhibition using plaque reduction assay, RT-qPCR, western blot analysis, and plaque assay. Microneutralization assay was used to determine the EC50 of suramin in the CHIKV-S27 strain as well as in three other clinical strains (0611aTw, 0810bTw and 0706aTw). Time-of-addition was used to reveal the anti-CHIKV mechanism of suramin. We also evaluated anti-CHIKV activity with regard to viral entry, virus release, and cell-to-cell transmission. Cytopathic effect, viral RNA, viral protein, and the virus yield of CHIKV infection were shown to diminish in the presence of suramin in a dose-dependent manner. Suramin was also shown the inhibitory activities of the three clinical isolates. Suramin inhibited the early progression of CHIKV infection, due perhaps to interference with virus fusion and binding, which subsequently prevented viral entry. Results of a molecular docking simulation indicate that suramin may embed within the cavity of the E1/E2 heterodimer to interfere with their function. Suramin was also shown to reduce viral release and cell-to-cell transmission of CHIKV. In conclusion, Suramin shows considerable potential as a novel anti-CHIKV agent targeting viral entry, extracellular transmission, and cell-to-cell transmission.	[Ho, Yi-Jung; Wang, Yu-Ming; Kuo, Szu-Cheng; Lin, Chang-Chi] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Ho, Yi-Jung; Kuo, Szu-Cheng; Lin, Chang-Chi] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Chang-Chi] Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, Taipei, Taiwan; [Kuo, Szu-Cheng] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Kuo, Szu-Cheng] Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Taipei, Taiwan; [Lu, Jeng-wei; Lin, Liang-In] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Lu, Jeng-wei; Lin, Liang-In] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Lin, Liang-In] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Kuo, SC (corresponding author), Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan.	szucheng1234@gmail.com; chalin3@ndmctsgh.edu.tw	Lin, Liang-In/K-4600-2019	Lu, Jeng-Wei/0000-0003-2128-2046; LIN, LIANG-IN/0000-0002-3561-1093	Institute of Preventive Medicine, National Defense Medical Center [104-9-B19, 103-A8, 103-B14, 103-B22, 103-B23]	Institute of Preventive Medicine, National Defense Medical Center	This study was supported by grants (104-9-B19, 103-A8, 103-B14, 103-B22 and 103-B23) from the Institute of Preventive Medicine, National Defense Medical Center.	Aguilar JS, 1999, VIROLOGY, V258, P141, DOI 10.1006/viro.1999.9723; Al Olaby RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111333; Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113; Basu A, 2004, J VIROL, V78, P4478, DOI 10.1128/JVI.78.9.4478-4486.2004; Brindley MA, 2015, J VIROL, V89, P1230, DOI 10.1128/JVI.02754-14; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Chijioke CP, 1998, EUR J CLIN PHARMACOL, V54, P249, DOI 10.1007/s002280050454; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Croci R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091765; Cruz DJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002471; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Ellenbecker M, 2014, ANTIMICROB AGENTS CH; Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500; Gardner CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002719; Garoff H, 2004, VIRUS RES, V106, P103, DOI 10.1016/j.virusres.2004.08.008; Garson JA, 1999, J MED VIROL, V57, P238; HAHON N, 1970, APPL MICROBIOL, V19, P389, DOI 10.1128/AEM.19.2.389-391.1970; Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181; Higgs S, 2006, VECTOR-BORNE ZOONOT, V6, P115, DOI 10.1089/vbz.2006.6.115; Huang JH, 2009, EMERG INFECT DIS, V15, P1854, DOI 10.3201/eid1511.090398; Jiao LY, 2013, J VIROL, V87, P6829, DOI 10.1128/JVI.00672-13; Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12; KESSLER HA, 1986, AIDS RES HUM RETROV, V2, P63, DOI 10.1089/aid.1.1986.2.63; Khan K., 2014, PLOS CURR, V6, DOI [10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5, DOI 10.1371/CURRENTS.OUTBREAKS.2134A0A7BF37FD8D388181539FEA2DA5]; Kuo SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-44; Kuo SC, 2011, J VIROL METHODS, V175, P206, DOI 10.1016/j.jviromet.2011.05.015; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Lee CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002390; Madsen C, 2014, ANTIVIR RES, V112, P26, DOI 10.1016/j.antiviral.2014.10.002; Masrinoul P, 2014, VIROLOGY, V464, P111, DOI 10.1016/j.virol.2014.05.038; Mastrangelo E, 2014, CHEMMEDCHEM, V9, P933, DOI 10.1002/cmdc.201300563; MITSUYA H, 1984, SCIENCE, V226, P172, DOI 10.1126/science.6091268; Moghaddam E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05452; Monel B, 2012, J VIROL, V86, P3924, DOI 10.1128/JVI.06478-11; Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14; Noret M, 2012, J INFECT DIS, V206, P455, DOI 10.1093/infdis/jis368; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Rashad AA, 2014, J MED CHEM, V57, P1147, DOI 10.1021/jm400460d; Rashad AA, 2013, J MOL GRAPH MODEL, V44, P241, DOI 10.1016/j.jmgm.2013.07.001; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Shih SR, 2010, J ANTIMICROB CHEMOTH, V65, P63, DOI 10.1093/jac/dkp393; Silva LA, 2014, J VIROL, V88, P2385, DOI 10.1128/JVI.03116-13; Sjoberg M, 2003, J VIROL, V77, P3441, DOI 10.1128/JVI.77.6.3441-3450.2003; Soonsawad P, 2010, J VIROL, V84, P11145, DOI 10.1128/JVI.00036-10; Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Wang YX, 2014, ANTIVIR RES, V103, P1, DOI 10.1016/j.antiviral.2013.12.008; Xu Keshu, 2003, J Huazhong Univ Sci Technolog Med Sci, V23, P375; YAHI N, 1994, J BIOL CHEM, V269, P24349	53	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133511	10.1371/journal.pone.0133511	http://dx.doi.org/10.1371/journal.pone.0133511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208101	Green Submitted, gold, Green Published			2022-12-26	WOS:000358622000094
J	Huang, LL; Damle, SS; Booten, S; Singh, P; Sabripour, M; Hsu, J; Jo, MJ; Katz, M; Watt, A; Hart, CE; Freier, SM; Monia, BP; Guo, SL				Huang, Lulu; Damle, Sagar S.; Booten, Sheri; Singh, Priyam; Sabripour, Mahyar; Hsu, Jeff; Jo, Minji; Katz, Melanie; Watt, Andy; Hart, Christopher E.; Freier, Susan M.; Monia, Brett P.; Guo, Shuling			Partial Hepatectomy Induced Long Noncoding RNA Inhibits Hepatocyte Proliferation during Liver Regeneration	PLOS ONE			English	Article							EXPRESSION PROFILES; CANCER; MALAT1; MOUSE; MECHANISMS; PROTEINS; GENOME; CELLS; GENE; IDENTIFICATION	Liver regeneration after partial hepatectomy (PHx) is a complex and well-orchestrated biological process in which synchronized cell proliferation is induced in response to the loss of liver mass. To define long noncoding RNAs (lncRNAs) that participate in the regulation of liver regeneration, we performed microarray analysis and identified more than 400 lncRNAs exhibiting significantly altered expression. Of these, one lncRNA, LncPHx2 (Long noncoding RNA induced by PHx 2), was highly upregulated during liver regeneration. Depletion of LncPHx2 during liver regeneration using antisense oligonucleotides led to a transient increase in hepatocyte proliferation and more rapid liver regeneration. Gene expression analysis showed that LncPHx2 depletion resulted in upregulation of mRNAs encoding proteins known to promote cell proliferation, including MCM components, DNA polymerases, histone proteins, and transcription factors. LncPHx2 interacts with the mRNAs of MCM components, making it a candidate to regulate the expression of MCMs and other genes post-transcriptionally. Collectively, our data demonstrate that LncPHx2 is a key lncRNA that participates in a negative feedback loop modulating hepatocyte proliferation through RNA-RNA interactions.	[Huang, Lulu; Damle, Sagar S.; Booten, Sheri; Singh, Priyam; Sabripour, Mahyar; Hsu, Jeff; Jo, Minji; Katz, Melanie; Watt, Andy; Hart, Christopher E.; Freier, Susan M.; Monia, Brett P.; Guo, Shuling] Isis Pharmaceut Inc, Dept Antisense Drug Discovery, Carlsbad, CA 92010 USA	Isis Pharmaceuticals Inc	Guo, SL (corresponding author), Isis Pharmaceut Inc, Dept Antisense Drug Discovery, Carlsbad, CA 92010 USA.	sguo@isisph.com	Singh, Priyam/P-3985-2019; Singh, Priyam/AAA-8574-2019		Isis Pharmaceuticals	Isis Pharmaceuticals	The work was supported by Isis Pharmaceuticals in the form of salaries for authors LH, SSD, SB, PS, MS, JH, MJ, MK, ATW, CEH, SMF, BPM and SG, but the company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Hortelano S, 2007, FRONT BIOSCI-LANDMRK, V12, P13, DOI 10.2741/2045; Hu GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107016; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kambara H, 2014, NUCLEIC ACIDS RES, V42, P10668, DOI 10.1093/nar/gku713; Kitagawa M, 2013, CELL MOL LIFE SCI, V70, P4785, DOI 10.1007/s00018-013-1423-0; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kurinna S, 2011, INT J BIOCHEM CELL B, V43, P189, DOI 10.1016/j.biocel.2010.03.013; Lalith S., 2013, INCRNA PROTEIN INTER; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu XF, 2012, EMBO J, V31, P4415, DOI 10.1038/emboj.2012.292; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sanchez Y, 2013, NUCLEIC ACID THER, V23, P15, DOI 10.1089/nat.2012.0414; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zong Xingying H L, 2015, KNOCKDOWN NUCL RETAI	51	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132798	10.1371/journal.pone.0132798	http://dx.doi.org/10.1371/journal.pone.0132798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207833	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000041
J	Ng, CS; Wei, W; Bankson, JA; Ravoori, MK; Han, L; Brammer, DW; Klumpp, S; Waterton, JC; Jackson, EF				Ng, Chaan S.; Wei, Wei; Bankson, James A.; Ravoori, Murali K.; Han, Lin; Brammer, David W.; Klumpp, Sherry; Waterton, John C.; Jackson, Edward F.			Dependence of DCE-MRI biomarker values on analysis algorithm	PLOS ONE			English	Article							CONTRAST-ENHANCED-MRI; ARTERIAL INPUT FUNCTION; CLINICAL-TRIALS; DYNAMIC MRI; TUMORS; AGENT; INHIBITOR; CANCER; MODEL; AZD2171	Background Dynamic contrast-enhanced MRI (DCE-MRI) biomarkers have proven utility in tumors in evaluating microvascular perfusion and permeability, but it is unclear whether measurements made in different centers are comparable due to methodological differences. Purpose To evaluate how commonly utilized analytical methods for DCE-MRI biomarkers affect both the absolute parameter values and repeatability. Materials and Methods DCE-MRI was performed on three consecutive days in twelve rats bearing C6 xenografts. Endothelial transfer constant (K-trans), extracellular extravascular space volume fraction (v(e)), and contrast agent reflux rate constant (k(ep)) measures were computed using: 2-parameter ("Tofts" or "standard Kety") vs. 3-parameter ("General Kinetic" or "extended Kety") compartmental models (including blood plasma volume fraction (v(p)) with 3-parameter models); individual-vs. population-based vascular input functions (VIFs); and pixel-by-pixel vs. whole tumor-ROI. Variability was evaluated by within-subject coefficient of variation (wCV) and variance components analyses. Results DCE-MRI absolute parameter values and wCVs varied widely by analytical method. Absolute parameter values ranged, as follows, median K-trans, 0.09-0.18 min(-1); k(ep), 0.51-0.92 min(-1); v(e), 0.17-0.23; and v(p), 0.02-0.04. wCVs also varied widely by analytical method, as follows: mean K-trans, 32.9-61.9%; k(ep), 11.6- 41.9%; v(e), 16.1-54.9%; and v(p), 53.9-77.2%. K-trans and k(ep) values were lower with 3-than 2-parameter modeling (p<0.0001); k(ep) and v(p) were lower with pixel-than whole-ROI analyses (p<0.0006). wCVs were significantly smaller for v(e), and larger for k(ep), with individual-than population-based VIFs. Conclusions DCE-MRI parameter values and repeatability can vary widely by analytical methodology. Absolute values of DCE-MRI biomarkers are unlikely to be comparable between different studies unless analyses are carefully standardized.	[Ng, Chaan S.; Ravoori, Murali K.; Han, Lin] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA; [Wei, Wei] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Bankson, James A.] Univ Texas MD Anderson Canc Ctr, Dept Biostat Imaging Phys, Houston, TX 77030 USA; [Brammer, David W.; Klumpp, Sherry] Univ Texas MD Anderson Canc Ctr, Dept Biostat Vet Med & Surg, Houston, TX 77030 USA; [Waterton, John C.] AstraZeneca, Personalised Healthcare & Biomarkers, Alderley Pk, Cheshire, England; [Jackson, Edward F.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; AstraZeneca; University of Wisconsin System; University of Wisconsin Madison	Ng, CS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA.	cng@mdanderson.org	Jackson, Edward F/L-5159-2013; Bankson, James A./J-9798-2014; Waterton, John Charles/A-8565-2008	Bankson, James A./0000-0002-8574-154X; Waterton, John Charles/0000-0002-7734-2290; Jackson, Edward/0000-0002-5958-0076; Wei, Wei/0000-0002-0960-7269	MDACC - AstraZeneca Research Collaboration Alliance; Cancer Center Support Grant [P30-CA016672]; John S. Dunn Sr. Distinguished Chair in Diagnostic Imaging; AstraZeneca; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	MDACC - AstraZeneca Research Collaboration Alliance; Cancer Center Support Grant; John S. Dunn Sr. Distinguished Chair in Diagnostic Imaging; AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by MDACC - AstraZeneca Research Collaboration Alliance; Cancer Center Support Grant (P30-CA016672); John S. Dunn Sr. Distinguished Chair in Diagnostic Imaging. AstraZeneca provided support in the form of salary for author JCW.	Ashton EA, 2007, P 15 ANN M ISMRM BER; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bland M, 2003, INTRO MED STAT, P268; Bradley DP, 2008, NMR BIOMED, V21, P42, DOI 10.1002/nbm.1161; Bradley DP, 2009, MAGN RESON IMAGING, V27, P377, DOI 10.1016/j.mri.2008.07.021; Checkley D, 2003, BRIT J CANCER, V89, P1889, DOI 10.1038/sj.bjc.6601386; Evelhoch JL, 2004, CLIN CANCER RES, V10, P3650, DOI 10.1158/1078-0432.CCR-03-0417; Galbraith SM, 2002, NMR BIOMED, V15, P132, DOI 10.1002/nbm.731; KETY SS, 1951, PHARMACOL REV, V3, P1; Laking GR, 2006, CRIT REV ONCOL HEMAT, V58, P95, DOI 10.1016/j.critrevonc.2005.10.006; Lankester KJ, 2007, J MAGN RESON IMAGING, V25, P796, DOI 10.1002/jmri.20881; Lankester KJ, 2005, BRIT J CANCER, V93, P979, DOI 10.1038/sj.bjc.6602814; LARSSON HBW, 1990, MAGNET RESON MED, V16, P117, DOI 10.1002/mrm.1910160111; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Liu G, 2005, J CLIN ONCOL, V23, P5464, DOI 10.1200/JCO.2005.04.143; Loveless ME, 2012, MAGN RESON MED, V67, P226, DOI 10.1002/mrm.22988; McGrath DM, 2009, MAGN RESON MED, V61, P1173, DOI 10.1002/mrm.21959; Morgan B, 2003, J CLIN ONCOL, V21, P3955, DOI 10.1200/JCO.2003.08.092; Ng CS, 2012, TECHNOL CANCER RES T, V11, P279, DOI 10.7785/tcrt.2012.500296; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Pickup S, 2003, ACAD RADIOL, V10, P963, DOI 10.1016/s1076-6332(03)00291-5; Ragan DK, 2011, NMR BIOMED, V24, P373, DOI 10.1002/nbm.1601; Ragan DK, 2011, J MAGN RESON IMAGING, V33, P1256, DOI 10.1002/jmri.22523; Rijpkema M, 2001, J MAGN RESON IMAGING, V14, P457, DOI 10.1002/jmri.1207; Roberts C, 2006, J MAGN RESON IMAGING, V23, P554, DOI 10.1002/jmri.20529; Stevenson JP, 2003, J CLIN ONCOL, V21, P4428, DOI 10.1200/JCO.2003.12.986; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Waterton JC, 2013, NEW DEV NMR, P333, DOI 10.1039/9781849737661-00333; WEINMANN HJ, 1984, PHYSIOL CHEM PHYS ME, V16, P167; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988	33	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130168	10.1371/journal.pone.0130168	http://dx.doi.org/10.1371/journal.pone.0130168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208254	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000006
J	Takahashi, Y; Nagata, N; Shimbo, T; Nishijima, T; Watanabe, K; Aoki, T; Sekine, K; Okubo, H; Watanabe, K; Sakurai, T; Yokoi, C; Kobayakawa, M; Yazaki, H; Teruya, K; Gatanaga, H; Kikuchi, Y; Mine, S; Igari, T; Takahashi, Y; Mimori, A; Oka, S; Akiyama, J; Uemura, N				Takahashi, Yuta; Nagata, Naoyoshi; Shimbo, Takuro; Nishijima, Takeshi; Watanabe, Koji; Aoki, Tomonori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Kobayakawa, Masao; Yazaki, Hirohisa; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Mine, Sohtaro; Igari, Toru; Takahashi, Yuko; Mimori, Akio; Oka, Shinichi; Akiyama, Junichi; Uemura, Naomi			Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients	PLOS ONE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; HELICOBACTER-PYLORI INFECTION; ANTIRETROVIRAL THERAPY; DEFENSE-MECHANISMS; DIAGNOSIS; ALBICANS; DISEASE; ERA	Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Methods Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immuno-suppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. Results CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/mu L (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). Conclusions This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.	[Takahashi, Yuta; Nagata, Naoyoshi; Aoki, Tomonori; Sekine, Katsunori; Okubo, Hidetaka; Sakurai, Toshiyuki; Yokoi, Chizu; Kobayakawa, Masao; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Fukushima, Japan; [Nishijima, Takeshi; Watanabe, Koji; Watanabe, Kazuhiro; Yazaki, Hirohisa; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, Div AIDS Clin Ctr ACC, Tokyo, Japan; [Mine, Sohtaro; Igari, Toru] Natl Ctr Global Hlth & Med, Dept Pathol, Tokyo, Japan; [Takahashi, Yuko; Mimori, Akio] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Tokyo, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp	宗太郎, 峰/ABB-7890-2020; 小早川, 雅男/HII-5007-2022	宗太郎, 峰/0000-0002-4912-4077; Takahashi, Yuta/0000-0002-6996-3505	Ministry of Health, Labour and Welfare of Japan [H26-003]; National Center for Global Health and Medicine [26A-201]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported in part by a Grant-in Aid for AIDS research from the Ministry of Health, Labour and Welfare of Japan (H26-003 http://www.mhlw.go.jp/english/), and a Grants-in-Aid for Research from the National Center for Global Health and Medicine (26A-201 http://www.ncgm.go.jp/eng/). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTINORI A, 1995, ENDOSCOPY, V27, P371, DOI 10.1055/s-2007-1005716; Asare K, 2007, PHARMACOTHERAPY, V27, P1512, DOI 10.1592/phco.27.11.1512; Asayama N, 2014, DIS ESOPHAGUS, V27, P214, DOI 10.1111/dote.12102; BAEHR PH, 1994, GASTROENTEROLOGY, V106, P509, DOI 10.1016/0016-5085(94)90613-0; BALISH E, 1990, INFECT IMMUN, V58, P107, DOI 10.1128/IAI.58.1.107-113.1990; BONACINI M, 1991, ARCH INTERN MED, V151, P1567, DOI 10.1001/archinte.151.8.1567; Choi JH, 2013, YONSEI MED J, V54, P160, DOI 10.3349/ymj.2013.54.1.160; Fock KM, 2010, J GASTROEN HEPATOL, V25, P479, DOI 10.1111/j.1440-1746.2009.06188.x; GIANNELLA RA, 1973, ANN INTERN MED, V78, P271, DOI 10.7326/0003-4819-78-2-271; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Hamada Y, 2014, JAIDS-J ACQ IMM DEF, V65, P312, DOI 10.1097/QAI.0000000000000016; HEIDENREICH S, 1994, CELL IMMUNOL, V157, P320, DOI 10.1006/cimm.1994.1230; KODSI BE, 1976, GASTROENTEROLOGY, V71, P715; Lionakis MS, 2003, LANCET, V362, P1828, DOI 10.1016/S0140-6736(03)14904-5; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Martinez AC, 2000, EUR J CLIN MICROBIOL, V19, P96; Mocroft A, 2005, AM J GASTROENTEROL, V100, P1446, DOI 10.1111/j.1572-0241.2005.41949.x; Monkemuller KE, 2000, AM J GASTROENTEROL, V95, P457, DOI 10.1111/j.1572-0241.2000.01768.x; Nagata N, 2014, J GASTROENTEROL HEPA; Naito Y, 1988, Gastroenterol Jpn, V23, P363; Negata N, 2012, EMERG INFECT DIS, V18, P717, DOI 10.3201/eid1805.111275; Nishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058217; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; PORGES AJ, 1992, J RHEUMATOL, V19, P1191; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Underwood JA, 2003, DIS ESOPHAGUS, V16, P66, DOI 10.1046/j.1442-2050.2003.00305.x; Weerasuriya N, 2006, DIS ESOPHAGUS, V19, P189, DOI 10.1111/j.1442-2050.2006.00563.x; WHEELER RR, 1987, REV INFECT DIS, V9, P88; Willemot Patrick, 2004, Expert Rev Anti Infect Ther, V2, P521, DOI 10.1586/14787210.2.4.521; Yakoob A, 2003, WORLD J GASTROENTERO, V9, P2328; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5; YEH CK, 1988, J ACQ IMMUN DEF SYND, V1, P361	34	31	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133589	10.1371/journal.pone.0133589	http://dx.doi.org/10.1371/journal.pone.0133589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208220	Green Published, gold, Green Submitted			2022-12-26	WOS:000358622000105
J	Xie, FY; Feng, YL; Wang, HH; Ma, YF; Yang, Y; Wang, YC; Shen, W; Pan, QJ; Yin, S; Sun, YJ; Ma, JY				Xie, Feng-Yun; Feng, Yu-Long; Wang, Hong-Hui; Ma, Yun-Feng; Yang, Yang; Wang, Yin-Chao; Shen, Wei; Pan, Qing-Jie; Yin, Shen; Sun, Yu-Jiang; Ma, Jun-Yu			De Novo Assembly of the Donkey White Blood Cell Transcriptome and a Comparative Analysis of Phenotype-Associated Genes between Donkeys and Horses	PLOS ONE			English	Article							PACT; INTEGRATION	Prior to the mechanization of agriculture and labor-intensive tasks, humans used donkeys (Equus africanus asinus) for farm work and packing. However, as mechanization increased, donkeys have been increasingly raised for meat, milk, and fur in China. To maintain the development of the donkey industry, breeding programs should focus on traits related to these new uses. Compared to conventional marker-assisted breeding plans, genome- and transcriptome-based selection methods are more efficient and effective. To analyze the coding genes of the donkey genome, we assembled the transcriptome of donkey white blood cells de novo. Using transcriptomic deep-sequencing data, we identified 264,714 distinct donkey unigenes and predicted 38,949 protein fragments. We annotated the donkey unigenes by BLAST searches against the non-redundant (NR) protein database. We also compared the donkey protein sequences with those of the horse (E. caballus) and wild horse (E. przewalskii), and linked the donkey protein fragments with mammalian phenotypes. As the outer ear size of donkeys and horses are obviously different, we compared the outer ear size-associated proteins in donkeys and horses. We identified three ear size-associated proteins, HIC1, PRKRA, and KMT2A, with sequence differences among the donkey, horse, and wild horse loci. Since the donkey genome sequence has not been released, the de novo assembled donkey transcriptome is helpful for preliminary investigations of donkey cultivars and for genetic improvement.	[Xie, Feng-Yun; Wang, Hong-Hui; Shen, Wei; Yin, Shen; Ma, Jun-Yu] Qingdao Agr Univ, Inst Reprod Sci, Qingdao 266109, Shandong, Peoples R China; [Xie, Feng-Yun; Wang, Hong-Hui; Shen, Wei; Pan, Qing-Jie; Yin, Shen; Ma, Jun-Yu] Qingdao Agr Univ, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao 266109, Shandong, Peoples R China; [Xie, Feng-Yun; Feng, Yu-Long; Wang, Hong-Hui; Ma, Yun-Feng; Yang, Yang; Shen, Wei; Pan, Qing-Jie; Yin, Shen; Sun, Yu-Jiang; Ma, Jun-Yu] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao 266109, Shandong, Peoples R China; [Feng, Yu-Long; Ma, Yun-Feng; Wang, Yin-Chao] Shandong Dongeejiao Co Ltd, Black Donkey Res Inst, Liaocheng 252000, Shandong, Peoples R China	Qingdao Agricultural University; Qingdao Agricultural University; Qingdao Agricultural University	Ma, JY (corresponding author), Qingdao Agr Univ, Inst Reprod Sci, Qingdao 266109, Shandong, Peoples R China.	jun_yu_ma@aliyun.com			Shandong Province	Shandong Province	Funding was provided to Yu-Jiang Sun from Breeding Projects in Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000909; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Denis Fielding PS, 1997, PEOPLE AND DEVELOPME; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hancock JM, 2007, MAMM GENOME, V18, P157, DOI 10.1007/s00335-007-9004-x; Hoehenwarter W, 2008, PROTEOMICS, V8, P4214, DOI 10.1002/pmic.200701047; Huang JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04958; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; Pearson WR, 2013, CURR PROTOC BIOINFOR, V42, DOI 10.1002/0471250953.bi0301s42; Peters GA, 2006, J BIOL CHEM, V281, P35129, DOI 10.1074/jbc.M607714200; Resources CNCoAG, 2011, RESOURCES CNCOAG ANI; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stock KF, 2013, REPROD DOMEST ANIM, V48, P2, DOI 10.1111/rda.12201; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Waltraud Kugler H-PG, 2008, CONSERVATION REPORT	21	1	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133258	10.1371/journal.pone.0133258	http://dx.doi.org/10.1371/journal.pone.0133258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208029	Green Published, Green Submitted, gold			2022-12-26	WOS:000358622000073
J	Franchini, AG; Ihssen, J; Egli, T				Franchini, Alessandro G.; Ihssen, Julian; Egli, Thomas			Effect of Global Regulators RpoS and Cyclic-AMP/CRP on the Catabolome and Transcriptome of Escherichia coli K12 during Carbon- and Energy-Limited Growth	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; STATIONARY-PHASE; GENE-EXPRESSION; RNA-POLYMERASE; SALMONELLA-ENTERICA; CONTINUOUS-CULTURE; SIGMA(S)-DEPENDENT GENES; PROTEIN TRANSLOCATION; SIGMA(S) ACTIVITY; MICROBIAL-GROWTH	For heterotrophic microbes, limited availability of carbon and energy sources is one of the major nutritional factors restricting the rate of growth in most ecosystems. Physiological adaptation to this hunger state requires metabolic versatility which usually involves expression of a wide range of different catabolic pathways and of high-affinity carbon transporters; together, this allows for simultaneous utilization of mixtures of carbonaceous compounds at low concentrations. In Escherichia coli the stationary phase sigma factor RpoS and the signal molecule cAMP are the major players in the regulation of transcription under such conditions; however, their interaction is still not fully understood. Therefore, during growth of E. coli in carbon-limited chemostat culture at different dilution rates, the transcriptomes, expression of periplasmic proteins and catabolomes of strains lacking one of these global regulators, either rpoS or adenylate cyclase (cya), were compared to those of the wild-type strain. The inability to synthesize cAMP exerted a strong negative influence on the expression of alternative carbon source uptake and degradation systems. In contrast, absence of RpoS increased the transcription of genes belonging to high-affinity uptake systems and central metabolism, presumably due to reduced competition of sigma(D) with sigma(S). Phenotypical analysis confirmed this observation: The ability to respire alternative carbon substrates and to express periplasmic high-affinity binding proteins was eliminated in cya and crp mutants, while these properties were not affected in the rpoS mutant. As expected, transcription of numerous stress defence genes was negatively affected by the rpoS knock-out mutation. Interestingly, several genes of the RpoS stress response regulon were also down-regulated in the cAMP-negative strain indicating a coordinated global regulation. The results demonstrate that cAMP is crucial for catabolic flexibility during slow, carbon-limited growth, whereas RpoS is primarily involved in the regulation of stress response systems necessary for the survival of this bacterium under hunger conditions.	[Franchini, Alessandro G.; Ihssen, Julian; Egli, Thomas] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Franchini, Alessandro G.; Ihssen, Julian; Egli, Thomas] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Franchini, AG (corresponding author), Univ Zurich, Univ Zurich Hosp, Surg Intens Care Med, Zurich, Switzerland.	alessandro.franchini@usz.ch			Swiss National Science Foundation (SNF) [31-63466.00]; Eawag, Swiss Federal Institute of Aquatic Science and Technology	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Eawag, Swiss Federal Institute of Aquatic Science and Technology	The authors gratefully acknowledge the financial support for this research, which was provided for AGF by the Swiss National Science Foundation (SNF grant 31-63466.00) and for JI by Eawag, Swiss Federal Institute of Aquatic Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; [Anonymous], 1975, PRINCIPLES MICROBIAL; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Berney M, 2006, APPL ENVIRON MICROB, V72, P2586, DOI 10.1128/AEM.72.4.2586-2593.2006; Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; BISHOP RE, 1995, J BIOL CHEM, V270, P23097, DOI 10.1074/jbc.270.39.23097; Bougdour A, 2007, P NATL ACAD SCI USA, V104, P12896, DOI 10.1073/pnas.0705561104; Campanacci V, 2004, FEBS LETT, V562, P183, DOI 10.1016/S0014-5793(04)00199-1; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Chubukov V, 2014, APPL ENVIRON MICROB, V80, P2901, DOI 10.1128/AEM.00061-14; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; Cunningham L, 1997, MICROBIOL-UK, V143, P3795, DOI 10.1099/00221287-143-12-3795; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Egli T, 1995, ADV MICROB ECOL, V14, P305; Egli T, 2009, DESK ENCY MICROBIOLO, P788; Egli T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00287; Egli T, 2010, WATER RES, V44, P4826, DOI 10.1016/j.watres.2010.07.023; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; Ferenci T, 1996, FEMS MICROBIOL REV, V18, P301, DOI 10.1016/0168-6445(96)00019-8; Ferenci T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-62; Fong JCN, 2008, J BACTERIOL, V190, P6646, DOI 10.1128/JB.00466-08; Franchini AG, 2006, MICROBIOL-SGM, V152, P2111, DOI 10.1099/mic.0.28939-0; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Gross CA, 1996, ESCHERICHIA COLI SAL, P1382; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; HARDER W, 1977, J APPL BACTERIOL, V43, P1, DOI 10.1111/j.1365-2672.1977.tb00717.x; HARDER W, 1982, PHILOS T ROY SOC B, V297, P459, DOI 10.1098/rstb.1982.0055; Hengge-Aronis R, 2002, CURR OPIN MICROBIOL, V5, P591, DOI 10.1016/S1369-5274(02)00372-7; Hengge-Aronis R., 1996, ESCHERICHIA COLI SAL, P1497; Herbert D., 1961, S SOC GEN MICROBIOL, V11, P391; Hung SP, 2002, J BIOL CHEM, V277, P40309, DOI 10.1074/jbc.M204044200; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; Ihssen J, 2005, ENVIRON MICROBIOL, V7, P1568, DOI 10.1111/j.1462-2920.2005.00846.x; Ihssen J, 2004, MICROBIOL-SGM, V150, P1637, DOI 10.1099/mic.0.26849-0; Ikegami A, 2005, BIOSCI BIOTECH BIOCH, V69, P1595, DOI 10.1271/bbb.69.1595; Ingraham JL, 2009, GROWTH BACTERIAL CEL; Izutsu K, 2001, J BACTERIOL, V183, P2765, DOI 10.1128/JB.183.9.2765-2773.2001; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jeong KC, 2006, BBA-GENE STRUCT EXPR, V1759, P51, DOI 10.1016/j.bbaexp.2006.02.001; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; Khankal Reza, 2009, J Biol Eng, V3, P13, DOI 10.1186/1754-1611-3-13; Klumpp S, 2014, CURR OPIN BIOTECH, V28, P96, DOI 10.1016/j.copbio.2014.01.001; Koch A L, 1971, Adv Microb Physiol, V6, P147, DOI 10.1016/S0065-2911(08)60069-7; KOMINE Y, 1990, J MOL BIOL, V212, P579, DOI 10.1016/0022-2836(90)90224-A; Kovarova K, 1996, J BACTERIOL, V178, P4530, DOI 10.1128/jb.178.15.4530-4539.1996; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995; LANGE R, 1991, J BACTERIOL, V173, P4474, DOI 10.1128/JB.173.14.4474-4481.1991; Lee SK, 2005, J BACTERIOL, V187, P2793, DOI 10.1128/JB.187.8.2793-2800.2005; Maciag A, 2011, NUCLEIC ACIDS RES, V39, P5338, DOI 10.1093/nar/gkr129; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Martinez-Antonio A, 2008, J MOL BIOL, V381, P238, DOI 10.1016/j.jmb.2008.05.054; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; MATIN A, 1982, J BACTERIOL, V149, P801, DOI 10.1128/JB.149.3.801-807.1982; Matin A., 1979, STRATEGIES MICROBIAL; MORITA RY, 1988, CAN J MICROBIOL, V34, P436, DOI 10.1139/m88-076; Morita RY, 1993, STARVATION BACTERIA, P1, DOI [10.1007/978-1-4899-2439-1_1, DOI 10.1007/978-1-4899-2439-1_1]; MUNSTER U, 1993, ANTON LEEUW INT J G, V63, P243, DOI 10.1007/BF00871222; Nahku R, 2010, J BIOTECHNOL, V145, P60, DOI 10.1016/j.jbiotec.2009.10.007; Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, V1, P1310; NISHIYAMA K, 1993, EMBO J, V12, P3409, DOI 10.1002/j.1460-2075.1993.tb06015.x; Notley L, 1996, J BACTERIOL, V178, P1465, DOI 10.1128/jb.178.5.1465-1468.1996; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P33, DOI 10.1046/j.1462-2920.1999.00002.x; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P45, DOI 10.1046/j.1462-2920.1999.00003.x; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; NotleyMcRobb L, 1997, MICROBIOL-SGM, V143, P1909, DOI 10.1099/00221287-143-6-1909; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Nystrom T, 1998, FEMS MICROBIOL REV, V21, P283, DOI 10.1111/j.1574-6976.1998.tb00354.x; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Phan K, 2013, ISME J, V7, P2034, DOI 10.1038/ismej.2013.82; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; SCHULTZ JE, 1988, J BACTERIOL, V170, P3903, DOI 10.1128/jb.170.9.3903-3909.1988; Tan K, 2001, GENOME RES, V11, P566, DOI 10.1101/gr.149301; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Teich A, 1999, BIOTECHNOL PROGR, V15, P123, DOI 10.1021/bp980102h; Traxler MF, 2011, MOL MICROBIOL, V79, P830, DOI 10.1111/j.1365-2958.2010.07498.x; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; Vieira HLA, 2004, APPL ENVIRON MICROB, V70, P5682, DOI 10.1128/AEM.70.9.5682-5684.2004; Visick JE, 1997, J BACTERIOL, V179, P4158, DOI 10.1128/jb.179.13.4158-4163.1997; Vital M, 2012, WATER RES, V46, P6279, DOI 10.1016/j.watres.2012.08.043; Wang L, 2005, J BACTERIOL, V187, P2066, DOI 10.1128/JB.187.6.2066-2076.2005; WANNER U, 1990, FEMS MICROBIOL LETT, V75, P19, DOI 10.1111/j.1574-6968.1990.tb04084.x; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wei BD, 2000, J BACTERIOL, V182, P1632, DOI 10.1128/JB.182.6.1632-1640.2000; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Wick LM, 2002, MICROBIOL-SGM, V148, P2889, DOI 10.1099/00221287-148-9-2889; Wick LM, 2001, ENVIRON MICROBIOL, V3, P588, DOI 10.1046/j.1462-2920.2001.00231.x; Yang HH, 1996, J BACTERIOL, V178, P1012, DOI 10.1128/jb.178.4.1012-1017.1996	103	45	46	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2015	10	7							e0133793	10.1371/journal.pone.0133793	http://dx.doi.org/10.1371/journal.pone.0133793			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NJ	26204448	Green Published, gold			2022-12-26	WOS:000358621000039
J	Gullon, S; Marin, S; Mellado, RP				Gullon, Sonia; Marin, Silvia; Mellado, Rafael P.			Overproduction of a Model Sec- and Tat-Dependent Secretory Protein Elicits Different Cellular Responses in Streptomyces lividans	PLOS ONE			English	Article							SIGNAL PEPTIDASE; BACILLUS-SUBTILIS; COELICOLOR A3(2); GENE; OVEREXPRESSION; CONSTRUCTION; SPORULATION; DEFICIENCY; ALPHA; SIPY	Streptomyces lividans is considered an efficient host for the secretory production of homologous and heterologous proteins. To identify possible bottlenecks in the protein production process, a comparative transcriptomic approach was adopted to study cellular responses during the overproduction of a Sec-dependent model protein (alpha-amylase) and a Tat-dependent model protein (agarase) in Streptomyces lividans. The overproduction of the model secretory proteins via the Sec or the Tat route in S. lividans does elicit a different major cell response in the bacterium. The stringent response is a bacterial response to nutrients' depletion, which naturally occurs at late times of the bacterial cell growth. While the induction of the stringent response at the exponential phase of growth may limit overall productivity in the case of the Tat route, the induction of that response does not take place in the case of the Sec route, which comparatively is an advantage in secretory protein production processes. Hence, this study identifies a potential major drawback in the secretory protein production process depending on the secretory route, and provides clues to improving S. lividans as a protein production host.	[Gullon, Sonia; Marin, Silvia; Mellado, Rafael P.] Ctr Nacl Biotecnol CNB CSIC, Dept Biotecnol Microbiana, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Mellado, RP (corresponding author), Ctr Nacl Biotecnol CNB CSIC, Dept Biotecnol Microbiana, C Darwin 3, Madrid 28049, Spain.	rpmellado@cnb.csic.es	Gullón, Sonia/P-7460-2018; Mellado, Rafael P/D-2680-2009		Spanish Ministry of the Environment and Rural and Marine Affairs [EGO22008]	Spanish Ministry of the Environment and Rural and Marine Affairs(Spanish Government)	This work was funded by Spanish Ministry of the Environment and Rural and Marine Affairs grant no. EGO22008 to RPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne J, 2014, BBA-MOL CELL RES, V1843, P1750, DOI 10.1016/j.bbamcr.2013.12.023; Anne J, 2012, J BIOTECHNOL, V158, P159, DOI 10.1016/j.jbiotec.2011.06.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; D'Huys PJ, 2011, J BIOTECHNOL, V152, P132, DOI 10.1016/j.jbiotec.2010.08.011; Diaz M, 2008, APPL MICROBIOL BIOT, V79, P1001, DOI 10.1007/s00253-008-1495-1; Escutia MR, 2006, PROTEOMICS, V6, P4137, DOI 10.1002/pmic.200500927; GIBERT M, 1995, CRIT REV BIOTECHNOL, V15, P13, DOI 10.3109/07388559509150530; Gullon S, 2013, APPL MICROBIOL BIOT, V97, P10069, DOI 10.1007/s00253-013-5219-9; Gullon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048987; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hyyrylainen HL, 2005, APPL MICROBIOL BIOT, V67, P389, DOI 10.1007/s00253-005-1898-1; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lule I, 2012, APPL MICROBIOL BIOT, V96, P367, DOI 10.1007/s00253-012-4182-1; Lulko AT, 2007, APPL ENVIRON MICROB, V73, P5354, DOI 10.1128/AEM.00472-07; MartinezCosta OH, 1996, J BIOL CHEM, V271, P10627, DOI 10.1074/jbc.271.18.10627; Mellado RP, 2011, WORLD J MICROB BIOT, V27, P2231, DOI 10.1007/s11274-011-0709-3; Palacin A, 2002, J BACTERIOL, V184, P4875, DOI 10.1128/JB.184.17.4875-4880.2002; Palomino C, 2008, INT MICROBIOL, V11, P25, DOI 10.2436/20.1501.01.41; PARRO V, 1994, GENE, V145, P49, DOI 10.1016/0378-1119(94)90321-2; PARRO V, 1993, FEMS MICROBIOL LETT, V106, P347; Posta K, 2004, J BASIC MICROB, V44, P383, DOI 10.1002/jobm.200410422; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Rozas D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031760; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sianidis G, 2006, J BIOTECHNOL, V121, P498, DOI 10.1016/j.jbiotec.2005.08.002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; THOMPSON CJ, 1982, GENE, V20, P51, DOI 10.1016/0378-1119(82)90086-5; TIMMONS TM, 1990, METHOD ENZYMOL, V182, P679; Vrancken K, 2007, APPL MICROBIOL BIOT, V73, P1150, DOI 10.1007/s00253-006-0571-7; Vrancken K, 2009, FUTURE MICROBIOL, V4, P181, DOI 10.2217/17460913.4.2.181; WARD JM, 1986, MOL GEN GENET, V203, P468, DOI 10.1007/BF00422072; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103	36	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0133645	10.1371/journal.pone.0133645	http://dx.doi.org/10.1371/journal.pone.0133645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200356	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100074
J	Penzo-Mendez, AI; Chen, YJ; Li, JY; Witze, ES; Stanger, BZ				Penzo-Mendez, Alfredo I.; Chen, Yi-Ju; Li, Jinyang; Witze, Eric S.; Stanger, Ben Z.			Spontaneous Cell Competition in Immortalized Mammalian Cell Lines	PLOS ONE			English	Article							DROSOPHILA MYC; FETAL LIVER; GROWTH; DIFFERENTIATION; NEIGHBORS; ELIMINATE; WINGLESS; MUTANTS; FITNESS; YORKIE	Cell competition is a form of cell-cell interaction by which cells compare relative levels of fitness, resulting in the active elimination of less-fit cells, "losers," by more-fit cells, "winners." Here, we show that in three routinely-used mammalian cell lines - U2OS, 3T3, and MDCK cells - sub-clones arise stochastically that exhibit context-dependent competitive behavior. Specifically, cell death is elicited when winner and loser sub-clones are cultured together but not alone. Cell competition and elimination in these cell lines is caspase-dependent and requires cell-cell contact but does not require de novo RNA synthesis. Moreover, we show that the phenomenon involves differences in cellular metabolism. Hence, our study demonstrates that cell competition is a common feature of immortalized mammalian cells in vitro and implicates cellular metabolism as a mechanism by which cells sense relative levels of "fitness."	[Penzo-Mendez, Alfredo I.; Chen, Yi-Ju; Li, Jinyang; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Penzo-Mendez, Alfredo I.; Chen, Yi-Ju; Li, Jinyang; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Witze, Eric S.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Penzo-Mendez, Alfredo I.; Chen, Yi-Ju; Li, Jinyang; Witze, Eric S.; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Stanger, BZ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.	bstanger@exchange.upenn.edu		Li, Jinyang/0000-0001-8125-6603	Pew Charitable Trusts; Abramson Family Cancer Research Institute	Pew Charitable Trusts; Abramson Family Cancer Research Institute	This work was supported by the Pew Charitable Trusts and the Abramson Family Cancer Research Institute.	Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Dabeva MD, 2000, AM J PATHOL, V156, P2017, DOI 10.1016/S0002-9440(10)65074-2; de Beco S, 2012, DEV DYNAM, V241, P831, DOI 10.1002/dvdy.23783; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; de la Cova C, 2014, CELL METAB, V19, P470, DOI 10.1016/j.cmet.2014.01.012; Diaz B, 2005, EXP CELL RES, V306, P317, DOI 10.1016/j.yexcr.2005.03.017; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Johnston LA, 2014, COLD SPRING HARBOR P, V4; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Lolo FN, 2012, CELL REP, V2, P526, DOI 10.1016/j.celrep.2012.08.012; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Petrova E, 2012, DIS MODEL MECH, V5, P553, DOI 10.1242/dmm.008623; Rhiner C, 2010, DEV CELL, V18, P985, DOI 10.1016/j.devcel.2010.05.010; Rodrigues AB, 2012, DEVELOPMENT, V139, P4051, DOI 10.1242/dev.076760; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Senoo-Matsuda N, 2007, P NATL ACAD SCI USA, V104, P18543, DOI 10.1073/pnas.0709021104; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Vincent JP, 2011, DEV CELL, V21, P366, DOI 10.1016/j.devcel.2011.06.021; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Ziosi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001140	34	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2015	10	7							e0132437	10.1371/journal.pone.0132437	http://dx.doi.org/10.1371/journal.pone.0132437			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7EO	26200654	Green Published, gold, Green Submitted			2022-12-26	WOS:000358597100036
